FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Taanman, JW
   Rahman, S
   Pagnamenta, AT
   Morris, AAM
   Bitner-Glindzicz, M
   Wolf, NI
   Leonard, JV
   Clayton, PT
   Schapira, AHV
AF Taanman, Jan-Willem
   Rahman, Shamima
   Pagnamenta, Alistair T.
   Morris, Andrew A. M.
   Bitner-Glindzicz, Maria
   Wolf, Nicole I.
   Leonard, James V.
   Clayton, Peter T.
   Schapira, Anthony H. V.
TI Analysis of Mutant DNA Polymerase γ in Patients With Mitochondrial DNA
   Depletion
SO HUMAN MUTATION
LA English
DT Article
DE POLG; mitochondrial DNA; mtDNA; DNA polymerase gamma; Leigh syndrome;
   mitochondrial DNA depletion syndrome; Alpers-Huttenlocher syndrome
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SACCHAROMYCES-CEREVISIAE;
   ACCESSORY SUBUNIT; HUMAN-CELLS; MUTATIONS; DEFECTS; REPLICATION; MTDNA;
   POLG; IDENTIFICATION
AB We studied six unrelated children with depletion of mitochondrial DNA (mtDNA). They presented with Leigh syndrome, infantile hepatocerebral mtDNA depletion syndrome, or Alpers-Huttenlocher syndrome. Several genes have been implicated in mtDNA depletion. Screening of candidate genes indicated that all six patients were compound heterozygous for missense mutations in the gene for the catalytic subunit of DNA polymerase I (POLG). Three of the identified mutations, c.3328C>T (p.H1110Y), c.3401A>G (p.H1134R) and c.3406G>A (p.E1136K), have not been reported earlier. To investigate the functional consequences of the mutations, we carried out a series of biochemical assays in cultured fibroblasts. These studies revealed that fibroblast cultures from the patients with infantile hepatocerebral mtDNA depletion syndrome progressively lost their mtDNA during culturing, whereas fibroblast cultures from patients presenting with Leigh syndrome or Alpers-Huttenlocher syndrome had reduced but stable levels of mtDNA. DNA polymerase gamma activity was below the normal range in all patient cultures, except for one; however, this culture showed low levels of the heterodimeric enzyme and poor DNA polymerase gamma processivity. Parental fibroblast cultures had normal catalytic efficiency of DNA polymerase gamma, consistent with the observation that all carriers are asymptomatic. Thus, we report the first patient with Leigh syndrome caused by POLG mutations. The cell culture experiments established the pathogenicity of the identified POLQ mutations and helped to define the molecular mechanisms responsible for mtDNA depletion in the patients tissues. The assays may facilitate the identification of those patients in whom screening for POLG mutations would be most appropriate.
C1 [Taanman, Jan-Willem; Schapira, Anthony H. V.] UCL, Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England.
   [Rahman, Shamima; Pagnamenta, Alistair T.; Bitner-Glindzicz, Maria; Leonard, James V.] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London NW3 2PF, England.
   [Morris, Andrew A. M.] Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester M27 1HA, Lancs, England.
   [Wolf, Nicole I.] Univ Childrens Hosp Heidelberg, Dept Pediat Neurol, Heidelberg, Germany.
   [Clayton, Peter T.] UCL, Inst Child Hlth, Biochem Res Grp, London NW3 2PF, England.
   [Clayton, Peter T.] UCL, Inst Child Hlth, Endocrinol Res Grp, London NW3 2PF, England.
C3 University of London; University College London; University of London;
   University College London; Royal Manchester Children's Hospital;
   Ruprecht Karls University Heidelberg; University of London; University
   College London; University of London; University College London
RP Taanman, JW (corresponding author), UCL, Inst Neurol, Dept Clin Neurosci, Rowland Hill St, London NW3 2PF, England.
EM j.taanman@medsch.ucl.ac.uk
RI Maier, Andrea/Q-5548-2019; Clayton, Peter/C-1523-2008; Rahman,
   Shamima/C-5232-2008; Bitner-Glindzicz, Maria/A-4231-2009; Wolf, Nicole
   Ingeborg/H-3943-2014; Schapira, Anthony/A-1245-2010; Taanman,
   Jan-Willem/A-5379-2011
OI Wolf, Nicole Ingeborg/0000-0003-1721-0728; Clayton,
   Peter/0000-0001-7592-4302; Schapira, Anthony/0000-0002-3018-3966;
   Taanman, Jan-Willem/0000-0002-5476-9785
FU Children Living with Inherited Metabolic Diseases; Child Health Research
   Appeal Trust; Medical Research Council; National Health Service
   Executive; The Wellcome Trust [048410]; MRC [G0601943, G0200335] Funding
   Source: UKRI
FX Contract grant sponsor: Children Living with Inherited Metabolic
   Diseases; Child Health Research Appeal Trust; Medical Research Council,
   and the National Health Service Executive; Contract grant sponsor: The
   Wellcome Trust; Grant number: 048410.
CR Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0
   BODNAR AG, 1995, BIOCHEM J, V305, P817, DOI 10.1042/bj3050817
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Kapsa RMI, 1998, NUCLEIC ACIDS RES, V26, P4365, DOI 10.1093/nar/26.19.4365
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, CLIN CHEM, V45, P1725
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Rickwood D., 1987, Mitochondria: a pratical approach, P1
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   TASHIRO F, 1978, J BIOCHEM, V84, P385, DOI 10.1093/oxfordjournals.jbchem.a132139
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843
NR 34
TC 41
Z9 43
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1059-7794
J9 HUM MUTAT
JI Hum. Mutat.
PD FEB
PY 2009
VL 30
IS 2
BP 248
EP 254
DI 10.1002/humu.20852
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 405WF
UT WOS:000263254200015
PM 18828154
OA gold
DA 2024-11-01
ER

PT J
AU Souza, PVS
   Bortholin, T
   Teixeira, CAC
   Seneor, DD
   Marin, VDGB
   Dias, RB
   Farias, IB
   Badia, BML
   Silva, LHL
   Pinto, WBVR
   Oliveira, ASB
   DiMauro, S
AF Souza, P. V. S.
   Bortholin, Thiago
   Castro Teixeira, Carlos Alberto
   Seneor, Daniel Delgado
   Barrios Marin, Vitor Dias Gomes
   Dias, Renan Braido
   Farias, Igor Braga
   Badia, B. M. L.
   Libardi Silva, Luiz Henrique
   Pinto, W. B. V. R.
   Bulle Oliveira, Acary Souza
   DiMauro, Salvatore
TI Leigh syndrome caused by mitochondrial DNA-maintenance defects revealed
   by whole exome sequencing
SO MITOCHONDRION
LA English
DT Article
DE Leigh syndrome; Mitochondrial disorders; Mitochondrial DNA maintenance;
   Whole exome sequencing
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CHINESE PATIENTS; MUTATIONS;
   DISEASE; DEPLETION; DELETIONS; DOMINANT
AB Leigh syndrome represents a complex inherited neurometabolic and neurodegenerative disorder associated with different clinical, genetic and neuroimaging findings in the context of bilateral symmetrical lesions involving the brainstem and basal ganglia. Heterogeneous neurological manifestations such as spasticity, cerebellar ataxia, dystonia, choreoathetosis and parkinsonism are associated with multisystemic and ophthalmological abnormalities due to > 75 different monogenic causes. Here, we describe the clinical and genetic features of a Brazilian cohort of patients with Leigh Syndrome in which muscle biopsy analysis showed mitochondrial DNA defects and determine the utility of whole exome sequencing for a final genetic diagnostic in this cohort.
C1 [Souza, P. V. S.; Bortholin, Thiago; Castro Teixeira, Carlos Alberto; Seneor, Daniel Delgado; Barrios Marin, Vitor Dias Gomes; Dias, Renan Braido; Farias, Igor Braga; Badia, B. M. L.; Libardi Silva, Luiz Henrique; Pinto, W. B. V. R.; Bulle Oliveira, Acary Souza] Fed Univ Scio Paulo UNIFESP, Div Neuromuscular Dis, Dept Neurol, Dept Neurosurg, Rua Estado Israel 899, BR-04022002 Sao Paulo, SP, Brazil.
   [DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
C3 Universidade Federal de Sao Paulo (UNIFESP); Columbia University
RP Souza, PVS (corresponding author), Fed Univ Scio Paulo UNIFESP, Div Neuromuscular Dis, Dept Neurol, Dept Neurosurg, Rua Estado Israel 899, BR-04022002 Sao Paulo, SP, Brazil.
EM paulo.sgobbi@unifesp.br
RI de Mattos Lombardi Badia, Bruno/AAO-4354-2020; Silva,
   Luiz/AAH-4131-2019; Pinto, Wladimir/J-6555-2014; Teixeira,
   Carlos/N-9892-2018; Sgobbi, Paulo/N-2958-2014
OI Delgado Seneor, Daniel/0000-0002-2173-6127; Sgobbi,
   Paulo/0000-0002-7416-7108; de Mattos Lombardi Badia,
   Bruno/0000-0001-7360-0494
CR Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bugiardini E, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000168
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Del Bo R, 2008, NEUROLOGY, V71, P1959, DOI 10.1212/01.wnl.0000327095.32005.a4
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Gerards M, 2016, MOL GENET METAB, V117, P300, DOI 10.1016/j.ymgme.2015.12.004
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   Leigh PN, 2015, J NEUROL NEUROSUR PS, V86, P363, DOI 10.1136/jnnp-2012-304601
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   McKelvie P, 2012, J CLIN NEUROSCI, V19, P195, DOI 10.1016/j.jocn.2011.09.009
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Paul R, 1996, TRENDS GENET, V12, P131
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   Sadat R, 2016, MOL GENET METAB, V118, P28, DOI 10.1016/j.ymgme.2016.03.004
   Santel A, 2001, J CELL SCI, V114, P867
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   de Souza PVS, 2017, CEREBELLUM, V16, P525, DOI 10.1007/s12311-016-0803-z
   Sofou K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-52
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
   Zhang Y, 2007, J INHERIT METAB DIS, V30, P265, DOI 10.1007/s10545-006-0481-y
NR 41
TC 3
Z9 3
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2019
VL 49
BP 25
EP 34
DI 10.1016/j.mito.2019.06.008
PG 10
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA JX2AW
UT WOS:000503545000004
PM 31271879
DA 2024-11-01
ER

PT J
AU Morrow, RM
   Picard, M
   Derbeneva, O
   Leipzig, J
   McManus, MJ
   Gouspillou, G
   Barbat-Artigas, S
   Dos Santos, C
   Hepple, RT
   Murdock, DG
   Wallace, DC
AF Morrow, Ryan M.
   Picard, Martin
   Derbeneva, Olga
   Leipzig, Jeremy
   McManus, Meagan J.
   Gouspillou, Gilles
   Barbat-Artigas, Sebastien
   Dos Santos, Carlos
   Hepple, Russell T.
   Murdock, Deborah G.
   Wallace, Douglas C.
TI Mitochondrial energy deficiency leads to hyperproliferation of skeletal
   muscle mitochondria and enhanced insulin sensitivity
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE mitochondria; skeletal muscle; ANT1; insulin sensitivity
ID DIFFERENTIATION FACTOR 15; UNCOUPLING PROTEIN-1; OXIDATIVE-METABOLISM;
   LIPID-METABOLISM; EXPRESSION; DNA; RESISTANCE; BIOMARKER; MYOPATHY;
   MUTATION
AB Diabetes is associated with impaired glucose metabolism in the presence of excess insulin. Glucose and fatty acids provide reducing equivalents to mitochondria to generate energy, and studies have reported mitochondrial dysfunction in type II diabetes patients. If mitochondrial dysfunction can cause diabetes, then we hypothesized that increased mitochondrial metabolism should render animals resistant to diabetes. This was confirmed in mice in which the heart-muscle-brain adenine nucleotide translocator isoform 1 (ANT1) was inactivated. ANT1-deficient animals are insulin-hypersensitive, glucose-tolerant, and resistant to high fat diet (HFD)-induced toxicity. In ANT1-deficient skeletal muscle, mitochondrial gene expression is induced in association with the hyperproliferation of mitochondria. The ANT1-deficient muscle mitochondria produce excess reactive oxygen species (ROS) and are partially uncoupled. Hence, the muscle respiration under nonphosphorylating conditions is increased. Muscle transcriptome analysis revealed the induction of mitochondrial biogenesis, down-regulation of diabetes-related genes, and increased expression of the genes encoding the myokines FGF21 and GDF15. However, FGF21 was not elevated in serum, and FGF21 and UCP1 mRNAs were not induced in liver or brown adipose tissue (BAT). Hence, increased oxidation of dietary-reducing equivalents by elevated muscle mitochondrial respiration appears to be the mechanism by which ANT1-deficient mice prevent diabetes, demonstrating that the rate of mitochondrial oxidation of calories is important in the etiology of metabolic disease.
C1 [Morrow, Ryan M.; Picard, Martin; Derbeneva, Olga; McManus, Meagan J.; Dos Santos, Carlos; Murdock, Deborah G.; Wallace, Douglas C.] Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.
   [Morrow, Ryan M.; Picard, Martin; Derbeneva, Olga; McManus, Meagan J.; Dos Santos, Carlos; Murdock, Deborah G.; Wallace, Douglas C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Leipzig, Jeremy] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.
   [Gouspillou, Gilles] Univ Qubec Montreal, Fac Sci, Dept Sci & Act Phys, Montreal, PQ H2L 2C4, Canada.
   [Barbat-Artigas, Sebastien] Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ H3T 1J4, Canada.
   [Hepple, Russell T.] McGill Univ, McGill Univ Hlth Ctr, Dept Kinesiol, Montreal, PQ H3A 0G4, Canada.
   [Picard, Martin] Columbia Univ, Coll Phys & Surg, Med Ctr,Div Behav Med, Columbia Translat Neurosci Initiat,Dept Neurol,De, Columbia, NY 10032 USA.
   [Derbeneva, Olga] DxTer Diagnost, Res & Operat, Rancho Dominguez, CA 90220 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Pennsylvania; University of Pennsylvania;
   Pennsylvania Medicine; Childrens Hospital of Philadelphia; Universite de
   Montreal; McGill University; Columbia University
RP Wallace, DC (corresponding author), Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.; Wallace, DC (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
EM wallaced1@email.chop.edu
RI Murdock, Deborah/C-3483-2012; McManus, Meagan/F-7932-2018
OI Leipzig, Jeremy/0000-0001-7224-9620; Gouspillou,
   Gilles/0000-0002-8543-3619; Hepple, Russell/0000-0003-3640-486X; Picard,
   Martin/0000-0003-2835-0478
FU NIH Grants [NS021328, CA182384, OD01944, DK73691]; University of
   Pennsylvania Diabetes Research Center Mouse Phenotyping, Physiology, and
   Metabolism Core Grant [P30DK19525]
FX This work was supported by NIH Grants NS021328, CA182384, OD01944, and
   DK73691 (to D.C.W.) and University of Pennsylvania Diabetes Research
   Center Mouse Phenotyping, Physiology, and Metabolism Core Grant
   P30DK19525.
CR Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Gouspillou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103044
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Keipert S, 2011, AGING CELL, V10, P122, DOI 10.1111/j.1474-9726.2010.00648.x
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Klaus S, 2005, PHYSIOL GENOMICS, V21, P193, DOI 10.1152/physiolgenomics.00299.2004
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013
   Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288
   Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007
   Nies VJM, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00193
   Ost M, 2016, MOL METAB, V5, P79, DOI 10.1016/j.molmet.2015.11.002
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI [DOI 10.1056/NEJMOA031314, 10.1056/NEJMoa031314]
   Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008
   Picard M, 2015, PSYCHONEUROENDOCRINO, V61, P74, DOI 10.1016/j.psyneuen.2015.07.595
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Sanz A, 2006, FASEB J, V20, P1064, DOI 10.1096/fj.05-5568com
   Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006
   Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004
   Shin MY, 2016, J KOREAN MED SCI, V31, P1413, DOI 10.3346/jkms.2016.31.9.1413
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Wall CE, 2015, P NATL ACAD SCI USA, V112, P8714, DOI 10.1073/pnas.1509930112
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 39
TC 65
Z9 68
U1 0
U2 25
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 7
PY 2017
VL 114
IS 10
BP 2705
EP 2710
DI 10.1073/pnas.1700997114
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EM7SA
UT WOS:000395511400086
PM 28223503
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Tumiene, B
   Voisin, N
   Preiksaitiene, E
   Petroska, D
   Grikiniene, J
   Samaitiene, R
   Utkus, A
   Reymond, A
   Kucinskas, V
AF Tumiene, Birute
   Voisin, Norine
   Preiksaitiene, Egle
   Petroska, Donatas
   Grikiniene, Jurgita
   Samaitiene, Ruta
   Utkus, Algirdas
   Reymond, Alexandre
   Kucinskas, Vaidutis
TI Inflammatory myopathy in a patient with Aicardi-Goutieres syndrome
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE Inflammatory myopathy; Aicardi-Goutieres syndrome; Type I
   interferonopathy; Autoimmune myositis; Exome sequencing
ID P.ASP18ASN MUTATION; LUPUS-ERYTHEMATOSUS; AUTOIMMUNE-DISEASE; I
   INTERFERONS; TREX1; DNA; ACTIVATION; BIOMARKERS; RNASEH2A; SAMHD1
AB Aicardi-Goutieres syndrome (AGS) is an inflammatory disorder belonging to the recently characterized group of type I interferonopathies. The most consistently affected tissues in AGS are the central nervous system and skin, but various organ systems and tissues have been reported to be affected, pointing to the systemic nature of the disease. Here we describe a patient with AGS due to a homozygous p.Arg114His mutation in the TREX1 gene. The histologically proven inflammatory myopathy in our patient expands the range of clinical features of AGS. Histological signs of muscle biopsies in the proband, and in two other AGS patients described earlier, are similar to those seen in various autoimmune myositises and could be ascribed to inapproapriate IFN I activation. In view of signs of possible mitochondrial damage in AGS, we propose that mitochondrial DNA could be a trigger of autoimmune responses in AGS. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Tumiene, Birute; Preiksaitiene, Egle; Utkus, Algirdas; Kucinskas, Vaidutis] Vilnius Univ, Ctr Med Genet, Dept Human & Med Genet, Vilnius, Lithuania.
   [Voisin, Norine; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.
   [Petroska, Donatas] Vilnius Univ, Fac Med, Dept Pathol Forens Med & Pharmacol, Vilnius, Lithuania.
   [Petroska, Donatas] Vilnius Univ, Hosp Santariskiu Klin, Natl Ctr Pathol, Vilnius, Lithuania.
   [Grikiniene, Jurgita; Samaitiene, Ruta] Vilnius Univ, Fac Med, Clin Childrens Dis, Vilnius, Lithuania.
C3 Vilnius University; University of Lausanne; Vilnius University; Vilnius
   University; Vilnius University Hospital Santariskiu Klinikos; Vilnius
   University
RP Tumiene, B (corresponding author), Vilnius Univ, Fac Med, Dept Human & Med Genet, Santariskiu 2, LT-08661 Vilnius, Lithuania.
EM tumbir@gmail.com
RI Samaitiene- Alekniene, Rūta/GOK-1072-2022; Preiksaitiene,
   Egle/HMD-4367-2023; Tumiene, Birute/ABD-4907-2020; Kutalik,
   Zoltan/HHZ-5697-2022; KUČINSKAS, Vaidutis/A-4798-2013; Kasiulevicius,
   Vytautas/P-6819-2014
OI Kasiulevicius, Vytautas/0000-0001-9967-8257; Reymond,
   Alexandre/0000-0003-1030-8327; Voisin, Norine/0000-0001-9479-4179;
   Utkus, Algirdas/0000-0001-5766-6653; Grikiniene,
   Jurgita/0000-0003-0532-4218; Samaitiene Alekniene,
   Ruta/0000-0001-6503-1578; , Egle/0000-0003-0282-134X
FU Lithuanian-Swiss cooperation program to reduce economic and social
   disparities within the enlarged European Union [CH-3-SMM-0104]; Swiss
   National Science Foundation [31003A_160203]; Swiss National Science
   Foundation (SNF) [31003A_160203] Funding Source: Swiss National Science
   Foundation (SNF)
FX This work was supported by grants from the Lithuanian-Swiss cooperation
   program to reduce economic and social disparities within the enlarged
   European Union (No. CH-3-SMM-0104, Unigene project) to AR and VK and the
   Swiss National Science Foundation (31003A_160203) to AR. The providers
   of the grants had no role in the study design, data collection or
   analysis, decision to publish, or preparation of the manuscript.
CR Abe J, 2013, RHEUMATOLOGY, V52, P406, DOI 10.1093/rheumatology/kes181
   Alfaiz AA, 2016, EUR J HUM GENET, V24, P1001, DOI 10.1038/ejhg.2015.227
   Alfaiz AA, 2014, HUM MUTAT, V35, P447, DOI 10.1002/humu.22529
   Atianand MK, 2013, J IMMUNOL, V190, P1911, DOI 10.4049/jimmunol.1203162
   Beck-Engeser GB, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-91
   Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845
   Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005
   Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887
   Dalakas MC, 2011, NEUROPATH APPL NEURO, V37, P226, DOI 10.1111/j.1365-2990.2010.01153.x
   Ellyard JI, 2014, ARTHRITIS RHEUMATOL, V66, P3382, DOI 10.1002/art.38824
   Greenberg SA, 2012, GENES IMMUN, V13, P207, DOI 10.1038/gene.2011.61
   Greenberg Steven A, 2010, Curr Rheumatol Rep, V12, P198, DOI 10.1007/s11926-010-0101-6
   Haaxma CA, 2010, AM J MED GENET A, V152A, P2612, DOI 10.1002/ajmg.a.33620
   Hayashi K, 2015, INT IMMUNOL, V27, P435, DOI 10.1093/intimm/dxv021
   Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jakati S, 2015, INT J RHEUM DIS, V18, P886, DOI 10.1111/1756-185X.12592
   Kalliolias GD, 2012, BIOMARK MED, V6, P137, DOI 10.2217/BMM.12.8
   Leshinsky-Silver E, 2011, EUR J HUM GENET, V19, P287, DOI 10.1038/ejhg.2010.213
   Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367
   Rice GI, 2015, J CLIN IMMUNOL, V35, P235, DOI 10.1007/s10875-015-0147-3
   Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8
   Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032
   Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017
NR 26
TC 14
Z9 14
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1769-7212
EI 1878-0849
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD MAR
PY 2017
VL 60
IS 3
BP 154
EP 158
DI 10.1016/j.ejmg.2016.12.004
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA EQ4SL
UT WOS:000398068600002
PM 28089741
OA Bronze
DA 2024-11-01
ER

PT S
AU Yang, X
   Zhang, RY
   Nakahira, K
   Gu, ZL
AF Yang, Xuan
   Zhang, Ruoyu
   Nakahira, Kiichi
   Gu, Zhenglong
BE Stover, PJ
   Balling, R
TI Mitochondrial DNA Mutation, Diseases, and Nutrient-Regulated Mitophagy
SO ANNUAL REVIEW OF NUTRITION, VOL 39, 2019
SE Annual Review of Nutrition
LA English
DT Review; Book Chapter
DE mitochondria; mtDNA; heteroplasmy; mitophagy; nutrients
ID ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; PINK1/PARKIN-MEDIATED
   MITOPHAGY; SUPEROXIDE-DISMUTASE; MANGANESE CHLORIDE; PARKINSONS-DISEASE;
   INDUCED APOPTOSIS; SKELETAL-MUSCLE; STING PATHWAY; LIFE-SPAN
AB A wide spectrum of human diseases, including cancer, neurodegenerative diseases, and metabolic disorders, have been shown to be associated with mitochondrial dysfunction through multiple molecular mechanisms. Mitochondria are particularly susceptible to nutrient deficiencies, and nutritional intervention is an essential way to maintain mitochondrial homeostasis. Recent advances in genetic manipulation and next-generation sequencing reveal the crucial roles of mitochondrial DNA (mtDNA) in various pathophysiological conditions. Mitophagy, a term coined to describe autophagy that targets dysfunctional mitochondria, has emerged as an important cellular process to maintain mitochondrial homeostasis and has been shown to be regulated by various nutrients and nutritional stresses. Given the high prevalence of mtDNA mutations in humans and their impact on mitochondrial function, it is important to investigate the mechanisms that regulate mtDNA mutation. Here, we discuss mitochondrial genetics and mtDNA mutations and their implications for human diseases. We also examine the role of mitophagy as a therapeutic target, highlighting how nutrients may eliminate mtDNA mutations through mitophagy.
C1 [Yang, Xuan; Zhang, Ruoyu; Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Nakahira, Kiichi] Weill Cornell Med, Joan & Sanford I Weill Dept Med, Div Pulm & Crit Care Med, New York, NY 10065 USA.
C3 Cornell University; Cornell University; Weill Cornell Medicine
RP Yang, X (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
EM xy394@cornell.edu; rz253@cornell.edu; kin2007@med.cornell.edu;
   zg27@cornell.edu
RI Zhang, Ruoyu/AAB-6508-2019
OI Zhang, Ruoyu/0000-0001-5672-5527
FU NIGMS NIH HHS [R01 GM117190] Funding Source: Medline
CR Anding AL, 2018, CURR BIOL, V28, P287, DOI 10.1016/j.cub.2017.11.064
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Baek SH, 2017, J NEUROSCI, V37, P5099, DOI 10.1523/JNEUROSCI.2385-16.2017
   Ban T, 2017, NAT CELL BIOL, V19, P856, DOI 10.1038/ncb3560
   Band M, 2009, FASEB J, V23, P2327, DOI 10.1096/fj.08-122978
   Bargiela D, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.051
   Bargiela D, 2018, TRENDS ENDOCRIN MET, V29, P249, DOI 10.1016/j.tem.2018.02.002
   Bartolome F., 2017, SCI REP, V7, P1
   Basit F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.133
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780
   Berridge MJ, 2017, J PHYSIOL-LONDON, V595, P6825, DOI 10.1113/JP274887
   Bhujabal Z, 2017, EMBO REP, V18, P947, DOI 10.15252/embr.201643147
   Bian XY, 2018, FREE RADICAL RES, V52, P80, DOI 10.1080/10715762.2017.1414949
   Bin-Umer MA, 2014, P NATL ACAD SCI USA, V111, P11798, DOI 10.1073/pnas.1403145111
   Boilard E, 2016, NAT REV RHEUMATOL, V12, P195, DOI 10.1038/nrrheum.2016.24
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Boyle KA, 2018, J BIOL CHEM, V293, P14891, DOI 10.1074/jbc.RA117.001469
   Brenner SR, 2010, NEUROLOGY, V74, P182, DOI 10.1212/WNL.0b013e3181c77678
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623
   Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558
   Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Colombo B, 2014, NEUROL SCI, V35, pS141, DOI 10.1007/s10072-014-1755-z
   Cornelius N, 2014, HUM MOL GENET, V23, P4285, DOI 10.1093/hmg/ddu146
   Correia-Melo C, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.159
   Das DN, 2017, FREE RADICAL BIO MED, V112, P452, DOI 10.1016/j.freeradbiomed.2017.08.020
   Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798
   de Vries RLA, 2012, AUTOPHAGY, V8, P699, DOI 10.4161/auto.19470
   Depeint F, 2006, CHEM-BIOL INTERACT, V163, P94, DOI 10.1016/j.cbi.2006.04.014
   Dietrich LEP, 2006, CURR BIOL, V16, pR395, DOI 10.1016/j.cub.2006.05.017
   Dudek J, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00090
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011
   Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026
   Fiesel FC, 2017, ONCOTARGET, V8, P106233, DOI 10.18632/oncotarget.22287
   Filadi R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0023-6
   Filichia E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32656
   Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9
   Fu M, 2013, MOL BIOL CELL, V24, P1153, DOI 10.1091/mbc.E12-08-0607
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017
   Garcia-Muñoz C, 2014, CRIT REV FOOD SCI, V54, P1584, DOI 10.1080/10408398.2011.644643
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Ghosh SS, 1996, AM J HUM GENET, V58, P325
   Giardina G, 2015, FEBS J, V282, P1225, DOI 10.1111/febs.13211
   Giménez-Cassina A, 2015, TRENDS ENDOCRIN MET, V26, P165, DOI 10.1016/j.tem.2015.02.004
   Gong GH, 2015, SCIENCE, V350, DOI 10.1126/science.aad2459
   Greaves LC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003082
   Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204
   Hamacher-Brady A, 2016, CELL MOL LIFE SCI, V73, P775, DOI 10.1007/s00018-015-2087-8
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012971
   Hsu TC, 2010, FOOD CHEM, V119, P62, DOI 10.1016/j.foodchem.2009.05.088
   Huang F, 2009, FREE RADICAL BIO MED, V46, P1186, DOI 10.1016/j.freeradbiomed.2009.01.026
   Hyland K, 2009, NEUROLOGY, V72, pA347
   Ishihara M, 2013, AM J PHYSIOL-RENAL, V305, pF495, DOI 10.1152/ajprenal.00642.2012
   Jain A, 2015, J BIOL CHEM, V290, P14945, DOI 10.1074/jbc.M115.656116
   Jensen KS, 2011, EMBO J, V30, P4554, DOI 10.1038/emboj.2011.323
   Jian FL, 2018, CELL REP, V23, P2989, DOI 10.1016/j.celrep.2018.05.015
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Jin X, 2018, NEUROPSYCH DIS TREAT, V14, P3159, DOI 10.2147/NDT.S186209
   JONES CW, 1978, BIOCHIM BIOPHYS ACTA, V526, P369, DOI 10.1016/0005-2744(78)90128-6
   Jong CJ, 2015, AMINO ACIDS, V47, P2609, DOI 10.1007/s00726-015-2053-7
   Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7
   Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658
   Kameyama K, 2017, INT J NANOMED, V12, P3433, DOI 10.2147/IJN.S133482
   Kang HT, 2009, AGING CELL, V8, P426, DOI 10.1111/j.1474-9726.2009.00487.x
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Ke Z, 2013, ANN NUTR METAB, V63, P555
   Keene D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4379
   KIESSLING KH, 1962, EXP CELL RES, V26, P198, DOI 10.1016/0014-4827(62)90215-X
   Kogot-Levin A, 2014, BIOCHIMIE, V100, P88, DOI 10.1016/j.biochi.2013.07.027
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lee HN, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00621
   Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044
   Lee S, 2018, INT J MED SCI, V15, P1083, DOI 10.7150/ijms.26314
   Lee S, 2009, AM J PHYSIOL-HEART C, V297, pH569, DOI 10.1152/ajpheart.00293.2009
   Lee YJ, 2017, AUTOPHAGY, V13, P1615, DOI 10.1080/15548627.2017.1339845
   Li J, 2015, AUTOPHAGY, V11, P1216, DOI 10.1080/15548627.2015.1017180
   Li MT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0984-0
   Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139
   Li Y, 2017, BIOCHEM BIOPH RES CO, V484, P118, DOI 10.1016/j.bbrc.2017.01.061
   Liu L, 2014, CELL RES, V24, P787, DOI 10.1038/cr.2014.75
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   Liu SY, 2012, APOPTOSIS, V17, P1156, DOI 10.1007/s10495-012-0758-6
   Luz AL, 2017, TOXICOLOGY, V387, P81, DOI 10.1016/j.tox.2017.05.018
   Ma SP, 2016, ANTIOXID REDOX SIGN, V24, P486, DOI 10.1089/ars.2015.6336
   MacVicar TDB, 2015, INT J MOL SCI, V16, P13356, DOI 10.3390/ijms160613356
   Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788
   Marin JJG, 2013, FREE RADICAL BIO MED, V61, P218, DOI 10.1016/j.freeradbiomed.2013.04.002
   Matilainen O, 2017, TRENDS CELL BIOL, V27, P453, DOI 10.1016/j.tcb.2017.02.004
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039
   Meng X, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040367
   Menzies KJ, 2013, J BIOL CHEM, V288, P6968, DOI 10.1074/jbc.M112.431155
   Mirica SN, 2013, CAN J PHYSIOL PHARM, V91, P108, DOI 10.1139/cjpp-2012-0216
   Mitsuhashi S, 2011, AUTOPHAGY, V7, P1559, DOI 10.4161/auto.7.12.17925
   Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527
   Murphy E, 2007, ANNU REV PHYSIOL, V69, P51, DOI 10.1146/annurev.physiol.69.031905.163645
   Murphy MP, 2015, CELL METAB, V22, P363, DOI 10.1016/j.cmet.2015.08.012
   Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Norenberg MD, 2004, J BIOENERG BIOMEMBR, V36, P303, DOI 10.1023/B:JOBB.0000041758.20071.19
   Ohtake F, 2018, P NATL ACAD SCI USA, V115, pE1401, DOI 10.1073/pnas.1716673115
   Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013
   Ongan D, 2017, PAK J MED SCI, V33, P417, DOI 10.12669/pjms.332.11838
   Onodera R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04417
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Palikaras K, 2017, PHARMACOL THERAPEUT, V178, P157, DOI 10.1016/j.pharmthera.2017.04.005
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Paul BT, 2017, EXPERT REV HEMATOL, V10, P65, DOI 10.1080/17474086.2016.1268047
   Peng TI, 2012, J PINEAL RES, V52, P93, DOI 10.1111/j.1600-079X.2011.00923.x
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Pichiah PBT, 2011, MED HYPOTHESES, V77, P677, DOI 10.1016/j.mehy.2011.07.014
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778
   Powell JM, 2008, J DAIRY SCI, V91, P857, DOI 10.3168/jds.2007-0588
   Qi YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24700
   Requejo-Aguilar R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5514
   Ricca C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061672
   Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107
   Rimessi A, 2013, AUTOPHAGY, V9, P1677, DOI 10.4161/auto.24795
   Robb EL, 2017, BIOCHEM BIOPH RES CO, V485, P249, DOI 10.1016/j.bbrc.2017.02.102
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Roth JA, 2009, NEUROMOL MED, V11, P281, DOI 10.1007/s12017-009-8088-8
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Ryan T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03241-9
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005
   Sauve AA, 2012, CURR OPIN CHEM BIOL, V16, P535, DOI 10.1016/j.cbpa.2012.10.003
   Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002
   Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059
   Schipper HM, 2004, AGEING RES REV, V3, P265, DOI 10.1016/j.arr.2004.02.001
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seibenhener ML, 2013, BBA-MOL CELL RES, V1833, P452, DOI 10.1016/j.bbamcr.2012.11.004
   Sekine S, 2018, BMC BIOL, V16, DOI 10.1186/s12915-017-0470-7
   Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059
   Shaik A, 2016, CELL CYCLE, V15, P1805, DOI 10.1080/15384101.2016.1181876
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   Song DM, 2017, METALLOMICS, V9, P1251, DOI 10.1039/c7mt00085e
   Song SB, 2017, MOL CELLS, V40, P503, DOI 10.14348/molcells.2017.0081
   Springer MZ, 2016, J PATHOL, V240, P253, DOI 10.1002/path.4774
   Steward CG, 2010, PRENATAL DIAG, V30, P970, DOI 10.1002/pd.2599
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670
   Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Tatar M, 2016, CELL, V165, P1052, DOI 10.1016/j.cell.2016.05.021
   Thakur N, 2016, HUM HEALT HANDB, V12, P353, DOI 10.3920/978-90-8686-822-3_21
   Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039
   Thomas RL, 2013, CIRC J, V77, P2449, DOI 10.1253/circj.CJ-13-0835
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Varga NA, 2018, BEHAV BRAIN FUNCT, V14, DOI 10.1186/s12993-018-0135-x
   Vazquez-Martin A, 2016, AGING-US, V8, P1330, DOI 10.18632/aging.100976
   Villa E, 2018, TRENDS CELL BIOL, V28, P882, DOI 10.1016/j.tcb.2018.07.004
   Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wang H, 2011, J PINEAL RES, V50, P418, DOI 10.1111/j.1600-079X.2011.00860.x
   Wang H, 2018, TOXICOL LETT, V282, P100, DOI 10.1016/j.toxlet.2017.10.021
   Wang X, 2017, TOXICOL APPL PHARM, V320, P26, DOI 10.1016/j.taap.2017.02.009
   Wang YQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006391
   Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125
   Wei X, 2014, TOXICOL MECH METHOD, V24, P504, DOI 10.3109/15376516.2014.943444
   Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042
   WEISIGER RA, 1973, J BIOL CHEM, V248, P4793
   Wu J, 2016, EXP CELL RES, V341, P42, DOI 10.1016/j.yexcr.2016.01.014
   Wu SP, 2015, GUT, V64, P1082, DOI 10.1136/gutjnl-2014-307436
   Xiao B, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.463
   Xiao B, 2017, J BIOL CHEM, V292, P16697, DOI 10.1074/jbc.M117.787739
   Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999
   Xue Y, 2017, J BIOL CHEM, V292, P13197, DOI 10.1074/jbc.M117.784249
   Yamada T, 2018, CELL METAB, V28, P588, DOI 10.1016/j.cmet.2018.06.014
   Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yuan Y, 2017, AUTOPHAGY, V13, P1754, DOI 10.1080/15548627.2017.1357792
   Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108
   Zhang HT, 2016, TOXICOL IN VITRO, V34, P212, DOI 10.1016/j.tiv.2016.04.006
   Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16
   Zhang SR, 2004, TOXICOL IN VITRO, V18, P71, DOI 10.1016/j.tiv.2003.09.002
   Zhang TM, 2016, J BIOL CHEM, V291, P21616, DOI 10.1074/jbc.M116.733410
   Zhang WL, 2016, ELIFE, V5, DOI [10.7554/eLife.21407, 10.7554/eLife.21407.001]
   Zhang XN, 2014, AUTOPHAGY, V10, P1801, DOI 10.4161/auto.32136
   Zhang Y, 2013, J MEMBRANE BIOL, V246, P365, DOI 10.1007/s00232-013-9540-0
   Zhou HB, 2017, MICRO NANO TECHNOL, P1, DOI 10.1016/B978-0-32-346240-2.00001-7
   Zhou XL, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0097-z
   Zhu LY, 2010, CELL RES, V20, P676, DOI 10.1038/cr.2010.46
NR 197
TC 18
Z9 20
U1 2
U2 45
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0199-9885
EI 1545-4312
BN 978-0-8243-2839-9
J9 ANNU REV NUTR
JI Annu. Rev. Nutr.
PY 2019
VL 39
BP 201
EP 226
DI 10.1146/annurev-nutr-082018-124643
PG 26
WC Nutrition & Dietetics
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA BN4PC
UT WOS:000482643700009
PM 31433742
OA Bronze
DA 2024-11-01
ER

PT J
AU Zekonyte, U
   Bacman, SR
   Smith, J
   Shoop, W
   Pereira, CV
   Tomberlin, G
   Stewart, J
   Jantz, D
   Moraes, CT
AF Zekonyte, Ugne
   Bacman, Sandra R.
   Smith, Jeff
   Shoop, Wendy
   Pereira, Claudia, V
   Tomberlin, Ginger
   Stewart, James
   Jantz, Derek
   Moraes, Carlos T.
TI Mitochondrial targeted meganuclease as a platform to eliminate mutant
   mtDNA in vivo
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SELECTIVE DEGRADATION; DNA HETEROPLASMY; AAV SEROTYPES; GENE-TRANSFER;
   ENDONUCLEASES; MUTATIONS; GENOMES; MOUSE; CLEAVAGE; DELIVERY
AB Diseases caused by heteroplasmic mitochondrial DNA mutations have no effective treatment or cure. In recent years, DNA editing enzymes were tested as tools to eliminate mutant mtDNA in heteroplasmic cells and tissues. Mitochondrial-targeted restriction endonucleases, ZFNs, and TALENs have been successful in shifting mtDNA heteroplasmy, but they all have drawbacks as gene therapy reagents, including: large size, heterodimeric nature, inability to distinguish single base changes, or low flexibility and effectiveness. Here we report the adaptation of a gene editing platform based on the I-CreI meganuclease known as ARCUS((R)). These mitochondrial-targeted meganucleases (mitoARCUS) have a relatively small size, are monomeric, and can recognize sequences differing by as little as one base pair. We show the development of a mitoARCUS specific for the mouse m.5024C>T mutation in the mt-tRNA(Ala) gene and its delivery to mice intravenously using AAV9 as a vector. Liver and skeletal muscle show robust elimination of mutant mtDNA with concomitant restoration of mt-tRNA(Ala) levels. We conclude that mitoARCUS is a potential powerful tool for the elimination of mutant mtDNA. Heteroplasmic mitochondrial DNA mutations lack effective treatments. Here the authors adapt I-CreI meganuclease to target the mitochondria and specifically-eliminate mtDNA with a m.5024C>T mutation in the mttRNA Ala gene.
C1 [Zekonyte, Ugne] Univ Miami, Miller Sch Med, Grad Program Human Genet & Genom, Miami, FL 33136 USA.
   [Bacman, Sandra R.; Pereira, Claudia, V; Moraes, Carlos T.] Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA.
   [Smith, Jeff; Shoop, Wendy; Tomberlin, Ginger; Jantz, Derek] Precis BioSci, Durham, NC USA.
   [Stewart, James] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England.
   [Stewart, James] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
C3 University of Miami; University of Miami; Newcastle University - UK;
   Newcastle University - UK
RP Moraes, CT (corresponding author), Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA.
EM Cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021; Stewart, Jim/C-9633-2011
OI Stewart, Jim/0000-0002-2902-4968
FU Muscular Dystrophy Association; National Institute of Health
   [5R01EY010804]; NIH [1R01NS079965, 1R01AG036871]; CHAMP Foundation
FX This work was supported primarily by the Muscular Dystrophy Association
   and the National Institute of Health Grants 5R01EY010804. Additional
   support was received from NIH grants 1R01NS079965, 1R01AG036871, and the
   CHAMP Foundation.
CR Antunes MS, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-86
   Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065
   Arnould S, 2011, PROTEIN ENG DES SEL, V24, P27, DOI 10.1093/protein/gzq083
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2020, MOL CELL, V79, P708, DOI 10.1016/j.molcel.2020.08.009
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Bacman SR, 2014, METHOD ENZYMOL, V547, P373, DOI 10.1016/B978-0-12-801415-8.00018-7
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bish LT, 2008, HUM GENE THER, V19, P1359, DOI 10.1089/hum.2008.123
   Candas D., 2016, J VIS EXP, V53417
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gray SJ, 2016, MOL THER, V24, P1017, DOI 10.1038/mt.2016.20
   Grieger JC, 2005, J VIROL, V79, P9933, DOI 10.1128/JVI.79.15.9933-9944.2005
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   He T, 2019, HUM GENE THER CL DEV, V30, P169, DOI 10.1089/humc.2019.030
   Hickey DG, 2017, GENE THER, V24, P787, DOI 10.1038/gt.2017.85
   Jantz D., 2013, US Patent, Patent No. [US8021867B2, 8021867]
   Kanaan NM, 2017, MOL THER-NUCL ACIDS, V8, P184, DOI 10.1016/j.omtn.2017.06.011
   Katwal AB, 2013, GENE THER, V20, P930, DOI 10.1038/gt.2013.16
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Lee H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21464-1
   Li CW, 2020, NAT REV GENET, V21, P255, DOI 10.1038/s41576-019-0205-4
   Martino AT, 2013, BLOOD, V121, P2224, DOI 10.1182/blood-2012-10-460733
   Matsuzaki Y, 2019, MOL THER, V27, P700, DOI 10.1016/j.ymthe.2019.02.016
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Pacak Christina A, 2008, Genet Vaccines Ther, V6, P13, DOI 10.1186/1479-0556-6-13
   Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w
   Pereira CV, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708084
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Smith J. J., 2017, US Patent, Patent No. [US9683257B2, 9683257]
   Smith J. J., 2012, USPatent, Patent No. [201113245596 A, 201113245596]
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wang LL, 2018, NAT BIOTECHNOL, V36, P717, DOI 10.1038/nbt.4182
   Wang LL, 2015, MOL THER, V23, P1877, DOI 10.1038/mt.2015.179
   Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155
   Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76
NR 53
TC 47
Z9 55
U1 6
U2 23
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 28
PY 2021
VL 12
IS 1
AR 3210
DI 10.1038/s41467-021-23561-7
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA SO7GY
UT WOS:000659144000007
PM 34050192
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Sobenin, IA
   Zhelankin, AV
   Mitrofanov, KY
   Sinyov, VV
   Sazonova, MA
   Postnov, AY
   Orekhov, AN
AF Sobenin, Igor A.
   Zhelankin, Andrey V.
   Mitrofanov, Konstantin Y.
   Sinyov, Vasily V.
   Sazonova, Margarita A.
   Postnov, Anton Y.
   Orekhov, Alexander N.
TI Mutations of Mitochondrial DNA in Atherosclerosis and
   Atherosclerosis-Related Diseases
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Atherosclerosis; atherogenesis; mitochondrial DNA; mutations;
   heteroplasmy; coronary heart disease
ID MATERNALLY INHERITED HYPERTENSION; SMOOTH-MUSCLE-CELLS; POINT MUTATION;
   MICROSATELLITE INSTABILITY; RISK-FACTOR; DAMAGE; GENE; HETEROZYGOSITY;
   MTDNA; CARDIOMYOPATHY
AB Atherosclerosis, the primary cause of cardiovascular disease, is a complex and multifactorial pathology resulted from the harmful interactions between genetic and environmental factors. There is a growing body of evidence in support of the role of mitochondrial factors in the pathogenesis of atherosclerosis. Impaired mitochondrial function and structural and qualitative changes in mitochondrial components such as mitochondrial DNA (mtDNA) damage may be directly involved in the development of multiple mechanisms of atherogenesis. Recent findings show that several heteroplasmic mutations of mtDNA are related to atherosclerosis, coronary heart disease and several atherosclerosis-related diseases such as arterial hypertension and diabetes mellitus. Therefore, heteroplasmic mtDNA mutations could represent a promising molecular biomarker of genetic susceptibility to atherosclerosis and related pathologies. This review is focused on the latest findings in the studies of mutations of mitochondrial genome, which are associated with atherosclerosis and atherosclerosis- related diseases.
C1 [Sobenin, Igor A.; Zhelankin, Andrey V.; Sinyov, Vasily V.; Sazonova, Margarita A.; Postnov, Anton Y.] Russian Cardiol Res & Prod Complex, Med Genet Lab, Moscow 121552, Russia.
   [Sobenin, Igor A.; Mitrofanov, Konstantin Y.; Sinyov, Vasily V.; Sazonova, Margarita A.; Orekhov, Alexander N.] Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow 125315, Russia.
   [Orekhov, Alexander N.] Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Moscow 143025, Russia.
C3 National Medical Research Center of Cardiology; Russian Academy of
   Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS
RP Sobenin, IA (corresponding author), Russian Cardiol Res & Prod Complex, Med Genet Lab, 15-a 3rd Cherepkovskaya Str, Moscow 121552, Russia.
EM sobenin@cardio.ru
RI Sazonova, Margarita/O-9685-2017; Sinyov, Vasiliy/K-9084-2014; Zhelankin,
   Andrey/F-8247-2014; Sobenin, Igor/J-4282-2013
OI Sazonova, Margarita/0000-0002-8610-4593; Sinyov,
   Vasiliy/0000-0001-5105-5763; Zhelankin, Andrey/0000-0002-3014-2005;
   Postnov, Anton/0000-0002-2501-7269; Sobenin, Igor/0000-0003-0978-6444
FU Russian Scientific Foundation [14-14-01038]
FX This study was supported by Russian Scientific Foundation, grant
   14-14-01038.
CR Andreassi MG, 2000, ENVIRON MOL MUTAGEN, V35, P265, DOI 10.1002/1098-2280(2000)35:4<265::AID-EM1>3.0.CO;2-M
   Andreassi MG, 2003, TRENDS CARDIOVAS MED, V13, P270, DOI 10.1016/S1050-1738(03)00109-9
   BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753
   Binková B, 2002, MUTAT RES-FUND MOL M, V501, P115, DOI 10.1016/S0027-5107(02)00019-2
   Borghini A, 2013, ATHEROSCLEROSIS, V230, P202, DOI 10.1016/j.atherosclerosis.2013.07.038
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Botto N, 2001, MUTAT RES-GEN TOX EN, V493, P23, DOI 10.1016/S1383-5718(01)00162-0
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Chung IM, 1998, AM J PATHOL, V152, P913
   Clark KJ, 2001, ARTERIOSCL THROM VAS, V21, P555, DOI 10.1161/01.ATV.21.4.555
   Dandona Sonny, 2009, Curr Cardiol Rep, V11, P282
   Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d
   DeFlora S, 1997, FASEB J, V11, P1021, DOI 10.1096/fasebj.11.12.9337155
   DeFlora S, 1996, MUTAT RES-REV GENET, V366, P197, DOI 10.1016/S0165-1110(96)00043-7
   Diehl AM, 1999, J BIOENERG BIOMEMBR, V31, P493, DOI 10.1023/A:1005452624640
   Döring Y, 2012, ARTERIOSCL THROM VAS, V32, P182, DOI 10.1161/ATVBAHA.111.232686
   Fiotti N, 2006, ARTERIOSCL THROM VAS, V26, P1330, DOI 10.1161/01.ATV.0000219233.31702.c9
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Fujimoto H, 2010, CIRC J, V74, P353, DOI 10.1253/circj.CJ-09-0491
   Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620
   Goldstein I, 2012, TRENDS ENDOCRIN MET, V23, P567, DOI 10.1016/j.tem.2012.06.007
   Grati FR, 2001, ATHEROSCLEROSIS, V159, P261, DOI 10.1016/S0021-9150(01)00466-X
   Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585
   Hatzistamou J, 1996, BIOCHEM BIOPH RES CO, V225, P186, DOI 10.1006/bbrc.1996.1151
   Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392
   Izzotti A, 2001, FASEB J, V15, P752, DOI 10.1096/fj.00-0312com
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Jaksch M, 2001, NEUROLOGY, V57, P1440, DOI 10.1212/WNL.57.8.1440
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Kiaris H, 1996, ATHEROSCLEROSIS, V125, P47, DOI 10.1016/0021-9150(96)05841-8
   Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130
   KOWALD A, 1993, MUTAT RES, V295, P93, DOI 10.1016/0921-8734(93)90011-Q
   Lee SH, 2001, TRENDS CARDIOVAS MED, V11, P148, DOI 10.1016/S1050-1738(01)00094-9
   Li RL, 2001, ATHEROSCLEROSIS, V154, P729, DOI 10.1016/S0021-9150(00)00582-7
   Li RH, 2009, HYPERTENSION, V54, P329, DOI 10.1161/HYPERTENSIONAHA.109.129270
   Li ZB, 2008, BIOCHEM BIOPH RES CO, V367, P906, DOI 10.1016/j.bbrc.2007.12.150
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Liu CS, 2005, ANN NY ACAD SCI, V1042, P70, DOI 10.1196/annals.1338.008
   Liu YQ, 2009, HYPERTENSION, V53, P1083, DOI 10.1161/HYPERTENSIONAHA.109.128702
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007
   Malik Q, 2012, FREE RADICAL RES, V46, P554, DOI 10.3109/10715762.2012.663913
   Markowitz SD, 1997, J CLIN INVEST, V100, P2143, DOI 10.1172/JCI119749
   McCaffrey TA, 1997, J CLIN INVEST, V100, P2182, DOI 10.1172/JCI119754
   Mercer JR, 2011, CIRC RES, V108, pE2, DOI 10.1161/RES.0b013e31820a13f1
   Miniati P, 2001, INT J BIOL MARKER, V16, P167, DOI 10.1177/172460080101600302
   Mueller EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016455
   Murry CE, 1997, AM J PATHOL, V151, P697
   Nomiyama T, 2004, ANN NY ACAD SCI, V1011, P193, DOI 10.1196/annals.1293.020
   Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360
   PARKES JL, 1991, AM J PATHOL, V138, P765
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Ross JS, 2001, ANN NY ACAD SCI, V947, P271
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   SCHWARTZ CJ, 1993, AM J CARDIOL, V71, pB9, DOI 10.1016/0002-9149(93)90139-4
   Schwartz SM, 1998, ANNU REV MED, V49, P437
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Singh R, 2006, J MOL DIAGN, V8, P225, DOI 10.2353/jmoldx.2006.050067
   Sivapalaratnam S, 2011, CURR ATHEROSCLER REP, V13, P225, DOI 10.1007/s11883-011-0173-4
   Smith PM, 2011, J INHERIT METAB DIS, V34, P309, DOI 10.1007/s10545-010-9122-6
   Sobenin IA, 2013, CURR PHARM DESIGN, V19, P5942
   Sobenin IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068070
   Sobenin IA, 2013, WORLD J CARDIOL, V5, P132, DOI 10.4330/wjc.v5.i5.132
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Sobenin IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046573
   Sobenin IA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/832464
   Spandidos DA, 1996, BIOCHEM BIOPH RES CO, V220, P137, DOI 10.1006/bbrc.1996.0370
   Stary HC, 1990, PATHOBIOLOGY HUMAN A, P93
   Tabas I, 2001, CIRC RES, V88, P747, DOI 10.1161/hh0801.090536
   Tatarková Z, 2011, PHYSIOL RES, V60, P281, DOI 10.33549/physiolres.932019
   Van Schooten FJ, 1998, FASEB J, V12, P1409, DOI 10.1096/fasebj.12.13.1409
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang YC, 2011, J NEPHROL, V24, P351, DOI 10.5301/JN.2010.5816
   Weinberg RA, 1996, MOL ONCOLOGY, P179
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X
   Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010
   Yu E, 2012, CARDIOVASC RES, V95, P173, DOI 10.1093/cvr/cvs111
NR 83
TC 23
Z9 28
U1 3
U2 15
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 9
BP 1158
EP 1163
DI 10.2174/1381612820666141013133000
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA CB2NE
UT WOS:000349463600008
PM 25312735
DA 2024-11-01
ER

PT J
AU Ohno, A
   Mori, A
   Doi, R
   Yonenaga, Y
   Asano, N
   Uemoto, S
AF Ohno, Ayami
   Mori, Akira
   Doi, Ryuichiro
   Yonenaga, Yoshikuni
   Asano, Noboru
   Uemoto, Shinji
TI Successful left hemihepatectomy and perioperative management of a
   patient with biliary cystadenocarcinoma, complicated with MELAS
   syndrome: Report of a case
SO SURGERY TODAY
LA English
DT Article
DE MELAS; Hepatectomy; Biliary cystadenocarcinoma; F-18-Fluorodeoxyglucose
   positron emission tomography
ID STROKE-LIKE EPISODES; HUMAN PANCREATIC TUMORS; LACTIC-ACIDOSIS;
   MITOCHONDRIAL MYOPATHY; ANESTHETIC MANAGEMENT; ENCEPHALOPATHY; GLUCOSE;
   LIVER; POPULATION; PREVALENCE
AB Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like syndrome (MELAS) is a rare, fetal disease caused by a mutation in mitochondrial DNA that leads to impaired oxidative metabolism in skeletal muscle, the central nervous system, and liver function. This report presents the case of a 50-year-old woman with biliary cystadenocarcinoma complicated by MELAS who underwent a successful left hemihepatectomy. In this case, the diagnostic key for the malignant tumor was an F-18-fluorodeoxyglucose positron emission tomography study, which was useful even in a patient with MELAS, which causes abnormal glucose metabolism. The perioperative management of such patients includes special precautions to prevent lactic acidosis and deterioration of the reserved liver function after a hepatectomy, since the mitochondrial function in MELAS patients is abnormal. The patient in this report has remained free of liver dysfunctions and cancer recurrence for 2 years following the hepatectomy. This is the first report of a successful major hepatectomy for a patient with MELAS.
C1 [Ohno, Ayami; Mori, Akira; Doi, Ryuichiro; Yonenaga, Yoshikuni; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg & Transplantat, Dept Surg,Sakyo Ku, Kyoto 6068507, Japan.
   [Ohno, Ayami] Kyoto Med Ctr, Dept Radiol, Natl Hosp Org, Kyoto, Japan.
   [Asano, Noboru] Minami Kyoto Hosp, Dept Surg, Natl Hosp Org, Kyoto, Japan.
C3 Kyoto University
RP Mori, A (corresponding author), Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg & Transplantat, Dept Surg,Sakyo Ku, 54 Shogoin,Kawahara Cho, Kyoto 6068507, Japan.
OI Doi, Ryuichiro/0000-0002-7298-2301
CR Chioléro R, 1999, ANN SURG, V229, P505, DOI 10.1097/00000658-199904000-00009
   Del Poggio P, 2008, WORLD J GASTROENTERO, V14, P3616, DOI 10.3748/wjg.14.3616
   Furukawa H, 2008, EUR RADIOL, V18, P2841, DOI 10.1007/s00330-008-1062-2
   Higashi T, 1997, J NUCL MED, V38, P1337
   Higashi T, 1998, J NUCL MED, V39, P1727
   Läuffer JM, 1998, EUR J CANCER, V34, P1845
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marko P, 2004, J CLIN ANESTH, V16, P389, DOI 10.1016/j.jclinane.2003.09.012
   MITA S, 1995, MUSCLE NERVE, pS113
   Pojchamarnwiputh S, 2008, SINGAP MED J, V49, P392
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Sasano N, 2007, J ANESTH, V21, P72, DOI 10.1007/s00540-006-0449-y
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Thambisetty M, 2004, EXPERT REV MOL DIAGN, V4, P631, DOI 10.1586/14737159.4.5.631
   Vilela H, 2005, PEDIATR ANESTH, V15, P77, DOI 10.1111/j.1460-9592.2005.01384.x
NR 17
TC 7
Z9 7
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0941-1291
EI 1436-2813
J9 SURG TODAY
JI Surg. Today
PD SEP
PY 2010
VL 40
IS 9
BP 878
EP 882
DI 10.1007/s00595-009-4145-z
PG 5
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA 643XH
UT WOS:000281333300014
PM 20740354
DA 2024-11-01
ER

PT J
AU Keränen, T
   Kuusisto, H
AF Keranen, Tapani
   Kuusisto, Hanna
TI NARP syndrome and adult-onset generalised seizures
SO EPILEPTIC DISORDERS
LA English
DT Article
DE NARP; mitochondrial disease; epilepsy; generalised; adult; retinitis
   pigmentosa
ID CLINICAL PRESENTATION; RETINITIS-PIGMENTOSA; DNA MUTATION;
   MITOCHONDRIAL; DISEASE; MTDNA; HETEROPLASMY; FAMILIES; ATAXIA
AB The neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) syndrome is a maternally inherited disorder attributable to a heteroplasmic mtDNA point mutation. Catastrophic epilepsy may accompany severe, early onset forms of NARP, but seizures seem to be rare in cases with adolescent and adult onset. We describe a patient who developed clumsiness and visual problems in her teens. She had no clinical seizures but an EEG showed generalized spike and wave discharges. At this time the patient remained without a specific diagnosis. At the age of 21, the patient developed progressive ataxia and she also experienced a tonic-clonic status epilepticus. Further examinations revealed NARP syndrome. EEG abnormalities may precede adult onset seizures in the NARP syndrome.
C1 Tampere Univ Hosp, Dept Neurol, Tampere 33251, Finland.
C3 Tampere University; Tampere University Hospital
RP Keränen, T (corresponding author), Tampere Univ Hosp, Dept Neurol, POB 2000, Tampere 33251, Finland.
EM tapani.keranen@pshp.fi
RI Keranen, Tapani/LFU-3063-2024
CR CIAFALONI E, 1993, J PEDIATR-US, V122, P419, DOI 10.1016/S0022-3476(05)83431-6
   Desguerre I, 2003, NEUROPEDIATRICS, V34, P265
   FRYER A, 1994, ARCH DIS CHILD, V71, P419, DOI 10.1136/adc.71.5.419
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   ORTIZ RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1525, DOI 10.1001/archopht.1993.01090110091031
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   PUDDU P, 1993, BRIT J OPHTHALMOL, V77, P84, DOI 10.1136/bjo.77.2.84
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tatuch Yuriy, 1994, European Journal of Human Genetics, V2, P35
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
NR 12
TC 9
Z9 11
U1 0
U2 0
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1294-9361
J9 EPILEPTIC DISORD
JI Epileptic Disord.
PD SEP
PY 2006
VL 8
IS 3
BP 200
EP 203
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 098BO
UT WOS:000241495800005
PM 16987741
DA 2024-11-01
ER

PT J
AU Müller-Höcker, J
   Horvath, R
   Schäfer, S
   Hessel, H
   Müller-Felber, W
   Kühr, J
   Copeland, WC
   Seibel, P
AF Mueller-Hoecker, J.
   Horvath, R.
   Schaefer, S.
   Hessel, H.
   Mueller-Felber, W.
   Kuehr, J.
   Copeland, W. C.
   Seibel, P.
TI Mitochondrial DNA depletion and fatal infantile hepatic failure due to
   mutations in the mitochondrial polymerase γ (POLG) gene: a combined
   morphological/enzyme histochemical and immunocytochemical/biochemical
   and molecular genetic study
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE depletion of mtDNA; polymerase gamma; mitochondrial single stranded
   binding protein(mtSSB); mitochondrial transcription factor A (mtTFA);
   liver failure; in situ hybridization
ID DEOXYGUANOSINE KINASE GENE; MTDNA DEPLETION; RESPIRATORY-CHAIN;
   TRANSCRIPTION FACTOR; INSITU HYBRIDIZATION; COPY NUMBER; LIVER;
   EXPRESSION; REPLICATION; DEFICIENCY
AB Combined morphological, immunocytochemical, biochemical and molecular genetic studies were performed on skeletal muscle, heart muscle and liver tissue of a 16-months boy with fatal liver failure. The pathological characterization of the tissues revealed a severe depletion of mtDNA (mitochondrial DNA) that was most pronounced in liver, followed by a less severe, but still significant depletion in skeletal muscle and the heart. The primary cause of the disease was linked to compound heterozygous mutations in the polymerase gamma (POLG) gene (DNA polymerase gamma; A467T, K1191N). We present evidence, that compound heterozygous POLG mutations lead to tissue selective impairment of mtDNA replication and thus to a mosaic defect pattern even in the severely affected liver. A variable defect pattern was found in liver, muscle and heart tissue as revealed by biochemical, cytochemical, immunocytochemical and in situ hybridization analysis. Functionally, a severe deficiency of cytochrome-c-oxidase (cox) activity was seen in the liver. Although mtDNA depletion was detected in heart and skeletal muscle, there was no cox deficiency in these tissues. Depletion of mtDNA and microdissection of cox-positive or negative areas correlated with the histological pattern in the liver. Interestingly, the mosaic pattern detected for cox-activity and mtDNA copy number fully aligned with the immunohistologically revealed defect pattern using Pol gamma, mtSSB-and mtTFA-antibodies, thus substantiating the hypothesis that nuclear encoded proteins located within mitochondria become unstable and are degraded when they are not actively bound to mtDNA. Their disappearance could also aggravate the mtDNA depletion and contribute to the non-homogenous defect pattern.
C1 [Mueller-Hoecker, J.; Schaefer, S.; Hessel, H.] Univ Munich, Inst Pathol, D-80337 Munich, Germany.
   [Horvath, R.] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80337 Munich, Germany.
   [Horvath, R.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Mueller-Felber, W.] Univ Munich, Neurol Klin & Poliklin, Friedrich Baur Inst, D-80337 Munich, Germany.
   [Kuehr, J.] Municipal Hosp Karlsruhe, Clin Pediat & Adolescent Med, Karlsruhe, Germany.
   [Copeland, W. C.] NIEHS, Res Triangle Pk, NC 27709 USA.
   [Seibel, P.] Univ Leipzig, Biotechnol Biomed Zentrum, Leipzig, Germany.
C3 University of Munich; University of Munich; Newcastle University - UK;
   University of Munich; Municipal Hospital Karlsruhe; National Institutes
   of Health (NIH) - USA; NIH National Institute of Environmental Health
   Sciences (NIEHS); Leipzig University
RP Müller-Höcker, J (corresponding author), Univ Munich, Inst Pathol, Thalkirchnerstr 36, D-80337 Munich, Germany.
EM josef.mueller-hoecker@med.uni-muenchen.de
RI Horvath, Rita/AAY-7042-2020; Copeland, William/C-4242-2019
OI Horvath, Rita/0000-0002-9841-170X; Copeland, William/0000-0002-0359-0953
FU National Institutes of Health, NIEHS; Sachsische Ministerium fur
   Wissenschaft und Kunst; Deutsche Forschungsgemeinschaft [HO 2505/2-1]
FX The authors are indebted to Mrs. Diane Raabe and Mrs. Monika
   Attmanspacher for invaluable help in preparing the manuscript. Funding
   information: W. C. C. is funded by intramural funds from the National
   Institutes of Health, NIEHS. This work was in part (P. S.) supported by
   the Sachsische Ministerium fur Wissenschaft und Kunst. RH is supported
   by the Deutsche Forschungsgemeinschaft HO 2505/2-1.
CR Bakker HD, 1996, J PEDIATR-US, V128, P683, DOI 10.1016/S0022-3476(96)80135-1
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   BLACKSCHAEFER CL, 1991, BIOCHEM J, V274, P199, DOI 10.1042/bj2740199
   Bonod-Bidaud C, 2001, MITOCHONDRION, V1, P217, DOI 10.1016/S1567-7249(01)00017-4
   Campbell KM, 2007, J PEDIATR GASTR NUTR, V44, P99, DOI 10.1097/01.mpg.0000243434.54958.21
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1
   Ducluzeau PH, 2002, J HEPATOL, V36, P698, DOI 10.1016/S0168-8278(02)00021-1
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Elpeleg O, 2003, PEDIATR RES, V54, P153, DOI 10.1203/01.PDR.0000072796.25097.A5
   Elpeleg O, 2002, J MOL MED-JMM, V80, P389, DOI 10.1007/s00109-002-0343-5
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   FISHER RP, 1992, J BIOL CHEM, V267, P3358
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   MaaswinkelMooij PD, 1996, J PEDIATR-US, V128, P679, DOI 10.1016/S0022-3476(96)80134-X
   Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morris AAM, 1998, J HEPATOL, V28, P556, DOI 10.1016/S0168-8278(98)80278-X
   Müller-Höcker J, 1998, VIRCHOWS ARCH, V433, P529, DOI 10.1007/s004280050285
   Müller-Höcker J, 1998, VIRCHOWS ARCH, V432, P349, DOI 10.1007/s004280050177
   Müller-Höcker J, 2002, HUM PATHOL, V33, P247, DOI 10.1053/hupa.2002.31477
   Müller-Höcker J, 2001, APPL IMMUNOHISTO M M, V9, P276, DOI 10.1097/00022744-200109000-00013
   MUller-Hocker J., 1996, METHODS ENZYMOLOGY M, P540
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   MULLERHOCKER J, 1992, HUM PATHOL, V23, P1431, DOI 10.1016/0046-8177(92)90065-B
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   MULLERHOCKER J, 1989, HUM PATHOL, V20, P666, DOI 10.1016/0046-8177(89)90154-8
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   POULTON J, 1994, HUM MOL GENET, V3, P1763, DOI 10.1093/hmg/3.10.1763
   Reichenbach J, 2006, PEDIATR RES, V60, P321, DOI 10.1203/01.pdr.0000233252.60457.cf
   Roels F, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-4
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Santorelli FM, 2002, NEUROMUSCULAR DISORD, V12, P56, DOI 10.1016/S0960-8966(01)00248-6
   Schultz RA, 1998, J BIOL CHEM, V273, P3447, DOI 10.1074/jbc.273.6.3447
   SEIBEL P, 1991, Methods in Molecular and Cellular Biology, V2, P147
   Setzer B, 2005, J INFECT DIS, V191, P848, DOI 10.1086/427655
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Taanman JW, 2002, ANN NEUROL, V52, P237, DOI 10.1002/ana.10247
   Tanji K, 2003, LIVER INT, V23, P397, DOI 10.1034/j.1478-3231.2003.00864.x
   Tesarova M, 2004, NEUROPEDIATRICS, V35, P217, DOI 10.1055/s-2004-821081
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 63
TC 12
Z9 15
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1582-1838
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD FEB
PY 2011
VL 15
IS 2
BP 445
EP 456
DI 10.1111/j.1582-4934.2009.00819.x
PG 12
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA 726TL
UT WOS:000287749000023
PM 19538466
OA hybrid, Green Accepted, Green Published
DA 2024-11-01
ER

PT J
AU Garcia-Diaz, B
   Garone, C
   Barca, E
   Mojahed, H
   Gutierrez, P
   Pizzorno, G
   Tanji, K
   Arias-Mendoza, F
   Quinzii, CM
   Hirano, M
AF Garcia-Diaz, Beatriz
   Garone, Caterina
   Barca, Emanuele
   Mojahed, Hamed
   Gutierrez, Purification
   Pizzorno, Giuseppe
   Tanji, Kurenai
   Arias-Mendoza, Fernando
   Quinzii, Caterina M.
   Hirano, Michio
TI Deoxynucleoside stress exacerbates the phenotype of a mouse model of
   mitochondrial neurogastrointestinal encephalopathy
SO BRAIN
LA English
DT Article
DE MNGIE; animal model; thymidine; deoxyuridine; deoxynucleotide;
   mitochondrial DNA
ID THYMIDINE PHOSPHORYLASE GENE; ENZYME-REPLACEMENT THERAPY;
   ENCEPHALOMYOPATHY MNGIE; MULTIPLE DELETIONS; MTDNA MAINTENANCE; DNA
   DEPLETION; NUCLEOSIDE; TRANSPORTERS; TOXICITY; METABOLISM
AB Mitochondrial neurogastrointestinal encephalopathy (MNGIE) is an autosomal recessive disease caused by thymidine phosphorylase mutations. Garcia-Diaz et al. describe a mouse model of MNGIE, in which the clinical phenotype, leukoencephalopathy, and biochemical defects are exacerbated by thymidine and deoxyuridine administration.Balanced pools of deoxyribonucleoside triphosphate precursors are required for DNA replication, and alterations of this balance are relevant to human mitochondrial diseases including mitochondrial neurogastrointestinal encephalopathy. In this disease, autosomal recessive TYMP mutations cause severe reductions of thymidine phosphorylase activity; marked elevations of the pyrimidine nucleosides thymidine and deoxyuridine in plasma and tissues, and somatic multiple deletions, depletion and site-specific point mutations of mitochondrial DNA. Thymidine phosphorylase and uridine phosphorylase double knockout mice recapitulated several features of these patients including thymidine phosphorylase activity deficiency, elevated thymidine and deoxyuridine in tissues, mitochondrial DNA depletion, respiratory chain defects and white matter changes. However, in contrast to patients with this disease, mutant mice showed mitochondrial alterations only in the brain. To test the hypothesis that elevated levels of nucleotides cause unbalanced deoxyribonucleoside triphosphate pools and, in turn, pathogenic mitochondrial DNA instability, we have stressed double knockout mice with exogenous thymidine and deoxyuridine, and assessed clinical, neuroradiological, histological, molecular, and biochemical consequences. Mutant mice treated with exogenous thymidine and deoxyuridine showed reduced survival, body weight, and muscle strength, relative to untreated animals. Moreover, in treated mutants, leukoencephalopathy, a hallmark of the disease, was enhanced and the small intestine showed a reduction of smooth muscle cells and increased fibrosis. Levels of mitochondrial DNA were depleted not only in the brain but also in the small intestine, and deoxyribonucleoside triphosphate imbalance was observed in the brain. The relative proportion, rather than the absolute amount of deoxyribonucleoside triphosphate, was critical for mitochondrial DNA maintenance. Thus, our results demonstrate that stress of exogenous pyrimidine nucleosides enhances the mitochondrial phenotype of our knockout mice. Our mouse studies provide insights into the pathogenic role of thymidine and deoxyuridine imbalance in mitochondrial neurogastrointestinal encephalopathy and an excellent model to study new therapeutic approaches.
C1 [Garcia-Diaz, Beatriz; Garone, Caterina; Barca, Emanuele; Gutierrez, Purification; Quinzii, Caterina M.; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Garone, Caterina] Univ Bologna, Human Genet Joint PhD Program, I-10126 Turin, Italy.
   [Garone, Caterina] Univ Turin, Human Genet Joint PhD Program, I-10126 Turin, Italy.
   [Mojahed, Hamed] Columbia Univ, Med Ctr, Dept Biomed Engn, New York, NY 10032 USA.
   [Pizzorno, Giuseppe] Desert Res Inst, Human Hlth & Environm Program, Las Vegas, NV 89135 USA.
   [Tanji, Kurenai] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.
   [Arias-Mendoza, Fernando] Columbia Univ, Med Ctr, Dept Radiol, New York, NY 10032 USA.
C3 Columbia University; University of Bologna; University of Turin;
   Columbia University; Nevada System of Higher Education (NSHE); Desert
   Research Institute NSHE; Columbia University; Columbia University
RP Hirano, M (corresponding author), Columbia Univ, Med Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
EM mh29@columbia.edu
RI Ríos, Purificación/I-4234-2015; Garone, Caterina/AAB-8659-2019; Garcia
   Diaz, Beatriz/HJZ-2823-2023
OI Garcia Diaz, Beatriz/0000-0003-2655-571X; BARCA,
   EMANUELE/0009-0007-6672-6524; Garone, Caterina/0000-0003-4928-1037
FU National Institutes of Health (NIH) [R01 HD056103]; "Fundacion Alfonso
   Martin Escudero", Spain; NIH [R01 HD057543, U54 NS078059, P01 HD032062];
   Muscular Dystrophy Association (MDA); Marriott Mitochondrial Disorder
   Clinical Research Fund (MMDCRF)
FX This work was supported by National Institutes of Health (NIH) grant R01
   HD056103 (National Institute for Child Health and Development). Dr.
   Beatriz Garcia-Diaz is supported by a grant from the "Fundacion Alfonso
   Martin Escudero", Spain. In addition Dr. Michio Hirano is supported by
   grants from the NIH (R01 HD057543, U54 NS078059, and P01 HD032062) and
   Muscular Dystrophy Association (MDA) and by the Marriott Mitochondrial
   Disorder Clinical Research Fund (MMDCRF).
CR Blazquez A, 2005, NEUROMUSCULAR DISORD, V15, P775, DOI 10.1016/j.nmd.2005.07.008
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   De Vocht C, 2009, J CONTROL RELEASE, V137, P246, DOI 10.1016/j.jconrel.2009.03.020
   DESGRANGES C, 1981, BIOCHIM BIOPHYS ACTA, V654, P211, DOI 10.1016/0005-2787(81)90174-X
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2<107::AID-DVG3>3.0.CO;2-D
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   González-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Hirano M, 2004, TOP CURR GENET, V8, P177
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Johansson M, 2003, BIOCHEM BIOPH RES CO, V307, P41, DOI 10.1016/S0006-291X(03)01062-3
   Koczor CA, 2012, EXPERT OPIN DRUG MET, V8, P665, DOI 10.1517/17425255.2012.680885
   la Marca G, 2006, J MASS SPECTROM, V41, P586, DOI 10.1002/jms.1013
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Levene M, 2013, TOXICOL SCI, V131, P311, DOI 10.1093/toxsci/kfs278
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Martí R, 2003, CLIN CHEM LAB MED, V41, P845, DOI 10.1515/CCLM.2003.128
   Martí R, 2012, METHODS MOL BIOL, V837, P135, DOI 10.1007/978-1-61779-504-6_9
   Massaquoi SG, 1998, PARKINSONS DIS MOVEM, P623
   Minuesa G, 2009, J PHARMACOL EXP THER, V329, P252, DOI 10.1124/jpet.108.146225
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Quinzii CM, 2013, FASEB J, V27, P612, DOI 10.1096/fj.12-209361
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schupbach M, 2009, NEUROLOGY, V73, P332
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007
NR 46
TC 15
Z9 16
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD MAY
PY 2014
VL 137
BP 1337
EP 1349
DI 10.1093/brain/awu068
PN 5
PG 13
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AH6PK
UT WOS:000336252800014
PM 24727567
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Pons, R
   Andreu, AL
   Checcarelli, N
   Vilá, MR
   Engelstad, K
   Sue, CM
   Shungu, D
   Haggerty, R
   De Vivo, DC
   DiMauro, S
AF Pons, R
   Andreu, AL
   Checcarelli, N
   Vilá, MR
   Engelstad, K
   Sue, CM
   Shungu, D
   Haggerty, R
   De Vivo, DC
   DiMauro, S
TI Mitochondrial DNA abnormalities and autistic spectrum disorders
SO JOURNAL OF PEDIATRICS
LA English
DT Article
ID THYMIDINE KINASE; MELAS; GENE; DEPLETION; MUTATION
AB Objectives To further characterize mtDNA defects associated with autistic features, especially the A3243G mtDNA mutation and mtDNA depletion.
   Study design Five patients with autistic spectrum disorders and family histories of mitochondrial DNA diseases were studied. We performed mtDNA analysis in all patients and magnetic resonance spectroscopy in three.
   Results Three patients manifested isolated autistic spectrum features and two had additional neurologic symptoms. Two patients harbored the A3243G mutation. In two others, the A3243G mutation was not found in accessible tissues but was present in tissues from their mothers. The fifth patient had 72% mtDNA depletion in skeletal muscle.
   Conclusions Autistic spectrum disorders with or without additional neurologic features can be early presentations of the A3243G mtDNA mutation and can be a prominent clinical manifestation of mtDNA depletion. Mitochondrial dysfunction should be considered in patients who have autistic features and associated neurologic findings or who have evidence of maternal inheritance.
C1 Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA.
   Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA.
   Hosp Gen Valle Hebron, Ctr Invest Bioquim & Biol Mol, Barcelona, Spain.
C3 Columbia University; Columbia University; Columbia University; Hospital
   Universitari Vall d'Hebron
RP Columbia Univ Coll Phys & Surg, Dept Neurol, 4-420,630 W 168th St, New York, NY 10032 USA.
EM sd12@columbia.edu
RI Shungu, Dikoma/H-7110-2019
OI Sue, Carolyn/0000-0003-1255-3617; Shungu, Dikoma C/0000-0001-9452-2245;
   ANDREU, antonio luis/0000-0002-3936-3234
CR Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chugani DC, 1999, PROG NEURO-PSYCHOPH, V23, P635, DOI 10.1016/S0278-5846(99)00022-6
   DeLong GR, 1999, NEUROLOGY, V52, P911, DOI 10.1212/WNL.52.5.911
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 1998, NEUROSCIENTIST, V4, P53, DOI 10.1177/107385849800400113
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607
   Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559
   GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   Kaufmann P, 2002, NEUROLOGY, V58, pA315
   Kemper TL, 2002, MOL PSYCHIATR, V7, pS12, DOI 10.1038/sj.mp.4001165
   LASZLO A, 1994, CLIN CHIM ACTA, V229, P205, DOI 10.1016/0009-8981(94)90243-7
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Marin-Garcia J, 1999, PEDIATR NEUROL, V21, P538, DOI 10.1016/S0887-8994(99)00038-7
   MINSHEW NJ, 1993, BIOL PSYCHIAT, V33, P762, DOI 10.1016/0006-3223(93)90017-8
   Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Piven J, 1997, CURR OPIN NEUROBIOL, V7, P708, DOI 10.1016/S0959-4388(97)80093-1
   Rapin I, 1999, NEUROLOGY, V52, P902, DOI 10.1212/WNL.52.5.902
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sue CM, 1999, J PEDIATR-US, V134, P696, DOI 10.1016/S0022-3476(99)70283-0
   Thomeer EC, 1998, J NEUROL NEUROSUR PS, V64, P692, DOI 10.1136/jnnp.64.5.692
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
NR 28
TC 110
Z9 118
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3476
EI 1097-6833
J9 J PEDIATR-US
JI J. Pediatr.
PD JAN
PY 2004
VL 144
IS 1
BP 81
EP 85
DI 10.1016/j.jpeds.2003.10.023
PG 5
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 763MZ
UT WOS:000188091100015
PM 14722523
DA 2024-11-01
ER

PT J
AU Guney, O
   Ak, H
   Atay, S
   Ozkaya, AB
   Aydin, HH
AF Guney, Ozgur
   Ak, Handan
   Atay, Sevcan
   Ozkaya, Ali Burak
   Aydin, Hikmet Hakan
TI Mitochondrial DNA polymorphisms associated with longevity in the Turkish
   population
SO MITOCHONDRION
LA English
DT Article
DE Aging; Mitochondrial DNA; Sequencing; Longevity; Turkish
ID HUMAN SKELETAL-MUSCLE; CONTROL REGION; JAPANESE CENTENARIANS; MUTATIONS
   ACCUMULATE; ALZHEIMERS PATIENTS; POINT MUTATIONS; D-LOOP; HAPLOGROUP;
   SEQUENCE; INCREASE
AB The accumulation of mutations in mitochondrial DNA is a widely recognized mechanism for aging and age related diseases. However, studies indicate that some mutations could be beneficial to longevity by slowing down the function of the electron transport chain, reducing free radical production. In this study, we re-sequenced the entire mitochondrial DNA from 50 individuals and examined aging-related variations in the Turkish population. We evaluated sequence data by comparing whole SNP frequencies, individual SNP frequencies, the effect of SNPs, SNP accumulation in certain mtDNA regions and haplotype profiles between elderly and control groups. The frequency of total mitochondrial SNPs was significantly higher in nonagenarians than controls (p = 0.0094). Furthermore, non-coding, synonymous and tRNA mutations were more prevalent in the 90 + group compared to controls (p = 0.0001, p < 0.001, p = 0.0096, respectively). A73G and C152T polymorphisms were significantly associated with longevity in the Turkish population (p = 0.0086 and p = 0.004, respectively). Additionally, C150T was specific to the 90 + group, but the difference failed to reach statistical significance (p = 0.053). We also detected a novel transversion in the ATPase6 gene (C8899A) that was negatively associated with longevity (p = 0.0016). Examining the distribution of SNPs among genes and functionally associated gene regions revealed a significant accumulation of mutations in the D-loop region and genes encoding Complex I subunits (ND1-6) (p < 0.0001, p = 0.0302, respectively). Moreover, there was an increase in the non-synonymous mutation frequency of Complex I genes in aged subjects (p < 0.0001). Haplotype H was also significantly increased in the control group (p = 0.0405). Overall, our findings support a role for mitochondrial genome variations and the functionality of oxidative phosphorylation in longevity. In this report, we sequenced the whole mtDNA of the Turkish population for the first time. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Guney, Ozgur; Ak, Handan; Atay, Sevcan; Ozkaya, Ali Burak; Aydin, Hikmet Hakan] Ege Univ, Sch Med, Dept Med Biochem, TR-35100 Izmir, Turkey.
C3 Ege University
RP Aydin, HH (corresponding author), Ege Univ, Sch Med, Dept Med Biochem, TR-35100 Izmir, Turkey.
EM hhakan.aydin@gmail.com
RI GÜNEY, ÖZGÜR/HKN-1605-2023; Özkaya, Ali/D-2540-2017; Aydin,
   Hikmet/W-2845-2017; Ak, Handan/B-4746-2018
OI Aydin, Hikmet/0000-0002-4387-6745; Ak, Handan/0000-0002-3261-0036;
   Ozkaya, Ali Burak/0000-0002-4811-2082; GUNEY, OZGUR/0000-0002-1805-0626
FU Ege University Research Funds [2010 TIP 013]
FX This project was supported by the Ege University Research Funds (Project
   No. 2010 TIP 013).
CR Alexe G, 2007, HUM GENET, V121, P347, DOI 10.1007/s00439-007-0330-6
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Bandelt HJ, 2014, J HUM GENET, V59, P66, DOI 10.1038/jhg.2013.120
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Beekman M, 2013, AGING CELL, V12, P184, DOI 10.1111/acel.12039
   Bilal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002421
   Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046473
   Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100
   Czarnecka AM, 2010, ONCOL REP, V24, P1521, DOI 10.3892/or_00001014
   Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Feng J, 2011, EXP GERONTOL, V46, P987, DOI 10.1016/j.exger.2011.09.001
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Jin KL, 2010, AGING DIS, V1, P72
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Kenney M.C., 2013, BIOCHIM BIOPHYS ACTA, V1842, P208
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mergen H, 2004, J GENET, V83, P39, DOI 10.1007/BF02715828
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030874
   Navaglia F, 2006, AM J CLIN PATHOL, V126, P593, DOI 10.1309/GQFCCJMH5KHNVX73
   Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186
   Rea IM, 2013, AGE, V35, P1445, DOI 10.1007/s11357-012-9444-4
   Ren WH, 2008, CLIN EXP PHARMACOL P, V35, P1477, DOI 10.1111/j.1440-1681.2008.05028.x
   Richards M, 1996, AM J HUM GENET, V59, P185
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   SOONG NW, 1992, NAT GENET, V2, P318
   Takasaki S, 2008, COMPUT BIOL CHEM, V32, P332, DOI 10.1016/j.compbiolchem.2008.03.014
   Takasaki S, 2009, J GENET GENOMICS, V36, P425, DOI 10.1016/S1673-8527(08)60132-0
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Yang IS, 2013, J FORENSIC SCI, V58, P972, DOI 10.1111/1556-4029.12139
   Yang XR, 2012, MOL BIOL REP, V39, P9123, DOI 10.1007/s11033-012-1784-8
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zhang CF, 1998, HUM MUTAT, V11, P360
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
NR 56
TC 11
Z9 14
U1 11
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2014
VL 17
BP 7
EP 13
DI 10.1016/j.mito.2014.04.013
PG 7
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA AO1LD
UT WOS:000341072700002
PM 24792352
DA 2024-11-01
ER

PT J
AU Payne, BAI
   Wilson, IJ
   Yu-Wai-Man, P
   Coxhead, J
   Deehan, D
   Horvath, R
   Taylor, RW
   Samuels, DC
   Santibanez-Koref, M
   Chinnery, PF
AF Payne, Brendan A. I.
   Wilson, Ian J.
   Yu-Wai-Man, Patrick
   Coxhead, Jonathan
   Deehan, David
   Horvath, Rita
   Taylor, Robert W.
   Samuels, David C.
   Santibanez-Koref, Mauro
   Chinnery, Patrick F.
TI Universal heteroplasmy of human mitochondrial DNA
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID DOMINANT OPTIC ATROPHY; EXTERNAL OPHTHALMOPLEGIA; MUTATIONS; MTDNA;
   DISEASE; OPA1; COMMON; SEQUENCES; ATAXIA; CHAIN
AB Mammalian cells contain thousands of copies of mitochondrial DNA (mtDNA). At birth, these are thought to be identical in most humans. Here, we use long read length ultra-deep resequencing-by-synthesis to interrogate regions of the mtDNA genome from related and unrelated individuals at unprecedented resolution. We show that very low-level heteroplasmic variance is present in all tested healthy individuals, and is likely to be due to both inherited and somatic single base substitutions. Using this approach, we demonstrate an increase in mtDNA mutations in the skeletal muscle of patients with a proofreading-deficient mtDNA polymerase due to POLG mutations. In contrast, we show that OPA1 mutations, which indirectly affect mtDNA maintenance, do not increase point mutation load. The demonstration of universal mtDNA heteroplasmy has fundamental implications for our understanding of mtDNA inheritance and evolution. Ostensibly de novo somatic mtDNA mutations, seen in mtDNA maintenance disorders and neurodegenerative disease and aging, will partly be due to the clonal expansion of low-level inherited variants.
C1 [Payne, Brendan A. I.; Wilson, Ian J.; Yu-Wai-Man, Patrick; Coxhead, Jonathan; Horvath, Rita; Santibanez-Koref, Mauro; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Deehan, David] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Taylor, Robert W.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Samuels, David C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; Vanderbilt University
RP Chinnery, PF (corresponding author), Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM patrick.chinnery@ncl.ac.uk
RI Horvath, Rita/AAY-7042-2020; Payne, Brendan/I-1233-2016; Samuels,
   David/A-5393-2008
OI Horvath, Rita/0000-0002-9841-170X; Payne, Brendan/0000-0002-3101-3512;
   Samuels, David/0000-0003-3529-7791; Chinnery,
   Patrick/0000-0002-7065-6617; Wilson, Ian/0000-0001-6893-2873; Deehan,
   David/0000-0001-5780-8818
FU Wellcome Trust [906919]; Medical Research Council (UK); UK NIHR
   Biomedical Research Centre for Ageing and Age-related disease award; MRC
   (UK); National Institutes of Health [GM073744]; MRC [MR/K000608/1,
   G1002570, G0800470, G0701386] Funding Source: UKRI
FX Funding to pay Open Access publication for this article was provided by
   the Wellcome Trust.B.P. is a M. R. C. Clinical Research Training Fellow.
   P. F. C. is a Wellcome Trust Senior Fellow in Clinical Science and an
   NIHR Senior Investigator who also receives funding from the Medical
   Research Council (UK) and the UK NIHR Biomedical Research Centre for
   Ageing and Age-related disease award to the Newcastle upon Tyne
   Foundation Hospitals NHS Trust. R. H. was supported by the MRC (UK).
   P.Y.W.M. is an MRC Clinician Scientist. D. C. S. was supported by the
   National Institutes of Health through grant GM073744. R. W. T. was
   supported by the Wellcome Trust (906919).
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Daly GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028879
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Just RS, 2009, J FORENSIC SCI, V54, P887, DOI 10.1111/j.1556-4029.2009.01069.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/nmeth.1361, 10.1038/NMETH.1361]
   Santos M.A., 2011, METHOD MOL BIOL, V822, P189
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Simone D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-517
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wallace DC, 2010, P NATL ACAD SCI USA, V107, P8947, DOI 10.1073/pnas.0914635107
   Wonnapinij P, 2010, AM J HUM GENET, V86, P540, DOI 10.1016/j.ajhg.2010.02.023
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 37
TC 290
Z9 325
U1 2
U2 75
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 15
PY 2013
VL 22
IS 2
BP 384
EP 390
DI 10.1093/hmg/dds435
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 058RP
UT WOS:000312651800015
PM 23077218
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Jha, R
   Patel, H
   Dubey, R
   Goswami, JN
   Bhagwat, C
   Saini, L
   Manokaran, RK
   John, BM
   Kovilapu, UB
   Mohimen, A
   Saxena, A
   Sondhi, V
AF Jha, Ruchika
   Patel, Harshkumar
   Dubey, Rachana
   Goswami, Jyotindra N.
   Bhagwat, Chandana
   Saini, Lokesh
   Manokaran, Ranjith K.
   John, Biju M.
   Kovilapu, Uday B.
   Mohimen, Aneesh
   Saxena, Apoorv
   Sondhi, Vishal
TI Clinical and molecular spectrum associated with Polymerase-gamma related
   disorders
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mtDNA depletion; mitochondrial disease; Leigh; Alpers; ophthalmoplegia
ID DISEASE MUTATIONS; MITOCHONDRIAL; POLG; DEFECTS; A467T; MTDNA
AB Background POLG pathogenic variants are the commonest single-gene cause of inherited mitochondrial disease. However, the data on clinicogenetic associations in POLG-related disorders are sparse. This study maps the clinicogenetic spectrum of POLG-related disorders in the pediatric population. Methods Individuals were recruited across 6 centers in India. Children diagnosed between January 2015 and August 2020 with pathogenic or likely pathogenic POLG variants and age of onset <15 years were eligible. Phenotypically, patients were categorized into Alpers-Huttenlocher syndrome; myocerebrohepatopathy syndrome; myoclonic epilepsy, myopathy, and sensory ataxia; ataxia-neuropathy spectrum; Leigh disease; and autosomal dominant / recessive progressive external ophthalmoplegia. Results A total of 3729 genetic reports and 4256 hospital records were screened. Twenty-two patients with pathogenic variants were included. Phenotypically, patients were classifiable into Alpers-Huttenlocher syndrome (8/22; 36.4%), progressive external ophthalmoplegia (8/22; 36.4%), Leigh disease (2/22; 9.1%), ataxia-neuropathy spectrum (2/22; 9.1%), and unclassified (2/22; 9.1%). The prominent clinical manifestations included developmental delay (n = 14; 63.7%), neuroregression (n = 14; 63.7%), encephalopathy (n = 11; 50%), epilepsy (n = 11; 50%), ophthalmoplegia (n = 8; 36.4%), and liver dysfunction (n = 8; 36.4%). Forty-four pathogenic variants were identified at 13 loci, and these were clustered at exonuclease (18/44; 40.9%), linker (13/44; 29.5%), polymerase (10/44; 22.7%), and N-terminal domains (3/44; 6.8%). Genotype-phenotype analysis suggested that serious outcomes including neuroregression (odds ratio [OR] 11, 95% CI 2.5, 41), epilepsy (OR 9, 95% CI 2.4, 39), encephalopathy (OR 5.7, 95% CI 1.4, 19), and hepatic dysfunction (OR 4.6, 95% CI 21.3, 15) were associated with at least 1 variant involving linker or polymerase domain. Conclusions We describe the clinical subgroups and their associations with different POLG domains. These can aid in the development of follow-up and management strategies of presymptomatic individuals.
C1 [Jha, Ruchika; John, Biju M.; Saxena, Apoorv; Sondhi, Vishal] Armed Forces Med Coll, Dept Pediat, Pune 40, Maharashtra, India.
   [Patel, Harshkumar] Zydus Hosp, Dept Pediat Neurol, Ahmadabad, Gujarat, India.
   [Dubey, Rachana] Medanta Hosp, Dept Pediat Neurol, Indore, Madhya Pradesh, India.
   [Goswami, Jyotindra N.] Army Hosp Res & Referral, Dept Pediat, New Delhi, India.
   [Bhagwat, Chandana; Saini, Lokesh] Postgrad Inst Med Educ & Res, Dept Pediat, Pediat Neurol Unit, Chandigarh, India.
   [Manokaran, Ranjith K.] Sri Ramachandra Inst Higher Educ, Dept Neurol, Div Pediat Neurol, Chennai, Tamil Nadu, India.
   [Kovilapu, Uday B.] Armed Forces Med Coll, Dept Radiodiag, Pune, Maharashtra, India.
   [Mohimen, Aneesh] Command Hosp Cent Command, Dept Radiodiag, Lucknow, Uttar Pradesh, India.
C3 Armed Forces Medical College; Post Graduate Institute of Medical
   Education & Research (PGIMER), Chandigarh; Sri Ramachandra Institute of
   Higher Education & Research; Armed Forces Medical College
RP Sondhi, V (corresponding author), Armed Forces Med Coll, Dept Pediat, Pune 40, Maharashtra, India.
EM vishalsondhi@gmail.com
RI Saini, Lokesh/AAW-4168-2020; Sondhi, Vishal/AAY-2385-2021
OI saini, lokesh/0000-0003-3153-0736
CR Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Cohen B. H., 1993, GeneReviews((R))
   Copeland William C, 2003, ScientificWorldJournal, V3, P34
   DeLano WL., 2002, The PyMOL molecular graphics system
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 21
TC 8
Z9 8
U1 0
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAR
PY 2022
VL 37
IS 4
BP 246
EP 255
AR 08830738211067065
DI 10.1177/08830738211067065
EA JAN 2022
PG 10
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 0W4QW
UT WOS:000743606700001
PM 34986040
DA 2024-11-01
ER

PT J
AU McFarland, R
   Chinnery, PF
   Blakely, EL
   Schaefer, AM
   Morris, AAM
   Foster, SM
   Tuppen, HAL
   Ramesh, V
   Dorman, PJ
   Turnbull, M
   Taylor, RW
AF McFarland, R.
   Chinnery, P. F.
   Blakely, E. L.
   Schaefer, A. M.
   Morris, A. A. M.
   Foster, S. M.
   Tuppen, H. A. L.
   Ramesh, V.
   Dorman, P. J.
   Turnbull, M.
   Taylor, R. W.
TI Homoplasmy, heteroplasmy, and mitochondrial dystonia
SO NEUROLOGY
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; DNA MUTATION; POINT MUTATIONS; GENOME
   DATABASE; TRANSFER-RNA; GENE; DEHYDROGENASE; DISORDERS; ENCEPHALOPATHY;
   PATHOGENESIS
AB Background: In clinical practice, mitochondrial disease is seldom considered until a variable combination of seizures, alteration in tone, muscle weakness, and developmental problems is evident. However, it is not uncommon for one symptom to occur in isolation and dominate the clinical phenotype. We report six patients from two families where dystonia was the principal clinical manifestation. A mitochondrial etiology was considered in each case because of the association of dystonia with other less prominent clinical features such as epilepsy.
   Methods: Histochemical and biochemical analyses were undertaken in skeletal muscle biopsies from individuals in both families. Sequencing of skeletal muscle mtDNA was also performed and suspected mutations were quantified by hot last cycle PCR-RFLP or primer extension assay. Functional consequences of one of the mutations were investigated by measurement of steady state levels of mitochondrial tRNA.
   Results: Two distinct mitochondrial pathologies were identified: a novel, homoplasmic mitochondrial tRNACys (MTTC) mutation and the primary, m. 11778G>A Leber hereditary optic neuropathy (LHON) mutation. The mild nature of both mutations has permitted very high levels of mutated mtDNA to accumulate. Patients with the mutation in the MTTC gene have no wild type mtDNA detectable and although the LHON mutation is heteroplasmic in the patients we report, it is commonly observed to be homoplasmic.
   Conclusions: The mitochondrial etiology identified in these patients emphasizes the pathologic potential of homoplasmic mutations and has important implications for the investigation and genetic counseling of families where dystonia is the principal clinical feature. We advocate that mitochondrial disease should be given serious consideration in patients with familial, progressive dystonia, particularly when additional neurologic features such as epilepsy are present.
C1 Willink Biochem Genet Unit, Manchester, Lancs, England.
   Newcastle Upon Tyne NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP McFarland, R (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, 4th Floor,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.mcfarland@ncl.ac.uk
OI Schaefer, Andrew/0000-0001-9891-7332; Tuppen, Helen/0000-0001-8762-0824;
   McFarland, Robert/0000-0002-8833-2688; Chinnery,
   Patrick/0000-0002-7065-6617
FU MRC [G108/539] Funding Source: UKRI; Medical Research Council [G108/539]
   Funding Source: Medline; Wellcome Trust [074454] Funding Source: Medline
CR Aguiar PMD, 2002, LANCET NEUROL, V1, P316, DOI 10.1016/S1474-4422(02)00137-0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Chapiro E, 2002, EUR J HUM GENET, V10, P851, DOI 10.1038/sj.ejhg.5200894
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   DeVries DD, 1996, AM J HUM GENET, V58, P703
   Head RA, 2004, DEV MED CHILD NEUROL, V46, P710
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Manfredi G, 1996, HUM MUTAT, V7, P158
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MEIRE FM, 1995, OPHTHALMIC GENET, V16, P119, DOI 10.3109/13816819509059971
   Möllers M, 2005, NUCLEIC ACIDS RES, V33, P5647, DOI 10.1093/nar/gki876
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477
   Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3
   Santorelli FM, 1997, NEUROMUSCULAR DISORD, V7, P156, DOI 10.1016/S0960-8966(97)00444-6
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   SCUDERI C, 2007, IN PRESS NEUROMUSCUL
   SHOFFNER JM, 1995, ANN NEUROL, V38, P163, DOI 10.1002/ana.410380207
   Sudarsky L, 1999, MOVEMENT DISORD, V14, P488, DOI 10.1002/1531-8257(199905)14:3<488::AID-MDS1017>3.0.CO;2-4
   Svetel M, 2001, MOVEMENT DISORD, V16, P719, DOI 10.1002/mds.1118
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Taylor RW, 1997, ORGANELLE DIS
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
NR 28
TC 48
Z9 53
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0028-3878
J9 NEUROLOGY
JI Neurology
PD AUG 28
PY 2007
VL 69
IS 9
BP 911
EP 916
DI 10.1212/01.wnl.0000267843.10977.4a
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 204EA
UT WOS:000249025200015
PM 17724295
DA 2024-11-01
ER

PT J
AU Souilem, S
   Kefi, M
   Mancuso, M
   Nesti, C
   Hentati, F
   Amouri, R
AF Souilem, Sihem
   Kefi, Mounir
   Mancuso, Michelangelo
   Nesti, Claudia
   Hentati, Faycal
   Amouri, Rim
TI A Novel Heteroplasmic tRNA<SUP>Ser(UCN)</SUP> mtDNA Point Mutation
   Associated With Progressive Ophthalmoplegia and Dysphagia
SO DIAGNOSTIC MOLECULAR PATHOLOGY
LA English
DT Article
DE PEO; tRNA(Ser(UCN)); mitochondrial DNA
ID EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL
AB We report a novel heteroplasmic mitochondrial DNA mutation in the tRNA(Ser(UCN)) gene at nucleotide 7458 (m.7458G>A) in a 26-year-old patient affected with sporadic progressive external ophthalmoplegia associated with dysphagia. Muscle biopsy showed a strong succinate dehydrogenase staining, ragged red fibers, and 15% of cytochrome c oxidase-negative fibers. Activities of mitochondrial respiratory chain complexes I+III and IV were reduced. The mutation was heteroplasmic (75%) in the muscle, but undetectable in accessible tissues from the patient and his maternal relatives. This report expands the molecular heterogeneity of progressive external ophthalmoplegia.
C1 [Souilem, Sihem; Kefi, Mounir; Hentati, Faycal; Amouri, Rim] Natl Inst Neurol, Dept Mol Neurobiol & Neuropathol Rabta, Tunis 1007, Tunisia.
   [Mancuso, Michelangelo; Nesti, Claudia] Univ Pisa, Neurol Clin, Dept Neurosci, I-56100 Pisa, Italy.
C3 Universite de Tunis-El-Manar; Institut National de Neurologie;
   University of Pisa
RP Souilem, S (corresponding author), Natl Inst Neurol, Dept Mol Neurobiol & Neuropathol Rabta, Tunis 1007, Tunisia.
EM sihemsouilem@yahoo.fr
RI Mancuso, Michelangelo/K-4170-2016; Nesti, Claudia/K-5866-2016
OI Nesti, Claudia/0000-0001-5769-8655; AMOURI, RIM/0000-0001-5641-5748
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   BROWN MD, 1992, GENETICS, V130, P163
   Cardaioli E, 2007, NEUROMUSCULAR DISORD, V17, P681, DOI 10.1016/j.nmd.2007.05.001
   Chen B, 2008, AM J MED GENET A, V146A, P1248, DOI 10.1002/ajmg.a.32285
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Jones KJ, 1997, NEUROMUSCULAR DISORD, V7, P143, DOI 10.1016/S0960-8966(97)00447-1
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
NR 16
TC 3
Z9 6
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1052-9551
EI 1533-4066
J9 DIAGN MOL PATHOL
JI Diagn. Mol. Pathol.
PD MAR
PY 2010
VL 19
IS 1
BP 28
EP 32
DI 10.1097/PDM.0b013e3181b00f02
PG 5
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Pathology
GA 568LL
UT WOS:000275523700005
PM 20186009
DA 2024-11-01
ER

PT J
AU Kobayashi, A
   Goto, Y
   Nagata, M
   Yamaguchi, Y
AF Kobayashi, Akimitsu
   Goto, Yu-ichi
   Nagata, Michio
   Yamaguchi, Yutaka
TI Granular Swollen Epithelial Cells: A Histologic and Diagnostic Marker
   for Mitochondrial Nephropathy
SO AMERICAN JOURNAL OF SURGICAL PATHOLOGY
LA English
DT Article
DE mitochondrial nephropathy; focal segmental glomerulosclerosis;
   mitochondrial disease
ID FOCAL SEGMENTAL GLOMERULOSCLEROSIS; LACTIC-ACIDOSIS; MUTATION; DNA;
   ENCEPHALOPATHY; MYOPATHY; DELETION; PATIENT; DISEASE
AB Focal segmental glomerulosclerosis (FSGS) is a progressive kidney disease, and mitochondrial disease known to be a primary malady for secondary FSGS. Mitochondrial nephropathy with FSGS is diagnosed by genetic analysis or electron microscopy when it is suspected. As adequate morphologic features to diagnose mitochondrial nephropathy by light microscopy are lacking, this study used 10 cases v genetically proven mitochondrial disease and analyzed the kidney samples obtained by biopsy (n = 7) or autopsy (n = 3). We found granular swollen epithelial cells (GSECs) among the distal tubuli and collecting ducts in all patients, whereas such features were absent in IgA nephropathy, primary FSGS, and interstitial nephritis. Ultrastructural analysis of GSECs displayed accumulation of abnormal-shaped mitochondria in GSECs. To test whether GSECs were really associated with mitochondrial mutations, laser-captured single GSECs in I case with a position where 3,271 mutation were measured using a single-cell PCR analysis. This revealed that the mutant load of GSECs was significantly higher than normal-appearing epithelial cells within the same sample (63.4 +/- 17.8% vs. 32.5 +/- 4.6%; P < 0.0001). This is direct evidence that GSEC is a characteristic Cellular feature, indicating cells with mutant mitochondrial DNA accumulation. In addition, the incidence of GSECs did not correlate with serum creatinine levels, proteinuria, percent glomerulosclerosis, tubulointerstitial changes, or arteriolar hyalinosis, suggesting that GSECs per se may not cause tissue damage. In conclusion, GSEC is a distinct morphologic feature suggesting mitochondrial nephropathy and is a useful tool to identify secondary FSGS on the basis of mitochondrial abnormalities.
C1 [Kobayashi, Akimitsu] Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens,Minato Ku, Tokyo 1058471, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Nagata, Michio] Univ Tsukuba, Dept Pathol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan.
   [Yamaguchi, Yutaka] Jikei Univ, Kashiwa Hosp, Sch Med, Dept Pathol, Chiba, Japan.
C3 Jikei University; National Center for Neurology & Psychiatry - Japan;
   University of Tsukuba; Jikei University
RP Kobayashi, A (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058471, Japan.
EM akimitsu@kk.iij4u.or.jp
FU Ministry of Health, Labour and Welfare of Japan [18A-5]; Japan Health
   Sciences Foundation [KHD2207]
FX This work was supported in part by a Research Grant (18A-5) for Nervous
   and Mental Disorders from the Ministry of Health, Labour and Welfare of
   Japan (Y.G.) and a grant of the Comprehensive Research Project on Health
   Sciences Focusing on Drug Innovation (KHD2207) from the Japan Health
   Sciences Foundation (Y.G.).
CR Adedoyin O, 2004, PEDIATR NEPHROL, V19, P408, DOI 10.1007/s00467-003-1396-6
   Au KM, 2007, PEDIATR NEPHROL, V22, P136, DOI 10.1007/s00467-006-0288-y
   D'Agati VD, 2008, CURR OPIN NEPHROL HY, V17, P271, DOI 10.1097/MNH.0b013e3282f94a96
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Dinour D, 2004, CLIN NEPHROL, V62, P149
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   EGGER J, 1981, ARCH DIS CHILD, V56, P741, DOI 10.1136/adc.56.10.741
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, J PEDIATR-US, V116, P904, DOI 10.1016/S0022-3476(05)80648-1
   Güçer S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Mallick N, 2003, NEPHROL DIAL TRANSPL, V18, P64, DOI 10.1093/ndt/gfg1065
   Mita S, 1998, MUSCLE NERVE, V21, P490, DOI 10.1002/(SICI)1097-4598(199804)21:4<490::AID-MUS7>3.0.CO;2-4
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Nagashima T, 2001, NEUROMUSCULAR DISORD, V11, P470, DOI 10.1016/S0960-8966(01)00190-0
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164, DOI 10.1007/BF00865468
   Niaudet P, 1997, KIDNEY INT, V51, P1000, DOI 10.1038/ki.1997.140
   Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x
   Yamagata K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019772.17954.F8
NR 23
TC 17
Z9 19
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0147-5185
EI 1532-0979
J9 AM J SURG PATHOL
JI Am. J. Surg. Pathol.
PD FEB
PY 2010
VL 34
IS 2
BP 262
EP 270
DI 10.1097/PAS.0b013e3181cb4ed3
PG 9
WC Pathology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Surgery
GA 551OV
UT WOS:000274219800015
PM 20090504
DA 2024-11-01
ER

PT J
AU Su, TH
   Turnbull, DM
   Greaves, LC
AF Su, Tianhong
   Turnbull, Doug M.
   Greaves, Laura C.
TI Roles of Mitochondrial DNA Mutations in Stem Cell Ageing
SO GENES
LA English
DT Review
DE stem cell; mitochondrial DNA mutation; ageing; purifying selection;
   mitochondrial mutagenesis; progenitor; mitochondrial disease; ageing
   mouse model; mitochondrial DNA-mutator mouse; mitochondria
ID PATHOGENIC MTDNA MUTATIONS; HUMAN SKELETAL-MUSCLE; 4977 BP DELETION;
   SEQUENCE HETEROGENEITY; PURIFYING SELECTION; AUTOPHAGY MAINTAINS; POINT
   MUTATIONS; TRANSMISSION; ACCUMULATE; PHENOTYPES
AB Mitochondrial DNA (mtDNA) mutations accumulate in somatic stem cells during ageing and cause mitochondrial dysfunction. In this review, we summarize the studies that link mtDNA mutations to stem cell ageing. We discuss the age-related behaviours of the somatic mtDNA mutations in stem cell populations and how they potentially contribute to stem cell ageing by altering mitochondrial properties in humans and in mtDNA-mutator mice. We also draw attention to the diverse fates of the mtDNA mutations with different origins during ageing, with potential selective pressures on the germline inherited but not the somatic mtDNA mutations.
C1 [Su, Tianhong; Turnbull, Doug M.; Greaves, Laura C.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Turnbull, Doug M.; Greaves, Laura C.] Newcastle Univ, Med Sch, LLHW Ctr Aging & Vital, Inst Aging, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Greaves, LC (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Greaves, LC (corresponding author), Newcastle Univ, Med Sch, LLHW Ctr Aging & Vital, Inst Aging, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM t.su2@newcastle.ac.uk; doug.tumbull@newcastle.ac.uk;
   laura.greaves@newcastle.ac.uk
OI Greaves, Laura/0000-0002-8071-5916; Turnbull, Doug/0000-0002-8878-9901
FU Newcastle University Centre for Aging and Vitality - Biotechnology and
   Biological Sciences Research Council (BBSRC); Newcastle University
   Centre for Aging and Vitality - Engineering and Physical Sciences
   Research Council (EPSRC); Newcastle University Centre for Aging and
   Vitality - Economic and Social Research Council (ESRC); Newcastle
   University Centre for Aging and Vitality - Medical Research Council
   (MRC) as part of the cross-council Lifelong Health and Wellbeing
   Initiative; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z];
   UK National Institute for Health Research (NIHR) Biomedical Research
   Centre in Age and Age Related Diseases; UK NHS Highly Specialized
   Service for Rare Mitochondrial Disorders of Adults and Children; MRC
   [MR/L016354/1] Funding Source: UKRI
FX This work was supported by the Newcastle University Centre for Aging and
   Vitality supported by the Biotechnology and Biological Sciences Research
   Council (BBSRC), Engineering and Physical Sciences Research Council
   (EPSRC), Economic and Social Research Council (ESRC), and Medical
   Research Council (MRC) as part of the cross-council Lifelong Health and
   Wellbeing Initiative; the Wellcome Centre for Mitochondrial Research
   (203105/Z/16/Z); UK National Institute for Health Research (NIHR)
   Biomedical Research Centre in Age and Age Related Diseases award to the
   Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation;
   the UK NHS Highly Specialized Service for Rare Mitochondrial Disorders
   of Adults and Children.
CR Ahlqvist KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7494
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alexeyev M., 2013, Cold Spring Harb Perspect Biol, V5, DOI DOI 10.1101/CSHPERSPECT.A012641
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Baines HL, 2014, AGING CELL, V13, P201, DOI 10.1111/acel.12199
   Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Greaves LC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003082
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Gutierrez-Gonzalez L, 2009, J PATHOL, V217, P489, DOI 10.1002/path.2502
   Hämäläinen RH, 2016, CURR OPIN GENET DEV, V38, P83, DOI 10.1016/j.gde.2016.04.008
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Li-Harms X, 2015, BLOOD, V125, P162, DOI 10.1182/blood-2014-07-586396
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nooteboom M, 2010, AGING CELL, V9, P96, DOI 10.1111/j.1474-9726.2009.00531.x
   NORBY S, 1994, J MED GENET, V31, P45, DOI 10.1136/jmg.31.1.45
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Olsson C, 2001, EUR J HUM GENET, V9, P917, DOI 10.1038/sj.ejhg.5200742
   Orogo AM, 2015, J BIOL CHEM, V290, P22061, DOI 10.1074/jbc.M115.649657
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pinto M, 2017, CELL DEATH DIFFER, V24, P288, DOI 10.1038/cdd.2016.123
   Popadin K, 2014, AM J PATHOL, V184, P2852, DOI 10.1016/j.ajpath.2014.09.001
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Shin MG, 2004, BLOOD, V103, P4466, DOI 10.1182/blood-2003-11-3949
   Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724
   Someya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171159
   Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952
   Tan DQ, 2018, ANTIOXID REDOX SIGN, V29, P149, DOI 10.1089/ars.2017.7273
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   tHart LM, 1996, HUM MUTAT, V7, P193
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042
   Wang X, 2013, HUM MOL GENET, V22, P3976, DOI 10.1093/hmg/ddt251
   Zheng YJ, 2012, BOSNIAN J BASIC MED, V12, P187, DOI 10.17305/bjbms.2012.2480
NR 76
TC 11
Z9 11
U1 1
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD APR
PY 2018
VL 9
IS 4
AR 182
DI 10.3390/genes9040182
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA GJ3HH
UT WOS:000435182200010
PM 29584704
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Arbeithuber, B
   Hester, J
   Cremona, MA
   Stoler, N
   Zaidi, A
   Higgins, B
   Anthony, K
   Chiaromonte, F
   Diaz, FJ
   Makova, KD
AF Arbeithuber, Barbara
   Hester, James
   Cremona, Marzia A.
   Stoler, Nicholas
   Zaidi, Arslan
   Higgins, Bonnie
   Anthony, Kate
   Chiaromonte, Francesca
   Diaz, Francisco J.
   Makova, Kateryna D.
TI Age-related accumulation of de novo mitochondrial mutations in mammalian
   oocytes and somatic tissues
SO PLOS BIOLOGY
LA English
DT Article
ID BASE EXCISION-REPAIR; RANDOM GENETIC DRIFT; POINT MUTATIONS; DNA
   MUTATIONS; MTDNA HETEROPLASMY; SEQUENCE; RATES; METHYLATION; MUSCLE;
   MICE
AB Mutations create genetic variation for other evolutionary forces to operate on and cause numerous genetic diseases. Nevertheless, how de novo mutations arise remains poorly understood. Progress in the area is hindered by the fact that error rates of conventional sequencing technologies (1 in 100 or 1,000 base pairs) are several orders of magnitude higher than de novo mutation rates (1 in 10,000,000 or 100,000,000 base pairs per generation). Moreover, previous analyses of germline de novo mutations examined pedigrees (and not germ cells) and thus were likely affected by selection. Here, we applied highly accurate duplex sequencing to detect low-frequency, de novo mutations in mitochondrial DNA (mtDNA) directly from oocytes and from somatic tissues (brain and muscle) of 36 mice from two independent pedigrees. We found mtDNA mutation frequencies 2- to 3-fold higher in 10-month-old than in 1-month-old mice, demonstrating mutation accumulation during the period of only 9 mo. Mutation frequencies and patterns differed between germline and somatic tissues and among mtDNA regions, suggestive of distinct mutagenesis mechanisms. Additionally, we discovered a more pronounced genetic drift of mitochondrial genetic variants in the germline of older versus younger mice, arguing for mtDNA turnover during oocyte meiotic arrest. Our study deciphered for the first time the intricacies of germline de novo mutagenesis using duplex sequencing directly in oocytes, which provided unprecedented resolution and minimized selection effects present in pedigree studies. Moreover, our work provides important information about the origins and accumulation of mutations with aging/maturation and has implications for delayed reproduction in modern human societies. Furthermore, the duplex sequencing method we optimized for single cells opens avenues for investigating low-frequency mutations in other studies.
C1 [Arbeithuber, Barbara; Zaidi, Arslan; Higgins, Bonnie; Anthony, Kate; Makova, Kateryna D.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA.
   [Hester, James; Chiaromonte, Francesca; Diaz, Francisco J.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.
   [Cremona, Marzia A.] Penn State Univ, Dept Stat, University Pk, PA 16802 USA.
   [Stoler, Nicholas] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.
   [Chiaromonte, Francesca] St Anna Sch Adv Studies, EMbeDS, Pisa, Italy.
   [Cremona, Marzia A.] Univ Laval, Dept Operat & Decis Syst, Quebec City, PQ, Canada.
   [Zaidi, Arslan] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park; Scuola Superiore Sant'Anna; Laval University;
   University of Pennsylvania
RP Makova, KD (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.
EM kdm16@psu.edu
RI Cremona, Marzia/AAU-2989-2020; Arbeithuber, Barbara/AAE-8557-2022
OI Makova, Kateryna/0000-0002-6212-9526; Arbeithuber,
   Barbara/0000-0001-8367-1560; Cremona, Marzia Angela/0000-0001-8899-7316
FU NIH [R01GM116044]; Austrian Science Fund (FWF) [J-4096]; Office of
   Science Engagement at Penn State; Huck Institute of Life Sciences at
   Penn State; Institute for Computational and Data Sciences at Penn State;
   Pennsylvania Department of Health; Eberly College of Sciences at Penn
   State; Austrian Science Fund (FWF) [J4096] Funding Source: Austrian
   Science Fund (FWF)
FX This project was supported by a grant from NIH (R01GM116044) for KDM and
   a Schrodinger Fellowship from the Austrian Science Fund (FWF) for BA:
   J-4096. Additional funding was provided by the Office of Science
   Engagement, Eberly College of Sciences, The Huck Institute of Life
   Sciences and the Institute for Computational and Data Sciences at Penn
   State, as well as, in part, under grants from the Pennsylvania
   Department of Health using Tobacco Settlement and CURE Funds. The
   department specifically disclaims any responsibility for any analyses,
   responsibility or conclusions. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379
   Ahn EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136216
   Alseth I, 2014, CURR OPIN GENET DEV, V26, P116, DOI 10.1016/j.gde.2014.07.008
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Ancora M, 2017, MITOCHONDRIAL DNA A, V28, P180, DOI 10.3109/19401736.2015.1115499
   Anderson AP, 2020, NUCLEIC ACIDS RES, V48, P817, DOI 10.1093/nar/gkz1018
   [Anonymous], [No title captured]
   [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174
   Barrett A, 2019, PHILOS T R SOC B, DOI [10.1098/rstb.2019-0175, DOI 10.1098/RSTB.2019-0175]
   Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Blankenberg D, 2014, GENOME BIOL, V15, DOI 10.1186/gb4161
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Boucret L, 2017, HUM REPROD, V32, P2101, DOI 10.1093/humrep/dex268
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016
   Burgstaller JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04797-2
   Calabrese FM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S15
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862
   Dianov GL, 2001, PROG NUCLEIC ACID RE, V68, P285
   DIMONTE DA, 1991, NEUROLOGY, V41, P38, DOI 10.1212/WNL.41.5_Suppl_2.38
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Fan LH, 2019, BIOCHEM BIOPH RES CO, V513, P912, DOI 10.1016/j.bbrc.2019.04.100
   Fox Edward J, 2014, Next Gener Seq Appl, V1
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Gianoarli L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102182
   Gigarel N, 2011, AM J HUM GENET, V88, P494, DOI 10.1016/j.ajhg.2011.03.010
   Goldmann JM, 2016, NAT GENET, V48, P935, DOI 10.1038/ng.3597
   Grazina M, 2006, GENES BRAIN BEHAV, V5, P92, DOI 10.1111/j.1601-183X.2006.00225.x
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Halldorsson BV, 2019, SCIENCE, V363, P364, DOI 10.1126/science.aau1043
   Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834
   Hendy MD, 2009, BIOL LETTERS, V5, P397, DOI 10.1098/rsbl.2009.0104
   Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098
   Hoekstra JG, 2016, ANN NEUROL, V80, P301, DOI 10.1002/ana.24709
   Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974
   Jacobs L, 2007, MOL HUM REPROD, V13, P149, DOI 10.1093/molehr/gal112
   Jayaprakash AD, 2015, NUCLEIC ACIDS RES, V43, P2177, DOI 10.1093/nar/gkv052
   Jee J, 2016, NATURE, V534, P693, DOI 10.1038/nature18313
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jónsson H, 2017, NATURE, V549, P519, DOI 10.1038/nature24018
   Jun G, 2015, GENOME RES, V25, P918, DOI 10.1101/gr.176552.114
   Katju V, 2019, GENOME BIOL EVOL, V11, P136, DOI 10.1093/gbe/evy252
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Kessler MD, 2020, P NATL ACAD SCI USA, V117, P2560, DOI 10.1073/pnas.1902766117
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396
   Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Lei L, 2016, SCIENCE, V352, P95, DOI 10.1126/science.aad2156
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lindsay SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12023-w
   Liu BJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23421
   Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003
   Ma H, 2020, BIOL REPROD, V102, P607, DOI 10.1093/biolre/ioz202
   Ma H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201304
   Maclaine KD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226860
   Marchington DR, 1997, AM J HUM GENET, V60, P408
   Mason PA, 2003, FEBS LETT, V554, P6, DOI 10.1016/S0014-5793(03)01169-4
   Mechta M, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00166
   Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Morris J, 2017, CELL REP, V21, P2706, DOI 10.1016/j.celrep.2017.11.031
   Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Patil V, 2019, NUCLEIC ACIDS RES, V47, P10072, DOI 10.1093/nar/gkz762
   POLLACK Y, 1984, NUCLEIC ACIDS RES, V12, P4811, DOI 10.1093/nar/12.12.4811
   Poulton J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001066
   Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Santibanez-Koref M, 2019, MITOCHONDRION, V46, P302, DOI 10.1016/j.mito.2018.08.003
   Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Shtolz N, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00342
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stoler N, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3419-8
   Stoler N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1039-4
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thrash A, 2018, ANAL BIOCHEM, V548, P38, DOI 10.1016/j.ab.2018.01.028
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Uchimura A, 2015, GENOME RES, V25, P1125, DOI 10.1101/gr.186148.114
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990
   Wong WSW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10486
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zambelli F, 2018, STEM CELL REP, V11, P102, DOI 10.1016/j.stemcr.2018.05.007
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 106
TC 48
Z9 56
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD JUL
PY 2020
VL 18
IS 7
AR e3000745
DI 10.1371/journal.pbio.3000745
PG 37
WC Biochemistry & Molecular Biology; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA MQ6ZX
UT WOS:000553044200001
PM 32667908
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Yamanaka, H
   Gatanaga, H
   Kosalaraksa, P
   Matsuoka-Aizawa, S
   Takahashi, T
   Kimura, S
   Oka, S
AF Yamanaka, Hikaru
   Gatanaga, Hiroyuki
   Kosalaraksa, Pope
   Matsuoka-Aizawa, Saori
   Takahashi, Takao
   Kimura, Satoshi
   Oka, Shinichi
TI Novel mutation of human DNA polymerase γ associated with mitochondrial
   toxicity induced by anti-HIV treatment
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT 16th International AIDS Conference
CY AUG 13-18, 2006
CL Toronto, CANADA
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HUMAN-IMMUNODEFICIENCY-VIRUS;
   INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; NUCLEOSIDE; POLG; AIDS;
   DEPLETION; DELETIONS; ANALOGS
AB Mitochondrial toxicity is a major adverse effect of the nucleoside reverse-transcriptase inhibitors (NRTIs) used for treatment of human immunodeficiency virus type 1 (HIV-1) infection and can result in life-threatening lactic acidosis. The toxicity is due to inhibition of polymerase gamma (Pol gamma), which is required for replication of mitochondrial DNA (mtDNA). Genetic factors could be involved in this process, given that not all NRTI treated patients experience the toxicity. In 1 patient with lactic acidosis, a novel homozygous Pol gamma mutation (arginine to cysteine at codon 964 [R964C]) was identified at a site close to polymerase motif B, which is highly conserved among family A polymerases. Recombinant R964C Pol gamma showed only 14% activity, compared with that of wild-type Pol gamma. Culture with stavudine significantly reduced mtDNA levels in patient-derived lymphoblastoid cell lines (LCLs) harboring R964C Pol gamma, compared with those in LCLs harboring wild-type Pol gamma. The novel Pol gamma mutation could be associated with the severe lactic acidosis induced by long-term NRTI use.
C1 Int Med Ctr Japan, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1628655, Japan.
   Keio Univ, Sch Med, Dept Pediat, Keio, Japan.
   Tokyo Teishin Hosp, Tokyo, Japan.
   Khon Kaen Univ, Fac Med, Dept Pediat, Khon Kaen, Thailand.
C3 National Center for Global Health & Medicine - Japan; Keio University;
   Khon Kaen University
RP Gatanaga, H (corresponding author), Int Med Ctr Japan, AIDS Clin Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.
EM higatana@imcj.acc.go.jp
CR [Anonymous], GUID US ANT AG HIV 1
   Boubaker K, 2001, CLIN INFECT DIS, V33, P1931, DOI 10.1086/324353
   Cohen J, 2003, SCIENCE, V301, P1662, DOI 10.1126/science.301.5640.1662
   Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155
   Cossarizza A, 2004, AIDS, V18, P137, DOI 10.1097/00002030-200401230-00002
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   DUDLEY MN, 1992, J INFECT DIS, V166, P480, DOI 10.1093/infdis/166.3.480
   Fang GW, 1999, NAT MED, V5, P239, DOI 10.1038/5607
   Feng JY, 2001, J BIOL CHEM, V276, P23832, DOI 10.1074/jbc.M101156200
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Miró O, 2004, CLIN INFECT DIS, V39, P710, DOI 10.1086/423176
   Montaner JSG, 2003, JAIDS-J ACQ IMM DEF, V34, pS85, DOI 10.1097/00126334-200309011-00013
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Odawara F, 2002, J VIROL METHODS, V106, P115, DOI 10.1016/S0166-0934(02)00142-8
   Penzak SR, 2003, JAMA-J AM MED ASSOC, V289, P2648, DOI 10.1001/jama.289.20.2648-c
   Petit C, 2003, JAIDS-J ACQ IMM DEF, V33, P461, DOI 10.1097/00126334-200308010-00006
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Suzuki T, 1997, J GEN VIROL, V78, P3073, DOI 10.1099/0022-1317-78-12-3073
   Suzuki T, 2002, JPN J PHARMACOL, V90, P210, DOI 10.1254/jjp.90.210
   UENO T, 1995, J BIOL CHEM, V270, P23605, DOI 10.1074/jbc.270.40.23605
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251
NR 32
TC 67
Z9 75
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAY 15
PY 2007
VL 195
IS 10
BP 1419
EP 1425
DI 10.1086/513872
PG 7
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Immunology; Infectious Diseases; Microbiology
GA 158HG
UT WOS:000245781800006
PM 17436221
OA Bronze
DA 2024-11-01
ER

PT J
AU Alila-Fersi, O
   Chamkha, I
   Majdoub, I
   Gargouri, L
   Mkaouar-Rebai, E
   Tabebi, M
   Tlili, A
   Keskes, L
   Mahfoudh, A
   Fakhfakh, F
AF Alila-Fersi, Olfa
   Chamkha, Imen
   Majdoub, Imen
   Gargouri, Lamia
   Mkaouar-Rebai, Emna
   Tabebi, Mouna
   Tlili, Abdelaziz
   Keskes, Leila
   Mahfoudh, Abdelmajid
   Fakhfakh, Faiza
TI Co segregation of the m.1555A>G mutation in the MT-RNR1 gene and
   mutations in MT-ATP6 gene in a family with dilated mitochondrial
   cardiomyopathy and hearing loss: A whole mitochondrial genome screening
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Dilated mitochondrial cardiomyopathy; Hearing loss; m.1555A>G;
   m.8605C>T; m.8527A>G; m.8932C>T
ID PROLINE RESIDUES; PREDICTION; PATIENT; HELIX
AB Mitochondrial disease refers to a heterogeneous group of disorders resulting in defective cellular energy production due to dysfunction of the mitochondrial respiratory chain, which is responsible for the generation of most cellular energy. Because cardiac muscles are one of the high energy demanding tissues, mitochondrial cardiomyopathies is one of the most frequent mitochondria disorders. Mitochondrial cardiomyopathy has been associated with several point mutations of mtDNA in both genes encoded mitochondrial proteins and mitochondrial tRNA and rRNA.
   We reported here the first description of mutations in MT-ATP6 gene in two patients with clinical features of dilated mitochondrial cardiomyopathy. The mutational analysis of the whole mitochondrial DNA revealed the presence of m.1555A>G mutation in MT-RNR1 gene associated to the m.8527A>G (p.M>V) and the m.8392C>T (p.136P>S) variations in the mitochondrial MT-ATP6 gene in patient) and his family members with variable phenotype including hearing impairment. The second patient with isolated mitochondrial cardiomyopathy presented the m.8605C>T (p.27P>S) mutation in the MT-ATP6 gene. The three mutations p.M1V, p.P27S and p.P136S detected in MT-ATP6 affected well conserved residues of the mitochondrial protein ATPase 6. In addition, the substitution of proline residue at position 27 and 136 effect hydrophobicity and structure flexibility conformation of the protein. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Alila-Fersi, Olfa; Mkaouar-Rebai, Emna; Fakhfakh, Faiza] Univ Sfax, Fac Sci Sfax, Sfax, Sfax, Tunisia.
   [Chamkha, Imen] Lund Univ, Dept Mitochondrial Med, S-22100 Lund, Sweden.
   [Majdoub, Imen; Gargouri, Lamia; Mahfoudh, Abdelmajid] CHU Hedi Chaker Sfax Tunisia, Serv Reanimat Pediat, Sfax, Tunisia.
   [Tabebi, Mouna; Keskes, Leila] Univ Sfax, Fac Med Sfax, Lab Genet Mol Humaine, Sfax, Sfax, Tunisia.
   [Mahfoudh, Abdelmajid] Univ Sharjah, Coll Sci, Dept Appl Biol, Sharjah, U Arab Emirates.
C3 Universite de Sfax; Faculty of Sciences Sfax; Lund University;
   Universite de Sfax; Hopital Hedi Chaker; Universite de Sfax; University
   of Sharjah
RP Alila-Fersi, O; Fakhfakh, F (corresponding author), Fac Sci Sfax, Lab Genet Mol & Fonct, Route Soukra Km 2-5, Sfax 3000, Tunisia.
EM alilafersiolfa@yahoo.fr; faiza.fakhfakh02@gmail.com
RI Tlili, Abdelaziz/AAE-8699-2020; tabebi, mouna/AAL-2270-2020;
   MKAOUAR-REBAI, Emna/AAE-6650-2019
OI Tlili, Abdelaziz/0000-0002-8039-3013; Keskes, Leila/0000-0002-8420-139X;
   Mkaouar-Rebai, Emna/0000-0003-3095-510X; Chamkha,
   Imen/0000-0002-6919-585X; tabebi, mouna/0000-0002-2873-161X
FU Ministry of the Higher Education; Scientific Research in Tunisia
FX We thank the patients and their families for their cooperation in the
   present study. This work was supported by The Ministry of the Higher
   Education and the Scientific Research in Tunisia.
CR Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Arnold RS, 2009, PROSTATE, V69, P1, DOI 10.1002/pros.20854
   Arnold S, 2001, FEBS LETT, V490, P70, DOI 10.1016/S0014-5793(01)02139-1
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Biedermannova L, 2008, PHYS CHEM CHEM PHYS, V10, P6350, DOI 10.1039/b805087b
   Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   Brunel-Guitton C, 2015, CAN J CARDIOL, V31, P1360, DOI 10.1016/j.cjca.2015.08.017
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Chen J, 2006, DIABETES RES CLIN PR, V74, P148, DOI 10.1016/j.diabres.2006.03.024
   Cheng Zu-jian, 2009, Zhonghua Yi Xue Za Zhi, V89, P2536
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   CONSLER TG, 1991, BIOCHEMISTRY-US, V30, P1291, DOI 10.1021/bi00219a019
   Deschauer M, 2000, MOL GENET METAB, V70, P235, DOI 10.1006/mgme.2000.3002
   Dubot A, 2004, BIOCHEM BIOPH RES CO, V313, P687, DOI 10.1016/j.bbrc.2003.12.013
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Felhi R, 2016, BIOCHEM BIOPH RES CO, V473, P61, DOI 10.1016/j.bbrc.2016.03.050
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Hagen CM, 2013, MOL GENET GENOM MED, V1, P54, DOI 10.1002/mgg3.5
   Hejzlarová K, 2014, PHYSIOL RES, V63, pS57, DOI 10.33549/physiolres.932643
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818
   MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H
   Marin-Garcia J, 2000, J CARD FAIL, V6, P321, DOI 10.1054/jcaf.2000.19232
   Mkaouar-Rebai E, 2006, BIOCHEM BIOPH RES CO, V340, P1251, DOI 10.1016/j.bbrc.2005.12.123
   Niedzwiecka K, 2016, MITOCHONDRION, V29, P7, DOI 10.1016/j.mito.2016.04.003
   Nilsson I, 1998, J MOL BIOL, V284, P1165, DOI 10.1006/jmbi.1998.2217
   Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Tsai JD, 2012, PEDIATR NEONATOL, V53, P60, DOI 10.1016/j.pedneo.2011.11.012
NR 40
TC 8
Z9 9
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD FEB 26
PY 2017
VL 484
IS 1
BP 71
EP 78
DI 10.1016/j.bbrc.2017.01.070
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA EL1VW
UT WOS:000394410500012
PM 28104394
DA 2024-11-01
ER

PT J
AU Palmieri, F
   Scarcia, P
   Monné, M
AF Palmieri, Ferdinando
   Scarcia, Pasquale
   Monne, Magnus
TI Diseases Caused by Mutations in Mitochondrial Carrier Genes
   <i>SLC25</i>: A Review
SO BIOMOLECULES
LA English
DT Review
DE disease; error of metabolism; mitochondrial carrier; mitochondrial
   carrier disease; mitochondrial disease; mitochondrial transporter;
   membrane transport; mutation; SLC25
ID RECONSTITUTED DICARBOXYLATE CARRIER; CARNITINE-ACYLCARNITINE
   TRANSLOCASE; S-ADENOSYLMETHIONINE TRANSPORTER; ADENINE-NUCLEOTIDE
   TRANSLOCATOR; RAT-LIVER MITOCHONDRIA; DE-NOVO MUTATIONS;
   LOSS-OF-FUNCTION; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION;
   PHOSPHATE-CARRIER
AB In the 1980s, after the mitochondrial DNA (mtDNA) had been sequenced, several diseases resulting from mtDNA mutations emerged. Later, numerous disorders caused by mutations in the nuclear genes encoding mitochondrial proteins were found. Agroup of these diseases are due to defects of mitochondrial carriers, a family of proteins named solute carrier family 25 (SLC25), that transport a variety of solutes such as the reagents of ATP synthase (ATP, ADP, and phosphate), tricarboxylic acid cycle intermediates, cofactors, amino acids, and carnitine esters of fatty acids. The disease-causing mutations disclosed in mitochondrial carriers range from point mutations, which are often localized in the substrate translocation pore of the carrier, to large deletions and insertions. The biochemical consequences of deficient transport are the compartmentalized accumulation of the substrates and dysfunctional mitochondrial and cellular metabolism, which frequently develop into various forms of myopathy, encephalopathy, or neuropathy. Examples of diseases, due to mitochondrial carrier mutations are: combined D-2- and L-2-hydroxyglutaric aciduria, carnitine-acylcarnitine carrier deficiency, hyperornithinemia-hyperammonemia-homocitrillinuria (HHH) syndrome, early infantile epileptic encephalopathy type 3, Amish microcephaly, aspartate/glutamate isoform 1 deficiency, congenital sideroblastic anemia, Fontaine progeroid syndrome, and citrullinemia type II. Here, we review all the mitochondrial carrier-related diseases known until now, focusing on the connections between the molecular basis, altered metabolism, and phenotypes of these inherited disorders.
C1 [Palmieri, Ferdinando; Scarcia, Pasquale; Monne, Magnus] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Lab Biochem & Mol Biol, Via E Orabona 4, I-70125 Bari, Italy.
   [Monne, Magnus] Univ Basilicata, Dept Sci, Via Ateneo Lucano 10, I-85100 Potenza, Italy.
C3 Universita degli Studi di Bari Aldo Moro; University of Basilicata;
   Italfarmaco
RP Palmieri, F; Monné, M (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Lab Biochem & Mol Biol, Via E Orabona 4, I-70125 Bari, Italy.; Monné, M (corresponding author), Univ Basilicata, Dept Sci, Via Ateneo Lucano 10, I-85100 Potenza, Italy.
EM ferdpalmieri@gmail.com; pasquale.scarcia@uniba.it;
   magnus.monne@unibas.it
RI Monne, Magnus/D-5642-2012; Scarcia, Pasquale/A-8830-2010
OI Monne, Magnus/0000-0003-2344-3878; Scarcia, Pasquale/0000-0001-6216-0411
FU Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR);
   Centre of Excellence "Genomics: genes involved in pathopysiological
   processes in the biomedical and agricultural fields" (CEGBA); Comitato
   Telethon Fondazione Onlus [GGP11139]; Italian Human ProteomeNet; PRIN
   2017 [2017PAB8EM_004]
FX Research in the authors' laboratories was supported by grants from the
   Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR),
   Centre of Excellence "Genomics: genes involved in pathopysiological
   processes in the biomedical and agricultural fields" (CEGBA), Comitato
   Telethon Fondazione Onlus No. GGP11139, Italian Human ProteomeNet, and
   PRIN 2017 (2017PAB8EM_004).
CR Abrams AJ, 2018, HUM MUTAT, V39, P1995, DOI 10.1002/humu.23639
   Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664
   Almannai M, 2018, CLIN GENET, V93, P1097, DOI 10.1111/cge.13210
   Bhoj EJ, 2015, JIMD REP, V19, P59, DOI 10.1007/8904_2014_364
   BISACCIA F, 1988, BIOCHIM BIOPHYS ACTA, V933, P229, DOI 10.1016/0005-2728(88)90030-8
   BISACCIA F, 1984, BIOCHIM BIOPHYS ACTA, V766, P386, DOI 10.1016/0005-2728(84)90254-8
   BISACCIA F, 1989, BIOCHIM BIOPHYS ACTA, V977, P171, DOI 10.1016/S0005-2728(89)80068-4
   BISACCIA F, 1993, BIOCHIM BIOPHYS ACTA, V1142, P139, DOI 10.1016/0005-2728(93)90095-W
   BISACCIA F, 1985, BIOCHIM BIOPHYS ACTA, V810, P362, DOI 10.1016/0005-2728(85)90222-1
   Boczonadi V, 2018, GENET MED, V20, P1224, DOI 10.1038/gim.2017.251
   Bottega R, 2019, J HUM GENET, V64, P1075, DOI 10.1038/s10038-019-0666-5
   Braunisch MC, 2018, CLIN GENET, V93, P255, DOI 10.1111/cge.13084
   Buffet A, 2018, CANCER RES, V78, P1914, DOI 10.1158/0008-5472.CAN-17-2463
   Camacho JA, 1999, NAT GENET, V22, P151, DOI 10.1038/9658
   Camacho JA, 2006, PEDIATR RES, V60, P423, DOI 10.1203/01.pdr.0000238301.25938.f5
   Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220
   Chaouch Amina, 2014, J Neuromuscul Dis, V1, P75
   Cohen I, 2018, AM J MED GENET A, V176, P330, DOI 10.1002/ajmg.a.38574
   CROMPTON M, 1974, FEBS LETT, V46, P247, DOI 10.1016/0014-5793(74)80379-0
   CROMPTON M, 1974, BIOCHEM J, V142, P127, DOI 10.1042/bj1420127
   CROMPTON M, 1975, BIOCHEM J, V146, P667, DOI 10.1042/bj1460667
   Dahlin M, 2015, EPILEPSIA, V56, pe176, DOI 10.1111/epi.13193
   Dard L, 2020, MOL ASPECTS MED, V71, DOI 10.1016/j.mam.2019.100842
   Davis Ryan L, 2018, Handb Clin Neurol, V147, P125, DOI 10.1016/B978-0-444-63233-3.00010-5
   De Lucas JR, 2008, MOL MEMBR BIOL, V25, P152, DOI 10.1080/09687680701697476
   del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200
   Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034
   DOLCE V, 1994, J BIOL CHEM, V269, P10451
   Dolce V, 1996, FEBS LETT, V399, P95, DOI 10.1016/S0014-5793(96)01294-X
   Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Edvardson S, 2013, J MED GENET, V50, P240, DOI 10.1136/jmedgenet-2012-101485
   Eguchi M, 2018, AM J MED GENET A, V176, P351, DOI 10.1002/ajmg.a.38578
   Ehmke N, 2017, AM J HUM GENET, V101, P833, DOI 10.1016/j.ajhg.2017.09.016
   Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911
   Falk MJ, 2014, JIMD REP, V14, P77, DOI 10.1007/8904_2013_287
   Ferrara CT, 2017, J CLIN ENDOCR METAB, V102, P942, DOI 10.1210/jc.2016-3164
   Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200
   Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200
   Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200
   Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782
   Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200
   Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754
   FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293
   Fiermonte G, 1992, DNA Seq, V3, P71, DOI 10.3109/10425179209033999
   Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118
   Gorgoglione R, 2019, BBA-BIOENERGETICS, V1860, P724, DOI 10.1016/j.bbabio.2019.07.010
   Goubert E, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00149
   Gowda VK, 2019, NEUROPEDIATRICS, V50, P313, DOI 10.1055/s-0039-1693148
   Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359
   Hammer MB, 2017, NEURODEGENER DIS, V17, P208, DOI 10.1159/000464445
   Harborne SPD, 2015, BBA-BIOENERGETICS, V1847, P1245, DOI 10.1016/j.bbabio.2015.07.002
   Hayasaka K, 2018, J INHERIT METAB DIS, V41, P777, DOI 10.1007/s10545-018-0176-1
   Hellebrekers DM, 2017, EUR J HUM GENET, V25, P886, DOI 10.1038/ejhg.2017.62
   Huizing M, 1998, J BIOENERG BIOMEMBR, V30, P277, DOI 10.1023/A:1020501021222
   Huizing M, 1997, AM J HUM GENET, V61, P1239, DOI 10.1086/301628
   Iacobazzi V, 2004, HUM MUTAT, V24, P312, DOI 10.1002/humu.20085
   Ijlst L, 2001, BIOCHEM BIOPH RES CO, V280, P700, DOI 10.1006/bbrc.2000.4178
   INDIVERI C, 1989, BIOCHIM BIOPHYS ACTA, V977, P187, DOI 10.1016/S0005-2728(89)80070-2
   INDIVERI C, 1992, EUR J BIOCHEM, V207, P449, DOI 10.1111/j.1432-1033.1992.tb17070.x
   INDIVERI C, 1987, J BIOL CHEM, V262, P15979
   INDIVERI C, 1989, BIOCHIM BIOPHYS ACTA, V977, P194, DOI 10.1016/S0005-2728(89)80071-4
   Indiveri C, 1997, BIOCHEM J, V327, P349, DOI 10.1042/bj3270349
   INDIVERI C, 1987, BIOCHIM BIOPHYS ACTA, V890, P310, DOI 10.1016/0005-2728(87)90158-7
   Indiveri C, 1997, BIOCHEM J, V321, P713, DOI 10.1042/bj3210713
   Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008
   Iuso Arcangela, 2019, JIMD Rep, V44, P1, DOI 10.1007/8904_2018_115
   Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200
   Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khan S, 2018, BRIT J DERMATOL, V178, P556, DOI 10.1111/bjd.15661
   Kim J, 2018, P NATL ACAD SCI USA, V115, P4690, DOI 10.1073/pnas.1800138115
   King MS, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000256
   Kishita Y, 2015, AM J HUM GENET, V97, P761, DOI 10.1016/j.ajhg.2015.09.013
   KLINGENBERG M, 1979, TRENDS BIOCHEM SCI, V4, P249, DOI 10.1016/0968-0004(79)90215-9
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Köse MD, 2020, J PEDIATR ENDOCR MET, V33, P157, DOI 10.1515/jpem-2019-0377
   Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5
   Kwong JQ, 2014, CELL DEATH DIFFER, V21, P1209, DOI 10.1038/cdd.2014.36
   Lasorsa FM, 2003, J BIOL CHEM, V278, P38686, DOI 10.1074/jbc.M304988200
   Le Rouzic MA, 2017, BLOOD CELL MOL DIS, V66, P11, DOI 10.1016/j.bcmd.2017.07.003
   Lemattre C, 2019, EUR J HUM GENET, V27, P1692, DOI 10.1038/s41431-019-0433-2
   Lindhurst MJ, 2006, P NATL ACAD SCI USA, V103, P15927, DOI 10.1073/pnas.0607661103
   Liu J, 2017, J MOL NEUROSCI, V62, P262, DOI 10.1007/s12031-017-0929-6
   Lunetti P, 2016, J BIOL CHEM, V291, P19746, DOI 10.1074/jbc.M116.736876
   Majd H, 2018, BBA-BIOENERGETICS, V1859, P1, DOI 10.1016/j.bbabio.2017.10.002
   Marobbio CMT, 2008, J BIOL CHEM, V283, P28445, DOI 10.1074/jbc.M804637200
   Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574
   Marobbio CMT, 2002, EMBO J, V21, P5653, DOI 10.1093/emboj/cdf583
   Martinelli D, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0242-9
   Matsumoto S, 2019, J HUM GENET, V64, P833, DOI 10.1038/s10038-019-0614-4
   Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788
   Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005
   McCormick EM, 2018, CURR OPIN PEDIATR, V30, P714, DOI 10.1097/MOP.0000000000000686
   MCGIVAN JD, 1971, EUR J BIOCHEM, V20, P392, DOI 10.1111/j.1432-1033.1971.tb01405.x
   Molinari F, 2005, AM J HUM GENET, V76, P334, DOI 10.1086/427564
   Molinari F, 2009, CLIN GENET, V76, P188, DOI 10.1111/j.1399-0004.2009.01236.x
   Monné M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184456
   Monné M, 2017, J BIOENERG BIOMEMBR, V49, P369, DOI 10.1007/s10863-017-9721-0
   Monné M, 2014, CURR TOP MEMBR, V73, P289, DOI 10.1016/B978-0-12-800223-0.00008-6
   Monné M, 2013, MOL MEMBR BIOL, V30, P149, DOI 10.3109/09687688.2012.737936
   Monné M, 2012, J BIOL CHEM, V287, P7925, DOI 10.1074/jbc.M111.324855
   Napolioni V, 2011, MOL NEUROBIOL, V44, P83, DOI 10.1007/s12035-011-8192-2
   Nguyen M, 2017, CLIN GENET, V91, P121, DOI 10.1111/cge.12774
   Nota B, 2013, AM J HUM GENET, V92, P627, DOI 10.1016/j.ajhg.2013.03.009
   Ortigoza-Escobar JD, 2017, ANN NEUROL, V82, P317, DOI 10.1002/ana.24998
   PALMIERI F, 1970, EUR J BIOCHEM, V17, P230, DOI 10.1111/j.1432-1033.1970.tb01158.x
   Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7
   Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3
   PALMIERI F, 1972, EUR J BIOCHEM, V26, P587, DOI 10.1111/j.1432-1033.1972.tb01801.x
   PALMIERI F, 1993, J BIOENERG BIOMEMBR, V25, P493, DOI 10.1007/BF01108406
   PALMIERI F, 1971, EUR J BIOCHEM, V22, P66, DOI 10.1111/j.1432-1033.1971.tb01515.x
   PALMIERI F, 1972, EUR J BIOCHEM, V29, P408, DOI 10.1111/j.1432-1033.1972.tb02003.x
   PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7
   Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008
   Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023
   Palmieri F, 2016, BBA-MOL CELL RES, V1863, P2362, DOI 10.1016/j.bbamcr.2016.03.007
   Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5
   Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005
   Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x
   Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/BSE0470037, 10.1042/bse0470037]
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200
   Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060
   Palmieri L, 2006, PLANT PHYSIOL, V142, P855, DOI 10.1104/pp.106.086975
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Pérez P, 2003, FUNGAL GENET BIOL, V39, P211, DOI 10.1016/S1087-1845(03)00049-5
   Petralla S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184486
   Pfeiffer B, 2020, NEUROPEDIATRICS, V51, P160, DOI 10.1055/s-0039-3400976
   Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007
   Pierri CL, 2014, CELL MOL LIFE SCI, V71, P349, DOI 10.1007/s00018-013-1389-y
   Poduri A, 2013, ANN NEUROL, V74, P873, DOI 10.1002/ana.23998
   Pop A, 2018, J INHERIT METAB DIS, V41, P169, DOI 10.1007/s10545-017-0106-7
   Prasun P, 2015, JIMD REP, V19, P111, DOI 10.1007/8904_2014_378
   Profilo E, 2017, BBA-MOL BASIS DIS, V1863, P1422, DOI 10.1016/j.bbadis.2017.02.022
   Prohl C, 2001, MOL CELL BIOL, V21, P1089, DOI 10.1128/MCB.21.4.1089-1097.2001
   Punzi G, 2018, HUM MOL GENET, V27, P499, DOI 10.1093/hmg/ddx419
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Reid ES, 2017, J INHERIT METAB DIS, V40, P385, DOI 10.1007/s10545-017-0025-7
   Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103
   Rosenberg MJ, 2002, NAT GENET, V32, P175, DOI 10.1038/ng948
   Rosenthal EA, 2013, AM J HUM GENET, V93, P1035, DOI 10.1016/j.ajhg.2013.10.019
   RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004
   Ruprecht JJ, 2019, CELL, V176, P435, DOI 10.1016/j.cell.2018.11.025
   Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, pE426, DOI 10.1073/pnas.1320692111
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Ryu J, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0921-9
   Saheki T, 2002, J HUM GENET, V47, P333, DOI 10.1007/s100380200046
   Saheki T., 2017, GENEREVIEWS NCBI BOO
   Saheki T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39627-y
   SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0
   Scarcia P, 2017, MOL GENET METAB, V122, P54, DOI 10.1016/j.ymgme.2017.07.004
   Schiff M, 2016, NEW ENGL J MED, V374, P795, DOI 10.1056/NEJMc1513610
   Shamseldin HE, 2016, HUM GENET, V135, P21, DOI 10.1007/s00439-015-1608-8
   Shelton GD, 2019, J NEUROMUSCULAR DIS, V6, P485, DOI 10.3233/JND-190421
   Smith A, 2016, JIMD REP, V30, P73, DOI 10.1007/8904_2016_536
   Spaan AN, 2005, MOL GENET METAB, V86, P441, DOI 10.1016/j.ymgme.2005.07.014
   Spiegel R, 2009, ANN NEUROL, V66, P419, DOI 10.1002/ana.21752
   Stanley C.A., 2013, ONLINE MOL METHODS B
   STANLEY CA, 1992, NEW ENGL J MED, V327, P19, DOI 10.1056/NEJM199207023270104
   Sulaiman RA, 2017, CLIN GENET, V92, P230, DOI 10.1111/cge.12963
   Tabata A, 2008, J HUM GENET, V53, P534, DOI 10.1007/s10038-008-0282-2
   Tessa A, 2009, HUM MUTAT, V30, P741, DOI 10.1002/humu.20930
   Thangaratnarajah C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6491
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200
   Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200
   Tonazzi A, 2012, BBA-BIOENERGETICS, V1817, P697, DOI 10.1016/j.bbabio.2012.02.007
   Tosserams A, 2018, MITOCHONDRION, V39, P26, DOI 10.1016/j.mito.2017.08.009
   Trabelsi Y, 2017, GLIA, V65, P401, DOI 10.1002/glia.23099
   Tunali NE, 2014, MOL GENET METAB, V112, P25, DOI 10.1016/j.ymgme.2014.03.002
   Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   von Renesse Anja, 2019, JIMD Rep, V43, P27, DOI 10.1007/8904_2018_93
   Vozza A, 2017, BBA-BIOENERGETICS, V1858, P137, DOI 10.1016/j.bbabio.2016.11.006
   Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111
   Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wan JJ, 2016, BRAIN, V139, P2877, DOI 10.1093/brain/aww212
   Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591
   Writzl K, 2017, AM J HUM GENET, V101, P844, DOI 10.1016/j.ajhg.2017.09.017
   Zara V, 2003, J MOL BIOL, V325, P399, DOI 10.1016/S0022-2836(02)01236-6
   ZARA V, 1992, J BIOL CHEM, V267, P12077
   Zara V, 2009, BIOCHEM J, V419, P369, DOI 10.1042/BJ20082270
   ZARRILLI R, 1989, MOL ENDOCRINOL, V3, P1498, DOI 10.1210/mend-3-9-1498
NR 188
TC 68
Z9 75
U1 1
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD APR
PY 2020
VL 10
IS 4
AR 655
DI 10.3390/biom10040655
PG 32
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA LW9WG
UT WOS:000539492400159
PM 32340404
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, P
   Davies, VJ
   Piechota, MJ
   Cree, LM
   Votruba, M
   Chinnery, PF
AF Yu-Wai-Man, Patrick
   Davies, Vanessa J.
   Piechota, Malgorzata J.
   Cree, Lynsey M.
   Votruba, Marcela
   Chinnery, Patrick F.
TI Secondary mtDNA Defects Do Not Cause Optic Nerve Dysfunction in a Mouse
   Model of Dominant Optic Atrophy
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID MITOCHONDRIAL-DNA DELETIONS; SUBSTANTIA-NIGRA NEURONS; OPA1 MUTATIONS;
   EXTERNAL OPHTHALMOPLEGIA; DEFICIENCY; MORPHOLOGY; PHENOTYPE; MOLECULES;
   DISEASE; CELLS
AB PURPOSE. The majority of patients with autosomal dominant optic atrophy (DOA) harbor pathogenic OPA1 mutations and certain missense mutations, mostly within the GTPase domain, have recently been shown to cause multiple mitochondrial DNA (mtDNA) deletions in skeletal muscle. This raises the possibility that the optic neuropathy could be the result of secondary mtDNA defects accumulating within retinal ganglion cells (RGCs). To explore this hypothesis, the authors looked for evidence of mitochondrial dysfunction in a mouse model of DOA and documented the visual and neurologic progression in aging mutant mice.
   METHODS. Visual function was assessed with a rotating optokinetic (OKN) drum at ages 13 and 18 months and neurologic phenotyping was performed using the primary SHIRPA screen at age 13 months, comparing mutant Opa1(+/-) mice with wild-type C57B1/6 mice. The presence of cytochrome c oxidase (COX) deficiency and multiple mtDNA deletions was investigated in gastrocnemius muscle and eye specimens harvested from 2- and 11-month-old Opa1(+/+) and Opa1(+/-) mice.
   RESULTS. At age 13 months, Opa1(+/-) mice had a statistically significant reduction in OKN responses compared to C57B1/6 controls with both 2 degrees and 8 degrees gratings (P < 0.001). At age 18 months, the difference between the two groups was significant for the 8 degrees grating (P = 0.003) but not for the 2 degrees grating (P = 0.082). Opa1(+/-) mice did not exhibit any significant neuromuscular deficits and no COX deficient areas or secondary mtDNA deletions were identified in skeletal muscle or the RGC layer. There was also no evidence of significant mtDNA depletion or proliferation in skeletal muscle from Opa1(+/-) mice.
   CONCLUSIONS. COX deficiency and mtDNA abnormalities do not contribute to optic nerve dysfunction in pure DOA. (Invest Ophthalmol Vis Sci. 2009; 50: 4561-4566) DOI:10.1167/iovs.093634
C1 [Yu-Wai-Man, Patrick; Cree, Lynsey M.; Chinnery, Patrick F.] Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Davies, Vanessa J.] Cardiff Univ, Cardiff Neurosci Ctr, Cardiff, S Glam, Wales.
   [Davies, Vanessa J.; Piechota, Malgorzata J.; Votruba, Marcela] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales.
   [Votruba, Marcela] Univ Wales Hosp, Cardiff Eye Unit, Cardiff CF4 4XW, S Glam, Wales.
C3 Newcastle University - UK; Newcastle University - UK; Cardiff
   University; Cardiff University; Cardiff University
RP Yu-Wai-Man, P (corresponding author), Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM patrick.yu-wai-man@ncl.ac.uk
RI Votruba, Marcela/B-7306-2015; Votruba, Marcela/A-6182-2011
OI Piechota, Malgorzata/0000-0001-7511-8626; Votruba,
   Marcela/0000-0002-7680-9135; Chinnery, Patrick/0000-0002-7065-6617;
   Cree, Lynsey/0000-0003-2090-1589
FU Medical Research Council, UK; MRC [G0700949, G0701386] Funding Source:
   UKRI
FX Supported by a grant from the Medical Research Council, UK (MV). PY is
   an MRC Clinical Research Fellow; PFC is a Wellcome Trust Senior Fellow
   in Clinical Science.
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Carpenter S, 2001, PATHOLOGY SKELETAL M, P8
   COHN AC, 2008, BR J OPHTHALMOL, V24, P24
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Davies V, 2006, EXP EYE RES, V83, P1003, DOI 10.1016/j.exer.2005.11.021
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Ferré M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161
   Hart AW, 2005, INVEST OPHTH VIS SCI, V46, P3443, DOI 10.1167/iovs.05-0254
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   JOHNSON MA, 1996, HDB MUSCLE DIS, P61
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lightowlers RH, 1999, TRENDS GENET, V15, P91, DOI 10.1016/S0168-9525(98)01684-9
   Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278
   Newman NJ, 2004, EYE, V18, P1144, DOI 10.1038/sj.eye.6701591
   Puomila A, 2005, ACTA OPHTHALMOL SCAN, V83, P337, DOI 10.1111/j.1600-0420.2005.00448.x
   Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thaung C, 2002, NEUROSCI LETT, V325, P21, DOI 10.1016/S0304-3940(02)00223-9
   Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793
   White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   [No title captured]
NR 30
TC 19
Z9 20
U1 0
U2 5
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD OCT
PY 2009
VL 50
IS 10
BP 4561
EP 4566
DI 10.1167/iovs.09-3634
PG 6
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 497XE
UT WOS:000270097200007
PM 19443720
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Pham, TD
   Wallace, DC
   Burke, PJ
AF Pham, Ted D.
   Wallace, Douglas C.
   Burke, Peter J.
TI Microchambers with Solid-State Phosphorescent Sensor for Measuring
   Single Mitochondrial Respiration
SO SENSORS
LA English
DT Article
DE respiration; mitochondria; oxygen consumption rate; phosphorescent
   probes; PtTFPP
ID OXYGEN SENSORS; HETEROPLASMY; TISSUE; PROBES; CELLS; SELECTION;
   LIFETIME; MUSCLE; MTDNA; DNA
AB It is now well established that, even within a single cell, multiple copies of the mitochondrial genome may be present (genetic heteroplasmy). It would be interesting to develop techniques to determine if and to what extent this genetic variation results in functional variation from one mitochondrion to the next (functional heteroplasmy). Measuring mitochondrial respiration can reveal the organelles' functional capacity for Adenosine triphosphate (ATP) production and determine mitochondrial damage that may arise from genetic or age related defects. However, available technologies require significant quantities of mitochondria. Here, we develop a technology to assay the respiration of a single mitochondrion. Our "micro-respirometer" consists of micron sized chambers etched out of borofloat glass substrates and coated with an oxygen sensitive phosphorescent dye Pt(II) meso-tetra(pentafluorophenyl) porphine (PtTFPP) mixed with polystyrene. The chambers are sealed with a polydimethylsiloxane layer coated with oxygen impermeable Viton rubber to prevent diffusion of oxygen from the environment. As the mitochondria consume oxygen in the chamber, the phosphorescence signal increases, allowing direct determination of the respiration rate. Experiments with coupled vs. uncoupled mitochondria showed a substantial difference in respiration, confirming the validity of the microchambers as single mitochondrial respirometers. This demonstration could enable future high-throughput assays of mitochondrial respiration and benefit the study of mitochondrial functional heterogeneity, and its role in health and disease.
C1 [Pham, Ted D.; Burke, Peter J.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.
   [Wallace, Douglas C.] Univ Penn, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.
   [Burke, Peter J.] Univ Calif Irvine, Dept Elect Engn, Irvine, CA 92697 USA.
C3 University of California System; University of California Irvine;
   University of Pennsylvania; University of California System; University
   of California Irvine
RP Burke, PJ (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.; Burke, PJ (corresponding author), Univ Calif Irvine, Dept Elect Engn, Irvine, CA 92697 USA.
EM tedp@uci.edu; wallaced1@email.chop.edu; pburke@uci.edu
RI Burke, Peter/F-3308-2010
OI Burke, Peter/0000-0002-8883-1014
FU NIH National Cancer Institute [1R21CA143351-01]
FX This work was made possible, in part, through access to the confocal
   facility of the Optical Biology Shared Resource at UCIrvine. Peter J.
   Burke acknowledges funding from NIH National Cancer Institute Grant
   1R21CA143351-01.
CR [Anonymous], 2013, BIOENERGETICS 4
   Celina M, 2005, MACROMOLECULES, V38, P2754, DOI 10.1021/ma0487913
   Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025
   CLARK LC, 1953, J APPL PHYSIOL, V6, P189, DOI 10.1152/jappl.1953.6.3.189
   Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   Dmitriev RI, 2014, BIOMATER SCI-UK, V2, P853, DOI 10.1039/c3bm60272a
   Dmitriev RI, 2012, CELL MOL LIFE SCI, V69, P2025, DOI 10.1007/s00018-011-0914-0
   Dragavon J, 2008, J R SOC INTERFACE, V5, pS151, DOI [10.1098/rsif.2008.0106.focus, 10.1098/rsif.2008.0106]
   Drioli E., 2010, Comprehensive Membrane Science and Engineering, V1st
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   GEAR ARL, 1972, J CELL BIOL, V54, P325, DOI 10.1083/jcb.54.2.325
   Grad LI, 2005, P NATL ACAD SCI USA, V102, P18367, DOI 10.1073/pnas.0506939102
   Grist SM, 2015, SENSORS-BASEL, V15, P20030, DOI 10.3390/s150820030
   Hütter E, 2006, EXP GERONTOL, V41, P457, DOI 10.1016/j.exger.2006.02.004
   Hüser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311
   Instruments W., WARN INSTR MIT MIN R
   Kurokawa H, 2015, SCI REP-UK, V5, DOI 10.1038/srep10657
   Lascaratos G, 2007, VISION RES, V47, P1191, DOI 10.1016/j.visres.2006.12.014
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Liu H, 2013, SMALL, V9, P2639, DOI 10.1002/smll.201203127
   Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794
   Molter TW, 2008, IEEE T AUTOM SCI ENG, V5, P32, DOI 10.1109/TASE.2007.909441
   Molter TW, 2009, SENSOR ACTUAT B-CHEM, V135, P678, DOI 10.1016/j.snb.2008.10.036
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Nock V, 2008, LAB CHIP, V8, P1300, DOI 10.1039/b801879k
   Nock V, 2010, MICROELECTRON ENG, V87, P814, DOI 10.1016/j.mee.2009.11.076
   O'Riordan TC, 2000, ANAL BIOCHEM, V278, P221, DOI 10.1006/abio.1999.4431
   Papkovsky DB, 2004, METHOD ENZYMOL, V381, P715
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   PEACOCK RN, 1980, J VAC SCI TECHNOL, V17, P330, DOI 10.1116/1.570380
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Quaranta Michela, 2012, Bioanal Rev, V4, P115
   Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746
   RUMSEY WL, 1988, SCIENCE, V241, P1649, DOI 10.1126/science.3420417
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Skolimowski M, 2010, LAB CHIP, V10, P2162, DOI 10.1039/c003558k
   SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671
   Van Dam M., 2006, THESIS
   Vollmer AP, 2005, LAB CHIP, V5, P1059, DOI 10.1039/b508097e
   Wallace DC, 2011, COLD SH Q B, V76, P1, DOI 10.1101/sqb.2011.76.010462
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Will Y, 2006, NAT PROTOC, V1, P2563, DOI 10.1038/nprot.2006.351
   Wu CF, 2009, ANGEW CHEM INT EDIT, V48, P2741, DOI 10.1002/anie.200805894
   Wu CC, 2010, TALANTA, V81, P228, DOI 10.1016/j.talanta.2009.11.062
   Wu RR, 2015, BIOCHEM BIOPH RES CO, V460, P572, DOI 10.1016/j.bbrc.2015.03.071
NR 48
TC 3
Z9 6
U1 1
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD JUL
PY 2016
VL 16
IS 7
AR 1065
DI 10.3390/s16071065
PG 14
WC Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments
   & Instrumentation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Engineering; Instruments & Instrumentation
GA DS7MG
UT WOS:000380967000122
PM 27409618
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Nalini, A
   Gayathri, N
AF Nalini, Atchayaram
   Gayathri, Narayanappa
TI Mitochondrial neurogastrointestinal encephalopathy in an Indian family
   with possible manifesting carriers of heterozygous <i>TYMP</i> mutation
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial neurogastrointestinal encephalomyopathy; MNGIE; Thymidine
   phosphorylase
ID THYMIDINE PHOSPHORYLASE-DEFICIENCY; ENCEPHALOMYOPATHY MNGIE; MULTIPLE
   DELETIONS; DNA DEPLETION; DISORDER; LEUKOENCEPHALOPATHY;
   OPHTHALMOPLEGIA; DYSFUNCTION; FEATURES
AB Background: Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a distinctive autosomal recessive disorder with mitochondrial alterations due to mutations TYMP gene encoding thymidine phosphorylase.
   Materials and methods: Study of clinical and biochemical characteristics of a family with MNGIE.
   Results: Index case was a 32 year old man presenting with recurrent vomiting, early satiety and progressive weight loss. He had ptosis, restricted eye movements, generalized muscle wasting, and absent tendon reflexes. Lactate levels were elevated in venous blood and CSF lactate. MRI brain showed diffuse leucoencephalopathy. Barium swallow showed near total obstruction at mid portion of vertical limb of duodenum with ileus. Esophageal manometry suggested myopathy. Muscle biopsy revealed moderate numbers of ragged blue and ragged red fibers as well as cytochrome c oxidase deficient fibers. An elder brother had similar symptoms and expired after a surgical procedure and a 28 year old brother has similar illness. The father had asymptomatic bilateral ptosis with mild ophthalmoparesis. The paternal grandfather and paternal aunt also had bilateral ptosis. Clinical diagnosis of MNGIE was confirmed in the two living brothers by demonstrating severe defects of thymidine phosphorylase activity in buffy coat, elevated thymidine and deoxyuridine in plasma, and a homozygous 7YMP c.893 G>A mutation.
   Conclusions: This family with biochemically and genetically confirmed mitochondrial neurogastrointestinal encephalopathy syndrome uncharacteristically included heterozygous IYMP mutation carriers manifesting extra-ocular weakness. It is important to identify MNGIE patients early because therapeutic options are emerging. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Nalini, Atchayaram] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India.
   [Gayathri, Narayanappa] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India.
C3 National Institute of Mental Health & Neurosciences - India; National
   Institute of Mental Health & Neurosciences - India
RP Nalini, A (corresponding author), Neurosci Fac Block,Behind Neuroctr,Hosur Rd, Bangalore 560029, Karnataka, India.
EM atchayaramnalini@yahoo.co.in
RI Nalini, Atchayaram/AAT-2469-2021
FU Columbia University Medical Center, New York
FX We thank Professor Salvatore Dimauro, Professor Michio Hirano and their
   team from Columbia University Medical Center, New York for supporting us
   with the biochemical (TP activity and plasma nucleoside measurements)
   and molecular genetic studies.
CR Carod-Artal FJ, 2007, EUR J NEUROL, V14, P581, DOI 10.1111/j.1468-1331.2007.01720.x
   Giordano C, 2006, GASTROENTEROLOGY, V130, P893, DOI 10.1053/j.gastro.2006.01.004
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2004, NUCLEOS NUCLEOT NUCL, V23, P1217, DOI 10.1081/NCN-200027485
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Martí R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8
   Millar WS, 2004, AM J ROENTGENOL, V182, P1537, DOI 10.2214/ajr.182.6.1821537
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   SIMON LT, 1990, ANN NEUROL, V28, P349, DOI 10.1002/ana.410280308
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Szigeti K, 2004, ANN NEUROL, V56, P881, DOI 10.1002/ana.20302
   UNCINI A, 1994, MUSCLE NERVE, V17, P667, DOI 10.1002/mus.880170616
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
NR 20
TC 10
Z9 10
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2011
VL 309
IS 1-2
BP 131
EP 135
DI 10.1016/j.jns.2011.06.052
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 825SV
UT WOS:000295303300027
PM 21794876
DA 2024-11-01
ER

PT J
AU Mukai, M
   Sugaya, K
   Yabe, I
   Goto, YI
   Yokochi, F
   Miyamoto, K
   Cai, H
   Sasaki, H
   Matsubara, S
AF Mukai, Masako
   Sugaya, Keizo
   Yabe, Ichiro
   Goto, Yu-ichi
   Yokochi, Fusako
   Miyamoto, Kazuhito
   Cai, Huaying
   Sasaki, Hidenao
   Matsubara, Shiro
TI Neuromelanin MRI in a family with mitochondrial parkinsonism harboring a
   Y955C mutation in <i>POLG1</i>
SO PARKINSONISM & RELATED DISORDERS
LA English
DT Article
DE Progressive external ophthalmoplegia; Parkinsonism; POLG1; Neuromelanin
   imaging; Mitochondrial DNA
ID SUBSTANTIA-NIGRA; DNA; NEUROPATHOLOGY; DELETIONS; GENE
AB Background: Progressive external ophthalmoplegia (PEO) and parkinsonism can be caused by genetic mutations that affect mitochondrial DNA (mtDNA) maintenance. We characterized parkinsonism in a family with dominantly inherited PEO.
   Methods: We conducted clinical, histological and genetic analyses on two affected members suffering from PEO and parkinsonism, and reviewed the cases in the literature. To clarify parkinsonism related to multiple mtDNA deletions, we used 3-T neuromelanin magnetic resonance imaging (MRI) to assess signal changes in the substantia nigra (SN) and locus ceruleus (LC) in our patients, and compared the results to those observed in idiopathic Parkinson's disease (iPD) (n = 35).
   Results: We report the first case of a Japanese family harboring a heterozygous p.Y955C mutation in POLG1. The clinical features of parkinsonism related to the Y955C mutation in a total of 16 patients, including our two cases, are indistinguishable from iPD. However, neuromelanin MRI showed a distinct pattern in our cases compared to iPD. The neuromelanin imaging results were consistent with the neuropathological findings reported in cases of POLG1 mutations, in which neurons of the SN were profoundly affected while those in the LC were preserved.
   Conclusions: Our results suggest that 3-T neuromelanin MRI may be useful for differentiating POLG1 mutation-associated parkinsonism from iPD, and that POLG1 mutations may cause selective neuronal loss in the SN via a mechanism different from that of iPD. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Mukai, Masako; Sugaya, Keizo; Yokochi, Fusako; Miyamoto, Kazuhito; Matsubara, Shiro] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo 1830042, Japan.
   [Yabe, Ichiro; Cai, Huaying; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Div Mental Retardat & Birth Defect Res, Kodaira, Tokyo 187, Japan.
C3 Tokyo Metropolitan Institute for Neuroscience; Hokkaido University;
   National Center for Neurology & Psychiatry - Japan
RP Sugaya, K (corresponding author), Tokyo Metropolitan Neurol Hosp, Dept Neurol, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan.
EM keizo_sugaya@member.metro.tokyo.jp
RI Yabe, Ichiro/AAU-2495-2020
OI Sugaya, Kiminobu/0000-0002-2788-5457
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Elstner M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-43
   Hattori N, 1998, ANN NEUROL, V44, P935, DOI 10.1002/ana.410440612
   Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Ohtsuka C, 2013, NEUROSCI LETT, V541, P93, DOI 10.1016/j.neulet.2013.02.012
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Poulopoulos M, 2012, MOVEMENT DISORD, V27, P831, DOI 10.1002/mds.24962
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Schwarz ST, 2011, MOVEMENT DISORD, V26, P1633, DOI 10.1002/mds.23722
   Shibata Eri, 2006, Magn Reson Med Sci, V5, P197, DOI 10.2463/mrms.5.197
NR 12
TC 15
Z9 16
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1353-8020
EI 1873-5126
J9 PARKINSONISM RELAT D
JI Parkinsonism Relat. Disord.
PD SEP
PY 2013
VL 19
IS 9
BP 821
EP 824
DI 10.1016/j.parkreldis.2013.04.011
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 204WH
UT WOS:000323401500009
PM 23673011
DA 2024-11-01
ER

PT J
AU Singh, B
   Schoeb, TR
   Bajpai, P
   Slominski, A
   Singh, KK
AF Singh, Bhupendra
   Schoeb, Trenton R.
   Bajpai, Prachi
   Slominski, Andrzej
   Singh, Keshav K.
TI Reversing wrinkled skin and hair loss in mice by restoring mitochondrial
   function
SO CELL DEATH & DISEASE
LA English
DT Article
ID DNA COPY NUMBER; RENAL-CELL CARCINOMA; MTDNA DEPLETION; SKELETAL-MUSCLE;
   GENE-EXPRESSION; KINASE GENE; MUTATIONS; DISEASE; ASSOCIATION; PROTEIN
AB Mitochondrial DNA (mtDNA) depletion is involved in mtDNA depletion syndromes, mitochondrial diseases, aging and aging-associated chronic diseases, and other human pathologies. To evaluate the consequences of depletion of mtDNA in the whole animal, we created an inducible mtDNA-depleter mouse expressing, in the polymerase domain of POLG1, a dominant-negative mutation to induce depletion of mtDNA in various tissues. These mice showed reduced mtDNA content, reduced mitochondrial gene expression, and instability of supercomplexes involved in oxidative phosphorylation (OXPHOS) resulting in reduced OXPHOS enzymatic activities. We demonstrate that ubiquitous depletion of mtDNA in mice leads to predominant and profound effects on the skin resulting in wrinkles and visual hair loss with an increased number of dysfunctional hair follicles and inflammatory responses. Development of skin wrinkle was associated with the significant epidermal hyperplasia, hyperkeratosis, increased expression of matrix metalloproteinases, and decreased expression of matrix metalloproteinase inhibitor TIMP1. We also discovered markedly increased skin inflammation that appears to be a contributing factor in skin pathology. Histopathologic analyses revealed dysfunctional hair follicles. mtDNA-depleter mice also show changes in expression of agingassociated markers including IGF1R, KLOTHO, VEGF, and MRPS5. mtDNA-repleter mice showed that, by turning off the mutant POLG1 transgene expression, mitochondrial function, as well as the skin and hair pathology, is reversed to wildtype level. To our knowledge that restoration of mitochondrial functions can reverse the skin and hair pathology is unprecedented.
C1 [Singh, Bhupendra; Schoeb, Trenton R.; Bajpai, Prachi; Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.
   [Slominski, Andrzej] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.
   [Singh, Keshav K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA.
   [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Aging, Ctr Free Radical Biol, Birmingham, AL 35294 USA.
   [Singh, Keshav K.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA.
C3 University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Veterans Affairs Medical Center - Birmingham; University of Alabama
   System; University of Alabama Birmingham; University of Alabama System;
   University of Alabama Birmingham
RP Singh, KK (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.; Singh, KK (corresponding author), Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA.; Singh, KK (corresponding author), Univ Alabama Birmingham, Ctr Aging, Ctr Free Radical Biol, Birmingham, AL 35294 USA.; Singh, KK (corresponding author), Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA.
EM kksingh@uab.edu
RI Bajpai, Prachi/U-7462-2018
FU Veterans Administration [1I01BX001716]; NIH [R01 CA204430,
   1R01AR071189-01A1, R01AR073004]
FX This work was supported by grants from Veterans Administration
   1I01BX001716 and NIH R01 CA204430 to K.K.S., and partial support from
   NIH grants 1R01AR071189-01A1 and R01AR073004 to A.S.
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bielenberg DR, 1998, J INVEST DERMATOL, V111, P864, DOI 10.1046/j.1523-1747.1998.00378.x
   Birch-Machin MA, 1998, J INVEST DERMATOL, V110, P149, DOI 10.1046/j.1523-1747.1998.00099.x
   Bonomi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042423
   Bosset S, 2003, BRIT J DERMATOL, V149, P826, DOI 10.1046/j.1365-2133.2003.05456.x
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Carson F.L., 2009, Histotechnology: A self-instructional text, V3rd
   Cho YS, 2009, MOL CELLS, V28, P537, DOI 10.1007/s10059-009-0148-2
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0
   Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638
   Hebert SL, 2015, J GERONTOL A-BIOL, V70, P1409, DOI 10.1093/gerona/glv086
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Iriyama S, 2010, EXP DERMATOL, V19, P965, DOI 10.1111/j.1600-0625.2009.01027.x
   Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200
   Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200
   Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007
   Kloepper JE, 2015, J INVEST DERMATOL, V135, P679, DOI 10.1038/jid.2014.475
   Koochekpour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074688
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Lahmann C, 2001, LANCET, V357, P935, DOI 10.1016/S0140-6736(00)04220-3
   Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu LP, 2017, ATHEROSCLEROSIS, V261, P105, DOI 10.1016/j.atherosclerosis.2017.02.013
   López-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003
   Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McCullough JL, 2006, ANN NY ACAD SCI, V1067, P323, DOI 10.1196/annals.1354.044
   Melkonian SC, 2015, CARCINOGENESIS, V36, P249, DOI 10.1093/carcin/bgu248
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miettinen TP, 2016, DEV CELL, V39, P370, DOI 10.1016/j.devcel.2016.09.004
   Monickaraj F, 2012, MOL CELL BIOCHEM, V365, P343, DOI 10.1007/s11010-012-1276-0
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   NAG AC, 1983, J MOL CELL CARDIOL, V15, P301, DOI 10.1016/0022-2828(83)91342-1
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   Nile DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115433
   Owens KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023846
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Pinto M, 2014, BBA-MOL BASIS DIS, V1842, P1198, DOI 10.1016/j.bbadis.2013.11.012
   Rodríguez-Santiago B, 2001, EUR J HUM GENET, V9, P279, DOI 10.1038/sj.ejhg.5200629
   Ross JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6
   Schroeder P, 2008, J INVEST DERMATOL, V128, P2297, DOI 10.1038/jid.2008.57
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Singh B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139846
   Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71
   SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449
   STOCCO DM, 1978, J GERONTOL, V33, P802, DOI 10.1093/geronj/33.6.802
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Varani J, 2000, J INVEST DERMATOL, V114, P480, DOI 10.1046/j.1523-1747.2000.00902.x
   Velarde Michael C, 2014, Longev Healthspan, V3, P2, DOI 10.1186/2046-2395-3-2
   Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377
   Weiland D, 2018, J INVEST DERMATOL, V138, P132, DOI 10.1016/j.jid.2017.08.019
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang RY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4287-0
NR 78
TC 75
Z9 79
U1 8
U2 46
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JUL 20
PY 2018
VL 9
AR 735
DI 10.1038/s41419-018-0765-9
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GN7MA
UT WOS:000439324200001
PM 30026579
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU deBruyn, JC
   Chan, AK
   Bhargava, R
   Idikio, H
   Huynh, HQ
AF deBruyn, Jennifer C.
   Chan, Alicia K.
   Bhargava, Ravi
   Idikio, Halliday
   Huynh, Hien Q.
TI Liver failure in mitochondrial DNA depletion syndrome: The importance of
   serial neuroimaging in liver transplantation evaluation
SO JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
LA English
DT Article
ID MTDNA DEPLETION; MYOPATHY; MUSCLE; INVOLVEMENT
C1 Univ Alberta, Div Pediat Gastroenterol & Nutr, Dept Pediat, Edmonton, AB T6G 2J3, Canada.
   Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2J3, Canada.
   Univ Alberta, Div Pediat Radiol, Dept Pediat, Edmonton, AB T6G 2J3, Canada.
   Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2J3, Canada.
C3 University of Alberta; University of Alberta; University of Alberta;
   University of Alberta
RP Huynh, HQ (corresponding author), Univ Alberta, Stollery Childrens Hosp, Dept Pediat, Div Pediat Gastroenterol & Nutr, 8213 Aberhart Ctr 1,11402 Univ Ave, Edmonton, AB T6G 2J3, Canada.
EM hien.huynh@ualberta.ca
RI Huynh, Hien/Q-8543-2019; Bhargava, Ravi/K-1645-2019
CR Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Campos Y, 1998, NEUROMUSCULAR DISORD, V8, P568, DOI 10.1016/S0960-8966(98)00080-7
   Carrozzo R, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9135
   Dubern B, 2001, TRANSPLANTATION, V71, P633, DOI 10.1097/00007890-200103150-00009
   Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1
   FIGARELLABRANGER D, 1992, J NEUROL SCI, V108, P105, DOI 10.1016/0022-510X(92)90195-Q
   Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664
   MARIOTTI C, 1995, J NEUROL, V242, P547, DOI 10.1007/BF00868806
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morris AAM, 1998, J HEPATOL, V28, P556, DOI 10.1016/S0168-8278(98)80278-X
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   POULTON J, 1994, HUM MOL GENET, V3, P1763, DOI 10.1093/hmg/3.10.1763
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   TELERMANTOPPET N, 1992, J INHERIT METAB DIS, V15, P323, DOI 10.1007/BF02435967
   Thomson M, 1998, J PEDIATR GASTR NUTR, V26, P478, DOI 10.1097/00005176-199804000-00024
   TRITSCHLER HJ, 1980, NEUROLOGY, V30, P795
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
NR 17
TC 9
Z9 9
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0277-2116
J9 J PEDIATR GASTR NUTR
JI J. Pediatr. Gastroenterol. Nutr.
PD AUG
PY 2007
VL 45
IS 2
BP 252
EP 256
DI 10.1097/MPG.0b013e318048838f
PG 5
WC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
GA 194BH
UT WOS:000248318400019
PM 17667724
OA Bronze
DA 2024-11-01
ER

PT J
AU Emperador, S
   Garrido-Pérez, N
   Amezcua-Gil, J
   Gaudó, P
   Andrés-Sanz, JA
   Yubero, D
   Fernández-Marmiesse, A
   O'Callaghan, MM
   Ortigoza-Escobar, JD
   Iriondo, M
   Ruiz-Pesini, E
   García-Cazorla, A
   Gil-Campos, M
   Artuch, R
   Montoya, J
   Bayona-Bafaluy, MP
AF Emperador, Sonia
   Garrido-Perez, Nuria
   Amezcua-Gil, Javier
   Gaudo, Paula
   Alberto Andres-Sanz, Julio
   Yubero, Delia
   Fernandez-Marmiesse, Ana
   O'Callaghan, Maria M.
   Ortigoza-Escobar, Juan D.
   Iriondo, Marti
   Ruiz-Pesini, Eduardo
   Garcia-Cazorla, Angels
   Gil-Campos, Mercedes
   Artuch, Rafael
   Montoya, Julio
   Pilar Bayona-Bafaluy, Maria
TI Molecular Characterization of New FBXL4 Mutations in Patients With mtDNA
   Depletion Syndrome
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mitochondrial disease; encephalomyopathic mtDNA depletion syndrome 13;
   F-box leucine-rich repeat protein 4; mitochondrial DNA; mtDNA depletion;
   mtDNA transcription; oxidative phosphorylation
ID MITOCHONDRIAL; MECHANISMS; ASSAYS
AB Encephalomyopathic mitochondrial DNA (mtDNA) depletion syndrome 13 (MTDPS13) is a rare genetic disorder caused by defects in F-box leucine-rich repeat protein 4 (FBXL4). Although FBXL4 is essential for the bioenergetic homeostasis of the cell, the precise role of the protein remains unknown. In this study, we report two cases of unrelated patients presenting in the neonatal period with hyperlactacidemia and generalized hypotonia. Severe mtDNA depletion was detected in muscle biopsy in both patients. Genetic analysis showed one patient as having in compound heterozygosis a splice site variant c.858+5G>C and a missense variant c.1510T>C (p.Cys504Arg) in FBXL4. The second patient harbored a frameshift novel variant c.851delC (p.Pro284LeufsTer7) in homozygosis. To validate the pathogenicity of these variants, molecular and biochemical analyses were performed using skin-derived fibroblasts. We observed that the mtDNA depletion was less severe in fibroblasts than in muscle. Interestingly, the cells harboring a nonsense variant in homozygosis showed normal mtDNA copy number. Both patient fibroblasts, however, demonstrated reduced mitochondrial transcript quantity leading to diminished steady state levels of respiratory complex subunits, decreased respiratory complex IV (CIV) activity, and finally, low mitochondrial ATP levels. Both patients also revealed citrate synthase deficiency. Genetic complementation assays established that the deficient phenotype was rescued by the canonical version of FBXL4, confirming the pathological nature of the variants. Further analysis of fibroblasts allowed to establish that increased mitochondrial mass, mitochondrial fragmentation, and augmented autophagy are associated with FBXL4 deficiency in cells, but are probably secondary to a primary metabolic defect affecting oxidative phosphorylation.
C1 [Emperador, Sonia; Garrido-Perez, Nuria; Amezcua-Gil, Javier; Gaudo, Paula; Alberto Andres-Sanz, Julio; Ruiz-Pesini, Eduardo; Montoya, Julio; Pilar Bayona-Bafaluy, Maria] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza, Spain.
   [Emperador, Sonia; Garrido-Perez, Nuria; Ruiz-Pesini, Eduardo; Montoya, Julio; Pilar Bayona-Bafaluy, Maria] IIS Aragon, Zaragoza, Spain.
   [Emperador, Sonia; Garrido-Perez, Nuria; Ruiz-Pesini, Eduardo] Univ Zaragoza, Fdn ARAID, Zaragoza, Spain.
   [Yubero, Delia; O'Callaghan, Maria M.; Ortigoza-Escobar, Juan D.; Iriondo, Marti; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Recerca St Joan de Deu, Clin Biochem Dept, Barcelona, Spain.
   [Yubero, Delia; O'Callaghan, Maria M.; Ortigoza-Escobar, Juan D.; Iriondo, Marti; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Recerca St Joan de Deu, Genet Dept, Barcelona, Spain.
   [Yubero, Delia; O'Callaghan, Maria M.; Ortigoza-Escobar, Juan D.; Iriondo, Marti; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Recerca St Joan de Deu, Pediat Neurol Dept, Barcelona, Spain.
   [Yubero, Delia; O'Callaghan, Maria M.; Ortigoza-Escobar, Juan D.; Iriondo, Marti; Garcia-Cazorla, Angels; Artuch, Rafael] Inst Recerca St Joan de Deu, Neonatal Dept, Barcelona, Spain.
   [Yubero, Delia; O'Callaghan, Maria M.; Ortigoza-Escobar, Juan D.; Iriondo, Marti; Ruiz-Pesini, Eduardo; Garcia-Cazorla, Angels; Artuch, Rafael; Montoya, Julio; Pilar Bayona-Bafaluy, Maria] CIBERER, Madrid, Spain.
   [Fernandez-Marmiesse, Ana] Santiago de Compostela Univ, Mol Med & Chron Dis Res Ctr CiMUS, Genomes & Dis Grp, IDIS, Santiago De Compostela, Spain.
   [Gil-Campos, Mercedes] Univ Cordoba, Reina Sofia Univ Clin Hosp, Inst Maimonides Biomed Invest Cordoba IMIBIC, Metab Unit, Cordoba, Spain.
   [Gil-Campos, Mercedes] CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Madrid, Spain.
C3 University of Zaragoza; University of Zaragoza; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de
   Compostela; Universidad de Cordoba; CIBER - Centro de Investigacion
   Biomedica en Red; CIBEROBN
RP Montoya, J; Bayona-Bafaluy, MP (corresponding author), Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza, Spain.; Montoya, J; Bayona-Bafaluy, MP (corresponding author), IIS Aragon, Zaragoza, Spain.; Montoya, J; Bayona-Bafaluy, MP (corresponding author), CIBERER, Madrid, Spain.
EM jmontoya@unizar.es; pbayona@unizar.es
RI Ortigoza-Escobar, Juan/AAP-8165-2021
OI Gil-Campos, Mercedes/0000-0002-9007-0242; Ortigoza Escobar, Juan
   Dario/0000-0002-6320-2641; Andres Sanz, Julio
   Alberto/0000-0003-1138-7012; Artuch, Rafael/0000-0002-3422-9685
FU Instituto de Salud Carlos III [PI17/00021, PI17/00166, PI/1700109];
   Fundacion Mutua Madrilena; Precipita-FECYT Crowdfunding program [PR194];
   Gobierno de Aragon [B33_17R]; FEDER 2014-2020 "Construyendo Europa desde
   Aragon"; Asociacion de Enfermos de Patologia Mitocondrial (AEPMI)
FX This work was supported by grants from Instituto de Salud Carlos III
   (PI17/00021, PI17/00166, and PI/1700109); Fundacion Mutua Madrilena;
   Precipita-FECYT Crowdfunding program (PR194); Gobierno de Aragon (Grupos
   Consolidados B33_17R); FEDER 2014-2020 "Construyendo Europa desde
   Aragon" and Asociacion de Enfermos de Patologia Mitocondrial (AEPMI).
   The CIBERER is an initiative of the ISCIII.
CR Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Antoun G, 2016, JIMD REP, V27, P1, DOI 10.1007/8904_2015_491
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Emperador S, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00469
   Fernández-Marmiesse A, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0844-5
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163
   Gómez-Durán A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Jou C, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010068
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338
   Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549
   Morton SU, 2017, JIMD REP, P7, DOI 10.1007/8904_2016_17
   Perales-Clemente E, 2008, P NATL ACAD SCI USA, V105, P18735, DOI 10.1073/pnas.0810518105
   Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yubero D, 2016, MITOCHONDRION, V30, P51, DOI 10.1016/j.mito.2016.06.007
NR 25
TC 9
Z9 10
U1 1
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JAN 8
PY 2020
VL 10
AR 1300
DI 10.3389/fgene.2019.01300
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA KF8ZW
UT WOS:000509526800001
PM 31969900
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Wenz, TN
   Wang, X
   Marini, M
   Moraes, CT
AF Wenz, Tina
   Wang, Xiao
   Marini, Matteo
   Moraes, Carlos T.
TI A metabolic shift induced by a PPAR panagonist markedly reduces the
   effects of pathogenic mitochondrial tRNA mutations
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE mitochondria; bezafibrate; mitochondrial disease; PPAR; PGC-1a
ID RESPIRATORY-CHAIN; PROTEIN-SYNTHESIS; POINT MUTATION; PGC-1-ALPHA;
   DISORDERS; MYOPATHY; DISEASE; MUSCLE; CELLS; OVEREXPRESSION
AB Mutations in mitochondrial DNA-encoded tRNA genes are associated with many human diseases. Activation of peroxisome proliferator-activated receptors (PPARs) by synthetic agonists stimulates oxidative metabolism, induces an increase in mitochondrial mass and partially compensates for oxidative phosphorylation system (OXPHOS) defects caused by single OXPHOS enzyme deficiencies in vitro and in vivo. Here, we analysed whether treatment with the PPAR panagonist bezafibrate in cybrids homoplasmic for different mitochondrial tRNA mutations could ameliorate the OXPHOS defect. We found that bezafibrate treatment increased mitochondrial mass, mitochondrial tRNA steady state levels and enhanced mitochondrial protein synthesis. This improvement resulted in increased OXPHOS activity and finally in enhanced mitochondrial ATP generating capacity. PPAR panagonists are known to increase the expression of PPAR gamma coactivator-1a (PGC-1a), a master regulator of mitochondrial biogenesis. Accordingly, we found that clones of a line harbouring a mutated mitochondrial tRNA gene mutation selected for the ability to grow in a medium selective for OXPHOS function had a 3-fold increase in PGC-1a expression, an increase that was similar to the one observed after bezafibrate treatment. These findings show that increasing mitochondrial mass and thereby boosting residual OXPHOS capacity can be beneficial to an important class of mitochondrial defects reinforcing the potential therapeutic use of approaches stimulating mitochondrial proliferation for mitochondrial disorders.
C1 [Wenz, Tina; Marini, Matteo; Moraes, Carlos T.] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Wang, Xiao] Univ Miami, Sch Med, Canc Biol Grad Program, Miami, FL 33136 USA.
   [Marini, Matteo; Moraes, Carlos T.] Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.
C3 University of Miami; University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Sch Med, Dept Neurol, 1095 NW 14th Terrace, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Marini, Matteo/C-7544-2016; Moraes, Carlos/AAT-3818-2021
FU Public Health Service [AG036871, CA85700, EY10804]; Florida James and
   Esther King Biomedical Research Program; Muscular Dystrophy Association;
   United Mitochondrial Disease Foundation
FX Our work was supported by Public Health Service grants AG036871, CA85700
   and EY10804 (C. T. M.), by grants from the Florida James and Esther King
   Biomedical Research Program and the Muscular Dystrophy Association (C.
   T. M.). Dr. Wenz was supported by a fellowship from the United
   Mitochondrial Disease Foundation. We are grateful to Actavis
   Pharmaceuticals for the generous gift of bezafibrate.
CR Anderson Rozalyn M., 2007, V35, P18
   Barrientos A, 1998, J NEUROSCI RES, V53, P475, DOI 10.1002/(SICI)1097-4547(19980815)53:4<475::AID-JNR9>3.0.CO;2-3
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Benton CR, 2008, APPL PHYSIOL NUTR ME, V33, P843, DOI 10.1139/H08-074
   Cantó C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dong WP, 2007, MED HYPOTHESES, V69, P700, DOI 10.1016/j.mehy.2007.01.017
   Goldenberg I, 2008, VASC HEALTH RISK MAN, V4, P131, DOI 10.2147/vhrm.2008.04.01.131
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117
   Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347
   Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOGA Y, 1993, NUCLEIC ACIDS RES, V21, P657, DOI 10.1093/nar/21.3.657
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Nadanaciva S, 2007, TOXICOL APPL PHARM, V223, P277, DOI 10.1016/j.taap.2007.06.003
   Pérez-Martínez X, 2008, CURR TOP MED CHEM, V8, P1335, DOI 10.2174/156802608786141124
   Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093
   Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460
   Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
NR 29
TC 18
Z9 18
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD NOV
PY 2011
VL 15
IS 11
BP 2317
EP 2325
DI 10.1111/j.1582-4934.2010.01223.x
PG 9
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA 859DQ
UT WOS:000297855400005
PM 21129152
OA Green Published, hybrid, Green Accepted
DA 2024-11-01
ER

PT J
AU Casas, RB
   Zuppardo, A
   Risato, G
   Dinarello, A
   Celeghin, R
   Fontana, C
   Grelloni, E
   Gilea, AI
   Viscomi, C
   Rasola, A
   Dalla Valle, L
   Lodi, T
   Baruffini, E
   Facchinello, N
   Argenton, F
   Tiso, N
AF Casas, Raquel Branas
   Zuppardo, Alessandro
   Risato, Giovanni
   Dinarello, Alberto
   Celeghin, Rudy
   Fontana, Camilla
   Grelloni, Eleonora
   Gilea, Alexandru Ionut
   Viscomi, Carlo
   Rasola, Andrea
   Dalla Valle, Luisa
   Lodi, Tiziana
   Baruffini, Enrico
   Facchinello, Nicola
   Argenton, Francesco
   Tiso, Natascia
TI Zebrafish <i>polg2</i> knock-out recapitulates human POLG-disorders;
   implications for drug treatment
SO CELL DEATH & DISEASE
LA English
DT Article
ID DNA-POLYMERASE-GAMMA; MITOCHONDRIAL GENOME MAINTENANCE; DEPLETION
AB The human mitochondrial DNA polymerase gamma is a holoenzyme, involved in mitochondrial DNA (mtDNA) replication and maintenance, composed of a catalytic subunit (POLG) and a dimeric accessory subunit (POLG2) conferring processivity. Mutations in POLG or POLG2 cause POLG-related diseases in humans, leading to a subset of Mendelian-inherited mitochondrial disorders characterized by mtDNA depletion (MDD) or accumulation of multiple deletions, presenting multi-organ defects and often leading to premature death at a young age. Considering the paucity of POLG2 models, we have generated a stable zebrafish polg2 mutant line (polg2(ia304)) by CRISPR/Cas9 technology, carrying a 10-nucleotide deletion with frameshift mutation and premature stop codon. Zebrafish polg2 homozygous mutants present slower development and decreased viability compared to wild type siblings, dying before the juvenile stage. Mutants display a set of POLG-related phenotypes comparable to the symptoms of human patients affected by POLG-related diseases, including remarkable MDD, altered mitochondrial network and dynamics, and reduced mitochondrial respiration. Histological analyses detected morphological alterations in high-energy demanding tissues, along with a significant disorganization of skeletal muscle fibres. Consistent with the last finding, locomotor assays highlighted a decreased larval motility. Of note, treatment with the Clofilium tosylate drug, previously shown to be effective in POLG models, could partially rescue MDD in Polg2 mutant animals. Altogether, our results point at zebrafish as an effective model to study the etiopathology of human POLG-related disorders linked to POLG2, and a suitable platform to screen the efficacy of POLG-directed drugs in POLG2-associated forms.
C1 [Casas, Raquel Branas; Risato, Giovanni; Dinarello, Alberto; Fontana, Camilla; Grelloni, Eleonora; Dalla Valle, Luisa; Argenton, Francesco; Tiso, Natascia] Univ Padua, Dept Biol, I-35131 Padua, Italy.
   [Zuppardo, Alessandro; Viscomi, Carlo; Rasola, Andrea] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.
   [Risato, Giovanni; Celeghin, Rudy] Univ Padua, Dept Cardiothoraco Vasc Sci & Publ Hlth, I-35128 Padua, Italy.
   [Dinarello, Alberto] Univ Copenhagen, Novo Nord Fdn Ctr Stem Cell Med reNEW, DK-2200 Copenhagen, Denmark.
   [Fontana, Camilla] Chiang Mai Univ, Fac Agr, Dept Anim & Aquat Sci, Chiang Mai 50200, Thailand.
   [Gilea, Alexandru Ionut; Lodi, Tiziana; Baruffini, Enrico] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, I-43124 Parma, Italy.
   [Facchinello, Nicola] Neurosci Inst, Italian Res Council CNR, I-35131 Padua, Italy.
C3 University of Padua; University of Padua; University of Padua;
   University of Copenhagen; Chiang Mai University; University of Parma
RP Argenton, F; Tiso, N (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.; Facchinello, N (corresponding author), Neurosci Inst, Italian Res Council CNR, I-35131 Padua, Italy.
EM nicola.facchinello@cnr.it; francesco.argenton@unipd.it;
   natascia.tiso@unipd.it
RI Facchinello, Nicola/P-5255-2019; Celeghin, Rudy/HKO-1478-2023; Dalla
   Valle, Luisa/G-6721-2011; Argenton, Francesco/AAS-8494-2021; Tiso,
   Natascia/E-2182-2011; Baruffini, Enrico/C-1057-2015
OI Rasola, Andrea/0000-0003-4522-3008; Risato,
   Giovanni/0000-0003-0651-7409; Tiso, Natascia/0000-0002-5444-9853;
   Zuppardo, Alessandro/0000-0001-9601-3567; Branas Casas,
   Raquel/0000-0002-0908-4330; Baruffini, Enrico/0000-0002-8280-7849; Dalla
   Valle, Luisa/0000-0001-8097-6369
FU Fondazione Telethon (Telethon Foundation) [GGP20013]; Italian Telethon
   Foundation [IG-2017-19928]; AIRC [23706]; AFM-Telethon [PNRR M4C2
   CN00000041]; Italian Ministry of University and Research; Associazione
   Luigi Comini Onlus [SID2022]; Department of Biomedical Sciences, UniPD
FX The authors would like to thank Drs. E. Fiore and S. Ravarotto (Telethon
   scholars), Mrs. S. Iljazi and the staff of the Zebrafish Facility at
   DeBio, UniPD, for their technical assistance. NT and FA were supported
   by Italian Telethon Foundation (grant GGP19287 to NT and FA, and
   GGP19287A to EB), AIRC (grant IG-2017-19928 to FA), AFM-Telethon (grant
   18572 to NT) and Italian Ministry of University and Research (grant PNRR
   M4C2 CN00000041 to NT). CV is supported by: Italian Telethon Foundation
   (GGP20013); Associazione Luigi Comini Onlus (MitoFight2), AFM-Telethon
   (23706); Department of Biomedical Sciences, UniPD (SID2022).
CR Aleström P, 2020, LAB ANIM-UK, V54, P213, DOI 10.1177/0023677219869037
   Basel D, 2020, CLIN PERINATOL, V47, P123, DOI 10.1016/j.clp.2019.10.008
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Facchinello N, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03359-z
   Facchinello N, 2016, METHODS MOL BIOL, V1481, P81, DOI 10.1007/978-1-4939-6393-5_9
   Faria M, 2019, SCI TOTAL ENVIRON, V650, P87, DOI 10.1016/j.scitotenv.2018.08.421
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Kim MJ, 2008, BIOTECHNIQUES, V45, P331, DOI 10.2144/000112909
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Ma ZP, 2020, ZEBRAFISH, V17, P157, DOI 10.1089/zeb.2019.1824
   MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011
   Nogueira C, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-34
   Pitayu L, 2016, HUM MOL GENET, V25, P715, DOI 10.1093/hmg/ddv509
   Popoiu TA, 2023, CURR HEART FAIL REP, V20, P76, DOI 10.1007/s11897-023-00592-3
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rahn JJ, 2015, NUCLEIC ACIDS RES, V43, P10338, DOI 10.1093/nar/gkv1139
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x
   Stocco A, 2021, PHARMACOL RES, V165, DOI 10.1016/j.phrs.2021.105421
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Vettori A, 2017, P NATL ACAD SCI USA, V114, P9948, DOI 10.1073/pnas.1705338114
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Westerfield M., 2000, ZEBRAFISH BOOK GUIDE
   Wojtaszek JL, 2023, NUCLEIC ACIDS RES, V51, P9716, DOI 10.1093/nar/gkad679
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Zhao LL, 2019, ENZYMES, V45, P311, DOI 10.1016/bs.enz.2019.08.004
NR 35
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD APR 20
PY 2024
VL 15
IS 4
AR 281
DI 10.1038/s41419-024-06622-9
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA OF8H3
UT WOS:001205938400001
PM 38643274
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Lamb, JA
AF Lamb, Janine A.
TI The Genetics of Autoimmune Myositis
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE myositis; idiopathic inflammatory myopathies; genetics; genetic risk
   factors; gene expression; pathogenesis; human leukocyte antigen
ID IDIOPATHIC INFLAMMATORY MYOPATHIES; RISK; ASSOCIATION; DERMATOMYOSITIS;
   CLASSIFICATION; MITOCHONDRIAL; ANTIBODIES; ADULT; MEN
AB The idiopathic inflammatory myopathies (IIM) are rare, heterogeneous systemic autoimmune disorders, characterized by inflammation of skeletal muscle and multi-organ involvement. Studies to identify genetic risk factors and dysregulated gene expression in IIM aim to increase our understanding of disease pathogenesis. Genome-wide association studies have confirmed the HLA region as the most strongly associated region in IIM, with different associations between clinically-defined subgroups. Associated genes are involved in both the innate and adaptive immune response, while identification of variants reported in other autoimmune disorders suggests shared biological pathways. Targeted imputation analysis has identified key associated amino acid residues within HLA molecules that may influence antigen recognition. These amino acids increase risk for specific clinical phenotypes and autoantibody subgroups, and suggest that serology-defined subgroups may be more homogeneous. Recent data support the contribution of rare genetic variation to disease susceptibility in IIM, including mitochondrial DNA variation in sporadic inclusion body myositis and somatic mutations and loss of heterozygosity in cancer-associated myositis. Gene expression studies in skeletal muscle, blood and skin from individuals with IIM has confirmed the role of interferon signalling and other dysregulated pathways, and identified cell-type specific signatures. These dysregulated genes differentiate IIM subgroups and identify potential biomarkers. Here, we review recent genetic studies in IIM, and how these inform our understanding of disease pathogenesis and provide mechanistic insights into biological pathways.
C1 [Lamb, Janine A.] Univ Manchester, Sch Hlth Sci, Epidemiol & Publ Hlth Grp, Manchester, Lancs, England.
C3 University of Manchester
RP Lamb, JA (corresponding author), Univ Manchester, Sch Hlth Sci, Epidemiol & Publ Hlth Grp, Manchester, Lancs, England.
EM Janine.Lamb@manchester.ac.uk
CR Acosta-Herrera M, 2018, ANN RHEUM DIS, V78, DOI [10.1136/annrheumdis-2018-214127, DOI 10.1136/ANNRHEUMDIS-2018-214127]
   Allenbach Y, 2018, NEUROMUSCULAR DISORD, V28, P87, DOI 10.1016/j.nmd.2017.09.016
   Amici DR, 2021, ACTA NEUROPATHOL, V142, P887, DOI 10.1007/s00401-021-02365-5
   Barturen G, 2021, ARTHRITIS RHEUMATOL, V73, P1073, DOI 10.1002/art.41610
   Bianchi M, 2022, ARTHRITIS RHEUMATOL, V74, P342, DOI 10.1002/art.41929
   Burren OS, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00797-4
   Che WI, 2021, ANN RHEUM DIS, V80, P1461, DOI 10.1136/annrheumdis-2021-219914
   Chen ZY, 2017, J RHEUMATOL, V44, P1389, DOI 10.3899/jrheum.170165
   Chinoy H, 2012, ANN RHEUM DIS, V71, P961, DOI 10.1136/annrheumdis-2011-200182
   Deakin CT, 2022, HUM MOL GENET, V31, P2471, DOI 10.1093/hmg/ddac019
   Dillon SP, 2012, J AUTOIMMUN, V38, pJ129, DOI 10.1016/j.jaut.2011.10.004
   Gang Q, 2016, NEUROBIOL AGING, V47, DOI 10.1016/j.neurobiolaging.2016.07.024
   González-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166
   Greenberg SA, 2019, BRAIN, V142, P2590, DOI 10.1093/brain/awz207
   Güttsches AK, 2017, ANN NEUROL, V81, P227, DOI 10.1002/ana.24847
   Harris VM, 2016, CLIN IMMUNOL, V168, P25, DOI 10.1016/j.clim.2016.04.002
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12931
   Hou C, 2021, ARTHRITIS RHEUMATOL, V73, P1044, DOI 10.1002/art.41625
   Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683
   Joseph CG, 2014, SCIENCE, V343, P152, DOI 10.1126/science.1246886
   Kang EH, 2019, SEMIN ARTHRITIS RHEU, V49, P283, DOI 10.1016/j.semarthrit.2019.03.005
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Kim H, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-02160-9
   Kishi T, 2017, ARTHRIT CARE RES, V69, P1088, DOI 10.1002/acr.23113
   Kochi Y, 2018, ANN RHEUM DIS, V77, P602, DOI 10.1136/annrheumdis-2017-212149
   Lee-Kirsch MA, 2017, ANNU REV MED, V68, P297, DOI 10.1146/annurev-med-050715-104506
   Lenz TL, 2015, NAT GENET, V47, P1085, DOI 10.1038/ng.3379
   Liang L, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.628128
   Lintner KE, 2016, ANN RHEUM DIS, V75, P1599, DOI 10.1136/annrheumdis-2015-207762
   Lundberg IE, 2017, ANN RHEUM DIS, V76, P1955, DOI 10.1136/annrheumdis-2017-211468
   Mammen AL, 2012, ARTHRIT CARE RES, V64, P1233, DOI 10.1002/acr.21671
   Melki I, 2020, RHEUMATOLOGY, V59, P1927, DOI 10.1093/rheumatology/kez525
   Menconi F, 2010, P NATL ACAD SCI USA, V107, P16899, DOI 10.1073/pnas.1009511107
   Miller FW, 2013, ARTHRITIS RHEUM-US, V65, P3239, DOI 10.1002/art.38137
   Nishina N, 2020, RMD OPEN, V6, DOI 10.1136/rmdopen-2020-001202
   Pinal-Fernandez I, 2020, ANN RHEUM DIS, V79, P1234, DOI 10.1136/annrheumdis-2019-216599
   Pinal-Fernandez I, 2019, NEUROLOGY, V93, pE1193, DOI 10.1212/WNL.0000000000008128
   Pinal-Fernandez I, 2019, ARTHRITIS RHEUMATOL, V71, P1371, DOI 10.1002/art.40883
   Pinal-Fernandez I, 2018, RHEUMATOLOGY, V57, P388, DOI 10.1093/rheumatology/kex413
   Preusse C, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12957
   Rothwell S., 2022, MYOSITIS GENETICS CO
   Rothwell S, 2019, ANN RHEUM DIS, V78, P996, DOI 10.1136/annrheumdis-2019-215046
   Rothwell S, 2017, ARTHRITIS RHEUMATOL, V69, P1090, DOI 10.1002/art.40045
   Rothwell S, 2016, CURR OPIN RHEUMATOL, V28, P651, DOI 10.1097/BOR.0000000000000328
   Rothwell S, 2016, ANN RHEUM DIS, V75, P1558, DOI 10.1136/annrheumdis-2015-208119
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Schiffenbauer A, 2018, SEMIN ARTHRITIS RHEU, V48, P504, DOI 10.1016/j.semarthrit.2018.02.003
   Scofield RH, 2022, ACR OPEN RHEUMATOL, V4, P528, DOI 10.1002/acr2.11413
   Shah AA, 2015, ARTHRITIS RHEUMATOL, V67, P317, DOI 10.1002/art.38928
   Tasa T, 2019, EUR J HUM GENET, V27, P442, DOI 10.1038/s41431-018-0300-6
   Thomsen H, 2020, RHEUMATOL ADV PRACT, V4, DOI 10.1093/rap/rkaa048
   Phuong TNT, 2019, RHEUMATOLOGY, V58, P361, DOI 10.1093/rheumatology/key313
   Tsoi LC, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139558
   Weihl CC, 2015, NEUROMUSCULAR DISORD, V25, P289, DOI 10.1016/j.nmd.2014.12.009
   Wienke J, 2020, ARTHRITIS RHEUMATOL, V72, P1214, DOI 10.1002/art.41236
   Zhang CE, 2016, J DERMATOL, V43, P1307, DOI 10.1111/1346-8138.13397
NR 57
TC 7
Z9 7
U1 1
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAY 26
PY 2022
VL 13
AR 886290
DI 10.3389/fimmu.2022.886290
PG 9
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 1Y6KJ
UT WOS:000808251000001
PM 35693792
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Schicks, J
   Synofzik, M
   Schulte, C
   Schöls, L
AF Schicks, Julia
   Synofzik, Matthis
   Schulte, Claudia
   Schoels, Ludger
TI <i>POLG</i>, but not <i>PEO1</i>, is a Frequent Cause of Cerebellar
   Ataxia in Central Europe
SO MOVEMENT DISORDERS
LA English
DT Article
DE ataxia; mitochondrial; genetics; epilepsy
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RECESSIVE TWINKLE MUTATIONS;
   PHENOTYPIC SPECTRUM; NEUROPATHY; ENCEPHALOPATHY; DEPLETION; DISEASE;
   GENE
AB Nuclear genes, in particular mitochondrial polymerase gamma (POLG) and PEO1, have been increasingly recognized to cause mitochondrial diseases. Both genes assume a complementary role as part of the mitochondrial DNA (mtDNA) replication fork and, accordingly, seem to present with largely overlapping phenotypical spectra. We assessed the frequency and phenotypic spectrum of PEO1 compared to POLG mutations in a cohort of 80 patients with cerebellar ataxia for which common repeat expansion diseases had been excluded. Patients were selected to present additional features previously described for PEO1 mutations, namely early age of onset, progressive external ophthalmoplegia (PEO), or epilepsy. Whereas PEO1 mutations were not found in our cohort, POLG frequently caused ataxia with PEO (47%), psychiatric comorbidities (20%) and, more rarely, with epilepsy (14%). Thus, PEO1 is rare in Central Europe even in those patients displaying characteristic phenotypic features. In contrast, POLG is rather common in Central European ataxia patients. It should be particularly considered in ataxia patients with PEO, psychiatric comorbidities, and/or sensory neuropathy, even if characteristic mitochondrial extra-CNS features are absent. (c) 2010 Movement Disorder Society
C1 [Schoels, Ludger] Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany.
   Univ Tubingen, German Res Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany.
C3 Eberhard Karls University of Tubingen; Eberhard Karls University
   Hospital; Helmholtz Association; German Center for Neurodegenerative
   Diseases (DZNE); Helmholtz Association; German Center for
   Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen
RP Schöls, L (corresponding author), Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.
EM ludger.schoels@uni-tuebingen.de
RI Schöls, Ludger/ABB-2482-2021
OI Schols, Ludger/0000-0001-7774-5025; Schulte,
   Claudia/0000-0003-4006-1265; Synofzik, Matthis/0000-0002-2280-7273
FU German Ministry for Education and Research (BMBF) [01GM0864]; Movement
   Disorder Society; University of Tuebingen [1890-0-0]; Volkswagen
   Foundation (European platform); Santhera Pharmaceuticals; Deutsche
   Forschungsgemeinschaft [SCHO754/3-1, SCHO754/4-1]; German Research
   Council (BMBF) [01GM0864, 01GM0644, 01GM0603]; EU [LSHM-CT-2004-503304];
   E-RARE program [01GM0807, 01GM0820]; HSP-Selbsthilfegruppe Deutschland
   eV.
FX L.S. was supported by a grant from the German Ministry for Education and
   Research (BMBF) to mitoNET (01GM0864). Dr. Schicks received a travel
   grant by the Movement Disorder Society and financial support by the
   Fortune-Programm, University of Tuebingen (1890-0-0). Dr. Synofzik
   received speakers honoraria from Fresenius Kabi and Actelion
   Pharmaceuticals and research support from the Volkswagen Foundation
   (European platform). Dr. Schols served as an editorial board member of
   Movement Disorders; received research support from Santhera
   Pharmaceuticals [MICONOS trial (Co-PI)], the Deutsche
   Forschungsgemeinschaft [SCHO754/3-1 (PI) and SCHO754/4-1 (PI)], the
   German Research Council (BMBF)[#01GM0644 to Leukonet (PI), #01GM0603 to
   GeNeMove (PI)] and #01GM0864 to mitoNET (PI), the EU
   [#LSHM-CT-2004-503304 to EUROSCA (Co-investigator)], the E-RARE program
   [#01GM0807 to EUROSPA (PI) and #01GM0820 to RISCA(Co-PI], and the
   HSP-Selbsthilfegruppe Deutschland eV.
CR Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P503, DOI 10.1136/jnnp.44.6.503
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 17
TC 26
Z9 26
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD NOV 15
PY 2010
VL 25
IS 15
BP 2678
EP 2682
DI 10.1002/mds.23286
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 678FX
UT WOS:000284060600031
PM 20803511
DA 2024-11-01
ER

PT J
AU Nolte, KW
   Trepels-Kottek, S
   Honnef, D
   Weis, J
   Bien, CG
   van Baalen, A
   Ritter, K
   Czermin, B
   Rudnik-Schöneborn, S
   Wagner, N
   Häusler, M
AF Nolte, Kay W.
   Trepels-Kottek, Sonja
   Honnef, Dagmar
   Weis, Joachim
   Bien, Christian G.
   van Baalen, Andreas
   Ritter, Klaus
   Czermin, Birgit
   Rudnik-Schoeneborn, Sabine
   Wagner, Norbert
   Haeusler, Martin
TI Early muscle and brain ultrastructural changes in polymerase gamma
   1-related encephalomyopathy
SO NEUROPATHOLOGY
LA English
DT Article
DE Alpers-Huttenlocher disease; electron microscopy; epilepsia partialis
   continua; mitochondrial disorder; polymerase gamma-1 mutations
ID PROGRESSIVE NEURONAL DEGENERATION; MITOCHONDRIAL-DNA POLYMERASE;
   EPILEPSIA PARTIALIS CONTINUA; ALPERS-DISEASE; MUTATIONS; ENCEPHALOPATHY;
   CHILDHOOD; CHILDREN; PATIENT; POLG
AB Mutations affecting the mitochondrial DNA-polymerase gamma 1 (POLG1) gene have been shown to cause Alpers-Huttenlocher disease. Ultrastructural data on brain and muscle tissue are rare. We report on ultrastructural changes in brain and muscle tissue of two sisters who were compound heterozygous for the c.2243G>C and c.1879C>T POLG1 mutations. Patient 1 (16 years) presented with epilepsia partialis continua that did not respond to antiepileptic treatment. Neuroimaging showed right occipital and bithalamic changes. Light microscopy from a brain biopsy performed after 3 weeks suggested chronic encephalitis showing astro- and microgliosis as well as perivascular CD8-positive T-cells. However, immunosuppressive therapy failed to improve her condition. When her 17-year-old sister (patient 2) also developed epilepsy, an intensified search for metabolic diseases led to the diagnosis. On electron microscopy mitochondrial abnormalities mainly affecting neurons were detected in the brain biopsy of patient 1, including an increase in number and size, structural changes and globoid inclusions. In patient 2, light and electron microscopy on a muscle biopsy confirmed a mitochondrial myopathy, also revealing an increase in mitochondrial size and number, as well as globoid inclusions. Neurons may be the primary target of mitochondrial dysfunction in brains of patients with Alpers disease related to POLG1 mutations. During early disease stages, brain histopathology may be misleading, showing reactive inflammatory changes.
C1 [Nolte, Kay W.; Weis, Joachim] Rhein Westfal TH Aachen, Inst Neuropathol, Fac Med, Aachen, Germany.
   [Trepels-Kottek, Sonja; Wagner, Norbert; Haeusler, Martin] Rhein Westfal TH Aachen, Dept Pediat, Fac Med, Aachen, Germany.
   [Honnef, Dagmar] Rhein Westfal TH Aachen, Dept Diagnost & Intervent Neuroradiol, Fac Med, Aachen, Germany.
   [Ritter, Klaus] Rhein Westfal TH Aachen, Inst Med Microbiol, Div Virol, Fac Med, Aachen, Germany.
   [Rudnik-Schoeneborn, Sabine] Rhein Westfal TH Aachen, Inst Human Genet, Fac Med, Aachen, Germany.
   [Bien, Christian G.] Univ Bonn, Dept Epileptol, Med Ctr Bonn, Bonn, Germany.
   [van Baalen, Andreas] Univ Hosp Kiel, Dept Neuropediat, Kiel, Germany.
   [Czermin, Birgit] Ctr Med Genet, Munich, Germany.
C3 RWTH Aachen University; RWTH Aachen University; RWTH Aachen University;
   RWTH Aachen University; RWTH Aachen University; University of Bonn;
   University of Kiel; Schleswig Holstein University Hospital
RP Häusler, M (corresponding author), Rhein Westfal TH Aachen, Dept Pediat, Univ Hosp, Pauwels St 30, D-52074 Aachen, Germany.
EM haeusler@rwth-aachen.de; haeusler@rwth-aachen.de
RI Bien, Christian/D-2633-2012; Häusler, Martin/G-8164-2015;
   Rudnik-Schöneborn, Sabine/F-8473-2015; Weis, Joachim/G-1984-2014
OI Weis, Joachim/0000-0003-3280-6773; Bien, Christian
   G./0000-0003-2225-8654
CR Bao XH, 2008, BRAIN DEV-JPN, V30, P295, DOI 10.1016/j.braindev.2007.08.009
   Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x
   Boes M, 2009, SEIZURE-EUR J EPILEP, V18, P232, DOI 10.1016/j.seizure.2008.08.003
   BOYD SG, 1986, NEUROPEDIATRICS, V17, P75, DOI 10.1055/s-2008-1052505
   Cardenas JF, 2010, SEMIN PEDIATR NEUROL, V17, P62, DOI 10.1016/j.spen.2010.02.012
   Charles P, 2002, BRAIN, V125, P1972, DOI 10.1093/brain/awf216
   de Vries MC, 2008, J INHERIT METAB DIS, V31, pS299, DOI 10.1007/s10545-008-0871-4
   El Sabbagh S, 2010, EPILEPSIA, V51, P1225, DOI 10.1111/j.1528-1167.2009.02504.x
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fabene PF, 2010, J NEUROIMMUNOL, V224, P22, DOI 10.1016/j.jneuroim.2010.05.016
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Komulainen T, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-29
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Nishri D, 2010, EUR J PAEDIATR NEURO, V14, P456, DOI 10.1016/j.ejpn.2010.03.002
   SANDBANK U, 1972, J NEUROL NEUROSUR PS, V35, P749, DOI 10.1136/jnnp.35.6.749
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   SCHRODER JM, 1985, J NEUROL, V232, P83, DOI 10.1007/BF00313906
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   Stenqvist L, 2005, PEDIATR RES, V58, P258, DOI 10.1203/01.PDR.0000169966.82325.1A
   Takahashi Y, 2003, NEUROLOGY, V61, P891, DOI 10.1212/01.WNL.0000086819.53078.70
   Tezer FI, 2008, EPILEPTIC DISORD, V10, P306, DOI 10.1684/epd.2008.0220
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   van Baalen A, 2010, EPILEPSIA, V51, P1323, DOI 10.1111/j.1528-1167.2010.02535.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   WEIS J, 1995, MUSCLE NERVE, V18, P175, DOI 10.1002/mus.880180205
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
NR 32
TC 6
Z9 8
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0919-6544
EI 1440-1789
J9 NEUROPATHOLOGY
JI Neuropathology
PD FEB
PY 2013
VL 33
IS 1
BP 59
EP 67
DI 10.1111/j.1440-1789.2012.01317.x
PG 9
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA 083NT
UT WOS:000314472000007
PM 22537151
DA 2024-11-01
ER

PT J
AU Newell, C
   Hume, S
   Greenway, SC
   Podemski, L
   Shearer, J
   Khan, A
AF Newell, Christopher
   Hume, Stacey
   Greenway, Steven C.
   Podemski, Lynn
   Shearer, Jane
   Khan, Aneal
TI Plasma-derived cell-free mitochondrial DNA: A novel non-invasive
   methodology to identify mitochondrial DNA haplogroups in humans
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondrial disease; Cell-free mitochondrial DNA; mtDNA Mutations;
   mtDNA Haplotype
ID NUCLEIC-ACIDS; TRANSCRIPTION; MUTATIONS; DAMAGE; TOOL
AB Background: Mitochondrial diseases are a clinically heterogeneous group of diseases caused by mutations in either nuclear or mitochondrial DNA (mtDNA). The diagnosis is challenging and has frequently required a tissue biopsy to obtain a sufficient quantity of mtDNA. Less-invasive sources mtDNA, such as peripheral blood leukocytes, urine sediment, or buccal swab, contain a lower quantity of mtDNA compared to tissue sources which may reduce sensitivity. Cellular apoptosis of tissues and hematopoetic cells releases fragments of DNA and mtDNA into the circulation and these molecules can be extracted from plasma as cell-free DNA (cfDNA). However, entire mtDNA has not been successfully identified from the cell free fraction previously. We hypothesized that the circular nature of mtDNA would prevent its degradation and a higher sensitivity method, such as next generation sequencing, could identify intact cf-mtDNA from human plasma.
   Methods: Plasma was obtained from patients with mitochondrial disease diagnosed from skeletal muscle biopsy (n = 7) and healthy controls (n = 7) using a specially cfDNA collection tube (Streck Inc.; La Vista, NE). To demonstrate the presence of mtDNA within these samples, we amplified the isolated DNA using custom PCR primers specific to overlapping fragments of mtDNA. cfDNA samples were then sequenced using the Illumina MiSeq sequencing platform.
   Results: We confirmed the presence of mtDNA, demonstrating that the full mitochondrial genome is in fact present within the cell-free plasma fraction of human blood. Sequencing identified the mitochondrial haplogroup matching with the tissue specimen for all patients.
   Conclusion: We report the existence of full length mtDNA in cell-free human plasma that was successfully used to perform haplogroup matching. Clinical applications for this work include patient monitoring for heteroplasmy status after mitochondrially-targeted therapies or haplogroup monitoring as a measure of stem cell transplantation.
C1 [Newell, Christopher; Khan, Aneal] Univ Calgary, Cumming Sch Med, Dept Med Genet, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
   [Hume, Stacey; Podemski, Lynn] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
   [Greenway, Steven C.] Univ Calgary, Dept Cardiac Sci, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.
   [Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.
   [Greenway, Steven C.; Khan, Aneal] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp, Dept Pediat,Res Inst, Calgary, AB, Canada.
C3 University of Calgary; University of Alberta; Libin Cardiovascular
   Institute Of Alberta; University of Calgary; University of Calgary;
   University of Calgary; Alberta Childrens Hospital
RP Newell, C (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med Genet, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
EM cnewell@ucalgary.ca
RI Greenway, Steven/S-7777-2019; Khan, Aneal/W-2019-2018
OI Hume, Stacey/0000-0002-3217-3032
FU Alberta Children's Hospital Research Foundation; Department of
   Pediatrics; MitoCanada; Alberta Innovates - Health Solutions MD/PhD
   Studentship
FX This study was supported by the Alberta Children's Hospital Research
   Foundation, Department of Pediatrics and MitoCanada (AK). This research
   was supported by PhD funding to CN from MitoCanada and an Alberta
   Innovates - Health Solutions MD/PhD Studentship.
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094
   Bohers E, 2015, HAEMATOLOGICA, V100, pE280, DOI 10.3324/haematol.2015.123612
   Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801
   Chan AKC, 2003, ANN CLIN BIOCHEM, V40, P122, DOI 10.1258/000456303763046030
   Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Gordon PMK, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00033
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee CH, 2013, TRENDS ENDOCRIN MET, V24, P222, DOI [10.1016/j.tem.2013.01.005, 10.1016/j.technovation.2020.102140]
   Lehmann-Werman R, 2016, P NATL ACAD SCI USA, V113, pE1826, DOI 10.1073/pnas.1519286113
   Li L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23992
   Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005
   Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205
   Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002
   Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887
   Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050
   Sparks AB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.030
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tsang JCH, 2007, PATHOLOGY, V39, P197, DOI 10.1080/00313020701230831
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW64, DOI 10.1093/nar/gkw247
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Zhong Xiao Yan, 2007, Archives of Gynecology and Obstetrics, V276, P327, DOI 10.1007/s00404-007-0345-1
NR 33
TC 18
Z9 20
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD DEC
PY 2018
VL 125
IS 4
BP 332
EP 337
DI 10.1016/j.ymgme.2018.10.002
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA HE7RO
UT WOS:000453637800003
PM 30361042
DA 2024-11-01
ER

PT J
AU Spiegel, R
   Saada, A
   Flannery, PJ
   Burté, F
   Soiferman, D
   Khayat, M
   Eisner, V
   Vladovski, E
   Taylor, RW
   Bindoff, LA
   Shaag, A
   Mandel, H
   Schuler-Furman, O
   Shalev, SA
   Elpeleg, O
   Yu-Wai-Man, P
AF Spiegel, Ronen
   Saada, Ann
   Flannery, Padraig J.
   Burte, Florence
   Soiferman, Devorah
   Khayat, Morad
   Eisner, Veronica
   Vladovski, Eugene
   Taylor, Robert W.
   Bindoff, Laurence A.
   Shaag, Avraham
   Mandel, Hanna
   Schuler-Furman, Ora
   Shalev, Stavit A.
   Elpeleg, Orly
   Yu-Wai-Man, Patrick
TI Fatal infantile mitochondrial encephalomyopathy, hypertrophic
   cardiomyopathy and optic atrophy associated with a homozygous
   <i>OPA1</i> mutation
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID SKELETAL-MUSCLE; DNA INSTABILITY; GENE; DEFICIENCY; PHENOTYPE; DISORDER;
   DEAFNESS; FUSION; MOUSE
AB Background Infantile-onset encephalopathy and hypertrophic cardiomyopathy caused by mitochondrial oxidative phosphorylation defects are genetically heterogeneous with defects involving both the mitochondrial and nuclear genomes.
   Objective To identify the causative genetic defect in two sisters presenting with lethal infantile encephalopathy, hypertrophic cardiomyopathy and optic atrophy.
   Methods We describe a comprehensive clinical, biochemical and molecular genetic investigation of two affected siblings from a consanguineous family. Molecular genetic analysis was done by a combined approach involving genome-wide autozygosity mapping and next-generation exome sequencing. Biochemical analysis was done by enzymatic analysis and Western blot. Evidence for mitochondrial DNA (mtDNA) instability was investigated using long-range and real-time PCR assays. Mitochondrial cristae morphology was assessed with transmission electron microscopy.
   Results Both affected sisters presented with a similar cluster of neurodevelopmental deficits marked by failure to thrive, generalised neuromuscular weakness and optic atrophy. The disease progression was ultimately fatal with severe encephalopathy and hypertrophic cardiomyopathy. Mitochondrial respiratory chain complex activities were globally decreased in skeletal muscle biopsies. They were found to be homozygous for a novel c. 1601T>G (p. Leu534Arg) mutation in the OPA1 gene, which resulted in a marked loss of steady-state levels of the native OPA1 protein. We observed severe mtDNA depletion in DNA extracted from the patients' muscle biopsies. Mitochondrial morphology was consistent with abnormal mitochondrial membrane fusion.
   Conclusions We have established, for the first time, a causal link between a pathogenic homozygous OPA1 mutation and human disease. The fatal multisystemic manifestations observed further extend the complex phenotype associated with pathogenic OPA1 mutations, in particular the previously unreported association with hypertrophic cardiomyopathy. Our findings further emphasise the vital role played by OPA1 in mitochondrial biogenesis and mtDNA maintenance.
C1 [Spiegel, Ronen] Emek Med Ctr, Dept Pediat B, Genet Inst, IL-18101 Afula, Israel.
   [Spiegel, Ronen; Khayat, Morad; Shalev, Stavit A.] Technion Israel Inst Technol, Rappaport Sch Med, Emek Med Ctr, Genet Inst, Haifa, Israel.
   [Saada, Ann; Soiferman, Devorah; Shaag, Avraham; Elpeleg, Orly] Hebrew Univ Jerusalem, Hadassah Med Ctr, Mon & Jacques Roboh Dept Genet Res, Jerusalem, Israel.
   [Flannery, Padraig J.; Burte, Florence; Taylor, Robert W.; Yu-Wai-Man, Patrick] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Eisner, Veronica] Pontificia Univ Catolica Chile, Sch Biol Sci, Dept Cellular & Mol Biol, Santiago, Chile.
   [Vladovski, Eugene] Rambam Med Ctr, Dept Pathol, Haifa, Israel.
   [Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Mandel, Hanna] Hebrew Univ Jerusalem, Rambam Med Ctr, Metabol Unit, Jerusalem, Israel.
   [Schuler-Furman, Ora] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Microbiol & Mol Genet, Jerusalem, Israel.
   [Yu-Wai-Man, Patrick] Royal Victoria Infirm, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 Emek Medical Center; Technion Israel Institute of Technology; Rappaport
   Faculty of Medicine; Emek Medical Center; Hebrew University of
   Jerusalem; Hadassah University Medical Center; Newcastle University -
   UK; Pontificia Universidad Catolica de Chile; Rambam Health Care Campus;
   University of Bergen; Hebrew University of Jerusalem; Rambam Health Care
   Campus; Hebrew University of Jerusalem; Hadassah University Medical
   Center; Newcastle University - UK
RP Spiegel, R (corresponding author), Emek Med Ctr, Dept Pediat B, IL-18101 Afula, Israel.
EM spiegelr@zahav.net.il
RI Flannery, Padraig/HCI-9510-2022; Bindoff, Nathaniel/C-8050-2011; Burte,
   Florence/U-8257-2017; Saada, Ann/J-6864-2017
OI Bindoff, Laurence/0000-0003-0988-276X; Burte,
   Florence/0000-0001-9020-7838; Saada, Ann/0000-0003-2951-0656; Eisner,
   Veronica/0000-0002-9458-7150
FU Clinician Scientist Fellowship Award from the Medical Research Council
   (UK) [G1002570]; Fight for Sight (UK); UK National Institute of Health
   Research (NIHR) as part of the Rare Diseases Translational Research
   Collaboration; Wellcome Trust Strategic Award [096919Z/11/Z]; Medical
   Research Council (UK) Centre for Translational Muscle Disease Research
   [G0601943]; MRC [G1002570, G0701386, G0601943] Funding Source: UKRI
FX PYWM is supported by a Clinician Scientist Fellowship Award (G1002570)
   from the Medical Research Council (UK). PYWM also receives funding from
   Fight for Sight (UK) and the UK National Institute of Health Research
   (NIHR) as part of the Rare Diseases Translational Research
   Collaboration. RWT is supported by a Wellcome Trust Strategic Award
   (096919Z/11/Z) and the Medical Research Council (UK) Centre for
   Translational Muscle Disease Research (G0601943).
CR Abdulhag UN, 2015, EUR J HUM GENET, V23, P159, DOI 10.1038/ejhg.2014.85
   Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bonifert T, 2014, BRAIN, V137, P2164, DOI 10.1093/brain/awu165
   Bonneau D, 2014, BRAIN, V137, DOI 10.1093/brain/awu184
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Carelli V, 2014, BRAIN, V137, pe302
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Joost K, 2010, PEDIATR NEUROL, V42, P227, DOI 10.1016/j.pediatrneurol.2009.10.004
   Liguori M, 2008, J NEUROL, V255, P127, DOI 10.1007/s00415-008-0571-x
   Liskova P, 2013, ACTA OPHTHALMOL, V91, pE225, DOI 10.1111/aos.12038
   Liu HY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-29
   Lodi R, 2011, ARCH NEUROL-CHICAGO, V68, P67, DOI 10.1001/archneurol.2010.228
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303
   Schaaf CP, 2011, MOL GENET METAB, V103, P383, DOI 10.1016/j.ymgme.2011.04.018
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 24
TC 87
Z9 92
U1 0
U2 15
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD FEB
PY 2016
VL 53
IS 2
BP 127
EP 131
DI 10.1136/jmedgenet-2015-103361
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA DB4SF
UT WOS:000368502700007
PM 26561570
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Seneca, S
   Goemans, N
   Van Coster, R
   Givron, P
   Reybrouck, T
   Sciot, R
   Meulemans, A
   Smet, J
   Van Hove, JLK
AF Seneca, S
   Goemans, N
   Van Coster, R
   Givron, P
   Reybrouck, T
   Sciot, R
   Meulemans, A
   Smet, J
   Van Hove, JLK
TI A mitochondrial tRNA Aspartate mutation causing isolated mitochondrial
   myopathy
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE mitochondrial myopathy; exercise intolerance; mitochondrial DNA; tRNA
   genes; tRNA(Asp)
ID RESPIRATORY-CHAIN; ANAEROBIC THRESHOLD; DIAGNOSTIC-CRITERIA; FAMILIAL
   MYOPATHY; GAS-EXCHANGE; EXERCISE; GENE; CHILDREN; DISORDERS; MUSCLE
AB Several mutations in mitochondrial transfer RNA (tRNA) genes can cause mitochondrial myopathy. We describe a young girl who presented with pronounced exercise intolerance. The anaerobic threshold and the maximal oxygen consumption were decreased. She had decreased complex I and IV enzyme activity and ragged red fibers on muscle biopsy. An A to G transition at nucleotide position 7526 in tRNA Aspartate (tRNA(Asp)) gene was heteroplasmic in several of the patient's tissues. We were unable to detect the mutation in muscle tissue from the patient's mother. This case adds a new genetic etiology for mitochondrial myopathy. It also illustrates for patients with combined deficiency of the complex I and IV enzyme activity the value of sequencing in the affected tissue muscle, and not only in blood, all mitochondrial tRNA genes including those not commonly affected, such as in this case mt tRNA(Asp). (c) 2005 Wiley-Liss, Inc.
C1 Free Univ Brussels, Ctr Med Genet, Brussels, Belgium.
   Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Pediat, Louvain, Belgium.
   State Univ Ghent, Dept Pediat, B-9000 Ghent, Belgium.
   Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Pathol, Louvain, Belgium.
   Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80202 USA.
C3 Universite Libre de Bruxelles; KU Leuven; University Hospital Leuven;
   Ghent University; KU Leuven; University Hospital Leuven; University of
   Colorado System; University of Colorado Anschutz Medical Campus;
   University of Colorado Denver
RP Childrens Hosp, Dept Pediat, Box B153,Tammen Hall 7T-26,1056 E 19th Ave, Denver, CO 80218 USA.
EM Johan.Vanhove@uchsc.edu
RI Smet, Joél/B-7428-2013
OI Seneca, Sara/0000-0002-0853-9890; sciot, raf/0000-0003-2244-5839;
   Meulemans, Ann/0000-0003-3938-2408
CR BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025
   Chinnery PF, 1997, ANN NEUROL, V41, P408, DOI 10.1002/ana.410410319
   Dey R, 2000, NEUROMUSCULAR DISORD, V10, P488, DOI 10.1016/S0960-8966(00)00125-5
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Dubowitz V., 1985, MUSCLE BIOPSY PRACTI, V2nd
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P425, DOI 10.1164/ajrccm.164.3.2005110
   Hadjigeorgiou GM, 1999, J NEUROL SCI, V164, P153, DOI 10.1016/S0022-510X(99)00062-3
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Horváth R, 2003, J MED GENET, V40, P752, DOI 10.1136/jmg.40.10.752
   HUGHSON RL, 1991, COMPUT BIOMED RES, V24, P118, DOI 10.1016/0010-4809(91)90024-Q
   JANKE A, 1994, GENETICS, V137, P243
   KATSUMATA K, 1994, BIOCHEM BIOPH RES CO, V202, P102, DOI 10.1006/bbrc.1994.1899
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   MILLER DL, 1981, J BIOL CHEM, V256, P9774
   *MIT, 2005, HUM MIT GEN DAT
   Nishigaki Y, 2002, NEUROLOGY, V58, P1282, DOI 10.1212/WNL.58.8.1282
   REYBROUCK T, 1985, EUR J APPL PHYSIOL, V54, P278, DOI 10.1007/BF00426145
   Reybrouck T, 2001, EUR HEART J, V22, P1052, DOI 10.1053/euhj.2000.2425
   Rowland TW, 1997, CHEST, V111, P327, DOI 10.1378/chest.111.2.327
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Seneca S, 1998, J MED GENET, V35, P963, DOI 10.1136/jmg.35.11.963
   Shoffner JM, 2001, METABOLIC MOL BASES, P2367
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Srere P.A., 1969, Methods in Enzymology, V13, P3
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   van Beekvelt MCP, 1999, ANN NEUROL, V46, P667, DOI 10.1002/1531-8249(199910)46:4<667::AID-ANA19>3.0.CO;2-D
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Vives-Bauza C, 2001, ANN MED, V33, P493, DOI 10.3109/07853890109002099
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   2004, MTDB MAP
NR 38
TC 27
Z9 28
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD AUG 30
PY 2005
VL 137A
IS 2
BP 170
EP 175
DI 10.1002/ajmg.a.30854
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 961AP
UT WOS:000231634600009
PM 16059939
DA 2024-11-01
ER

PT J
AU Kasahara, T
   Kato, T
AF Kasahara, Takaoki
   Kato, Tadafumi
TI What Can Mitochondrial DNA Analysis Tell Us About Mood Disorders?
SO BIOLOGICAL PSYCHIATRY
LA English
DT Review
DE Chronic progressive external ophthalmoplegia; Mitochondrial disease;
   Mitochondrial DNA; Mitochondrial dysfunction; Paraventricular thalamus;
   POLG
ID GENOME-WIDE ASSOCIATION; BIPOLAR DISORDER; 3243A-GREATER-THAN-G
   MUTATION; EXTERNAL OPHTHALMOPLEGIA; QUANTITATIVE-ANALYSIS;
   PSYCHIATRIC-SYMPTOMS; MULTIPLE DELETIONS; OXIDATIVE STRESS; COMMON
   DELETION; MTDNA
AB Variants in mitochondrial DNA (mtDNA) and nuclear genes encoding mitochondrial proteins in bipolar disorder, depression, or other psychiatric disorders have been studied for decades, since mitochondrial dysfunction was first suggested in the brains of patients with these diseases. Candidate gene association studies initially resulted in findings compatible with the mitochondrial dysfunction hypothesis. Many of those studies, however, were conducted with modest sample sizes (N, 1000), which could cause false positive findings. Furthermore, the DNA samples examined in these studies, including genome-wide association studies, were generally derived from peripheral tissues. One key unanswered question is whether there is an association between mood disorders and somatic mtDNA mutations (deletions and point mutations) in brain regions that accumulate a high amount of mtDNA mutations and/or are involved in the regulation of mood. Two lines of robust evidence supporting the importance of mtDNA mutations in brain tissues for mood disorders have come from clinical observation of mitochondrial disease patients who carry primary mtDNA mutations or accumulate secondary mtDNA mutations due to nuclear mutations and an animal model study. More than half of mitochondrial disease patients have comorbid mood disorders, and mice with neuronspecific accumulation of mtDNA mutations show spontaneous depression-like episodes. In this review, we first summarize the current knowledge of mtDNA and its genetics and discuss what mtDNA analysis tells us about neuropsychiatric disorders based on an example of Parkinson's disease. We also discuss challenges and future directions beyond mtDNA analysis toward an understanding of the pathophysiology of "idiopathic" mood disorders.
C1 [Kasahara, Takaoki; Kato, Tadafumi] RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
C3 RIKEN
RP Kato, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM kato@brain.riken.jp
RI Kasahara, Takaoki/AAJ-5367-2020; Kato, Tadafumi/J-3583-2014
OI Kato, Tadafumi/0000-0001-7856-3952
FU Advanced Genome Research and Bioinformatics Study to Facilitate Medical
   Innovation from the Japan Agency for Medical Research and Development
   [16815678]; MEXT [17H01573]; Grants-in-Aid for Scientific Research
   [17H01573] Funding Source: KAKEN
FX This work was supported by the Advanced Genome Research and
   Bioinformatics Study to Facilitate Medical Innovation from the Japan
   Agency for Medical Research and Development (Grant No. 16815678 to T.
   Kato) and MEXT Grants-in-Aid for Scientific Research (Grant No. 17H01573
   to T. Kato).
CR Alexeyev M., 2013, Cold Spring Harb Perspect Biol, V5, DOI DOI 10.1101/CSHPERSPECT.A012641
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Anglin RE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.107
   [Anonymous], GENEREVIEWS GENE TES
   [Anonymous], J AFFECT DISORD
   BARON M, 1994, BIOL PSYCHIAT, V35, P757, DOI 10.1016/0006-3223(94)91135-5
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Birur B, 2017, NPJ SCHIZOPHR, V3, DOI 10.1038/s41537-017-0013-9
   Bohnert M, 2007, FEBS LETT, V581, P2802, DOI 10.1016/j.febslet.2007.03.004
   Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   CACCAMO DV, 1989, AM J PATHOL, V135, P801
   Cai N, 2015, CURR BIOL, V25, P3170, DOI 10.1016/j.cub.2015.10.065
   Calabrese C, 2014, BIOINFORMATICS, V30, P3115, DOI 10.1093/bioinformatics/btu483
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Carter MJ, 2014, THER RECREAT J, V48, P275
   Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Fu ZX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00043-3
   Fuke S, 2008, NEUROSCI LETT, V439, P173, DOI 10.1016/j.neulet.2008.05.009
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Goldsmith DR, 2016, MOL PSYCHIATR, V21, P1696, DOI 10.1038/mp.2016.3
   Goulopoulou S, 2012, CLIN SCI, V123, P429, DOI 10.1042/CS20120130
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834
   Hu QS, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0060-6
   Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369
   Ikeda M, 2018, MOL PSYCHIATR, V23, P639, DOI 10.1038/mp.2016.259
   Inczedy-Farkas G, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-9
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Kakiuchi C, 2005, INT J NEUROPSYCHOPH, V8, P515, DOI 10.1017/S1461145705005213
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kasahara T, 2016, MOL PSYCHIATR, V21, P39, DOI 10.1038/mp.2015.156
   Kasahara T, 2017, PSYCHIAT CLIN NEUROS, V71, P518, DOI 10.1111/pcn.12496
   Kataoka M, 2016, MOL PSYCHIATR, V21, P885, DOI 10.1038/mp.2016.69
   Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   Kato T, 2001, MOL PSYCHIATR, V6, P625, DOI 10.1038/sj.mp.4000926
   Kato T, 2008, TRENDS NEUROSCI, V31, P495, DOI 10.1016/j.tins.2008.07.007
   Kato T, 2017, SCHIZOPHR RES, V187, P62, DOI 10.1016/j.schres.2016.10.037
   Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128
   Kirches E, 2009, CURR GENOMICS, V10, P585, DOI 10.2174/138920209789503879
   Kirk R, 1999, AM J HUM GENET, V65, P508, DOI 10.1086/302507
   Kivisild T, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0022-2
   Koene S, 2009, J AFFECT DISORDERS, V114, P327, DOI 10.1016/j.jad.2008.06.023
   Köhler CA, 2017, ACTA PSYCHIAT SCAND, V135, P373, DOI 10.1111/acps.12698
   Ku C, 2015, NATURE, V524, P427, DOI 10.1038/nature14963
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lin MK, 2014, GENOME MED, V6, DOI 10.1186/gm566
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mamdani F, 2014, SCHIZOPHR RES, V159, P370, DOI 10.1016/j.schres.2014.08.026
   Mancuso M, 2008, J AFFECT DISORDERS, V106, P173, DOI 10.1016/j.jad.2007.05.016
   Mancuso M, 2013, NEUROL SCI, V34, P71, DOI 10.1007/s10072-011-0901-0
   Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229
   Modica-Napolitano JS, 2003, ARCH PHARM RES, V26, P951, DOI 10.1007/BF02980205
   Molinari F, 2005, AM J HUM GENET, V76, P334, DOI 10.1086/427564
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Morén C, 2016, CURR DRUG METAB, V17, P648, DOI 10.2174/1389200217666160322143631
   Mühleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339
   Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041
   Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277
   Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478
   Perier C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009332
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   PONCHAUT S, 1993, BIOCHEM PHARMACOL, V46, P199, DOI 10.1016/0006-2952(93)90404-K
   Rodríguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520
   Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913
   Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266
   Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682
   Sato A, 2005, P NATL ACAD SCI USA, V102, P6057, DOI 10.1073/pnas.0408666102
   Schneider S, 1999, GENETICS, V152, P1079
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sequeira A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127280
   Sequeira Adolfo, 2012, Frontiers in Genetics, V3, P103, DOI 10.3389/fgene.2012.00103
   Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   STINE OC, 1993, BIOL PSYCHIAT, V33, P141, DOI 10.1016/0006-3223(93)90317-7
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003
   Tyrka AR, 2016, BIOL PSYCHIAT, V79, P78, DOI 10.1016/j.biopsych.2014.12.025
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830
   Wenceslau CF, 2014, EUR HEART J, V35, P1172, DOI 10.1093/eurheartj/ehu047
NR 107
TC 43
Z9 47
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0006-3223
EI 1873-2402
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD MAY 1
PY 2018
VL 83
IS 9
BP 731
EP 738
DI 10.1016/j.biopsych.2017.09.010
PG 8
WC Neurosciences; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Neurosciences & Neurology; Psychiatry
GA GB9YQ
UT WOS:000429431400005
PM 29102411
OA hybrid
DA 2024-11-01
ER

PT J
AU Ji, XB
   Zhao, LZ
   Ji, KQ
   Zhao, YY
   Li, W
   Zhang, R
   Hou, Y
   Lu, JQ
   Yan, CZ
AF Ji, Xinbo
   Zhao, Lizhen
   Ji, Kunqian
   Zhao, Yuying
   Li, Wei
   Zhang, Rui
   Hou, Ying
   Lu, Jianqiang
   Yan, Chuanzhu
TI Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of
   Mitochondrial Diseases
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Mitochondrial disease; Neuromuscular disorders; Histology; Growth
   differentiation factor 15; Biomarker
ID MACROPHAGE INHIBITORY CYTOKINE-1; DNA MUTATIONS; DISORDERS; GDF15;
   PROGRESSION; PREVALENCE; CELLS; BETA
AB The present study aimed to investigate whether serum growth differentiation factor 15 concentration is a valuable and reliable diagnostic biomarker of mitochondrial diseases. We examined consecutive patients with mitochondrial diseases, in comparison with patients with non-mitochondrial disease neuromuscular disorders and healthy controls. The serum concentrations of growth differentiation factor 15 were measured by ELISA, and compared with those of FGF21, lactate, and creatine kinase. We also evaluated the correlations between growth differentiation factor 15 concentrations and the Newcastle Mitochondrial Disease Adult Scale, numbers of ragged-red fibers, and COX-negative fibers in the biopsied muscles. The median serum growth differentiation factor 15 concentration was significantly elevated in 42 patients with mitochondrial diseases, compared with 20 patients with non-mitochondrial disease neuromuscular disorders and 50 healthy controls. The area under the curve of growth differentiation factor 15 for the diagnosis of muscle-manifesting mitochondrial diseases was 0.999, in comparison with those area under the curves of the other biomarkers including fibroblast growth factor 21 (0.935, p < 0.01), lactate (0.845 for p < 0.001), and creatine kinase (0.575, p < 0.001). Growth differentiation factor 15 was significantly correlated with mitochondrial disease severity and the proportion of ragged-red fibers identified in the biopsied muscles. Circulating growth differentiation factor 15 measurement is a superior biomarker with high sensitivity and specificity, which can be used as a non-invasive test to screen for primary mitochondrial diseases and dysmetabolic myopathy with associated mitochondrial dysfunction in susceptible individuals.
C1 [Ji, Xinbo; Zhao, Lizhen; Ji, Kunqian; Zhao, Yuying; Li, Wei; Zhang, Rui; Hou, Ying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Lab Neuromuscular Disorders, Jinan 250012, Shandong, Peoples R China.
   [Ji, Xinbo; Zhao, Lizhen; Ji, Kunqian; Zhao, Yuying; Li, Wei; Zhang, Rui; Hou, Ying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Shandong, Peoples R China.
   [Zhao, Lizhen] Yidu Cent Hosp Weifang City, Dept Neurol, Qingzhou Shi, Peoples R China.
   [Lu, Jianqiang] Univ Alberta, WCM Hlth Sci Ctr, Neuropathol Sect, Edmonton, AB, Canada.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Minist Educ, Dept Neurol,Qilu Hosp,Key Lab Expt Teratol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University; University of Alberta;
   Shandong University
RP Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Lab Neuromuscular Disorders, Jinan 250012, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Brain Sci Res Inst, Minist Educ, Dept Neurol,Qilu Hosp,Key Lab Expt Teratol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
EM jixinbo@yeah.net; zhaolizhendoc@163.com; kunqianji@163.com;
   zyy72@126.com; weili722@163.com; ruizhang1991@yahoo.com;
   purewligirl@163.com; jqlu@live.ca; czyan1964@gmail.com
RI LU, JIAN-QIANG/AAL-1634-2020
OI Hou, Ying/0000-0001-8116-4928
FU National Natural Science Foundation of China [81171182, 81671235]
FX This study was supported by grants from the National Natural Science
   Foundation of China (No. 81171182 and No. 81671235). The authors thank
   the subjects for their participation, referring doctors, and Ms. Dandan
   Zhao for her assistance with muscle histology.
CR Breit SN, 2012, NEPHROL DIAL TRANSPL, V27, P70, DOI 10.1093/ndt/gfr575
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Fujita Y, 2016, GERIATR GERONTOL INT, V16, P17, DOI 10.1111/ggi.12724
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Izumiya Y, 2014, CAN J CARDIOL, V30, P338, DOI 10.1016/j.cjca.2013.12.010
   Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020
   Kempf T, 2013, CRIT CARE, V17, DOI 10.1186/cc12765
   Koene S, 2015, JIMD REP, V24, P69, DOI 10.1007/8904_2015_436
   Li PX, 2000, J BIOL CHEM, V275, P20127, DOI 10.1074/jbc.M909580199
   Liu FC, 2016, INT J NEUROSCI, V126, P499, DOI 10.3109/00207454.2015.1034801
   Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196
   Montoro-García S, 2012, EUR J INTERN MED, V23, P169, DOI 10.1016/j.ejim.2011.08.022
   Osada M, 2007, BIOCHEM BIOPH RES CO, V354, P913, DOI 10.1016/j.bbrc.2007.01.089
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Tiwari KK, 2015, TOXICOL IN VITRO, V29, P1369, DOI 10.1016/j.tiv.2015.05.008
   Trovik J, 2014, INT J GYNECOL CANCER, V24, P252, DOI 10.1097/IGC.0000000000000037
   Unsicker K, 2013, CYTOKINE GROWTH F R, V24, P373, DOI 10.1016/j.cytogfr.2013.05.003
   Yang CZ, 2014, ANN ONCOL, V25, P1215, DOI 10.1093/annonc/mdu120
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 28
TC 38
Z9 41
U1 0
U2 6
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD DEC
PY 2017
VL 54
IS 10
BP 8110
EP 8116
DI 10.1007/s12035-016-0283-7
PG 7
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA FM8MF
UT WOS:000415341900044
PM 27889897
DA 2024-11-01
ER

PT J
AU Spyropoulos, A
   Manford, M
   Horvath, R
   Alston, CL
   Yu-Wai-Man, P
   He, LP
   Taylor, RW
   Chinnery, PF
AF Spyropoulos, Achilles
   Manford, Mark
   Horvath, Rita
   Alston, Charlotte L.
   Yu-Wai-Man, Patrick
   He, Langping
   Taylor, Robert W.
   Chinnery, Patrick F.
TI Near-Identical Segregation of mtDNA Heteroplasmy in Blood, Muscle,
   Urinary Epithelium, and Hair Follicles in Twins With Optic Atrophy,
   Ptosis, and Intractable Epilepsy
SO JAMA NEUROLOGY
LA English
DT Article
ID COMPLEX-I DEFICIENCY; LEIGH-SYNDROME; ND6 GENE; MUTATIONS; PATIENT
AB IMPORTANCE Mitochondrial DNA (mtDNA) disorders have emerged as major causes of inherited neurologic disease. Despite being well recognized for more than 2 decades, the clinical presentation continues to broaden. The phenotypic heterogeneity is partly owing to different percentage levels of mutant mtDNA heteroplasmy in different tissues, but the factors influencing this are poorly understood.
   OBSERVATIONS This case report describes monozygotic male twins with ptosis, optic atrophy, and recent-onset intractable myoclonic epilepsy. The assessment of respiratory chain enzyme activities in the muscle from 1 twin revealed a severe and isolated defect involving mitochondrial complex I. Mitochondrial DNA sequencing revealed a pathogenic m.14487T>C MTND6 mutation, which was present at very high levels of heteroplasmy in muscle (84%) and lower levels in blood (15%), urinary epithelium (75%), and buccal mucosa (58%). Of particular interest, his identical twin was found to harbor very similar levels of the m. 14487T>C mutation in his blood, urine, buccal mucosa, and hair follicle DNA samples, while the presence of low levels in the mother's tissues confirmed maternal transmission.
   CONCLUSIONS AND RELEVANCE It was shown that m14487T>C can also cause the unusual combination of optic atrophy, ptosis, and encephalomyopathy leading to intractable seizures. Near-identical heteroplasmy levels in different tissues in both siblings support a nuclear genetic mechanism controlling the tissue segregation of mtDNA mutations.
C1 [Spyropoulos, Achilles; Horvath, Rita; Yu-Wai-Man, Patrick; Chinnery, Patrick F.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Manford, Mark] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England.
   [Alston, Charlotte L.; He, Langping; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Newcastle University - UK; University of Cambridge; Newcastle University
   - UK
RP Chinnery, PF (corresponding author), Newcastle Univ, Inst Med Genet, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
RI Horvath, Rita/AAY-7042-2020; Alston, Charlotte/ABG-9602-2020
OI Horvath, Rita/0000-0002-9841-170X; Chinnery,
   Patrick/0000-0002-7065-6617; Alston, Charlotte/0000-0003-2095-5464
FU Wellcome Trust; MRC [G0701386, G1002570, MR/K000608/1] Funding Source:
   UKRI
FX The Wellcome Trust sponsored this study.
CR Andrew T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022332
   Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161
   Koene S, 2012, J INHERIT METAB DIS, V35, P737, DOI 10.1007/s10545-012-9492-z
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   Leshinsky-Silver E, 2011, J CHILD NEUROL, V26, P476, DOI 10.1177/0883073810384615
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Wang J, 2009, MOL GENET METAB, V96, P59, DOI 10.1016/j.ymgme.2008.10.006
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
NR 16
TC 15
Z9 15
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD DEC
PY 2013
VL 70
IS 12
BP 1552
EP 1555
DI 10.1001/jamaneurol.2013.4111
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 295LS
UT WOS:000330118200013
PM 24126373
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Rimoldi, M
   Magri, F
   Antognozzi, S
   Ripolone, M
   Salani, S
   Piga, D
   Bertolasi, L
   Zanotti, S
   Ciscato, P
   Fortunato, F
   Moggio, M
   Corti, S
   Comi, GP
   Ronchi, D
AF Rimoldi, Martina
   Magri, Francesca
   Antognozzi, Sara
   Ripolone, Michela
   Salani, Sabrina
   Piga, Daniela
   Bertolasi, Letizia
   Zanotti, Simona
   Ciscato, Patrizia
   Fortunato, Francesco
   Moggio, Maurizio
   Corti, Stefania
   Comi, Giacomo Pietro
   Ronchi, Dario
TI Prominent muscle involvement in a familial form of mitochondrial disease
   due to a <i>COA8</i> variant
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mitochondrial myopathy; cytochrome c oxidase deficiency; COA8;
   mitochondrial encefalomyopathies; whole exome sequencing
ID MUTATIONS; PROTEIN
AB Isolated mitochondrial respiratory chain Complex IV (Cytochrome c Oxidase or COX) deficiency is the second most frequent isolated respiratory chain defect. Causative mutations are mainly identified in structural COX subunits or in proteins involved in the maturation and assembly of the COX holocomplex. We describe an Italian familial case of mitochondrial myopathy due to a variant in the COX assembly factor 8 gene (COA8). Patient 1 is a 52-year-old woman who presented generalized epilepsy and retinitis pigmentosa at 10 years of age. From her early adulthood she complained about cramps and myalgia after exercise, and bilateral hearing loss emerged. Last neurological examination (52 years of age) showed bilateral ptosis, muscle weakness, peripheral neuropathy, mild dysarthria and dysphonia, cognitive impairment. Muscle biopsy had shown the presence of ragged-red fibers. Patient 2 (Patient 1's sister) is a 53-year-old woman presenting fatigability, myalgia, and hearing loss. Neurological examination showed ptosis and muscle weakness. Muscle biopsy displayed a diffuse reduction of COX activity staining and ragged-red fibers. Both sisters presented secondary amenorrhea. After ruling out mtDNA mutations, Whole Exome Sequencing analysis identified the novel homozygous COA8 defect c.170_173dupGACC, p.(Pro59fs) in the probands. Loss-of-function COA8 mutations have been associated with cavitating leukoencephalopathy with COX deficiency in 9 reported individuals. Disease course shows an early-onset rapid clinical deterioration, affecting both cognitive and motor functions over months, followed by stabilization and slow improvement over several years. Our findings expand the clinical spectrum of COA8-related disease. We confirm the benign course of this rare disorder, highlighting its (intrafamilial) clinical variability.
C1 [Rimoldi, Martina; Ripolone, Michela; Zanotti, Simona; Ciscato, Patrizia; Moggio, Maurizio; Corti, Stefania] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Magri, Francesca; Antognozzi, Sara; Salani, Sabrina; Piga, Daniela; Bertolasi, Letizia; Fortunato, Francesco; Comi, Giacomo Pietro; Ronchi, Dario] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Corti, Stefania; Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale
   Maggiore Policlinico; University of Milan
RP Ronchi, D (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.; Ronchi, D (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
EM dario.ronchi@unimi.it
RI Ronchi, Dario/O-4138-2019; Corti, Stefania/K-6034-2016
FU Italian Ministry of Health-Current research IRCCS Ca' Granda Ospedale
   Maggiore Policlinico
FX The author(s) declare financial support was received for the research,
   authorship, and/or publication of this article. This study was
   (partially) funded by Italian Ministry of Health-Current research IRCCS
   Ca' Granda Ospedale Maggiore Policlinico and by SEQMD project (IRCCS Ca
   Granda Ospedale Maggiore Policlinico, PI: GC).r The author(s) declare
   financial support was received for the research, authorship, and/or
   publication of this article. This study was (partially) funded by
   Italian Ministry of Health-Current research IRCCS Ca' Granda Ospedale
   Maggiore Policlinico and by SEQMD project (IRCCS Ca Granda Ospedale
   Maggiore Policlinico, PI: GC).
CR Brischigliaro M, 2021, BBA-BIOENERGETICS, V1862, DOI 10.1016/j.bbabio.2020.148335
   Brischigliaro M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01143
   Chapleau A, 2023, FRONT CELL NEUROSCI, V17, DOI 10.3389/fncel.2023.1216487
   Chinnery P.F., 1993, MITOCHONDRIAL DISORD
   Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006
   Hedberg-Oldfors C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000464
   Lax NZ, 2011, NEUROSCIENTIST, V17, P645, DOI 10.1177/1073858411385469
   Melchionda L, 2014, AM J HUM GENET, V95, P315, DOI 10.1016/j.ajhg.2014.08.003
   Mu WY, 2019, J NEUROGENET, V33, P21, DOI 10.1080/01677063.2018.1555249
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Richman TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11884
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Sferruzza G, 2021, NEUROL-GENET, V7, DOI 10.1212/NXG.0000000000000573
   Sharma S, 2018, J CHILD NEUROL, V33, P428, DOI 10.1177/0883073818760875
   Signes A, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809582
   Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005
   Stenton SL, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102784
   Sun X, 2008, BIOCHEM BIOPH RES CO, V377, P1097, DOI 10.1016/j.bbrc.2008.10.109
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Yasuda O, 2006, J BIOL CHEM, V281, P23899, DOI 10.1074/jbc.M512610200
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 23
TC 2
Z9 2
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD NOV 30
PY 2023
VL 14
AR 1278572
DI 10.3389/fgene.2023.1278572
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA CJ5Z6
UT WOS:001124911700001
PM 38098475
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Inoue, M
   Uchino, S
   Iida, A
   Noguchi, S
   Hayashi, S
   Takahashi, T
   Fujii, K
   Komaki, H
   Takeshita, E
   Nonaka, I
   Okada, Y
   Yoshizawa, T
   Van Lommel, L
   Schuit, F
   Goto, Y
   Mimaki, M
   Nishino, I
AF Inoue, Michio
   Uchino, Shumpei
   Iida, Aritoshi
   Noguchi, Satoru
   Hayashi, Shinichiro
   Takahashi, Tsutomu
   Fujii, Katsunori
   Komaki, Hirofumi
   Takeshita, Eri
   Nonaka, Ikuya
   Okada, Yukinori
   Yoshizawa, Takuya
   Van Lommel, Leentje
   Schuit, Frans
   Goto, Yu-ichi
   Mimaki, Masakazu
   Nishino, Ichizo
TI <i>COX6A2</i> variants cause a muscle-specific cytochrome <i>c</i>
   oxidase deficiency
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA DEPLETION; SUBUNIT; MUTATIONS; MYOPATHY; COMPLEXES;
   GENES
AB Objective Cytochrome c oxidase (COX) deficiency is a major mitochondrial respiratory chain defect that has vast genetic and phenotypic heterogeneity. This study aims to identify novel causative genes of COX deficiency with only striated muscle-specific symptoms. Methods Whole exome sequencing was performed in 2 unrelated individuals who were diagnosed with congenital myopathy and presented COX deficiency in muscle pathology. We assessed the COX6A2 variants using measurements of enzymatic activities and assembly of mitochondrial respiratory chain complexes in the samples from the patients and knockout mice. Results Both patients presented muscle weakness and hypotonia in 4 limbs along with facial muscle weakness. One patient had cardiomyopathy. Neither patient exhibited involvement from other organs. Whole exome sequencing identified biallelic missense variants in COX6A2, which is expressed only in the skeletal muscle and heart. The variants detected were homozygous c.117C > A (p.Ser39Arg) and compound heterozygous c.117C > A (p.Ser39Arg) and c.127T > C (p.Cys43Arg). We found specific reductions in complex IV activities in the skeletal muscle of both individuals. Assembly of complex IV and its supercomplex formation were impaired in the muscle. Interpretation This study indicates that biallelic variants in COX6A2 cause a striated muscle-specific form of COX deficiency. ANN NEUROL 2019;86:193-202
C1 [Inoue, Michio; Noguchi, Satoru; Hayashi, Shinichiro; Nonaka, Ikuya; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.
   [Inoue, Michio] Univ Yamanashi, Integrated Grad Sch Med Engn & Agr Sci, Yamanashi, Japan.
   [Inoue, Michio; Iida, Aritoshi; Noguchi, Satoru; Hayashi, Shinichiro; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Tokyo, Japan.
   [Uchino, Shumpei; Komaki, Hirofumi; Takeshita, Eri; Goto, Yu-ichi; Mimaki, Masakazu] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Uchino, Shumpei; Mimaki, Masakazu] Teikyo Univ, Dept Pediat, Sch Med, Tokyo, Japan.
   [Takahashi, Tsutomu] Saiseikai Utsunomiya Hosp, Dept Pediat, Utsunomiya, Tochigi, Japan.
   [Fujii, Katsunori] Chiba Univ, Dept Pediat, Grad Sch Med, Chiba, Japan.
   [Komaki, Hirofumi; Takeshita, Eri; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Natl Ctr Hosp, Tokyo, Japan.
   [Okada, Yukinori] Osaka Univ, Dept Stat Genet, Grad Sch Med, Osaka, Japan.
   [Yoshizawa, Takuya] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Japan.
   [Van Lommel, Leentje; Schuit, Frans] Katholieke Univ Leuven, Fac Med, Dept Cellular & Mol Med, Leuven, Belgium.
C3 National Center for Neurology & Psychiatry - Japan; University of
   Yamanashi; National Center for Neurology & Psychiatry - Japan; National
   Center for Neurology & Psychiatry - Japan; Teikyo University; Chiba
   University; National Center for Neurology & Psychiatry - Japan; Osaka
   University; Ritsumeikan University; KU Leuven
RP Noguchi, S (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.
EM noguchi@ncnp.go.jp
RI Inoue, Michio/KVY-0444-2024; Iida, Aritoshi/CAA-1373-2022; Nishino,
   Ichizo/G-2676-2010
OI Inoue, Michio/0000-0003-2757-3266; Komaki, Hirofumi/0000-0002-0659-1417;
   Iida, Aritoshi/0000-0001-7538-1651
FU Grants-in-Aid for Scientific Research [16K09999] Funding Source: KAKEN
CR Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   BONNE G, 1993, EUR J BIOCHEM, V217, P1099, DOI 10.1111/j.1432-1033.1993.tb18342.x
   Cogliati S, 2016, NATURE, V539, P579, DOI 10.1038/nature20157
   DiMauro S, 2012, ADV EXP MED BIOL, V748, P341, DOI 10.1007/978-1-4614-3573-0_14
   Endo Y, 2015, HUM MOL GENET, V24, P637, DOI 10.1093/hmg/ddu477
   Giordano C, 2010, ARCH NEUROL-CHICAGO, V67, P1144, DOI 10.1001/archneurol.2010.200
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Inoue M, 2018, HUM GENOME VAR, V5, DOI 10.1038/s41439-018-0009-7
   KIM K, 1995, BIOCHEM J, V306, P353, DOI 10.1042/bj3060353
   Ma YY, 2011, J CHILD NEUROL, V26, P974, DOI 10.1177/0883073811399905
   Malicdan MCV, 2009, METHOD ENZYMOL, V453, P379, DOI 10.1016/S0076-6879(08)04019-6
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   Noguchi S, 2017, EBIOMEDICINE, V15, P193, DOI 10.1016/j.ebiom.2016.12.011
   Okada Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087645
   Okada Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03274-0
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Quintens R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056719
   Radford NB, 2002, AM J PHYSIOL-HEART C, V282, pH726, DOI 10.1152/ajpheart.00308.2001
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   SCHLERF A, 1988, EMBO J, V7, P2387, DOI 10.1002/j.1460-2075.1988.tb03083.x
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   TAANMAN JW, 1992, BIOCHIM BIOPHYS ACTA, V1139, P155, DOI 10.1016/0925-4439(92)90095-5
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957
NR 31
TC 18
Z9 22
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD AUG
PY 2019
VL 86
IS 2
BP 193
EP 202
DI 10.1002/ana.25517
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA IJ1PL
UT WOS:000475670500005
PM 31155743
DA 2024-11-01
ER

PT J
AU Li, T
   Chen, GL
   Lan, H
   Mao, L
   Zeng, B
AF Li, Tao
   Chen, Gui-Lan
   Lan, Huan
   Mao, Liang
   Zeng, Bo
TI Prevalence of the 4977-bp and 4408-bp mitochondrial DNA deletions in
   mesenteric arteries from patients with colorectal cancer
SO MITOCHONDRIAL DNA PART A
LA English
DT Article
DE Colorectal cancer; mesenteric artery; mitochondrial DNA deletion
ID BP DELETION; ATRIAL-FIBRILLATION; VIETNAMESE PATIENTS; OXIDATIVE STRESS;
   BREAST-CANCER; HUMAN-CELLS; GENOME; ACCUMULATION; MUSCLE
AB Mitochondrial DNA (mtDNA) deletions are found in many diseased tissues and lead to impairment of mitochondrial functions. In this study, we found wide presence of the common 4977-bp and a novel 4408-bp deletion in the mtDNA of mesenteric arteries from patients with colorectal cancer. These two deletions were also detected in samples from healthy individuals. The content of mtDNA with the 4977-bp deletion was significantly lower in healthy controls than cancer-associated samples, and there was no significant difference for the 4408-bp deletion between the two groups. These results suggest that mtDNA in blood vessels around cancer cells may be strongly affected by oxidative stress and tend to accumulate more large-scale variations.
C1 Luzhou Med Coll, Minist Educ, Key Lab Med Elect, Luzhou 646000, Sichuan, Peoples R China.
   [Zeng, Bo] Luzhou Med Coll, Inst Cardiovasc Res, Luzhou 646000, Sichuan, Peoples R China.
C3 Southwest Medical University; Southwest Medical University
RP Zeng, B (corresponding author), Luzhou Med Coll, Inst Cardiovasc Res, Luzhou 646000, Sichuan, Peoples R China.
EM zengbo@lzmc.edu.cn
RI Li, Tao/KQU-9516-2024
OI Li, Tao/0000-0003-2255-1885
FU National Natural Science Foundation of China [31300949, 31300965]
FX The authors declare that there is no conflict of interest. This work was
   supported by grants from National Natural Science Foundation of China
   (31300949 to B. Z. and 31300965 to G. L. C.)
CR Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Dani Maria Angela C, 2004, Genet Mol Res, V3, P395
   Dimberg J, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0843-8
   Dimberg J, 2014, ANTICANCER RES, V34, P147
   Goto YI, 1996, BIOCHEM BIOPH RES CO, V222, P215, DOI 10.1006/bbrc.1996.0724
   Lai LP, 2003, CHEST, V123, P539, DOI 10.1378/chest.123.2.539
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lin PH, 2003, FREE RADICAL BIO MED, V35, P1310, DOI 10.1016/j.freeradbiomed.2003.07.002
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Nie HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067953
   Nourazarian AR, 2014, ASIAN PAC J CANCER P, V15, P4745, DOI 10.7314/APJCP.2014.15.12.4745
   Singh AK, 2014, MITOCHONDR DNA, V25, P329, DOI 10.3109/19401736.2013.796520
   van Guldener C, 2000, SEMIN THROMB HEMOST, V26, P281, DOI 10.1055/s-2000-8472
   Wei YH, 2001, ANN NY ACAD SCI, V928, P97
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
NR 17
TC 3
Z9 3
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2470-1394
EI 2470-1408
J9 MITOCHONDRIAL DNA A
JI Mitochondrial DNA Part A
PY 2016
VL 27
IS 5
BP 3774
EP 3776
DI 10.3109/19401736.2015.1079900
PG 3
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA DO7IU
UT WOS:000377956700285
PM 26332461
DA 2024-11-01
ER

PT J
AU Filograna, R
   Mennuni, M
   Alsina, D
   Larsson, NG
AF Filograna, Roberta
   Mennuni, Mara
   Alsina, David
   Larsson, Nils-Goran
TI Mitochondrial DNA copy number in human disease: the more the better?
SO FEBS LETTERS
LA English
DT Review
DE ageing; Alzheimer&#8217; s disease; cancer; mitochondria; mitochondrial
   diseases; mtDNA; mtDNA copy number; neurodegenerative disorders;
   Parkinson&#8217; s disease; TFAM
ID TRANSCRIPTION FACTOR-A; PERIPHERAL-BLOOD CELLS; IN-SITU HYBRIDIZATION;
   SKELETAL-MUSCLE; COLORECTAL-CANCER; MTDNA HETEROPLASMY;
   POLYMERASE-GAMMA; POINT MUTATIONS; MOUSE MODEL; GENOMIC LANDSCAPE
AB Most of the genetic information has been lost or transferred to the nucleus during the evolution of mitochondria. Nevertheless, mitochondria have retained their own genome that is essential for oxidative phosphorylation (OXPHOS). In mammals, a gene-dense circular mitochondrial DNA (mtDNA) of about 16.5 kb encodes 13 proteins, which constitute only 1% of the mitochondrial proteome. Mammalian mtDNA is present in thousands of copies per cell and mutations often affect only a fraction of them. Most pathogenic human mtDNA mutations are recessive and only cause OXPHOS defects if present above a certain critical threshold. However, emerging evidence strongly suggests that the proportion of mutated mtDNA copies is not the only determinant of disease but that also the absolute copy number matters. In this review, we critically discuss current knowledge of the role of mtDNA copy number regulation in various types of human diseases, including mitochondrial disorders, neurodegenerative disorders and cancer, and during ageing. We also provide an overview of new exciting therapeutic strategies to directly manipulate mtDNA to restore OXPHOS in mitochondrial diseases.
C1 [Filograna, Roberta; Mennuni, Mara; Alsina, David; Larsson, Nils-Goran] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Metab, S-17176 Stockholm, Sweden.
   [Filograna, Roberta; Mennuni, Mara; Alsina, David; Larsson, Nils-Goran] Karolinska Inst, Karolinska Inst Lab, Max Planck Inst Biol Ageing, Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska Institutet
RP Larsson, NG (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Metab, S-17176 Stockholm, Sweden.
EM nils-goran.larsson@ki.se
RI Larsson, Nils-Göran/GVS-5578-2022; Filograna, Roberta/KHE-2279-2024
OI Mennuni, Mara/0000-0001-6199-6233; Larsson,
   Nils-Goran/0000-0001-5100-996X; Filograna, Roberta/0000-0002-6581-9426;
   Alsina, David/0000-0003-0708-7391
FU Swedish Research Council [2015.00418]; Knut and Alice Wallenberg
   Foundation [KAW 2016.0050]; European Research Council [2016-741366];
   Swedish Cancer Society [2018.602]; Novo Nordisk Foundation; Swedish
   government [SLL2018.0471]; Swedish county councils, the ALF agreement
   [SLL2018.0471]
FX This review was supported by grants to NGL from the Swedish Research
   Council (2015.00418), the Knut and Alice Wallenberg Foundation (KAW
   2016.0050), the European Research Council (Advanced Grant 2016-741366),
   the Swedish Cancer Society (2018.602), Novo Nordisk Foundation and
   grants from the Swedish state under the agreement between the Swedish
   government and the county councils, the ALF agreement (SLL2018.0471).
   Figures have been created using BioRender.com.
CR Alán L, 2010, ACTA BIOCHIM POL, V57, P403
   Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   Alsina D, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911659
   Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Barriocanal-Casado E, 2019, EBIOMEDICINE, V42, P511, DOI 10.1016/j.ebiom.2019.03.025
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bensard CL, 2020, CELL METAB, V31, P284, DOI 10.1016/j.cmet.2019.11.002
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   BEREGI E, 1987, ACTA MORPHOL HUNG, V35, P219
   Bianco Angelica, 2018, BMC Res Notes, V11, P911, DOI 10.1186/s13104-018-4025-y
   Bianco A, 2017, INVEST OPHTH VIS SCI, V58, P2193, DOI 10.1167/iovs.16-20389
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bonekamp NA, 2018, CELL, V172, P388, DOI 10.1016/j.cell.2017.12.039
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018
   Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11
   Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chu HT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S5
   Ciron C, 2012, HUM MOL GENET, V21, P1861, DOI 10.1093/hmg/ddr618
   Civiletto G, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708799
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cui HH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-110
   Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889
   Dasgupta S, 2012, J CELL PHYSIOL, V227, P2451, DOI 10.1002/jcp.22980
   Datta S, 2015, TUMOR BIOL, V36, P3025, DOI 10.1007/s13277-014-2937-2
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Dickinson A, 2013, CELL DEATH DIFFER, V20, P1644, DOI 10.1038/cdd.2013.115
   Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4
   Dillon LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044335
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   EVANS MJ, 1989, J BIOL CHEM, V264, P14361
   EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Farge G, 2014, CELL REP, V8, P66, DOI 10.1016/j.celrep.2014.05.046
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Feng S, 2011, ONCOL LETT, V2, P899, DOI 10.3892/ol.2011.322
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917
   Filograna R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9824
   Fink W J, 1977, Ann N Y Acad Sci, V301, P323
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fukuoh A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145117
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gopal RK, 2018, P NATL ACAD SCI USA, V115, pE6283, DOI 10.1073/pnas.1711888115
   Gorelick AN, 2020, RESP COMPLEX TISSUE
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Grandhi S, 2017, HUM MOL GENET, V26, P2912, DOI 10.1093/hmg/ddx172
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895
   Griffiths LM, 2009, METHODS MOL BIOL, V554, P267, DOI 10.1007/978-1-59745-521-3_17
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Gui YX, 2015, PARKINSONISM RELAT D, V21, P282, DOI 10.1016/j.parkreldis.2014.12.030
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Guo Y, 2013, BIOINFORMATICS, V29, P1210, DOI 10.1093/bioinformatics/btt118
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   He YH, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.015
   Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034
   Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hofer A, 2014, HUM MOL GENET, V23, P2400, DOI 10.1093/hmg/ddt631
   Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013
   Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045
   Huang B, 2014, CANCER EPIDEM BIOMAR, V23, P2357, DOI 10.1158/1055-9965.EPI-14-0297
   Hurtado-Roca Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163770
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Jackson CB, 2020, TRENDS MOL MED, V26, P698, DOI 10.1016/j.molmed.2020.02.006
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Janes MS, 2004, J HISTOCHEM CYTOCHEM, V52, P1011, DOI 10.1369/jhc.3a6209.2004
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Joshi S, 2015, CELL REP, V13, P1895, DOI 10.1016/j.celrep.2015.10.059
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   KASAMATS.H, 1973, NATURE-NEW BIOL, V241, P103, DOI 10.1038/newbio241103a0
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krishnan KJ, 2012, NEUROBIOL AGING, V33, P2210, DOI 10.1016/j.neurobiolaging.2011.08.009
   Kühl I, 2017, ELIFE, V6, DOI 10.7554/eLife.30952
   Kürschner G, 2017, ONCOTARGET, V8, P105882, DOI 10.18632/oncotarget.22413
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lemnrau A, 2015, CANCER RES, V75, P2844, DOI 10.1158/0008-5472.CAN-14-1692
   Leung MCK, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-9
   Lin Chen-Sung, 2008, Interact Cardiovasc Thorac Surg, V7, P954, DOI 10.1510/icvts.2008.177006
   Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4
   Lindholm D, 2012, CELL MOL LIFE SCI, V69, P2465, DOI 10.1007/s00018-012-1043-0
   Lindsay AK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004567
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Longchamps RJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228166
   Lunnon K, 2017, NEUROBIOL AGING, V53, P36, DOI 10.1016/j.neurobiolaging.2016.12.029
   Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MARTENS PA, 1979, J MOL BIOL, V135, P327, DOI 10.1016/0022-2836(79)90440-6
   Matsushima Y, 2003, J BIOL CHEM, V278, P31149, DOI 10.1074/jbc.M303842200
   McMahon S, 2014, CARCINOGENESIS, V35, P1046, DOI 10.1093/carcin/bgu012
   Memon Ashfaque A, 2017, Biomol Detect Quantif, V13, P32, DOI 10.1016/j.bdq.2017.08.001
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mi J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10039
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034
   Momcilovic M, 2019, NATURE, V575, P380, DOI 10.1038/s41586-019-1715-0
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Ngo Huu B, 2014, Nat Commun, V5, P3077, DOI 10.1038/ncomms4077
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nishiyama S, 2010, BIOCHEM BIOPH RES CO, V401, P26, DOI 10.1016/j.bbrc.2010.08.143
   Nissanka N, 2020, EMBO REP, V21, DOI 10.15252/embr.201949612
   Oka S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37889
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w
   Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Qian Y, 2017, BIOINFORMATICS, V33, P1399, DOI 10.1093/bioinformatics/btw835
   Rabanal-Ruiz Y, 2017, ESSAYS BIOCHEM, V61, P565, DOI 10.1042/EBC20170027
   Rackham O, 2016, CELL REP, V16, P1874, DOI 10.1016/j.celrep.2016.07.031
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Renaldo F, 2012, BRAIN, V135, DOI 10.1093/brain/aws111
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rodríguez-Santiago B, 2001, EUR J HUM GENET, V9, P279, DOI 10.1038/sj.ejhg.5200629
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160
   Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schöpf B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15237-5
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shen J, 2016, MOL CARCINOGEN, V55, P2089, DOI 10.1002/mc.22453
   Shen J, 2015, CARCINOGENESIS, V36, P1307, DOI 10.1093/carcin/bgv130
   Shen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131649
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Smith ALM, 2020, NAT CANCER, V1, P976, DOI 10.1038/s43018-020-00112-5
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Steele H, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911589
   Stewart JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005333
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Theunissen TEJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00400
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   Valente WJ, 2016, NUCLEIC ACIDS RES, V44, P8513, DOI 10.1093/nar/gkw716
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   van Leeuwen N, 2014, AGE, V36, P1463, DOI 10.1007/s11357-014-9629-0
   van Osch FHM, 2015, CARCINOGENESIS, V36, P1502, DOI 10.1093/carcin/bgv151
   Varma H, 2016, EUR J MED GENET, V59, P540, DOI 10.1016/j.ejmg.2016.08.012
   Vasan K, 2020, CELL METAB, V32, P341, DOI 10.1016/j.cmet.2020.06.019
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Viscomi C, 2016, BIOCHEM SOC T, V44, P1483, DOI 10.1042/BST20160085
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Walker MA, 2020, NEW ENGL J MED, V383, P1556, DOI 10.1056/NEJMoa2001265
   Wang Y, 2016, INT J BIOL MARKER, V31, pE382, DOI 10.5301/jbm.5000211
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Weerts MJA, 2016, ONCOTARGET, V7, P29166, DOI 10.18632/oncotarget.8688
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0404-6
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Yadav N, 2013, BBA-REV CANCER, V1836, P336, DOI 10.1016/j.bbcan.2013.10.002
   Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   YONEDA M, 1995, MUSCLE NERVE, pS95
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Yu M, 2010, CLIN CHIM ACTA, V411, P679, DOI 10.1016/j.cca.2010.01.035
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zdralevic M, 2018, J BIOL CHEM, V293, P15947, DOI 10.1074/jbc.RA118.004180
   Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763
   Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105242
   Zhang RY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4287-0
   Zhang YF, 2015, AM J CANCER RES, V5, P1207
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 253
TC 240
Z9 257
U1 8
U2 68
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD APR
PY 2021
VL 595
IS 8
SI SI
BP 976
EP 1002
DI 10.1002/1873-3468.14021
EA DEC 2020
PG 27
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA RU2RV
UT WOS:000601879900001
PM 33314045
OA Green Published, hybrid
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Huang, G
   Wang, YM
   Yao, DY
AF Huang, Gang
   Wang, Yanmei
   Yao, Dongyuan
TI Myoclonic epilepsy with ragged red fibers syndrome associated with
   mitochondrial 3302A&gt;G mutation in the MT-TL1 gene: A case report
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE myoclonic epilepsy with ragged red fibers syndrome; mitochondrial DNA;
   gene mutation; MT-TL1 gene; mitochondrial encephalomyopathy
ID A3302G MUTATION
AB A 37-year-old woman presented with proximal limb weakness, an unstable gait, tiredness and paroxysmal jitters. Neurological examination showed decreased deep tendon reflexes and positive signs indicating damage to the cerebellum. The patient's children reported no symptoms but were found to have the mitochondrial 3302A>G mutation in the mitochondrially encoded tRNA-Leu (UUA/G) 1 gene. The patient presented with increased blood lactic acid and lactic acid dehydrogenase levels, myopathy-related limb muscle electromyographic activities, ragged red fibers (RRFs), cytochrome oxidase-negative muscle fibers and mitochondrial 3302A>G mutation. Inverted lactic acid peaks in the basal ganglia, an atrophied cerebellum and multiple electroencephalographic spike waves were also observed. Therefore, myoclonic epilepsy with RRFs syndrome with the 3302A>G mutation was considered.
C1 [Huang, Gang; Wang, Yanmei; Yao, Dongyuan] Jiangxi Prov Peoples Hosp, Dept Neurol, Nanchang 330006, Jiangxi, Peoples R China.
   [Huang, Gang; Wang, Yanmei; Yao, Dongyuan] Nanchang Med Coll, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.
   [Huang, Gang; Wang, Yanmei; Yao, Dongyuan] Jiangxi Prov Peoples Hosp, Neurol Inst Jiangxi Prov, Nanchang 330006, Jiangxi, Peoples R China.
   [Yao, Dongyuan] Jiangxi Prov Peoples Hosp, Dept Neurol, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China.
   [Yao, Dongyuan] Nanchang Med Coll, Affiliated Hosp 1, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China.
RP Yao, DY (corresponding author), Jiangxi Prov Peoples Hosp, Dept Neurol, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China.; Yao, DY (corresponding author), Nanchang Med Coll, Affiliated Hosp 1, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China.
EM yao9000@gmail.com
RI wang, yanmei/HPH-0538-2023; Huang, Gang/JTU-1276-2023
FU Jiangxi Provincial People's Hospital [2019-009]
FX This case report was supported by Jiangxi Provincial People's Hospital
   (grant no. 2019-009).
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Bornstein R, 2020, MITOCHONDRION, V54, P72, DOI 10.1016/j.mito.2020.07.007
   Ding Y, 2016, REPROD SCI, V23, P228, DOI 10.1177/1933719115602777
   Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, P21
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Goto M, 2014, BRAIN DEV-JPN, V36, P180, DOI 10.1016/j.braindev.2013.03.001
   Hahn A, 2011, NEUROPEDIATRICS, V42, P148, DOI 10.1055/s-0031-1283167
   Hutchison WM, 2005, ARCH NEUROL-CHICAGO, V62, P1920, DOI 10.1001/archneur.62.12.1920
   Lopriore P, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232113216
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Maniura-Weber K, 2006, NUCLEIC ACIDS RES, V34, P6404, DOI 10.1093/nar/gkl727
   Rahman S, 2018, EPILEPSIA, V59, P70, DOI 10.1111/epi.14485
   Siira SJ, 2017, INT J BIOCHEM CELL B, V85, P106, DOI 10.1016/j.biocel.2017.02.003
   van den Bosch BJC, 2004, NEUROMUSCULAR DISORD, V14, P683, DOI 10.1016/j.nmd.2004.06.004
   Veenin K, 2022, FRONT PEDIATR, V10, DOI 10.3389/fped.2022.876436
   Wong LJC, 2020, GENET MED, DOI 10.1038/s41436-019-0746-0
NR 18
TC 2
Z9 2
U1 0
U2 0
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD FEB
PY 2023
VL 25
IS 2
AR 87
DI 10.3892/etm.2023.11786
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 7X2GN
UT WOS:000914021500001
PM 36684660
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Hsu, YHR
   Yogasundaram, H
   Parajuli, N
   Valtuille, L
   Sergi, C
   Oudit, GY
AF Hsu, Ying-Han R.
   Yogasundaram, Haran
   Parajuli, Nirmal
   Valtuille, Lucas
   Sergi, Consolato
   Oudit, Gavin Y.
TI MELAS syndrome and cardiomyopathy: linking mitochondrial function to
   heart failure pathogenesis
SO HEART FAILURE REVIEWS
LA English
DT Article
DE Cardiomyopathy; Mitochondria; MELAS syndrome; HF
ID KEARNS-SAYRE-SYNDROME; STROKE-LIKE EPISODES; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; GREATER-THAN-G; CLINICAL-FEATURES; LACTIC-ACIDOSIS;
   CARDIAC INVOLVEMENT; ENERGY-METABOLISM; A3243G MUTATION; DNA MUTATION
AB Heart failure remains an important clinical burden, and mitochondrial dysfunction plays a key role in its pathogenesis. The heart has a high metabolic demand, and mitochondrial function is a key determinant of myocardial performance. In mitochondrial disorders, hypertrophic remodeling is the early pattern of cardiomyopathy with progression to dilated cardiomyopathy, conduction defects and ventricular pre-excitation occurring in a significant proportion of patients. Cardiac dysfunction occurs in approximately a third of patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome, a stereotypical example of a mitochondrial disorder leading to a cardiomyopathy. We performed unique comparative ultrastructural and gene expression in a MELAS heart compared with non-failing controls. Our results showed a remarkable increase in mitochondrial inclusions and increased abnormal mitochondria in MELAS cardiomyopathy coupled with variable sarcomere thickening, heterogeneous distribution of affected cardiomyocytes and a greater elevation in the expression of disease markers. Investigation and management of patients with mitochondrial cardiomyopathy should follow the well-described contemporary heart failure clinical practice guidelines and include an important role of medical and device therapies. Directed metabolic therapy is lacking, but current research strategies are dedicated toward improving mitochondrial function in patients with mitochondrial disorders.
C1 [Hsu, Ying-Han R.; Sergi, Consolato] Univ Alberta, Dept Lab Med & Pathol, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada.
   [Yogasundaram, Haran; Parajuli, Nirmal; Valtuille, Lucas; Oudit, Gavin Y.] Univ Alberta, Mazankowski Alberta Heart Inst, Dept Med, Div Cardiol, Edmonton, AB T6G 2B7, Canada.
C3 University of Alberta; University of Alberta
RP Oudit, GY (corresponding author), Univ Alberta, Mazankowski Alberta Heart Inst, Dept Med, Div Cardiol, 8440 112 St NW, Edmonton, AB T6G 2B7, Canada.
EM gavin.oudit@ualberta.ca
RI Hsu, Ying-Han/JEF-1863-2023; Yogasundaram, Haran/P-6502-2019; Parajuli,
   Nirmal/E-2536-2016; Sergi, Consolato/A-1126-2009
OI Parajuli, Nirmal/0000-0002-0799-6301
FU Heart and Stroke Foundation (HSF); Canadian Institutes of Health
   Research (CIHR); Alberta Innovates-Health Solutions (AIHS)
FX Our research was funded by operating grants from Heart and Stroke
   Foundation (HSF), Canadian Institutes of Health Research (CIHR) and
   Alberta Innovates-Health Solutions (AIHS).
CR Ahuja P, 2013, CIRCULATION, V127, P1957, DOI 10.1161/CIRCULATIONAHA.112.001219
   Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], J AM COLL CARDIOL
   Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   BOGOUSSLAVSKY J, 1982, J NEUROL SCI, V55, P351, DOI 10.1016/0022-510X(82)90132-0
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Bonnet D, 2001, HEART, V86, P570, DOI 10.1136/heart.86.5.570
   Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Chin J, 2014, MITOCHONDRION, V17, P34, DOI 10.1016/j.mito.2014.05.005
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fayssoil Abdallah, 2009, Congest Heart Fail, V15, P284, DOI 10.1111/j.1751-7133.2009.00108.x
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   FUJII T, 1991, J NEUROL SCI, V103, P37, DOI 10.1016/0022-510X(91)90280-K
   Gallagher D, 1998, AM J PHYSIOL-ENDOC M, V275, pE249, DOI 10.1152/ajpendo.1998.275.2.E249
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Gunter TE, 2000, CELL CALCIUM, V28, P285, DOI 10.1054/ceca.2000.0168
   HAMAZAKI S, 1989, ACTA PATHOL JAPON, V39, P599
   Herrmann G, 1939, ANN INTERN MED, V12, P1233, DOI 10.7326/0003-4819-12-8-1233
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405
   Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931
   ISHIKAWA Y, 1995, PATHOL RES PRACT, V191, P64, DOI 10.1016/S0344-0338(11)80927-1
   Katayama Y, 2009, MITOCHONDRION, V9, P306, DOI 10.1016/j.mito.2009.04.002
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Lagedrost SJ, 2011, AM HEART J, V161, P639, DOI 10.1016/j.ahj.2010.10.038
   Laloi-Michelin M, 2006, DIABETES METAB, V32, P182, DOI 10.1016/S1262-3636(07)70267-7
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   LINZBACH AJ, 1960, AM J CARDIOL, V5, P370, DOI 10.1016/0002-9149(60)90084-9
   Lodi R, 2001, CARDIOVASC RES, V52, P111, DOI 10.1016/S0008-6363(01)00357-1
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Maassen JA, 2006, ENDOCRIN METAB CLIN, V35, P385, DOI 10.1016/j.ecl.2006.02.014
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Marín-García J, 2008, HEART FAIL REV, V13, P137, DOI 10.1007/s10741-007-9079-1
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Mori J, 2013, J MOL CELL CARDIOL, V63, P98, DOI 10.1016/j.yjmcc.2013.07.010
   MULLERHOCKER J, 1993, ARCH PATHOL LAB MED, V117, P202
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Nakanishi M, 2007, CIRCULATION, V116, pE25, DOI 10.1161/CIRCULATIONAHA.107.691808
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052
   NISHIZAWA M, 1987, J NEUROL SCI, V78, P189, DOI 10.1016/0022-510X(87)90060-8
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   OLDFORS A, 1987, ACTA NEUROPATHOL, V74, P287, DOI 10.1007/BF00688194
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pang CY, 2001, DIABETES RES CLIN PR, V54, pS45, DOI 10.1016/S0168-8227(01)00335-7
   Parkinson MH, 2013, J NEUROCHEM, V126, P103, DOI 10.1111/jnc.12317
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   ROBERTS NK, 1979, AM J CARDIOL, V44, P1396, DOI 10.1016/0002-9149(79)90459-4
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   Sanaker PS, 2007, ACTA NEUROL SCAND, V115, P64, DOI 10.1111/j.1600-0404.2007.00850.x
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   SATO W, 1994, AM HEART J, V128, P733, DOI 10.1016/0002-8703(94)90272-0
   Schmauss D, 2007, PEDIATR TRANSPLANT, V11, P560, DOI 10.1111/j.1399-3046.2007.00719.x
   Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006
   Silvestri G, 1997, MUSCLE NERVE, V20, P221
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Stalder N, 2012, CIRC-HEART FAIL, V5, pE1, DOI 10.1161/CIRCHEARTFAILURE.111.963900
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Teodorescu C, 2010, CIRCULATION, V122, P2116, DOI 10.1161/CIRCULATIONAHA.110.966333
   Terauchi A, 1996, BRAIN DEV-JPN, V18, P224, DOI 10.1016/0387-7604(96)00015-0
   Tonska K, 2010, BBA-BIOENERGETICS, V1797, P1119, DOI 10.1016/j.bbabio.2010.02.032
   TRANCHANT C, 1993, NEUROMUSCULAR DISORD, V3, P561, DOI 10.1016/0960-8966(93)90116-2
   Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002
   Vardas PE, 2007, EUR HEART J, V28, P2256, DOI 10.1093/eurheartj/ehm305
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477
   WILLIAMS RS, 1995, CIRCULATION, V91, P1266, DOI 10.1161/01.CIR.91.4.1266
   Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807
   Young TJ, 2005, PACE, V28, P454, DOI 10.1111/j.1540-8159.2005.40049.x
   Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492
NR 95
TC 38
Z9 46
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1382-4147
EI 1573-7322
J9 HEART FAIL REV
JI Heart Fail. Rev.
PD JAN
PY 2016
VL 21
IS 1
BP 103
EP 116
DI 10.1007/s10741-015-9524-5
PG 14
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA DB0FH
UT WOS:000368183500008
PM 26712328
DA 2024-11-01
ER

PT J
AU Chen, YM
   Lin, CM
   Thajeb, P
AF Chen, Yi-Min
   Lin, Chih-Ming
   Thajeb, Peterus
TI Paradoxical effect of sodium valproate that aggravates epilepsy of MELAS
   in a patient with A3243G mutation of the mitochondrial DNA
SO CENTRAL EUROPEAN JOURNAL OF MEDICINE
LA English
DT Article
DE acidosis; epilepsy; MELAS; mitochondrial disease; paradoxical effect;
   sodium valproate
ID C-OXIDASE DEFICIENCY; LACTIC-ACIDOSIS; ENCEPHALOPATHY; MYOPATHY;
   DISEASES; EPISODES
AB Epilepsy is an associated feature of patients with the syndrome of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). A substitution at nucleotide position 3243 A>G of the mitochondrial DNA is the most common mutation encountered both in Caucasians and in Chinese/Taiwanese. We herein report a 38-year-old man with A3243G mutation of the mitochondrial DNA whom developed MELAS. The manifestation of his focal motor epilepsy was aggravated by use of sodium valproate (VPA). The mechanism of this paradoxical effect is proposed. (C) Versita Warsaw and Springer-Verlag Berlin Heidelberg. All rights reserved.
C1 [Chen, Yi-Min; Lin, Chih-Ming; Thajeb, Peterus] Mackay Mem Hosp, Dept Neurol & Med Res, Taipei, Taiwan.
   [Thajeb, Peterus] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.
   [Thajeb, Peterus] Taipei Med Univ, Taipei, Taiwan.
C3 Mackay Memorial Hospital; National Yang Ming Chiao Tung University;
   Taipei Medical University
RP Thajeb, P (corresponding author), Mackay Mem Hosp, Dept Neurol & Med Res, Taipei, Taiwan.
EM thajebp@hotmail.com
RI Chen, Yimin/P-6574-2017
CR ALTRUP U, 1992, EPILEPSIA, V33, P753, DOI 10.1111/j.1528-1157.1992.tb02357.x
   CHABROL B, 1994, EUR J PEDIATR, V153, P133, DOI 10.1007/BF01959226
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   FANG W, 1993, ARCH NEUROL-CHICAGO, V50, P977, DOI 10.1001/archneur.1993.00540090074013
   HUANG CC, 1994, J NEUROL NEUROSUR PS, V57, P586, DOI 10.1136/jnnp.57.5.586
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   LIOU CW, 1994, ACTA NEUROL SCAND, V90, P354
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PONCHAUT S, 1995, EUR J PEDIATR, V154, P79, DOI 10.1007/BF01972980
   PONCHAUT S, 1992, BIOCHEM PHARMACOL, V43, P644, DOI 10.1016/0006-2952(92)90590-F
   Shoffner JM, 1996, LANCET, V348, P1283, DOI 10.1016/S0140-6736(96)09138-6
   Thajeb P, 2005, ANN NY ACAD SCI, V1042, P48, DOI 10.1196/annals.1338.005
   Thajeb Peterus, 2006, Taiwan J Obstet Gynecol, V45, P201
   Tzen CY, 2003, MUSCLE NERVE, V28, P575, DOI 10.1002/mus.10473
   ZHANG Y, 2001, CHIN MED J BEIJING, V114, P129
NR 17
TC 4
Z9 4
U1 0
U2 1
PU VERSITA
PI WARSAW 41
PA 9 DRUGA POPRZECNA ST, 04-604 WARSAW 41, POLAND
SN 1895-1058
J9 CENT EUR J MED
JI Cent. Eur. J. Med.
PD MAR
PY 2007
VL 2
IS 1
BP 103
EP 107
DI 10.2478/s11536-007-0007-5
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 273OH
UT WOS:000253940300009
OA hybrid
DA 2024-11-01
ER

PT J
AU Kujoth, GC
   Bradshaw, PC
   Haroon, S
   Prolla, TA
AF Kujoth, Gregory C.
   Bradshaw, Patrick C.
   Haroon, Suraiya
   Prolla, Tomas A.
TI The role of mitochondrial DNA mutations in mammalian aging
SO PLOS GENETICS
LA English
DT Review
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ONSET SPINOCEREBELLAR ATAXIA;
   OXYGEN RADICAL GENERATION; MULTIPLE MTDNA DELETIONS; FATTY-ACID
   UNSATURATION; MAXIMUM LIFE-SPAN; POLYMERASE-GAMMA; OXIDATIVE DAMAGE;
   POINT MUTATIONS; CALORIC RESTRICTION
AB Mitochondrial DNA (mtDNA) accumulates both base-substitution mutations and deletions with aging in several tissues in mammals. Here, we examine the evidence supporting a causative role for mtDNA mutations in mammalian aging. We describe and compare human diseases and mouse models associated with mitochondrial genome instability. We also discuss potential mechanisms for the generation of these mutations and the means by which they may mediate their pathological consequences. Strategies for slowing the accumulation and attenuating the effects of mtDNA mutations are discussed.
C1 Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA.
C3 University of Wisconsin System; University of Wisconsin Madison
RP Prolla, TA (corresponding author), Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA.
EM taprolla@wisc.edu
RI Bradshaw, Patrick/AAR-9189-2020
OI Kujoth, Gregory/0000-0002-6636-2800
FU NIA NIH HHS [T32 AG00213, AG021905, T32 AG000213, R01 AG021905] Funding
   Source: Medline
CR ADACHI K, 1993, BIOCHEM BIOPH RES CO, V195, P945, DOI 10.1006/bbrc.1993.2135
   Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   ANDREEVA L, 1995, EUR J BIOCHEM, V230, P1125, DOI 10.1111/j.1432-1033.1995.tb20664.x
   Bannikova S, 2005, DNA CELL BIOL, V24, P710, DOI 10.1089/dna.2005.24.710
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berneburg M, 2005, J INVEST DERMATOL, V125, P213, DOI 10.1111/j.0022-202X.2005.23806.x
   BLOK RB, 1995, HUM GENET, V95, P75
   Brown TA, 2006, CELL CYCLE, V5, P917, DOI 10.4161/cc.5.9.2710
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389
   Chen LS, 2003, AGING CELL, V2, P191, DOI 10.1046/j.1474-9728.2003.00052.x
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Eicker J, 2003, PHOTOCH PHOTOBIO SCI, V2, P655, DOI 10.1039/b300808h
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Estabrook RW, 1996, P NATL ACAD SCI USA, V93, P13552, DOI 10.1073/pnas.93.24.13552
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Gershon D, 2005, SCIENCE, V310, P441
   Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Haripriya D, 2005, EXP GERONTOL, V40, P129, DOI 10.1016/j.exger.2004.10.006
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   HRUSZKEWYCZ AM, 1990, MUTAT RES, V244, P123, DOI 10.1016/0165-7992(90)90060-W
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Inoue SI, 2006, HUM MOL GENET, V15, P1801, DOI 10.1093/hmg/ddl102
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   Kajitani K, 2006, J NEUROSCI, V26, P1688, DOI 10.1523/JNEUROSCI.4948-05.2006
   KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200
   Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821
   Maki H, 2002, ANNU REV GENET, V36, P279, DOI 10.1146/annurev.genet.36.042602.094806
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miller RA, 2005, SCIENCE, V310, P441, DOI 10.1126/science.310.5747.441
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Mookerjee SA, 2005, CURR GENET, V47, P84, DOI 10.1007/s00294-004-0537-1
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Mott JL, 2005, REJUV RES, V8, P216, DOI 10.1089/rej.2005.8.216
   Mott JL, 2004, BIOCHEM BIOPH RES CO, V319, P1210, DOI 10.1016/j.bbrc.2004.05.104
   Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Nakada K, 2001, SEMIN CELL DEV BIOL, V12, P459, DOI 10.1006/scdb.2001.0283
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Pamplona R, 1999, MECH AGEING DEV, V106, P283, DOI 10.1016/S0047-6374(98)00121-3
   PEPIN B, 1980, J NEUROL SCI, V45, P191, DOI 10.1016/0022-510X(80)90165-3
   Pinz KG, 2006, DNA REPAIR, V5, P121, DOI 10.1016/j.dnarep.2005.08.014
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   POULTON J, 1991, AM J HUM GENET, V48, P649
   Rachek LI, 2002, J BIOL CHEM, V277, P44932, DOI 10.1074/jbc.M208770200
   Rachek LI, 2004, NUCLEIC ACIDS RES, V32, P3240, DOI 10.1093/nar/gkh648
   Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011
   Sakumi K, 2003, CANCER RES, V63, P902
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Santoro L, 2006, J NEUROL, V253, P869, DOI 10.1007/s00415-006-0082-6
   Sanz A, 2006, FASEB J, V20, P1064, DOI 10.1096/fj.05-5568com
   Sastre J, 1998, FREE RADICAL BIO MED, V24, P298, DOI 10.1016/S0891-5849(97)00228-1
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Sharer JD, 2005, IUBMB LIFE, V57, P607, DOI 10.1080/15216540500217735
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711
   Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003
   Stuart JA, 2005, FREE RADICAL BIO MED, V38, P737, DOI 10.1016/j.freeradbiomed.2004.12.003
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TRIFUNOVIC A, 2005, P NATL ACAD SCI USA, V429, P357
   Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang ED, 1997, MUTAT RES-FUND MOL M, V377, P157, DOI 10.1016/S0027-5107(97)00091-2
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamaguchi H, 2006, CELL DEATH DIFFER, V13, P551, DOI 10.1038/sj.cdd.4401788
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang CF, 1998, HUM MUTAT, V11, P360
   Zhang D, 2005, AM J PHYSIOL-HEART C, V288, pH2476, DOI 10.1152/ajpheart.00670.2004
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 168
TC 140
Z9 162
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD FEB
PY 2007
VL 3
IS 2
BP 161
EP 173
AR e24
DI 10.1371/journal.pgen.0030024
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 143HR
UT WOS:000244711700007
PM 17319745
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Guyatt, AL
   Burrows, K
   Guthrie, PAI
   Ring, S
   McArdle, W
   Day, INM
   Ascione, R
   Lawlor, DA
   Gaunt, TR
   Rodriguez, S
AF Guyatt, Anna L.
   Burrows, Kimberley
   Guthrie, Philip A. I.
   Ring, Sue
   McArdle, Wendy
   Day, Ian N. M.
   Ascione, Raimondo
   Lawlor, Debbie A.
   Gaunt, Tom R.
   Rodriguez, Santiago
TI Cardiometabolic phenotypes and mitochondrial DNA copy number in two
   cohorts of UK women
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; Copy number; ALSPAC; Complex traits; Cardiovascular
   disease; Diabetes
ID CORONARY-HEART-DISEASE; PERIPHERAL-BLOOD; SKELETAL-MUSCLE; TELOMERE
   LENGTH; ASSOCIATION; RISK; DELETION; CELLS; MTDNA; AGE
AB The mitochondrial genome is present at variable copy number between individuals. Mitochondria are vulnerable to oxidative stress, and their dysfunction may be associated with cardiovascular disease.
   The association of mitochondrial DNA copy number with cardiometabolic risk factors (lipids, glycaemic traits, inflammatory markers, anthropometry and blood pressure) was assessed in two independent cohorts of European origin women, one in whom outcomes were measured at mean (SD) age 30 (4.3) years (N = 2278) and the second at 69.4 (5.5) years (N = 2872). Mitochondrial DNA copy number was assayed by quantitative polymerase chain reaction. Associations were adjusted for smoking, sociodemographic status, laboratory factors and white cell traits.
   Out of a total of 12 outcomes assessed in both cohorts, mitochondrial DNA copy number showed little or no association with the majority (point estimates were close to zero and nearly all p-values were > 0.01). The strongest evidence was for an inverse association in the older cohort with insulin (standardised beta [95%CI]: 0.06, [0.098, 0.022], p = 0.002), but this association did not replicate in the younger cohort.
   Our findings do not provide support for variation in mitochondrial DNA copy number having an important impact on cardio-metabolic risk factors in European origin women.
C1 [Guyatt, Anna L.; Burrows, Kimberley; Ring, Sue; McArdle, Wendy; Lawlor, Debbie A.; Gaunt, Tom R.; Rodriguez, Santiago] Univ Bristol, MRC Integrat Epidemiol Unit, Oakfield House, Bristol BS8 2BN, Avon, England.
   [Guyatt, Anna L.; Burrows, Kimberley; Guthrie, Philip A. I.; Ring, Sue; McArdle, Wendy; Day, Ian N. M.; Lawlor, Debbie A.; Gaunt, Tom R.; Rodriguez, Santiago] Univ Bristol, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England.
   [Ascione, Raimondo] Univ Bristol, Sch Clin Sci, Bristol Heart Inst, Bristol, Avon, England.
C3 University of Bristol; University of Bristol; University of Bristol
RP Rodriguez, S (corresponding author), Univ Bristol, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England.
EM santi.rodriguez@bristol.ac.uk
RI Lawlor, David/JOJ-7815-2023; McArdle, Wendy/AGM-4831-2022; Gaunt,
   Tom/O-3918-2014
OI Lawlor, Debbie A/0000-0002-6793-2262; Gaunt, Tom/0000-0003-0924-3247;
   Rodriguez, Santiago/0000-0001-6551-932X; Burrows,
   Kimberley/0000-0002-3208-0389; Guyatt, Anna/0000-0003-1860-6337
FU UK Medical Research Council; Wellcome Trust [102215/2/13/2]; British
   Heart Foundation [PG/13/66/30442]; Medical Research Council (MRC)
   [MR/K002767/1]; Wellcome Trust PhD studentship [102433/Z/13/Z]; Wellcome
   Trust [102433/Z/13/Z] Funding Source: Wellcome Trust; MRC [MR/K002767/1,
   MC_UU_00011/4, MC_UU_12013/8, MC_UU_12013/5] Funding Source: UKRI
FX We are extremely grateful to all the families who took part in ALSPAC,
   the midwives for their help in recruiting them, and the whole ALSPAC
   team, which includes interviewers, computer and laboratory technicians,
   clerical workers, research scientists, volunteers, managers,
   receptionists and nurses. The UK Medical Research Council and the
   Wellcome Trust (Grant ref.: 102215/2/13/2) and the University of Bristol
   provide core support for ALSPAC. We are equally grateful to BWHHS
   participants and for the support and advice of the staff who manage the
   study, and for the hard work of those responsible for recruitment, data
   collection and curation. The British Women's Heart and Health Study is
   supported by the British Heart Foundation (PG/13/66/30442). This
   research was specifically funded by a Medical Research Council (MRC)
   grant awarded to SR (MR/K002767/1). AG is funded by a Wellcome Trust PhD
   studentship (102433/Z/13/Z). Work was carried out in the MRC Integrative
   Epidemiology Unit at the University of Bristol (MC_UU_12013/8).
CR [Anonymous], MITOCHONDRIAL DIS CL
   [Anonymous], INT J EPIDEMIOL
   ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790
   Arai T, 2003, AGING CLIN EXP RES, V15, P1
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230
   Bersani FS, 2016, PROG NEURO-PSYCHOPH, V64, P10, DOI 10.1016/j.pnpbp.2015.06.012
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Chang CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125855
   Chang CC, 2014, PSYCHIAT CLIN NEUROS, V68, P551, DOI 10.1111/pcn.12163
   Chen SY, 2014, ATHEROSCLEROSIS, V237, P220, DOI 10.1016/j.atherosclerosis.2014.08.051
   Chien MC, 2012, GENET MOL RES, V11, P3339, DOI 10.4238/2012.September.17.4
   Chinnery PF, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.048876
   Chinnery P F., 2014, Mitochondrial disorders overview
   Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   de Sousa RT, 2014, PROG NEURO-PSYCHOPH, V48, P32, DOI 10.1016/j.pnpbp.2013.09.002
   Diba LZ, 2016, MITOCHONDRIAL DNA A, V27, P3008, DOI 10.3109/19401736.2015.1063046
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066
   Gatt AP, 2013, NEUROSCI LETT, V557, P177, DOI 10.1016/j.neulet.2013.10.045
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hosnijeh FS, 2014, BLOOD, V124, P530, DOI 10.1182/blood-2013-10-532085
   Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86
   Hsieh CJ, 2011, DIABETES RES CLIN PR, V92, P106, DOI 10.1016/j.diabres.2011.01.010
   Huang CH, 2011, J ATHEROSCLER THROMB, V18, P867, DOI 10.5551/jat.8698
   Huang J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003323
   Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369
   Hulgan T, 2011, AIDS, V25, P37, DOI 10.1097/QAD.0b013e32833f9d02
   Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6
   Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067227
   Kim JH, 2012, MENOPAUSE, V19, P1109, DOI 10.1097/gme.0b013e3182503e97
   Kim JH, 2012, MENOPAUSE, V19, P582, DOI 10.1097/gme.0b013e31823a3e46
   Kim MY, 2011, ARCH GERONTOL GERIAT, V53, pE218, DOI 10.1016/j.archger.2010.11.019
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35
   Laubenthal L, 2016, J DAIRY SCI, V99, P1571, DOI 10.3168/jds.2015-9847
   Lawlor DA, 2005, J EPIDEMIOL COMMUN H, V59, P785, DOI 10.1136/jech.2004.029991
   Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134
   Lee JY, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/586017
   Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024
   Lindinger A, 2010, OBES SURG, V20, P84, DOI 10.1007/s11695-009-9987-3
   Liu CS, 2005, ANN NY ACAD SCI, V1042, P70, DOI 10.1196/annals.1338.008
   Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   Malik Afshan N, 2009, Diabetes Res Clin Pract, V86, pe22, DOI 10.1016/j.diabres.2009.07.002
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868
   Mozhei O I, 2014, Mol Biol (Mosk), V48, P677
   Nardelli C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/631082
   Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Purdue MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043149
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2010, INTENS CARE MED, V36, P956, DOI 10.1007/s00134-010-1823-7
   Qiu CF, 2015, CLIN LAB, V61, P363, DOI 10.7754/Clin.Lab.2014.140313
   Rea IM, 2013, AGE, V35, P1445, DOI 10.1007/s11357-012-9444-4
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Richmond RC, 2015, HUM MOL GENET, V24, P2201, DOI 10.1093/hmg/ddu739
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003
   Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Yu XH, 2013, CLIN CHIM ACTA, V424, P245, DOI 10.1016/j.cca.2013.06.006
   Zabaneh D, 2011, ANN HUM GENET, V75, P456, DOI 10.1111/j.1469-1809.2011.00654.x
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 81
TC 11
Z9 14
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR
PY 2018
VL 39
BP 9
EP 19
DI 10.1016/j.mito.2017.08.007
PG 11
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA FY0YL
UT WOS:000426538500002
PM 28818596
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Lee, JH
   Kim, MJ
   Park, SH
   Chae, JH
   Shin, K
AF Lee, Jae Hyun
   Kim, Min Jung
   Park, Sung-Hye
   Chae, Jong-Hee
   Shin, Kichul
TI Case study of an inborn error manifested in the elderly: A woman with
   adult-onset mitochondrial disease mimicking systemic vasculitis
SO INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
LA English
DT Article
DE Fanconi syndrome; MELAS; mitochondrial myopathy
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; MELAS; ENCEPHALOPATHY; MYOPATHY
AB Mitochondrial diseases are a group of disorders presenting mainly during infancy due to pathological dysfunction of the mitochondrial respiratory chain. We report a case of mitochondrial disease in an elderly woman complaining of generalized myalgia. A 69-year-old woman was admitted due to fatigue, general weakness, and a drowsy mental status. A brain magnetic resonance imaging (MRI) demonstrated multifocal lesions of increased T2 signal intensity, and laboratory findings were consistent with Fanconi syndrome. During her hospital course, she developed seizures, stress-induced cardiomyopathy, and respiratory failure. A muscle biopsy demonstrated ragged-red fibers in the muscle tissues seen in mitochondrial myopathy. We confirmed an 8 kb deletion in her mitochondrial DNA. Following treatment with l-carnitine, coenzyme Q10, and supportive measures, brain lesions on MRI scans disappeared, and the general symptoms gradually improved.
C1 [Lee, Jae Hyun] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Kim, Min Jung] Seoul Natl Univ, Seoul Natl Univ Hosp, Div Rheumatol, Coll Med, Seoul, South Korea.
   [Park, Sung-Hye] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Pathol, Coll Med, Seoul, South Korea.
   [Chae, Jong-Hee] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Coll Med, Seoul, South Korea.
   [Shin, Kichul] Seoul Metropolitan Govt Seoul Natl Univ, Div Rheumatol, Boramae Med Ctr, Seoul, South Korea.
C3 Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU); Seoul National University Hospital
RP Shin, K (corresponding author), Seoul Metropolitan Govt Seoul Natl Univ, Div Rheumatol, Boramae Med Ctr, Seoul, South Korea.
EM kideb1@snu.ac.kr
RI Lee, Jae/AAL-6917-2020; KIM, MINJI/IXD-7702-2023
OI Shin, Kichul/0000-0002-6749-7598
CR Abdullah Mishal, 2012, J Med Case Rep, V6, P55, DOI 10.1186/1752-1947-6-55
   Cohen BH, 2013, NEUROTHERAPEUTICS, V10, P227, DOI 10.1007/s13311-013-0188-3
   DeSouza RA, 2004, SOUTH MED J, V97, P528, DOI 10.1097/00007611-200405000-00023
   Enns GM, 2014, J CHILD NEUROL, V29, P1235, DOI 10.1177/0883073814538509
   FERNANDEZSOLA J, 1992, POSTGRAD MED J, V68, P212, DOI 10.1136/pgmj.68.797.212
   Finsterer J, 2009, FORTSCHR NEUROL PSYC, V77, P631, DOI 10.1055/s-0028-1109759
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   MANCIAS P, 1995, PHARMACOTHERAPY, V15, P528
   Muravchick S, 2008, ADV DRUG DELIVER REV, V60, P1553, DOI 10.1016/j.addr.2008.03.019
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Villanova M, 1999, MUSCLE NERVE, V22, P289, DOI 10.1002/(SICI)1097-4598(199902)22:2<289::AID-MUS26>3.0.CO;2-O
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 14
TC 5
Z9 5
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1756-1841
EI 1756-185X
J9 INT J RHEUM DIS
JI Int. J. Rheum. Dis.
PD JUN
PY 2019
VL 22
IS 6
BP 1152
EP 1156
DI 10.1111/1756-185X.13575
PG 5
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA II8OC
UT WOS:000475450300027
PM 30968563
DA 2024-11-01
ER

PT J
AU Saunders, C
   Longman, C
   Gorman, G
   James, K
   Oliwa, A
   Petty, R
   Snadden, L
   Farrugia, ME
AF Saunders, Charlie
   Longman, Cheryl
   Gorman, Grainne
   James, Kelly
   Oliwa, Agata
   Petty, Richard
   Snadden, Lesley
   Farrugia, Maria Elena
TI The West of Scotland Cohort of Mitochondrial Individuals with the
   m.3243A>G Variant: Variations in Phenotypes and Predictors of Disease
   Severity
SO JOURNAL OF NEUROMUSCULAR DISEASES
LA English
DT Article
DE Epidemiology; mitochondrial conditions; mitochondrial DNA; m.3243A>G;
   multidisciplinary team
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; M.3243A-GREATER-THAN-G MUTATION;
   CLINICAL-FEATURES; DNA MUTATIONS; MELAS; HETEROPLASMY; PREVALENCE;
   A3243G; ENCEPHALOMYOPATHY
AB Background: The m.3243A>G variant is the commonest mitochondrial (mt) DNA pathogenic variant and a frequent cause of mitochondrial disease. Individuals present with a variety of clinical manifestations from diabetes to neurological events resembling strokes. Due to this, patients are commonly cared for by a multidisciplinary team.
   Objectives: This project aimed to identify patients with confirmed mt.3243A>G-related mitochondrial disease attending the Muscle Clinic at Queen Elizabeth University Hospital in Glasgow. We explored potential correlates between clinical phenotypes and mtDNA heteroplasmy levels, HbA1c levels, body mass index, and specific clinical manifestations. We investigated if there were discrepancies between non-neurological speciality labelling in clinical records and individuals' phenotypes.
   Methods: Data were gathered from theWest of Scotland electronic records. Phenotypes were ascertained by a clinician with expertise in mitochondrial disorders. Statistical analyses were applied to study relationships between tissue heteroplasmy, HbA1c and clinical phenotypes including body mass index (BMI).
   Results: Forty-six individuals were identified from 31 unrelated pedigrees. Maternally inherited diabetes and deafness was the prominent syndromic phenotype (48%). A significant association was found between overall number of symptoms and bowel dysmotility (p < 0.01). HbA1c was investigated as a predictor of severity with potential association seen. Although used widely as a prognosticator, neither corrected blood nor urine mtDNAheteroplasmy levels were associated with increased number of symptoms. In 74.1% of records, syndromic phenotypes were incorrectly used by non-neurological specialities.
   Conclusions: This m.3243 A> G patient cohort present with marked clinical heterogeneity. Urine and blood heteroplasmy levels are not reliable predictors of disease severity. HbA1c may be a novel predictor of disease severity with further research required to investigate this association. We infer that prognosis may be worse in patients with low BMIs and in those with bowel dysmotility. These results underscore a multidisciplinary approach and highlight a problem with inaccurate use of the existing nomenclature.
C1 [Saunders, Charlie; Petty, Richard; Farrugia, Maria Elena] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Neurol Dept, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.
   [Longman, Cheryl; Oliwa, Agata; Snadden, Lesley] Queen Elizabeth Univ Hosp, West Scotland Reg Genet Serv, Genet Dept, Glasgow, Lanark, Scotland.
   [Gorman, Grainne] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [James, Kelly] Univ Glasgow, Dept Geog & Earth Sci, Glasgow, Lanark, Scotland.
   [Gorman, Grainne] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Glasgow, Lanark, Scotland.
   [Saunders, Charlie] Univ Hosp Crosshouse, Stroke Dept, Kilmarnock KA2 0BE, Scotland.
   [Oliwa, Agata] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Snadden, Lesley] Aberdeen Royal Infirm, Dept Genet, Aberdeen AB25 2ZN, Scotland.
C3 University of Glasgow; Queen Elizabeth University Hospital (QEUH); Queen
   Elizabeth University Hospital (QEUH); Newcastle University - UK;
   University of Glasgow; University of Glasgow; Newcastle University - UK;
   University of Aberdeen
RP Farrugia, ME (corresponding author), Queen Elizabeth Univ Hosp, Inst Neurol Sci, Neurol Dept, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.
EM mariaelena.farrugia@ggc.scot.nhs.uk
CR Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   de Laat P, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.523
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   El-Hattab AW, 2014, MITOCHONDRION, V18, P63, DOI 10.1016/j.mito.2014.07.008
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Farrugia ME, 2018, J Neuromuscul Dis, V5, pS128, DOI [10.3233/JND-, DOI 10.3233/JND]
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Finsterer J, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.927938
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   Hou Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219628
   Koene S, 2014, NEUROLOGY, V83, P125, DOI 10.1212/WNL.0000000000000578
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lindroos MM, 2009, DIABETES, V58, P543, DOI 10.2337/db08-0981
   Liu GL, 2020, J NEUROL SCI, V408, DOI 10.1016/j.jns.2019.116562
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mavraki E, 2023, EUR J HUM GENET, V31, P148, DOI 10.1038/s41431-022-01249-w
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Narbonne H, 2004, DIABETES METAB, V30, P61, DOI 10.1016/S1262-3636(07)70090-3
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   Ng Yi Shiau, 2019, Wellcome Open Res, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Papadopoulos C, 2020, J INHERIT METAB DIS, V43, P459, DOI 10.1002/jimd.12185
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Poulsen NS, 2020, MITOCHONDRION, V50, P35, DOI 10.1016/j.mito.2019.10.005
   R Core Team, 2020, R: A Language and Environment for Statistical Computing
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   World Health Organization, INT CLASSIFICATION D
   Yang MG, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.728043
   Yee ML, 2018, ENDOCRINOL DIAB META, DOI 10.1530/EDM-18-0091
NR 43
TC 0
Z9 0
U1 1
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 2214-3599
EI 2214-3602
J9 J NEUROMUSCULAR DIS
JI J. Neuromusc. Dis.
PY 2024
VL 11
IS 1
BP 179
EP 189
DI 10.3233/JND-230166
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA IP8F2
UT WOS:001167617500015
PM 38108361
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Viader, A
   Golden, JP
   Baloh, RH
   Schmidt, RE
   Hunter, DA
   Milbrandt, J
AF Viader, Andreu
   Golden, Judith P.
   Baloh, Robert H.
   Schmidt, Robert E.
   Hunter, Daniel A.
   Milbrandt, Jeffrey
TI Schwann Cell Mitochondrial Metabolism Supports Long-Term Axonal Survival
   and Peripheral Nerve Function
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID TRANSCRIPTION FACTOR; NEUROPATHY; MICE; GENE; INACTIVATION; PROGRESSION;
   DISRUPTION; MUTATIONS; MECHANISM; PROTEINS
AB Mitochondrial dysfunction is a common cause of peripheral neuropathies. While the role of neuron and axonal mitochondria in peripheral nerve disease is well appreciated, whether Schwann cell (SC) mitochondrial deficits contribute to peripheral neuropathies is unclear. Here, we examine how SC mitochondrial dysfunction affects axonal survival and contributes to the decline of peripheral nerve function by generating mice with SC-specific mitochondrial deficits. These mice (Tfam-SCKOs) were produced through the tissue-specific deletion of the mitochondrial transcription factor A gene (Tfam), which is essential for mitochondrial DNA (mtDNA) transcription and maintenance. Tfam-SCKOs were viable, but as they aged, they developed a progressive peripheral neuropathy characterized by nerve conduction abnormalities as well as extensive muscle denervation. Morphological examination of Tfam-SCKO nerves revealed early preferential loss of small unmyelinated fibers followed by prominent demyelination and degeneration of larger-caliber axons. Tfam-SCKOs displayed sensory and motor deficits consistent with this pathology. Remarkably, the severe mtDNA depletion and respiratory chain abnormalities in Tfam-SCKO mice did not affect SC proliferation or survival. Mitochondrial function in SCs is therefore essential for maintenance of axonal survival and normal peripheral nerve function, suggesting that SC mitochondrial dysfunction contributes to human peripheral neuropathies.
C1 [Viader, Andreu; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.
   [Golden, Judith P.] Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA.
   [Golden, Judith P.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.
   [Baloh, Robert H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.
   [Schmidt, Robert E.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.
   [Baloh, Robert H.; Schmidt, Robert E.; Milbrandt, Jeffrey] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA.
   [Hunter, Daniel A.] Washington Univ, Sch Med, Div Plast & Reconstruct Surg, St Louis, MO 63110 USA.
C3 Washington University (WUSTL); Washington University (WUSTL); Washington
   University (WUSTL); Washington University (WUSTL); Washington University
   (WUSTL); Washington University (WUSTL); Washington University (WUSTL)
RP Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Genet, 660 S Euclid Ave,Box 8232, St Louis, MO 63110 USA.
EM jmilbrandt@wustl.edu
OI Milbrandt, Jeffrey/0000-0002-5477-7689; Golden,
   Judith/0000-0002-5168-8525
FU NIH Neuroscience Blueprint Center [P30 NS057105]; Hope Center for
   Neurological Disorders; NIH [NS040745, AG13730, NS055980, DK19645,
   R21NS059566]; Muscular Dystrophy Association [10040, 135428]
FX This work was supported by NIH Neuroscience Blueprint Center Core Grant
   P30 NS057105 (Washington University), the Hope Center for Neurological
   Disorders, NIH Grants NS040745 (J.M.), AG13730 (J.M.), NS055980 (R. H.
   B.), DK19645 (R. E. S.), and R21NS059566 (J.P.G.), and Muscular
   Dystrophy Association Grants 10040 (J.M.) and 135428 (R. H. B.). We
   thank Michael A. Kiebish for providing valuable technical advice and
   helpful discussions, Amy Strickland and Nina Panchenko for experimental
   assistance, Nils-Goran Larsson for the Tfam<SUP>loxP</SUP> mice and
   comments on this manuscript, Lawrence Wrabetz and Albee Messing for the
   P<INF>0</INF>-Cre mice, and members of the Milbrandt Laboratory for
   their comments on this manuscript and helpful discussions.
CR Arezzo JC, 2002, INT REV NEUROBIOL, V50, P229
   Baloh RH, 2008, NEUROSCIENTIST, V14, P12, DOI 10.1177/1073858407307354
   Baloh RH, 2009, J NEUROSCI, V29, P2312, DOI 10.1523/JNEUROSCI.2168-08.2009
   Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511
   Chen SZ, 2003, NAT NEUROSCI, V6, P1186, DOI 10.1038/nn1139
   Dalakas MC, 2001, LAB INVEST, V81, P1537, DOI 10.1038/labinvest.3780367
   Ebenezer GJ, 2007, J NEUROPATH EXP NEUR, V66, P1059, DOI 10.1097/nen.0b013e31815c8989
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021
   Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x
   Fernyhough P, 2003, J PERIPHER NERV SYST, V8, P227, DOI 10.1111/j.1085-9489.2003.03028.x
   Geuna S, 2009, INT REV NEUROBIOL, V87, P27, DOI 10.1016/S0074-7742(09)87003-7
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   Golden JP, 2010, J NEUROSCI, V30, P3983, DOI 10.1523/JNEUROSCI.5930-09.2010
   Grinspan JB, 1996, J NEUROSCI, V16, P6107
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Hughes RAC, 2002, BRIT MED J, V324, P466, DOI 10.1136/bmj.324.7335.466
   Hunter DA, 2007, J NEUROSCI METH, V166, P116, DOI 10.1016/j.jneumeth.2007.06.018
   Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164
   Kalichman MW, 1998, ACTA NEUROPATHOL, V95, P47, DOI 10.1007/s004010050764
   Kennedy WR, 1996, NEUROLOGY, V47, P1042, DOI 10.1212/WNL.47.4.1042
   KENNEDY WR, 1993, J NEUROL SCI, V115, P184, DOI 10.1016/0022-510X(93)90223-L
   KING RHM, 2005, PERIPHERAL NEUROPATH, P35
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490
   Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766
   McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4
   Horste GMZ, 2007, ANN NEUROL, V61, P61, DOI 10.1002/ana.21026
   Montana MC, 2009, J PHARMACOL EXP THER, V330, P834, DOI 10.1124/jpet.109.154138
   Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3
   Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309
   Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217
   Pellerin L, 2003, J PHYSIOL-LONDON, V546, P325, DOI 10.1113/jphysiol.2002.035105
   Reddy LV, 2003, NEURON, V40, P563, DOI 10.1016/S0896-6273(03)00682-2
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Ryu EJ, 2007, J NEUROSCI, V27, P11552, DOI 10.1523/JNEUROSCI.5497-06.2007
   Sadun Alfredo A, 2002, Semin Ophthalmol, V17, P29, DOI 10.1076/soph.17.1.29.10290
   SCHRODER JM, 1993, BRAIN PATHOL, V3, P177, DOI 10.1111/j.1750-3639.1993.tb00742.x
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Véga C, 2003, J PHYSIOL-LONDON, V546, P551, DOI 10.1113/jphysiol.2002.029751
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang LJ, 2009, NEUROBIOL DIS, V35, P234, DOI 10.1016/j.nbd.2009.05.002
   Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047
   Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032
NR 49
TC 131
Z9 151
U1 0
U2 20
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUL 13
PY 2011
VL 31
IS 28
BP 10128
EP 10140
DI 10.1523/JNEUROSCI.0884-11.2011
PG 13
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 791WP
UT WOS:000292699600003
PM 21752989
OA Bronze, Green Published, Green Accepted
DA 2024-11-01
ER

PT J
AU Suzuki, J
   Iwata, M
   Moriyoshi, H
   Nishida, S
   Yasuda, T
   Ito, Y
AF Suzuki, Junichiro
   Iwata, Mai
   Moriyoshi, Hideyuki
   Nishida, Suguru
   Yasuda, Takeshi
   Ito, Yasuhiro
TI Familial Pernicious Chronic Intestinal Pseudo-obstruction with a
   Mitochondrial DNA A3243G Mutation
SO INTERNAL MEDICINE
LA English
DT Article
DE chronic intestinal pseudo-obstruction; mitochondrial DNA A3243G
   mutation; MELAS; familial occurrence
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; GASTROINTESTINAL-TRACT; PROMINENT
   DEGENERATION; MELAS; ENCEPHALOMYOPATHY; ENCEPHALOPATHY; PATHOLOGY;
   MYOPATHY; DISEASES
AB We report the case of a mother and two children who shared a mitochondrial DNA A3243G mutation. The mother had diabetes mellitus, neurogenic bladder, bradykinesia, dystonia, and slowly progressive cerebellar ataxia. Her two daughters were diagnosed with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes at adolescence. They all presented with gastrointestinal symptoms at an advanced clinical stage. They were diagnosed with chronic intestinal pseudo-obstruction, and they were resistant to therapy. The mother and her youngest daughter died from aspiration pneumonia because of vomiting. The determination of chronic intestinal pseudo-obstruction is an important prognostic factor in patients with the mitochondrial DNA A3243G variant.
C1 [Suzuki, Junichiro; Iwata, Mai; Moriyoshi, Hideyuki; Nishida, Suguru; Yasuda, Takeshi; Ito, Yasuhiro] TOYOTA Mem Hosp, Dept Neurol, Toyota, Japan.
RP Suzuki, J (corresponding author), TOYOTA Mem Hosp, Dept Neurol, Toyota, Japan.
EM junichiro_suzuki@mail.toyota.co.jp
RI YASUDA, Takeshi/H-2855-2011
CR Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Chinnery PF, 2001, GUT, V48, P121, DOI 10.1136/gut.48.1.121
   Chiyonobu T, 2008, BRAIN DEV-JPN, V30, P430, DOI 10.1016/j.braindev.2007.12.006
   Hara K, 1994, Rinsho Shinkeigaku, V34, P361
   HESS J, 1995, LANCET, V346, P189, DOI 10.1016/S0140-6736(95)91251-7
   Hiel JAP, 1998, NETH J MED, V53, P27, DOI 10.1016/S0300-2977(98)00018-7
   Hirano I, 2000, DIGEST DIS, V18, P83, DOI 10.1159/000016969
   Hom XB, 2004, MITOCHONDRION, V4, P601, DOI 10.1016/j.mito.2004.07.014
   KAGEYAMA Y, 1991, ACTA NEUROPATHOL, V83, P99, DOI 10.1007/BF00294438
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Kobayashi Z, 2005, INTERNAL MED, V44, P328, DOI 10.2169/internalmedicine.44.328
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Kuroiwa T, 1998, ACTA NEUROPATHOL, V96, P86, DOI 10.1007/s004010050863
   Lee YC, 2009, EUR J NEUROL, V16, P513, DOI 10.1111/j.1468-1331.2008.02524.x
   Li JY, 2007, J FORMOS MED ASSOC, V106, P528, DOI 10.1016/S0929-6646(07)60003-5
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Mori O, 2000, ACTA NEUROPATHOL, V100, P712, DOI 10.1007/s004010000209
   Ohkubo H, 2012, DIGESTION, V86, P12, DOI 10.1159/000337528
   Petruzzella V, 2004, CLIN GENET, V65, P64, DOI 10.1111/j..2004.00185.x
   Sekino Y, 2012, WORLD J GASTROENTERO, V18, P4557, DOI 10.3748/wjg.v18.i33.4557
   Shimotake T, 1998, J PEDIATR SURG, V33, P1837, DOI 10.1016/S0022-3468(98)90301-3
   Sudarsky L, 1999, MOVEMENT DISORD, V14, P488, DOI 10.1002/1531-8257(199905)14:3<488::AID-MDS1017>3.0.CO;2-4
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   TRUONG DD, 1990, MOVEMENT DISORD, V5, P109, DOI 10.1002/mds.870050204
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
NR 26
TC 8
Z9 8
U1 0
U2 1
PU JAPAN SOC INTERNAL MEDICINE
PI TOKYO
PA 34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN
SN 0918-2918
EI 1349-7235
J9 INTERNAL MED
JI Intern. Med.
PY 2017
VL 56
IS 9
BP 1089
EP 1093
DI 10.2169/internalmedicine.56.7753
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA EU3JR
UT WOS:000400925800017
PM 28458318
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Malfatti, E
   Cardaioli, E
   Battisti, C
   Da Pozzo, P
   Malandrini, A
   Rufa, A
   Rocchi, R
   Federico, A
AF Malfatti, Edoardo
   Cardaioli, Elena
   Battisti, Carla
   Da Pozzo, Paola
   Malandrini, Alessandro
   Rufa, Alessandra
   Rocchi, Raffaele
   Federico, Antonio
TI A novel point mutation in the mitochondrial tRNA<SUP>(TrP)</SUP> gene
   produces late-onset encephalomyopathy, plus additional features
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial diseases; mtDNA; Transfer RNA(TrP)
ID TRANSFER-RNA; TRNA(TRP) GENE; MTDNA MUTATION; ENCEPHALOPATHY;
   DEFICIENCY; MYOPATHY; DATABASE; GENOME
AB Background: Mitochondrial diseases due to mitochondrial tRNA genes mutations are usually multisystem disorders with infantile or adult onset.
   Objective: To identify the molecular defect underlying a mitochondrial encephalomyopathy.
   Methods/Patients: Case report of a 51 year-old woman presenting with late-onset myoclonic epilepsy plus additional features. Proband's mother presented hypothyroidism and diabetes.
   Results: Muscle biopsy showed mitochondrial changes. Respiratory chain activities were reduced. The novel G5538A mutation was identified in different tissues DNAs from the proband and from her mother.
   Conclusion: We were able to identify a novel mtDNA tRNA((TrP)) gene pathogenic mutation. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Malfatti, Edoardo; Cardaioli, Elena; Battisti, Carla; Da Pozzo, Paola; Malandrini, Alessandro; Rufa, Alessandra; Federico, Antonio] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy.
   [Rocchi, Raffaele] Univ Siena, Dept Neurosci, Neurol Sect, I-53100 Siena, Italy.
C3 University of Siena; University of Siena
RP Federico, A (corresponding author), Univ Siena, Dept Neurol Neurosurg & Behav Sci, Viale Mario Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
RI Federico, Antonio/H-8871-2017; Rufa, Alessandra/E-8298-2011; Malfatti,
   Edoardo/KEI-9379-2024
OI Rufa, Alessandra/0000-0002-2254-2869; federico,
   antonio/0000-0002-5246-1621; Cardaioli, Elena/0000-0003-2850-6698
FU Regione Toscana; University of Siena
FX Research supported by a grant from the Regione Toscana and University of
   Siena to AF.
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Da Pozzo P, 2004, BIOCHEM BIOPH RES CO, V324, P360, DOI 10.1016/j.bbrc.2004.09.058
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sanaker PS, 2010, ACTA NEUROL SCAND, V121, P109, DOI 10.1111/j.1600-0404.2009.01243.x
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHOFFNER JM, 2001, METABOLIC MOL BASES, V2, P2367
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 16
TC 9
Z9 9
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2010
VL 297
IS 1-2
BP 105
EP 108
DI 10.1016/j.jns.2010.06.009
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 663QY
UT WOS:000282904000023
PM 20708751
DA 2024-11-01
ER

PT J
AU Roos, S
   Hedberg-Oldfors, C
   Visuttijai, K
   Stein, M
   Kollberg, G
   Elíasdóttir, O
   Lindberg, C
   Darin, N
   Oldfors, A
AF Roos, Sara
   Hedberg-Oldfors, Carola
   Visuttijai, Kittichate
   Stein, My
   Kollberg, Gittan
   Eliasdottir, Olof
   Lindberg, Christopher
   Darin, Niklas
   Oldfors, Anders
TI Expression pattern of mitochondrial respiratory chain enzymes in
   skeletal muscle of patients with mitochondrial myopathy associated with
   the homoplasmic m.14674T>C variant
SO BRAIN PATHOLOGY
LA English
DT Article
DE homoplasmic mt-tRNA(Glu) variant; mitochondrial myopathy; mtDNA;
   reversible infantile respiratory chain deficiency; whole genome
   sequencing
ID C-OXIDASE DEFICIENCY; MUTATION; ARTHROGRYPOSIS; GENES
AB Two homoplasmic variants in tRNA(Glu) (m.14674T>C/G) are associated with reversible infantile respiratory chain deficiency. This study sought to further characterize the expression of the individual mitochondrial respiratory chain complexes and to describe the natural history of the disease. Seven patients from four families with mitochondrial myopathy associated with the homoplasmic m.14674T>C variant were investigated. All patients underwent skeletal muscle biopsy and mtDNA sequencing. Whole-genome sequencing was performed in one family. Western blot and immunohistochemical analyses were used to characterize the expression of the individual respiratory chain complexes. Patients presented with hypotonia and feeding difficulties within the first weeks or months of life, except for one patient who first showed symptoms at 4 years of age. Histopathological findings in muscle included lipid accumulation, numerous COX-deficient fibers, and mitochondrial proliferation. Ultrastructural abnormalities included enlarged mitochondria with concentric cristae and dense mitochondrial matrix. The m.14674T>C variant in MT-TE was identified in all patients. Immunohistochemistry and immunoblotting demonstrated pronounced deficiency of the complex I subunit NDUFB8. The expression of MTCO1, a complex IV subunit, was also decreased, but not to the same extent as NDUFB8. Longitudinal follow-up data demonstrated that not all features of the disorder are entirely transient, that the disease may be progressive, and that signs and symptoms of myopathy may develop during childhood. This study sheds new light on the involvement of complex I in reversible infantile respiratory chain deficiency, it shows that the disorder may be progressive, and that myopathy can develop without an infantile episode.
C1 [Roos, Sara; Hedberg-Oldfors, Carola; Visuttijai, Kittichate; Kollberg, Gittan; Oldfors, Anders] Univ Gothenburg, Inst Biomed, Dept Lab Med, Gothenburg, Sweden.
   [Stein, My] Helsingborg Hosp, Dept Pediat, Helsingborg, Sweden.
   [Eliasdottir, Olof; Lindberg, Christopher] Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
   [Darin, Niklas] Univ Gothenburg, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
C3 University of Gothenburg; Helsingborgs Hospital; Sahlgrenska University
   Hospital; University of Gothenburg
RP Roos, S (corresponding author), Univ Gothenburg, Inst Biomed, Dept Lab Med, Gothenburg, Sweden.
EM sara.m.roos@vgregion.se
RI Visuttijai, Kittichate/S-4927-2019
OI Visuttijai, Kittichate/0000-0002-4800-8533
FU Swedish Research Council [2018-02821]; ALF agreement grants
   [ALFGBG-716821, ALFGBG-718681]; Swedish Research Council [2018-02821]
   Funding Source: Swedish Research Council; Vinnova [2018-02821] Funding
   Source: Vinnova
FX Swedish Research Council, Grant/Award Number: 2018-02821; ALF agreement
   grants, Grant/Award Number: ALFGBG-716821 and ALFGBG-718681
CR Attali R, 2009, HUM MOL GENET, V18, P3462, DOI 10.1093/hmg/ddp290
   Baumann M, 2017, EUR J HUM GENET, V25, P262, DOI 10.1038/ejhg.2016.144
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   DIMAURO S, 1981, T AM NEUROL ASSOC, V106, P205
   Dubowitz V., 2013, MUSCLE BIOPSY PRACTI, V4th, P1, DOI DOI 10.1177/000271623618500112
   Gurgel-Giannetti J, 2018, BRAIN, V141, P2289, DOI 10.1093/brain/awy172
   Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577
   Hathazi D, 2020, EMBO J, V39, DOI 10.15252/embj.2020105364
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12931
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2
   Jennions E, 2019, J INHERIT METAB DIS, V42, P898, DOI 10.1002/jimd.12149
   Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048
   Laquérriere A, 2014, HUM MOL GENET, V23, P2279, DOI 10.1093/hmg/ddt618
   Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111
   OLDFORS A, 1989, ACTA NEUROPATHOL, V77, P267, DOI 10.1007/BF00687578
   Schuelke M, 2017, NEUROPATH APPL NEURO, V43, P44, DOI 10.1111/nan.12374
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300
   Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995
   Visuttijai K, 2021, ACTA NEUROL SCAND, V143, P103, DOI 10.1111/ane.13339
   Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002
   Zhang JL, 2010, HUM MOL GENET, V19, P329, DOI 10.1093/hmg/ddp499
NR 24
TC 4
Z9 4
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD JUL
PY 2022
VL 32
IS 4
AR e13038
DI 10.1111/bpa.13038
EA NOV 2021
PG 16
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA 2J7FM
UT WOS:000720790300001
PM 34806237
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Fuke, S
   Kametani, M
   Yamada, K
   Kasahara, T
   Kubota-Sakashita, M
   Kujoth, GC
   Prolla, TA
   Hitoshi, S
   Kato, T
AF Fuke, Satoshi
   Kametani, Mizue
   Yamada, Kazuyuki
   Kasahara, Takaoki
   Kubota-Sakashita, Mie
   Kujoth, Gregory C.
   Prolla, Tomas A.
   Hitoshi, Seiji
   Kato, Tadafumi
TI Heterozygous <i>Polg</i> mutation causes motor dysfunction due to mtDNA
   deletions
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
AB Objective: Mutations in nuclear-encoded mitochondrial DNA (mtDNA) polymerase (POLG) are known to cause autosomal dominant chronic progressive external ophthalmoplegia (adCPEO) with accumulation of multiple mtDNA deletions in muscles. However, no animal model with a heterozygous Polg mutation representing mtDNA impairment and symptoms of CPEO has been established. To understand the pathogenic mechanism of CPEO, it is important to determine the age dependency and tissue specificity of mtDNA impairment resulting from a heterozygous mutation in the Polg gene in an animal model. Methods: We assessed behavioral phenotypes, tissue-specific accumulation of mtDNA deletions, and its age dependency in heterozygous Polg(D257A) knock-in mice carrying a proofreading-deficient mutation in the Polg. Results: Heterozygous Polg(D257A) knock-in mice exhibited motor dysfunction in a rotarod test. Polg(+/D257A) mice had significant accumulation of multiple mtDNA deletions, but did not show significant accumulation of point mutations or mtDNA depletion in the brain. While mtDNA deletions increased in an age-dependent manner regardless of the tissue even in Polg(+/+) mice, the age-dependent accumulation of mtDNA deletions was enhanced in muscles and in the brain of Polg(+/D257A) mice. Interpretation: Heterozygous Polg(D257A) knock-in mice showed tissue-specific, age-dependent accumulation of multiple mtDNA deletions in muscles and the brain which was likely to result in neuromuscular symptoms. Polg(+/D257A) mice may be used as an animal model of adCPEO associated with impaired mtDNA maintenance.
C1 [Fuke, Satoshi; Kametani, Mizue; Kasahara, Takaoki; Kubota-Sakashita, Mie; Kato, Tadafumi] RIKEN, Lab Mol Dynam Mental Disorders, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
   [Fuke, Satoshi; Hitoshi, Seiji] Shiga Univ Med Sci, Dept Integrat Physiol, Otsu, Shiga 5202192, Japan.
   [Yamada, Kazuyuki] RIKEN, Brain Sci Inst, Res Resources Ctr, Wako, Saitama 3510198, Japan.
   [Kujoth, Gregory C.] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.
C3 RIKEN; Shiga University of Medical Science; RIKEN; University of
   Wisconsin System; University of Wisconsin Madison; University of
   Wisconsin System; University of Wisconsin Madison; University of
   Wisconsin System; University of Wisconsin Madison
RP Kato, T (corresponding author), RIKEN, Lab Mol Dynam Mental Disorders, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM kato@brain.riken.jp
RI Kato, Tadafumi/J-3583-2014; Kubota-Sakashita, Mie/AAM-4064-2021;
   Kasahara, Takaoki/AAJ-5367-2020
OI Kasahara, Takaoki/0000-0002-0953-5146; Kato,
   Tadafumi/0000-0001-7856-3952
FU Grants-in-Aid for Scientific Research [26110710, 24116005, 25650005]
   Funding Source: KAKEN
CR Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   Carrozzo R, 1998, NEUROLOGY, V50, P99, DOI 10.1212/WNL.50.1.99
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fuke S, 2011, BBA-BIOENERGETICS, V1807, P270, DOI 10.1016/j.bbabio.2010.11.016
   Hayashi A, 2007, J BIOL CHEM, V282, P34525, DOI 10.1074/jbc.M704300200
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kato T, 2007, CNS DRUGS, V21, P1, DOI 10.2165/00023210-200721010-00001
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Melberg A, 1996, MUSCLE NERVE, V19, P1561, DOI 10.1002/(SICI)1097-4598(199612)19:12<1561::AID-MUS5>3.0.CO;2-8
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
NR 40
TC 17
Z9 18
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD NOV
PY 2014
VL 1
IS 11
BP 909
EP 920
DI 10.1002/acn3.133
PG 12
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA V45KO
UT WOS:000209815700006
PM 25540805
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Chan, SSL
   Copeland, WC
AF Chan, Sherine S. L.
   Copeland, William C.
TI DNA polymerase gamma and mitochondrial disease: Understanding the
   consequence of <i>POLG</i> mutations
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT International Symposium on Mitchondrial Physiology and Pathology
CY JUN, 2008
CL Bari, ITALY
DE Mitochondria; Mitochondrial disease; DNA polymerase gamma; Mitochondrial
   DNA replication; Oxidative stress
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CAG REPEAT;
   SACCHAROMYCES-CEREVISIAE; ALPERS-SYNDROME; W748S MUTATION; GENE POLG;
   POLYMORPHISM; DEFECTS; TOXICITY; PATIENT
AB DNA polymerase gamma is the only known DNA polymerase in human mitochondria and is essential for mitochondrial DNA replication and repair. It is well established that defects in mtDNA replication lead to mitochondrial dysfunction and disease. Over 160 coding variations in the gene encoding the catalytic subunit of DNA polymerase gamma (POLG) have been identified. Our group and others have characterized a number of the more common and interesting mutations, as well as those disease mutations in the DNA polymerase gamma accessory subunit. We review the results of these studies, which provide clues to the mechanisms leading to the disease state. Published by Elsevier B.V.
C1 [Chan, Sherine S. L.; Copeland, William C.] Natl Inst Environm Hlth Sci, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Chan, SSL (corresponding author), Natl Inst Environm Hlth Sci, Mol Genet Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
EM sherine.s.l.chan@gmail.com; copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU Intramural NIH HHS [Z01 ES065078-14, Z01 ES065080-13] Funding Source:
   Medline; NIEHS NIH HHS [R00 ES015555, 1K99-ES015555-01, K99 ES015555-01,
   K99 ES015555] Funding Source: Medline
CR Aknin-Seifer IE, 2005, HUM REPROD, V20, P736, DOI 10.1093/humrep/deh666
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Brusco A, 2006, J ENDOCRINOL INVEST, V29, P1
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Chan SSL, 2007, ENVIRON MOL MUTAGEN, V48, P190, DOI 10.1002/em.20191
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   DEVRIES MC, 2006, EUR J PEDIAT
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   Jensen MB, 2008, ANN ONCOL, V19, P1910, DOI 10.1093/annonc/mdn407
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nowak R, 2005, ANN ONCOL, V16, P1211, DOI 10.1093/annonc/mdi205
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Rovio AT, 2004, MAMM GENOME, V15, P492, DOI 10.1007/s00335-004-3049-x
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Westerveld GH, 2008, MOL HUM REPROD, V14, P245, DOI 10.1093/molehr/gan012
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
NR 52
TC 122
Z9 150
U1 0
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD MAY
PY 2009
VL 1787
IS 5
SI SI
BP 312
EP 319
DI 10.1016/j.bbabio.2008.10.007
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics
GA 451MX
UT WOS:000266475400005
PM 19010300
OA Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Matthes, T
   Rustin, P
   Trachsel, H
   Darbellay, R
   Costaridou, S
   Xaidara, A
   Rideau, A
   Beris, P
AF Matthes, Thomas
   Rustin, Pierre
   Trachsel, Hedwige
   Darbellay, Regis
   Costaridou, S.
   Xaidara, A.
   Rideau, Alexandra
   Beris, Photis
TI Different pathophysiological mechanisms of intramitochondrial iron
   accumulation in acquired and congenital sideroblastic anemia caused by
   mitochondrial DNA deletion
SO EUROPEAN JOURNAL OF HAEMATOLOGY
LA English
DT Article
DE sideroblastic anemia; mitochondrial DNA; respiratory chain function;
   Pearson's disease; iron metabolism
ID KEARNS-SAYRE SYNDROME; CYTOCHROME-C-OXIDASE; ENERGY-DEPENDENT
   ACCUMULATION; MYELODYSPLASTIC SYNDROMES; PEARSON-SYNDROME;
   GENE-MUTATIONS; MTDNA; FERROCHELATASE; DEFICIENCY; DISORDER
AB Sideroblastic anemias (SA) are characterized by iron accumulation in the mitochondria of erythroblasts. Although we have evidence of mitochondrial gene alterations in sporadic congenital cases, the origin of acquired forms [refractory anemia with ring sideroblasts (RARS)], is still largely unknown. Here, we report the analysis of respiratory chain function in a patient with a large mitochondrial deletion and in patients with RARS. A young boy with SA showed symptoms typical of a mitochondrial disease with metabolic acidosis, muscle weakness and cerebral involvement. His bone marrow DNA was analyzed for the presence of mitochondrial deletions. We found a new mitochondrial (mt)DNA deletion spanning 3614 bp and including all the mt genes encoding complex IV, plus ATPase 6 and 8, and several transfer (t)RNAs. All tissues analyzed (liver, skeletal muscle, brain, pancreas) showed a heteroplasmic distribution of this mutant DNA. Bone marrow homogenates were obtained from five patients with RARS and from three patients with normal bone marrow and respiratory chain function assayed by spectrophotometric analysis. Cytochrome c oxidase (CCO) activity was greatly reduced in the patient's bone marrow. In contrast, CCO activity and global respiratory chain function were conserved in patients with RARS. We conclude that deficient CCO activity secondary to mtDNA deletions is related to intramitochondrial iron accumulation, as in our patient or in those with Pearson's syndrome, whereas other mechanisms, e.g. nuclear DNA mutations, have to be proposed to be involved in the acquired forms of SA.
C1 Univ Hosp Geneva, Dept Internal Med, Unit Clin Hematol, Geneva, Switzerland.
   Hop Necker Enfants Malad, Paris, France.
   Aghia Sophia Childrens Hosp, Athens, Greece.
C3 University of Geneva; Assistance Publique Hopitaux Paris (APHP);
   Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades -
   APHP; The Aghia Sophia Children's Hospital
RP Matthes, T (corresponding author), Hop Cantonal Univ Geneva, Serv Hematol, CH-1211 Geneva 14, Switzerland.
EM thomas.matthes@hcuge.ch
RI Thomas, Matthes/AGP-1703-2022
OI Rustin, Pierre/0000-0002-5500-7280
CR Bröker S, 1998, EUR J BIOCHEM, V258, P132, DOI 10.1046/j.1432-1327.1998.2580132.x
   CASADEMONT J, 1994, HUM MOL GENET, V3, P1945, DOI 10.1093/hmg/3.11.1945
   Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249
   FISCHELGHODSIAN N, 1992, PEDIATR RES, V31, P557, DOI 10.1203/00006450-199206000-00004
   FLATMARK T, 1975, J BIOL CHEM, V250, P6433
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Jacobs LJAM, 2004, J INHERIT METAB DIS, V27, P47, DOI 10.1023/B:BOLI.0000016601.49372.18
   Matthes TW, 2000, BRIT J HAEMATOL, V111, P843, DOI 10.1046/j.1365-2141.2000.02425.x
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   NORBY S, 1994, J MED GENET, V31, P45, DOI 10.1136/jmg.31.1.45
   Parfait B, 1997, HUM GENET, V101, P247, DOI 10.1007/s004390050625
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   PORRA RJ, 1963, BIOCHEM J, V87, P186, DOI 10.1042/bj0870186
   PORRA RJ, 1963, BIOCHEM J, V87, P181, DOI 10.1042/bj0870181
   Reddy PL, 2002, BRIT J HAEMATOL, V116, P564, DOI 10.1046/j.0007-1048.2001.03323.x
   ROMSLO I, 1974, BIOCHIM BIOPHYS ACTA, V357, P34, DOI 10.1016/0005-2728(74)90109-1
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Shin MG, 2003, BLOOD, V101, P3118, DOI 10.1182/blood-2002-06-1825
   TANG HY, 1993, EUR J IMMUNOL, V23, P899, DOI 10.1002/eji.1830230420
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 23
TC 6
Z9 7
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0902-4441
EI 1600-0609
J9 EUR J HAEMATOL
JI Eur. J. Haematol.
PD AUG
PY 2006
VL 77
IS 2
BP 169
EP 174
DI 10.1111/j.1600-0609.2006.00674.x
PG 6
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 059QO
UT WOS:000238747500012
PM 16856911
DA 2024-11-01
ER

PT J
AU Bannwarth, S
   Figueroa, A
   Fragaki, K
   Destroismaisons, L
   Lacas-Gervais, S
   Lespinasse, F
   Vandenbos, F
   Pradelli, LA
   Ricci, JE
   Rötig, A
   Michiels, JF
   Vande Velde, C
   Paquis-Flucklinger, V
AF Bannwarth, Sylvie
   Figueroa, Alexia
   Fragaki, Konstantina
   Destroismaisons, Laurie
   Lacas-Gervais, Sandra
   Lespinasse, Francoise
   Vandenbos, Fanny
   Pradelli, Ludivine A.
   Ricci, Jean-Ehrland
   Roetig, Agnes
   Michiels, Jean-Francois
   Vande Velde, Christine
   Paquis-Flucklinger, Veronique
TI The human MSH5 (MutS Homolog 5) protein localizes to mitochondria and
   protects the mitochondrial genome from oxidative damage
SO MITOCHONDRION
LA English
DT Article
DE mtDNA instability; DNA polymerase gamma; Twinkle helicase; Mitochondrial
   diseases
ID MISMATCH-REPAIR SYSTEM; SACCHAROMYCES-CEREVISIAE; MAMMALIAN
   MITOCHONDRIA; DNA-DAMAGE; HUMAN-CELLS; GENE; MTDNA; DELETIONS; MEIOSIS;
   HMSH5
AB MutS homologs play a central role in maintaining genetic stability. We show that MSH5 (MutS Homolog 5) is localized into the mitochondria of germ and somatic cells. This protein binds to mtDNA and interacts with the Twinkle helicase and the DNA polymerase gamma. hMSH5 stimulates mtDNA repair in response to DNA damage induced by oxidative stress. Furthermore, we observed a subsarcolemmal accumulation of hMSH5 in COX negative muscle fibers of patients presenting a mitochondrial myopathy. We report a novel localization for hMSH5 suggesting that this protein may have functions other than those known in meiotic recombination. (C) 2012 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Bannwarth, Sylvie; Figueroa, Alexia; Fragaki, Konstantina; Lespinasse, Francoise; Paquis-Flucklinger, Veronique] Fac Med Nice, IRCAN, CNRS UMR 7284, UNS,Inserm U1081, F-06107 Nice 2, France.
   [Bannwarth, Sylvie; Figueroa, Alexia; Fragaki, Konstantina; Paquis-Flucklinger, Veronique] CHU Nice, Hop Archet 2, Serv Genet Med, Nice, France.
   [Destroismaisons, Laurie; Vande Velde, Christine] Univ Montreal, CHUM, Ctr Rech, Ctr Excellence Neurom, Montreal, PQ H2L 4M1, Canada.
   [Destroismaisons, Laurie; Vande Velde, Christine] Univ Montreal, Dept Med, Montreal, PQ H2L 4M1, Canada.
   [Lacas-Gervais, Sandra] Univ Nice Sophia Antipolis, Fac Sci, Ctr Commun Microscopie Elect Appl, Nice, France.
   [Vandenbos, Fanny; Michiels, Jean-Francois] CHU Nice, Hop Louis Pasteur, Serv Neuropathol, Nice, France.
   [Pradelli, Ludivine A.; Ricci, Jean-Ehrland] Equipe 3 AVENIR, C3M, INSERM, U895, F-06204 Nice 3, France.
   [Roetig, Agnes] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Cote d'Azur; CHU Nice; Universite de Montreal; Universite de
   Montreal; Universite Cote d'Azur; CHU Nice; Institut National de la
   Sante et de la Recherche Medicale (Inserm); Universite Paris Cite;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Necker-Enfants Malades - APHP; Institut National de la Sante et de la
   Recherche Medicale (Inserm)
RP Paquis-Flucklinger, V (corresponding author), Fac Med Nice, IRCAN, CNRS UMR 7284, UNS,Inserm U1081, 28 Av Valombrose, F-06107 Nice 2, France.
EM paquis@hermes.unice.fr
RI Velde, Christine/F-2721-2016; RICCI, Jean-Ehrland/I-7117-2016; ROTIG,
   AGNES/G-9592-2017
OI RICCI, Jean-Ehrland/0000-0003-1585-8117; ROTIG,
   AGNES/0000-0003-0589-0703; LESPINASSE, francoise/0000-0001-7710-0649
FU Association Francaise contre les Myopathies (AFM) [12885]; Fond de
   Recherche en Sante du Quebec [14015]; Canadian Institutes of Health
   Research [JNM-85074]
FX We thank Hans Spelbrink for the kind gift of Twinkle and polymerase
   gamma constructs, Dr. Mohammed Benhamed for access to human sperm and
   Thierry Virolle for the technical help. This work was supported by the
   Association Francaise contre les Myopathies (AFM)
   [AM/NM/2007-1103/Dossier No. 12885 to V.P-F], the Fond de Recherche en
   Sante du Quebec [14015 to C.V.V.] and the Canadian Institutes of Health
   Research [JNM-85074 to C.V.V.].
CR Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374
   Her C, 1998, GENOMICS, V52, P50, DOI 10.1006/geno.1998.5374
   Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794
   Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907
   Jun SH, 2006, FEBS J, V273, P1609, DOI 10.1111/j.1742-4658.2006.05190.x
   Kaniak A, 2009, DNA REPAIR, V8, P318, DOI 10.1016/j.dnarep.2008.11.004
   Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307
   Lahaye F, 2010, NUCLEIC ACIDS RES, V38, P3655, DOI 10.1093/nar/gkq098
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Mookerjee SA, 2006, MUTAT RES-FUND MOL M, V595, P91, DOI 10.1016/j.mrfmmm.2005.10.006
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Neyton S, 2004, MOL HUM REPROD, V10, P917, DOI 10.1093/molehr/gah123
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PaquisFlucklinger V, 1997, GENOMICS, V44, P188, DOI 10.1006/geno.1997.4857
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Paul R, 2000, EUR J HUM GENET, V8, P331, DOI 10.1038/sj.ejhg.5200463
   Pogorzala L, 2009, GENETICS, V182, P699, DOI 10.1534/genetics.109.103796
   REENAN RAG, 1992, GENETICS, V132, P963
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Santos Janine H, 2006, Methods Mol Biol, V314, P183
   Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200
   Santucci-Darmanin S, 2000, FASEB J, V14, P1539, DOI 10.1096/fj.14.11.1539
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHULL S, 1991, J BIOL CHEM, V266, P24398
   Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551
   Tompkins JD, 2009, EXP CELL RES, V315, P2420, DOI 10.1016/j.yexcr.2009.05.004
   VandeVelde C, 2008, P NATL ACAD SCI USA, V105, P4022, DOI DOI 10.1073/PNAS.0712209105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Xu YZ, 2011, PLANT CELL, V23, P3428, DOI 10.1105/tpc.111.089136
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yi W, 2006, CANCER RES, V66, P151, DOI 10.1158/0008-5472.CAN-05-3019
   Yi W, 2005, BIOCHEM BIOPH RES CO, V332, P524, DOI 10.1016/j.bbrc.2005.04.154
NR 48
TC 18
Z9 19
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2012
VL 12
IS 6
BP 654
EP 665
DI 10.1016/j.mito.2012.07.111
PG 12
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 046IQ
UT WOS:000311759100009
PM 22917773
DA 2024-11-01
ER

PT J
AU Crimi, M
   Rigolio, R
AF Crimi, Marco
   Rigolio, Roberta
TI The mitochondrial genome, a growing interest inside an organelle
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Review
DE mtDNA; heteroplasmy; molecular diagnostics; mitochondriopathies;
   nanogenomics
ID DNA; DISEASE; CANCER; RESVERATROL; MICE; POLYMORPHISM; MYOPATHIES;
   POLYMERASE; MUTATION
AB Mitochondria are semi-autonomously reproductive organelles within eukaryotic cells carrying their own genetic material, called the mitochondrial genome (mtDNA). Until some years ago, mtDNA had primarily been used as a tool in population genetics. As scientists began associating mtDNA mutations with dozens of mysterious disorders, as well as the aging process and a variety of chronic degenerative diseases, it became increasingly evident that the information contained in this genome had substantial potential applications to improve human health. Today, mitochondria research covers a wide range of disciplines, including clinical medicine, biochemistry, genetics, molecular cell biology, bioinformatics, plant sciences and physiology. The present review intends to present a summary of the most exiting fields of the mitochondrial research bringing together several contributes in terms of original prospective and future applications.
C1 [Crimi, Marco] INGM, Funct Genom Unit, I-20122 Milan, Italy.
   [Rigolio, Roberta] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Monza, Italy.
C3 University of Milano-Bicocca
RP Crimi, M (corresponding author), INGM, Funct Genom Unit, Via F Sforza 28, I-20122 Milan, Italy.
EM crimi@ingm.it
RI Crimi, Marco/A-4032-2008
OI Crimi, Marco/0000-0001-6903-9163
CR Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Biggin A, 2005, MOL GENET METAB, V84, P61, DOI 10.1016/j.ymgme.2004.09.011
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Canter JA, 2005, CANCER RES, V65, P8028, DOI 10.1158/0008-5472.CAN-05-1428
   Capri M, 2006, ANN NY ACAD SCI, V1067, P252, DOI 10.1196/annals.1354.033
   CHUANG LY, 2006, BMC BIOINFORMATICS, V15, P7
   Crimi M, 2005, IUBMB LIFE, V57, P811, DOI 10.1080/15216540500460269
   Crimi M, 2003, EUR J HUM GENET, V11, P896, DOI 10.1038/sj.ejhg.5201056
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   DiMauro S, 2006, BRAIN, V129, P1637, DOI 10.1093/brain/awl169
   Flierl A, 2003, MOL THER, V7, P550, DOI 10.1016/S1525-0016(03)00037-6
   Hall VJ, 2006, STEM CELLS, V24, P1628, DOI 10.1634/stemcells.2005-0592
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jakupciak JP, 2006, CURR OPIN MOL THER, V8, P500
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4839, DOI 10.2741/2432
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
NR 32
TC 33
Z9 45
U1 0
U2 5
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1176-9114
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2008
VL 3
IS 1
BP 51
EP 57
PG 7
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 313DY
UT WOS:000256722500005
PM 18488415
DA 2024-11-01
ER

PT J
AU McFarland, R
   Swalwell, H
   Blakely, EL
   He, LP
   Groen, EJ
   Turnbull, DM
   Bushby, KM
   Taylor, RW
AF McFarland, Robert
   Swalwell, Helen
   Blakely, Emma L.
   He, Langping
   Groen, Emma J.
   Turnbull, Douglass M.
   Bushby, Kate M.
   Taylor, Robert W.
TI The m.5650G &gt; A mitochondrial tRNA<SUP>A1a</SUP> mutation is
   pathogenic and causes a phenotype of pure myopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mitochondrial myopathy; mitochondrial tRNA mutation; maternal
   inheritance
ID GENOME DATABASE; DNA MUTATION; TRANSFER-RNA; GENE; SEQUENCE
AB We report a family where a predominantly proximal myopathy has become increasingly severe with successive generations of the maternal lineage. This pure myopathy has been caused by a mutation (m.5650G > A) in the mt-tRNA(A1a) gene that has been reported only once previously in a patient with CADASIL where the phenotype was dominated by neurological complications. This report is therefore the first description of the phenotype associated solely with this mutation and confirms its pathogenicity. (C) 2007 Elsevier B.V. All rights reserved.
C1 [McFarland, Robert; Swalwell, Helen; Blakely, Emma L.; He, Langping; Turnbull, Douglass M.; Taylor, Robert W.] Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Groen, Emma J.; Turnbull, Douglass M.; Bushby, Kate M.; Taylor, Robert W.] Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP McFarland, R (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.mcfarland@ncl.ac.uk
OI McFarland, Robert/0000-0002-8833-2688
FU MRC [G0601943, G108/539] Funding Source: UKRI; Medical Research Council
   [G108/539, G0601943] Funding Source: Medline; Wellcome Trust [074454]
   Funding Source: Medline
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Annunen-Rasila J, 2006, NEUROGENETICS, V7, P185, DOI 10.1007/s10048-006-0049-x
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Finnilä S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268
   Hadjigeorgiou GM, 1999, J NEUROL SCI, V164, P153, DOI 10.1016/S0022-510X(99)00062-3
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kiyomoto BH, 2006, J NEUROL NEUROSUR PS, V77, P541, DOI 10.1136/jnnp.2005.079954
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   PARK SJ, 1988, J BIOL CHEM, V263, P16527
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
NR 14
TC 27
Z9 28
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JAN
PY 2008
VL 18
IS 1
BP 63
EP 67
DI 10.1016/j.nmd.2007.07.007
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 276OH
UT WOS:000254151400010
PM 17825557
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Zarrouk-Mahjoub, S
AF Finsterer, Josef
   Zarrouk-Mahjoub, Sinda
TI Management of epilepsy in MERRF syndrome
SO SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
LA English
DT Review
DE mtDNA; MERRF; m.8344A > G; Seizures; Stroke-like episode; Gene;
   Mitochondrial disorder; Epilepsy
ID RAGGED-RED FIBERS; PROGRESSIVE MYOCLONUS EPILEPSY; STROKE-LIKE EPISODES;
   MITOCHONDRIAL-DNA; A8344G MUTATION; ASTATIC EPILEPSY; ANTIEPILEPTIC
   DRUGS; GREATER-THAN; DISORDERS; PATIENT
AB Myoclonic epilepsy with ragged-red fibers (MERRF) syndrome is a rare syndromic mitochondrial disorder (MID) with a broad phenotypic but narrow genotypic heterogeneity. One of the predominant phenotypic features in addition to myopathy is epilepsy. The most frequent seizure type in MERRF is generalised myoclonic seizure but also focal myoclonic, focal atonic, generalised tonic-clonic, generalised atonic, generalised myoclonic-atonic, typical absences, or tonic-clonic seizures of unknown onset have been reported. There are no guidelines available for the management of epilepsy in MERRF syndrome but several expert opinions and general recommendations for the treatment of mitochondria] epilepsy have been published. According to these recommendations the antiepileptic drugs (AEDs) of choice are levetiracetam, topiramate, zonisamide, piracetam, and benzodiazepines. Perampanel has not been applied in MERRF patients but is promising in non-mitochondrial myoclonic epilepsy. Mitochondrion toxic agents, including mitochondrion-toxic AEDs, such as valproate, carbamazepine, phenytoin, and barbiturates, should be avoided as well as AEDs potentially enhancing the frequency of myoclonus, such as phenytoin, carbamazepine, lamotrigine, vigabatrin, tiagabine, gabapentin, pregabalin, and oxcarbazepine. (C) 2017 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Zarrouk-Mahjoub, Sinda] Univ Tunis El Manar, Pasteur Inst Tunis, Genom Platform, Tunis, Tunisia.
C3 Rudolfstiftung Hospital; Pasteur Network; Universite de Tunis-El-Manar;
   Institut Pasteur Tunis
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
OI ZARROUK-MAHJOUB, SINDA/0000-0002-6763-4644
CR Afra P, 2012, SEIZURE-EUR J EPILEP, V21, P202, DOI 10.1016/j.seizure.2011.12.010
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   [Anonymous], 2010, NEURO ENDOCRINOL LET, V31, P336
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Biancheri R, 2010, AJNR Am J Neuroradiol, V31, pE78, DOI 10.3174/ajnr.A2182
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chen ST, 2008, J CHILD NEUROL, V23, P1447, DOI 10.1177/0883073808318541
   Crest C, 2004, NEUROLOGY, V62, P640, DOI 10.1212/01.WNL.0000110193.78872.DD
   Delgado-Escueta AV, 2001, AM J MED GENET, V106, P129, DOI 10.1002/ajmg.1575
   DiMauro S, 2002, ADV NEUROL, V89, P217
   DiMauro S., 2003, GeneReviews
   Fan PC, 2014, J FORMOS MED ASSOC, V113, P258, DOI 10.1016/j.jfma.2013.02.008
   Fedi M, 2001, ARCH NEUROL-CHICAGO, V58, P781, DOI 10.1001/archneur.58.5.781
   Finsterer J, 2013, ACTA NEUROL SCAND, V128, P141, DOI 10.1111/ane.12122
   Finsterer J, 2017, IRAN J NEUR IN PRESS
   Finsterer J, 2016, EUR J PAEDIATR NEURO, V20, P824, DOI 10.1016/j.ejpn.2016.08.002
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Frye RE, 2015, EPILEPSY BEHAV, V47, P147, DOI 10.1016/j.yebeh.2014.08.134
   Hahn A, 2011, NEUROPEDIATRICS, V42, P148, DOI 10.1055/s-0031-1283167
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Iwanga K, 1992, Rinsho Shinkeigaku, V32, P870
   Kilaru S, 2007, EPILEPSIA, V48, P1703, DOI 10.1111/j.1528-1167.2007.01186.x
   Lamperti C, 2016, EPILEPTIC DISORD, V18, pS94
   Lee HN, 2016, PEDIATR NEUROL
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Mancuso M, 2006, J NEUROL SCI, V243, P97, DOI 10.1016/j.jns.2005.11.021
   Mancuso M, 2008, PARKINSONISM RELAT D, V14, P381, DOI 10.1016/j.parkreldis.2007.10.001
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mantoan L, 2011, CURR TREAT OPTION NE, V13, P355, DOI 10.1007/s11940-011-0131-z
   Michelucci R, 2016, EPILEPTIC DISORD, V18, pS145, DOI 10.1684/epd.2016.0861
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Monden Y, 2013, BRAIN DEV-JPN, V35, P582, DOI 10.1016/j.braindev.2012.08.006
   Nomura T, 1993, Rinsho Shinkeigaku, V33, P1198
   PONCHAUT S, 1992, BIOCHEM PHARMACOL, V43, P644, DOI 10.1016/0006-2952(92)90590-F
   PRANZATELLI MR, 1995, EPILEPSIA, V36, P783, DOI 10.1111/j.1528-1157.1995.tb01615.x
   Santamarina E, 2015, EPILEPSY BEHAV CASE, V4, P56, DOI 10.1016/j.ebcr.2015.06.007
   Santos NAG, 2008, TOXICOL IN VITRO, V22, P1143, DOI 10.1016/j.tiv.2008.03.004
   Scalais E, 2007, Eur J Neurol, V14, pe3, DOI 10.1111/j.1468-1331.2007.01926.x
   Scalais E, 2013, EUR J PAEDIATR NEURO, V17, P625, DOI 10.1016/j.ejpn.2013.05.013
   Sitburana Oraporn, 2001, Journal of the Medical Association of Thailand, V84, P1051
   Steele HE, 2015, SEMIN NEUROL, V35, P300, DOI 10.1055/s-0035-1552624
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   Vastagh I, 2011, IDEGGYOGY SZEMLE, V64, P399
   Vilela H, 2005, PEDIATR ANESTH, V15, P77, DOI 10.1111/j.1460-9592.2005.01384.x
   von Stülpnagel C, 2012, EUR J PAEDIATR NEURO, V16, P459, DOI 10.1016/j.ejpn.2011.12.012
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wang YL, 1999, AM J HEMATOL, V60, P83, DOI 10.1002/(SICI)1096-8652(199901)60:1<83::AID-AJH19>3.0.CO;2-N
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Yang Hecheng, 2014, Pediatr Neurol, V51, pe19, DOI 10.1016/j.pediatrneurol.2014.08.020
   Zaganas I, 2009, J NEUROL, V256, P271, DOI 10.1007/s00415-009-0921-3
   Zsurka G, 2013, SEIZURE-EUR J EPILEP, V22, P483, DOI 10.1016/j.seizure.2013.03.003
   Zupanc ML, 2010, PEDIATR NEUROL, V42, P396, DOI 10.1016/j.pediatrneurol.2010.02.013
NR 64
TC 14
Z9 19
U1 0
U2 7
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1059-1311
EI 1532-2688
J9 SEIZURE-EUR J EPILEP
JI Seizure
PD AUG
PY 2017
VL 50
BP 166
EP 170
DI 10.1016/j.seizure.2017.06.010
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA FF3HR
UT WOS:000408786600029
PM 28686997
OA Bronze
DA 2024-11-01
ER

PT J
AU Paramasivam, A
   Meena, AK
   Pedaparthi, L
   Jyothi, V
   Uppin, MS
   Jabeen, SA
   Sundaram, C
   Thangaraj, K
AF Paramasivam, Arumugam
   Meena, Angamuthu Kannan
   Pedaparthi, Lalitha
   Jyothi, Vuskamalla
   Uppin, Megha S.
   Jabeen, Shaikh Afshan
   Sundaram, Challa
   Thangaraj, Kumarasamy
TI Novel mutation in <i>C10orf2</i> associated with multiple mtDNA
   deletions, chronic progressive external ophthalmoplegia and premature
   aging
SO MITOCHONDRION
LA English
DT Article
DE Ptosis; CPEO; mtDNA; Multiple mtDNA deletions; C10orf2 mutation
ID RECESSIVE TWINKLE MUTATIONS; MITOCHONDRIAL; GENE; PROTEIN; POLG
AB Chronic progressive external ophthalmoplegia (CPEO) is caused by defects in both mitochondrial and nuclear genes, however, the causal genetic factors in large number of patients remains undetermined. Therefore, our aim was to screen 12 unrelated patients with CPEO for mutation/multiple deletions in mtDNA and mutations in the coding regions of C10orf2, which is essential for mtDNA replication. Histopathological study of muscle biopsy revealed cytochrome c oxidase-deficient fibers and ragged blue fibers in all the patients. Long-range PCR of DNA from skeletal muscle revealed multiple mtDNA deletions in all the 12 patients. Further, sequencing coding regions of C10orf2 revealed three variants in three different patients, of which two were novel (c.1964G > A/p.G655D; c.204G > A/p.G68G) variants and one was reported (c.1052A > G/p.N351S). Sequencing of other nuclear genes that are associated with CPEO and multiple mtDNA deletions, such as; POLG1, POLG2, TK2, ANTI, DGUOK, MPV17 and RRM2B did not reveal any pathogenic mutation in patients with C10orf2 mutation. Since in silico analyses revealed p.G655D could be a potentially pathogenic and it was absent in 200 healthy controls, p.G655D could be the causative factor for CPEO. Therefore, we suggest that C10orf2 gene should be screened in CPEO individuals with multiple mtDNA deletions, which might help in prognosis of this disease and appropriate genetic counseling. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Paramasivam, Arumugam; Jyothi, Vuskamalla; Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.
   [Meena, Angamuthu Kannan; Pedaparthi, Lalitha; Jabeen, Shaikh Afshan] Nizams Inst Med Sci, Dept Neurol, Hyderabad, Andhra Pradesh, India.
   [Uppin, Megha S.; Sundaram, Challa] Nizams Inst Med Sci, Dept Pathol, Hyderabad, Andhra Pradesh, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Centre for Cellular & Molecular Biology (CCMB); Nizam's Institute of
   Medical Sciences; Nizam's Institute of Medical Sciences
RP Thangaraj, K (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.
EM thangs@ccmb.res.in
RI Arumugam, Paramasivam/JAC-6846-2023; Thangaraj, Kumarasamy/G-5596-2010;
   Challa, Sundaram/JZD-6201-2024; Jayaseelan, Dr. Vijayashree
   Priyadharsini/AAD-4261-2019
OI Jayaseelan, Dr. Vijayashree Priyadharsini/0000-0001-7884-5466;
   Thangaraj, Kumarasamy/0000-0002-0075-0106; Arumugam,
   Paramasivam/0000-0001-6117-1178
FU Department of Biotechnology (DBT), Government of India [BT/PR7470/MED];
   Council of Scientific and Industrial Research (CSIR), Government of
   India [BioAge-BSC0208]
FX Authors would like to thank the patient, their families and other
   participants for their contribution to this research. This work was
   supported by the Department of Biotechnology (DBT), Government of India
   (grant no. BT/PR7470/MED); and the Council of Scientific and Industrial
   Research (CSIR) (BioAge-BSC0208), Government of India.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hartley JN, 2012, CASE REP PEDIAT, V2012, DOI 10.1155/2012/303096
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Thangaraj K, 2002, J ANDROL, V23, P815
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 27
TC 12
Z9 16
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN
PY 2016
VL 26
BP 81
EP 85
DI 10.1016/j.mito.2015.12.006
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA DE6UC
UT WOS:000370768100009
PM 26689116
DA 2024-11-01
ER

PT J
AU Schaaf, CP
   Blazo, M
   Lewis, RA
   Tonini, RE
   Takei, H
   Wang, J
   Wong, LJ
   Scaglia, F
AF Schaaf, Christian P.
   Blazo, Maria
   Lewis, Richard Alan
   Tonini, Ross E.
   Takei, Hidehiro
   Wang, Jing
   Wong, Lee-Jun
   Scaglia, Fernando
TI Early-onset severe neuromuscular phenotype associated with compound
   heterozygosity for <i>OPA1</i> mutations
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Optic atrophy; Semi-dominant inheritance; Mitochondrial dysfunction;
   Neurological disease; Compound heterozygosity
ID MITOCHONDRIAL-DNA DEPLETION; DOMINANT OPTIC ATROPHY; MOUSE MODEL; GENE;
   DYSFUNCTION; DEFICIENCY; MORPHOLOGY; FEATURES; DEFECTS
AB Introduction: Pathogenic mutations in the OPA1 gene are the most common identifiable cause of autosomal dominant optic atrophy (DOA), which is characterized by selective retinal ganglion cell loss, a distinctive pattern of temporal pallor of the optic nerve and a typical color vision deficit, with variable effects on visual acuity. Haploinsufficiency has been suggested as the major pathogenic mechanism for DOA. Here we present two siblings with severe ataxia, hypotonia, gastrointestinal dysmotility, dysphagia, and severe, early-onset optic atrophy who were found to be compound heterozygotes for two pathogenic OPA1 mutations. This example expands the clinical phenotype of OPA1-associated disorders and provides additional evidence for semi-dominant inheritance.
   Methods and results: Molecular analysis of the OPA1 gene in this family by Sanger sequencing revealed compound heterozygosity for two mutations in trans configuration, a p.I382M missense mutation and a p.V903GfsX3 frameshift deletion in both affected siblings. Electron microscopy of a skeletal muscle biopsy of the older sibling revealed dense osmiophilic bodies within the mitochondria. Mitochondrial DNA (mtDNA) content was within normal limits, and electron transport chain analysis showed no deficiencies of the mitochondrial respiratory chain enzymes. Multiple mtDNA deletions were not found.
   Conclusion: Compound heterozygosity of pathogenic OPA1 mutations may cause severe neuromuscular phenotypes in addition to early-onset optic atrophy. While a role for OPA1 in mtDNA maintenance has been discussed, compound biallelic pathogenic OPA1 mutations in our patients did not result in altered mtDNA copy number, mtDNA deletions, or deficiencies of the electron transport chain, despite the severe clinical phenotype. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Schaaf, Christian P.; Lewis, Richard Alan; Wang, Jing; Wong, Lee-Jun; Scaglia, Fernando] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Blazo, Maria] Scott & White Hosp, Div Med Genet, Temple, TX USA.
   [Lewis, Richard Alan] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA.
   [Tonini, Ross E.] Baylor Coll Med, Dept Otolaryngol, Houston, TX 77030 USA.
   [Takei, Hidehiro] Methodist Hosp, Dept Pathol, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Houston Methodist Hospital
RP Scaglia, F (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
EM fscaglia@bcm.edu
RI Schaaf, Christian/AAJ-7318-2021
OI Schaaf, Christian Patrick/0000-0002-2148-7490
FU Research to Prevent Blindness, New York, N.Y
FX We thank P. Zimmerman and V. Gudell for their help in scheduling the
   patients' and family's appointments. We thank Zbigniew Krason C.R.A. for
   the retinal imaging and color vision testing. This investigation was
   supported in part by an unrestricted award to R.A.L. from Research to
   Prevent Blindness, New York, N.Y.
CR Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   Mayorov Vladimir I., 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-22
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Milone M, 2009, MITOCHONDRION, V9, P279, DOI 10.1016/j.mito.2009.03.001
   Pesch UEA, 2001, HUM MOL GENET, V10, P1359, DOI 10.1093/hmg/10.13.1359
   Schimpf S, 2008, HUM MUTAT, V29, P106, DOI 10.1002/humu.20607
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715
   Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369
   Votruba M, 1998, ARCH OPHTHALMOL-CHIC, V116, P351, DOI 10.1001/archopht.116.3.351
   Vu TH, 1998, NEUROLOGY, V51, P1190, DOI 10.1212/WNL.51.4.1190
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Yu-Wai-Man P, 2009, INVEST OPHTH VIS SCI, V50, P4561, DOI 10.1167/iovs.09-3634
NR 22
TC 63
Z9 65
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD AUG
PY 2011
VL 103
IS 4
BP 383
EP 387
DI 10.1016/j.ymgme.2011.04.018
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 809ZY
UT WOS:000294096400012
PM 21636302
DA 2024-11-01
ER

PT J
AU Chaussenot, A
   Paquis-Flucklinger, V
AF Chaussenot, A.
   Paquis-Flucklinger, V.
TI An overview of neurological and neuromuscular signs in mitochondrial
   diseases
SO REVUE NEUROLOGIQUE
LA English
DT Article
DE Mitochondrial diseases; MtDNA; Nuclear genome; Progressive external
   ophthalmoplegia; Exercise intolerance; Cerebellar ataxia; Refractory
   epilepsy; Movement disorders
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SPINAL-CORD INVOLVEMENT; MULTIPLE
   MTDNA DELETIONS; DNA-POLYMERASE-GAMMA; COMPLEX I DEFICIENCY; HIGH BRAIN
   LACTATE; ONSET SPINOCEREBELLAR ATAXIA; HEREDITARY OPTIC NEUROPATHY;
   STROKE-LIKE LESIONS; POLG MUTATIONS
AB Mitochondrial disorders have a broad clinical spectrum and are genetically heterogeneous, involving two genomes. These disorders may be develop at any age, with isolated or multiple system involvement, and any pattern of inheritance. Neurological involvement is the most frequent, and concerns muscular, peripheral and central nervous system. Among these diverse signs, some are suggestive of mitochondrial disease, such as progressive external ophthalmoplegia, exercise intolerance, psychomotor regression, stroke-like episodes, refractory epilepsy and Epilepsia Partialis Continua. Others are less specific and mitochondrial hypothesis may be evocated because of either association of different neuromuscular signs or a multisystemic involvement. This review describes the wealth of this neurological and neuromuscular symptomatology through different syndromes reported in the literature, according to preponderant signs and to modes of inheritance, as key elements to guide genetics testing. (C) 2014 Elsevier Masson SAS. All rights reserved.
C1 [Chaussenot, A.; Paquis-Flucklinger, V.] Nice Teaching Hosp, Natl Ctr Mitochondrial Dis, Dept Med Genet, Nice, France.
   [Chaussenot, A.; Paquis-Flucklinger, V.] Univ Nice Sophia Antipolis, UMR CNRS Inserm UNS U1081 7284, IRCAN, F-06189 Nice, France.
C3 CHU Nice; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite Cote d'Azur
RP Chaussenot, A (corresponding author), Hop Archet 2 Niveau 3, Serv Genet Med, 151,Route St Antoine de Ginestiere,BP 3079, F-06202 Nice 3, France.
EM chaussenot.a@chu-nice.fr
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Anglin RE, 2012, J NEUROPSYCH CLIN N, V24, P394, DOI 10.1176/appi.neuropsych.11110345
   Auré K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   BRUYN GW, 1992, J NEUROL SCI, V113, P55, DOI 10.1016/0022-510X(92)90265-M
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Cagnoli C, 2006, BRAIN, V129, P235, DOI 10.1093/brain/awh651
   Cagnoli C, 2010, HUM MUTAT, V31, P1117, DOI 10.1002/humu.21342
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   Cerri C, 1983, MITOCHONDRIAL PATHOL, P141
   Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   Crosby AH, 2010, AM J HUM GENET, V87, P655, DOI 10.1016/j.ajhg.2010.09.013
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Doss S, 2014, J NEUROL, V261, P207, DOI 10.1007/s00415-013-7177-7
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Távora DGF, 2007, ARQ NEURO-PSIQUIAT, V65, P506, DOI 10.1590/S0004-282X2007000300028
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   García-Velasco A, 2003, J INTERN MED, V253, P381, DOI 10.1046/j.1365-2796.2003.01095.x
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   Horvath R, 2009, NEUROLOGY, V256, P810
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kevelam SH, 2013, NEUROLOGY, V80, P1577, DOI 10.1212/WNL.0b013e31828f1914
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kolb SJ, 2003, J NEUROL SCI, V216, P11, DOI 10.1016/S0022-510X(03)00218-1
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Labauge P, 2007, EUR NEUROL, V58, P59, DOI 10.1159/000102171
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Linnankivi T, 2004, NEUROLOGY, V63, P688, DOI 10.1212/01.WNL.0000134658.35601.41
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Mendelsohn B. A., 2013, JIMD REP
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Ojala T, 2012, PEDIATR RES, V72, P432, DOI 10.1038/pr.2012.92
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Petzold GC, 2006, J NEUROL NEUROSUR PS, V77, P889, DOI 10.1136/jnnp.2005.078568
   Pierson TM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002325
   Pitceathly RDS, 2013, JAMA NEUROL, V70, P1556, DOI 10.1001/jamaneurol.2013.3242
   Pitceathly RDS, 2013, J NEUROL NEUROSUR PS, V84, P107, DOI 10.1136/jnnp-2012-303232
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Serkov SV, 2004, NEUROPEDIATRICS, V35, P1, DOI 10.1055/s-2003-43548
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Shimazaki H, 2012, J MED GENET, V49, P777, DOI 10.1136/jmedgenet-2012-101212
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Spiegel R, 2013, EUR J HUM GENET, V2013
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stuart S, 2012, MOL GENET GENOMICS, V287, P837, DOI 10.1007/s00438-012-0723-7
   Szklarczyk R, 2013, HUM MOL GENET, V22, P656, DOI 10.1093/hmg/dds473
   Tarnopolsky MA, 2004, AM J MED GENET A, V125A, P310, DOI 10.1002/ajmg.a.20466
   Thiffault I, 2006, BRAIN, V129, P2332, DOI 10.1093/brain/awl110
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uluc K, 2008, J NEUROL SCI, V273, P118, DOI 10.1016/j.jns.2008.06.002
   van der Knaap MS, 2003, ANN NEUROL, V53, P252, DOI 10.1002/ana.10456
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zelnik N, 1996, PEDIATR NEUROL, V14, P251, DOI 10.1016/0887-8994(96)00046-X
NR 140
TC 5
Z9 8
U1 0
U2 8
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD MAY
PY 2014
VL 170
IS 5
BP 323
EP 338
DI 10.1016/j.neurol.2014.03.007
PG 16
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AH4JK
UT WOS:000336093000003
PM 24792434
DA 2024-11-01
ER

PT J
AU Bykhovskaya, Y
   Mengesha, E
   Fischel-Ghodsian, N
AF Bykhovskaya, Yelena
   Mengesha, Emebet
   Fischel-Ghodsian, Nathan
TI Pleiotropic effects and compensation mechanisms determine tissue
   specificity in mitochondrial myopathy and sideroblastic anemia (MLASA)
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE oxidative phosphorylation disorder; pseudouridylation; expression;
   microarray; sideroblastic anemia; myopathy
ID ERYTHROID 5-AMINOLEVULINATE SYNTHASE; PSEUDOURIDINE-SYNTHASE;
   GENE-EXPRESSION; IRON-METABOLISM; MESSENGER-RNA; CELL-LINES;
   DYSKERATOSIS-CONGENITA; MISSENSE MUTATION; U2 SNRNA; ERYTHROPOIETIN
AB The tissue specificity of mitochondrial diseases is poorly understood. Recently, tissue-specific quantitative differences of the components of the mitochondrial translation system have been found to correlate with disease presentation in fatal hepatopathy caused by mutations in mitochondrial translation factor EFGI. MLASA is an autosomal recessive inherited progressive oxidative phosphorylation disorder that affects muscle and erythroid cells. The disease is caused by the homozygous point mutation C656T (R116W) in the catalytic domain of the pseudouridylate synthase 1 (PUS1) gene, which leads to a complete lack of pseudouridylation at the expected sites in mitochondrial and cytoplasmic tRNAs. Despite the presence of these altered tRNAs, most tissues are unaffected, and even in muscle and erythroid cells the disease phenotype only slowly emerges over the course of years. In order to elucidate intracellular pathways through which the homozygous mutation leads to tissue-restricted phenotype, we performed microarray expression analysis of EBV-transformed lymphoblasts from MLASA patients, heterozygous parents, and controls using human Beadchip microarray with 47,296 transcripts. Genes coding for proteins involved in DNA transcription and its regulation, and metal binding proteins, demonstrated major differences in expression between patients and all other individuals with normal phenotype. Genes coding for ribosomal proteins differed significantly between individual with at least one copy of the mutated PUS1 gene and controls. These findings indicate that the lack of tRNA pseudouridylation can be overcome by compensatory changes in levels of ribosomal proteins, and that the disease phenotype in affected tissues is likely due to pleiotropic effects of PUS1p on non-tRNA molecules involved in DNA transcription and iron metabolism. Similar combinations of mechanisms may play a role in the tissue specificity of other mitochondrial disorders. (c) 2007 Elsevier Inc. All rights reserved.
C1 Cedars Sinai Med Ctr, Steven Spielberg Pediat Res Ctr, Inst Med Genet, Ahmanson Dept Pediat, Los Angeles, CA 90048 USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA.
C3 Cedars Sinai Medical Center; University of California System; University
   of California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA
RP Fischel-Ghodsian, N (corresponding author), Cedars Sinai Med Ctr, Steven Spielberg Pediat Res Ctr, Inst Med Genet, Ahmanson Dept Pediat, 8700 Beverly Blvd,Suite SSB378, Los Angeles, CA 90048 USA.
EM nathan.fischel@cshs.org
OI Mengesha, Emebet/0000-0001-7830-1557
FU NCRR NIH HHS [M01-RR00425, M01 RR000425] Funding Source: Medline; NIDDK
   NIH HHS [R01 DK074368-02, R01 DK074368-01A2, R01-DK74368, R01 DK074368]
   Funding Source: Medline
CR Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Baron CA, 2006, J AUTISM DEV DISORD, V36, P973, DOI 10.1007/s10803-006-0134-x
   Behm-Ansmant I, 2003, RNA, V9, P1371, DOI 10.1261/rna.5520403
   Behm-Ansmant I, 2006, RNA, V12, P1583, DOI 10.1261/rna.100806
   Busfield SJ, 1997, EUR J BIOCHEM, V249, P77, DOI 10.1111/j.1432-1033.1997.t01-1-00077.x
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   CASEY JL, 1989, EMBO J, V8, P3693, DOI 10.1002/j.1460-2075.1989.tb08544.x
   Charette M, 2000, IUBMB LIFE, V49, P341
   Chen JG, 2000, BIOCHEM J, V352, P465, DOI 10.1042/0264-6021:3520465
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2004, MITOCHONDRION, V4, P799, DOI 10.1016/j.mito.2004.07.032
   Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x
   Gunderson KL, 2004, GENOME RES, V14, P870, DOI 10.1101/gr.2255804
   Haas CS, 2006, ARTHRITIS RHEUM-US, V54, P2047, DOI 10.1002/art.21953
   HANSON ES, 2002, MOL CELLULAR IRON TR, P207
   Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175
   Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70
   Hube F, 2006, DNA CELL BIOL, V25, P418, DOI 10.1089/dna.2006.25.418
   KLAUSNER RD, 1993, MOL BIOL CELL, V4, P1
   Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411
   Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104
   Makita T, 2001, GENE DEV, V15, P889, DOI 10.1101/gad.871601
   Massenet S, 1999, MOL CELL BIOL, V19, P2142
   Massenet S., 1998, MODIFICATION EDITING, P201
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101
   Morello F, 2004, ARTERIOSCL THROM VAS, V24, P2149, DOI 10.1161/01.ATV.0000145978.70872.63
   Motorin Y, 1998, RNA, V4, P856, DOI 10.1017/S1355838298980396
   Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   PATTON JR, 1994, BIOCHIMIE, V76, P1129, DOI 10.1016/0300-9084(94)90041-8
   Ponka P, 1997, BLOOD, V89, P1
   PRESSMAN S, 1991, AM J HUM GENET, V49, P467
   Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447
   Sadlon TJ, 1999, INT J BIOCHEM CELL B, V31, P1153, DOI 10.1016/S1357-2725(99)00073-4
   THEIL EC, 1990, J BIOL CHEM, V265, P4771
   Watts JA, 2002, AM J HUM GENET, V71, P791, DOI 10.1086/342974
   Weiss G, 1997, BLOOD, V89, P680, DOI 10.1182/blood.V89.2.680
   Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835
   Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044
   Zoller H, 2002, BRIT J HAEMATOL, V118, P619, DOI 10.1046/j.1365-2141.2002.03626.x
NR 43
TC 13
Z9 13
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JUN
PY 2007
VL 91
IS 2
BP 148
EP 156
DI 10.1016/j.ymgme.2007.02.006
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 181AE
UT WOS:000247408300005
PM 17374500
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Gagliardi, D
   Mauri, E
   Magri, F
   Velardo, D
   Meneri, M
   Abati, E
   Brusa, R
   Faravelli, I
   Piga, D
   Ronchi, D
   Triulzi, F
   Peverelli, L
   Sciacco, M
   Bresolin, N
   Comi, GP
   Corti, S
   Govoni, A
AF Gagliardi, Delia
   Mauri, Eleonora
   Magri, Francesca
   Velardo, Daniele
   Meneri, Megi
   Abati, Elena
   Brusa, Roberta
   Faravelli, Irene
   Piga, Daniela
   Ronchi, Dario
   Triulzi, Fabio
   Peverelli, Lorenzo
   Sciacco, Monica
   Bresolin, Nereo
   Comi, Giacomo Pietro
   Corti, Stefania
   Govoni, Alessandra
TI Can Intestinal Pseudo-Obstruction Drive Recurrent Stroke-Like Episodes
   in Late-Onset MELAS Syndrome? A Case Report and Review of the Literature
SO FRONTIERS IN NEUROLOGY
LA English
DT Review
DE MELAS; mitochondrial disorders; intestinal pseudo-obstruction;
   stroke-like episodes; gastrointestinal disturbance
ID LACTIC-ACIDOSIS; MITOCHONDRIAL MYOPATHY; ENCEPHALOPATHY; INVOLVEMENT;
   FEATURES
AB Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a maternally inherited mitochondrial disorder that is most commonly caused by the m. 3243A>G mutation in the MT-TL1 mitochondrial DNA gene, resulting in impairment of mitochondrial energy metabolism. Although childhood is the typical age of onset, a small fraction (1-6%) of individuals manifest the disease after 40 years of age and usually have a less aggressive disease course. The clinicalmanifestations are variable and mainly depend on the degree of heteroplasmy in the patient's tissues and organs. They include muscle weakness, diabetes, lactic acidemia, gastrointestinal disturbances, and stroke-like episodes, which are the most commonly observed symptom. We describe the case of a 50-year-old male patient who presented with relapsing intestinal pseudo-obstruction (IPO) episodes, which led to a late diagnosis of MELAS. After diagnosis, he presented several stroke-like episodes in a short time period and developed a rapidly progressive cognitive decline, which unfortunately resulted in his death. We describe the variable clinical manifestations of MELAS syndrome in this atypical and relatively old patient, with a focus on paralytic ileus and stroke-like episodes; the first symptom may have driven the others, leading to a relentless decline. Moreover, we provide a brief revision of previous reports of IPO occurrence in MELAS patients with the m. 3243A>G mutation, and we investigate its relationship with stroke-like episodes. Our findings underscore the importance of recognizing gastrointestinal disturbance to prevent neurological comorbidities.
C1 [Gagliardi, Delia; Mauri, Eleonora; Magri, Francesca; Abati, Elena; Brusa, Roberta; Faravelli, Irene; Ronchi, Dario; Bresolin, Nereo; Comi, Giacomo Pietro; Corti, Stefania] Univ Milan, Neurosci Sect, Dept Pathophysiol & Transplantat DEPT, Dino Ferrari Ctr, Milan, Italy.
   [Velardo, Daniele; Meneri, Megi; Piga, Daniela; Bresolin, Nereo; Comi, Giacomo Pietro; Corti, Stefania; Govoni, Alessandra] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Triulzi, Fabio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuroradiol Unit, Milan, Italy.
   [Peverelli, Lorenzo; Sciacco, Monica] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Corti, Stefania; Govoni, Alessandra] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Neurol Unit,Neurosci Sect,Dino Ferrari Ctr, Milan, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico;
   IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale
   Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale
   Maggiore Policlinico; University of Milan
RP Corti, S (corresponding author), Univ Milan, Neurosci Sect, Dept Pathophysiol & Transplantat DEPT, Dino Ferrari Ctr, Milan, Italy.; Corti, S; Govoni, A (corresponding author), IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.; Corti, S; Govoni, A (corresponding author), Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Neurol Unit,Neurosci Sect,Dino Ferrari Ctr, Milan, Italy.
EM stefania.corti@unimi.it; alessandra.govoni@policlinico.mi.it
RI Gagliardi, Delia/AAD-6240-2021; Comi, Giacomo/K-5702-2016; Faravelli,
   Irene/AAP-6300-2020; Corti, Stefania/K-6034-2016; abati,
   elena/AAY-3879-2021; Ronchi, Dario/K-8011-2016; Sciacco,
   Monica/AAC-6500-2022; Magri, Francesca/K-5739-2016; Mauri,
   Eleonora/AHE-1428-2022; Govoni, Alessandra/K-7944-2016
OI Gagliardi, Delia/0000-0001-8460-938X; Mauri,
   Eleonora/0000-0002-7736-8968; Abati, Elena/0000-0003-0797-8282; MENERI,
   MEGI/0000-0002-3429-1809; Govoni, Alessandra/0000-0002-5393-5462;
   simoncini, costanza/0000-0002-6724-5964; Ronchi,
   Dario/0000-0002-6093-9816; Sciacco, Monica/0000-0003-4593-4977;
   Faravelli, Irene/0000-0001-8126-7353
CR Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Chang TM, 2004, PEDIATR NEUROL, V31, P374, DOI 10.1016/j.pediatrneurol.2004.05.009
   Chiyonobu T, 2008, BRAIN DEV-JPN, V30, P430, DOI 10.1016/j.braindev.2007.12.006
   Downes TJ, 2018, J CLIN GASTROENTEROL, V52, P477, DOI 10.1097/MCG.0000000000001047
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fryer RH, 2016, PEDIATR NEUROL, V56, P59, DOI 10.1016/j.pediatrneurol.2015.12.010
   García-Velasco A, 2003, J INTERN MED, V253, P381, DOI 10.1046/j.1365-2796.2003.01095.x
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Iida H, 2013, J EPIDEMIOL, V23, P288, DOI 10.2188/jea.JE20120173
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Muehlenberg K, 2002, DEUT MED WOCHENSCHR, V127, P611, DOI 10.1055/s-2002-22669
   Nakae Yoshiharu, 2007, Rinsho Shinkeigaku, V47, P177
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Primiano G, 2014, NEUROLOGY, V82, P1932, DOI 10.1212/WNL.0000000000000458
   Seessle J, 2012, Z GASTROENTEROL, V50, P1161, DOI 10.1055/s-0032-1313125
   Sekino Y, 2012, WORLD J GASTROENTERO, V18, P4557, DOI 10.3748/wjg.v18.i33.4557
   Suzuki J, 2018, INTERNAL MED, V57, P771, DOI 10.2169/internalmedicine.9632-17
   Suzuki J, 2017, INTERNAL MED, V56, P1089, DOI 10.2169/internalmedicine.56.7753
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Walcott BP, 2012, NEUROLOGIST, V18, P159, DOI 10.1097/NRL.0b013e318247bcd8
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 24
TC 16
Z9 16
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD JAN 31
PY 2019
VL 10
AR 38
DI 10.3389/fneur.2019.00038
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA HJ7HX
UT WOS:000457368100002
PM 30766507
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Schlieben, LD
   Prokisch, H
AF Schlieben, Lea D.
   Prokisch, Holger
TI The Dimensions of Primary Mitochondrial Disorders
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE mitochondrial disease; genetics; mutation; diagnostic; challenges
ID MUTATIONS CAUSE; DISEASE; DIAGNOSIS; DNA; GENETICS; MUSCLE; ONSET;
   DELETIONS; DEFECT
AB The concept of a mitochondrial disorder was initially described in 1962, in a patient with altered energy metabolism. Over time, mitochondrial energy metabolism has been discovered to be influenced by a vast number of proteins with a multitude of functional roles. Amongst these, defective oxidative phosphorylation arose as the hallmark of mitochondrial disorders. In the premolecular era, the diagnosis of mitochondrial disease was dependent on biochemical criteria, with inherent limitations such as tissue availability and specificity, preanalytical and analytical artifacts, and secondary effects. With the identification of the first mitochondrial disease-causing mutations, the genetic complexity of mitochondrial disorders began to unravel. Mitochondrial dysfunctions can be caused by pathogenic variants in genes encoded by the mitochondrial DNA or the nuclear DNA, and can display heterogenous phenotypic manifestations. The application of next generation sequencing methodologies in diagnostics is proving to be pivotal in finding the molecular diagnosis and has been instrumental in the discovery of a growing list of novel mitochondrial disease genes. In the molecular era, the diagnosis of a mitochondrial disorder, suspected on clinical grounds, is increasingly based on variant detection and associated statistical support, while invasive biopsies and biochemical assays are conducted to an ever-decreasing extent. At present, there is no uniform biochemical or molecular definition for the designation of a disease as a "mitochondrial disorder". Such designation is currently dependent on the criteria applied, which may encompass clinical, genetic, biochemical, functional, and/or mitochondrial protein localization criteria. Given this variation, numerous gene lists emerge, ranging from 270 to over 400 proposed mitochondrial disease genes. Herein we provide an overview of the mitochondrial disease associated genes and their accompanying challenges.
C1 [Schlieben, Lea D.; Prokisch, Holger] Tech Univ Munich, Sch Med, Inst Human Genet, Munich, Germany.
   [Schlieben, Lea D.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Neurogenom, Munich, Germany.
C3 Technical University of Munich; Helmholtz Association; Helmholtz-Center
   Munich - German Research Center for Environmental Health
RP Prokisch, H (corresponding author), Tech Univ Munich, Sch Med, Inst Human Genet, Munich, Germany.; Prokisch, H (corresponding author), Helmholtz Zentrum Munchen, Inst Neurogenom, Munich, Germany.
EM prokisch@helmholtz-muenchen.de
RI Prokisch, Holger/N-8964-2013
OI Schlieben, Lea Dewi/0000-0001-6583-256X
FU BMBF (German Federal Ministry of Education and Research) through mitoNET
   German Network for Mitochondrial Diseases [01GM1906B]; PerMiM
   Personalized Mitochondrial Medicine [01KU2016A]; GENOMIT European
   Network for Mitochondrial Disease [01GM1920A]
FX This work was supported by the BMBF (German Federal Ministry of
   Education and Research) through mitoNET German Network for Mitochondrial
   Diseases [grant number 01GM1906B (to HP)], PerMiM Personalized
   Mitochondrial Medicine [grant number 01KU2016A (to HP)], and GENOMIT
   European Network for Mitochondrial Disease [grant number 01GM1920A (to
   HP)].
CR Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Chen YF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49663-3
   Cole LW, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00085
   Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209
   Di Nottia M, 2020, NEUROBIOL DIS, V141, DOI 10.1016/j.nbd.2020.104880
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   DiMauro S, 2010, DEV DISABIL RES REV, V16, P106, DOI 10.1002/ddrr.102
   Distelmaier F, 2017, BRAIN, V140, DOI 10.1093/brain/aww303
   Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001
   ENDO H, 1989, AM J HUM GENET, V44, P358
   Falk MJ, 2020, Mitochondrial Disease Genes Compendium: From Genes to Clinical Manifestations
   Ferreira CR, 2019, GENET MED, V21, P102, DOI 10.1038/s41436-018-0022-8
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   French CE, 2019, INTENS CARE MED, V45, P627, DOI 10.1007/s00134-019-05552-x
   Fresard L, 2019, NAT MED, V25, P911, DOI 10.1038/s41591-019-0457-8
   Gonorazky HD, 2019, AM J HUM GENET, V104, P466, DOI 10.1016/j.ajhg.2019.01.012
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Grier J, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000230
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holzerova E, 2016, BRAIN, V139, P346, DOI 10.1093/brain/awv350
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Khan NA, 2015, INDIAN J MED RES, V141, P13
   Koch J, 2017, BRAIN, V140, P279, DOI 10.1093/brain/aww300
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679
   Kopajtich R, 2016, AM J HUM GENET, V99, P414, DOI 10.1016/j.ajhg.2016.05.027
   Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lee HN, 2020, GENET MED, V22, P490, DOI 10.1038/s41436-019-0672-1
   Lott MT., 2013, Curr Protoc Bioinf, V44, P1231, DOI DOI 10.1002/0471250953.BI0123S44
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Montero R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148709
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1
   Parikh S, 2019, J MED GENET, V56, P123, DOI 10.1136/jmedgenet-2018-105800
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Phadke R, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070064
   Pitceathly RDS, 2021, J INHERIT METAB DIS, V44, P22, DOI 10.1002/jimd.12281
   Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011
   Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9
   Rahman J, 2017, ANN NEUROL, V81, P9, DOI 10.1002/ana.24835
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   Stenton SL, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102784
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tan J, 2020, EBIOMEDICINE, V54, DOI 10.1016/j.ebiom.2020.102730
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Udhayabanu T, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050052
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wetterstrand K, 2020, DNA sequencing costs: data from the NHGRI Genome Sequencing Program (GSP)
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 73
TC 48
Z9 50
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD NOV 26
PY 2020
VL 8
AR 600079
DI 10.3389/fcell.2020.600079
PG 11
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA PC2OS
UT WOS:000596847100001
PM 33324649
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Celotto, AM
   Frank, AC
   McGrath, SW
   Fergestad, T
   Van Voorhies, WA
   Buttle, KF
   Mannella, CA
   Palladino, MJ
AF Celotto, AM
   Frank, AC
   McGrath, SW
   Fergestad, T
   Van Voorhies, WA
   Buttle, KF
   Mannella, CA
   Palladino, MJ
TI Mitochondrial encephalomyopathy in <i>Drosophila</i>
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE ATP6; ANT; ATP synthase; neurodegeneration; muscle degeneration; aging;
   mitochondria
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; NUCLEOTIDE TRANSLOCATOR-1 GENE;
   MULTIPLE DELETIONS; POINT MUTATION; LEIGH-SYNDROME; ATP SYNTHASE;
   OXIDATIVE-PHOSPHORYLATION; BEHAVIORAL MUTANTS; STRUCTURAL-CHANGES; DNA
   MUTATIONS
AB Mitochondrial encephalomyopathies are common and devastating multisystem genetic disorders characterized by neuromuscular dysfunction and tissue degeneration. Point mutations in the human mitochondrial ATP6 gene are known to cause several related mitochondrial disorders: NARP( neuropathy, ataxia, and retinitis pigmentosa), MILS ( maternally inherited Leigh's syndrome), and FBSN ( familial bilateral striatal necrosis). We identified a pathogenic mutation in the Drosophila mitochondrial ATP6 gene that causes progressive, adult-onset neuromuscular dysfunction and myodegeneration. Our results demonstrate ultrastructural defects in the mitochondrial innermembrane, neural dysfunction, and a marked reduction in mitochondrial ATP synthase activity associated with this mutation. This Drosophila mutant recapitulates key features of the human neuromuscular disorders enabling detailed in vivo studies of these enigmatic diseases.
C1 Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodgenerat Dis, Pittsburgh, PA 15261 USA.
   Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA.
   Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.
   New York State Dept Hlth, Resource Visualizat Biol Complex, Wadsworth Ctr, Albany, NY 12201 USA.
   New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; University of Wisconsin System;
   University of Wisconsin Madison; Wadsworth Center; State University of
   New York (SUNY) System; New Mexico State University
RP Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodgenerat Dis, 200 Lothrop,Biomed Sci Tower E1355, Pittsburgh, PA 15261 USA.
EM mjp44@pitt.edu
OI Frank, Adam/0000-0001-8203-8480
FU NCRR NIH HHS [RR01219, P41 RR001219] Funding Source: Medline; NINDS NIH
   HHS [T32NS07391-07, T32 NS007391] Funding Source: Medline
CR Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   DEMEIRLEIR L, 1995, PEDIATR NEUROL, V13, P242, DOI 10.1016/0887-8994(95)00184-H
   Deng YR, 1999, J STRUCT BIOL, V127, P231, DOI 10.1006/jsbi.1999.4147
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1
   FRYER A, 1994, ARCH DIS CHILD, V71, P419, DOI 10.1136/adc.71.5.419
   GANETZKY B, 1982, GENETICS, V100, P597
   HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269
   Hart P.E., 2002, Mitochondrial Disorders in Neurology, V2, P35
   HARTZOG PE, 1993, J BIOL CHEM, V268, P12250
   HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Holyoake AJ, 1999, ANDROLOGIA, V31, P339, DOI 10.1046/j.1439-0272.1999.00150.x
   HOMYK T, 1977, GENETICS, V87, P95
   HUIZING M, 1998, THESIS U NIJMEGEN NE
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawasaki F, 1998, J NEUROSCI, V18, P10241
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Kretzschmar D, 1997, J NEUROSCI, V17, P7425
   LAMMINEN T, 1995, AM J HUM GENET, V56, P1238
   Manfredi G, 2001, METHOD CELL BIOL, V65, P133, DOI 10.1016/S0091-679X(01)65008-8
   Marin-Garcia J, 2001, CARDIOVASC RES, V49, P17, DOI 10.1016/S0008-6363(00)00241-8
   Marko M, 1996, J STRUCT BIOL, V116, P93, DOI 10.1006/jsbi.1996.0016
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Min KT, 1997, CURR BIOL, V7, P885, DOI 10.1016/S0960-9822(06)00378-2
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Min KT, 1999, SCIENCE, V284, P1985, DOI 10.1126/science.284.5422.1985
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MITCHELL P, 1967, NATURE, V213, P137, DOI 10.1038/213137a0
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425
   Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003
   Palladino MJ, 2002, GENETICS, V161, P1197
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   PENCZEK P, 1995, ULTRAMICROSCOPY, V60, P393, DOI 10.1016/0304-3991(95)00078-X
   Radermacher M., 1992, WEIGHTED BACK PROJEC
   Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224
   Rogina B, 1997, P NATL ACAD SCI USA, V94, P6303, DOI 10.1073/pnas.94.12.6303
   SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Schapira AHV, 1999, EUR J CLIN INVEST, V29, P886
   SCHERER B, 1974, BIOCHEMISTRY-US, V13, P161, DOI 10.1021/bi00698a025
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   Sciacco M, 2003, J NEUROL, V250, P1498, DOI 10.1007/s00415-003-0246-6
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   SLAUTTERBACK DB, 1965, J CELL BIOL, V24, P1, DOI 10.1083/jcb.24.1.1
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Voorhies WA, 2004, J APPL PHYSIOL, V97, P1915, DOI 10.1152/japplphysiol.00505.2004
   Van Voorhies WA, 2003, J APPL PHYSIOL, V95, P2605, DOI 10.1152/japplphysiol.00448.2003
   Vergani L, 1999, HUM MOL GENET, V8, P1751, DOI 10.1093/hmg/8.9.1751
   WALKER JE, 1995, BBA-MOL BASIS DIS, V1271, P221, DOI 10.1016/0925-4439(95)00031-X
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang YQ, 1999, GENETICS, V153, P891
NR 78
TC 58
Z9 76
U1 0
U2 10
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
EI 1529-2401
J9 J NEUROSCI
JI J. Neurosci.
PD JAN 18
PY 2006
VL 26
IS 3
BP 810
EP 820
DI 10.1523/JNEUROSCI.4162-05.2006
PG 11
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 003XG
UT WOS:000234715000012
PM 16421301
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Lin, CM
   Thajeb, P
AF Lin, Chih-Ming
   Thajeb, Peterus
TI Valproic acid aggravates epilepsy due to MELAS in a patient with an
   A3243G mutation of mitochondrial DNA
SO METABOLIC BRAIN DISEASE
LA English
DT Article
DE epilepsy; mitochondrial disease; valproate; valproic acid; MELAS
ID SYSTEM BUCCAL GANGLIA; C-OXIDASE DEFICIENCY; LACTIC-ACIDOSIS;
   HELIX-POMATIA; ENCEPHALOPATHY; MYOPATHY; EPISODES; DISEASES; FAILURE;
   LIVER
AB Epilepsy is one of the most common presentations of patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). MELAS is typically caused by an A-to-G substitution at nucleotide position 3243 of mitochondrial DNA. Valproic acid, a common anticonvulsant, can actually increase the frequency of seizures in individuals with MELAS. Here, we report a single case-study of a 38-year-old man who presented with focal seizures and had MELAS Syndrome due to the A3243G mitochondrial DNA mutation. Manifestation of epilepsia partialis continua was aggravated by use of valproic acid. Convulsions abated after discontinuation of valproic acid. Our experience suggests that valproic acid should be avoided for the treatment of epilepsy in individuals with mitochondrial disease.
C1 Mackay Mem Hosp, Dept Neurol, Taipei, Taiwan.
C3 Mackay Memorial Hospital
RP Lin, CM (corresponding author), Mackay Mem Hosp, Dept Neurol, 92 Chungshan N Rd,Sect 2, Taipei, Taiwan.
EM googlejoseph@yahoo.com.tw
CR ALTRUP U, 1992, EPILEPSIA, V33, P743, DOI 10.1111/j.1528-1157.1992.tb02356.x
   ALTRUP U, 1992, EPILEPSIA, V33, P753, DOI 10.1111/j.1528-1157.1992.tb02357.x
   Auré K, 2005, ANN PATHOL, V25, P270, DOI 10.1016/S0242-6498(05)80131-2
   CHABROL B, 1994, EUR J PEDIATR, V153, P133, DOI 10.1007/BF01959226
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   LIOU CW, 1994, ACTA NEUROL SCAND, V90, P354
   Morris AAM, 1999, LIVER, V19, P357, DOI 10.1111/j.1478-3231.1999.tb00063.x
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PONCHAUT S, 1995, EUR J PEDIATR, V154, P79, DOI 10.1007/BF01972980
   PONCHAUT S, 1992, BIOCHEM PHARMACOL, V43, P644, DOI 10.1016/0006-2952(92)90590-F
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
NR 15
TC 56
Z9 68
U1 0
U2 2
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0885-7490
EI 1573-7365
J9 METAB BRAIN DIS
JI Metab. Brain Dis.
PD MAR
PY 2007
VL 22
IS 1
BP 105
EP 109
DI 10.1007/s11011-006-9039-9
PG 5
WC Endocrinology & Metabolism; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA 166HW
UT WOS:000246370800011
PM 17226098
DA 2024-11-01
ER

PT J
AU Mezghani, N
   Mnif, M
   Mkaouar-Rebai, E
   Kallel, N
   Charfi, N
   Abid, M
   Fakhfakh, F
AF Mezghani, Najla
   Mnif, Mouna
   Mkaouar-Rebai, Emna
   Kallel, Nozha
   Charfi, Nadia
   Abid, Mohamed
   Fakhfakh, Faiza
TI A maternally inherited diabetes and deafness patient with the 12S rRNA
   m.1555A&gt;G and the ND1 m.3308T&gt;C mutations associated with multiple
   mitochondrial deletions
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE MIDD; m.1555A > G; m.3308T > C; Mitochondrial deletions
ID A3243G MUTATION; SENSORINEURAL DEAFNESS; TUNISIAN PATIENTS;
   WOLFRAM-SYNDROME; A1555G MUTATION; DNA MUTATION; MELLITUS; FAMILY; GENE;
   PREVALENCE
AB Maternally inherited diabetes and deafness (MIDD) is a mitochondrial syndrome characterized by the onset of sensorineural hearing loss and diabetes in adults. Some patients may have other additional clinical features common in mitochondrial disorders such as pigmentary retinopathy, ptosis, cardiomyopathy, myopathy and renal affections. We report a 40-year-old Tunisian patient presenting maternally inherited type 2 diabetes and deafness (MIDD). A molecular genetic analysis was conducted in the patient and his twin sister, but no reported mutations in the tRNA(Leu(UUR)) and tRNA(Glu) genes were found, especially the two mitochondrial m.3243A>G and the m.14709T>C mutations in muscle and blood leukocytes. The results showed the presence of the mitochondrial NADH deshydrogenase 1 (ND1) homoplasmic m.3308T>C mutation the 2 tested tissues (blood leukocytes and skeletal muscle) of the proband and in the patient's sister blood leukocytes. In addition, we identified the mitochondrial 12S rRNA m.1555A>G mutation in muscle and blood leukocytes. The Long-range PCR amplification revealed the presence of multiple deletions of the mitochondrial DNA extracted from the patient's skeletal muscle removing several tRNA and protein-coding genes. Our study reported a Tunisian patient with clinical features of MIDD in whom we detected the 12S rRNA m.1555A>G and the ND1 m.3308T>C mutations with mitochondrial multiple deletions. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Mezghani, Najla; Mkaouar-Rebai, Emna; Fakhfakh, Faiza] Univ Sfax, Fac Med Sfax, Lab Genet Mol Humaine, Sfax 3029, Tunisia.
   [Mnif, Mouna; Kallel, Nozha; Charfi, Nadia; Abid, Mohamed] CHU Habib Bourguiba Sfax, Serv Endocrinol, Sfax, Tunisia.
C3 Universite de Sfax; Universite de Sfax; Hopital Habib Bourguiba; Hopital
   Hedi Chaker
RP Mezghani, N (corresponding author), Univ Sfax, Fac Med Sfax, Lab Genet Mol Humaine, Ave Magida Boulila, Sfax 3029, Tunisia.
EM najla.mezghani1980@gmail.com; faiza.fakh-fakh@gmail.com
RI MKAOUAR-REBAI, Emna/AAE-6650-2019
OI Mkaouar-Rebai, Emna/0000-0003-3095-510X
CR Akbari M, 2004, SCAND J CLIN LAB INV, V64, P86, DOI 10.1080/00365510410004209
   Alkowari MK, 2012, INT J AUDIOL, V51, P181, DOI 10.3109/14992027.2011.625983
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Campos Y, 1997, BIOCHEM BIOPH RES CO, V238, P323, DOI 10.1006/bbrc.1997.7166
   Cao YY, 2010, MITOCHONDRION, V10, P330, DOI 10.1016/j.mito.2010.01.008
   Chen J, 2006, DIABETES RES CLIN PR, V74, P148, DOI 10.1016/j.diabres.2006.03.024
   Cheng Zu-jian, 2009, Zhonghua Yi Xue Za Zhi, V89, P2536
   Deng G.H., 2009, ZHONGHUA YI XUE ZA Z, V40, P2822
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W
   Fukao T, 2009, MOL MED REP, V2, P69, DOI 10.3892/mmr_00000063
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Li MZ, 2008, CHINESE MED J-PEKING, V121, P682, DOI 10.1097/00029330-200804020-00004
   Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226
   Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1
   Malik SG, 2003, J HUM GENET, V48, P480, DOI 10.1007/s10038-003-0056-9
   Maseda E, 2008, ACTA OTORRINOLAR ESP, V59, P472, DOI 10.1016/S0001-6519(08)75121-5
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002
   Mkaouar-Rebai E, 2006, BIOCHEM BIOPH RES CO, V340, P1251, DOI 10.1016/j.bbrc.2005.12.123
   Mkaouar-Rebai E, 2007, BIOCHEM BIOPH RES CO, V355, P1031, DOI 10.1016/j.bbrc.2007.02.083
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778
   Nicolino M, 1997, J CLIN ENDOCR METAB, V82, P3063, DOI 10.1210/jc.82.9.3063
   Perucca-Lostanlen D, 2002, BBA-MOL BASIS DIS, V1588, P210, DOI 10.1016/S0925-4439(02)00167-9
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Rigoli L, 1999, ACTA DIABETOL, V36, P163, DOI 10.1007/s005920050161
   ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Souied EH, 1998, AM J OPHTHALMOL, V125, P100, DOI 10.1016/S0002-9394(99)80243-8
   Sudoyo H, 2003, ADV EXP MED BIOL, V531, P19
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Suzuki Y, 2003, DIABETES CARE, V26, P1315, DOI 10.2337/diacare.26.4.1315
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Vilarinho L, 1999, J NEUROL SCI, V163, P168, DOI 10.1016/S0022-510X(99)00030-1
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Zhang AM, 2008, BIOCHEM BIOPH RES CO, V376, P221, DOI 10.1016/j.bbrc.2008.08.128
NR 42
TC 12
Z9 14
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD FEB 22
PY 2013
VL 431
IS 4
BP 670
EP 674
DI 10.1016/j.bbrc.2013.01.063
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 103QZ
UT WOS:000315935300005
PM 23357420
DA 2024-11-01
ER

PT J
AU Wortmann, SB
   Champion, MP
   van den Heuvel, L
   Barth, H
   Trutnau, B
   Craig, K
   Lammens, M
   Schreuder, MF
   Taylor, RW
   Smeitink, JAM
   Wevers, RA
   Rodenburg, RJ
   Morava, E
AF Wortmann, Saskia B.
   Champion, Michael P.
   van den Heuvel, Lambert
   Barth, H.
   Trutnau, B.
   Craig, Kate
   Lammens, Martin
   Schreuder, Michiel F.
   Taylor, Robert W.
   Smeitink, Jan A. M.
   Wevers, Ron A.
   Rodenburg, Richard J.
   Morava, Eva
TI Mitochondrial DNA m.3242G &gt; A mutation, an under diagnosed cause of
   hypertrophic cardiomyopathy and renal tubular dysfunction?
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE CK elevation; Lipid myopathy; 3-Methylglutaconic aciduria; Muscular
   hypotonia; MELAS syndrome; Mitochondriopathy
ID KEARNS-SAYRE-SYNDROME; DIABETES-MELLITUS; TRNA(LEU(UUR)) GENE;
   LACTIC-ACIDOSIS; DISORDERS; INVOLVEMENT; FEATURES; DISEASE; PATIENT
AB We present two new patients with the recently described mitochondrial m. 3242G > A mutation. Although the mutation is situated next to the well known m.3243A > G mutation, the most common alteration associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome, the clinical presentation is quite different, but characteristic. All three m. 3242G > A patients presented in the neonatal period with hypertrophic and dilated cardiomyopathy, generalized muscle hypotonia and lactic acidosis. Two additionally had creatine kinase elevation, renal tubular acidosis/dysfunction and showed a mild clinical course with a favourable psychomotor development. The third patient had more neurological involvement and died in infancy. The mutation occurred de novo in the two patients where maternal investigations were performed. The combination of hypertrophic cardiomyopathy and renal tubular acidosis/renal tubular dysfunction is clinically distinctive and may represent a separate entity. (C) 2012 Elsevier Masson SAS. All rights reserved.
C1 [Wortmann, Saskia B.; van den Heuvel, Lambert; Smeitink, Jan A. M.; Rodenburg, Richard J.; Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders NCMD, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
   [Wortmann, Saskia B.; van den Heuvel, Lambert; Smeitink, Jan A. M.; Rodenburg, Richard J.; Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis IGMD, NL-6500 HB Nijmegen, Netherlands.
   [Champion, Michael P.] Kings Coll Hosp London, Dept Paediat Metab Med, London, England.
   [Trutnau, B.] Nierenzentrum Kinder & Jugendliche, Marburg, Germany.
   [Craig, Kate; Taylor, Robert W.] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Lammens, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands.
   [Schreuder, Michiel F.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Nephrol, NL-6500 HB Nijmegen, Netherlands.
   [Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Lab Genet Endocrine & Metab Dis LGEM, Dept Lab Med, NL-6500 HB Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; King's College
   Hospital NHS Foundation Trust; King's College Hospital; Newcastle
   University - UK; Radboud University Nijmegen; Radboud University
   Nijmegen; Radboud University Nijmegen
RP Wortmann, SB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders NCMD, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
EM s.wortmann@cukz.umcn.nl
RI Morava, E./L-4529-2015; Wortmann, Saskia/E-6125-2010; Schreuder,
   Michiel/P-5465-2014; van den Heuvel, Lambertus/AAM-1772-2021; Smeitink,
   Jan/C-1351-2013; Wevers, Ron/H-8116-2014; Lammens, Martin/H-1503-2011;
   Rodenburg, Richard/N-3579-2014
OI Lammens, Martin/0000-0002-3881-6692; Rodenburg,
   Richard/0000-0001-5227-3527
FU UK NHS
FX We thank the technicians from the Laboratory of Genetic, Endocrine and
   Metabolic disorders (LGEM), the Institute of Genetic and Metabolic
   Disease (IGMD) and the Department of Pathology of the Radboud University
   Nijmegen Medical Centre for excellent technical assistance. The
   mitochondrial diagnostic laboratory in Newcastle upon Tyne is funded by
   the UK NHS Specialised Services to provide the "Rare Mitochondrial
   Disease of Adults and Children Service".
CR Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   EVIATAR L, 1990, NEUROLOGY, V40, P1761, DOI 10.1212/WNL.40.11.1761
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Gattermann N, 2004, BLOOD, V103, P1499, DOI 10.1182/blood-2003-07-2446
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1990, J PEDIATR-US, V116, P904, DOI 10.1016/S0022-3476(05)80648-1
   Iwasaki N, 2001, J HUM GENET, V46, P330, DOI 10.1007/s100380170068
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Katsanos KH, 2001, AM J NEPHROL, V21, P150, DOI 10.1159/000046239
   Kishnani PS, 1996, EUR J PEDIATR, V155, P898
   MAJANDER A, 1991, PEDIATR RES, V30, P327, DOI 10.1203/00006450-199110000-00007
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005
   Miyata R, 2007, AM J MED GENET A, V143A, P189, DOI 10.1002/ajmg.a.31584
   Olpin SE, 2001, J INHERIT METAB DIS, V24, P35, DOI 10.1023/A:1005694320063
   Oppenheim MLS, 2009, J INHERIT METAB DIS, V32, P269, DOI 10.1007/s10545-009-1061-8
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PintosMorell G, 1997, PEDIATR NEPHROL, V11, P386
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Rötig A, 2003, J AM SOC NEPHROL, V14, P2995, DOI 10.1097/01.ASN.0000095481.24091.C9
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   TULINIUS MH, 1995, EUR J PEDIATR, V154, P35, DOI 10.1007/BF01972970
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Wortmann SB, 2007, ACTA PAEDIATR, V96, P450, DOI 10.1111/j.1651-2227.2006.00158.x
NR 25
TC 24
Z9 28
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1769-7212
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD OCT
PY 2012
VL 55
IS 10
BP 552
EP 556
DI 10.1016/j.ejmg.2012.06.002
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 019MI
UT WOS:000309743500010
PM 22781753
DA 2024-11-01
ER

PT J
AU Claeys, KG
   Abicht, A
   Häusler, M
   Kleinle, S
   Wiesmann, M
   Schulz, JB
   Horvath, R
   Weis, J
AF Claeys, Kristl G.
   Abicht, Angela
   Haeusler, Martin
   Kleinle, Stephanie
   Wiesmann, Martin
   Schulz, Joerg B.
   Horvath, Rita
   Weis, Joachim
TI NOVEL GENETIC AND NEUROPATHOLOGICAL INSIGHTS IN NEUROGENIC MUSCLE
   WEAKNESS, ATAXIA, AND RETINITIS PIGMENTOSA (NARP)
SO MUSCLE & NERVE
LA English
DT Article
DE electron microscopy; genetic counseling; MILS; mitochondrial; NARP;
   nerve biopsy; ultrastructural
ID MITOCHONDRIAL-DNA HETEROPLASMY; LEIGHS-SYNDROME; T8993G MUTATION; POINT
   MUTATION; ATP SYNTHASE; DISEASE; MTDNA
AB Introduction: Neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP) is caused by m.8993T>G/C mutations in the mitochondrial adenosine triphosphate synthase subunit 6 gene (MT-ATP6). Traditionally, heteroplasmy levels between 70% and 90% lead to NARP, and >90% result in Leigh syndrome. Methods: In this study we report a 30-year-old man with NARP and m.8993T>G in MT-ATP6. Results: Although the patient carried the mutation in homoplasmic state in blood with similarly high levels in urine (94%) and buccal swab (92%), he presented with NARP and not the expected, more severe Leigh phenotype. The mutation could not be detected in any of the 3 analyzed tissues of the mother, indicating a large genetic shift between mother and offspring. Nerve biopsy revealed peculiar endoneurial Schwann cell nuclear accumulations, clusters of concentrically arranged Schwann cells devoid of myelinated axons, and degenerated mitochondria. Conclusions: We emphasize the phenotypic variability of the m.8993T>G MT-ATP6 mutation and the need for caution in predictive counseling in such patients.
C1 [Claeys, Kristl G.] Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany.
   [Claeys, Kristl G.] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.
   [Claeys, Kristl G.] Univ Hosp Leuven, Dept Neurol, Herestr 49, B-3000 Leuven, Belgium.
   [Claeys, Kristl G.] Katholieke Univ Leuven, Univ Leuven, Herestr 49, B-3000 Leuven, Belgium.
   [Abicht, Angela; Kleinle, Stephanie] Ctr Med Genet, Munich, Germany.
   [Haeusler, Martin] Rhein Westfal TH Aachen, Div Neuropediat & Social Pediat, Dept Pediat, Aachen, Germany.
   [Wiesmann, Martin] Rhein Westfal TH Aachen, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany.
   [Schulz, Joerg B.] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.
   [Schulz, Joerg B.] Rhein Westfal TH Aachen, Julich Aachen Res Alliance Translat Brain Med, Aachen, Germany.
   [Horvath, Rita] Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne, Tyne & Wear, England.
   [Weis, Joachim] Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany.
C3 RWTH Aachen University; RWTH Aachen University; KU Leuven; University
   Hospital Leuven; KU Leuven; RWTH Aachen University; RWTH Aachen
   University; RWTH Aachen University; RWTH Aachen University; Newcastle
   University - UK; RWTH Aachen University
RP Claeys, KG (corresponding author), Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany.; Claeys, KG (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.; Claeys, KG (corresponding author), Univ Hosp Leuven, Dept Neurol, Herestr 49, B-3000 Leuven, Belgium.; Claeys, KG (corresponding author), Katholieke Univ Leuven, Univ Leuven, Herestr 49, B-3000 Leuven, Belgium.
EM kristl.claeys@uzleuven.be
RI Wiesmann, Martin/GLU-1902-2022; Horvath, Rita/AAY-7042-2020; Weis,
   Joachim/G-1984-2014; Schulz, Jorg B./D-9786-2012
OI Weis, Joachim/0000-0003-3280-6773; Schulz, Jorg B./0000-0002-8903-0593;
   Horvath, Rita/0000-0002-9841-170X; Claeys, Kristl/0000-0001-9937-443X
FU German Federal Ministry of Education and Research: mitoNET
   [BMBF-01GM0862]; Deutsche Gesellschaft fur Muskelkranke (DGM); Medical
   Research Council (UK) [G1000848]; European Research Council [309548];
   European Research Council (ERC) [309548] Funding Source: European
   Research Council (ERC); MRC [G1000848] Funding Source: UKRI; Newton Fund
   [MR/N027302/1] Funding Source: UKRI
FX This study was supported by grants from the German Federal Ministry of
   Education and Research: mitoNET (BMBF-01GM0862, patient recruitment,
   2013-2015) to K.G.C.; the Deutsche Gesellschaft fur Muskelkranke (DGM)
   to K.G.C. for projects unrelated to this study; the Medical Research
   Council (UK) (G1000848) and the European Research Council (309548) to
   R.H.
CR Bianchi MC, 2003, AM J NEURORADIOL, V24, P1958
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Elbracht M, 2014, CLIN NEUROPATHOL, V33, P335, DOI 10.5414/NP300742
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Hayashi N, 2000, OPHTHALMOLOGY, V107, P1397, DOI 10.1016/S0161-6420(00)00110-X
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   LANGES K, 1985, VIRCHOWS ARCH A, V407, P97, DOI 10.1007/BF00701332
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Mangold S, 2011, MOL GENET METAB, V104, P369, DOI 10.1016/j.ymgme.2011.06.004
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Quijada-Fraile P, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0217-2
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   SCHRODER JM, 1993, BRAIN PATHOL, V3, P177, DOI 10.1111/j.1750-3639.1993.tb00742.x
   SCHRODER JM, 1985, J NEUROL, V232, P83, DOI 10.1007/BF00313906
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
NR 27
TC 18
Z9 19
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD AUG
PY 2016
VL 54
IS 2
BP 328
EP 333
DI 10.1002/mus.25125
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DW2IP
UT WOS:000383466400024
PM 27015314
DA 2024-11-01
ER

PT J
AU Khaghani, F
   Hemmati, M
   Ebrahimi, M
   Salmaninejad, A
AF Khaghani, Faeze
   Hemmati, Mahboube
   Ebrahimi, Masoumeh
   Salmaninejad, Arash
TI Emerging Multi-Omic Approaches to the Molecular Diagnosis of
   Mitochondrial Disease and Available Strategies for Treatment and
   Prevention
SO CURRENT GENOMICS
LA English
DT Review
DE Mitochondrial disease; omics; genomic; transcriptomics; proteomics;
   metabolomics
ID ACTIVATED PROTEIN-KINASE; THERAPEUTIC STRATEGY; QUALITY-CONTROL;
   LEIGH-SYNDROME; GENE-THERAPY; MUTATIONS; BIOGENESIS; DISORDERS;
   MYOPATHY; EXERCISE
AB Mitochondria are semi-autonomous organelles present in several copies within most cells in the human body that are controlled by the precise collaboration of mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) encoding mitochondrial proteins. They play important roles in numerous metabolic pathways, such as the synthesis of adenosine triphosphate (ATP), the predominant energy substrate of the cell generated through oxidative phosphorylation (OXPHOS), intracellular calcium homeostasis, metabolite biosynthesis, aging, cell cycles, and so forth. Previous studies revealed that dysfunction of these multi-functional organelles, which may arise due to mutations in either the nuclear or mitochondrial genome, leads to a diverse group of clinically and genetically heterogeneous disorders. These diseases include neurodegenerative and metabolic disorders as well as cardiac and skeletal myopathies in both adults and newborns. The plethora of phenotypes and defects displayed leads to challenges in the diagnosis and treatment of mitochondrial diseases. In this regard, the related literature proposed several diagnostic options, such as high throughput mitochondrial genomics and omics technologies, as well as numerous therapeutic options, such as pharmacological approaches, manipulating the mitochondrial genome, increasing the mitochondria content of the affected cells, and recently mitochondrial diseases transmission prevention. Therefore, the present article attempted to review the latest advances and challenges in diagnostic and therapeutic options for mitochondrial diseases.
C1 [Khaghani, Faeze] Guilan Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Rasht, Iran.
   [Khaghani, Faeze; Hemmati, Mahboube; Salmaninejad, Arash] Mashhad Univ Med Sci, Med Genet Res Ctr, Fac Med, Mashhad, Iran.
   [Ebrahimi, Masoumeh] Univ Tabriz, Sch Nat Sci, Dept Anim Biol, Tabriz, Iran.
   [Salmaninejad, Arash] Guilan Univ Med Sci, Razi Hosp, Regenerat Med Organ Procurement & Transplantat Mul, Sch Med, Rasht, Iran.
C3 Guilan University of Medical Sciences; Mashhad University of Medical
   Sciences; University of Tabriz; Guilan University of Medical Sciences
RP Salmaninejad, A (corresponding author), Mashhad Univ Med Sci, Med Genet Res Ctr, Fac Med, Mashhad, Iran.
EM Arash.salmany@yahoo.com
RI Salmaninejad, Arash/AAM-5624-2021; Khaghani, Faeze/HLX-4389-2023;
   hemmati, mahboobeh/JSA-2624-2023
OI hemmati, mahboobeh/0009-0007-0586-1431
FU University of Oulu, Finland
FX The authors would like to thank Dr. Alexander Kastaniotis from the
   University of Oulu, Finland, for his humble guidance in writing this
   article.
CR Aboulmaouahib B, 2022, HUM MOL GENET, V31, P3367, DOI 10.1093/hmg/ddab312
   Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776
   Ahmad R, 2021, INT J HEALTH SCI-IJH, V15, P1
   Aicher JK, 2020, GENET MED, V22, P1181, DOI 10.1038/s41436-020-0780-y
   Aldossary AM, 2022, SAUDI PHARM J, V30, P1065, DOI 10.1016/j.jsps.2022.05.011
   Alemany VS, 2024, J THORAC CARDIOV SUR, V167, pe6, DOI 10.1016/j.jtcvs.2023.05.010
   Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   Alshial EE, 2023, LIFE SCI, V334, DOI 10.1016/j.lfs.2023.122257
   Alston CL, 2021, J PATHOL, V254, P430, DOI 10.1002/path.5641
   Alston CL, 2020, AM J HUM GENET, V106, P92, DOI 10.1016/j.ajhg.2019.12.001
   Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012
   Anthony RM, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11051454
   Aryamvally A, 2021, J GENET COUNS, V30, P828, DOI 10.1002/jgc4.1382
   Avula S, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0292-7
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bacman SR, 2020, METHOD CELL BIOL, V155, P441, DOI 10.1016/bs.mcb.2019.12.004
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Barrera-Paez JD, 2022, TRENDS GENET, V38, P869, DOI 10.1016/j.tig.2022.04.011
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Begum AA, 2019, CURR DRUG DELIV, V16, P588, DOI 10.2174/1567201816666190529072914
   Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112
   Berlin S, 2020, IJC HEART VASC, V29, DOI 10.1016/j.ijcha.2020.100573
   Bishop DJ, 2019, PHYSIOLOGY, V34, P56, DOI 10.1152/physiol.00038.2018
   Blanchet L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08035
   Boenzi S, 2018, ESSAYS BIOCHEM, V62, P443, DOI 10.1042/EBC20170111
   Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389
   Borna NN, 2019, NEUROGENETICS, V20, P9, DOI 10.1007/s10048-018-0561-9
   Bourchany A, 2017, EUR J MED GENET, V60, P595, DOI 10.1016/j.ejmg.2017.08.011
   Braun E, 2024, J MED ETHICS, DOI 10.1136/jme-2023-109660
   Chang JC, 2024, MOL THER METH CLIN D, V32, DOI 10.1016/j.omtm.2024.101193
   Chen L, 2022, FRONT CELL DEV BIOL, V10, DOI 10.3389/fcell.2022.871357
   Chen X, 2021, BRIEF BIOINFORM, V22, P485, DOI 10.1093/bib/bbz159
   Chinnery P.F., 2021, Primary mitochondrial disorders overview
   Clark MM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat6177
   Coene KLM, 2018, J INHERIT METAB DIS, V41, P337, DOI 10.1007/s10545-017-0131-6
   CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x
   Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209
   De Paepe B, 2014, PHYTOTHER RES, V28, P312, DOI 10.1002/ptr.4988
   Dillon LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044335
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223
   Emani SM, 2018, TRANSL PEDIATR, V7, P169, DOI 10.21037/tp.2018.02.02
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Falabella M, 2022, NAT REV NEUROL, V18, P689, DOI 10.1038/s41582-022-00715-9
   Fan XY, 2023, AUTOPHAGY, V19, P363, DOI 10.1080/15548627.2022.2077552
   Fan XY, 2022, NAT BIOMED ENG, V6, P339, DOI 10.1038/s41551-022-00881-7
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917
   Ferraro NM, 2020, SCIENCE, V369, P1334, DOI 10.1126/science.aaz5900
   Ferri L, 2016, CLIN GENET, V90, P461, DOI 10.1111/cge.12756
   Filipovska A, 2013, RNA BIOL, V10, P1426, DOI 10.4161/rna.24769
   Fitzsimons PE, 2018, AM J MED GENET A, V176, P1115, DOI 10.1002/ajmg.a.38658
   Frazier AE, 2021, MED-CAMBRIDGE, V2, P49, DOI 10.1016/j.medj.2020.06.004
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Golubitzky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026883
   Gonorazky HD, 2019, AM J HUM GENET, V104, P466, DOI 10.1016/j.ajhg.2019.01.012
   Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Graves PR, 2002, MICROBIOL MOL BIOL R, V66, P39, DOI 10.1128/MMBR.66.1.39-63.2002
   Greenfield A, 2017, NAT BIOTECHNOL, V35, P1059, DOI 10.1038/nbt.3997
   Guarani V, 2014, MOL CELL BIOL, V34, P847, DOI 10.1128/MCB.01551-13
   Guariento A, 2021, J THORAC CARDIOV SUR, V162, P992, DOI 10.1016/j.jtcvs.2020.10.151
   Gusic M, 2021, FEBS LETT, V595, P1132, DOI 10.1002/1873-3468.14068
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   Hendel A, 2015, TRENDS BIOTECHNOL, V33, P132, DOI 10.1016/j.tibtech.2014.12.001
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Hidalgo-Gutiérrez A, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10040520
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Hong S, 2023, CELLS-BASEL, V12, DOI 10.3390/cells12202494
   Hussain SRA, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.627050
   Ibrahim AZ, 2020, MOL GENET METAB REP, V25, DOI 10.1016/j.ymgmr.2020.100645
   Jacoby E, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abo3724
   Janssen MCH, 2019, CLIN PHARMACOL THER, V105, P101, DOI 10.1002/cpt.1197
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jo A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/305716
   Johnson SC, 2016, ONCOTARGET, V7, P44876, DOI 10.18632/oncotarget.10381
   Kastaniotis AJ, 2021, NEUROSCIENTIST, V27, P143, DOI 10.1177/1073858420936162
   Keshavan N, 2024, J INHERIT METAB DIS, V47, P145, DOI 10.1002/jimd.12699
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kim MB, 2018, J MED FOOD, V21, P30, DOI 10.1089/jmf.2017.3989
   Klopstock T, 2013, BRAIN, V136, DOI 10.1093/brain/aws279
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Knottnerus SJG, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165725
   Korchivaia E, 2023, BIOSYSTEMS, V223, DOI 10.1016/j.biosystems.2022.104819
   Kra G, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060905
   Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824
   Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Landsverk ML, 2014, MOLEC GENET METAB RE, V1, P451, DOI 10.1016/j.ymgmr.2014.09.007
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Li MY, 2016, TRENDS GENET, V32, P815, DOI 10.1016/j.tig.2016.10.005
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Macken William L, 2023, Expert Rev Mol Diagn, V23, P797, DOI 10.1080/14737159.2023.2241365
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Maguolo A, 2020, MOL GENET METAB REP, V24, DOI 10.1016/j.ymgmr.2020.100632
   Mai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082459
   Marangon K, 1999, FREE RADICAL BIO MED, V27, P1114, DOI 10.1016/S0891-5849(99)00155-0
   Marini C, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11081231
   McArdle AJ, 2021, ARCH DIS CHILDHOOD-E, V106, P178, DOI 10.1136/archdischild-2019-317434
   McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1
   McCormick EM, 2018, CURR OPIN PEDIATR, V30, P714, DOI 10.1097/MOP.0000000000000686
   Meienberg J, 2016, HUM GENET, V135, P359, DOI 10.1007/s00439-015-1631-9
   Mermigkis C, 2013, SLEEP BREATH, V17, P1129, DOI 10.1007/s11325-013-0816-5
   Mertes C., 2019, DETECTION ABERRANT S, DOI [10.1101/2019.12.18.866830, DOI 10.1101/2019.12.18.866830]
   Mertes C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20573-7
   Miyagawa Y, 2015, P NATL ACAD SCI USA, V112, pE1632, DOI 10.1073/pnas.1423556112
   Mizuguchi T, 2019, J HUM GENET, V64, P359, DOI 10.1038/s10038-019-0569-5
   Mizuguchi Y, 2017, MITOCHONDRION, V34, P43, DOI 10.1016/j.mito.2016.12.006
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Moraes CT, 2014, TRENDS CELL BIOL, V24, P209, DOI 10.1016/j.tcb.2014.02.002
   Mu WB, 2019, GENET MED, V21, P1603, DOI 10.1038/s41436-018-0397-6
   Mutti C., 2022, BIOCHEMIST, V44, P9, DOI [10.1042/bio2022120, DOI 10.1042/BIO2022120]
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Orefice NS, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12080705
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Papatheodorou I, 2020, NUCLEIC ACIDS RES, V48, pD77, DOI 10.1093/nar/gkz947
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019
   Peranteau WH, 2020, MOL DIAGN THER, V24, P135, DOI 10.1007/s40291-020-00445-y
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Potgieter M, 2013, NUTR REV, V71, P180, DOI 10.1111/nure.12011
   Poulton J, 2019, NEUROMUSCULAR DISORD, V29, P725, DOI 10.1016/j.nmd.2019.08.004
   Prakash R, 2021, PROG MOL BIOL TRANSL, V178, P193, DOI 10.1016/bs.pmbts.2020.12.009
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Quinzii CM, 2014, MOL SYNDROMOL, V5, P141, DOI 10.1159/000360490
   Rahman MA, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.925993
   Reisman SA, 2019, DRUG DES DEV THER, V13, P1259, DOI 10.2147/DDDT.S193889
   Rossi A, 2023, ANN SURG, V278, pE1313, DOI 10.1097/SLA.0000000000006005
   Rudolph G, 2013, J NEURO-OPHTHALMOL, V33, P30, DOI 10.1097/WNO.0b013e318272c643
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Sa BK, 2017, J MED FOOD, V20, P1047, DOI 10.1089/jmf.2017.3970
   Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013
   Salehi B, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9080356
   San-Millan I, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12040782
   Sato R, 2018, CLIN GENET, V93, P242, DOI 10.1111/cge.13068
   Sato Y, 2000, MUSCLE NERVE, V23, P1069, DOI 10.1002/1097-4598(200007)23:7<1069::AID-MUS9>3.0.CO;2-0
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schaefer PM, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2200549119
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Schubert MB, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-1297-9
   Sendra L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020551
   Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014
   Sharma H, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04643
   Sharma R, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136055
   Shayota BJ, 2024, NEUROTHERAPEUTICS, V21, DOI 10.1016/j.neurot.2024.e00325
   Shepherd DL, 2017, J MOL CELL CARDIOL, V110, P15, DOI 10.1016/j.yjmcc.2017.06.012
   Shrader WD, 2011, BIOORG MED CHEM LETT, V21, P3693, DOI 10.1016/j.bmcl.2011.04.085
   Simon MT, 2019, MOL GENET METAB, V126, P53, DOI 10.1016/j.ymgme.2018.11.001
   Singh A, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103244
   Smeets HJM, 2013, REPROD BIOMED ONLINE, V27, P599, DOI 10.1016/j.rbmo.2013.08.007
   Smeitink J, 2022, BMC NEUROL, V22, DOI 10.1186/s12883-022-02685-3
   Smuts I, 2013, METABOLOMICS, V9, P379, DOI 10.1007/s11306-012-0455-z
   Somuncu B, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0268391
   Steele H, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911589
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI [10.1152/physrev.00011.2008, 10.15252/embj.201488104]
   Stendel C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000393
   Stenton SL, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102784
   Stenton SL, 2020, J INHERIT METAB DIS, V43, P25, DOI 10.1002/jimd.12130
   Stenton SL, 2018, ESSAYS BIOCHEM, V62, P399, DOI 10.1042/EBC20170110
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tang JX, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113820
   Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Tengan CH, 2017, BBA-BIOENERGETICS, V1858, P573, DOI 10.1016/j.bbabio.2017.02.009
   Thangavelu S., 2010, Indian Journal of Practical Pediatrics, V12, P181
   Thomas RH, 2022, J INHERIT METAB DIS, V45, P796, DOI 10.1002/jimd.12521
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Tiberi J, 2023, BIOMEDICINES, V11, DOI 10.3390/biomedicines11051293
   Tinker RJ, 2021, MOL DIAGN THER, V25, P181, DOI 10.1007/s40291-020-00510-6
   Tort F, 2013, MOL GENET METAB, V110, P73, DOI 10.1016/j.ymgme.2013.04.021
   Valenti D, 2022, J CLIN MED, V11, DOI 10.3390/jcm11144209
   Vaughan RA, 2014, J PHYSIOL BIOCHEM, V70, P271, DOI 10.1007/s13105-013-0301-4
   Vignal C, 2018, OPHTHALMOLOGY, V125, P945, DOI 10.1016/j.ophtha.2017.12.036
   Vigne E, 2003, GENE THER, V10, P153, DOI 10.1038/sj.gt.3301845
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wang G, 2012, BBA-GENE REGUL MECH, V1819, P998, DOI 10.1016/j.bbagrm.2011.10.001
   Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035
   Wang LY, 2018, PHARMACOLOGY, V102, P117, DOI 10.1159/000490418
   Wang X, 2013, HUM MOL GENET, V22, P3976, DOI 10.1093/hmg/ddt251
   Watson E., 2020, J. Transl. Genet. Genomics, V4, P188, DOI [DOI 10.20517/JTGG.2020.31, 10.20517/jtgg.2020.31]
   Whitaker RM, 2016, ANNU REV PHARMACOL, V56, P229, DOI 10.1146/annurev-pharmtox-010715-103155
   Wilmer MJ, 2011, BBA-MOL BASIS DIS, V1812, P643, DOI 10.1016/j.bbadis.2011.02.010
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Wu TH, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-31134-5
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Zhang Y, 2016, BIOCHEM SOC T, V44, P1717, DOI 10.1042/BST20160071C
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
   Zytkovicz TH, 2001, CLIN CHEM, V47, P1945
NR 198
TC 0
Z9 0
U1 3
U2 3
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2029
EI 1875-5488
J9 CURR GENOMICS
JI Curr. Genomics
PY 2024
VL 25
IS 5
BP 358
EP 379
DI 10.2174/0113892029308327240612110334
EA JUN 2024
PG 22
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA F9G0T
UT WOS:001253110400001
PM 39323625
OA Green Published
DA 2024-11-01
ER

PT J
AU Remes, AM
   Majamaa-Voltti, K
   Kärppä, M
   Moilanen, JS
   Uimonen, S
   Helander, H
   Rusanen, H
   Salmela, PI
   Sorri, M
   Hassinen, IE
   Majamaa, K
AF Remes, AM
   Majamaa-Voltti, K
   Kärppä, M
   Moilanen, JS
   Uimonen, S
   Helander, H
   Rusanen, H
   Salmela, PI
   Sorri, M
   Hassinen, IE
   Majamaa, K
TI Prevalence of large-scale mitochondrial DNA deletions in an adult
   Finnish population
SO NEUROLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; TISSUE DISTRIBUTION; EPIDEMIOLOGY;
   MUTATION; A3243G; MTDNA
AB Background: Large-scale mitochondrial DNA ( mtDNA) deletions are associated with clinical conditions such as Kearns - Sayre syndrome and chronic progressive external ophthalmoplegia in adults and Pearson syndrome in children. Reported case series have suggested that deletions are not uncommon in the population, but their prevalence has not been documented. Methods: The authors ascertained patients with clinical features associated with mtDNA deletions in a defined adult population in northern Finland. Buccal epithelial samples were requested from each patient fulfilling the selection criteria, and full-length mtDNA was amplified using the long PCR method. Deletion breakpoints were identified using sequencing. Patients with deletions were examined clinically. Results: The authors identified four patients with single large-scale mtDNA deletions. The prevalence of deletions was calculated to be 1.6/ 100,000 in the adult population in the province of Northern Ostrobothnia ( 0.0 to 3.2; 95% CI). Analysis of incident cases from a neighboring province revealed two patients with deletions and yielded a similar population frequency. Conclusions: The frequency of large- scale mitochondrial DNA deletions is similar among populations, suggesting that there is a constant rate of new deletions.
C1 Univ Oulu, Dept Neurol, FIN-90014 Oulu, Finland.
   Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland.
   Univ Oulu, Dept Otorhinolaryngol, FIN-90014 Oulu, Finland.
   Univ Oulu, Dept Internal Med, FIN-90014 Oulu, Finland.
   Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University
   of Oulu; University of Oulu
RP Univ Oulu, Dept Neurol, POB 5000, FIN-90014 Oulu, Finland.
EM kari.majamaa@oulu.fi
RI Majamaa, Kari/A-1344-2012; Moilanen, Jukka/G-2604-2012
OI Moilanen, Jukka/0000-0002-8041-3205; Helander, Heli/0000-0002-7319-3531;
   Majamaa, Kari/0000-0002-9070-3791
CR Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   DEVRIES DD, 1992, NEUROMUSCULAR DISORD, V2, P185, DOI 10.1016/0960-8966(92)90005-Q
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   GERBITZ KD, 1990, J CLIN CHEM CLIN BIO, V28, P241
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Harrison TJ, 1997, AM J OPHTHALMOL, V124, P217, DOI 10.1016/S0002-9394(14)70787-1
   Hartl D.L., 2000, A Primer of Population Genetics, V3rd ed.
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Lehtonen MS, 2000, EUR J HUM GENET, V8, P315, DOI 10.1038/sj.ejhg.5200455
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Moilanen JS, 2001, EUR J HUM GENET, V9, P59, DOI 10.1038/sj.ejhg.5200550
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Nishino I, 2000, ANN NEUROL, V47, P792
   PONZETTO C, 1990, J NEUROL SCI, V96, P207, DOI 10.1016/0022-510X(90)90133-8
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   REMES AM, 1994, J AM COLL CARDIOL, V23, P935, DOI 10.1016/0735-1097(94)90640-8
   Remes AM, 2003, J NEUROL NEUROSUR PS, V74, P1158, DOI 10.1136/jnnp.74.8.1158
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Simon DK, 1999, ANNU REV MED, V50, P111
   YAMAMOTO M, 1991, NEUROLOGY, V41, P1822, DOI 10.1212/WNL.41.11.1822
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
NR 31
TC 38
Z9 41
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD MAR 22
PY 2005
VL 64
IS 6
BP 976
EP 981
DI 10.1212/01.WNL.0000154518.31302.ED
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 908RH
UT WOS:000227806600009
PM 15781811
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Nesti, C
   Ienco, EC
   Orsucci, D
   Pizzanelli, C
   Chiti, A
   Giorgi, FS
   Meschini, MC
   Fontanini, G
   Santorelli, FM
   Logerfo, A
   Romano, A
   Siciliano, G
   Bonuccelli, U
AF Mancuso, Michelangelo
   Nesti, Claudia
   Ienco, Elena Caldarazzo
   Orsucci, Daniele
   Pizzanelli, Chiara
   Chiti, Alberto
   Giorgi, Filippo S.
   Meschini, Maria Chiara
   Fontanini, Gabriella
   Santorelli, Filippo Maria
   Logerfo, Annalisa
   Romano, Alessandro
   Siciliano, Gabriele
   Bonuccelli, Ubaldo
TI Novel <i>MTCYB</i> Mutation in a Young Patient with Recurrent
   Stroke-like Episodes and Status Epilepticus
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE cytochrome b; genetics MELAS; mitochondrial encephalomyopathy with
   lactic acidosis and stroke-like episodes; mtDNA; stroke
AB The acronym MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) denotes patients with histological, biochemical and/or molecular evidence of mitochondrial disease who experience stroke-like episodes. Here we report on a girl with repeated stroke-like episodes and status epilepticus, who was diagnosed with MELAS due to a novel mitochondrial cytochrome b gene (MTCYB) mutation (m.15092G>A, which predicts p.G116S). Western blotting and in silico analyses suggested that this mutation could affect the stability of complex III. Cytochrome b is the only mtDNA-encoded subunit of respiratory chain complex III. Mutations in MTCYB have been associated with isolated mitochondrial myopathy and exercise intolerance, and rarely with multisystem and/or central nervous system involvement. If the m.3243A>G and other common MELAS mutations are absent in several tissues, MTCYB should be sequenced from muscle in patients with stroke-like episodes, especially if muscle histology does not support a mitochondrial myopathy and lactic acidosis is absent. (c) 2014 Wiley Periodicals, Inc.
C1 [Mancuso, Michelangelo; Ienco, Elena Caldarazzo; Orsucci, Daniele; Pizzanelli, Chiara; Chiti, Alberto; Giorgi, Filippo S.; Logerfo, Annalisa; Siciliano, Gabriele; Bonuccelli, Ubaldo] Univ Pisa, Neurol Clin, Dept Expt & Clin Med, Pisa, Italy.
   [Nesti, Claudia; Meschini, Maria Chiara; Santorelli, Filippo Maria] IRCCS Stella Maris, Mol Med, Pisa, Italy.
   [Fontanini, Gabriella] Univ Pisa, Div Anat Pathol, Dept Surg, Pisa, Italy.
   [Romano, Alessandro] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy.
C3 University of Pisa; IRCCS Fondazione Stella Maris; University of Pisa;
   University of Salento
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Dept Expt & Clin Med, Via Roma 67, Pisa, Italy.
EM mancusomichelangelo@gmail.com
RI Ienco, Elena/K-9142-2016; Mancuso, Michelangelo/K-4170-2016; Giorgi,
   Filippo/AHD-2444-2022; Pizzanelli, Chiara/ABD-1693-2020; Romano,
   Alessandro/AAN-8124-2020; Orsucci, Daniele/AAA-7576-2019; LoGerfo,
   Annalisa/K-6491-2016; Santorelli, Filippo M/ABE-5124-2020; Fontanini,
   Gabriella/O-7636-2015; Nesti, Claudia/K-5866-2016; Siciliano,
   Gabriele/K-7259-2016; Bonuccelli, Ubaldo/K-8681-2016
OI LoGerfo, Annalisa/0000-0001-7825-0649; Meschini, Maria
   Chiara/0009-0006-6291-7852; Santorelli, Filippo M/0000-0002-1359-9062;
   Caldarazzo Ienco, Elena/0000-0003-0134-5062; Fontanini,
   Gabriella/0000-0003-1957-2052; Giorgi, Filippo Sean/0000-0002-2940-8128;
   Nesti, Claudia/0000-0001-5769-8655; Siciliano,
   Gabriele/0000-0002-6142-2384; Bonuccelli, Ubaldo/0000-0001-6218-6312;
   Romano, Alessandro/0000-0003-2766-8847; Orsucci,
   Daniele/0000-0003-4847-7812; PIZZANELLI, CHIARA/0000-0001-5044-8944;
   mancuso, michelangelo/0000-0003-2738-8562
CR De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Emmanuele V, 2013, J CHILD NEUROL, V28, P236, DOI 10.1177/0883073812445787
   Mancuso M, 2009, CURR MOL MED, V9, P1095, DOI 10.2174/156652409789839099
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Massie R, 2010, MUSCLE NERVE, V42, P136, DOI 10.1002/mus.21649
   Souilem S, 2011, J NEUROL SCI, V300, P187, DOI 10.1016/j.jns.2010.08.065
NR 6
TC 4
Z9 4
U1 1
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD NOV
PY 2014
VL 164
IS 11
BP 2922
EP 2925
DI 10.1002/ajmg.a.36725
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA AS3OB
UT WOS:000344187200034
PM 25125337
OA Bronze
DA 2024-11-01
ER

PT J
AU Hassani, A
   Horvath, R
   Chinnery, PF
AF Hassani, Adam
   Horvath, Rita
   Chinnery, Patrick F.
TI Mitochondrial myopathies: developments in treatment
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Article
DE coenzyme Q10; exercise training; mitochondrial myopathies; peroxisome
   proliferator-activated receptor/peroxisome proliferator-activated
   receptor-gamma coactivator-1 alpha pathway; treatment
ID C-OXIDASE DEFICIENCY; RESPIRATORY-CHAIN; L-ARGININE; KETOGENIC DIET;
   COENZYME Q(10); EXERCISE; MUSCLE; MTDNA; ACTIVATION; DEPLETION
AB Purpose of review
   Treatment options for mitochondrial myopathies remain limited despite rapid advances in the understanding of the molecular basis of these conditions. Existing therapies continue to be evaluated and novel treatment strategies are starting to appear on the horizon.
   Recent findings
   Exercise training continues to show promise as a method of improving exercise tolerance and enhancing oxidative capacity. Coenzyme Q10 deficiency appears to be a relatively common finding in mitochondrial disorders and is likely to benefit from exogenous supplementation. Large-scale randomized clinical trials to evaluate these treatment options are now underway and this represents one of the most important developments in recent years. Activation of the peroxisome proliferator-activated receptor/peroxisome proliferator-activated receptor-gamma coactivator-1 alpha pathway has been shown to induce mitochondrial biogenesis leading to a delayed onset of myopathy and prolonged lifespan in mouse models. A ketogenic diet has also been found to induce mitochondrial biogenesis in mice with mitochondrial myopathy.
   Summary
   Therapeutic trials of exercise training and coenzyme Q10 supplementation should continue to be offered to patients with mitochondrial myopathies pending the results of evaluation in randomized clinical trials. Further investigation of peroxisome proliferator-activated receptor/peroxisome proliferator-activated receptor-g coactivator-1a pathway activation, ketogenic diets and other new strategies is required.
C1 [Hassani, Adam; Horvath, Rita; Chinnery, Patrick F.] Newcastle Univ, Inst Human Genet, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Newcastle University - UK
RP Chinnery, PF (corresponding author), Newcastle Univ, Inst Human Genet, Mitochondrial Res Grp, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
RI Horvath, Rita/AAY-7042-2020
OI Chinnery, Patrick/0000-0002-7065-6617; Horvath, Rita/0000-0002-9841-170X
FU Medical Research Council (UK); UK Parkinson's Disease Society;
   Association Francaise contre les Myopathies; UK NIHR Biomedical Research
   Centre for Ageing and Age-related disease; RVI/NGH; Newcastle upon Tyne
   Hospitals NHS Charity [RES0211/7262]; Academy of Medical Sciences, UK
   [BH090164]; MRC [G0601943] Funding Source: UKRI
FX P. F. C. is a Wellcome Trust Senior Fellow in Clinical Science and a UK
   NIHR Senior Investigator who also receives funding from the Medical
   Research Council (UK), the UK Parkinson's Disease Society, the
   Association Francaise contre les Myopathies and the UK NIHR Biomedical
   Research Centre for Ageing and Age-related disease award to the
   Newcastle upon Tyne Foundation Hospitals NHS Trust. R. H. is supported
   by the RVI/NGH and Newcastle upon Tyne Hospitals NHS Charity
   (RES0211/7262) and the Academy of Medical Sciences, UK (BH090164). A. H.
   is on the Academic Foundation Programme at Newcastle upon Tyne Hospitals
   NHS Trust.
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   *COL U, 2009, NCT00887562 NLM COL
   Coman D, 2008, CLIN NUTR, V27, P489, DOI 10.1016/j.clnu.2008.05.007
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   De Vocht C, 2009, J CONTROL RELEASE, V137, P246, DOI 10.1016/j.jconrel.2009.03.020
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   HALTER J, 2010, BONE MARROW TRA 0503
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirata K, 2008, BRAIN DEV-JPN, V30, P238, DOI 10.1016/j.braindev.2007.08.007
   Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092
   Horvath R, 2008, NEUROTHERAPEUTICS, V5, P558, DOI 10.1016/j.nurt.2008.07.002
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Janssen RJRJ, 2009, HUM MOL GENET, V18, P3365, DOI 10.1093/hmg/ddp276
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mancuso M, 2010, J NEUROL, V257, P774, DOI 10.1007/s00415-009-5409-7
   Montero R, 2005, BIOFACTORS, V25, P109, DOI 10.1002/biof.5520250112
   Montero R, 2009, CLIN BIOCHEM, V42, P742, DOI 10.1016/j.clinbiochem.2008.10.027
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   Moran NF, 2008, NEUROLOGY, V71, P686, DOI 10.1212/01.wnl.0000324602.97205.ab
   Moutaouakil F, 2009, REV NEUROL-FRANCE, V165, P482, DOI 10.1016/j.neurol.2008.08.006
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   *NIAMS, 2009, NCT00457314 NLM
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   SCHREUDER LT, 2010, INHERIT METAB D 0505
   Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   *U FL, 2009, NCT00432744 NLM U FL
   Voet NBM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003907.pub3
   Wang YL, 2002, J BIOL CHEM, V277, P31781, DOI 10.1074/jbc.M204279200
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 62
TC 29
Z9 30
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD OCT
PY 2010
VL 23
IS 5
BP 459
EP 465
DI 10.1097/WCO.0b013e32833d1096
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 647LR
UT WOS:000281620500003
PM 20651591
DA 2024-11-01
ER

PT J
AU Machado, P
   Miller, A
   Holton, J
   Hanna, M
AF Machado, Pedro
   Miller, Adrian
   Holton, Janice
   Hanna, Michael
TI SPORADIC INCLUSION BODY MYOSITIS: AN UNSOLVED MYSTERY
SO ACTA REUMATOLOGICA PORTUGUESA
LA English
DT Review
DE Inclusion Body Myositis; Myositis; Myopathy; Inflammation; Degeneration
ID IDIOPATHIC INFLAMMATORY MYOPATHIES; PRECURSOR PROTEIN GENE; MAJOR
   HISTOCOMPATIBILITY COMPLEX; MITOCHONDRIAL-DNA DELETIONS; HEAT-SHOCK
   PROTEINS; ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE;
   MONOCLONAL-ANTIBODY ANALYSIS; AUTOSOMAL-DOMINANT MYOPATHY;
   PAIRED-HELICAL FILAMENTS; RANDOMIZED PILOT TRIAL
AB Sporadic inclusion body myositis (sIBM) is considered to be the most common acquired muscle disease associated with aging. It is a disabling disorder still without effective treatment. sIBM causes weakness and atrophy of the distal and proximal muscles. Involvement of quadriceps and deep finger flexors are clues to early diagnosis. Dysphagia in the course of the disease is common. Muscle biopsy shows chronic myopathic features, lymphocytic infiltration invading non-necrotic fibbers, rimmed vacuoles and accumulation of amyloid-related proteins. It remains uncertain whether sIBM is primarily an immune-mediated inflammatory myopathy or a degenerative myopathy with an associated inflammatory component. This review describes the epidemiology and clinical features of the disease as well as the current genetic and pathogenic concepts and therapeutic approaches. Despite recent clues, in many respects sIBM remains an unsolved mystery.
C1 [Machado, Pedro] Coimbra Univ Hosp, Dept Rheumatol, Coimbra, Portugal.
   [Machado, Pedro; Miller, Adrian; Holton, Janice; Hanna, Michael] Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
C3 Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra
   (CHUC); University of London; University College London; UCL Medical
   School; University College London Hospitals NHS Foundation Trust
RP Machado, P (corresponding author), Hosp Univ Coimbra, Serv Reumatol, P-3000075 Coimbra, Portugal.
EM pedrommcmachado@gmail.com
RI Holton, Janice/F-6831-2011; Hanna, Michael/B-1995-2009; Machado,
   Pedro/C-8621-2013
OI Machado, Pedro/0000-0002-8411-7972; Hanna, Michael/0000-0003-0825-4075
FU EULAR; MRC [G0601943] Funding Source: UKRI
FX P. Machado has been supported by an EULAR scientific training bursary
CR ADAMS EM, 1995, RADIOGRAPHICS, V15, P563, DOI 10.1148/radiographics.15.3.7624563
   ADAMS R. D., 1965, TRANS AMER NEUROL ASS, V90, P213
   Alexanderson H, 2005, CURR OPIN RHEUMATOL, V17, P164, DOI 10.1097/01.bor.0000152665.41493.49
   Alexanderson H, 1999, RHEUMATOLOGY, V38, P608, DOI 10.1093/rheumatology/38.7.608
   Amato AA, 1996, ANN NEUROL, V40, P581, DOI 10.1002/ana.410400407
   Amato AA, 1998, NEUROLOGY, V51, P598, DOI 10.1212/WNL.51.2.598
   Amato AA, 1998, NEUROLOGY, V51, P1646, DOI 10.1212/WNL.51.6.1646
   AMATO AA, 1994, NEUROLOGY, V44, P1516, DOI 10.1212/WNL.44.8.1516
   ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206
   Argov Z, 2003, NEUROLOGY, V60, P1519, DOI 10.1212/01.WNL.0000061617.71839.42
   Argov Z, 1998, MUSCLE NERVE, V21, P1523, DOI 10.1002/(SICI)1097-4598(199811)21:11<1523::AID-MUS22>3.0.CO;2-#
   ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4
   Arnardottir S, 2003, J REHABIL MED, V35, P31, DOI 10.1080/16501970306110
   Askanas V, 2006, NEUROLOGY, V66, pS39, DOI 10.1212/01.wnl.0000192128.13875.1e
   Askanas V, 2005, MICROSC RES TECHNIQ, V67, P114, DOI 10.1002/jemt.20186
   Askanas V, 2003, CURR OPIN RHEUMATOL, V15, P737, DOI 10.1097/00002281-200311000-00009
   Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002
   Askanas V, 1996, ANN NEUROL, V39, P389, DOI 10.1002/ana.410390318
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   ASKANAS V, 1992, NEUROLOGY, V42, P460, DOI 10.1212/WNL.42.2.460
   Askanas V, 2001, J NEUROPATH EXP NEUR, V60, P1
   ASKANAS V, 1994, AM J PATHOL, V144, P177
   ASKANAS V, 1996, NEUROLOGY, V46, P487
   Askanas Valerie, 1993, Current Opinion in Rheumatology, V5, P732
   Badrising UA, 2000, NEUROLOGY, V55, P1385, DOI 10.1212/WNL.55.9.1385
   Badrising UA, 2005, J NEUROL, V252, P1448, DOI 10.1007/s00415-005-0884-y
   Badrising UA, 2004, NEUROLOGY, V63, P2396, DOI 10.1212/01.WNL.0000148588.15052.4C
   Badrising UA, 2002, ANN NEUROL, V51, P369, DOI 10.1002/ana.10121
   Banwell BL, 2000, NEUROLOGY, V54, P1033, DOI 10.1212/WNL.54.5.1033
   BAROHN RJ, 1995, NEUROLOGY, V45, P1302, DOI 10.1212/WNL.45.7.1302
   Barohn RJ, 2006, NEUROLOGY, V66, pS123, DOI 10.1212/01.wnl.0000192258.32408.54
   BEYENBURG S, 1993, CLIN INVESTIGATOR, V71, P351
   BILAK M, 1993, ACTA NEUROPATHOL, V85, P378, DOI 10.1007/BF00334447
   Blume G, 1997, BRAIN, V120, P39, DOI 10.1093/brain/120.1.39
   Bradshaw EM, 2007, J IMMUNOL, V178, P547, DOI 10.4049/jimmunol.178.1.547
   CALABRESE LH, 1987, ARTHRITIS RHEUM-US, V30, P397, DOI 10.1002/art.1780300406
   Cantwell C, 2005, CLIN RADIOL, V60, P261, DOI 10.1016/j.crad.2004.06.027
   Chahin N, 2008, NEUROLOGY, V70, P418, DOI 10.1212/01.wnl.0000277527.69388.fe
   Cherin P, 2002, NEUROLOGY, V58, P326, DOI 10.1212/WNL.58.2.326
   Choi YC, 2000, NEUROLOGY, V54, P65, DOI 10.1212/WNL.54.1.65
   CHOU SM, 1986, HUM PATHOL, V17, P765, DOI 10.1016/S0046-8177(86)80197-6
   CHOU SM, 1967, SCIENCE, V158, P1453, DOI 10.1126/science.158.3807.1453
   Christen U, 2004, CURR OPIN IMMUNOL, V16, P759, DOI 10.1016/j.coi.2004.09.002
   Christensen RA, 2004, J BIOL CHEM, V279, P53524, DOI 10.1074/jbc.M408473200
   Civatte M, 2005, NEUROPATH APPL NEURO, V31, P70, DOI 10.1111/j.1365-2990.2004.00591.x
   COHEN MR, 1989, ARTHRITIS RHEUM-US, V32, P734, DOI 10.1002/anr.1780320611
   Confalonieri P, 2000, J NEUROPATH EXP NEUR, V59, P164, DOI 10.1093/jnen/59.2.164
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   Dalakas MC, 2007, ANN NEUROL, V62, pS60
   Dalakas MC, 2007, ANN NEUROL, V61, P466, DOI 10.1002/ana.21103
   Dalakas MC, 2006, NAT CLIN PRACT NEURO, V2, P437, DOI 10.1038/ncpneuro0261
   Dalakas MC, 1998, ARCH NEUROL-CHICAGO, V55, P1509, DOI 10.1001/archneur.55.12.1509
   Dalakas MC, 2006, NEUROMUSCULAR DISORD, V16, P223, DOI 10.1016/j.nmd.2005.12.008
   Dalakas MC, 2004, CURR OPIN NEUROL, V17, P561, DOI 10.1097/00019052-200410000-00006
   Dalakas MC, 2001, NEUROLOGY, V56, P323, DOI 10.1212/WNL.56.3.323
   Dalakas MC, 1997, NEUROLOGY, V48, P712, DOI 10.1212/WNL.48.3.712
   Darin N, 1998, ANN NEUROL, V44, P242, DOI 10.1002/ana.410440215
   DARROW DH, 1992, ARCH OTOLARYNGOL, V118, P313
   De Bleecker JL, 1999, NEUROMUSCULAR DISORD, V9, P239, DOI 10.1016/S0960-8966(98)00126-6
   De Bleecker JL, 2002, NEUROLOGY, V58, P1779, DOI 10.1212/WNL.58.12.1779
   De Paepe B, 2008, FRONT BIOSCI-LANDMRK, V13, P2548, DOI 10.2741/2866
   De Paepe B, 2007, ANN NY ACAD SCI, V1109, P441, DOI 10.1196/annals.1398.050
   DeBleecker JL, 1996, J NEUROPATH EXP NEUR, V55, P563, DOI 10.1097/00005072-199605000-00009
   Dehmel T, 2007, NEUROBIOL DIS, V25, P665, DOI 10.1016/j.nbd.2006.11.008
   Dion E, 2004, REV MED INTERNE, V25, P435, DOI 10.1016/j.revmed.2004.01.021
   Dion E, 2002, J RHEUMATOL, V29, P1897
   Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718
   ENGEL AG, 1984, ANN NEUROL, V16, P209, DOI 10.1002/ana.410160207
   Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162
   Felice KJ, 2001, MEDICINE, V80, P320, DOI 10.1097/00005792-200109000-00006
   Felice KJ, 1998, MUSCLE NERVE, V21, P659, DOI 10.1002/(SICI)1097-4598(199805)21:5<659::AID-MUS17>3.0.CO;2-Q
   Ferrer I, 2004, J NEUROPATH EXP NEUR, V63, P484, DOI 10.1093/jnen/63.5.484
   FIGARELLABRANGER D, 1992, REV NEUROL, V148, P281
   Fox SA, 1996, MUSCLE NERVE, V19, P23, DOI 10.1002/(SICI)1097-4598(199601)19:1<23::AID-MUS4>3.3.CO;2-Y
   Fukuchi K, 1998, AM J PATHOL, V153, P1687, DOI 10.1016/S0002-9440(10)65682-9
   Garcia J, 2000, SKELETAL RADIOL, V29, P425, DOI 10.1007/s002560000238
   Garlepp MJ, 1996, ANN NEUROL, V40, P826, DOI 10.1002/ana.410400603
   GARLEPP MJ, 1994, CLIN EXP IMMUNOL, V98, P40
   GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606
   Gossrau G, 2004, EUR NEUROL, V51, P215, DOI 10.1159/000078488
   Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20
   Greenberg SA, 2007, MUSCLE NERVE, V35, P17, DOI 10.1002/mus.20649
   Griggs RC, 2006, NEUROLOGY, V66, pS30, DOI 10.1212/01.wnl.0000192262.29924.9e
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   GRILLI M, 1995, J BIOL CHEM, V270, P26774, DOI 10.1074/jbc.270.45.26774
   Grilli M, 1996, J BIOL CHEM, V271, P15002, DOI 10.1074/jbc.271.25.15002
   HEWER E, 2008, PATHOL RES PRACT
   Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313
   HOPKINSON ND, 1993, ANN RHEUM DIS, V52, P147, DOI 10.1136/ard.52.2.147
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   Jaworska-Wilczynska M, 2002, NEUROLOGY, V58, P438, DOI 10.1212/WNL.58.3.438
   Jin LW, 1998, AM J PATHOL, V153, P1679, DOI 10.1016/S0002-9440(10)65681-7
   JOFFE MM, 1993, AM J MED, V94, P379, DOI 10.1016/0002-9343(93)90148-I
   Johnson LG., 2007, Clin Neuromuscul Dis, V8, P187
   Kalmar B, 2003, EXP NEUROL, V184, P636, DOI 10.1016/S0014-4886(03)00343-1
   Kalmar B, 2002, EXP NEUROL, V176, P87, DOI 10.1006/exnr.2002.7945
   KARPATI G, 1988, ANN NEUROL, V23, P64, DOI 10.1002/ana.410230111
   Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372
   Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021
   Kieseier BC, 2001, BRAIN, V124, P341, DOI 10.1093/brain/124.2.341
   Kitazawa M., 2008, ANN NEUROL
   Kitazawa M, 2006, AM J PATHOL, V168, P1986, DOI 10.2353/ajpath.2006.051232
   Koffman BM, 1998, MUSCLE NERVE, V21, P115, DOI 10.1002/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.3.CO;2-G
   Koffman BM, 1998, J NEUROIMMUNOL, V84, P139, DOI 10.1016/S0165-5728(97)00245-2
   Kok CC, 1999, IMMUNOGENETICS, V49, P508, DOI 10.1007/s002510050528
   Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256
   KULA R W, 1989, Current Opinion in Rheumatology, V1, P460
   Lampe J, 2001, NEUROLOGY, V57, P368
   Lampe J, 1999, LANCET, V353, P465, DOI 10.1016/S0140-6736(98)05208-8
   Lampe JB, 2003, J NEUROL, V250, P1313, DOI 10.1007/s00415-003-0204-3
   LEFF RL, 1993, MEDICINE, V72, P225, DOI 10.1097/00005792-199307000-00002
   LEFF RL, 1992, LANCET, V339, P1192, DOI 10.1016/0140-6736(92)91134-T
   Lindberg C, 2003, NEUROLOGY, V61, P260, DOI 10.1212/01.WNL.0000071852.27182.C7
   LINDBERG C, 1994, ACTA NEUROL SCAND, V89, P123
   Liu LWC, 2004, CAN J GASTROENTEROL, V18, P397, DOI 10.1155/2004/360537
   Lodi R, 1998, BRAIN, V121, P2119, DOI 10.1093/brain/121.11.2119
   LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727
   LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002
   Lu DC, 2003, ANN NEUROL, V54, P781, DOI 10.1002/ana.10761
   Lundberg I, 1997, ARTHRITIS RHEUM, V40, P865, DOI 10.1002/art.1780400514
   Lünemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115
   Martinsson T, 1999, AM J HUM GENET, V64, P1420, DOI 10.1086/302375
   Martinsson T, 2000, P NATL ACAD SCI USA, V97, P14614, DOI 10.1073/pnas.250289597
   MEDSGER TA, 1970, AM J MED, V48, P715, DOI 10.1016/S0002-9343(70)80006-7
   MENDELL JR, 1991, ARCH NEUROL-CHICAGO, V48, P1229, DOI 10.1001/archneur.1991.00530240033013
   MHIRI C, 1990, NEUROPATH APPL NEURO, V16, P333, DOI 10.1111/j.1365-2990.1990.tb01267.x
   MICHAELIS D, 1993, AM J PATHOL, V143, P1142
   Mirabella M, 1996, ANN NEUROL, V40, P864, DOI 10.1002/ana.410400608
   Mowzoon N, 2001, J NEUROL SCI, V185, P119, DOI 10.1016/S0022-510X(01)00478-6
   Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587
   Müntzing K, 2003, SCAND J IMMUNOL, V58, P195, DOI 10.1046/j.1365-3083.2003.01251.x
   Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103
   Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209
   Naumann M, 1996, J NEUROL, V243, P126, DOI 10.1007/BF02444002
   Needham M, 2008, NEUROMUSCULAR DISORD, V18, P6, DOI 10.1016/j.nmd.2007.11.001
   Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0
   Needham M, 2008, J CLIN NEUROSCI, V15, P1350, DOI 10.1016/j.jocn.2008.01.011
   Nirmalananthan N, 2004, CURR OPIN RHEUMATOL, V16, P684, DOI 10.1097/01.bor.0000143441.27065.bc
   Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6
   NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8
   O'Hanlon TP, 2005, MEDICINE, V84, P338, DOI 10.1097/01.md.0000189818.63141.8c
   ODDIS CV, 1990, J RHEUMATOL, V17, P1329
   Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Oldfors A, 2005, CURR OPIN NEUROL, V18, P497, DOI 10.1097/01.wco.0000183115.14175.29
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Orth M, 2000, NEUROLOGY, V55, P1235, DOI 10.1212/WNL.55.8.1235
   Ozden S, 2004, J VIROL, V78, P10320, DOI 10.1128/JVI.78.19.10320-10327.2004
   Paciello O, 2006, Acta Myol, V25, P13
   Page G, 2004, ARTHRITIS RHEUM, V50, P199, DOI 10.1002/art.11428
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Park J H, 2001, Curr Rheumatol Rep, V3, P334, DOI 10.1007/s11926-001-0038-x
   Peng A, 2000, NEUROLOGY, V55, P296, DOI 10.1212/WNL.55.2.296
   Phillips BA, 2000, MUSCLE NERVE, V23, P970, DOI 10.1002/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I
   Phillips BA, 2001, MUSCLE NERVE, V24, P1526, DOI 10.1002/mus.1178
   Prayson RA, 2001, ARCH PATHOL LAB MED, V125, P1326
   Price P, 2004, TISSUE ANTIGENS, V64, P575, DOI 10.1111/j.1399-0039.2004.00310.x
   Querfurth HW, 2001, MOL CELL NEUROSCI, V17, P793, DOI 10.1006/mcne.2001.0972
   Raju R, 2005, BRAIN, V128, P1887, DOI 10.1093/brain/awh518
   Raju R, 2003, J NEUROIMMUNOL, V141, P125, DOI 10.1016/S0165-5728(03)00218-2
   Ranque-Francois B, 2005, ANN RHEUM DIS, V64, P634, DOI 10.1136/ard.2004.025494
   Rider LG, 1998, ARTHRITIS RHEUM, V41, P710, DOI 10.1002/1529-0131(199804)41:4<710::AID-ART19>3.0.CO;2-K
   RINGEL SP, 1987, ARCH NEUROL-CHICAGO, V44, P1154, DOI 10.1001/archneur.1987.00520230042011
   Rose MR, 2001, NEUROLOGY, V57, P548, DOI 10.1212/WNL.57.3.548
   Rutkove SB, 2002, NEUROLOGY, V58, P1081, DOI 10.1212/WNL.58.7.1081
   SADEH M, 1993, BRAIN, V116, P217, DOI 10.1093/brain/116.1.217
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   SARKOZI E, 1994, AM J PATHOL, V145, P1280
   SARKOZI E, 1993, NEUROREPORT, V4, P815, DOI 10.1097/00001756-199306000-00055
   SAYERS ME, 1992, J RHEUMATOL, V19, P1385
   Schmidt J, 2004, BRAIN, V127, P1182, DOI 10.1093/brain/awh148
   Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053
   Schoser BGH, 2002, ACTA NEUROL SCAND, V105, P309, DOI 10.1034/j.1600-0404.2002.1o104.x
   SCHWEITZER ME, 1995, AM J ROENTGENOL, V165, P1469, DOI 10.2214/ajr.165.6.7484589
   Scott AP, 2006, NEUROMUSCULAR DISORD, V16, P311, DOI 10.1016/j.nmd.2006.02.002
   Sekul EA, 1997, NEUROLOGY, V48, P863, DOI 10.1212/WNL.48.4.863
   Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052
   Semino-Mora C, 1998, HUM PATHOL, V29, P1128, DOI 10.1016/S0046-8177(98)90425-7
   Shamim EA, 2002, ARTHRITIS RHEUM, V46, P1885, DOI 10.1002/art.10358
   SHIFTMAN A, 2008, NEUROBIOL AGING
   Sivakumar K, 1997, BRAIN, V120, P653, DOI 10.1093/brain/120.4.653
   SIVAKUMAR K, 1995, ANN NEUROL, V38, P267, DOI 10.1002/ana.410380222
   Sivakumar K, 1996, NEUROLOGY, V47, P977, DOI 10.1212/WNL.47.4.977
   SOUEIDAN SA, 1993, NEUROLOGY, V43, P876, DOI 10.1212/WNL.43.5.876
   Spector SA, 1997, MUSCLE NERVE, V20, P1242, DOI 10.1002/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.3.CO;2-X
   Sugarman MC, 2006, NEUROBIOL AGING, V27, P423, DOI 10.1016/j.neurobiolaging.2005.02.011
   SUNOHARA N, 1989, BRAIN, V112, P65, DOI 10.1093/brain/112.1.65
   Tateyama M, 2003, INTERNAL MED, V42, P1035, DOI 10.2169/internalmedicine.42.1035
   Tawil R, 2004, NEUROLOGY, V63, P718
   Tawil R, 2002, CURR OPIN RHEUMATOL, V14, P653, DOI 10.1097/00002281-200211000-00004
   Tawil R, 2001, NEUROLOGY, V57, P1566
   TEMIZ P, 2008, J NEUROL SCI
   TERRACCIANO C, 2008, FREE RADIC BIOL MED
   Tews DS, 1996, J NEUROPATH EXP NEUR, V55, P342, DOI 10.1097/00005072-199603000-00009
   Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102
   Tournadre Anne, 2007, Curr Rheumatol Rep, V9, P286, DOI 10.1007/s11926-007-0046-6
   Tsuruta Y, 2002, ACTA NEUROPATHOL, V103, P59, DOI 10.1007/s004010100428
   Tucker W S Jr, 1982, Trans Assoc Am Physicians, V95, P126
   Udd B, 2001, CURR OPIN NEUROL, V14, P561, DOI 10.1097/00019052-200110000-00003
   van der Meulen MFG, 1998, J NEUROL NEUROSUR PS, V64, P396, DOI 10.1136/jnnp.64.3.396
   van der Meulen MFG, 2001, NEUROMUSCULAR DISORD, V11, P447, DOI 10.1016/S0960-8966(00)00219-4
   Voermans NC, 2004, NEUROLOGY, V63, P2191, DOI 10.1212/01.WNL.0000145834.17020.86
   Walter MC, 2000, J NEUROL, V247, P22, DOI 10.1007/s004150050005
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334
   Wiendl H, 2005, TRENDS IMMUNOL, V26, P373, DOI 10.1016/j.it.2005.05.003
   Wiesinger GF, 1998, BRIT J RHEUMATOL, V37, P196
   Wilson FC, 2008, J RHEUMATOL, V35, P445
   Yakushiji Y, 2004, NEUROLOGY, V63, P587, DOI 10.1212/01.WNL.0000133411.10574.BA
   YOOD RA, 1985, J RHEUMATOL, V12, P568
   Yosipovitch G, 1999, ARCH DERMATOL, V135, P721, DOI 10.1001/archderm.135.6.721
   YUNIS EJ, 1971, LAB INVEST, V25, P240
NR 213
TC 11
Z9 11
U1 0
U2 5
PU PUBLISAUDE-EDICOES MEDICAS LDA
PI ALGES
PA ALAMEDA ANTONIO SERGIO 22, 4 B EDIF AMADEO SOUZA-CARDOSO, ALGES,
   1495-132, PORTUGAL
SN 0303-464X
J9 ACTA REUMATOL PORT
JI Acta Reumatol. Port.
PD APR-JUN
PY 2009
VL 34
IS 2
BP 161
EP 182
PG 22
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA 447VL
UT WOS:000266220000002
PM 19474772
DA 2024-11-01
ER

PT J
AU Compton, AG
   Troedson, C
   Wilson, M
   Procopis, PG
   Li, FY
   Brundage, EK
   Yamazaki, T
   Thorburn, DR
   Wong, LJC
AF Compton, Alison G.
   Troedson, Christopher
   Wilson, Meredith
   Procopis, Peter G.
   Li, Fang-Yuan
   Brundage, Ellen K.
   Yamazaki, Taro
   Thorburn, David R.
   Wong, Lee-Jun C.
TI Application of oligonucleotide array CGH in the detection of a large
   intragenic deletion in <i>POLG</i> associated with Alpers Syndrome
SO MITOCHONDRION
LA English
DT Article
DE POLG; Array CGH; Intragenic deletion; Alpers syndrome
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COMPARATIVE GENOMIC HYBRIDIZATION;
   MITOCHONDRIAL-DNA DEPLETION; POLYMERASE-GAMMA; MUTATIONS
AB Mutations in the polymerase gamma (POLG) gene are among the most common causes of mitochondrial disease and more than 160 POLG mutations have been reported. However, a large proportion of patients suspected of having POLG mutations only have one (heterozygous) definitive pathogenic mutation identified. Using oligonucleotide array CGH, we identified a compound heterozygous large intragenic deletion encompassing exons 15-21 of this gene in a child with Alpers syndrome due to mtDNA depletion. This is the first large POLG deletion reported and the findings show the clinical utility of using array CGH in cases where a single heterozygous mutation has been identified in POLG. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Compton, Alison G.; Yamazaki, Taro; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
   [Compton, Alison G.; Yamazaki, Taro; Thorburn, David R.] Royal Childrens Hosp, Genet Hlth Serv Victoria, Parkville, Vic 3052, Australia.
   [Troedson, Christopher; Procopis, Peter G.] Childrens Hosp Westmead, TY Nelson Dept Neurol, Sydney, NSW, Australia.
   [Wilson, Meredith] Univ Sydney, Western Sydney Genet Program, Childrens Hosp Westmead, Sydney, NSW 2006, Australia.
   [Wilson, Meredith] Univ Sydney, Discipline Paediat, Sydney, NSW 2006, Australia.
   [Wilson, Meredith] Univ Sydney, Discipline Child Hlth & Genet Med, Sydney, NSW 2006, Australia.
   [Li, Fang-Yuan; Brundage, Ellen K.; Wong, Lee-Jun C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Yamazaki, Taro] Saitama Med Univ, Dept Pediat, Sch Med, Saitama, Japan.
   [Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
C3 Murdoch Children's Research Institute; Royal Children's Hospital
   Melbourne; Royal Children's Hospital Melbourne; NSW Health; The
   Children's Hospital at Westmead; University of Sydney; University of
   Sydney; NSW Health; The Children's Hospital at Westmead; University of
   Sydney; University of Sydney; Baylor College of Medicine; Saitama
   Medical University; University of Melbourne
RP Thorburn, DR (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.
EM david.thorburn@mcri.edu.au
RI Compton, Alison/KOT-7713-2024; Thorburn, David/G-6266-2013
OI thorburn, david/0000-0002-7725-9470; Compton, Alison/0000-0002-2725-7055
FU Australian National Health and Medical Research Council
FX This work was supported by grants and a Principal Research Fellowship
   (DRT) from the Australian National Health and Medical Research Council.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Lamandé SR, 1998, HUM MOL GENET, V7, P981, DOI 10.1093/hmg/7.6.981
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 13
TC 9
Z9 9
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN
PY 2011
VL 11
IS 1
BP 104
EP 107
DI 10.1016/j.mito.2010.07.012
PG 4
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 709OP
UT WOS:000286450300015
PM 20708716
DA 2024-11-01
ER

PT J
AU Ahuja, AS
AF Ahuja, Abhimanyu S.
TI Understanding mitochondrial myopathies: a review
SO PEERJ
LA English
DT Review
DE Genetic mutations; Pathology; Treatment
ID MANIFESTATIONS; CELLS
AB Mitochondria are small, energy-producing structures vital to the energy needs of the body. Genetic mutations cause mitochondria to fail to produce the energy needed by cells and organs which can cause severe disease and death. These genetic mutations are likely to be in the mitochondrial DNA (mtDNA), or possibly in the nuclear DNA (nDNA). The goal of this review is to assess the current understanding of mitochondrial diseases. This review focuses on the pathology, causes, risk factors, symptoms, prevalence data, symptomatic treatments, and new research aimed at possible preventions and/or treatments of mitochondrial diseases. Mitochondrial myopathies are mitochondrial diseases that cause prominent muscular symptoms such as muscle weakness and usually present with a multitude of symptoms and can affect virtually all organ systems. There is no cure for these diseases as of today. Treatment is generally supportive and emphasizes symptom management. Mitochondrial diseases occur infrequently and hence research funding levels tend to be low in comparison with more common diseases. On the positive side, quite a few genetic defects responsible for mitochondrial diseases have been identified, which are in turn being used to investigate potential treatments. Speech therapy, physical therapy, and respiratory therapy have been used in mitochondrial diseases with variable results. These therapies are not curative and at best help with maintaining a patients current abilities to move and function.
C1 [Ahuja, Abhimanyu S.] Florida Atlantic Univ, Wilkes Honors Coll, Jupiter, FL 33458 USA.
C3 State University System of Florida; Florida Atlantic University
RP Ahuja, AS (corresponding author), Florida Atlantic Univ, Wilkes Honors Coll, Jupiter, FL 33458 USA.
EM aahuja2016@fau.edu
OI Ahuja, Abhimanyu/0000-0003-4333-9189
CR Agamanolis D., 2017, NEUROPATHOLOGY
   Alberts B., 2007, MOL BIOL CELL
   Australian Mitochondrial Disease Foundation (AMDF), 2017, MIT DIS INF
   Bartsakoulia M, 2018, HUM MOL GENET, V27, P1186, DOI 10.1093/hmg/ddy033
   Berridge MV, 2016, CURR OPIN GENET DEV, V38, P75, DOI 10.1016/j.gde.2016.04.003
   Clarke C, 2016, NEUROLOGY QUEEN SQUA, DOI [10.1002/9781118186160, DOI 10.1002/9781118186160]
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Hirano M., GeneReviews()
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413
   Lemonick Michael D, 2006, Time, V168, P58
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Martikainen M, 2012, MITOCHONDRIAL DIS SW
   Millhouse-Flourie T, 2016, 101 MITO UN MIT DIS
   Millhouse-Flourie T, 2016, BENEFITS SUPPLEMENTA
   MitoAction, MIT DISMIT FAO MITOA
   Muscular Dystrophy Association (MDA), 2009, PROGR MIT MYOP
   Muscular Dystrophy Association (MDA), 2009, MDAS SEARCH TREATM C
   Muscular Dystrophy Association (MDA), 2018, MIT MYOP CAUS INH
   Muscular Dystrophy Association (MDA), 2018, MIT MYOP SIGNS SYMPT
   Muscular Dystrophy Association (MDA), 2009, FACTS GEN NEUR DIS
   Muscular Dystrophy Association (MDA), 2009, AR MIT DIS TREAT
   National Institute of Neurological Disorders and Stroke (NINDS), 2018, NINDS MIT MYOP INF P
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Powledge T., 2014, 3 PARENT BABY DEBATE
   Scarpelli M, 2018, NEUROMUSCULAR DISORD, V28, P137, DOI 10.1016/j.nmd.2017.10.006
   Science 2.0, 2015, MIT DIS 2500 UK WOM
   Shrikhande DY, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-62
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00107
   United Mitochondrial Disease Foundation, 2017, UND MIT DIS
   United Mitochondrial Disease Foundation, 2017, SUPP THER
   United Mitochondrial Disease Foundation, 2013, EPI73 UN MIT DIS FDN
   Vandana VP, 2015, J PEDIATR NEUROSCI, V10, P31, DOI 10.4103/1817-1745.154326
NR 35
TC 14
Z9 15
U1 0
U2 4
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD MAY 21
PY 2018
VL 6
AR e4790
DI 10.7717/peerj.4790
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GI2VG
UT WOS:000434229400005
PM 29844960
OA gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Gharti, P
   Fletcher, JF
   Chapman, KE
AF Gharti, Prashamsa
   Fletcher, Jessica F.
   Chapman, Katherine E.
TI Evaluation of endpoints for the study and diagnosis of mitochondrial
   toxicity and disease: a narrative review
SO MUTAGENESIS
LA English
DT Review
ID OXIDATIVE DAMAGE; ATP SYNTHESIS; DNA; LYMPHOBLAST; DISORDERS; BIOMARKER;
   NUCLEAR; FGF-21; RESPIRATION; MANAGEMENT
AB Mitochondrial DNA mutation and toxicity have been linked to several inherited and acquired diseases; however, these are challenging to diagnose and characterize due to clinical and genetic heterogeneity. This review investigates current techniques for the analysis of mitochondrial perturbations, and novel, emerging endpoints for routine application within the clinical setting. Particular focus is given to the biochemistry of the mitochondria influencing each endpoint and the relation of these to toxicity. Current approaches such as the use of metabolic markers (e.g. lactate production), and muscle biopsies to measure mitochondrial proteins were found to lack specificity. Newly emerging identified endpoints were: fibroblast growth factor-21, glucose uptake, mitochondrial membrane potential, mitochondrial morphology, mtDNA heteroplasmy, and mutation of mtDNA and nuclear DNA. Owed to the advancement in genetic analysis techniques, it is suggested by this review that genotypic endpoints of mtDNA mutation and heteroplasmy show particular promise as indicators of mitochondrial disease. It is, however, acknowledged that any single endpoint in isolation offers limited information; therefore, it is recommended that analysis of several endpoints simultaneously will offer the greatest benefit in terms of disease diagnosis and study. It is hoped that this review further highlights the need for advancement in understanding mitochondrial disease.
C1 [Gharti, Prashamsa; Fletcher, Jessica F.; Chapman, Katherine E.] Swansea Univ, Med Sch, Swansea SA2 8PP, Wales.
   [Chapman, Katherine E.] Swansea Univ, Med Sch, Inst Life Sci 1, Swansea SA2 8PP, Wales.
C3 Swansea University; Swansea University
RP Chapman, KE (corresponding author), Swansea Univ, Med Sch, Inst Life Sci 1, Swansea SA2 8PP, Wales.
EM K.E.Chapman@swansea.ac.uk
RI Chapman, Katherine/KWU-8899-2024
OI Chapman, Katherine/0000-0001-6668-0705
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Almannai M, 2020, MOL GENET METAB, V131, P1, DOI 10.1016/j.ymgme.2020.10.002
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Battelli MG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3527579
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   Cai CY, 2019, MODERN PATHOL, V32, P462, DOI 10.1038/s41379-018-0164-x
   Corpas FJ, 2001, TRENDS PLANT SCI, V6, P145, DOI 10.1016/S1360-1385(01)01898-2
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Fernández-Vizarra E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00134
   Finsterer J, 2018, J CLIN MED, V7, DOI 10.3390/jcm7020016
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Konno T, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020233
   Kuna L, 2018, CURR DRUG METAB, V19, P830, DOI 10.2174/1389200219666180523095355
   Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lu YW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00003
   Maeda R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67686-z
   Mayorov Vladimir I., 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-22
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Missiroli S, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102943
   Mitrofanov KY, 2018, RUSS J GENET+, V54, P121, DOI 10.1134/S1022795417100064
   Moindijie H., 2021, CANCERS, V13, P1
   Morava E, 2015, J INHERIT METAB DIS, V38, P387, DOI 10.1007/s10545-015-9852-6
   Morovat A, 2017, J CLIN MED, V6, DOI 10.3390/jcm6080080
   Muraresku CC, 2018, CURR GENET MED REP, V6, P62, DOI 10.1007/s40142-018-0138-9
   Naini A, 2020, METHOD CELL BIOL, V155, P383, DOI 10.1016/bs.mcb.2019.11.009
   Navaratnarajah T, 2021, INT J BIOCHEM CELL B, V134, DOI 10.1016/j.biocel.2021.105951
   O'Hara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Perez-Albert Paula, 2018, JIMD Rep, V42, P61, DOI 10.1007/8904_2017_78
   Pino RM, 2021, ANESTHESIOLOGY, V134, P637, DOI 10.1097/ALN.0000000000003655
   Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094
   Rana P, 2019, CHEM RES TOXICOL, V32, P156, DOI 10.1021/acs.chemrestox.8b00246
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Sabouny R, 2020, TRENDS BIOCHEM SCI, V45, P564, DOI 10.1016/j.tibs.2020.03.009
   Salehi MH, 2013, MOL BIOL REP, V40, P6495, DOI 10.1007/s11033-013-2767-0
   Singh S, 2017, INFLAMMOPHARMACOLOGY, V25, P383, DOI 10.1007/s10787-017-0347-y
   Sofronova JK, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1031, DOI 10.1134/S0006297916100011
   Steele HE, 2017, BRAIN, V140, P2530, DOI 10.1093/brain/awx168
   Stenton SL, 2018, ESSAYS BIOCHEM, V62, P399, DOI 10.1042/EBC20170110
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tsygankova PG, 2019, J INHERIT METAB DIS, V42, P918, DOI 10.1002/jimd.12142
   Van Bergen NJ, 2014, MITOCHONDRION, V15, P24, DOI 10.1016/j.mito.2014.03.003
   Van Bergen NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021347
   Viale A, 2015, CANCER RES, V75, P3687, DOI 10.1158/0008-5472.CAN-15-0491
   White EJ., 2017, BIORXIV, V222109
   Xie LL, 2018, CANCER SCI, V109, P3686, DOI 10.1111/cas.13830
   Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274
   Zhang BB, 2015, FAM CANCER, V14, P19, DOI 10.1007/s10689-014-9757-9
   Zhao M, 2021, THERANOSTICS, V11, P1845, DOI 10.7150/thno.50905
   Zhu CL, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-03739-0, 10.1038/s41598-017-03603-1]
   Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011
   Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009
NR 62
TC 1
Z9 1
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0267-8357
EI 1464-3804
J9 MUTAGENESIS
JI Mutagenesis
PD JUN 20
PY 2023
VL 38
IS 3
BP 132
EP 138
DI 10.1093/mutage/gead010
EA MAY 2023
PG 7
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA J2OJ3
UT WOS:000992061500001
PM 37144479
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Du, AL
   Naviaux, RK
   Thuy, L
   Xu, CF
   Sommer, SS
   Haas, RH
AF Du, Ailian
   Naviaux, Robert K.
   Thuy Le
   Xu, Congfeng
   Sommer, Steven S.
   Haas, Richard H.
TI Fibroblast immuno-diagnosis of cytochrome oxidase (COX) deficiency in
   mitochondrial disease
SO MITOCHONDRION
LA English
DT Article
DE Fibroblast; Immunocytochemistry; Cytochrome oxidase (COX); Quantitative
   confocal microscopy; mtDNA heteroplasmy; SURF1
ID EMBRYONIC STEM-CELLS; C-OXIDASE; SKELETAL-MUSCLE; GENE-MUTATIONS;
   SOMATIC-CELLS; LEIGH-DISEASE; DNA; DELETIONS; FIBERS; SURF1
AB We studied cytochrome c oxidase (COX) expression patterns in nuclear and mtDNA gene defects. Using quantitative immunocytochemical assay for COX. heteroplasmic staining was seen in MELAS patients with mtDNA mutations but similar staining variability was seen in control cell lines and nuclear gene defects. All fibroblast lines showed a wide variability in cell-to-cell COX I staining intensity. All 8 patient fibroblast lines had reduced COX staining on immunocytochemistry. In 6 lines reduced protein amount was seen on Western blotting and 7 had low COX activity. This study demonstrates that nuclear gene defects can produce a heteroplasmic appearance on immunocytochemistry. (C) 2010 Published by Elsevier B.V. and Mitochondria Research Society.
C1 [Du, Ailian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China.
   [Du, Ailian; Naviaux, Robert K.; Thuy Le; Haas, Richard H.] Univ Calif San Diego, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA.
   [Xu, Congfeng] Sanford Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.
   [Sommer, Steven S.] MEDomics, Azusa, CA 91702 USA.
   [Haas, Richard H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.
   [Haas, Richard H.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.
C3 Zhejiang University; University of California System; University of
   California San Diego; Sanford Burnham Prebys Medical Discovery
   Institute; University of California System; University of California San
   Diego; University of California System; University of California San
   Diego
RP Haas, RH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.
EM rhaas@ucsd.edu
RI Xu, Congfeng/E-4806-2013
OI Xu, Congfeng/0000-0002-8009-4865
FU Autism Speaks [5668]
FX Autism Speaks, Grant # 5668.
CR Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Capaldi RA, 2004, MITOCHONDRION, V4, P417, DOI 10.1016/j.mito.2004.07.006
   Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199
   Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Gourley PL, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799198
   Hanson BJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1281, DOI 10.1177/002215540205001001
   HATEFI Y, 1961, ARCH BIOCHEM BIOPHYS, V94, P148, DOI 10.1016/0003-9861(61)90022-4
   Hong Y, 2007, MUTAT RES-FUND MOL M, V614, P48, DOI 10.1016/j.mrfmmm.2006.06.006
   Mancuso M, 2010, ADV EXP MED BIOL, V685, P34
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Parfait B, 1997, HUM GENET, V101, P247, DOI 10.1007/s004390050625
   Pronicki M, 2008, J CLIN PATHOL, V61, P460, DOI 10.1136/jcp.2007.051060
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A
   Sacconi S, 2009, J HUM GENET, V54, P419, DOI 10.1038/jhg.2009.36
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Taanman JW, 2001, BIOCHEM SOC T, V29, P446, DOI 10.1042/BST0290446
   Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tubbs RR, 2004, AM J SURG PATHOL, V28, P417, DOI 10.1097/00000478-200403000-00022
   Vielhaber S, 2002, J NEUROPATH EXP NEUR, V61, P885, DOI 10.1093/jnen/61.10.885
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   von Kleist-Retzow JC, 1999, BBA-MOL BASIS DIS, V1455, P35, DOI 10.1016/S0925-4439(99)00050-2
   Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009
   YAMAMOTO M, 1989, J NEUROL SCI, V91, P207, DOI 10.1016/0022-510X(89)90088-9
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 30
TC 0
Z9 1
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
J9 MITOCHONDRION
JI Mitochondrion
PD MAY
PY 2011
VL 11
IS 3
BP 430
EP 436
DI 10.1016/j.mito.2010.12.014
PG 7
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 753HS
UT WOS:000289763500008
PM 21187165
DA 2024-11-01
ER

PT J
AU Winterthun, S
   Ferrari, G
   He, L
   Taylor, RW
   Zeviani, M
   Turnbull, DM
   Engelsen, BA
   Moen, G
   Bindoff, LA
AF Winterthun, S
   Ferrari, G
   He, L
   Taylor, RW
   Zeviani, M
   Turnbull, DM
   Engelsen, BA
   Moen, G
   Bindoff, LA
TI Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial
   polymerase γ mutations
SO NEUROLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DNA DELETIONS; POLG; NEUROPATHY;
   DOMINANT; TWINKLE; MERRF
AB Objective: To investigate three families and one sporadic case with a recessively inherited ataxic syndrome. Methods: Clinical and genetic studies were performed in six individuals. Southern blotting and real time PCR were used to detect deletions of mtDNA and mutations in the POLG gene were identified using a combination of DHPLC and direct DNA sequencing. Results: The patients have a distinctive, progressive disorder that starts with episodic symptoms such as migraine-like headache or epilepsy. Ataxia, which is a combination of central and peripheral disease, develops later as does ophthalmoplegia. The commonest form of epilepsy was focal and involved the occipital lobes. Myoclonus was common and patients have a high risk of status epilepticus. MRI typically shows signal changes in the central cerebellum, olivary nuclei, occipital cortex, and thalami. COX negative muscle fibers were found in four of six; in one patient these were rare and in another absent. Multiple mtDNA deletions were identified in all patients, although in two these were not apparent on Southern blotting and real time PCR was required to demonstrate the defect. Two families were homozygous for a previously described POLG mutation, G1399A (A467T). One family and the sporadic case had the same two new mutations, a G to C at position 1491 (Q497H) and a G to C at 2243 (W748S). Conclusions: Mutations in POLG cause a recessively inherited syndrome with episodic features and progressive ataxia. Characteristic changes on MRI are seen and although skeletal muscle may appear morphologically normal, multiple mtDNA deletions can be detected using real-time PCR.
C1 Univ Bergen, Haukeland Univ Hosp, Dept Neurol, Inst Clin Med & Mol Med, N-5021 Bergen, Norway.
   Univ Bergen, Haukeland Univ Hosp, Dept Radiol, N-5021 Bergen, Norway.
   Unit Mol Neurogenet Pierfranco, Milan, Italy.
   Luisa Mariani Ctr Study Childrens Mitochondrial D, Milan, Italy.
   Natl Neurol Inst C Besta, Milan, Italy.
   Newcastle Univ, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Sch Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 University of Bergen; Haukeland University Hospital; University of
   Bergen; Haukeland University Hospital; Fondazione IRCCS Istituto
   Neurologico Carlo Besta; Newcastle University - UK
RP Bindoff, LA (corresponding author), Univ Bergen, Haukeland Univ Hosp, Dept Neurol, Inst Clin Med & Mol Med, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
RI Bindoff, Nathaniel/C-8050-2011; Zeviani, Massimo/K-2891-2014
OI Zeviani, Massimo/0000-0002-9067-5508; Ferrari,
   Giovanfrancesco/0000-0001-8864-0771; Bindoff,
   Laurence/0000-0003-0988-276X
FU Telethon [GGP030039] Funding Source: Medline; Wellcome Trust [074454]
   Funding Source: Medline
CR Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   HARDING AE, 1995, CURR OPIN NEUROL, V8, P306, DOI 10.1097/00019052-199508000-00010
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Rantamäki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   vanDomburg PHMF, 1996, BRAIN, V119, P997, DOI 10.1093/brain/119.3.997
   Zhou L, 1997, J NEUROSCI, V17, P7746
NR 15
TC 186
Z9 199
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0028-3878
J9 NEUROLOGY
JI Neurology
PD APR 12
PY 2005
VL 64
IS 7
BP 1204
EP 1208
DI 10.1212/01.WNL.0000156516.77696.5A
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 915BO
UT WOS:000228272800021
PM 15824347
DA 2024-11-01
ER

PT J
AU Ashley, N
   O'Rourke, A
   Smith, C
   Adams, S
   Gowda, V
   Zeviani, M
   Brown, GK
   Fratter, C
   Poulton, J
AF Ashley, Neil
   O'Rourke, Anthony
   Smith, Conrad
   Adams, Susan
   Gowda, Vasantha
   Zeviani, Massimo
   Brown, Garry K.
   Fratter, Carl
   Poulton, Joanna
TI Depletion of mitochondrial DNA in fibroblast cultures from patients with
   POLG1 mutations is a consequence of catalytic mutations
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLYMERASE-GAMMA; MTDNA DEPLETION;
   SACCHAROMYCES-CEREVISIAE; ALPERS-SYNDROME; W748S MUTATION; TK2
   DEFICIENCY; HUMAN-CELLS; DISEASE; EXPRESSION
AB We investigated clinical and cellular phenotypes of 24 children with mutations in the catalytic (alpha) subunit of the mitochondrial DNA (mtDNA) gamma polymerase (POLG1). Twenty-one had Alpers syndrome, the commonest severe POLG1 autosomal recessive phenotype, comprising hepatoencephalopathy and often mtDNA depletion. The cellular mtDNA content reflected the genotype more closely than did clinical features. Patients with tissue depletion of mtDNA all had at least one allele with either a missense mutation in a catalytic domain or a nonsense mutation. Four out of 12 patients exhibited a progressive, mosaic pattern of mtDNA depletion in cultured fibroblasts. All these patients had mutations in a catalytic domain in both POLG1 alleles, in either the polymerase or exonuclease domain or both. The tissue mtDNA content of patients who had two linker mutations was normal, and their phenotypes the mildest. Epilepsy and/or movement disorder were major features in all 21. Previous studies have implicated replication stalling as a mechanism for mtDNA depletion. The mosaic cellular depletion that we have demonstrated in cell cultures may be a manifestation of severe replication stalling. One patient with a severe cellular and clinical phenotype was a compound heterozygote with POLG1 mutations in the polymerase and exonuclease domain in trans. This suggests that POLG1 requires both polymerase and 3'-5' exonuclease activity in the same molecule. This is consistent with current functional models for eukaryotic DNA polymerases, which alternate between polymerizing and editing modes, as determined by competition between these two active sites for the 3' end of the DNA.
C1 [Ashley, Neil; Gowda, Vasantha; Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Womens Ctr, John Radcliffe Hosp, Oxford OX3 9DU, England.
   [O'Rourke, Anthony; Smith, Conrad; Adams, Susan; Fratter, Carl] Churchill Hosp, Oxford Med Genet Lab, Oxford OX3 7LJ, England.
   [Zeviani, Massimo] Natl Neurol Inst C Besta, Div Mol Neurogenet, I-20126 Milan, Italy.
   [Brown, Garry K.] Univ Oxford, Dept Biochem, Oxford OX3 9DU, England.
C3 University of Oxford; University of Oxford; Fondazione IRCCS Istituto
   Neurologico Carlo Besta; University of Oxford
RP Poulton, J (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Womens Ctr, John Radcliffe Hosp, Oxford OX3 9DU, England.
EM joanna.poulton@obs-gyn.ox.ac.uk
RI Gowda, Vasantha/HPF-7886-2023; Poulton, Joanna/AAB-4828-2021; adams,
   susan/I-7423-2016; Zeviani, Massimo/K-2891-2014
OI Zeviani, Massimo/0000-0002-9067-5508; Gowda,
   Vasantha/0000-0002-8367-5489; Ashley, Neil/0000-0002-1655-5137; Poulton,
   Joanna/0000-0002-2460-5587
FU MRC [G0500695] Funding Source: UKRI; Medical Research Council [G0500695]
   Funding Source: Medline; Wellcome Trust Funding Source: Medline
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Barthélémy C, 2002, HUM GENET, V110, P479, DOI 10.1007/s00439-002-0708-4
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0
   BODNAR AG, 1993, AM J HUM GENET, V53, P663
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Ducluzeau PH, 2002, J HEPATOL, V36, P698, DOI 10.1016/S0168-8278(02)00021-1
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   LEWIN B, 2004, GENES, V8, P387
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Moraes Carlos T., 1993, P97
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   MORTEN KJ, 2007, MITOCHONDRION, V16, P1400
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
NR 45
TC 47
Z9 50
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD AUG 15
PY 2008
VL 17
IS 16
BP 2496
EP 2506
DI 10.1093/hmg/ddn150
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 330SL
UT WOS:000257963000009
PM 18487244
OA Green Submitted, Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Kornblum, C
   Broicher, R
   Walther, E
   Herberhold, S
   Klockgether, T
   Herberhold, C
   Schröder, R
AF Kornblum, C
   Broicher, R
   Walther, E
   Herberhold, S
   Klockgether, T
   Herberhold, C
   Schröder, R
TI Sensorineural hearing loss in patients with chronic progressive external
   ophthalmoplegia or Kearns-Sayre syndrome
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE mitochondrial disorders; hearing loss; mtDNA deletion; CPEO; cochlear
   dysfunction
ID MITOCHONDRIAL-DNA; COCHLEAR IMPLANTATION; POINT MUTATION; MELAS
   SYNDROME; QUANTITATIVE-ANALYSIS; DEFECTS; GENE; IMPAIRMENT; FEATURES
AB In the present study we assessed the prevalence and nature of hearing loss in patients with chronic progressive external ophthalmoplegia (CPEO) or Kearns-Sayre syndrome (KSS) due to single large-scale mitochondrial DNA (mtDNA) deletion or mtDNA tRNA(Leu (UUR)) A3243G point mutation (A3243G PM). 14 patients with mtDNA deletion and three patients with A3243G PM underwent audiological evaluation comprising pure-tone and speech audiometry as well as transient evoked otoacoustic emissions (OAE). Audiological evaluation revealed hearing impairment in 10/17 patients. Hearing loss was mild to moderate predominantly affecting high frequencies in five patients with subjective hearing problems (three patients with mtDNA deletions, two patients with A3243G PM). Subclinical hearing deficits restricted to high frequencies were seen in further five asymptomatic patients (four patients with mtDNA deletions, one patients with A3243G PM). Audiological findings suggested a cochlear origin of hearing loss in all subjects. Our results demonstrate that CPEO or KSS patients due to mtDNA deletion or A3243G PM are at high risk of developing sensorineural hearing deficits.
C1 Univ Bonn, Dept Neurol, D-53105 Bonn, Germany.
   Univ Bonn, Dept Otorhinolaryngol, D-5300 Bonn, Germany.
C3 University of Bonn; University of Bonn
RP Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM cornelia.kornblum@ukb.uni-bonn.de
RI Schröder, Rolf/B-2774-2011; Kornblum, Cornelia/IUM-4180-2023
OI Schroder, Rolf/0000-0002-2772-2615
CR Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   DAVIS A, 1998, HEARING ADULTS
   Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885
   Griffiths TD, 2001, JARO-J ASSOC RES OTO, V2, P172, DOI 10.1007/s101620010061
   Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673
   LINDSAY JR, 1976, ARCH OTOLARYNGOL, V102, P747
   LIU XZ, 1994, ANN OTO RHINOL LARYN, V103, P428, DOI 10.1177/000348949410300602
   MORGANHUGHES JA, 1995, MYOLOGY, P1610
   Nishizaki K, 1999, ACTA OTO-LARYNGOL, P34
   Oshima T, 1996, LARYNGOSCOPE, V106, P43, DOI 10.1097/00005537-199601000-00009
   Rosenthal EL, 1999, AM J OTOL, V20, P187
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Takahashi K, 2003, LARYNGOSCOPE, V113, P1362, DOI 10.1097/00005537-200308000-00018
   Tamagawa Y, 1997, ANN OTO RHINOL LARYN, V106, P338
   THALMANN R, 1981, ACTA OTO-LARYNGOL, V91, P535, DOI 10.3109/00016488109138539
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Warrick PD, 1997, J LARYNGOL OTOL, V111, P279, DOI 10.1017/S0022215100137089
   Yamaguchi T, 1997, ADV OTO-RHINO-LARYNG, V52, P321
   Yamasoba T, 1996, LARYNGOSCOPE, V106, P49, DOI 10.1097/00005537-199601000-00010
   Yamasoba T, 1999, NEUROLOGY, V52, P1705, DOI 10.1212/WNL.52.8.1705
   Zwirner P, 2001, LARYNGOSCOPE, V111, P515, DOI 10.1097/00005537-200103000-00024
NR 26
TC 13
Z9 17
U1 0
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD SEP
PY 2005
VL 252
IS 9
BP 1101
EP 1107
DI 10.1007/s00415-005-0827-7
PG 7
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 965TX
UT WOS:000231974300014
PM 15827867
DA 2024-11-01
ER

PT J
AU Van Hove, JLK
   Freehauf, C
   Miyamoto, S
   Vladutiu, GD
   Pancrudo, J
   Bonilla, E
   Lovell, MA
   Mierau, GW
   Thomas, JA
   Shanske, S
AF Van Hove, Johan L. K.
   Freehauf, Cynthia
   Miyamoto, Shelley
   Vladutiu, Georgirene D.
   Pancrudo, Jacklyn
   Bonilla, Eduardo
   Lovell, Mark A.
   Mierau, Gary W.
   Thomas, Janet A.
   Shanske, Sara
TI Infantile cardiomyopathy caused by the T14709C mutation in the
   mitochondrial tRNA glutamic acid gene
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Article
DE mitochondrial respiratory chain; tRNA glutamic acid; cardiomyopathy;
   arrhythmias; heteroplasmy
ID DIABETES-MELLITUS; A3243G MUTATION; ONSET MYOPATHY; DNA; DEAFNESS;
   DISEASE; FAMILY; MIDD
AB A 6-week-old child presented with hypotonia, myopathy, and a rapidly worsening dilated cardiomyopathy with severe atrial and ventricular arrhythmias and pulmonary hypertension, which proved fatal at age 3 months. Biochemical analysis showed a combined deficiency of the enzymatic activities of complexes I and IV and molecular studies identified a T14709C mutation in the mitochondrial tRNA glutamic acid gene. A review of symptomatology in patients with this mutation shows that it mainly presents in childhood or young adults with mild myopathy and diabetes mellitus. Infants with a high, nearly homoplasmic mutant load can present with more severe symptoms including cardiomyopathy. Families with this mitochondrial DNA mutation should be aware that increased mutant load in a subsequent generation may result in severe and often fatal cardiac symptoms.
C1 [Van Hove, Johan L. K.] Univ Colorado, Hlth Sci Ctr Fitzsimmons, Dept Pediat, Aurora, CO 80045 USA.
   [Van Hove, Johan L. K.; Freehauf, Cynthia; Miyamoto, Shelley; Thomas, Janet A.] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA.
   [Van Hove, Johan L. K.; Freehauf, Cynthia; Miyamoto, Shelley; Lovell, Mark A.; Mierau, Gary W.; Thomas, Janet A.] Childrens Hosp, Denver, CO 80218 USA.
   [Vladutiu, Georgirene D.] SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA.
   [Pancrudo, Jacklyn; Bonilla, Eduardo; Shanske, Sara] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   [Lovell, Mark A.; Mierau, Gary W.] Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Colorado System; University of Colorado Denver;
   University of Colorado Anschutz Medical Campus; Children's Hospital
   Colorado; State University of New York (SUNY) System; University at
   Buffalo, SUNY; Columbia University; University of Colorado System;
   University of Colorado Denver; University of Colorado Anschutz Medical
   Campus
RP Van Hove, JLK (corresponding author), Univ Colorado, Hlth Sci Ctr Fitzsimmons, Dept Pediat, Mail Stop 8313,RC-1 N,12800 E 19th Ave,Room P18-4, Aurora, CO 80045 USA.
EM Johan.Vanhove@uchsc.edu
CR Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Barclay AR, 2005, J INHERIT METAB DIS, V28, P1081, DOI 10.1007/s10545-005-4484-x
   Choo-Kang ATW, 2002, DIABETES, V51, P2317, DOI 10.2337/diabetes.51.7.2317
   Damore ME, 1999, J PEDIATR ENDOCR MET, V12, P207
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   King T.E., 1967, METHODS ENZYMOLOGY, V10, P322, DOI [10.1016/0076-6879(67)10061-X, DOI 10.1016/0076-6879(67)10061-X]
   King T E., 1967, Methods in enzymology Eds, V10, P275, DOI DOI 10.1016/0076-6879(67)10055-4
   Mancuso M, 2005, J NEUROL SCI, V228, P93, DOI 10.1016/j.jns.2004.10.018
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Meulemans A, 2007, EUR J PAEDIATR NEURO, V11, P17, DOI 10.1016/j.ejpn.2006.10.004
   Narbonne H, 2004, DIABETES METAB, V30, P61, DOI 10.1016/S1262-3636(07)70090-3
   Rigoli L, 2001, DIABETIC MED, V18, P334, DOI 10.1046/j.1464-5491.2001.00429-2.x
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   SCHON EA, 2006, MITOCHONDRIAL MED, P329
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Srere P.A., 1969, Methods in Enzymology, V13, P3
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Wharton D.C., 1967, Methods Enzymol, V10, P245, DOI [10.1016/0076-6879(67)10048-7, DOI 10.1016/0076-6879(67)10048-7]
NR 20
TC 11
Z9 12
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-6199
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD JUL
PY 2008
VL 167
IS 7
BP 771
EP 776
DI 10.1007/s00431-007-0587-8
PG 6
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 304BL
UT WOS:000256084900010
PM 17891417
DA 2024-11-01
ER

PT J
AU Tranah, GJ
   Katzman, SM
   Lauterjung, K
   Yaffe, K
   Manini, TM
   Kritchevsky, S
   Newman, AB
   Harris, TB
   Cummings, SR
AF Tranah, Gregory J.
   Katzman, Shana M.
   Lauterjung, Kevin
   Yaffe, Kristine
   Manini, Todd M.
   Kritchevsky, Stephen
   Newman, Anne B.
   Harris, Tamara B.
   Cummings, Steven R.
TI Mitochondrial DNA m.3243A &gt; G heteroplasmy affects multiple aging
   phenotypes and risk of mortality
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LACTIC-ACIDOSIS; A3243G MUTATION; MELAS MUTATION; TRANSFER
   RNA(LEU(UUR)); CLINICAL-FEATURES; CLONAL EXPANSIONS; READ ALIGNMENT; ND3
   GENE; MTDNA; MUSCLE
AB Mitochondria contain many copies of a circular DNA molecule (mtDNA), which has been observed as a mixture of normal and mutated states known as heteroplasmy. Elevated heteroplasmy at a single mtDNA site, m.3243A > G, leads to neurologic, sensory, movement, metabolic, and cardiopulmonary impairments. We measured leukocyte mtDNA m.3243A > G heteroplasmy in 789 elderly men and women from the bi-racial, population-based Health, Aging, and Body Composition Study to identify associations with age-related functioning and mortality. Mutation burden for the m.3243A > G ranged from 0-19% and elevated heteroplasmy was associated with reduced strength, cognitive, metabolic, and cardiovascular functioning. Risk of all-cause, dementia and stroke mortality was significantly elevated for participants in the highest tertiles of m.3243A > G heteroplasmy. These results indicate that the accumulation of a rare genetic disease mutation, m.3243A > G, manifests as several aging outcomes and that some diseases of aging may be attributed to the accumulation of mtDNA damage.
C1 [Tranah, Gregory J.; Lauterjung, Kevin; Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA.
   [Katzman, Shana M.] LA Eye Ctr & Clin, Los Angeles, CA 90037 USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94121 USA.
   [Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA 94121 USA.
   [Manini, Todd M.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32601 USA.
   [Kritchevsky, Stephen] Wake Forest Sch Med, Sticht Ctr Aging, Winston Salem, NC 27157 USA.
   [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA.
   [Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA.
C3 California Pacific Medical Center; California Pacific Medical Center
   Research Institute; University of California System; University of
   California San Francisco; University of California System; University of
   California San Francisco; University of California System; University of
   California San Francisco; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); San Francisco VA Medical Center; State
   University System of Florida; University of Florida; Wake Forest
   University; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh
RP Tranah, GJ (corresponding author), Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA.
EM gtranah@sfcc-cpmc.net
OI STINDT, KEVIN/0000-0002-6028-3773; Manini, Todd/0000-0002-5970-4462
FU Intramural Research Program of the NIH, National Institute on Aging
   [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; National Institutes of
   Health [R01-AG028050, R03-AG032498, R01-NR012459, Z01A6000932,
   R01-HL121023]; Research and Education Leadership Committee of the CPMC
   Foundation; L.K. Whittier Foundation
FX This research was supported in part by the Intramural Research Program
   of the NIH, National Institute on Aging, Contracts N01-AG-6-2101,
   N01-AG-6-2103, and N01-AG-6-2106; National Institutes of Health grants
   R01-AG028050, R03-AG032498, R01-NR012459, Z01A6000932, R01-HL121023.
   Foundation grants from the Research and Education Leadership Committee
   of the CPMC Foundation and the L.K. Whittier Foundation also supported
   this research. We are grateful to the Health, Aging and Body Composition
   Study participants and researchers.
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   BERES CA, 1981, J GERONTOL, V36, P591, DOI 10.1093/geronj/36.5.591
   Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Comte C, 2013, NUCLEIC ACIDS RES, V41, P418, DOI 10.1093/nar/gks965
   Coon KD, 2006, MITOCHONDRION, V6, P194, DOI 10.1016/j.mito.2006.07.002
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   DAMIAN MS, 1995, ACTA NEUROL SCAND, V92, P409
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382
   JEANFRANCOIS MJB, 1994, AUST NZ J MED, V24, P188, DOI 10.1111/j.1445-5994.1994.tb00556.x
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Kärppä M, 2004, J NEUROL, V251, P556, DOI 10.1007/s00415-004-0363-x
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirches E, 2001, J MED GENET, V38, P312, DOI 10.1136/jmg.38.5.312
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002
   Naviaux RK, 2000, EUR J PEDIATR, V159, pS219, DOI 10.1007/PL00014407
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   PENISSONBESNIER I, 1992, J NEUROL SCI, V110, P144, DOI 10.1016/0022-510X(92)90021-C
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Ross J. M, 2013, NATURE
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Spyropoulos A, 2013, JAMA NEUROL, V70, P1552, DOI 10.1001/jamaneurol.2013.4111
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   TENG EL, 1987, J CLIN PSYCHIAT, V48, P314
   Tranah GJ, 2015, J GERONTOL A-BIOL, V70, P1418, DOI 10.1093/gerona/glv097
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tyrrell DJ, 2015, J GERONTOL A-BIOL, V70, P1394, DOI 10.1093/gerona/glu096
   van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183
   Van Remmen H, 2009, J GERONTOL A-BIOL, V64, P171, DOI 10.1093/gerona/gln058
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1992, J INHERIT METAB DIS, V15, P472, DOI 10.1007/BF01799605
   Wechsler D., 1997, Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV)
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
NR 76
TC 36
Z9 39
U1 3
U2 10
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 8
PY 2018
VL 8
AR 11887
DI 10.1038/s41598-018-30255-6
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics
GA GP6JH
UT WOS:000440985500010
PM 30089816
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU De Paepe, B
AF De Paepe, Boel
TI Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with
   Extras
SO BIOMOLECULES
LA English
DT Review
DE mitochondrial dysfunction; myositis; sporadic inclusion body myositis
ID SKELETAL-MUSCLE; DNA; ABNORMALITIES; PATHOLOGY; AUTOANTIBODIES;
   INFLAMMATION; MAINTENANCE; DYSFUNCTION; MITOPHAGY; CYTOKINES
AB The sporadic form of inclusion body myositis (IBM) is the most common late-onset myopathy. Its complex pathogenesis includes degenerative, inflammatory and mitochondrial aspects. However, which of those mechanisms are cause and which effect, as well as their interrelations, remain partly obscured to this day. In this review the nature of the mitochondrial dysregulation in IBM muscle is explored and comparison is made with other muscle disorders. Mitochondrial alterations in IBM are evidenced by histological and serum biomarkers. Muscular mitochondrial dynamics is disturbed, with deregulated organelle fusion leading to subsequent morphological alterations and muscle displays abnormal mitophagy. The tissue increases mitochondrial content in an attempt to compensate dysfunction, yet mitochondrial DNA (mtDNA) alterations and mild mtDNA depletion are also present. Oxidative phosphorylation defects have repeatedly been shown, most notably a reduction in complex IV activities and levels of mitokines and regulatory RNAs are perturbed. Based on the cumulating evidence of mitochondrial abnormality as a disease contributor, it is therefore warranted to regard IBM as a mitochondrial disease, offering a feasible therapeutic target to be developed for this yet untreatable condition.
C1 [De Paepe, Boel] Ghent Univ Hosp, Neuromuscular Reference Ctr, Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
C3 Ghent University; Ghent University Hospital
RP De Paepe, B (corresponding author), Ghent Univ Hosp, Neuromuscular Reference Ctr, Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
EM boel.depaepe@ugent.be
RI De Paepe, Boel/B-7548-2013
OI De Paepe, Boel/0000-0001-9403-4401
FU Association Belge contre les Maladies neuro-Musculaires (ABMM) aides a
   la recherche [2018]
FX The author received research funding from the Association Belge contre
   les Maladies neuro-Musculaires (ABMM) aides a la recherche 2016 and
   2018.
CR Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200
   Amato A.A., 2017, NEUROLOGY, V88, P1
   Askanas V, 2015, BBA-MOL BASIS DIS, V1852, P633, DOI [10.1016/j.bbadis.201409.005, 10.1016/j.bbadis.2014.09.005]
   Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8
   Brady S, 2018, NEUROMUSCULAR DISORD, V28, pS30, DOI 10.1016/S0960-8966(18)30380-8
   Breithaupt M, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0329-z
   Buzkova J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809091
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   De Paepe B, 2018, CURR GENET, V64, P163, DOI 10.1007/s00294-017-0744-1
   Dimachkie MM, 2012, SEMIN NEUROL, V32, P237, DOI 10.1055/s-0032-1329197
   Enns GM, 2014, J CHILD NEUROL, V29, P1235, DOI 10.1177/0883073814538509
   Gambelli S., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P85
   Georgantas RW, 2014, ARTHRITIS RHEUMATOL, V66, P1022, DOI 10.1002/art.38292
   Gidlund EK, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13063
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Hamann PD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08603-9
   Ivanidze J, 2011, AM J PATHOL, V179, P1347, DOI 10.1016/j.ajpath.2011.05.055
   Johnson Liam G, 2009, J Clin Neuromuscul Dis, V10, P178, DOI 10.1097/CND.0b013e3181a23c86
   Joshi PR, 2014, J CLIN NEUROSCI, V21, P1959, DOI 10.1016/j.jocn.2014.05.051
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, pH2726, DOI 10.1152/ajpheart.00376.2007
   Matsubara S, 2018, NEUROMUSCULAR DISORD, V28, P283, DOI 10.1016/j.nmd.2018.01.004
   Meyer A, 2017, ACTA NEUROPATHOL, V134, P655, DOI 10.1007/s00401-017-1731-9
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Nie YH, 2016, FASEB J, V30, P3745, DOI 10.1096/fj.201600529R
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Päivä H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006
   Pluk H, 2013, ANN NEUROL, V73, P397, DOI 10.1002/ana.23822
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Rojana-Udomsart A, 2012, J NEUROIMMUNOL, V250, P77, DOI 10.1016/j.jneuroim.2012.05.003
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Shabrokh E., 2014, Open J Mol Integr Physiol, V04, P11, DOI [DOI 10.4236/ojmip.2014.42002, 10.4236/OJMIP.2014.42002, DOI 10.4236/OJMIP.2014.42002]
   Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023
   Sunitha B, 2016, J NEUROCHEM, V138, P174, DOI 10.1111/jnc.13626
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010
   Vaamonde-García C, 2012, ARTHRITIS RHEUM-US, V64, P2927, DOI 10.1002/art.34508
   Wang Y, 2018, NAT CELL BIOL, V20, P1145, DOI 10.1038/s41556-018-0204-2
   WOO M, 1988, J NEUROL SCI, V88, P133, DOI 10.1016/0022-510X(88)90211-0
   Xie T, 2017, AM J PHYSIOL-ENDOC M, V313, pE292, DOI 10.1152/ajpendo.00101.2017
   Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047
NR 50
TC 23
Z9 23
U1 1
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD JAN
PY 2019
VL 9
IS 1
AR 15
DI 10.3390/biom9010015
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA HK6AT
UT WOS:000458051700015
PM 30621041
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Wang, HY
   Han, YJ
   Li, SW
   Chen, YA
   Chen, YF
   Wang, J
   Zhang, YQ
   Zhang, YW
   Wang, JS
   Xia, Y
   Yuan, JX
AF Wang, Haiying
   Han, Yijun
   Li, Shenwei
   Chen, Yunan
   Chen, Yafen
   Wang, Jing
   Zhang, Yuqing
   Zhang, Yawen
   Wang, Jingsuo
   Xia, Yong
   Yuan, Jinxiang
TI Mitochondrial DNA Depletion Syndrome and Its Associated Cardiac Disease
SO FRONTIERS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
DE mitochondrial DNA depletion syndrome; nuclear gene mutation; mtDNA;
   cardiac disease; ATP
ID COA LIGASE DEFICIENCY; SKELETAL-MUSCLE; CARDIOVASCULAR-DISEASE;
   ACYLGLYCEROL KINASE; MAINTENANCE DEFECT; OXIDATIVE STRESS; MTDNA
   DEPLETION; MUTATIONS; HEART; GENE
AB Mitochondria is a ubiquitous, energy-supplying (ATP-based) organelle found in nearly all eukaryotes. It acts as a "power plant" by producing ATP through oxidative phosphorylation, providing energy for the cell. The bioenergetic functions of mitochondria are regulated by nuclear genes (nDNA). Mitochondrial DNA (mtDNA) and respiratory enzymes lose normal structure and function when nuclear genes encoding the related mitochondrial factors are impaired, resulting in deficiency in energy production. Massive generation of reactive oxygen species and calcium overload are common causes of mitochondrial diseases. The mitochondrial depletion syndrome (MDS) is associated with the mutations of mitochondrial genes in the nucleus. It is a heterogeneous group of progressive disorders characterized by the low mtDNA copy number. TK2, FBXL4, TYPM, and AGK are genes known to be related to MDS. More recent studies identified new mutation loci associated with this disease. Herein, we first summarize the structure and function of mitochondria, and then discuss the characteristics of various types of MDS and its association with cardiac diseases.
C1 [Wang, Haiying] Jining Med Univ, Inst Basic Med Coll, Dept Physiol, Jining, Peoples R China.
   [Han, Yijun] Jining Med Univ, Clin Med Coll, Jining, Peoples R China.
   [Li, Shenwei; Chen, Yunan; Chen, Yafen; Zhang, Yuqing; Zhang, Yawen; Wang, Jingsuo] Jining Med Univ, Inst Basic Med Coll, Jining, Peoples R China.
   [Wang, Jing] Dongying Fifth Peoples Hosp, Dongying, Peoples R China.
   [Xia, Yong] Jining Med Univ, Inst Precis Med, Key Lab Precis Oncol Shandong Higher Educ, Jining, Peoples R China.
   [Yuan, Jinxiang] Jining Med Univ, Collaborat Innovat Ctr, Jining, Peoples R China.
C3 Jining Medical University; Jining Medical University; Jining Medical
   University; Jining Medical University; Jining Medical University
RP Xia, Y (corresponding author), Jining Med Univ, Inst Precis Med, Key Lab Precis Oncol Shandong Higher Educ, Jining, Peoples R China.; Yuan, JX (corresponding author), Jining Med Univ, Collaborat Innovat Ctr, Jining, Peoples R China.
EM xiayong@mail.jnmc.edu.cn; yuanjinxiang18@163.com
RI lu, yuan/JZD-0832-2024; Yuan, Jinxiang/KFA-2500-2024; Xia,
   Yong/E-8689-2013
FU Jining Medical University [600791001]; Foundation of Medical Health
   Science and Technology Development Program of Shandong Province
   [202002061311]; Jining Medical University [JYFC2019KJ013]; Jining
   Medical College Student Innovation and Entrepreneurship Training Program
   [cx2021053]
FX The authors would like to acknowledge funding from the Research Start-up
   Fund of Jining Medical University (Reference: 600791001), the Foundation
   of Medical Health Science and Technology Development Program of Shandong
   Province (Reference: 202002061311), the Research Support Fund for
   Teachers of Jining Medical University (Reference: JYFC2019KJ013), and
   the Jining Medical College Student Innovation and Entrepreneurship
   Training Program Project (Reference: cx2021053).
CR Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009
   El Cadi CA, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7614634
   Alonzo JR, 2018, J BIOL CHEM, V293, P20285, DOI 10.1074/jbc.RA118.004788
   Ambrose LJA, 2014, J CARDIOVASC PHARM T, V19, P574, DOI 10.1177/1074248414524480
   AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083
   Antoun G, 2016, JIMD REP, V27, P1, DOI 10.1007/8904_2015_491
   Ballout RA, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00039
   Baroy T, 2016, EUR J MED GENET, V59, P342, DOI 10.1016/j.ejmg.2016.05.005
   Behjati M, 2021, HEART FAIL REV, V26, P391, DOI 10.1007/s10741-020-10009-1
   Benard G, 2010, BBA-BIOENERGETICS, V1797, P698, DOI 10.1016/j.bbabio.2010.02.030
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Boschetti E, 2021, AM J PHYSIOL-GASTR L, V320, pG768, DOI 10.1152/ajpgi.00047.2021
   Bouchez C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040287
   Bouda E, 2019, PROTEIN SCI, V28, P1594, DOI 10.1002/pro.3688
   Briston T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10673-8
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Chaturvedi S, 2005, MED SCI MONITOR, V11, pRA238
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Dai H, 2017, CLIN GENET, V91, P634, DOI 10.1111/cge.12894
   de Oliveira VC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235856
   Demirbas Didem, 2019, JIMD Rep, V46, P63, DOI 10.1002/jmd2.12018
   Deshpande OA., 2020, BIOCH OXIDATIVE PHOS
   Dey S, 2018, CIRC RES, V123, P356, DOI 10.1161/CIRCRESAHA.118.312708
   Dogan SA, 2018, CELL METAB, V28, P764, DOI 10.1016/j.cmet.2018.07.012
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115
   Dunham-Snary KJ, 2013, FREE RADICAL BIO MED, V65, P1229, DOI 10.1016/j.freeradbiomed.2013.09.007
   Dziewulska A, 2010, POSTEP HIG MED DOSW, V64, P513
   El-Hattab AW., 1993, SUCLG1 RELATED MITOC
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Emperador S, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01300
   Fangdai L., 2019, CHIN J PEDIAT, V57, P211, DOI [10.3760/cma.j.issn.0578-1310.2019.03.011, DOI 10.3760/CMA.J.ISSN.0578-1310.2019.03.011]
   Felhi R, 2019, CLIN CHIM ACTA, V488, P104, DOI 10.1016/j.cca.2018.11.003
   Fernández-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028
   Filosto M, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110389
   Flores-Herrera O, 2015, BBA-BIOENERGETICS, V1847, P143, DOI 10.1016/j.bbabio.2014.10.002
   Fuhrmann DC, 2017, REDOX BIOL, V12, P208, DOI 10.1016/j.redox.2017.02.012
   Gao P, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.604240
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Gherardi G, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.554904
   Gherardi G, 2019, CELL DEATH DIFFER, V26, P362, DOI 10.1038/s41418-018-0191-7
   Gödiker J, 2018, J HUM GENET, V63, P707, DOI 10.1038/s10038-018-0442-y
   Gómez-Valadés AG, 2017, CURR DIABETES REV, V13, P370, DOI 10.2174/1573399812666151012115229
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Guarani V, 2016, ELIFE, V5, DOI 10.7554/eLife.17163
   Guarani V, 2015, ELIFE, V4, DOI 10.7554/eLife.06265
   Guo WJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02351-0
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Hebbar M, 2017, EUR J MED GENET, V60, P533, DOI 10.1016/j.ejmg.2017.07.010
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   Hoff KE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203198
   Hoshino A, 2019, NATURE, V575, P375, DOI 10.1038/s41586-019-1667-4
   Hou TT, 2019, CELL RES, V29, P754, DOI 10.1038/s41422-019-0208-x
   Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Jackson TD, 2021, MOL BIOL CELL, V32, P475, DOI 10.1091/mbc.E20-06-0390
   Jamali F, 2019, ARCH IRAN MED, V22, P728
   Ji LL, 2015, ADV PHYSIOL EDUC, V39, P352, DOI 10.1152/advan.00106.2014
   Kalari S, 2009, AM J PHYSIOL-LUNG C, V296, pL328, DOI 10.1152/ajplung.90431.2008
   Kamath VG, 2015, J BIOL CHEM, V290, P2034, DOI 10.1074/jbc.M114.624213
   Kashiki T, 2022, BRAIN DEV-JPN, V44, P56, DOI 10.1016/j.braindev.2021.08.005
   Kim J, 2016, MOL GENET METAB REP, V8, P74, DOI 10.1016/j.ymgmr.2016.06.006
   Kishita Y, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1427
   Kondadi AK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174311
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Köse E, 2020, TURKISH J PEDIATR, V62, P652, DOI 10.24953/turkjped.2020.04.016
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Krzywanski DM, 2011, LAB INVEST, V91, P1122, DOI 10.1038/labinvest.2011.95
   Kume K, 2020, BMC MED GENET, V21, DOI 10.1186/s12881-020-01002-4
   Lamperti C, 2009, Acta Myol, V28, P2
   Landsverk ML, 2014, MOLEC GENET METAB RE, V1, P451, DOI 10.1016/j.ymgmr.2014.09.007
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Lee CF, 2016, CIRCULATION, V134, P883, DOI 10.1161/CIRCULATIONAHA.116.022495
   Lee H, 2016, BIOCHEM SOC T, V44, P1725, DOI 10.1042/BST20160129
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Li XH, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0875-y
   Liang K., 2014, BIOMED ENG CLIN MED, V18, P501, DOI [10.13339/j.cnki.sglc.2014.05.049, DOI 10.13339/J.CNKI.SGLC.2014.05.049]
   Lim AZ., RRM2B MITOCHONDRIAL
   Lin Gui-Zhi, 2020, Zhongguo Dang Dai Er Ke Za Zhi, V22, P274
   Liu YP, 2016, BRAIN DEV-JPN, V38, P61, DOI 10.1016/j.braindev.2015.05.002
   [陆相朋 Lu Xiangpeng], 2017, [临床儿科杂志, Journal of Chinical Pediatrics], V35, P810
   Madungwe NB, 2020, AM J TRANSL RES, V12, P3412
   Mahjoub G, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0893-9
   Martínez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3
   Marzetti E, 2013, AM J PHYSIOL-HEART C, V305, pH459, DOI 10.1152/ajpheart.00936.2012
   Matic S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03552-x
   Meurs KM, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020168
   Meyer JN, 2017, TOXICOLOGY, V391, P42, DOI 10.1016/j.tox.2017.07.019
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060
   Neary MT, 2014, J MOL CELL CARDIOL, V74, P340, DOI 10.1016/j.yjmcc.2014.06.013
   Nemani N, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aaz6206
   Nogueira C, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-34
   Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002
   Papadimas George K, 2020, Acta Myol, V39, P94, DOI 10.36185/2532-1900-012
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Pohjoismäki JL, 2017, FREE RADICAL BIO MED, V106, P345, DOI 10.1016/j.freeradbiomed.2017.02.032
   Pohjoismäki JLO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010426
   Prasun Pankaj, 2019, P83, DOI 10.1016/B978-0-12-817006-9.00015-0
   Pronicki M, 2018, POL J PATHOL, V69, P292, DOI [10.5114/PJP.2018.79549, 10.5114/pjp.2018.79549]
   Protasoni M, 2020, EMBO J, V39, DOI 10.15252/embj.2019102817
   Riva A, 2005, AM J PHYSIOL-HEART C, V289, pH868, DOI 10.1152/ajpheart.00866.2004
   Rivera H, 2010, MITOCHONDRION, V10, P362, DOI 10.1016/j.mito.2010.03.003
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Sabouny R, 2019, BBA-MOL BASIS DIS, V1865, DOI 10.1016/j.bbadis.2019.165536
   Saki M, 2017, FREE RADICAL BIO MED, V107, P216, DOI 10.1016/j.freeradbiomed.2016.11.050
   Santorelli FM, 2002, NEUROMUSCULAR DISORD, V12, P56, DOI 10.1016/S0960-8966(01)00248-6
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Sas K, 2018, MOLECULES, V23, DOI 10.3390/molecules23010191
   Scarpelli M, 2017, APPL CLIN GENET, V10, P21, DOI 10.2147/TACG.S94267
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Shvetsova AN, 2017, REDOX BIOL, V12, P1052, DOI 10.1016/j.redox.2017.05.003
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Stojanovic V, 2013, CROAT MED J, V54, P579, DOI 10.3325/cmj.2013.54.579
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Szabadosova V, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22254
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067642
   Tang XQ, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00280
   Teodoro JS, 2018, METHODS MOL BIOL, V1782, P109, DOI 10.1007/978-1-4939-7831-1_6
   Thomas LW, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00071
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Thorburn D.R., 1993, GeneReviews
   Tian R, 2019, CIRCULATION, V140, P1205, DOI 10.1161/CIRCULATIONAHA.119.040551
   Tseng YT, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1497
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   Victor VM, 2009, CURR MED CHEM, V16, P4654, DOI 10.2174/092986709789878265
   Vukotic M, 2017, MOL CELL, V67, P471, DOI 10.1016/j.molcel.2017.06.013
   Wang BZ, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.639687
   Wang J, 1993, TK2-related mitochondrial DNA maintenance defect, myopathic form.
   Wang LY, 2020, BMC MOL CELL BIOL, V21, DOI 10.1186/s12860-020-00272-3
   Wang SM, 2020, J NEUROL SCI, V416, DOI 10.1016/j.jns.2020.116948
   Wang W, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac7410
   Wei H., 2018, J PRACT DIABETOL, V14, P9
   WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3
   Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024
   Wu Y, 2018, Zhonghua Er Ke Za Zhi, V56, P381, DOI 10.3760/cma.j.issn.0578-1310.2018.05.016
   Yadak R, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1016-6
   Yan Y., 2018, J PRACT MED, V34, P2892, DOI [10.3969/j.issn.1006-5725.2018.17.018, DOI 10.3969/J.ISSN.1006-5725.2018.17.018]
   Yang C, 2018, NUCLEIC ACIDS RES, V46, P11075, DOI 10.1093/nar/gky855
   Zapico SC, 2013, AGING DIS, V4, P364, DOI 10.14336/AD.2013.0400364
   Zeharia A, 2016, EUR J HUM GENET, V24, P1778, DOI 10.1038/ejhg.2016.83
   Zerbes RM, 2016, J MOL BIOL, V428, P1485, DOI 10.1016/j.jmb.2016.02.031
   Zhang J., 2013, SLC26A4 TFAM GENE PO
   Zhou ZD, 2017, MOL NEUROBIOL, V54, P5534, DOI 10.1007/s12035-016-0099-5
NR 160
TC 5
Z9 5
U1 0
U2 21
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2297-055X
J9 FRONT CARDIOVASC MED
JI Front. Cardiovasc. Med.
PD FEB 14
PY 2022
VL 8
AR 808115
DI 10.3389/fcvm.2021.808115
PG 16
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA ZI5YG
UT WOS:000761696000001
PM 35237671
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Nguyen, NNY
   Kim, SS
   Jo, YH
AF Ngoc Ngo Yen Nguyen
   Kim, Sung Soo
   Jo, Yong Hwa
TI Deregulated Mitochondrial DNA in Diseases
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE mitochondrial DNA; mutation; cancer; predictor; oxidative stress
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HEREDITARY OPTIC NEUROPATHY; COPY
   NUMBER; BREAST-CANCER; COLORECTAL-CANCER; MTDNA MUTATION; OXIDATIVE
   STRESS; LEIGH-SYNDROME; CARDIAC INVOLVEMENT; MYOCLONIC EPILEPSY
AB Mitochondria play various important roles in energy production, metabolism, and apoptosis. Mitochondrial dysfunction caused by alterations in mitochondrial DNA (mtDNA) can lead to the initiation and progression of cancers and other diseases. These alterations include mutations and copy number variations. Especially, the mutations in D-loop, MT-ND1, and MT-ND5 affect mitochondrial functions and are widely detected in various cancers. Meanwhile, several other mutations have been correlated with muscular and neuronal diseases, especially MT-TL1 is deeply related. These pieces of evidence indicated mtDNA alterations in diseases show potential as a novel therapeutic target. mtDNA repair enzymes are the target for delaying or stalling the mtDNA damage-induced cancer progression and metastasis. Moreover, some mutations reveal a prognosis ability of the drug resistance. Current efforts aim to develop mitochondrial transplantation technique as a direct cure for deregulated mitochondria-associated diseases. This review summarizes the implications of mitochondrial dysfunction in cancers and other pathologies; and discusses the relevance of mitochondria-targeted therapies, along with their contribution as potential biomarkers.
C1 [Ngoc Ngo Yen Nguyen] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea.
   [Ngoc Ngo Yen Nguyen; Kim, Sung Soo; Jo, Yong Hwa] Kyung Hee Univ, Biomed Sci Inst, Seoul, South Korea.
   [Kim, Sung Soo; Jo, Yong Hwa] Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, 26 Kyungheedae Ro, Seoul 02447, South Korea.
C3 Kyung Hee University; Kyung Hee University; Kyung Hee University
RP Kim, SS; Jo, YH (corresponding author), Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, 26 Kyungheedae Ro, Seoul 02447, South Korea.
EM sgskim@khu.ac.kr; yonghwa.jo@gmail.com
RI Kim, Seongman/N-6910-2014; Kim, Sung Soo/S-2540-2017
OI Kim, Sung Soo/0000-0002-6817-7668
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Korean government [NRF-2017R1A6A3A11028420,
   NRF-2018R1A6A 1A03025124, NRF-2017R1A2B2007870]
FX This study was supported by Basic Science Research Program through the
   National Research Foundation of Korea (NRF) grant funded by the Korean
   government (NRF-2017R1A6A3A11028420 to Y.H.J., NRF-2018R1A6A 1A03025124,
   and NRF-2017R1A2B2007870 to S.S.K.)
CR Akbari M, 2014, DNA REPAIR, V16, P44, DOI 10.1016/j.dnarep.2014.01.015
   Akouchekian M, 2011, J RES MED SCI, V16, P50
   Akouchekian M, 2009, DIS COLON RECTUM, V52, P526, DOI 10.1007/DCR.0b013e31819acb99
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], 2019, HOM SAP MIT COMPL GE
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Babenko VA, 2015, STEM CELL TRANSL MED, V4, P1011, DOI 10.5966/sctm.2015-0010
   Bakhoum MF, 2018, GRAEF ARCH CLIN EXP, V256, P583, DOI 10.1007/s00417-018-3914-z
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Bianco A, 2018, INVEST OPHTH VIS SCI, V59, P331, DOI 10.1167/iovs.17-22822
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Bodzioch M, 2009, GENOMICS, V94, P247, DOI 10.1016/j.ygeno.2009.05.006
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Chang CY, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0158-8
   Choi Y, 2016, CIRCULATION, V133, P1297, DOI 10.1161/CIRCULATIONAHA.115.020463
   Cloos CR, 2009, RADIAT RES, V171, P581, DOI 10.1667/RR1395.1
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617
   Dang SW, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-28
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   Delsite Robert, 2002, Mol Cancer, V1, P6, DOI 10.1186/1476-4598-1-6
   Desler C, 2007, MUTAT RES-FUND MOL M, V625, P112, DOI 10.1016/j.mrfmmm.2007.06.002
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Dianov GL, 2001, PROG NUCLEIC ACID RE, V68, P285
   Dionisi-Vici C, 1998, J INHERIT METAB DIS, V21, P2, DOI 10.1023/A:1005397227996
   Dylag AM, 2019, AM J PHYSIOL-LUNG C, V317, pL737, DOI 10.1152/ajplung.00395.2019
   El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Falk MJ, 2010, CURR OPIN PEDIATR, V22, P711, DOI 10.1097/MOP.0b013e3283402e21
   Fan AXC, 2009, J CANCER RES CLIN, V135, P983, DOI 10.1007/s00432-008-0533-9
   Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236
   Feng S, 2011, ONCOL LETT, V2, P899, DOI 10.3892/ol.2011.322
   Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267
   Fu AL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00241
   Gao JH, 2015, MOL MED REP, V12, P7033, DOI 10.3892/mmr.2015.4256
   Ghaffarpour M, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-21
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guerra F, 2012, J CLIN ONCOL, V30, pE373, DOI 10.1200/JCO.2012.43.5933
   Hahn A, 2011, NEUROPEDIATRICS, V42, P148, DOI 10.1055/s-0031-1283167
   Han H, 2016, MOL MED REP, V13, P1517, DOI 10.3892/mmr.2015.4726
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Harrington JS, 2019, CHEST, V156, P1120, DOI 10.1016/j.chest.2019.07.014
   Hashizume M, 2013, AM J PHYSIOL-LUNG C, V304, pL287, DOI 10.1152/ajplung.00071.2012
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Hofmann JN, 2014, CARCINOGENESIS, V35, P1028, DOI 10.1093/carcin/bgt495
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hopkins JF, 2018, GASTROENTEROLOGY, V154, P1620, DOI 10.1053/j.gastro.2018.01.029
   HOWELL N, 1991, AM J HUM GENET, V49, P939
   Hsu CW, 2010, BREAST J, V16, P264, DOI 10.1111/j.1524-4741.2010.00908.x
   Huang B, 2014, CANCER EPIDEM BIOMAR, V23, P2357, DOI 10.1158/1055-9965.EPI-14-0297
   Hwang J M, 2000, Korean J Ophthalmol, V14, P45
   Iommarini L, 2017, BBA-BIOENERGETICS, V1858, P582, DOI 10.1016/j.bbabio.2017.02.006
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Ivanova R, 1998, INT J CANCER, V76, P495, DOI 10.1002/(SICI)1097-0215(19980518)76:4<495::AID-IJC9>3.3.CO;2-3
   Jerónimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   Jones JB, 2001, CANCER RES, V61, P1299
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kang KA, 2012, TUMOR BIOL, V33, P403, DOI 10.1007/s13277-012-0322-6
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   Kassauei K, 2006, J GASTROINTEST CANC, V37, P57, DOI 10.1007/s12029-007-0008-2
   Kim H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122049
   Kim HR, 2015, ANN LAB MED, V35, P1, DOI 10.3343/alm.2015.35.1.1
   Kim MM, 2004, CLIN CANCER RES, V10, P8512, DOI 10.1158/1078-0432.CCR-04-0734
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Koshikawa N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15592-2
   Kuo SJ, 2010, CANCER GENET CYTOGEN, V201, P94, DOI 10.1016/j.cancergencyto.2010.05.013
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Li X., 2017, TUMOUR BIOL, V39, p1010428317713671
   Lin CS, 2010, J THORAC CARDIOV SUR, V139, P189, DOI 10.1016/j.jtcvs.2009.04.007
   Lin Chen-Sung, 2008, Interact Cardiovasc Thorac Surg, V7, P954, DOI 10.1510/icvts.2008.177006
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   Liu VWS, 2001, CANCER RES, V61, P5998
   Loureiro R, 2017, SEMIN CANCER BIOL, V47, P18, DOI 10.1016/j.semcancer.2017.06.012
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002
   Maceluch Jaros Aw, 2006, Pediatr Endocrinol Rev, V4, P117
   Macmillan CJ, 1996, PEDIATR NEUROL, V14, P203, DOI 10.1016/0887-8994(96)00018-5
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   Makino M, 1998, NEUROMUSCULAR DISORD, V8, P149, DOI 10.1016/S0960-8966(98)00017-0
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Manfredi G, 1996, HUM MUTAT, V7, P158
   Máximo V, 2002, AM J PATHOL, V160, P1857, DOI 10.1016/S0002-9440(10)61132-7
   Máximo V, 2001, GENE CHROMOSOME CANC, V32, P136, DOI 10.1002/gcc.1175
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MERANTE F, 1994, AM J HUM GENET, V55, P437
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   Miyazono F, 2002, ONCOGENE, V21, P3780, DOI 10.1038/sj.onc.1205532
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Naito A, 2008, INT J CANCER, V122, P1506, DOI 10.1002/ijc.23235
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   NOER AS, 1991, AM J HUM GENET, V49, P715
   Parrella P, 2001, CANCER RES, V61, P7623
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Qu FL, 2015, CARCINOGENESIS, V36, P543, DOI 10.1093/carcin/bgv042
   Rachek LI, 2006, DIABETES, V55, P1022, DOI 10.2337/diabetes.55.04.06.db05-0865
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahmani Babak, 2012, Acta Med Iran, V50, P447
   Reddy PL, 2002, BRIT J HAEMATOL, V116, P564, DOI 10.1046/j.0007-1048.2001.03323.x
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Ronchi D, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-85
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sanchez-Cespedes M, 2001, CANCER RES, V61, P7015
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   Santorelli FM, 1997, NEUROMUSCULAR DISORD, V7, P156, DOI 10.1016/S0960-8966(97)00444-6
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schrijver I, 2009, GENET MED, V11, P118, DOI 10.1097/GIM.0b013e318190356b
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Shen J, 2015, CARCINOGENESIS, V36, P1307, DOI 10.1093/carcin/bgv130
   Shi XX, 2017, MITOCHONDRION, V34, P91, DOI 10.1016/j.mito.2017.02.005
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Singh KK, 2005, GENE, V354, P140, DOI 10.1016/j.gene.2005.03.027
   Singh RK, 2017, MITOCHONDRION, V35, P35, DOI 10.1016/j.mito.2017.05.001
   Smiraglia DJ, 2008, CANCER BIOL THER, V7, P1182, DOI 10.4161/cbt.7.8.6215
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Suzuki M, 2003, CLIN CANCER RES, V9, P5636
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tabebi M, 2017, J DIABETES COMPLICAT, V31, P253, DOI 10.1016/j.jdiacomp.2016.06.028
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tamura G, 1999, EUR J CANCER, V35, P316, DOI 10.1016/S0959-8049(98)00360-8
   Tan DJ, 2002, CANCER RES, V62, P972
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T
   Tranah GJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30255-6
   Tranah GJ, 2015, J GERONTOL A-BIOL, V70, P1418, DOI 10.1093/gerona/glv097
   Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326
   Tuchalska-Czurón J, 2019, PANCREATOLOGY, V19, P73, DOI 10.1016/j.pan.2018.11.009
   van Osch FHM, 2015, CARCINOGENESIS, V36, P1502, DOI 10.1093/carcin/bgv151
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   Voets AM, 2012, BBA-BIOENERGETICS, V1817, P1971, DOI 10.1016/j.bbabio.2012.07.001
   Voets AM, 2012, BBA-MOL BASIS DIS, V1822, P1161, DOI 10.1016/j.bbadis.2011.10.009
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211
   Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Webb E, 2008, BRIT J CANCER, V99, P2088, DOI 10.1038/sj.bjc.6604805
   Weerts MJA, 2017, CLIN CANCER RES, V23, P4735, DOI 10.1158/1078-0432.CCR-17-0032
   Wen SL, 2013, ONCOL LETT, V6, P1098, DOI 10.3892/ol.2013.1492
   Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Xu JF, 2020, CARCINOGENESIS, V41, P267, DOI 10.1093/carcin/bgz139
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002
   Yeh JJ, 2000, ONCOGENE, V19, P2060, DOI 10.1038/sj.onc.1203537
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   Yu EPK, 2016, FREE RADICAL BIO MED, V100, P223, DOI 10.1016/j.freeradbiomed.2016.06.011
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Yu M, 2009, EUR J CANCER PREV, V18, P445, DOI 10.1097/CEJ.0b013e32832f9bd6
   Yu Y, 2015, GENET MOL RES, V14, P17426, DOI 10.4238/2015.December.21.12
   Yuzefovych LV, 2016, CANCER RES, V76, P30, DOI 10.1158/0008-5472.CAN-15-0692
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhu X, 2017, MOL CARCINOGEN, V56, P2593, DOI 10.1002/mc.22703
NR 195
TC 17
Z9 19
U1 1
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD AUG 1
PY 2020
VL 39
IS 8
BP 1385
EP 1400
DI 10.1089/dna.2019.5220
EA JAN 2020
PG 16
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA MU1AS
UT WOS:000507621000001
PM 31944832
DA 2024-11-01
ER

PT J
AU Yokota, Y
   Hara, M
   Akimoto, T
   Mizoguchi, T
   Goto, Y
   Nishino, I
   Kamei, S
   Nakajima, H
AF Yokota, Yuki
   Hara, Makoto
   Akimoto, Takayoshi
   Mizoguchi, Tomotaka
   Goto, Yu-ichi
   Nishino, Ichizo
   Kamei, Satoshi
   Nakajima, Hideto
TI Late-onset MELAS syndrome with mtDNA 14453G→A mutation masquerading as
   an acute encephalitis: a case report
SO BMC NEUROLOGY
LA English
DT Article
DE MELAS; Late-onset; ND6 gene; Encephalitis
ID HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL-DNA MUTATION; ND6 GENE;
   LACTIC-ACIDOSIS; CLINICAL-FEATURES; SEQUENCE-ANALYSIS; EPISODES MELAS;
   ENCEPHALOPATHY; MYOPATHY; FAMILY
AB Background A unique patient with MELAS syndrome, who initially masqueraded as having acute encephalitis and was eventually diagnosed with MELAS syndrome harboring a mtDNA 14453G -> A mutation, is described. Case presentation A 74-year-old Japanese man was admitted to another hospital due to acute onset of cognitive impairment and psychosis. After 7 days he was transferred to our hospital with seizures and deteriorating psychosis. The results of primary ancillary tests that included EEG, CSF findings, and brain MRI supported the diagnosis of an acute encephalitis. HSV-DNA and antibodies against neuronal surface antigens in the CSF were all negative. With the assistance of the lactate peak on the brain lesions in the magnetic resonance spectroscopy image and genetic analysis of the biopsied muscle, he was eventually diagnosed with MELAS syndrome harboring mtDNA 14453G -> A mutation in the ND6 gene. Conclusions This case provides a caveat that MELAS syndrome can manifest in the symptoms and ancillary tests masquerading as an acute encephalitis caused by infection or autoimmunity. This is the first adult patient seen to harbor the mtDNA14453G -> A with a unique onset, which broadens the phenotypic spectrum of MELAS syndrome associated with ND6 gene mutation.
C1 [Yokota, Yuki; Hara, Makoto; Akimoto, Takayoshi; Mizoguchi, Tomotaka; Kamei, Satoshi; Nakajima, Hideto] Nihon Univ, Dept Med, Div Neurol, Sch Med,Itabashi Ku, 30-1 Oyaguchi Kamicyo, Tokyo 1738610, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Tokyo, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan.
   [Kamei, Satoshi] Ageo Cent Gen Hosp, Ctr Neuroinfect, Dept Neurol, Saitama, Japan.
C3 Nihon University; National Center for Neurology & Psychiatry - Japan;
   National Center for Neurology & Psychiatry - Japan; National Center for
   Neurology & Psychiatry - Japan
RP Hara, M (corresponding author), Nihon Univ, Dept Med, Div Neurol, Sch Med,Itabashi Ku, 30-1 Oyaguchi Kamicyo, Tokyo 1738610, Japan.
EM hara.makoto@nihon-u.ac.jp
RI Akimoto, Takayoshi/HLH-0519-2023; Nishino, Ichizo/G-2676-2010
OI Nakajima, Hideto/0000-0002-2154-9196
FU Intramural Research Grant for Neurological and Psychiatric Disorders of
   NCNP [29-4]; Takeda Science Foundation
FX This study was supported partly by Intramural Research Grant (29-4) for
   Neurological and Psychiatric Disorders of NCNP, and Takeda Science
   Foundation (to MH). The funding bodies supplied the manuscript with
   funding for data acquisition and analyses, writing the manuscript, and
   publication.
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Caporali L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007210
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DeVries DD, 1996, AM J HUM GENET, V58, P703
   Fassone E, 2012, J MED GENET, V49, P668, DOI 10.1136/jmedgenet-2012-101159corr1
   Gieraerts C, 2013, J COMPUT ASSIST TOMO, V37, P279, DOI 10.1097/RCT.0b013e3182811170
   Gooriah R, 2015, ACTA NEUROL BELG, V115, P789, DOI 10.1007/s13760-014-0416-6
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9
   Howell N, 1998, AM J HUM GENET, V62, P196, DOI 10.1086/301675
   Howell N, 2003, AM J HUM GENET, V72, P1460, DOI 10.1086/375537
   Hsu Yu-Chuan, 2012, J Emerg Med, V43, pe163, DOI 10.1016/j.jemermed.2009.10.021
   Ienco EC, 2016, MITOCHONDRION, V30, P148, DOI 10.1016/j.mito.2016.07.008
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   JOHNS DR, 1993, NEUROLOGY, V43, P2471, DOI 10.1212/WNL.43.12.2471
   Jun AS, 1996, MOL CELL BIOL, V16, P771
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   LeoKottler B, 1996, GER J OPHTHALMOL, V5, P233
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Lukyanova LD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00320
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   MIYABAYASHI S, 1992, J INHERIT METAB DIS, V15, P797, DOI 10.1007/BF01800024
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Qian YP, 2005, BIOCHEM BIOPH RES CO, V332, P614, DOI 10.1016/j.bbrc.2005.05.003
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Wang QX, 2004, AM J MED GENET A, V131A, P50, DOI 10.1002/ajmg.a.30323
   Wissinger B, 1997, BIOCHEM BIOPH RES CO, V234, P511, DOI 10.1006/bbrc.1997.6660
   Yokota M, 2015, HUM MOL GENET, V24, P4698, DOI 10.1093/hmg/ddv201
   Zhadanov SI, 2005, BIOCHEM BIOPH RES CO, V332, P1115, DOI 10.1016/j.bbrc.2005.05.059
NR 40
TC 13
Z9 17
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD JUN 17
PY 2020
VL 20
IS 1
AR 247
DI 10.1186/s12883-020-01818-w
PG 9
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA MB6DP
UT WOS:000542692100001
PM 32552696
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Eriksson, S
   Wang, L
AF Eriksson, Staffan
   Wang, Liya
TI Molecular mechanisms of mitochondrial DNA depletion diseases caused by
   deficiencies in enzymes in purine and pyrimidine metabolism
SO NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
LA English
DT Article; Proceedings Paper
CT 12th International Symposium on Purine and Pyrimidine Metabolism
CY JUN 24-28, 2007
CL Chicago, IL
DE mitochondrial DNA depletion syndrome; thymidine kinase2; deoxyguanosine
   kinase; mtDNA synthesis
ID THYMIDINE KINASE 2; CELLULAR DEOXYRIBONUCLEOSIDE KINASES; DEOXYGUANOSINE
   KINASE; RIBONUCLEOTIDE REDUCTASE; KINETIC-PROPERTIES; MTDNA DEPLETION;
   ALPERS-SYNDROME; POLG MUTATIONS; GENE; EXPRESSION
AB Mitochondrial DNA depletion syndrome (MDS), a reduction of mitochondrial DNA copy number, often affects muscle or liver. Mutations in enzymes of deoxyribonucleotide metabolism give MDS, for example, the mitochondrial thymidine kinase 2 (TK2) and deoxyguanosine kinase (dGK) genes. Sixteen TK2 and 22 dGK alterations are known. Their characteristics and symptoms are described. Levels of five key deoxynucleotide metabolizing enzymes in mouse tissues were measured. TK2 and dGK levels in muscles were 5- to 10-fold lower than other nonproliferating tissues and 100-fold lower compared to spleen. Each type of tissue apparently relies on de novo and salvage synthesis of DNA precursors to varying degrees.
C1 [Eriksson, Staffan; Wang, Liya] Swedish Univ Agr Sci, Dept Anat Phys & Biochem, SE-75123 Uppsala, Sweden.
C3 Swedish University of Agricultural Sciences
RP Eriksson, S (corresponding author), Swedish Univ Agr Sci, Dept Anat Phys & Biochem, BMC,POB 575, SE-75123 Uppsala, Sweden.
EM Staffan.Eriksson@afb.slu.se
CR Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Elpeleg O, 2003, PEDIATR RES, V54, P153, DOI 10.1203/01.PDR.0000072796.25097.A5
   Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Lam W, 2005, MOL PHARMACOL, V67, P408, DOI 10.1124/mol.104.007120
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Wang LY, 2003, FEBS LETT, V554, P319, DOI 10.1016/S0014-5793(03)01181-5
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
NR 30
TC 16
Z9 18
U1 0
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1525-7770
J9 NUCLEOS NUCLEOT NUCL
JI Nucleosides Nucleotides Nucleic Acids
PY 2008
VL 27
IS 6-7
BP 800
EP 808
DI 10.1080/15257770802146197
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology
GA 321XA
UT WOS:000257338600043
PM 18600543
DA 2024-11-01
ER

PT J
AU Baykara, O
   Sahin, SK
   Akbas, F
   Guven, M
   Onaran, I
AF Baykara, O.
   Sahin, S. K.
   Akbas, F.
   Guven, M.
   Onaran, I.
TI The effects of mitochondrial DNA deletion and copy number variations on
   different exercise intensities in highly trained swimmers
SO CELLULAR AND MOLECULAR BIOLOGY
LA English
DT Article
DE mtDNA4977 deletion; oxidative stress; mtDNA content
ID 4977 BP DELETION; BLOOD OXIDATIVE STRESS; ANTIOXIDANT STATUS; COMMON
   DELETION; HUMAN-DISEASE; CELLS; MUTATIONS; MUSCLE; LYMPHOCYTES;
   METABOLISM
AB It has been suggested that heavy exercise might increase oxidative stress, causing mitochondrial DNA (mtDNA) mutations as well as DNA mutations and changes in the mtDNA copy number in cells. mtDNA(4977) deletion is one of the most common deletions seen on mitochondria. We hypothesize association between exercise induced oxidative stress and mtDNA damage in peripheral blood lymphocytes (PBLs) of highly trained swimmers. Therefore we studied the mtDNA(4977) deletion level, mtDNA copy number and their relationship with cellular ATP and oxidative stress status in PBLs of swimmers. 8 highly trained and 8 normal trained swimmers and 8 non-athlete subjects were included in the study. The mtDNA(4977) deletion and amount of mtDNA were measured using RT-PCR method whereas dichlorohydrofluoroscein (DCF) assay method was used to assess cellular oxidative stress and ATP levels were measured using bioluminescence method. Even though an increase in mtDNA(4977) deletion was found in all study groups, the difference was not statistically significant (p=0.98). The mtDNA copy numbers were found to be surprisingly high in highly trained swimmers compared to normal trained swimmers and non-athlete subjects by 4.03 fold (p= 0.0002) and 5.58 fold (p= 0.0003), respectively. No significant differences were found between groups by means of intracellular ATP levels (p= 0.406) and oxidative stress (p= 0.430). No correlation was found between mtDNA copy number and intracellular ATP content of the PBLs (p= 0.703). Our results suggest that heavy training does not have a specific effect on mtDNA(4977) deletion but it may be affecting mitochondrial copy numbers which may act as a compensatory mechanism related to ATP levels in blood.
C1 [Baykara, O.; Guven, M.; Onaran, I.] Istanbul Univ, Cerrahpasa Med Fac, Dept Med Biol, Istanbul, Turkey.
   [Sahin, S. K.] Uludag Univ, Fac Educ, Dept Phys Educ, Bursa, Turkey.
   [Akbas, F.] Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Istanbul, Turkey.
C3 Istanbul University - Cerrahpasa; Istanbul University; Uludag
   University; Bezmialem Vakif University
RP Baykara, O (corresponding author), Istanbul Univ, Cerrahpasa Tip Fak, Tibbi Biyol & Genet ABD, Kat 6, TR-34098 Istanbul, Turkey.
EM obaykara@istanbul.edu.tr
RI Onaran, İlhan/AAH-9124-2019; Akbas, Fahri/AAQ-7015-2020; GUVEN,
   MEHMET/C-9833-2019; Baykara, Onur/V-5990-2018
OI Onaran, Ilhan/0000-0003-4630-9516; Baykara, Onur/0000-0002-9754-8456;
   SAHIN, SENAY/0000-0002-5670-7166; GUVEN, MEHMET/0000-0002-8749-1708
FU Research Fund of Istanbul University (Istanbul Universitesi Bilimsel
   Arastirma Projeleri Birimi) [46470]
FX This work was supported by the Research Fund of Istanbul University
   (Istanbul Universitesi Bilimsel Arastirma Projeleri Birimi) (Project
   number: 46470).
CR Alessio HM, 1997, INT J SPORT NUTR, V7, P1
   [Anonymous], 2015, HUMAN MITOCHONDRIAL
   Awobajo F O, 2013, Nig Q J Hosp Med, V23, P117
   Balakrishnan SD, 1998, CELL BIOCHEM FUNCT, V16, P269, DOI 10.1002/(SICI)1099-0844(1998120)16:4<269::AID-CBF797>3.3.CO;2-2
   Chen B, 2011, MOL BIOL REP, V38, P3635, DOI 10.1007/s11033-010-0476-5
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   De Lucas RD, 2014, J SPORT SCI, V32, P22, DOI 10.1080/02640414.2013.797098
   Dimberg J, 2014, ANTICANCER RES, V34, P147
   Drew B, 2004, ACTA PHYSIOL SCAND, V182, P333, DOI 10.1111/j.1365-201X.2004.01371.x
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   Finaud J, 2006, SPORTS MED, V36, P327, DOI 10.2165/00007256-200636040-00004
   Finaud J, 2006, INT J SPORTS MED, V27, P87, DOI 10.1055/s-2005-837489
   GATTERMANN N, 1995, LEUKEMIA, V9, P1704
   Gougoura S, 2007, EUR J APPL PHYSIOL, V100, P235, DOI 10.1007/s00421-007-0423-x
   Hou JH, 1998, MUTAT RES, V403, P5
   Howell N, 1996, AM J HUM GENET, V59, P501
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Jafari A, 2005, BRIT J SPORT MED, V39, P517, DOI 10.1136/bjsm.2004.014068
   Jou MJ, 2007, J PINEAL RES, V43, P389, DOI 10.1111/j.1600-079X.2007.00490.x
   Kara M, 2012, BALK J MED GENET, V15, P25, DOI 10.2478/v10034-012-0004-0
   Lanza IR, 2009, AM J CLIN NUTR, V89, p467S, DOI 10.3945/ajcn.2008.26717D
   LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012
   Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lobachev AN, 1978, DEPOSITED DOC, P2172
   Lobachev AN, 1985, DEPOSITED DOC, V6756-B85, P28
   Malik Afshan N, 2009, Diabetes Res Clin Pract, V86, pe22, DOI 10.1016/j.diabres.2009.07.002
   Marin DP, 2013, INT IMMUNOPHARMACOL, V17, P462, DOI 10.1016/j.intimp.2013.07.009
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mohamed SA, 2004, EXP GERONTOL, V39, P181, DOI 10.1016/j.exger.2003.10.011
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Navarro F, 2013, EUR J APPL PHYSIOL, V113, P1343, DOI 10.1007/s00421-012-2554-y
   Nie HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067953
   Nielsen HB, 2003, SPORTS MED, V33, P853, DOI 10.2165/00007256-200333110-00005
   Nikolaidis MG, 2007, APPL PHYSIOL NUTR ME, V32, P197, DOI 10.1139/H06-097
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Ramond A, 2013, FUND CLIN PHARMACOL, V27, P252, DOI 10.1111/j.1472-8206.2011.01015.x
   SAHIN SK, 2013, EUR J EXP BIOL, V3, P211
   Schneider CD, 2005, CAN J APPL PHYSIOL, V30, P723, DOI 10.1139/h05-151
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Siems WG, 1999, QJM-INT J MED, V92, P193, DOI 10.1093/qjmed/92.4.193
   SINGH N, 1995, MOL CELL BIOCHEM, V147, P77, DOI 10.1007/BF00944786
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   von Wurmb N, 1998, MUTAT RES-FUND MOL M, V422, P247, DOI 10.1016/S0027-5107(98)00205-X
   von Wurmb-Schwark N, 2010, MECH AGEING DEV, V131, P179, DOI 10.1016/j.mad.2010.01.005
   WALLACE DC, 1990, PEDIATR RES, V28, P525, DOI 10.1203/00006450-199011000-00023
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Wen Q, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-133
   Wong J, 2009, DIABETOLOGIA, V52, P1953, DOI 10.1007/s00125-009-1424-6
   Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454
   Ye CZ, 2002, CLIN CHIM ACTA, V318, P33, DOI 10.1016/S0009-8981(01)00799-9
NR 56
TC 9
Z9 11
U1 1
U2 10
PU C M B  ASSOC
PI POITIERS
PA 34 BOULEVARD SOLFERINO, 86000 POITIERS, FRANCE
SN 0145-5680
EI 1165-158X
J9 CELL MOL BIOL
JI Cell. Mol. Biol.
PY 2016
VL 62
IS 12
BP 109
EP 115
DI 10.14715/cmb/2016.62.12.19
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA EN6NX
UT WOS:000396121800019
PM 27894409
DA 2024-11-01
ER

PT J
AU Stojanovic, V
   Mayr, JA
   Sperl, W
   Barisic, N
   Doronjski, A
   Milak, G
AF Stojanovic, Vesna
   Mayr, Johannes A.
   Sperl, Wolfgang
   Barisic, Nenad
   Doronjski, Aleksandra
   Milak, Gordana
TI Infantile peripheral neuropathy, deafness, and proximal tubulopathy
   associated with a novel mutation of the RRM2B gene: case study
SO CROATIAN MEDICAL JOURNAL
LA English
DT Article
ID MITOCHONDRIAL-DNA DEPLETION
AB Mitochondrial DNA depletion syndromes are a group of autosomal recessive hereditary disorders characterized by reduction of the amount of mitochondrial DNA in the affected tissue (muscle, liver, brain, or kidneys). We report a case of an infant with myopathy, deafness, peripheral neuropathy, nephrocalcinosis, proximal renal tubulopathy, moderate lactic acidosis, and a novel mutation of the RRM2B gene.
C1 [Stojanovic, Vesna; Barisic, Nenad; Doronjski, Aleksandra] Univ Novi Sad, Fac Med, Novi Sad 21000, Serbia.
   [Stojanovic, Vesna; Barisic, Nenad; Doronjski, Aleksandra; Milak, Gordana] Inst Child & Youth Hlth Care Vojvodina, Novi Sad, Serbia.
   [Mayr, Johannes A.; Sperl, Wolfgang] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.
C3 University of Novi Sad; Paracelsus Private Medical University
RP Barisic, N (corresponding author), Univ Novi Sad, Fac Med, Inst Child & Youth Hlth Care Vojvodina, Hajduk Veljkova 10, Novi Sad 21000, Serbia.
EM barisicnenadns@gmail.com
RI Barisic, Nenad/H-8099-2019
OI Barisic, Nenad/0000-0002-6881-7856; Stojanovic,
   Vesna/0000-0003-4917-8961; Mayr, Johannes/0000-0001-6970-336X
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Santoro L, 2006, J NEUROL, V253, P869, DOI 10.1007/s00415-006-0082-6
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
NR 7
TC 13
Z9 15
U1 0
U2 8
PU MEDICINSKA NAKLADA
PI ZAGREB
PA VLASKA 69, HR-10000 ZAGREB, CROATIA
SN 0353-9504
EI 1332-8166
J9 CROAT MED J
JI Croat. Med. J.
PD DEC
PY 2013
VL 54
IS 6
BP 579
EP 584
DI 10.3325/cmj.2013.54.579
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 291KE
UT WOS:000329826800011
PM 24382854
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Brinckmann, A
   Rüther, K
   Williamson, K
   Lorenz, B
   Lucke, B
   Nuernberg, P
   Trijbels, F
   Janssen, A
   Schuelke, M
AF Brinckmann, Anja
   Ruether, Klaus
   Williamson, Kathleen
   Lorenz, Birgit
   Lucke, Barbara
   Nuernberg, Peter
   Trijbels, Frans
   Janssen, Antoon
   Schuelke, Markus
TI De novo double mutation in <i>PAX6</i> and mtDNA
   <i>tRNA<SUP>Lys</SUP></i> associated with atypical aniridia and
   mitochondrial disease
SO JOURNAL OF MOLECULAR MEDICINE-JMM
LA English
DT Article
DE mtDNA; heteroplasmy; PAX6; ptosis; nystagmus; pyrosequencing
ID DNA; POLYMORPHISM; HUMANS; GENE
AB We report on the clinical, molecular and biochemical findings of a patient with the rare event (< 4.02 x 10(-9) per generation) of coinciding de novo mutations in the nuclear PAX6 ( c. 1252 - 1267del16) and the mitochondrial mt.RNA(Lys) (8347A -> G) genes. The boy suffers from exercise intolerance, ptosis, nystagmus, macular hypoplasia and anterior segment abnormalities evocative of Axenfeld-Rieger anomaly. The PAX6 mutation is predicted to cause haploinsufficiency. The novel mt.RNA(Lys) mutation is located close to the classic myoclonic epilepsy with ragged-red-fibers mutation, but the patient exhibits neither myoclonic epilepsy nor ragged-red-fibers. The degree of mutant mtDNA heteroplasmy, as determined by a very accurate pyrosequencing assay, varies between 31% ( muscle) and 38% ( fibroblasts). We discuss a potential effect of the PAX6 mutation on the mtDNA mutation rate.
C1 Charite Univ Med Berlin, Dept Neuropediat, D-13353 Berlin, Germany.
   Charite Univ Med Berlin, Neurosci Res Ctr, D-13353 Berlin, Germany.
   Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany.
   Charite Univ Med Berlin, Dept Ophthalmol, D-13353 Berlin, Germany.
   Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.
   Klinikum Univ Regensburg, Dept Pediat Ophthalmol Strabismol & Ophthalmogene, Regensburg, Germany.
   Univ Cologne, Cologne Ctr Genome, D-5000 Cologne 41, Germany.
   Univ Cologne, Inst Genet, D-5000 Cologne 41, Germany.
   Univ Med Ctr St Radboud, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, Nijmegen, Netherlands.
C3 Berlin Institute of Health; Berlin Institute of Health; Free University
   of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin; Berlin Institute of Health; Berlin Institute of Health; Free
   University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Free University of Berlin; Berlin Institute
   of Health; Berlin Institute of Health; Free University of Berlin;
   Humboldt University of Berlin; Charite Universitatsmedizin Berlin;
   University of Edinburgh; University of Regensburg; University of
   Cologne; University of Cologne; Radboud University Nijmegen
RP Schuelke, M (corresponding author), Charite Univ Med Berlin, Dept Neuropediat, Augustenburger Pl 1, D-13353 Berlin, Germany.
EM markus.schuelke@charite.de
OI Schuelke, Markus/0000-0003-2824-3891
FU PHS HHS [01GR0416] Funding Source: Medline
CR [Anonymous], HUMAN PAX6 ALLELIC V
   Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   CORONA P, 2001, ANN NEUROL, V51, P122
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   ERNST BP, 1994, MOL CELL PROBE, V8, P45, DOI 10.1006/mcpr.1994.1006
   GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232
   Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028
   Krempler F, 2002, DIABETES, V51, P3331, DOI 10.2337/diabetes.51.11.3331
   Levitt NC, 2002, TRENDS MOL MED, V8, P179, DOI 10.1016/S1471-4914(02)02298-0
   Malandrini A, 2001, CLIN GENET, V60, P151, DOI 10.1034/j.1399-0004.2001.600210.x
   Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16
   Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042
   SPENCER Herbert, 1901, ENCY LIFE SCI, P1
   Tzoulaki I, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-27
   Uhlmann K, 2002, ELECTROPHORESIS, V23, P4072, DOI 10.1002/elps.200290023
   van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Wong LJC, 1997, CLIN CHEM, V43, P1241
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
NR 22
TC 8
Z9 10
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0946-2716
J9 J MOL MED-JMM
JI J. Mol. Med.
PD FEB
PY 2007
VL 85
IS 2
BP 163
EP 168
DI 10.1007/s00109-006-0112-y
PG 6
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA 137NS
UT WOS:000244299900008
PM 17031679
DA 2024-11-01
ER

PT J
AU Russell, O
   Turnbull, D
AF Russell, Oliver
   Turnbull, Doug
TI Mitochondrial DNA disease-molecular insights and potential routes to a
   cure
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Review
DE Mitochondrial disease; Treatments; Zinc-finger nucleases; TALENs
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MYOCLONUS EPILEPSY; TRANSFER-RNA;
   MUTATION; MTDNA; DELETIONS; DEFECT; MERRF; TRNA(LYS); ELECTRON
AB Mitochondrial DNA diseases are common neurological conditions caused by mutations in the mitochondrial genome or nuclear genes responsible for its maintenance. Current treatments for these disorders are focussed on the management of the symptoms, rather than the correction of biochemical defects caused by the mutation. This review focuses on the molecular effects of mutations, the symptoms they cause and current work focusing on the development of targeted treatments for mitochondrial DNA disease. (C) 2014 The Authors. Published by Elsevier Inc.
C1 [Turnbull, Doug] Newcastle Univ, Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Turnbull, D (corresponding author), Newcastle Univ, Ctr Brain Ageing & Vital, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
OI Turnbull, Doug/0000-0002-8878-9901; Russell, Oliver/0000-0002-9414-9193
FU Newcastle University Centre for Brain Ageing and Vitality -
   Biotechnology and Biological Sciences Research Council; Engineering and
   Physical Sciences Research Council; Economic and Social Research
   Council; Medical Research Council [G0700718]; UK NIHR Biomedical
   Research Centre in Age and Age Related Diseases award; MRC Centre for
   Neuromuscular Disease [G000608-1]; Wellcome Trust Centre for
   Mitochondrial Research [096919/Z/11/Z]]; Lily Foundation; UK NHS
   Specialist Commissioners "Rare Mitochondrial Disorders of Adults and
   Children" Service; MRC [G0700718, MR/K006312/1] Funding Source: UKRI
FX The authors are funded by Newcastle University Centre for Brain Ageing
   and Vitality (supported by the Biotechnology and Biological Sciences
   Research Council, Engineering and Physical Sciences Research Council,
   Economic and Social Research Council and Medical Research Council
   [G0700718]), the UK NIHR Biomedical Research Centre in Age and Age
   Related Diseases award to the Newcastle upon Tyne Hospitals NHS
   Foundation Trust, MRC Centre for Neuromuscular Disease [G000608-1], The
   Wellcome Trust Centre for Mitochondrial Research [096919/Z/11/Z], The
   Lily Foundation and the UK NHS Specialist Commissioners "Rare
   Mitochondrial Disorders of Adults and Children" Service.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bacman S.R., 2013, NAT MED
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady J.P., 2013, BRAIN
   HARTZOG PE, 1993, J BIOL CHEM, V268, P12250
   Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927
   HOLME E, 1993, AM J HUM GENET, V52, P551
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   LARSSON NG, 1992, BIOCHIM BIOPHYS ACTA, V1139, P311, DOI 10.1016/0925-4439(92)90106-W
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2002, ACTA NEUROL BELG, V102, P39
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 40
TC 68
Z9 73
U1 0
U2 13
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD JUL 1
PY 2014
VL 325
IS 1
SI SI
BP 38
EP 43
DI 10.1016/j.yexcr.2014.03.012
PG 6
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA AI9QF
UT WOS:000337267100006
PM 24675282
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Serag, M
   Plutino, M
   Charles, P
   Azulay, JP
   Chaussenot, A
   Paquis-Flucklinger, V
   Saadi, SAE
   Rouzier, C
AF Serag, Mounir
   Plutino, Morgane
   Charles, Perrine
   Azulay, Jean-Philippe
   Chaussenot, Annabelle
   Paquis-Flucklinger, Veronique
   Saadi, Samira Ait-El-Mkadem
   Rouzier, Cecile
TI A Case Report of SYNE1 Deficiency-Mimicking Mitochondrial Disease and
   the Value of Pangenomic Investigations
SO GENES
LA English
DT Article
DE WES; array-CGH; SYNE1; mitochondrial disorder
ID NEWLY DISCOVERED FORM; MUTATIONS; DNA; NESPRIN-1; FEATURES; CRITERIA;
   DEFECTS; ATAXIA; MUSCLE; LEAD
AB Mitochondrial disorders are characterized by a huge clinical, biochemical, and genetic heterogeneity, which poses significant diagnostic challenges. Several studies report that more than 50% of patients with suspected mitochondrial disease could have a non-mitochondrial disorder. Thus, only the identification of the causative pathogenic variant can confirm the diagnosis. Herein, we describe the diagnostic journey of a family suspected of having a mitochondrial disorder who were referred to our Genetics Department. The proband presented with the association of cerebellar ataxia, COX-negative fibers on muscle histology, and mtDNA deletions. Whole exome sequencing (WES), supplemented by a high-resolution array, comparative genomic hybridization (array-CGH), allowed us to identify two pathogenic variants in the non-mitochondrial SYNE1 gene. The proband and her affected sister were found to be compound heterozygous for a known nonsense variant (c.13258C>T, p.(Arg4420Ter)), and a large intragenic deletion that was predicted to result in a loss of function. To our knowledge, this is the first report of a large intragenic deletion of SYNE1 in patients with cerebellar ataxia (ARCA1). This report highlights the interest in a pangenomic approach to identify the genetic basis in heterogeneous neuromuscular patients with the possible cause of mitochondrial disease. Moreover, even rare copy number variations should be considered in patients with a phenotype suggestive of SYNE1 deficiency.
C1 [Serag, Mounir; Plutino, Morgane; Chaussenot, Annabelle; Paquis-Flucklinger, Veronique; Saadi, Samira Ait-El-Mkadem; Rouzier, Cecile] Hop Archet 2, Serv Genet Medicale, Serv Genet Med, 151 Route St Antoine Ginestiere, F-06202 Nice, France.
   [Serag, Mounir; Plutino, Morgane; Chaussenot, Annabelle; Paquis-Flucklinger, Veronique; Saadi, Samira Ait-El-Mkadem; Rouzier, Cecile] Univ Cote Azur, CNRS UMR7284 INSERM U1081, Fac Med, F-06107 Nice, France.
   [Charles, Perrine] La Pitie Salpetriere, Pitie Salpetriere, AP HP, F-75610 Paris, France.
   [Azulay, Jean-Philippe] Serv Neurol, F-13005 Marseille, France.
C3 CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS -
   National Institute for Biology (INSB); Institut National de la Sante et
   de la Recherche Medicale (Inserm); Universite Cote d'Azur; Sorbonne
   Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP
RP Rouzier, C (corresponding author), Hop Archet 2, Serv Genet Medicale, Serv Genet Med, 151 Route St Antoine Ginestiere, F-06202 Nice, France.; Rouzier, C (corresponding author), Univ Cote Azur, CNRS UMR7284 INSERM U1081, Fac Med, F-06107 Nice, France.
EM serag.m@chu-nice.fr; plutino.m@chu-nice.fr; perrine.charles@aphp.fr;
   jean-philippe.azulay@ap-hm.fr; chaussenot.a@chu-nice.fr;
   veronique.paquis@unice.fr; saadi.s@chu-nice.fr; rouzier.c@chu-nice.fr
RI Plutino, Morgane/JGD-4310-2023; Rouzier, Cecile/KCY-3619-2024
OI Rouzier, cecile/0000-0002-2969-1904
FU Fondation Maladies Rares
FX No Statement Available
CR Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024
   Arias M, 2022, NEUROLOGIA, V37, P257, DOI 10.1016/j.nrl.2019.01.004
   Attali R, 2009, HUM MOL GENET, V18, P3462, DOI 10.1093/hmg/ddp290
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Bargiela David, 2015, Cerebellum Ataxias, V2, P16, DOI 10.1186/s40673-015-0035-x
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bris C, 2021, GENET MED, V23, P1769, DOI 10.1038/s41436-021-01206-w
   BYRNE E, 1992, MUTAT RES, V275, P125, DOI 10.1016/0921-8734(92)90017-J
   Chen ZZ, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0424-5
   COLLINS S, 1995, ACTA NEUROL SCAND, V91, P287, DOI 10.1111/j.1600-0404.1995.tb07007.x
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Duan XH, 2021, CEREBELLUM, V20, P74, DOI 10.1007/s12311-020-01186-8
   Dupré N, 2007, M S-MED SCI, V23, P261, DOI 10.1051/medsci/2007233261
   Frascarelli C, 2023, FRONT GENET, V14, DOI 10.3389/fgene.2023.1089956
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927
   Indelicato E, 2019, PARKINSONISM RELAT D, V62, P210, DOI 10.1016/j.parkreldis.2018.12.007
   Izumi Y, 2013, NEUROLOGY, V80, P600, DOI 10.1212/WNL.0b013e3182815529
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   Legati A, 2021, J MOL DIAGN, V23, P732, DOI 10.1016/j.jmoldx.2021.03.002
   Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5
   Mademan I, 2016, BRAIN, V139, DOI 10.1093/brain/aww115
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Ngo KJ, 2020, HUM MUTAT, V41, P487, DOI 10.1002/humu.23946
   Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9
   Pyle A, 2015, BRAIN, V138, P276, DOI 10.1093/brain/awu348
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Schon KR, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-066288
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   Swan L, 2018, CLINICS PRACT, V8, P91, DOI 10.4081/cp.2018.1071
   Synofzik M, 2016, BRAIN, V139, P1378, DOI 10.1093/brain/aww079
   Theunissen TEJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00400
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wedding IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086340
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   YAMAMOTO M, 1989, J NEUROL SCI, V91, P207, DOI 10.1016/0022-510X(89)90088-9
   Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238
   Zhou C, 2017, HUM MOL GENET, V26, P2258, DOI 10.1093/hmg/ddx116
NR 39
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD DEC
PY 2023
VL 14
IS 12
AR 2154
DI 10.3390/genes14122154
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA DM2U8
UT WOS:001132403200001
PM 38136976
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Rahman, MM
   Young, CKJ
   Goffart, S
   Pohjoismäki, JLO
   Young, MJ
AF Rahman, Md Mostafijur
   Young, Carolyn K. J.
   Goffart, Steffi
   Pohjoismaki, Jaakko L. O.
   Young, Matthew J.
TI Heterozygous p.Y955C mutation in DNA polymerase γ leads to alterations
   in bioenergetics, complex I subunit expression, and mtDNA replication
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HUMAN MITOCHONDRIAL-DNA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   TRANSCRIPTION-FACTOR-A; SACCHAROMYCES-CEREVISIAE; NUCLEOSIDE ANALOGS;
   HELICASE TWINKLE; DISEASE VARIANT; TOXICITY; CELLS; POLG
AB In human cells, ATP is generated using oxidative phosphorylation machinery, which is inoperable without proteins encoded by mitochondrial DNA (mtDNA). The DNA polymerase gamma (Pol gamma) repairs and replicates the multicopy mtDNA genome in concert with additional factors. The Pol gamma catalytic subunit is encoded by the POLG gene, and mutations in this gene cause mtDNA genome instability and disease. Barriers to studying the molecular effects of disease mutations include scarcity of patient samples and a lack of available mutant models; therefore, we developed a human SJCRH30 myoblast cell line model with the most common autosomal dominant POLG mutation, c.2864A>G/p.Y955C, as individuals with this mutation can present with progressive skeletal muscle weakness. Using on-target sequencing, we detected a 50% conversion frequency of the mutation, confirming heterozygous Y955C substitution. We found mutated cells grew slowly in a glucose-containing medium and had reduced mitochondrial bioenergetics compared with the parental cell line. Furthermore, growing Y955C cells in a galactose-containing medium to obligate mitochondrial function enhanced these bioenergetic deficits. Also, we show complex I NDUFB8 and ND3 protein levels were decreased in the mutant cell line, and the maintenance of mtDNA was severely impaired (i.e., lower copy number, fewer nucleoids, and an accumulation of Y955C-specific replication intermediates). Finally, we show the mutant cells have increased sensitivity to the mitochondrial toxicant 2'-3'-dideoxycytidine. We expect this POLG Y955C cell line to be a robust system to identify new mitochondrial toxicants and therapeutics to treat mitochondrial dysfunction.
C1 [Rahman, Md Mostafijur; Young, Carolyn K. J.; Young, Matthew J.] Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA.
   [Goffart, Steffi; Pohjoismaki, Jaakko L. O.] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland.
C3 Southern Illinois University System; Southern Illinois University;
   University of Eastern Finland
RP Young, MJ (corresponding author), Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA.
EM matthew.young@siu.edu
RI Pohjoismaeki, Jaakko/AAC-7995-2019; Rahman, Md. Mostafijur/GPC-8781-2022
OI Pohjoismaki, Jaakko/0000-0002-1185-3610; Rahman, Md.
   Mostafijur/0000-0002-2857-0369
FU National Institute of Environmental Health Sciences (NIEHS, National
   Institutes of Health) Pathway to Independence Award [5R00ES022638-04];
   NIEHS, National Institutes of Health [1R15ES033394-01]; SIU School of
   Medicine; SIU Carbondale Doctoral Research Fellowship
FX This research was supported by a National Institute of Environmental
   Health Sciences (NIEHS, National Institutes of Health) Pathway to
   Independence Award to M. J. Y. (5R00ES022638-04), an NIEHS, National
   Institutes of Health R15 to M. J. Y. (1R15ES033394-01), start-up funds
   from SIU School of Medicine to M. J. Y, and by an SIU Carbondale
   Doctoral Research Fellowship to M. M. R. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health.
CR Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186
   Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002
   Bjork JA, 2021, TOXICOL APPL PHARM, V433, DOI 10.1016/j.taap.2021.115783
   Chaudhry A, 2020, AM J PHYSIOL-ENDOC M, V318, pE87, DOI 10.1152/ajpendo.00457.2019
   Chen C, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104631
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   Ciesielska EJ, 2021, MITOCHONDRION, V61, P147, DOI 10.1016/j.mito.2021.09.010
   Civitarese AE, 2010, CELL METAB, V11, P412, DOI 10.1016/j.cmet.2010.04.004
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Clayton David A, 2014, Cold Spring Harb Protoc, V2014, DOI 10.1101/pdb.prot080002
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3
   Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677
   Duong VN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66153-z
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r
   Falabella M, 2019, CURR MED CHEM, V26, P2918, DOI 10.2174/0929867325666180228165527
   Falkenberg M, 2020, CRIT REV BIOCHEM MOL, V55, P509, DOI 10.1080/10409238.2020.1818684
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Green M.R., 2012, MOL CLONING LAB MANU
   Gustafson MA, 2020, DNA REPAIR, V93, DOI 10.1016/j.dnarep.2020.102916
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182
   Khurana L, 2019, METHOD ENZYMOL, V629, P307, DOI 10.1016/bs.mie.2019.05.053
   Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253
   Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1324
   Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li CF, 2021, AUTOPHAGY, V17, P948, DOI [10.1080/15548627.2020.1739447, 10.1145/3421766.3421867]
   Li M, 2016, ANTIMICROB AGENTS CH, V60, P5608, DOI 10.1128/AAC.00976-16
   Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011
   Lobo-Jarne T, 2018, SEMIN CELL DEV BIOL, V76, P179, DOI 10.1016/j.semcdb.2017.07.021
   Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052
   MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743
   Matic S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03552-x
   MEDINA DJ, 1994, ANTIMICROB AGENTS CH, V38, P1824, DOI 10.1128/AAC.38.8.1824
   Melkonian E. A, 2022, Biochemistry, Anaerobic Glycolysis
   Mello DF, 2022, ENVIRON SCI TECHNOL, V56, P1113, DOI 10.1021/acs.est.1c05915
   Morino K, 2012, DIABETES, V61, P877, DOI 10.2337/db11-1391
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Ohnstad HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-211
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Pohjoismäki JLO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010426
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Prasad R, 2017, DNA REPAIR, V60, P77, DOI 10.1016/j.dnarep.2017.10.011
   Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2
   ROBERTS WM, 1989, CANCER RES, V49, P5407
   Rocher C, 2008, J BIOENERG BIOMEMBR, V40, P59, DOI 10.1007/s10863-008-9130-5
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Schlieben LD, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.600079
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Setzer B, 2005, ANTIVIR THER, V10, P327
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Siibak T, 2017, HUM MOL GENET, V26, P2515, DOI 10.1093/hmg/ddx146
   Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177
   Singh B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140409
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Sufit A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165107
   Sykora P, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00237-17
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Torregrosa-Muñumer R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45244-6
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wallace KB, 2022, TOXICOL APPL PHARM, V442, DOI 10.1016/j.taap.2022.116003
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wheeler Joel H, 2019, Curr Protoc Toxicol, V80, pe75, DOI 10.1002/cptx.75
   Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI [10.1038/nchembio.2102, 10.1038/NCHEMBIO.2102]
   Xu YL, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.02237-20
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   Young CKJ, 2019, CELL CYCLE, V18, P476, DOI 10.1080/15384101.2019.1578133
   Young CKJ, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.014885
   Young MJ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00074
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
NR 101
TC 1
Z9 1
U1 2
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG
PY 2022
VL 298
IS 8
AR 102196
DI 10.1016/j.jbc.2022.102196
EA JUL 2022
PG 29
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 3S2WH
UT WOS:000839461200010
PM 35760101
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Scruggs, ER
   Naylor, AJD
AF Scruggs, Erin R.
   Naylor, Amie J. Dirks
TI Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy
SO PHARMACOLOGY
LA English
DT Review
DE azidothymidine; zidovudine; skeletal muscle; apoptosis; oxidative stress
ID SKELETAL-MUSCLE; OXIDATIVE STRESS; DNA DEPLETION; L-CARNITINE;
   APOPTOSIS; AZT; CELLS; EXPRESSION; INHIBITOR; SUSCEPTIBILITY
AB Zidovudine (3-azido-3 '-deoxythymidine), also referred to as azidothymidine (AZT), has become an integral component in highly active antiretroviral therapy, and has also been used in the treatment of cancer. The clinical effectiveness of AZT is constrained due to its association with increased adverse effects, such as myopathy. There are numerous potential mechanisms that may contribute to AZT-induced myopathy. The first hypothesized mechanism to explain AZT-induced toxicity was mtDNA depletion due to inhibition of DNA polymerase gamma. Although mtDNA depletion is present in patients with myopathy, current data suggests that alternative mechanisms may play a more direct role in the myotoxicity. These mechanisms include AZT-induced oxidative stress, direct inhibition of mitochondrial bioenergetic machinery, and mitochondrial depletion of L-carnitine. Furthermore, we hypothesize that apoptosis may play a role in AZT-induced myopathy. Copyright (C) 2008 S. Karger AG, Basel.
C1 [Scruggs, Erin R.; Naylor, Amie J. Dirks] Wingate Univ, Sch Pharm, Wingate, NC 28174 USA.
C3 Wingate University
RP Naylor, AJD (corresponding author), Wingate Univ, Sch Pharm, 316 N Main St, Wingate, NC 28174 USA.
EM adirks@wingate.edu
CR Adams V, 1999, J AM COLL CARDIOL, V33, P959, DOI 10.1016/S0735-1097(98)00626-3
   Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579
   Alway SE, 2003, J GERONTOL A-BIOL, V58, P687
   Alway SE, 2002, AM J PHYSIOL-CELL PH, V283, pC66, DOI 10.1152/ajpcell.00598.2001
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Belizário JE, 2001, BRIT J CANCER, V84, P1135, DOI 10.1054/bjoc.2001.1700
   Cazzalini O, 2001, BIOCHEM PHARMACOL, V62, P893, DOI 10.1016/S0006-2952(01)00713-4
   Collier AC, 2003, TOXICOL APPL PHARM, V192, P164, DOI 10.1016/S0041-008X(03)00274-6
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   DALAKAS MC, 1994, ANN NEUROL, V35, P482, DOI 10.1002/ana.410350418
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   de la Asunción JG, 1998, J CLIN INVEST, V102, P4, DOI 10.1172/JCI1418
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001
   Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003
   Dirks AJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1208, DOI 10.1152/ajpcell.00226.2006
   Falchetti A, 2005, J BONE MINER RES, V20, P410, DOI 10.1359/JBMR.041123
   Formichi P., 2003, Journal of Submicroscopic Cytology and Pathology, V35, P29
   Georges B, 2003, BIOCHEM PHARMACOL, V65, P1483, DOI 10.1016/S0006-2952(03)00110-2
   Ikezoe K, 2002, ACTA NEUROPATHOL, V103, P531, DOI 10.1007/s00401-001-0502-8
   Ji HJ, 2005, BREAST CANCER RES TR, V93, P227, DOI 10.1007/s10549-005-5156-0
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   Lebrecht D, 2008, ARTHRITIS RHEUM-US, V58, P318, DOI 10.1002/art.23235
   Lee MC, 2005, J NUTR, V135, p1806S, DOI 10.1093/jn/135.7.1806S
   Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288
   LINNANE AW, 1995, BBA-MOL BASIS DIS, V1271, P191, DOI 10.1016/0925-4439(95)00027-2
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   Lynx MD, 2006, BIOCHEM PHARMACOL, V72, P239, DOI 10.1016/j.bcp.2006.04.004
   MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743
   Masanés F, 1998, J NEUROL SCI, V159, P226, DOI 10.1016/S0022-510X(98)00151-8
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   MODICANAPOLITANO JS, 1993, BIOCHEM BIOPH RES CO, V194, P170, DOI 10.1006/bbrc.1993.1800
   Owczarek J, 2005, PHARMACOL REP, V57, P23
   Purevjav E, 2007, CARDIOVASC TOXICOL, V7, P255, DOI 10.1007/s12012-007-9004-9
   RATAN RR, 1994, J NEUROCHEM, V62, P376
   Rosenfeldt FL, 2005, INT J STD AIDS, V16, P827, DOI 10.1258/095646205774988127
   Rylova SN, 2005, BIOCHEM PHARMACOL, V69, P951, DOI 10.1016/j.bcp.2004.12.010
   SANDRI M, 1995, FEBS LETT, V373, P291, DOI 10.1016/0014-5793(95)00908-R
   SEMINOMORA MC, 1994, LAB INVEST, V71, P102
   Sun YQ, 2007, WORLD J GASTROENTERO, V13, P4185, DOI 10.3748/wjg.v13.i31.4185
   Tolomeo M, 2003, J CLIN PATHOL, V56, P147, DOI 10.1136/jcp.56.2.147
   Umaki Y, 2002, ACTA NEUROPATHOL, V103, P163
   Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6
   Wheeler S, 2005, RESPIROLOGY, V10, P171, DOI 10.1111/j.1440-1843.2005.00646.x
   Yamaguchi T, 2002, EUR J BIOCHEM, V269, P2782, DOI 10.1046/j.1432-1033.2002.02954.x
   Zhou FX, 2007, BIOCHEM BIOPH RES CO, V354, P351, DOI 10.1016/j.bbrc.2006.12.180
NR 45
TC 102
Z9 121
U1 0
U2 7
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0031-7012
EI 1423-0313
J9 PHARMACOLOGY
JI Pharmacology
PY 2008
VL 82
IS 2
BP 83
EP 88
DI 10.1159/000134943
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 341EL
UT WOS:000258696900001
PM 18504416
OA Bronze
DA 2024-11-01
ER

PT J
AU Horváth, R
   Schoser, BGH
   Müller-Höcker, J
   Völpel, M
   Jaksch, M
   Lochmüller, H
AF Horváth, R
   Schoser, BGH
   Müller-Höcker, J
   Völpel, M
   Jaksch, M
   Lochmüller, H
TI Mutations in mtDNA-encoded cytochrome c oxidase subunit genes causing
   isolated myopathy or severe encephalomyopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mitochondrial myopathy; cytochrome c oxidase deficiency; COII; COIII
   mutations
ID ONSET MITOCHONDRIAL MYOPATHY; STOP-CODON MUTATION; NONSENSE MUTATION;
   MISSENSE MUTATION; I GENE; DEFICIENCY; MICRODELETION; PATIENT; PROTEIN
AB We report on clinical, histological and genetic findings in two patients carrying novel heteroplasmic mutations in the mitochondrial cytochrome c oxidase subunit genes COII and COIII. The first patient, a 35 year-old man had a multisystemic disease, with clinical symptoms of bilateral cataract, sensori-neural hearing loss, myopathy, ataxia, cardiac arrhythmia, depression and short stature and carried a 7970 G > T (E129X) nonsense mutation in COII. A sudden episode of metabolic encephalopathy caused by extremely high blood lactate lead to coma. The second patient developed exercise intolerance and rhabdomyolysis at age 22 years. A heteroplasmic missense mutation 9789 T > C (S195P) was found in skeletal muscle, but not in blood and myoblasts pointing to a sporadic mutation. Our report of two patients with isolated COX deficiency and new mutations in COX subunit genes may help to draw more attention to this type of mtDNA defects and provide new aspects for counselling affected families. (C) 2005 Elsevier B.V. All rights reserved.
C1 Acad Hosp Schwabing, Metab Dis Ctr Munich Schwabing, Inst Clin Chem Mol Diagnost & Mitochondrial Genet, D-80804 Munich, Germany.
   Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany.
   Univ Munich, Inst Pathol, Munich, Germany.
   Hosp Krefeld, Inst Pathol, Krefeld, Germany.
C3 University of Munich; University of Munich
RP Acad Hosp Schwabing, Metab Dis Ctr Munich Schwabing, Inst Clin Chem Mol Diagnost & Mitochondrial Genet, Kolner Pl 1, D-80804 Munich, Germany.
EM Rita.Horvath@lrz.uni-muenchen.de
RI Horvath, Rita/AAY-7042-2020; Inerbaev, Talgat/AAB-7633-2020
OI Schoser, Benedikt/0000-0002-2757-8131; Horvath,
   Rita/0000-0002-9841-170X; Lochmuller, Hanns/0000-0003-2324-8001
CR Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200
   DALAKAS MC, 1994, ANN NEUROL, V35, P482, DOI 10.1002/ana.410350418
   DiMauro S, 2003, NEW ENGL J MED, V349, P1294
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Horváth R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015024
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Macmillan CJ, 1996, PEDIATR NEUROL, V14, P203, DOI 10.1016/0887-8994(96)00018-5
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   Moraes C T, 1996, Methods Enzymol, V264, P522, DOI 10.1016/S0076-6879(96)64046-4
   MULLERHOCKER J, 1989, HUM PATHOL, V20, P666, DOI 10.1016/0046-8177(89)90154-8
   MUNOZINFANTE JP, 2000, FEBS LETT, V468, P1
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
NR 27
TC 43
Z9 47
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD DEC
PY 2005
VL 15
IS 12
BP 851
EP 857
DI 10.1016/j.nmd.2005.09.005
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 998JD
UT WOS:000234313700006
PM 16288875
DA 2024-11-01
ER

PT J
AU Shin, YH
   Kim, AJ
   Ro, H
   Chang, JH
   Jung, JY
   Chung, WK
   Lee, HH
AF Shin, Yong Hoon
   Kim, Ae Jin
   Ro, Han
   Chang, Jae Hyun
   Jung, Ji Yong
   Chung, Woo Kyung
   Lee, Hyun Hee
TI Concomitant Mitochondrial Diabetes and Myopathy Mistook for
   Complications of Immunosuppressants After Kidney Transplant
SO EXPERIMENTAL AND CLINICAL TRANSPLANTATION
LA English
DT Article
DE Lactic acidosis; Maternally inherited diabetes deafness; Mitochondrial
   disease; Mitochondrial encephalomyopathy; Stroke-like episodes
ID HEARING-LOSS; MELLITUS; MUTATION
AB Posttransplant diabetes mellitus, presenile deafness, and myopathy are not commonly accompanied symptoms after kidney transplant. We report the case of a 48-year-old woman with diabetes mellitus, sensorineural hearing loss, and severe myopathy without neuropathy after deceased donor kidney transplant. She had a mitochondrial DNA point mutation at position 3243 (A>G), and mitochondrial diseases such as maternally inherited diabetes deafness or mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes were suspected. Diabetes and other symptoms following kidney transplant can often be overlooked as complications of immunosuppressants taken after kidney transplant. However, in patients without a known cause of their symptoms, appropriate examinations and consultation for other diseases, including genetic diseases, should be considered.
C1 [Shin, Yong Hoon; Kim, Ae Jin; Ro, Han; Chang, Jae Hyun; Jung, Ji Yong; Chung, Woo Kyung; Lee, Hyun Hee] Gachon Univ, Coll Med, Dept Internal Med, 21,Namdong Dero,774 Beon Gil, Incheon 21565, South Korea.
C3 Gachon University
RP Lee, HH (corresponding author), Gachon Univ, Coll Med, Dept Internal Med, 21,Namdong Dero,774 Beon Gil, Incheon 21565, South Korea.
EM lhh90@gilhospital.com
RI Shin, Yonghoon/ACR-0501-2022
OI Shin, Yonghoon/0000-0001-7657-8640
CR Akinpelu OV, 2014, LARYNGOSCOPE, V124, P767, DOI 10.1002/lary.24354
   Bainbridge KE, 2008, ANN INTERN MED, V149, P1, DOI 10.7326/0003-4819-149-1-200807010-00231
   Bamanie AH, 2011, SAUDI MED J, V32, P271
   Cho Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003423
   Ciorba A, 2011, J LARYNGOL OTOL, V125, P776, DOI 10.1017/S0022215111001101
   Dalton DS, 1998, DIABETES CARE, V21, P1540, DOI 10.2337/diacare.21.9.1540
   de Laat P, 2019, CLIN KIDNEY J, V12, P840, DOI 10.1093/ckj/sfz020
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Johnson SC, 2019, KIDNEY INT, V95, P455, DOI 10.1016/j.kint.2018.08.038
   Mozaffari M, 2010, East Mediterr Health J, V16, P947
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Vilayur E, 2010, AM J KIDNEY DIS, V56, P661, DOI 10.1053/j.ajkd.2010.05.015
NR 13
TC 0
Z9 0
U1 0
U2 4
PU BASKENT UNIV
PI ANKARA
PA TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY
SN 1304-0855
EI 2146-8427
J9 EXP CLIN TRANSPLANT
JI Exp. Clin. Transplant.
PD JUL
PY 2021
VL 19
IS 7
BP 736
EP 738
DI 10.6002/ect.2020.0505
PG 3
WC Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Transplantation
GA TH9FA
UT WOS:000672387000016
PM 34325625
DA 2024-11-01
ER

PT J
AU Korhonen, JA
   Pham, XH
   Pellegrini, M
   Falkenberg, M
AF Korhonen, JA
   Pham, XH
   Pellegrini, M
   Falkenberg, M
TI Reconstitution of a minimal mtDNA replisome <i>in vitro</i>
SO EMBO JOURNAL
LA English
DT Article
DE DNA polymerase gamma; mitochondrion; mtSSB; TWINKLE
ID HUMAN MITOCHONDRIAL-DNA; POLYMERASE-GAMMA; BINDING PROTEIN; ACCESSORY
   SUBUNIT; HELICASE ACTIVITY; CRYSTAL-STRUCTURE; REPLICATION; STRAND;
   TRANSCRIPTION; BACTERIOPHAGE-T7
AB We here reconstitute a minimal mammalian mitochondrial DNA (mtDNA) replisome in vitro. The mtDNA polymerase (POLgamma) cannot use double-stranded DNA (dsDNA) as template for DNA synthesis. Similarly, the TWINKLE DNA helicase is unable to unwind longer stretches of dsDNA. In combination, POLgamma and TWINKLE form a processive replication machinery, which can use dsDNA as template to synthesize single-stranded DNA (ssDNA) molecules of about 2kb. The addition of the mitochondrial ssDNA-binding protein stimulates the reaction further, generating DNA products of about 16kb, the size of the mammalian mtDNA molecule. The observed DNA synthesis rate is 180 base pairs (bp)/min, corresponding closely to the previously calculated value of 270 bp/min for in vivo DNA replication. Our findings provide the first biochemical evidence that TWINKLE is the helicase at the mitochondrial DNA replication fork. Furthermore, mutations in TWINKLE and POLgamma cause autosomal dominant progressive external ophthalmoplegia (adPEO), a disorder associated with deletions in mitochondrial DNA. The functional interactions between TWINKLE and POLgamma thus explain why mutations in these two proteins cause an identical syndrome.
C1 Karolinska Inst, Novum, Dept Med Nutr, S-14186 Huddinge, Sweden.
C3 Karolinska Institutet
RP Karolinska Inst, Novum, Dept Med Nutr, S-14186 Huddinge, Sweden.
EM maria.falkenberg-gustafsson@mednut.ki.se
OI Pham, Xuan Hoi/0000-0002-9629-2970; Falkenberg,
   Maria/0000-0001-8713-173X
CR Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267
   Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181
   Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CRUTE JJ, 1991, J BIOL CHEM, V266, P4484
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   ENGLER MJ, 1983, J BIOL CHEM, V258, P1165
   Falkenberg M, 1998, J BIOL CHEM, V273, P32154, DOI 10.1074/jbc.273.48.32154
   Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   HUBER HE, 1987, J BIOL CHEM, V262, P16224
   ITO J, 1990, NUCLEIC ACIDS RES, V18, P6716, DOI 10.1093/nar/18.22.6716
   Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.bi.63.070194.002523
   Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821
   MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Ye F, 1996, NUCLEIC ACIDS RES, V24, P1481, DOI 10.1093/nar/24.8.1481
NR 30
TC 300
Z9 353
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD JUN 16
PY 2004
VL 23
IS 12
BP 2423
EP 2429
DI 10.1038/sj.emboj.7600257
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 842WT
UT WOS:000223035900010
PM 15167897
OA Green Published
DA 2024-11-01
ER

PT J
AU Yap, ZY
   Park, YH
   Wortmann, SB
   Gunning, AC
   Ezer, S
   Lee, S
   Duraine, L
   Wilichowski, E
   Wilson, K
   Mayr, JA
   Wagner, M
   Li, H
   Kini, U
   Black, ED
   Monaghan, KG
   Lupski, JR
   Ellard, S
   Westphal, DS
   Harel, T
   Yoon, WH
AF Yap, Zheng Yie
   Park, Yo Han
   Wortmann, Saskia B.
   Gunning, Adam C.
   Ezer, Shlomit
   Lee, Sukyeong
   Duraine, Lita
   Wilichowski, Ekkehard
   Wilson, Kate
   Mayr, Johannes A.
   Wagner, Matias
   Li, Hong
   Kini, Usha
   Black, Emily Davis
   Monaghan, Kristin G.
   Lupski, James R.
   Ellard, Sian
   Westphal, Dominik S.
   Harel, Tamar
   Yoon, Wan Hee
TI Functional interpretation of ATAD3A variants in neuro-mitochondrial
   phenotypes
SO GENOME MEDICINE
LA English
DT Article
DE ATAD3A; Mitochondria; Disease; Autosomal recessive; Autophagy;
   Neurogenesis; Drosophila; AAA plus protein
AB BackgroundATPase family AAA-domain containing protein 3A (ATAD3A) is a nuclear-encoded mitochondrial membrane-anchored protein involved in diverse processes including mitochondrial dynamics, mitochondrial DNA organization, and cholesterol metabolism. Biallelic deletions (null), recessive missense variants (hypomorph), and heterozygous missense variants or duplications (antimorph) in ATAD3A lead to neurological syndromes in humans.MethodsTo expand the mutational spectrum of ATAD3A variants and to provide functional interpretation of missense alleles in trans to deletion alleles, we performed exome sequencing for identification of single nucleotide variants (SNVs) and copy number variants (CNVs) in ATAD3A in individuals with neurological and mitochondrial phenotypes. A Drosophila Atad3a Gal4 knockin-null allele was generated using CRISPR-Cas9 genome editing technology to aid the interpretation of variants.ResultsWe report 13 individuals from 8 unrelated families with biallelic ATAD3A variants. The variants included four missense variants inherited in trans to loss-of-function alleles (p.(Leu77Val), p.(Phe50Leu), p.(Arg170Trp), p.(Gly236Val)), a homozygous missense variant p.(Arg327Pro), and a heterozygous non-frameshift indel p.(Lys568del). Affected individuals exhibited findings previously associated with ATAD3A pathogenic variation, including developmental delay, hypotonia, congenital cataracts, hypertrophic cardiomyopathy, and cerebellar atrophy. Drosophila studies indicated that Phe50Leu, Gly236Val, Arg327Pro, and Lys568del are severe loss-of-function alleles leading to early developmental lethality. Further, we showed that Phe50Leu, Gly236Val, and Arg327Pro cause neurogenesis defects. On the contrary, Leu77Val and Arg170Trp are partial loss-of-function alleles that cause progressive locomotion defects and whose expression leads to an increase in autophagy and mitophagy in adult muscles.ConclusionOur findings expand the allelic spectrum of ATAD3A variants and exemplify the use of a functional assay in Drosophila to aid variant interpretation.
C1 [Yap, Zheng Yie; Park, Yo Han; Yoon, Wan Hee] Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK 73104 USA.
   [Wortmann, Saskia B.; Wagner, Matias; Westphal, Dominik S.] Tech Univ Munich, Inst Human Genet, Munich, Germany.
   [Wortmann, Saskia B.; Mayr, Johannes A.] Paracelsus Med Univ PMU, Univ Childrens Hosp, Salzburg, Austria.
   [Wortmann, Saskia B.] Amalia Childrens Hosp, Radboud Ctr Mitochondrial Med RCMM, Nijmegen, Netherlands.
   [Gunning, Adam C.; Ellard, Sian] Royal Devon & Exeter NHS Fdn Trust, Exeter Genom Lab, Exeter EX2 5DW, Devon, England.
   [Gunning, Adam C.; Ellard, Sian] Univ Exeter, Coll Med & Hlth, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England.
   [Ezer, Shlomit; Harel, Tamar] Hadassah Med Ctr, Dept Genet, POB 12000, IL-9112001 Jerusalem, Israel.
   [Ezer, Shlomit; Harel, Tamar] Hebrew Univ Jerusalem, Fac Med, POB 12000, IL-9112001 Jerusalem, Israel.
   [Lee, Sukyeong] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.
   [Duraine, Lita] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.
   [Wilichowski, Ekkehard] Georg August Univ Gottingen, Univ Med Ctr Gottingen, Dept Pediat & Pediat Neurol, Gottingen, Germany.
   [Wilson, Kate; Kini, Usha] Oxford Univ Hosp NHS Fdn Trust, Oxford Ctr Genom Med, Oxford, England.
   [Wagner, Matias] Helmholtz Zentrum Munchen, Inst Neurogen, Neuherberg, Germany.
   [Li, Hong; Black, Emily Davis] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA.
   [Li, Hong] Emory Univ, Sch Med, Dept Pediat, Childrens Healthcare Atlanta, Atlanta, GA USA.
   [Monaghan, Kristin G.] GeneDx Inc, Gaithersburg, MD USA.
   [Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
   [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA.
C3 Oklahoma Medical Research Foundation; Technical University of Munich;
   Paracelsus Private Medical University; University of Exeter; University
   of Exeter; Hebrew University of Jerusalem; Hebrew University of
   Jerusalem; Baylor College of Medicine; Baylor College of Medicine;
   University of Gottingen; UNIVERSITY GOTTINGEN HOSPITAL; Oxford
   University Hospitals NHS Foundation Trust; Helmholtz Association;
   Helmholtz-Center Munich - German Research Center for Environmental
   Health; Emory University; Children's Healthcare of Atlanta (CHOA); Emory
   University; Baylor College of Medicine; Baylor College of Medicine;
   Baylor College of Medicine; Baylor College of Medicine
RP Yoon, WH (corresponding author), Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK 73104 USA.; Harel, T (corresponding author), Hadassah Med Ctr, Dept Genet, POB 12000, IL-9112001 Jerusalem, Israel.; Harel, T (corresponding author), Hebrew Univ Jerusalem, Fac Med, POB 12000, IL-9112001 Jerusalem, Israel.
EM tamarhe@hadassah.org.il; wanhee-yoon@omrf.org
RI Wortmann, Saskia/E-6125-2010; Harel, Tamar/HJH-0772-2022; Wagner,
   Matias/AEB-0432-2022
OI Yoon, Wan Hee/0000-0002-9459-3139; Westphal, Dominik
   Sebastian/0000-0003-4870-9863; Wagner, Matias/0000-0002-4454-8823; Kini,
   Usha/0000-0001-9111-5433
FU NIH/COBRE [GM103636]
FX The authors wish to thank the families for their participation in this
   study. We appreciate Dr. Hugo Bellen for his generous technical support.
   We appreciate Dr. Scott Plafker for the critical reading of this
   manuscript. We are grateful to Dr. Sheng Zhang's kind gift of rabbit
   anti-Ref (2) P antibodies. We appreciate Jae Sun Kang and Karen Vargas
   Parra for the Drosophila care and line establishment. We thank the
   assistance of the OMRF Imaging Core (supported by NIH/COBRE GM103636).
CR Al Madhoun A, 2019, APPL CLIN GENET, V12, P79, DOI 10.2147/TACG.S194204
   Baudier J, 2018, BIOL REV, V93, P827, DOI 10.1111/brv.12373
   Bellen HJ, 2019, HUM MOL GENET, V28, pR207, DOI 10.1093/hmg/ddz135
   Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104
   Cooper HM, 2017, HUM MOL GENET, V26, P1432, DOI 10.1093/hmg/ddx042
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Diao FQ, 2015, CELL REP, V10, P1410, DOI 10.1016/j.celrep.2015.01.059
   Dorison N, 2020, MOL GENET METAB, V131, P107, DOI 10.1016/j.ymgme.2020.09.002
   Fang HY, 2010, J CELL SCI, V123, P1171, DOI 10.1242/jcs.062034
   Frazier AE, 2021, MED-CAMBRIDGE, V2, P49, DOI 10.1016/j.medj.2020.06.004
   Frazier AE, 2017, BRAIN, V140, DOI 10.1093/brain/awx240
   Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10
   Goller T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054799
   Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084
   Gunning AC, 2020, AM J HUM GENET, V106, P272, DOI 10.1016/j.ajhg.2020.01.007
   Hanes I, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000452
   Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007
   He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266
   Hoffmann M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007644
   Issop L, 2015, ENDOCRINOLOGY, V156, P334, DOI 10.1210/en.2014-1503
   Jin GX, 2018, NAT IMMUNOL, V19, P29, DOI 10.1038/s41590-017-0002-1
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737
   Lang LW, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21217917
   Lee PT, 2018, ELIFE, V7, DOI 10.7554/eLife.35574
   Li H, CLINVAR, DOI [10.1186/s13073-021-00873-3, DOI 10.1186/S13073-021-00873-3]
   Li SJ, 2014, GENE, V535, P60, DOI 10.1016/j.gene.2013.10.062
   Madabattula ST, 2015, JOVE-J VIS EXP, DOI 10.3791/52741
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Peeters-Scholte CMPCD, 2017, BRAIN, V140, DOI 10.1093/brain/awx239
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Puchades C, 2020, NAT REV MOL CELL BIO, V21, P43, DOI 10.1038/s41580-019-0183-6
   Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Sacoto MJG, 2020, AM J HUM GENET, V107, P352, DOI 10.1016/j.ajhg.2020.06.013
   Stals KL, 2018, PRENATAL DIAG, V38, P33, DOI 10.1002/pd.5175
   Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1
   Teng Y, 2016, ONCOGENE, V35, P333, DOI 10.1038/onc.2015.86
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
   Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366
   Yap ZY, **DROPPED REF**
   You WC, 2013, NEURO-ONCOLOGY, V15, P1342, DOI 10.1093/neuonc/not077
   Zhao YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09291-x
NR 43
TC 16
Z9 17
U1 2
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-994X
J9 GENOME MED
JI Genome Med.
PD APR 12
PY 2021
VL 13
IS 1
AR 55
DI 10.1186/s13073-021-00873-3
PG 21
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA RM8EB
UT WOS:000639889100001
PM 33845882
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Camilleri, M
   Carlson, P
   Zinsmeister, AR
   McKinzie, S
   Busciglio, I
   Burton, D
   Zaki, EA
   Boles, RG
AF Camilleri, Michael
   Carlson, Paula
   Zinsmeister, Alan R.
   McKinzie, Sanna
   Busciglio, Irene
   Burton, Duane
   Zaki, Essam A.
   Boles, Richard G.
TI Mitochondrial DNA and gastrointestinal motor and sensory functions in
   health and functional gastrointestinal disorders
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE 16519T; 3010A; 7028C; irritable bowel syndrome; dyspepsia; haplogroup H;
   genotype; constipation; nonspecific abdominal pain; gastric emptying;
   accommodation; satiation; somatic symptoms
ID IRRITABLE-BOWEL-SYNDROME; CYCLIC VOMITING SYNDROME; BODY-MASS INDEX; US
   COMMUNITY; DYSPEPSIA; DISEASE; MUTATIONS; SYMPTOMS; POLYMORPHISMS;
   PROTEIN
AB Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zaki EA, Boles RG. Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol 296: G510-G516, 2009. First published January 15, 2009; doi:10.1152/ajpgi.90650.2008.-Nerve, muscle, and inflammatory cells involved in gastrointestinal (GI) function have high-energy requirements and are affected in mitochondrial disorders. Familial aggregation of irritable bowel syndrome (IBS) frequently involves mothers and their children. Since mitochondrial DNA (mtDNA) is maternally inherited, mtDNA single nucleotide polymorphisms (SNPs) could confer risk to the development of IBS. The mtDNA SNPs, 16519C>T and 3010G>A, are associated with migraine and childhood cyclic vomiting syndrome. Our hypothesis is that these mtDNA SNPs are associated with functional GI disorders (FGIDs) and GI functions. The mt genome was first tested for the 7028C polymorphism (defining haplogroup H) in 699 patients or controls, and those with 7028C were further genotyped at 16519 and 3010. Phenotypes were based on symptoms (validated questionnaires and criteria) and GI physiology using validated motor and sensory studies. Constipation-predominant IBS and alternating constipation and diarrhea IBS are less prevalent in individuals with the 7028C mtDNA polymorphism than in individuals with 7028T. Conversely, 7028C is associated with higher maximum tolerated volume (lower satiation) compared with 7028T. Among those with 7028C, nonspecific abdominal pain (chronic abdominal pain or dyspepsia) was significantly associated with 3010A compared with 3010G (odds ratio 3.3, P = 0.02), and slower gastric emptying was statistically associated with 3010G. There were no significant associations of mtDNA genotypes tested and stomach volumes, small bowel or colonic transit, rectal compliance, and motor or sensory functions. Thus variation in mtDNA may be associated with satiation, gastric emptying, and possibly pain; further studies of mtDNA in appetite regulation and larger numbers of patients with FGIDs are warranted.
C1 [Camilleri, Michael; Carlson, Paula; McKinzie, Sanna; Busciglio, Irene; Burton, Duane] Mayo Clin, CENTER, Rochester, MN 55905 USA.
   [Zinsmeister, Alan R.] Mayo Clin, Coll Med, Div Biostat, Dept Hlth Sci Res, Rochester, MN 55905 USA.
   [Zaki, Essam A.; Boles, Richard G.] Childrens Hosp Los Angeles, Div Med Genet, Los Angeles, CA 90027 USA.
   [Zaki, Essam A.; Boles, Richard G.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA.
   [Boles, Richard G.] Univ So Calif, Keck Sch Med, Div Pediat, Los Angeles, CA 90033 USA.
C3 Mayo Clinic; Mayo Clinic; Children's Hospital Los Angeles; Children's
   Hospital Los Angeles; University of Southern California
RP Camilleri, M (corresponding author), Mayo Clin, CENTER, Charlton 8-110,200 1st St SW, Rochester, MN 55905 USA.
EM rboles@chla.usc.edu; rboles@chla.usc.edu
RI Zaki, Essam/K-8456-2015
OI Zaki, Essam/0000-0002-3906-623X
CR Andresen V, 2006, GASTROENTEROLOGY, V130, P1985, DOI 10.1053/j.gastro.2006.03.017
   Boles RG, 1997, LANCET, V350, P1299, DOI 10.1016/S0140-6736(05)62477-4
   Boles RG, 2005, AM J MED GENET A, V133A, P71, DOI 10.1002/ajmg.a.30524
   Bouras EP, 2002, GUT, V51, P781, DOI 10.1136/gut.51.6.781
   Burnett BB, 2005, J AFFECT DISORDERS, V88, P109, DOI 10.1016/j.jad.2005.05.009
   Camilleri CE, 2006, AM J GASTROENTEROL, V101, P581, DOI 10.1111/j.1572-0241.2006.00481.x
   Camilleri M, 2005, NEUROGASTROENT MOTIL, V17, P311, DOI 10.1111/j.1365-2982.2004.00632.x
   Camilleri M, 2002, GASTROENTEROLOGY, V123, P425, DOI 10.1053/gast.2002.34780
   CAMILLERI M, NEUROGASTRO IN PRESS
   Camilleri M, 2008, CLIN GASTROENTEROL H, V6, P772, DOI 10.1016/j.cgh.2008.02.060
   Castillo EJ, 2004, CLIN GASTROENTEROL H, V2, P985, DOI 10.1016/S1542-3565(04)00454-9
   Chial HJ, 2002, NEUROGASTROENT MOTIL, V14, P249, DOI 10.1046/j.1365-2982.2002.00326.x
   Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6
   Cremonini F, 2002, ALIMENT PHARM THER, V16, P1781, DOI 10.1046/j.1365-2036.2002.01344.x
   Cremonini F, 2005, NEUROGASTROENT MOTIL, V17, P810, DOI 10.1111/j.1365-2982.2005.00709.x
   Delgado-Aros S, 2004, AM J GASTROENTEROL, V99, P1801, DOI 10.1111/j.1572-0241.2004.30887.x
   Delgado-Aros S, 2004, GASTROENTEROLOGY, V127, P1685, DOI 10.1053/j.gastro.2004.09.006
   FAJARDO NR, 2006, NEUROGASTROENT MOTIL, V18, P728
   Gardner A, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-7
   Gardner A, 2008, PSYCHOTHER PSYCHOSOM, V77, P127, DOI 10.1159/000112891
   Halder SLS, 2007, GASTROENTEROLOGY, V133, P799, DOI 10.1053/j.gastro.2007.06.010
   Hammer HF, 1998, AM J PHYSIOL-GASTR L, V274, pG584, DOI 10.1152/ajpgi.1998.274.3.G584
   Holtmann G, 2004, GASTROENTEROLOGY, V126, P971, DOI 10.1053/j.gastro.2004.01.006
   Ito M, 2001, MITOCHONDRION, V1, P269, DOI 10.1016/S1567-7249(01)00028-9
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kalantar JS, 2003, GUT, V52, P1703, DOI 10.1136/gut.52.12.1703
   Kim HJ, 2004, GUT, V53, P829, DOI 10.1136/gut.2003.030882
   Locke GR, 2005, NEUROGASTROENT MOTIL, V17, P29, DOI 10.1111/j.1365-2982.2004.00581.x
   Mayer EA, 2008, GASTROENTEROLOGY, V134, P1826, DOI 10.1053/j.gastro.2008.05.003
   Murakami H, 2002, JPN J PHYSIOL, V52, P247, DOI 10.2170/jjphysiol.52.247
   Navaglia F, 2006, AM J CLIN PATHOL, V126, P593, DOI 10.1309/GQFCCJMH5KHNVX73
   Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Saito YA, 2008, NEUROGASTROENT MOTIL, V20, P790, DOI 10.1111/j.1365-2982.2007.1077.x
   SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535
   Tahara T, 2008, DIGEST DIS SCI, V53, P642, DOI 10.1007/s10620-007-9923-0
   TALLEY NJ, 1990, MAYO CLIN PROC, V65, P1456, DOI 10.1016/S0025-6196(12)62169-7
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Van Kerkhoven LAS, 2007, ALIMENT PHARM THER, V26, P979, DOI 10.1111/j.1365-2036.2007.03453.x
   Van Lelyveld N, 2008, NEUROGASTROENT MOTIL, V20, P767, DOI 10.1111/j.1365-2982.2008.01102.x
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   Wang QX, 2004, AM J MED GENET A, V131A, P50, DOI 10.1002/ajmg.a.30323
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   ZAKI EA, CEPHALALGIA IN PRESS
NR 44
TC 36
Z9 40
U1 0
U2 4
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD MAR
PY 2009
VL 296
IS 3
BP G510
EP G516
DI 10.1152/ajpgi.90650.2008
PG 7
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA 414YJ
UT WOS:000263900800007
PM 19147801
DA 2024-11-01
ER

PT J
AU Biffi, S
   Bortot, B
   Carrozzi, M
   Severini, GM
AF Biffi, Stefania
   Bortot, Barbara
   Carrozzi, Marco
   Severini, Giovanni Maria
TI Quantification of Heteroplasmic Mitochondrial DNA Mutations for DNA
   Samples in the Low Picogram Range by Nested Real-time ARMS-qPCR
SO DIAGNOSTIC MOLECULAR PATHOLOGY
LA English
DT Article
DE nested real-time PCR; ARMS-PCR; SYBR Green; mitochondrial DNA;
   heteroplasmy; single-fiber PCR
ID RAPID IDENTIFICATION; PCR ANALYSIS; COPY NUMBER; MELAS;
   ENCEPHALOMYOPATHY; EXPRESSION; NUCLEASE; DISEASE; TISSUES; FIBERS
AB In many mitochondrial diseases, different clinical manifestations are related to tissue-specific distribution of mutated mitochondrial DNA (mtDNA). In this study, we describe an assay for the determination of mutated mtDNA copy number in small clinical samples, using standard polymerase chain reaction (PCR) followed by SYBR Green real-time allelic-specific PCR [amplification refractory mutation system-quantitative PCR (ARMS-qPCR)]. To assess the degree of heteroplasmy in a patient harboring 2 cosegregating mtDNA mutations (4415A > G and 9922A > C) starting from picogram amounts of DNA, we first amplified the mutated target sequence by standard PCR, and then analyzed it by real-time ARMS-qPCR. To validate this method, we analyzed by real-time ARMS-qPCR the PCR amplification products derived from different mixtures containing known proportions of mutant and wild-type cloned mtDNA fragments. The correlation coefficient of 0.994 between expected and observed values for the percentage of mutant A4415G confirms that the relative proportion of mutated and wild-type mtDNA was maintained after the first PCR amplification. This method allows the precise quantification of heteroplasmic mutations in DNA samples extracted from hairs, urine, small stomach biopsies, and, more importantly, single-muscle fiber, with a limit of detection close to 0.5%. This nested real-time ARMS-PCR represents a rapid, efficient, and less expensive method for the detection and quantification of heteroplasmic mutant mtDNA, even in very small clinical samples.
C1 [Biffi, Stefania; Bortot, Barbara; Severini, Giovanni Maria] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Mol Med & Lab, I-34137 Trieste, Italy.
   [Carrozzi, Marco] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Child Neurol & Psychiat Unit, I-34137 Trieste, Italy.
   [Biffi, Stefania] CBM Scrl, Opt Imaging Lab, Trieste, Italy.
C3 IRCCS Burlo Garofolo; IRCCS Burlo Garofolo
RP Severini, GM (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Mol Med & Lab, Via Istria 65-1, I-34137 Trieste, Italy.
EM severini@burlo.trieste.it
RI ; biffi, stefania/C-6652-2015
OI Carrozzi, Marco/0000-0001-6282-4417; biffi, stefania/0000-0003-2257-2053
FU Italian Ministry of Health
FX Supported by grants of the Italian Ministry of Health.
CR Alvarez-Iglesias V, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-26
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bannwarth S, 2005, HUM MUTAT, V25, P575, DOI 10.1002/humu.20177
   Bannwarth S, 2006, NAT PROTOC, V1, P2037, DOI 10.1038/nprot.2006.318
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Bonin S, 2003, J CLIN PATHOL-MOL PA, V56, P184, DOI 10.1136/mp.56.3.184
   Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Meierhofer D, 2005, MITOCHONDRION, V5, P282, DOI 10.1016/j.mito.2005.06.001
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   Sambrook J, 1999, MOL CLONING LAB MANU
   Szuhai K, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e13
   vandeCorput MPC, 1997, J HISTOCHEM CYTOCHEM, V45, P55
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
NR 20
TC 4
Z9 6
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1052-9551
J9 DIAGN MOL PATHOL
JI Diagn. Mol. Pathol.
PD JUN
PY 2011
VL 20
IS 2
BP 117
EP 122
DI 10.1097/PDM.0b013e3181efe2c6
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Pathology
GA 764VI
UT WOS:000290662100009
PM 21532488
DA 2024-11-01
ER

PT J
AU Bonnen, PE
   Yarham, JW
   Besse, A
   Wu, P
   Faqeih, EA
   Al-Asmari, AM
   Saleh, MAM
   Eyaid, W
   Hadee, A
   He, LP
   Smith, F
   Yau, S
   Simcox, EM
   Miwa, S
   Donti, T
   Abu-Amero, KK
   Wong, LJ
   Craigen, WJ
   Graham, BH
   Scott, KL
   McFarland, R
   Taylor, RW
AF Bonnen, Penelope E.
   Yarham, John W.
   Besse, Arnaud
   Wu, Ping
   Faqeih, Eissa A.
   Al-Asmari, Ali Mohammad
   Saleh, Mohammad A. M.
   Eyaid, Wafaa
   Hadee, Alrukban
   He, Langping
   Smith, Frances
   Yau, Shu
   Simcox, Eve M.
   Miwa, Satomi
   Donti, Taraka
   Abu-Amero, Khaled K.
   Wong, Lee-Jun
   Craigen, William J.
   Graham, Brett H.
   Scott, Kenneth L.
   McFarland, Robert
   Taylor, Robert W.
TI Mutations in <i>FBXL4</i> Cause Mitochondrial Encephalopathy and a
   Disorder of Mitochondrial DNA Maintenance
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID PROTEIN; FRAMEWORK; DEPLETION; DISEASE; FAMILY
AB Nuclear genetic disorders causing mitochondrial DNA (mtDNA) depletion are clinically and genetically heterogeneous, and the molecular etiology remains undiagnosed in the majority of cases. Through whole-exome sequencing, we identified recessive nonsense and splicing mutations in FBXL4 segregating in three unrelated consanguineous kindreds in which affected children present with a fatal encephalopathy, lactic acidosis, and severe mtDNA depletion in muscle. We show that FBXL4 is an F-box protein that colocalizes with mitochondria and that loss-of-function and splice mutations in this protein result in a severe respiratory chain deficiency, loss of mitochondrial membrane potential, and a disturbance of the dynamic mitochondrial network and nucleoid distribution in fibroblasts from affected individuals. Expression of the wild-type FBXL4 transcript in cell lines from two subjects fully rescued the levels of mtDNA copy number, leading to a correction of the mitochondrial biochemical deficit. Together our data demonstrate that mutations in FBXL4 are disease causing and establish FBXL4 as a mitochondrial protein with a possible role in maintaining mtDNA integrity and stability.
C1 [Bonnen, Penelope E.; Besse, Arnaud; Wu, Ping; Donti, Taraka; Wong, Lee-Jun; Craigen, William J.; Graham, Brett H.; Scott, Kenneth L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Bonnen, Penelope E.; Besse, Arnaud] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
   [Yarham, John W.; He, Langping; Simcox, Eve M.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Faqeih, Eissa A.; Al-Asmari, Ali Mohammad; Saleh, Mohammad A. M.] King Fahad Med City, Childrens Hosp, Sect Med Genet, Riyadh 11525, Saudi Arabia.
   [Eyaid, Wafaa; Hadee, Alrukban] King Saud Bin Abdulaziz Univ Hlth & Sci, King Abdulaziz Med City, Dept Pediat, Riyadh 11426, Saudi Arabia.
   [Smith, Frances; Yau, Shu] Guys Hosp, Guys & St Thomas Serco Pathol, DNA Lab, London SE1 9RT, England.
   [Miwa, Satomi] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Abu-Amero, Khaled K.] King Saud Univ, Coll Med, Dept Ophthalmol, Ophthalm Genet Lab, Riyadh 11411, Saudi Arabia.
C3 Baylor College of Medicine; Baylor College of Medicine; Newcastle
   University - UK; King Fahad Medical City; King Saud Bin Abdulaziz
   University for Health Sciences; Guy's & St Thomas' NHS Foundation Trust;
   Newcastle University - UK; King Saud University
RP Bonnen, PE (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
EM pbonnen@bcm.edu; robert.taylor@ncl.ac.uk
RI Graham, Brett/R-8685-2018; Donti, Taraka/K-5648-2013
OI McFarland, Robert/0000-0002-8833-2688; Miwa, Satomi/0000-0002-1239-1198;
   Graham, Brett/0000-0001-8451-8154; Donti, Taraka/0000-0002-3830-155X
FU Texas Norman Hackerman Advanced Research Program [[THECB] 02006];
   Cytometry and Cell Sorting Core at Baylor College of Medicine; National
   Institutes of Health [AI036211, CA125123, RR024574]; NHARP
   [0049-0041-2009]; Medical Research Council (UK) Centenary Early Career
   Award; HEFCE/DoH Clinical Senior Lecturer Award; Wellcome Trust
   Strategic Award [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases
   [G0601943]; Lily Foundation; UK NHS Specialist Commissioners; MRC
   [G0601943, MR/K000608/1, G0800674] Funding Source: UKRI; Wellcome Trust
   [096919/Z/11/Z] Funding Source: Wellcome Trust
FX This work was supported by the Texas Norman Hackerman Advanced Research
   Program under Grant No. [THECB] 02006, the Cytometry and Cell Sorting
   Core at Baylor College of Medicine with funding from the National
   Institutes of Health (AI036211, CA125123, and RR024574), NHARP proposal
   number 0049-0041-2009 (P.E.B.), a Medical Research Council (UK)
   Centenary Early Career Award (J.W.Y.), an HEFCE/DoH Clinical Senior
   Lecturer Award (R.M.), a Wellcome Trust Strategic Award (096919/Z/11/Z)
   (R.W.T.), the MRC Centre for Neuromuscular Diseases (G0601943) (R.M. and
   R.W.T.), the Lily Foundation (R.M. and R.W.T.), and the UK NHS
   Specialist Commissioners that funds the "Rare Mitochondrial Disorders of
   Adults and Children" Diagnostic Service in Newcastle upon Tyne. We thank
   the families for participating in this study and Gavin Falkous and Joel
   Sederstrom for excellent technical support.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68
   BENNETT RL, 1995, AM J HUM GENET, V56, P745, DOI 10.1007/BF01408073
   Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272
   Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405
   Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025
   Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4
   Wong LJC, 2003, J MED GENET, V40
NR 37
TC 121
Z9 128
U1 0
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD SEP 5
PY 2013
VL 93
IS 3
BP 471
EP 481
DI 10.1016/j.ajhg.2013.07.017
PG 11
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 297QB
UT WOS:000330268900006
PM 23993193
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Bohra, SK
   Achar, RR
   Chidambaram, SB
   Pellegrino, C
   Laurin, J
   Masoodi, M
   Srinivasan, A
AF Bohra, Shraman Kumar
   Achar, Raghu Ram
   Chidambaram, Saravana Babu
   Pellegrino, Christophe
   Laurin, Jerome
   Masoodi, Mojgan
   Srinivasan, Asha
TI Current perspectives on mitochondrial dysfunction in migraine
SO EUROPEAN JOURNAL OF NEUROSCIENCE
LA English
DT Review
DE impairment; metabolism; migraine; mitochondrial dysfunction;
   mitochondrial genetics
ID MAGNETIC-RESONANCE-SPECTROSCOPY; CYCLIC VOMITING SYNDROME; HIGH-DOSE
   RIBOFLAVIN; FAMILIAL HEMIPLEGIC MIGRAINE; TRANSFER RNALEU(UUR) GENE;
   MONOAMINE-OXIDASE-A; LOW BRAIN MAGNESIUM; ALPHA-LIPOIC ACID; OXIDATIVE
   STRESS; LACTIC-ACIDOSIS
AB Mitochondria are an autonomous organelle that plays a crucial role in the metabolic aspects of a cell. Cortical spreading depression (CSD) and fluctuations in the cerebral blood flow have for long been mechanisms underlying migraine. It is a neurovascular disorder with a unilateral manifestation of disturbing, throbbing and pulsating head pain. Migraine affects 2.6% and 21.7% of the general population and is the major cause of partial disability in the age group 15-49. Higher mutation rates, imbalance in concentration of physiologically relevant molecules and oxidative stress biomarkers have been the main themes of discussion in determining the role of mitochondrial disability in migraine. The correlation of migraine with other disorders like hemiplegic migraine; mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes [MELAS]; tension-type headache (TTH); cyclic vomiting syndrome (CVS), ischaemic stroke; and hypertension has helped in the assessment of the physiological and morphogenetic basis of migraine. Here, we have reviewed the different nuances of mitochondrial dysfunction and migraine. The different mtDNA polymorphisms that can affect the generation and transmission of nerve impulse has been highlighted and supported with research findings. In addition to this, the genetic basis of migraine pathogenesis as a consequence of mutations in nuclear DNA that can, in turn, affect the synthesis of defective mitochondrial proteins is discussed along with a brief overview of epigenetic profile. This review gives an overview of the pathophysiology of migraine and explores mitochondrial dysfunction as a potential underlying mechanism. Also, therapeutic supplements for managing migraine have been discussed at different junctures in this paper.
C1 [Bohra, Shraman Kumar] Pooja Bhagavat Mem Mahajana Educ Ctr, Dept Life Sci, Mysore, Karnataka, India.
   [Achar, Raghu Ram] JSS Acad Higher Educ & Res, Sch Life Sci, Div Biochem, Mysore, Karnataka, India.
   [Chidambaram, Saravana Babu] JSS Acad Higher Educ & Res, JSS Coll Pharm, Dept Pharmacol, Mysore, Karnataka, India.
   [Pellegrino, Christophe] Aix Marseille Univ, INSERM, Inst Mediterranean Neurobiol, Marseille, France.
   [Laurin, Jerome] Aix Marseille Univ, Sport Sci Fac, Inst Neurobiol Mediterranee, INMED INSERM AMU, Marseille, France.
   [Masoodi, Mojgan] Univ Hosp Bern, Inst Clin Chem, Bern, Switzerland.
   [Srinivasan, Asha] JSS Acad Higher Educ & Res, JSS Med Coll, Sch Life Sci, Div Nanosci & Technol, Mysore 570015, Karnataka, India.
   [Srinivasan, Asha] JSS Acad Higher Educ & Res, JSS Med Coll, Ctr Excellence Mol Biol & Regenerat Med, Mysore 570015, Karnataka, India.
C3 JSS Academy of Higher Education & Research; JSS Academy of Higher
   Education & Research; JSS College of Pharmacy, Mysuru; Aix-Marseille
   Universite; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Aix-Marseille Universite; University of Bern; University
   Hospital of Bern; JSS Academy of Higher Education & Research; JSS
   Medical College, Mysuru; JSS Academy of Higher Education & Research; JSS
   Medical College, Mysuru
RP Srinivasan, A (corresponding author), JSS Acad Higher Educ & Res, JSS Med Coll, Sch Life Sci, Div Nanosci & Technol, Mysore 570015, Karnataka, India.; Srinivasan, A (corresponding author), JSS Acad Higher Educ & Res, JSS Med Coll, Ctr Excellence Mol Biol & Regenerat Med, Mysore 570015, Karnataka, India.
EM asha.srinivasan@jssuni.edu.in
RI Achar, Raghu Ram/ABC-8489-2021; Chidambaram, Saravana/V-2319-2019;
   LAURIN, Jérôme/Q-3503-2018; MASOODI, MOJGAN/B-8814-2012; Pellegrino,
   christophe/P-5266-2016
OI Pellegrino, christophe/0000-0002-0669-4918
CR Aggarwal M, 2012, ANN NEUROSCI, V19, P88, DOI 10.5214/ans.0972.7531.12190210
   Al Khalili Y., 2019, StatPearls
   Albrecht DS, 2019, NEUROLOGY, V92, pE2038, DOI 10.1212/WNL.0000000000007371
   Alloush R., 2019, NEUROSCIENCE MED, V10, P339, DOI [10.4236/nm.2019.104025, DOI 10.4236/NM.2019.104025]
   Amin FM, 2014, BRAIN, V137, P779, DOI 10.1093/brain/awt369
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Ashoori M, 2014, BRIT J NUTR, V111, P1985, DOI 10.1017/S0007114514000178
   Atlante A, 2001, FEBS LETT, V497, P1, DOI 10.1016/S0014-5793(01)02437-1
   Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746
   Banne AF, 2003, J ANTI-AGING MED, V6, P327, DOI 10.1089/109454503323028920
   BARBIROLI B, 1990, CEPHALALGIA, V10, P263, DOI 10.1046/j.1468-2982.1990.1005263.x
   Borte S, 2020, CEPHALALGIA, V40, P625, DOI 10.1177/0333102420906835
   Bron C, 2021, NEUROPSYCH DIS TREAT, V17, P1183, DOI 10.2147/NDT.S282562
   Brown GC, 2007, FRONT BIOSCI-LANDMRK, V12, P1024, DOI 10.2741/2122
   Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482
   Burow P, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10092471
   Burstein R, 2015, J NEUROSCI, V35, P6619, DOI 10.1523/JNEUROSCI.0373-15.2015
   Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004
   Charbit AR, 2010, CURR OPIN NEUROL, V23, P275, DOI 10.1097/WCO.0b013e3283378d5c
   Cheng J, 2011, EUR J PHARMACOL, V650, P184, DOI 10.1016/j.ejphar.2010.09.033
   Chial H., 2008, Nature Educ, V1, P217
   Condò M, 2009, J HEADACHE PAIN, V10, P361, DOI 10.1007/s10194-009-0142-2
   Daniel O, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0398-1
   Davis Ryan L, 2018, Handb Clin Neurol, V147, P125, DOI 10.1016/B978-0-444-63233-3.00010-5
   De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081
   Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dong YR, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0149-x
   Durham PL, 2006, HEADACHE, V46, pS3, DOI 10.1111/j.1526-4610.2006.00483.x
   ERECINSKA M, 1990, J GEN PHYSIOL, V95, P591, DOI 10.1085/jgp.95.4.591
   Eren Y, 2015, ACTA NEUROL BELG, V115, P643, DOI 10.1007/s13760-015-0427-y
   Fanibunda SE, 2019, P NATL ACAD SCI USA, V116, P11028, DOI 10.1073/pnas.1821332116
   Farré AL, 2001, HYPERTENSION, V38, P1400, DOI 10.1161/hy1201.099612
   Fazzini F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33684-5
   Ferrari MD, 2015, LANCET NEUROL, V14, P65, DOI 10.1016/S1474-4422(14)70220-0
   Fila M, 2019, ARCH MED SCI, V15, P944, DOI 10.5114/aoms.2019.86061
   Filic V, 2005, J NEUROL SCI, V228, P149, DOI 10.1016/j.jns.2004.11.045
   Geyik S, 2016, J HEADACHE PAIN, V17, DOI [10.1186/s10194-016-0623-z, 10.1186/s10194-016-0606-0]
   Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Green MW, 2021, CURR OPIN NEUROL, V34, P329, DOI 10.1097/WCO.0000000000000939
   Gross EC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84102-2
   Gross EC, 2019, NAT REV NEUROL, V15, P627, DOI 10.1038/s41582-019-0255-4
   Guo S, 2016, EUR J NEUROL, V23, P175, DOI 10.1111/ene.12832
   Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127
   Holland P, 2007, HEADACHE, V47, P951, DOI 10.1111/j.1526-4610.2007.00842.x
   Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c
   Ikeda K, 2003, J NEUROSCI, V23, P4667
   Jimenez L, 2014, J CELL SCI, V127, P719, DOI 10.1242/jcs.137141
   Kagan R, 2013, NEUROSCIENCE, V248, P359, DOI 10.1016/j.neuroscience.2013.06.014
   Kataria S, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9226
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kausar S, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120274
   Kelishadi MR, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-021-04397-z
   KEMP GJ, 1993, NMR BIOMED, V6, P302, DOI 10.1002/nbm.1940060504
   Kim HK, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/408136
   KOBARI M, 1989, HEADACHE, V29, P282, DOI 10.1111/j.1526-4610.1989.hed2905282.x
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Köseoglu E, 2008, MAGNESIUM RES, V21, P101
   Kraya T, 2018, HEADACHE, V58, P45, DOI 10.1111/head.13219
   Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007
   Lemos C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050626
   Li BUK, 2003, GASTROENTEROL CLIN N, V32, P997, DOI 10.1016/S0889-8553(03)00045-1
   Li BUK, 1999, J PEDIATR-US, V134, P567, DOI 10.1016/S0022-3476(99)70242-8
   Lin KH, 2016, CEPHALALGIA, V36, P1218, DOI 10.1177/0333102415623069
   Liu F, 2018, AGING DIS, V9, P924, DOI 10.14336/AD.2017.1126
   Lodi R, 1997, PEDIATR RES, V42, P866, DOI 10.1203/00006450-199712000-00024
   Loggia ML, 2015, BRAIN, V138, P604, DOI 10.1093/brain/awu377
   MacGregor EA, 2004, LANCET NEUROL, V3, P354, DOI 10.1016/S1474-4422(04)00768-9
   MacLennan SC, 2008, J CHILD NEUROL, V23, P1300, DOI 10.1177/0883073808318053
   Maizels M, 2012, HEADACHE, V52, P1553, DOI 10.1111/j.1526-4610.2012.02209.x
   Majamaa K, 1998, LANCET, V352, P455, DOI 10.1016/S0140-6736(05)79190-X
   Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71
   Marrocco I, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6501046
   Marziniak M, 2005, NEUROLOGY, V64, P157, DOI 10.1212/01.WNL.0000148597.52312.9E
   Marziniak M, 2004, J NEURAL TRANSM, V111, P603, DOI 10.1007/s00702-004-0108-0
   MATALON R, 1984, J PEDIATR-US, V104, P65, DOI 10.1016/S0022-3476(84)80591-0
   Mathew NT, 1999, CEPHALALGIA, V19, P17, DOI 10.1177/0333102499019S2504
   Matilainen O, 2017, TRENDS CELL BIOL, V27, P453, DOI 10.1016/j.tcb.2017.02.004
   Matsuda M, 2019, J ANESTH, V33, P131, DOI 10.1007/s00540-018-2579-4
   May A, 2006, J NEUROSCI, V26, P3589, DOI 10.1523/JNEUROSCI.4609-05.2006
   Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006
   Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6
   Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055
   Montagna L.P., 2003, J HEADACHE PAIN, V4, P47, DOI [10.1007/s10194-003-0030-0, DOI 10.1007/S10194-003-0030-0]
   Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109
   Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052
   Nicolson GL, 2014, ALTERN THER HEALTH M, V20, P18
   Nyholt DR, 1998, HUM MOL GENET, V7, P459, DOI 10.1093/hmg/7.3.459
   Okada H, 1998, HEADACHE, V38, P39, DOI 10.1046/j.1526-4610.1998.3801039.x
   Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202
   Ong JJY, 2018, NEUROTHERAPEUTICS, V15, P274, DOI 10.1007/s13311-017-0592-1
   Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2
   Ouyang JP, 2019, PAIN RES MANAG, V2019, DOI 10.1155/2019/3173149
   Paprocka J, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110849
   Passaro D, 2010, BRAIN RES, V1329, P1, DOI 10.1016/j.brainres.2010.03.001
   Pescador Ruschel M.A., 2021, STATPEARLS
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Pomes LM, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1010-3
   Ramachandran R, 2014, CEPHALALGIA, V34, P136, DOI 10.1177/0333102413502735
   RAMADAN NM, 1989, HEADACHE, V29, P590, DOI 10.1111/j.1526-4610.1989.hed2909590.x
   Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003
   Rosen N, 2008, HEADACHE, V48, P733, DOI 10.1111/j.1526-4610.2008.01118.x
   Rudkin TM, 1999, ARCH NEUROL-CHICAGO, V56, P919, DOI 10.1001/archneur.56.8.919
   RUSSELL MB, 1993, CEPHALALGIA, V13, P245, DOI 10.1046/j.1468-2982.1993.1304245.x
   Russell MB, 1997, ACTA NEUROL SCAND, V96, P171
   Sacco S, 2012, J HEADACHE PAIN, V13, P177, DOI 10.1007/s10194-012-0424-y
   Sándor PS, 2005, CEPHALALGIA, V25, P507, DOI 10.1111/j.1468-2982.2005.00900.x
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   Sanoobar M, 2015, NUTR NEUROSCI, V18, P169, DOI 10.1179/1476830513Y.0000000106
   Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005
   Scarrone S, 2007, CEPHALALGIA, V27, P128, DOI 10.1111/j.1468-2982.2007.01267.x
   Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49
   SCHOENEN J, 1994, CEPHALALGIA, V14, P328, DOI 10.1046/j.1468-2982.1994.1405328.x
   Schoenen J, 1998, NEUROLOGY, V50, P466, DOI 10.1212/WNL.50.2.466
   Schulte LH, 2017, NEUROLOGY, V88, P2011, DOI 10.1212/WNL.0000000000003963
   Shatillo A, 2013, NEUROSCIENCE, V253, P341, DOI 10.1016/j.neuroscience.2013.09.002
   Shay KP, 2008, IUBMB LIFE, V60, P362, DOI 10.1002/iub.40
   Shoeibi A, 2017, ACTA NEUROL BELG, V117, P103, DOI 10.1007/s13760-016-0697-z
   SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535
   Smeitink Jan, 2019, JIMD Rep, V46, P52, DOI 10.1002/jmd2.12017
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x
   Stuart S, 2012, MOL GENET GENOMICS, V287, P837, DOI 10.1007/s00438-012-0723-7
   Sun-Edelstein C, 2009, EXPERT REV NEUROTHER, V9, P369, DOI 10.1586/14737175.9.3.369
   Symon DNK, 1995, J PEDIATR GASTR NUTR, V21, pS42, DOI 10.1097/00005176-199501001-00012
   Takeshima T, 2001, CEPHALALGIA, V21, P987, DOI 10.1046/j.1468-2982.2001.00305.x
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Togha M, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1555-4
   Tottene A, 2011, CHANNELS, V5, P110, DOI 10.4161/chan.5.2.14149
   Tripathi GM, 2018, INT J NEUROSCI, V128, P318, DOI 10.1080/00207454.2017.1374959
   UNCINI A, 1995, J NEUROL SCI, V129, P214, DOI 10.1016/0022-510X(94)00283-T
   van der Wijst MGP, 2015, TRENDS GENET, V31, P353, DOI 10.1016/j.tig.2015.03.009
   VEECH RL, 1979, J BIOL CHEM, V254, P6538
   Veitia RA, 2018, HUM MOL GENET, V27, P1565, DOI 10.1093/hmg/ddy063
   Vernieri F, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-18
   Vuralli D, 2021, EXPERT REV NEUROTHER, V21, P1069, DOI 10.1080/14737175.2021.1947797
   Wang QX, 2004, AM J MED GENET A, V131A, P50, DOI 10.1002/ajmg.a.30323
   Wang Shuu-Jiun, 2003, Curr Neurol Neurosci Rep, V3, P104, DOI 10.1007/s11910-003-0060-7
   Warfvinge K, 2013, CEPHALALGIA, V33, P593, DOI 10.1177/0333102412472072
   Wei PH, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00073
   WEYLER W, 1990, PHARMACOL THERAPEUT, V47, P391, DOI 10.1016/0163-7258(90)90064-9
   Wieser T, 2010, HEADACHE, V50, P420, DOI 10.1111/j.1526-4610.2009.01428.x
   WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505
   Wouters J, 1998, CURR MED CHEM, V5, P137
   Yablon L A., 2011, Magnesium in the Central Nervous System [Internet]
   Yetkin E, 2007, HEADACHE, V47, P104, DOI 10.1111/j.1526-4610.2007.00657.x
   Yorns WR, 2013, SEMIN PEDIATR NEUROL, V20, P188, DOI 10.1016/j.spen.2013.09.002
   Zaki E A, 2009, Cephalalgia, V29, P719, DOI 10.1111/j.1468-2982.2008.01793.x
   Zamorano-León JJ, 2010, CELL PHYSIOL BIOCHEM, V25, P347, DOI 10.1159/000276567
NR 151
TC 7
Z9 8
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0953-816X
EI 1460-9568
J9 EUR J NEUROSCI
JI Eur. J. Neurosci.
PD JUL
PY 2022
VL 56
IS 1
BP 3738
EP 3754
DI 10.1111/ejn.15676
EA MAY 2022
PG 17
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 2R0AB
UT WOS:000794045600001
PM 35478208
DA 2024-11-01
ER

PT J
AU Palecek, T
   Tesarova, M
   Kuchynka, P
   Dytrych, V
   Elleder, M
   Hulkova, H
   Hansikova, H
   Honzik, T
   Zeman, J
   Linhart, A
AF Palecek, Tomas
   Tesarova, Marketa
   Kuchynka, Petr
   Dytrych, Vladimir
   Elleder, Milan
   Hulkova, Helena
   Hansikova, Hana
   Honzik, Tomas
   Zeman, Jiri
   Linhart, Ales
TI Hypertrophic Cardiomyopathy Due to the Mitochondrial DNA Mutation
   m.3303C&gt;T Diagnosed in an Adult Male
SO INTERNATIONAL HEART JOURNAL
LA English
DT Article
DE Mitochondrial disease; Short PR interval
ID MATERNALLY INHERITED CARDIOMYOPATHY; POINT MUTATION; TRNA(LEU(UUR))
   GENE; DISEASE; PATIENT; MYOPATHY; DEFECTS; TISSUES; BRAIN; ONSET
AB Mitochondrial disorders comprise a heterogeneous group of diseases with multisystem involvement including myocardium. Most cases of mitochondrial cardiomyopathy are associated with myopathy and encephalopathy and are generally present in infancy or childhood. The disease often exhibits a rapid downward course with death frequently occuring within the first year of life. We describe a unique case of hypertrophic cardiomyopathy due to mitochondrial DNA mutation m.3303C>T in the MT-TL1 gene, diagnosed accidentally in a 35-year-old male. The patient initially presented with stroke of assumed cardioembolic origin due to the presence of two interatrial communications associated with mobile aneurysm of the interatrial septum. No other extracardiac manifestations of mitochondrial disorder were observed. (Int Heart J 2012; 53: 383-387)
C1 [Palecek, Tomas; Kuchynka, Petr; Dytrych, Vladimir; Linhart, Ales] Charles Univ Prague, Fac Med 1, Dept Med 2, Dept Cardiovasc Med,Gen Univ Hosp Prague, Prague 12808 2, Czech Republic.
   [Palecek, Tomas] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic.
   [Tesarova, Marketa; Hansikova, Hana; Honzik, Tomas; Zeman, Jiri] Charles Univ Prague, Fac Med 1, Gen Univ Hosp Prague, Dept Pediat & Adolescent Med, Prague 12808 2, Czech Republic.
   [Elleder, Milan; Hulkova, Helena] Charles Univ Prague, Fac Med 1, Gen Univ Hosp Prague, Inst Inherited Metab Disorders, Prague 12808 2, Czech Republic.
C3 Charles University Prague; General University Hospital Prague;
   University Hospital Hradec Kralove; St Anne's University Hospital Brno
   (FNUSA); St Anne's University Hospital Brno (FNUSA-ICRC); Charles
   University Prague; General University Hospital Prague; General
   University Hospital Prague; Charles University Prague
RP Palecek, T (corresponding author), Charles Univ Prague, Fac Med 1, Dept Med 2, Dept Cardiovasc Med,Gen Univ Hosp Prague, U Nemocnice 2, Prague 12808 2, Czech Republic.
RI Hansikova, Hana/E-9350-2017; Tesarova, Marketa/I-1531-2016; Kuchynka,
   Petr/M-3754-2017; Linhart, Ales/O-2375-2017; Honzik, Tomas/N-7509-2017;
   Zeman, Jiri/K-2691-2017; Hulkova, Helena/O-2268-2017
OI Tesarova, Marketa/0000-0002-5141-2289; Kuchynka,
   Petr/0000-0002-1816-5634; Linhart, Ales/0000-0002-3372-7850; Honzik,
   Tomas/0000-0003-4300-2519; Zeman, Jiri/0000-0002-2678-7919; Hulkova,
   Helena/0000-0002-7441-6610
FU European Regional Development Fund - Project FNUSA-ICRC
   [CZ.1.05/1.1.00/02.0123];  [PRVOUK-P35/LF1/5];  [PRVOUK-P24/LF1/3]; 
   [RVO-VFN64165/2012]
FX The study was supported by research projects PRVOUK-P35/LF1/5,
   PRVOUK-P24/LF1/3, RVO-VFN64165/2012, and European Regional Development
   Fund - Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123).
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349
   Bruno C, 1999, J PEDIATR-US, V135, P197, DOI 10.1016/S0022-3476(99)70022-3
   CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   FUJII T, 1990, PEDIATR NEUROL, V6, P253, DOI 10.1016/0887-8994(90)90116-I
   Goldstein JD, 1999, PEDIATR DEVEL PATHOL, V2, P78, DOI 10.1007/s100249900094
   GUENTHARD J, 1995, ARCH DIS CHILD, V72, P223, DOI 10.1136/adc.72.3.223
   Honzík T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096
   Hsu PC, 2008, INT J CARDIOL, V129, P441, DOI 10.1016/j.ijcard.2007.06.098
   HUANG CC, 1995, EUR NEUROL, V35, P199, DOI 10.1159/000117128
   HUG G, 1970, LAB INVEST, V22, P541
   Hulková H, 2009, J INHERIT METAB DIS, V32, P551, DOI 10.1007/s10545-009-1178-9
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Lindberg C, 2008, ACTA NEUROL SCAND, V117, P128, DOI 10.1111/j.1600-0404.2007.00913.x
   MARON BJ, 1975, J MOL CELL CARDIOL, V7, P697, DOI 10.1016/0022-2828(75)90146-7
   Palecek T, 2006, HEART VESSELS, V21, P13, DOI 10.1007/s00380-005-0852-6
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Schiff M, 2011, SEMIN FETAL NEONAT M, V16, P216, DOI 10.1016/j.siny.2011.04.002
   Schwartz ML, 1996, CIRCULATION, V94, P2021, DOI 10.1161/01.CIR.94.8.2021
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Vesela K, 2008, APMIS, V116, P41, DOI 10.1111/j.1600-0463.2008.00772.x
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Yokoyama U, 2002, JPN HEART J, V43, P61, DOI 10.1536/jhj.43.61
   ZEVIANI M, 1989, NEUROL CLIN, V7, P123, DOI 10.1016/S0733-8619(18)30832-6
NR 29
TC 16
Z9 16
U1 0
U2 3
PU INT HEART JOURNAL ASSOC
PI TOKYO
PA UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE,
   HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN
SN 1349-2365
J9 INT HEART J
JI Int. Heart J.
PD NOV
PY 2012
VL 53
IS 6
BP 383
EP 387
DI 10.1536/ihj.53.383
PG 5
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 218SC
UT WOS:000324451800009
PM 23258140
OA Bronze
DA 2024-11-01
ER

PT J
AU Bergmann, AK
   Campagna, DR
   McLoughlin, EM
   Agarwal, S
   Fleming, MD
   Bottomley, SS
   Neufeld, EJ
AF Bergmann, Anke K.
   Campagna, Dean R.
   McLoughlin, Erin M.
   Agarwal, Suneet
   Fleming, Mark D.
   Bottomley, Sylvia S.
   Neufeld, Ellis J.
TI Systematic Molecular Genetic Analysis of Congenital Sideroblastic
   Anemia: Evidence for Genetic Heterogeneity and Identification of Novel
   Mutations
SO PEDIATRIC BLOOD & CANCER
LA English
DT Article
DE iron; microcytic anemia; ringed sideroblasts; sideroblastic anemia
ID MITOCHONDRIAL MYOPATHY; MEGALOBLASTIC-ANEMIA; MISSENSE MUTATION; ATAXIA;
   ABC7; TRANSPORTER; DISORDER; REPEAT
AB Background. Sideroblastic anemias are heterogeneous congenital and acquired bone marrow disorders characterized by pathologic iron deposits in mitochondria of erythroid precursors. Among the congenital sideroblastic anemias (CSAs), the most common form is X-linked sideroblastic anemia, due to Mutations in 5-aminolevulinate synthase (ALAS2). A novel autosomal recessive CSA, caused by mutations in the erythroid specific mitochondrial transporter SLC25A38, was recently defined. Other known etiologies include mutations in genes encoding the thiamine transporter SLC19A2, the RNA-modifying enzyme pSeLldouridine synthase 1 (PUS1), a mitochondrial ATP-binding cassette transporter (ABCB7), glutaredoxin 5 (GLRX5), as well as mitochondrial DNA deletions. Despite these known diverse causes, in a Substantial portion of CSA cases a presumed genetic defect remains unknown. Procedure. In the context of the recent discovery of SLC25A38 as a major novel cause, we systematically analyzed a large cohort of previously unreported CSA patients. Sixty CSA probands (28 females, 32 males) were examined for ALAS2, SLC25A38, PUS1, GLRX5, and ABCB7 mutations. SLC19A2 and mitochondrial DNA were only analyzed if characteristic syndromic features were apparent. Results. Twelve probands had biallelic mutations in SLC25A38. Seven ALAS2 mutations were detected in eight sporadic CSA cases, two being novel. We also identified a novel homozygous null PUSI mutation and novel mitochondrial DNA deletions in two patients with Pearson syndrome. No mutations were encountered in GLRX5, ABCB7, or SLC19A2. Conclusions. The remaining undefined probands (43%) can be grouped according to gender, family, and clinical characteristics, suggesting novel X-linked and autosomal recessive forms of CSA. Pediatr Blood Cancer 2010;54:273-278. (C) 2009 Wiley-Liss, Inc.
C1 [Campagna, Dean R.; Fleming, Mark D.] Harvard Univ, Dept Pathol, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA.
   [Bergmann, Anke K.; McLoughlin, Erin M.; Agarwal, Suneet; Neufeld, Ellis J.] Harvard Univ, Div Hematol Oncol, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA.
   [Agarwal, Suneet; Neufeld, Ellis J.] Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Bottomley, Sylvia S.] Univ Oklahoma, Coll Med, Hematol Oncol Sect, Oklahoma City, OK 73190 USA.
C3 Harvard University; Harvard Medical School; Boston Children's Hospital;
   Harvard University; Harvard Medical School; Boston Children's Hospital;
   Harvard University; Dana-Farber Cancer Institute; University of Oklahoma
   System; University of Oklahoma Health Sciences Center
RP Fleming, MD (corresponding author), Harvard Univ, Dept Pathol, Childrens Hosp Boston, Sch Med, 300 Longwood Ave,Enders 1116-1, Boston, MA 02115 USA.
EM mark.fleming@childrens.harvard.edu
RI Bergmann, Anke/AAT-2509-2020; Neufeld, Ellis/F-9331-2011
OI Neufeld, Ellis/0000-0001-8092-6281; Bergmann, Anke
   Katharina/0000-0002-1367-2725; Fleming, Mark/0000-0003-0948-4024
FU NIH [R01 DK080011, K08 HL089150, K24 HL004184]; The U.S. Department of
   Veterans, Affairs, University of Oklahoma Health Sciences Center
   Provost's Fund; The Oklahoma Center for Advancement of Science and
   Technology
FX We express our gratitude to the patients, their families and referring
   physicians. We thank Mathew Heeney for help with consenting some of the
   patients, Philip Wise and Eric Wasson for technical assistance, and Mark
   Samuels and his colleagues at the Atlantic Medical Genetics and Genomics
   Initiative for discussions concerning SLC25A38 in advance Of
   publication. This work was supported in part by NIH grant R01 DK080011
   (M.D.F.); The U.S. Department of Veterans, Affairs, University of
   Oklahoma Health Sciences Center Provost's Fund and The Oklahoma Center
   for Advancement of Science and Technology (S.S.B.); NIH grant K08
   HL089150 (S.A.), and NIH grant K24 HL004184 (E.J.N.).
CR ABBOUD MR, 1985, J PEDIATR-US, V107, P537, DOI 10.1016/S0022-3476(85)80011-1
   ALLEN RC, 1992, AM J HUM GENET, V51, P1229
   Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792
   Bekri S, 2000, BLOOD, V96, P3256
   Bekri S, 2003, BLOOD, V102, P698, DOI 10.1182/blood-2002-06-1623
   BERGMANN AK, 2009, J PEDIAT
   Bottomley S.S., 2008, Wintrobe's Clinical Hematology, V12th, P835
   Bottomley Sylvia S, 2006, Curr Hematol Rep, V5, P41
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   COOLEY TB, 1945, AM J MED SCI, V209, P561
   DIERLAMM J, 1995, BRIT J HAEMATOL, V91, P885, DOI 10.1111/j.1365-2141.1995.tb05405.x
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Fleming MD, 2002, SEMIN HEMATOL, V39, P270, DOI 10.1053/shem.2002.35637
   Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359
   Maguire A, 2001, BRIT J HAEMATOL, V115, P910, DOI 10.1046/j.1365-2141.2001.03015.x
   May A., 2005, BLOOD, V106, p988a
   Neufeld EJ, 2001, BLOOD CELL MOL DIS, V27, P135, DOI 10.1006/bcmd.2000.0356
   PAGON RA, 1985, J MED GENET, V22, P267, DOI 10.1136/jmg.22.4.267
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   PEGORARO E, 1994, AM J HUM GENET, V54, P989
   Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768
   Ricketts CJ, 2006, ACTA PAEDIATR, V95, P99, DOI 10.1080/08035250500323715
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1989, LANCET, V1, P902
   ROTIG A, 1995, MUSCLE NERVE, pS159
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   SLEDDENS HFBM, 1992, NUCLEIC ACIDS RES, V20, P1427
   Surinya KH, 1998, J BIOL CHEM, V273, P16798, DOI 10.1074/jbc.273.27.16798
   Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
NR 34
TC 102
Z9 116
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD FEB
PY 2010
VL 54
IS 2
BP 273
EP 278
DI 10.1002/pbc.22244
PG 6
WC Oncology; Hematology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Hematology; Pediatrics
GA 538TK
UT WOS:000273206700019
PM 19731322
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Xu, HL
   Wang, ZX
   Zheng, LM
   Zhang, W
   Lv, H
   Jin, SQ
   Yuan, Y
AF Xu, Hongliang
   Wang, Zhaoxia
   Zheng, Lemin
   Zhang, Wei
   Lv, He
   Jin, Suqin
   Yuan, Yun
TI Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage,
   mitochondrial dysfunction and mitochondrial DNA depletion
SO JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
ID CHRONIC HEPATITIS-B; CULTURED HUMAN-CELLS; LONG-TERM; DYNAMICS;
   TOXICITY; THERAPY; COMPLEMENTATION; CYTOTOXICITY; TELBIVUDINE;
   ZIDOVUDINE
AB Aims Myopathy or neuropathy has been associated with lamivudine/telbivudine therapy in hepatitis B patients. We aim to describe the pathological changes of lamivudine/telbivudine-associated neuromyopathy.
   Methods We retrospectively recruited six patients who were diagnosed with nucleotide analogues-associated myopathy or neuropathy. Muscle and nerve biopsy were performed, and the specimens were prepared for the light microscopy and electron microscopy. Genomic DNA was extracted from frozen muscle specimens, and the mitochondrial DNA (mtDNA) content was quantified by real-time PCR.
   Results Recovery of the myopathy can be achieved after the discontinuation or changing the drugs to entecavir. Muscle and nerve biopsy revealed similar changes under either the light or electronic microscopy in all the subjects. Quantitative real-time PCR revealed decrease of mtDNA content in the affected muscle.
   Conclusions MtDNA depletion results in mitochondrial dysfunction in the lamivudine/telbivudine-associated neuromyopathy. Myopathy was characterised by mitochondrial dysfunction accompanied with neurogenic damage due to axonal neuropathy. Ultrastructure changes of mitochondria included vacuolisation, simplification of the cristae and homogenised matrix.
C1 [Xu, Hongliang; Wang, Zhaoxia; Zhang, Wei; Lv, He; Jin, Suqin; Yuan, Yun] Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.
   [Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Cardiovasc Sci, Beijing 100191, Peoples R China.
   [Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Syst Biomed,Sch Basic Med Sci, Beijing 100191, Peoples R China.
   [Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China.
C3 Peking University; Peking University; Peking University; Peking
   University
RP Yuan, Y (corresponding author), Peking Univ, Hosp 1, Dept Neurol, 8 Xishiku St, Beijing 100034, Peoples R China.
EM yuanyun2002@sohu.com
RI Wang, Zilong/IQV-2260-2023
FU National Natural Science Foundation of China [30870864]; Twelfth Five
   Years Plan [2011ZX09307-001-07]
FX This work was supported by the National Natural Science Foundation of
   China (no. 30870864) and Twelfth Five Years Plan (no.
   2011ZX09307-001-07).
CR Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   CHEN CH, 1989, J BIOL CHEM, V264, P11934
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Divi RL, 2007, ENVIRON MOL MUTAGEN, V48, P179, DOI 10.1002/em.20245
   Fleischer RD, 2009, J HEPATOL, V51, P787, DOI 10.1016/j.jhep.2009.06.011
   Fontana RJ, 2009, HEPATOLOGY, V49, pS185, DOI 10.1002/hep.22885
   Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1
   Harkisoen S, 2012, ANN HEPATOL
   Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422
   Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s
   Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026
   Mazzucco CE, 2008, ANTIMICROB AGENTS CH, V52, P598, DOI 10.1128/AAC.01122-07
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Sato A, 2009, BIOFACTORS, V35, P130, DOI 10.1002/biof.14
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Vidal F, 2006, ANTIMICROB AGENTS CH, V50, P3824, DOI 10.1128/AAC.00437-06
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 25
TC 26
Z9 27
U1 0
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0021-9746
EI 1472-4146
J9 J CLIN PATHOL
JI J. Clin. Pathol.
PD NOV
PY 2014
VL 67
IS 11
BP 999
EP 1005
DI 10.1136/jclinpath-2013-202069
PG 7
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA AS1UP
UT WOS:000344067700012
PM 25190818
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Siva, MA
   Mahalakshmi, R
   Bhakta-Guha, D
   Guha, G
AF Siva, M. Aravintha
   Mahalakshmi, R.
   Bhakta-Guha, Dipita
   Guha, Gunjan
TI Gene therapy for the mitochondrial genome: Purging mutations, pacifying
   ailments
SO MITOCHONDRION
LA English
DT Review
DE Mitochondrial diseases; Mystondria; mtDNA mutations; Gene therapy
ID HEREDITARY OPTIC NEUROPATHY; MESSENGER-RNA LOCALIZATION; MATERNALLY
   INHERITED CARDIOMYOPATHY; LIPOSOME-BASED CARRIER; DNA MUTATIONS;
   OXIDATIVE STRESS; LEIGH-SYNDROME; MTDNA HETEROPLASMY; SKELETAL-MUSCLE;
   MITO-PORTER
AB In the recent years, the reported cases of mitochondrial disorders have reached a colossal number. These disorders spawn a sundry of pathological conditions, which lead to pernicious symptoms and even fatality. Due to the unpredictable etiologies, mitochondrial diseases are putatively referred to as "mystondria" (mysterious diseases of mitochondria). Although present-day research has greatly improved our understanding of mitochondrial disorders, effective therapeutic interventions are still at the precursory stage. The conundrum becomes further complicated because these pathologies might occur due to either mitochondrial DNA (mtDNA) mutations or due to mutations in the nuclear DNA (nDNA), or both. While correcting nDNA mutations by using gene therapy (replacement of defective genes by delivering wild-type (WT) ones into the host cell, or silencing a dominant mutant allele that is pathogenic) has emerged as a promising strategy to address some mitochondrial diseases, the complications in correcting the defects of mtDNA in order to renovate mitochondrial functions have remained a steep challenge. In this review, we focus specifically on the selective gene therapy strategies that have demonstrated prospects in targeting the pathological mutations in the mitochondrial genome, thereby treating mitochondrial ailments.
C1 [Siva, M. Aravintha; Mahalakshmi, R.; Bhakta-Guha, Dipita; Guha, Gunjan] SASTRA Univ, Sch Chem & Bio Technol, Cellular Dyshomeostasis Lab CDHL, Thanjavur 613401, Tamil Nadu, India.
C3 Shanmugha Arts, Science, Technology & Research Academy (SASTRA)
RP Bhakta-Guha, D; Guha, G (corresponding author), SASTRA Univ, SCBT, CDHL, Thanjavur 613401, Tamil Nadu, India.
EM dipitaguha@scbt.sastra.edu; gunjanguha@scbt.sastra.edu
RI Bhakta-Guha, Dipita/E-8076-2012; Guha, Gunjan/D-8197-2011
OI Bhakta-Guha, Dipita/0000-0002-7144-3947; Guha,
   Gunjan/0000-0002-9224-0241; , Mahalakshmi/0000-0003-4251-5064
CR Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   [Anonymous], EXP CELL RES, DOI DOI 10.1016/J.YEXCR.2014.03.012
   [Anonymous], MITOCHONDRION, DOI DOI 10.1016/J.MITO.2015.10.008
   Asayama S, 2015, PHARMACEUTICS, V7, P224, DOI 10.3390/pharmaceutics7030224
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Birch-Machin MA, 2016, BRIT J DERMATOL, V175, P26, DOI 10.1111/bjd.14906
   Bonnardel J., 2019, IMMUNITY, DOI [10.1016/j.immuni.2019.08.017, DOI 10.1016/J.IMMUNI.2005.06.008]
   Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526
   Bonnet Crystel, 2007, Journal de la Societe de Biologie, V201, P69, DOI 10.1051/jbio:2007008
   Boominathan A, 2016, NUCLEIC ACIDS RES, V44, P9342, DOI 10.1093/nar/gkw756
   Camus MF, 2012, CURR BIOL, V22, P1717, DOI 10.1016/j.cub.2012.07.018
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Chadderton N, 2013, EUR J HUM GENET, V21, P62, DOI 10.1038/ejhg.2012.112
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chin RM, 2018, CELL REP, V22, P2818, DOI 10.1016/j.celrep.2018.02.059
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168
   Choong C.-J., 2015, EXPERT OPIN BIOL TH, P1, DOI [10.1517/14712598.2016, DOI 10.1517/14712598.2016]
   Coxhead J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.036
   Cwerman-Thibault H, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.3
   D'Souza GGM, 2005, MITOCHONDRION, V5, P352, DOI 10.1016/j.mito.2005.07.001
   Das P, 2010, J SCI RES, V3, P177, DOI [10.3329/jsr.v3i1.5078, DOI 10.3329/JSR.V3I1.5078]
   Davis Ryan L, 2018, Handb Clin Neurol, V147, P125, DOI 10.1016/B978-0-444-63233-3.00010-5
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   De Praeter C, 2015, EUR J PEDIATR, V174, P267, DOI 10.1007/s00431-014-2370-y
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dipchand AI, 2001, PEDIATR CARDIOL, V22, P14, DOI 10.1007/s002460010145
   Doyle SR, 2008, HUM GENE THER, V19, P1335, DOI [10.1089/hum.2008.090, 10.1089/hgt.2008.090]
   Dunn DA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/541245
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Faridi U, 2016, OMICS, V20, P53, DOI 10.1089/omi.2015.0118
   Feuer WJ, 2016, OPHTHALMOLOGY, V123, P558, DOI 10.1016/j.ophtha.2015.10.025
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Fogleman S, 2016, AM J STEM CELLS, V5, P39
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299
   Gerards M, 2016, MOL GENET METAB, V117, P300, DOI 10.1016/j.ymgme.2015.12.004
   Gibson SAJ, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt102
   Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698
   Gómez-Tatay L, 2017, J CLIN MED, V6, DOI 10.3390/jcm6030025
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Heller A, 2012, EUR J PHARM BIOPHARM, V82, P1, DOI 10.1016/j.ejpb.2012.05.014
   Herold MJ, 2002, J IMMUNOL, V168, P3902, DOI 10.4049/jimmunol.168.8.3902
   HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465
   Hoptasz M, 2014, NEUROL NEUROCHIR POL, V48, P150, DOI 10.1016/j.pjnns.2013.12.007
   Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264
   Ishikawa T, 2018, J CONTROL RELEASE, V274, P109, DOI 10.1016/j.jconrel.2018.02.005
   Iyer S, 2012, HUM GENE THER, V23, P647, DOI 10.1089/hum.2011.177
   Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Joseph LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145750
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Kagawa Y, 1997, GENE THER, V4, P6, DOI 10.1038/sj.gt.3300347
   Kaltimbacher V, 2006, RNA, V12, P1408, DOI 10.1261/rna.18206
   Kambe Y, 2016, J MOL NEUROSCI, V59, P106, DOI 10.1007/s12031-015-0710-7
   Kamimura K, 2015, PHARMACEUTICS, V7, P213, DOI 10.3390/pharmaceutics7030213
   Kanabus M, 2014, BRIT J PHARMACOL, V171, P1798, DOI 10.1111/bph.12456
   Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287
   Kaurola P, 2016, BBA-BIOMEMBRANES, V1858, P2116, DOI 10.1016/j.bbamem.2016.06.016
   Khan SM, 2004, J BIOENERG BIOMEMBR, V36, P387, DOI 10.1023/B:JOBB.0000041773.20072.9e
   Kim JY, 2002, ANN NEUROL, V51, P630, DOI 10.1002/ana.10177
   Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156
   Koilkonda RD, 2010, ARCH OPHTHALMOL-CHIC, V128, P876, DOI 10.1001/archophthalmol.2010.135
   Kwiecien S, 2014, J PHYSIOL PHARMACOL, V65, P613
   Kyriakouli DS, 2008, GENE THER, V15, P1017, DOI 10.1038/gt.2008.91
   Kytövuori L, 2016, J NEUROL, V263, P2188, DOI 10.1007/s00415-016-8249-2
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343
   Leslie N, 2016, HUM PATHOL, V49, P27, DOI 10.1016/j.humpath.2015.09.039
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lyrawati D, 2011, PHARM RES-DORDR, V28, P2848, DOI 10.1007/s11095-011-0544-0
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Mangiafico RA, 2004, INT J CLIN PHARM RES, V24, P15
   Marella M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025910
   Marella M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011472
   Martikainen MH, 2013, MITOCHONDRION, V13, P83, DOI 10.1016/j.mito.2013.01.012
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   Mkaouar-Rebai E, 2011, J CHILD NEUROL, V26, P12, DOI 10.1177/0883073810371227
   Mkaouar-Rebai E, 2009, MOL GENET METAB, V97, P179, DOI 10.1016/j.ymgme.2009.03.003
   Moggio Maurizio, 2014, Acta Myol, V33, P86
   Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092
   Moon HE, 2015, EXP NEUROBIOL, V24, P103, DOI 10.5607/en.2015.24.2.103
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Nagata K, 2014, J CONTROL RELEASE, V183, P27, DOI 10.1016/j.jconrel.2014.03.021
   NAGLEY P, 1988, P NATL ACAD SCI USA, V85, P2091, DOI 10.1073/pnas.85.7.2091
   National Organization for Rare Disorders, 2016, LEIGH SYNDR
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Niazi AK, 2013, MITOCHONDRION, V13, P548, DOI 10.1016/j.mito.2012.05.004
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010
   Palomo GM, 2015, BRAIN RES, V1607, P36, DOI 10.1016/j.brainres.2014.09.065
   Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945
   Quijano C, 2016, REDOX BIOL, V8, P28, DOI 10.1016/j.redox.2015.11.010
   Rahman S., 1993, GeneReviews
   Rahman S, 2015, J INHERIT METAB DIS, V38, P641, DOI 10.1007/s10545-015-9855-3
   Ramalingam S, 2011, J MOL BIOL, V405, P630, DOI 10.1016/j.jmb.2010.10.043
   Rat Genome Database, 2017, LEIGH SYNDR DUE MIT
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   Selosse MA, 2011, TRENDS MICROBIOL, V19, P255, DOI 10.1016/j.tim.2011.04.001
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   Singh K.K., 2015, Mitochondrion, V24, pS6
   Singh K. K., 2013, MITOCHONDRIAL DNA MU
   Sofou K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-52
   Spruijt L, 2007, ARCH NEUROL-CHICAGO, V64, P890, DOI 10.1001/archneur.64.6.890
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Steele HE, 2017, BRAIN, V140, P2530, DOI 10.1093/brain/awx168
   Sundaram C, 2011, J CLIN NEUROSCI, V18, P535, DOI 10.1016/j.jocn.2010.06.014
   Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Thajeb Peterus, 2006, Taiwan J Obstet Gynecol, V45, P201
   Thambisetty M, 2004, EXPERT REV MOL DIAGN, V4, P631, DOI 10.1586/14737159.4.5.631
   Thomas RR, 2011, MITOCHONDRION, V11, P108, DOI 10.1016/j.mito.2010.08.004
   Thorburn DR, 1993, GENEREVIEWS
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271
   Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vaidya B, 2009, CURR GENE THER, V9, P475, DOI 10.2174/156652309790031102
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Van Trappen PO, 2007, GYNECOL ONCOL, V104, P129, DOI 10.1016/j.ygyno.2006.07.010
   Verdile G., 2015, INFLAMMATION OXIDATI, DOI [10.1155/2015/105828 ID 105828., DOI 10.1155/2015/105828]
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wan X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21587
   Wang YG, 2016, WORLD J GASTROENTERO, V22, P326, DOI 10.3748/wjg.v22.i1.326
   Weber-Lotfi F, 2015, BBA-MOL CELL RES, V1853, P3165, DOI 10.1016/j.bbamcr.2015.09.011
   Weissig V, 2004, MOL THER, V9, pS259
   Weissig V, 2000, DRUG DELIV, V7, P1, DOI 10.1080/107175400266722
   Weissig V, 2001, J DRUG TARGET, V9, P1
   Weissig Volkmar, 2015, Methods Mol Biol, V1265, P1, DOI 10.1007/978-1-4939-2288-8_1
   Wernick RI, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00051
   WESTARP ME, 1992, EUR NEUROL, V32, P206, DOI 10.1159/000116823
   Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013
   Wyman TB, 1997, BIOCHEMISTRY-US, V36, P3008, DOI 10.1021/bi9618474
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Yamada Y, 2007, MITOCHONDRION, V7, P63, DOI 10.1016/j.mito.2006.12.003
   Yamada Y, 2017, BIOMATERIALS, V136, P56, DOI 10.1016/j.biomaterials.2017.05.016
   Yamada Yuma, 2015, Methods Mol Biol, V1265, P123, DOI 10.1007/978-1-4939-2288-8_10
   Yamada Y, 2014, YAKUGAKU ZASSHI, V134, P1143, DOI 10.1248/yakushi.14-00191
   Yamada Y, 2012, BIOMATERIALS, V33, P1589, DOI 10.1016/j.biomaterials.2011.10.082
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yang Ai-fen, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P165, DOI 10.3760/cma.j.issn.1003-9406.2011.02.010
   Yang S, 2016, EBIOMEDICINE, V10, P258, DOI 10.1016/j.ebiom.2016.07.002
   Yao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139416
   Yasuzaki Y, 2015, MOL PHARMACEUT, V12, P4311, DOI 10.1021/acs.molpharmaceut.5b00511
   Yasuzaki Y, 2013, J CONTROL RELEASE, V172, P805, DOI 10.1016/j.jconrel.2013.09.029
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yu H, 2015, P NATL ACAD SCI USA, V112, pE5689, DOI 10.1073/pnas.1506129112
   Yu H, 2012, P NATL ACAD SCI USA, V109, pE1238, DOI 10.1073/pnas.1119577109
   Yu-Wai-Man P., 1993, GENEREVIEWS
   Yu-Wai-Man P, 2016, BRIT J OPHTHALMOL, V100, P1322, DOI 10.1136/bjophthalmol-2015-308329
   Zhao LJ, 2016, PHYTOMEDICINE, V23, P114, DOI 10.1016/j.phymed.2015.12.019
   Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001
   Zhu XY, 2009, ACTA BIOCH BIOPH SIN, V41, P179, DOI 10.1093/abbs/gmn021
   Zsurka G, 2010, NEUROLOGY, V74, P507, DOI 10.1212/WNL.0b013e3181cef7ab
   Zupancic S, 2014, MOL PHARMACEUT, V11, P2334, DOI 10.1021/mp500003q
   2013, NATURE, V493, P627, DOI DOI 10.1038/NATURE11647
   2015, REDOX BIOL, V6, P372, DOI DOI 10.1016/J.REDOX.2015.08.016
   2009, MITOCHONDRION, V9, P196, DOI DOI 10.1016/J.MITO.2009.01.012
   2009, HUM GENE THER, V20, P897, DOI DOI 10.1089/HUM.2009.023
   2014, MOL GENET METAB, V113, P207, DOI DOI 10.1016/J.YMGME.2014.06.004
   2007, MITOCHONDRION, V7, P45, DOI DOI 10.1016/J.MITO.2006.11.025
   2010, ENVIRON MOL MUTAGEN, V51, P451, DOI DOI 10.1002/EM.20570
   2013, DISCOV MED, V15, P141
NR 195
TC 9
Z9 10
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAY
PY 2019
VL 46
BP 195
EP 208
DI 10.1016/j.mito.2018.06.002
PG 14
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA HX8NY
UT WOS:000467663800024
PM 29890303
DA 2024-11-01
ER

PT J
AU Klein, HU
   Trumpff, C
   Yang, HS
   Lee, AJ
   Picard, M
   Bennett, DA
   De Jager, PL
AF Klein, Hans-Ulrich
   Trumpff, Caroline
   Yang, Hyun-Sik
   Lee, Annie J.
   Picard, Martin
   Bennett, David A.
   De Jager, Philip L.
TI Characterization of mitochondrial DNA quantity and quality in the human
   aged and Alzheimer's disease brain
SO MOLECULAR NEURODEGENERATION
LA English
DT Article
DE Mitochondria; Neurodegeneration; Alzheimer's disease; Mitochondrial DNA
   copy number; Mitochondrial heteroplasmy; Tau; Amyloid; TDP-43
ID TDP-43 PATHOLOGY; SKELETAL-MUSCLE; COPY NUMBER; MUTATIONS; NEURONS;
   MEMORY; TRANSCRIPTION; ACCUMULATION; IMPAIRMENT; LEVEL
AB Background Mitochondrial dysfunction is a feature of neurodegenerative diseases, including Alzheimer's disease (AD). Changes in the mitochondrial DNA copy number (mtDNAcn) and increased mitochondrial DNA mutation burden have both been associated with neurodegenerative diseases and cognitive decline. This study aims to systematically identify which common brain pathologies in the aged human brain are associated with mitochondrial recalibrations and to disentangle the relationship between these pathologies, mtDNAcn, mtDNA heteroplasmy, aging, neuronal loss, and cognitive function. Methods Whole-genome sequencing data from n = 1361 human brain samples from 5 different regions were used to quantify mtDNAcn as well as heteroplasmic mtDNA point mutations and small indels. Brain samples were assessed for 10 common pathologies. Annual cognitive test results were used to assess cognitive function proximal to death. For a subset of samples, neuronal proportions were estimated from RNA-seq profiles, and mass spectrometry was used to quantify the mitochondrial protein content of the tissue. Results mtDNAcn was 7-14% lower in AD relative to control participants. When accounting for all 10 common neuropathologies, only tau was significantly associated with lower mtDNAcn in the dorsolateral prefrontal cortex. In the posterior cingulate cortex, TDP-43 pathology demonstrated a distinct association with mtDNAcn. No changes were observed in the cerebellum, which is affected late by pathologies. Neither age nor gender was associated with mtDNAcn in the studied brain regions when adjusting for pathologies. Mitochondrial content and mtDNAcn independently explained variance in cognitive function unaccounted by pathologies, implicating complex mitochondrial recalibrations in cognitive decline. In contrast, mtDNA heteroplasmy levels increased by 1.5% per year of life in the cortical regions, but displayed no association with any of the pathologies or cognitive function. Conclusions We studied mtDNA quantity and quality in relation to mixed pathologies of aging and showed that tau and not amyloid-beta is primarily associated with reduced mtDNAcn. In the posterior cingulate cortex, the association of TDP-43 with low mtDNAcn points to a vulnerability of this region in limbic-predominant age-related TDP-43 encephalopathy. While we found low mtDNAcn in brain regions affected by pathologies, the absence of associations with mtDNA heteroplasmy burden indicates that mtDNA point mutations and small indels are unlikely to be involved in the pathogenesis of late-onset neurodegenerative diseases.
C1 [Klein, Hans-Ulrich; De Jager, Philip L.] Columbia Univ, Ctr Translat & Computat Neuroimmunol, Dept Neurol, Irving Med Ctr, New York, NY 10032 USA.
   [Klein, Hans-Ulrich; Lee, Annie J.; De Jager, Philip L.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Irving Med Ctr, New York, NY 10032 USA.
   [Trumpff, Caroline; Picard, Martin] Columbia Univ, Div Behav Med, Dept Psychiat, Irving Med Ctr, New York, NY 10032 USA.
   [Yang, Hyun-Sik] Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimer Res & Treatment, 75 Francis St, Boston, MA 02115 USA.
   [Picard, Martin] Columbia Univ, Merritt Ctr, Irving Med Ctr, New York, NY 10032 USA.
   [Picard, Martin] Columbia Univ, Columbia Translat Neurosci Initiat, Dept Neurol, Irving Med Ctr, New York, NY 10032 USA.
   [Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA.
C3 Columbia University; NewYork-Presbyterian Hospital; NewYork-Presbyterian
   Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia
   University; Harvard University; Brigham & Women's Hospital;
   NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian
   Hospital; Columbia University; Rush University
RP Klein, HU; De Jager, PL (corresponding author), Columbia Univ, Ctr Translat & Computat Neuroimmunol, Dept Neurol, Irving Med Ctr, New York, NY 10032 USA.; Klein, HU; De Jager, PL (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Irving Med Ctr, New York, NY 10032 USA.
EM hk2948@cumc.columbia.edu; pld2115@cumc.columbia.edu
RI Klein, Hans-Ulrich/O-5118-2019
OI Lee, Annie/0000-0003-3726-6024; Klein, Hans-Ulrich/0000-0002-6382-9428
FU NIH [U01AG046152, U01AG061356, P30AG010161, R01AG015819, R01AG017917]
FX This work was supported by NIH grants U01AG046152 (PLD, DAB),
   U01AG061356 (PLD, DAB), P30AG010161 (DAB), R01AG015819 (DAB), and
   R01AG017917 (DAB).
CR Allen M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.89
   Area-Gomez E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61142-8
   Area-Gomez E, 2019, J CLIN INVEST, V129, P34, DOI 10.1172/JCI120848
   Arvanitakis Z, 2017, BRAIN PATHOL, V27, P77, DOI 10.1111/bpa.12365
   Arvanitakis Z, 2011, STROKE, V42, P722, DOI 10.1161/STROKEAHA.110.595082
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378
   Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3
   Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939
   Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031
   Botha H, 2018, BRAIN, V141, P1201, DOI 10.1093/brain/awy049
   Boyle PA, 2015, NEUROLOGY, V85, P1930, DOI 10.1212/WNL.0000000000002175
   Brinckmann A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013513
   Buchman AS, 2011, STROKE, V42, P3183, DOI 10.1161/STROKEAHA.111.623462
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   De Jager PL, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.142
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868
   Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fries GR, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0048-8
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Hägg S, 2021, HUM GENET, V140, P849, DOI 10.1007/s00439-020-02249-w
   Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004
   Imai K, 2010, STAT SCI, V25, P51, DOI 10.1214/10-STS321
   Josephs KA, 2016, ACTA NEUROPATHOL, V131, P571, DOI 10.1007/s00401-016-1537-1
   Kandimalla R, 2016, HUM MOL GENET, V25, P4881, DOI 10.1093/hmg/ddw312
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep24756
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263
   Longchamps R, GENOME WIDE ANAL MIT, V2021, DOI [10.1101/2021.01.25.428086, DOI 10.1101/2021.01.25.428086]
   Longchamps RJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228166
   Love Seth, 2014, Am J Neurodegener Dis, V3, P19
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Moore AZ, 2018, AGING CELL, V17, DOI 10.1111/acel.12683
   Murray ME, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt254
   Nacheva E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180467
   Nag S, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0531-3
   Nag S, 2017, NEUROLOGY, V88, P653, DOI 10.1212/WNL.0000000000003610
   Nag S, 2015, ANN NEUROL, V77, P942, DOI 10.1002/ana.24388
   Nelson PT, 2019, BRAIN, V142, P1503, DOI 10.1093/brain/awz099
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Patrick E, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008120
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Rausser S, MITOCHONDRIAL PHENOT, V2021, P2020, DOI 10.16.342923
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Rodríguez-Santiago B, 2001, EUR J HUM GENET, V9, P279, DOI 10.1038/sj.ejhg.5200629
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Schneider JA, 2012, BRAIN, V135, P3005, DOI 10.1093/brain/aws234
   Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24
   Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012
   Shim HB, 2020, MITOCHONDRION, V52, P108, DOI 10.1016/j.mito.2020.03.001
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321
   Vaillant-Beuchot L, 2021, ACTA NEUROPATHOL, V141, P39, DOI 10.1007/s00401-020-02234-7
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Wang MH, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.185
   Wang WZ, 2016, NAT MED, V22, P869, DOI 10.1038/nm.4130
   Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319
   Wang X, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00392-6
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0404-6
   Weidling IW, 2020, J ALZHEIMERS DIS, V77, P149, DOI 10.3233/JAD-200286
   Wingo AP, 2020, NAT NEUROSCI, V23, P696, DOI 10.1038/s41593-020-0635-5
   Yang SY, 2021, GENOME RES, V31, P349, DOI 10.1101/gr.269381.120
   Yin JX, 2020, NEUROLOGY, V94, pE2404, DOI 10.1212/WNL.0000000000009582
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zhang RY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4287-0
   Zhong Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-89
NR 80
TC 53
Z9 55
U1 0
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1750-1326
J9 MOL NEURODEGENER
JI Mol. Neurodegener.
PD NOV 6
PY 2021
VL 16
IS 1
AR 75
DI 10.1186/s13024-021-00495-8
PG 17
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA WS2OZ
UT WOS:000715027900001
PM 34742335
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Korhonen, JA
   Pande, V
   Holmlund, T
   Farge, G
   Pham, XH
   Nilsson, L
   Falkenberg, M
AF Korhonen, Jenny A.
   Pande, Vineet
   Holmlund, Teresa
   Farge, Geraldine
   Pham, Xuan Hoi
   Nilsson, Lennart
   Falkenberg, Maria
TI Structure-function defects of the TWINKLE linker region in progressive
   external ophthalmoplegia
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE TWINKLE; DNA replication; helicase; mitochondrion; bacteriophage T7
ID MITOCHONDRIAL-DNA HELICASE; SINGLE-STRANDED-DNA; BACTERIOPHAGE T7;
   GENE-4 PROTEIN; MULTIPLE DELETIONS; HEXAMER FORMATION;
   CRYSTAL-STRUCTURE; PRIMASE-HELICASE; POLYMERASE; BINDING
AB TWINKLE is the helicase at the mitochondrial DNA (mtDNA) replication fork in mammalian cells. Mutations in the PEO1 gene, which encodes TWINKLE, cause autosomal dominant progressive external ophthalmoplegia (AdPEO), a disorder associated with deletions in mtDNA. Here, we characterized seven different AdPEO-causing mutations in the linker region of TWINKLE and we identified distinct molecular phenotypes. For some mutations, protein hexamerization and DNA helicase activity are completely abolished whereas others display more subtle effects. To better, understand these distinct phenotypes, we constructed a molecular model of TWINKLE based on the three-dimensional structure of the bacteriophage T7 gene 4 protein. The structural model explains the molecular phenotypes and also predicts the functional consequences of other AdPEO-causing mutations. Our findings provide a molecular platform for further studies in cell- and animal-based model systems and demonstrate that knowledge of the bacteriophage T7 DNA replication machinery may be key to understanding the molecular and phenotypic consequences of mutations in the mtDNA replication apparatus. (C) 2008 Published by Elsevier Ltd.
C1 [Korhonen, Jenny A.; Holmlund, Teresa; Farge, Geraldine; Pham, Xuan Hoi; Falkenberg, Maria] Karolinska Inst, Dept Lab Med, Div Metab Dis, Novum, SE-14186 Stockholm, Sweden.
   [Pande, Vineet; Nilsson, Lennart] Karolinska Inst, Dept Biosci & Nutr, Novum, SE-14186 Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska Institutet
RP Falkenberg, M (corresponding author), Karolinska Inst, Dept Lab Med, Div Metab Dis, Novum, SE-14186 Stockholm, Sweden.
EM maria.falkenberg@ki.se
RI farge, geraldine/M-2803-2018; Nilsson, Lennart/B-7208-2009
OI Nilsson, Lennart/0000-0002-5067-6397; farge,
   geraldine/0000-0003-1054-4274; Falkenberg, Maria/0000-0001-8713-173X;
   Pham, Xuan Hoi/0000-0002-9629-2970
CR Arenas J, 2003, ANN NEUROL, V53, P278, DOI 10.1002/ana.10430
   BERNSTEIN JA, 1989, J BIOL CHEM, V264, P13066
   Chowdhury K, 2000, P NATL ACAD SCI USA, V97, P12469, DOI 10.1073/pnas.230448397
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037
   Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200
   Li FY, 1999, NEUROLOGY, V53, P1265, DOI 10.1212/WNL.53.6.1265
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   MENDELMAN LV, 1993, J BIOL CHEM, V268, P27208
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315
   Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
NR 44
TC 51
Z9 57
U1 1
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAR 28
PY 2008
VL 377
IS 3
BP 691
EP 705
DI 10.1016/j.jmb.2008.01.035
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 293ZP
UT WOS:000255374200011
PM 18279890
DA 2024-11-01
ER

PT J
AU Ozawa, K
   Mochizuki, K
   Manabe, Y
   Yoshikura, N
   Shimohata, T
   Nishino, I
   Goto, Y
AF Ozawa, Kenji
   Mochizuki, Kiyofumi
   Manabe, Yusuke
   Yoshikura, Nobuaki
   Shimohata, Takayoshi
   Nishino, Ichizo
   Goto, Yu-ichi
TI Retinal dystrophy associated with a single-base deletion mutation in
   mitochondrial DNA 3271 in patient with MELAS syndrome
SO DOCUMENTA OPHTHALMOLOGICA
LA English
DT Article
DE Mitochondrial DNA; 3271; MELAS; M; 3271delT; Retinopathy
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; ISCEV STANDARD; ENCEPHALOPATHY;
   RETINOPATHY; MYOPATHY
AB PurposeMitochondrial encephalopathy with lactic acid and stroke-like episodes (MELAS) is caused by mutations in the mitochondrial DNA. Approximately 80% of MELAS patients have an A>G transition mutation at nucleotide pair 3243 in the mitochondrial DNA, m.3243A>G. There are also MELAS patients with a one-base deletion at nucleotide pair 3271 in the mitochondrial DNA, m.3271delT, but these cases are very rare. We report a case of MELAS with the m.3271delT and describe the retinal structure and electrophysiological alterations.MethodsThe retinal structure and function of a 37-year-old woman who was referred to our clinic for of nyctalopia were studied. Standard ophthalmological examinations including the medical history, measurements of the best-corrected visual acuity, intraocular pressures, and slit-lamp biomicroscopy, ophthalmoscopy, fluorescein angiography, fundus autofluorescence, spectral-domain optical coherence tomography (SD-OCT), full-field electroretinography (ERG), and multifocal electroretinography (mfERG) were performed.ResultsFundus examination showed bilateral hypopigmentary changes of the retinal pigment epithelium which extended from the posterior pole to the equator. Fluorescein angiography showed patchy hyperfluorescence due to window defects at the atrophic areas. Fundus autofluorescence demonstrated mild hyperfluorescent lesions in both eyes. SD-OCT showed that the interdigitation zone was indistinct in both eyes, and the inner nuclear layer was slightly thinner. The amplitudes of the rod, cone, and 30-Hz flicker ERGs were severely reduced, and the implicit times were prolonged. The a- and b-waves of the bright-flash mixed rod-cone ERGs were also reduced. The dark-adapted oscillatory potentials were reduced. The amplitudes of the mfERGs were severely depressed except at the fovea in both eyes.ConclusionsThese findings indicate that the RPE atrophy was wider and the rod dysfunction was more severe affected than that of previously reported MELAS cases with the m.3243A>G mutation.
C1 [Ozawa, Kenji; Mochizuki, Kiyofumi; Manabe, Yusuke] Gifu Univ, Dept Ophthalmol, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.
   [Yoshikura, Nobuaki; Shimohata, Takayoshi] Gifu Univ, Dept Neurol & Geriatr, Grad Sch Med, Gifu, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurol & Psychiat, Dept Neuromuscular Res, Tokyo, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurol & Psychiat, Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Tokyo, Japan.
C3 Gifu University; Gifu University; National Center for Neurology &
   Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan;
   National Center for Neurology & Psychiatry - Japan
RP Ozawa, K (corresponding author), Gifu Univ, Dept Ophthalmol, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.
EM kj-ozawa@umin.ac.jp
RI Nishino, Ichizo/G-2676-2010
OI Ozawa, Kenji/0000-0002-9860-3736
FU Intramural Research Grant for Neurological and Psychiatric Disorders of
   NCNP [29-4]
FX We thank Professor Emeritus Duco Hamasaki of the Bascom Palmer Eye
   Institute of the University of Miami, FL, for discussions and editing
   the manuscript. This study was supported partly by Intramural Research
   Grant (29-4) for Neurological and Psychiatric Disorders of NCNP.
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   Bellmann C, 2004, INVEST OPHTH VIS SCI, V45, P2355, DOI 10.1167/iovs.03-1090
   BRESNICK GH, 1984, ARCH OPHTHALMOL-CHIC, V102, P1307, DOI 10.1001/archopht.1984.01040031057023
   BRESNICK GH, 1987, ARCH OPHTHALMOL-CHIC, V105, P929, DOI 10.1001/archopht.1987.01060070065030
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hood DC, 2012, DOC OPHTHALMOL, V124, P1, DOI 10.1007/s10633-011-9296-8
   Hori N, 2012, DOC OPHTHALMOL, V125, P235, DOI 10.1007/s10633-012-9351-0
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Latvala T, 2002, GRAEF ARCH CLIN EXP, V240, P795, DOI 10.1007/s00417-002-0555-y
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   Shinmei Y, 2007, J NEURO-OPHTHALMOL, V27, P22, DOI 10.1097/WNO.0b013e3180334cb0
   SHOFFNER JM, 1995, NEUROLOGY, V45, P286, DOI 10.1212/WNL.45.2.286
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   YONEMURA D, 1962, ARCH OPHTHALMOL-CHIC, V68, P19
NR 22
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0012-4486
EI 1573-2622
J9 DOC OPHTHALMOL
JI Doc. Ophthalmol.
PD APR
PY 2019
VL 138
IS 2
BP 147
EP 152
DI 10.1007/s10633-019-09673-y
PG 6
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA HP0QA
UT WOS:000461369500007
PM 30701423
DA 2024-11-01
ER

PT J
AU Roos, S
   Darin, N
   Kollberg, G
   Grönlund, MA
   Tulinius, M
   Holme, E
   Moslemi, AR
   Oldfors, A
AF Roos, Sara
   Darin, Niklas
   Kollberg, Gittan
   Gronlund, Marita Andersson
   Tulinius, Mar
   Holme, Elisabeth
   Moslemi, Ali-Reza
   Oldfors, Anders
TI A novel mitochondrial tRNA Arg mutation resulting in an anticodon swap
   in a patient with mitochondrial encephalomyopathy
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE mitochondrial diseases; mtDNA; PCR-RFLP; retinal dystrophy
ID CHILDHOOD; TRNA(ARG); MYOPATHY; GENES; MTDNA
AB We report a mutation in the anticodon of the tRNA(Arg) gene (m.10437G>A),resulting in an anticodon swap from GCU to ACU, which is the anticodon of tRNA(Trp), in a boy with mitochondrial encephalomyopathy. Enzyme histochemical analysis of muscle tissue and biochemical analysis of isolated muscle mitochondria demonstrated cytochrome c oxidase (COX) deficiency. Restriction fragment length polymorphism analysis showed that 90% of muscle and 82% of urinary epithelium mtDNA harbored the mutation. The mutation was not identified in blood, fibroblasts, hair roots, or buccal epithelial cells and it was absent in the asymptomatic mother, suggesting that it was a de novo mutation. Single-fiber PCR analysis showed that the proportion of mutated mtDNA correlated with enzyme histochemical COX deficiency. This mutation adds to the three previously described disease-causing mutations in tRNA(Arg), but it is the first mutation occurring in the anticodon of tRNA(Arg). European Journal of Human Genetics (2013) 21, 571-573; doi:10.1038/ejhg.2012.153; published online 11 July 2012
C1 [Roos, Sara; Moslemi, Ali-Reza; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol, SE-41345 Gothenburg, Sweden.
   [Darin, Niklas; Tulinius, Mar] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, SE-41345 Gothenburg, Sweden.
   [Kollberg, Gittan; Holme, Elisabeth] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Clin Chem, SE-41345 Gothenburg, Sweden.
   [Gronlund, Marita Andersson] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol Ophthalmol, Dept Pediat Ophthalmol, SE-41345 Gothenburg, Sweden.
C3 University of Gothenburg; University of Gothenburg; University of
   Gothenburg; University of Gothenburg
RP Roos, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol, Gula Straket 8, SE-41345 Gothenburg, Sweden.
EM sara.roos@gu.se
RI Darin, Niklas/AAL-6345-2020
FU Swedish Research Council [07122]
FX This study was supported by grants from the Swedish Research Council
   (grant 07122). The fragment analysis was performed at the Genomics Core
   Facility platform at the Sahlgrenska Academy at the University of
   Gothenburg.
CR Abu-Amero EK, 2006, J CHILD NEUROL, V21, P971, DOI 10.2310/7010.2006.00208
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Oldfors Anders, 2007, Handb Clin Neurol, V86, P125, DOI 10.1016/S0072-9752(07)86006-4
   Pancrudo J, 2007, NEUROMUSCULAR DISORD, V17, P651, DOI 10.1016/j.nmd.2007.04.005
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zanssen S, 1997, MOL CELL BIOCHEM, V174, P231, DOI 10.1023/A:1006864709515
NR 13
TC 7
Z9 7
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD MAY
PY 2013
VL 21
IS 5
BP 571
EP 573
DI 10.1038/ejhg.2012.153
PG 3
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 127VQ
UT WOS:000317727300016
PM 22781096
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU O'Donnell, L
   Blakely, EL
   Baty, K
   Alexander, M
   Bogdanova-Mihaylova, P
   Craig, J
   Walsh, R
   Brett, F
   Taylor, RW
   Murphy, SM
AF O'Donnell, Luke
   Blakely, Emma L.
   Baty, Karen
   Alexander, Michael
   Bogdanova-Mihaylova, Petya
   Craig, John
   Walsh, Ronan
   Brett, Francesca
   Taylor, Robert W.
   Murphy, Sinead M.
TI Chronic Progressive External Ophthalmoplegia due to a Rare <i>de
   novo</i> m.12334G&gt;A MT-TL2 Mitochondrial DNA Variant
SO JOURNAL OF NEUROMUSCULAR DISEASES
LA English
DT Article
DE Chronic progressive external ophthalmoplegia; CPEO; mitochondrial DNA;
   cytochrome c oxidase
ID MUTATION
AB We describe a patient with chronic progressive external ophthalmoplegia (CPEO) due to a rare mitochondrial genetic variant. Muscle biopsy revealed numerous cytochrome c oxidase (COX)-deficient fibres, prompting sequencing of the entire mitochondrial genome in muscle which revealed a rare m.12334G>A variant in the mitochondrial (mt-) tRNA(Leu(CUN))(MT-TL2) gene. Analysis of several tissues showed this to be a de novo mutational event. Single fibre studies confirmed the segregation of high m.12334G>A heteroplasmy levels with the COX histochemical defect, confirming pathogenicity of the m.12334G>A MT-TL2 variant. This case illustrates the importance of pursuing molecular genetic analysis in clinically-affected tissues when mitochondrial disease is suspected.
C1 [O'Donnell, Luke; Bogdanova-Mihaylova, Petya; Murphy, Sinead M.] Tallaght Univ Hosp, Dept Neurol, Dublin 24, Ireland.
   [Blakely, Emma L.; Baty, Karen; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.
   [Blakely, Emma L.; Baty, Karen; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
   [Alexander, Michael] Tallaght Univ Hosp, Dept Neurophysiol, Dublin, Ireland.
   [Alexander, Michael; Murphy, Sinead M.] Univ Dublin, Acad Unit Neurol, Trinity Coll Dublin, Dublin, Ireland.
   [Craig, John] Belfast Hlth & Social Care Trust, Dept Neurol, Belfast, Antrim, North Ireland.
   [Walsh, Ronan] Hermitage Med Clin, Dept Neurol, Dublin, Ireland.
   [Brett, Francesca] Beaumont Hosp, Dept Neuropathol, Dublin, Ireland.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation
   Trust; Trinity College Dublin
RP O'Donnell, L (corresponding author), Tallaght Univ Hosp, Dept Neurol, Dublin 24, Ireland.
EM odonnell4ie@hotmail.com
OI Mihaylova, Petya/0000-0002-8944-4921; Murphy,
   Sinead/0000-0002-7277-414X; Brett, Francesca/0000-0002-7453-4027
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical
   Research Council (MRC) International Centre for Genomic Medicine in
   Neuromuscular Disease; MRC Mitochondrial Disease Patient Cohort: A
   Natural History Study and Patient Registry [G0800674]; Lily Foundation;
   UK NIHR Biomedical Research Centre for Ageing; Newcastle upon Tyne
   Foundation Hospitals NHS Trust; MRC/EPSRC Molecular Pathology Node; UK
   NHS Highly Specialised Service for Rare Mitochondrial Disorders of
   Adults and Children
FX RWT is supported by the Wellcome Centre for Mitochondrial Research
   (203105/Z/16/Z), the Medical Research Council (MRC) International Centre
   for Genomic Medicine in Neuromuscular Disease, the MRC Mitochondrial
   Disease Patient Cohort: A Natural History Study and Patient Registry
   (G0800674), the Lily Foundation, the UK NIHR Biomedical Research Centre
   for Ageing, the Newcastle upon Tyne Foundation Hospitals NHS Trust, the
   MRC/EPSRC Molecular Pathology Node and the UK NHS Highly Specialised
   Service for Rare Mitochondrial Disorders of Adults and Children. We
   thank the Oxford University Hospitals Genetics Laboratory who performed
   the diagnostic gene panel testing for mtDNA maintenance disorders.
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Edgar R, 2013, PLOS ONE, V8
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Kirches E, 2001, J MED GENET, V38, P312, DOI 10.1136/jmg.38.5.312
   Lott MT., 2013, Curr Protoc Bioinf, V44, P1231, DOI DOI 10.1002/0471250953.BI0123S44
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pinós T, 2011, MITOCHONDRION, V11, P228, DOI 10.1016/j.mito.2010.08.008
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Soldath P, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1781-0
   U.S. Department of Health & Human Services, 2016, PROGR EXT OPHTH
   Vives-Bauza C, 2001, ANN MED, V33, P493, DOI 10.3109/07853890109002099
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 16
TC 1
Z9 1
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 2214-3599
EI 2214-3602
J9 J NEUROMUSCULAR DIS
JI J. Neuromusc. Dis.
PY 2020
VL 7
IS 3
BP 355
EP 360
DI 10.3233/JND-200486
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA UA4BQ
UT WOS:000685106600016
PM 32310184
DA 2024-11-01
ER

PT J
AU Sazonova, MA
   Sinyov, VV
   Ryzhkova, AI
   Sazonova, MD
   Doroschuk, NA
   Karagodin, VP
   Popov, MA
   Sukhorukov, VN
   Poggio, P
   Moschetta, D
   Postnov, AY
AF Sazonova, Margarita A.
   Sinyov, Vasily V.
   Ryzhkova, Anastasia I.
   Sazonova, Marina D.
   Doroschuk, Natalya A.
   Karagodin, Vasily P.
   Popov, Mikhail A.
   Sukhorukov, Vasily N.
   Poggio, Paolo
   Moschetta, Donato
   Postnov, Anton Yu.
TI Analysis of Mutational Burden of Mitochondrial Genome in Cells of
   Different Human Organs and Tissues
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review; Early Access
DE Mitochondrial genome; mutation; heteroplasmy level; mutational burden;
   human organ; human tissue; cells
ID DNA CONTROL REGION; MTDNA HETEROPLASMY; SEQUENCE HETEROPLASMY; POINT
   MUTATIONS; MOLECULAR-BASIS; BLOOD; SEGREGATION; ATHEROSCLEROSIS;
   SELECTION; ADULT
AB Background Cells of different human organs and tissues contain different numbers of mitochondria. In these organelles, there are different copies of the mitochondrial genome, which is characteristic of a certain organ or tissue.Objective The aim of the investigation was to analyze the results of scientific works dedicated to the analysis of heteroplasmy levels of mitochondrial genome mutations in a number of organs and tissues.Methods Based on literature data, the level of heteroplasmy of mitochondrial genome mutations was analyzed in organs such as the liver, lungs, muscles, small intestine, large intestine, spleen, kidney, brain, heart, and hair. In addition, this parameter was studied in such tissues as leukocytes, buccal epithelium, and epithelial cells from urine.Results Significant differences in the mutational burden of the mitochondrial genome were found in various samples of organs and tissues. The highest heteroplasmy level for mtDNA mutations was in muscles; it was lower in buccal epithelium; and in human blood cells, the heteroplasmy level of mitochondrial mutations turned out to be significantly lower compared to other tissues. During the comparison of samples of patients with different diseases and healthy people, significant differences were found in the heteroplasmy level between some organs and tissues.Conclusion The heteroplasmy level of mitochondrial genome mutations can significantly differ in the organs and tissues of individuals. In addition, in a number of literature sources, it is noted that there is a dependence on the mutational burden of the mitochondrial genome from the type of disease, sex, and age of a person.
C1 [Sazonova, Margarita A.; Ryzhkova, Anastasia I.; Sazonova, Marina D.; Doroschuk, Natalya A.; Karagodin, Vasily P.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiiskaya St, Moscow 125315, Russia.
   [Sazonova, Margarita A.; Sinyov, Vasily V.; Postnov, Anton Yu.] Natl Med Res Ctr Cardiol, Inst Expt Cardiol, Lab Med Genet, 15a,3rd Cherepkovskaya Str, Moscow 121552, Russia.
   [Sinyov, Vasily V.; Sukhorukov, Vasily N.; Postnov, Anton Yu.] Petrovsky Natl Res Ctr Surg FSBSI Petrovsky NRCS, Fed State Budgetary Sci Inst, Lab Cellular & Mol Pathol Cardiovasc Syst, Moscow, Russia.
   [Karagodin, Vasily P.] Plekhanov Russian Univ Econ, Stremyanny Lane 36, Moscow 117997, Russia.
   [Popov, Mikhail A.] Moscow Reg Res & Clin Inst MONIKI, Dept Cardiac Surg, 61-2 Shchepkin St, Moscow 129110, Russia.
   [Poggio, Paolo; Moschetta, Donato] IRCCS, Ctr Cardiol Monzino, Unit Study Aort Valvular & Coronary Pathol, Via C Parea 4, I-20138 Milan, Italy.
C3 Russian Academy of Medical Sciences; Institute of General Pathology &
   Pathophysiology, RAMS; National Medical Research Center of Cardiology;
   Plekhanov Russian University of Economics; IRCCS Centro Cardiologico
   Monzino
RP Sazonova, MA (corresponding author), Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiiskaya St, Moscow 125315, Russia.
EM margaritaasazonova@gmail.com
RI Vasily, Karagodin/V-2773-2017; Popov, Mikhail/HIR-7175-2022; Moschetta,
   Donato/D-6842-2019; Sinyov, Vasiliy/K-9084-2014; Sukhorukov,
   Vasily/H-6545-2016; Poggio, Paolo/J-7347-2016; Ryzhkova,
   Anastasiya/F-1677-2014
OI Sinyov, Vasiliy/0000-0001-5105-5763; Sukhorukov,
   Vasily/0000-0002-0312-3773; Poggio, Paolo/0000-0002-7225-3379; Ryzhkova,
   Anastasiya/0000-0002-8838-7750; Mikhail, Popov/0000-0002-0316-8410
FU Russian Science Foundation [20-15-00337]
FX This work was supported by the Russian Science Foundation (Grant #
   20-15-00337)
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   An Jisong, 2022, Methods Mol Biol, V2493, P153, DOI 10.1007/978-1-0716-2293-3_10
   Andrew T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022332
   Arthur CR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-37
   Aryaman J, 2019, GENETICS, V212, P1429, DOI 10.1534/genetics.119.302423
   Atilano SR, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246114
   Bi CW, 2023, NUCLEIC ACIDS RES, V51, P3793, DOI 10.1093/nar/gkad209
   Bi R, 2010, CLIN CHIM ACTA, V411, P1671, DOI 10.1016/j.cca.2010.06.026
   Blaha MJ, 2021, J AM COLL CARDIOL, V77, P3195, DOI 10.1016/j.jacc.2021.05.006
   Brockmann SJ, 2023, HUM GENOMICS, V17, DOI 10.1186/s40246-023-00516-1
   Burr SP, 2018, DEV GROWTH DIFFER, V60, P21, DOI 10.1111/dgd.12420
   Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844
   Campbell T, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11182835
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chen YP, 2022, EUR J NEUROL, V29, P3218, DOI 10.1111/ene.15509
   Chiaratti MR, 2022, PHARMACOL RES, V185, DOI 10.1016/j.phrs.2022.106466
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chung UH, 2005, INT J LEGAL MED, V119, P50, DOI 10.1007/s00414-004-0487-7
   Claeys KG, 2016, MUSCLE NERVE, V54, P328, DOI 10.1002/mus.25125
   de Laat P, 2015, NETH J MED, V73, P30
   de Laat P, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.523
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Duggan AT, 2013, AM J HUM GENET, V92, P279, DOI 10.1016/j.ajhg.2012.12.004
   Fan XY, 2022, NAT BIOMED ENG, V6, P339, DOI 10.1038/s41551-022-00881-7
   Florido R, 2022, J AM COLL CARDIOL, V80, P22, DOI 10.1016/j.jacc.2022.04.042
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   Galera-Monge T, 2019, J CELL PHYSIOL, V234, P19511, DOI 10.1002/jcp.28549
   Giuliani C, 2014, AGING-US, V6, P454, DOI 10.18632/aging.100661
   González MD, 2020, MITOCHONDRION, V50, P88, DOI 10.1016/j.mito.2019.10.006
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Gupta R, 2023, NATURE, V620, DOI 10.1038/s41586-023-06426-5
   Guyatt AL, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-018-0190-2
   Hammond ER, 2016, MOL HUM REPROD, V22, P261, DOI 10.1093/molehr/gaw003
   Harrison TJ, 1997, AM J OPHTHALMOL, V124, P217, DOI 10.1016/S0002-9394(14)70787-1
   Hefti E, 2018, MITOCHONDRIAL DNA A, V29, P587, DOI 10.1080/24701394.2017.1325480
   Holt AG, 2022, J THEOR BIOL, V551-552, DOI 10.1016/j.jtbi.2022.111244
   Hühne J, 1998, INT J LEGAL MED, V112, P27, DOI 10.1007/s004140050193
   Hummel EM, 2023, PSYCHONEUROENDOCRINO, V148, DOI 10.1016/j.psyneuen.2022.105993
   Imai-Okazaki A, 2022, J INHERIT METAB DIS, V45, P1143, DOI 10.1002/jimd.12547
   Kamiya J, 2003, DIABETOLOGIA, V46, P1559, DOI 10.1007/s00125-003-1215-4
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kärppä M, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1159-4
   Keeter WC, 2022, SEMIN IMMUNOPATHOL, V44, P363, DOI 10.1007/s00281-022-00914-y
   Klein HU, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00495-8
   Krjutskov K, 2014, CURR GENET, V60, P11, DOI 10.1007/s00294-013-0398-6
   Kytövuori L, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0883-5
   Langdahl JH, 2018, CLIN GENET, V93, P925, DOI 10.1111/cge.13201
   Latic N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186483
   Lee HY, 2006, ANN HUM GENET, V70, P59, DOI 10.1111/j.1529-8817.2005.00217.x
   Lee HY, 2004, ELECTROPHORESIS, V25, P28, DOI 10.1002/elps.200305681
   Lee SR, 2017, ADV EXP MED BIOL, V982, P81, DOI 10.1007/978-3-319-55330-6_5
   Li H, 2017, MOL NEUROBIOL, V54, P4343, DOI 10.1007/s12035-016-9996-x
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li Y, 2022, LIFE SCI, V306, DOI 10.1016/j.lfs.2022.120834
   Libby P, 2021, NATURE, V592, P524, DOI 10.1038/s41586-021-03392-8
   Lin DS, 2023, CELLS-BASEL, V12, DOI 10.3390/cells12010015
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Litvinova N. A., 2015, Rossiiskii Vestnik Perinatologii i Pediatrii, V60, P76
   Maeda H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90316-1
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   MATTHEWS PM, 1995, HUM GENET, V96, P261
   Mitrofanov KY, 2016, EXP MOL PATHOL, V100, P87, DOI 10.1016/j.yexmp.2015.12.003
   Moraes CT, 2019, CURR BIOL, V29, pR746, DOI 10.1016/j.cub.2019.06.029
   Mukhopadhyay A, 2018, NATL MED J INDIA, V31, P228, DOI 10.4103/0970-258X.258225
   Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002
   Naue J, 2011, INT J LEGAL MED, V125, P427, DOI 10.1007/s00414-011-0549-6
   Nayor M, 2021, CIRC RES, V128, P287, DOI 10.1161/CIRCRESAHA.120.315890
   Nie Y, 2022, ACTA NEUROPATHOL, V143, P687, DOI 10.1007/s00401-022-02423-6
   Orekhov AN, 2020, CURR ATHEROSCLER REP, V22, DOI 10.1007/s11883-020-00873-5
   Pai CY, 2006, FORENSIC SCI INT, V156, P124, DOI 10.1016/j.forsciint.2004.12.021
   Panadés-de Oliveira L, 2020, MITOCHONDRION, V50, P14, DOI 10.1016/j.mito.2019.10.001
   Pereira CV, 2021, CRIT REV BIOCHEM MOL, V56, P510, DOI 10.1080/10409238.2021.1934812
   Pereira CV, 2017, FRONT BIOSCI-LANDMRK, V22, P991, DOI 10.2741/4529
   Pfeiffer H, 2004, INT J LEGAL MED, V118, P71, DOI 10.1007/s00414-003-0409-0
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Rai PK, 2018, ESSAYS BIOCHEM, V62, P455, DOI 10.1042/EBC20170113
   Roberts KA, 2011, J FORENSIC SCI, V56, P46, DOI 10.1111/j.1556-4029.2010.01540.x
   Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929
   Sarbacher Carolyn Ann, 2019, Subcell Biochem, V91, P281, DOI 10.1007/978-981-13-3681-2_11
   Sarig O, 2017, J INVEST DERMATOL, V137, pE79, DOI 10.1016/j.jid.2016.02.818
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   Sazonova M A, 2011, Patol Fiziol Eksp Ter, P81
   Sazonova MA, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/9749457
   Sazonova MA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6934394
   Sazonova MA, 2016, DATA BRIEF, V7, P1570, DOI 10.1016/j.dib.2016.04.055
   Sazonova MA, 2016, CURR PHARM DESIGN, V22, P390, DOI 10.2174/1381612822666151112152335
   Sazonova MA, 2015, EXP MOL PATHOL, V99, P25, DOI 10.1016/j.yexmp.2015.04.003
   Sazonova MA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/825468
   Schlapakow E, 2019, NEUROMUSCULAR DISORD, V29, P358, DOI 10.1016/j.nmd.2019.02.009
   Sharbrough J, 2023, MOL BIOL EVOL, V40, DOI 10.1093/molbev/msad007
   Sharma MA, 2019, MITOCHONDRION, V46, P298, DOI 10.1016/j.mito.2018.08.002
   Sinyov VV, 2016, RUSS J GENET+, V52, P847, DOI 10.1134/S1022795416080123
   Sinyov V V., 2017, Vessel Plus, P145, DOI 10.20517/2574-1209.2016.04
   Soltész B, 2022, MOL CELL PROBE, V66, DOI 10.1016/j.mcp.2022.101875
   Song WH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981867
   Spyropoulos A, 2013, JAMA NEUROL, V70, P1552, DOI 10.1001/jamaneurol.2013.4111
   Spyropoulos AC, 2021, HEART INT, V15, P62, DOI 10.17925/HI.2021.15.2.62
   Stefano GB, 2017, ADV EXP MED BIOL, V982, P577, DOI 10.1007/978-3-319-55330-6_30
   Tully G, 2004, FORENSIC SCI INT, V140, P1, DOI 10.1016/S0379-0738(03)00181-6
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   Visuttijai K, 2021, ACTA NEUROL SCAND, V143, P103, DOI 10.1111/ane.13339
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wang AS, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00247
   Wang WL, 2020, CELL BIOL TOXICOL, V36, P391, DOI 10.1007/s10565-020-09549-x
   Wong LJC, 2020, HUM MUTAT, V41, P1783, DOI 10.1002/humu.24082
   Yang X, 2019, ANNU REV NUTR, V39, P201, DOI 10.1146/annurev-nutr-082018-124643
   Yang ZY, 2022, CURR PROTOC, V2, DOI 10.1002/cpz1.412
   Yao YG, 2015, MUTAT RES-FUND MOL M, V779, P68, DOI 10.1016/j.mrfmmm.2015.06.009
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zhang P, 2016, MITOCHONDRION, V31, P75, DOI 10.1016/j.mito.2016.08.018
   Zhang P, 2016, MITOCHONDRION, V28, P16, DOI 10.1016/j.mito.2016.03.001
   Zhou H, 2020, CLIN CHIM ACTA, V507, P210, DOI 10.1016/j.cca.2020.04.033
NR 116
TC 0
Z9 0
U1 2
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PD 2024 AUG 23
PY 2024
DI 10.2174/0109298673296881240816065357
EA AUG 2024
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA E3P7S
UT WOS:001302166400001
PM 39185646
DA 2024-11-01
ER

PT J
AU Stewart, JD
   Tennant, S
   Powell, H
   Pyle, A
   Blakely, EL
   He, L
   Hudson, G
   Roberts, M
   du Plessis, D
   Gow, D
   Mewasingh, LD
   Hanna, MG
   Omer, S
   Morris, AA
   Roxburgh, R
   Livingston, JH
   McFarland, R
   Turnbull, DM
   Chinnery, PF
   Taylor, RW
AF Stewart, J. D.
   Tennant, S.
   Powell, H.
   Pyle, A.
   Blakely, E. L.
   He, L.
   Hudson, G.
   Roberts, M.
   du Plessis, D.
   Gow, D.
   Mewasingh, L. D.
   Hanna, M. G.
   Omer, S.
   Morris, A. A.
   Roxburgh, R.
   Livingston, J. H.
   McFarland, R.
   Turnbull, D. M.
   Chinnery, P. F.
   Taylor, R. W.
TI Novel <i>POLG1</i> mutations associated with neuromuscular and liver
   phenotypes in adults and children
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   MITOCHONDRIAL-DNA; ALPERS-SYNDROME; W748S MUTATION; DELETIONS;
   DISORDERS; DIAGNOSIS; DEPLETION; DISEASE
AB Background: The POLG1 gene encodes the catalytic subunit of DNA polymerase gamma, essential for mitochondrial DNA replication and repair. Mutations in POLG1 have been linked to a spectrum of clinical phenotypes, and may account for up to 25% of all adult presentations of mitochondrial disease.
   Methods and results: We present 14 patients, with characteristic features of mitochondrial disease including progressive external ophthalmoplegia (PEO) and Alpers-Huttenlocher syndrome and laboratory findings indicative of mitochondrial dysfunction, including cytochrome c oxidase (COX) deficiency and multiple deletions or depletion of the mitochondrial DNA. Four novel POLG1 missense substitutions (p.R597W, p.L605R, p.G746S, p.A862T), are described, together with the first adult patient with a recently described polymerase domain mutation (p.R1047W). All novel changes were rare in a control population and affected highly conserved amino acids.
   Conclusion: The addition of these substitutions including the first report of a dinucleotide mutation (c.1814_1815TT>GC)-to the growing list of defects further confirms the importance of POLG1 mutations as the underlying abnormality in a range of neurological presentations.
C1 [Stewart, J. D.; Pyle, A.; Blakely, E. L.; He, L.; Hudson, G.; McFarland, R.; Turnbull, D. M.; Chinnery, P. F.; Taylor, R. W.] Univ Newcastle, Mitochondrial Res Grp, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Tennant, S.; Powell, H.; Turnbull, D. M.; Chinnery, P. F.; Taylor, R. W.] Univ Newcastle, Inst Hlth & Aging, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Roberts, M.; du Plessis, D.; Gow, D.] Hope Hosp, Dept Neurol, Salford M6 8HD, Lancs, England.
   [Roberts, M.; du Plessis, D.; Gow, D.] Hope Hosp, Dept Neuropathol, Salford M6 8HD, Lancs, England.
   [Mewasingh, L. D.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Paediat Neurol, London, England.
   [Hanna, M. G.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
   [Omer, S.] Univ London St Georges Hosp, Dept Neurol, London, England.
   [Morris, A. A.] Royal Manchester Childrens Hosp, Willink Unit, Manchester M27 1HA, Lancs, England.
   [Livingston, J. H.] Leeds Teaching Hosp NHS Trust, Dept Paediat Neurol, Leeds, W Yorkshire, England.
   [Tennant, S.; Powell, H.; Turnbull, D. M.; Chinnery, P. F.; Taylor, R. W.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Roxburgh, R.] Auckland City Hosp, Auckland, New Zealand.
C3 Newcastle University - UK; Newcastle University - UK; Imperial College
   London; University of London; University College London; City St
   Georges, University of London; Royal Manchester Children's Hospital;
   University of Leeds; Newcastle University - UK; Auckland City Hospital
RP Taylor, RW (corresponding author), Univ Newcastle, Mitochondrial Res Grp, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM w.taylor@ncl.ac.uk
RI Hudson, Gavin/E-7117-2017; Hanna, Michael/B-1995-2009; Maier,
   Andrea/Q-5548-2019; Stewart, Joanna D/H-1614-2012
OI Chinnery, Patrick/0000-0002-7065-6617; Hanna,
   Michael/0000-0003-0825-4075; Hudson, Gavin/0000-0001-7210-2733; Stewart,
   Joanna D/0000-0002-2608-1967; Roxburgh, Richard/0000-0002-8930-7003;
   McFarland, Robert/0000-0002-8833-2688
FU United Mitochondrial Diseases Foundation; US Army; Parkinson's Disease
   Society; EU [FP6]; MITOCIRCLE; Wellcome Trust; Muscular Dystrophy
   Campaign; NHS Trust; Department of Health; MRC [G0800674, G0601943]
   Funding Source: UKRI
FX PFC is a Wellcome Trust Senior Fellow in Clinical Science who also
   receives funding from the United Mitochondrial Diseases Foundation, an
   unconditional research grant from the US Army, The Parkinson's Disease
   Society, and the EU FP6 program EUmitocombat and MITOCIRCLE. RWT and DMT
   acknowledge the Wellcome Trust, the Muscular Dystrophy Campaign, the
   Newcastle upon Tyne Hospitals Foundation NHS Trust and the Department of
   Health (NCG Rare Mitochondrial Disorders of Adults and Children Service)
   for their continuing financial support.
CR Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Fratter C, 2006, J MED GENET, V43, pS80
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 27
TC 38
Z9 43
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD MAR
PY 2009
VL 46
IS 3
BP 209
EP 214
DI 10.1136/jmg.2008.058180
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 412JY
UT WOS:000263722300009
PM 19251978
DA 2024-11-01
ER

PT J
AU Akouchekian, M
   Houshmand, M
   Hemati, S
   Shafa, M
AF Akouchekian, Mansoureh
   Houshmand, Massoud
   Hemati, Simin
   Shafa, Mehdi
TI Occurrence of large-scale mitochondrial DNA deletions in human
   colorectal cancer
SO ARCHIVES OF MEDICAL SCIENCE
LA English
DT Article
DE mitochondrial DNA; colon cancer; large-scale deletion; 8.7 kb deletion
ID MICROSATELLITE INSTABILITY; SOMATIC MUTATIONS; GASTRIC-CANCER; CONTROL
   REGION; NUCLEAR-DNA; TUMORS; CARCINOMAS; GENOME
AB Introduction: The aim of this study was to determine the mutation patterns of colon cancers through screening of different regions of mitochondrial DNA (mtDNA) in colon cancer patients.
   Material and methods: In order to investigate whether deletions exist in the mitochondrial DNA of colon cancer patients, we used a PCR assay to assess the presence of large-scale deletions. We screened four regions of the mitochondrial genome by PCR amplification and Southern blot analysis followed by DNA sequencing. Previously, deficiency in mitochondrial complex I has been reported; therefore we focused on the region of mtDNA that encodes the genes of this complex.
   Results: In 11 out of 90 patients, we found an 8.7 kb deletion. Large-scale deletions of mtDNA are common events that have been found to occur in human ageing and in patients with mitochondrial myopathies. Based on our results the mtDNA 8.7 kb deletion occurs in 12.2% of the colorectal cancer (CRC) samples.
   Conclusions: As reactive oxygen species (ROS) are continuously generated by the respiratory chain, they may cause significant oxidative damage to mtDNA (for example mtDNA deletions or mutations) if not efficiently eliminated. Defective respiratory enzymes containing protein subunits encoded by the deleted mtDNA may further enhance free radical production, resulting in more profound oxidative damage in CRC patients.
C1 [Akouchekian, Mansoureh; Houshmand, Massoud; Shafa, Mehdi] NIGEB, Dept Med Genet, Tehran, Iran.
   [Akouchekian, Mansoureh] Leibniz Univ Hannover, Dept Biol, Hannover, Germany.
   [Akouchekian, Mansoureh; Houshmand, Massoud; Shafa, Mehdi] Special Med Ctr, Dept Genet, Tehran, Iran.
   [Hemati, Simin] Sayedalshohada Hosp, Dept Oncol, Esfahan, Iran.
C3 Leibniz University Hannover
RP Houshmand, M (corresponding author), NIGEB, Dept Med Genet, POB 14155-6343, Tehran, Iran.
EM massoudh@nigeb.ac.ir
RI Houshmand, Massoud/AEG-9909-2022; Akouchekian, Mansoureh/S-6233-2018
OI Houshmand, Massoud/0000-0002-2198-223X; , Masoud/0000-0001-7687-7464
FU National Institute for Genetic Engineering and Biotechnology and
   Department of Genetics, Special Medical Center, Tehran
FX This work was supported by Dr. M. Houshmand, National Institute for
   Genetic Engineering and Biotechnology and Department of Genetics,
   Special Medical Center, Tehran.
CR Alonso A, 1997, ELECTROPHORESIS, V18, P682, DOI 10.1002/elps.1150180504
   BURGART LJ, 1995, AM J PATHOL, V147, P1105
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Habano W, 1998, ONCOGENE, V17, P1931, DOI 10.1038/sj.onc.1202112
   Habano W, 1999, INT J CANCER, V83, P625, DOI 10.1002/(SICI)1097-0215(19991126)83:5<625::AID-IJC10>3.0.CO;2-N
   Habano W, 2000, GASTROENTEROLOGY, V118, P835, DOI 10.1016/S0016-5085(00)70169-7
   Hibi K, 2001, INT J CANCER, V94, P429, DOI 10.1002/ijc.1480
   Jerónimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646
   Jones JB, 2001, CANCER RES, V61, P1299
   Kamalidehghan B, 2006, ARCH MED RES, V37, P848, DOI 10.1016/j.arcmed.2006.03.007
   Kirches E, 2001, INT J CANCER, V93, P534, DOI 10.1002/ijc.1375
   Lee HC, 1997, J FORMOS MED ASSOC, V96, P770
   Liu VWS, 2001, CANCER RES, V61, P5998
   Marcelino LA, 1999, MUTAT RES-DNA REPAIR, V434, P177, DOI 10.1016/S0921-8777(99)00028-2
   Máximo V, 2000, GASTROENTEROLOGY, V119, P1808, DOI 10.1016/S0016-5085(00)70044-8
   Máximo V, 2001, GENE CHROMOSOME CANC, V32, P136, DOI 10.1002/gcc.1175
   Miyazono F, 2002, ONCOGENE, V21, P3780, DOI 10.1038/sj.onc.1205532
   Nishikawa M, 2001, CANCER RES, V61, P1843
   Park J I, 2000, Arch Facial Plast Surg, V2, P43, DOI 10.1001/archfaci.2.1.43
   Parrella P, 2001, CANCER RES, V61, P7623
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Sanchez-Cespedes M, 2001, CANCER RES, V61, P7015
   Shoffner JM., 1995, METABOLIC MOL BASES, V7th, P1535
   Tamura G, 1999, EUR J CANCER, V35, P316, DOI 10.1016/S0959-8049(98)00360-8
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Yeh JJ, 2000, ONCOGENE, V19, P2060, DOI 10.1038/sj.onc.1203537
NR 27
TC 5
Z9 5
U1 0
U2 0
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA KLEEBERGA ST 2, POZNAN, 61-615, POLAND
SN 1734-1922
EI 1896-9151
J9 ARCH MED SCI
JI Arch. Med. Sci.
PD SEP
PY 2008
VL 4
IS 3
BP 249
EP 253
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 390YB
UT WOS:000262198500006
DA 2024-11-01
ER

PT J
AU Yao, YG
   Bandelt, HJ
   Young, NS
AF Yao, Yong-Gang
   Bandelt, Hans-Juergen
   Young, Neal S.
TI External Contamination in Single Cell mtDNA Analysis
SO PLOS ONE
LA English
DT Article
ID MITOCHONDRIAL-DNA MUTATIONS; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS;
   SEQUENCE; INHERITANCE; ACCUMULATION; PENETRANCE; PHYLOGENY; DELETIONS;
   ABUNDANT
AB Background. Mitochondrial DNA (mtDNA) variation in single hematopoietic cells, muscle fibers, oocytes, and from tiny amount of tumor tissues and degraded clinical specimens has been reported in many medical publications. External DNA contamination, notoriously difficult to avoid, threatens the integrity of such studies. Methodology/Principal Findings. Employing a phylogenetic approach, we analyzed the geographic origins of mtDNA sequence anomalies observed during multiple studies of mtDNA sequence variation in a total of 7094 single hematopoietic cells. 40 events with irregular mtDNA patterns were detected: eight instances (from seven different haplotypes) could be traced to laboratory personnel; six cases were caused by sample cross-contamination. The sources of the remaining events could not be identified, and the anomalous sequence variation referred to matrilines from East Asia, Africa, or West Eurasia, respectively. These mtDNA sequence anomalies could be best explained by contamination. Conclusions. Using the known world mtDNA phylogeny, we could distinguish the geographic origin of the anomalous mtDNA types, providing some useful information regarding the source of contamination. Our data suggest that routine mtDNA sequence analysis of laboratory personnel is insufficient to identify and eliminate all contaminants. A rate of 0.6% of external contamination in this study, while low, is not negligible: Unrecognized contaminants will be mistaken as evidence of remarkable somatic mutations associated with the development of cancer and other diseases. The effective contamination rate can increase by a factor of more than an order of magnitude in some studies that did not institute high standards. Our results are of particular relevance to mtDNA research in medicine, and such an approach should be adopted to maintain and improve quality control in single-cell analyses.
C1 [Yao, Yong-Gang; Young, Neal S.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA.
   [Bandelt, Hans-Juergen] Univ Hamburg, Dept Math, Hamburg, Germany.
C3 National Institutes of Health (NIH) - USA; NIH National Heart Lung &
   Blood Institute (NHLBI); University of Hamburg
RP Yao, YG (corresponding author), NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA.
EM yaoy3@nhlbi.nih.gov
RI Yao, Yong-Gang/AAH-2303-2021
OI Yao, Yong-Gang/0000-0002-2955-0693
FU NIH
FX This work was supported by the Intramural Research Program of the NIH.
CR Alonso A, 2005, J CLIN PATHOL, V58, P83, DOI 10.1136/jcp.2004.017673
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bandelt HJ, 2007, EUR J HUM GENET, V15, P400, DOI 10.1038/sj.ejhg.5201781
   Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131
   Bandelt HJ, 2006, NUCL ACID M, V18, P117
   Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589
   Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055
   Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9
   Chan CCW, 2005, MOL HUM REPROD, V11, P843, DOI 10.1093/molehr/gah243
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   Cormio A, 2005, NEUROBIOL AGING, V26, P655, DOI 10.1016/j.neurobiolaging.2004.06.014
   Czarnecka AM, 2006, J APPL GENET, V47, P67, DOI 10.1007/BF03194602
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071
   Jakupciak JP, 2005, J MOL DIAGN, V7, P258, DOI 10.1016/S1525-1578(10)60553-3
   Johns DR, 2003, ANN NEUROL, V54, P422, DOI 10.1002/ana.10771
   Kirches E, 2001, INT J CANCER, V93, P534, DOI 10.1002/ijc.1375
   Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   LEONARD JL, 2007, J ARCHAEOL IN PRESS, DOI DOI 10.1016/J.JAS.2006.1010.1023
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   Malmström H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Nagley P, 1998, TRENDS GENET, V14, P513, DOI 10.1016/S0168-9525(98)01580-7
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Ogasawara Y, 2005, BLOOD, V106, P3271, DOI 10.1182/blood-2005-01-0150
   Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566
   Pääbo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871
   Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9
   Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380
   Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296
   Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724
   Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001
   Vega A, 2004, ONCOGENE, V23, P1314, DOI 10.1038/sj.onc.1207214
   Verma Mukesh, 2007, Cancer Res, V67, P437, DOI 10.1158/0008-5472.CAN-06-4119
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang CY, 2007, INT J CANCER, V121, P1253, DOI 10.1002/ijc.22822
   Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813
   Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9
   Yao YG, 2007, BLOOD, V109, P756, DOI 10.1182/blood-2006-01-011007
   Yao YG, 2007, HUM MOL GENET, V16, P286, DOI 10.1093/hmg/ddl457
   Zanssen S, 2005, PLOS MED, V2, P1082, DOI 10.1371/journal.pmed.0020401
NR 64
TC 20
Z9 22
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 1
PY 2007
VL 2
IS 8
AR e681
DI 10.1371/journal.pone.0000681
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA V10GK
UT WOS:000207452300017
PM 17668059
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Nissanka, N
   Minczuk, M
   Moraes, CT
AF Nissanka, Nadee
   Minczuk, Michal
   Moraes, Carlos T.
TI Mechanisms of Mitochondrial DNA Deletion Formation
SO TRENDS IN GENETICS
LA English
DT Review
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MULTIPLE MTDNA DELETIONS;
   RESOLVING ENZYME CCE1; HUMAN SKELETAL-MUSCLE; LARGE-SCALE DELETIONS;
   STRAND BREAK REPAIR; POINT MUTATIONS; DIRECT REPEATS; REPLICATION;
   GENOMES
AB Mitochondrial DNA (mtDNA) encodes a subset of genes which are essential for oxidative phosphorylation. Deletions in the mtDNA can ablate a number of these genes and result in mitochondrial dysfunction, which is associated with bona fide mitochondrial disorders. Although mtDNA deletions are thought to occur as a result of replication errors or following double-strand breaks, the exact mechanism(s) behind deletion formation have yet to be determined. In this review we discuss the current knowledge about the fate of mtDNA following double-strand breaks, including the molecular players which mediate the degradation of linear mtDNA fragments and possible mechanisms of recircularization. We propose that mtDNA deletions formed from replication errors versus following double-strand breaks can be mediated by separate pathways.
C1 [Nissanka, Nadee; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Minczuk, Michal] Univ Cambridge, MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 University of Miami; University of Cambridge
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021; Minczuk, Michal/G-1638-2014
OI Nissanka, Nadee/0000-0002-4639-7192; Minczuk, Michal/0000-0001-8242-1420
FU National Institutes of Health [1R01AG036871, 5R01EY010804,
   1R01NS079965]; Muscular Dystrophy Association; Champ Foundation; Medical
   Research Council [MC_UU_00015/4]; MRC [MC_UU_00015/4] Funding Source:
   UKRI
FX We are grateful for support from the National Institutes of Health
   Grants 1R01AG036871, 5R01EY010804, and 1R01NS079965, the Muscular
   Dystrophy Association and the Champ Foundation (to C.T.M.); and the
   Medical Research Council Grant MC_UU_00015/4 (to M.M.). We are grateful
   to Maria Falkenberg (University of Gothenburg) for sharing unpublished
   information.
CR Abnet CC, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-30
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bruni F, 2017, FEBS J, V284, P1767, DOI 10.1111/febs.13981
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Coffey G, 1999, NUCLEIC ACIDS RES, V27, P3348, DOI 10.1093/nar/27.16.3348
   Coffey G, 2000, NUCLEIC ACIDS RES, V28, P3793, DOI 10.1093/nar/28.19.3793
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Dmitrieva NI, 2011, AM J PHYSIOL-REG I, V301, pR632, DOI 10.1152/ajpregu.00853.2010
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Fogg JM, 2000, BIOCHEMISTRY-US, V39, P4082, DOI 10.1021/bi992785v
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467
   Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Matic S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03552-x
   Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250
   Medeiros TC, 2018, J CELL BIOL, V217, P1601, DOI 10.1083/jcb.201801168
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   Moretton A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176795
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w
   Perrson O, NAT COMMUN
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   White MF, 1996, J MOL BIOL, V257, P330, DOI 10.1006/jmbi.1996.0166
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI [10.1038/nchembio.2102, 10.1038/NCHEMBIO.2102]
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   Zinovkina LA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P233, DOI 10.1134/S0006297918030045
NR 84
TC 59
Z9 64
U1 1
U2 14
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0168-9525
EI 1362-4555
J9 TRENDS GENET
JI Trends Genet.
PD MAR
PY 2019
VL 35
IS 3
BP 235
EP 244
DI 10.1016/j.tig.2019.01.001
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA HL1CE
UT WOS:000458430700007
PM 30691869
OA Green Submitted
DA 2024-11-01
ER

PT J
AU McKiernan, P
   Ball, S
   Santra, S
   Foster, K
   Fratter, C
   Poulton, J
   Craig, K
   McFarland, R
   Rahman, S
   Hargreaves, I
   Gupte, G
   Sharif, K
   Taylor, RW
AF McKiernan, Patrick
   Ball, Sarah
   Santra, Saikat
   Foster, Katherine
   Fratter, Carl
   Poulton, Joanna
   Craig, Kate
   McFarland, Robert
   Rahman, Shamima
   Hargreaves, Iain
   Gupte, Girish
   Sharif, Khalid
   Taylor, Robert W.
TI Incidence of Primary Mitochondrial Disease in Children Younger Than 2
   Years Presenting With Acute Liver Failure
SO JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
LA English
DT Article
DE acute liver failure; liver transplantation; mitochondrial disease;
   mitochondrial DNA depletion syndrome; respiratory chain deficiency
ID DNA DEPLETION SYNDROME; MUTATIONS; ONSET; TRANSPLANTATION; DISORDERS
AB Background:Mitochondrial liver disease (MLD), and in particular mitochondrial DNA (mtDNA) depletion syndrome (MDS) is an important cause of acute liver failure (ALF) in infancy. Early and accurate diagnosis is important because liver transplantation (LT) is often contraindicated. It is unclear which methods are the best to diagnose MLD in the setting of ALF.Objective:The aim of the study was to determine the incidence of MLD in children younger than 2 years with ALF and the utility of routine investigations to detect MLD.Methods:Thirty-nine consecutive infants with ALF were admitted to a single unit from 2009 to 2011. All were extensively investigated using an established protocol. Genes implicated in mitochondrial DNA depletion syndrome were sequenced in all cases and tissue mtDNA copy number measured where available.Results:Five infants (17%) had genetically proven MLD: DGUOK (n=2), POLG (n=2), and MPV17 (1). Four of these died, whereas 1 recovered. Two had normal muscle mtDNA copy number and 3 had normal muscle respiratory chain enzymes. An additional 8 children had low hepatic mtDNA copy number but pathogenic mutations were not detected. One of these developed fatal multisystemic disease after LT, whereas 5 who survived remain well without evidence of multisystemic disease up to 6 years later. Magnetic resonance spectroscopy did not distinguish between those with and without MLD.Conclusions:Low liver mtDNA copy number may be a secondary phenomenon in ALF.Screening for mtDNA maintenance gene mutations may be the most efficient way to confirm MLD in ALF in the first 2 years of life.
C1 [McKiernan, Patrick; Gupte, Girish; Sharif, Khalid] Birmingham Childrens Hosp, Liver Unit, Birmingham, W Midlands, England.
   [McKiernan, Patrick; Gupte, Girish] Univ Birmingham, Birmingham, W Midlands, England.
   [Ball, Sarah; Santra, Saikat] Birmingham Childrens Hosp, Dept Clin IMD, Birmingham, W Midlands, England.
   [Foster, Katherine] Birmingham Childrens Hosp, Dept Radiol, Birmingham, W Midlands, England.
   [Fratter, Carl] Oxford Univ Hosp NHS Fdn Trust, Oxford Med Genet Labs, London, England.
   [Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, London, England.
   [Craig, Kate; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res & Highly Spe, London, England.
   [Rahman, Shamima; Hargreaves, Iain] UCL Inst Child Hlth, Genet & Genom Med, London, England.
C3 University of Birmingham; University of Birmingham; University of
   Birmingham; University of Birmingham; Oxford University Hospitals NHS
   Foundation Trust; University of Oxford; Newcastle University - UK;
   University of London; University College London
RP McKiernan, P (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Gastroenterol Hepatol Nutr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.
EM patrick.mckiernan@chp.edu
RI Rahman, Shamima/C-5232-2008; Hargreaves, Iain/AAJ-6757-2020; Poulton,
   Joanna/AAB-4828-2021
OI Poulton, Joanna/0000-0002-2460-5587; Gupte, Girish/0000-0002-9026-1583;
   McFarland, Robert/0000-0002-8833-2688; Santra,
   Saikat/0000-0002-7497-3556
FU UK NHS Highly Specialized "Rare Mitochondrial Disorders of Adults and
   Children" Service; Wellcome Trust [096919Z/11/Z]; Great Ormond Street
   Hospital Children's Charity; MRC [G0800674] Funding Source: UKRI
FX The diagnostic laboratories in Oxford, London, and Newcastle upon Tyne
   are funded by the UK NHS Highly Specialized "Rare Mitochondrial
   Disorders of Adults and Children" Service. R.M. and R.W.T. are supported
   by a Wellcome Trust Strategic Award (096919Z/11/Z). S.R. is supported by
   Great Ormond Street Hospital Children's Charity.
CR Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   CormierDaire V, 1997, J PEDIATR-US, V130, P817, DOI 10.1016/S0022-3476(97)80027-3
   Davit-Spraul A, 2014, JIMD REP, V14, P17, DOI 10.1007/8904_2013_278
   deBruyn JC, 2007, J PEDIATR GASTR NUTR, V45, P252, DOI 10.1097/MPG.0b013e318048838f
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Fitzpatrick E, 2014, ARCH DIS CHILD, V99, P354, DOI 10.1136/archdischild-2013-304426
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Haack TB, 2015, AM J HUM GENET, V97, P163, DOI 10.1016/j.ajhg.2015.05.009
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Helbling D, 2013, J PEDIATR GASTR NUTR, V57, P438, DOI 10.1097/MPG.0b013e31829ef4b4
   Lane M, 2016, J INHERIT METAB DIS, V39, P427, DOI 10.1007/s10545-016-9927-z
   Lee WS, 2013, J PEDIATR-US, V163, P942, DOI 10.1016/j.jpeds.2013.05.036
   Lee WS, 2005, J PEDIATR GASTR NUTR, V40, P575, DOI 10.1097/01.MPG.0000158524.30294.E2
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Molleston JP, 2013, J PEDIATR GASTR NUTR, V57, P269, DOI 10.1097/MPG.0b013e31829ef67a
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Rahman S, 2013, J INHERIT METAB DIS, V36, P659, DOI 10.1007/s10545-013-9614-2
   Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uusimaa J, 2013, EUR J HUM GENET, V22, P553
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 24
TC 35
Z9 36
U1 0
U2 14
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-2116
EI 1536-4801
J9 J PEDIATR GASTR NUTR
JI J. Pediatr. Gastroenterol. Nutr.
PD DEC
PY 2016
VL 63
IS 6
BP 592
EP 597
DI 10.1097/MPG.0000000000001345
PG 6
WC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
GA ED3EW
UT WOS:000388733200026
PM 27482763
OA Green Accepted, hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Fragoso, CAV
   Manini, TM
   Kairalla, JA
   Buford, TW
   Hsu, FC
   Gill, TM
   Kritchevsky, SB
   McDermott, MM
   Sanders, JL
   Cummings, SR
   Tranah, GJ
AF Fragoso, Carlos A. Vaz
   Manini, Todd M.
   Kairalla, John A.
   Buford, Thomas W.
   Hsu, Fang-Chi
   Gill, Thomas M.
   Kritchevsky, Stephen B.
   McDermott, Mary M.
   Sanders, Jason L.
   Cummings, Steven R.
   Tranah, Gregory J.
TI Mitochondrial DNA variants and pulmonary function in older persons
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Mitochondrial DNA; Pulmonary function; Aging
ID GENOME-WIDE ASSOCIATION; LIFE-STYLE INTERVENTIONS; LUNG-FUNCTION;
   SEQUENCE VARIATION; RESPIRATORY IMPAIRMENT; DISEASE; PERFORMANCE; RISK;
   AGE; INDEPENDENCE
AB Background: We provide the first examination of mitochondrial DNA (mtDNA) variants and pulmonary function in older persons.
   Methods: Cross-sectional associations between mtDNA variants and pulmonary function were evaluated as a combined p-values meta-analysis, using data from two independent cohorts of older persons. The latter included white and black participants, aged >= 70 years, from the Lifestyle Interventions and Independence for Elders study (LIFE) (N = 1247) and the Health, Aging and Body Composition study (Health ABC) (N = 731), respectively. Pulmonary function included the forced expiratory volume in one-second as a Z-score (FEV1z) and the maximal inspiratory pressure (MIP) in cm of water.
   Results: In black participants, significant associations were found between mtDNA variants and MIP: m.7146A > G, COI (p = 3E-5); m.7389T > C, COI (p = 2E-4); m.15301G > A, CYB (p = 9E-5); m.16265A > G, HV1 (p = 9E-5); meta-analytical p-values < 0.0002. Importantly, these mtDNA variants were unique to black participants and were not present in white participants. Moreover, in black participants, aggregate genetic effects on MIP were observed across mutations in oxidative phosphorylation complex IV (p = 0.004), complex V (p = 0.0007), and hypervariable (p = 0.003) regions. The individual and aggregate variant results were significant after adjustment for multiple comparisons. Otherwise, no significant associations were detected for MIP in whites or for FEV1z in whites or blacks.
   Conclusions: We have shown that mtDNA variants of African origin are cross-sectionally associated with MIP, a measure of respiratory muscle strength. Thus, our results establish the rationale for longitudinal studies to evaluate whether mtDNA variants of African origin identify those at risk of subsequently developing a respiratory muscle impairment (lower MIP values).
C1 [Fragoso, Carlos A. Vaz; Gill, Thomas M.] Yale Sch Med, Dept Med, New Haven, CT USA.
   [Fragoso, Carlos A. Vaz] Vet Affairs Connecticut Healthcare Syst, Dept Med, West Haven, CT USA.
   [Manini, Todd M.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA.
   [Kairalla, John A.] Univ Florida, Dept Biostat, Gainesville, FL USA.
   [Buford, Thomas W.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.
   [Hsu, Fang-Chi] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA.
   [Kritchevsky, Stephen B.] Wake Forest Sch Med, Sticht Ctr Hlth Aging & Absheimers Prevent, Winston Salem, NC USA.
   [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Sanders, Jason L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.
   [Cummings, Steven R.; Tranah, Gregory J.] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA.
C3 Yale University; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Connecticut Healthcare System; State University
   System of Florida; University of Florida; State University System of
   Florida; University of Florida; University of Alabama System; University
   of Alabama Birmingham; Wake Forest University; Wake Forest University;
   Northwestern University; Feinberg School of Medicine; Harvard
   University; Massachusetts General Hospital; California Pacific Medical
   Center; California Pacific Medical Center Research Institute
RP Fragoso, CAV (corresponding author), 950 Campbell Ave, West Haven, CT 06516 USA.
EM carlos.fragoso@yale.edu
RI Buford, Thomas/B-1111-2011; Gill, Thomas/H-7043-2019; McDermott,
   Michael/S-8490-2019
OI Gill, Thomas/0000-0002-6450-0368; Vaz Fragoso,
   Carlos/0000-0002-7045-3334; Manini, Todd/0000-0002-5970-4462
FU National Institutes of Health (NIH), National Institute on Aging
   [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; National Institutes of
   Health [R01-AG028050, R03-AG032498, R01-NR012459, Z01A6000932,
   R01-HL121023]; Research and Education Leadership Committee of the CPMC
   Foundation; L. K. Whittier Foundation; Academic Leadership Award from
   the National Institute on Aging [K07AG043587]; Yale Claude D. Pepper
   Older Americans Independence Center [P30AG21342]
FX The Intramural Research Program of the National Institutes of Health
   (NIH), National Institute on Aging, Contracts N01-AG-6-2101,
   N01-AG-6-2103, and N01-AG-6-2106; National Institutes of Health grants
   R01-AG028050, R03-AG032498, R01-NR012459, Z01A6000932, R01-HL121023, and
   grants from the Research and Education Leadership Committee of the CPMC
   Foundation and the L. K. Whittier Foundation. Dr. Gill is the recipient
   of an Academic Leadership Award (K07AG043587) from the National
   Institute on Aging and is supported by the Yale Claude D. Pepper Older
   Americans Independence Center (P30AG21342).
CR [Anonymous], J AM GERIATR SOC
   [Anonymous], OP MAN
   Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB288, DOI 10.1093/gerona/56.7.B288
   ENRIGHT PL, 1994, CHEST, V106, P827, DOI 10.1378/chest.106.3.827
   Evangelou E, 2014, ANN RHEUM DIS, V73, P2130, DOI 10.1136/annrheumdis-2012-203114
   Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123
   Fragoso CAV, 2012, AM J MED, V125, P79, DOI 10.1016/j.amjmed.2011.06.024
   Giorgi EE, 2016, CANCER EPIDEM BIOMAR, V25, P1001, DOI 10.1158/1055-9965.EPI-16-0111
   Gögele M, 2012, AM J EPIDEMIOL, V175, P739, DOI 10.1093/aje/kwr385
   GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074
   Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Katzman SM, 2015, J GERONTOL A-BIOL, V70, P1400, DOI 10.1093/gerona/glu175
   Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290
   Lam ET, 2012, CANCER RES, V72, P686, DOI 10.1158/0008-5472.CAN-11-1682
   LANGSTON JW, 1983, NEW ENGL J MED, V309, P310
   Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200
   MCCLEARN GE, 1994, J GERONTOL, V49, pM264, DOI 10.1093/geronj/49.6.M264
   Miura S, 2013, AM J PHYSIOL-ENDOC M, V305, pE213, DOI 10.1152/ajpendo.00114.2013
   Nam HS, 2017, BIOMARK MED, V11, P475, DOI 10.2217/bmm-2016-0373
   Nguyen TT, 2009, ANN HUM GENET, V73, P638, DOI 10.1111/j.1469-1809.2009.00544.x
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Ong BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072899
   Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205
   Picard M, 2015, J APPL PHYSIOL, V118, P1161, DOI 10.1152/japplphysiol.00873.2014
   Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109
   Prakash YS, 2017, CHEST, V152, P618, DOI 10.1016/j.chest.2017.03.020
   Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312
   RAMSAY RR, 1986, J BIOL CHEM, V261, P7585
   Rejeski WJ, 2005, CONTEMP CLIN TRIALS, V26, P141, DOI 10.1016/j.cct.2004.12.005
   Sachs MC, 2009, RESP CARE, V54, P1321
   Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240
   Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474
   Tang WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100776
   Tranah GJ, 2015, NEUROLOGY, V85, P325, DOI 10.1212/WNL.0000000000001744
   Tranah GJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.05.023
   Tranah GJ, 2012, BBA-BIOENERGETICS, V1817, P1691, DOI 10.1016/j.bbabio.2012.05.012
   Tranah GJ, 2011, MITOCHONDRION, V11, P855, DOI 10.1016/j.mito.2011.04.005
   Tseng CC, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1637-5
   van der Palen J, 2004, THORAX, V59, P1063, DOI 10.1136/thx.2004.021915
   Vaz Fragoso CA, 2012, J GERONTOL A-BIOL, V67, P264, DOI 10.1093/gerona/glr198
   Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x
   Wain LV, 2017, NAT GENET, V49, P416, DOI 10.1038/ng.3787
   Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900
   Wallace DC, 2010, P NATL ACAD SCI USA, V107, P8947, DOI 10.1073/pnas.0914635107
   Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340
   Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029
   Yao TC, 2014, J ALLERGY CLIN IMMUN, V133, P248, DOI 10.1016/j.jaci.2013.06.018
   Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191
NR 56
TC 4
Z9 4
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN
PY 2019
VL 115
BP 96
EP 103
DI 10.1016/j.exger.2018.11.023
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA HG8BZ
UT WOS:000455223100011
PM 30508565
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Lamperti, C
   Fang, MY
   Invernizzi, F
   Liu, XZ
   Wang, HR
   Zhang, Q
   Carrara, F
   Moroni, I
   Zeviani, M
   Zhang, JG
   Ghezzi, D
AF Lamperti, Costanza
   Fang, Mingyan
   Invernizzi, Federica
   Liu, Xuanzhu
   Wang, Hairong
   Zhang, Qing
   Carrara, Franco
   Moroni, Isabella
   Zeviani, Massimo
   Zhang, Jianguo
   Ghezzi, Daniele
TI A novel homozygous mutation in <i>SUCLA2</i> gene identified by exome
   sequencing
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondrial disorder; Encephalomyopathy; Mitochondrial DNA depletion;
   SUCLA2; Exome-sequencing
ID MITOCHONDRIAL-DNA DEPLETION; SUCCINYL-COA SYNTHETASES; DEFICIENCY;
   ENCEPHALOMYOPATHY; EXPRESSION; PROTEIN; KINASE
AB Mitochondrial disorders with multiple mitochondrial respiratory chain (MRC) enzyme deficiency and depletion of mitochondrial DNA (mtDNA) are autosomal recessive conditions due to mutations in several nuclear genes necessary for proper mtDNA maintenance.
   In this report, we describe two Italian siblings presenting with encephalomyopathy and mtDNA depletion in muscle. By whole exome-sequencing and prioritization of candidate genes, we identified a novel homozygous missense mutation in the SUCLA2 gene in a highly conserved aminoacid residue. Although a recurrent mutation in the SUCLA2 gene is relatively frequent in the Faroe Islands, mutations in other populations are extremely rare. In contrast with what has been reported in other patients, methyl-malonic aciduria, a biomarker for this genetic defect, was absent in our proband and very mildly elevated in her affected sister. This report demonstrates that next-generation technologies, particularly exome-sequencing, are user friendly, powerful means for the identification of disease genes in genetically and clinically heterogeneous inherited conditions, such as mitochondrial disorders. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Lamperti, Costanza; Invernizzi, Federica; Carrara, Franco; Zeviani, Massimo; Ghezzi, Daniele] Ist Ricovero & Cura Carattere Sci, Fdn Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Moroni, Isabella] Ist Ricovero & Cura Carattere Sci, Fdn Ist Neurol Carlo Besta, Div Child Neurol, I-20126 Milan, Italy.
   [Fang, Mingyan; Liu, Xuanzhu; Wang, Hairong; Zhang, Qing; Zhang, Jianguo] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China.
   [Zhang, Jianguo] Fudan Univ, T Life Res Ctr, Shanghai 200433, Peoples R China.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto
   Neurologico Carlo Besta; Fondazione IRCCS Istituto Neurologico Carlo
   Besta; IRCCS Ca Granda Ospedale Maggiore Policlinico; Beijing Genomics
   Institute (BGI); Fudan University
RP Zhang, JG (corresponding author), Main Bldg,Floor 6, Shenzhen 518083, Peoples R China.
EM zhangjg@genomics.org.cn; dghezzi@istituto-besta.it
RI Wang, Hairong/HGF-1825-2022; Zeviani, Massimo/K-2891-2014; lamperti,
   costanza/J-8801-2016; Fang, Mingyan/B-8505-2017; Zhang,
   Jian-Guo/C-7137-2008; ZHANG, QING/AGY-7972-2022; moroni,
   isabella/AAL-1336-2021; Ghezzi, Daniele/J-7873-2016; Invernizzi,
   Federica/J-9849-2016
OI moroni, isabella/0000-0002-3322-1681; Fang, Mingyan/0000-0001-7185-6445;
   Ghezzi, Daniele/0000-0002-6564-3766; Zhang, Jianguo/0000-0003-0723-1701;
   Invernizzi, Federica/0000-0001-8072-0152; Zeviani,
   Massimo/0000-0002-9067-5508
FU Pierfranco and Luisa Mariani Foundation of Italy; Fondazione Telethon
   [GGP11011, GPP10005]; CARIPLO [2011/0526]; Italian Ministry of Health
   [GR2010 - 2316392]; Italian Association of Mitochondrial Disease
   Patients and Families (Mitocon)
FX This work was supported by the Pierfranco and Luisa Mariani Foundation
   of Italy; Fondazione Telethon grants GGP11011 and GPP10005; CARIPLO
   grant 2011/0526; the Italian Ministry of Health (GR2010 - 2316392); and
   the Italian Association of Mitochondrial Disease Patients and Families
   (Mitocon).
CR Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HECKMATT JZ, 1984, MUSCLE NERVE, V7, P594
   Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580
   Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200
   Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336
   Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pippucci T, 2011, HUM HERED, V72, P45, DOI 10.1159/000330164
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
NR 24
TC 35
Z9 38
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD NOV
PY 2012
VL 107
IS 3
BP 403
EP 408
DI 10.1016/j.ymgme.2012.08.020
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 032LM
UT WOS:000310720200023
PM 23010432
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Clark, J
   Dai, Y
   Simon, DK
AF Clark, Joanne
   Dai, Ying
   Simon, David K.
TI Do Somatic Mitochondrial DNA Mutations Contribute to Parkinson's
   Disease?
SO PARKINSONS DISEASE
LA English
DT Review
ID MTDNA POINT MUTATIONS; COMPLEX-I; POLYMERASE-GAMMA; SUBSTANTIA-NIGRA;
   CLONAL EXPANSION; PATHOGENIC MTDNA; MUSCLE-FIBERS; DELETIONS; RISK;
   POLYMORPHISMS
AB A great deal of evidence supports a role for mitochondrial dysfunction in the pathogenesis of Parkinson's disease (PD), although the origin of the mitochondrial dysfunction in PD remains unclear. Expression of mitochondrial DNA (mtDNA) from PD patients in "cybrid" cell lines recapitulates the mitochondrial defect, implicating a role for mtDNA mutations, but the specific mutations responsible for the mitochondrial dysfunction in PD have been difficult to identify. Somatic mtDNA point mutations and deletions accumulate with age and reach high levels in substantia nigra (SN) neurons. Mutations in mitochondrial DNA polymerase gamma (POLG) that lead to the accumulation of mtDNA mutations are associated with a premature aging phenotype in "mutator" mice, although overt parkinsonism has not been reported in these mice, and with parkinsonism in humans. Together these data support, but do not yet prove, the hypothesis that the accumulation of somatic mtDNA mutations in SN neurons contribute to the pathogenesis of PD.
C1 [Clark, Joanne; Dai, Ying; Simon, David K.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.
C3 Harvard University; Beth Israel Deaconess Medical Center
RP Simon, DK (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, 330 Brookline Ave,E CLS 628, Boston, MA 02215 USA.
EM dsimon1@bidmc.harvard.edu
RI DAI, YING/A-2103-2012
FU NINDS [1R01NS058988, 1R03AG035223]; Michael J. Fox Foundation
FX Dr. Simon's laboratory is funded by the NINDS (1R01NS058988 and
   1R03AG035223) and by the Michael J. Fox Foundation.
CR ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Bandmann O, 1997, J NEUROL, V244, P262, DOI 10.1007/s004150050082
   Bashkatova V, 2004, EXP NEUROL, V186, P235, DOI 10.1016/j.expneurol.2003.12.005
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   BURNS RS, 1985, NEW ENGL J MED, V312, P1418, DOI 10.1056/NEJM198505303122203
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Capaldi RA, 2002, BBA-BIOENERGETICS, V1555, P192, DOI 10.1016/S0005-2728(02)00277-3
   Carbon M, 2007, NEUROIMAGE, V34, P361, DOI 10.1016/j.neuroimage.2006.08.019
   Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802
   Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   Coller HA, 2002, ANN NY ACAD SCI, V959, P434, DOI 10.1111/j.1749-6632.2002.tb02113.x
   Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Egensperger R, 1997, NEUROPATH APPL NEURO, V23, P315, DOI 10.1046/j.1365-2990.1997.4098040.x
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   FRIDLENDER B, 1972, P NATL ACAD SCI USA, V69, P452, DOI 10.1073/pnas.69.2.452
   Fukuda M, 2001, PARKINSONISM RELAT D, V8, P91, DOI 10.1016/S1353-8020(01)00022-0
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   Hirano M, 1997, P NATL ACAD SCI USA, V94, P14894, DOI 10.1073/pnas.94.26.14894
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Huerta C, 2007, NEUROSCI LETT, V413, P202, DOI 10.1016/j.neulet.2006.11.044
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002
   Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mayr-Wohlfart U, 1997, Eur J Med Res, V2, P111
   Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MIZUNO Y, 1987, BIOCHEM BIOPH RES CO, V143, P971, DOI 10.1016/0006-291X(87)90346-9
   MULLERHOCKER J, 1993, ARCH PATHOL LAB MED, V117, P202
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, MOVEMENT DISORD, V5, P294, DOI 10.1002/mds.870050406
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Schon EA, 2010, BBA-GEN SUBJECTS, V1800, P245, DOI 10.1016/j.bbagen.2009.07.007
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003
   Swerdlow RH, 2001, EXP NEUROL, V169, P479, DOI 10.1006/exnr.2001.7674
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Tan EK, 2000, NEUROLOGY, V55, P533, DOI 10.1212/WNL.55.4.533
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vielhaber S, 2000, BIOCHEM SOC T, V28, P159, DOI 10.1042/bst0280159
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 100
TC 13
Z9 13
U1 0
U2 3
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-8083
EI 2042-0080
J9 PARKINSONS DIS-US
JI Parkinsons Dis.
PY 2011
VL 2011
AR 659694
DI 10.4061/2011/659694
PG 9
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA V29RN
UT WOS:000208765600057
PM 21603185
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU McManus, MJ
   Picard, M
   Chen, HW
   De Haas, HJ
   Potluri, P
   Leipzig, J
   Towheed, A
   Angelin, A
   Sengupta, P
   Morrow, RM
   Kauffman, BA
   Vermulst, M
   Narula, J
   Wallace, DC
AF McManus, Meagan J.
   Picard, Martin
   Chen, Hsiao-Wen
   De Haas, Hans J.
   Potluri, Prasanth
   Leipzig, Jeremy
   Towheed, Atif
   Angelin, Alessia
   Sengupta, Partho
   Morrow, Ryan M.
   Kauffman, Brett A.
   Vermulst, Marc
   Narula, Jagat
   Wallace, Douglas C.
TI Mitochondrial DNA Variation Dictates Expressivity and Progression of
   Nuclear DNA Mutations Causing Cardiomyopathy
SO CELL METABOLISM
LA English
DT Article
ID ADENINE-NUCLEOTIDE TRANSLOCATOR; OPTIC ATROPHY 1; ATP SYNTHASE;
   PERMEABILITY TRANSITION; MYOCARDIAL MECHANICS; SKELETAL-MUSCLE; MOUSE
   MODEL; CRISTAE; DEFICIENCY; GENE
AB Nuclear-encoded mutations causing metabolic and degenerative diseases have highly variable expressivity. Patients sharing the homozygous mutation (c.523delC) in the adenine nucleotide translocator 1 gene (SLC25A4, ANT1) develop cardiomyopathy that varies from slowly progressive to fulminant. This variability correlates with the mitochondrial DNA (mtDNA) lineage. To confirm that mtDNA variants can modulate the expressivity of nuclear DNA (nDNA)-encoded diseases, we combined in mice the nDNA Slc25a4(-/-) null mutation with a homoplasmic mtDNA ND6(P25L) or COIV421A variant. The ND6(P25L) variant significantly increased the severity of cardiomyopathy while the COIV421A variant was phenotypically neutral. The adverse Slc25a4(-/-) and ND6(P25L) combination was associated with impaired mitochondrial complex I activity, increased oxidative damage, decreased l-Opa1, altered mitochondrial morphology, sensitization of the mitochondrial permeability transition pore, augmented somatic mtDNA mutation levels, and shortened lifespan. The strikingly different phenotypic effects of these mild mtDNA variants demonstrate that mtDNA can be an important modulator of autosomal disease.
C1 [McManus, Meagan J.; Picard, Martin; Chen, Hsiao-Wen; Potluri, Prasanth; Leipzig, Jeremy; Towheed, Atif; Angelin, Alessia; Morrow, Ryan M.; Vermulst, Marc; Wallace, Douglas C.] Childrens Hosp Philadelphia, Ctr Mitochondria & Epigen Med, Colket Translat Res Bldg,Room 6060, Philadelphia, PA 19104 USA.
   [McManus, Meagan J.; Picard, Martin; Chen, Hsiao-Wen; Potluri, Prasanth; Leipzig, Jeremy; Towheed, Atif; Angelin, Alessia; Morrow, Ryan M.; Vermulst, Marc; Wallace, Douglas C.] Univ Penn, Colket Translat Res Bldg,Room 6060, Philadelphia, PA 19104 USA.
   [Picard, Martin] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY 10032 USA.
   [Picard, Martin] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
   [De Haas, Hans J.; Sengupta, Partho; Narula, Jagat] Mt Sinai Hosp, Dept Med, New York, NY 10029 USA.
   [Kauffman, Brett A.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA.
   [Wallace, Douglas C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Sengupta, Partho] West Virginia Univ, Sch Med, Div Cardiol, WVU Heart & Vasc Inst, Morgantown, WV 26506 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Pennsylvania; Columbia University; Columbia
   University; Icahn School of Medicine at Mount Sinai; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; University of Pennsylvania; West Virginia University
RP Wallace, DC (corresponding author), Childrens Hosp Philadelphia, Ctr Mitochondria & Epigen Med, Colket Translat Res Bldg,Room 6060, Philadelphia, PA 19104 USA.; Wallace, DC (corresponding author), Univ Penn, Colket Translat Res Bldg,Room 6060, Philadelphia, PA 19104 USA.; Wallace, DC (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
EM wallaced1@email.chop.edu
RI Sengupta, Partho/AAG-9508-2020; Kaufman, Brett/IUP-1225-2023; McManus,
   Meagan/F-7932-2018; Towheed, Atif/P-2326-2015
OI ANGELIN, Alessia/0000-0002-7115-5451; Towheed, Atif/0000-0003-4390-7844
FU NIH [5R01-NS021328-30, 1R01MH10859201A1, 1R01MN110185-01A1, RO1NS41850,
   R01OD010944-05]; DOD [PR150585]
FX This work was supported by NIH grants 5R01-NS021328-30,
   1R01MH10859201A1, 1R01MN110185-01A1, RO1NS41850, and R01OD010944-05 and
   DOD grant PR150585.
CR Acín-Pérez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Arbustini E, 1998, HEART, V80, P548, DOI 10.1136/hrt.80.6.548
   Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P19, DOI 10.1152/physiolgenomics.2001.6.1.19
   Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493
   Biering-Sorensen T, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005521
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890
   Burke MA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86898
   Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989
   Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012
   Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008
   Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909
   Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016
   Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109
   Duckles SP, 2006, MOL INTERV, V6, P26, DOI 10.1124/mi.6.1.6
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358
   Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015
   Glytsou C, 2016, CELL REP, V17, P3024, DOI 10.1016/j.celrep.2016.11.049
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Gray JJ, 2013, BRAIN RES, V1494, P28, DOI 10.1016/j.brainres.2012.12.001
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034
   Jang JY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-160
   Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109
   Ji YC, 2014, J HUM GENET, V59, P134, DOI 10.1038/jhg.2013.134
   Kim A, 2010, MAMM GENOME, V21, P534, DOI 10.1007/s00335-010-9299-x
   Kokoszka JE, 2016, BBA-BIOENERGETICS, V1857, P1203, DOI 10.1016/j.bbabio.2016.03.026
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   McManus MJ, 2014, MOL CELL NEUROSCI, V63, P13, DOI 10.1016/j.mcn.2014.09.002
   Mofarrahi M, 2013, AUTOPHAGY, V9, P1604, DOI 10.4161/auto.25955
   Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114
   Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652
   Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Narula N, 2011, JACC-CARDIOVASC IMAG, V4, P1, DOI 10.1016/j.jcmg.2010.06.018
   Navarro SJ, 2012, G3-GENES GENOM GENET, V2, P99, DOI 10.1534/g3.111.000778
   Norton M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004374
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   Picard M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7259
   Porter GA, 2011, PROG PEDIATR CARDIOL, V31, P75, DOI 10.1016/j.ppedcard.2011.02.002
   Ramonet D, 2013, CELL DEATH DIFFER, V20, P77, DOI 10.1038/cdd.2012.95
   Scialò F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x
   Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z
   van der Westhuizen FH, 2010, J INHERIT METAB DIS, V33, pS55, DOI 10.1007/s10545-009-9020-y
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Wallace DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0267
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
   Yadava N, 2002, J BIOL CHEM, V277, P21221, DOI 10.1074/jbc.M202016200
   Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104
   Zamora M, 2004, J BIOL CHEM, V279, P38415, DOI 10.1074/jbc.M404928200
   Zamora M, 2004, FEBS LETT, V563, P155, DOI 10.1016/S0014-5793(04)00293-5
   Zaragoza MV, 2011, EUR J HUM GENET, V19, P200, DOI 10.1038/ejhg.2010.169
   Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001
NR 72
TC 46
Z9 49
U1 1
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD JAN 8
PY 2019
VL 29
IS 1
BP 78
EP +
DI 10.1016/j.cmet.2018.08.002
PG 18
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA HG6KK
UT WOS:000455090100012
PM 30174309
OA Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Castagna, AE
   Addis, J
   McInnes, RR
   Clarke, JTR
   Ashby, P
   Blaser, S
   Robinson, BH
AF Castagna, Avril E.
   Addis, Jane
   McInnes, Roderick R.
   Clarke, Joe T. R.
   Ashby, Peter
   Blaser, Susan
   Robinson, Brian H.
TI Late onset Leigh syndrome and ataxia due to a T to C mutation at bp
   9,185 of mitochondrial DNA
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE Leigh syndrome; ataxia; mitochondrial DNA mutation
ID ATPASE 6 GENE; RESPIRATORY-CHAIN DEFECTS; CLINICAL-FEATURES; POINT
   MUTATION; MTDNA; TRANSITION; SYNTHASE; DISEASE
AB A T-to-C missense mutation at nucleotide position 9,185 in the protein-coding ATP6 gene of the mitochondrial genome was present at high heteroplasmy in members of a Canadian family with Leigh syndrome with predominant ataxia and peripheral neuropathy. This mutation results in the substitution of a proline residue for an evolutionary-conserved leucine at position of amino acid 220 near the carboxyl terminus of the mitochondrial protein. The index patient and brother, who had an identical clinical presentation, had > 90% mutant mtDNA in Cultured skin fibroblasts, lymphocytes, and whole blood. Their mother and a maternal uncle, symptomatic with a peripheral neuropathy alone, had 86% and 85% heteroplasmy, respectively. Symptomatic maternal cousins with early onset revealed 90% and 91% mutant mtDNA in all tissues analyzed. Studies of lymphoblasts from the asymptomatic maternal grandmother and eldest brother of the proband were heteroplasmic for Mutant mtDNA with 56% and 17%, respectively. Biochemical analysis demonstrated normal respiratory chain enzyme activity in muscle and fibroblasts, normal ATP synthesis, but reduced oligomycin-sensitive H(+)ATPase in cultured lymphoblast mitochondria. We propose that the 9,185T > C mtDNA Mutation is pathogenic even though the initial phenotype is mild and the biochemical phenotype not easily detectable. (c) 2007 Wiley-Liss, Inc.
C1 Hosp Sick Children, Metab Res Programme, Inst Res, Toronto, ON M5G 1X8, Canada.
   Hosp Sick Children, Dev Biol Programme, Inst Res, Toronto, ON M5G 1X8, Canada.
   Hosp Sick Children, Scarborough Gen Hosp, Toronto, ON M5G 1X8, Canada.
   Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada.
   Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada.
   Univ Toronto, Dept Biochem & Paediat, Toronto, ON, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; Hospital for Sick Children (SickKids); University of
   Toronto; Hospital for Sick Children (SickKids); Scarborough Hospital;
   University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; University Health Network Toronto; University of Toronto
RP Robinson, BH (corresponding author), Hosp Sick Children, Metab Res Programme, Inst Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM bhr@sickkids.ca
RI Robinson, B/LBH-2242-2024
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H
   BOURGERON T, 1992, BIOCHEM BIOPH RES CO, V186, P16, DOI 10.1016/S0006-291X(05)80769-7
   BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   DAS AM, 1990, AM J PHYSIOL, V259, pH1264, DOI 10.1152/ajpheart.1990.259.4.H1264
   DEMEIRLEIR L, 1995, PEDIATR NEUROL, V13, P242, DOI 10.1016/0887-8994(95)00184-H
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   KANEKO M, 1993, GENET RES, V61, P195, DOI 10.1017/S0016672300031360
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   MERANTE F, 1994, AM J HUM GENET, V55, P437
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   Merante F, 1996, Methods Mol Biol, V58, P3
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Ogilvie I, 1999, FEBS LETT, V453, P179, DOI 10.1016/S0014-5793(99)00605-5
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   ROBINSON BH, 1986, J CLIN INVEST, V77, P1422, DOI 10.1172/JCI112453
   ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027
   SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tatuch Yuriy, 1994, European Journal of Human Genetics, V2, P35
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
NR 28
TC 51
Z9 57
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD APR 15
PY 2007
VL 143A
IS 8
BP 808
EP 816
DI 10.1002/ajmg.a.31637
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 156PP
UT WOS:000245661800005
PM 17352390
DA 2024-11-01
ER

PT J
AU Buneeva, O
   Fedchenko, V
   Kopylov, A
   Medvedev, A
AF Buneeva, Olga
   Fedchenko, Valerii
   Kopylov, Arthur
   Medvedev, Alexei
TI Mitochondrial Dysfunction in Parkinson's Disease: Focus on Mitochondrial
   DNA
SO BIOMEDICINES
LA English
DT Review
DE Parkinson's disease; Parkinson's disease models; mitochondrial
   dysfunction; mitochondrial DNA; proteins encoded by mitochondrial genes;
   proteomics
ID COMPLEX-I DEFICIENCY; STOP-CODON MUTATION; OXIDATIVE DAMAGE;
   SUBSTANTIA-NIGRA; POINT MUTATIONS; INTRAMITOCHONDRIAL FIBERS;
   SEQUENCE-ANALYSIS; GLYCOSYLASE OGG1; SKELETAL-MUSCLE; RNA-POLYMERASE
AB Mitochondria, the energy stations of the cell, are the only extranuclear organelles, containing their own (mitochondrial) DNA (mtDNA) and the protein synthesizing machinery. The location of mtDNA in close proximity to the oxidative phosphorylation system of the inner mitochondrial membrane, the main source of reactive oxygen species (ROS), is an important factor responsible for its much higher mutation rate than nuclear DNA. Being more vulnerable to damage than nuclear DNA, mtDNA accumulates mutations, crucial for the development of mitochondrial dysfunction playing a key role in the pathogenesis of various diseases. Good evidence exists that some mtDNA mutations are associated with increased risk of Parkinson's disease (PD), the movement disorder resulted from the degenerative loss of dopaminergic neurons of substantia nigra. Although their direct impact on mitochondrial function/dysfunction needs further investigation, results of various studies performed using cells isolated from PD patients or their mitochondria (cybrids) suggest their functional importance. Studies involving mtDNA mutator mice also demonstrated the importance of mtDNA deletions, which could also originate from abnormalities induced by mutations in nuclear encoded proteins needed for mtDNA replication (e.g., polymerase gamma). However, proteomic studies revealed only a few mitochondrial proteins encoded by mtDNA which were downregulated in various PD models. This suggests nuclear suppression of the mitochondrial defects, which obviously involve cross-talk between nuclear and mitochondrial genomes for maintenance of mitochondrial functioning.
C1 [Buneeva, Olga; Fedchenko, Valerii; Kopylov, Arthur; Medvedev, Alexei] Inst Biomed Chem, 10 Pogodinskaya St, Moscow 119121, Russia.
C3 Russian Academy of Medical Sciences; Institute of Biomedical Chemistry
RP Medvedev, A (corresponding author), Inst Biomed Chem, 10 Pogodinskaya St, Moscow 119121, Russia.
EM olbuneeva@gmail.com; valfed38@yandex.ru; a.t.kopylov@gmail.com;
   professor57@yandex.ru
RI Kopylov, Arthur/E-3288-2012
OI Kopylov, Arthur/0000-0002-7199-372X
FU Russian Foundation for Basic Research [19-015-00073a]
FX This work performed within the framework of the Program for Basic
   Research of State Academies of Sciences for 2013-2020 was partially
   supported by the Russian Foundation for Basic Research (project
   no.19-015-00073a).
CR Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x
   Alexeyev M, 2020, MITOCHONDRIAL DNA A, V31, P45, DOI 10.1080/24701394.2020.1734586
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Aomi Y, 2001, BIOCHEM BIOPH RES CO, V280, P265, DOI 10.1006/bbrc.2000.4113
   Arduino Daniela M, 2015, Methods Mol Biol, V1265, P415, DOI 10.1007/978-1-4939-2288-8_31
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Buneeva O. A., 2011, Biomeditsinskaya Khimiya, V57, P246
   Buneeva O, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7080091
   Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Castegna A, 2015, PHYSIOL GENOMICS, V47, P299, DOI 10.1152/physiolgenomics.00096.2014
   Cavelier L, 2001, HEREDITAS, V135, P65, DOI 10.1111/j.1601-5223.2001.00065.x
   Chen C, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020038
   Chen DX, 2002, J NEUROCHEM, V81, P1273, DOI 10.1046/j.1471-4159.2002.00916.x
   Chen LJ, 2005, J PINEAL RES, V39, P34, DOI 10.1111/j.1600-079X.2005.00209.x
   Chin MH, 2008, J PROTEOME RES, V7, P666, DOI 10.1021/pr070546l
   Choi YS, 2011, MOL BIOSYST, V7, P1523, DOI 10.1039/c0mb00277a
   Collins AR, 2000, FREE RADICAL RES, V32, P333, DOI 10.1080/10715760000300331
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400
   Cui J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00595
   D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200
   D'Souza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102
   Dai Y, 2014, NEUROTOXICOL TERATOL, V46, P62, DOI 10.1016/j.ntt.2014.10.004
   Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484
   Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Deng JH, 2006, MOL CELL BIOL, V26, P1077, DOI 10.1128/MCB.26.3.1077-1086.2006
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Egensperger R, 1997, NEUROPATH APPL NEURO, V23, P315, DOI 10.1046/j.1365-2990.1997.4098040.x
   Esteves AR, 2010, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.005.2009
   Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x
   Esteves AR, 2010, NEUROBIOL DIS, V37, P723, DOI 10.1016/j.nbd.2009.12.011
   Esteves AR, 2009, ANTIOXID REDOX SIGN, V11, P439, DOI [10.1089/ars.2008.2247, 10.1089/ARS.2008.2247]
   Esteves ARF, 2008, MITOCHONDRION, V8, P219, DOI 10.1016/j.mito.2008.03.004
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Farge G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112770
   Fukae J, 2005, ACTA NEUROPATHOL, V109, P256, DOI 10.1007/s00401-004-0937-9
   Fusté JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   García-Lozano JR, 2002, EUR NEUROL, V48, P34, DOI 10.1159/000064955
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011080
   Goetz CG, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a008862
   Gonzalo R, 2005, FEBS LETT, V579, P6909, DOI 10.1016/j.febslet.2005.11.034
   Gray MW, 1998, NUCLEIC ACIDS RES, V26, P865, DOI 10.1093/nar/26.4.865
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343
   Gredilla R, 2010, NEUROBIOL AGING, V31, P993, DOI 10.1016/j.neurobiolaging.2008.07.004
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Gusdon AM, 2015, NEUROSCI LETT, V587, P98, DOI 10.1016/j.neulet.2014.12.005
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Han S, 2017, CELL CHEM BIOL, V24, P404, DOI 10.1016/j.chembiol.2017.02.002
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hauser DN, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0075-14.2015
   Hauser DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094646
   He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266
   Hebert SL, 2010, MECH AGEING DEV, V131, P451, DOI 10.1016/j.mad.2010.03.007
   Heinz S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45465
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Horowitz MP, 2010, J ALZHEIMERS DIS, V20, pS551, DOI 10.3233/JAD-2010-100354
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Houshmand M, 1997, J ASSIST REPROD GEN, V14, P223, DOI 10.1007/BF02766114
   Hsieh CL, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00406-18
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002
   Janetzky B, 1996, EUR NEUROL, V36, P149, DOI 10.1159/000117233
   Jiang S, 2019, EMBO REP, V20, DOI 10.15252/embr.201948101
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kadenbach B, 2015, MITOCHONDRION, V24, P64, DOI 10.1016/j.mito.2015.07.002
   Karthikkeyan G, 2020, ACS OMEGA, V5, P26611, DOI 10.1021/acsomega.0c03420
   Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197
   Keeney PM, 2009, EXP NEUROL, V220, P374, DOI 10.1016/j.expneurol.2009.09.025
   King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583
   Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LANGSTON JW, 1984, ACTA NEUROL SCAND, V70, P49
   Lapkouski M, 2015, NUCLEIC ACIDS RES, V43, P9065, DOI 10.1093/nar/gkv861
   Lauritzen KH, 2011, MECH AGEING DEV, V132, P424, DOI 10.1016/j.mad.2011.02.006
   Lauritzen KH, 2010, MOL CELL BIOL, V30, P1357, DOI 10.1128/MCB.01149-09
   LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6
   Lin XM, 2015, BBA-PROTEINS PROTEOM, V1854, P779, DOI 10.1016/j.bbapap.2015.01.007
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Mandavilli BS, 2000, BRAIN RES, V885, P45, DOI 10.1016/S0006-8993(00)02926-7
   Marchington DR, 2002, MOL HUM REPROD, V8, P1046, DOI 10.1093/molehr/8.11.1046
   MARET G, 1990, DRUG METAB REV, V22, P291, DOI 10.3109/03602539009041087
   Mayr-Wohlfart U, 1997, Eur J Med Res, V2, P111
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160
   Medvedev AE, 2017, BIOCHEMISTRY-MOSCOW+, V82, P330, DOI 10.1134/S0006297917030117
   Müller-Nedebock AC, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104495
   MYTILINEOU C, 1994, J NEURAL TRANSM-PARK, V8, P223, DOI 10.1007/BF02260943
   Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200
   Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637
   Obeso JA, 2017, MOVEMENT DISORD, V32, P1, DOI 10.1002/mds.26904
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   Passamonti M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65084-z
   Pilger A, 2006, INT ARCH OCC ENV HEA, V80, P1, DOI 10.1007/s00420-006-0106-7
   Podlesniy P, 2019, EBIOMEDICINE, V48, P554, DOI 10.1016/j.ebiom.2019.09.015
   Posse V, 2017, J BIOL CHEM, V292, P2637, DOI 10.1074/jbc.M116.751008
   Qin JS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18202-4
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082
   Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392
   Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014
   Santos RX, 2013, ANTIOXID REDOX SIGN, V18, P2444, DOI 10.1089/ars.2012.5039
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043
   Song WH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981867
   Sousa JS, 2018, SUBCELL BIOCHEM, V87, P167, DOI 10.1007/978-981-10-7757-9_7
   Spinazzola A, 2009, ADV EXP MED BIOL, V652, P69, DOI 10.1007/978-90-481-2813-6_6
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Swerdlow RH, 2001, EXP NEUROL, V169, P479, DOI 10.1006/exnr.2001.7674
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167
   Swerdlow RH, 2012, ANTIOXID REDOX SIGN, V16, P950, DOI 10.1089/ars.2011.3948
   Taravari A, 2014, BRATISL MED J, V115, P7, DOI 10.4149/BLL_2014_002
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trinkle-Mulcahy Laura, 2019, F1000Res, V8, DOI 10.12688/f1000research.16903.1
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0404-6
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   Wilkins HM, 2014, REDOX BIOL, V2, P619, DOI 10.1016/j.redox.2014.03.006
   Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008
   Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamaguchi H, 2006, CELL DEATH DIFFER, V13, P551, DOI 10.1038/sj.cdd.4401788
   Yasukawa T, 2018, J BIOCHEM, V164, P183, DOI 10.1093/jb/mvy058
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Zhang J, 2002, PARKINSONISM RELAT D, V8, P165, DOI 10.1016/S1353-8020(01)00041-4
   Zhang X, 2010, J PROTEOME RES, V9, P1496, DOI 10.1021/pr901024z
NR 173
TC 32
Z9 37
U1 1
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD DEC
PY 2020
VL 8
IS 12
AR 591
DI 10.3390/biomedicines8120591
PG 22
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA PK1FI
UT WOS:000602198600001
PM 33321831
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Safdar, A
   Khrapko, K
   Flynn, JM
   Saleem, A
   De Lisio, M
   Johnston, APW
   Kratysberg, Y
   Samjoo, IA
   Kitaoka, Y
   Ogborn, DI
   Little, JP
   Raha, S
   Parise, G
   Akhtar, M
   Hettinga, BP
   Rowe, GC
   Arany, Z
   Prolla, TA
   Tarnopolsky, MA
AF Safdar, Adeel
   Khrapko, Konstantin
   Flynn, James M.
   Saleem, Ayesha
   De Lisio, Michael
   Johnston, Adam P. W.
   Kratysberg, Yevgenya
   Samjoo, Imtiaz A.
   Kitaoka, Yu
   Ogborn, Daniel I.
   Little, Jonathan P.
   Raha, Sandeep
   Parise, Gianni
   Akhtar, Mahmood
   Hettinga, Bart P.
   Rowe, Glenn C.
   Arany, Zoltan
   Prolla, Tomas A.
   Tarnopolsky, Mark A.
TI RETRACTED: Exercise-induced mitochondrial p53 repairs mtDNA mutations in
   mutator mice (Retracted Article)
SO SKELETAL MUSCLE
LA English
DT Article; Retracted Publication
DE Skeletal muscle; Satellite cells; Endurance exercise; p53; Mitochondrial
   DNA mutations; Mutator mouse; Oxidative stress; Telomere; Apoptosis;
   Senescence
ID ENDURANCE EXERCISE; TELOMERE LENGTH; PHYSICAL-ACTIVITY; OXIDATIVE
   STRESS; SKELETAL-MUSCLE; DNA MUTATIONS; PCR; ASSOCIATION; MORTALITY;
   CATALASE
AB Background: Human genetic disorders and transgenic mouse models have shown that mitochondrial DNA (mtDNA) mutations and telomere dysfunction instigate the aging process. Epidemiologically, exercise is associated with greater life expectancy and reduced risk of chronic diseases. While the beneficial effects of exercise are well established, the molecular mechanisms instigating these observations remain unclear.
   Results: Endurance exercise reduces mtDNA mutation burden, alleviates multisystem pathology, and increases lifespan of the mutator mice, with proofreading deficient mitochondrial polymerase gamma (POLG1). We report evidence for a POLG1-independent mtDNA repair pathway mediated by exercise, a surprising notion as POLG1 is canonically considered to be the sole mtDNA repair enzyme. Here, we show that the tumor suppressor protein p53 translocates to mitochondria and facilitates mtDNA mutation repair and mitochondrial biogenesis in response to endurance exercise. Indeed, in mutator mice with muscle-specific deletion of p53, exercise failed to prevent mtDNA mutations, induce mitochondrial biogenesis, preserve mitochondrial morphology, reverse sarcopenia, or mitigate premature mortality.
   Conclusions: Our data establish a new role for p53 in exercise-mediated maintenance of the mtDNA genome and present mitochondrially targeted p53 as a novel therapeutic modality for diseases of mitochondrial etiology.
C1 [Safdar, Adeel; Saleem, Ayesha; Kitaoka, Yu; Raha, Sandeep; Hettinga, Bart P.; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   [Safdar, Adeel; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada.
   [Safdar, Adeel; De Lisio, Michael; Johnston, Adam P. W.; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON L8N 3Z5, Canada.
   [Samjoo, Imtiaz A.] McMaster Univ, Dept Med Sci, Hamilton, ON L8N 3Z5, Canada.
   [Parise, Gianni] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8N 3Z5, Canada.
   [Khrapko, Konstantin; Kratysberg, Yevgenya] Northeastern Univ, Boston, MA 02115 USA.
   [Flynn, James M.] Buck Inst Res Aging, Novato, CA 94945 USA.
   [Little, Jonathan P.] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC V1V 1V7, Canada.
   [Rowe, Glenn C.] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA.
   [Arany, Zoltan] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.
C3 McMaster University; McMaster University; McMaster University; McMaster
   University; McMaster University; Northeastern University; Buck Institute
   for Research on Aging; University of British Columbia; University of
   British Columbia Okanagan; University of Alabama System; University of
   Alabama Birmingham; University of Pennsylvania; University of Wisconsin
   System; University of Wisconsin Madison; University of Wisconsin System;
   University of Wisconsin Madison
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.; Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
RI Saleem, Ayesha/J-6685-2019; Little, Jonathan/T-4076-2019; Khrapko,
   Konstantin/A-3244-2009; Raha, Sandeep/AAF-3655-2020; Rowe,
   Glenn/N-5314-2019
OI khrapko, konstantin/0000-0002-9250-8033; Raha,
   Sandeep/0000-0001-7307-3292; Little, Jonathan/0000-0002-9796-2008;
   Saleem, Ayesha/0000-0003-2146-5379; Safdar, Adeel/0000-0003-2469-0467
FU Canadian Institutes of Health Research (CIHR); CIHR; American Federation
   for Aging Research; Ellison Medical Foundation (EMF); Natural Sciences
   and Engineering Research Council of Canada; United Mitochondrial Disease
   Foundation; NIH [AG019787]; EMF
FX We like to acknowledge the late Mrs. Suzanne Southward (McMaster
   University) for assisting in enzyme assays and Dr. William C. Copeland
   (NIH) for his kind donation of POLG1 antibody. This work was supported
   by the Canadian Institutes of Health Research (CIHR) grant and a kind
   donation from Mr. Warren Lammert and family to M.A.T. A. Safdar was
   funded by Banting Fellowship (CIHR) and American Federation for Aging
   Research and Ellison Medical Foundation (EMF) Fellowship. A. Saleem is
   funded by Natural Sciences and Engineering Research Council of Canada
   postdoctoral fellowship. K.K. was supported by the United Mitochondrial
   Disease Foundation, the NIH (AG019787) and the EMF Senior Scholarship.
   The authors declare no competing and financial interests. T.A.P. was
   awarded a US patent 7,126,040 for the Polg<SUP>D257A</SUP> mouse model.
   T.A.P. is a partial owner of LifeGen Technologies, specializing in
   nutrigenomics, as well as a Scientific Advisory Board member for Nu Skin
   Enterprises. M.A.T. is the founder, president, and CEO of Exerkine
   Corporation and a member of its scientific advisory board.
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103
   Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106
   Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122
   Buchner DM, 2009, CLIN GERIATR MED, V25, P661, DOI 10.1016/j.cger.2009.08.002
   Callicott RJ, 2006, COMPARATIVE MED, V56, P17
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Elly L, 2009, METHOD ENZYMOL, V456, P169, DOI 10.1016/S0076-6879(08)04409-1
   Ema H, 2005, CURR PROTOC IMMUNOL
   HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281
   HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421
   JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778
   Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Saleem A, 2013, J PHYSIOL-LONDON, V591, P3625, DOI 10.1113/jphysiol.2013.252791
   Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070
   Sanz C, 2010, DIABETES METAB, V36, P346, DOI 10.1016/j.diabet.2010.06.001
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wolf SA, 2011, BRAIN BEHAV IMMUN
NR 43
TC 53
Z9 59
U1 0
U2 19
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2044-5040
J9 SKELET MUSCLE
JI Skeletal Muscle
PD JAN 31
PY 2016
VL 6
AR 7
DI 10.1186/s13395-016-0075-9
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DC5BW
UT WOS:000369236600001
PM 26834962
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Zsurka, G
   Hampel, KG
   Nelson, I
   Jardel, C
   Mirandola, SR
   Sassen, R
   Kornblum, C
   Marcorelles, P
   Lavoué, S
   Lombès, A
   Kunz, WS
AF Zsurka, G.
   Hampel, K. G.
   Nelson, I.
   Jardel, C.
   Mirandola, S. R.
   Sassen, R.
   Kornblum, C.
   Marcorelles, P.
   Lavoue, S.
   Lombes, A.
   Kunz, W. S.
TI Severe epilepsy as the major symptom of new mutations in the
   mitochondrial tRNA<SUP>Phe</SUP> gene
SO NEUROLOGY
LA English
DT Article
ID DNA; MERRF; MELAS
AB Objective: To present 2 families with maternally inherited severe epilepsy as the main symptom of mitochondrial disease due to point mutations at position 616 in the mitochondrial tRNAPhe (MTTF) gene.
   Methods: Histologic stainings were performed on skeletal muscle slices from the 2 index patients. Oxidative phosphorylation activity was measured by oxygraphic and spectrophotometric methods. The patients' complete mitochondrial DNA (mtDNA) and the relevant mtDNA region in maternal relatives were sequenced.
   Results: Muscle histology showed only decreased overall COX staining, while a combined respiratory chain defect, most severely affecting complex IV, was noted in both patients' skeletal muscle. Sequencing of the mtDNA revealed in both patients a mutation at position 616 in the MT-TF gene (T > C or T > G). These mutations disrupt a base pair in the anticodon stem at a highly conserved position. They were apparently homoplasmic in both patients, and had different heteroplasmy levels in the investigated maternal relatives.
   Conclusions: Deleterious mutations in the mitochondrial tRNAPhe may solely manifest with epilepsy when segregating to homoplasmy. They may be overlooked in the absence of lactate accumulation and typical mosaic mitochondrial defects in muscle. Neurology (R) 2010; 74: 507-512
C1 [Kunz, W. S.] Univ Bonn, Dept Epileptol, Med Ctr, D-53105 Bonn, Germany.
   [Zsurka, G.; Hampel, K. G.; Mirandola, S. R.; Sassen, R.; Kunz, W. S.] Univ Bonn, Life & Brain Ctr, D-53105 Bonn, Germany.
   [Kornblum, C.] Univ Bonn, Dept Neurol, D-5300 Bonn, Germany.
   [Nelson, I.; Jardel, C.; Lombes, A.] INSERM, UMRS 975, Paris, France.
   [Lombes, A.] Univ Pierre & Marie Curie UPMC Paris 6, Paris, France.
   [Jardel, C.; Lombes, A.] Hop La Pitie Salpetriere, AP HP, Dept Metab Biochem, Paris, France.
   [Marcorelles, P.] Morvan Hosp, Dept Pathol, Brest, France.
   [Lavoue, S.] CHU Rennes, Intens Care Unit, Rennes, France.
C3 University of Bonn; University of Bonn; University of Bonn; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Sorbonne
   Universite; Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; CHU Brest; CHU
   Rennes; Universite de Rennes
RP Kunz, WS (corresponding author), Univ Bonn, Dept Epileptol, Med Ctr, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM wolfram.kunz@ukb.uni-bonn.de
RI Lombes, Anne/G-4684-2014; Kornblum, Cornelia/IUM-4180-2023; Kunz,
   Wolfram/K-1232-2019
OI nelson, isabelle/0000-0001-6390-622X; Hampel, Kevin/0000-0003-3582-060X;
   Zsurka, Gabor/0000-0002-6379-849X; Kunz, Wolfram/0000-0003-1113-3493
FU Deutsche Forschungsgemeinschaft [KU-911/15-1, TR3-A11, TR3-D12]; BMBF
   [01GZ0704, 01GM0868]; AFM (Association Francaise contre les Myopathies)
FX Study funding: Supported by the Deutsche Forschungsgemeinschaft
   (KU-911/15-1, TR3-A11 and TR3-D12) and the BMBF (01GZ0704, 01GM0868) to
   W.S.K. and by the AFM (Association Francaise contre les Myopathies) to
   I.N. and A.L.
CR Dinour D, 2004, CLIN NEPHROL, V62, P149
   Dubowitz V., 1973, MUSCLE BIOPSY MODERN
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HIRANO M, 2008, EPILEPSY COMPREHENSI, V3, P2621
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Kudin AP, 2009, EXP NEUROL, V218, P326, DOI 10.1016/j.expneurol.2009.02.014
   Kunz WS, 2000, J BIOL CHEM, V275, P27741
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   TEREIRA L, 2009, AM J HUM GENET, V84, P628
   Wiedemann FR, 2000, ANAL BIOCHEM, V279, P55, DOI 10.1006/abio.1999.4434
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
   Zsurka G, 2007, AM J HUM GENET, V80, P298, DOI 10.1086/511282
NR 21
TC 36
Z9 40
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD FEB 9
PY 2010
VL 74
IS 6
BP 507
EP 512
DI 10.1212/WNL.0b013e3181cef7ab
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 553PF
UT WOS:000274378600012
PM 20142618
DA 2024-11-01
ER

PT J
AU Murakami, T
   Ueba, Y
   Shinoto, Y
   Koga, Y
   Kaneda, D
   Hatoko, T
   Kato, T
   Yonemitsu, S
   Murol, S
   Okil, S
AF Murakami, Takaaki
   Ueba, Yoko
   Shinoto, Yuya
   Koga, Yasutoshi
   Kaneda, Daita
   Hatoko, Tomonobu
   Kato, Tomoko
   Yonemitsu, Shin
   Murol, Seiji
   Okil, Shogo
TI Successful Glycemic Control Decreases the Elevated Serum FGF21 Level
   without Affecting Normal Serum GDF15 Levels in a Patient with
   Mitochondrial Diabetes
SO TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE biomarker; FGF21; GDF15; GLP-1 receptor agonist; mitochondrial diabetes
   mellitus
ID GROWTH-FACTOR 21; PANCREATIC BETA-CELLS; DISEASE; RESISTANCE; BIOMARKER;
   MELLITUS; MUTATION; JAPANESE; DAMAGE
AB Mitochondrial diabetes mellitus is a subtype of diabetes linked to mutations in mitochondrial DNA. In patients with mitochondrial diabetes mellitus, the effect of glycemic control on the serum concentrations of fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) has not been evaluated. FGF21 and GDF15 have been reported to be useful biomarkers for the diagnosis and severity assessment of mitochondrial diseases like mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Recent studies have shown FGF21 acts in an endocrine fashion to regulate glucose and lipid metabolism in type 2 diabetes mellitus, while the exact biological functions of GDF15 remain unknown. Although mitochondrial diabetes mellitus is commonly found in cases with mitochondrial diseases, the comparison of FGF21 and GDF15 levels between those with and without diabetes has not been performed. Here, we report a 24-year-old woman with mitochondrial diabetes mellitus, who showed a high level of serum FGF21, but not serum GDF15, at diagnosis. In our case, liraglutide, a glucagon-like peptide-1 receptor agonist, added to insulin glargine was effective for her glycemic control and showed no adverse effects, including gastrointestinal symptoms and hypoglycemia, during a 14-week observation. The successful glycemic control caused a decrease in the FGF21 level, without affecting the GDF15 level. Thus, we should consider patients' glycemic control levels in using FGF21 values for the diagnosis of mitochondrial diseases. In addition, sustained GDF15 levels during glycemic treatment in our case suggest the usefulness of GDF15 as a marker for clinical severity of muscle-manifested mitochondrial diseases.
C1 [Murakami, Takaaki; Ueba, Yoko; Hatoko, Tomonobu; Kato, Tomoko; Yonemitsu, Shin; Murol, Seiji; Okil, Shogo] Osaka Red Cross Hosp, Dept Endocrinol & Diabet, Osaka, Osaka 5430027, Japan.
   [Shinoto, Yuya] Osaka Red Cross Hosp, Dept Neurol, Osaka, Osaka 5430027, Japan.
   [Koga, Yasutoshi] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 830, Japan.
   [Kaneda, Daita] Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo 173, Japan.
   [Kaneda, Daita] Inst Gerontol, Tokyo, Japan.
C3 Osaka Red Cross Hospital; Osaka Red Cross Hospital; Kurume University;
   Tokyo Metropolitan Institute of Gerontology
RP Murakami, T (corresponding author), Osaka Red Cross Hosp, Dept Endocrinol & Diabet, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka, Osaka 5430027, Japan.
EM t.murakami@osaka-med.jrc.or.jp
RI Murakami, Takaaki/ABH-6301-2020
OI Koga, Yasutoshi/0000-0002-6664-1295
CR Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684
   Chen C, 2011, DIABETES CARE, V34, P2113, DOI 10.2337/dc11-0294
   Ciregia F, 2015, MOL BIOSYST, V11, P1696, DOI 10.1039/c5mb00022j
   Fan R, 2010, DIABETES OBES METAB, V12, P815, DOI 10.1111/j.1463-1326.2010.01238.x
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Iglesias P, 2012, EUR J ENDOCRINOL, V167, P301, DOI 10.1530/EJE-12-0357
   Koene S, 2014, NEUROLOGY, V83, P125, DOI 10.1212/WNL.0000000000000578
   Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Mukai E, 2011, DIABETES, V60, P218, DOI 10.2337/db10-0021
   Murakami T, 2016, TOHOKU J EXP MED, V238, P311, DOI 10.1620/tjem.238.311
   Ogata M, 2014, BIOCHEM BIOPH RES CO, V447, P133, DOI 10.1016/j.bbrc.2014.03.143
   Samson SL, 2011, DIABETOLOGIA, V54, P3093, DOI 10.1007/s00125-011-2317-z
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Sun F, 2012, EXP DIABETES RES, V2012, DOI DOI 10.1155/2012/230624
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Xiao Y, 2012, J CLIN ENDOCR METAB, V97, pE54, DOI 10.1210/jc.2011-1930
   Yang ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026359
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 21
TC 13
Z9 15
U1 0
U2 10
PU TOHOKU UNIV MEDICAL PRESS
PI SENDAI
PA 2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN
SN 0040-8727
EI 1349-3329
J9 TOHOKU J EXP MED
JI Tohoku J. Exp. Med.
PD JUN
PY 2016
VL 239
IS 2
BP 89
EP 94
DI 10.1620/tjem.239.89
PG 6
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA DO9IW
UT WOS:000378100900001
PM 27212224
OA gold
DA 2024-11-01
ER

PT J
AU Valente, L
   Piga, D
   Lamantea, E
   Carrara, F
   Uziel, G
   Cudia, P
   Zani, A
   Farina, L
   Morandi, L
   Mora, M
   Spinazzola, A
   Zeviani, M
   Tiranti, V
AF Valente, Lucia
   Piga, Daniela
   Lamantea, Eleonora
   Carrara, Franco
   Uziel, Graziella
   Cudia, Paola
   Zani, Anna
   Farina, Laura
   Morandi, Lucia
   Mora, Marina
   Spinazzola, Antonella
   Zeviani, Massimo
   Tiranti, Valeria
TI Identification of novel mutations in five patients with mitochondrial
   encephalomyopathy
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT International Symposium on Mitchondrial Physiology and Pathology
CY JUN, 2008
CL Bari, ITALY
DE Mitochondrial DNA; Respiratory chain complex deficiency; mtDNA Sequence
   analysis; mtDNA mutation
ID CYTOCHROME-C-OXIDASE; COMPLEX-I DEFICIENCY; MTDNA POINT MUTATION;
   NONSENSE MUTATION; SPORADIC PATIENT; SKELETAL-MUSCLE; TRNA(TRP) GENE;
   DNA MUTATION; SUBUNIT-I; EXERCISE INTOLERANCE
AB MELAS, MERRF, LHON and NARP, are well-established mitochondrial syndromes associated with specific point mutations of mitochondrial DNA (mtDNA). However, these recurrent mtDNA mutations account for only a minority of mitochondrial disease cases. To evaluate the impact of novel mtDNA mutations, we performed mtDNA sequence analysis in muscle and other tissues of 240 patients with different mitochondrial neuromuscular syndromes. We identified a total of 33 subjects with novel, private or uncommon mutations. Among these, five novel mutations were found in both paediatric and adult cases. We here report on the clinical description of these patients, as well as the biochemical and molecular genetic characterization of the corresponding mutations. Patients 1 and 2 showed changes in ND genes, patient 3 carried a heteroplasmic deletion in the COI gene, patients 4 and 5 carried heteroplasmic mutations in tRNA(Trp) and tRNA(Phe), respectively. Altogether, these data indicate that mtDNA analysis must become part of the routine screening for mitochondrial disorders. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Valente, Lucia; Piga, Daniela; Lamantea, Eleonora; Carrara, Franco; Zani, Anna; Spinazzola, Antonella; Zeviani, Massimo; Tiranti, Valeria] IRCCS, Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, I-20126 Milan, Italy.
   [Uziel, Graziella] IRCCS, Fdn Neurol Inst C Besta, Unit Child Neurol, I-20126 Milan, Italy.
   [Cudia, Paola; Morandi, Lucia; Mora, Marina] IRCCS, Fdn Neurol Inst C Besta, Unit Neuromuscular Dis, I-20126 Milan, Italy.
   [Farina, Laura] IRCCS, Fdn Neurol Inst C Besta, Unit Neuroradiol, I-20126 Milan, Italy.
RP Tiranti, V (corresponding author), IRCCS, Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, Via Temolo 4, I-20126 Milan, Italy.
EM tiranti@istituto-besta.it
RI Zeviani, Massimo/K-2891-2014; Cudia, Paola/AAA-3179-2021; Pane,
   Marika/K-1818-2017; Spinazzola, Antonella/P-5298-2017; Mora,
   Marina/J-2883-2018; Tiranti, Valeria/J-8233-2016; Lamantea,
   Eleonora/J-8339-2016
OI Spinazzola, Antonella/0000-0003-4242-8091; Mora,
   Marina/0000-0002-5765-2320; Tiranti, Valeria/0000-0002-3584-7338;
   Zeviani, Massimo/0000-0002-9067-5508; Lamantea,
   Eleonora/0000-0001-5090-6028
FU Telethon [GGP07019] Funding Source: Medline
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Chinnery PF, 1997, ANN NEUROL, V41, P408, DOI 10.1002/ana.410410319
   Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Darin N, 2006, NEUROMUSCULAR DISORD, V16, P504, DOI 10.1016/j.nmd.2006.05.010
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fetoni V, 2004, NEUROMUSCULAR DISORD, V14, P723, DOI 10.1016/j.nmd.2004.07.002
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Lucioli S, 2006, NEUROGENETICS, V7, P51, DOI 10.1007/s10048-005-0015-z
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Munaro M, 1997, HUM MOL GENET, V6, P221, DOI 10.1093/hmg/6.2.221
   Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Spinazzola A, 2004, NEUROMUSCULAR DISORD, V14, P815, DOI 10.1016/j.nmd.2004.09.002
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   TIRANTI V, 1995, HUM MOL GENET, V4, P2017, DOI 10.1093/hmg/4.11.2017
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Uziel G, 2000, NEUROMUSCULAR DISORD, V10, P415, DOI 10.1016/S0960-8966(99)00115-7
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Weber K, 1997, AM J HUM GENET, V60, P373
   Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 54
TC 75
Z9 83
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD MAY
PY 2009
VL 1787
IS 5
SI SI
BP 491
EP 501
DI 10.1016/j.bbabio.2008.10.001
PG 11
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics
GA 451MX
UT WOS:000266475400025
PM 18977334
OA Bronze
DA 2024-11-01
ER

PT J
AU Smigrodzki, R
   Parks, J
   Parker, WD
AF Smigrodzki, R
   Parks, J
   Parker, WD
TI High frequency of mitochondrial complex I mutations in Parkinson's
   disease and aging
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE Parkinson's disease; mitochondrial DNA mutations; complex I deficiency
ID DNA MISMATCH CORRECTION; METHYL-DIRECTED REPAIR; TRANSFER-RNA GENES;
   ALZHEIMERS-DISEASE; RESPIRATORY-CHAIN; SKELETAL-MUSCLE; POINT MUTATIONS;
   SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; OVERLAP SYNDROME
AB Idiopathic Parkinson's disease (PD) involves a systemic loss of activity of complex I of the mitochondrial electron transport chain. This biochemical lesion plays a key pathogenic role. Transfer of PD mitochondrial DNA recapitulates this loss of activity and several other pathogenic features of PD suggesting that this lesion may arise, at least in part, from mitochondrial DNA. We investigated this possibility by an extensive clonal sequencing of the seven mitochondrial genes encoding complex I subunits in PD and age-matched control frontal cortex. Each gene was completely sequenced an average of 94.4 times for each subject. Aminoacid-changing mutations were found at the frequency of 59.3 per million bases in both PD and controls, corresponding to approximately 32% of the mitochondrial genomes in the average sample having at least one mutation in a complex I gene. Individual low frequency mutations had an abundance of 1-10%. Significant interindividual variation in mutation frequency was observed. Several aminoacid-changing mutations were identified and multiple PD brains but not in controls. Genetic algorithm analysis detected areas in ND genes with a higher mutation frequency in PD that allowed differentiation of PD from controls. Total mutational burden due to low-abundance heteroplasmy is high and may play a role in human disease. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA.
C3 University of Virginia
RP Univ Virginia, Dept Neurol, BNG1370,Res Lane, Charlottesville, VA 22908 USA.
EM dp8m@virginia.edu
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDERSON JJ, 1993, J NEUROL NEUROSUR PS, V56, P477, DOI 10.1136/jnnp.56.5.477
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Bhagwat AS, 2002, MOL MICROBIOL, V44, P1421, DOI 10.1046/j.1365-2958.2002.02989.x
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   DOHET C, 1986, P NATL ACAD SCI USA, V83, P3395, DOI 10.1073/pnas.83.10.3395
   Fang WH, 1997, J BIOL CHEM, V272, P22714, DOI 10.1074/jbc.272.36.22714
   Gahan ME, 2001, J CLIN VIROL, V22, P241, DOI 10.1016/S1386-6532(01)00195-0
   García-Lozano JR, 2002, EUR NEUROL, V48, P34, DOI 10.1159/000064955
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Hattori N, 1998, GENOMICS, V49, P52, DOI 10.1006/geno.1997.5192
   Hirano M, 1997, P NATL ACAD SCI USA, V94, P14894, DOI 10.1073/pnas.94.26.14894
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935
   JENSEN MA, 1993, PCR METH APPL, V3, P186
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Kirchner SC, 2000, NEUROTOXICOLOGY, V21, P441
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   Kösel S, 2000, NEUROGENETICS, V2, P227
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   MODRICH P, 1987, ANNU REV BIOCHEM, V56, P435, DOI 10.1146/annurev.biochem.56.1.435
   MODRICH P, 1989, J BIOL CHEM, V264, P6597
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V176, P938, DOI 10.1016/S0006-291X(05)80276-1
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   PARKER WD, 1994, NEUROLOGY, V44, P1086, DOI 10.1212/WNL.44.6.1086
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Parks J. K., 1999, Society for Neuroscience Abstracts, V25, P1337
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Pulkes T, 2000, ANN NEUROL, V47, P841
   REICHMANN H, 1994, EUR NEUROL, V34, P263, DOI 10.1159/000117053
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   ROSS OA, IN PRESS EXP GERONTO
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ruano G, 1992, PCR Methods Appl, V2, P112
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Sheehan JP, 1997, J NEUROCHEM, V68, P1221
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Shults CW, 1998, MOV DISORD S2, V13, P217
   SIMON D, 2003, NEUROLOGY S
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Simon DK, 2001, GENOMICS, V73, P113, DOI 10.1006/geno.2001.6515
   Smith MA, 1998, J HISTOCHEM CYTOCHEM, V46, P731, DOI 10.1177/002215549804600605
   Suter M, 1999, BIOCHEMISTRY-US, V38, P459, DOI 10.1021/bi9811922
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Tanaka M, 2002, J NEUROSCI RES, V70, P347, DOI 10.1002/jnr.10444
   Tanaka Masashi, 2002, Journal of Neurology, V249, P11
   Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   Trimmer P. A., 1999, Society for Neuroscience Abstracts, V25, P1336
   Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333
   TRIMMER PA, IN PRESS J NEUROCHEM
   VIVESBAUZA C, 1908, BIOCHEM BIOPH RES CO, V290, P1593
   Wallace D C., 1997, The Molecular and Genetic Basis of Neurological Disease, P237
   Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900
   Wooten GF, 1997, ANN NEUROL, V41, P265, DOI 10.1002/ana.410410218
   Xia X, 2002, MOL BIOL EVOL, V19, P58, DOI 10.1093/oxfordjournals.molbev.a003982
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Zhang J, 2002, PARKINSONISM RELAT D, V8, P165, DOI 10.1016/S1353-8020(01)00041-4
NR 88
TC 123
Z9 136
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0197-4580
EI 1558-1497
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD NOV-DEC
PY 2004
VL 25
IS 10
BP 1273
EP 1281
DI 10.1016/j.neurobiolaging.2004.02.020
PG 9
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA 864UY
UT WOS:000224659600002
PM 15465623
DA 2024-11-01
ER

PT J
AU Mani, S
   Rao, SN
   Kumar, MVK
AF Mani, Shalini
   Rao, S. Narasimha
   Kumar, M. V. Kranthi
TI Genetic heterogeneity of mitochondrial genome in thiamine deficient
   Leigh syndrome patients
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Leigh syndrome; Thiamine deficiency; Mitochondrial genome; Complex I;
   Complex IV
ID HEREDITARY OPTIC NEUROPATHY; CYTOCHROME-C-OXIDASE; SEQUENCE-ANALYSIS;
   COMPLEX-I; PHYLOGENETIC ANALYSIS; PARKINSONS-DISEASE;
   MULTIPLE-SCLEROSIS; CHINESE FAMILIES; SKELETAL-MUSCLE; MTDNA MUTATIONS
AB In our previously published study, we cared for 165 thiamine deficient Leigh syndrome (LS) patients who presented in acute life threatening conditions with severe neurological abnormalities. However the molecular basis for this atypical phenotype was not explored. This study is an effort to undermine the possible molecular defects in mitochondria of those patients and put-forth an explanation towards this clinical presentation.
   Protein coding genes of mitochondrial (mt) DNA were sequenced in total 165 LS patients and 94 age matched controls. To understand their pathogenic significance, nucleotide variations were also studied using various insilico tools. Histochemical and electron microscopic analysis was also done in tissue samples obtained from 23 patients.
   We observed a very high level of genetic heterogeneity across the mt DNA of all these patients. In the concordance of published literature we also observed a large number of variations in ND5 gene (hot spot for LS). We also observed a total 13 nucleotide variations across COX genes, which is otherwise not common in LS. As per insilico analysis, many of these variations were suggested to be pathogenic. Histochemical and electron microscopic studies also suggested the defects in the mitochondria of these patients.
   As these patients were thiamine deficient, hence we propose that genetic defects and thiamine deficiency may together severely affect the ATP level of these patients, leading to acute and life threatening clinical presentation. Present study has opened up many avenues for further research towards understanding the genetic basis and possible role of thiamine deficiency in LS patients.
C1 [Mani, Shalini] Jaypee Inst Informat Technol, Ctr Emerging Dis, Dept Biotechnol, Noida 201301, India.
   [Mani, Shalini; Kumar, M. V. Kranthi] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.
   [Rao, S. Narasimha] Niloufer Hosp Women & Children, Govt Inst Child Hlth, Red Hills, Hyderabad, India.
C3 Jaypee Institute of Information Technology (JIIT); Council of Scientific
   & Industrial Research (CSIR) - India; CSIR - Centre for Cellular &
   Molecular Biology (CCMB)
RP Mani, S (corresponding author), Jaypee Inst Informat Technol, Ctr Emerging Dis, Dept Biotechnol, Noida 201301, India.
EM shalini.mani@jiit.ac.in
OI Mani, Shalini/0000-0003-2500-6962
FU CSIR, Govt of India; CCMB Hyderabad
FX This work was supported by CSIR, Govt of India and CCMB Hyderabad.
CR Andalib S, 2017, REV NEUROL-FRANCE, V173, P164, DOI 10.1016/j.neurol.2017.02.002
   Andalib S, 2017, EXPERT REV MOL MED, V19, DOI 10.1017/erm.2017.5
   Andalib S, 2016, ACTA NEUROL BELG, V116, P439, DOI 10.1007/s13760-016-0675-5
   Andalib S, 2015, J NEUROL SCI, V356, P55, DOI 10.1016/j.jns.2015.04.050
   Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y
   Bi R, 2012, MOL VIS, V18, P3087
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   BUTTERWORTH RF, 1989, ALCOHOL ALCOHOLISM, V24, P271, DOI 10.1093/oxfordjournals.alcalc.a044913
   Chi CS, 2015, PEDIATR NEONATOL, V56, P7, DOI 10.1016/j.pedneo.2014.03.009
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   Di Rocco M, 2000, Eur J Paediatr Neurol, V4, P115, DOI 10.1053/ejpn.2000.0278
   Dombi E, 2016, NEUROLOGY, V86, P1921, DOI 10.1212/WNL.0000000000002688
   Emperador S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00061
   Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1
   Finnila Saara, 2001, Mutation Research, V458, P31, DOI 10.1016/S1383-5726(01)00012-7
   GENGE A, 1995, NEUROMUSCULAR DISORD, V5, P139, DOI 10.1016/0960-8966(94)00039-C
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   HAYAKAWA M, 1993, MOL CELL BIOCHEM, V119, P95, DOI 10.1007/BF00926859
   Horvath J, 2002, J INHERIT METAB DIS, V25, P323, DOI 10.1023/A:1016518811940
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529
   Imanishi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023401
   Janssen GMC, 2006, EXP CLIN ENDOCR DIAB, V114, P168, DOI 10.1055/s-2006-924066
   JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   KYRIAKIDES T, 1993, MUSCLE NERVE, V16, P418, DOI 10.1002/mus.880160413
   Lehmann D., 2018, J INBORN ERRORS META, V6, P1
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6
   Lissens W, 1996, HUM MUTAT, V7, P46, DOI 10.1002/(SICI)1098-1004(1996)7:1<46::AID-HUMU6>3.3.CO;2-2
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Mannan A. A. S. R., 2004, Indian Journal of Pediatrics, V71, P1029, DOI 10.1007/BF02828121
   MANZ HJ, 1980, VIRCHOWS ARCH A, V386, P1, DOI 10.1007/BF00432641
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   Naito E, 1997, J INHERIT METAB DIS, V20, P539, DOI 10.1023/A:1005305614374
   Nardone R, 2013, SCI WORLD J, DOI 10.1155/2013/309143
   Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B
   Pandit L, 2007, Ann Indian Acad Neurol., V10, P55, DOI [10.4103/0972-2327.31488, DOI 10.4103/0972-2327.31488]
   Pant I, 2015, ANN INDIAN ACAD NEUR, V18, P398, DOI 10.4103/0972-2327.165455
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Povalko N, 2005, MITOCHONDRION, V5, P194, DOI 10.1016/j.mito.2005.03.003
   Pradhan S, 1997, NEUROL INDIA, V45, P177
   Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D
   Qian YP, 2005, BIOCHEM BIOPH RES CO, V332, P614, DOI 10.1016/j.bbrc.2005.05.003
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rai PK, 2015, BRIT MED BULL, V116, P5, DOI 10.1093/bmb/ldv046
   Rao SN, 2008, J TROP PEDIATRICS, V54, P328, DOI 10.1093/tropej/fmn031
   REID FM, 1994, HUM MOL GENET, V3, P1435
   Rinninella E, 2018, EUR REV MED PHARMACO, V22, P4288, DOI 10.26355/eurrev_201807_15425
   Rodríguez-Ballesteros M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.042440
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHWARTZKOPFF B, 1991, VIRCHOWS ARCH A, V419, P63, DOI 10.1007/BF01600154
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Simon DK, 2003, NEUROGENETICS, V4, P199, DOI 10.1007/s10048-003-0150-3
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   TIRANTI V, 1995, HUM MOL GENET, V4, P2017, DOI 10.1093/hmg/4.11.2017
   Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610
   Wallace D. C., 1992, American Journal of Human Genetics, V51, pA30
   Zhang J, 2015, EUR J HUM GENET, V23, P86, DOI 10.1038/ejhg.2014.52
   Zhao FX, 2009, BIOCHEM BIOPH RES CO, V389, P466, DOI 10.1016/j.bbrc.2009.08.168
   Zhou XT, 2012, INVEST OPHTH VIS SCI, V53, P4586, DOI 10.1167/iovs.11-9109
   Zhou XT, 2010, MOL GENET METAB, V100, P379, DOI 10.1016/j.ymgme.2010.04.013
NR 70
TC 8
Z9 8
U1 0
U2 20
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD SEP 15
PY 2019
VL 404
BP 91
EP 100
DI 10.1016/j.jns.2019.07.007
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA IU5PM
UT WOS:000483639800020
PM 31352295
DA 2024-11-01
ER

PT J
AU Nesti, C
   Rubegni, A
   Tolomeo, D
   Baldacci, J
   Cassandrini, D
   D'Amore, F
   Santorelli, FM
AF Nesti, Claudia
   Rubegni, Anna
   Tolomeo, Deborah
   Baldacci, Jacopo
   Cassandrini, Denise
   D'Amore, Francesca
   Santorelli, Filippo M.
TI Complex multisystem phenotype associated with the mitochondrial DNA
   m.5522G&gt;A mutation
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE mtDNA mutation; Heteroplasmy; tRNA(Trp); Multisystem disorder; Massive
   parallel sequencing
AB Mitochondrial tRNAs are responsible for more than half of pathogenic point mutations in the mitochondrial genome (mtDNA). Different mutations give rise to widely differing phenotypes, ranging from isolated organ-specific diseases to multisystem conditions. Herein, we report a 40-year-old woman presenting with a complex multisystem phenotype including sensorineural hearing loss, retinopathy, severe dilated cardiomyopathy, non-insulin dependent diabetes mellitus, and renal failure. Sequence analysis of mtDNA identified the m.5522G>A mutation in MT-TW, the gene encoding mitochondrial tRNA for tryptophan. The heteroplasmic variant, thus far described once, was almost exclusively confined to skeletal muscle tissue, as shown by massive parallel sequencing and corroborated by an ad hoc designed PCR-based strategy. This patient, presenting a severe, multisystem involvement apparently sparing the brain, contributes to the genetic heterogeneity of mitochondrial diseases caused by mutations in mitochondrial tRNAs.
C1 [Nesti, Claudia; Rubegni, Anna; Baldacci, Jacopo; Cassandrini, Denise; D'Amore, Francesca; Santorelli, Filippo M.] IRCCS Stella Maris Fdn, Mol Med Neurodegenerat & Neuromuscular Dis Unit, Via Giacinti 2, I-56128 Pisa, Italy.
   [Tolomeo, Deborah] Univ Pisa, Dept Clin & Expt Med, Via Giacinti 2, I-56128 Pisa, Italy.
C3 IRCCS Fondazione Stella Maris; University of Pisa
RP Nesti, C; Santorelli, FM (corresponding author), IRCCS Stella Maris Fdn, Mol Med Neurodegenerat & Neuromuscular Dis Unit, Via Giacinti 2, I-56128 Pisa, Italy.
EM cla_nesti@yahoo.it; filippo3364@gmail.com
RI Baldacci, Jacopo/AAS-9813-2020; Rubegni, Anna/I-3221-2018; cassandrini,
   denise/J-7783-2016; TOLOMEO, DEBORAH/AAC-1106-2020; Santorelli, Filippo
   M/ABE-5124-2020; Nesti, Claudia/K-5866-2016
OI Rubegni, Anna/0000-0002-0484-3799; cassandrini,
   denise/0000-0002-3556-8638; TOLOMEO, DEBORAH/0000-0002-0470-2240;
   Baldacci, Jacopo/0000-0002-1727-5233; Santorelli, Filippo
   M/0000-0002-1359-9062; Nesti, Claudia/0000-0001-5769-8655
FU Italian Ministry of Health
FX This work was partially supported by grant MITONEXT (to FMS) and Ricerca
   Corrente 5x1000 2018 from the Italian Ministry of Health.
CR Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272
   Cardaioli E, 2018, BIOCHEM BIOPH RES CO, V500, P158, DOI 10.1016/j.bbrc.2018.04.009
   Cassandrini D, 2006, J CHILD NEUROL, V21, P983, DOI 10.1177/08830738060210111001
   De Michele G, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00728
   Rubegni A, 2018, PEDIATR NEUROL, V89, P63, DOI 10.1016/j.pediatrneurol.2018.08.021
   Sonney S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005867
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 8
TC 10
Z9 10
U1 0
U2 3
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD AUG
PY 2019
VL 40
IS 8
BP 1705
EP 1708
DI 10.1007/s10072-019-03864-w
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA IJ2CO
UT WOS:000475706000024
PM 30937556
DA 2024-11-01
ER

PT J
AU Correa, CC
   Aw, W
   Melvin, RG
   Pichaud, N
   Ballard, JWO
AF Correa, C. C.
   Aw, Wc
   Melvin, R. G.
   Pichaud, N.
   Ballard, J. W. O.
TI Mitochondrial DNA variants influence mitochondrial bioenergetics in
   <i>Drosophila melanogaster</i>
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial bioenergetics; Reactive oxygen species; mtDNA copy number
ID ORGANISMAL PHENOTYPE; ACID DELETION; SIMULANS; CELLS; OXIDASE; LIFE;
   RESPIRATION; DYSFUNCTION; METABOLISM; MUTATIONS
AB The influence of mitochondrial DNA (mtDNA) mutations on human disease has been extensively studied, but the impact of mutations within the adaptive range is debated. We studied males from lines of Drosophila melanogaster that have a highly standardized nuclear genome but different mtDNA, at two ages. We measured mitochondrial respiration on permeabilized muscle fibers, hydrogen peroxide production of isolated mitochondria and mtDNA copy number of whole individuals. The results show that a small set of naturally occurring mtDNA mutations can have a significant influence on mitochondrial bioenergetics that may change as the organism ages. (C) 2012 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Correa, C. C.; Aw, Wc; Pichaud, N.; Ballard, J. W. O.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
   [Melvin, R. G.] Univ Helsinki, Inst Biotechnol, Bioctr 3, FIN-00014 Helsinki, Finland.
C3 University of New South Wales Sydney; University of Helsinki
RP Ballard, JWO (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
EM w.ballard@unsw.edu.au
RI Ballard, John/ABB-2743-2020; Melvin, Richard George/AGH-4179-2022
OI Ballard, J. William O./0000-0002-2358-6003; Melvin, Richard
   George/0000-0001-6428-6763; Pichaud, Nicolas/0000-0002-2820-8124
FU University of New South Wales; ARC [DP110104542]
FX The work was supported by University of New South Wales internal grants
   and ARC grant DP110104542. Members of the Ballard Lab and an anonymous
   reviewer provided useful comments on a draft of the manuscript.
CR AKASHI H, 1994, GENETICS, V136, P927
   Amo T, 2008, GENE, V411, P69, DOI 10.1016/j.gene.2008.01.007
   Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609
   Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45
   Aragonés J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62
   Aw WC, 2011, MITOCHONDRION, V11, P756, DOI 10.1016/j.mito.2011.06.012
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x
   Ballard JWO, 2011, EVOLUTION, V65, P1400, DOI 10.1111/j.1558-5646.2010.01209.x
   Ballard JWO, 2010, AM NAT, V176, pE98, DOI 10.1086/656263
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Clancy DJ, 2008, AGING CELL, V7, P795, DOI 10.1111/j.1474-9726.2008.00428.x
   Dean MD, 2005, MOL PHYLOGENET EVOL, V36, P328, DOI 10.1016/j.ympev.2005.02.016
   Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011
   Estabrook R.W., 1967, METHODS ENZYMOL, V6
   Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002
   Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706
   Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   Horan M.P., J GEONTOL IN PRESS
   Innocenti P, 2011, SCIENCE, V332, P845, DOI 10.1126/science.1201157
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Katewa SD, 2007, INSECT BIOCHEM MOLEC, V37, P923, DOI 10.1016/j.ibmb.2007.04.008
   Kidd P M, 2000, Altern Med Rev, V5, P502
   Kidd PM, 2005, ALTERN MED REV, V10, P268
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1159/000025424
   Melvin RG, 2006, AGING CELL, V5, P225, DOI 10.1111/j.1474-9726.2006.00211.x
   Mithani SK, 2008, MELANOMA RES, V18, P214, DOI 10.1097/CMR.0b013e3282f88a56
   Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Moreno-Loshuertos R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001379
   Passes JF, 2007, BIOESSAYS, V29, P908, DOI 10.1002/bies.20634
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Pichaud N., 2011, AM J PHYSIOL, V301, P30
   Pichaud N., EVOLUTION IN PRESS
   Rasmussen HN, 2003, ANAL BIOCHEM, V319, P105, DOI 10.1016/S0003-2697(03)00274-4
   THOMAS JW, 1993, BIOCHEMISTRY-US, V32, P10923, DOI 10.1021/bi00091a048
   Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391
NR 43
TC 43
Z9 48
U1 1
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2012
VL 12
IS 4
BP 459
EP 464
DI 10.1016/j.mito.2012.06.005
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 988ZM
UT WOS:000307530000006
PM 22735574
DA 2024-11-01
ER

PT J
AU Gawel, M
   Kierdaszuk, B
   Tonska, K
   Kaliszewska, M
   Kubiszewska, J
   Jamrozik, Z
   Bartnik, E
   Kwiecinski, H
   Kaminska, AM
AF Gawel, Malgorzata
   Kierdaszuk, Biruta
   Tonska, Katarzyna
   Kaliszewska, Magdalena
   Kubiszewska, Justyna
   Jamrozik, Zygmunt
   Bartnik, Ewa
   Kwiecinski, Hubert
   Kaminska, Anna M.
TI Mitochondrial encephalomyopathy: Towards diagnosis. A case report
SO NEUROLOGIA I NEUROCHIRURGIA POLSKA
LA English
DT Article
DE Mitochondrial encephalomyopathy; Molecular genetics; mtDNA; Muscle
   biopsy
ID DNA; DELETIONS; MUTATIONS; DISEASE; UPDATE
AB Mitochondrial diseases may cause a wide range of central and peripheral nervous system disorders, as well as muscle disorders. The diagnostic workup routinely includes electrophysiological, morphological, neuroimaging and genetic studies. In some cases, the diagnosis may be ascertained only when mitochondrial DNA (mtDNA) examination in the muscle is performed. We report on a case of a 24-year-old woman, with a 7-year history of slowly progressive cerebellar syndrome and bilateral ptosis. Mitochondrial encephalomyopathy was suspected, based on the clinical picture and results of examinations, but the typical red ragged fibers were not found in the muscle biopsy. The results of molecular analysis of mtDNA showed a mtDNA deletion in the muscle and, on a level detectable only with polymerase chain reaction method, in blood leukocytes. This case emphasizes the important role of mtDNA studies in muscle in nonspecific multisystem mitochondrial disorders, even without clinical muscle involvement. (C) 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
C1 [Gawel, Malgorzata; Kierdaszuk, Biruta; Kubiszewska, Justyna; Jamrozik, Zygmunt; Kwiecinski, Hubert; Kaminska, Anna M.] Med Univ Warsaw, Dept Neurol, Warsaw, Poland.
   [Tonska, Katarzyna; Kaliszewska, Magdalena; Bartnik, Ewa] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland.
   [Bartnik, Ewa] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.
C3 Medical University of Warsaw; University of Warsaw; Polish Academy of
   Sciences; Institute of Biochemistry & Biophysics - Polish Academy of
   Sciences
RP Gawel, M (corresponding author), Warszawski Uniwersytet Med, Neurol Klin, Ul Banacha 1a, PL-02097 Warsaw, Poland.
EM mgawel@wum.edu.pl
OI Kaliszewska, Magdalena/0000-0003-3649-4375; Tonska,
   Katarzyna/0000-0002-1793-6089
FU Polish Ministry of Science and Higher Education [N N401 049238]; 
   [VENTURES/2011-8/3]
FX This work was supported by grant N N401 049238 from the Polish Ministry
   of Science and Higher Education and by grant VENTURES/2011-8/3.
CR Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Dubowitz V, 2007, MUSCLE BIOPSY PRACTI, P3
   Femandez-Silva P, 2003, EXP PHYSIOL, V88, P41
   Fernández-Moreno MA, 2000, MOL GENET METAB, V71, P481, DOI 10.1006/mgme.2000.3083
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kierdaszuk B, 2009, NEUROL NEUROCHIR POL, V43, P216
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Soong N W, 1996, Methods Enzymol, V264, P421, DOI 10.1016/S0076-6879(96)64038-5
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Zeviani Massimo, 2003, Curr Neurol Neurosci Rep, V3, P423, DOI 10.1007/s11910-003-0026-9
NR 16
TC 1
Z9 1
U1 0
U2 6
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA WENEDOW ST 9-1, POZNAN, 61-614, POLAND
SN 0028-3843
J9 NEUROL NEUROCHIR POL
JI Neurol. Neurochir. Pol.
PY 2014
VL 48
IS 1
BP 76
EP 80
DI 10.1016/j.pjnns.2013.09.003
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AE8OL
UT WOS:000334261100013
PM 24636775
DA 2024-11-01
ER

PT J
AU Urata, M
   Wada, Y
   Kim, SH
   Chumpia, W
   Kayamori, Y
   Hamasaki, N
   Kang, DC
AF Urata, M
   Wada, Y
   Kim, SH
   Chumpia, W
   Kayamori, Y
   Hamasaki, N
   Kang, DC
TI High-sensitivity detection of the A3243G mutation of mitochondrial DNA
   by a combination of allele-specific PCR and peptide nucleic
   acid-directed PCR clamping
SO CLINICAL CHEMISTRY
LA English
DT Article
ID DIABETES-MELLITUS; MUSCLE; ACCUMULATION; SEQUENCES; FEATURES; NETWORK;
   MTDNA; BLOOD; CELL
AB Background: The A3243G mutation of mitochondrial DNA (mtDNA) is involved in many common diseases, including diabetes mellitus and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). For detection of this mutation, allele-specific PCR is highly sensitive but requires strict control of PCR conditions; it thus is not adequate for a routine clinical test. We aimed to develop a routinely available PCR method for quantitative detection of low-level heteroplasmy of the A3243G mutation.
   Methods: Quantitative allele-specific PCR for the A3243G mutation was performed in the presence of peptide nucleic acid (PNA), in which PNA is complementary to the wild-type mtDNA, with one primer having a 3' end matched to nucleotide position 3243 of the mutant.
   Results: With our method, amplification of wild-type mtDNA was suppressed 7000-fold compared with amplification of the mutant mtDNA under a broad range of conditions: DNA, 5-100 ng; annealing temperature, 61-66 degreesC; and PNA, 1.5-3.5 mumol/L. Hence, 0.1% heteroplasmy of the A3243G mutation can be reliably quantified by this method. Blood samples form 40 healthy volunteers showed <0.06% heteroplasmy, suggesting that 0.1% is diagnostically significant.
   Conclusions: PNA maintains the specificity of allele-specific PCR over a wide range of conditions, which is important for routine clinical testing. (C) 2004 American Association for Clinical Chemistry.
C1 Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Higashi Ku, Fukuoka 8128582, Japan.
   Daegue Univ, Dept Biol Educ, Kyungsan, South Korea.
   Mahidol Univ, Inst Sci & Technol Res & Dev, Thalassemia Res Ctr, Nakhon Pathom, Thailand.
C3 Kyushu University; Mahidol University
RP Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
EM kang@mailserver.med.kyushu-u.ac.jp
CR Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   Hancock DK, 2002, CLIN CHEM, V48, P2155
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kang D, 2003, CLIN CHEM LAB MED, V41, P1281, DOI 10.1515/CCLM.2003.195
   Kobayashi T, 1997, DIABETES, V46, P1567, DOI 10.2337/diabetes.46.10.1567
   Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   Puomila A, 2002, J NEUROL SCI, V205, P41, DOI 10.1016/S0022-510X(02)00276-9
   Rotig A, 1996, DIABETES METAB, V22, P291
   SMITH ML, 1997, J CLIN ENDOCR METAB, V82, P2816
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Suzuki Y, 2004, DIABETES RES CLIN PR, V63, P225, DOI 10.1016/j.diabres.2003.10.024
   Suzuki Y, 1997, J NEUROL SCI, V145, P49, DOI 10.1016/S0022-510X(96)00239-0
   TANAKA M, HUMAN MITOCHONDRIAL
   Urata M, 1998, CLIN CHEM, V44, P2088
   Wallace D. C, MITOMAP HUMAN MITOCH
   Wollheim CB, 2000, DIABETOLOGIA, V43, P265, DOI 10.1007/s001250050044
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
NR 26
TC 28
Z9 36
U1 0
U2 4
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD NOV
PY 2004
VL 50
IS 11
BP 2045
EP 2051
DI 10.1373/clinchem.2004.033761
PG 7
WC Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology
GA 865QL
UT WOS:000224717500016
PM 15364886
OA Bronze
DA 2024-11-01
ER

PT J
AU Li, G
   Duan, YX
   Zhang, XB
   Wu, F
AF Li, G.
   Duan, Y. X.
   Zhang, X. B.
   Wu, F.
TI Mitochondrial tRNA mutations may be infrequent in hepatocellular
   carcinoma patients
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Hepatocellular carcinoma; mt-tRNA; Mutations; Polymorphisms
ID DNA; GENE; POLYMORPHISM; HAPLOGROUPS; MYOPATHY; DELETION; CANCER; LIVER;
   RISK
AB Mitochondrial DNA mutations have been shown to play important roles in the pathogenesis of hepatocellular carcinoma (HCC). In particular, genes encoding mitochondrial tRNA (mt-tRNA) are hotspots for pathogenic mutations associated with HCC. Recently, an increasing number of studies have reported the involvement of such mutations in this disease. As a result, several mt-tRNA mutations associated with HCC have been described. Some of these are neutral polymorphisms and may not cause mitochondrial dysfunction. Moreover, the molecular mechanisms by which these pathogenic mutations result in HCC remain unclear. To address this problem, we evaluated five mt-tRNA variants (tRNAVal T1659C, tRNA(Ala) G5650A, tRNA(Arg) T10463C, tRNA(Glu) A14679G, and tRNA(Pro) C15975T) implicated in the clinical manifestation of HCC in humans. We performed evolutionary conservation analysis and used a bioinformatic tool to predict the secondary structure of the mt-tRNAs carrying these mutations. Using an established pathogenicity scoring system, we classified T10463C and A14679G as neutral polymorphisms, and determined that the T1659C, G5650A, and C15975T variants should be regarded as pathogenic mutations. To the best of our knowledge, this is the first report to establish the pathogenicity of HCC-associated mt-tRNA mutations.
C1 [Li, G.; Zhang, X. B.] Wenzhou Med Univ, Dept Chemoradiat Oncol, Affiliated Hosp 1, Wenzhou, Peoples R China.
   [Duan, Y. X.] Wenzhou Med Univ, Radiat Dept, Affiliated Hosp 1, Wenzhou, Peoples R China.
   [Wu, F.] Wenzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Wenzhou, Peoples R China.
C3 Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical
   University
RP Wu, F (corresponding author), Wenzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Wenzhou, Peoples R China.
EM wufangwzmc@sina.com
RI Duan, Yuxia/D-7334-2013; li, taotao/IAQ-4479-2023
FU Natural Science Foundation of Zhejiang Province [LY15H030015]; Wenzhou
   Bureau of Science and Technology [Y20140281]
FX Research supported by the Natural Science Foundation of Zhejiang
   Province (#LY15H030015) and the Wenzhou Bureau of Science and Technology
   (#Y20140281).
CR Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158
   Blakely EL, 2004, J NEUROL SCI, V225, P99, DOI 10.1016/j.jns.2004.07.007
   Da Pozzo P, 2009, EUR J HUM GENET, V17, P1092, DOI 10.1038/ejhg.2009.12
   Ding Y, 2012, MITOCHONDR DNA, V23, P323, DOI 10.3109/19401736.2012.674119
   Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421
   Fang Y, 2015, GENET MOL RES, V14, P5031, DOI 10.4238/2015.May.12.6
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Finnilä S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268
   Marku E, 2015, GENET MOL RES, V14, P5221, DOI 10.4238/2015.May.18.13
   Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   PARK SJ, 1988, J BIOL CHEM, V263, P16527
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schütte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339
   Servidei Serenella, 2003, Neuromuscul Disord, V13, P848
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Vivekanandan P, 2010, MODERN PATHOL, V23, P790, DOI 10.1038/modpathol.2010.51
   Wan YY, 2014, GENET MOL RES, V13, P6820, DOI 10.4238/2014.August.29.3
   Wheelhouse NM, 2005, BRIT J CANCER, V92, P1268, DOI 10.1038/sj.bjc.6602496
   Wong LJC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013532
   Yang Y, 2015, CHINESE J CANCER RES, V27, P497, DOI 10.3978/j.issn.1000-9604.2015.10.05
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yin PH, 2010, MITOCHONDRION, V10, P174, DOI 10.1016/j.mito.2009.12.147
   Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838
NR 24
TC 1
Z9 1
U1 0
U2 1
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2016
VL 15
IS 2
AR 15027665
DI 10.4238/gmr.15027665
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DY1UH
UT WOS:000384879400144
PM 27420959
OA Bronze
DA 2024-11-01
ER

PT J
AU Laing, NG
AF Laing, Nigel G.
TI Genetics of neuromuscular disorders
SO CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
LA English
DT Review
DE Carrier detection; congenital myopathies; distal myopathies; molecular
   diagnosis; muscular dystrophies; next generation DNA sequencing;
   pre-implantation diagnosis; prenatal diagnosis; pre-symptomatic
   diagnosis; spinal muscular atrophy
ID DUCHENNE MUSCULAR-DYSTROPHY; CENTRAL CORE DISEASE; MYOSIN STORAGE
   MYOPATHY; RYANODINE RECEPTOR GENE; MARIE-TOOTH DISEASE; RECESSIVE
   NEMALINE MYOPATHY; POLYMERASE CHAIN-REACTION; FIBER-TYPE DISPROPORTION;
   SKELETAL-MUSCLE ACTIN; MYOTONIC-DYSTROPHY
AB Neuromuscular disorders affect the peripheral nervous system and muscle. The principle effect of neuromuscular disorders is therefore on the ability to perform voluntary movements. Neuromuscular disorders cause significant incapacity, including, at the most extreme, almost complete paralysis. Neuromuscular diseases include some of the most devastating disorders that afflict mankind, for example motor neuron disease. Neuromuscular diseases have onset any time from in utero until old age. They are most often genetic. The last 25 years has been the golden age of genetics, with the disease genes responsible for many genetic neuromuscular disorders now identified. Neuromuscular disorders may be inherited as autosomal dominant, autosomal recessive, or X-linked traits. They may also result from mutations in mitochondrial DNA or from de novo mutations not present in the peripheral blood DNA of either parent. The high incidence of de novo mutation has been one of the surprises of the recent increase in information about the genetics of neuromuscular disorders. The disease burden imposed on families is enormous including decision making in relation to presymptomatic diagnosis for late onset neurodegenerative disorders and reproductive choices. Diagnostic molecular neurogenetics laboratories have been faced with an ever-increasing range of disease genes that could be tested for and usually a finite budget with which to perform the possible testing. Neurogenetics has moved from one known disease gene, the Duchenne muscular dystrophy gene in July 1987, to hundreds of disease genes in 2011. It can be anticipated that with the advent of next generation sequencing (NGS), most, if not all, causative genes will be identified in the next few years. Any type of mutation possible in human DNA has been shown to cause genetic neuromuscular disorders, including point mutations, small insertions and deletions, large deletions and duplications, repeat expansions or contraction and somatic mosaicism. The diagnostic laboratory therefore has to be capable of a large number of techniques in order to identify the different mutation types and requires highly skilled staff. Mutations causing neuromuscular disorders affect the largest human proteins for example titin and nebulin. Successful molecular diagnosis can make invasive and expensive diagnostic procedures such as muscle biopsy unnecessary. Molecular diagnosis is currently largely based on Sanger sequencing, which at most can sequence a small number of exons in one gene at a time. NGS techniques will facilitate molecular diagnostics, but not for all types of mutations. For example, NGS is not good at identifying repeat expansions or copy number variations. Currently, diagnostic molecular neurogenetics is focused on identifying the causative mutation(s) in a patient. In the future, the focus might move to prevention, by identifying carriers of recessive diseases before they have affected children. The pathobiology of many of the diseases remains obscure, as do factors affecting disease severity. The aim of this review is to describe molecular diagnosis of genetic neuromuscular disorders in the past, the present and speculate on the future.
C1 [Laing, Nigel G.] Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Nedlands, WA 6009, Australia.
C3 University of Western Australia
RP Laing, NG (corresponding author), Univ Western Australia M519, Med Res Ctr, Western Australian Inst Med Res, QE Med Ctr 2, B Block,Hovea Lane, Nedlands, WA 6009, Australia.
EM nlaing@cyllene.uwa.edu.au
OI Laing, Nigel/0000-0001-5111-3732
FU Australian National Health and Medical Research Council (NHMRC)
   [APP1002147]
FX NGL was supported by Australian National Health and Medical Research
   Council (NH&MRC) Principal Research Fellowship APP1002147.
CR ABBS S, 1990, GENOMICS, V7, P602, DOI 10.1016/0888-7543(90)90205-9
   Abbs Stephen, 2010, Neuromuscul Disord, V20, P422, DOI 10.1016/j.nmd.2010.04.005
   Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402
   Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   [Anonymous], HIST GENETIC DIS DUC
   [Anonymous], INCR OPT INF CHOIC R
   ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0
   Baets J, 2011, BRAIN, V134, P2664, DOI 10.1093/brain/awr184
   BAKKER E, 1986, J MED GENET, V23, P573, DOI 10.1136/jmg.23.6.573
   BAKKER E, 1985, LANCET, V1, P655
   Bartoli M, 2008, HUM MOL GENET, V17, P1214, DOI 10.1093/hmg/ddn029
   BEGGS AH, 1990, HUM GENET, V86, P45
   Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756
   BRADLEY DM, 1993, BRIT MED J, V306, P357, DOI 10.1136/bmj.306.6874.357
   BROCK DJH, 1990, J MED GENET, V27, P8, DOI 10.1136/jmg.27.1.8
   BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5
   BUNDEY S, 1978, J MED GENET, V15, P249, DOI 10.1136/jmg.15.4.249
   BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0
   Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886
   Carmignac V, 2007, ANN NEUROL, V61, P340, DOI 10.1002/ana.21089
   Castets P, 2011, HUM MOL GENET, V20, P694, DOI 10.1093/hmg/ddq515
   Catalli C, 2010, J MOL DIAGN, V12, P601, DOI 10.2353/jmoldx.2010.090239
   CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X
   CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350
   Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3
   Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975
   Clarke NF, 2010, HUM MUTAT, V31, pE1544, DOI 10.1002/humu.21278
   COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347
   Dalakas MC, 2011, CURR OPIN NEUROL, V24, P457, DOI 10.1097/WCO.0b013e32834a9589
   Davis M, 2002, BRIT J ANAESTH, V88, P508, DOI 10.1093/bja/88.4.508
   Davis MR, 2003, NEUROMUSCULAR DISORD, V13, P151, DOI 10.1016/S0960-8966(02)00218-3
   de Visser M, 2004, MYOLOGY, P655
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Donner K, 2004, EUR J HUM GENET, V12, P744, DOI 10.1038/sj.ejhg.5201242
   DORKINS H, 1985, HUM GENET, V71, P103, DOI 10.1007/BF00283362
   Dubourg O, 2011, J NEUROL, V258, P1157, DOI 10.1007/s00415-011-5900-9
   Dubowitz V., 2007, Muscle Biopsy: A Practical Approach
   Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2
   EMERY AEH, 1980, BRIT MED BULL, V36, P117, DOI 10.1093/oxfordjournals.bmb.a071624
   Emery AlanE. H., 1998, NEUROMUSCULAR DISORD, P1
   Fee DB, 2004, MUSCLE NERVE, V30, P375, DOI 10.1002/mus.20092
   Ferreiro A, 2002, ANN NEUROL, V51, P750, DOI 10.1002/ana.10231
   Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b
   Flanigan KM, 2003, AM J HUM GENET, V72, P931, DOI 10.1086/374176
   Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815
   GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862
   Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380
   Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403
   HARPER PS, 1992, AM J HUM GENET, V51, P10
   Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353
   Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221
   Homayoun H, 2011, NEUROMUSCULAR DISORD, V21, P219, DOI 10.1016/j.nmd.2010.12.005
   HURSE P V, 1974, Proceedings of the Australian Association of Neurologists, V11, P145
   JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0
   Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036
   Jungbluth H, 2005, NEUROLOGY, V65, P1930, DOI 10.1212/01.wnl.0000188870.37076.f2
   Jungbluth H, 2005, NEUROMUSCULAR DISORD, V15, P681
   Jungbluth H, 2004, NEUROMUSCULAR DISORD, V14, P779, DOI 10.1016/j.nmd.2004.08.005
   Jungbluth H, 2002, NEUROLOGY, V59, P284, DOI 10.1212/WNL.59.2.284
   Kaback MM, 2001, ADV GENET, V44, P253
   Kelly K F, 2002, Health Bull (Edinb), V60, P83
   Klein A, 2011, ARCH NEUROL-CHICAGO, V68, P1171, DOI 10.1001/archneurol.2011.188
   KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6
   Kono S, 2010, NEUROLOGY, V75, P547, DOI 10.1212/WNL.0b013e3181ec7fbd
   Krivosic-Horber R, 2004, EUR J ANAESTH, V21, P572, DOI 10.1017/S0265021504227120
   KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0
   LAING NG, 1990, MED J AUSTRALIA, V152, P270, DOI 10.5694/j.1326-5377.1990.tb120926.x
   Laing NG, 2007, MYOPATHIES 3, P1
   Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059
   Laing NG, 2008, J MUSCLE RES CELL M, V29, P247, DOI 10.1007/s10974-008-9158-5
   Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293
   Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463
   LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0
   LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3
   Lehtokari VL, 2006, HUM MUTAT, V27, P946, DOI 10.1002/humu.20370
   Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035
   Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936
   Lo HP, 2008, NEUROMUSCULAR DISORD, V18, P34, DOI 10.1016/j.nmd.2007.08.009
   Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094
   LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4
   Mercuri E, 2005, CURR OPIN NEUROL, V18, P526, DOI 10.1097/01.wco.0000183947.01362.fe
   Mercuri E, 2010, DISORDERS VOLUNTARY, P151
   Meredith C, 2004, AM J HUM GENET, V75, P703, DOI 10.1086/424760
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9
   MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0
   Monnier N, 2000, HUM MOL GENET, V9, P2599, DOI 10.1093/hmg/9.18.2599
   Montenegro G, 2011, ANN NEUROL, V69, P464, DOI 10.1002/ana.22235
   Muelas N, 2010, NEUROLOGY, V75, P732, DOI 10.1212/WNL.0b013e3181eee4d5
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499
   Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250
   Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837
   Nowak KJ, 2007, ANN NEUROL, V61, P175, DOI 10.1002/ana.21035
   Ockeloen CW, 2011, NEUROMUSCULAR DISORD, V21, P696, DOI 10.1016/j.nmd.2011.06.941
   Odgerel Z, 2010, CLIN CHEM LAB MED, V48, P1409, DOI 10.1515/CCLM.2010.272
   ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8
   Ortolano S, 2011, NEUROMUSCULAR DISORD, V21, P254, DOI 10.1016/j.nmd.2010.12.011
   Peat RA, 2008, NEUROLOGY, V71, P312, DOI 10.1212/01.wnl.0000284605.27654.5a
   Pegoraro E, 2007, NEUROMUSCULAR DISORD, V17, P321, DOI 10.1016/j.nmd.2007.01.010
   Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305
   PRIOR TW, 1995, AM J HUM GENET, V57, P22
   QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51
   Radvansky J, 2011, GENET TEST MOL BIOMA, V15, P133, DOI 10.1089/gtmb.2010.0127
   Ravenscroft G, 2011, J MED GENET, V48, P793, DOI 10.1136/jmedgenet-2011-100211
   Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010
   Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54
   Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   ROSES AD, 1988, ARCH NEUROL-CHICAGO, V45, P84, DOI 10.1001/archneur.1988.00520250090026
   Saillour Y, 2008, HUM MUTAT, V29, P1083, DOI 10.1002/humu.20829
   Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166
   Sato I, 2008, NEUROLOGY, V70, P114, DOI 10.1212/01.wnl.0000269792.63927.86
   Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221
   Scacheri PC, 2000, NEUROLOGY, V55, P1689, DOI 10.1212/WNL.55.11.1689
   Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056
   Sejerson T, 2009, ADV EXP MED BIOL, V652, P13, DOI 10.1007/978-90-481-2813-6_2
   Sewry CA, 2002, NEUROMUSCULAR DISORD, V12, P930, DOI 10.1016/S0960-8966(02)00135-9
   Sewry CA, 2008, CURR OPIN NEUROL, V21, P569, DOI 10.1097/WCO.0b013e32830f93c7
   Silander K, 1996, HUM MUTAT, V8, P304, DOI 10.1002/(SICI)1098-1004(1996)8:4<304::AID-HUMU2>3.3.CO;2-6
   Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Supala-Berger A, 2009, MUSCLE NERVE, V40, P657, DOI 10.1002/mus.21079
   SUTHERS G, 1994, LANCET, V344, P1773, DOI 10.1016/S0140-6736(94)92913-0
   Tabet AC, 2010, AM J MED GENET A, V152A, P1781, DOI 10.1002/ajmg.a.33433
   Tajsharghi H, 2003, ANN NEUROL, V54, P494, DOI 10.1002/ana.10693
   Tajsharghi H, 2007, NEUROLOGY, V68, P962, DOI 10.1212/01.wnl.0000257131.13438.2c
   TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192
   VALENTIJN LJ, 1995, HUM MUTAT, V5, P76, DOI 10.1002/humu.1380050110
   VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7
   Villard E, 2005, EUR HEART J, V26, P794, DOI 10.1093/eurheartj/ehi193
   von der Hagen M, 2006, NEUROMUSCULAR DISORD, V16, P4, DOI 10.1016/j.nmd.2005.10.001
   Wallgren-Pettersson C, 2010, DISORDERS VOLUNTARY, P282
   Wallgren-Pettersson Carina, 2004, Neuromuscul Disord, V14, P56, DOI 10.1016/j.nmd.2003.09.003
   WallgrenPettersson C, 1996, NEUROMUSCULAR DISORD, V6, P389, DOI 10.1016/0960-8966(96)00354-9
   Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107
   Warner JP, 1996, J MED GENET, V33, P1022, DOI 10.1136/jmg.33.12.1022
   Weedon MN, 2011, AM J HUM GENET, V89, P308, DOI 10.1016/j.ajhg.2011.07.002
   WIRTH B, 1995, PRENATAL DIAG, V15, P407, DOI 10.1002/pd.1970150503
   Wu SW, 2006, BRAIN, V129, P1470, DOI 10.1093/brain/awl077
   ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46
   Zlotogora J, 2009, HUM GENET, V126, P247, DOI 10.1007/s00439-009-0669-y
NR 142
TC 56
Z9 60
U1 1
U2 22
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1040-8363
J9 CRIT REV CL LAB SCI
JI Crit. Rev. Clin. Lab. Sci.
PD MAR-APR
PY 2012
VL 49
IS 2
BP 33
EP 48
DI 10.3109/10408363.2012.658906
PG 16
WC Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology
GA 919JR
UT WOS:000302321500001
PM 22468856
DA 2024-11-01
ER

PT J
AU Smits, BW
   Fermont, J
   Delnooz, CCS
   Kalkman, JS
   Bleijenberg, G
   van Engelen, BGM
AF Smits, Bart W.
   Fermont, Jiske
   Delnooz, Catherine C. S.
   Kalkman, Joke S.
   Bleijenberg, Gijs
   van Engelen, Baziel G. M.
TI Disease impact in chronic progressive external ophthalmoplegia: More
   than meets the eye
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Chronic progressive external ophthalmoplegia; Kearns-Sayre syndrome;
   Quality of life; Depression; Myotonic dystrophy
ID SENSORY ATAXIC NEUROPATHY; MUSCLE MITOCHONDRIAL-DNA;
   KEARNS-SAYRE-SYNDROME; MAJOR DEPRESSION; MYOTONIC-DYSTROPHY; CHRONIC
   FATIGUE; ANT1 GENE; FEATURES; MUTATIONS; DELETIONS
AB We determined the extent of disease impact in 28 patients with genetically confirmed chronic progressive external ophthalmoplegia (CPEO) and compared the outcomes to those of matched myotonic dystrophy type I patients.
   CPEO patients reported a high frequency of severe fatigue (67.9%), pain (96.2%), depression (32.1%) and dependency in daily life (46.4%). The frequency and extent of depression were significantly higher than in DM1 patients (32.1% vs. 7.1%, p = 0.040; mean Beck's depression inventory for primary care score 3.8 +/- 3.5 vs. 1.3 +/- 1.4, p = 0.001), as were fatigue severity, pain intensity and extent of functional impairments.
   CPEO patients with polymerase gamma-1 mutations reported more functional impairments than those with mitochondrial DNA mutations. Disease impact was however not influenced by most clinical features. The present results help physicians to identify and to treat the factors that influence quality of life in CPEO patients and to provide symptomatic treatment where needed. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Smits, Bart W.; Fermont, Jiske; Delnooz, Catherine C. S.; van Engelen, Baziel G. M.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Neuromuscular Ctr Nijmegen, NL-6500 HB Nijmegen, Netherlands.
   [Kalkman, Joke S.; Bleijenberg, Gijs] Radboud Univ Nijmegen, Med Ctr, Expert Ctr Chron Fatigue, NL-6500 HB Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen
RP Smits, BW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Neuromuscular Ctr Nijmegen, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM b.smits@neuro.umcn.nl
RI Bleijenberg, Gijs/E-6984-2010; van Engelen, Baziel/H-8027-2014
OI van Engelen, Baziel/0000-0001-9867-9047
FU Global FSH; Netherlands Organization for Scientific Research; Prinses
   Beatrix Fonds; Dutch FSHD Foundation
FX Dr. Baziel van Engelen is research director of the European
   Neuromuscular Centre and receives institutional support from the Radboud
   University Nijmegen Medical Centre and the ENMC, grant support from the
   Global FSH, Netherlands Organization for Scientific Research, Prinses
   Beatrix Fonds, and the Dutch FSHD Foundation.
CR Amemiya S, 2000, NEUROLOGY, V55, P600, DOI 10.1212/WNL.55.4.600
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Bau V, 2009, KLIN MONATSBL AUGENH, V226, P822, DOI 10.1055/s-0028-1109800
   Beck Aaron T., 1997, Behaviour Research and Therapy, V35, P785, DOI 10.1016/S0005-7967(97)00025-9
   Bindoff L, 1997, MITOCHONDRIAL MYOPAT, P85
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   DREVETS WC, 1992, J NEUROSCI, V12, P3628
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Gagnon C, 2007, J NEUROL NEUROSUR PS, V78, P800, DOI 10.1136/jnnp.2006.107185
   Graff-Guerrero A, 2004, J AFFECT DISORDERS, V80, P55, DOI 10.1016/S0165-0327(03)00049-1
   Harper P.S., 2004, Myotonic dystrophy: Present management, future therapy
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Hugdahl K, 2007, COGNITIVE THER RES, V31, P147, DOI 10.1007/s10608-006-9116-8
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jacobs H M, 1990, Ned Tijdschr Geneeskd, V134, P1950
   Kalkman JS, 2005, J NEUROL NEUROSUR PS, V76, P1406, DOI 10.1136/jnnp.2004.050005
   KALKMAN JS, 2006, PREVALENCE PREDICTOR, P73
   Koene S, 2009, J AFFECT DISORDERS, V114, P327, DOI 10.1016/j.jad.2008.06.023
   LESTIENNE P, 1988, LANCET, V1, P885
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5
   MITSUMOTO H, 1983, NEUROLOGY, V33, P452, DOI 10.1212/WNL.33.4.452
   ROLAND PE, 1987, J NEUROSCI, V7, P2373
   Servaes P, 2002, ANN ONCOL, V13, P589, DOI 10.1093/annonc/mdf082
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604
   VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X
   Willison HJ, 2001, BRAIN, V124, P1968, DOI 10.1093/brain/124.10.1968
NR 35
TC 26
Z9 27
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR
PY 2011
VL 21
IS 4
BP 272
EP 278
DI 10.1016/j.nmd.2010.12.008
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 753ED
UT WOS:000289747700005
PM 21236670
OA Bronze
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Wakil, SM
AF Finsterer, Josef
   Wakil, Salma Majid
TI Stroke-like episodes, peri-episodic seizures, and MELAS mutations
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Review
DE Encephalopathy; Mitochondrial DNA; Cerebrum; Brain; Stroke;
   Electroencephalography
ID LACTIC-ACIDOSIS; MITOCHONDRIAL-DNA; OXIDASE DEFICIENCY; STATUS
   EPILEPTICUS; L-ARGININE; ENCEPHALOPATHY; MYOPATHY; PATIENT;
   ENCEPHALOMYOPATHY; EPILEPSY
AB Purpose: Stroke-like episodes (SLEs) are a hallmark of various mitochondrial disorders, in particular MELAS syndrome. SLEs manifest with vasogenic oedema (DWI and ADC hyperintensity) or partial cytotoxic oedema (DWI hyperintensity, ADC hypointensity) in the acute and subacute stage, and with gyriform T1-hyperintensity (cortical necrosis) in the chronic stage.
   Principal results: SLEs must be clearly distinguished from ischaemic stroke, since management of these two entities is different. SLEs may go along with or without seizures or epileptiform discharges on EEG. However, in MELAS syndrome seizures may also occur in the absence of SLEs. Focal and generalised seizures have been reported but it is currently unknown if the one or the other prevail. SLEs with and without seizures may respond to NO-precursors 1-arginine, succinate, or citrulline. As a supportive measure a ketogenic diet should be initiated. Seizures prior to or during a SLE or paroxysmal EEG-activity during a SLE should be initially treated with antiepileptic drugs (AEDs) with low mitochondrion toxicity. Only in case these AEDs are ineffective, AEDs with higher mitochondrion-toxicity should be added.
   Major conclusions: All patients with SLEs need to have an EEG recorded irrespective if they have manifesting seizures or not. There are no mtDNA or nDNA mutations which predispose for SLEs with seizures. (C) 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Wakil, Salma Majid] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia.
C3 Rudolfstiftung Hospital; King Faisal Specialist Hospital & Research
   Center
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.; Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
RI Majid, Salma/AAT-2616-2020
OI WAKIL, SALMA/0000-0002-7883-2515
CR BARAK Y, 1995, ISRAEL J MED SCI, V31, P224
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Battisti C, 2014, J NEUROL, V261, P768, DOI 10.1007/s00415-014-7257-3
   Broyer M, 1996, J INHERIT METAB DIS, V19, P65, DOI 10.1007/BF01799350
   CHEN RS, 1993, ACTA NEUROL SCAND, V87, P494
   Chevallier JA, 2014, EPILEPSIA, V55, P707, DOI 10.1111/epi.12570
   Chiyonobu T, 2008, BRAIN DEV-JPN, V30, P430, DOI 10.1016/j.braindev.2007.12.006
   De Greef E, 2012, JIMD REP, V4, P5, DOI 10.1007/8904_2011_29
   Demarest ST, 2014, J CHILD NEUROL, V29, P1249, DOI 10.1177/0883073814538511
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Finsterer J, 2012, OPEN NEUROL J, V6, P26, DOI DOI 10.2174/1874205X01206010026
   Finsterer J., 2016, HDB EXPT PH IN PRESS
   Furuya H, 1997, Rinsho Shinkeigaku, V37, P680
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hynynen J, 2014, LIVER TRANSPLANT, V20, P1402, DOI 10.1002/lt.23965
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ishikawa N, 2009, BRAIN DEV-JPN, V31, P240, DOI 10.1016/j.braindev.2008.03.012
   JEANFRANCOIS MJB, 1994, AUST NZ J MED, V24, P188, DOI 10.1111/j.1445-5994.1994.tb00556.x
   Kaufman KR, 2010, EPILEPSY BEHAV, V18, P494, DOI 10.1016/j.yebeh.2010.05.020
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Lam CW, 2015, CLIN CHIM ACTA, V448, P211, DOI 10.1016/j.cca.2015.06.028
   Lamperti C, 2012, NEUROMUSCULAR DISORD, V22, P990, DOI 10.1016/j.nmd.2012.06.003
   Liang WC, 2007, J FORMOS MED ASSOC, V106, pS27, DOI 10.1016/S0929-6646(09)60349-1
   Liu Xiao-li, 2013, Zhonghua Er Ke Za Zhi, V51, P130
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Magner M, 2014, PSYCHIATR POL, V48, P1035, DOI 10.12740/PP/24062
   Mignot C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-173
   Morin C, 1999, ANN NEUROL, V45, P389, DOI 10.1002/1531-8249(199903)45:3<389::AID-ANA16>3.0.CO;2-B
   Motoda Atsuko, 2013, Rinsho Shinkeigaku, V53, P446
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Sagnelli A, 2014, J PERIPHER NERV SYST, V19, P183, DOI 10.1111/jns5.12070
   SAITOH S, 1992, BRAIN DEV-JPN, V14, P260, DOI 10.1016/S0387-7604(12)80244-0
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Scholl-Bürgi S, 2009, NEUROPEDIATRICS, V40, P76, DOI 10.1055/s-0029-1231065
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Toribe Yasuhisa, 2007, No To Hattatsu, V39, P38
   Tsujikawa Koyo, 2014, Rinsho Shinkeigaku, V54, P882
   Tzoulis C, 2012, BRAIN, V135, P3627, DOI 10.1093/brain/aws223
   VALLEE L, 1994, EUR J PEDIATR, V153, P598, DOI 10.1007/s004310050198
   van Baalen A, 2009, BRAIN DEV-JPN, V31, P183, DOI 10.1016/j.braindev.2008.08.014
   Vastagh I, 2011, IDEGGYOGY SZEMLE, V64, P399
   Wei CY, 2012, CLIN NUCL MED, V37, P876, DOI 10.1097/RLU.0b013e318262ad48
   Wheeler PG, 1998, CLIN DYSMORPHOL, V7, P69
   Whittaker R.G., 2015, ANN NEUROL
   Yoshida T, 2013, INTERNAL MED, V52, P1389, DOI 10.2169/internalmedicine.52.0188
NR 51
TC 16
Z9 19
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD NOV
PY 2016
VL 20
IS 6
BP 824
EP 829
DI 10.1016/j.ejpn.2016.08.002
PG 6
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA EA1BC
UT WOS:000386322300005
PM 27562097
DA 2024-11-01
ER

PT J
AU Montano, V
   Gruosso, F
   Carelli, V
   Comi, GP
   Filosto, M
   Lamperti, C
   Mongini, T
   Musumeci, O
   Servidei, S
   Tonin, P
   Toscano, A
   Modenese, A
   Primiano, G
   Valentino, ML
   Bortolani, S
   Marchet, S
   Meneri, M
   Tavilla, G
   Siciliano, G
   Mancuso, M
AF Montano, Vincenzo
   Gruosso, Francesco
   Carelli, Valerio
   Comi, Giacomo Pietro
   Filosto, Massimiliano
   Lamperti, Costanza
   Mongini, Tiziana
   Musumeci, Olimpia
   Servidei, Serenella
   Tonin, Paola
   Toscano, Antonio
   Modenese, Angela
   Primiano, Guido
   Valentino, Maria Lucia
   Bortolani, Sara
   Marchet, Silvia
   Meneri, Megi
   Tavilla, Graziana
   Siciliano, Gabriele
   Mancuso, Michelangelo
TI Primary mitochondrial myopathy: Clinical features and outcome measures
   in 118 cases from Italy
SO NEUROLOGY-GENETICS
LA English
DT Article
AB Objective
   To determine whether a set of functional tests, clinical scales, patient-reported questionnaires, and specific biomarkers can be considered reliable outcome measures in patients with primary mitochondrial myopathy (PMM), we analyzed a cohort of Italian patients.
   Methods
   Baseline data were collected from 118 patients with PMM, followed by centers of the Italian network for mitochondrial diseases. We used the 6-Minute Walk Test (6MWT), Timed Up-and-Go Test (x3) (3TUG), Five-Times Sit-To-Stand Test (5XSST), Timed Water Swallow Test (TWST), and Test of Masticating and Swallowing Solids (TOMASS) as functional outcome measures; the Fatigue Severity Scale and West Haven-Yale Multidimensional Pain Inventory as patient-reported outcome measures; and FGF21, GDF15, lactate, and creatine kinase (CK) as biomarkers.
   Results
   A total of 118 PMM cases were included. Functional outcome measures (6MWT, 3TUG, 5XSST, TWST, and TOMASS) and biomarkers significantly differed from healthy reference values and controls. Moreover, functional measures correlated with patients' perceived fatigue and pain severity. Patients with either mitochondrial or nuclear DNA point mutations performed worse in functional measures than patients harboring single deletion, even if the latter had an earlier age at onset but similar disease duration. Both the biomarkers FGF21 and GDF15 were significantly higher in the patients compared with a matched control population; however, there was no relation with severity of disease.
   Conclusions
   We characterized a large cohort of PMM by evaluating baseline mitochondrial biomarkers and functional scales that represent potential outcome measures to monitor the efficacy of treatment in clinical trials; these outcome measures will be further reinvestigated longitudinally to define the natural history of PMM.
C1 [Montano, Vincenzo; Gruosso, Francesco; Meneri, Megi; Siciliano, Gabriele] Univ Pisa, Neurol Clin, Dept Clin & Expt Med, Pisa, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Bologna, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy.
   [Comi, Giacomo Pietro] Univ Milan, Dept Pathophysiol & Transplantat DEPT, Dino Ferrari Ctr, Milan, Italy.
   [Comi, Giacomo Pietro; Mancuso, Michelangelo] ASST Spedali Civili, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuromuscular & Rare Dis Unit, Brescia, Italy.
   [Filosto, Massimiliano] ASST Spedali Civili, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Unit Neurol, Brescia, Italy.
   [Filosto, Massimiliano] Univ Brescia, Brescia, Italy.
   [Lamperti, Costanza; Marchet, Silvia] Fdn IRCCS Ist Neurol C Besta, UO Med Genet & Neurogenet, Milan, Italy.
   [Mongini, Tiziana; Bortolani, Sara] Univ Torino, Dept Neurosci, Neuromuscular Unit, Turin, Italy.
   [Musumeci, Olimpia; Toscano, Antonio; Tavilla, Graziana] Univ Messina, UOC Neurol & Malattie Neuromuscolari, Dept Clin & Expt Med, Messina, Italy.
   [Servidei, Serenella; Primiano, Guido] Fdn Policlin Univ A Gemelli IRCCS, UOC Neurofisiopatol, Rome, Italy.
   [Servidei, Serenella; Primiano, Guido] Univ Cattolica Sacro Cuore, Dipartimento Univ Neurosci, Rome, Italy.
   [Tonin, Paola] Univ Verona, Sect Clin Neurol, Biomed & Movement Sci, Dept Neurosci, Verona, Italy.
   [Modenese, Angela] Univ Hosp Verona, Dept Neurosci, Neurorehabil Unit, Verona, Italy.
C3 University of Pisa; IRCCS Istituto delle Scienze Neurologiche di Bologna
   (ISNB); University of Bologna; University of Milan; Hospital Spedali
   Civili Brescia; IRCCS Ca Granda Ospedale Maggiore Policlinico; Hospital
   Spedali Civili Brescia; IRCCS Ca Granda Ospedale Maggiore Policlinico;
   University of Brescia; Fondazione IRCCS Istituto Neurologico Carlo
   Besta; University of Turin; University of Messina; Catholic University
   of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of
   the Sacred Heart; IRCCS Policlinico Gemelli; University of Verona;
   University of Verona; Azienda Ospedaliera Universitaria Integrata Verona
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Dept Clin & Expt Med, Pisa, Italy.
EM michelangelo.mancuso@unipi.it
RI Comi, Giacomo/K-5702-2016; Toscano, Antonio/ABG-8813-2020; lamperti,
   costanza/J-8801-2016; Montano, Vincenzo/AAB-8681-2022; Primiano,
   Guido/AAB-7829-2019; Tonin, Paola/AAC-5052-2022; Bortolani,
   Sara/ABI-5218-2020; Servidei, Serenella/ABC-4262-2021; Filosto,
   Massimiliano/S-9446-2019; Musumeci, Olimpia/AHE-3041-2022; MARCHET,
   SILVIA/AAF-5898-2021
OI Comi, Giacomo/0000-0002-1383-5248; Musumeci,
   Olimpia/0000-0002-9208-1527; Filosto, Massimiliano/0000-0002-2852-7512;
   SERVIDEI, Serenella/0000-0001-8478-2799; Gruosso,
   Francesco/0000-0001-5277-3548; MARCHET, SILVIA/0000-0002-7858-3256;
   Primiano, Guido/0000-0001-7616-7008; MENERI, MEGI/0000-0002-3429-1809;
   CARELLI, VALERIO/0000-0003-4923-6404; Montano,
   Vincenzo/0000-0002-7548-7699
FU Telethon Grant [GUP09004]; Telethon-MITOCON Grant [GSP16001]; GENOMIT; 
   [RF-2016-02361495]
FX Telethon Grant GUP09004 and Telethon-MITOCON Grant GSP16001 partially
   supported this work. C.L. and M.M. are supported by RF-2016-02361495 and
   by GENOMIT.
CR Bohannon RW, 2006, PERCEPT MOTOR SKILL, V103, P215, DOI 10.2466/PMS.103.1.215-222
   Brewster LM, 2007, AM HEART J, V154, P655, DOI 10.1016/j.ahj.2007.06.008
   Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Harboe E, 2008, J NEUROL NEUROSUR PS, V79, P199, DOI 10.1136/jnnp.2007.120626
   Hedermann G, 2017, MITOCHONDRION, V32, P27, DOI 10.1016/j.mito.2016.11.007
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Huckabee ML, 2018, INT J LANG COMM DIS, V53, P144, DOI 10.1111/1460-6984.12332
   Karaa A, 2018, NEUROLOGY, V90, pE1212, DOI 10.1212/WNL.0000000000005255
   KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1
   Kyriakides T, 2010, EUR J NEUROL, V17, P767, DOI 10.1111/j.1468-1331.2010.03012.x
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Madsen KL, 2020, NEUROLOGY, V94, pE687, DOI 10.1212/WNL.0000000000008861
   Mancuso M, 2012, NEUROMUSCULAR DISORD, V22, pS226, DOI 10.1016/j.nmd.2012.10.012
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902
   Morovat A, 2017, J CLIN MED, V6, DOI 10.3390/jcm6080080
   NATHADWARAWALA KM, 1992, J NEUROL NEUROSUR PS, V55, P822, DOI 10.1136/jnnp.55.9.822
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Sanders DB, 2018, MUSCLE NERVE, V57, P561, DOI 10.1002/mus.26052
   Sanders DB, 2018, MUSCLE NERVE, V57, P136, DOI 10.1002/mus.25700
   Smits BW, 2011, J NEUROL, V258, P2020, DOI 10.1007/s00415-011-6060-7
   Takeuchi Y, 2008, MUSCLE NERVE, V38, P964, DOI 10.1002/mus.21077
   van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859
   Vincent Katy, 2008, Rev Pain, V2, P20, DOI 10.1177/204946370800200206
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 31
TC 7
Z9 7
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
J9 NEUROL-GENET
JI Neurol.-Genet.
PD DEC
PY 2020
VL 6
IS 6
AR e519
DI 10.1212/NXG.0000000000000519
PG 10
WC Genetics & Heredity; Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Neurosciences & Neurology
GA PS3GO
UT WOS:000607814300003
PM 33209982
OA gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Navarro-Sastre, A
   Tort, F
   Garcia-Villoria, J
   Pons, MR
   Nascimento, A
   Colomer, J
   Campistol, J
   Yoldi, ME
   López-Gallardo, E
   Montoya, J
   Unceta, M
   Martinez, MJ
   Briones, P
   Ribes, A
AF Navarro-Sastre, Aleix
   Tort, Frederic
   Garcia-Villoria, Judit
   Ruiz Pons, Monica
   Nascimento, Andres
   Colomer, Jaume
   Campistol, Jaume
   Eugenia Yoldi, Maria
   Lopez-Gallardo, Ester
   Montoya, Julio
   Unceta, Maria
   Jesus Martinez, Maria
   Briones, Paz
   Ribes, Antonia
TI Mitochondrial DNA depletion syndrome: New descriptions and the use of
   citrate synthase as a helpful tool to better characterise the patients
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE mtDNA depletion; SUCLA2; SUCLG1; DGUOK; MPV17; POLG
ID METHYLMALONIC ACIDURIA; THYMIDINE KINASE; LACTIC-ACIDOSIS; MTDNA
   CONTENT; MPV17 GENE; MUTATIONS; DEFICIENCY; ENCEPHALOMYOPATHY;
   SUCCINATE; DIAGNOSIS
AB Mitochondrial DNA depletion syndrome (MDS) is a clinically heterogeneous group of mitochondrial disorders characterised by a quantitative reduction of the mitochondrial DNA copy number. Three main clinical forms of MDS: myopathic, encephalomyopathic and hepatocerebral have been defined, although patients may present with other MDS associated clinical symptoms and signs that cover a wide spectrum of onset age and disease. We studied 52 paediatric individuals suspected to have MDS. These patients have been divided into three different groups, and the appropriate MDS genes have been screened according to their clinical and biochemical phenotypes. Mutational study of DGUOK, MPV17, SUCLA2, SUCLG1 and POLG allowed us to identify 3 novel mutations (c.1048G>A and c.1049G>T in SUCLA2 and c.531 + 4A>T in SUCLG1) and 7 already known mutations in 10 patients (8 families). Seventeen patients presented with mtDNA depletion in liver or muscle, but the cause of mtDNA depletion still remains unknown in 8 of them. When possible, we quantified mtDNA/nDNA and CS activity in the same tissue sample, providing an additional tool for the study of MDS. The ratio (mtDNA/nDNA)/CS has shed some light in the discrepant results between the mtDNA copy number and the enzymatic respiratory chain activities of some cases. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Ribes, Antonia] Hosp Clin Barcelona, Serv Bioquim & Genet Mol, Secc Errores Congenitos Metab IBC,Inst Invest Bio, Div Inborn Errors Metab,Dept Biochem & Mol Genet, Barcelona 08028, Spain.
   [Ruiz Pons, Monica] Hosp Univ NS de la Candelaria, Dept Pediat Nutr & Metab, Tenerife, Islas Canarias, Spain.
   [Nascimento, Andres; Colomer, Jaume; Campistol, Jaume] Hosp St Joan de Deu, Dept Neurol, Barcelona, Spain.
   [Eugenia Yoldi, Maria] Hosp Virgen Camino, Dept Pediat, Pamplona, Spain.
   [Lopez-Gallardo, Ester; Montoya, Julio] Univ Zaragoza, Biochem & Mol & Cellular Biol Dept, Inst Aragones Ciencias Salud, Zaragoza, Spain.
   [Unceta, Maria] Hosp Univ Cruces, Dept Biochem, Bizkaia, Spain.
   [Jesus Martinez, Maria] Hosp Univ Cruces, Neuropediat Dept, Bizkaia, Spain.
   [Briones, Paz] CSIC, E-08028 Barcelona, Spain.
   [Navarro-Sastre, Aleix; Tort, Frederic; Garcia-Villoria, Judit; Lopez-Gallardo, Ester; Montoya, Julio; Briones, Paz; Ribes, Antonia] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.
C3 University of Barcelona; Hospital Clinic de Barcelona; University of
   Barcelona; Servicio Navarro de Salud - Osasunbidea; Hospital Virgen del
   Camino; University of Zaragoza; Hospital Universitario Cruces; Hospital
   Universitario Cruces; Consejo Superior de Investigaciones Cientificas
   (CSIC); Instituto de Salud Carlos III; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERER
RP Ribes, A (corresponding author), Hosp Clin Barcelona, Serv Bioquim & Genet Mol, Secc Errores Congenitos Metab IBC,Inst Invest Bio, Div Inborn Errors Metab,Dept Biochem & Mol Genet, Edificio Helios 3,Planta Baja,C Mejia Lequerica S, Barcelona 08028, Spain.
EM aribes@clinic.ub.es
RI Garcia, Judit/AAN-1753-2021
OI Garcia-Villoria, Judit/0000-0003-2132-4138; Tort Escale,
   Frederic/0000-0003-2733-1603; Lopez Gallardo, Ester/0000-0002-3217-1424;
   Ribes Rubio, Antonia/0000-0002-2249-246X
FU Instituto de Salud Carlos III [FIS-PI08/90348, FIS-PI10/00662]
FX This research was supported in part by the Instituto de Salud Carlos III
   (FIS-PI08/90348 and FIS-PI10/00662). CIBERER is an initiative of the
   Instituto de Salud Carlos III. This work was performed in the context of
   the PhD programme of the Department of Biochemistry and Molecular
   Biology of the Autonomous University of Barcelona (UAB). The excellent
   technical assistance of Sonia Moliner, Patricia Alcala, Carlota Ogg and
   Cristina Fernandez is acknowledged. The contribution of Aida Font
   through the analysis of some samples is also acknowledged.
CR Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002
   Font A, 2011, JIMD REP, V1, P125, DOI 10.1007/8904_2011_27
   Fowler B, 2008, J INHERIT METAB DIS, V31, P350, DOI 10.1007/s10545-008-0839-4
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hirano M, 2000, BRAIN PATHOL, V10, P451
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Montero R, 2005, BIOFACTORS, V25, P109, DOI 10.1002/biof.5520250112
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Navarro-Sastre A., 2010, J INHERIT METAB DIS
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2008, J INHERIT METAB DIS, V31, P226, DOI 10.1007/s10545-008-0828-7
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Ostergaard E, 2010, EUR J PEDIATR, V169, P201, DOI 10.1007/s00431-009-1007-z
   Rivera H, 2010, MITOCHONDRION, V10, P362, DOI 10.1016/j.mito.2010.03.003
   Rouzier C, 2010, J MED GENET, V47, P670, DOI 10.1136/jmg.2009.073445
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sakamoto O, 2011, PEDIATR INT, V53, P921, DOI 10.1111/j.1442-200X.2011.03412.x
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scaglia F., 1993, HEPATOCEREBRAL FORM
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Srere P.A., 1969, CITRATE SYNTHASE, V13, P3
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valayannopoulos V, 2010, MITOCHONDRION, V10, P335, DOI 10.1016/j.mito.2010.02.006
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VILASECA MA, 1991, J INHERIT METAB DIS, V14, P285, DOI 10.1007/BF01811683
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wang WY, 2011, NUCLEIC ACIDS RES, V39, P44, DOI 10.1093/nar/gkq750
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 52
TC 31
Z9 37
U1 0
U2 26
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD NOV
PY 2012
VL 107
IS 3
BP 409
EP 415
DI 10.1016/j.ymgme.2012.08.018
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 032LM
UT WOS:000310720200024
PM 22980518
DA 2024-11-01
ER

PT S
AU Khusnutdinova, E
   Gilyazova, I
   Ruiz-Pesini, E
   Derbeneva, O
   Khusainova, R
   Khidiyatova, I
   Magzhanov, R
   Wallace, DC
AF Khusnutdinova, Elza
   Gilyazova, Irina
   Ruiz-Pesini, Eduardo
   Derbeneva, Olga
   Khusainova, Rita
   Khidiyatova, Irina
   Magzhanov, Rim
   Wallace, Douglas C.
BE Gibson, GE
   Ratan, RR
   Beal, MF
TI A Mitochondrial Etiology of Neurodegenerative Diseases: Evidence from
   Parkinson's Disease
SO MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT Conference on Mitochondria and Oxisative Stress in Neurodegenerative
   Disorders
CY SEP 26-29, 2007
CL New York Acad Sci, New York, NY
SP Weill Med Coll, Cornell Univ, Grad Sch Med Sci, Ellison Med Fdn, Burke Med Res Inst
HO New York Acad Sci
DE mitochondrial DNA; Parkinson's disease; disease risk; Tatars
ID HEREDITARY OPTIC NEUROPATHY; OXIDATIVE-PHOSPHORYLATION DEFECTS;
   ELECTRON-TRANSPORT CHAIN; SKELETAL-MUSCLE; DNA POLYMORPHISMS;
   SEQUENCE-ANALYSIS; CHLORAMPHENICOL RESISTANCE; DEGENERATIVE DISEASES;
   ADAPTIVE SELECTION; ALZHEIMERS-DISEASE
AB Evidence continues to accrue implicating mitochondrial dysfunction in the etiology of a number of neurodegenerative diseases. For example, Parkinson's disease (PD) can be induced by mitochondrial toxins, and nuclear DNA (nDNA) loci linked to PD have been associated with mitochondrial dysfunction. Although conclusions about the role of mitochondrial DNA (mtDNA) variants in PD vary, we argue here that this is attributable to the novel genetics of the mtDNA and the fact that clinically relevant: mtDNA variation encompasses ancient adaptive polymorphisms, recent deleterious mutations, and somatic mutations. An mtDNA association with PD is supported by an analysis of the Russian Tatar population which revealed that polymorphisms associated with haplogroup H mtDNAs increased PD risk (odds ratio (OR) = 2.58, P = 0.0001), whereas those associated with haplogroup UK cluster mtDNAs were protective (OR = 0.38, P = 0.003). Moreover, mtDNA sequencing revealed that PD patients with either haplogroup H or UK cluster mtDNAs can harbor additional recent variants that might further modulate PD risk. Therefore, the complexity of PD genetics may reflect the complex mitochondrial genetics.
C1 [Ruiz-Pesini, Eduardo; Derbeneva, Olga; Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondiral Med & Genet, Irvine, CA 92697 USA.
   [Khusnutdinova, Elza; Gilyazova, Irina; Khusainova, Rita; Khidiyatova, Irina] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa 450001, Bashkortostan, Russia.
   [Khusainova, Rita; Magzhanov, Rim] Bashkir State Med Univ, Ufa, Bashkortostan, Russia.
   [Ruiz-Pesini, Eduardo] Univ Zaragoza, CIBERER ISCIII, Dept Bioquim Biol Mol & Celular, Zaragoza, Spain.
   [Ruiz-Pesini, Eduardo; Derbeneva, Olga; Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.
   [Ruiz-Pesini, Eduardo; Derbeneva, Olga; Wallace, Douglas C.] Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92697 USA.
   [Ruiz-Pesini, Eduardo; Derbeneva, Olga; Wallace, Douglas C.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA.
C3 University of California System; University of California Irvine;
   Russian Academy of Sciences; Institute of Biochemistry & Genetics of Ufa
   Science Centre of the RAS; Bashkir State Medical University; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERER; University of
   Zaragoza; University of California System; University of California
   Irvine; University of California System; University of California
   Irvine; University of California System; University of California Irvine
RP Wallace, DC (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondiral Med & Genet, Hewit Hall,Room 2014, Irvine, CA 92697 USA.
EM dwallace@uri.edu
RI Khusainova, Rita/E-6061-2014; Khidiyatova, Irina/G-5896-2017; Gilyazova,
   Irina/E-5798-2014; Khusnutdinova, Elza/A-4810-2013
OI Gilyazova, Irina/0000-0001-9499-5632; Khusnutdinova,
   Elza/0000-0003-2987-3334
FU NIA NIH HHS [AG13154, AG24373, AG01751] Funding Source: Medline; ADAMHA
   HHS [AD16573] Funding Source: Medline
CR Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073
   ANDERSON JJ, 1993, J NEUROL NEUROSUR PS, V56, P477, DOI 10.1136/jnnp.56.5.477
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreatta M, 2001, TATRA MT MATH PUBL, V23, P1
   [Anonymous], 2002, Statistical Methods in Medical Research
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451
   Bermisheva M. A., 2003, Genetika, V39, P1013
   Bermisheva M. A., 2001, Genetika, V37, P1002
   Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bonafè M, 2002, GENE, V286, P121, DOI 10.1016/S0378-1119(01)00812-5
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   Brown MD, 1997, AM J HUM GENET, V60, P381
   BUNN CL, 1974, P NATL ACAD SCI USA, V71, P1681, DOI 10.1073/pnas.71.5.1681
   CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463
   Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7
   Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cortopassi G. A., 1994, American Journal of Human Genetics, V55, pA149
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   Egensperger R, 1997, NEUROPATH APPL NEURO, V23, P315, DOI 10.1046/j.1365-2990.1997.4098040.x
   Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258
   Garcia-Lozano J R, 2000, Hum Mutat, V15, P120, DOI 10.1002/(SICI)1098-1004(200001)15:1<120::AID-HUMU33>3.0.CO;2-8
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   Hutchin TP, 1997, BIOCHEM BIOPH RES CO, V241, P221, DOI 10.1006/bbrc.1997.7793
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   Ingman M, 2007, EUR J HUM GENET, V15, P115, DOI 10.1038/sj.ejhg.5201712
   JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973
   Kalman B, 1996, J NEUROL SCI, V140, P75, DOI 10.1016/0022-510X(96)00112-8
   Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128
   Khusainova R. I., 2004, Genetika, V40, P552
   Khusnutdinova E. K., 1999, Genetika, V35, P982
   Khusnutdinova E. K., 1999, Genetika, V35, P509
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   KRUEGER MJ, 1990, BIOCHEM BIOPH RES CO, V169, P123, DOI 10.1016/0006-291X(90)91442-U
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kutuev I, 2006, HUM HERED, V61, P1, DOI 10.1159/000091309
   Kuzeev R. G., 1992, NARODY SREDNEGO POVO
   Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200
   Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204
   MACKEY D, 1992, AM J HUM GENET, V51, P1218
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   MATHEW GG, 1984, ISOLUTION HIGH MOL W
   Mayr-Wohlfart U, 1997, Eur J Med Res, V2, P111
   McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058
   MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   *MITOMAP, 2006, HUM MIT GEN DAT WWW
   MIZUNO Y, 1995, BBA-MOL BASIS DIS, V1271, P265, DOI 10.1016/0925-4439(95)00038-6
   Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015
   NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Orth M, 2003, NEUROSCI LETT, V351, P29, DOI 10.1016/S0304-3940(03)00941-8
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V176, P938, DOI 10.1016/S0006-291X(05)80276-1
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   RAMSAY RR, 1986, J BIOL CHEM, V261, P7585
   REICHMANN H, 1994, EUR NEUROL, V34, P263, DOI 10.1159/000117053
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Shults CW, 1998, NEUROLOGY, V50, P793, DOI 10.1212/WNL.50.3.793
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   SWEENEY MG, 1993, Q J MED, V86, P435
   Tan EK, 2000, NEUROLOGY, V55, P533, DOI 10.1212/WNL.55.4.533
   Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304
   Tanno Y, 1998, NEUROBIOL AGING, V19, pS47, DOI 10.1016/S0197-4580(98)00028-1
   Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004
   Torroni A, 1996, GENETICS, V144, P1835
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   TORRONI A, 1994, AM J HUM GENET, V55, P760
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x
   Trimmer PA, 2004, NEUROBIOL DIS, V15, P29, DOI 10.1016/j.nbd.2003.09.011
   Trounce I, 2000, NUCLEIC ACIDS RES, V28, P2164, DOI 10.1093/nar/28.10.2164
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vaughan JR, 2001, ANN HUM GENET, V65, P111, DOI 10.1017/S0003480001008557
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wallace D.C., 2007, Emery and Rimoin's Principles and Practice of Medical Genetics, V5th, P194
   Wallace D C., 1997, The Molecular and Genetic Basis of Neurological Disease, P237
   WALLACE DC, 1992, ANN NEUROL, V32, P113, DOI 10.1002/ana.410320123
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WALLACE DC, 1975, J CELL BIOL, V67, P174, DOI 10.1083/jcb.67.1.174
   WALLACE DC, 2000, ORIGIN HUMANKIND, P9
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
NR 129
TC 90
Z9 104
U1 0
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER STREET, HOBOKEN, NJ, UNITED STATES
SN 0077-8923
BN 978-1-57331-713-9
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2008
VL 1147
BP 1
EP 20
DI 10.1196/annals.1427.001
PG 20
WC Cell Biology; Multidisciplinary Sciences; Neurosciences; Physiology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Science & Technology - Other Topics; Neurosciences &
   Neurology; Physiology
GA BIR99
UT WOS:000262397800002
PM 19076426
DA 2024-11-01
ER

PT J
AU Barbosa-Gouveia, S
   Vazquez-Mosquera, ME
   Gonzalez-Vioque, E
   Hermida-Ameijeiras, A
   Valverde, LL
   Armstrong-Moron, J
   Fons-Estupina, MD
   Wintjes, LT
   Kappen, A
   Rodenburg, RJ
   Couce, ML
AF Barbosa-Gouveia, Sofia
   Vazquez-Mosquera, Maria E.
   Gonzalez-Vioque, Emiliano
   Hermida-Ameijeiras, Alvaro
   Valverde, Laura L.
   Armstrong-Moron, Judith
   Fons-Estupina, Maria del Carmen
   Wintjes, Liesbeth T.
   Kappen, Antonia
   Rodenburg, Richard J.
   Couce, Maria L.
TI Characterization of a Novel Splicing Variant in Acylglycerol Kinase
   (AGK) Associated with Fatal Sengers Syndrome
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE acylglycerol kinase; mitochondrial dysfunction; mitochondrial ATP
   generation; oxidative phosphorylation machinery; Sengers syndrome
ID MITOCHONDRIAL MYOPATHY; CONGENITAL CATARACT; HEART; CARDIOLIPIN; ACID;
   METABOLISM; SKELETAL; SUBUNIT; MUSCLE; GENE
AB Mitochondrial functional integrity depends on protein and lipid homeostasis in the mitochondrial membranes and disturbances in their accumulation can cause disease. AGK, a mitochondrial acylglycerol kinase, is not only involved in lipid signaling but is also a component of the TIM22 complex in the inner mitochondrial membrane, which mediates the import of a subset of membrane proteins. AGK mutations can alter both phospholipid metabolism and mitochondrial protein biogenesis, contributing to the pathogenesis of Sengers syndrome. We describe the case of an infant carrying a novel homozygous AGK variant, c.518+1G>A, who was born with congenital cataracts, pielic ectasia, critical congenital dilated myocardiopathy, and hyperlactacidemia and died 20 h after birth. Using the patient's DNA, we performed targeted sequencing of 314 nuclear genes encoding respiratory chain complex subunits and proteins implicated in mitochondrial oxidative phosphorylation (OXPHOS). A decrease of 96-bp in the length of the AGK cDNA sequence was detected. Decreases in the oxygen consumption rate (OCR) and the OCR:ECAR (extracellular acidification rate) ratio in the patient's fibroblasts indicated reduced electron flow through the respiratory chain, and spectrophotometry revealed decreased activity of OXPHOS complexes I and V. We demonstrate a clear defect in mitochondrial function in the patient's fibroblasts and describe the possible molecular mechanism underlying the pathogenicity of this novel AGK variant. Experimental validation using in vitro analysis allowed an accurate characterization of the disease-causing variant.
C1 [Barbosa-Gouveia, Sofia; Vazquez-Mosquera, Maria E.; Hermida-Ameijeiras, Alvaro; Valverde, Laura L.; Couce, Maria L.] Santiago de Compostela Univ Clin Hosp, Unit Diag & Treatment Congenital Metab Dis, Dept Paediat, Santiago De Compostela 15706, Spain.
   [Barbosa-Gouveia, Sofia; Vazquez-Mosquera, Maria E.; Hermida-Ameijeiras, Alvaro; Valverde, Laura L.; Couce, Maria L.] Santiago de Compostela Univ Clin Hosp, Rare Dis Networking Biomed Res Ctr CIBERER, IDIS Hlth Res Inst Santiago de Compostela, European Reference Network Hereditary Metab Disor, Santiago De Compostela 15706, Spain.
   [Gonzalez-Vioque, Emiliano] Puerta de Hierro Majadahonda Univ Hosp, Clin Biochem Serv, Majadahonda 28222, Spain.
   [Armstrong-Moron, Judith] Hosp St Joan de Deu, Clin Genet Mol & Genet Med Sect, Esplugas de Llobregat 08950, Spain.
   [Armstrong-Moron, Judith] Inst Recerca St Joan de Deu, Esplugas de Llobregat 08950, Spain.
   [Armstrong-Moron, Judith; Fons-Estupina, Maria del Carmen] Inst Salud Carlos III ISCIII, CIBER ER Biomed Network Res Ctr Rare Dis, Madrid 28029, Spain.
   [Fons-Estupina, Maria del Carmen] St Joan de Deu Univ Hosp, Pediat Neurol Dept, Inst Recerca St Joan de Deu, Barcelona 08950, Spain.
   [Wintjes, Liesbeth T.; Kappen, Antonia] Radboud Univ Nijmegen Med Ctr, Translat Metab Lab, Dept Lab Med, NL-6525 GA Nijmegen, Netherlands.
   [Rodenburg, Richard J.] Radboud Univ Nijmegen Med Ctr, Dept Pediat, Radboud Ctr Mitochondrial Med, NL-6525 GA Nijmegen, Netherlands.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital
   Puerta de Hierro-Majadahonda; CIBER - Centro de Investigacion Biomedica
   en Red; CIBERER; Radboud University Nijmegen; Radboud University
   Nijmegen
RP Barbosa-Gouveia, S; Couce, ML (corresponding author), Santiago de Compostela Univ Clin Hosp, Unit Diag & Treatment Congenital Metab Dis, Dept Paediat, Santiago De Compostela 15706, Spain.; Barbosa-Gouveia, S; Couce, ML (corresponding author), Santiago de Compostela Univ Clin Hosp, Rare Dis Networking Biomed Res Ctr CIBERER, IDIS Hlth Res Inst Santiago de Compostela, European Reference Network Hereditary Metab Disor, Santiago De Compostela 15706, Spain.
EM sofiabsg@gmail.com; maria.eugenia.vazquez.mosquera@sergas.es;
   egvioque@gmail.com; alvaro.hermida@usc.es; laura261lv@gmail.com;
   jarmstrong@sjdhospitalbarcelona.org; cfons@sjdhospitalbarcelona.org;
   liesbeth.Wintjes@radboudumc.nl; antonia.vanheck-kappen@radboudumc.nl;
   richard.rodenburg@radboudumc.nl; maria.luz.couce.pico@sergas.es
RI Couce, Maria/R-8981-2019; Armstrong, Judith/JSA-1522-2023;
   Hermida-Ameijeiras, Alvaro/AAV-2259-2021; Barbosa-Gouveia,
   Sofia/AAZ-2774-2020; Rodenburg, Richard/N-3579-2014
OI Vazquez Mosquera, Maria Eugenia/0000-0003-3167-5919; Hermida-Ameijeiras,
   Alvaro/0000-0003-3757-262X; Barbosa-Gouveia, Sofia/0000-0003-1431-4644;
   Couce, Maria Luz/0000-0003-4861-9905; Wintjes, L.T./0000-0002-7988-1984;
   van Heck, Antonia/0000-0003-3115-8882; Lopez Valverde,
   Laura/0000-0003-2504-6008; Rodenburg, Richard/0000-0001-5227-3527;
   Armstrong, Judith/0000-0003-0588-9307
CR Abramowicz A, 2018, J APPL GENET, V59, P253, DOI 10.1007/s13353-018-0444-7
   Aldahmesh MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/humu.22071
   Anderson AJ, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190126
   Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Chu BX, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.659158
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23
   Cowell CF, 2009, J CELL SCI, V122, P919, DOI 10.1242/jcs.041061
   Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215
   Duncan AL, 2016, P NATL ACAD SCI USA, V113, P8687, DOI 10.1073/pnas.1608396113
   Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0119-3
   Hu ZL, 2019, CELL METAB, V30, P290, DOI 10.1016/j.cmet.2019.05.016
   Jackson TD, 2021, MOL BIOL CELL, V32, P475, DOI 10.1091/mbc.E20-06-0390
   Jiang HJ, 2020, BLOOD, V136, P119, DOI 10.1182/blood.2019003851
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011
   Kang YL, 2018, SEMIN CELL DEV BIOL, V76, P142, DOI 10.1016/j.semcdb.2017.07.028
   Kang YL, 2017, MOL CELL, V67, P457, DOI 10.1016/j.molcel.2017.06.014
   Kerkhofs M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0179-0
   Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400
   Le CH, 2014, CIRC-HEART FAIL, V7, P172, DOI 10.1161/CIRCHEARTFAILURE.113.000744
   Lu YW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00003
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Morava E, 2004, EUR J PEDIATR, V163, P467, DOI 10.1007/s00431-004-1465-2
   Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0
   Picard M, 2018, FRONT NEUROENDOCRIN, V49, P72, DOI 10.1016/j.yfrne.2018.01.001
   Qi LB, 2021, CELL RES, V31, P369, DOI 10.1038/s41422-020-00400-w
   Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945
   REIBEL DK, 1986, AM J PHYSIOL, V250, pH1, DOI 10.1152/ajpheart.1986.250.1.H1
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   Shen ZN, 2015, BIOMED RES INT-UK, V2015, DOI 10.1155/2015/891707
   Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200
   Srere P.A., 1969, Methods in Enzymology, V13, P3
   Steinegger M, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3019-7
   Stojanovski D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011320
   Suzuki-Hatano S, 2019, HUM GENE THER, V30, P139, DOI 10.1089/hum.2018.020
   VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157
   Vukotic M, 2017, MOL CELL, V67, P471, DOI 10.1016/j.molcel.2017.06.013
NR 42
TC 7
Z9 8
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC
PY 2021
VL 22
IS 24
AR 13484
DI 10.3390/ijms222413484
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA YJ6VL
UT WOS:000744669700001
PM 34948281
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Sinyov, VV
   Chicheva, MM
   Barinova, VA
   Ryzhkova, AI
   Zilinyi, RI
   Karagodin, VP
   Postnov, AY
   Sobenin, IA
   Orekhov, AN
   Sazonova, MA
AF Sinyov, V. V.
   Chicheva, M. M.
   Barinova, V. A.
   Ryzhkova, A. I.
   Zilinyi, R. I.
   Karagodin, V. P.
   Postnov, A. Yu.
   Sobenin, I. A.
   Orekhov, A. N.
   Sazonova, M. A.
TI The heteroplasmy level of some mutations in gene <i>MT-CYB</i> among
   women with asymptomatic atherosclerosis
SO RUSSIAN JOURNAL OF GENETICS
LA English
DT Article
DE atherosclerotic disease; mitochondrial genome; intima-media thickness;
   cytochrome B gene; single nucleotide substitution
ID CYTOCHROME-B GENE; EXERCISE INTOLERANCE; MITOCHONDRIAL-DNA; MYOPATHY;
   PATIENT; ONSET
AB Atherosclerosis is a polygenic socially significant disease whose risk factors include coronary heart disease, diabetes, hypertension, and myocardial infarction. According to the literature, mutations m.14846G > A (G34S), m.15762G > A (G339Q), m.15084G > A (W113Ter), and m.15059G > A (G190Ter) of cytochrome B gene (MT-CYB) are associated with mitochondrial myopathies, myoglobinuria, and exercise intolerance. Preliminary studies carried out by the authors made it possible to discover an association of certain mitochondrial genome mutations with atherosclerotic lesions of aortic intima in people who died as a result of an accident or sudden death. The most interesting seemed to be the data on the association of mutations m.14846G > A and m.15059G > A of the cytochrome B gene with lipofibrous aortic plaques, because these mutations affect the mitochondrial respiratory chain enzyme. Defects in the given chain may be the reason for the launch of pathogenic mechanisms in the human body. Owing to the fact that mutations in the mitochondrial genome are inherited by the maternal type, it was decided to analyze cytochrome B gene mutations in a sample of female volunteers from Moscow oblast. According to the findings, mutations m.14846G > A and m.15059G > A are highly significantly associated with atherosclerotic lesions of the carotid arteries: m.14846G > A is antiatherogenic and m.15059G > A is proatherogenic.
C1 [Sinyov, V. V.; Barinova, V. A.; Postnov, A. Yu.; Sobenin, I. A.; Sazonova, M. A.] Russian Cardiol Res & Prod Complex, Moscow 121552, Russia.
   [Chicheva, M. M.; Ryzhkova, A. I.; Sobenin, I. A.; Orekhov, A. N.; Sazonova, M. A.] Res Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia.
   [Ryzhkova, A. I.; Orekhov, A. N.] Skryabin Moscow State Acad Vet Med & Biotechnol, Moscow 109472, Russia.
   [Zilinyi, R. I.] Univ Debrecen, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary.
   [Karagodin, V. P.] Plekhanov Russian Univ Econ, Moscow 117997, Russia.
   [Orekhov, A. N.] Skolkovo Innovat Ctr, Inst Atherosclerosis Res, Skolkovo 121609, Moscow Oblast, Russia.
C3 National Medical Research Center of Cardiology; Russian Academy of
   Medical Sciences; Institute of General Pathology & Pathophysiology,
   RAMS; Moscow State Academy of Veterinary Medicine & Biotechnology named
   after K.I. Skryabin; University of Debrecen; Plekhanov Russian
   University of Economics
RP Sinyov, VV (corresponding author), Russian Cardiol Res & Prod Complex, Moscow 121552, Russia.
EM centaureaceanus@mail.ru
RI Sinyov, Vasiliy/K-9084-2014; Sobenin, Igor/J-4282-2013; Ryzhkova,
   Anastasiya/F-1677-2014; Karagodin, Vasilii/V-2773-2017; Chicheva,
   Mariia/I-4196-2017; Sazonova, Margarita/O-9685-2017
OI Ryzhkova, Anastasiya/0000-0002-8838-7750; Postnov,
   Anton/0000-0002-2501-7269; Karagodin, Vasilii/0000-0003-0501-8499;
   Chicheva, Mariia/0000-0002-8014-8798; Sazonova,
   Margarita/0000-0002-8610-4593
FU Russian Science Foundation [14-14-01038]; Russian Science Foundation
   [14-14-01038] Funding Source: Russian Science Foundation
FX This work was supported by the Russian Science Foundation, grant no.
   14-14-01038.
CR Amosenko F. A., 1997, RUSS J GENET, V33, P198
   AMOSENKO FA, 1995, GENETIKA+, V31, P532
   Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018
   Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444
   Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], 1982, MOL CLONING
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Döring Y, 2012, ARTERIOSCL THROM VAS, V32, P182, DOI 10.1161/ATVBAHA.111.232686
   Han CB, 2005, WORLD J GASTROENTERO, V11, P31, DOI 10.3748/wjg.v11.i1.31
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   Ivanova M.M., 2012, BIOMED ZH MEDLINE RU, V13, P309
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Kazubskaya T.P., 2003, 7 ROSS ONK K, P137
   Maniatis T., 1984, METODY GENETICHESKOI
   Miasoedova V A, 2012, Patol Fiziol Eksp Ter, P104
   Myasoedova V.A., 2013, POLOVYE RAZLICHIYA A
   Nagornev V A, 2006, PATOGENEZ ATEROSKLER
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   [Сазонова М.А. Sazonova M.A.], 2012, [Патологическая физиология и экспериментальная терапия, Patologicheskaya fiziologiya i eksperimental'naya terapiya], P67
   [Сазонова М.А. Sazonova M.A.], 2012, [Патологическая физиология и экспериментальная терапия, Patologicheskaya fiziologiya i eksperimental'naya terapiya], P62
   [Сазонова М.А. Sazonova M.A.], 2012, [Патологическая физиология и экспериментальная терапия, Patologicheskaya fiziologiya i eksperimental'naya terapiya], P71
   Sazonova M A, 2011, Patol Fiziol Eksp Ter, P81
   Sazonova MA, 2010, ATHEROSCLEROSIS, V209, P306, DOI 10.1016/j.atherosclerosis.2009.08.034
   Sazonova M.A., 2015, PATOL FIZIOL EKSP TE, V1, P17
   Sazonova M.A., 2014, MEZHDUNAR NAUCHNO IS, V20, P18
   Sazonova M.A., 1999, THESIS, P157
   Sazonova M.A., 2005, VESTN ROSS ONKOL TSE, P16
   Sazonova M.A., 1997, RUSS J GENET, V33, P1313
NR 29
TC 3
Z9 4
U1 0
U2 3
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1022-7954
EI 1608-3369
J9 RUSS J GENET+
JI Russ. J. Genet.
PD AUG
PY 2016
VL 52
IS 8
BP 847
EP 852
DI 10.1134/S1022795416080123
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA DW0NX
UT WOS:000383338200009
DA 2024-11-01
ER

PT J
AU Nasca, A
   Scotton, C
   Zaharieva, I
   Neri, M
   Selvatici, R
   Magnusson, OT
   Gal, A
   Weaver, D
   Rossi, R
   Armaroli, A
   Pane, M
   Phadke, R
   Sarkozy, A
   Muntoni, F
   Hughes, I
   Cecconi, A
   Hajnóczky, G
   Donati, A
   Mercuri, E
   Zeviani, M
   Ferlini, A
   Ghezzi, D
AF Nasca, Alessia
   Scotton, Chiara
   Zaharieva, Irina
   Neri, Marcella
   Selvatici, Rita
   Magnusson, Olafur Thor
   Gal, Aniko
   Weaver, David
   Rossi, Rachele
   Armaroli, Annarita
   Pane, Marika
   Phadke, Rahul
   Sarkozy, Anna
   Muntoni, Francesco
   Hughes, Imelda
   Cecconi, Antonella
   Hajnoczky, Gyoergy
   Donati, Alice
   Mercuri, Eugenio
   Zeviani, Massimo
   Ferlini, Alessandra
   Ghezzi, Daniele
TI Recessive mutations in <i>MSTO1</i> cause mitochondrial dynamics
   impairment, leading to myopathy and ataxia
SO HUMAN MUTATION
LA English
DT Article
DE ataxia; mitochondrial dynamics; MSTO1; myopathy; skeletal abnormalities
ID DOMINANT OPTIC ATROPHY; DNA-SEQUENCING DATA; PROTEIN; DIVISION; FUSION;
   CELLS; GENE; SACCHAROMYCES; MORPHOLOGY; DROSOPHILA
AB We report here the first families carrying recessive variants in the MSTO1 gene: compound heterozygous mutations were identified in two sisters and in an unrelated singleton case, who presented a multisystem complex phenotype mainly characterized by myopathy and cerebellar ataxia. Human MSTO1 is a poorly studied protein, suggested to have mitochondrial localization and to regulate morphology and distribution of mitochondria. As for other mutations affecting genes involved in mitochondrial dynamics, no biochemical defects typical of mitochondrial disorders were reported. Studies in patients' fibroblasts revealed that MSTO1 protein levels were strongly reduced, the mitochondrial network was fragmented, and the fusion events among mitochondria were decreased, confirming the deleterious effect of the identified variants and the role of MSTO1 in modulating mitochondrial dynamics. We also found that MSTO1 is mainly a cytosolic protein. These findings indicate recessive mutations in MSTO1 as a new cause for inherited neuromuscular disorders with multisystem features.
C1 [Nasca, Alessia; Ghezzi, Daniele] Fdn IRCCS Neurol Inst Besta, Mol Neurogenet Unit, Via Temolo 4, I-20126 Milan, Italy.
   [Scotton, Chiara; Neri, Marcella; Selvatici, Rita; Rossi, Rachele; Armaroli, Annarita; Ferlini, Alessandra] Univ Ferrara, Med Genet Unit, Dept Med Sci, Ferrara, Italy.
   [Zaharieva, Irina; Phadke, Rahul; Sarkozy, Anna; Muntoni, Francesco; Ferlini, Alessandra] UCL Great Ormond St Hosp, Dubowitz Neuromuscular Ctr, London, England.
   [Magnusson, Olafur Thor] deCODE Genet, Reykjavik, Iceland.
   [Gal, Aniko; Weaver, David; Hajnoczky, Gyoergy] Thomas Jefferson Univ, MitoCare Ctr Mitochondrial Imaging Res & Diagnost, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
   [Gal, Aniko] Semmelweis Univ, Inst Genom Med & Rare Disorders, Budapest, Hungary.
   [Pane, Marika; Mercuri, Eugenio] Catholic Univ, Neuropsichiat Unit, Policlin Gemelli, Rome, Italy.
   [Hughes, Imelda] Royal Manchester Childrens Hosp, Manchester, Lancs, England.
   [Cecconi, Antonella] Hosp S Maria Annunziata Bagno Ripoli, Pediat Med Genet, Florence, Italy.
   [Donati, Alice] Meyer Children Hosp, Unit Metab & Muscular Dis, Florence, Italy.
   [Zeviani, Massimo] Mitochondrial Biol Unit MRC, Cambridge, England.
C3 University of Ferrara; University of London; University College London;
   Jefferson University; Semmelweis University; Catholic University of the
   Sacred Heart; IRCCS Policlinico Gemelli; Royal Manchester Children's
   Hospital; University of Florence; Azienda Ospedaliera Universitaria
   (AOU) MEYER
RP Ghezzi, D (corresponding author), Fdn IRCCS Neurol Inst Besta, Mol Neurogenet Unit, Via Temolo 4, I-20126 Milan, Italy.; Ferlini, A (corresponding author), Univ Ferrara, Unit Med Genet, Via Fossato Mortara 74, I-44121 Ferrara, Italy.; Zeviani, M (corresponding author), Wellcome Trust Res Labs, MRC Mitochondrial Biol Unit, MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.
EM mdz21@mrc-mbu.cam.ac.uk; fla@unife.it; daniele.ghezzi@istituto-besta.it
RI Pane, Marika/K-1818-2017; Zeviani, Massimo/AAU-2632-2021; Phadke,
   Rahul/U-6960-2019; Neri, Marcella/GNP-6503-2022; Mercuri,
   Eugenio/G-1351-2015; Selvatici, Rita/K-3741-2018; FERLINI,
   ALESSANDRA/K-7532-2016; Nasca, Alessia/K-2227-2016; Ghezzi,
   Daniele/J-7873-2016
OI Mercuri, Eugenio/0000-0002-9851-5365; Selvatici,
   Rita/0000-0002-3099-0100; Pane, Marika/0000-0002-4851-6124; Neri,
   Marcella/0000-0001-6133-9831; Magnusson, Olafur
   Thor/0000-0002-5285-9904; FERLINI, ALESSANDRA/0000-0001-8385-9870;
   Nasca, Alessia/0000-0002-0640-9929; Zeviani,
   Massimo/0000-0002-9067-5508; Rossi, Rachele/0000-0001-8264-4798; Ghezzi,
   Daniele/0000-0002-6564-3766
FU EU NeurOmics [2012-305121-2]; European Community's Seventh Framework
   Programme; Regione Emilia Romagna; Telethon [GGP15041]; Pierfranco and
   Luisa Mariani Foundation; MRC-QQR [2015-20120]; ERC [FP7-322424];
   NRJ-Institut de France grant; Telethon Network of Genetic Biobanks
   [GTB12001J]; MRC Neuromuscular Centre; Muscular Dystrophy UK; National
   Institute for Health Research Biomedical Research Centre at Great Ormond
   Street Hospital for Children NHS Foundation Trust and University College
   London; MRC [MC_UU_00015/5, MC_UP_1002/1] Funding Source: UKRI
FX Contract grant sponsors: EU NeurOmics (project N.2012-305121-2); the
   European Community's Seventh Framework Programme (FP7/2007-2013);
   Regione Emilia Romagna; the Telethon (grant GGP15041); the Pierfranco
   and Luisa Mariani Foundation; the MRC-QQR (2015-20120); the ERC advanced
   grant (FP7-322424); the NRJ-Institut de France grant; Telethon Network
   of Genetic Biobanks (grant GTB12001J); MRC Neuromuscular Centre (for the
   Biobank); Muscular Dystrophy UK; National Institute for Health Research
   Biomedical Research Centre at Great Ormond Street Hospital for Children
   NHS Foundation Trust and University College London.
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Fernández-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Gal A., 2016, EUROPEAN J HUMAN S1, V24, P199
   Ghezzi D, 2009, HUM MOL GENET, V18, P1058, DOI 10.1093/hmg/ddn441
   Gurvitz A, 2002, FEMS YEAST RES, V2, P123, DOI 10.1111/j.1567-1364.2002.tb00077.x
   Kimura M, 2007, EXP CELL RES, V313, P1393, DOI 10.1016/j.yexcr.2007.02.004
   Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Mayorov Vladimir I., 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-22
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Miklos GLG, 1997, P NATL ACAD SCI USA, V94, P5189, DOI 10.1073/pnas.94.10.5189
   Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103
   Nasca A, 2016, HUM MUTAT, V37, P898, DOI 10.1002/humu.23033
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821
   Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198
   Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Weaver D, 2014, MOL CELL, V54, P870, DOI 10.1016/j.molcel.2014.03.048
   Weber TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063683
NR 27
TC 39
Z9 45
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD AUG
PY 2017
VL 38
IS 8
BP 970
EP 977
DI 10.1002/humu.23262
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA FA3EA
UT WOS:000405323500010
PM 28544275
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Ewert, R
   Elhadad, MA
   Habedank, D
   Heine, A
   Stubbe, B
AF Ewert, Ralf
   Elhadad, Mohamed A. A.
   Habedank, Dirk
   Heine, Alexander
   Stubbe, Beate
TI Primary mitochondrial disease as a rare cause of unclear breathlessness
   and distinctive performance degradation - a case report
SO BMC PULMONARY MEDICINE
LA English
DT Article
DE Case report; Dyspnea; Invasive cardiopulmonary exercise testing;
   Lactate; Metabolic myopathy; Mitochondriopathy
ID EXERCISE; STATEMENT
AB BackgroundPrimary muscular disorders (metabolic myopathies, including mitochondrial disorders) are a rare cause of dyspnea. We report a case of dyspnea caused by a mitochondrial disorder with a pattern of clinical findings that can be classified in the known pathologies of mitochondrial deletion syndrome.Case presentationThe patient presented to us at 29 years of age, having had tachycardia, dyspnea, and functional impairment since childhood. She had been diagnosed with bronchial asthma and mild left ventricular hypertrophy and treated accordingly, but her symptoms had worsened. After more than 20 years of progressive physical and social limitations was a mitochondrial disease suspected in the exercise testing. We performed cardiopulmonary exercise testing (CPET) with right heart catheterization showed typical signs of mitochondrial myopathy. Genetic testing confirmed the presence of a similar to 13 kb deletion in mitochondrial DNA from the muscle. The patient was treated with dietary supplements for 1 year. In the course of time, the patient gave birth to a healthy child, which is developing normally.ConclusionCPET and lung function data over 5 years demonstrated stable disease. We conclude that CPET and lung function analysis should be used consistently to evaluate the cause of dyspnea and for long-term observation.
C1 [Ewert, Ralf; Elhadad, Mohamed A. A.; Habedank, Dirk; Heine, Alexander; Stubbe, Beate] Univ Hosp Greifswald, Dept Internal Med B Pneumol, F Sauerbruchstr, D-17475 Greifswald, Germany.
   [Habedank, Dirk] Hosp Berlin, DRK, Berlin, Germany.
RP Stubbe, B (corresponding author), Univ Hosp Greifswald, Dept Internal Med B Pneumol, F Sauerbruchstr, D-17475 Greifswald, Germany.
EM beate.stubbe@med.uni-greifswald.de
FU Ernst-Moritz-Arndt University (Greifswald, Germany)
FX Histological analyses were performed at the Institute of Pathology,
   University Hospital Greifswald, Greifswald, Germany (Director: Prof. Dr
   Frank Dombrowski). Histochemical and genetic assessments were performed
   at the Institute of Human Genetics, Technical University of Munich,
   Munich, Germany (Director: Prof. Dr Thomas Meitinger). Dr Claire
   Mulligan (Beacon Medical Communications Ltd, Brighton, UK) provided
   editorial assistance (editing a draft developed by the authors), funded
   by the Ernst-Moritz-Arndt University (Greifswald, Germany).
CR Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   BOGAARD JM, 1988, EUR RESPIR J, V1, P445
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Das AM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/340849
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P425, DOI 10.1164/ajrccm.164.3.2005110
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Karaa A, 2019, MITOCHONDRION, V46, P214, DOI 10.1016/j.mito.2018.06.007
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST
   Riley MS, 2017, ANN AM THORAC SOC, V14, pS129, DOI 10.1513/AnnalsATS.201701-014FR
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Wasserman K, 2002, AM J RESP CRIT CARE, V166, P118
NR 15
TC 1
Z9 1
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2466
J9 BMC PULM MED
JI BMC Pulm. Med.
PD MAR 29
PY 2023
VL 23
IS 1
AR 104
DI 10.1186/s12890-023-02391-x
PG 6
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA C2RY6
UT WOS:000960463300002
PM 36991405
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Mao, PZ
   Gallagher, P
   Nedungadi, S
   Manczak, M
   Shirendeb, UP
   Kohama, SG
   Ferguson, B
   Park, BS
   Reddy, PH
AF Mao, Peizhong
   Gallagher, Patience
   Nedungadi, Samira
   Manczak, Maria
   Shirendeb, Ulziibat P.
   Kohama, Steven G.
   Ferguson, Betsy
   Park, Byung S.
   Reddy, P. Hemachandra
TI Mitochondrial DNA deletions and differential mitochondrial DNA content
   in Rhesus monkeys: Implications for aging
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Rhesus monkeys; Mitochondrial DNA; Aging; Real-time RT-PCR;
   Mitochondrial DNA deletion; Mitochondrial-encoded DNA
ID SKELETAL-MUSCLE; ALZHEIMERS-DISEASE; GENE-EXPRESSION; LIFE-SPAN; COMMON
   DELETION; AMYLOID-BETA; MUTATIONS; DYSFUNCTION; DAMAGE; ABNORMALITIES
AB The purpose of this study was to determine the relationship between mitochondria! DNA (mtDNA) deletions, mtDNA content and aging in rhesus monkeys. Using 2 sets of specific primers, we amplified an 8 kb mtDNA fragment covering a common 5.7 kb deletion and the entire 16.5 kb mitochondrial genome in the brain and buffy-coats of young and aged monkeys. We studied a total of 66 DNA samples: 39 were prepared from a buffy-coat and 27 were prepared from occipital cortex tissues. The mtDNA data were assessed using a permutation test to identify differences in mtDNA, in the different monkey groups. Using real-time RT-PCR strategy, we also assessed both mtDNA and nuclear DNA levels for young, aged and male and female monkeys. We found a 5.7 kb mtDNA deletion in 81.8% (54 of 66) of the total tested samples. In the young group of buffy-coat DNA, we found 5.7 kb deletions in 7 of 17 (41%), and in the aged group, we found 5.7 kb deletions in 12 of 22 (54%), suggesting that the prevalence of mtDNA deletions is related to age. We found decreased mRNA levels of mtDNA in aged monkeys relative to young monkeys. The increases in mtDNA deletions and mtDNA levels in aged rhesus monkeys suggest that damaged DNA accumulates as rhesus monkeys age and these altered mtDNA changes may have physiological relevance to compensate decreased mitochondrial function. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Reddy, P. Hemachandra] Oregon Hlth & Sci Univ, Neurogenet Lab, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA.
   [Park, Byung S.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Div Biostat, Portland, OR 97239 USA.
   [Reddy, P. Hemachandra] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA.
C3 Oregon Health & Science University; Oregon National Primate Research
   Center; Oregon Health & Science University; Oregon Health & Science
   University
RP Reddy, PH (corresponding author), Oregon Hlth & Sci Univ, Neurogenet Lab, Div Neurosci, Oregon Natl Primate Res Ctr, West Campus,505 NW 185th Ave, Beaverton, OR 97006 USA.
EM reddyh@ohsu.edu
OI /0000-0003-3516-7516
FU NIH [AG028072, RR00163]; Alzheimer Association IIRG [IIRG-09-92429]
FX This research presented was supported by NIH grants AG028072, RR00163
   and Alzheimer Association IIRG grant, IIRG-09-92429
CR Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x
   de Carvalho CV, 2000, BIOGERONTOLOGY, V1, P357, DOI 10.1023/A:1026542618182
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Fernandes A, 2003, INVEST OPHTH VIS SCI, V44, P2373, DOI 10.1167/iovs.02-0944
   Fu YJ, 2009, CELL MOL NEUROBIOL, V29, P649, DOI 10.1007/s10571-009-9359-5
   Gibson TC, 2005, MOL HUM REPROD, V11, P785, DOI 10.1093/molehr/gah227
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X
   Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LeDoux SP, 2007, NEUROSCIENCE, V145, P1249, DOI 10.1016/j.neuroscience.2006.10.002
   Lim PS, 2000, FREE RADICAL BIO MED, V29, P454, DOI 10.1016/S0891-5849(00)00334-8
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147
   Manczak M, 2009, HUM MOL GENET, V18, P3876, DOI 10.1093/hmg/ddp331
   Mao PZ, 2010, BBA-MOL BASIS DIS, V1802, P66, DOI 10.1016/j.bbadis.2009.07.002
   Mattson MP, 2000, EXP GERONTOL, V35, P489, DOI 10.1016/S0531-5565(00)00115-7
   Mehmet D, 2001, MOL HUM REPROD, V7, P301, DOI 10.1093/molehr/7.3.301
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Peng TI, 2006, BBA-MOL BASIS DIS, V1762, P241, DOI 10.1016/j.bbadis.2005.10.008
   Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002
   Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754
   Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z
   Reddy PH, 2004, HUM MOL GENET, V13, P1225, DOI 10.1093/hmg/ddh140
   Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541
   Sastre J, 2002, ANN NY ACAD SCI, V959, P448, DOI 10.1111/j.1749-6632.2002.tb02114.x
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Sedensky MM, 2006, EXP GERONTOL, V41, P237, DOI 10.1016/j.exger.2006.01.004
   Swerdlow RH, 2009, J ALZHEIMERS DIS, V17, P737, DOI 10.3233/JAD-2009-1095
   Tonska K, 2009, J APPL GENET, V50, P55, DOI 10.1007/BF03195653
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
NR 43
TC 14
Z9 16
U1 0
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD FEB
PY 2012
VL 1822
IS 2
BP 111
EP 119
DI 10.1016/j.bbadis.2011.10.014
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 888EM
UT WOS:000299986600002
PM 22056405
OA Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Li, YF
   Li, HZ
   Hu, PQ
   Deng, J
   Banoei, MM
   Sharma, LK
   Bai, YD
AF Li, Youfen
   Li, Hong-Zhi
   Hu, Peiqing
   Deng, Janice
   Banoei, Mohammad Mehdi
   Sharma, Lokendra Kumar
   Bai, Yidong
TI Generation and bioenergetic analysis of cybrids containing mitochondrial
   DNA from mouse skeletal muscle during aging
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID DELETION MUTATIONS; NADH DEHYDROGENASE; HUMAN-CELLS; MTDNA; FIBERS;
   ABNORMALITIES; RESTRICTION; SARCOPENIA; RAT; COMPLEMENTATION
AB Mitochondrial respiratory chain defects have been associated with various diseases and normal aging, particularly in tissues with high energy demands including skeletal muscle. Muscle-specific mitochondrial DNA (mtDNA) mutations have also been reported to accumulate with aging. Our understanding of the molecular processes mediating altered mitochondrial gene expression to dysfunction associated with mtDNA mutations in muscle would be greatly enhanced by our ability to transfer muscle mtDNA to established cell lines. Here, we report the successful generation of mouse cybrids carrying skeletal muscle mtDNA. Using this novel approach, we performed bioenergetic analysis of cells bearing mtDNA derived from young and old mouse skeletal muscles. A significant decrease in oxidative phosphorylation coupling and regulation capacity has been observed with cybrids carrying mtDNA from skeletal muscle of old mice. Our results also revealed decrease growth capacity and cell viability associated with the mtDNA derived from muscle of old mice. These findings indicate that a decline in mitochondrial function associated with compromised mtDNA quality during aging leads to a decrease in both the capacity and regulation of oxidative phosphorylation.
C1 [Li, Youfen; Li, Hong-Zhi; Hu, Peiqing; Deng, Janice; Banoei, Mohammad Mehdi; Sharma, Lokendra Kumar; Bai, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   [Li, Youfen] Xi An Jiao Tong Univ, Sch Life Sci, Xian 710049, Peoples R China.
   [Li, Hong-Zhi] Wenzhou Med Coll, Sch Life Sci, Wenzhou 325035, Peoples R China.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; Xi'an Jiaotong University; Wenzhou Medical University
RP Bai, YD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
EM baiy@uthscsa.edu
RI Banoei, Mohammad Mehdi/KDN-6268-2024; Bai, Yidong/A-4959-2012; Li,
   You-Fen/W-9042-2019
FU National Institute of Aging/National Institutions of Health [R01
   AG025223, R03AG024640]
FX The National Institute of Aging/National Institutions of Health (grants
   R01 AG025223 and R03AG024640 to Y.B.). Funding for open access charges:
   National Institutions of Health (R01 AG025223).
CR Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   [Anonymous], SCI AGING KNOWLEDGE
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X
   Bai YD, 2004, ANN NY ACAD SCI, V1011, P272, DOI 10.1196/annals.1293.026
   Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848
   Bai YD, 2005, ANN NY ACAD SCI, V1042, P25, DOI 10.1196/annals.1338.003
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Inoue K, 1997, J BIOL CHEM, V272, P15510, DOI 10.1074/jbc.272.24.15510
   Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lee CM, 1998, ANN NY ACAD SCI, V854, P182, DOI 10.1111/j.1749-6632.1998.tb09901.x
   Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   MASORO EJ, 1993, J AM GERIATR SOC, V41, P994, DOI 10.1111/j.1532-5415.1993.tb06767.x
   McKiernan SH, 2007, AM J PHYSIOL-RENAL, V292, pF1751, DOI 10.1152/ajprenal.00307.2006
   McKiernan SH, 2009, EXP GERONTOL, V44, P170, DOI 10.1016/j.exger.2008.09.014
   Miquel J, 1992, EXS, V62, P47
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MORGANHUGHES JA, 1994, CURR OPIN NEUROL, V7, P457, DOI 10.1097/00019052-199410000-00014
   NAVARRO A, 2001, FRONT BIOSCI, V6, P26
   Pak JW, 2005, EXP GERONTOL, V40, P209, DOI 10.1016/j.exger.2004.12.005
   Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wanagat J, 2002, J MOL CELL CARDIOL, V34, P17, DOI 10.1006/jmcc.2001.1483
NR 40
TC 7
Z9 8
U1 1
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR
PY 2010
VL 38
IS 6
BP 1913
EP 1921
DI 10.1093/nar/gkp1162
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 578PB
UT WOS:000276304600023
PM 20022917
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Raz, Y
   Raz, V
AF Raz, Yotam
   Raz, Vered
TI Oculopharyngeal muscular dystrophy as a paradigm for muscle aging
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Review
DE adult myopathy; muscle degeneration; OPMD; PABPN1; RNA metabolism
ID POLY(A) BINDING-PROTEIN; NUCLEAR INCLUSIONS; MOLECULAR-MECHANISMS;
   MITOCHONDRIAL-DNA; MOUSE MODEL; PABP2 GENE; IN-VIVO; AGGREGATION;
   TOXICITY; MUTATION
AB Symptoms in late-onset neuromuscular disorders initiate only from midlife onward and progress with age. These disorders are primarily determined by identified hereditable mutations, but their late-onset symptom manifestation is not fully understood. Here, we review recent research developments on the late-onset autosomal dominant oculopharyngeal muscular dystrophy (OPMD). OPMD is caused by an expansion mutation in the gene encoding for poly-adenylate RNA binding protein1 (PABPN1). The molecular pathogenesis for the disease is still poorly understood. Despite a ubiquitous expression of PABPN1, symptoms in OPMD are limited to skeletal muscles. We discuss recent studies showing that PABPN1 levels in skeletal muscles are lower compared with other tissues, and specifically in skeletal muscles, PABPN1 expression declines from midlife onward. In OPMD, aggregation of expanded PABPN1 causes an additional decline in the level of the functional protein, which is associated with severe muscle weakness in OPMD. Reduced PABNPN1 expression in muscle cell culture causes myogenic defects, suggesting that PABPN1 loss-of-function causes muscle weakness in OPMD and in the elderly. Molecular signatures of OPMD muscles are similar to those of normal muscle aging, although expression trends progress faster in OPMD. We discuss a working hypothesis that aging-associated factors trigger late-onset symptoms in OPMD, and contribute to accelerated muscle weakness in OPMD. We focus on the pharyngeal and eyelid muscles, which are often affected in OPMD patients. We suggest that muscle weakness in OPMD is a paradigm for muscle aging.
C1 [Raz, Yotam; Raz, Vered] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RC Leiden, Netherlands.
C3 Leiden University - Excl LUMC; Leiden University; Leiden University
   Medical Center (LUMC)
RP Raz, V (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, Einthovenweg 20,Bldg 2,Room R3-17,Postzone S4-P, NL-2300 RC Leiden, Netherlands.
EM v.raz@lumc.nl
OI Raz, Yotam/0000-0001-9628-632X; raz, vered/0000-0003-3152-1952
FU French Muscular Dystrophy Association, France; Princess Beatrix Muscle
   Fund, The Netherlands
FX We thank the French Muscular Dystrophy Association, France, and from the
   Princess Beatrix Muscle Fund, The Netherlands for financial support on
   OPMD research.
CR Abu-Baker A, 2005, TRAFFIC, V6, P766, DOI 10.1111/j.1600-0854.2005.00315.x
   Anthony K, 2010, BRAIN RES, V1338, P67, DOI 10.1016/j.brainres.2010.03.008
   Anvar SY, 2013, AGING-US, V5, P412, DOI 10.18632/aging.100567
   Anvar SY, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-15
   Apponi LH, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-23
   Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569
   Beaulieu YB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003078
   Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002
   Berciano MT, 2004, HUM MOL GENET, V13, P829, DOI 10.1093/hmg/ddh101
   Bhattacharjee RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053036
   Blumen SC, 2000, NEUROLOGY, V55, P1267, DOI 10.1212/WNL.55.9.1267
   Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389
   Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164
   Bresson SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003893
   Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924
   Catoire H, 2008, HUM MOL GENET, V17, P2108, DOI 10.1093/hmg/ddn109
   Chartier A, 2009, HUM MOL GENET, V18, P1849, DOI 10.1093/hmg/ddp101
   Corbeil-Girard LP, 2005, NEUROBIOL DIS, V18, P551, DOI 10.1016/j.nbd.2004.10.019
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Davies JE, 2008, HUM MOL GENET, V17, P1097, DOI 10.1093/hmg/ddm382
   Davies JE, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000723
   Davies JE, 2006, HUM MOL GENET, V15, P23, DOI 10.1093/hmg/ddi422
   Davies JE, 2005, NAT MED, V11, P672, DOI 10.1038/nm1242
   de Klerk E, 2012, NUCLEIC ACIDS RES, V40, P9089, DOI 10.1093/nar/gks655
   Eshed I, 2007, ANN RHEUM DIS, V66, P1553, DOI 10.1136/ard.2007.070243
   Fea A, 2013, Minerva Chir, V68, P49
   Feng X, 2013, J GERONTOL A-BIOL, V68, P853, DOI 10.1093/gerona/gls225
   Fischmann A, 2012, J NEUROL, V259, P1648, DOI 10.1007/s00415-011-6393-2
   Iida T, 2013, TOHOKU J EXP MED, V231, P223, DOI 10.1620/tjem.231.223
   Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022
   Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347
   Laberge AM, 2005, CLIN GENET, V68, P287, DOI 10.1111/j.1399-0004.2005.00497.x
   Ney DM, 2009, NUTR CLIN PRACT, V24, P395, DOI 10.1177/0884533609332005
   O'Rourke JR, 2009, J BIOL CHEM, V284, P7419, DOI 10.1074/jbc.R800025200
   Peter L, 2011, GEN COMP ENDOCR, V172, P39, DOI 10.1016/j.ygcen.2011.02.005
   Purves-Smith FM, 2014, EXERC SPORT SCI REV, V42, P45, DOI 10.1249/JES.0000000000000012
   Raz V, 2014, AM J PATHOL, V184, P1119, DOI 10.1016/j.ajpath.2013.12.011
   Raz V, 2013, NEUROMUSCULAR DISORD, V23, P516, DOI 10.1016/j.nmd.2013.03.001
   Raz V, 2011, AM J PATHOL, V179, P1988, DOI 10.1016/j.ajpath.2011.06.044
   Raz V, 2011, NUCLEUS-PHILA, V2, P208, DOI 10.4161/nucl.2.3.15736
   Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742
   Rüegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537
   Rüegg S, 2005, SWISS MED WKLY, V135, P574
   Salvi SM, 2006, POSTGRAD MED J, V82, P581, DOI 10.1136/pgmj.2005.040857
   Schindler JS, 2002, LARYNGOSCOPE, V112, P589, DOI 10.1097/00005537-200204000-00001
   Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003
   Sluijs B., 2003, J NEUROL, V250, P1307, DOI [DOI 10.1007/S00415-003-0201-6, 10.1007/s00415-003-0201-6]
   Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105
   TOME FMS, 1980, ACTA NEUROPATHOL, V49, P85, DOI 10.1007/BF00692226
   Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Willis TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070993
   Witting N, 2014, ACTA NEUROL SCAND, V130, P125, DOI 10.1111/ane.12244
   Yokoyama M, 2000, LARYNGOSCOPE, V110, P434, DOI 10.1097/00005537-200003000-00021
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 55
TC 25
Z9 30
U1 0
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1663-4365
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD NOV 10
PY 2014
VL 6
AR 317
DI 10.3389/fnagi.2014.00317
PG 5
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA AY9OM
UT WOS:000347880300001
PM 25426070
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Lam, CW
   Law, CY
   Siu, WK
   Fung, CW
   Yau, MM
   Huen, KF
   Lee, HHC
   Mak, CM
AF Lam, Ching-Wan
   Law, Chun-Yiu
   Siu, Wai-Kwan
   Fung, Cheuk-Wing
   Yau, Man-Mut
   Huen, Kwai-Fun
   Lee, Hencher Han-Chih
   Mak, Chloe Miu
TI Novel <i>POLG</i> mutation in a patient with sensory ataxia, neuropathy,
   ophthalmoparesis and stroke
SO CLINICA CHIMICA ACTA
LA English
DT Article
DE POLG; Stroke; Sensory ataxia; Neuropathy; Ophthalmoparesis
ID DNA-POLYMERASE-GAMMA; MITOCHONDRIAL; OPHTHALMOPLEGIA; DISORDERS; SANDO
AB Background: Clinical diagnosis of POLG-related disorders can be challenging because the phenotypic spectrums are heterogeneous which can mimic different types of mitochondrial disorders.
   Case: We report a case of POLG-related disorder in an 18 y Chinese girl who had been diagnosed as MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) for the past 8 y. She first presented at 10 y with sudden onset of headache, repeated focal seizures and visual loss, complicated with residual sensory and motor neuropathy, ophthalmoparesis and cortical blindness. MRI brain showed extensive cytotoxic edema and ischemia in bilateral parietal-occipital lobes. Mutation analysis for common point mutations in the mitochondrial DNA and muscle biopsy was negative. She was referred to us for mitochondrial whole genome analysis. However, no pathogenic variants can be determined. We initiated further genetic analysis for POLG which confirmed compound heterozygous mutations NM_002693.2:c.925C>T (p.Arg309Cys) and a novel mutation c.2244G>T (p.Trp748Cys). Both were determined to be pathogenic using in silico analysis.
   Conclusions: The novel mutation contributes to the expanding spectrum of disease-causing mutations. A definitive diagnosis can benefit our patient and also the relatives by avoiding sodium valproate induced liver toxicity in POLG patients and also the heterozygotes. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Lam, Ching-Wan; Law, Chun-Yiu] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.
   [Siu, Wai-Kwan; Lee, Hencher Han-Chih; Mak, Chloe Miu] Princess Margaret Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.
   [Fung, Cheuk-Wing] Queen Mary Hosp, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.
   [Yau, Man-Mut; Huen, Kwai-Fun] Tseung Kwan O Hosp, Dept Pediat, Hong Kong, Hong Kong, Peoples R China.
C3 University of Hong Kong; University of Hong Kong
RP Lam, CW (corresponding author), Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.
EM ching-wanlam@pathology.hku.hk
RI Law, Chun Yiu/B-3515-2012
OI Law, Chun Yiu/0000-0001-8714-4792; Lee, Han-Chih
   Hencher/0000-0002-0162-5681
CR Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Chinnery P.F., 1997, MITOCHONDRIAL DISORD
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Lam CW, 2015, CLIN CHIM ACTA, V440, P201, DOI 10.1016/j.cca.2014.10.030
   Lam CW, 2014, CLIN CHIM ACTA, V436, P217, DOI 10.1016/j.cca.2014.05.014
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   LESTIENNE P, 1987, BIOCHEM BIOPH RES CO, V146, P1146, DOI 10.1016/0006-291X(87)90767-4
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Santoro L, 2006, J NEUROL, V253, P869, DOI 10.1007/s00415-006-0082-6
   Siu WK, 2011, FAM CANCER, V10, P695, DOI 10.1007/s10689-011-9466-6
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 29
TC 11
Z9 11
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0009-8981
EI 1873-3492
J9 CLIN CHIM ACTA
JI Clin. Chim. Acta
PD AUG 25
PY 2015
VL 448
BP 211
EP 214
DI 10.1016/j.cca.2015.06.028
PG 4
WC Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology
GA CQ8OZ
UT WOS:000360869300034
PM 26169155
DA 2024-11-01
ER

PT J
AU Frank, M
   Finsterer, J
AF Frank, Marlies
   Finsterer, Josef
TI CREATINE KINASE ELEVATION, LACTACIDEMIA, AND METABOLIC MYOPATHY IN ADULT
   PATIENTS WITH DIABETES MELLITUS
SO ENDOCRINE PRACTICE
LA English
DT Article
ID MYOTONIC-DYSTROPHY TYPE-2; MUSCULAR-DYSTROPHY; MITOCHONDRIAL-DNA; MTDNA
   MUTATION; RENAL-FAILURE; RHABDOMYOLYSIS; PHENOTYPE; DISEASE;
   ROSIGLITAZONE; SPECTRUM
AB Objective: To determine the frequency of elevated creatine kinase (CK) levels among patients with diabetes mellitus and to determine how often elevated CK is attributable to primary myopathy.
   Methods: In this prospective study, we investigated how often CK, aspartate aminotransferase, alanine aminotransferase, and resting lactate were elevated among consecutive diabetic patients attending our clinic. Those with elevated CK values were offered a neurologic workup.
   Results: Ninety-nine patients with diabetes mellitus, aged 19 to 87 years, were assessed between May 2008 and April 2010. Seven patients had type 1 diabetes and 92 patients had type 2 diabetes. CK, aspartate aminotransferase, alanine aminotransferase, and resting lactate were elevated in 19 of 99, 25 of 99, 22 of 99, and 24 of 98 patients, respectively. Eleven of 19 patients with increased CK were self-injecting insulin. Ten of 24 patients with elevated serum lactate took metformin. Seven of 19 patients with elevated CK consented to neurologic workup. Two of the 7 had elevated resting lactate. In all 7 patients, the findings from neurologic investigation were indicative of a metabolic defect and further diagnostic evaluation was recommended.
   Conclusions: In diabetic patients attending our clinic, elevated CK levels occur in one-fifth and lactacidemia occurs in one-quarter. Elevated CK levels are attributable to a primary metabolic myopathy in most cases. Elevated CK levels in the setting of diabetes mellitus require further neurologic evaluation. (Endocr Pract. 2012;18:387-393)
C1 [Frank, Marlies] First Med Dept, Vienna, Austria.
   [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Finsterer, Josef] Danube Univ Krems, Vienna, Austria.
C3 Rudolfstiftung Hospital; Danube University Krems
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Berardo A, 2010, NEUROMUSCULAR DISORD, V20, P204, DOI 10.1016/j.nmd.2010.01.006
   Bertipaglia I., 2007, V45, P29
   Bhattacharjee M, 2006, ULTRASTRUCT PATHOL, V30, P481, DOI 10.1080/01913120600689624
   Bird TD, 1993, GENEREVIEWS INTERNET
   BRAITHWAITE SS, 1987, DIABETES CARE, V10, P540, DOI 10.2337/diacare.10.4.540
   Casteels Kristina, 2003, Pediatr Diabetes, V4, P29, DOI 10.1034/j.1399-5448.2003.00026.x
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9
   De Block CEM, 2004, EXP CLIN ENDOCR DIAB, V112, P80, DOI 10.1055/s-2004-815754
   Debray FG, 2006, AM J MED GENET A, V140A, P2330, DOI 10.1002/ajmg.a.31457
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   DiGregorio RV, 2009, PHARMACOTHERAPY, V29, P352, DOI 10.1592/phco.29.3.352
   Emery AEH, 2000, NEUROMUSCULAR DISORD, V10, P228, DOI 10.1016/S0960-8966(00)00105-X
   Engelmann G, 2008, J INHERIT METAB DIS, V31, P540, DOI 10.1007/s10545-008-0867-0
   Faubert P F, 1987, Ann Intern Med, V107, P785
   Finsterer J, 2001, J INHERIT METAB DIS, V24, P560, DOI 10.1023/A:1012415810881
   Fromont I, 2009, J NEUROL, V256, P1696, DOI 10.1007/s00415-009-5185-4
   Galtrey Clare M, 2008, J Med Case Rep, V2, P159, DOI 10.1186/1752-1947-2-159
   Gangopadhyay KK, 2006, J ROY SOC MED, V99, P200, DOI 10.1258/jrsm.99.4.200
   Goksen D, 2006, PEDIATR DIABETES, V7, P279, DOI 10.1111/j.1399-5448.2006.00201.x
   Higa EMS, 1997, RENAL FAILURE, V19, P289, DOI 10.3109/08860229709026291
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   Huang BK, 2010, AM J ROENTGENOL, V195, P198, DOI 10.2214/AJR.09.2494
   Kelley DE, 2004, DIABETES CARE, V27, P33, DOI 10.2337/diacare.27.1.33
   Kennie N, 2007, ANN PHARMACOTHER, V41, P521, DOI 10.1345/aph.1H609
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Kilbane BJ, 2006, PEDIATR CRIT CARE ME, V7, P169, DOI 10.1097/01.PCC.0000192340.09136.82
   Kim MS, 2009, J PEDIATR ENDOCR MET, V22, P565
   Komulainen T, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-29
   Layne RD, 2004, ANN PHARMACOTHER, V38, P232, DOI 10.1345/aph.1D282
   Ledl M, 2005, DIABETOLOGIA, V48, P1996, DOI 10.1007/s00125-005-1919-8
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   Liu SM, 2007, DIABETES RES CLIN PR, V76, P425, DOI 10.1016/j.diabres.2006.09.032
   Makovi Helga, 2002, Orv Hetil, V143, P2489
   Malfatti E, 2010, J NEUROL SCI, V297, P105, DOI 10.1016/j.jns.2010.06.009
   Mancuso M, 2005, J NEUROL SCI, V228, P93, DOI 10.1016/j.jns.2004.10.018
   McNab Tammy L, 2005, Endocr Pract, V11, P18
   Mitani S, 2000, HEART VESSELS, V15, P23, DOI 10.1007/s003800070044
   Muschke P, 2007, AM J MED GENET A, V143A, P2810, DOI 10.1002/ajmg.a.32046
   Nagashima T, 1999, ACTA NEUROPATHOL, V97, P416, DOI 10.1007/s004010051007
   Oishi M, 2008, INTERNAL MED, V47, P441, DOI 10.2169/internalmedicine.47.0579
   Ranjbar SH, 2008, J PEDIATR ENDOCR MET, V21, P1185
   Saccone V, 2008, HUM MUTAT, V29, P240, DOI 10.1002/humu.20633
   Savkur RS, 2004, AM J HUM GENET, V74, P1309, DOI 10.1086/421528
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   TRUMP D, 1994, POSTGRAD MED J, V70, P44, DOI 10.1136/pgmj.70.819.44
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   van Rossum Ineke A, 2010, Ned Tijdschr Geneeskd, V154, pA2168
   WANG LM, 1994, DIABETES RES CLIN PR, V26, P209, DOI 10.1016/0168-8227(94)90062-0
   Yamauchi A, 1996, INTERNAL MED, V35, P403, DOI 10.2169/internalmedicine.35.403
   Yokoyama M, 2000, DIABETES CARE, V23, P421, DOI 10.2337/diacare.23.3.421
NR 52
TC 11
Z9 12
U1 12
U2 17
PU AMER ASSOC CLINICAL ENDOCRINOLOGISTS
PI JACKSONVILLE
PA 245 RIVERSIDE AVENUE, STE 200, JACKSONVILLE, FL 32202 USA
SN 1530-891X
J9 ENDOCR PRACT
JI Endocr. Pract.
PD MAY-JUN
PY 2012
VL 18
IS 3
BP 387
EP 393
DI 10.4158/EP11316.OR
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 944WI
UT WOS:000304234100012
PM 22297056
DA 2024-11-01
ER

PT J
AU Nardi, N
   Proulx, F
   Brunel-Guiton, C
   Oligny, LL
   Piché, N
   Mitchell, GA
   Joyal, JS
AF Nardi, Nicolas
   Proulx, Francois
   Brunel-Guiton, Catherine
   Oligny, Luc L.
   Piche, Nelson
   Mitchell, Grant A.
   Joyal, Jean Sebastien
TI Fulminant Necrotizing Enterocolitis and Multiple Organ Dysfunction in a
   Toddler with Mitochondrial DNA Depletion Syndrome-13
SO JOURNAL OF PEDIATRIC INTENSIVE CARE
LA English
DT Article
DE necrotizing enterocolitis; mitochondrial DNA depletion syndrome; FBXL4;
   multiple organ dysfunction syndrome
ID CRITICAL-CARE; FBXL4; PROTEIN; MUTATIONS; THERAPY
AB Necrotizing enterocolitis (NEC) is exceptional after the neonatal period. A toddler with encephalopathy, mitochondrial myopathy, and hypertrophic cardiomyopathy developed fatal NEC and multiple organ dysfunction within 48 hours of the introduction of enteral feeding. She was subsequently found to have pathogenic mutations in FBXL4 , a cause of mitochondrial DNA depletion syndrome-13. Intestinal dysmotility in the context of deficient mitochondrial respiration may have contributed to the development of NEC. Current paradigms call for early introduction of enteral nutrition to reinstate energy homeostasis. Enteral feeding should be administered with caution during metabolic crises of patients with mitochondrial DNA depletion syndromes.
C1 [Nardi, Nicolas; Proulx, Francois; Brunel-Guiton, Catherine; Mitchell, Grant A.; Joyal, Jean Sebastien] Univ Montreal, St Justine Hosp, Dept Pediat, Montreal, PQ, Canada.
   [Oligny, Luc L.] Univ Montreal, St Justine Hosp, Dept Pediat Pathol, Montreal, PQ, Canada.
   [Piche, Nelson] Univ Montreal, St Justine Hosp, Dept Pediat Surg, Montreal, PQ, Canada.
C3 Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine;
   Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine;
   Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine
RP Joyal, JS (corresponding author), St Justine Hosp, Dept Pediat, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.
EM js.joyal@umontreal.ca
RI Piché, Nelson/JWP-9260-2024
OI Brunel-Guitton, Catherine/0000-0002-5470-2249
FU BurroughsWellcome Fund Career Award for Medical Scientists [1012321.01];
   CIHR [141956, 390615]
FX J.S.J. is supported by the BurroughsWellcome Fund Career Award for
   Medical Scientists (1012321.01) and CIHR (141956, 390615).
CR Ackland G, 2000, CRIT CARE, V4, P269, DOI 10.1186/cc709
   Almannai M, 2017, GENEREVIEWS, P15
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   BALLANCE WA, 1990, J PEDIATR-US, V117, pS6, DOI 10.1016/S0022-3476(05)81124-2
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Diekman EF, 2013, JIMD REP, V7, P1, DOI 10.1007/8904_2012_128
   Ebrahimi-Fakhari D, 2015, PEDIATR NEUROL, V53, P549, DOI 10.1016/j.pediatrneurol.2015.08.018
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Finsterer J, 2017, THER ADV GASTROENTER, V10, P142, DOI 10.1177/1756283X16666806
   Gagnier JJ., 2013, Forsch Komplementarmed, V7, P385, DOI DOI 10.7453/GAHMJ.2013.008
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Guzman JA, 1999, J APPL PHYSIOL, V87, P1102, DOI 10.1152/jappl.1999.87.3.1102
   Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jouvet P, 2007, EUR J PEDIATR, V166, P461, DOI 10.1007/s00431-006-0265-2
   Li QY, 2017, SCI REP-UK, V7, DOI 10.1038/srep43042
   Mehta NM, 2017, PEDIATR CRIT CARE ME, V18, P675, DOI 10.1097/PCC.0000000000001134
   Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408
   Ostlie DJ, 2003, J PEDIATR SURG, V38, P1039, DOI 10.1016/S0022-3468(03)00187-8
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
NR 23
TC 3
Z9 3
U1 0
U2 4
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 2146-4618
EI 2146-4626
J9 J PEDIATR INTENSIVE
JI J. Pediatr. Intensive Care
PD MAR
PY 2020
VL 9
IS 1
BP 54
EP 59
DI 10.1055/s-0039-1697620
PG 6
WC Pediatrics
WE Emerging Sources Citation Index (ESCI)
SC Pediatrics
GA KF0BT
UT WOS:000508915000010
PM 31984159
OA Green Published
DA 2024-11-01
ER

PT J
AU Hoptasz, M
   Szczucinski, A
   Losy, J
AF Hoptasz, Magdalena
   Szczucinski, Adam
   Losy, Jacek
TI Heterogeneous phenotypic manifestations of maternally inherited deafness
   associated with the mitochondrial A3243G mutation. Case report
SO NEUROLOGIA I NEUROCHIRURGIA POLSKA
LA English
DT Article
DE Mitochondrial disorder; A3243G mutation; Maternally inherited deafness;
   Mitochondrial encephalomyopathy lactic acidosis and strokelike episodes
ID DNA MUTATION; HETEROPLASMY; MELAS
AB The A3243G mutation is one of the most frequent mutations of mitochondrial DNA. The phenotypic expression of the A3243G mutation is variable and causes a wide range of syndromic and non-syndromic clinical disorders. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome is the most frequent syndromic manifestation of the A3243G mutation. Stroke-like episodes seem to be the dominant feature of MELAS. We have investigated the case of a family with A3243G mutation, in which a dominant symptom in three generations was the maternally inherited hearing loss with absence of stroke-like episodes. Besides deafness, we found also other clinical features such as myopathy, neuropathy, migraine, ataxia, short stature, diabetes mellitus, and cardiomyopathy. (C) 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
C1 [Hoptasz, Magdalena; Szczucinski, Adam; Losy, Jacek] Univ Med Sci, Clin Hosp H Swiecicki, Dept Clin Neurol, Poznan, Poland.
   [Szczucinski, Adam] Univ Med Sci, Dept Neurochem & Neuropathol, Poznan, Poland.
   [Losy, Jacek] Univ Med Sci, Chair Neurol, Dept Clin Neuroimmunol, Poznan, Poland.
   [Losy, Jacek] Polish Acad Sci, Inst Expt & Clin Med, Neuroimmunol Unit, Poznan, Poland.
C3 Polish Academy of Sciences
RP Szczucinski, A (corresponding author), UM K Marcinkowskiego Poznaniu, Zaklad Neurochem & Neuropatol, Ul Przybyszewskiego 49, PL-60355 Poznan, Poland.
EM adamszczucinski@poczta.onet.pl
RI Losy, Jacek/IUN-2312-2023
OI Losy, Jacek/0000-0002-7027-7289
CR Blum S, 2011, INTERN MED J, V41, P200, DOI 10.1111/j.1445-5994.2010.02379.x
   Chinnery PF., 2010, Mitochondrial Disorders Overview
   DiMauro S, 2012, GENEREVIEWS
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2012, OPEN NEUROL J, V6, P26, DOI DOI 10.2174/1874205X01206010026
   Finsterer J, 2009, INT J CARDIOL, V137, P60, DOI 10.1016/j.ijcard.2008.04.089
   Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Liou CW, 2001, DIABETES RES CLIN PR, V54, pS39, DOI 10.1016/S0168-8227(01)00334-5
   Olsson C, 1998, HUM MUTAT, V12, P52, DOI 10.1002/(SICI)1098-1004(1998)12:1<52::AID-HUMU8>3.0.CO;2-K
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 14
TC 5
Z9 6
U1 0
U2 3
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA WENEDOW ST 9-1, POZNAN, 61-614, POLAND
SN 0028-3843
J9 NEUROL NEUROCHIR POL
JI Neurol. Neurochir. Pol.
PY 2014
VL 48
IS 2
BP 150
EP 153
DI 10.1016/j.pjnns.2013.12.007
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AI4YU
UT WOS:000336873400012
PM 24821643
OA Green Published
DA 2024-11-01
ER

PT J
AU Yarham, JW
   Elson, JL
   Blakely, EL
   McFarland, R
   Taylor, RW
AF Yarham, John W.
   Elson, Joanna L.
   Blakely, Emma L.
   McFarland, Robert
   Taylor, Robert W.
TI Mitochondrial tRNA mutations and disease
SO WILEY INTERDISCIPLINARY REVIEWS-RNA
LA English
DT Review
AB Mitochondrial (mt-) tRNA (MTT) gene mutations are an important cause of human morbidity and are associated with a wide range of pathology, from isolated organ-specific diseases such as myopathy or hearing loss, through to multisystem disorders with encephalopathy, gastrointestinal dysmotility, and life-threatening cardiomyopathy. Our understanding of how MTT mutations cause disease remains poor and progress has been hampered by the complex interaction of genotype with phenotype that can result in patients who harbor the same mutation exhibiting starkly contrasting phenotypes, whereas other (genetically heterogeneous) patients manifest clinically identical syndromes. A further complexity is the highly polymorphic nature of mitochondrial DNA (mtDNA), which must temper any reflex assumptions of pathogenicity for novel MTT substitutions. Nevertheless significant progress is being made and we shall review the methods employed to identify and characterize MTT mutations as pathogenic. Also important is our understanding of the molecular processes involved and we shall discuss the data available on two of the most studied MTT mutations (m.8344A>G and m.3243A>G) as well as other potential pathogenic mechanisms. Knowledge of factors influencing the inheritance of MTT mutations, and therefore the likelihood of disease transmission, is of particular importance to female patients. At present, the factors determining transmission remain elusive, but we shall examine several possible mechanisms and discuss the evidence for each. Finally, a number of different yeast and mouse models are currently used to investigate mitochondrial disease and we will assess the importance of and difficulties associated with each model as well as the future of possible therapies for patients with mitochondrial disease. (C) 2010 John Wiley & Sons, Ltd. WIREs RNA 2010 1 304-324
C1 [Yarham, John W.; Elson, Joanna L.; Blakely, Emma L.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
OI Yarham, John/0000-0003-4792-1790; /0000-0002-3551-5624; McFarland,
   Robert/0000-0002-8833-2688
FU Medical Research Council (UK); Research Council UK RCUK; HEFCE/DoH;
   Medical Research Council Centre for Translational Research in
   Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK)
   [G0800674]; Wellcome Trust [074454/Z/04/Z]; Newcastle upon Tyne
   Hospitals NHS Foundation Trust; UK National Commissioning Group; MRC
   [G0800674, G108/539, G90/63] Funding Source: UKRI
FX JWY is funded by a studentship from the Medical Research Council (UK).
   JLE is supported by a Research Council UK RCUK Academic fellowship. RM
   is supported by a HEFCE/DoH Clinical Senior Lecturer Award and Medical
   Research Council Centre for Translational Research in Neuromuscular
   Disease Mitochondrial Disease Patient Cohort (UK) (G0800674). RWT is
   funded by a Wellcome Trust Programme Grant (074454/Z/04/Z), the
   Newcastle upon Tyne Hospitals NHS Foundation Trust and the UK National
   Commissioning Group which funds The Rare Mitochondrial Disease Service
   for Adults and Children (http://www.mitochondrialncg.nhs.uk).
CR Acin-Perez R, 2009, EMBO MOL MED, V1, P392, DOI 10.1002/emmm.200900046
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   [Anonymous], MAMIT TRNA DATABASE
   BARRELL BG, 1980, P NATL ACAD SCI-BIOL, V77, P3164, DOI 10.1073/pnas.77.6.3164
   BARRELL BG, 1979, NATURE, V282, P189, DOI 10.1038/282189a0
   Blakely EL, 2007, J NEUROL, V254, P1283, DOI 10.1007/s00415-006-0490-7
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105
   Börner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Brulé H, 1998, NUCLEIC ACIDS RES, V26, P537, DOI 10.1093/nar/26.2.537
   CANN RL, 1982, SCIENCE, V217, P303, DOI 10.1126/science.217.4557.303
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Chen J, 2008, MITOCHONDRION, V8, P285, DOI 10.1016/j.mito.2008.05.002
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 1998, J INHERIT METAB DIS, V21, P321, DOI 10.1023/A:1005357221101
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0
   D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   De Luca C, 2006, GENE, V377, P169, DOI 10.1016/j.gene.2006.04.003
   De Luca C, 2009, MITOCHONDRION, V9, P408, DOI 10.1016/j.mito.2009.07.004
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8
   Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505
   Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   FOX TD, 1991, METHOD ENZYMOL, V194, P149
   Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153
   Gambello MJ, 2006, MUSCLE NERVE, V34, P437, DOI 10.1002/mus.20605
   Giegé R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636
   Howell N, 2008, HEREDITY, V101, P107, DOI 10.1038/hdy.2008.52
   Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673
   Hyslop SJ, 1997, BIOCHEM MOL BIOL INT, V42, P567
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jin LJ, 2007, BIOCHEM BIOPH RES CO, V361, P133, DOI 10.1016/j.bbrc.2007.06.171
   Kamenski P, 2010, MITOCHONDRION, V10, P284, DOI 10.1016/j.mito.2010.01.002
   Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200
   KING MP, 1993, J BIOL CHEM, V268, P10228
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   KOGA Y, 1993, NUCLEIC ACIDS RES, V21, P657, DOI 10.1093/nar/21.3.657
   Kogelnik AM, 1997, NUCLEIC ACIDS RES, V25, P196, DOI 10.1093/nar/25.1.196
   Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931
   Kornblum C, 2008, BIOSCIENCE REP, V28, P89, DOI 10.1042/BSR20080004
   KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MANAM S, 1987, J BIOL CHEM, V262, P10272
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Martin Nancy C., 1995, P127
   MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x
   Meinnel Thierry, 1995, P251
   Meulemans A, 2007, ARCH NEUROL-CHICAGO, V64, P1339, DOI 10.1001/archneur.64.9.1339
   Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005
   Möllers M, 2005, NUCLEIC ACIDS RES, V33, P5647, DOI 10.1093/nar/gki876
   Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   MUKERJI SK, 1972, J BIOL CHEM, V247, P481
   MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8
   Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758
   Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5
   Ohtsuki T, 2002, NAT STRUCT BIOL, V9, P669, DOI 10.1038/nsb826
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Pancrudo J, 2007, NEUROMUSCULAR DISORD, V17, P651, DOI 10.1016/j.nmd.2007.04.005
   Pandya A, 1999, AM J HUM GENET, V65, P1803, DOI 10.1086/302658
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   Pereira C, 2007, BIOCHEM BIOPH RES CO, V354, P937, DOI 10.1016/j.bbrc.2007.01.068
   Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487
   Pinkert CA, 1997, TRANSGENIC RES, V6, P379, DOI 10.1023/A:1018431316831
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Rohou H, 2001, YEAST, V18, P219, DOI 10.1002/1097-0061(200102)18:3<219::AID-YEA651>3.0.CO;2-C
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sanaker PS, 2010, ACTA NEUROL SCAND, V121, P109, DOI 10.1111/j.1600-0404.2009.01243.x
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.0.CO;2-M
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 2008, SCIENCE, V319, P914, DOI 10.1126/science.1154515
   Sissler M, 2005, AMINOACYL TRNA SYNTH
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Spencer AC, 2004, NUCLEIC ACIDS RES, V32, P5464, DOI 10.1093/nar/gkh886
   Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Takeuchi N, 2001, J BIOL CHEM, V276, P20064, DOI 10.1074/jbc.M101007200
   Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674
   The MitoMAP database, MITOMAP DAT ONL COMP
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   YAMANE T, 1977, P NATL ACAD SCI USA, V74, P2246, DOI 10.1073/pnas.74.6.2246
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2002, MITOCHONDRION, V2, P129, DOI 10.1016/S1567-7249(02)00033-8
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
   Zsurka G, 2007, AM J HUM GENET, V80, P298, DOI 10.1086/511282
NR 147
TC 140
Z9 151
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-7004
EI 1757-7012
J9 WIRES RNA
JI Wiley Interdiscip. Rev.-RNA
PD SEP-OCT
PY 2010
VL 1
IS 2
BP 304
EP 324
DI 10.1002/wrna.27
PG 21
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA V22HV
UT WOS:000208267200009
PM 21935892
DA 2024-11-01
ER

PT J
AU Abe, S
   Nagano, M
   Nishio, S
   Kumakawa, K
   Usami, S
AF Abe, Satoko
   Nagano, Makoto
   Nishio, Shin-ya
   Kumakawa, Kozo
   Usami, Shin-ichi
TI High-Frequency Involved Hearing Loss Caused by Novel Mitochondrial DNA
   Mutation in 16S Ribosomal RNA Gene
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE Hearing loss; Mitochondrial DNA; 16S ribosomal RNA
ID SENSORINEURAL DEAFNESS; CARDIOMYOPATHY; MYOPATHY; GENOME
AB Objective: To clarify the responsible gene for a family associated with hearing loss but having no well-known mitochondrial mutations.
   Subjects: A Japanese family showing late-onset, progressive, and ski-sloping sensorineural hearing loss.
   Results: Whole mitochondrial genome sequencing identified the 1673T>C mutation, a novel mitochondrial DNA mutation in the 16S ribosomal RNA gene.
   Conclusion: Whole mitochondrial genome sequencing is a powerful tool to identify the responsible gene for plausible mitochondrially inherited families. This is additional evidence that mitochondrial gene mutations may cause late-onset, progressive, and ski-sloping sensorineural hearing loss.
C1 [Abe, Satoko] Abe ENT Clin, Tokyo 1430026, Japan.
   [Abe, Satoko; Kumakawa, Kozo] Toranomon Gen Hosp, Dept Otorhinolaryngol, Tokyo, Japan.
   [Nagano, Makoto] Biomed Labs Inc, Dept Clin Genom, Kawagoe, Saitama, Japan.
   [Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.
C3 Toranomon Hospital; Shinshu University
RP Abe, S (corresponding author), Abe ENT Clin, Ota Ku, 2-2-5 Nishimagome, Tokyo 1430026, Japan.
EM abe3387@ybb.ne.jp
OI Nishio, Shin-ya/0000-0001-6640-2297
FU Ministry of Health and Welfare of Japan
FX S. A., K. K., and S. U. are currently receiving a Health Sciences
   Research Grant from the Ministry of Health and Welfare of Japan. For the
   remaining authors, no conflicts of interest were declared.
CR Abe S, 2007, GENET TEST, V11, P333, DOI 10.1089/gte.2007.0002
   Choo-Kang ATW, 2002, DIABETES, V51, P2317, DOI 10.2337/diabetes.51.7.2317
   Coulbault L, 2007, BIOCHEM BIOPH RES CO, V362, P601, DOI 10.1016/j.bbrc.2007.08.040
   Ellaway CJ, 1999, J INHERIT METAB DIS, V22, P946, DOI 10.1023/A:1005616229456
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Feigenbaum A, 2006, AM J MED GENET A, V140A, P2216, DOI 10.1002/ajmg.a.31436
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437
   Leveque M, 2007, EUR J HUM GENET, V15, P1145, DOI 10.1038/sj.ejhg.5201891
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885
   Seibel P, 2008, NUCLEIC ACIDS RES, V36, P5872, DOI 10.1093/nar/gkn592
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Tang S, 2010, MITOCHONDRION, V10, P350, DOI 10.1016/j.mito.2010.02.003
   Usami S, 2000, ADV OTO-RHINO-LARYNG, V56, P203
   Usami S, 2010, AUDIOLOGICAL MED, V8, P28
   Usami S, 2012, ACTA OTO-LARYNGOL, V132, P377, DOI 10.3109/00016489.2011.649493
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
NR 20
TC 2
Z9 2
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1531-7129
EI 1537-4505
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD JUL
PY 2014
VL 35
IS 6
BP 1087
EP 1090
PG 4
WC Clinical Neurology; Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Otorhinolaryngology
GA AJ9MA
UT WOS:000338034100026
PM 24770403
DA 2024-11-01
ER

PT J
AU Sabella-Jiménez, V
   Otero-Herrera, C
   Silvera-Redondo, C
   Garavito-Galofre, P
AF Sabella-Jimenez, Vanessa
   Otero-Herrera, Carlos
   Silvera-Redondo, Carlos
   Garavito-Galofre, Pilar
TI Mitochondrial DNA deletion and duplication in Kearns-Sayre Syndrome
   (KSS) with initial presentation as Pearson Marrow-Pancreas Syndrome
   (PMPS): Two case reports in Barranquilla, Colombia
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE Kearns-Sayre syndrome; mitochondrial diseases; ophthalmoplegia (MeSH)
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; FANCONI SYNDROME; PATIENT;
   HYPOPARATHYROIDISM; REARRANGEMENTS; INVOLVEMENT; GLAUCOMA; FEATURES;
   DISEASE
AB Background: Kearns-Sayre Syndrome (KSS) and Pearson Marrow-Pancreas Syndrome (PMPS) are among the classic phenotypes caused by mitochondrial DNA (mtDNA) deletions. KSS is a rare mitochondrial disease defined by a classic triad of progressive external ophthalmoplegia, atypical pigmentary retinopathy, and onset before 20 years. PMPS presents in the first year of life with bone marrow failure and exocrine pancreatic dysfunction, and can evolve into KSS later in life. Even though an mtDNA deletion is the most frequent mutation in KSS and PMPS, cases of duplications and molecular rearrangements have also been described. In Colombia, few case reports of KSS and PMPS have been published in indexed journals or have been registered in scientific events.
   Methods: We discuss clinical and genetic aspects of two case reports of pediatric female patients, with initial clinical diagnosis of PMPS who later evolved into KSS, with confirmatory molecular studies of an mtDNA deletion and an mtDNA duplication.
   Results: A large-scale mtDNA deletion, NC_012920.1:m.8286_14416del, was confirmed by Southern Blot in patient 1. An mtDNA duplication of 7.9 kb was confirmed by MLPA in patient 2.
   Conclusions: Our findings are compatible with the phenotypic and genetic presentation of PMPS and KSS. We present the first molecularly confirmed case reports of Colombian patients, diagnosed initially with PMPS, who later evolved to KSS.
C1 [Sabella-Jimenez, Vanessa; Otero-Herrera, Carlos] Univ Norte, Genet & Mol Med Res Grp, Barranquilla, Colombia.
   [Silvera-Redondo, Carlos; Garavito-Galofre, Pilar] Univ Norte, Dept Med, Genet & Mol Med Res Grp, Genet, Barranquilla, Colombia.
C3 Universidad del Norte Colombia; Universidad del Norte Colombia
RP Garavito-Galofre, P (corresponding author), Univ Norte, Hlth Sci Div, Dept Med, Km 5 Via Puerto Colombia, Barranquilla, Colombia.
EM mpgaravi@uninorte.edu.co
OI Otero-Herrera, Carlos/0000-0001-5908-1392; Sabella-Jimenez,
   Vanessa/0000-0003-2946-8996
CR Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639
   Barrera-Ramírez CF, 2005, REV ESP CARDIOL, V58, P443
   BARRIENTOS A, 1995, MED CLIN-BARCELONA, V105, P180
   Becher MW, 1999, HUM PATHOL, V30, P577, DOI 10.1016/S0046-8177(99)90204-6
   Berio A., 2010, Gazzetta Medica Italiana Archivio per le Scienze Mediche, V169, P333
   BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   Cohen BH, 2001, CLEV CLIN J MED, V68, P625, DOI 10.3949/ccjm.68.7.625
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   EVIATAR L, 1990, NEUROLOGY, V40, P1761, DOI 10.1212/WNL.40.11.1761
   Frezzotti P, 2005, EUR J OPHTHALMOL, V15, P809, DOI 10.1177/112067210501500625
   Furuya H, 1997, Rinsho Shinkeigaku, V37, P680
   Goldstein A, 2003, MITOCHONDRIAL DNA DE
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Jacobs LJAM, 2004, J INHERIT METAB DIS, V27, P47, DOI 10.1023/B:BOLI.0000016601.49372.18
   KALENAK JW, 1989, AM J OPHTHALMOL, V108, P335, DOI 10.1016/0002-9394(89)90134-7
   Katsanos KH, 2001, AM J NEPHROL, V21, P150, DOI 10.1159/000046239
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Krishna Mani Ram, 2017, Indian Pacing Electrophysiol J, V17, P78, DOI 10.1016/j.ipej.2017.03.003
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Maceluch Jaros Aw, 2006, Pediatr Endocrinol Rev, V4, P117
   Mihai Cristina Maria, 2009, J Med Case Rep, V3, P101, DOI 10.1186/1752-1947-3-101
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORI K, 1991, AM J MED GENET, V38, P583, DOI 10.1002/ajmg.1320380417
   Muraki K, 2001, AM J MED GENET, V98, P205, DOI 10.1002/1096-8628(20010122)98:3<205::AID-AJMG1077>3.0.CO;2-P
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pitchon EM, 2007, KLIN MONATSBL AUGENH, V224, P340, DOI 10.1055/s-2007-962854
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1995, MUSCLE NERVE, pS154
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Simaan EM, 1999, PEDIATR NEUROL, V21, P830, DOI 10.1016/S0887-8994(99)00084-3
   SIMONSZ HJ, 1992, DOC OPHTHALMOL, V82, P73, DOI 10.1007/BF00156996
   SMITH OP, 1995, BRIT J HAEMATOL, V90, P469, DOI 10.1111/j.1365-2141.1995.tb05178.x
   Subbiah RN, 2007, PACE, V30, P137
   SUPERTIFURGA A, 1993, EUR J PEDIATR, V152, P44, DOI 10.1007/BF02072515
   Tesarova M, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27591
   Thajeb Peterus, 2006, Taiwan J Obstet Gynecol, V45, P201
   Tzoufi M, 2013, EUR J PEDIATR, V172, P557, DOI 10.1007/s00431-012-1798-1
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wild KT, 2020, AM J MED GENET A, V182, P365, DOI 10.1002/ajmg.a.61433
   Yu M, 2016, CHINESE MED J-PEKING, V129, P1419, DOI 10.4103/0366-6999.183417
   Zarnowski T, 2003, ACTA OPHTHALMOL SCAN, V81, P543, DOI 10.1034/j.1600-0420.2003.00120.x
   Zarnowski T, 2012, CLIN EXP OPHTHALMOL, V40, P218, DOI 10.1111/j.1442-9071.2011.02721.x
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 48
TC 10
Z9 11
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD NOV
PY 2020
VL 8
IS 11
AR e1509
DI 10.1002/mgg3.1509
EA OCT 2020
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA PV2IX
UT WOS:000575910600001
PM 33030289
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Mehta, AR
   Fox, SH
   Tarnopolsky, M
   Yoon, G
AF Mehta, Arpan R.
   Fox, Susan H.
   Tarnopolsky, Mark
   Yoon, Grace
TI Mitochondrial Mimicry of Multiple System Atrophy of the Cerebellar
   Subtype
SO MOVEMENT DISORDERS
LA English
DT Article
DE mitochondrial disease; multiple system atrophy; polymerase gamma gene;
   parkinsonism; ataxia
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLG1
   MUTATIONS; PARKINSONISM; GENE; PERSPECTIVE; DISORDERS; CHILDREN;
   DISEASE; ATAXIA
AB Background: We describe a patient with clinical and radiological findings suggestive of multiple system atrophy of the cerebellar subtype (MSA-C). Methods/Results: Sequencing of the polymerase-gamma 1 (POLG1) gene revealed the patient had compound heterozygous mutations of the POLG1 gene. Muscle biopsy revealed the presence of multiple mitochondrial DNA deletions and depletion, confirming the pathogenic nature of the POLG1 mutations. Discussion: This case expands the spectrum of phenotypes associated with POLG1 mutations to include multiple system atrophy and prompts further consideration regarding whether routine screening for POLG1 mutations is indicated in this patient population. (C) 2011 Movement Disorder Society
C1 [Yoon, Grace] Univ Toronto, Hosp Sick Children, Div Clin Metab Genet, Toronto, ON M5G 1X8, Canada.
   [Yoon, Grace] Univ Toronto, Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada.
   [Mehta, Arpan R.; Fox, Susan H.] Univ Toronto, Toronto Western Hosp, Movement Disorder Clin, Toronto, ON M5G 1X8, Canada.
   [Tarnopolsky, Mark] McMaster Univ, Med Ctr, Div Neuromuscular & Neurometab Dis, Hamilton, ON, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; Hospital for Sick Children (SickKids); University of
   Toronto; University Health Network Toronto; McMaster University
RP Yoon, G (corresponding author), Univ Toronto, Hosp Sick Children, Div Clin Metab Genet, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM grace.yoon@utoronto.ca
CR Corral J, 2005, ANN NEUROL, V57, P549, DOI 10.1002/ana.20421
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15
   Hadjivassiliou M, 2003, BRAIN, V126, P685, DOI 10.1093/brain/awg050
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   TRUONG DD, 1990, MOVEMENT DISORD, V5, P109, DOI 10.1002/mds.870050204
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Venna N, 2004, NEUROL INDIA, V52, P305
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 21
TC 17
Z9 17
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0885-3185
J9 MOVEMENT DISORD
JI Mov. Disord.
PD MAR
PY 2011
VL 26
IS 4
BP 753
EP 755
DI 10.1002/mds.23510
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 762AO
UT WOS:000290444800034
PM 21259344
DA 2024-11-01
ER

PT J
AU Dai, Y
   Kiselak, T
   Clark, J
   Clore, E
   Zheng, KN
   Cheng, A
   Kujoth, GC
   Prolla, TA
   Maratos-Flier, E
   Simon, DK
AF Dai, Ying
   Kiselak, Tomas
   Clark, Joanne
   Clore, Elizabeth
   Zheng, Kangni
   Cheng, Allen
   Kujoth, Gregory C.
   Prolla, Tomas A.
   Maratos-Flier, Eleftheria
   Simon, David K.
TI Behavioral and metabolic characterization of heterozygous and homozygous
   <i>POLG</i> mutator mice
SO MITOCHONDRION
LA English
DT Article
DE mtDNA polymerase gamma; mtDNA mutation; Parkinson's disease; Dopamine;
   Behavioral deficits; Metabolic deficits
ID MITOCHONDRIAL-DNA MUTATIONS; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HUMAN
   SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; POINT
   MUTATIONS; MTDNA MUTATIONS; COMPLEX-I; DELETIONS; ABNORMALITIES
AB The mitochondrial DNA (mtDNA) polymerase (POLG) mutator mice provide the first experimental evidence that high levels of somatic mtDNA mutations can be functionally significant. Here we report that older homozygous, but not heterozygous, POLG mice show significant reductions in striatal dopaminergic terminals as well as deficits in motor function. However, resting oxygen consumption, heat production, mtDNA content and mitochondrial electron transport chain activities are significantly decreased at older ages in both homozygous and heterozygous mice. These results indicate that high levels of somatic mtDNA mutations can contribute to dopaminergic dysfunction and to behavioral and metabolic deficits. (c) 2013 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Dai, Ying; Kiselak, Tomas; Clark, Joanne; Clore, Elizabeth; Zheng, Kangni; Simon, David K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Neurol, Sch Med, Boston, MA 02215 USA.
   [Cheng, Allen] Harvard Univ, Sch Med, MD PhD Program, Boston, MA 02115 USA.
   [Kujoth, Gregory C.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA.
   [Maratos-Flier, Eleftheria] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med,Med Sch, Boston, MA 02215 USA.
C3 Harvard University; Harvard Medical School; Beth Israel Deaconess
   Medical Center; Harvard University; Harvard Medical School; University
   of Wisconsin System; University of Wisconsin Madison; Harvard
   University; Harvard Medical School; Beth Israel Deaconess Medical Center
RP Dai, Y (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Room CLS 628, Brookline, MA 02445 USA.
EM ydai@bidmc.harvard.edu; tomas.kiselak@gmail.com;
   jclark3@bidmc.harvard.edu; eclore@gmail.com;
   kzheng@caregroup.harvard.edu; allen_cheng@hms.harvard.edu;
   gckujoth@wisc.edu; taprolla@wisc.edu; emaratos@bidmc.harvard.edu;
   dsimon1@bidmc.harvard.edu
FU National Institute on Aging [1R03AG035223-01]; National Institute of
   Neurological Disorders and Stroke [1R21NS077758]
FX We thank Dr. Ippolita Cantuti-Castelvetri and Katharina Bilotti for the
   helpful comments and suggestions. This study was supported by the
   National Institute on Aging (1R03AG035223-01; DKS) and the National
   Institute of Neurological Disorders and Stroke (1R21NS077758; DKS). None
   of the authors or co-authors has a financial interest that might be
   construed to influence the results or interpretation of this manuscript.
CR Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BURNS RS, 1985, NEW ENGL J MED, V312, P1418, DOI 10.1056/NEJM198505303122203
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Clark J, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/659694
   Clark J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012333
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CRUZSANCHEZ FF, 1995, J NEUROPATH EXP NEUR, V54, P74, DOI 10.1097/00005072-199501000-00009
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Emborg ME, 1998, J COMP NEUROL, V401, P253
   FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283
   Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006
   Guttman M, 1997, NEUROLOGY, V48, P1578, DOI 10.1212/WNL.48.6.1578
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   KELLY PH, 1975, BRAIN RES, V94, P507, DOI 10.1016/0006-8993(75)90233-4
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Kokkotou E, 2005, AM J PHYSIOL-REG I, V289, pR117, DOI 10.1152/ajpregu.00861.2004
   Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Ma SY, 1999, NEUROPATH APPL NEURO, V25, P394
   Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265
   PAKKENBERG B, 1991, J NEUROL NEUROSUR PS, V54, P30, DOI 10.1136/jnnp.54.1.30
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Rudow G, 2008, ACTA NEUROPATHOL, V115, P461, DOI 10.1007/s00401-008-0352-8
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SEVERSON JA, 1982, J NEUROCHEM, V39, P1623, DOI 10.1111/j.1471-4159.1982.tb07996.x
   Siddiqi ZA, 1999, J NEUROPATH EXP NEUR, V58, P903, DOI 10.1097/00005072-199909000-00002
   TATTON WG, 1991, NEUROBIOL AGING, V12, P543, DOI 10.1016/0197-4580(91)90086-Y
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
NR 48
TC 26
Z9 32
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2013
VL 13
IS 4
BP 282
EP 291
DI 10.1016/j.mito.2013.03.006
PG 10
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 162VR
UT WOS:000320294600004
PM 23542163
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Scuderi, C
   Borgione, E
   Musumeci, S
   Elia, M
   Castello, F
   Fichera, M
   Davidzon, G
   DiMauro, S
AF Scuderi, Carmela
   Borgione, Eugenia
   Musumeci, Sebastiano
   Elia, Maurizio
   Castello, Filippa
   Fichera, Marco
   Davidzon, Guido
   DiMauro, Salvatore
TI Severe encephalomyopathy in a patient with homoplasmic A5814G point
   mutation in mitochondrial tRNA<SUP>Cys</SUP> gene
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mitochondrial DNA; tRNA(Cys); homoplasmic mutation; nuclear factors
ID MYOPATHY; MUTANT; DNA
AB We report a patient with severe encephalomyopathy and homoplasmic A5814G point mutation in the mitochondrial DNA tRNA gene for cysteine. This mutation had been reported in heteroplasmic condition in patients with different clinical phenotypes. Our results confirm the pathogenicity of the mutation and support the concept that homoplasmic mutations in tRNA genes can be responsible for mitochondrial disorders with variable penetrance. This report also extends the clinical spectrum associated with the A5814G mutation. (C) 2006 Elsevier B.V. All rights reserved.
C1 IRCCS Oasi Maria SS, Dipartimento Neurol, Troina, Italy.
   IRCCS Oasi Maria SS, Lab Neuropatol Clin, Troina, Italy.
   IRCCS Oasi Maria SS, Lab Diag Genet, Troina, Italy.
   Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
C3 IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; Columbia
   University
RP Scuderi, C (corresponding author), IRCCS Oasi Maria SS, Dipartimento Neurol, Troina, Italy.
EM cscuderi@oasi.en.it
RI Borgione, Eugenia/D-9168-2017; Castello, Filippa/D-4266-2017; Elia,
   Maurizio/K-3285-2016; Musumeci, Sebastiano Antonino/E-3879-2017;
   Fichera, Marco/K-9220-2016; Scuderi, Carmela/D-4734-2017
OI Borgione, Eugenia/0000-0001-5458-7415; Castello,
   Filippa/0000-0002-2780-1583; Elia, Maurizio/0000-0002-0414-1359;
   Musumeci, Sebastiano Antonino/0000-0002-6865-5367; Davidzon,
   Guido/0000-0001-5579-6825; Fichera, Marco/0000-0002-8225-6880; Scuderi,
   Carmela/0000-0001-5901-0041
FU NICHD NIH HHS [HD32062] Funding Source: Medline; NINDS NIH HHS [NS11766]
   Funding Source: Medline
CR Carelli V., 2002, MITOCHONDRIAL DISORD, P115
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Karadimas C, 2001, J CHILD NEUROL, V16, P531, DOI 10.1177/088307380101600715
   Manfredi G, 1996, HUM MUTAT, V7, P158
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Santorelli FM, 1996, PEDIATR NEUROL, V15, P145, DOI 10.1016/0887-8994(96)00163-4
   Santorelli FM, 1997, NEUROMUSCULAR DISORD, V7, P156, DOI 10.1016/S0960-8966(97)00444-6
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   TULINIUS MH, 1991, J PEDIATR-US, V119, P251, DOI 10.1016/S0022-3476(05)80735-8
NR 12
TC 13
Z9 14
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAR
PY 2007
VL 17
IS 3
BP 258
EP 261
DI 10.1016/j.nmd.2006.11.006
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 162WG
UT WOS:000246119600011
PM 17241783
DA 2024-11-01
ER

PT J
AU El-Khoury, R
   Sainsard-Chanet, A
AF El-Khoury, Riyad
   Sainsard-Chanet, Annie
TI Suppression of Mitochondrial DNA Instability of Autosomal Dominant Forms
   of Progressive External Ophthalmoplegia-Associated <i>ANT1</i> Mutations
   in <i>Podospora anserina</i>
SO GENETICS
LA English
DT Article
ID ADENINE-NUCLEOTIDE TRANSLOCATOR; SACCHAROMYCES-CEREVISIAE; ADP/ATP
   CARRIER; MULTIPLE DELETIONS; LIFE-SPAN; GENE; PROTEIN; GENOME;
   RESPIRATION; SENESCENCE
AB Maintenance and expression of mitochondrial DNA (mtDNA) are essential for the cell and the organism. In humans, several mutations in the adenine nucleotide translocase gene ANTI are associated with multiple mtDNA deletions and autosomal dominant for-ins of progressive external ophthalmoplegia (adPEO). The mechanisms underlying the mtDNA instability are still obscure. A current hypothesis proposes that these pathogenic mutations primarily uncouple the mitochondrial inner membrane, which secondarily causes mtDNA instability Here we show that the three adPEO-associated mutations equivalent to A114P, L98P, and V289M introduced into the Podaspora anserina ANT1 ortholog dominantly cause severe growth defects, decreased reactive oxygen species production (RCS), decreased mitochondrial inner membrane potential (Delta psi), and accumulation of large-scale mtDNA deletions leading to premature death. Interestingly, we show that, at least for the adPEO-type M106P and A121P mutant alleles, the associated mtDNA instability cannot be attributed only to a reduced membrane potential or to an increased ROS level since it can be suppressed without restoration of the Delta psi or modification of the ROS production. Suppression of mtDNA instability due to the M106P and A121P mutations was obtained by an allele of the rmp1 gene involved in nucleo-mitochondrial cross-talk and also by an allele of the AS1 gene encoding a cytosolic ribosomal protein. In contrast, die mtDNA instability caused by the S296M mutation was not suppressed by these alleles.
C1 [El-Khoury, Riyad; Sainsard-Chanet, Annie] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.
   [Sainsard-Chanet, Annie] Univ Paris 11, F-91405 Orsay, France.
C3 Universite Paris Saclay; Centre National de la Recherche Scientifique
   (CNRS); Universite Paris Saclay
RP Sainsard-Chanet, A (corresponding author), CNRS, Ctr Genet Mol, Allee Terrasse, F-91198 Gif Sur Yvette, France.
EM annie.sainsard@cgm.cnrs-gif.fr
FU Association Francaise contre les Myopathies; European Community
   [LSHM-CT-200-512020]
FX We are very grateful to Carole Sellem for her constant interest in this
   work. We thank Sandrine Bach-Berkowicz for the construction of the
   vectors carrying the PaAnt mutant alleles and Edmund R. S. Kunji for his
   generous gift of the Aac2 monoclonal antibody. We thank Guy Lauquin and
   Veronique Trezeguet for useful discussions and critical comments,
   Vincent Rincheval for his help in the flow cytometry analysis, Chris
   Herbert and Linda Sperling for Critical reading of the manuscript, and
   Delphine Petit for technical help. This work was supported by grants
   from the Association Francaise contre les Myopathies and the European
   Community's Sixth Framework Programme (LSHM-CT-200-512020).
CR [Anonymous], 1974, Bacteria, Bacteriophages, and Fungi
   ARENDS H, 1984, EMBO J, V3, P377, DOI 10.1002/j.1460-2075.1984.tb01815.x
   Bamber L, 2007, J MOL BIOL, V371, P388, DOI 10.1016/j.jmb.2007.05.072
   Begel O, 1999, MOL CELL BIOL, V19, P4093
   BELCOUR L, 1991, P NATL ACAD SCI USA, V88, P3579, DOI 10.1073/pnas.88.9.3579
   BELCOUR L, 1999, MITOCHONDRIAL DIS, P209
   BERGES T, 1989, J GEN MICROBIOL, V135, P601
   Borghouts C, 2002, BIOGERONTOLOGY, V3, P143, DOI 10.1023/A:1015696404723
   Chen XJ, 2004, GENETICS, V167, P607, DOI 10.1534/genetics.103.023655
   Chen XJ, 2002, HUM MOL GENET, V11, P1835, DOI 10.1093/hmg/11.16.1835
   Chinnery PF, 2003, TRENDS GENET, V19, P60, DOI 10.1016/S0168-9525(02)00030-6
   Contamine V, 1996, GENETICS, V144, P541
   Contamine W, 2004, GENETICS, V166, P135, DOI 10.1534/genetics.166.1.135
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Coppin E, 2000, GENETICS, V155, P657
   COPPINRAYNAL E, 1981, BIOCHEM GENET, V19, P729, DOI 10.1007/BF00484005
   CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517
   DEQUARDCHABLAT M, 1994, J BIOL CHEM, V269, P14951
   Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402
   Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034
   Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997
   El-Khoury R, 2008, CURR GENET, V53, P249, DOI 10.1007/s00294-008-0180-3
   Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536
   Lorin S, 2001, MOL MICROBIOL, V42, P1259, DOI 10.1046/j.1365-2958.2001.02690.x
   Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490
   Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747
   Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Riccio P, 1975, FEBS Lett, V56, P192
   RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51
   Sainsard-Chanet A, 1998, CURR GENET, V34, P326, DOI 10.1007/s002940050403
   Sellem CH, 2007, FUNGAL GENET BIOL, V44, P648, DOI 10.1016/j.fgb.2006.09.005
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Silar P, 2001, BIOGERONTOLOGY, V2, P1, DOI 10.1023/A:1010000816277
   Silar P, 1995, FUNG GENET NEWSLETT, V42, P73, DOI [10.4148/1941-4765.1353, DOI 10.4148/1941-4765.1353]
   STEPIEN G, 1992, J BIOL CHEM, V267, P14592
   Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004
   Wang XW, 2008, NAT CELL BIOL, V10, P1090, DOI 10.1038/ncb1769
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
NR 50
TC 12
Z9 12
U1 1
U2 1
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD NOV
PY 2009
VL 183
IS 3
BP 861
EP 871
DI 10.1534/genetics.109.107813
PG 11
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 526NA
UT WOS:000272295800010
PM 19687137
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU DeBalsi, KL
   Hoff, KE
   Copeland, WC
AF DeBalsi, Karen L.
   Hoff, Kirsten E.
   Copeland, William C.
TI Role of the mitochondrial DNA replication machinery in mitochondrial DNA
   mutagenesis, aging and age-related diseases
SO AGEING RESEARCH REVIEWS
LA English
DT Review
DE Mitochondrial DNA mutations; MtDNA replication; DNA polymerase gamma;
   POLG; Aging; Age-related diseases
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; TRANSCRIPTION-FACTOR-A;
   STRUCTURE-FUNCTION DEFECTS; SOMATIC MTDNA MUTATIONS; HUMAN
   SKELETAL-MUSCLE; HYDROGEN-PEROXIDE RELEASE; POLYMERASE-GAMMA;
   AUTOSOMAL-DOMINANT; CALORIC RESTRICTION; POINT MUTATIONS
AB As regulators of bioenergetics in the cell and the primary source of endogenous reactive oxygen species (ROS), dysfunctional mitochondria have been implicated for decades in the process of aging and age related diseases. Mitochondria( DNA (mtDNA) is replicated and repaired by nuclear-encoded mtDNA polymerase gamma (Pol gamma) and several other associated proteins, which compose the mtDNA replication machinery. Here, we review evidence that errors caused by this replication machinery and failure to repair these mtDNA errors results in mtDNA mutations. Clonal expansion of mtDNA mutations results in mitochondrial dysfunction, such as decreased electron transport chain (ETC) enzyme activity and impaired cellular respiration. We address the literature that mitochondrial dysfunction, in conjunction with altered mitochondrial dynamics, is a major driving force behind aging and age-related diseases. Additionally, interventions to improve mitochondrial function and attenuate the symptoms of aging are examined. Published by Elsevier B.V.
C1 [DeBalsi, Karen L.; Hoff, Kirsten E.; Copeland, William C.] NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU Intramural Research Program of the NIH, National Institute of
   Environmental Health Sciences [ES 065078]
FX This work was supported by the Intramural Research Program of the NIH,
   National Institute of Environmental Health Sciences (ES 065078).
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alvarez V, 2008, NEUROSCI LETT, V432, P79, DOI 10.1016/j.neulet.2007.12.010
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Barbieri E, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/917085
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Bayne ACV, 2005, BIOCHEM J, V391, P277, DOI 10.1042/BJ20041872
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Belin AC, 2007, NEUROSCI LETT, V420, P257, DOI 10.1016/j.neulet.2007.05.010
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bensch KG, 2007, DIABETES OBES METAB, V9, P74, DOI 10.1111/j.1463-1326.2007.00776.x
   Bensch KG, 2009, AM J PHYSIOL-ENDOC M, V296, pE672, DOI 10.1152/ajpendo.90839.2008
   Bereiter-Hahn J, 2014, PROG MOL BIOL TRANSL, V127, P93, DOI 10.1016/B978-0-12-394625-6.00004-0
   Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934
   Bori Z, 2012, EXP GERONTOL, V47, P417, DOI 10.1016/j.exger.2012.03.004
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cabelof DC, 2003, DNA REPAIR, V2, P295, DOI 10.1016/S1568-7864(02)00219-7
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x
   Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chauhan A, 2014, BIOGERONTOLOGY, V15, P1, DOI 10.1007/s10522-013-9474-z
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Coxhead J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.036
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337
   DUVOISIN RC, 1992, ANN NY ACAD SCI, V648, P187, DOI 10.1111/j.1749-6632.1992.tb24537.x
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Filippov V, 2001, MOL GENET GENOMICS, V265, P771, DOI 10.1007/s004380100483
   FISHER RP, 1985, J BIOL CHEM, V260, P1330
   FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002
   Gaziev AI, 2014, BIOGERONTOLOGY, V15, P417, DOI 10.1007/s10522-014-9515-2
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Gredilla R, 2002, MICROSC RES TECHNIQ, V59, P273, DOI 10.1002/jemt.10204
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877
   Gui YX, 2015, PARKINSONISM RELAT D, V21, P282, DOI 10.1016/j.parkreldis.2014.12.030
   Halsne R, 2012, DNA REPAIR, V11, P278, DOI 10.1016/j.dnarep.2011.12.001
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Heydari AR, 2007, NUCLEIC ACIDS RES, V35, P7485, DOI 10.1093/nar/gkm860
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Hubbard VM, 2012, BIOGERONTOLOGY, V13, P21, DOI 10.1007/s10522-011-9331-x
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Ikeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119687
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Ingram DK, 2015, AGEING RES REV, V20, P46, DOI 10.1016/j.arr.2014.11.005
   Irving BA, 2015, J CLIN ENDOCR METAB, V100, P1654, DOI 10.1210/jc.2014-3081
   Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974
   Iyer S, 2009, MITOCHONDRION, V9, P196, DOI 10.1016/j.mito.2009.01.012
   Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327
   Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004
   Kanki T, 2004, ANN NY ACAD SCI, V1011, P61, DOI 10.1196/annals.1293.007
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Khan SM, 2004, J BIOENERG BIOMEMBR, V36, P387, DOI 10.1023/B:JOBB.0000041773.20072.9e
   Khrapko K, 2004, ANN NY ACAD SCI, V1019, P240, DOI 10.1196/annals.1297.040
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   Kim YA, 2013, J PHYSIOL BIOCHEM, V69, P697, DOI 10.1007/s13105-013-0246-7
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Konopka AR, 2014, J GERONTOL A-BIOL, V69, P371, DOI 10.1093/gerona/glt107
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat A, 2009, EXP GERONTOL, V44, P101, DOI 10.1016/j.exger.2008.05.006
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782
   Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x
   Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004
   Lee SK, 2015, THERIOGENOLOGY, V83, P121, DOI 10.1016/j.theriogenology.2014.08.019
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Luo L, 2013, EXP GERONTOL, V48, P427, DOI 10.1016/j.exger.2013.02.009
   Luo Y, 2015, INT J MOL SCI, V16, P20704, DOI 10.3390/ijms160920704
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Martin-Montalvo A, 2013, ANTIOXID REDOX SIGN, V19, P310, DOI 10.1089/ars.2012.4866
   Masoro EJ, 2009, BBA-GEN SUBJECTS, V1790, P1040, DOI 10.1016/j.bbagen.2009.02.011
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Ngo HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4077
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Nishiyama S, 2010, BIOCHEM BIOPH RES CO, V401, P26, DOI 10.1016/j.bbrc.2010.08.143
   Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z
   Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Orr WC, 2013, ANTIOXID REDOX SIGN, V19, P788, DOI 10.1089/ars.2012.5002
   Pagano AF, 2014, MED SCI SPORT EXER, V46, P1314, DOI 10.1249/MSS.0000000000000237
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Pohjoismäki JLO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010426
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231
   Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005
   Ruhanen H, 2011, BBA-MOL CELL RES, V1813, P2000, DOI 10.1016/j.bbamcr.2011.08.008
   Safdar A, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0075-9
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Saleem A, 2014, AM J PHYSIOL-CELL PH, V306, pC241, DOI 10.1152/ajpcell.00270.2013
   Sanchez-Martinez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043954
   Sanz A, 2005, J BIOENERG BIOMEMBR, V37, P83, DOI 10.1007/s10863-005-4131-0
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   Schriner SE, 2006, AGE, V28, P209, DOI 10.1007/s11357-006-9010-z
   Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, pE92, DOI 10.1152/ajpendo.00366.2003
   Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   STEIN H, 1969, SCIENCE, V166, P393, DOI 10.1126/science.166.3903.393
   Suarez J, 2008, AM J PHYSIOL-CELL PH, V295, pC1561, DOI 10.1152/ajpcell.00076.2008
   Sun JT, 1999, MOL CELL BIOL, V19, P216
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540
   Tarnopolsky MA, 2009, APPL PHYSIOL NUTR ME, V34, P348, DOI 10.1139/H09-022
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Testa G, 2014, CURR PHARM DESIGN, V20, P2950, DOI 10.2174/13816128113196660699
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wenz Tina, 2011, J Aging Res, V2011, P810619, DOI 10.4061/2011/810619
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Wu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071006
   Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834
   Xu SC, 2009, FEBS J, V276, P4224, DOI 10.1111/j.1742-4658.2009.07094.x
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang D, 2005, AM J PHYSIOL-HEART C, V288, pH2476, DOI 10.1152/ajpheart.00670.2004
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 271
TC 122
Z9 141
U1 2
U2 61
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1568-1637
EI 1872-9649
J9 AGEING RES REV
JI Ageing Res. Rev.
PD JAN
PY 2017
VL 33
SI SI
BP 89
EP 104
DI 10.1016/j.arr.2016.04.006
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EJ9DX
UT WOS:000393527900009
PM 27143693
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Chabi, B
   de Camaret, WM
   Chevrollier, A
   Boisgard, S
   Stepien, G
AF Chabi, B
   de Camaret, WM
   Chevrollier, A
   Boisgard, S
   Stepien, G
TI Random mtDNA deletions and functional consequence in aged human skeletal
   muscle
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE aging; mitochondria; mtDNA deletion; respiratory chain; oxidative
   phosphorylation
ID MITOCHONDRIAL-DNA DELETIONS; RESPIRATORY-CHAIN FUNCTION; ACCUMULATION;
   SEQUENCE; MUTATION; DECLINE; DISEASE; TISSUES; ORGANIZATION; DEFICIENCY
AB Mitochondrial respiratory chain deteriorates with age, mostly in tissues with high energy requirements. Damage to mitochondrial DNA (mtDNA) by reactive oxygen species is thought to contribute primarily to this impairment. However, the overall extent of random mtDNA mutations has still not been evaluated. We carried out molecular and biochemical analyses in muscle biopsies from healthy young and aged subjects. Deleted mtDNA accumulation was followed by both quantitative PCR analysis to quantify total mtDNA, and Southern-blotting, to determine deleted to full length mtDNA ratio. Enzymatic activities of the mitochondrial respiratory chain were measured in all subjects. Randomly deleted mtDNA appeared mainly in the oldest subjects (beyond 80 years old), affecting up to 70% of mtDNA molecules. The activities of complexes III and IV of the respiratory chain, complexes with mtDNA encoded subunits, are lower in the aged subjects. Physical activity could be one major parameter modulating the mitochondrial respiratory chain activity in aged muscle. (C) 2005 Elsevier Inc. All rights reserved.
C1 Univ Auvergne, INSERM, U484, Clermont Ferrand, France.
   Univ Auvergne, INRA, U1019, Clermont Ferrand, France.
   Hop Debrousse, Biochim Lab, Lyon, France.
   Univ Angers, INSERM, U694, Angers, France.
   CHU Gabriel Montpied, Serv Chirurg Orthoped, Clermont Ferrand, France.
C3 Universite Clermont Auvergne (UCA); Institut National de la Sante et de
   la Recherche Medicale (Inserm); INRAE; Universite Clermont Auvergne
   (UCA); CHU Lyon; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite d'Angers; CHU Clermont Ferrand
RP Univ Auvergne, INSERM, U484, Clermont Ferrand, France.
EM stepien@inserm484.u-clermont1.fr
RI ; CHEVROLLIER, Arnaud/K-2853-2015
OI CHABI, Beatrice/0000-0002-5604-5668; CHEVROLLIER,
   Arnaud/0000-0002-5135-6643
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
   BERTHON P, 1995, ACTA PHYSIOL SCAND, V154, P269, DOI 10.1111/j.1748-1716.1995.tb09908.x
   Biagini G, 1998, MECH AGEING DEV, V101, P269, DOI 10.1016/S0047-6374(97)00181-4
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   DAVIES KJA, 1981, ARCH BIOCHEM BIOPHYS, V209, P539, DOI 10.1016/0003-9861(81)90312-X
   Ferlin T, 1997, MOL CELL BIOCHEM, V174, P221, DOI 10.1023/A:1006860508606
   Gerhard GS, 2002, MECH AGEING DEV, V123, P155, DOI 10.1016/S0047-6374(01)00328-1
   Geromel V, 1997, BIOCHEM BIOPH RES CO, V236, P643, DOI 10.1006/bbrc.1997.7024
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hayakawa M, 1996, BIOCHEM BIOPH RES CO, V226, P369, DOI 10.1006/bbrc.1996.1363
   HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HSIEH RH, 1994, BIOCHEM MOL BIOL INT, V32, P1009
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   Kovalenko SA, 1997, BIOCHEM BIOPH RES CO, V232, P147, DOI 10.1006/bbrc.1997.6251
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MOUSSON B, 1995, ACTA NEUROL SCAND, V91, P488
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   NECKELMANN N, 1989, GENOMICS, V5, P829, DOI 10.1016/0888-7543(89)90125-0
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9
   REYNIER P, 1995, BIOCHEM BIOPH RES CO, V217, P59, DOI 10.1006/bbrc.1995.2745
   Rooyackers OE, 1996, CLIN SCI, V91, P475, DOI 10.1042/cs0910475
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   ZHANG CF, 1993, BIOCHEM BIOPH RES CO, V195, P1104, DOI 10.1006/bbrc.1993.2158
NR 40
TC 27
Z9 33
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 1
PY 2005
VL 332
IS 2
BP 542
EP 549
DI 10.1016/j.bbrc.2005.04.153
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 932RY
UT WOS:000229572300033
PM 15896715
DA 2024-11-01
ER

PT J
AU Wanrooij, S
   Luoma, P
   van Goethem, G
   van Broeckhoven, C
   Suomalainen, A
   Spelbrink, JN
AF Wanrooij, S
   Luoma, P
   van Goethem, G
   van Broeckhoven, C
   Suomalainen, A
   Spelbrink, JN
TI Twinkle and POLG defects enhance age-dependent accumulation of mutations
   in the control region of mtDNA
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HUMAN MITOCHONDRIAL-DNA;
   LARGE-SCALE DELETIONS; POLYMERASE GAMMA-A; D-LOOP REGION;
   AUTOSOMAL-DOMINANT; MULTIPLE DELETIONS; NEUROGASTROINTESTINAL
   ENCEPHALOMYOPATHY; THYMIDINE PHOSPHORYLASE; POINT MUTATIONS
AB Autosomal dominant and/or recessive progressive external ophthalmoplegia (ad/arPEO) is associated with mtDNA mutagenesis. It can be caused by mutations in three nuclear genes, encoding the adenine nucleotide translocator 1, the mitochondrial helicase Twinkle or DNA polymerase gamma (POLG). How mutations in these genes result in progressive accumulation of multiple mtDNA deletions in post- mitotic tissues is still unclear. A recent hypothesis suggested that mtDNA replication infidelity could promote slipped mispairing, thereby stimulating deletion formation. This hypothesis predicts that mtDNA of ad/arPEO patients will contain frequent mutations throughout; in fact, our analysis of muscle from ad/arPEO patients revealed an age-dependent, enhanced accumulation of point mutations in addition to deletions, but specifically in the mtDNA control region. Both deleted and non-deleted mtDNA molecules showed increased point mutation levels, as did mtDNAs of patients with a single mtDNA deletion, suggesting that point mutations do not cause multiple deletions. Deletion breakpoint analysis showed frequent breakpoints around homopolymeric runs, which could be a signature of replication stalling. Therefore, we propose replication stalling as the principal cause of deletion formation.
C1 Inst Med Technol, Tampere, Finland.
   Tampere Univ Hosp, Tampere, Finland.
   Univ Helsinki, Biomed Helsinki, Programme Neurosci, Helsinki, Finland.
   Univ Helsinki, Biomed Helsinki, Dept Neurol, Helsinki, Finland.
   Univ Antwerp, Born Bunge Fdn, B-2020 Antwerp, Belgium.
   Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium.
C3 Tampere University; Tampere University Hospital; University of Helsinki;
   University of Helsinki; University of Antwerp; Flanders Institute for
   Biotechnology (VIB); University of Antwerp
RP Inst Med Technol, Tampere, Finland.
EM lthasp@uta.fi
RI Wanrooij, Sjoerd/J-1367-2019; Van Broeckhoven, Christine/M-7853-2019;
   Van Broeckhoven, Christine/G-8362-2017; Spelbrink, Johannes/L-4661-2015
OI Van Broeckhoven, Christine/0000-0003-0183-7665; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195; Wanrooij, Sjoerd/0000-0001-6126-4382;
   Spelbrink, Johannes/0000-0002-9756-2602
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Carrozzo R, 1998, NEUROLOGY, V50, P99, DOI 10.1212/WNL.50.1.99
   Chinnery PF, 2003, NEUROLOGY, V61, P878, DOI 10.1212/WNL.61.7.878
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7
   Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   GHIVIZZANI SC, 1994, MOL CELL BIOL, V14, P7717, DOI 10.1128/MCB.14.12.7717
   Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5
   Grossman LI, 1996, BIOESSAYS, V18, P983, DOI 10.1002/bies.950181208
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5
   Liu HT, 2000, J VIROL, V74, P11681, DOI 10.1128/JVI.74.24.11681-11689.2000
   LUOMA P, 2004, IN PRESS LANCET
   MADSEN CS, 1993, MOL CELL BIOL, V13, P2162, DOI 10.1128/MCB.13.4.2162
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oshima J, 2002, CANCER RES, V62, P547
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SACCONE C, 1987, J MOL EVOL, V26, P205, DOI 10.1007/BF02099853
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Solano A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e86
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   VanGoethem G, 1997, EUR J NEUROL, V4, P476
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
NR 60
TC 98
Z9 110
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUN
PY 2004
VL 32
IS 10
BP 3053
EP 3064
DI 10.1093/nar/gkh634
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 830JQ
UT WOS:000222118600017
PM 15181170
OA Green Published, Bronze
DA 2024-11-01
ER

PT B
AU Hirano, M
AF Hirano, M.
BE Kompoliti, K
   Metman, LV
TI Neurogenic Muscle Weakness, Ataxia, and Retinitis Pigmentosa (NARP)
SO ENCYCLOPEDIA OF MOVEMENT DISORDERS, VOL 2: H-P
LA English
DT Article; Book Chapter
ID MITOCHONDRIAL-DNA; PRENATAL-DIAGNOSIS; T8993C MUTATION; LEIGHS SYNDROME;
   DISEASE; MTDNA; GENE
C1 Columbia Univ, Med Ctr, New York, NY 10027 USA.
C3 Columbia University
RP Hirano, M (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.
CR Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Fujii T, 2002, PEDIATR NEUROL, V27, P58, DOI 10.1016/S0887-8994(02)00378-8
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   Pettman R, 2007, J Inherit Metab Dis, V30, P404, DOI 10.1007/s10545-007-0460-y
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   White SL, 1999, PRENATAL DIAG, V19, P1165, DOI 10.1002/(SICI)1097-0223(199912)19:12<1165::AID-PD719>3.3.CO;2-4
   Yoon MK, 2009, INVEST OPHTH VIS SCI, V50, P1838, DOI 10.1167/iovs.08-2029
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
BN 978-0-12-374105-9; 978-0-12-374101-1
PY 2010
BP 270
EP 272
PG 3
WC Clinical Neurology; Neurosciences
WE Book Citation Index – Science (BKCI-S)
SC Neurosciences & Neurology
GA BA3XC
UT WOS:000335076600086
DA 2024-11-01
ER

PT J
AU Phan, HTL
   Lee, HYJ
   Kim, K
AF Phan, Hong Thi Lam
   Lee, Hyunji
   Kim, Kyoungmi
TI Trends and prospects in mitochondrial genome editing
SO EXPERIMENTAL AND MOLECULAR MEDICINE
LA English
DT Review
ID ZINC-FINGER PROTEINS; SEQUENCE-SPECIFIC MODIFICATION; 5S RIBOSOMAL-RNA;
   SELECTIVE DEGRADATION; RESTRICTION ENZYMES; DNA HETEROPLASMY; MUTANT
   MTDNA; ELIMINATION; MUTATIONS; EXPRESSION
AB Mitochondria are of fundamental importance in programmed cell death, cellular metabolism, and intracellular calcium concentration modulation, and inheritable mitochondrial disorders via mitochondrial DNA (mtDNA) mutation cause several diseases in various organs and systems. Nevertheless, mtDNA editing, which plays an essential role in the treatment of mitochondrial disorders, still faces several challenges. Recently, programmable editing tools for mtDNA base editing, such as cytosine base editors derived from DddA (DdCBEs), transcription activator-like effector (TALE)-linked deaminase (TALED), and zinc finger deaminase (ZFD), have emerged with considerable potential for correcting pathogenic mtDNA variants. In this review, we depict recent advances in the field, including structural biology and repair mechanisms, and discuss the prospects of using base editing tools on mtDNA to broaden insight into their medical applicability for treating mitochondrial diseases.
   Gene editing: moving into mitochondriaApplying gene editing techniques to the DNA found within mitochondria, the intracellular energy-producing organelles, is being explored as an approach to treating various diseases. Most of the cell's genetic information is found in the nucleus, but mitochondria carry their own set of genes. Hong Thi Lam Phan Korea University, Seoul, South Korea, and coworkers review current trends and prospects in mitochondrial gene editing. Genetic defects in mitochondria have been implicated in many diseases, mainly affecting muscle and nervous tissues. A variety of methods for editing mitochondrial DNA are being explored, both as possible treatments and as methods to create animal models of human mitochondrial diseases. Challenges yet to be overcome, initially in animal studies, including finding effective means to deliver the molecular editing tools into mitochondria and achieving therapeutic results without harmful side effects.
C1 [Phan, Hong Thi Lam; Kim, Kyoungmi] Korea Univ, Coll Med, Dept Physiol, Seoul 02841, South Korea.
   [Lee, Hyunji] Korea Res Inst Biosci & Biotechnol, Lab Anim Resource & Res Ctr, Cheongju 28116, South Korea.
   [Lee, Hyunji] Sungkyunkwan Univ, Sch Med, Suwon 16419, South Korea.
   [Kim, Kyoungmi] Korea Univ, Coll Med, Dept Biomed Sci, Seoul 02841, South Korea.
C3 Korea University; Korea University Medicine (KU Medicine); Korea
   Research Institute of Bioscience & Biotechnology (KRIBB); Sungkyunkwan
   University (SKKU); Korea University; Korea University Medicine (KU
   Medicine)
RP Kim, K (corresponding author), Korea Univ, Coll Med, Dept Physiol, Seoul 02841, South Korea.; Lee, HYJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Lab Anim Resource & Res Ctr, Cheongju 28116, South Korea.; Lee, HYJ (corresponding author), Sungkyunkwan Univ, Sch Med, Suwon 16419, South Korea.; Kim, K (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Seoul 02841, South Korea.
EM hjlee102@kribb.re.kr; kim0912@korea.ac.kr
RI Phan, Lamhong/JGD-7037-2023; Kim, Kyoungmi/AEP-3965-2022
OI Lee, Hyunji/0000-0001-9957-9275; Thi Lam Hong, Phan/0000-0001-9203-6489;
   Kim, Kyoungmi/0000-0003-0941-806X
FU Bio & Medical Technology Development Program of the National Research
   Foundation (NRF) of Korea [NRF-2020M3A9D5A01082439,
   NRF-2019R1A2C2087198]; Korea Research Institute of Bioscience and
   Biotechnology (KRIBB) Research Initiative Program
FX This study was supported by the Chung Yang, Cha Young Sun, and Jang Hi
   Joo Memorial Fund. This work was also supported by the Bio & Medical
   Technology Development Program of the National Research Foundation (NRF)
   of Korea (NRF-2020M3A9D5A01082439 and NRF-2019R1A2C2087198) and the
   Korea Research Institute of Bioscience and Biotechnology (KRIBB)
   Research Initiative Program. The illustrations were generated using
   BioRender.com.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Antón Z, 2020, J CELL SCI, V133, DOI 10.1242/jcs.248468
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Banskota S, 2022, CELL, V185, P250, DOI 10.1016/j.cell.2021.12.021
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628
   Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697
   Bian WP, 2019, ACS SYNTH BIOL, V8, P621, DOI 10.1021/acssynbio.8b00411
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Cho SI, 2022, CELL, V185, P1764, DOI 10.1016/j.cell.2022.03.039
   Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   Filippi MD, 2019, BLOOD, V133, P1943, DOI 10.1182/blood-2018-10-808873
   Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gaude E, 2018, MOL CELL, V69, P581, DOI 10.1016/j.molcel.2018.01.034
   Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Guo JY, 2022, MOL THER-NUCL ACIDS, V27, P73, DOI 10.1016/j.omtn.2021.11.016
   Guo JY, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00307-9
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530
   Hussain SRA, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.627050
   Jo A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/305716
   Kang BC, 2021, NAT PLANTS, V7, P899, DOI 10.1038/s41477-021-00943-9
   Kaniak-Golik A, 2015, FREE RADICAL BIO MED, V82, P73, DOI 10.1016/j.freeradbiomed.2015.01.013
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249, DOI [10.1007/BF01694557, DOI 10.1007/BF01694557]
   Lee H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21464-1
   Lei ZX, 2022, NATURE, V606, P804, DOI 10.1038/s41586-022-04836-5
   Lim K, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-27962-0
   Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mangeot PE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07845-z
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Minczuk M, 2010, NAT PROTOC, V5, P342, DOI 10.1038/nprot.2009.245
   Mok BY, 2022, NAT BIOTECHNOL, V40, P1378, DOI 10.1038/s41587-022-01256-8
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Moraes CT, 2014, EMBO MOL MED, V6, P434, DOI 10.1002/emmm.201303769
   Nakazato I, 2021, NAT PLANTS, V7, P906, DOI 10.1038/s41477-021-00954-6
   Pereira CV, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708084
   Perez-Quintero AL, 2019, ANNU REV PHYTOPATHOL, V57, P459, DOI 10.1146/annurev-phyto-082718-100026
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001
   Qi XL, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00325-7
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Richter A, 2016, METHODS MOL BIOL, V1338, P9, DOI 10.1007/978-1-4939-2932-0_2
   Sabharwal A, 2021, CRISPR J, V4, P799, DOI 10.1089/crispr.2021.0061
   Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Silva-Pinheiro P, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28358-w
   Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208
   Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711
   Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tang SH, 2015, BIOCHEM BIOPH RES CO, V458, P186, DOI 10.1016/j.bbrc.2015.01.092
   Tonin Y, 2014, J BIOL CHEM, V289, P13323, DOI 10.1074/jbc.M113.528968
   Towheed A, 2014, NEUROBIOL DIS, V69, P15, DOI 10.1016/j.nbd.2014.04.017
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607
   Wang YJ, 2022, CELL REP, V40, DOI 10.1016/j.celrep.2022.111418
   Wei YH, 2022, CELL DISCOV, V8, DOI 10.1038/s41421-022-00391-5
   Wei YH, 2022, CELL DISCOV, V8, DOI 10.1038/s41421-021-00372-0
   Wu ZW, 2021, NAT CHEM BIOL, V17, P1132, DOI 10.1038/s41589-021-00868-6
   Xiong H, 2004, NEUROBIOL AGING, V25, P349, DOI 10.1016/S0197-4580(03)00123-4
   Yahata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15871-y
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287
   Yin T, 2022, FRONT PHYSIOL, V13, DOI 10.3389/fphys.2022.883459
   Yu H, 2012, P NATL ACAD SCI USA, V109, pE1238, DOI 10.1073/pnas.1119577109
   Zelenka J, 2016, METHODS MOL BIOL, V1351, P175, DOI 10.1007/978-1-4939-3040-1_13
NR 84
TC 9
Z9 9
U1 2
U2 18
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1226-3613
EI 2092-6413
J9 EXP MOL MED
JI Exp. Mol. Med.
PD MAY
PY 2023
VL 55
IS 5
BP 871
EP 878
DI 10.1038/s12276-023-00973-7
EA MAY 2023
PG 8
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA H7IM4
UT WOS:000978586000005
PM 37121968
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Tzoulis, C
   Henriksen, E
   Miletic, H
   Bindoff, LA
AF Tzoulis, Charalampos
   Henriksen, Eilen
   Miletic, Hrvoje
   Bindoff, Laurence A.
TI No evidence of ischemia in stroke-like lesions of mitochondrial POLG
   encephalopathy
SO MITOCHONDRION
LA English
DT Article
DE Polymerase gamma; Mitochondria; Mitochondrial disease; Ischemia;
   Vessels; Infarction; Angiogenesis
ID ANGIOGENESIS; MUTATIONS; MYOPATHY; EPISODES; LACTATE; OXYGEN
AB Stroke-like lesions are characteristically associated with mitochondrial encephalopathies such as those caused by mutations of polymerase gamma (POLG) and the m.3243A > G mitochondrial DNA (mtDNA) mutation. The combination of acute clinical onset, MRI and pathological abnormalities, have led to the suggestion that these lesions are ischemic. Here, we sought to determine the role of ischemia in the pathogenesis of mitochondrial stroke-like lesions. We performed a systematic study of cerebral blood vessel morphology, density and distribution in post mortem brain tissue from nine patients with POLG-encephalopathy and seven neurologically healthy controls. We found that patients had significantly higher cerebral vascular density than controls: this was more pronounced in areas of chronic neurodegeneration, where vascular density correlated with the severity of neuronal loss, but was also seen in acute lesions. Further, blood vessels were patent and, in acute lesions, dilated suggesting increased perfusion. In contrast to what would be expected in ischemia, stroke-like lesions were not pan-necrotic and were highly vascularized. Our results suggest that ischemia does not contribute to the pathogenesis of either the chronic neurodegeneration or acute lesions in POLG encephalopathy. Neovascularization and vascular dilatation does occur and suggests a compensatory response. We suggested the acute lesions are more likely to reflect energy insufficiency and our earlier studies suggest that this is driven in large part by seizure activity. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Tzoulis, Charalampos; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, Bergen, Norway.
   [Tzoulis, Charalampos; Henriksen, Eilen; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway.
   [Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, Bergen, Norway.
   [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of
   Bergen; University of Bergen; Haukeland University Hospital; University
   of Bergen
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
RI Tzoulis, Charalampos/AGD-5114-2022
OI Tzoulis, Charalampos/0000-0003-0341-5191; Bindoff,
   Laurence/0000-0003-0988-276X
FU Western Norway Health Trust [911650]; Meltzer Foundation
FX This work was supported by grants from the Western Norway Health Trust
   (grant no: 911650) and the Meltzer Foundation.
CR BARZ H, 1975, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V119, P488
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hunt TK, 2008, ADV EXP MED BIOL, V614, P73, DOI 10.1007/978-0-387-74911-2_9
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0
   Taivassalo T, 2012, BRAIN, V135, P53, DOI 10.1093/brain/awr293
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
NR 15
TC 10
Z9 10
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN
PY 2017
VL 32
BP 10
EP 15
DI 10.1016/j.mito.2016.11.004
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA EI0LG
UT WOS:000392165400002
PM 27838477
DA 2024-11-01
ER

PT J
AU Chen, TH
   Koh, KY
   Lin, KMC
   Chou, CK
AF Chen, Tsung-Hsien
   Koh, Kok-Yean
   Lin, Kurt Ming-Chao
   Chou, Chu-Kuang
TI Mitochondrial Dysfunction as an Underlying Cause of Skeletal Muscle
   Disorders
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mitochondrial dysfunction; skeletal muscle disorders; OXPHOS; mtDNA
   mutation; mitochondrial dynamics; mitophagy; mitochondrial chaperone
   protein
ID OXIDATIVE STRESS; GENE-EXPRESSION; DNA-DELETION; EXERCISE; AUTOPHAGY;
   PHOSPHORYLATION; TRANSCRIPTION; CALCIUM; ATROPHY; ACTIVATION
AB Mitochondria are an important energy source in skeletal muscle. A main function of mitochondria is the generation of ATP for energy through oxidative phosphorylation (OXPHOS). Mitochondrial defects or abnormalities can lead to muscle disease or multisystem disease. Mitochondrial dysfunction can be caused by defective mitochondrial OXPHOS, mtDNA mutations, Ca2+ imbalances, mitochondrial-related proteins, mitochondrial chaperone proteins, and ultrastructural defects. In addition, an imbalance between mitochondrial fusion and fission, lysosomal dysfunction due to insufficient biosynthesis, and/or defects in mitophagy can result in mitochondrial damage. In this review, we explore the association between impaired mitochondrial function and skeletal muscle disorders. Furthermore, we emphasize the need for more research to determine the specific clinical benefits of mitochondrial therapy in the treatment of skeletal muscle disorders.
C1 [Chen, Tsung-Hsien] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi 60002, Taiwan.
   [Koh, Kok-Yean; Chou, Chu-Kuang] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Div Gastroenterol & Hepatol, Chiayi 60002, Taiwan.
   [Lin, Kurt Ming-Chao] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Zhunan 35053, Taiwan.
   [Chou, Chu-Kuang] Chia Yi Christian Hosp, Ditmanson Med Fdn, Obes Ctr, Chiayi 60002, Taiwan.
C3 National Health Research Institutes - Taiwan
RP Chou, CK (corresponding author), Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Div Gastroenterol & Hepatol, Chiayi 60002, Taiwan.; Lin, KMC (corresponding author), Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Zhunan 35053, Taiwan.; Chou, CK (corresponding author), Chia Yi Christian Hosp, Ditmanson Med Fdn, Obes Ctr, Chiayi 60002, Taiwan.
EM klin@nhri.edu.tw; vacinu@gmail.com
RI Chou, Chu-kuang/AAF-5875-2020; Lin, Kurt/E-3975-2010; Chen,
   Tsung-Hsien/KZU-0182-2024
OI Lin, Kurt/0000-0003-1371-5569; Chen, Tsung-Hsien/0000-0002-1542-1495;
   Chou, Chu-kuang/0000-0003-2588-6883
CR Agrawal A, 2017, CELL STRESS CHAPERON, V22, P429, DOI 10.1007/s12192-017-0795-8
   Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200
   Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   Baker N, 2019, MITOCHONDRION, V49, P259, DOI 10.1016/j.mito.2019.06.003
   Balakrishnan R, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23094636
   Ballarò R, 2021, CANCERS, V13, DOI 10.3390/cancers13040850
   Ballarò R, 2019, CANCERS, V11, DOI 10.3390/cancers11030285
   Ballarò R, 2019, FASEB J, V33, P5482, DOI 10.1096/fj.201801862R
   Baracos VE, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.105
   Barone R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19781
   Barreto R, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00472
   Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Bertero E, 2018, J CLIN INVEST, V128, P5191, DOI 10.1172/JCI124944
   Beyfuss K, 2018, REDOX REP, V23, P100, DOI 10.1080/13510002.2017.1416773
   Bock FJ, 2020, NAT REV MOL CELL BIO, V21, P85, DOI 10.1038/s41580-019-0173-8
   Boonyarom O, 2006, ACTA PHYSIOL, V188, P77, DOI 10.1111/j.1748-1716.2006.01613.x
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Brioche T, 2016, CURR PHARM DESIGN, V22, P2664, DOI 10.2174/1381612822666160219120531
   Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007
   Carson JA, 2016, SEMIN CELL DEV BIOL, V54, P53, DOI 10.1016/j.semcdb.2015.11.005
   Carson JA, 2010, EXERC SPORT SCI REV, V38, P168, DOI 10.1097/JES.0b013e3181f44f11
   Castellanos E, 2019, YALE J BIOL MED, V92, P523
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Challa S, 2004, NEUROL INDIA, V52, P353
   Chen TH, 2016, ONCOTARGET, V7, P54274, DOI 10.18632/oncotarget.11026
   Chen TH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/539805
   Choi MH, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6842568
   Conley KE, 2007, EXERC SPORT SCI REV, V35, P43
   Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005
   Correia-Melo C, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.159
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67
   De Mario A, 2021, CELL CALCIUM, V94, DOI 10.1016/j.ceca.2021.102357
   De Paepe Boel, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1902s63
   Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016
   Diaz Francisca, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1904s63
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019
   Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9
   Fernando R, 2019, FREE RADICAL BIO MED, V132, P58, DOI 10.1016/j.freeradbiomed.2018.08.037
   Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Fry Christopher S, 2011, Curr Aging Sci, V4, P260
   Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96
   Galluzzi L, 2011, CURR BIOL, V21, pR478, DOI 10.1016/j.cub.2011.05.002
   Gammazza AM, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120224
   Gehrig SM, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0488-x
   Gherardi G, 2019, CELL DEATH DIFFER, V26, P362, DOI 10.1038/s41418-018-0191-7
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a
   Houzelle A, 2021, DIABETOLOGIA, V64, P424, DOI 10.1007/s00125-020-05335-w
   Hung CHL, 2018, REDOX BIOL, V14, P7, DOI 10.1016/j.redox.2017.08.010
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   Jackson MJ, 2016, J PHYSIOL-LONDON, V594, P1979, DOI 10.1113/JP270564
   Jeppesen TD, 2021, J CLIN MED, V10, DOI 10.3390/jcm10081796
   Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807
   Mateos-Aierdi AJ, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00125
   Kaludercic N, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3869610
   Knuth S.T., 2000, THESIS MARQUETTE U M
   Komulainen T, 2015, JIMD REP, V23, P91, DOI 10.1007/8904_2015_438
   Kozakowska M, 2015, J MUSCLE RES CELL M, V36, P377, DOI 10.1007/s10974-015-9438-9
   Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005
   Kumaran S, 2005, MOL CELL BIOCHEM, V280, P83, DOI 10.1007/s11010-005-8234-z
   Kunz WS, 2001, BBA-BIOENERGETICS, V1504, P12, DOI 10.1016/S0005-2728(00)00235-8
   Lalia AZ, 2016, J CLIN ENDOCR METAB, V101, P626, DOI 10.1210/jc.2015-2892
   Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Li B, 2022, PHARMACOL THERAPEUT, V232, DOI 10.1016/j.pharmthera.2021.107995
   Luo Xiaoting, 2017, Curr Protoc Protein Sci, V87, DOI 10.1002/cpps.21
   Mammucari C, 2015, CELL REP, V10, P1269, DOI 10.1016/j.celrep.2015.01.056
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782
   Mareedu S, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.647010
   Marzetti E, 2017, EXP GERONTOL, V87, P92, DOI 10.1016/j.exger.2016.10.003
   Mason S, 2007, ADV EXP MED BIOL, V618, P229
   McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736
   Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704
   Mingrone G, 2005, DIABETOLOGIA, V48, P2108, DOI 10.1007/s00125-005-1918-9
   Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823
   Molinari F, 2017, J CACHEXIA SARCOPENI, V8, P954, DOI 10.1002/jcsm.12226
   Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471
   Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178
   Najbauer EE, 2021, EUR BIOPHYS J BIOPHY, V50, P159, DOI 10.1007/s00249-021-01515-7
   Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0
   Naresh NU, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033944
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Neupane N, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-04034-z
   O'Leary MF, 2013, AM J PHYSIOL-CELL PH, V304, pC422, DOI 10.1152/ajpcell.00240.2012
   Onesti JK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/168407
   Onopiuk M, 2009, BIOCHEM BIOPH RES CO, V386, P463, DOI 10.1016/j.bbrc.2009.06.053
   Ophuis RJAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008024
   Orfany A, 2020, J VASC SURG, V71, P1014, DOI 10.1016/j.jvs.2019.03.079
   Padilha CS, 2017, APPL PHYSIOL NUTR ME, V42, P916, DOI 10.1139/apnm-2016-0436
   Padrao AI, 2013, INT J BIOCHEM CELL B, V45, P1399, DOI 10.1016/j.biocel.2013.04.014
   Pala F, 2018, J CELL SCI, V131, DOI 10.1242/jcs.212977
   Pant M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123875
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Penna F, 2020, ANTIOXID REDOX SIGN, V33, P542, DOI 10.1089/ars.2020.8041
   Penna F, 2019, J MOL BIOL, V431, P2674, DOI 10.1016/j.jmb.2019.05.032
   Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011
   Pigna E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26991
   Pin F, 2019, J CACHEXIA SARCOPENI, V10, P140, DOI 10.1002/jcsm.12360
   Pin F, 2018, CURR OPIN SUPPORT PA, V12, P420, DOI 10.1097/SPC.0000000000000382
   Pin F, 2015, ONCOTARGET, V6, P43202, DOI 10.18632/oncotarget.6439
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054
   Powers SK, 2012, CURR OPIN CLIN NUTR, V15, P240, DOI 10.1097/MCO.0b013e328352b4c2
   Primeau AJ, 2002, CAN J APPL PHYSIOL, V27, P349, DOI 10.1139/h02-020
   Puppa MJ, 2012, J CACHEXIA SARCOPENI, V3, P117, DOI 10.1007/s13539-011-0047-1
   Ranjbar K, 2019, MED SCI SPORT EXER, V51, P1387, DOI 10.1249/MSS.0000000000001916
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102
   Rybalka E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115763
   Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3
   Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177
   Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Shanina E., 2022, ELECTRODIAGNOSTIC EV
   Sharma S, 2006, FREE RADICAL BIO MED, V40, P2223, DOI 10.1016/j.freeradbiomed.2006.02.019
   Shin B, 2017, ADV EXP MED BIOL, V982, P595, DOI 10.1007/978-3-319-55330-6_31
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Singh M, 2007, MITOCHONDRION, V7, P367, DOI 10.1016/j.mito.2007.07.003
   Smith ME, 2013, BIOCHEM J, V456, P427, DOI 10.1042/BJ20130807
   Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312
   Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Tagliavini Francesca, 2013, Muscles Ligaments Tendons J, V3, P281
   Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952
   Talbert EE, 2016, SEMIN CELL DEV BIOL, V54, P82, DOI 10.1016/j.semcdb.2015.09.009
   Tan PL, 2015, INT J BIOCHEM CELL B, V62, P72, DOI 10.1016/j.biocel.2015.02.015
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970
   VanderVeen BN, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.01037
   Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006
   Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610
   Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902
   Wang YF, 2009, J NEUROCHEM, V110, P687, DOI 10.1111/j.1471-4159.2009.06167.x
   White JP, 2011, AM J PHYSIOL-REG I, V300, pR201, DOI 10.1152/ajpregu.00300.2010
   Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015
   Wu WX, 2016, EMBO J, V35, P1368, DOI 10.15252/embj.201593102
   Xia QH, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.638983
   Xiao T, 2020, J MOL ENDOCRINOL, V64, P67, DOI 10.1530/JME-19-0207
   Yan Y, 2017, FREE RADICAL BIO MED, V109, P108, DOI 10.1016/j.freeradbiomed.2016.12.003
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zarse K, 2021, NAT METAB, V3, P588, DOI 10.1038/s42255-021-00387-7
   Zielonka D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00380
NR 175
TC 25
Z9 26
U1 8
U2 34
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV
PY 2022
VL 23
IS 21
AR 12926
DI 10.3390/ijms232112926
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 6B3JU
UT WOS:000881234300001
PM 36361713
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU El-Hattab, AW
   Scaglia, F
AF El-Hattab, Ayman W.
   Scaglia, Fernando
TI Mitochondrial cytopathies
SO CELL CALCIUM
LA English
DT Review
DE Mitochondrial diseases; Mitochondrial dysfunction; Mitochondrial DNA;
   Electron transport chain; Diagnosis of mitochondrial diseases; Treatment
   of mitochondrial diseases
ID DNA MUTATIONS; DISEASE; MELAS; REPLICATION; BIOGENESIS; DEFICIENCY;
   CITRULLINE; DISORDERS; DEPLETION; COQ(10)
AB Mitochondria are found in all nucleated human cells and perform a variety of essential functions, including the generation of cellular energy. Most of mitochondrial proteins are encoded by the nuclear DNA (nDNA) whereas a very small fraction is encoded by the mitochondrial DNA (mtDNA). Mutations in mtDNA or mitochondria-related nDNA genes can result in mitochondrial dysfunction which leads to a wide range of cellular perturbations including aberrant calcium homeostasis, excessive reactive oxygen species production, dysregulated apoptosis, and insufficient energy generation to meet the needs of various organs, particularly those with high energy demand. Impaired mitochondrial function in various tissues and organs results in the multi-organ manifestations of mitochondrial diseases including epilepsy, intellectual disability, skeletal and cardiac myopathies, hepatopathies, endocrinopathies, and nephropathies. Defects in nDNA genes can be inherited in an autosomal or X-linked manners, whereas, mtDNA is maternally inherited. Mitochondrial diseases can result from mutations of nDNA genes encoding subunits of the electron transport chain complexes or their assembly factors, proteins associated with the mitochondrial import or networking, mitochondria translation factors, or proteins involved in mtDNA maintenance. MtDNA defects can be either point mutations or rearrangements. The diagnosis of mitochondrial disorders can be challenging in many cases and is based on clinical recognition, biochemical screening, histopathological studies, functional studies, and molecular genetic testing. Currently, there are no satisfactory therapies available for mitochondrial disorders that significantly alter the course of the disease. Therapeutic options include symptomatic treatment, cofactor supplementation, and exercise. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [El-Hattab, Ayman W.] Tawam Hosp, Dept Pediat, Div Clin Genet & Metab Disorders, Al Ain, U Arab Emirates.
   [Scaglia, Fernando] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza,MS BCM225, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Scaglia, F (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza,MS BCM225, Houston, TX 77030 USA.
EM fscaglia@bcm.edu
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Calvo J., 2009, ARCH NEUROL, V66
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Chinnery P.F., 2000, GENEREVIEWS, P1993
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Coenen M.J., 2004, N ENGL J MED, V351
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   El-Hattab A.W., 2015, INBORN ERRORS METABO, P180
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285
   Kang CH, 2012, ANN NY ACAD SCI, V1271, P110, DOI 10.1111/j.1749-6632.2012.06738.x
   Koene S, 2015, JIMD REP, V24, P69, DOI 10.1007/8904_2015_436
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351
   Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009
   MacKenzie JA, 2007, BBA-MOL BASIS DIS, V1772, P509, DOI 10.1016/j.bbadis.2006.12.002
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Munnich A., 2012, INBORN METABOLIC DIS, P223
   Potgieter M, 2013, NUTR REV, V71, P180, DOI 10.1111/nure.12011
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Shitara H, 1998, GENETICS, V148, P851
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen Anu, 2013, Expert Opin Med Diagn, V7, P313, DOI 10.1517/17530059.2013.812070
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Tarnopolsky MA, 2011, AMINO ACIDS, V40, P1397, DOI 10.1007/s00726-011-0876-4
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thorburn D.R., 2003, GeneReviews
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Willems PHGM, 2008, CELL CALCIUM, V44, P123, DOI 10.1016/j.ceca.2008.01.002
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 49
TC 65
Z9 69
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-4160
EI 1532-1991
J9 CELL CALCIUM
JI Cell Calcium
PD SEP
PY 2016
VL 60
IS 3
SI SI
BP 199
EP 206
DI 10.1016/j.ceca.2016.03.003
PG 8
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DW8YB
UT WOS:000383940300007
PM 26996063
DA 2024-11-01
ER

PT J
AU Catania, C
   Spitaleri, G
   Delmonte, A
   Giovannini, M
   Toffalorio, F
   Noberasco, C
   Bresolin, N
   Comi, G
   De Pas, T
AF Catania, Chiara
   Spitaleri, Gianluca
   Delmonte, Angelo
   Giovannini, Monica
   Toffalorio, Francesca
   Noberasco, Cristina
   Bresolin, Nereo
   Comi, Giacomo
   De Pas, Tommaso
TI Safety of Systemic Chemotherapy in a Patient With Mitochondrial Myopathy
   and Non-Small-Cell Lung Cancer
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Article
ID DNA MUTATIONS; SOMATIC MUTATIONS; BREAST-CANCER; TUMORS; GENOME;
   PREVENTION; CARCINOMAS; CISPLATIN; VARIANTS; SEQUENCE
C1 [Catania, Chiara; Spitaleri, Gianluca; Delmonte, Angelo; Giovannini, Monica; Toffalorio, Francesca; Noberasco, Cristina; De Pas, Tommaso] European Inst Oncol, Milan, Italy.
   [Bresolin, Nereo; Comi, Giacomo] Univ Milan, Dino Ferrari Ctr, Ist Ric & Cura Carettere, Fdn Ca Granda,Sci Osped Maggiore Policlin, Milan, Italy.
C3 IRCCS European Institute of Oncology (IEO); University of Milan; IRCCS
   Ca Granda Ospedale Maggiore Policlinico
RP Catania, C (corresponding author), European Inst Oncol, Milan, Italy.
RI Comi, Giacomo/K-5702-2016; Spitaleri, Gianluca/AAQ-7125-2020; De Pas,
   tommaso/K-4879-2018
OI Delmonte, Angelo/0000-0001-9065-6123; Comi, Giacomo/0000-0002-1383-5248;
   Bresolin, Nereo/0000-0001-6694-3595
CR Aleisa AM, 2007, CLIN EXP PHARMACOL P, V34, P1252, DOI 10.1111/j.1440-1681.2007.04714.x
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   GRIVELL LA, 1983, SCI AM, V248, P78, DOI 10.1038/scientificamerican0383-78
   dos Santos NAG, 2007, CHEM-BIOL INTERACT, V170, P177, DOI 10.1016/j.cbi.2007.07.014
   Langsjoen PH, 1997, MOL ASPECTS MED, V18, pS145
   Liu VWS, 2001, CANCER RES, V61, P5998
   Máximo V, 2002, AM J PATHOL, V160, P1857, DOI 10.1016/S0002-9440(10)61132-7
   Mythili Y, 2005, TOXICOLOGY, V215, P108, DOI 10.1016/j.tox.2005.07.001
   Nissim I, 2006, CANCER RES, V66, P7824, DOI 10.1158/0008-5472.CAN-06-1043
   Parrella P, 2001, CANCER RES, V61, P7623
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Sanchez-Cespedes M, 2001, CANCER RES, V61, P7015
   Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012
   Tan DJ, 2002, CANCER RES, V62, P972
   Walker UA, 2000, MED KLIN, V95, P689, DOI 10.1007/PL00002087
   Yeh JJ, 2000, ONCOGENE, V19, P2060, DOI 10.1038/sj.onc.1203537
NR 18
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CLINICAL ONCOLOGY
PI ALEXANDRIA
PA 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA
SN 0732-183X
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD AUG 20
PY 2012
VL 30
IS 24
BP E226
EP E228
DI 10.1200/JCO.2011.40.1828
PG 3
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 996JR
UT WOS:000308082300003
PM 22711848
OA Bronze
DA 2024-11-01
ER

PT J
AU Robinson, KN
   Terrazas, S
   Giordano-Mooga, S
   Xavier, NA
AF Robinson, Katie Nahay
   Terrazas, Sari
   Giordano-Mooga, Samantha
   Xavier, Neena A.
TI THE ROLE OF HETEROPLASMY IN THE DIAGNOSIS AND MANAGEMENT OF MATERNALLY
   INHERITED DIABETES AND DEAFNESS
SO ENDOCRINE PRACTICE
LA English
DT Review
ID MITOCHONDRIAL-DNA; MUTATION
AB Objective: Maternally inherited diabetes and deafness (MIDD) is a rare diabetic syndrome mainly caused by a point mutation in the mitochondrial DNA (mtDNA), mt3243 adenine to guanine (A>G). The objective of this paper is to review the genetic inheritance, clinical manifestations, and treatment of patients with MIDD.
   Methods: The current review used a literature search of scientific papers on this rare syndrome.
   Results: mtDNA is primarily inherited through the maternal oocyte; therefore, the genetic abnormali-ties in MIDD are associated with maternal inheritance. Mitochondria contain circular mtDNA, which codes for various mitochondria! genes. The mtDNA can be heteroplasmic, containing more than one type of mtDNA sequence; if one of the mtDNAs contains the mt3243 A>G mutation, a patient may develop MIDD. Patients can inherit different amounts of mutated mtDNA and normal mtDNA that affect the severity of the clinical manifestations of MIDD. The most common clinical manifestations include diabetes mellitus, deafness, ophthalmic disease, cardiac disease, renal disease, gastrointestinal disease, short stature, and myopathies. In order to effectively treat patients with MIDD, it is important to recognize the underlying pathophysiology of this specific form of diabetes and the pathophysiology associated with the organ-specific complications present in this disease.
   Conclusion: The heteroplasmic inheritance of mutated mtDNA plays an important role in the clinical manifestations of various mitochondrial diseases, specifically MIDD. This review will alert endocrinologists of the signs and symptoms of MIDD and important clinical considerations when managing this disease.
C1 [Robinson, Katie Nahay; Xavier, Neena A.] Univ Alabama Birmingham, Phys Assistant Studies Program, Dept Clin & Diagnost Sci, Sch Hlth Profess, Birmingham, AL USA.
   [Terrazas, Sari; Giordano-Mooga, Samantha] Univ Alabama Birmingham, Biomed Sci Program, Dept Clin & Diagnost Sci, Sch Hlth Profess, Birmingham, AL USA.
C3 University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham
RP Xavier, NA (corresponding author), Sch Hlth Profess, Phys Assistant Program, SHP 480,1716 9th Ave South, Birmingham, AL 35294 USA.
EM naxavier@uab.edu
OI Terrazas, Sari/0000-0002-9714-2472
CR Alves D, 2017, ACTA MEDICA PORT, V30, P581, DOI 10.20344/amp.8638
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Cao XY, 2013, INDIAN J PATHOL MICR, V56, P272, DOI 10.4103/0377-4929.120392
   Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   Dunham-Snary KJ, 2015, SCIENCE, V349, P1449, DOI 10.1126/science.aac5271
   Duran J, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020034
   Geng X, 2019, DIABETIC MED, V36, P776, DOI 10.1111/dme.13874
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Godinho I, 2017, CLIN KIDNEY J, V10, P487, DOI 10.1093/ckj/sfx021
   Li HZ, 2014, FRONT BIOSCI-LANDMRK, V19, P777, DOI 10.2741/4244
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Yee ML, 2018, ENDOCRINOL DIAB META, DOI 10.1530/EDM-18-0091
NR 19
TC 16
Z9 17
U1 0
U2 7
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1530-891X
EI 1934-2403
J9 ENDOCR PRACT
JI Endocr. Pract.
PD FEB
PY 2020
VL 26
IS 2
BP 241
EP 246
DI 10.4158/EP-2019-0270
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA KS8HK
UT WOS:000518547300011
PM 31682520
DA 2024-11-01
ER

PT J
AU Iizuka, T
   Sakai, F
AF Iizuka, T
   Sakai, F
TI Pathogenesis of stroke-like episodes in MELAS: Analysis of neurovascular
   cellular mechanisms
SO CURRENT NEUROVASCULAR RESEARCH
LA English
DT Review
DE MELAS; stroke-like episodes; neuronal hyperexcitability; pathogenesis
ID MAGNETIC-RESONANCE-SPECTROSCOPY; MITOCHONDRIAL-DNA MUTATION; ANTICODON
   WOBBLE NUCLEOTIDE; CEREBRAL-BLOOD-FLOW; LACTIC-ACIDOSIS; POINT MUTATION;
   CREATINE MONOHYDRATE; MTDNA MUTATION; NICOTINAMIDE TREATMENT;
   MODIFICATION DEFECT
AB The pathogenesis of stroke-like episodes in mitochondrial encephalopathy, myopathy, lactic acidosis and stroke-like episodes (MELAS) is not fully understood although two main theories have been proposed; ischemic vascular hypothesis caused by "mitochondrial angiopathy" and generalized cytopathic hypothesis caused by "mitochondrial cytopathy". Crucial molecular mechanism includes the lack of taurine modification at the wobble uridine of mutant transfer RNAS(Leu(UUR)) resulting in defective translation of cognate codons due to a defect in codon-anticodon interaction. Whereas recent clinical studies have shed light on the neuronal hyperexcitability, which may potentially initiate a cascade of stroke-like events. Stroke-like episodes are characterized by neuronal hyperexcitability, neuronal vulnerability, increased capillary permeability, and focal hyperaemia. It is recognized that stroke-like lesions not only evolve in the area incongruent to a vascular territory, but also potentially spread into the surrounding cortex with concomitant vasogenic edema presumably provoked by prolonged epileptic activities.
   Based on the clinical observations, we speculate that stroke-like episodes appear to be non-ischemic neurovascular events; once neuronal hyperexcitability developed in a localized brain region as a result from either mitochondrial dysfunction in the capillary endothelial cells, or in neurons or astrocytes, epileptic activities may depolarize the adjacent neurons leading to propagation of epileptic activities in the surrounding cortex. Increased capillary permeability provoked by epileptic activities in the presence of mitochondrial capillary angiopathy may cause unique, edematous brain lesions predominantly involving the cortex. As a consequence, susceptible neuronal population in the cortex may result in neuronal loss with a laminar or pseudo-laminar distribution.
C1 Kitasato Univ, Sch Med, Dept Med Neurol, Sagamihara, Kanagawa 2288555, Japan.
C3 Kitasato University
RP Kitasato Univ, Sch Med, Dept Med Neurol, 1-15-1 Kitasato, Sagamihara, Kanagawa 2288555, Japan.
EM takahiro@med.kitasato-u.ac.jp
OI Iizuka, Takahiro/0000-0002-7234-0720
CR Abe K, 1999, J NEUROL SCI, V162, P65, DOI 10.1016/S0022-510X(98)00296-2
   Amagasaki K, 2001, J NEUROSURG, V94, P133, DOI 10.3171/jns.2001.94.1.0133
   Barisic N, 2002, NEUROPEDIATRICS, V33, P157, DOI 10.1055/s-2002-33679
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Berbel-Garcia A, 2004, CLIN NEUROPHARMACOL, V27, P187, DOI 10.1097/01.wnf.0000137862.67131.bf
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   Börner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BRENINGSTALL GN, 1988, PEDIATR NEUROL, V4, P366, DOI 10.1016/0887-8994(88)90085-9
   BRESOLIN N, 1990, J NEUROL SCI, V100, P70, DOI 10.1016/0022-510X(90)90015-F
   CAMPISTOL J, 2000, REV NEUROL S, V1, P105
   Campos Y, 1997, BIOCHEM BIOPH RES CO, V238, P323, DOI 10.1006/bbrc.1997.7166
   Campos Y, 2000, NEUROMUSCULAR DISORD, V10, P493, DOI 10.1016/S0960-8966(00)00107-3
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Clark JM, 1996, NEUROLOGY, V46, P223, DOI 10.1212/WNL.46.1.223
   Cock H, 1999, EPILEPSIA, V40, P33, DOI 10.1111/j.1528-1157.1999.tb00897.x
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Cray SH, 1998, CRIT CARE MED, V26, P2087, DOI 10.1097/00003246-199812000-00046
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   Cummins JM, 1997, ZYGOTE, V5, P301, DOI 10.1017/S0967199400003889
   Curran J., 1998, MODIFIED NUCLEOSIDES, P493
   DANKS RA, 1988, AUST NZ J MED, V18, P69, DOI 10.1111/j.1445-5994.1988.tb02245.x
   Dashe JF, 1998, NEW ENGL J MED, V339, P1914, DOI 10.1056/NEJM199812243392608
   de Toledo M, 2001, REV NEUROLOGIA, V33, P148, DOI 10.33588/rn.3302.2001016
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   DURCAN L, 1992, Neurology, V42, P282
   El Idrissi A, 2004, NEUROCHEM RES, V29, P189, DOI 10.1023/B:NERE.0000010448.17740.6e
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Feddersen B, 2003, NEUROLOGY, V61, P1149, DOI 10.1212/01.WNL.0000092497.53706.1B
   FUJII T, 1990, PEDIATR NEUROL, V6, P253, DOI 10.1016/0887-8994(90)90116-I
   Funakawa I, 1997, ELECTROEN CLIN NEURO, V103, P370, DOI 10.1016/S0013-4694(97)00020-9
   Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   GROPEN TI, 1994, STROKE, V25, P1873, DOI 10.1161/01.STR.25.9.1873
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   Hart P.E., 2002, Mitochondrial Disorders in Neurology, V2, P35
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Hattori Y, 2001, Rinsho Shinkeigaku, V41, P668
   Hirano M, 2000, BRAIN PATHOL, V10, P451
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hirano M, 1998, AM J HUM GENET, V63, P526, DOI 10.1086/301979
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Iizuka T, 2003, NEUROLOGY, V61, P577, DOI 10.1212/01.WNL.0000078931.87815.B3
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583
   Ikezoe K, 2002, ACTA NEUROPATHOL, V103, P531, DOI 10.1007/s00401-001-0502-8
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   Kamada K, 2001, J NEUROL NEUROSUR PS, V70, P675, DOI 10.1136/jnnp.70.5.675
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   KEEP RF, 1993, ADV EXP MED BIOL, V331, P43
   Kim IO, 1996, AM J ROENTGENOL, V166, P641, DOI 10.2214/ajr.166.3.8623642
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Kolb SJ, 2003, J NEUROL SCI, V216, P11, DOI 10.1016/S0022-510X(03)00218-1
   Komura K, 2003, PEDIATR NEUROL, V28, P53, DOI 10.1016/S0887-8994(02)00469-1
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282
   Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   LOVE S, 1993, J PATHOL, V170, P9, DOI 10.1002/path.1711700103
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Majamaa K, 1996, LIFE SCI, V58, P691, DOI 10.1016/0024-3205(95)02338-0
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   MATTHEWS PM, 1993, NEUROLOGY, V43, P884, DOI 10.1212/WNL.43.5.884
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   Menotti Francesca, 2004, Ital Heart J, V5, P460
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   Miyamoto A, 1997, NEURORADIOLOGY, V39, P427, DOI 10.1007/s002340050438
   MIZUKAMI K, 1992, ACTA NEUROPATHOL, V83, P449, DOI 10.1007/BF00713541
   Möller HE, 2002, MUSCLE NERVE, V25, P593, DOI 10.1002/mus.10084
   Molnár MJ, 2000, NEUROLOGY, V55, P544, DOI 10.1212/WNL.55.4.544
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morgan-Hughes JA, 1999, BBA-BIOENERGETICS, V1410, P125, DOI 10.1016/S0005-2728(98)00162-5
   Mörl M, 2001, EMBO REP, V2, P17, DOI 10.1093/embo-reports/kve006
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ohshita T, 2000, NEURORADIOLOGY, V42, P651, DOI 10.1007/s002340000335
   Okatani Y, 2003, EUR J PHARMACOL, V465, P163, DOI 10.1016/S0014-2999(03)01463-8
   OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502
   Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446
   Oppenheim C, 2000, J NEUROL NEUROSUR PS, V69, P248, DOI 10.1136/jnnp.69.2.248
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Pavlakis SG, 1998, ARCH NEUROL-CHICAGO, V55, P849, DOI 10.1001/archneur.55.6.849
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Penisson-Besnier I, 2000, NEUROLOGY, V55, P317, DOI 10.1212/WNL.55.2.317
   PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147
   Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798
   Rajesh KG, 2003, AM J PHYSIOL-HEART C, V285, pH2171, DOI 10.1152/ajpheart.00143.2003
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Remes AM, 2002, NEUROLOGY, V59, P1275, DOI 10.1212/WNL.59.8.1275
   Rossi FH, 2002, NEUROLOGIST, V8, P313, DOI 10.1097/00127893-200209000-00004
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   Saitoh S, 1998, NEUROLOGY, V50, P531, DOI 10.1212/WNL.50.2.531
   Sakuta R, 2002, PEDIATR NEUROL, V27, P397, DOI 10.1016/S0887-8994(02)00456-3
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Sano M, 1995, ACTA NEUROL SCAND, V92, P497
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Scarabelli TM, 2004, J AM COLL CARDIOL, V43, P865, DOI 10.1016/j.jacc.2003.09.050
   SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100
   Schon EA, 2003, CURR MED CHEM, V10, P2523, DOI 10.2174/0929867033456503
   Schürer H, 2001, BIOL CHEM, V382, P1147, DOI 10.1515/BC.2001.144
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sciacco M, 2001, NEUROLOGY, V56, P1070, DOI 10.1212/WNL.56.8.1070
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Sue CM, 2000, BRAIN PATHOL, V10, P442
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Suzuki T, 2001, Nucleic Acids Res Suppl, P257
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Takahashi S, 1998, J NEUROL SCI, V158, P58, DOI 10.1016/S0022-510X(98)00105-1
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Tarnopolsky M, 1999, NEUROLOGY, V52, P854, DOI 10.1212/WNL.52.4.854
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Thambisetty M, 2004, EXPERT REV MOL DIAGN, V4, P631, DOI 10.1586/14737159.4.5.631
   Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001
   Toyoda K, 2004, J NEUROL SCI, V221, P11, DOI 10.1016/j.jns.2004.03.002
   Umaki Y, 2002, ACTA NEUROPATHOL, V103, P163
   Valanne L, 1996, NEUROPEDIATRICS, V27, P154, DOI 10.1055/s-2007-973767
   VEGGIOTTI P, 1995, NEUROPHYSIOL CLIN, V25, P158, DOI 10.1016/0987-7053(96)80168-7
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Watanabe Y, 1998, J NUCL MED, V39, P961
   Welch KMA, 2003, NEUROLOGY, V61, pS2, DOI 10.1212/WNL.61.8_suppl_4.S2
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
   Yonemura K, 2001, AM J NEURORADIOL, V22, P269
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
NR 157
TC 77
Z9 99
U1 0
U2 3
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1567-2026
EI 1875-5739
J9 CURR NEUROVASC RES
JI Curr. Neurovasc. Res.
PD JAN
PY 2005
VL 2
IS 1
BP 29
EP 45
DI 10.2174/1567202052773544
PG 17
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 904UD
UT WOS:000227522300005
PM 16181098
DA 2024-11-01
ER

PT J
AU Wang, A
   Zhao, J
   Zhao, Y
   Yan, Y
AF Wang, Ai
   Zhao, Ji
   Zhao, Yun
   Yan, Yan
TI Late-onset MELAS syndrome in a 46-year-old man with initial symptom of
   chest tightness: a case report
SO EUROPEAN HEART JOURNAL-CASE REPORTS
LA English
DT Article
DE Cardiomyopathy; MELAS syndrome; Mitochondrial disease; Case report
ID STROKE-LIKE-EPISODES; MITOCHONDRIAL-MYOPATHY; LACTIC-ACIDOSIS;
   ENCEPHALOPATHY; PREVALENCE; DISEASE; ADULTS
AB Background Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) syndrome is a rare mitochondrial disorder caused by mutations in mitochondrial DNA, resulting in impaired energy production and affecting multiple organs. We present a suspected MELAS syndrome case with the initial symptom of chest tightness.Case summary A 46-year-old man sought medical attention due to progressively worsening chest tightness during physical activity. He had been receiving treatment for type 2 diabetes for 15 years. One year ago, he presented with symptoms of hearing impairment. Transthoracic echocardiography revealed increased thickness of the left ventricular wall. Serum protein electrophoresis showed no evidence of light-chain amyloidosis, and the 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scan showed no definite uptake in the heart muscle. The patient's head magnetic resonance imaging (MRI) indicated lacunar infarcts. The lactate threshold test was positive. The biopsy of the skeletal muscle showed broken red fibre infiltration on modified Gomori trichrome staining, and electron microscopy revealed signs of mitochondrial cardiomyopathy, including mild mitochondrial swelling, lipid accumulation, and myofibril damage. A whole-exome genetic test was used to detect the m.3243A>G mutation in the MT-TL1 gene. Based on these findings, MELAS syndrome was the most probable diagnosis.Discussion The patient presented with chest tightness in adulthood, without any accompanying psychoneurological symptoms. However, the patient presented with other symptoms, including diabetes mellitus, hearing loss, abnormal lactate levels, ischaemic lesions on head MRI, and left ventricular hypertrophy. By identifying a mutation in the MT-TL1 gene and conducting a muscle biopsy, the diagnosis of MELAS syndrome was definitively confirmed.
C1 [Wang, Ai; Zhao, Ji; Yan, Yan] Fudan Univ, Zhongshan Hosp, Dept Cardiol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.
   [Zhao, Yun] Shanghai Geriatr Med Ctr, Dept Cardiovasc Surg, 2560 Chunshen Rd, Shanghai 201104, Peoples R China.
C3 Fudan University
RP Yan, Y (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Cardiol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.
EM yan.yan@zhongshan-hospital.sh.cn
FU National Natural Science Foundation of China [81873538, 82070463]
FX This work was supported by the National Natural Science Foundation of
   China (grants 81873538 and 82070463).
CR Brambilla A, 2019, INT J CARDIOL, V276, P14, DOI 10.1016/j.ijcard.2018.10.051
   Di Toro A, 2022, J AM COLL CARDIOL, V80, P1431, DOI 10.1016/j.jacc.2022.04.067
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Lee SH., 2023, EUR HEART J-CASE REP, V7, pytad028
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Salpeter SR, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002967.pub3, 10.1002/14651858.CD002967.pub4]
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Sunde K, 2016, MOL GENET METAB REP, V9, P94, DOI 10.1016/j.ymgmr.2016.11.002
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Wu G, 2023, NEUROLOGIST, V28, P190, DOI 10.1097/NRL.0000000000000457
NR 16
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2514-2119
J9 EUR HEART J-CASE REP
JI Eur. Heart J.-Case Rep.
PD SEP 1
PY 2023
VL 7
IS 9
AR ytad441
DI 10.1093/ehjcr/ytad441
EA SEP 2023
PG 5
WC Cardiac & Cardiovascular Systems
WE Emerging Sources Citation Index (ESCI)
SC Cardiovascular System & Cardiology
GA S8XJ5
UT WOS:001073939700002
PM 37767231
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Sen, A
   Kallabis, S
   Gaedke, F
   Jüngst, C
   Boix, J
   Nüchel, J
   Maliphol, K
   Hofmann, J
   Schauss, AC
   Krüger, M
   Wiesner, RJ
   Pla-Martín, D
AF Sen, Ayesha
   Kallabis, Sebastian
   Gaedke, Felix
   Juengst, Christian
   Boix, Julia
   Nuechel, Julian
   Maliphol, Kanjanamas
   Hofmann, Julia
   Schauss, Astrid C.
   Krueger, Marcus
   Wiesner, Rudolf J.
   Pla-Martin, David
TI Mitochondrial membrane proteins and VPS35 orchestrate selective removal
   of mtDNA
SO NATURE COMMUNICATIONS
LA English
DT Article
ID QUALITY-CONTROL; SKELETAL-MUSCLE; DNA; MUTATIONS; MITOPHAGY; DELETIONS;
   STABILITY; AUTOPHAGY; TRANSPORT; PATHWAY
AB Understanding the mechanisms governing selective turnover of mutation-bearing mtDNA is fundamental to design therapeutic strategies against mtDNA diseases. Here, we show that specific mtDNA damage leads to an exacerbated mtDNA turnover, independent of canonical macroautophagy, but relying on lysosomal function and ATG5. Using proximity labeling and Twinkle as a nucleoid marker, we demonstrate that mtDNA damage induces membrane remodeling and endosomal recruitment in close proximity to mitochondrial nucleoid sub-compartments. Targeting of mitochondrial nucleoids is controlled by the ATAD3-SAMM50 axis, which is disrupted upon mtDNA damage. SAMM50 acts as a gatekeeper, influencing BAK clustering, controlling nucleoid release and facilitating transfer to endosomes. Here, VPS35 mediates maturation of early endosomes to late autophagy vesicles where degradation occurs. In addition, using a mouse model where mtDNA alterations cause impairment of muscle regeneration, we show that stimulation of lysosomal activity by rapamycin, selectively removes mtDNA deletions without affecting mtDNA copy number, ameliorating mitochondrial dysfunction. Taken together, our data demonstrates that upon mtDNA damage, mitochondrial nucleoids are eliminated outside the mitochondrial network through an endosomal-mitophagy pathway. With these results, we unveil the molecular players of a complex mechanism with multiple potential benefits to understand mtDNA related diseases, inherited, acquired or due to normal ageing.
   Mitochondrial quality control mechanisms prevent damage accumulation, including in mitochondrial DNA (mtDNA). Here, Sen et al. show that altered mtDNA elicits local rearrangements in mitochondrial membrane potential and cristae structure, with mtDNA eliminated through VPS35 endosomes.
C1 [Sen, Ayesha; Boix, Julia; Maliphol, Kanjanamas; Hofmann, Julia; Wiesner, Rudolf J.; Pla-Martin, David] Univ Cologne, Fac Med, Ctr Physiol & Pathophysiol, Cologne, Germany.
   [Sen, Ayesha; Boix, Julia; Nuechel, Julian; Maliphol, Kanjanamas; Hofmann, Julia; Wiesner, Rudolf J.; Pla-Martin, David] Univ Cologne, Univ Hosp Cologne, Cologne, Germany.
   [Kallabis, Sebastian; Gaedke, Felix; Juengst, Christian; Schauss, Astrid C.; Krueger, Marcus; Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
   [Boix, Julia; Wiesner, Rudolf J.; Pla-Martin, David] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.
   [Nuechel, Julian] Univ Cologne, Fac Med, Ctr Biochem, Cologne, Germany.
C3 University of Cologne; University of Cologne; University of Cologne;
   University of Cologne; University of Cologne
RP Pla-Martín, D (corresponding author), Univ Cologne, Fac Med, Ctr Physiol & Pathophysiol, Cologne, Germany.; Pla-Martín, D (corresponding author), Univ Cologne, Univ Hosp Cologne, Cologne, Germany.; Pla-Martín, D (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.
EM dplamart@uni-koeln.de
RI PlaMartin, David/LGY-6405-2024; Krüger, Marcus/N-8667-2019
OI Jungst, Christian/0000-0002-6586-7129; Nuchel,
   Julian/0000-0002-8126-415X; Gaedke, Felix/0000-0002-7744-4940; Pla
   Martin, David/0000-0002-5189-0723; Kruger, Marcus/0000-0002-5846-6941
FU Deutsche Forschungs-gemeinschaft [PL 895/1-1]; Koln Fortune [341/2019]
FX We are thankful to CECAD Imaging and Proteomics facility for excellent
   technical support, especially Beatrix Martiny for immunogold
   preparation. We thank Nadine Niehoff and Katrin Lanz for technical
   assistance, and Thomas Pa ss for scientific discussion. This work was
   supported by grants from the Deutsche Forschungs-gemeinschaft (PL
   895/1-1) to D.P.M. and R.J.W. and Koln Fortune (341/2019) to D.P.M.
CR Abudu YP, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202009092
   Alsina D, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911659
   Arguello T, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.110139
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Basu S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009242
   Bono K, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00675-5
   Bové J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068
   Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066
   Cantarero L, 2020, HUM MOL GENET, V29, P3589, DOI 10.1093/hmg/ddaa243
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen L, 2022, HEPATOLOGY, V76, P1389, DOI 10.1002/hep.32471
   Civiletto G, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708799
   Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249
   Crupi AN, 2018, AGING-US, V10, P3327, DOI 10.18632/aging.101643
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Dong B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2347
   Dossou AS, 2019, CANCERS, V11, DOI 10.3390/cancers11101422
   Eleuteri S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01272
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hammerling BC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14050
   Han S, 2017, CELL CHEM BIOL, V24, P404, DOI 10.1016/j.chembiol.2017.02.002
   Hanss Z, 2021, MOVEMENT DISORD, V36, P704, DOI 10.1002/mds.28365
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   Jakubke C, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abi8886
   Jian FL, 2018, CELL REP, V23, P2989, DOI 10.1016/j.celrep.2018.05.015
   Jin GX, 2018, NAT IMMUNOL, V19, P29, DOI 10.1038/s41590-017-0002-1
   Kallabis S, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-00226-5
   Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kimoloi S, 2022, J CACHEXIA SARCOPENI, V13, P2132, DOI 10.1002/jcsm.13026
   Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280
   Kloepper JE, 2015, J INVEST DERMATOL, V135, P679, DOI 10.1038/jid.2014.475
   Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Linhart R, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-23
   Liu S, 2016, FEBS LETT, V590, P1313, DOI 10.1002/1873-3468.12170
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma KY, 2021, TRANSL NEURODEGENER, V10, DOI 10.1186/s40035-021-00243-4
   Mai S, 2012, AUTOPHAGY, V8, P47, DOI 10.4161/auto.8.1.18174
   McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   Montoro AG, 2018, DEV CELL, V45, P621, DOI 10.1016/j.devcel.2018.05.011
   Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291
   Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038
   Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217
   Ock CY, 2012, WORLD J GASTROENTERO, V18, P302, DOI 10.3748/wjg.v18.i4.302
   Oexner RR, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.12.14
   Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015
   Pass T, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.676187
   Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   Remtulla S, 2019, PEDIATR NEUROL, V90, P61, DOI 10.1016/j.pediatrneurol.2018.08.007
   Riley JS, 2018, EMBO J, V37, DOI 10.15252/embj.201899238
   Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278
   Sage-Schwaede A, 2019, ANN CLIN TRANSL NEUR, V6, P1877, DOI 10.1002/acn3.50846
   Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013
   Shu L, 2021, EMBO J, V40, DOI 10.15252/embj.2020106283
   Silwal P, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02073-6
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Sprenger HG, 2021, NAT METAB, V3, P636, DOI 10.1038/s42255-021-00385-9
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Szczepanowska K., 2020, HUMAN MITOCHONDRIAL, P221
   Tang JH, 2020, CELL DEATH DIFFER, V27, P146, DOI 10.1038/s41418-019-0345-2
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Weiland D, 2018, J INVEST DERMATOL, V138, P132, DOI 10.1016/j.jid.2017.08.019
   Williams ET, 2018, HUM MOL GENET, V27, P3189, DOI 10.1093/hmg/ddy224
   Yamano K, 2018, ELIFE, V7, DOI 10.7554/eLife.31326
   Yang X, 2019, ANNU REV NUTR, V39, P201, DOI 10.1146/annurev-nutr-082018-124643
   Zhao YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09291-x
   Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11
   Zhu Shusen, 2017, BMC Res Notes, V10, P269, DOI 10.1186/s13104-017-2593-x
NR 75
TC 32
Z9 34
U1 2
U2 18
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 7
PY 2022
VL 13
IS 1
AR 6704
DI 10.1038/s41467-022-34205-9
PG 20
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 5Z3DW
UT WOS:000879857400001
PM 36344526
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Greaves, LC
   Reeve, AK
   Taylor, RW
   Turnbull, DM
AF Greaves, Laura C.
   Reeve, Amy K.
   Taylor, Robert W.
   Turnbull, Doug M.
TI Mitochondrial DNA and disease
SO JOURNAL OF PATHOLOGY
LA English
DT Review
DE mitochondrion; oxidative phosphorylation; disease; mitochondrial DNA;
   mutation
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CYTOCHROME-C-OXIDASE; HEREDITARY
   OPTIC NEUROPATHY; SUBSTANTIA-NIGRA NEURONS; KEARNS-SAYRE SYNDROME;
   COMPLEX I DEFICIENCY; RED FIBERS MERRF; STEM-CELLS; MYOCLONIC EPILEPSY;
   SKELETAL-MUSCLE
AB Mitochondrial DNA (mtDNA) defects are a relatively common cause of inherited disease and have been implicated in both ageing and cancer. MtDNA encodes essential subunits of the mitochondrial respiratory chain and defects result in impaired oxidative phosphorylation (OXPHOS). Similar OXPHOS defects have been shown to be present in a number of neurodegenerative conditions, including Parkinson's disease, as well as in normal ageing human tissues. Additionally, a number of tumours have been shown to contain mtDNA mutations and an altered metabolic phenotype. In this review we outline the unique characteristics of mitochondrial genetics before detailing important pathological features of mtDNA diseases, focusing on adult neurological disease as well as the role of mtDNA mutations in neurodegenerative diseases, ageing and cancer. Copyright (C) 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
C1 [Greaves, Laura C.; Reeve, Amy K.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Greaves, LC (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM laura.greaves@ncl.ac.uk; doug.turnbull@ncl.ac.uk
OI Turnbull, Doug/0000-0002-8878-9901; Greaves, Laura/0000-0002-8071-5916;
   Reeve, Amy/0000-0002-4474-2204
FU Newcastle University Centre for Brain Ageing and Vitality; BBSRC; EPSRC;
   ESRC; MRC [G0700718]; Wellcome Trust [074454/Z/04/Z]; UK NIHR Biomedical
   Research Centre for Ageing and Age-related Disease; UK NHS Specialist
   Commissioners; MRC [G0700718, G0900652, G0502157, G0400074, G1100540,
   G0601943] Funding Source: UKRI
FX Our work on mitochondrial diseases is currently supported by the
   Newcastle University Centre for Brain Ageing and Vitality, supported by
   BBSRC, EPSRC, ESRC and MRC as part of the cross-council Lifelong Health
   and Wellbeing Initiative (Grant No. G0700718), the Wellcome Trust (Grant
   No. 074454/Z/04/Z), the UK NIHR Biomedical Research Centre for Ageing
   and Age-related Disease award to the Newcastle upon Tyne Hospitals NHS
   Foundation Trust and the UK NHS Specialist Commissioners, which funds
   the 'Rare Mitochondrial Disorders of Adults and Children' Diagnostic
   Service in Newcastle upon Tyne.
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews HE, 2005, MED HYPOTHESES, V64, P669, DOI 10.1016/j.mehy.2004.09.001
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Blackwood JK, 2011, J PATHOL, V225, P181, DOI 10.1002/path.2965
   BONILLA E, 1992, BRAIN PATHOL, V2, P113, DOI 10.1111/j.1750-3639.1992.tb00679.x
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Cottrell DA, 2000, J NEUROPATH EXP NEUR, V59, P621, DOI 10.1093/jnen/59.7.621
   Cottrell DA, 2001, NEUROPATH APPL NEURO, V27, P206, DOI 10.1046/j.1365-2990.2001.00315.x
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   De Alwis N, 2009, HEPATOLOGY, V50, P992, DOI 10.1002/hep.23160
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fellous TG, 2009, STEM CELLS, V27, P1410, DOI 10.1002/stem.67
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   FUKUHARA N, 1991, REV NEUROL, V147, P476
   Gaisa NT, 2011, J PATHOL, V225, P163, DOI 10.1002/path.2945
   Gaisa NT, 2011, J PATHOL, V225, P172, DOI 10.1002/path.2959
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   He L, 2003, LEUKEMIA, V17, P2487, DOI 10.1038/sj.leu.2403146
   Heerdt BG, 2006, CANCER RES, V66, P1591, DOI 10.1158/0008-5472.CAN-05-2717
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Irrcher I, 2010, HUM MOL GENET
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lax NZ, 2011, ARCH NEUROL IN PRESS
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MITOMAP, 2009, MITOMAP HUM MIT GEN
   Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Moraes CT, 2001, METHOD CELL BIOL, V65, P397, DOI 10.1016/S0091-679X(01)65023-4
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8
   Parrella P, 2001, CANCER RES, V61, P7623
   Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Porcelli AM, 2010, HUM MOL GENET, V19, P1019, DOI 10.1093/hmg/ddp566
   Pozzan T, 2000, CELL CALCIUM, V28, P279, DOI 10.1054/ceca.2000.0166
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rotig A, 2010, BIOCHIM BIOPHYS ACTA, V1807, P1198
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Tan DJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-93
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WARBURG O, 1956, SCIENCE, V124, P269
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Yin PH, 2010, MITOCHONDRION, V10, P174, DOI 10.1016/j.mito.2009.12.147
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhou L, 1997, J NEUROSCI, V17, P7746
NR 114
TC 214
Z9 233
U1 2
U2 113
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
J9 J PATHOL
JI J. Pathol.
PD JAN
PY 2012
VL 226
IS 2
SI SI
BP 274
EP 286
DI 10.1002/path.3028
PG 13
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA 877DQ
UT WOS:000299157600011
PM 21989606
OA Bronze
DA 2024-11-01
ER

PT J
AU Hebert, SL
   Marquet-de Rougé, P
   Lanza, IR
   McCrady-Spitzer, SK
   Levine, JA
   Middha, S
   Carter, RE
   Klaus, KA
   Therneau, TM
   Highsmith, EW
   Nair, KS
AF Hebert, Sadie L.
   Marquet-de Rouge, Perrine
   Lanza, Ian R.
   McCrady-Spitzer, Shelly K.
   Levine, James A.
   Middha, Sumit
   Carter, Rickey E.
   Klaus, Katherine A.
   Therneau, Terry M.
   Highsmith, Edward W.
   Nair, K. Sreekumaran
TI Mitochondrial Aging and Physical Decline: Insights From Three
   Generations of Women
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Mitochondrial DNA; Aging; SIRT3; Oxidative capacity; Acetylated protein;
   Skeletal muscle
ID DNA-DELETION MUTATIONS; HUMAN SKELETAL-MUSCLE; ALL-CAUSE MORTALITY;
   OXIDATIVE STRESS; DEGENERATIVE DISEASES; INSULIN-RESISTANCE;
   ELDERLY-WOMEN; SIRT3; MEN; EXERCISE
AB Decline in mitochondrial DNA (mtDNA) copy number, function, and accumulation of mutations and deletions have been proposed to contribute to age-related physical decline, based on cross sectional studies in genetically unrelated individuals. There is wide variability of mtDNA and functional measurements in many population studies and therefore we assessed mitochondrial function and physical function in 18 families of grandmothers, mothers, and daughters who share the same maternally inherited mtDNA sequence. A significant age-related decline in mtDNA copy number, mitochondrial protein expression, citrate synthase activity, cytochrome c oxidase content, and VO2 peak were observed. Also, a lower abundance of SIRT3, accompanied by an increase in acetylated skeletal muscle proteins, was observed in grandmothers. Muscle tissue-based full sequencing of mtDNA showed greater than 5% change in minor allele frequency over a lifetime in two locations, position 189 and 408 in the noncoding D-loop region but no changes were noted in blood cells mtDNA. The decline in oxidative capacity and muscle function with age in three generations of women who share the same mtDNA sequence are associated with a decline in muscle mtDNA copy number and reduced protein deacetylase activity of SIRT3.
C1 [Hebert, Sadie L.; Marquet-de Rouge, Perrine; Lanza, Ian R.; McCrady-Spitzer, Shelly K.; Levine, James A.; Klaus, Katherine A.; Highsmith, Edward W.; Nair, K. Sreekumaran] Mayo Clin, Div Endocrinol, Rochester, MN 55905 USA.
   [Middha, Sumit; Carter, Rickey E.; Therneau, Terry M.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic
RP Nair, KS (corresponding author), Mayo Clin, Div Endocrinol, 200 First St SW,Joseph 5-194, Rochester, MN 55905 USA.
EM nair.sree@mayo.edu
RI ; Carter, Rickey/A-1594-2012
OI Lanza, Ian/0000-0002-9858-3384; Carter, Rickey/0000-0002-0818-273X;
   Middha, Sumit/0000-0003-4135-6268; Marquet-de Rouge,
   Perrine/0000-0002-4412-1133
FU National Institutes of Health [R01 AG09531]; CTSA from the National
   Center for Advancing Translational Science (NCATS) [UL1 TR000135]; Mayo
   Clinic Metabolomics Resource Core from the National Institute of
   Diabetes and Digestive and Kidney Diseases [U24DK100469]
FX This work was supported by grants from the National Institutes of Health
   R01 AG09531, CTSA Grant Number UL1 TR000135 from the National Center for
   Advancing Translational Science (NCATS), and Mayo Clinic Metabolomics
   Resource Core (grant number U24DK100469) from the National Institute of
   Diabetes and Digestive and Kidney Diseases which originates from the
   National Institutes of Health Director's Common Fund.
CR Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638
   Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j
   Chow LS, 2007, J APPL PHYSIOL, V102, P1078, DOI 10.1152/japplphysiol.00791.2006
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Harris AM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1207, DOI 10.1152/ajpendo.00509.2006
   HEATH GW, 1981, J APPL PHYSIOL, V51, P634, DOI 10.1152/jappl.1981.51.3.634
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135
   Johnson ML, 2015, J GERONTOL A-BIOL, V70, P1386, DOI 10.1093/gerona/glu221
   Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445
   Kirkwood TBL, 2002, NATURE, V419, P794, DOI 10.1038/419794a
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003
   LARSSON L, 1978, ACTA PHYSIOL SCAND, V103, P31, DOI 10.1111/j.1748-1716.1978.tb06187.x
   LEE CM, 1993, J GERONTOL, V48, pB201, DOI 10.1093/geronj/48.6.B201
   Levine J, 2001, AM J PHYSIOL-ENDOC M, V281, pE670, DOI 10.1152/ajpendo.2001.281.4.E670
   Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561
   Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lutz S, 2000, INT J LEGAL MED, V113, P155, DOI 10.1007/s004140050288
   Mitchell P, 2014, DIABETES, V63, P3569, DOI 10.2337/db14-1059
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858
   Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629
   NAIR KS, 1988, AM J PHYSIOL, V254, pE208, DOI 10.1152/ajpendo.1988.254.2.E208
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Nicklett EJ, 2012, J AM GERIATR SOC, V60, P862, DOI 10.1111/j.1532-5415.2012.03924.x
   PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Proctor DN, 1996, J APPL PHYSIOL, V81, P2495, DOI 10.1152/jappl.1996.81.6.2495
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Robinson J.B., 1987, Mitochondria: A Practical Approach, P153
   Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2
   Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048
   Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shokolenko IN, 2013, DNA REPAIR, V12, P488, DOI 10.1016/j.dnarep.2013.04.023
   Short K, 2003, DIABETES, V52, pA346
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Talbot LA, 2007, PREV MED, V45, P169, DOI 10.1016/j.ypmed.2007.05.014
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP AG, V207, P1950
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Villareal DT, 2006, AM J PHYSIOL-ENDOC M, V291, pE1003, DOI 10.1152/ajpendo.00100.2006
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
NR 58
TC 41
Z9 45
U1 1
U2 16
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV
PY 2015
VL 70
IS 11
BP 1409
EP 1417
DI 10.1093/gerona/glv086
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA CW1QF
UT WOS:000364765700015
PM 26297939
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Enns, GM
   Bai, RK
   Beck, AE
   Wong, LJ
AF Enns, Gregory M.
   Bai, Ren-Kui
   Beck, Anita E.
   Wong, Lee-Jun
TI Molecular-clinical correlations in a family with variable tissue
   mitochondrial DNA T8993G mutant load
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Leigh syndrome; NARP; mitochondrial DNA mutation T8993G; mitochondrial
   DNA segregation; prenatal diagnosis
ID HETEROPLASMIC MTDNA MUTATION; LEIGH-SYNDROME; NUCLEOTIDE 8993;
   PRENATAL-DIAGNOSIS; RAPID SEGREGATION; HUMAN OOCYTES; DISEASE; PATIENT;
   NT-8993
AB Unlike many pathogenic mitochondrial DNA mutations, the T8993G mutation associated with Leigh syndrome (LS) and neurogenic muscle weakness, ataxia, retinitis pigmentosa (NARP) typically shows little variation in mutant load between different tissue types. We describe the molecular and clinical findings in a family with variable disease severity and tissue T8993G mutant loads. Real-time ARMS qPCR testing showed that two brothers with features of NARP and LS had high mutant loads (> 90%) in all tissues tested, similar to previously reported cases. Their sister, who has mild speech delay but attends normal school, was found to have a relatively high mutant load (mean 93%) in tissues derived from endoderm. (buccal mucosa) and mesoderm (blood and skin fibroblasts). However, in tissue derived from ectoderm (hair bulbs), she carried a considerably lower proportion of mutant mtDNA. Because both surface ectoderm, which gives rise to outer epithelia and hair, and neuroectoderm, which gives rise to the central nervous system, are derived from ectoderm, it is tempting to speculate that the mutant load detected in the oligosymptomatic sister's hair bulbs is a reflection of the brain mutant load. We conclude that significant variation in tissue mutant load may occur in at least some individuals that harbor the T8993G mutation. This adds additional complexity to genetic counseling and prenatal diagnosis in such instances. Given the shared embryonic origin of hair bulbs and brain, we recommend performing hair bulb mtDNA analysis in asymptomatic or oligosymptomatic individuals that have high blood mutant loads in order to understand better the genotype-phenotype correlations related to the T8993G mutation. (c) 2006 Elsevier Inc. All rights reserved.
C1 Stanford Univ, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA.
   Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA.
C3 Stanford University; Baylor College of Medicine
RP Enns, GM (corresponding author), Stanford Univ, Dept Pediat, Div Med Genet, 300 Pasteur Dr H-315, Stanford, CA 94305 USA.
EM greg.enns@stanford.edu
RI Beck, Anita/AAS-8775-2021
CR ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bartley J., 1996, American Journal of Human Genetics, V59, pA316
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   CIAFALONI E, 1993, J PEDIATR-US, V122, P419, DOI 10.1016/S0022-3476(05)83431-6
   Dahl H H, 2000, Hum Reprod, V15 Suppl 2, P246
   Degoul F, 1997, J INHERIT METAB DIS, V20, P49, DOI 10.1023/A:1005357506614
   Degoul F, 1995, J INHERIT METAB DIS, V18, P682, DOI 10.1007/BF02436757
   Ferlin T, 1997, J PEDIATR-US, V131, P447, DOI 10.1016/S0022-3476(97)80074-1
   FRYER A, 1994, ARCH DIS CHILD, V71, P419, DOI 10.1136/adc.71.5.419
   HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   LERTRIT P, 1992, HUM GENET, V90, P251
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   Moore KL., 1982, DEV HUMAN CLIN ORIEN
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Poulton J, 2002, REPRODUCTION, V123, P751, DOI 10.1530/rep.0.1230751
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   White SL, 1999, PRENATAL DIAG, V19, P1165, DOI 10.1002/(SICI)1097-0223(199912)19:12<1165::AID-PD719>3.3.CO;2-4
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wong LJC, 1997, CLIN CHEM, V43, P1241
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Wong LJC, 2002, GENET MED, V4, P78, DOI 10.1097/00125817-200203000-00005
   YOSHINAGA H, 1993, J CHILD NEUROL, V8, P129, DOI 10.1177/088307389300800204
NR 37
TC 27
Z9 28
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD AUG
PY 2006
VL 88
IS 4
BP 364
EP 371
DI 10.1016/j.ymgme.2006.02.001
PG 8
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 077LB
UT WOS:000240029700010
PM 16546428
DA 2024-11-01
ER

PT J
AU Matsushima, Y
   Kaguni, LS
AF Matsushima, Yuichi
   Kaguni, Laurie S.
TI Functional importance of the conserved N-terminal domain of the
   mitochondrial replicative DNA helicase
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT International Symposium on Mitchondrial Physiology and Pathology
CY JUN, 2008
CL Bari, ITALY
DE Mitochondria; Mitochondrial DNA; Replisome; Primase; Helicase; Autosomal
   dominant progressive external ophthalmoplegia
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SCHNEIDER CELLS; COPY NUMBER;
   MODULAR ARCHITECTURE; TWINKLE HELICASE; ZINC MOTIF; PRIMASE;
   BACTERIOPHAGE-T7; MUTATIONS; BINDING
AB The mitochondrial replicative DNA helicase is an essential cellular protein that shows high similarity with the bifunctional primase-helicase of bacteriophage 17, the gene 4 protein (T7 gp4). The N-terminal primase domain of T7 gp4 comprises seven conserved sequence motifs, I, II, III, IV, V, VI, and an RNA polymerase basic domain. The putative primase domain of metazoan mitochondrial DNA helicases has diverged from T7 gp4 and in particular, the primase domain of vertebrates lacks motif I, which comprises a zinc binding domain. Interestingly, motif I is conserved in insect mtDNA helicases. Here, we evaluate the effects of overexpression in Drosophila cell culture of variants carrying mutations in conserved amino acids in the N-terminal region, including the zinc binding domain. Overexpression of alanine substitution mutants of conserved amino acids in motifs I, IV, V and VI and the RNA polymerase basic domain results in increased mtDNA copy number as is observed with overexpression of the wild type enzyme. In contrast, overexpression of three N-terminal mutants W282L, R301Q and P302L that are analogous to human autosomal dominant progressive external ophthalmoplegia mutations results in mitochondrial DNA depletion, and in the case of R301Q, a dominant negative cellular phenotype. Thus whereas our data suggest lack of a DNA primase activity in Drosophila mitochondrial DNA helicase, they show that specific N-terminal amino acid residues that map close to the central linker region likely play a physiological role in the C-terminal helicase function of the protein. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
C3 Michigan State University; Michigan State University
RP Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
EM lskaguni@msu.edu
FU NIGMS NIH HHS [R01 GM045295-13A1, GM45295, R01 GM045295-14, R01
   GM045295-15, R01 GM045295-16, R01 GM045295] Funding Source: Medline
CR Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kusakabe T, 1996, J BIOL CHEM, V271, P19563, DOI 10.1074/jbc.271.32.19563
   Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200
   Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200
   Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499
   Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200
   Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   MENDELMAN LV, 1994, EMBO J, V13, P3909, DOI 10.1002/j.1460-2075.1994.tb06702.x
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
NR 23
TC 12
Z9 16
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD MAY
PY 2009
VL 1787
IS 5
SI SI
BP 290
EP 293
DI 10.1016/j.bbabio.2008.11.005
PG 4
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics
GA 451MX
UT WOS:000266475400002
PM 19063859
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Nicholls, TJ
   Zsurka, G
   Peeva, V
   Schöler, S
   Szczesny, RJ
   Cysewski, D
   Reyes, A
   Kornblum, C
   Sciacco, M
   Moggio, M
   Dziembowski, A
   Kunz, WS
   Minczuk, M
AF Nicholls, Thomas J.
   Zsurka, Gabor
   Peeva, Viktoriya
   Schoeler, Susanne
   Szczesny, Roman J.
   Cysewski, Dominik
   Reyes, Aurelio
   Kornblum, Cornelia
   Sciacco, Monica
   Moggio, Maurizio
   Dziembowski, Andrzej
   Kunz, Wolfram S.
   Minczuk, Michal
TI Linear mtDNA fragments and unusual mtDNA rearrangements associated with
   pathological deficiency of MGME1 exonuclease
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA REPLICATION; DOUBLE-STRAND BREAKS; PROGRESSIVE
   EXTERNAL OPHTHALMOPLEGIA; POLYMERASE-GAMMA; TRANSCRIPTION TERMINATION;
   HOMOLOGOUS RECOMBINATION; LAGGING-STRAND; CONTROL REGION; 7S DNA;
   MUTATIONS
AB MGME1, also known as Ddk1 or C20orf72, is a mitochondrial exonuclease found to be involved in the processing of mitochondrial DNA (mtDNA) during replication. Here, we present detailed insights on the role of MGME1 in mtDNA maintenance. Upon loss of MGME1, elongated 7S DNA species accumulate owing to incomplete processing of 5' ends. Moreover, an 11-kb linear mtDNA fragment spanning the entire major arc of the mitochondrial genome is generated. In contrast to control cells, where linear mtDNA molecules are detectable only after nuclease S1 treatment, the 11-kb fragment persists in MGME1-deficient cells. In parallel, we observed characteristic mtDNA duplications in the absence of MGME1. The fact that the breakpoints of these mtDNA rearrangements do not correspond to either classical deletions or the ends of the linear 11-kb fragment points to a role of MGME1 in processing mtDNA ends, possibly enabling their repair by homologous recombination. In agreement with its functional involvement in mtDNA maintenance, we show that MGME1 interacts with the mitochondrial replicase PolgA, suggesting that it is a constituent of the mitochondrial replisome, to which it provides an additional exonuclease activity. Thus, our results support the viewpoint that MGME1-mediated mtDNA processing is essential for faithful mitochondrial genome replication and might be required for intramolecular recombination of mtDNA.
C1 [Nicholls, Thomas J.; Reyes, Aurelio; Minczuk, Michal] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Zsurka, Gabor; Peeva, Viktoriya; Schoeler, Susanne; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Dept Epileptol, Bonn, Germany.
   [Zsurka, Gabor; Peeva, Viktoriya; Schoeler, Susanne; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Life & Brain Ctr, Bonn, Germany.
   [Kornblum, Cornelia] Univ Bonn, Med Ctr, Dept Neurol, Bonn, Germany.
   [Szczesny, Roman J.; Cysewski, Dominik; Dziembowski, Andrzej] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland.
   [Szczesny, Roman J.; Cysewski, Dominik; Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.
   [Sciacco, Monica; Moggio, Maurizio] Univ Milan, Ctr Dino Ferrari, Osped Maggiore Policlin, Neuromuscular Unit,Fdn IRCCS Ca Granda, Milan, Italy.
C3 University of Bonn; University of Bonn; University of Bonn; University
   of Warsaw; Polish Academy of Sciences; Institute of Biochemistry &
   Biophysics - Polish Academy of Sciences; University of Milan; IRCCS Ca
   Granda Ospedale Maggiore Policlinico
RP Minczuk, M (corresponding author), MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.
EM wolfram.kunz@ukb.uni-bonn.de; michal.minczuk@mrc-mbu.cam.ac.uk
RI Kornblum, Cornelia/IUM-4180-2023; Sciacco, Monica/AAC-6500-2022;
   Cysewski, Dominik/U-1352-2019; Kunz, Wolfram/K-1232-2019; Minczuk,
   Michal/G-1638-2014
OI Szczesny, Roman/0000-0002-0686-1632; Sciacco,
   Monica/0000-0003-4593-4977; Kunz, Wolfram/0000-0003-1113-3493; Zsurka,
   Gabor/0000-0002-6379-849X; Nicholls, Thomas/0000-0002-3034-4109;
   Cysewski, Dominik/0000-0001-6206-0672; Dziembowski,
   Andrzej/0000-0001-8492-7572; Minczuk, Michal/0000-0001-8242-1420
FU Medical Research Council, UK; Deutsche Forschungsgemeinschaft [KU
   911/21-1, ZS 99/3-1]; European Community [279062]; Ministry of Science
   and Higher Education of Poland [0542/IP1/2011/71]; MRC [MC_U105697135]
   Funding Source: UKRI
FX This work was supported by the Medical Research Council, UK. This work
   was also supported by the Deutsche Forschungsgemeinschaft (KU 911/21-1
   to W.S.K. and ZS 99/3-1 to G.Z.), the European Community (FP7 project
   EpiPGX, grant 279062 to W.S.K.) and the Grant from the Ministry of
   Science and Higher Education of Poland (to R.J.S., 0542/IP1/2011/71
   Iuventus programme). Funding to pay the Open Access publication charges
   for this article was provided by the Medical Research Council, UK.
CR Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   BOGENHAGEN D, 1978, J MOL BIOL, V119, P69, DOI 10.1016/0022-2836(78)90270-X
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BROWN GG, 1986, J MOL BIOL, V192, P503, DOI 10.1016/0022-2836(86)90272-X
   Canceill D, 1999, J BIOL CHEM, V274, P27481, DOI 10.1074/jbc.274.39.27481
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   ENGLER MJ, 1983, J BIOL CHEM, V258, P1165
   FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Goodarzi AA, 2013, ADV GENET, V82, P1, DOI 10.1016/B978-0-12-407676-1.00001-9
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012971
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200
   Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Orlowska KP, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt650
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rudolph CJ, 2013, NATURE, V500, P608, DOI 10.1038/nature12312
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Senkevich TG, 2009, P NATL ACAD SCI USA, V106, P17921, DOI 10.1073/pnas.0909529106
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Wei YH, 1996, ANN NY ACAD SCI, V786, P82, DOI 10.1111/j.1749-6632.1996.tb39054.x
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d
NR 66
TC 58
Z9 63
U1 2
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 1
PY 2014
VL 23
IS 23
BP 6147
EP 6162
DI 10.1093/hmg/ddu336
PG 16
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AX2MF
UT WOS:000346777400002
PM 24986917
OA Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Roos, S
   Sofou, K
   Hedberg-Oldfors, C
   Kollberg, G
   Lindgren, U
   Thomsen, C
   Tulinius, M
   Oldfors, A
AF Roos, Sara
   Sofou, Kalliopi
   Hedberg-Oldfors, Carola
   Kollberg, Gittan
   Lindgren, Ulrika
   Thomsen, Christer
   Tulinius, Mar
   Oldfors, Anders
TI Mitochondrial complex IV deficiency caused by a novel frameshift variant
   in <i>MT-CO2</i> associated with myopathy and perturbed acylcarnitine
   profile
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID CYTOCHROME-C-OXIDASE; SUBUNIT-II; MUTATION; GENE
AB Mitochondrial myopathies are a heterogeneous group of disorders associated with a wide range of clinical phenotypes. We present a 16-year-old girl with a history of exercise intolerance since childhood. Acylcarnitine species suggestive of multiple acyl-CoA dehydrogenase deficiency were found in serum, however genetic analysis did not reveal variants in genes associated with this disorder. Biochemical analyses of skeletal muscle mitochondria revealed an isolated and extremely low activity of cytochrome c oxidase (COX). This finding was confirmed by enzyme histochemistry, which demonstrated an almost complete absence of fibers with normal COX activity. Whole-exome sequencing revealed a single base-pair deletion (m.8088delT) in MT-CO2, which encodes subunit 2 of COX, resulting in a premature stop codon. Restriction fragment length polymorphism-analysis confirmed mtDNA heteroplasmy with high mutant load in skeletal muscle, the only clinically affected tissue, but low levels in other investigated tissues. Single muscle fiber analysis showed segregation of the mutant genotype with respiratory chain dysfunction. Immuno-histochemical studies indicated that the truncating variant in COX2 has an inhibitory effect on the assembly of the COX holoenzyme.
C1 [Roos, Sara; Hedberg-Oldfors, Carola; Lindgren, Ulrika; Thomsen, Christer; Oldfors, Anders] Univ Gothenburg, Dept Pathol & Genet, Gothenburg, Sweden.
   [Roos, Sara; Hedberg-Oldfors, Carola; Lindgren, Ulrika; Thomsen, Christer; Oldfors, Anders] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden.
   [Sofou, Kalliopi] Sahlgrens Univ Hosp, Dept Pediat, Queen Silvia Childrens Hosp, Gothenburg, Sweden.
   [Kollberg, Gittan] Univ Gothenburg, Inst Biomed, Dept Clin Chem, Gothenburg, Sweden.
   [Tulinius, Mar] Univ Gothenburg, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
C3 University of Gothenburg; University of Gothenburg; Sahlgrenska
   University Hospital; Queen Silvia Children's Hospital; University of
   Gothenburg; University of Gothenburg
RP Roos, S (corresponding author), Univ Gothenburg, Dept Pathol & Genet, Gothenburg, Sweden.; Roos, S (corresponding author), Univ Gothenburg, Inst Biomed, Gothenburg, Sweden.
EM sara.roos@gu.se
RI Lindgren, Ulrika/HJH-0146-2022
FU Swedish Research Council [2012-2014]
FX The authors gratefully acknowledge the expert technical assistance of
   Brith Leidvik and Armita Mandegari. This work was supported by the
   Swedish Research Council (Proj No 2012-2014).
CR Abdulhag UN, 2015, EUR J HUM GENET, V23, P159, DOI 10.1038/ejhg.2014.85
   Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   Dubowitz V., 2013, MUSCLE BIOPSY PRACTI, V4th, P1, DOI DOI 10.1177/000271623618500112
   Hallmann K, 2016, BRAIN, V139, P338, DOI 10.1093/brain/awv357
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Roos S, 2014, NEUROMUSCULAR DISORD, V24, P713, DOI 10.1016/j.nmd.2014.05.009
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Uusimaa J, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e262
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Wajner M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150240
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
NR 19
TC 15
Z9 18
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD FEB
PY 2019
VL 27
IS 2
BP 331
EP 335
DI 10.1038/s41431-018-0286-0
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA HH8LP
UT WOS:000455983900019
PM 30315213
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Vandecasteele, SJ
   Seneca, S
   Smet, J
   Reynders, M
   De Ceulaer, J
   Vanlander, AV
   van Coster, R
AF Vandecasteele, S. J.
   Seneca, S.
   Smet, J.
   Reynders, M.
   De Ceulaer, J.
   Vanlander, A. V.
   van Coster, R.
TI Tigecycline-induced inhibition of mitochondrial DNA translation may
   cause lethal mitochondrial dysfunction in humans
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE 12SrRNApolymorphism; Mitochondrial toxicity; mtDNA Translation; Side
   effect; Tigecycline
ID RIBOSOMAL-RNA; MUTATIONS; PATHOLOGY
AB Background: A 65-year-old patient developed an unexplained and ultimately lethal metabolic acidosis under prolonged treatment with tigecycline. Tigecycline is known to have a selective inhibitory effect on eukaryotic mitochondrial translation. The underlying molecular mechanisms of the metabolic acidosis in this patient were explored.
   Methods: Oxidative phosphorylation system (OXPHOS) analysis, blue native polyacrylamide gel electrophoresis followed by in-gel activity staining in mitochondria, molecular analysis of mitochondrial DNA (mtDNA) for genomic rearrangements and sequencing of the rRNA genes was performed on the subject's skeletal muscle.
   Results: OXPHOS analysis revealed a combined deficiency of the complexes I, III, IV and V, with a preserved function of complex II (encoded by nuclear DNA), thus demonstrating a defective mtDNA translation. There were no known underlying mitochondrial genetic defects. The patient had a (m.1391T > A) variant within the 12SrRNA gene in heteroplasmy (50-60%).
   Conclusions: This patient developed an ultimately lethal mitochondrial toxicity while receiving prolonged treatment with tigecycline, which was caused by a defective translation of the mtDNA. Tigecycline is known to suppress eukaryotic mitochondrial DNA translation, but until now this effect has been considered to be clinically insignificant. The observations in this patient suggest a clinically significant mitochondrial toxicity of tigecycline in this patient, and warrant further investigation. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Vandecasteele, S. J.] AZ Sint Jan Brugge, Dept Nephrol & Infect Dis, Rudderhove 10, B-8000 Brugge, Belgium.
   [Vandecasteele, S. J.; Reynders, M.] AZ Sint Jan Brugge, Dept Microbiol, Brugge, Belgium.
   [De Ceulaer, J.] AZ Sint Jan Brugge, Dept Maxillofacial Surg, Brugge, Belgium.
   [Seneca, S.] Vrije Univ Brussel, UZ Brussel, Ctr Med Genet, Res Grp Reprod & Genet, Ixelles, Belgium.
   [Smet, J.; Vanlander, A. V.; van Coster, R.] Ghent Univ Hosp, Div Pediat Neurol & Metab, Dept Pediat, Ghent, Belgium.
C3 University Hospital Brussels; Vrije Universiteit Brussel; Ghent
   University; Ghent University Hospital
RP Vandecasteele, SJ (corresponding author), AZ Sint Jan Brugge, Dept Nephrol & Infect Dis, Rudderhove 10, B-8000 Brugge, Belgium.
EM stefaan.vandecasteele@azsintjan.be
RI Arnaud, Vanlander/ABB-5978-2021
OI Seneca, Sara/0000-0002-0853-9890; Vanlander, Arnaud/0000-0002-9520-5564
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006
   Hargreaves IP, 2016, DRUG SAFETY, V39, P661, DOI 10.1007/s40264-016-0417-x
   Jhas B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058367
   Jitkova Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095281
   Olson MW, 2006, ANTIMICROB AGENTS CH, V50, P2156, DOI 10.1128/AAC.01499-05
   Prasad P, 2012, CLIN INFECT DIS, V54, P1699, DOI 10.1093/cid/cis270
   Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08
   Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Smith PM, 2014, HUM MOL GENET, V23, P949, DOI 10.1093/hmg/ddt490
   Stein GE, 2013, DIAGN MICR INFEC DIS, V75, P331, DOI 10.1016/j.diagmicrobio.2012.12.004
   Yamasoba T, 2002, NEUROMUSCULAR DISORD, V12, P506, DOI 10.1016/S0960-8966(01)00329-7
NR 15
TC 11
Z9 11
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD APR
PY 2018
VL 24
IS 4
DI 10.1016/j.cmi.2017.08.018
PG 3
WC Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Microbiology
GA FZ8AG
UT WOS:000427826500021
PM 28870729
OA Bronze
DA 2024-11-01
ER

PT B
AU Shikata, C
   Nemoto, M
   Ebisawa, T
   Nishiyama, A
   Takeda, N
AF Shikata, Chihiro
   Nemoto, Masami
   Ebisawa, Takanori
   Nishiyama, Akihiro
   Takeda, Nobuakira
BE Ostadal, B
   Nagano, M
   Dhalla, NS
TI Mitochondrial DNA and Heart Disease
SO GENES AND CARDIOVASCULAR FUNCTION
LA English
DT Article; Book Chapter
DE Arrhythmia; Cardiomyopathy; Heart failure; Kearns-Sayre syndrome; MELAS;
   MERRF; Mitochondrial DNA; Mitochondrial encephalomyopathy
ID KEARNS-SAYRE SYNDROME; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MATERNALLY
   INHERITED MYOPATHY; PARKINSON-WHITE-SYNDROME; CARDIAC INVOLVEMENT;
   LACTIC-ACIDOSIS; LEIGH-SYNDROME; DILATED CARDIOMYOPATHY; POINT
   MUTATIONS; MELAS SUBGROUP
AB The relationship between abnormalities of myocardial mitochondrial DNA and heart disease is reviewed. Myocardial mitochondrial DNA abnormalities can induce both hypertrophic and dilated cardiomyopathies. In mitochondrial encephalomyopathy, abnormalities of myocardial mitochondrial DNA can also induce cardiac involvement, for example, heart failure and arrhythmia. The influence of acquired mitochondrial DNA mutations is also discussed.
C1 [Shikata, Chihiro] Jikei Univ, Dept Internal Med, Aoto Hosp, Sch Med, Tokyo, Japan.
C3 Jikei University
RP Takeda, N (corresponding author), Jikei Univ, Dept Internal Med, Aoto Hosp, Sch Med, Tokyo, Japan.
EM ntakeda@jikei.ac.jp
CR ADACHI K, 1993, BIOCHEM BIOPH RES CO, V195, P945, DOI 10.1006/bbrc.1993.2135
   Akita Y, 2000, HUM MUTAT, V15, P382, DOI 10.1002/(SICI)1098-1004(200004)15:4<382::AID-HUMU15>3.0.CO;2-B
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Azevedo O, 2010, CARDIOLOGY, V115, P71, DOI 10.1159/000252811
   BAUMER A, 1994, AM J HUM GENET, V54, P618
   BORDARIER C, 1990, NEUROPEDIATRICS, V21, P106, DOI 10.1055/s-2008-1071473
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   DiMauro S, 2004, ANN NY ACAD SCI, V1011, P232, DOI 10.1196/annals.1293.023
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   ELLES CN, 1987, BIOCHEM J, V245, P309
   Fosslien E, 2003, ANN CLIN LAB SCI, V33, P371
   FOURET RJ, 1994, FORENSIC SCI, V39, P693
   GERBITZ KD, 1990, J NEUROL, V237, P5, DOI 10.1007/BF00319660
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HATTORI K, 1991, AM HEART J, V122, P866, DOI 10.1016/0002-8703(91)90542-P
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   HAYAKAWA M, 1993, MOL CELL BIOCHEM, V119, P95, DOI 10.1007/BF00926859
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   HAYASHI JI, 1994, J BIOL CHEM, V269, P19060
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   HOLT IJ, 1988, LANCET, V1, P1462
   KATSUMATA K, 1994, BIOCHEM BIOPH RES CO, V202, P102, DOI 10.1006/bbrc.1994.1899
   KENNY D, 1990, AM HEART J, V120, P440, DOI 10.1016/0002-8703(90)90097-H
   Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6
   Komaki H, 2010, BBA-GEN SUBJECTS, V1800, P313, DOI 10.1016/j.bbagen.2009.07.008
   Kyriakouli DS, 2008, GENE THER, V15, P1017, DOI 10.1038/gt.2008.91
   Li YY, 2001, CIRCULATION, V104, P2492, DOI 10.1161/hc4501.098944
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   MELACINI P, 1990, JPN HEART J, V31, P115
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   OBAYASHI T, 1992, AM HEART J, V124, P1263, DOI 10.1016/0002-8703(92)90410-W
   OBERMAIERKUSSER B, 1990, BIOCHEM BIOPH RES CO, V169, P1007, DOI 10.1016/0006-291X(90)91994-4
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W
   OZAWA T, 1991, JPN CIRC J, V55, P1158, DOI 10.1253/jcj.55.1158
   Ozawa T, 1995, EUR HEART J, V16, P10, DOI 10.1093/eurheartj/16.suppl_O.10
   OZAWA T, 1995, BIOCHEM BIOPH RES CO, V207, P613, DOI 10.1006/bbrc.1995.1232
   OZAWA T, 1988, BIOCHEM BIOPH RES CO, V154, P1240, DOI 10.1016/0006-291X(88)90272-0
   OZAWA T, 1995, LANCET, V345, P189, DOI 10.1016/S0140-6736(95)90191-4
   OZAWA T, 1994, HERZ, V19, P105
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   PONZETTO C, 1990, J NEUROL SCI, V96, P207, DOI 10.1016/0022-510X(90)90133-8
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Salles JE, 2006, DIABETES RES CLIN PR, V72, P100, DOI 10.1016/j.diabres.2005.09.005
   SATO W, 1993, AM HEART J, V125, P550, DOI 10.1016/0002-8703(93)90046-C
   SATO W, 1994, AM HEART J, V128, P733, DOI 10.1016/0002-8703(94)90272-0
   SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/0005-2728(92)90226-R
   Shin WS, 2000, AM J HUM GENET, V67, P1617, DOI 10.1086/316896
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0
   SUOMALAINEN A, 1992, LANCET, V340, P1319, DOI 10.1016/0140-6736(92)92496-3
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   TAKEDA N, 1993, MOL CELL BIOCHEM, V119, P105, DOI 10.1007/BF00926860
   TAKEDA N, 1995, HEART HYPERTROPHY FA, P59
   TAKEI YI, 1995, MUSCLE NERVE, V18, P1321, DOI 10.1002/mus.880181115
   TANAKA M, 1989, BIOCHEM BIOPH RES CO, V164, P156, DOI 10.1016/0006-291X(89)91696-3
   TANAKA M, 1991, BIOCHEM BIOPH RES CO, V174, P861, DOI 10.1016/0006-291X(91)91497-Z
   TANAKA M, 1995, MUSCLE NERVE, pS165
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   TRANCHANT C, 1993, NEUROMUSCULAR DISORD, V3, P561, DOI 10.1016/0960-8966(93)90116-2
   Turner LF, 1998, EUR HEART J, V19, P1725, DOI 10.1053/euhj.1998.1125
   ULICNY KS, 1994, PACE, V17, P991, DOI 10.1111/j.1540-8159.1994.tb01445.x
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wang Shi-Bing, 2008, Pediatrics and Neonatology, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   Wortmann SB, 2007, ACTA PAEDIATR, V96, P450, DOI 10.1111/j.1651-2227.2006.00158.x
   YOON KL, 1993, PEDIATR RES, V33, P433, DOI 10.1203/00006450-199305000-00002
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   ZEVIANI M, 1995, MUSCLE NERVE, pS170
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
NR 82
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
BN 978-1-4419-7206-4
PY 2011
BP 79
EP 84
DI 10.1007/978-1-4419-7207-1_8
D2 10.1007/978-1-4419-7207-1
PG 6
WC Cardiac & Cardiovascular Systems; Genetics & Heredity
WE Book Citation Index – Science (BKCI-S)
SC Cardiovascular System & Cardiology; Genetics & Heredity
GA BWM92
UT WOS:000294269500008
DA 2024-11-01
ER

PT S
AU Bouchereau, J
   Barrot, SV
   Dupré, T
   Moore, SEH
   Cardas, R
   Capri, Y
   Gaignard, P
   Slama, A
   Delanoë, C
   de Baulny, HO
   Seta, N
   Schiff, M
   Servais, L
AF Bouchereau, Juliette
   Barrot, Sandrine Vuillaumier
   Dupre, Thierry
   Moore, Stuart E. H.
   Cardas, Ruxandra
   Capri, Yline
   Gaignard, Pauline
   Slama, Abdelhamid
   Delanoe, Catherine
   de Baulny, Helene Ogier
   Seta, Nathalie
   Schiff, Manuel
   Servais, Laurent
BE Baumgartner, M
   Patterson, M
   Rahman, S
   Zschocke, J
   Morava, E
   Peters, V
TI Abnormal Glycosylation Profile and High Alpha-Fetoprotein in a Patient
   with <i>Twinkle</i> Variants
SO JIMD REPORTS, VOL 29
SE JIMD Reports
LA English
DT Article; Book Chapter
ID ONSET SPINOCEREBELLAR ATAXIA; SENSORY NEUROPATHY; MITOCHONDRIA;
   MUTATIONS; DEPLETION; DISEASE
AB The C10orf2 gene encodes Twinkle, a protein involved in mitochondrial DNA (mtDNA) replication. Twinkle mutations cause mtDNA deletion or depletion and are associated with a large spectrum of clinical symptoms including dominant progressive external ophthalmoplegia (adPEO), infantile-onset spinocerebellar ataxia (IOSCA), and early-onset encephalopathy. The diagnosis remains difficult because of the wide range of symptoms and lack of association with specific metabolic changes. We report herein a child with early-onset encephalopathy, unusual abnormal movements, deafness, and axonal neuropathy. All laboratory investigations were normal with the exceptions of high alpha-fetoprotein levels and an abnormal glycosylation profile. These abnormal parameters resulted in misdiagnosis as a previously unidentified congenital disorder of glycosylation (CDG) type I syndrome. Whole exome sequencing revealed two point mutations in C10orf2 that were confirmed by Sanger sequencing; neither had been previously reported. This report enlarges the clinical phenotype of Twinkle mutations and suggests that an abnormal glycosylation profile suggestive of CDG type I associated with high blood alpha-fetoprotein levels without obvious cause should prompt Twinkle sequencing.
C1 [Bouchereau, Juliette; de Baulny, Helene Ogier; Schiff, Manuel] Hop Robert Debre, AP HP, Reference Ctr Inborn Errors Metab Dis, Paris, France.
   [Barrot, Sandrine Vuillaumier; Dupre, Thierry; Seta, Nathalie] Hop Bichat Claude Bernard, AP HP, Biochim Metab & Cellulaire, Paris, France.
   [Barrot, Sandrine Vuillaumier; Dupre, Thierry; Moore, Stuart E. H.] Univ Paris Diderot, INSERM, Ctr Rech Bichat Beaujon CRB3, U773, Paris, France.
   [Cardas, Ruxandra; Servais, Laurent] Hop La Pitie Salpetriere, Inst Myol, Paris, France.
   [Capri, Yline] Hop Robert Debre, AP HP, Genet Clin, Paris, France.
   [Gaignard, Pauline; Slama, Abdelhamid] Hop Bicetre, AP HP, Biochim, Le Kremlin Bicetre, France.
   [Delanoe, Catherine] Hop Robert Debre, Serv Explorat Fonct, Paris, France.
   [Schiff, Manuel] Univ Paris Diderot, Sorbonne Paris Cite, Hop Robert Debre, Inserm,U1141, Paris, France.
C3 Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Robert-Debre - APHP; Universite Paris Cite;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Bichat-Claude Bernard - APHP; Universite Paris Cite; Institut National
   de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Universite Paris Cite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP;
   Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire
   Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Universite
   Paris Cite; Hopital Universitaire Robert-Debre - APHP; Assistance
   Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital
   Universitaire Robert-Debre - APHP; Institut National de la Sante et de
   la Recherche Medicale (Inserm)
RP Servais, L (corresponding author), Hop La Pitie Salpetriere, Inst Myol, Paris, France.
EM l.servais@institut-myologie.org
RI Servais, Laurent/AAL-7384-2020; Seta, Nathalie/F-1824-2018; Moore,
   Stuart/AAF-3920-2021
OI Gaignard, Pauline/0000-0002-9520-2013; Seta,
   Nathalie/0000-0002-9240-8630; Moore, Stuart/0000-0002-1020-2242;
   Servais, Laurent/0000-0001-9270-4061
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   GASNIER F, 1991, CLIN CHIM ACTA, V199, P69, DOI 10.1016/0009-8981(91)90010-A
   GASNIER F, 1991, J BIOCHEM, V110, P702, DOI 10.1093/oxfordjournals.jbchem.a123644
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Helander A, 2001, CLIN CHEM, V47, P1225
   Jaeken J, 2011, J INHERIT METAB DIS, V34, P853, DOI 10.1007/s10545-011-9299-3
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Seta N, 1996, CLIN CHIM ACTA, V254, P131, DOI 10.1016/0009-8981(96)06379-6
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790
NR 14
TC 4
Z9 8
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
BN 978-3-662-53278-2; 978-3-662-53277-5
J9 JIMD REP
PY 2016
VL 29
BP 109
EP 113
DI 10.1007/8904_2016_526
D2 10.1007/978-3-662-53278-2
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity
WE Book Citation Index – Science (BKCI-S)
SC Endocrinology & Metabolism; Genetics & Heredity
GA BI0RO
UT WOS:000405118700015
PM 26920903
OA Green Published
DA 2024-11-01
ER

PT J
AU Moore, TM
   Zhou, ZQ
   Strumwasser, AR
   Cohn, W
   Lin, AJ
   Cory, K
   Whitney, K
   Ho, T
   Ho, T
   Lee, JL
   Rucker, DH
   Hoang, AN
   Widjaja, K
   Abrishami, AD
   Charugundla, S
   Stiles, L
   Whitelegge, JP
   Turcotte, LP
   Wanagat, J
   Hevener, AL
AF Moore, Timothy M.
   Zhou, Zhenqi
   Strumwasser, Alexander R.
   Cohn, Whitaker
   Lin, Amanda J.
   Cory, Kevin
   Whitney, Kate
   Ho, Theodore
   Ho, Timothy
   Lee, Joseph L.
   Rucker, Daniel H.
   Hoang, Austin N.
   Widjaja, Kevin
   Abrishami, Aaron D.
   Charugundla, Sarada
   Stiles, Linsey
   Whitelegge, Julian P.
   Turcotte, Lorraine P.
   Wanagat, Jonathan
   Hevener, Andrea L.
TI Age-induced mitochondrial DNA point mutations are inadequate to alter
   metabolic homeostasis in response to nutrient challenge
SO AGING CELL
LA English
DT Article
DE aging; insulin resistance; metabolism; mitochondria; mitochondrial DNA;
   obesity; POLG
ID SKELETAL-MUSCLE; ENDURANCE; DYSFUNCTION; BIOGENESIS; DISEASE; MICE;
   HETEROPLASMY; RESISTANCE; DEFECTS; PROGRAM
AB Mitochondrial dysfunction is frequently associated with impairment in metabolic homeostasis and insulin action, and is thought to underlie cellular aging. However, it is unclear whether mitochondrial dysfunction is a cause or consequence of insulin resistance in humans. To determine the impact of intrinsic mitochondrial dysfunction on metabolism and insulin action, we performed comprehensive metabolic phenotyping of the polymerase gamma (PolG) D257A "mutator" mouse, a model known to accumulate supraphysiological mitochondrial DNA (mtDNA) point mutations. We utilized the heterozygous PolG mutator mouse (PolG(+/mut)) because it accumulates mtDNA point mutations similar to 500-fold > wild-type mice (WT), but fails to develop an overt progeria phenotype, unlike PolG(mut/mut) animals. To determine whether mtDNA point mutations induce metabolic dysfunction, we examined male PolG(+/mut) mice at 6 and 12 months of age during normal chow feeding, after 24-hr starvation, and following high-fat diet (HFD) feeding. No marked differences were observed in glucose homeostasis, adiposity, protein/gene markers of metabolism, or oxygen consumption in muscle between WT and PolG(+/mut) mice during any of the conditions or ages studied. However, proteomic analyses performed on isolated mitochondria from 12-month-old PolG(+/mut) mouse muscle revealed alterations in the expression of mitochondrial ribosomal proteins, electron transport chain components, and oxidative stress-related factors compared with WT. These findings suggest that mtDNA point mutations at levels observed in mammalian aging are insufficient to disrupt metabolic homeostasis and insulin action in male mice.
C1 [Moore, Timothy M.; Turcotte, Lorraine P.] Univ Southern Calif, Dept Biol Sci, Dana & David Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90007 USA.
   [Moore, Timothy M.; Zhou, Zhenqi; Strumwasser, Alexander R.; Lin, Amanda J.; Cory, Kevin; Whitney, Kate; Ho, Theodore; Ho, Timothy; Lee, Joseph L.; Rucker, Daniel H.; Hoang, Austin N.; Widjaja, Kevin; Stiles, Linsey; Wanagat, Jonathan; Hevener, Andrea L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA.
   [Cohn, Whitaker; Whitelegge, Julian P.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.
   [Cohn, Whitaker; Whitelegge, Julian P.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.
   [Abrishami, Aaron D.; Charugundla, Sarada] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA.
   [Hevener, Andrea L.] Univ Calif Los Angeles, Iris Cantor UCLA Womens Hlth Ctr, Los Angeles, CA 90095 USA.
C3 University of Southern California; University of California System;
   University of California Los Angeles; University of California Los
   Angeles Medical Center; David Geffen School of Medicine at UCLA;
   University of California System; University of California Los Angeles;
   University of California System; University of California Los Angeles;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles
RP Hevener, AL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Hlth Sci, Div Endocrinol Diabet & Hypertens,Dept Med,Mol En, 650 Charles E Young Dr South,STE 34-115, Los Angeles, CA 90095 USA.
EM ahevener@mednet.ucla.edu
RI zhou, qi/JEF-7253-2023; Turcotte, Lorraine/IVV-3015-2023; Wanagat,
   Jonathan/B-2856-2009
OI Moore, Timothy/0000-0003-4250-3370; Cory, Kevin/0000-0002-9570-7601;
   Stiles, Linsey/0000-0002-1514-458X; Zhou, Zhenqi/0000-0001-6560-9704;
   Lin, Amanda/0000-0002-1889-0051
FU Kirschstein-NRSA predoctoral fellowship from NIDDK [F31DK108657]; Carl
   V. Gisolfi Memorial Research grant from the American College of Sports
   Medicine; Dornsife College at the University of Southern California;
   UCLA Department of Medicine; UCLA Iris Cantor Women's Health Foundation;
   UCLA CTSI [ULTR000124]; UCLA Claude D. Pepper Older Americans
   Independence Center; National Institutes of Health [DK109724,
   P30DK063491, U54DK120342, NURSA NDSP U24DK097748]; NIH T32
   Neuroendocrinology, Sex Differences, and Reproduction Training Grant
   [5T32HD007228]; Center for Duchenne Muscular Dystrophy Training Grant
   [T32AR065972]; Molecular, Cellular, and Integrative Physiology Training
   Grant [T32GM065823]; American College of Sports Medicine-NASA Space
   Physiology Research Grant; UCLA Claude Pepper Older Americans
   Independence Center - National Institute of Aging [5P30AG028748];
   NIH/NCATS UCLA CTSI Grant [UL1TR000124]; UCLA Center for Duchenne
   Muscular Dystrophy-NIH NIAMS Wellstone Center of Excellence Training
   Fellowship [U54 AR052646]; American Federation for Aging Research; Glenn
   Foundation for Medical Research; UCLA Hartford Center of Excellence;
   National Institute on Aging [AG059847, AG055518]; UCLA Older Americans
   Independence Center [P30 AG028748]; UCSD/UCLA Diabetes Research Center
   Pilot and Feasibility Grant [DK063491]; University of Southern
   California Women in Science and Engineering program
FX Timothy M. Moore was supported by Kirschstein-NRSA predoctoral
   fellowship (F31DK108657) from NIDDK, a Carl V. Gisolfi Memorial Research
   grant from the American College of Sports Medicine, and a predoctoral
   graduate student award from the Dornsife College at the University of
   Southern California. Andrea L. Hevener was supported by the UCLA
   Department of Medicine, the UCLA Iris Cantor Women's Health Foundation
   and UCLA CTSI (ULTR000124), the UCLA Claude D. Pepper Older Americans
   Independence Center, and the National Institutes of Health (DK109724,
   P30DK063491, U54DK120342, and NURSA NDSP U24DK097748). Amana J. Lin was
   supported by an NIH T32 Neuroendocrinology, Sex Differences, and
   Reproduction Training Grant (5T32HD007228); Center for Duchenne Muscular
   Dystrophy Training Grant (T32AR065972); Molecular, Cellular, and
   Integrative Physiology Training Grant (T32GM065823); and the American
   College of Sports Medicine-NASA Space Physiology Research Grant. Zhenqi
   Zhou was supported by UCLA Claude Pepper Older Americans Independence
   Center funded by the National Institute of Aging (5P30AG028748),
   NIH/NCATS UCLA CTSI Grant (UL1TR000124), and UCLA Center for Duchenne
   Muscular Dystrophy-NIH NIAMS (U54 AR052646) Wellstone Center of
   Excellence Training Fellowship. Jonathan Wanagat was supported by the
   American Federation for Aging Research, the Glenn Foundation for Medical
   Research, the UCLA Hartford Center of Excellence, National Institute on
   Aging Grants AG059847 and AG055518, UCLA Older Americans Independence
   Center P30 AG028748, UCSD/UCLA Diabetes Research Center Pilot and
   Feasibility Grant DK063491. Lorraine P. Turcotte was supported by a
   research grant from the University of Southern California Women in
   Science and Engineering program.
CR Ahlqvist KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7494
   Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245
   Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392
   Center M.A.M.D., SPEC MIT DIS TREATM
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Civelek M, 2017, AM J HUM GENET, V100, P428, DOI 10.1016/j.ajhg.2017.01.027
   Coleman V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20901-4
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Crilly MJ, 2016, J APPL PHYSIOL, V121, P730, DOI 10.1152/japplphysiol.00042.2016
   Czajka A, 2015, EBIOMEDICINE, V2, P499, DOI 10.1016/j.ebiom.2015.04.002
   Drew BG, 2014, DIABETES, V63, P1488, DOI 10.2337/db13-0665
   DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0
   Fan WW, 2017, CELL METAB, V25, P1186, DOI 10.1016/j.cmet.2017.04.006
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011
   Gilkerson R, 2016, DIABETES-METAB RES, V32, P672, DOI 10.1002/dmrr.2833
   Graham J. M., 2001, CURR PROTEC CELL BIO, V4
   Haroon S, 2018, CELL REP, V22, P3115, DOI 10.1016/j.celrep.2018.02.099
   He Q, 2013, MITOCHONDRION, V13, P592, DOI 10.1016/j.mito.2013.08.003
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104
   Hicks S, 2013, AM J PHYSIOL-HEART C, V304, pH903, DOI 10.1152/ajpheart.00567.2012
   Hu DL, 2018, ISCIENCE, V9, P84, DOI 10.1016/j.isci.2018.10.012
   Huang DD, 2019, EXP GERONTOL, V119, P61, DOI 10.1016/j.exger.2019.01.022
   Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285
   Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659
   Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849
   Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327
   Joseph AM, 2012, EXP DIABETES RES, DOI 10.1155/2012/642038
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Krishnan KC, 2018, CELL SYST, V6, P103, DOI 10.1016/j.cels.2017.12.006
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Mandillo S, 2014, DIS MODEL MECH, V7, P397, DOI 10.1242/dmm.013946
   McManus MJ, 2019, CELL METAB, V29, P78, DOI 10.1016/j.cmet.2018.08.002
   Merry TL, 2016, J PHYSIOL-LONDON, V594, P5195, DOI 10.1113/JP271957
   Monickaraj F, 2012, MOL CELL BIOCHEM, V365, P343, DOI 10.1007/s11010-012-1276-0
   Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092
   Nile DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115433
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261
   Ribas V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3815
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Ross JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Saleem A, 2015, MITOCHONDRION, V21, P19, DOI 10.1016/j.mito.2014.12.001
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Tranah GJ, 2011, MITOCHONDRION, V11, P855, DOI 10.1016/j.mito.2011.04.005
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Uruno A, 2016, MOL CELL BIOL, V36, P1655, DOI 10.1128/MCB.01095-15
   Valente WJ, 2016, NUCLEIC ACIDS RES, V44, P8513, DOI 10.1093/nar/gkw716
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wanagat J, 2016, CURR OPIN GENET DEV, V38, P118, DOI 10.1016/j.gde.2016.05.007
   Wang SJ, 2013, GENE, V531, P472, DOI 10.1016/j.gene.2013.09.019
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059
   Zabielski P, 2016, DIABETES, V65, P561, DOI 10.2337/db15-0823
   Zappia MP, 2019, CELL REP, V26, P702, DOI 10.1016/j.celrep.2018.12.080
NR 72
TC 6
Z9 5
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD NOV
PY 2020
VL 19
IS 11
AR e13166
DI 10.1111/acel.13166
EA OCT 2020
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA PA5EA
UT WOS:000579083000001
PM 33049094
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Coon, KD
   Valla, J
   Szelinger, S
   Schneider, LE
   Niedzielko, TL
   Brown, KM
   Pearson, JV
   Halperin, R
   Dunckley, T
   Papassotiropoulos, A
   Caselli, RJ
   Reiman, EM
   Stephan, DA
AF Coon, Keith D.
   Valla, Jon
   Szelinger, Szabolics
   Schneider, Lonnie E.
   Niedzielko, Tracy L.
   Brown, Kevin M.
   Pearson, John V.
   Halperin, Rebecca
   Dunckley, Travis
   Papassotiropoulos, Andreas
   Caselli, Richard J.
   Reiman, Eric M.
   Stephan, Dietrich A.
TI Quantitation of heteroplasmy of mtDNA sequence variants identified in a
   population of AD patients and controls by array-based resequencing
SO MITOCHONDRION
LA English
DT Article
DE mitochondria; Alzheimer's disease; heteroplasmy; microarray;
   resequencing
ID CYTOCHROME-C-OXIDASE; HUMAN MITOCHONDRIAL-DNA; COMPLEX-I DEFICIENCY;
   RAGGED-RED FIBERS; ALZHEIMERS-DISEASE; POINT MUTATIONS; SKELETAL-MUSCLE;
   CONTROL-REGION; HUMAN-GENOME; COPY NUMBER
AB The role of mitochondrial dysfunction in the pathogenesis of Alzheimer's disease (AD) has been well documented. Though evidence for the role of mitochondria in AD seems incontrovertible, the impact of mitochondrial DNA (mtDNA) mutations in AD etiology remains controversial. Though mutations in mitochondrially encoded genes have repeatedly been implicated in the pathogenesis of AD, many of these studies have been, plagued by lack of replication as well as potential contamination of nuclear-encoded mitochondrial pseudogenes. To assess the role of mtDNA mutations in the pathogenesis of AD, while avoiding the pitfalls of nuclear-encoded mitochondrial pseudogenes encountered in previous investigations and showcasing the benefits of a novel resequencing technology, we sequenced the entire coding region (15,452 bp) of mtDNA from 19 extremely well-characterized AD patients and 18 age-matched, unaffected controls utilizing a new, reliable, high-throughput array-based resequencing technique, the Human MitoChip. High-throughput, array-based DNA resequencing of the entire mtDNA coding region from platelets of 37 subjects revealed the presence of 208 loci displaying a total of 917 sequence variants. There were no statistically significant differences in overall mutational burden between cases and controls, however, 265 independent sites of statistically significant change between cases and controls were identified. Changed sites were found in genes associated with complexes I (30.2%), III (3.0%), IV (33.2%), and V (9.1%) as well as tRNA (10.6%) and rRNA (14.0%). Despite their statistical significance, the subtle nature of the observed changes makes it difficult to determine whether they represent true functional variants involved in AD etiology or merely naturally occurring dissimilarity. Regardless, this study demonstrates the tremendous value of this novel mtDNA resequencing platform, which avoids the pitfalls of erroneously amplifying nuclear-encoded mtDNA pseudogenes, and our proposed analysis paradigm, which utilizes the availability of raw signal intensity values for each of the four potential alleles to facilitate quantitative estimates of mtDNA heteroplasmy. This information provides a potential new target for burgeoning diagnostics and therapeutics that could truly assist those suffering from this devastating disorder. (c) 2006 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA.
   St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA.
   Univ Zurich, Div Psychiat Res, Zurich, Switzerland.
   Mayo Clin, Dept Neurol, Scottsdale, AZ USA.
   Univ Arizona, Dept Psychiat, PET Ctr, Banner Good Smaritan Med Ctr, Tucson, AZ 85721 USA.
   Arizona Alzheimers Dis Consortium, Phoenix, AZ USA.
C3 Translational Genomics Research Institute; St. Joseph's Hospital and
   Medical Center; Barrow Neurological Institute; University of Zurich;
   Mayo Clinic; Mayo Clinic Phoenix; Banner Research; Banner Health;
   University of Arizona
RP Stephan, DA (corresponding author), Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA.
EM dstephan@tgen.org
RI Valla, Jonathan/B-5432-2009; Pearson, John/AAT-4211-2020; Reiman,
   Eric/D-2491-2009
OI Pearson, John/0000-0003-0904-4598; Papassotiropoulos,
   Andreas/0000-0002-2210-9651
FU NIA NIH HHS [P30 AG19610] Funding Source: Medline
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   BALAZS L, 1994, NEUROCHEM RES, V19, P1131, DOI 10.1007/BF00965146
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   BENDALL KE, 1995, AM J HUM GENET, V57, P248
   Bensasson D, 2003, J MOL EVOL, V57, P343, DOI 10.1007/s00239-003-2485-7
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   CALIFANO J, 2005, AFFYMETRIX MICROARRA
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Chang SW, 2000, BIOCHEM BIOPH RES CO, V273, P203, DOI 10.1006/bbrc.2000.2885
   CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0
   Chinnery PF, 2001, AM J HUM GENET, V68, P529, DOI 10.1086/318204
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   Conley YP, 2003, BRAIN RES PROTOC, V12, P99, DOI 10.1016/j.brainresprot.2003.08.005
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201
   Davis JN, 1998, BIOCHEM BIOPH RES CO, V244, P877, DOI 10.1006/bbrc.1998.8353
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Ghosh SS, 1999, ANN NY ACAD SCI, V893, P176, DOI 10.1111/j.1749-6632.1999.tb07825.x
   Gibson GE, 2000, ANN NEUROL, V48, P297, DOI 10.1002/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z
   Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200
   Hazkani-Covo E, 2003, J MOL EVOL, V56, P169, DOI 10.1007/s00239-002-2390-5
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hirano M, 1997, P NATL ACAD SCI USA, V94, P14894, DOI 10.1073/pnas.94.26.14894
   Hou JH, 1998, MUTAT RES-FUND MOL M, V403, P75, DOI 10.1016/S0027-5107(98)00054-2
   JAKUPCIAK J, 2005, NEW MICROARRAY IMPRO
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jun AS, 1996, MOL CELL BIOL, V16, P771
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Khan SM, 2000, ANN NEUROL, V48, P148, DOI 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7
   Kroemer G, 1998, CELL DEATH DIFFER, V5, P547, DOI 10.1038/sj.cdd.4400387
   Leist M, 1999, EXP CELL RES, V249, P396, DOI 10.1006/excr.1999.4514
   Levin BC, 1999, GENOMICS, V55, P135, DOI 10.1006/geno.1998.5513
   LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147
   Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971
   PALMER AM, 1994, BRAIN RES, V645, P338, DOI 10.1016/0006-8993(94)91670-5
   PAPPOLLA MA, 1992, AM J PATHOL, V140, P621
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   PARKER WD, 1995, NEUROLOGY, V45, P482, DOI 10.1212/WNL.45.3.482
   Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102
   PETTEGREW JW, 1995, NEUROBIOL AGING, V16, P973, DOI 10.1016/0197-4580(95)02017-9
   PETTEGREW JW, 1994, NEUROBIOL AGING, V15, P117, DOI 10.1016/0197-4580(94)90152-X
   Ramassamy C, 2000, NEUROBIOL DIS, V7, P23, DOI 10.1006/nbdi.1999.0273
   Schapira AHV, 1998, ANN NEUROL, V44, pS89, DOI 10.1002/ana.410440714
   Sciacco M, 2005, J NEUROL SCI, V239, P21, DOI 10.1016/j.jns.2005.07.008
   SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Simon DK, 2001, GENOMICS, V73, P113, DOI 10.1006/geno.2001.6515
   SMEETS B, 2005, GENOME SCAN FINDS MU
   Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0
   Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Szuhai K, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e13
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tengan CH, 1998, BBA-MOL BASIS DIS, V1406, P73, DOI 10.1016/S0925-4439(97)00087-2
   Terasaki F, 2001, JPN CIRC J, V65, P691, DOI 10.1253/jcj.65.691
   Tretter L, 2004, NEUROCHEM RES, V29, P569, DOI 10.1023/B:NERE.0000014827.94562.4b
   Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wragg MA, 1995, NEUROSCI LETT, V201, P107, DOI 10.1016/0304-3940(95)12146-3
   Yan SD, 1997, NATURE, V389, P689
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Zhang L, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni156
   Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606
NR 79
TC 39
Z9 46
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD AUG
PY 2006
VL 6
IS 4
BP 194
EP 210
DI 10.1016/j.mito.2006.07.002
PG 17
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 095VM
UT WOS:000241336400004
PM 16920408
DA 2024-11-01
ER

PT J
AU Santhoshkumar, R
   Preethish-Kumar, V
   Polavarapu, K
   Reghunathan, D
   Chaudhari, S
   Satyamoorthy, K
   Vengalil, S
   Nashi, S
   Faruq, M
   Joshi, A
   Atchayaram, N
   Narayanappa, G
AF Santhoshkumar, Rashmi
   Preethish-Kumar, Veeramani
   Polavarapu, Kiran
   Reghunathan, Dinesh
   Chaudhari, Sima
   Satyamoorthy, Kapaettu
   Vengalil, Seena
   Nashi, Saraswati
   Faruq, Muhammed
   Joshi, Aditi
   Atchayaram, Nalini
   Narayanappa, Gayathri
TI A Novel L1 Linker Mutation in <i>DES</i> Resulted in Total Absence of
   Protein
SO JOURNAL OF MOLECULAR NEUROSCIENCE
LA English
DT Article
DE Desmin; L1 linker; Dilated cardiomyopathy; Cardio-skeletal phenotype
ID PATHOLOGY; MYOPATHY; GENE
AB Desminopathies (MIM*601419) are clinically heterogeneous, manifesting with myopathy and/or cardiomyopathy and with intra-sarcoplasmic desmin-positive deposits. They have either an autosomal dominant (AD) or recessive (AR) pattern of inheritance. Desmin is a crucial intermediate filament protein regulating various cellular functions in muscle cells. Here, we report a 13-year-old girl, born of second-degree consanguineous parents, with normal developmental milestones, who presented with dilated cardiomyopathy, respiratory insufficiency and predominant distal upper limb weakness. A striking feature on muscle biopsy was the presence of a peripheral chain of nuclei in addition to myopathic features. Immunostaining showed complete lack of desmin expression, further confirmed by western blot analysis. Ultrastructurally, subsarcolemmal granular material, expanded Z-band aggregation, distortion of myofilaments, focal Z-band streaming, lobed and clustered myonuclei were observed. Next-generation sequencing revealed a novel homozygous nonsense mutation c.448C>T, p.R150X in the patient, while the parents were heterozygous carriers. Single mitochondrial DNA deletion and isolated complex IV deficiency were noted. Our findings add to the ever-expanding phenotype and molecular spectrum of desminopathies.
C1 [Santhoshkumar, Rashmi; Narayanappa, Gayathri] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bengaluru 560029, Karnataka, India.
   [Preethish-Kumar, Veeramani; Polavarapu, Kiran; Vengalil, Seena; Nashi, Saraswati; Atchayaram, Nalini] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bengaluru 560029, Karnataka, India.
   [Chaudhari, Sima; Satyamoorthy, Kapaettu] Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal 576104, Karnataka, India.
   [Faruq, Muhammed; Joshi, Aditi] CSIR Inst Genom & Integrat Biol, New Delhi 110007, India.
C3 National Institute of Mental Health & Neurosciences - India; National
   Institute of Mental Health & Neurosciences - India; Manipal Academy of
   Higher Education (MAHE); Council of Scientific & Industrial Research
   (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology
   (IGIB)
RP Narayanappa, G (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bengaluru 560029, Karnataka, India.
EM rashuj21@gmail.com; prthshkumar@gmail.com; kinnudreamz@gmail.com;
   dineshgene89@gmail.com; simachaudhari88@gmail.co;
   ksatyamoorthy@manipal.edu; seenavengalil@gmail.com;
   nandanashi@gmail.com; faruq.mohd@igib.in; joshi.aditi21@gmail.com;
   atchayaramnalini@yahoo.co.in; gayathri.narayanappa@gmail.com
RI Preethish-Kumar, Veeramani/KLE-2419-2024; Nalini,
   Atchayaram/AAT-2469-2021; Satyamoorthy, Kapaettu/KIJ-2967-2024
OI Nashi, Saraswati/0000-0002-3184-2345; Preethish-Kumar,
   Veeramani/0000-0003-1158-0971; Nalini, Atchayaram/0000-0001-9791-3639;
   SANTHOSHKUMAR, RASHMI/0000-0002-4964-438X
FU Department of Science and Technology [DST], Govt. of India
   [SO/HS-103/2009/1(G)]
FX Financial assistance was received from Department of Science and
   Technology [DSTRef No. F. NO.SR/SO/HS-103/2009/1(G) dated -8th Sept
   2011], Govt. of India.
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6
   Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033
   Henderson M, 2013, ACTA NEUROPATHOL, V125, P917, DOI 10.1007/s00401-013-1113-x
   Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Muñoz-Mármol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312
   Nalini A, 2013, NEUROL INDIA, V61, P622, DOI 10.4103/0028-3886.125269
   Oldfors A, 2013, MUSCLE BIOPSYA PRACI
   Renjini R, 2012, INDIAN J MED RES, V135, P878
   Sunitha B, 2016, J NEUROCHEM, V138, P174, DOI 10.1111/jnc.13626
   Thangaraj K, 2002, J ANDROL, V23, P815
   van Spaendonck-Zwarts KY, 2011, CLIN GENET, V80, P354, DOI 10.1111/j.1399-0004.2010.01512.x
   Vincent AE, 2016, NEUROMUSCULAR DISORD, V26, P691, DOI 10.1016/j.nmd.2016.08.004
NR 16
TC 6
Z9 6
U1 0
U2 2
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0895-8696
EI 1559-1166
J9 J MOL NEUROSCI
JI J. Mol. Neurosci.
PD DEC
PY 2021
VL 71
IS 12
BP 2468
EP 2473
DI 10.1007/s12031-021-01856-0
EA JUN 2021
PG 6
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA XA2BJ
UT WOS:000659399000003
PM 34106405
DA 2024-11-01
ER

PT J
AU Daniels, EG
   Alders, M
   Lezzerini, M
   McDonald, A
   Peters, M
   Kuijpers, TW
   Lakeman, P
   Houtkooper, RH
   MacInnes, AW
AF Daniels, Eileen G.
   Alders, Marielle
   Lezzerini, Marco
   McDonald, Andrew
   Peters, Marjolein
   Kuijpers, Taco W.
   Lakeman, Phillis
   Houtkooper, Riekelt H.
   MacInnes, Alyson W.
TI A uniparental isodisomy event introducing homozygous pathogenic variants
   drives a multisystem metabolic disorder
SO COLD SPRING HARBOR MOLECULAR CASE STUDIES
LA English
DT Article
ID SIDEROBLASTIC ANEMIA-MLASA; MITOCHONDRIAL MYOPATHY; LACTIC-ACIDOSIS;
   MISSENSE MUTATION; P53; DISOMY; PHOSPHOFRUCTOKINASE; SUSCEPTIBILITY;
   CELLS; GENE
AB Uniparental isodisomy (UPiD) is a rare genetic event that occurs when two identical copies of a single chromosome are inherited from one parent. Here we report a patient with a severe, multisystem metabolic disorder who inherited two copies of Chromosome 12 from her father. He was a heterozygous carrier of a variant in the muscle-specific enzyme 6-phosphofructokinase (PFKM) gene and of a truncating variant in the pseudouridine synthase 1 (PUS1) gene (both on Chromosome 12), resulting in a homozygous state of these mutations in his daughter. The PFKM gene functions in glycolysis and is linked to Tarui syndrome. The PUS1 gene functions in mitochondrial tRNA processing and is linked to myopathy, lactic acidosis, and sideroblastic anemia (MLASA). Analysis of human dermal fibroblasts, which do not express PFKM, revealed a loss of PUS1 mRNA and PUS1 protein only in the patient cells compared to healthy controls. The patient cells also revealed a reduction of the mitochondrial-encoded protein MTCO1, whereas levels of the nuclear-encoded SDHA remained unchanged, suggesting a specific impairment of mitochondrial translation. Further destabilization of these cells is suggested by the altered levels of BAX, BCL-2, and TP53 proteins, alterations that become augmented upon exposure of the cells to DNA damage. The results illustrate the efficacy of UPiD events to reveal rare pathogenic variants in human disease and demonstrate how these events can lead to cellular destabilization.
C1 [Daniels, Eileen G.; Lezzerini, Marco; McDonald, Andrew; Houtkooper, Riekelt H.; MacInnes, Alyson W.] Univ Amsterdam, Emma Childrens Hosp, Amsterdam Gastroenterol & Metab, Lab Genet Metab Dis,Amsterdam UMC, NL-1105 AZ Amsterdam, Netherlands.
   [Alders, Marielle; Lakeman, Phillis] Univ Amsterdam, Emma Childrens Hosp, Amsterdam UMC, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands.
   [Peters, Marjolein] Univ Amsterdam, Emma Childrens Hosp, Amsterdam UMC, Dept Pediat Hematol, NL-1105 AZ Amsterdam, Netherlands.
   [Kuijpers, Taco W.] Univ Amsterdam, Emma Childrens Hosp, Amsterdam UMC, Dept Pediat Hematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands.
   [MacInnes, Alyson W.] Philips Res, Dept Precis Diagnost, NL-5656 AE Eindhoven, Netherlands.
C3 University of Amsterdam; Emma Children's Hospital; University of
   Amsterdam; Emma Children's Hospital; University of Amsterdam; Emma
   Children's Hospital; Emma Children's Hospital; University of Amsterdam;
   Philips; Philips Research
RP MacInnes, AW (corresponding author), Univ Amsterdam, Emma Childrens Hosp, Amsterdam Gastroenterol & Metab, Lab Genet Metab Dis,Amsterdam UMC, NL-1105 AZ Amsterdam, Netherlands.; MacInnes, AW (corresponding author), Philips Res, Dept Precis Diagnost, NL-5656 AE Eindhoven, Netherlands.
EM alyson.macinnes@philips.com
RI Houtkooper, Riekelt/P-5001-2019
OI Houtkooper, Riekelt/0000-0001-9961-0842
FU European Research Council (ERC) [638290]; Vidi grant from ZonMw
   [91715305]; Velux Stiftung [1063]; E-Rare-2, ERA-Net for Research on
   Rare Diseases ZonMw in the Netherlands [40-44000-98-1008]
FX R.H.H. is supported by a European Research Council (ERC) Starting grant
   (no. 638290), a Vidi grant from ZonMw (no. 91715305), and a grant from
   the Velux Stiftung (#1063). A.W.M. is supported under the frame of
   E-Rare-2, ERA-Net for Research on Rare Diseases ZonMw #40-44000-98-1008
   in the Netherlands.
CR Badhai J, 2009, BBA-MOL BASIS DIS, V1792, P1036, DOI 10.1016/j.bbadis.2009.08.002
   Balbeur S, 2016, CLIN CASE REP, V4, P265, DOI 10.1002/ccr3.501
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Campagnoli MF, 2008, HUM MUTAT, V29, P911, DOI 10.1002/humu.20752
   Cao M, 2016, NEUROGENETICS, V17, P65, DOI 10.1007/s10048-015-0465-x
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290
   Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Fleming MD, 2011, HEMATOL-AM SOC HEMAT, P525, DOI 10.1182/asheducation-2011.1.525
   Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137
   INBAL A, 1995, AM J MED GENET, V55, P372, DOI 10.1002/ajmg.1320550325
   Kasapkara CS, 2017, TURK J HEMATOL, V34, P376, DOI 10.4274/tjh.2017.0231
   King DA, 2014, GENOME RES, V24, P673, DOI 10.1101/gr.160465.113
   Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883
   Liehr T, 2019, CASES UNIPARENTAL DI
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   Metodiev MD, 2015, EUR J HUM GENET, V23, P880, DOI 10.1038/ejhg.2014.192
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Pereboeva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076473
   Perkins G, 2009, EXP NEUROL, V218, P183, DOI 10.1016/j.expneurol.2009.05.021
   RABEN N, 1995, HUM MUTAT, V6, P1, DOI 10.1002/humu.1380060102
   Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x
   Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Robinson WP, 2000, BIOESSAYS, V22, P452
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tesarova M, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27591
   Ulirsch JC, 2018, AM J HUM GENET, V103, P930, DOI 10.1016/j.ajhg.2018.10.027
   Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005
   VORA S, 1983, ISOZYMES-CURR T BIOL, V11, P3
   Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   Zhou LY, 2008, J CELL SCI, V121, P2186, DOI 10.1242/jcs.024703
   Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987
NR 39
TC 2
Z9 2
U1 0
U2 2
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 2373-2873
J9 CSH MOL CASE STUD
JI Cold Spring Harb. Mol. Case Stud.
PD DEC
PY 2019
VL 5
IS 6
AR a004457
DI 10.1101/mcs.a004457
PG 15
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA KJ8TM
UT WOS:000512328600007
PM 31653659
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Dombi, E
   Marinaki, T
   Spingardi, P
   Millar, V
   Hadjichristou, N
   Carver, J
   Johnston, IG
   Fratter, C
   Poulton, J
AF Dombi, Eszter
   Marinaki, Tony
   Spingardi, Paolo
   Millar, Val
   Hadjichristou, Nastasia
   Carver, Janet
   Johnston, Iain G.
   Fratter, Carl
   Poulton, Joanna
TI Nucleoside supplements as treatments for mitochondrial DNA depletion
   syndrome
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE mitochondrial DNA; mitochondrial DNA depletion syndrome; high-content
   imaging; nucleoside bypass therapy; heavy isotope labelling mass
   spectroscopy; alpers syndrome; POLG; TWNK
ID IN-VITRO SUPPLEMENTATION; THYMIDINE KINASE; DNTP POOLS; REPLICATION;
   DEFECTS; METABOLISM; THERAPY
AB Introduction: In mitochondrial DNA (mtDNA) depletion syndrome (MDS), patients cannot maintain sufficient mtDNA for their energy needs. MDS presentations range from infantile encephalopathy with hepatopathy (Alpers syndrome) to adult chronic progressive external ophthalmoplegia. Most are caused by nucleotide imbalance or by defects in the mtDNA replisome. There is currently no curative treatment available. Nucleoside therapy is a promising experimental treatment for TK2 deficiency, where patients are supplemented with exogenous deoxypyrimidines. We aimed to explore the benefits of nucleoside supplementation in POLG and TWNK deficient fibroblasts.Methods: We used high-content fluorescence microscopy with software-based image analysis to assay mtDNA content and membrane potential quantitatively, using vital dyes PicoGreen and MitoTracker Red CMXRos respectively. We tested the effect of 15 combinations (A, T, G, C, AT, AC, AG, CT, CG, GT, ATC, ATG, AGC, TGC, ATGC) of deoxynucleoside supplements on mtDNA content of fibroblasts derived from four patients with MDS (POLG1, POLG2, DGUOK, TWNK) in both a replicating (10% dialysed FCS) and quiescent (0.1% dialysed FCS) state. We used qPCR to measure mtDNA content of supplemented and non-supplemented fibroblasts following mtDNA depletion using 20 mu M ddC and after 14- and 21-day recovery in a quiescent state.Results: Nucleoside treatments at 200 mu M that significantly increased mtDNA content also significantly reduced the number of cells remaining in culture after 7 days of treatment, as well as mitochondrial membrane potential. These toxic effects were abolished by reducing the concentration of nucleosides to 50 mu M. In POLG1 and TWNK cells the combination of ATGC treatment increased mtDNA content the most after 7 days in non-replicating cells. ATGC nucleoside combination significantly increased the rate of mtDNA recovery in quiescent POLG1 cells following mtDNA depletion by ddC.Conclusion: High-content imaging enabled us to link mtDNA copy number with key read-outs linked to patient wellbeing. Elevated G increased mtDNA copy number but severely impaired fibroblast growth, potentially by inhibiting purine synthesis and/or causing replication stress. Combinations of nucleosides ATGC, T, or TC, benefited growth of cells harbouring POLG mutations. These combinations, one of which reflects a commercially available preparation, could be explored further for treatment of POLG patients.
C1 [Dombi, Eszter; Carver, Janet; Poulton, Joanna] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England.
   [Marinaki, Tony] Guys & St Thomas Hospitals, Dept Biochem Sci, Purine Res Lab, London, England.
   [Spingardi, Paolo] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Med, Med Sci Div, Oxford, England.
   [Millar, Val] Univ Oxford, Target Discovery Inst, Ctr Med Discovery, Nuffield Dept Med, Oxford, England.
   [Hadjichristou, Nastasia] Arch Makarios III Hosp, Dept Paediat, Nicosia, Cyprus.
   [Johnston, Iain G.] Univ Bergen, Dept Math, Bergen, Norway.
   [Johnston, Iain G.] Univ Bergen, Computat Biol Unit, Bergen, Norway.
   [Fratter, Carl] Oxford Univ Hosp NHS Fdn Trust, Oxford Genet Labs, Oxford, England.
C3 University of Oxford; Guy's & St Thomas' NHS Foundation Trust; Ludwig
   Institute for Cancer Research; University of Oxford; University of
   Oxford; University of Bergen; University of Bergen; Oxford University
   Hospitals NHS Foundation Trust
RP Poulton, J (corresponding author), Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England.
EM joanna.poulton@wrh.ox.ac.uk
FU Medical Research Council10.13039/501100000265
FX We thank the patients and their families and physicians for providing
   the cells, Professors David Fell and Karl Morten for encouragement, Dr
   Anneke Seller for comments on the MS, and Professor Krina Zondervan, and
   Skirmantas Kriaucionis for support. We thank Benedikt Kessler's team at
   the Target Discovery Institute, Centre for Medicines Discovery at the
   Nuffield Department of Medicine, University of Oxford, for expert help
   with the targeted nucleoside analysis by mass spectrometry. MS data is
   available on the online repository at
   https://github.com/StochasticBiology/mtdna-nucleosides.
CR Amtmann D, 2023, MITOCHONDRION, V68, P1, DOI 10.1016/j.mito.2022.10.003
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Batiuk TD, 2001, AM J PHYSIOL-CELL PH, V281, pC1776, DOI 10.1152/ajpcell.2001.281.6.C1776
   Blázquez-Bermejo C, 2019, FASEB J, V33, P7168, DOI 10.1096/fj.201801591R
   Bradshaw PC, 2005, AM J PHYSIOL-CELL PH, V288, pC989, DOI 10.1152/ajpcell.00530.2004
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Diot A, 2015, PHARMACOL RES, V100, P24, DOI 10.1016/j.phrs.2015.07.014
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Frölich S, 2020, CYTOM PART A, V97, P378, DOI 10.1002/cyto.a.23988
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   González-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   Hämäläinen RH, 2019, NAT METAB, V1, P958, DOI 10.1038/s42255-019-0120-1
   Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372
   KELLEY WN, 1975, ARTHRITIS RHEUM-US, V18, P673, DOI 10.1002/art.1780180706
   Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047
   Lodge T, 2017, NEUROMUSCULAR DISORD, V27, pS23
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mortiboys H., 2006, Influence of Mitochondrial Energy Metabolism on Cellular Function: Implications for Neurometabolic and Neurodegenerative Diseases
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Pai CC, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020057
   Pinheiro J, 2022, R package version 3.1-160,
   R Core Team, 2021, R LANG ENV STAT COMP
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Roy S, 2018, ELIFE, V7, DOI 10.7554/eLife.31723
   S K, 2021, R package version 0.9.1
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wickham H., 2016, ggplot2: Elegant Graphics for Data Analysis, DOI 10.1007/978-3-319-24277-4
   Wickham H B. J., 2023, R package version 1.4.2
NR 41
TC 1
Z9 1
U1 6
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD APR 2
PY 2024
VL 12
AR 1260496
DI 10.3389/fcell.2024.1260496
PG 17
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA OM4L6
UT WOS:001207676700001
PM 38665433
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Avital, G
   Buchshtav, M
   Zhidkov, I
   Tuval, J
   Dadon, S
   Rubin, E
   Glass, D
   Spector, TD
   Mishmar, D
AF Avital, Gal
   Buchshtav, Mor
   Zhidkov, Ilia
   Tuval (Feder), Jeanette
   Dadon, Sarah
   Rubin, Eitan
   Glass, Dan
   Spector, Timothy D.
   Mishmar, Dan
TI Mitochondrial DNA heteroplasmy in diabetes and normal adults: role of
   acquired and inherited mutational patterns in twins
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PATERNAL INHERITANCE; MTDNA MUTATION; ASSOCIATION; RESISTANCE;
   SELECTION; DISEASE; TOOL
AB Heteroplasmy, the mixture of mitochondrial genomes (mtDNA), varies among individuals and cells. Heteroplasmy levels alter the penetrance of pathological mtDNA mutations, and the susceptibility to age-related diseases such as Parkinsons disease. Although mitochondrial dysfunction occurs in age-related type 2 diabetes mellitus (T2DM), the involvement of heteroplasmy in diabetes is unclear. We hypothesized that the heteroplasmic mutational (HM) pattern may change in T2DM. To test this, we used next-generation sequencing, i.e. massive parallel sequencing (MPS), along with PCRcloningSanger sequencing to analyze HM in blood and skeletal muscle DNA samples from monozygotic (MZ) twins either concordant or discordant for T2DM. Great variability was identified in the repertoires and amounts of HMs among individuals, with a tendency towards more mutations in skeletal muscle than in blood. Whereas many HMs were unique, many were either shared among twin pairs or among tissues of the same individual, regardless of their prevalence. This suggested a heritable influence on even low abundance HMs. We found no clear differences between T2DM and controls. However, we found approximate to 5-fold increase of HMs in non-coding sequences implying the influence of negative selection (P 0.001). This negative selection was evident both in moderate to highly abundant heteroplasmy (5 of the molecules per sample) and in low abundance heteroplasmy (5 of the molecules). Although our study found no evidence supporting the involvement of HMs in the etiology of T2DM, the twin study found clear evidence of a heritable influence on the accumulation of HMs as well as the signatures of selection in heteroplasmic mutations.
C1 [Avital, Gal; Buchshtav, Mor; Zhidkov, Ilia; Tuval (Feder), Jeanette; Dadon, Sarah; Mishmar, Dan] Ben Gurion Univ Negev, Dept Life Sci, Fac Nat Sci, IL-84105 Beer Sheva, Israel.
   [Zhidkov, Ilia; Rubin, Eitan] Ben Gurion Univ Negev, NIBN, Fac Hlth Sci, IL-84105 Beer Sheva, Israel.
   [Rubin, Eitan] Ben Gurion Univ Negev, Dept Microbiol & Immunol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel.
   [Glass, Dan; Spector, Timothy D.] Kings Coll London, Div Genet & Mol Med, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England.
C3 Ben Gurion University; Ben Gurion University; Ben Gurion University;
   University of London; King's College London
RP Mishmar, D (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Bldg 40,Room 005, IL-84105 Beer Sheva, Israel.
EM dmishmar@bgu.ac.il
RI Spector, Tim/F-6533-2012; Mishmar, Dan/AAJ-6109-2020; Rubin,
   Eitan/E-5256-2011
OI Avital, Gal/0000-0001-6298-7152; Mishmar, Dan/0000-0003-3488-8792;
   Rubin, Eitan/0000-0002-7807-4005
FU Israeli Science Foundation [387/08]; National Institute of Biotechnology
   in the Negev (NIBN); Wellcome Trust; NIHR Biomedical Resource Centre;
   MRC
FX This work was funded by an Israeli Science Foundation grant 387/08 and a
   grant from the National Institute of Biotechnology in the Negev (NIBN)
   (D.M.). TwinsUK was funded by the Wellcome Trust and the NIHR Biomedical
   Resource Centre Grant to Guys and St Thomas' hospitals and KCL. D.G. was
   supported by the MRC.
CR Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Andrew T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022332
   Belle EMS, 2005, GENE, V355, P58, DOI 10.1016/j.gene.2005.05.019
   Budowle B, 2003, ANNU REV GENOM HUM G, V4, P119, DOI 10.1146/annurev.genom.4.070802.110352
   Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Clark J, 2011, PARKINSONS DIS, V2011, P659
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Craven L, 2011, HUM MOL GENET, V20, pR168, DOI 10.1093/hmg/ddr373
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Feder J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-60
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59
   Graur D, 2000, Fundamentals of Molecular Evolution, V2nd
   GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767
   Keller I, 2007, PLOS GENET, V3, P185, DOI 10.1371/journal.pgen.0030022
   Kloss-Brandstätter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lehtovirta M, 2010, DIABETOLOGIA, V53, P1314, DOI 10.1007/s00125-010-1746-4
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Lim S, 2001, MITOCHONDRION, V1, P71, DOI 10.1016/S1567-7249(01)00003-4
   Lutz-Bonengel S, 2008, INT J LEGAL MED, V122, P315, DOI 10.1007/s00414-008-0240-8
   Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Olsson C, 1998, HUM MUTAT, V12, P52, DOI 10.1002/(SICI)1098-1004(1998)12:1<52::AID-HUMU8>3.0.CO;2-K
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926
   Schwartz M, 2004, J NEUROL SCI, V218, P99, DOI 10.1016/j.jns.2003.11.008
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Wang CH, 2010, ANN NY ACAD SCI, V1201, P157, DOI 10.1111/j.1749-6632.2010.05625.x
   White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x
   Zhidkov I, 2011, MITOCHONDRION, V11, P924, DOI 10.1016/j.mito.2011.08.005
   Zhidkov I, 2009, GENOME RES, V19, P576, DOI 10.1101/gr.086462.108
NR 41
TC 69
Z9 76
U1 0
U2 16
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD OCT 1
PY 2012
VL 21
IS 19
BP 4214
EP 4224
DI 10.1093/hmg/dds245
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 007KV
UT WOS:000308888100007
PM 22736028
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Akhmedov, AT
   Marín-García, J
AF Akhmedov, Alexander T.
   Marin-Garcia, Jose
TI Mitochondrial DNA maintenance: an appraisal
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE CVD; mtDNA; Nucleoid; mtDNA replication; mtDNA repair
ID BASE-EXCISION-REPAIR; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   SINGLE-STRANDED-DNA; ROTHMUND-THOMSON-SYNDROME; TRANSCRIPTION FACTOR-A;
   HUMAN PIF1 HELICASE; STRUCTURE-FUNCTION DEFECTS; RECESSIVE TWINKLE
   MUTATIONS; POLYMERASE-GAMMA MUTATIONS; OXIDATIVELY DAMAGED DNA
AB Mitochondria play a crucial role in a variety of cellular processes ranging from energy metabolism, generation of reactive oxygen species (ROS), and Ca2+ handling to stress responses, cell survival, and death. Malfunction of the organelle may contribute to the pathogenesis of neuromuscular disorders, cancer, premature aging, and cardiovascular diseases, including myocardial ischemia, cardiomyopathy, and heart failure. Mitochondria are unique as they contain their own genome organized into DNA-protein complexes, so-called mitochondrial nucleoids, along with multiprotein machineries, which promote mitochondrial DNA (mtDNA) replication, transcription, and repair. Although the organelle possesses almost all known nuclear DNA repair pathways, including base excision repair, mismatch repair, and recombinational repair, the proximity of mtDNA to the main sites of ROS production and the lack of protective histones may result in increased susceptibility to oxidative stress and other types of mtDNA damage. Defects in the components of these highly organized machineries, which mediate mtDNA maintenance (replication and repair), may result in accumulation of point mutations and/or deletions in mtDNA and decreased mtDNA copy number impairing mitochondrial function. This review will focus on the mechanisms of mtDNA maintenance with emphasis on the proteins implicated in these processes and their functional role in various disease conditions and aging.
C1 [Akhmedov, Alexander T.; Marin-Garcia, Jose] Mol Cardiol & Neuromuscular Inst, Highland Pk, NJ 08904 USA.
RP Marín-García, J (corresponding author), Mol Cardiol & Neuromuscular Inst, 75 Raritan Ave, Highland Pk, NJ 08904 USA.
EM tmci@att.net
CR Aamann MD, 2010, FASEB J, V24, P2334, DOI 10.1096/fj.09-147991
   Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418
   Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641
   Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDERSON CTM, 1980, NUCLEIC ACIDS RES, V8, P875
   Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686
   Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4
   Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200
   Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609
   Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602
   Bochman ML, 2011, MOL BIOL CELL, V22, P1955, DOI 10.1091/mbc.E11-01-0045
   Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003
   Boulé JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200
   BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642
   Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5
   Burks LM, 2007, GENE, V391, P26, DOI 10.1016/j.gene.2006.11.019
   Cadenas S, 2010, CARDIOVASC RES, V88, P219, DOI 10.1093/cvr/cvq256
   Cadet Jean, 2011, Mutat Res, V711, P3, DOI 10.1016/j.mrfmmm.2011.02.004
   Cadet J, 2010, FREE RADICAL BIO MED, V49, P9, DOI 10.1016/j.freeradbiomed.2010.03.025
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Caradonna S, 1996, EXP CELL RES, V222, P345, DOI 10.1006/excr.1996.0044
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177
   Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712
   Chisholm KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030748
   Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682
   Clayton D A, 1975, Basic Life Sci, V5B, P589
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Cohen B.H., 2010, GENEREVIEWS GENETEST
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x
   Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169
   DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889
   De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025
   De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501
   de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004
   Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413
   Diray-Arce J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-36
   Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033
   Dodson ML, 2002, FREE RADICAL BIO MED, V32, P678, DOI 10.1016/S0891-5849(02)00767-0
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Duxin JP, 2012, J BIOL CHEM, V287, P21980, DOI 10.1074/jbc.M112.359018
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869
   Eki T, 1996, GENOMICS, V37, P408, DOI 10.1006/geno.1996.0581
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   FANNING E, 1992, ANNU REV BIOCHEM, V61, P55
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Farge G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2001
   Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FISHER RP, 1992, J BIOL CHEM, V267, P3358
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Freyer C, 2010, NUCLEIC ACIDS RES, V38, P6577, DOI 10.1093/nar/gkq527
   Fung H, 1998, CANCER RES, V58, P189
   Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002
   Futami K, 2007, BIOL PHARM BULL, V30, P1685, DOI 10.1248/bpb.30.1685
   Garcia CCM, 2010, CHEM RES TOXICOL, V23, P1245, DOI 10.1021/tx1001018
   Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301
   Garnier A, 2009, CIRC-HEART FAIL, V2, P342, DOI 10.1161/CIRCHEARTFAILURE.108.812099
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Gaston D, 2009, METHOD ENZYMOL, V457, P21, DOI 10.1016/S0076-6879(09)05002-2
   George T, 2009, NUCLEIC ACIDS RES, V37, P6491, DOI 10.1093/nar/gkp671
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213
   Gredilla R, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/282438
   Gu YQ, 2008, NUCLEIC ACIDS RES, V36, P6295, DOI 10.1093/nar/gkn609
   Gu YQ, 2013, PRION, V7, P341, DOI 10.4161/pri.26022
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HALLIWELL B, 1984, LANCET, V2, P1095
   Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359
   Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799
   Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200
   Huang Y, 2006, ACTA BIOCH BIOPH SIN, V38, P335, DOI 10.1111/j.1745-7270.2006.00165.x
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Huebscher Ulrich, 2009, V521, P19, DOI [10.1007/978-1-60327-815-7_2, 10.1007/978-1-60327-817-5_2]
   Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012
   Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033
   Ide H, 2004, BIOL PHARM BULL, V27, P480, DOI 10.1248/bpb.27.480
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106
   Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2
   Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233
   Kang YH, 2010, CRIT REV BIOCHEM MOL, V45, P71, DOI 10.3109/10409230903578593
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Karahalil B, 2003, J BIOL CHEM, V278, P33701, DOI 10.1074/jbc.M301617200
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005
   Kasiviswanathan R, 2012, J BIOL CHEM, V287, P9222, DOI 10.1074/jbc.M111.306852
   Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   KEIL RL, 1993, GENETICS, V135, P711
   Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005
   LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x
   Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880
   Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668
   Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1
   LeDoux SP, 1999, MUTAT RES-DNA REPAIR, V434, P149, DOI 10.1016/S0921-8777(99)00026-9
   LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967
   Lee KH, 2003, MOL CELLS, V15, P81
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2003, AM J PHYSIOL-HEART C, V284, pH1, DOI 10.1152/ajpheart.00814.2002
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Liu QQ, 2000, J BIOL CHEM, V275, P1615, DOI 10.1074/jbc.275.3.1615
   Lloyd DR, 2000, CANCER RES, V60, P517
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200
   Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005
   Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821
   Mandal SM, 2012, J BIOL CHEM, V287, P2819, DOI 10.1074/jbc.M111.272179
   Marin-Garcia J, 2000, J CHILD NEUROL, V15, P555, DOI 10.1177/088307380001500812
   Marin-Garcia J, 2001, CARDIOVASC RES, V49, P17, DOI 10.1016/S0008-6363(00)00241-8
   MarinGarcia J, 1997, J INHERIT METAB DIS, V20, P674, DOI 10.1023/A:1005322409330
   Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070
   Masuda-Sasa T, 2006, J BIOL CHEM, V281, P38555, DOI 10.1074/jbc.M604925200
   Mateyak MK, 2006, CELL CYCLE, V5, P2796, DOI 10.4161/cc.5.23.3524
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618
   Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269
   Nair J, 2011, METHODS MOL BIOL, V682, P189, DOI 10.1007/978-1-60327-409-8_14
   Nakamura J, 1999, CANCER RES, V59, P2522
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750
   NIRANJAN BG, 1982, SCIENCE, V215, P73, DOI 10.1126/science.6797067
   Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355
   OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598
   Olivero OA, 1997, MUTAT RES-GEN TOX EN, V391, P79, DOI 10.1016/S0165-1218(97)00037-2
   Osenbroch PO, 2009, FEBS J, V276, P2811, DOI 10.1111/j.1742-4658.2009.07004.x
   Ouyang KJ, 2008, MECH AGEING DEV, V129, P425, DOI 10.1016/j.mad.2008.03.003
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268
   Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Peng G, 2012, CANCER RES, V72, P2802, DOI 10.1158/0008-5472.CAN-11-3152
   Petkovic M, 2005, J CELL SCI, V118, P4261, DOI 10.1242/jcs.02556
   Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Pohjoismäki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   Pohjoismäki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137
   Pohjoismäki JLO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010426
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Roede JR, 2010, ENVIRON MOL MUTAGEN, V51, P380, DOI 10.1002/em.20553
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Rossi ML, 2010, DNA REPAIR, V9, P796, DOI 10.1016/j.dnarep.2010.04.003
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082
   Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Schurman SH, 2009, HUM MOL GENET, V18, P3470, DOI 10.1093/hmg/ddp291
   Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   Sharma NK, 2014, DNA REPAIR, V13, P22, DOI 10.1016/j.dnarep.2013.11.002
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F
   Singh DK, 2012, MUTAT RES-FUND MOL M, V736, P15, DOI 10.1016/j.mrfmmm.2011.06.002
   Singh DK, 2010, AGING CELL, V9, P358, DOI 10.1111/j.1474-9726.2010.00562.x
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Stierum RH, 1999, J BIOL CHEM, V274, P7128, DOI 10.1074/jbc.274.11.7128
   Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Suzuki T, 2009, J BIOCHEM, V146, P327, DOI 10.1093/jb/mvp074
   Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466
   Swenberg JA, 2008, CHEM RES TOXICOL, V21, P253, DOI 10.1021/tx700408t
   Sykora P, 2012, MECH AGEING DEV, V133, P169, DOI 10.1016/j.mad.2011.11.003
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Szczesny RJ, 2013, BBA-GENE REGUL MECH, V1829, P842, DOI 10.1016/j.bbagrm.2013.02.009
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Taghizadeh K, 2008, NAT PROTOC, V3, P1287, DOI 10.1038/nprot.2008.119
   Tahbaz N, 2012, NUCLEIC ACIDS RES, V40, P3484, DOI 10.1093/nar/gkr1245
   Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099
   Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917
   Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067642
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09
   Thorslund T, 2002, DNA REPAIR, V1, P261, DOI 10.1016/S1568-7864(02)00003-4
   Tomkinson AE, 2013, GENE, V531, P150, DOI 10.1016/j.gene.2013.08.061
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Vaisman A, 1999, BIOCHEMISTRY-US, V38, P11026, DOI 10.1021/bi9909187
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5
   Wilson TM, 1996, MUTAT RES-DNA REPAIR, V362, P237, DOI 10.1016/0921-8777(95)00053-4
   Wong LJC, 2010, DEV DISABIL RES REV, V16, P154, DOI 10.1002/ddrr.104
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Woo LL, 2006, EXP CELL RES, V312, P3443, DOI 10.1016/j.yexcr.2006.07.023
   Wu Y, 2012, J NUCL ACIDS, V2012, DOI DOI 10.1155/2012/140601
   Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235
   Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843
   Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153
   Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z
   Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269
   Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 310
TC 59
Z9 63
U1 0
U2 31
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD NOV
PY 2015
VL 409
IS 1-2
BP 283
EP 305
DI 10.1007/s11010-015-2532-x
PG 23
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA CS4IX
UT WOS:000362040600027
PM 26286847
DA 2024-11-01
ER

PT J
AU Baruffini, E
   Serafini, F
   Ferrero, I
   Lodi, T
AF Baruffini, Enrico
   Serafini, Fausta
   Ferrero, Iliana
   Lodi, Tiziana
TI Overexpression of DNA Polymerase Zeta Reduces the Mitochondrial
   Mutability Caused by Pathological Mutations in DNA Polymerase Gamma in
   Yeast
SO PLOS ONE
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COLI SHUTTLE VECTORS; LARGE
   RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; INDUCED MUTAGENESIS; REV1
   PROTEIN; RESISTANCE MUTATIONS; DEPLETION SYNDROMES; COMPLEX-FORMATION;
   GENE-EXPRESSION
AB In yeast, DNA polymerase zeta (Rev3 and Rev7) and Rev1, involved in the error-prone translesion synthesis during replication of nuclear DNA, localize also in mitochondria. We show that overexpression of Rev3 reduced the mtDNA extended mutability caused by a subclass of pathological mutations in Mip1, the yeast mitochondrial DNA polymerase orthologous to human Pol gamma. This beneficial effect was synergistic with the effect achieved by increasing the dNTPs pools. Since overexpression of Rev3 is detrimental for nuclear DNA mutability, we constructed a mutant Rev3 isoform unable to migrate into the nucleus: its overexpression reduced mtDNA mutability without increasing the nuclear one.
C1 [Baruffini, Enrico; Serafini, Fausta; Ferrero, Iliana; Lodi, Tiziana] Univ Parma, Dept Genet, I-43100 Parma, Italy.
C3 University of Parma
RP Baruffini, E (corresponding author), Univ Parma, Dept Genet, I-43100 Parma, Italy.
EM enrico.baruffini@nemo.unipr.it
RI Lodi, Tiziana/A-5993-2012; Baruffini, Enrico/C-1057-2015
OI Lodi, Tiziana/0000-0002-7294-8971; Baruffini, Enrico/0000-0002-8280-7849
FU Fondazione Telethon-Italy [GGP07019]
FX This work was supported by the Fondazione Telethon-Italy [GGP07019],
   http://www.telethon.it/. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005
   Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06
   Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Ausubel FM., 1994, Curr. Protoc. Mol. Biol
   Baruffini E, 2007, BIOCHIM BIOPHYS ACTA, V1772, P225
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   Baruffini E, 2009, J BIOTECHNOL, V143, P247, DOI 10.1016/j.jbiotec.2009.08.007
   BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   CHIT NW, 1994, J BIOL CHEM, V269, P29993
   CODON AC, 1995, APPL ENVIRON MICROB, V61, P630
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   CUI Z, 1989, CURR GENET, V16, P273, DOI 10.1007/BF00422114
   de Padula M, 2004, NUCLEIC ACIDS RES, V32, P5003, DOI 10.1093/nar/gkh831
   DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841
   Dujon B., 1981, MOL BIOL YEAST SACCH, P505
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Gibson BR, 2008, LETT APPL MICROBIOL, V46, P636, DOI 10.1111/j.1472-765X.2008.02360.x
   Gietz R Daniel, 2006, Methods Mol Biol, V313, P107
   GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0
   Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253
   Haracska L, 2003, MOL CELL BIOL, V23, P1453, DOI 10.1128/MCB.23.4.1453-1459.2003
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Huang ME, 2002, GENETICS, V160, P1409
   Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026
   Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030
   Kaiser C, 1994, METHODS YEAST GENETI
   Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005
   Kaniak A, 2009, DNA REPAIR, V8, P318, DOI 10.1016/j.dnarep.2008.11.004
   Kasiviswanathan R, 2011, J BIOL CHEM, DOI [10.1074/jbc.M111.306852jbc.M111.306852, DOI 10.1074/JBC.M111.306852JBC.M111.306852]
   KUENZI MT, 1974, J BACTERIOL, V117, P80
   Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167
   Lawrence CW, 1996, CANCER SURV, V28, P21
   Lawrence CW, 2000, COLD SPRING HARB SYM, V65, P61, DOI 10.1101/sqb.2000.65.61
   LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080
   Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Lee JC, 2001, FEMS YEAST RES, V1, P57
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001
   Mieczkowski PA, 1997, MOL GEN GENET, V253, P655, DOI 10.1007/s004380050369
   Mookerjee SA, 2006, MUTAT RES-FUND MOL M, V595, P91, DOI 10.1016/j.mrfmmm.2005.10.006
   MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989
   Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0
   Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646
   Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482
   PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Rajpal DK, 2000, MUTAT RES-DNA REPAIR, V461, P133, DOI 10.1016/S0921-8777(00)00047-1
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Sembongi H, 2007, HUM MOL GENET, V16, P2306, DOI 10.1093/hmg/ddm182
   Sherman F., 1986, LAB COURSE MANUAL ME
   Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71
   SINGHAL RK, 1992, MOL GEN GENET, V236, P17, DOI 10.1007/BF00279638
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   SOR F, 1982, NUCLEIC ACIDS RES, V10, P6571, DOI 10.1093/nar/10.21.6571
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053
   THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   Zhang HS, 2006, GENETICS, V172, P2683, DOI 10.1534/genetics.105.051029
   Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4
NR 81
TC 19
Z9 20
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 28
PY 2012
VL 7
IS 3
AR e34322
DI 10.1371/journal.pone.0034322
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 948FM
UT WOS:000304489000096
PM 22470557
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Mazurova, S
   Magner, M
   Kucerova-Vidrova, V
   Vondrackova, A
   Stranecky, V
   Pristoupilova, A
   Zamecnik, J
   Hansikova, H
   Zeman, J
   Tesarova, M
   Honzik, T
AF Mazurova, Stella
   Magner, Martin
   Kucerova-Vidrova, Vendula
   Vondrackova, Alzbeta
   Stranecky, Viktor
   Pristoupilova, Anna
   Zamecnik, Josef
   Hansikova, Hana
   Zeman, Jiri
   Tesarova, Marketa
   Honzik, Tomas
TI Thymidine kinase 2 and alanyl-tRNA synthetase 2 deficiencies cause
   lethal mitochondrial cardiomyopathy: case reports and review of the
   literature
SO CARDIOLOGY IN THE YOUNG
LA English
DT Article
DE Alanyl-tRNA synthetase 2; thymidine kinase 2; mitochondrial
   cardiomyopathy; ragged red fibres; leucoencephalopathy
ID RESPIRATORY-CHAIN DEFICIENCIES; DNA DEPLETION SYNDROMES; TK2 GENE;
   CARDIAC MANIFESTATIONS; CLINICAL SPECTRUM; MYOPATHIC FORM;
   HUMAN-DISEASE; MUTATIONS; DEFECTS; ONSET
AB Cardiomyopathy is a common manifestation in neonates and infants with mitochondrial disorders. In this study, we report two cases manifesting with fatal mitochondrial hypertrophic cardiomyopathy, which include the third known patient with thymidine kinase 2 deficiency and the ninth patient with alanyl-tRNA synthetase 2 deficiency. The girl with thymidine kinase 2 deficiency had hypertrophic cardiomyopathy together with regression of gross motor development at the age of 13 months. Neurological symptoms and cardiac involvement progressed into severe myopathy, psychomotor arrest, and cardiorespiratory failure at the age of 22 months. The imaging methods and autoptic studies proved that she suffered from unique findings of leucoencephalopathy, severe, mainly cerebellar neuronal degeneration, and hepatic steatosis. The girl with alanyl-tRNA synthetase 2 deficiency presented with cardiac failure and underlying hypertrophic cardiomyopathy within 12 hours of life and subsequently died at 9 weeks of age. Muscle biopsy analyses demonstrated respiratory chain complex I and IV deficiencies, and histological evaluation revealed massive mitochondrial accumulation and cytochrome c oxidase-negative fibres in both cases. Exome sequencing in the first case revealed compound heterozygozity for one novel c.209T>C and one previously published c.416C>T mutation in the TK2 gene, whereas in the second case homozygozity for the previously described mutation c.1774C>T in the AARS2 gene was determined. The thymidine kinase 2 mutations resulted in severe mitochondrial DNA depletion (to 12% of controls) in the muscle. We present, for the first time, severe leucoencephalopathy and hepatic steatosis in a patient with thymidine kinase 2 deficiency and the finding of a ragged red fibre-like image in the muscle biopsy in a patient with alanyl-tRNA synthetase 2 deficiency.
C1 [Mazurova, Stella; Magner, Martin; Kucerova-Vidrova, Vendula; Vondrackova, Alzbeta; Hansikova, Hana; Zeman, Jiri; Tesarova, Marketa; Honzik, Tomas] Charles Univ Prague, Med Fac 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Stranecky, Viktor; Pristoupilova, Anna] Charles Univ Prague, Med Fac 1, Inst Inherited Metab Disorders, Prague, Czech Republic.
   Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Zamecnik, Josef] Charles Univ Prague, Dept Pathol & Mol Med, Med Fac 2, Prague, Czech Republic.
   [Zamecnik, Josef] Univ Hosp Motol Prague, Prague, Czech Republic.
C3 Charles University Prague; Charles University Prague; General University
   Hospital Prague; Charles University Prague; Charles University Prague;
   Motol University Hospital
RP Honzik, T (corresponding author), Charles Univ Prague, Med Fac 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Honzik, T (corresponding author), Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM tomas.honzik@vfn.cz
RI Hansikova, Hana/E-9350-2017; Stranecky, Viktor/I-8524-2017;
   Pristoupilova, Anna/F-4990-2017; Kucerova Vidrova, Vendula/G-7161-2017;
   Honzik, Tomas/N-7509-2017; Vondrackova, Alzbeta/I-9534-2017; Magner,
   Martin/J-3553-2017; Tesarova, Marketa/I-1531-2016; Zeman,
   Jiri/K-2691-2017
OI Stranecky, Viktor/0000-0002-2599-6479; Pristoupilova,
   Anna/0000-0003-0047-9405; Kucerova Vidrova, Vendula/0000-0001-9046-1123;
   Honzik, Tomas/0000-0003-4300-2519; Vondrackova,
   Alzbeta/0000-0003-0954-703X; Magner, Martin/0000-0002-5883-9509;
   Tesarova, Marketa/0000-0002-5141-2289; Zeman, Jiri/0000-0002-2678-7919;
   Reichmannova, Stella/0000-0002-3719-8650; Zeman,
   Jiri/0000-0003-3336-7872
FU Charles University; General University Hospital in Prague
   [PRVOUK-P24/LF1/3, RVO-VFN 64165, SVV 260256/2016, UNCE 204011]; Grant
   Agency of the Czech Republic [GAUK 1402213, 14-36804G]; Ministry of
   Education of the Czech Republic [LQ1604 NPU II, LM2015091]; Ministry of
   Health of the Czech Republic [15-28208A]
FX This study was supported by grants and by institutional research support
   from Charles University and General University Hospital in Prague
   PRVOUK-P24/LF1/3 (TH, MM), RVO-VFN 64165 (VKV, HH, JZ), SVV 260256/2016
   (SM, AP), UNCE 204011 (AV), by grants GAUK 1402213 (AP), 14-36804G (MT,
   VS) from the Grant Agency of the Czech Republic, by the project LQ1604
   NPU II and LM2015091 (VS) from the Ministry of Education of the Czech
   Republic and by 15-28208A (VS) from the Ministry of Health of the Czech
   Republic.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Alston C, 2015, HUM GENET, V134, P869, DOI 10.1007/s00439-015-1568-z
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   Brisca G, 2015, BIOCHEM BIOPH RES CO, V458, P601, DOI 10.1016/j.bbrc.2015.01.157
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Chung WK, 2015, J MED GENET, V52, P627, DOI 10.1136/jmedgenet-2015-103140
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   Darley-Usmar VM, 1987, MITOCHONDRIA PRACTIC, Vxvi
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Euro L, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00021
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Haack TB, 2015, ANN CLIN TRANSL NEUR, V2, P492, DOI 10.1002/acn3.189
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Honzík T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096
   Knierim E, 2015, MITOCHONDRION, V20, P1, DOI 10.1016/j.mito.2014.10.007
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lax NZ, 2015, J NEUROPATH EXP NEUR, V74, P688, DOI 10.1097/NEN.0000000000000209
   Magner M, 2015, J INHERIT METAB DIS, V38, P417, DOI 10.1007/s10545-014-9774-8
   Magner M, 2011, EUR J PAEDIATR NEURO, V15, P101, DOI 10.1016/j.ejpn.2010.10.001
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Mazurova S, 2013, Prague Med Rep, V114, P139
   McLaughlin HM, 2012, HUM MUTAT, V33, P244, DOI 10.1002/humu.21635
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Pejznochová M, 2008, PHYSIOL RES, V57, P947, DOI 10.33549/physiolres.931246
   Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Sheehan DC, 1987, THEORY PRACTICE HIST, Vxiii
   Shehata BM, 2015, AM J MED GENET A, V167, P2114, DOI 10.1002/ajmg.a.37138
   Sokabe M, 2009, P NATL ACAD SCI USA, V106, P11028, DOI 10.1073/pnas.0904645106
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   SRERE PA, 1969, ARCH BIOCHEM BIOPHYS, V129, P708, DOI 10.1016/0003-9861(69)90231-8
   Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4
   Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047
   Zhao Z, 2012, NEUROLOGY, V78, P1644, DOI 10.1212/WNL.0b013e3182574f8f
NR 53
TC 25
Z9 27
U1 0
U2 10
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1047-9511
EI 1467-1107
J9 CARDIOL YOUNG
JI Cardiol. Young
PD JUL
PY 2017
VL 27
IS 5
BP 936
EP 944
DI 10.1017/S1047951116001876
PG 9
WC Cardiac & Cardiovascular Systems; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Pediatrics
GA EW3OH
UT WOS:000402408300016
PM 27839525
DA 2024-11-01
ER

PT J
AU Vandiver, AR
   Hoang, AN
   Herbst, A
   Lee, CC
   Aiken, JM
   McKenzie, D
   Teitell, MA
   Timp, W
   Wanagat, J
AF Vandiver, Amy R.
   Hoang, Austin N.
   Herbst, Allen
   Lee, Cathy C.
   Aiken, Judd M.
   McKenzie, Debbie
   Teitell, Michael A.
   Timp, Winston
   Wanagat, Jonathan
TI Nanopore sequencing identifies a higher frequency and expanded spectrum
   of mitochondrial DNA deletion mutations in human aging
SO AGING CELL
LA English
DT Article
DE aging; DNA sequencing; human; mitochondrial DNA; skeletal muscle;
   substantia nigra
ID HUMAN SKELETAL-MUSCLE; AGE; REGIONS; GENOME
AB Mitochondrial DNA (mtDNA) deletion mutations cause many human diseases and are linked to age-induced mitochondrial dysfunction. Mapping the mutation spectrum and quantifying mtDNA deletion mutation frequency is challenging with next-generation sequencing methods. We hypothesized that long-read sequencing of human mtDNA across the lifespan would detect a broader spectrum of mtDNA rearrangements and provide a more accurate measurement of their frequency. We employed nanopore Cas9-targeted sequencing (nCATS) to map and quantitate mtDNA deletion mutations and develop analyses that are fit-for-purpose. We analyzed total DNA from vastus lateralis muscle in 15 males ranging from 20 to 81 years of age and substantia nigra from three 20-year-old and three 79-year-old men. We found that mtDNA deletion mutations detected by nCATS increased exponentially with age and mapped to a wider region of the mitochondrial genome than previously reported. Using simulated data, we observed that large deletions are often reported as chimeric alignments. To address this, we developed two algorithms for deletion identification which yield consistent deletion mapping and identify both previously reported and novel mtDNA deletion breakpoints. The identified mtDNA deletion frequency measured by nCATS correlates strongly with chronological age and predicts the deletion frequency as measured by digital PCR approaches. In substantia nigra, we observed a similar frequency of age-related mtDNA deletions to those observed in muscle samples, but noted a distinct spectrum of deletion breakpoints. NCATS-mtDNA sequencing allows the identification of mtDNA deletions on a single-molecule level, characterizing the strong relationship between mtDNA deletion frequency and chronological aging.
C1 [Vandiver, Amy R.] UCLA, Dept Med, Div Dermatol, Los Angeles, CA USA.
   [Vandiver, Amy R.; Lee, Cathy C.; Wanagat, Jonathan] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Hoang, Austin N.; Lee, Cathy C.; Wanagat, Jonathan] UCLA, Dept Med, Div Geriatr, Los Angeles, CA USA.
   [Herbst, Allen] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA.
   [Aiken, Judd M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.
   [Teitell, Michael A.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA USA.
   [Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA.
   [Teitell, Michael A.] Univ Calif Los Angeles, Dept Bioengn, Calif NanoSyst Inst, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA USA.
   [Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA USA.
   [Teitell, Michael A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, David Geffen Sch Med, Los Angeles, CA USA.
   [Timp, Winston] Johns Hopkins Univ, Dept Mol Biol & Genet, Sch Med, Baltimore, MD USA.
   [Timp, Winston] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA.
   [Timp, Winston] Johns Hopkins Univ, Dept Genet Med, Sch Med, Baltimore, MD USA.
   [Wanagat, Jonathan] Univ Calif Los Angeles, Dept Med, Div Geriatr, 650 Charles E Young Dr South,RM 34-115, Los Angeles, CA 90095 USA.
C3 University of California System; University of California Los Angeles;
   US Department of Veterans Affairs; Veterans Health Administration (VHA);
   VA Greater Los Angeles Healthcare System; University of California
   System; University of California Los Angeles; United States Department
   of the Interior; United States Geological Survey; University of Alberta;
   University of Alberta; University of California System; University of
   California Los Angeles; University of California System; University of
   California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA; University of
   California System; University of California Los Angeles; University of
   California System; University of California Los Angeles; University of
   California Los Angeles Medical Center; David Geffen School of Medicine
   at UCLA; University of California System; University of California Los
   Angeles; University of California Los Angeles Medical Center; David
   Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer
   Center; Johns Hopkins University; Johns Hopkins University; Johns
   Hopkins University; University of California System; University of
   California Los Angeles
RP Wanagat, J (corresponding author), Univ Calif Los Angeles, Dept Med, Div Geriatr, 650 Charles E Young Dr South,RM 34-115, Los Angeles, CA 90095 USA.
EM jwanagat@mednet.ucla.edu
RI Wanagat, Jonathan/B-2856-2009; Timp, Winston/B-5215-2008
OI Wanagat, Jonathan/0000-0002-8460-8616; Vandiver,
   Amy/0000-0003-2176-9161; Aiken, Judd/0000-0001-6119-4521
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases
   [T32 AR071307]; National Institute on Aging [K02AG059847, R01AG055518,
   R01AG069924, R56AG060880]; Dermatology Foundation
FX National Institute of Arthritis and Musculoskeletal and Skin Diseases,
   Grant/Award Number: T32 AR071307; National Institute on Aging,
   Grant/Award Number: K02AG059847, R01AG055518, R01AG069924 and
   R56AG060880; The Dermatology Foundation
CR Albayrak L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3375-x
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Basu S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009242
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1821-7
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Cheema N, 2015, AGING CELL, V14, P1085, DOI 10.1111/acel.12399
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982
   Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038
   Devall M, 2015, BIOTECHNIQUES, V59, P241, DOI 10.2144/000114343
   Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2<107::AID-DVG3>3.0.CO;2-D
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Gilpatrick T, 2020, NAT BIOTECHNOL, V38, P433, DOI 10.1038/s41587-020-0407-5
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Herbst A, 2021, GEROSCIENCE, V43, P1253, DOI 10.1007/s11357-021-00351-z
   Herbst A, 2021, AGING CLIN EXP RES, V33, P1811, DOI 10.1007/s40520-020-01698-7
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Keraite I, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-33530-3
   Lawless C, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200061
   Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118
   Lee Cathy C, 2020, J Cytol Histol, V11, DOI 10.37421/jch.2020.11.553
   LEE CM, 1994, MECH AGEING DEV, V75, P69, DOI 10.1016/0047-6374(94)90029-9
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Lott MT., 2013, Curr Protoc Bioinf, V44, P1231, DOI DOI 10.1002/0471250953.BI0123S44
   Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sanchez-Contreras M, 2022, FRONT AGING-LAUSANNE, V2, DOI 10.3389/fragi.2021.805126
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Vandiver AR, 2022, MITOCHONDRION, V65, P176, DOI 10.1016/j.mito.2022.06.003
   Wei W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15336-3
   Weissensteiner H, 2021, GENOME RES, V31, P309, DOI 10.1101/gr.256545.119
   Wheeler Joel H, 2019, Curr Protoc Toxicol, V80, pe75, DOI 10.1002/cptx.75
   Yang C, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix010
   Yao Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53449-y
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 39
TC 8
Z9 8
U1 3
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD JUN
PY 2023
VL 22
IS 6
DI 10.1111/acel.13842
EA MAY 2023
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA I9NV0
UT WOS:000981568100001
PM 37132288
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Payne, BA
   Gardner, K
   Chinnery, PF
AF Payne, Brendan Ai
   Gardner, Kristian
   Chinnery, Patrick F.
TI Mitochondrial DNA mutations in ageing and disease: implications for HIV?
SO ANTIVIRAL THERAPY
LA English
DT Review
ID REVERSE-TRANSCRIPTASE INHIBITORS; HUMAN SKELETAL-MUSCLE; MTDNA
   CONTROL-REGION; ACTIVE ANTIRETROVIRAL THERAPY; CYTOCHROME-C-OXIDASE;
   INFECTED PATIENTS; ALZHEIMERS-DISEASE; NUCLEOSIDE ANALOGS; OXIDATIVE
   DAMAGE; POLYMERASE-GAMMA
AB Mitochondrial DNA (mtDNA) mutations cause neurological and multisystem disease. Somatic (acquired) mtDNA mutations are also associated with degenerative diseases and with normal human ageing. It is well established that certain nucleoside reverse transcriptase inhibitor (NRTI) antiretroviral drugs cause inhibition of the mtDNA polymerase, pol gamma, leading to a reduction in mtDNA content (depletion). Given this effect of NRTI therapy on mtDNA replication, it is plausible that NRTI treatment may also lead to increased mtDNA mutations. Here we review recent evidence for an effect of HIV infection or NRTI therapy on mtDNA mutations, as well as discussing the methodological challenges in addressing this question. Finally, we discuss the possible implications for HIV-infected persons, with particular reference to ageing.
C1 [Payne, Brendan Ai; Gardner, Kristian; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK
RP Payne, BA (corresponding author), Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM Brendan.Payne@ncl.ac.uk
RI ; Payne, Brendan/I-1233-2016
OI Chinnery, Patrick/0000-0002-7065-6617; Payne,
   Brendan/0000-0002-3101-3512
FU Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical
   Research Council (UK) Centre for Translational Muscle Disease research
   [G0601943]; EU FP7 TIR-CON; National Institute for Health Research
   (NIHR) Newcastle Biomedical Research Centre based at Newcastle-upon-Tyne
   Hospitals NHS Foundation Trust; Newcastle University; Medical Research
   Council, UK [G0800470]; AstraZeneca; MRC [G0800470, MR/K000608/1,
   G0601943] Funding Source: UKRI
FX PFC is a Wellcome Trust Senior Fellow in Clinical Science
   (101876/Z/13/Z) and a UK NIHR Senior Investigator. PFC receives
   additional support from the Wellcome Trust Centre for Mitochondrial
   Research (096919Z/11/Z), the Medical Research Council (UK) Centre for
   Translational Muscle Disease research (G0601943), and EU FP7 TIR-CON,
   and the National Institute for Health Research (NIHR) Newcastle
   Biomedical Research Centre based at Newcastle-upon-Tyne Hospitals NHS
   Foundation Trust and Newcastle University. The views expressed are those
   of the author(s) and not necessarily those of the NHS, the NIHR or the
   Department of Health. BAIP was funded by the Medical Research Council,
   UK (G0800470). KG is funded in part by AstraZeneca. The authors declare
   no competing interests.
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   [Anonymous], ANT THER HIV INF AD
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Balcarek K, 2010, JAIDS-J ACQ IMM DEF, V55, P550, DOI 10.1097/QAI.0b013e3181f25946
   Bartley PB, 2001, AIDS, V15, P419, DOI 10.1097/00002030-200102160-00018
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bilal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002421
   Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002
   BISSUEL F, 1994, J INTERN MED, V235, P367, DOI 10.1111/j.1365-2796.1994.tb01088.x
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buffet M, 2005, J CLIN VIROL, V33, P60, DOI 10.1016/j.jcv.2004.09.027
   Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28
   Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001
   Casademont J, 1996, BRAIN, V119, P1357, DOI 10.1093/brain/119.4.1357
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Chan SSL, 2007, ENVIRON MOL MUTAGEN, V48, P190, DOI 10.1002/em.20191
   Cherry CL, 2006, JAIDS-J ACQ IMM DEF, V42, P435, DOI 10.1097/01.qai.0000224974.67962.ce
   Cherry CL, 2002, J ACQ IMMUN DEF SYND, V30, P271, DOI [10.1097/00126334-200207010-00002, 10.1097/01.QAI.0000017962.22053.0E]
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chou JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064702
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Dalakas MC, 2001, LAB INVEST, V81, P1537, DOI 10.1038/labinvest.3780367
   de la Monte SM, 2000, LAB INVEST, V80, P1323, DOI 10.1038/labinvest.3780140
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Erlandson KM, 2013, JAIDS-J ACQ IMM DEF, V63, P209, DOI 10.1097/QAI.0b013e318289bb7e
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Guaraldi G, 2009, CLIN INFECT DIS, V49, P1756, DOI 10.1086/648080
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Haugaard SB, 2005, J MED VIROL, V77, P29, DOI 10.1002/jmv.20410
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   HELBERT M, 1988, LANCET, V2, P689
   Holt JL, 2012, J NEUROVIROL, V18, P291, DOI 10.1007/s13365-012-0114-1
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Jitratkosol MHJ, 2012, AIDS, V26, P675, DOI 10.1097/QAD.0b013e32835142eb
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lehmann HC, 2011, ANN NEUROL, V69, P100, DOI 10.1002/ana.22150
   Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057223
   Martin AM, 2003, AM J HUM GENET, V72, P549, DOI 10.1086/367849
   McComsey G, 2005, JAIDS-J ACQ IMM DEF, V39, P181
   McComsey GA, 2005, AIDS, V19, P15, DOI 10.1097/00002030-200501030-00002
   McComsey GA, 2010, AIDS, V24, P2503, DOI 10.1097/QAD.0b013e32833ea9bc
   Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miró O, 2003, ANTIVIR THER, V8, P333
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Nolan D, 2003, AIDS, V17, P1329, DOI 10.1097/00002030-200306130-00007
   Ortiz M, 2011, J INFECT DIS, V203, P620, DOI 10.1093/infdis/jiq106
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Rochira V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028512
   Rylova SN, 2005, BIOCHEM PHARMACOL, V69, P951, DOI 10.1016/j.bcp.2004.12.010
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Samuels DC, 2004, TRENDS GENET, V20, P226, DOI 10.1016/j.tig.2004.03.003
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Torres SM, 2009, ENVIRON MOL MUTAGEN, V50, P10, DOI 10.1002/em.20433
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Venhoff N, 2007, ANTIVIR THER, V12, P1075
   Venhoff N, 2010, AIDS, V24, P345, DOI 10.1097/QAD.0b013e328335cdea
   Walker Dale M, 2004, Cardiovasc Toxicol, V4, P133, DOI 10.1385/CT:4:2:133
   Walker UA, 2006, ANTIVIR THER, V11, P25
   Walker UA, 2004, HEPATOLOGY, V39, P311, DOI 10.1002/hep.20074
   Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Waters DL, 2009, MECH AGEING DEV, V130, P315, DOI 10.1016/j.mad.2009.01.006
   Wu YS, 2009, MUTAT RES-FUND MOL M, V664, P28, DOI 10.1016/j.mrfmmm.2009.02.006
   Zanet DL, 2014, CLIN INFECT DIS, V58, P1322, DOI 10.1093/cid/ciu051
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
   Zhang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085637
NR 99
TC 12
Z9 12
U1 1
U2 12
PU INT MEDICAL PRESS LTD
PI LONDON
PA 2-4 IDOL LANE, LONDON EC3R 5DD, ENGLAND
SN 1359-6535
J9 ANTIVIR THER
JI Antivir. Ther.
PY 2015
VL 20
IS 2
BP 109
EP 120
DI 10.3851/IMP2824
PG 12
WC Infectious Diseases; Pharmacology & Pharmacy; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Pharmacology & Pharmacy; Virology
GA CP5GL
UT WOS:000359909200001
PM 25032944
OA Bronze
DA 2024-11-01
ER

PT J
AU Fernandez-Vizarra, E
   Berardinelli, A
   Valente, L
   Tiranti, V
   Zeviani, M
AF Fernandez-Vizarra, Erika
   Berardinelli, Angela
   Valente, Lucia
   Tiranti, Valeria
   Zeviani, Massimo
TI Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers
   affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA)
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID TRANSFER-RNA; MITOCHONDRIAL MYOPATHY; PSEUDOURIDINE SYNTHASE-1; MISSENSE
   MUTATION; YEAST; GENE; PROTEIN; BIOGENESIS; DISEASE; IMPORT
AB Introduction: Myopathy, lactic acidosis and sideroblastic anaemia (MLASA) is a rare condition that combines early-onset myopathy with lactic acidosis and sideroblastic anaemia. MLASA has been associated with a missense mutation in pseudouridylate synthase 1 (PUS1), an enzyme located in both nucleus and mitochondria, which converts uridine into pseudouridine in several cytosolic and mitochondrial tRNA positions and increases the efficiency of protein synthesis in both compartments.
   Subjects and methods: We have identified two Italian brothers, offspring of distantly related parents, both of whom are affected by MLASA. The six exons of the PUS1 gene were analysed by automated sequencing.
   Results: We found combined defects in mitochondrial respiratory chain complexes in muscle and fibroblast homogenates of both patients, and low levels of mtDNA translation products in fibroblast mitochondria. A novel, homozygous stop mutation was present in PUS1 (E220X). We have investigated the structural and mechanistic aspects of the double localisation of PUS1, demonstrating that the isoform located in the nucleus contains an N-terminal extension which is absent in the mature mitochondrial isoform.
   Conclusions: The stop mutation in PUS1 is likely to determine the loss of function of the protein, since it predicts the synthesis of a protein missing 208/427 amino acid residues on the C terminus, and was associated with low mtDNA translation. The structural differences in nuclear versus mitochondrial isoforms of PUS1 may be implicated in the variability of the clinical presentations in MLASA.
C1 Natl Inst Neurol C Besta, Pierfranco & Luisa Mariani Ctr Study Mitochrondri, Div Mol Neurogenet, I-20126 Milan, Italy.
   IRCCS C Mondino Fdn, Dept Child Neurol & Psychiat, Pavia, Italy.
C3 IRCCS Fondazione Casimiro Mondino
RP Zeviani, M (corresponding author), Natl Inst Neurol C Besta, Pierfranco & Luisa Mariani Ctr Study Mitochrondri, Div Mol Neurogenet, Via Temolo 4, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
RI Fernandez-Vizarra, Erika/AAE-5600-2020; Zeviani, Massimo/K-2891-2014;
   Berardinelli, angela/AAA-9496-2019; Tiranti, Valeria/J-8233-2016
OI Zeviani, Massimo/0000-0002-9067-5508; Tiranti,
   Valeria/0000-0002-3584-7338; Fernandez-Vizarra,
   Erika/0000-0002-2469-142X; berardinelli, angela/0000-0002-4645-8055
FU Telethon [GGP030039] Funding Source: Medline
CR Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   Chen JG, 1999, RNA, V5, P409, DOI 10.1017/S1355838299981591
   Chen JG, 2000, BIOCHEM J, V352, P465, DOI 10.1042/0264-6021:3520465
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Fernández-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8
   Grosshans H, 2001, J BIOL CHEM, V276, P46333, DOI 10.1074/jbc.M107141200
   INBAL A, 1995, AM J MED GENET, V55, P372, DOI 10.1002/ajmg.1320550325
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Lecointe F, 2002, J BIOL CHEM, V277, P30445, DOI 10.1074/jbc.M203456200
   Lecointe F, 1998, J BIOL CHEM, V273, P1316, DOI 10.1074/jbc.273.3.1316
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580
   Simos G, 1996, EMBO J, V15, P2270, DOI 10.1002/j.1460-2075.1996.tb00580.x
   Singh B, 2006, BIOCHEM BIOPH RES CO, V346, P911, DOI 10.1016/j.bbrc.2006.05.188
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533
   Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653
   Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044
NR 23
TC 107
Z9 119
U1 1
U2 8
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD MAR
PY 2007
VL 44
IS 3
BP 173
EP 180
DI 10.1136/jmg.2006.045252
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 146GF
UT WOS:000244921800003
PM 17056637
OA Green Published
DA 2024-11-01
ER

PT J
AU Nissanka, N
   Moraes, CT
AF Nissanka, Nadee
   Moraes, Carlos T.
TI Mitochondrial DNA damage and reactive oxygen species in
   neurodegenerative disease
SO FEBS LETTERS
LA English
DT Review
DE mitochondrial DNA; neurodegeneration; reactive oxygen species
ID COMPLEX-I-DEFICIENCY; MULTIPLE MTDNA DELETIONS; TRANSGENIC MOUSE MODEL;
   HUMAN SKELETAL-MUSCLE; LEIGH-SYNDROME; SUBSTANTIA-NIGRA;
   ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; POINT MUTATIONS; OXIDATIVE
   STRESS
AB Mitochondria are essential organelles within the cell where most ATP is produced through oxidative phosphorylation (OXPHOS). A subset of the genes needed for this process are encoded by the mitochondrial DNA (mtDNA). One consequence of OXPHOS is the production of mitochondrial reactive oxygen species (ROS), whose role in mediating cellular damage, particularly in damaging mtDNA during ageing, has been controversial. There are subsets of neurons that appear to be more sensitive to ROS-induced damage, and mitochondrial dysfunction has been associated with several neurodegenerative disorders. In this review, we will discuss the current knowledge in the field of mtDNA and neurodegeneration, the debate about ROS as a pathological or beneficial contributor to neuronal function, bona fide mtDNA diseases, and insights from mouse models of mtDNA defects affecting the central nervous system.
C1 [Nissanka, Nadee; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, 1420 NW 9th Ave,Rm 229, Miami, FL 33136 USA.
C3 University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1420 NW 9th Ave,Rm 229, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021
OI Nissanka, Nadee/0000-0002-4639-7192
FU National Institutes of Health [1R01AG036871, 5R01EY010804,
   1R01NS079965]; American Heart Association [16PRE30480009]; Lois Pope
   LIFE Fellows Program; NEI center grant from the National Institutes of
   Health (NIH) [P30-EY014801]; American Heart Association (AHA)
   [16PRE30480009] Funding Source: American Heart Association (AHA)
FX Our work was supported by the National Institutes of Health Grants
   1R01AG036871, 5R01EY010804 and 1R01NS079965 (CTM); American Heart
   Association 16PRE30480009 and Lois Pope LIFE Fellows Program (NN). We
   acknowledge support from the NEI center grant P30-EY014801 from the
   National Institutes of Health (NIH).
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Andalib S, 2013, J NEUROL SCI, V330, P10, DOI 10.1016/j.jns.2013.04.018
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Andrus PK, 1998, J NEUROCHEM, V71, P2041
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell GR, 2013, NEUROPATH APPL NEURO, V39, P377, DOI 10.1111/j.1365-2990.2012.01290.x
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Coppedè F, 2015, MUTAT RES-FUND MOL M, V776, P84, DOI 10.1016/j.mrfmmm.2014.11.010
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Dhaliwal GK, 2000, NEUROREPORT, V11, P2507, DOI 10.1097/00001756-200008030-00032
   Diaz F, 2012, HUM MOL GENET, V21, P5066, DOI 10.1093/hmg/dds350
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107
   Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Ferrante RJ, 1997, J NEUROCHEM, V69, P2064
   Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694
   Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095
   Franco-Iborra S, 2016, NEUROSCIENTIST, V22, P266, DOI 10.1177/1073858415574600
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   GIBB WRG, 1991, J NEUROL NEUROSUR PS, V54, P388, DOI 10.1136/jnnp.54.5.388
   Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536
   Gyulkhandanyan AV, 2004, J NEUROCHEM, V90, P405, DOI 10.1111/j.1471-4159.2004.02489.x
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Hoekstra JG, 2016, ANN NEUROL, V80, P301, DOI 10.1002/ana.24709
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HUOPONEN K, 1991, AM J HUM GENET, V48, P1147
   HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Ingram CJE, 2012, AMYOTROPH LATERAL SC, V13, P341, DOI 10.3109/17482968.2012.654394
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lapointe J, 2012, J CELL BIOL, V199, P215, DOI 10.1083/jcb.201203090
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu RG, 1998, ANN NEUROL, V44, P763, DOI 10.1002/ana.410440510
   Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395
   Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Lubos E, 2011, J BIOL CHEM, V286, P35407, DOI 10.1074/jbc.M110.205708
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mancuso Michelangelo, 2008, Human Genomics, V3, P71
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marin SE, 2013, GENE, V516, P162, DOI 10.1016/j.gene.2012.12.024
   Martín MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659
   Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208
   MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886
   Mawrin C, 2004, NEUROREPORT, V15, P939, DOI 10.1097/00001756-200404290-00002
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023
   Mossmann D, 2014, CELL METAB, V20, P662, DOI 10.1016/j.cmet.2014.07.024
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nakada K, 2001, BIOCHEM BIOPH RES CO, V288, P901, DOI 10.1006/bbrc.2001.5873
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313
   Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018
   Parkinson Gemma M, 2014, Curr Aging Sci, V7, P155
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Pinto M, 2013, NEUROBIOL AGING, V34, P2399, DOI 10.1016/j.neurobiolaging.2013.04.014
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rao VK, 2014, BBA-MOL BASIS DIS, V1842, P1267, DOI 10.1016/j.bbadis.2013.09.003
   Reeve A, 2014, AGEING RES REV, V14, P19, DOI 10.1016/j.arr.2014.01.004
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Samuels DC, 2003, NUCLEIC ACIDS RES, V31, P6043, DOI 10.1093/nar/gkg784
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110
   Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640
   Sims-Robinson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068011
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Tzoulis C, 2016, MITOCHONDRION, V28, P33, DOI 10.1016/j.mito.2016.03.003
   Vergani L, 1999, HUM MOL GENET, V8, P1751, DOI 10.1093/hmg/8.9.1751
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wojtala A, 2017, MITOCHONDRION, V37, P62, DOI 10.1016/j.mito.2017.07.002
   Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 139
TC 290
Z9 321
U1 6
U2 76
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD MAR
PY 2018
VL 592
IS 5
SI SI
BP 728
EP 742
DI 10.1002/1873-3468.12956
PG 15
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA FZ3FW
UT WOS:000427473100007
PM 29281123
OA Green Accepted, Bronze
HC Y
HP N
DA 2024-11-01
ER

PT S
AU Lee, HC
   Wei, YH
AF Lee, Hsin-Chen
   Wei, Yau-Huei
BE Scatena, R
   Bottoni, P
   Giardina, B
TI Mitochondria and Aging
SO ADVANCES IN MITOCHONDRIAL MEDICINE
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Aging; mtDNA; Mitochondria; ROS; Oxidative damage; Caloric restriction
ID HUMAN SKELETAL-MUSCLE; DNA-DELETION MUTATIONS; ELECTRON-TRANSPORT CHAIN;
   HEART SUBMITOCHONDRIAL PARTICLES; MANGANESE SUPEROXIDE-DISMUTASE;
   HYDROGEN-PEROXIDE PRODUCTION; SUBSTANTIA-NIGRA NEURONS; CHRONIC IRON
   OVERLOAD; AGE-RELATED DECLINE; HUMAN LUNG TISSUES
AB Aging is a degenerative process that is associated with progressive accumulation of deleterious changes with time, reduction of physiological function and increase in the chance of disease and death. Studies in several species reveal a wide spectrum of alterations in mitochondria and mitochondrial DNA (mtDNA) with aging, including (1) increased disorganization of mitochondrial structure, (2) decline in mitochondrial oxidative phosphorylation (OXPHOS) function, (3) accumulation of mtDNA mutation, (4) increased mitochondrial production of reactive oxygen species (ROS) and (5) increased extent of oxidative damage to DNA, proteins, and lipids. In this chapter, we outline the common alterations in mitochondria of the aging tissues and recent advances in understanding the role of mitochondrial H2O2 production and mtDNA mutation in the aging process and lifespan determination. In addition, we discuss the effect of caloric restriction on age-associated mitochondrial changes and its role in longevity. Taking these findings together, we suggest that decline in mitochondrial energy metabolism, enhanced mitochondrial oxidative stress, and accumulation of mtDNA mutations are important contributors to human aging.
C1 [Lee, Hsin-Chen] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan.
   [Wei, Yau-Huei] Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan.
   [Wei, Yau-Huei] Mackay Med Coll, Dept Med, Danshui, Taipei County, Taiwan.
C3 National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung
   University; Mackay Medical College
RP Lee, HC (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Pharmacol, 155,Sec 2,Li Nong St, Taipei 112, Taiwan.
EM hclee2@ym.edu.tw
RI Lee, Hsin-Chen/JCO-2188-2023
OI Wei, Yau-Huei/0000-0002-6429-2546; Lee, Hsin-Chen/0000-0001-7455-9593
CR Agarwal S, 1995, MECH AGEING DEV, V85, P55, DOI 10.1016/0047-6374(95)01655-4
   ALBANO E, 1991, BIOCHIM BIOPHYS ACTA, V1091, P310, DOI 10.1016/0167-4889(91)90194-3
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BACON BR, 1993, GASTROENTEROLOGY, V105, P1134, DOI 10.1016/0016-5085(93)90959-G
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   BAILEY PJ, 1984, MECH AGEING DEV, V24, P233, DOI 10.1016/0047-6374(84)90074-5
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x
   BRITTON RS, 1990, HEPATOLOGY, V11, P93, DOI 10.1002/hep.1840110116
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   BULOS B, 1972, ARCH BIOCHEM BIOPHYS, V149, P461, DOI 10.1016/0003-9861(72)90345-1
   BULOS BA, 1975, ARCH BIOCHEM BIOPHYS, V166, P639, DOI 10.1016/0003-9861(75)90430-0
   CALLEJA M, 1993, J BIOL CHEM, V268, P18891
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fahn HJ, 1998, AM J RESP CELL MOL, V19, P901, DOI 10.1165/ajrcmb.19.6.3130
   Fernandez-Silva SP, 1991, BIOCHEM BIOPH RES CO, V176, P645
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248
   Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hagopian K, 2005, AM J PHYSIOL-ENDOC M, V288, pE674, DOI 10.1152/ajpendo.00382.2004
   Hamilton ML, 2001, NUCLEIC ACIDS RES, V29, P2117, DOI 10.1093/nar/29.10.2117
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harper ME, 1998, AM J PHYSIOL-ENDOC M, V275, pE197, DOI 10.1152/ajpendo.1998.275.2.E197
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   HRUSZKEWYCZ AM, 1992, MUTAT RES, V275, P243, DOI 10.1016/0921-8734(92)90028-N
   HSIEH RH, 1994, BIOCHEM MOL BIOL INT, V32, P1009
   Iñarrea P, 2007, BIOCHEM J, V405, P173, DOI 10.1042/BJ20061809
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   Kopsidas G, 1998, MUTAT RES-FUND MOL M, V421, P27, DOI 10.1016/S0027-5107(98)00150-X
   Kovalenko SA, 1997, BIOCHEM BIOPH RES CO, V232, P147, DOI 10.1006/bbrc.1997.6251
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lee CM, 1998, ANN NY ACAD SCI, V854, P182, DOI 10.1111/j.1749-6632.1998.tb09901.x
   Lee HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P309, DOI 10.1006/abbi.1998.1036
   Lee HC, 2001, MUTAT RES-GEN TOX EN, V493, P67, DOI 10.1016/S1383-5718(01)00160-7
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   LEE HC, 1994, FEBS LETT, V354, P79, DOI 10.1016/0014-5793(94)01063-3
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200
   Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Lin PH, 2003, FREE RADICAL BIO MED, V35, P1310, DOI 10.1016/j.freeradbiomed.2003.07.002
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Lu CY, 1999, MUTAT RES-FUND MOL M, V423, P11, DOI 10.1016/S0027-5107(98)00220-6
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   MARCUS DL, 1982, EXP GERONTOL, V17, P333, DOI 10.1016/0531-5565(82)90033-X
   MARTINEZ AO, 1979, EXP GERONTOL, V14, P231, DOI 10.1016/0531-5565(79)90034-2
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Miyoshi N, 2006, P NATL ACAD SCI USA, V103, P1727, DOI 10.1073/pnas.0510346103
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   MURFITT RR, 1978, MECH AGEING DEV, V8, P197, DOI 10.1016/0047-6374(78)90018-0
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   O'Brien KM, 2004, J BIOL CHEM, V279, P51817, DOI 10.1074/jbc.M405958200
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Ojaimi J, 1999, ANN NEUROL, V46, P656, DOI 10.1002/1531-8249(199910)46:4<656::AID-ANA16>3.3.CO;2-H
   Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200
   PANG CY, 1994, ARCH BIOCHEM BIOPHYS, V312, P534, DOI 10.1006/abbi.1994.1342
   Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6
   Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Petrosillo G, 2001, FEBS LETT, V509, P435, DOI 10.1016/S0014-5793(01)03206-9
   PIERI C, 1993, MECH AGEING DEV, V70, P201, DOI 10.1016/0047-6374(93)90048-V
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541
   Sanz A, 2005, J BIOENERG BIOMEMBR, V37, P83, DOI 10.1007/s10863-005-4131-0
   SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1995, FREE RADICAL BIO MED, V19, P499, DOI 10.1016/0891-5849(95)00037-X
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   TAKASAWA M, 1993, EXP GERONTOL, V28, P269, DOI 10.1016/0531-5565(93)90034-B
   TORII K, 1992, AM J RESP CELL MOL, V6, P543, DOI 10.1165/ajrcmb/6.5.543
   TORII K, 1992, AM J RESP CELL MOL, V6, P88, DOI 10.1165/ajrcmb/6.1.88
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wei YH, 1996, ANN NY ACAD SCI, V786, P82, DOI 10.1111/j.1749-6632.1996.tb39054.x
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   WEI YH, 1981, BIOCHEM BIOPH RES CO, V99, P1411, DOI 10.1016/0006-291X(81)90776-2
   Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
   YANG JH, 1995, ARCH DERMATOL RES, V287, P641
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   ZHANG CF, 1993, BIOCHEM BIOPH RES CO, V195, P1104, DOI 10.1006/bbrc.1993.2158
NR 141
TC 177
Z9 210
U1 2
U2 46
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-94-007-2868-4; 978-94-007-2869-1
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2012
VL 942
BP 311
EP 327
DI 10.1007/978-94-007-2869-1_14
D2 10.1007/978-94-007-2869-1
PG 17
WC Oncology; Medicine, Research & Experimental
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA BA2RR
UT WOS:000333840200015
PM 22399429
DA 2024-11-01
ER

PT J
AU Neuhaus, JFG
   Baris, OR
   Hess, S
   Moser, N
   Schröder, H
   Chinta, SJ
   Andersen, JK
   Kloppenburg, P
   Wiesner, RJ
AF Neuhaus, Johannes F. G.
   Baris, Olivier R.
   Hess, Simon
   Moser, Natasha
   Schroeder, Hannsjoerg
   Chinta, Shankar J.
   Andersen, Julie K.
   Kloppenburg, Peter
   Wiesner, Rudolf J.
TI Catecholamine metabolism drives generation of mitochondrial DNA
   deletions in dopaminergic neurons
SO BRAIN
LA English
DT Article
DE mitochondrial dysfunction; Parkinson's disease; mtDNA deletion; dopamine
ID SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; CLONAL EXPANSION; SKELETAL-MUSCLE;
   SH-SY5Y CELLS; HUMAN BRAIN; DAMAGE; MTDNA; NEUROMELANIN; CALCIUM
AB Accumulation of mitochondrial DNA deletions is observed especially in dopaminergic neurons of the substantia nigra during ageing and even more in Parkinson's disease. The resulting mitochondrial dysfunction is suspected to play an important role in neurodegeneration. However, the molecular mechanisms involved in the preferential generation of mitochondrial DNA deletions in dopaminergic neurons are still unknown. To study this phenomenon, we developed novel polymerase chain reaction strategies to detect distinct mitochondrial DNA deletions and monitor their accumulation patterns. Applying these approaches in in vitro and in vivo models, we show that catecholamine metabolism drives the generation and accumulation of these mitochondrial DNA mutations. As in humans, age-related accumulation of mitochondrial DNA deletions is most prominent in dopaminergic areas of mouse brain and even higher in the catecholaminergic adrenal medulla. Dopamine treatment of terminally differentiated neuroblastoma cells, as well as stimulation of dopamine turnover in mice over-expressing monoamine oxidase B both induce multiple mitochondrial DNA deletions. Our results thus identify catecholamine metabolism as the driving force behind mitochondrial DNA deletions, probably being an important factor in the ageing-associated degeneration of dopaminergic neurons.
C1 [Neuhaus, Johannes F. G.; Baris, Olivier R.; Wiesner, Rudolf J.] Univ Cologne, Fac Med, Inst Vegetat Physiol, Ctr Physiol & Pathophysiol, Cologne, Germany.
   [Hess, Simon; Kloppenburg, Peter] Univ Cologne, Bioctr, Inst Zool, Cologne, Germany.
   [Moser, Natasha; Schroeder, Hannsjoerg] Univ Cologne, Fac Med, Dept Anat 2, Cologne, Germany.
   [Chinta, Shankar J.; Andersen, Julie K.] Buck Inst Res Ageing, Novato, CA USA.
   [Kloppenburg, Peter; Wiesner, Rudolf J.] Univ Cologne, CMMC, Cologne, Germany.
   [Kloppenburg, Peter; Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
C3 University of Cologne; University of Cologne; University of Cologne;
   University of Cologne; University of Cologne
RP Wiesner, RJ (corresponding author), Uniklin Koln, Inst Vegetat Physiol, Robert Koch Str 39, D-50931 Cologne, Germany.
EM rudolf.wiesner@uni-koeln.de
RI Baris, Olivier/L-3463-2016
OI Andersen, Julie/0000-0003-1324-4875; Baris, Olivier/0000-0003-0974-6856;
   Hess, Simon/0000-0001-6085-5156
FU Deutsche Forschungsgemeinschaft (Cologne Excellence Cluster on Cellular
   Stress Responses in Ageing-associated Diseases, CECAD); Center of
   Molecular Medicine Cologne (CMMC)
FX Rudolf J. Wiesner and Peter Kloppenburg were funded by grants from the
   Deutsche Forschungsgemeinschaft (Cologne Excellence Cluster on Cellular
   Stress Responses in Ageing-associated Diseases, CECAD) and the Center of
   Molecular Medicine Cologne (CMMC).
CR Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   BARDEN H, 1983, BRAIN RES BULL, V10, P847, DOI 10.1016/0361-9230(83)90218-6
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   CALNE DB, 1983, LANCET, V2, P1457, DOI 10.1016/S0140-6736(83)90802-4
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Elstner M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-43
   Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x
   Fasano M, 2006, J NEUROCHEM, V96, P909, DOI 10.1111/j.1471-4159.2005.03638.x
   FORNSTEDT B, 1986, NEUROPHARMACOLOGY, V25, P451, DOI 10.1016/0028-3908(86)90242-X
   Gautam AH, 2011, BBA-BIOENERGETICS, V1807, P819, DOI 10.1016/j.bbabio.2011.03.013
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536
   HALLIWELL B, 1984, METHOD ENZYMOL, V105, P47
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Könner AC, 2011, CELL METAB, V13, P720, DOI 10.1016/j.cmet.2011.03.021
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   LACEY MG, 1989, J NEUROSCI, V9, P1233
   Li YB, 2002, NEUROSCI LETT, V330, P69, DOI 10.1016/S0304-3940(02)00444-5
   Liang CL, 1996, NEUROSCIENCE, V75, P523, DOI 10.1016/0306-4522(96)00228-X
   Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570
   Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102
   Mallajosyula JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001616
   MARSDEN CD, 1961, J ANAT, V95, P256
   McCoy MK, 2012, ANTIOXID REDOX SIGN, V16, P869, DOI [10.1089/ars.2011.4019, 10.1089/ars.2011.4074]
   McRitchie DA, 1996, J COMP NEUROL, V364, P121, DOI 10.1002/(SICI)1096-9861(19960101)364:1<121::AID-CNE11>3.0.CO;2-1
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MOLDEUS P, 1983, MUTAT RES, V124, P9
   Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x
   Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6
   ROSENGREN E, 1985, J NEURAL TRANSM, V63, P247, DOI 10.1007/BF01252029
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   SOONG NW, 1992, NAT GENET, V2, P318
   Spencer JPE, 2002, J NEUROCHEM, V81, P122, DOI 10.1046/j.1471-4159.2002.00808.x
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009
   Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6
   Surmeier DJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009290
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215
   Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
   Zecca L, 2008, J NEUROCHEM, V106, P1866, DOI 10.1111/j.1471-4159.2008.05541.x
NR 61
TC 37
Z9 41
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD FEB
PY 2014
VL 137
BP 354
EP 365
DI 10.1093/brain/awt291
PN 2
PG 12
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AA7QB
UT WOS:000331290900008
PM 24163249
OA Bronze
DA 2024-11-01
ER

PT J
AU Zhang, YC
   Ma, YN
   Bu, DF
   Liu, H
   Xia, CY
   Zhang, Y
   Zhu, SN
   Pan, H
   Pei, P
   Zheng, XF
   Wang, ST
   Xu, YF
   Qi, Y
AF Zhang, Yanchun
   Ma, Yinan
   Bu, Dingfang
   Liu, Hui
   Xia, Changyu
   Zhang, Ying
   Zhu, Sainan
   Pan, Hong
   Pei, Pei
   Zheng, Xuefei
   Wang, Songtao
   Xu, Yufeng
   Qi, Yu
TI Deletion of a 4977-bp Fragment in the Mitochondrial Genome Is Associated
   with Mitochondrial Disease Severity
SO PLOS ONE
LA English
DT Article
ID SKELETAL-MUSCLE; COMMON-DELETION; COPY NUMBER; QUANTITATIVE-ANALYSIS;
   DNA DELETION; BP DELETION; DISORDERS; DIAGNOSIS; MUTATION; BREAST
AB Large deletions in mitochondrial DNA (mtDNA) may be involved in the pathogenesis of mitochondrial disease. In this study, we investigated the relationship between a 4,977-bp deletion in the mitochondrial genome (Delta mtDNA(4977)) and the severity of clinical symptoms in patients with mitochondrial disease lacking known point mutations. A total of 160 patients with mitochondrial disease and 101 healthy controls were recruited for this study. The copy numbers of Delta mtDNA(4977) and wild-type mtDNA were determined by real-time quantitative PCR and analyzed using Spearman's bivariate correlation analysis, t-tests, or one-way ANOVA. The overall Delta mtDNA(4977) copy number per cell and the proportion of mtDNA(4977) relative to the total wild-type mtDNA, increased with patient age and symptom severity. Surprisingly, the total mtDNA copy number decreased with increasing symptom severity. Our analyses revealed that increases in the proportion and total copy number of Delta mtDNA(4977) in the blood may be associated with disease severity in patients with mitochondrial dysfunction.
C1 [Zhang, Yanchun; Ma, Yinan; Bu, Dingfang; Zhang, Ying; Pan, Hong; Pei, Pei; Zheng, Xuefei; Wang, Songtao; Xu, Yufeng; Qi, Yu] Peking Univ, Hosp 1, Dept Cent Lab, Beijing 100034, Peoples R China.
   [Liu, Hui] Beijing Childrens Hosp, Dept Resp, Beijing 100045, Peoples R China.
   [Xia, Changyu] Peking Univ, Hosp 1, Dept Clin Lab, Beijing 100034, Peoples R China.
   [Zhu, Sainan] Peking Univ, Hosp 1, Dept Biostat, Beijing 100034, Peoples R China.
C3 Peking University; Capital Medical University; Peking University; Peking
   University
RP Ma, YN (corresponding author), Peking Univ, Hosp 1, Dept Cent Lab, 8 West Dist, Beijing 100034, Peoples R China.
EM mayinan1014@163.com; qiyu0724@163.com
RI Zhang, Ying/JWP-8962-2024
FU National Natural Science Foundation of China [81271256, 81471153];
   Beijing Municipal Science & Technology Commission [Z131107002213062]
FX This study was financially supported by grants from the National Natural
   Science Foundation of China (No. 81271256) and (No. 81471153) and
   Beijing Municipal Science & Technology Commission (No.
   Z131107002213062). The funders had no roles in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akouchekian M, 2011, J RES MED SCI, V16, P50
   [Anonymous], A Human Mitochondrial Genome Database
   Aral C, 2010, GENET MOL BIOL, V33, P1, DOI 10.1590/S1415-47572009005000102
   Berneburg M, 1997, PHOTOCHEM PHOTOBIOL, V66, P271, DOI 10.1111/j.1751-1097.1997.tb08654.x
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8
   Cho YM, 2007, DIABETES RES CLIN PR, V77, pS172, DOI 10.1016/j.diabres.2007.01.052
   Czarny P, 2014, MUTAT RES-FUND MOL M, V760, P42, DOI 10.1016/j.mrfmmm.2013.12.001
   Kamalidehghan B, 2013, ARCH MED RES, V44, P79, DOI 10.1016/j.arcmed.2012.11.004
   Kato T, 1997, BIOL PSYCHIAT, V42, P311, DOI 10.1016/S0006-3223(96)00377-0
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067146
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Nie HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067953
   Obara-Moszynska M, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-27
   Ohnuki Y, 2014, INTERNAL MED, V53, P1365, DOI 10.2169/internalmedicine.53.1320
   Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009
   Pesce V, 2002, GENE, V286, P143, DOI 10.1016/S0378-1119(01)00815-0
   Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shao JY, 2004, WORLD J GASTROENTERO, V10, P1560, DOI 10.3748/wjg.v10.i11.1560
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sun MJ, 2009, INT UROGYNECOL J, V20, P867, DOI 10.1007/s00192-009-0871-4
   Thayer RE, 2003, EXP GERONTOL, V38, P567, DOI 10.1016/S0531-5565(03)00033-0
   Upadhyay R, 2009, CANCER GENET CYTOGEN, V195, P175, DOI 10.1016/j.cancergencyto.2009.06.017
   von Wurmb N, 1998, MUTAT RES-FUND MOL M, V422, P247, DOI 10.1016/S0027-5107(98)00205-X
   von Wurmb-Schwark N, 2010, MECH AGEING DEV, V131, P179, DOI 10.1016/j.mad.2010.01.005
   Wang J, 2009, CHINESE MED J-PEKING, V122, P431, DOI 10.3760/cma.j.issn.0366-6999.2009.04.0014
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
   Ye CZ, 2008, BREAST CANCER RES TR, V108, P427, DOI 10.1007/s10549-007-9613-9
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Zhang WM, 2013, CLIN BIOCHEM, V46, P694, DOI 10.1016/j.clinbiochem.2012.11.008
NR 39
TC 23
Z9 26
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2015
VL 10
IS 5
AR e0128624
DI 10.1371/journal.pone.0128624
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CJ2MQ
UT WOS:000355319400099
PM 26024530
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Franco, PC
   Patrocinio, M
   Costa-Riquetto, AD
   Junior, ACS
   Gomes, LG
   Teles, MG
AF Franco, Pedro Campos
   Patrocinio, Michelle
   Costa-Riquetto, Aline Dantas
   Santomauro Junior, Augusto Cezar
   Gomes, Larissa Garcia
   Teles, Milena G.
TI Phenotypic and molecular reanalysis of a cohort of patients with
   monogenic diabetes reveals a case of partial lipodystrophy due to the
   A8344G mutation in the mitochondrial DNA
SO ARCHIVES OF ENDOCRINOLOGY METABOLISM
LA English
DT Article
AB Familial partial lipodystrophy (FPLD) is a very rare genetic disease characterized by insulin resistance due to a loss of subcutaneous fat from the extremities together with a progressive storage of fat around the face and neck and inside the abdomen. In over 50% of cases, molecular genetic testing reveals pathogenic variants in two nuclear genes, LMNA and PPARG . The case reported here refers to a woman phenotypically diagnosed with FPLD, who presented with diabetes and multiple cervical lipomatosis and in whom no variant had been found in the nuclear genes classically associated with this syndrome that could explain her phenotype. Genetic sequencing using a target panel containing 48 nuclear genes related to monogenic diabetes plus the whole mitochondrial genome revealed the mitochondrial variant m.A8344G in 84.1% heteroplasmy. Following molecular diagnosis, her phenotype was expanded with the recognition of additional clinical characteristics: mild sensorineural hearing loss, proximal myopathy, fatigue, cognitive impairment, sensory ataxia, cardiac abnormalities and, finally, muscle biopsy findings compatible with mitochondrial disease. Therefore, careful and detailed phenotypic and genotypic reanalysis proved crucial in improving molecular diagnosis in FPLD.
C1 [Franco, Pedro Campos; Costa-Riquetto, Aline Dantas; Santomauro Junior, Augusto Cezar; Teles, Milena G.] Univ Sao Paulo, Hosp Clin, Fac Med, Unidade Endocrinol Genet LIM25,Grp Diabetes Monoge, Sao Paulo, SP, Brazil.
   [Patrocinio, Michelle] Hosp Santa Marcelina, Sao Paulo, SP, Brazil.
   [Gomes, Larissa Garcia] Univ Sao Paulo, Hosp Clin, Fac Med, Unidade Desenvolvimento, Sao Paulo, SP, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo
RP Teles, MG (corresponding author), Univ Sao Paulo, Hosp Clin, Fac Med, Unidade Endocrinol Genet LIM25,Grp Diabetes Monoge, Sao Paulo, SP, Brazil.
EM milena.teles@gmail.com
RI Santomauro Junior, Augusto/L-9978-2013; Campos Franco,
   Pedro/IWL-9856-2023
OI Santomauro Junior, Augusto Cezar/0000-0002-8467-7195
FU So Paulo Research Foundation (Fapesp) [2017/14703-4, 2013/19920-2,
   2017/15365-5]
FX the S & atilde;o Paulo Research Foundation (Fapesp) supported this study
   under grant numbers 2017/14703-4, 2013/19920-2 and 2017/15365-5.
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   de Santana LS, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.962
   Deignan JL, 2019, GENET MED, V21, P1267, DOI 10.1038/s41436-019-0478-1
   Hattersley AT, 2018, PEDIATR DIABETES, V19, P47, DOI 10.1111/pedi.12772
   Jéru I, 2017, EUR J HUM GENET, V25, DOI 10.1038/ejhg.2016.102
   Ng YS, 2021, ENDOCR REV, V43, P583, DOI 10.1210/endrev/bnab036
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194
   Takano C, 2023, BIOMOLECULES, V13, DOI 10.3390/biom13010126
   Vasandani C, 2020, J CLIN ENDOCR METAB, V105, P2132, DOI 10.1210/clinem/dgaa137
   Zammouri J, 2022, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.803189
NR 11
TC 0
Z9 0
U1 0
U2 0
PU SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
PI RIO DE JANEIRO, RJ
PA RUA HUMAITA, 85 CJ 501, RIO DE JANEIRO, RJ, 22261-000, BRAZIL
SN 2359-3997
EI 2359-4292
J9 ARCH ENDOCRIN METAB
JI Arch. Endocrinol. Metab.
PY 2024
VL 68
AR e230084
DI 10.20945/2359-4292-2023-0084
PG 4
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA YE9X4
UT WOS:001266937500001
PM 39420889
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Bruhn, H
   Samuelsson, K
   Schober, FA
   Engvall, M
   Lesko, N
   Wibom, R
   Nennesmo, I
   Calvo-Garrido, J
   Press, R
   Stranneheim, H
   Freyer, C
   Wedell, A
   Wredenberg, A
AF Bruhn, Helene
   Samuelsson, Kristin
   Schober, Florian A.
   Engvall, Martin
   Lesko, Nicole
   Wibom, Rolf
   Nennesmo, Inger
   Calvo-Garrido, Javier
   Press, Rayomand
   Stranneheim, Henrik
   Freyer, Christoph
   Wedell, Anna
   Wredenberg, Anna
TI Novel Mutation m.10372A&gt;G in <i>MT-ND3</i> Causing Sensorimotor
   Axonal Polyneuropathy
SO NEUROLOGY-GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA MUTATION; MUSCLE; GENE; ENCEPHALOPATHY; TRANSITION;
   PHENOTYPES; NEUROPATHY; NARP
AB Objective
   To investigate the pathogenicity of a novel MT-ND3 mutation identified in a patient with adult-onset sensorimotor axonal polyneuropathy and report the clinical, morphologic, and biochemical findings.
   Methods
   Clinical assessments and morphologic and biochemical investigations of skeletal muscle and cultured myoblasts from the patient were performed. Whole-genome sequencing (WGS) of DNA from skeletal muscle and Sanger sequencing of mitochondrial DNA (mtDNA) from both skeletal muscle and cultured myoblasts were performed. Heteroplasmic levels of mutated mtDNA in different tissues were quantified by last-cycle hot PCR.
   Results
   Muscle showed ragged red fibers, paracrystalline inclusions, a significant reduction in complex I (CI) respiratory chain (RC) activity, and decreased adenosine triphosphate (ATP) production for all substrates used by CI. Sanger sequencing of DNA from skeletal muscle detected a unique previously unreported heteroplasmic mutation in mtDNA encoded MT-ND3, coding for a subunit in CI. WGS confirmed the mtDNA mutation but did not detect any other mutation explaining the disease. Cultured myoblasts, however, did not carry the mutation, and RC activity measurements in myoblasts were normal.
   Conclusions
   We report a case with adult-onset sensorimotor axonal polyneuropathy caused by a novel mtDNAmutation in MT-ND3. Loss of heteroplasmy in blood, cultured fibroblasts and myoblasts from the patient, and normal measurement of RC activity of the myoblasts support pathogenicity of the mutation. These findings highlight the importance of mitochondrial investigations in patients presenting with seemingly idiopathic polyneuropathy, especially if muscle also is affected.
C1 [Bruhn, Helene; Wibom, Rolf; Freyer, Christoph; Wredenberg, Anna] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.
   [Bruhn, Helene; Engvall, Martin; Lesko, Nicole; Wibom, Rolf; Stranneheim, Henrik; Freyer, Christoph; Wedell, Anna; Wredenberg, Anna] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden.
   [Samuelsson, Kristin; Press, Rayomand] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
   [Samuelsson, Kristin; Press, Rayomand] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden.
   [Schober, Florian A.; Engvall, Martin; Lesko, Nicole; Calvo-Garrido, Javier; Stranneheim, Henrik; Wedell, Anna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Nennesmo, Inger] Karolinska Univ Hosp, Dept Pathol, Stockholm, Sweden.
   [Stranneheim, Henrik] Karolinska Inst, Sci Life Lab, Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska Institutet; Karolinska University
   Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska
   University Hospital; Karolinska Institutet; Karolinska Institutet;
   Karolinska University Hospital; Karolinska Institutet
RP Bruhn, H (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.; Bruhn, H (corresponding author), Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden.
EM helene.bruhn@sll.se
RI Press, Rayomand/AAW-8142-2020; Rosenberger, Florian/HLX-7402-2023;
   Calvo-Garrido, Javier/AAA-5344-2020
OI Bruhn, Helene/0009-0007-4449-5382; Freyer,
   Christoph/0000-0003-0418-1673; Wredenberg, Anna/0000-0002-2500-6121;
   Rosenberger, Florian/0000-0003-4604-6170
FU Swedish Research Council [2019-01154, VR2016-02179]; Stockholm County
   Council [20170022]; Swedish Research Council [2019-01154] Funding
   Source: Swedish Research Council
FX This study was supported by the Swedish Research Council (A. Wedell,
   2019-01154; A. Wredenberg, VR2016-02179) and the Stockholm County
   Council (20170022). A. Wedell is a Wallenberg Clinical Scholar (KAW
   2014.0293). A. Wredenberg is a Ragnar Soderberg fellow in Medicine
   (M77/13).
CR Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796
   Cabrera-Orefice A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06955-y
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Di Luca A, 2017, P NATL ACAD SCI USA, V114, pE6314, DOI 10.1073/pnas.1706278114
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e
   Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gilhuis HJ, 2006, NEUROMUSCULAR DISORD, V16, P394, DOI 10.1016/j.nmd.2006.03.006
   Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050
   Haapanen O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07930-1
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   MITOMAP, 2018, HUM MIT GEN DAT
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   Mukai M, 2017, INTERNAL MED, V56, P95, DOI 10.2169/internalmedicine.56.7301
   Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   Sciacco M, 2003, J NEUROL, V250, P1498, DOI 10.1007/s00415-003-0246-6
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 38
TC 4
Z9 5
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
J9 NEUROL-GENET
JI Neurol.-Genet.
PD APR
PY 2021
VL 7
IS 2
AR e566
DI 10.1212/NXG.0000000000000566
PG 10
WC Genetics & Heredity; Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Neurosciences & Neurology
GA SO2TR
UT WOS:000658830100008
PM 33732874
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Ylikallio, E
   Page, JL
   Xu, X
   Lampinen, M
   Bepler, G
   Ide, T
   Tyynismaa, H
   Weiss, RS
   Suomalainen, A
AF Ylikallio, Emil
   Page, Jennifer L.
   Xu, Xia
   Lampinen, Milla
   Bepler, Gerold
   Ide, Tomomi
   Tyynismaa, Henna
   Weiss, Robert S.
   Suomalainen, Anu
TI Ribonucleotide reductase is not limiting for mitochondrial DNA copy
   number in mice
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; THYMIDINE KINASE; DEOXYNUCLEOTIDE POOLS;
   RESTING CELLS; DNTP POOLS; IN-VITRO; DAMAGE; MTDNA; GENE; OVEREXPRESSION
AB Ribonucleotide reductase (RNR) is the rate-limiting enzyme in deoxyribonucleoside triphosphate (dNTP) biosynthesis, with important roles in nuclear genome maintenance. RNR is also essential for maintenance of mitochondrial DNA (mtDNA) in mammals. The mechanisms regulating mtDNA copy number in mammals are only being discovered. In budding yeast, RNR overexpression resulted in increased mtDNA levels, and rescued the disease phenotypes caused by a mutant mtDNA polymerase. This raised the question of whether mtDNA copy number increase by RNR induction could be a strategy for treating diseases with mtDNA mutations. We show here that high-level overexpression of RNR subunits (Rrm1, Rrm2 and p53R2; separately or in different combinations) in mice does not result in mtDNA copy number elevation. Instead, simultaneous expression of two RNR subunits leads to imbalanced dNTP pools and progressive mtDNA depletion in the skeletal muscle, without mtDNA mutagenesis. We also show that endogenous RNR transcripts are downregulated in response to large increases of mtDNA in mice, which is indicative of nuclear-mitochondrial crosstalk with regard to mtDNA copy number. Our results establish that RNR is not limiting for mtDNA copy number in mice, and provide new evidence for the importance of balanced dNTP pools in mtDNA maintenance in postmitotic tissues.
C1 [Ylikallio, Emil; Lampinen, Milla; Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Res Programme Mol Neurol, Biomedicum Helsinki, FIN-00290 Helsinki, Finland.
   [Page, Jennifer L.; Xu, Xia; Weiss, Robert S.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.
   [Bepler, Gerold] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA.
   [Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 8128582, Japan.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; Cornell University; H Lee Moffitt Cancer Center
   & Research Institute; Kyushu University; University of Helsinki;
   Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Programme Mol Neurol, Biomedicum Helsinki, RC523B,Haartmaninkatu 8,POB 63, FIN-00290 Helsinki, Finland.
EM rsw26@cornell.edu; anu.wartiovaara@helsinki.fi
RI Ylikallio, Emil/S-9434-2019; Tyynismaa, Henna/F-1428-2011; Xu,
   Xia/F-1307-2015
OI Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Tyynismaa,
   Henna/0000-0002-2493-2422; Ylikallio, Emil/0000-0001-5178-0703;
   Lampinen, Milla Annika/0000-0002-5963-0395; Xu, Xia/0000-0002-1982-7062
FU Academy of Finland; University of Helsinki; Sigrid Juselius Foundation;
   Jane and Aatos Erkko Foundation; Helsinki Biomedical Graduate School;
   Cornell University Center for Vertebrate Genomics; National Institutes
   of Health [T32 GM07617]
FX This work was supported by Academy of Finland (to H.T. and A.S.);
   University of Helsinki (to A.S.); Sigrid Juselius Foundation (to A.S.);
   Jane and Aatos Erkko Foundation (to A.S.); Helsinki Biomedical Graduate
   School (to E.Y.); the Cornell University Center for Vertebrate Genomics
   (to J.L.P. and X.X.); National Institutes of Health training grant
   number T32 GM07617 (to J.L.P.).
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fan HZ, 1996, P NATL ACAD SCI USA, V93, P14036, DOI 10.1073/pnas.93.24.14036
   FAUPEL RP, 1972, ARCH BIOCHEM BIOPHYS, V148, P509, DOI 10.1016/0003-9861(72)90170-1
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141
   Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Kochanowski N, 2006, ANAL BIOCHEM, V348, P243, DOI 10.1016/j.ab.2005.10.027
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9
   Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002
   REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SCHWENKE WD, 1981, BIOCHEM J, V200, P405, DOI 10.1042/bj2000405
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 45
TC 28
Z9 36
U1 2
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD DEC
PY 2010
VL 38
IS 22
BP 8208
EP 8218
DI 10.1093/nar/gkq735
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 696CU
UT WOS:000285420300037
PM 20724444
OA gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Campbell, GR
   Reeve, AK
   Ziabreva, I
   Reynolds, R
   Turnbull, DM
   Mahad, DJ
AF Campbell, Graham R.
   Reeve, Amy K.
   Ziabreva, Iryna
   Reynolds, Richard
   Turnbull, Doug M.
   Mahad, Don J.
TI No excess of mitochondrial DNA deletions within muscle in progressive
   multiple sclerosis
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Article
DE Mitochondria; muscle; multiple sclerosis
ID OXIDASE ACTIVITY; DYSFUNCTION; MUTATIONS; SINGLE; WOMEN; GENE
AB Background: Mitochondrial dysfunction is an established feature of multiple sclerosis (MS). We recently described high levels of mitochondrial DNA (mtDNA) deletions within respiratory enzyme-deficient (lacking mitochondrial respiratory chain complex IV with intact complex II) neurons and choroid plexus epithelial cells in progressive MS.
   Objectives: The objective of this paper is to determine whether respiratory enzyme deficiency and mtDNA deletions in MS were in excess of age-related changes within muscle, which, like neurons, are post-mitotic cells that frequently harbour mtDNA deletions with ageing and in disease.
   Methods: In progressive MS cases (n=17), known to harbour an excess of mtDNA deletions in the central nervous system (CNS), and controls (n=15), we studied muscle (paraspinal) and explored mitochondria in single fibres. Histochemistry, immunohistochemistry, laser microdissection, real-time polymerase chain reaction (PCR), long-range PCR and sequencing were used to resolve the single muscle fibres.
   Results: The percentage of respiratory enzyme-deficient muscle fibres, mtDNA deletion level and percentage of muscle fibres harbouring high levels of mtDNA deletions were not significantly different in MS compared with controls.
   Conclusion: Our findings do not provide support to the existence of a diffuse mitochondrial abnormality involving multiple systems in MS. Understanding the cause(s) of the CNS mitochondrial dysfunction in progressive MS remains a research priority.
C1 [Campbell, Graham R.; Mahad, Don J.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland.
   [Reeve, Amy K.; Ziabreva, Iryna; Turnbull, Doug M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Reynolds, Richard] Imperial Coll Fac Med, Wolfson Neurosci Labs, London, England.
C3 University of Edinburgh; Newcastle University - UK; Imperial College
   London
RP Mahad, DJ (corresponding author), Univ Edinburgh, Ctr Neuroregenerat, Chancellors Bldg, Edinburgh EH16 4SB, Midlothian, Scotland.
EM dmahad@staffmail.ed.ac.uk
OI Campbell, Graham/0000-0003-4828-421X; Turnbull,
   Doug/0000-0002-8878-9901; Reynolds, Richard/0000-0003-4622-4694; Reeve,
   Amy/0000-0002-4474-2204
FU Wellcome Trust; Newcastle Healthcare Charity; Newcastle upon Tyne
   Hospitals NHS charity; Lifelong Health and Wellbeing Initiative
   [G0700718]; Wellcome Trust Centre for Mitochondrial Research [906919];
   Newcastle NIHR Biomedical Research Centre; MRC [G0700718, MR/K000608/1]
   Funding Source: UKRI
FX This work was supported by the Wellcome Trust and the Newcastle
   Healthcare Charity and Newcastle upon Tyne Hospitals NHS charity.
   Newcastle University Centre for Brain Ageing and Vitality is supported
   by the Lifelong Health and Wellbeing Initiative (G0700718), The Wellcome
   Trust Centre for Mitochondrial Research (906919) and Newcastle NIHR
   Biomedical Research Centre.
CR Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Broadwater L, 2011, BBA-MOL BASIS DIS, V1812, P630, DOI 10.1016/j.bbadis.2011.01.012
   Campbell GR, 2013, NEUROPATH APPL NEURO, V39, P377, DOI 10.1111/j.1365-2990.2012.01290.x
   Campbell GR, 2012, ACTA NEUROPATHOL, V124, P209, DOI 10.1007/s00401-012-1001-9
   Campbell GR, 2012, CNS NEUROL DISORD-DR, V11, P589
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736
   Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Kumleh HH, 2006, J NEUROL SCI, V243, P65, DOI 10.1016/j.jns.2005.11.030
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Mähler A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043675
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Nociti V, 2009, J NEUROL SCI, V287, P288, DOI 10.1016/j.jns.2009.07.009
   Palace J, 2009, J NEUROL SCI, V286, P24, DOI 10.1016/j.jns.2009.09.009
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Patte M, 2003, J FR OPHTALMOL, V26, P381
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Sakiyama Y, 2011, ACTA NEUROPATHOL, V121, P775, DOI 10.1007/s00401-011-0818-y
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   Witte ME, 2013, ACTA NEUROPATHOL, V125, P231, DOI 10.1007/s00401-012-1052-y
   Witte ME, 2010, MITOCHONDRION, V10, P411, DOI 10.1016/j.mito.2010.05.014
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 31
TC 11
Z9 13
U1 0
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2013
VL 19
IS 14
BP 1858
EP 1866
DI 10.1177/1352458513490547
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 256LG
UT WOS:000327311100010
PM 23787892
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Jash, S
   Adhya, S
AF Jash, Sukanta
   Adhya, Samit
TI Suppression of reactive oxygen species in cells with multiple
   mitochondrial DNA deletions by exogenous protein-coding RNAs
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; Multiple deletions; RNA delivery; Respiration; ROS
   suppression
ID MUTANT MITOCHONDRIA; HUMAN BRAIN; MUSCLE; IMPORT; SUFFICIENT; MUTATIONS;
   AGE
AB Many human diseases are associated with mutations and deletions in mitochondrial DNA (mtDNA). We have generated a cell line, EB delta1, with multiple mtDNA deletions, that is respiration-defective and generates high levels of superoxide, a reactive oxygen species. Treatment of EB delta1 with tagged polycistronic (pc) RNAs, encoding parts of the mitochondrial proteome, bound to a multi-subunit carrier complex, resulted in cellular uptake and transfer of the RNA to mitochondria, restoration of respiration, and suppression of superoxide levels. These findings have implications for correction of mitochondrial defects in age-related disorders due to mtDNA mutations. (C) 2011 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Jash, Sukanta; Adhya, Samit] CSIR, Indian Inst Chem Biol, Genet Engn Lab, Kolkata 700032, W Bengal, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Indian Institute of Chemical Biology (IICB)
RP Adhya, S (corresponding author), CSIR, Indian Inst Chem Biol, Genet Engn Lab, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.
EM sadhya@iicb.res.in
FU Council of Scientific and Industrial Research (CSIR) [SIP0007]
FX We thank Santu Bandyopadhyay for the FACS analysis, Siddhartha Jana and
   Anupam Banerjee for confocal microscopy, Ashok Giri for anti-COXIV
   antibody, Susanta Roychowdhury for DNA sequencing, Uday Bandyopadhyay
   for PBN and Tapas Chowdhury for technical assistance. Supported by
   Suprainstitutional Project number SIP0007 from the Council of Scientific
   and Industrial Research (CSIR). S.J. was supported by a Senior Research
   Fellowship from CSIR.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Berliner LJ, 2009, APPL MAGN RESON, V36, P157, DOI 10.1007/s00723-009-0034-2
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Dean OM, 2009, CURR MED CHEM, V16, P2965, DOI 10.2174/092986709788803060
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Han YH, 2008, ONCOL REP, V20, P689, DOI 10.3892/or_00000061
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kopsidas G, 1998, MUTAT RES-FUND MOL M, V421, P27, DOI 10.1016/S0027-5107(98)00150-X
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Mahapatra S, 1998, NUCLEIC ACIDS RES, V26, P2037, DOI 10.1093/nar/26.9.2037
   Mahata B, 2005, J BIOL CHEM, V280, P5141, DOI 10.1074/jbc.C400572200
   Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754
   Mahato B, 2011, MITOCHONDRION, V11, P564, DOI 10.1016/j.mito.2011.03.006
   Mukherjee S, 2007, EMBO REP, V8, P589, DOI 10.1038/sj.embor.7400979
   Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337
   SOONG NW, 1992, NAT GENET, V2, P318
   Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]
NR 26
TC 7
Z9 8
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2011
VL 11
IS 4
BP 607
EP 614
DI 10.1016/j.mito.2011.03.124
PG 8
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 779GD
UT WOS:000291765200009
PM 21496501
DA 2024-11-01
ER

PT J
AU Chamkha, I
   Alila-Fersi, O
   Mkaouar-Rebai, E
   Aloulou, H
   Kifagi, C
   Hachicha, M
   Fakhfakh, F
AF Chamkha, Imen
   Alila-Fersi, Olfa
   Mkaouar-Rebai, Emna
   Aloulou, Hajer
   Kifagi, Chamseddine
   Hachicha, Mongia
   Fakhfakh, Faiza
TI A novel m.12908T&gt;A mutation in the mitochondrial <i>ND5</i> gene in
   patient with infantile-onset Pompe disease
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Pompe disease; MT-ND5; m.12908T > A; Mitochondrial mutation;
   Cardiomyopathy
ID COMPLEX-I DEFICIENCY; WOLFRAM-SYNDROME; NADH DEHYDROGENASE;
   CLINICAL-FEATURES; ENCODED SUBUNITS; SKELETAL-MUSCLE; OPTIC ATROPHY;
   DNA; SEQUENCE; CELLS
AB Pompe disease is a progressive metabolic myopathy caused by deficiency in lysosomal acid a-glucosidase and results in cellular lysosomal and cytoplasmic glycogen accumulation. A wide spectrum of clinical phenotypes exists from hypotonia and severe cardiac hypertrophy in the first few months of life to a milder form with the onset of symptoms in adulthood. The disease is typically due to severe mutations in GM gene. In the present study, we described a newborn boy with clinical features of Pompe disease particularly with hypertrophic cardiomyopathy, hypotonia and hepatomegaly. This case was at first mis-diagnosed as mitochondrial disorder. Accordingly, we performed a mitochondrial mutational analysis that revealed a novel mutation m.12908T>A in the ND5 gene. Secondary structure analysis of the ND5 protein further supported the deleterious role of the m.12908T>A mutation, as it was found to involve an extended imbalance in its hydrophobicity and affect its function. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Chamkha, Imen; Alila-Fersi, Olfa; Mkaouar-Rebai, Emna; Fakhfakh, Faiza] Univ Sfax, Human Mol Genet Lab, Fac Med Sfax, Sfax 3029, Tunisia.
   [Aloulou, Hajer; Hachicha, Mongia] CHU Hedi Chaker Sfax, Serv Pediat, Sfax, Tunisia.
   [Kifagi, Chamseddine] Univ Montpellier 2, CNRS, UMR5535, Inst Genet Mol Montpellier, F-34095 Montpellier 5, France.
C3 Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker; Universite
   de Montpellier; Centre National de la Recherche Scientifique (CNRS)
RP Chamkha, I (corresponding author), Univ Sfax, Human Mol Genet Lab, Fac Med Sfax, Ave Magida Boulila, Sfax 3029, Tunisia.
EM imen.chamkha@gmail.com; faiza.fakhfakh@gmail.com
RI MKAOUAR-REBAI, Emna/AAE-6650-2019
OI Kifagi, Chamseddine/0000-0002-3744-5228; Chamkha,
   Imen/0000-0002-6919-585X; Mkaouar-Rebai, Emna/0000-0003-3095-510X
FU Ministry of the Higher Education and the Scientific Research in Tunisia
FX We thank the patient and her family for their cooperation in the present
   study. This work was supported by The Ministry of the Higher Education
   and the Scientific Research in Tunisia.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Barrientos A, 1996, AM J HUM GENET, V58, P963
   Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256
   BUNDEY S, 1992, J INHERIT METAB DIS, V15, P315, DOI 10.1007/BF02435965
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013
   Fernández R, 1999, NEUROMUSCULAR DISORD, V9, P136, DOI 10.1016/S0960-8966(98)00117-5
   HOFHAUS G, 1995, MOL CELL BIOL, V15, P964
   Huang HP, 2011, HUM MOL GENET, V20, P4851, DOI 10.1093/hmg/ddr424
   Kishnani PS, 2006, GENET MED, V8, P267, DOI 10.1097/01.gim.0000218152.87434.f3
   Kroos MA, 2007, NEUROLOGY, V68, P110, DOI 10.1212/01.wnl.0000252798.25690.76
   Kroos M, 2012, AM J MED GENET C, V160C, P59, DOI [10.1002/ajmc.31318, 10.1002/ajmg.c.31318]
   Lewandowska E, 2008, FOLIA NEUROPATHOL, V46, P123
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Martí-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291
   Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Valentino ML, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037507
   van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X
   Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Winkel LPF, 2005, J NEUROL, V252, P875, DOI 10.1007/s00415-005-0922-9
   Wokke JHJ, 2008, MUSCLE NERVE, V38, P1236, DOI 10.1002/mus.21025
   Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038
   Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814
   Zhadanov SI, 2007, MITOCHONDRION, V7, P260, DOI 10.1016/j.mito.2007.01.003
   Zickermann V, 2009, BBA-BIOENERGETICS, V1787, P574, DOI 10.1016/j.bbabio.2009.01.012
NR 41
TC 6
Z9 8
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 7
PY 2012
VL 429
IS 1-2
BP 31
EP 38
DI 10.1016/j.bbrc.2012.10.105
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 056TG
UT WOS:000312513700006
PM 23131568
DA 2024-11-01
ER

PT J
AU Pitayu, L
   Baruffini, E
   Rodier, C
   Rötig, A
   Lodi, T
   Delahodde, A
AF Pitayu, Laras
   Baruffini, Enrico
   Rodier, Celine
   Roetig, Agnes
   Lodi, Tiziana
   Delahodde, Agnes
TI Combined use of <i>Saccharomyces cerevisiae</i>, <i>Caenorhabditis
   elegans</i> and patient fibroblasts leads to the identification of
   clofilium tosylate as a potential therapeutic chemical against
   POLG-related diseases
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID DNA-POLYMERASE-GAMMA; MITOCHONDRIAL GENOME; RESISTANCE MUTATIONS;
   PHOSPHATE-TRANSPORT; YEAST MITOCHONDRIA; PROTEIN; GENES;
   SUPPLEMENTATION; PHENOTYPE; DEPLETION
AB Mitochondria are organelles that have their own DNA (mitochondrial DNA, mtDNA) whose maintenance is necessary for the majority of ATP production in eukaryotic cells. Defects in mtDNA maintenance or integrity are responsible for numerous diseases. The DNA polymerase. (POLG) ensures proper mtDNA replication and repair. Mutations in POLG are a major cause of mitochondrial disorders including hepatic insufficiency, Alpers syndrome, progressive external ophthalmoplegia, sensory neuropathy and ataxia. Mutations in POLG are also associated with parkinsonism. To date, no effective therapy is available. Based on the conservation of mitochondrial function from yeast to human, we used Saccharomyces cerevisiae and Caenorhabditis elegans as first pass filters to identify a chemical that suppresses mtDNA instability in cultured fibroblasts of a POLG-deficient patient. We showed that this unsuspected compound, clofilium tosylate (CLO), belonging to a class of anti-arrhythmic agents, prevents mtDNA loss of all yeast mitochondrial polymerase mutants tested, improves behavior and mtDNA content of polg-1-deficient worms and increases mtDNA content of quiescent POLG-deficient fibroblasts. Furthermore, the mode of action of the drug seems conserved as CLO increases POLG steady-state level in yeast and human cells. Two other anti-arrhythmic agents (FDA-approved) sharing common pharmacological properties and chemical structure also show potential benefit for POLG deficiency in C. elegans. Our findings provide evidence of the first mtDNA-stabilizing compound that may be an effective pharmacological alternative for the treatment of POLG-related diseases.
C1 [Pitayu, Laras; Rodier, Celine; Delahodde, Agnes] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, F-91198 Gif Sur Yvette, France.
   [Baruffini, Enrico; Lodi, Tiziana] Univ Parma, Dept Life Sci, Parco Area Sci 11 A, I-43124 Parma, Italy.
   [Roetig, Agnes] Paris Descartes Sorbonne Paris Cite Univ, INSERM, Imagine Inst, Lab Genet Mitochondrial Disorders,UMR 1163, 24 Blvd Montparnasse, F-75015 Paris, France.
C3 Universite Paris Cite; Universite Paris Saclay; Centre National de la
   Recherche Scientifique (CNRS); CEA; University of Parma; Universite
   Paris Cite; Institut National de la Sante et de la Recherche Medicale
   (Inserm)
RP Delahodde, A (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, F-91198 Gif Sur Yvette, France.
EM agnes.delahodde@i2bc.paris-saclay.fr
RI ROTIG, AGNES/G-9592-2017; Baruffini, Enrico/C-1057-2015
OI ROTIG, AGNES/0000-0003-0589-0703; Baruffini, Enrico/0000-0002-8280-7849
FU Indonesian government (Beasiswa Unggulan Kemendiknas RI); University
   Paris-Sud; Fondation pour la Recherche Medicale [DRM20101220457];
   Asociation Francaise contre les Myopathies [MitoScreen 17122]; Telethon
   (Italia) [GGP11011]
FX This work was supported by the Indonesian government (Beasiswa Unggulan
   Kemendiknas RI), the University Paris-Sud (to L.P.) and by grants from
   Fondation pour la Recherche Medicale (DRM20101220457), Asociation
   Francaise contre les Myopathies (MitoScreen 17122) and Telethon (Italia,
   GGP11011).
CR Addo MG, 2010, BBA-MOL BASIS DIS, V1802, P765, DOI 10.1016/j.bbadis.2010.05.007
   Aiyar RS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6585
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2015, MITOCHONDRION, V20, P52, DOI 10.1016/j.mito.2014.11.003
   Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Couplan E, 2011, P NATL ACAD SCI USA, V108, P11989, DOI 10.1073/pnas.1101478108
   Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14
   Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x
   Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119
   Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021
   Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534
   Hofmann L, 2009, J CELL SCI, V122, P3673, DOI 10.1242/jcs.050229
   Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x
   Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Lodi T, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00106
   Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040
   Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422
   PUTRAMENT A, 1973, MOL GEN GENET, V126, P357, DOI 10.1007/BF00269445
   Qian YF, 2014, J BIOL CHEM, V289, P5970, DOI 10.1074/jbc.M113.526418
   Rötig A, 2007, MITOCHONDRION, V7, pS112, DOI 10.1016/j.mito.2007.02.008
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Tejada MD, 2012, BIOL-TARGETS THER, V6, P465, DOI 10.2147/BTT.S33827
   Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394
   Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275
   Zara V, 1996, MOL CELL BIOL, V16, P6524
   Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4
NR 42
TC 18
Z9 18
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD FEB 15
PY 2016
VL 25
IS 4
BP 715
EP 727
DI 10.1093/hmg/ddv509
PG 13
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DG5WS
UT WOS:000372151000009
PM 26692522
OA Bronze
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Phenotypic Heterogeneity of the Mitochondrial DNA Variant m.13513 G &gt;
   A
SO JOURNAL OF PEDIATRIC GENETICS
LA English
DT Review; Early Access
DE mtDNA; Leigh's syndrome; MELAS; heteroplasmy; m.13513G > A
ID LEIGH-SYNDROME; G13513A MUTATION; OVERLAP SYNDROME; COMPLEX-I; ND5 GENE;
   M.13513G-GREATER-THAN-A MUTATION; FREQUENT CAUSE; MELAS
AB The mitochondrial DNA (mtDNA) variant m.13513G > A is increasingly recognized as a cause of syndromic and nonsyndromic mitochondrial disorders (MIDs). This minireview aims a summarizing and discussing recent and previous findings about the phenotypic heterogeneity of this variant. A systematic literature review using the databases PubMed and Google Scholar by application of specific search terms was performed. As per the end of July 2021, at least 50 patients carrying the mtDNA variant m.13513G > A have been reported. Age ranged between 0 and 63 years, and of these patients, 28 were male and 22 were female. The phenotype was highly variable. The most common phenotypes were Leigh syndrome (LS) ( n = 25), mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) ( n = 11), Leigh-like syndrome ( n = 4), MELAS/LS ( n = 3), progressive external ophthalmoplegia ( n = 3), MELAS/Leber's hereditary optic neuropathy (LHON) ( n = 1), and LHON ( n = 1). More rarely are nonsyndromic phenotypes. Heteroplasmy rates were highly variable ranging from 0 to 86% depending on the investigated tissue. The outcome was reported in only a few cases but was worse in patients with LS compared with those with MELAS. The variant m.13513G > A is responsible for syndromic or nonsyndromic MIDs. Syndromic MIDs in which this variant should be particularly considered include LS, MELAS, and LHON and their overlaps. Patients with suspected MID and maternal inheritance should undergo sequencing of the entire mtDNA not to miss rare mtDNA variants.
C1 [Finsterer, Josef] Messerli Inst, Neurol Dept, Klin Landstr, Vienna, Austria.
   [Finsterer, Josef] Postfach 20, A-1180 Vienna, Austria.
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
RI Finsterer, J/AAE-5733-2020
OI finsterer, josef/0000-0003-2839-7305
CR Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Dickerson BC, 2005, NEW ENGL J MED, V353, P2271, DOI 10.1056/NEJMcpc059032
   Hsieh YT, 2011, OPHTHALMIC GENET, V32, P31, DOI 10.3109/13816810.2010.531880
   Jiménez-Legido M, 2019, REV NEUROLOGIA, V68, P312, DOI 10.33588/rn.6807.2018393
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Liang JM, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.700898
   Penisson-Besnier I, 2000, NEUROLOGY, V55, P317, DOI 10.1212/WNL.55.2.317
   Petruzzella V, 2003, NEUROLOGY, V61, P1017, DOI 10.1212/01.WNL.0000080363.10902.E9
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   van Karnebeek CDM, 2011, DEV MED CHILD NEUROL, V53, P565, DOI 10.1111/j.1469-8749.2010.03907.x
   Vázquez-Justes D, 2019, J PEDIATR GENET, V8, P231, DOI 10.1055/s-0039-1691812
   Wang Shi-Bing, 2008, Pediatrics and Neonatology, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   Wang ZX, 2010, NEUROPATHOLOGY, V30, P606, DOI 10.1111/j.1440-1789.2010.01115.x
   Wei YP, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.648740
   Yahata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15871-y
NR 21
TC 1
Z9 1
U1 0
U2 2
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 2146-4596
EI 2146-460X
J9 J PEDIATR GENET
JI J. Pediatr. Genet.
PD 2023 APR 27
PY 2023
DI 10.1055/s-0043-1768474
EA APR 2023
PG 5
WC Pediatrics
WE Emerging Sources Citation Index (ESCI)
SC Pediatrics
GA F1AD8
UT WOS:000979734800001
DA 2024-11-01
ER

PT J
AU Marín-García, J
AF Marin-Garcia, Jose
TI Mitochondrial DNA repair: a novel therapeutic target for heart failure
SO HEART FAILURE REVIEWS
LA English
DT Article
DE CVD; HF; mtDNA repair; POL gamma; TFAM; Twinkle
ID BASE-EXCISION-REPAIR; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MTDNA COPY
   NUMBER; STRAND BREAK REPAIR; OXIDATIVE STRESS; TRANSCRIPTION-FACTOR;
   GENE-EXPRESSION; HUMAN-CELLS; MAMMALIAN MITOCHONDRIA; DILATED
   CARDIOMYOPATHY
AB Mitochondria play a crucial role in a variety of cellular processes ranging from energy metabolism, generation of reactive oxygen species (ROS) and Ca2+ handling to stress responses, cell survival and death. Malfunction of the organelle may contribute to the pathogenesis of neuromuscular, cancer, premature aging and cardiovascular diseases (CVD), including myocardial ischemia, cardiomyopathy and heart failure (HF). Mitochondria contain their own genome organized into DNAprotein complexes, called "mitochondrial nucleoids," along with multiprotein machineries, which promote mitochondrial DNA (mtDNA) replication, transcription and repair. Although the mammalian organelle possesses almost all known nuclear DNA repair pathways, including base excision repair, mismatch repair and recombinational repair, the proximity of mtDNA to the main sites of ROS production and the lack of protective histones may result in increased susceptibility to various types of mtDNA damage. These include accumulation of mtDNA point mutations and/or deletions and decreased mtDNA copy number, which will impair mitochondrial function and finally, may lead to CVD including HF.
C1 [Marin-Garcia, Jose] Mol Cardiol & Neuromuscular Inst, 75 Raritan Ave, Highland Pk, NJ 08904 USA.
RP Marín-García, J (corresponding author), Mol Cardiol & Neuromuscular Inst, 75 Raritan Ave, Highland Pk, NJ 08904 USA.
EM tmci@att.net
CR Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641
   Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Antozzi C, 1997, CARDIOVASC RES, V35, P184, DOI 10.1016/S0008-6363(97)00141-7
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Chen PL, 2013, ONCOGENE, V32, P1193, DOI 10.1038/onc.2012.120
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501
   Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033
   Dodson ML, 2002, FREE RADICAL BIO MED, V32, P678, DOI 10.1016/S0891-5849(02)00767-0
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002
   Garcia CCM, 2010, CHEM RES TOXICOL, V23, P1245, DOI 10.1021/tx1001018
   Garnier A, 2009, CIRC-HEART FAIL, V2, P342, DOI 10.1161/CIRCHEARTFAILURE.108.812099
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012
   Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007
   L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005
   Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1
   LeDoux SP, 1999, MUTAT RES-DNA REPAIR, V434, P149, DOI 10.1016/S0921-8777(99)00026-9
   Lewis W, 2003, AM J PHYSIOL-HEART C, V284, pH1, DOI 10.1152/ajpheart.00814.2002
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   Marin-Garcia J, 2001, CARDIOVASC RES, V49, P17, DOI 10.1016/S0008-6363(00)00241-8
   MarinGarcia J, 1997, J INHERIT METAB DIS, V20, P674, DOI 10.1023/A:1005322409330
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7
   Nakamura J, 1999, CANCER RES, V59, P2522
   Olivero OA, 1997, MUTAT RES-GEN TOX EN, V391, P79, DOI 10.1016/S0165-1218(97)00037-2
   Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Pohjoismäki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137
   Pohjoismäki JLO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010426
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   ROBERTS NK, 1979, AM J CARDIOL, V44, P1396, DOI 10.1016/0002-9149(79)90459-4
   Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466
   Sykora P, 2012, MECH AGEING DEV, V133, P169, DOI 10.1016/j.mad.2011.11.003
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Thorslund T, 2002, DNA REPAIR, V1, P261, DOI 10.1016/S1568-7864(02)00003-4
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang JX, 2011, AM J PHYSIOL-HEART C, V301, pH2073, DOI 10.1152/ajpheart.00157.2011
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z
   Zhang D, 2005, AM J PHYSIOL-HEART C, V288, pH2476, DOI 10.1152/ajpheart.00670.2004
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 103
TC 32
Z9 34
U1 1
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1382-4147
EI 1573-7322
J9 HEART FAIL REV
JI Heart Fail. Rev.
PD SEP
PY 2016
VL 21
IS 5
BP 475
EP 487
DI 10.1007/s10741-016-9543-x
PG 13
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA EB2YG
UT WOS:000387227900002
PM 26940911
DA 2024-11-01
ER

PT J
AU Gramegna, LL
   Evangelisti, S
   Di Vito, L
   La Morgia, C
   Maresca, A
   Caporali, L
   Amore, G
   Talozzi, L
   Bianchini, C
   Testa, C
   Manners, DN
   Cortesi, I
   Valentino, ML
   Liguori, R
   Carelli, V
   Tonon, C
   Lodi, R
AF Gramegna, Laura L.
   Evangelisti, Stefania
   Di Vito, Lidia
   La Morgia, Chiara
   Maresca, Alessandra
   Caporali, Leonardo
   Amore, Giulia
   Talozzi, Lia
   Bianchini, Claudio
   Testa, Claudia
   Manners, David N.
   Cortesi, Irene
   Valentino, Maria L.
   Liguori, Rocco
   Carelli, Valerio
   Tonon, Caterina
   Lodi, Raffaele
TI Brain MRS correlates with mitochondrial dysfunction biomarkers in
   MELAS-associated mtDNA mutations
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; M.3243A-GREATER-THAN-G MUTATION;
   MATTER; DISEASE; ENCEPHALOMYOPATHY; SPECTROSCOPY; ENCEPHALOPATHY;
   PATHOGENESIS; DIAGNOSIS
AB Objective: The purpose of this study was to investigate correlations between brain proton magnetic resonance spectroscopy (H-1-MRS) findings with serum biomarkers and heteroplasmy of mitochondrial DNA (mtDNA) mutations. This study enrolled patients carrying mtDNA mutations associated with Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS), and MELAS-Spectrum Syndrome (MSS). Methods: Consecutive patients carrying mtDNA mutations associated with MELAS and MSS were recruited and their serum concentrations of lactate, alanine, and heteroplasmic mtDNA mutant load were evaluated. The brain protocol included single-voxel H-1-MRS (1.5T) in the medial parieto-occipital cortex (MPOC), left cerebellar hemisphere, parieto-occipital white matter (POWM), and lateral ventricles. Relative metabolite concentrations of N-acetyl-aspartate (NAA), choline (Cho), and myo-inositol (mI) were estimated relative to creatine (Cr), using LCModel 6.3. Results: Six patients with MELAS (age 28 +/- 13 years, 3 [50%] female) and 17 with MSS (age 45 +/- 11 years, 7 [41%] female) and 39 sex- and age-matched healthy controls (HC) were enrolled. These patients demonstrated a lower NAA/Cr ratio in MPOC compared to HC (p = 0.006), which inversely correlated with serum lactate (p = 0.021, rho = -0.68) and muscle mtDNA heteroplasmy (p < 0.001, rho = -0.80). Similarly, in the cerebellum patients had lower NAA/Cr (p < 0.001), Cho/Cr (p = 0.002), and NAA/mI (p = 0.001) ratios, which negatively correlated with mtDNA blood heteroplasmy (p = 0.001, rho = -0.81) and with alanine (p = 0.050, rho = -0.67). Ventricular lactate was present in 78.3% (18/23) of patients, correlating with serum lactate (p = 0.024, rho = 0.58). Conclusion: Correlations were found between the peripheral and biochemical markers of mitochondrial dysfunction and brain in vivo markers of neurodegeneration, supporting the use of both biomarkers as signatures of MELAS and MSS disease, to evaluate the efficacy of potential treatments.
C1 [Gramegna, Laura L.; Tonon, Caterina; Lodi, Raffaele] IRCCS Ist Sci Neurol Bologna, Funct & Mol Neuroimaging Unit, Via Altura 3, I-40139 Bologna, Italy.
   [Gramegna, Laura L.; Evangelisti, Stefania; Amore, Giulia; Talozzi, Lia; Bianchini, Claudio; Manners, David N.; Cortesi, Irene; Valentino, Maria L.; Liguori, Rocco; Carelli, Valerio; Tonon, Caterina; Lodi, Raffaele] Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy.
   [Di Vito, Lidia; La Morgia, Chiara; Maresca, Alessandra; Caporali, Leonardo; Valentino, Maria L.; Liguori, Rocco; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Bologna, Italy.
   [Testa, Claudia] Univ Bologna, Dept Phys & Astron, Bologna, Italy.
C3 IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University
   of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB);
   University of Bologna
RP Tonon, C (corresponding author), IRCCS Ist Sci Neurol Bologna, Funct & Mol Neuroimaging Unit, Via Altura 3, I-40139 Bologna, Italy.
EM caterina.tonon@unibo.it
RI Gramegna, Laura/AAC-6718-2022; Di Vito, Lidia/AAB-8691-2022; Manners,
   David/J-2415-2012; Talozzi, Lia/M-4786-2019; Liguori,
   Rocco/AAB-7860-2020; Tonon, Caterina/K-6680-2016; La Morgia,
   Chiara/H-6765-2012; Caporali, Leonardo/J-7398-2016; Maresca,
   Alessandra/J-7393-2016
OI TALOZZI, LIA/0000-0003-1827-0407; Caporali,
   Leonardo/0000-0002-0666-4380; EVANGELISTI, STEFANIA/0000-0003-4556-8233;
   Bianchini, Claudio/0000-0002-8335-3623; Maresca,
   Alessandra/0000-0002-8959-8832; Di Vito, Lidia/0000-0002-0266-6776
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Gramegna LL, 2018, AM J NEURORADIOL, V39, P427, DOI 10.3174/ajnr.A5507
   Gramegna LL, 2018, NEUROMUSCULAR DISORD, V28, P144, DOI 10.1016/j.nmd.2017.10.007
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Harper L, 2015, J NEUROL NEUROSUR PS, V86, P1225, DOI 10.1136/jnnp-2014-310090
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hovsepian DA, 2019, ACTA NEUROL SCAND, V139, P82, DOI 10.1111/ane.13027
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kloppenborg RP, 2014, NEUROLOGY, V82, P2127, DOI 10.1212/WNL.0000000000000505
   Koedam ELGE, 2011, EUR RADIOL, V21, P2618, DOI 10.1007/s00330-011-2205-4
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Lamperti C, 2012, NEUROMUSCULAR DISORD, V22, P990, DOI 10.1016/j.nmd.2012.06.003
   Leonards CO, 2012, STROKE, V43, P3046, DOI 10.1161/STROKEAHA.111.646554
   Li XD, 2018, J CLIN NEUROSCI, V55, P65, DOI 10.1016/j.jocn.2018.06.015
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   MITOMAP, A Human Mitochondrial Genome Database
   Modrego PJ, 2006, CNS DRUGS, V20, P867, DOI 10.2165/00023210-200620100-00006
   Möller HE, 2005, J NEUROL SCI, V229, P131, DOI 10.1016/j.jns.2004.11.014
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Öz G, 2014, RADIOLOGY, V270, P658, DOI 10.1148/radiol.13130531
   Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604
   Rose SMSF, 2019, NAT MED, V25, P792, DOI 10.1038/s41591-019-0414-6
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tsujikawa T, 2010, BRAIN DEV-JPN, V32, P143, DOI 10.1016/j.braindev.2008.12.003
   Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244
   Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318
   Whitehead MT, 2017, PEDIATR NEUROL, V75, P61, DOI 10.1016/j.pediatrneurol.2017.06.017
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yokoyama T, 2010, NEUROPATHOLOGY, V30, P56, DOI 10.1111/j.1440-1789.2009.01026.x
NR 46
TC 9
Z9 9
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD JUN
PY 2021
VL 8
IS 6
BP 1200
EP 1211
DI 10.1002/acn3.51329
EA MAY 2021
PG 12
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA SK1MK
UT WOS:000647180900001
PM 33951347
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU McInerny, SC
   Brown, AL
   Smith, DW
AF McInerny, Simone C.
   Brown, Amanda L.
   Smith, Doug W.
TI Region-specific changes in mitochondrial D-loop in aged rat CNS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Mitochondrial genome mutation; Hypothesis of aging; Real-time
   quantitative PCR; Mitochondrial genome deletions; Mitochondrial
   replication; Mitochondrial transcription
ID CALORIC RESTRICTION DIET; HUMAN SKIN FIBROBLASTS; MTDNA POINT MUTATIONS;
   DNA COPY NUMBER; OXIDATIVE-PHOSPHORYLATION; PARKINSONS-DISEASE;
   SUBSTANTIA-NIGRA; INDIVIDUAL CELLS; SKELETAL-MUSCLE; HUMAN BRAIN
AB Impaired mitochondrial oxidative phosphorylation (OXPHOS) is considered a cause of aging. A reduction in mitochondrial DNA (mtDNA) replication and/or transcription may contribute to this OXPHOS diminution. Impairments in the displacement (D) loop, or non-coding, region of the mitochondrial genome, or accumulation of mtDNA mutations, may affect mtDNA replication and transcription. We determined the effects of age on the D-loop and on mtDNA deletion mutations in the spinal cord, medulla, midbrain, cerebellum, striatum, and cerebral cortex of Fischer 344 rats. D-loop, 7S DNA levels were reduced by 3-fold in striatum, 2.5-fold in cortex, and 2-fold in the spinal cord of older animals. We did not detect a population of mtDNA affected by the most prevalent known (ND4-containing) deletions, indicating they do not comprise a significant portion of total mtDNA. However, we detected an age-related and region-specific increase in the common deletion, which comprised 0.0003-0.0007% of total mtDNA. Mitochondrial genome copy number varied between regions, in addition to an overall 18% decrease with age across the whole brain. These results suggest the age-related decline in OXPHOS may be related to a reduction in D-loop function. Crown Copyright (C) 2009 Published by Elsevier Ireland Ltd. All rights reserved.
C1 [McInerny, Simone C.; Brown, Amanda L.; Smith, Doug W.] Univ Newcastle, Discipline Anat, Sch Biomed Sci, Callaghan, NSW 2308, Australia.
   [McInerny, Simone C.; Brown, Amanda L.; Smith, Doug W.] Univ Newcastle, Ctr Brain & Mental Hlth Res, Callaghan, NSW 2308, Australia.
   [McInerny, Simone C.; Brown, Amanda L.; Smith, Doug W.] Hunter Med Res Inst, Newcastle, NSW 2310, Australia.
C3 University of Newcastle; University of Newcastle; University of
   Newcastle; Hunter Medical Research Institute
RP Smith, DW (corresponding author), Sch Biomed Sci, Room 306B,Med Sci Bldg,Univ Dr,Callaghan Campus, Callaghan, NSW 2308, Australia.
EM Douglas.smith@newcastle.edu.au
RI Brown, Amanda/KBD-2995-2024; Smith, Doug/ABC-3773-2021
OI Brown, Amanda/0000-0002-0405-0713; Smith, Doug/0000-0002-4406-8061
FU Hunter Medical Research Institute; University of Newcastle; Research
   Grants Scheme; Clive and Vera Ramaciotti Foundation
FX This work was supported by the Hunter Medical Research Institute, the
   University of Newcastle, Research Grants Scheme, and the Clive and Vera
   Ramaciotti Foundation. The authors wish to thank Henrik Steinberg,
   Professor Peter Dunkley and Dr. Chris Dayas for their input on the
   manuscript.
CR Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Cassano P, 2006, REJUV RES, V9, P211, DOI 10.1089/rej.2006.9.211
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Conde JR, 2006, J NEUROPATH EXP NEUR, V65, P199, DOI 10.1097/01.jnen.0000202887.22082.63
   CONLEY K, 2006, EXP PHYSL
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Filburn CR, 1996, MECH AGEING DEV, V87, P35, DOI 10.1016/0047-6374(96)01696-X
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Frietsch T, 2001, ANESTHESIOLOGY, V94, P290, DOI 10.1097/00000542-200102000-00019
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Gerhard GS, 2002, MECH AGEING DEV, V123, P155, DOI 10.1016/S0047-6374(01)00328-1
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Höglinger GU, 2003, J NEUROCHEM, V84, P491, DOI 10.1046/j.1471-4159.2003.01533.x
   Kanaan N.M., 2008, Neurobiol Aging
   Khaidakov A, 2005, EXP GERONTOL, V40, P396, DOI 10.1016/j.exger.2005.02.007
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Meissner C, 2006, EXP GERONTOL, V41, P518, DOI 10.1016/j.exger.2006.03.010
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miller PJ, 1997, EXP NEUROL, V146, P212, DOI 10.1006/exnr.1997.6522
   Nagley P, 2001, NEUROBIOL AGING, V22, P635, DOI 10.1016/S0197-4580(01)00228-7
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Olsson T, 2003, BRAIN RES, V982, P260, DOI 10.1016/S0006-8993(03)03014-2
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   PETRUZZELLA V, 1995, MOL CHEM NEUROPATHOL, V24, P193, DOI 10.1007/BF02962143
   Rex S, 2006, ANESTHESIOLOGY, V105, P936, DOI 10.1097/00000542-200611000-00014
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   SOONG NW, 1992, NAT GENET, V2, P318
   Storm T, 2002, EXP GERONTOL, V37, P1389, DOI 10.1016/S0531-5565(02)00121-3
   Stuart JA, 2005, FREE RADICAL BIO MED, V38, P737, DOI 10.1016/j.freeradbiomed.2004.12.003
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016
   VanTuyle GC, 1996, MUTAT RES-FUND MOL M, V349, P95, DOI 10.1016/0027-5107(95)00165-4
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Zhang CF, 1997, BIOCHEM BIOPH RES CO, V230, P630, DOI 10.1006/bbrc.1996.6020
NR 56
TC 25
Z9 28
U1 0
U2 8
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAY
PY 2009
VL 130
IS 5
BP 343
EP 349
DI 10.1016/j.mad.2009.01.008
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 442AO
UT WOS:000265812300009
PM 19428453
DA 2024-11-01
ER

PT J
AU Diao, SP
   Chen, SF
   Liu, AQ
   Zhou, ZH
   Peng, ZX
   Hong, MF
AF Diao, Sheng-Peng
   Chen, Song-Fa
   Liu, Ai-Qun
   Zhou, Zhi-Hua
   Peng, Zhong-Xing
   Hong, Ming-Fan
TI Elderly onset of MELAS in a male: A case report
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE MELAS; stroke-like episodes; magnetic resonance angiography (MRA);
   migraine; magnetic resonance imaging (MRI)
ID STROKE-LIKE-EPISODES; LACTIC-ACIDOSIS; MITOCHONDRIAL-MYOPATHY; MUSCLE
   BIOPSY; ENCEPHALOPATHY; MUTATION
AB BackgroundMitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) is one of the most common maternally inherited mitochondrial diseases which rarely affects elderly people. Case presentationWe reported the case of a 61-year-old male patient with MELAS. He was experiencing acute migraine-like headaches as the first symptoms. Laboratory data showed elevated lactate and creatine kinase levels. Brain magnetic resonance imaging (MRI) found a high signal intensity lesion in the left occipital-temporal-parietal lobe on diffusion-weighted imaging (DWI). Magnetic resonance angiography (MRA) revealed reversible vasoconstriction of the middle cerebral arteries and superficial temporal arteries. A muscle biopsy suggested minor muscle damage. A genetic study revealed a mitochondrial DNA A3243G mutation. ConclusionElderly onset of MELAS is rare and easily misdiagnosed as an ischemic stroke. MELAS with the onset of stroke-like episodes should be considered in adult or elderly patients with imaging findings that are atypical for cerebral infarction. The use of multimodal MRI in the clinical diagnosis of MELAS could be extremely beneficial.
C1 [Diao, Sheng-Peng; Chen, Song-Fa; Liu, Ai-Qun; Zhou, Zhi-Hua; Peng, Zhong-Xing; Hong, Ming-Fan] Guangdong Pharmaceut Univ, Affiliated Hosp 1, Coll Clin Med, Dept Neurol, Guangzhou, Peoples R China.
C3 Guangdong Pharmaceutical University
RP Hong, MF (corresponding author), Guangdong Pharmaceut Univ, Affiliated Hosp 1, Coll Clin Med, Dept Neurol, Guangzhou, Peoples R China.
EM hmf9001@163.com
RI Yang, Sujuan/ABH-8736-2020
CR Aurangzeb Sidra, 2014, Pract Neurol, V14, P432, DOI 10.1136/practneurol-2014-000853
   Baek MS, 2019, YONSEI MED J, V60, P98, DOI 10.3349/ymj.2019.60.1.98
   Cutrer FM, 2010, SEMIN NEUROL, V30, P120, DOI 10.1055/s-0030-1249222
   Dong X, 2017, NEUROSCI LETT, V636, P127, DOI 10.1016/j.neulet.2016.10.054
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 2019, YONSEI MED J, V60, P399, DOI 10.3349/ymj.2019.60.4.399
   Goldstein A., 2019, DIAGNOSIS MANAGEMENT, DOI [10.1007/978-3-030-05517-2_5, DOI 10.1007/978-3-030-05517-2_5]
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ikawa M, 2013, MITOCHONDRION, V13, P676, DOI 10.1016/j.mito.2013.09.007
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Maeda K, 2016, JAMA NEUROL, V73, P990, DOI 10.1001/jamaneurol.2016.0886
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mukai M, 2017, INTERNAL MED, V56, P95, DOI 10.2169/internalmedicine.56.7301
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Sinnecker T, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1306-6
   van Adel Brian A, 2009, J Clin Neuromuscul Dis, V10, P97, DOI 10.1097/CND.0b013e3181903126
   Yu Q, 2007, MITOCHONDRION, V7, P147, DOI 10.1016/j.mito.2006.11.019
NR 21
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD DEC 1
PY 2022
VL 13
AR 1018529
DI 10.3389/fneur.2022.1018529
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 6Y6CY
UT WOS:000897182100001
PM 36530638
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Da Pozzo, P
   Cardaioli, E
   Rubegni, A
   Gallus, GN
   Malandrini, A
   Rufa, A
   Battisti, C
   Carluccio, MA
   Rocchi, R
   Giannini, F
   Bianchi, A
   Mancuso, M
   Siciliano, G
   Dotti, MT
   Federico, A
AF Da Pozzo, Paola
   Cardaioli, Elena
   Rubegni, Anna
   Gallus, Gian Nicola
   Malandrini, Alessandro
   Rufa, Alessandra
   Battisti, Carla
   Carluccio, Maria Alessandra
   Rocchi, Raffaele
   Giannini, Fabio
   Bianchi, Amedeo
   Mancuso, Michelangelo
   Siciliano, Gabriele
   Dotti, Maria Teresa
   Federico, Antonio
TI Novel <i>POLG</i> mutations and variable clinical phenotypes in 13
   Italian patients
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial diseases; DNA polymerase gamma; Genetics; Clinical
   phenotypes
ID DNA-POLYMERASE-GAMMA; MITOCHONDRIAL; FAMILY; OPHTHALMOPLEGIA;
   NEUROPATHY; DISEASE; ATAXIA; GENE
AB POLG gene encodes the catalytic subunit of DNA polymerase gamma, essential for mitochondrial DNA (mtDNA) replication and repair. Mutations in POLG have been linked to a spectrum of clinical phenotypes, resulting in autosomal recessive or dominant mitochondrial diseases. These mutations have been associated with heterogeneous phenotypes, presenting with varying severity and at different ages of onset, ranging from the neonatal period to late adult life. We screened 13 patients for POLG mutations. All patients underwent a complete neurological examination, and in most of cases, muscle biopsy was performed. We detected 15 different variations in 13 unrelated Italian patients. Two mutations were novel and mapped in the pol domain (p.Thr989dup and p.Ala847Thr) of the enzyme. We also report new cases carrying controversial variations previously described as incompletely penetrant or a variant of unknown significance. Our study increases the range of clinical presentations associated with mutations in POLG gene, underlining some peculiar clinical features, such as PEO associated with corneal edema, and epilepsy, severe neuropathy with achalasia. The addition of two new substitutions, including the second report of an in-frame duplication, to the growing list of defects increases the value of POLG genetic diagnosis in a range of neurological presentations.
C1 [Da Pozzo, Paola; Cardaioli, Elena; Gallus, Gian Nicola; Malandrini, Alessandro; Rufa, Alessandra; Battisti, Carla; Carluccio, Maria Alessandra; Rocchi, Raffaele; Giannini, Fabio; Dotti, Maria Teresa; Federico, Antonio] Univ Siena, Dept Med Surg & Neurol Sci, Viale Bracci 2, I-53100 Siena, Italy.
   [Rubegni, Anna] IRCCS Fdn Stella Maris, Pisa, Italy.
   [Bianchi, Amedeo] Hosp Arezzo, Dept Neurosci, Arezzo, Italy.
   [Mancuso, Michelangelo; Siciliano, Gabriele] Univ Pisa, Dept Neurosci, Neurol Clin, Pisa, Italy.
C3 University of Siena; IRCCS Fondazione Stella Maris; University of Pisa
RP Federico, A (corresponding author), Univ Siena, Dept Med Surg & Neurol Sci, Viale Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
RI Rufa, Alessandra/E-8298-2011; Mancuso, Michelangelo/K-4170-2016; gallus,
   gian/Q-3489-2016; Federico, Antonio/H-8871-2017; Rubegni,
   Anna/I-3221-2018
OI Malandrini, Alessandro/0000-0003-1034-0845; Cardaioli,
   Elena/0000-0003-2850-6698; Rufa, Alessandra/0000-0002-2254-2869;
   Rubegni, Anna/0000-0002-0484-3799
FU Regione Toscana; Ministry of Public Health
FX Research was supported in part by a grant from Regione Toscana and
   Ministry of Public Health to AF (project entitled "Risk and determinants
   of dementia in patients with mild cognitive impairment and brain
   subcortical vascular changes: a study of clinical, neuro-imaging and
   biological markers").
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bortot B, 2009, DIGEST LIVER DIS, V41, P494, DOI 10.1016/j.dld.2008.11.013
   Burusnukul P, 2009, J CHILD NEUROL, V24, P482, DOI 10.1177/0883073808324539
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Colyer MH, 2007, BRIT J OPHTHALMOL, V91, P696, DOI 10.1136/bjo.2006.101055
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   NIEHS-Mitochondrial DNA Replication Group, HUM DNA POL GAMM MUT
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
NR 25
TC 16
Z9 16
U1 0
U2 3
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD APR
PY 2017
VL 38
IS 4
BP 563
EP 570
DI 10.1007/s10072-016-2734-3
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA ER6UF
UT WOS:000398943100004
PM 28130605
DA 2024-11-01
ER

PT S
AU Riley, LG
   Rudinger-Thirion, J
   Schmitz-Abe, K
   Thorburn, DR
   Davis, RL
   Teo, J
   Arbuckle, S
   Cooper, ST
   Campagna, DR
   Frugier, M
   Markianos, K
   Sue, CM
   Fleming, MD
   Christodoulou, J
AF Riley, Lisa G.
   Rudinger-Thirion, Joelle
   Schmitz-Abe, Klaus
   Thorburn, David R.
   Davis, Ryan L.
   Teo, Juliana
   Arbuckle, Susan
   Cooper, Sandra T.
   Campagna, Dean R.
   Frugier, Magali
   Markianos, Kyriacos
   Sue, Carolyn M.
   Fleming, Mark D.
   Christodoulou, John
BE Baumgartner, M
   Patterson, M
   Rahman, S
   Zschocke, J
   Morava, E
TI LARS2 Variants Associated with Hydrops, Lactic Acidosis, Sideroblastic
   Anemia, and Multisystem Failure
SO JIMD REPORTS, VOL 28
SE JIMD Reports
LA English
DT Article; Book Chapter
ID TRANSFER-RNA SYNTHETASE; PREMATURE OVARIAN FAILURE; ESCHERICHIA-COLI;
   MITOCHONDRIAL MYOPATHY; PERRAULT SYNDROME; YARS2 MUTATIONS;
   HEARING-LOSS; AMINOACYLATION; MANAGEMENT; DIAGNOSIS
AB Pathogenic variants in mitochondrial aminoacyl-tRNA synthetases result in a broad range of mitochondrial respiratory chain disorders despite their shared role in mitochondrial protein synthesis. LARS2 encodes the mitochondrial leucyl-tRNA synthetase, which attaches leucine to its cognate tRNA. Sequence variants in LARS2 have previously been associated with Perrault syndrome, characterized by premature ovarian failure and hearing loss (OMIM #615300). In this study, we report variants in LARS2 that are associated with a severe multisystem metabolic disorder. The proband was born prematurely with severe lactic acidosis, hydrops, and sideroblastic anemia. She had multisystem complications with hyaline membrane disease, impaired cardiac function, a coagulopathy, pulmonary hypertension, and progressive renal disease and succumbed at 5 days of age. Whole exome sequencing of patient DNA revealed compound heterozygous variants in LARS2 (c.1289C>T; p.Ala430Val and c.1565C>A; p.Thr522Asn). The c.1565C>A (p.Thr522Asn) LARS2 variant has previously been associated with Perrault syndrome and both identified variants are predicted to be damaging (SIFT, PolyPhen). Muscle and liver samples from the proband did not display marked mitochondrial respiratory chain enzyme deficiency. Immunoblotting of patient muscle and liver showed LARS2 levels were reduced in liver and complex I protein levels were reduced in patient muscle and liver. Aminoacylation assays revealed p.Ala430Val LARS2 had an 18-fold loss of catalytic efficiency and p.Thr522Asn a 9-fold loss compared to wild-type LARS2. We suggest that the identified LARS2 variants are responsible for the severe multisystem clinical phenotype seen in this baby and that mutations in LARS2 can result in variable phenotypes.
C1 [Riley, Lisa G.; Christodoulou, John] Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Locked Bag 4001, Westmead, NSW 2145, Australia.
   [Riley, Lisa G.; Cooper, Sandra T.; Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW, Australia.
   [Rudinger-Thirion, Joelle; Frugier, Magali] Univ Strasbourg, Architecture & Reactivite ARN, CNRS, IBMC, Strasbourg, France.
   [Schmitz-Abe, Klaus; Markianos, Kyriacos] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Div Genet & Genom, Boston, MA USA.
   [Schmitz-Abe, Klaus; Markianos, Kyriacos] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA.
   [Schmitz-Abe, Klaus] Broad Inst, Cambridge, MA USA.
   [Thorburn, David R.] Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Thorburn, David R.] Univ Melbourne, Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Davis, Ryan L.; Sue, Carolyn M.] Univ Sydney, Dept Neurogenet, Kolling Inst Med Res, Sydney, NSW, Australia.
   [Davis, Ryan L.; Sue, Carolyn M.] Royal North Shore Hosp, Sydney, NSW, Australia.
   [Teo, Juliana] Childrens Hosp Westmead, Dept Haematol, Sydney, NSW, Australia.
   [Arbuckle, Susan] Childrens Hosp Westmead, Dept Pathol, Sydney, NSW, Australia.
   [Cooper, Sandra T.] Childrens Hosp Westmead, Kids Res Inst, Inst Neurosci & Muscle Res, Sydney, NSW, Australia.
   [Campagna, Dean R.; Fleming, Mark D.] Harvard Med Sch, Boston Childrens Hosp, Dept Pathol, Boston, MA USA.
   [Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Genet Med, Sydney, NSW, Australia.
C3 NSW Health; The Children's Hospital at Westmead; University of Sydney;
   Sydney Childrens Hospitals Network; University of Sydney; Universites de
   Strasbourg Etablissements Associes; Universite de Strasbourg; Centre
   National de la Recherche Scientifique (CNRS); Harvard University; Boston
   Children's Hospital; Harvard Medical School; Harvard University; Boston
   Children's Hospital; Harvard University; Massachusetts Institute of
   Technology (MIT); Broad Institute; Murdoch Children's Research
   Institute; University of Melbourne; Murdoch Children's Research
   Institute; Victorian Clinical Genetics Services; University of
   Melbourne; Royal Children's Hospital Melbourne; University of Sydney;
   Kolling Institute of Medical Research; Royal North Shore Hospital;
   University of Sydney; NSW Health; The Children's Hospital at Westmead;
   University of Sydney; NSW Health; The Children's Hospital at Westmead;
   NSW Health; The Children's Hospital at Westmead; University of Sydney;
   Harvard University; Boston Children's Hospital; Harvard Medical School;
   University of Sydney
RP Riley, LG (corresponding author), Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Locked Bag 4001, Westmead, NSW 2145, Australia.
EM lisa.riley@health.nsw.gov.au
RI Thorburn, David/G-6266-2013; Christodoulou, John/M-3628-2019; Davis,
   Ryan/A-7430-2015
OI Schmitz-Abe, Klaus E./0000-0002-7242-8861; Sue,
   Carolyn/0000-0003-1255-3617; Davis, Ryan/0000-0003-0512-8989; thorburn,
   david/0000-0002-7725-9470; Markianos, Kyriacos/0000-0003-0214-6014;
   Cooper, Sandra/0000-0002-7314-5097
FU NIDDK NIH HHS [R01 DK087992] Funding Source: Medline
CR Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bottomley SS, 2014, HEMATOL ONCOL CLIN N, V28, P653, DOI 10.1016/j.hoc.2014.04.008
   Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956
   Du X, 2003, J PROTEIN CHEM, V22, P71, DOI 10.1023/A:1023071928587
   Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v
   McKenzie M, 2009, METHOD ENZYMOL, V456, P321, DOI 10.1016/S0076-6879(08)04418-2
   Menezes MJ, 2014, BBA-GEN SUBJECTS, V1840, P1368, DOI 10.1016/j.bbagen.2013.12.025
   Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w
   Nakajima J, 2014, J HUM GENET, V59, P229, DOI 10.1038/jhg.2013.143
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317
   PERRET V, 1990, NATURE, V344, P787, DOI 10.1038/344787a0
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193
   Sarkar J, 2012, J BIOL CHEM, V287, P14772, DOI 10.1074/jbc.M111.322412
   SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763
   Shahni R, 2013, AM J MED GENET A, V161, P2334, DOI 10.1002/ajmg.a.36065
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Talim B, 2013, BRAIN, V136, DOI 10.1093/brain/aws197
   Yao YN, 2003, PROTEIN EXPRES PURIF, V30, P112, DOI 10.1016/S1046-5928(03)00097-4
NR 29
TC 48
Z9 52
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
BN 978-3-662-52847-1; 978-3-662-52846-4
J9 JIMD REP
PY 2016
VL 28
BP 49
EP 57
DI 10.1007/8904_2015_515
D2 10.1007/978-3-662-52847-1
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity
WE Book Citation Index – Science (BKCI-S)
SC Endocrinology & Metabolism; Genetics & Heredity
GA BI0QY
UT WOS:000405111900006
PM 26537577
OA Green Published
DA 2024-11-01
ER

PT J
AU Miller, C
   Saada, A
   Shaul, N
   Shabtai, N
   Ben-Shalom, E
   Shaag, A
   Hershkovitz, E
   Elpeleg, O
AF Miller, C
   Saada, A
   Shaul, N
   Shabtai, N
   Ben-Shalom, E
   Shaag, A
   Hershkovitz, E
   Elpeleg, O
TI Defective mitochondrial translation caused by a ribosomal protein
   (MRPS16) mutation
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID SUBUNIT; COMPLEMENT; MYOPATHY; S16; DNA
AB The mitochondrial respiratory chain comprises 85 subunits, 13 of which are mitochondrial encoded. The synthesis of these 13 proteins requires many nuclear-encoded proteins that participate in mitochondrial DNA replication, transcript production, and a distinctive mitochondrial translation apparatus. We report a patient with agenesis of corpus callosum, dysmorphism, and fatal neonatal lactic acidosis with markedly decreased complex I and IV activity in muscle and liver and a generalized mitochondrial translation defect identified in pulse-label experiments. The defect was associated with marked reduction of the 12S rRNA transcript level likely attributed to a nonsense mutation in the MRPS16 gene. A new group of mitochondrial respiratory chain disorders is proposed, resulting from mutations in nuclear encoded components of the mitochondrial translation apparatus.
C1 Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel.
   Ben Gurion Univ Negev, Soroka Med Ctr, Fac Med, Dept Pediat, IL-84105 Beer Sheva, Israel.
   Hebrew Univ Jerusalem, Sch Med, IL-91010 Jerusalem, Israel.
C3 Hebrew University of Jerusalem; Shaare Zedek Medical Center; Ben Gurion
   University; Soroka Medical Center; Hebrew University of Jerusalem
RP Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel.
EM elpeleg@cc.huji.ac.il
RI Hershkovitz, Eli/F-1922-2012; Saada, Ann/J-6864-2017
OI Hershkovitz, Eli/0000-0003-1624-1960; Saada, Ann/0000-0003-2951-0656
CR Allard P, 2000, STRUCT FOLD DES, V8, P875, DOI 10.1016/S0969-2126(00)00177-5
   Bonnefoy E, 1997, EUR J BIOCHEM, V247, P852, DOI 10.1111/j.1432-1033.1997.t01-1-00852.x
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   CHOMYN A, 1996, METHOD ENZYMOL, V264, P196
   DENNIS PP, 1975, J BACTERIOL, V121, P994, DOI 10.1128/JB.121.3.994-999.1975
   DOOIJEWAARD G, 1976, BIOCHIM BIOPHYS ACTA, V440, P1, DOI 10.1016/0005-2728(76)90109-2
   HOPPEL C, 1969, ARCH BIOCHEM BIOPHYS, V135, P173, DOI 10.1016/0003-9861(69)90528-1
   Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285
   Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200
   Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sasarman F, 2002, HUM MOL GENET, V11, P1669, DOI 10.1093/hmg/11.14.1669
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Toivonen JM, 2001, GENETICS, V159, P241
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
NR 16
TC 178
Z9 201
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD NOV
PY 2004
VL 56
IS 5
BP 734
EP 738
DI 10.1002/ana.20282
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 869FR
UT WOS:000224969300020
PM 15505824
DA 2024-11-01
ER

PT J
AU Wang, M
   Zhou, XL
   Liu, RJ
   Fang, ZP
   Zhou, M
   Eriani, G
   Wang, ED
AF Wang, Meng
   Zhou, Xiao-Long
   Liu, Ru-Juan
   Fang, Zhi-Peng
   Zhou, Mi
   Eriani, Gilbert
   Wang, En-Duo
TI Multilevel functional and structural defects induced by two pathogenic
   mitochondrial tRNA mutations
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE CCA-adding modification; elongation factor Tu (EF-Tu); mitochondria;
   pathogenicity; tRNA
ID T-STEM; CRYSTAL-STRUCTURE; SPORADIC PATIENT; MTDNA MUTATION;
   AMINO-ACIDS; AMINOACYLATION; MATURATION; MYOPATHY; DYNAMICS; BINDING
AB Point mutations in hmtRNAs (human mitochondrial tRNAs) can cause various disorders, such as CPEO (chronic progressive external ophthalmoplegia) and MM (mitochondrial myopathy). Mitochondrial tRNA(Leu), especially the UUR codon isoacceptor, is recognized as a hot spot for pathogenic mtDNA point mutations. Thus far, 40 mutations have been reported in hmtRNAs(Leu). In the present paper, we describe the wide range of effects of two substitutions found in the T Psi C arms of two hmtRNAs(Leu) isoacceptors. The G52A substitution, corresponding to the pathogenic G12315A mutation in tRNA(Leu) (CUN), and G3283A in tRNA(Leu) (UUR) exhibited structural changes in the outer corner of the tRNA shape as shown by RNase probing. These mutations also induced reductions in aminoacylation, 3'-end processing and base modification processes. The main effects of the A57G substitution, corresponding to mutations Al2320G in tRNA(Leu)(CUN) and A3288G in tRNA(Leu)(UUR), were observed on the aminoacylation activity and binding to hmEF-Tu (human mitochondrial elongation factor Tu). These observations suggest that the wide range of effects may amplify the deleterious impact on mitochondrial protein synthesis in vivo. The findings also emphasize that an exact understanding of tRNA dysfunction is critical for the future development of therapies for mitochondrial diseases.
C1 [Wang, Meng; Zhou, Xiao-Long; Liu, Ru-Juan; Fang, Zhi-Peng; Zhou, Mi; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Ctr RNA Res,State Key Lab Mol Biol, Shanghai 200031, Peoples R China.
   [Wang, Meng; Eriani, Gilbert] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France.
C3 Chinese Academy of Sciences; Center for Excellence in Molecular Cell
   Science, CAS; Centre National de la Recherche Scientifique (CNRS);
   Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg
RP Eriani, G (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, 15 Rue Rene Descartes, F-67084 Strasbourg, France.
EM g.eriani@ibmc-cnrs.unistra.fr; edwang@sibcb.ac.cn
RI Fang, Zhipeng/HMW-1650-2023; li, jinsong/HJH-9559-2023; Li,
   Jia/F-9116-2011
OI Liu, Ru-Juan/0000-0001-7459-3126; Eriani, Gilbert/0000-0002-8518-4675;
   Fang, Zhipeng/0000-0001-5720-1709; Wang, Meng/0000-0001-6665-5884
FU National Key Basic Research Foundation of China [2012CB911000]; Natural
   Science Foundation of China [30930022, 31000355, 31130064]; Committee of
   Science and Technology in Shanghai [12JC1409700]; Centre National de la
   Recherche Scientific (CNRS); Chinese Academy of Sciences [2011T2S10];
   Chinese Academy of Sciences (Sino-France)
FX This work was supported by the National Key Basic Research Foundation of
   China [grant number 2012CB911000], the Natural Science Foundation of
   China [grant numbers 30930022, 31000355 and 31130064], the Committee of
   Science and Technology in Shanghai [grant number 12JC1409700], the
   Centre National de la Recherche Scientific (CNRS), a Visiting
   Professorship for Senior International Scientists from the Chinese
   Academy of Sciences [grant number 2011T2S10] and the Joint Doctoral
   Promotion Program of the Chinese Academy of Sciences (Sino-France) (to
   W.M.).
CR Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Brulé H, 2004, BIOCHEMISTRY-US, V43, P9243, DOI 10.1021/bi049671q
   Brunel C, 2000, METHOD ENZYMOL, V318, P3
   Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763
   Chimnaronk S, 2009, BIOCHEMISTRY-US, V48, P5057, DOI 10.1021/bi900337d
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010
   COLE PE, 1972, BIOCHEMISTRY-US, V11, P4358, DOI 10.1021/bi00773a024
   Du X, 2003, NUCLEIC ACIDS RES, V31, P2865, DOI 10.1093/nar/gkg382
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   ERICSON JU, 1991, J MOL BIOL, V218, P509, DOI 10.1016/0022-2836(91)90697-5
   Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Goto-Ito S, 2009, NAT STRUCT MOL BIOL, V16, P1109, DOI 10.1038/nsmb.1653
   Hadjigeorgiou GM, 1999, J NEUROL SCI, V164, P153, DOI 10.1016/S0022-510X(99)00062-3
   Hao R, 2005, NUCLEIC ACIDS RES, V33, P3606, DOI 10.1093/nar/gki677
   Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004
   Hauenstein SI, 2008, J BIOL CHEM, V283, P22007, DOI 10.1074/jbc.M801839200
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636
   Hino N, 2004, GENES CELLS, V9, P243, DOI 10.1111/j.1356-9597.2004.00718.x
   Hunter Senyene Eyo, 2004, RNA Biol, V1, P95, DOI 10.4161/rna.1.2.1034
   Jühling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   Kelley SO, 2001, J BIOL CHEM, V276, P10607, DOI 10.1074/jbc.M008320200
   LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242
   Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Li Y, 1999, PROTEIN EXPRES PURIF, V16, P355, DOI 10.1006/prep.1999.1083
   Maeso E, 2007, NEUROMUSCULAR DISORD, V17, P415, DOI 10.1016/j.nmd.2007.01.015
   MANS RJ, 1960, BIOCHEM BIOPH RES CO, V3, P540, DOI 10.1016/0006-291X(60)90171-6
   MORL M, 1995, NUCLEIC ACIDS RES, V23, P3380, DOI 10.1093/nar/23.17.3380
   Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200
   NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317
   PERRET V, 1990, NATURE, V344, P787, DOI 10.1038/344787a0
   PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304
   Pulkes T, 2001, ADV DRUG DELIVER REV, V49, P27, DOI 10.1016/S0169-409X(01)00124-7
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Seif E, 2009, J BIOL CHEM, V284, P6600, DOI 10.1074/jbc.C800235200
   Silberklang M, 1979, Methods Enzymol, V59, P58
   Sohm N, 2004, J MOL BIOL, V339, P17, DOI 10.1016/j.jmb.2004.03.066
   Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65
   Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712
   Tomita K, 2006, NATURE, V443, P956, DOI 10.1038/nature05204
   Valente L, 2009, BBA-MOL BASIS DIS, V1792, P791, DOI 10.1016/j.bbadis.2009.06.002
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711
   Yao YN, 2003, PROTEIN EXPRES PURIF, V30, P112, DOI 10.1016/S1046-5928(03)00097-4
   YARUS M, 1970, ANAL BIOCHEM, V35, P450, DOI 10.1016/0003-2697(70)90207-1
   Zhang CM, 2008, NAT STRUCT MOL BIOL, V15, P507, DOI 10.1038/nsmb.1423
NR 57
TC 10
Z9 11
U1 0
U2 9
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD AUG 1
PY 2013
VL 453
BP 455
EP 465
DI 10.1042/BJ20130294
PN 3
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 190RU
UT WOS:000322358700014
PM 23631826
OA Green Submitted
DA 2024-11-01
ER

PT S
AU Reeve, AK
   Krishnan, KJ
   Turnbull, D
AF Reeve, Amy K.
   Krishnan, Kim J.
   Turnbull, Doug
BE Gibson, GE
   Ratan, RR
   Beal, MF
TI Mitochondrial DNA Mutations in Disease, Aging, and Neurodegeneration
SO MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT Conference on Mitochondria and Oxisative Stress in Neurodegenerative
   Disorders
CY SEP 26-29, 2007
CL New York Acad Sci, New York, NY
SP Weill Med Coll, Cornell Univ, Grad Sch Med Sci, Ellison Med Fdn, Burke Med Res Inst
HO New York Acad Sci
DE mitochondrial; DNA; mutations
ID HUMAN SUBSTANTIA-NIGRA; MTDNA POINT MUTATIONS; PARKINSONS-DISEASE;
   CONTROL REGION; DELETION MUTATIONS; NEURONS; MUSCLE; ACCUMULATION;
   NEUROPATHOLOGY; APOPTOSIS
AB Patients with disorders from mutations in the mitochondrial genome have variable phenotypes, but common to many of these disorders are underlying changes in postmitotic cells, particularly neurons and muscle fibers. The mitochondrial dysfunction caused by these mutations has been shown to be associated with signs of apoptosis and to cause cell loss. Mutations of the mitochondrial genome have also been shown to accumulate with age and in common neurodegenerative diseases, such as Parkinson's disease. This review presents recent data to show that the information gained from studying patients with mitochondrial disorders can help our understanding of the role of mitochondrial DNA mutations in brain aging and neurodegeneration.
C1 [Reeve, Amy K.; Krishnan, Kim J.; Turnbull, Doug] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Krishnan, Kim J.; Turnbull, Doug] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Turnbull, D (corresponding author), Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM d.m.turnbull@ncl.ac.uk
RI Clugston, Kim/KBA-3107-2024
OI Reeve, Amy/0000-0002-4474-2204
CR Aomi Y, 2001, BIOCHEM BIOPH RES CO, V280, P265, DOI 10.1006/bbrc.2000.4113
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   BAUS J, 2004, NEUROCHEM RES, V29, P505
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   CARON F, 1979, P NATL ACAD SCI USA, V76, P4265, DOI 10.1073/pnas.76.9.4265
   Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Chinnery PF, 2001, AM J HUM GENET, V68, P529, DOI 10.1086/318204
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710
   HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   MARGULIS L, 1971, SCI AM, V225, P49
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350
   Nakabeppu Y, 2001, PROG NUCLEIC ACID RE, V68, P75
   Pak JW, 2005, EXP GERONTOL, V40, P209, DOI 10.1016/j.exger.2004.12.005
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Simon DK, 2001, GENOMICS, V73, P113, DOI 10.1006/geno.2001.6515
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
NR 58
TC 121
Z9 133
U1 2
U2 18
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA
SN 0077-8923
BN 978-1-57331-713-9
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2008
VL 1147
BP 21
EP 29
DI 10.1196/annals.1427.016
PG 9
WC Cell Biology; Multidisciplinary Sciences; Neurosciences; Physiology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Science & Technology - Other Topics; Neurosciences &
   Neurology; Physiology
GA BIR99
UT WOS:000262397800003
PM 19076427
DA 2024-11-01
ER

PT J
AU Artuso, L
   Zoccolella, S
   Favia, P
   Amati, A
   Capozzo, R
   Logroscino, G
   Serlenga, L
   Simone, I
   Gasparre, G
   Petruzzella, V
AF Artuso, Lucia
   Zoccolella, Stefano
   Favia, Paola
   Amati, Angela
   Capozzo, Rosa
   Logroscino, Giancarlo
   Serlenga, Luigi
   Simone, Isabella
   Gasparre, Giuseppe
   Petruzzella, Vittoria
TI Mitochondrial genome aberrations in skeletal muscle of patients with
   motor neuron disease
SO AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION
LA English
DT Article
DE SOD1; mitochondria; DNA
ID AMYOTROPHIC-LATERAL-SCLEROSIS; OXIDATIVE DAMAGE; SPINAL-CORDS; DNA;
   GENE; MUTATION; PROTEIN; INVOLVEMENT; STRESS; MODEL
AB Our objective was to assess the role of defects of mitochondrial function as contributing factors in the pathogenesis and/or progression of amyotrophic lateral sclerosis (ALS); mitochondrial genome structural alterations were investigated. DNA lesions, point alterations and gross rearrangements were screened by specific applications of real-time PCR including an optimized rapid gene-specific method for the accurate quantification of mitochondrial DNA (mtDNA) lesions as well as sequencing on skeletal muscle biopsies of three patients presenting with motor neuron disease. We found a higher frequency of mtDNA lesions, including multiple deletions, particularly in the only SOD1 mutated patient as well as in a patient negative for mutations in SOD1 but presenting a severe form of the disease. The occurrence and the extent of mtDNA lesions of the cases here presented were consistent in all the examined clinical phenotypes of ALS (SOD1 related ALS, bulbar onset, spinal onset) and correlated with the severity of clinical course of the illness and with the presence of SOD1 mutation as well. In conclusion, the strong association with mtDNA damages supports the hypothesis that mitochondrial dysfunction in skeletal muscle may contribute to the pathogenesis and progression of ALS.
C1 [Artuso, Lucia; Zoccolella, Stefano; Favia, Paola; Amati, Angela; Capozzo, Rosa; Logroscino, Giancarlo; Serlenga, Luigi; Simone, Isabella; Petruzzella, Vittoria] Univ Bari Aldo Moro, Dipartimento Sci Med Base Neurosci & Organi Sanso, I-70124 Bari, Italy.
   [Gasparre, Giuseppe] Univ Bologna, UO Genet Med, Dipartimento Sci Ginecol Ostetr & Pediat, Bologna, Italy.
C3 Universita degli Studi di Bari Aldo Moro; University of Bologna
RP Petruzzella, V (corresponding author), Univ Bari Aldo Moro, Dipartimento Sci Med Base Neurosci & Organi Sanso, Piazza Giulio Cesare 11, I-70124 Bari, Italy.
EM vittoria.petruzzella@uniba.it
RI zoccolella, stefano/AAA-2515-2020; Simone, sabella/K-9755-2018; d’Amati,
   Antonio/AAT-7253-2021; Capozzo, Rosa/AAC-2716-2019; Gasparre,
   Giuseppe/K-3879-2016; Logroscino, Giancarlo/K-5148-2016; Petruzzella,
   Vittoria/K-8863-2016
OI Gasparre, Giuseppe/0000-0003-1229-9006; Logroscino,
   Giancarlo/0000-0003-0423-3242; Petruzzella,
   Vittoria/0000-0001-8771-6033; Simone, Isabella
   Laura/0000-0002-7429-3091; Artuso, Lucia/0000-0002-3058-9739
FU University of Bari; FIRB 'Futuro in Ricerca' project TRANSMIT
FX This work was supported by 2010 funds from the University of Bari (Fondi
   ex-60%, 2009-2011) and partly by FIRB 'Futuro in Ricerca' project
   TRANSMIT to G.G.
CR Andrus PK, 1998, J NEUROCHEM, V71, P2041
   Bacman SR, 2006, MOL NEUROBIOL, V33, P113, DOI 10.1385/MN:33:2:113
   Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8
   BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x
   Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244
   Cleary JO, 2011, NEUROIMAGE, V56, P974, DOI 10.1016/j.neuroimage.2011.01.082
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Conforti FL, 2009, AMYOTROPH LATERAL SC, V10, P58, DOI 10.1080/17482960802163853
   Dhaliwal GK, 2000, NEUROREPORT, V11, P2507, DOI 10.1097/00001756-200008030-00032
   Ferrante RJ, 1997, J NEUROCHEM, V69, P2064
   Fischer LR, 2012, EXP NEUROL, V233, P163, DOI 10.1016/j.expneurol.2011.09.020
   Fitzmaurice PS, 1996, MUSCLE NERVE, V19, P797
   Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.0.CO;2-H
   Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489
   Hirano M, 2008, ARCH NEUROL-CHICAGO, V65, P403, DOI 10.1001/archneurol.2007.65
   Keeney PM, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-21
   Liu DX, 1999, FASEB J, V13, P2318, DOI 10.1096/fasebj.13.15.2318
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Magrané J, 2009, ANTIOXID REDOX SIGN, V11, P1615, DOI [10.1089/ars.2009.2604, 10.1089/ARS.2009.2604]
   Menzies FM, 2002, NEUROCHEM INT, V40, P543, DOI 10.1016/S0197-0186(01)00125-5
   Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518
   Pesaresi MG, 2011, HUM MOL GENET, V20, P4196, DOI 10.1093/hmg/ddr347
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082
   Sasaki S, 1996, NEUROSCI LETT, V204, P53, DOI 10.1016/0304-3940(96)12314-4
   Shi P, 2009, BIOCHIM BIOPHYS ACTA, V1802, P45
   SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001
   Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008
   Traub R, 2011, CURR NEUROL NEUROSCI, V11, P67, DOI 10.1007/s11910-010-0160-0
   Van Damme P, 2009, CURR OPIN NEUROL, V22, P486, DOI 10.1097/WCO.0b013e32832ffbe3
   Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
   Zoccolella S, 2012, EUR J NEUROL, V19, pe63, DOI 10.1111/j.1468-1331.2012.03720.x
NR 38
TC 12
Z9 13
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2167-8421
EI 2167-9223
J9 AMYOTROPH LAT SCL FR
JI Amyotroph. Lateral Scher. Frontotemp. Degenerat.
PD MAY
PY 2013
VL 14
IS 4
BP 261
EP 266
DI 10.3109/21678421.2012.735239
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 143QT
UT WOS:000318883000004
PM 23134511
DA 2024-11-01
ER

PT J
AU Esterhuizen, K
   Lindeque, JZ
   Mason, S
   van der Westhuizen, FH
   Rodenburg, RJ
   de Laat, P
   Smeitink, JAM
   Janssen, MCH
   Louw, R
AF Esterhuizen, Karien
   Lindeque, J. Zander
   Mason, Shayne
   van der Westhuizen, Francois H.
   Rodenburg, Richard J.
   de Laat, Paul
   Smeitink, Jan A. M.
   Janssen, Mirian C. H.
   Louw, Roan
TI One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD
   and myopathy caused by the m.3243A &gt; G mutation
SO METABOLOMICS
LA English
DT Article
DE MELAS; MIDD; Myopathy; Metabolomics; m.3243A > G; Mitochondrial disease
ID STROKE-LIKE-EPISODES; RAGGED-RED FIBERS; MITOCHONDRIAL-MYOPATHY;
   LACTIC-ACIDOSIS; LIPOIC ACID; DIAGNOSIS; ENCEPHALOPATHY; FEATURES;
   INSULIN; SYNTHASE
AB Introduction The m.3243A > G mitochondrial DNA mutation is one of the most common mitochondrial disease-causing mutations, with a carrier rate as high as 1:400. This point mutation affects the MT-TL1 gene, ultimately affecting the oxidative phosphorylation system and the cell's energy production. Strikingly, the m.3243A > G mutation is associated with different phenotypes, including mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), maternally inherited diabetes and deafness (MIDD) and myopathy.
   Objectives We investigated urine metabolomes of MELAS, MIDD and myopathy patients in order to identify affected metabolic pathways and possible treatment options.
   Methods A multiplatform metabolomics approach was used to comprehensively analyze the metabolome and compare metabolic profiles of different phenotypes caused by the m.3243A > G mutation. Our analytical array consisted of NMR spectroscopy, LC-MS/MS and GC-TOF-MS.
   Results The investigation revealed phenotypic specific metabolic perturbations, as well as metabolic similarities between the different phenotypes. We show that glucose metabolism is highly disturbed in the MIDD phenotype, but not in MELAS or myopathy, remodeled fatty acid oxidation is characteristic of the MELAS patients, while one-carbon metabolism is strongly modified in both MELAS and MIDD, but not in the myopathy group. Lastly we identified increased creatine in the urine of the myopathy patients, but not in MELAS or MIDD.
   Conclusion We conclude by giving novel insight on the phenotypes of the m.3243A > G mutation from a metabolomics point of view. Directives are also given for future investigations that could lead to better treatment options for patients suffering from this debilitating disease.
C1 [Esterhuizen, Karien; Lindeque, J. Zander; Mason, Shayne; van der Westhuizen, Francois H.; Louw, Roan] North West Univ, Mitochondria Res Lab, Human Metabol, Potchefstroom, South Africa.
   [Rodenburg, Richard J.; de Laat, Paul; Smeitink, Jan A. M.; Janssen, Mirian C. H.] Radboud Univ Nijmegen, Dept Pediat, Radboud Ctr Mitochondrial Med, Med Ctr, Nijmegen, Netherlands.
   [Janssen, Mirian C. H.] Radboud Univ Nijmegen, Dept Internal Med, Radboud Ctr Mitochondrial Med, Med Ctr, Nijmegen, Netherlands.
   [Louw, Roan] North West Univ, Fac Nat & Agr Sci, Human Metabol, Potchefstroom Campus,Private Bag X6001, Potchefstroom, South Africa.
C3 North West University - South Africa; Radboud University Nijmegen;
   Radboud University Nijmegen; North West University - South Africa
RP Louw, R (corresponding author), North West Univ, Mitochondria Res Lab, Human Metabol, Potchefstroom, South Africa.
EM Roan.Louw@nwu.ac.za
RI Rodenburg, Richard/N-3579-2014; Smeitink, Jan/D-6064-2011; Lindeque,
   Zander/HJZ-1473-2023; de Laat, Paul/O-9851-2019; van der Westhuizen,
   Francois/E-6959-2011; Janssen, Mirian/D-9777-2016
OI Lindeque, Zander/0000-0001-8017-4278; Louw, Roan/0000-0002-6542-8644;
   van der Westhuizen, Francois/0000-0002-7879-1776; Mason,
   Shayne/0000-0002-2945-5768; Janssen, Mirian/0000-0003-4668-9977
FU Technology Innovation Agency (TIA), South Africa [Metabol. 01]
FX We would like to thank Prof. L.J. Mienie from the North-West University,
   Potchefstroom, South Africa, for valuable help with the interpretation
   of the metabolic data. The research was supported by a grant from the
   Technology Innovation Agency (TIA, Grant Number Metabol. 01), South
   Africa. The research facilities were provided by the National
   Metabolomics Platform, North-West University, Potchefstroom Campus,
   Potchefstroom, South Africa.
CR Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575
   Brière JJ, 2004, BBA-BIOENERGETICS, V1659, P172, DOI 10.1016/j.bbabio.2004.07.002
   Buzkova J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809091
   Carbonneau M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12700
   Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Esterhuizen K, 2019, MITOCHONDRION, V45, P38, DOI 10.1016/j.mito.2018.02.003
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Fu XD, 2015, CELL METAB, V22, P508, DOI 10.1016/j.cmet.2015.06.009
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Hernández-Luis C, 2007, REV ESP CARDIOL, V60, P89, DOI 10.1016/S0300-8932(07)74995-3
   Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200
   HOLM S, 1979, SCAND J STAT, V6, P65
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kami K, 2012, MITOCHONDRION, V12, P644, DOI 10.1016/j.mito.2012.07.113
   KASSEL DB, 1986, BIOMED ENVIRON MASS, V13, P535, DOI 10.1002/bms.1200131004
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Kennedy AD, 2016, GENET TEST MOL BIOMA, V20, P485, DOI 10.1089/gtmb.2015.0291
   Khamis MM, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1418-9
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marshall DD, 2017, PROG NUCL MAG RES SP, V100, P1, DOI 10.1016/j.pnmrs.2017.01.001
   McLaughlin MJ, 2014, PM&R, V6, P544, DOI 10.1016/j.pmrj.2014.04.006
   Mignarri A, 2015, J NEUROL SCI, V349, P254, DOI 10.1016/j.jns.2014.12.040
   Muoio DM, 2008, DIABETES, V57, P1455, DOI 10.2337/db08-0281
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Padmalayam I, 2009, DIABETES, V58, P600, DOI 10.2337/db08-0473
   Park SY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00520
   Pinto M, 2014, BBA-MOL BASIS DIS, V1842, P1198, DOI 10.1016/j.bbadis.2013.11.012
   PISTERS PWT, 1992, SURGERY, V111, P301
   Reinecke CJ, 2012, METABOLOMICS, V8, P264, DOI 10.1007/s11306-011-0309-0
   Rowland LP, 1993, HDB CLIN NEUROLOGY, V22, P177
   Sage-Schwaede A, 2019, ANN CLIN TRANSL NEUR, V6, P1877, DOI 10.1002/acn3.50846
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Smuts I, 2013, METABOLOMICS, V9, P379, DOI 10.1007/s11306-012-0455-z
   Vollmar AKR, 2019, METABOLITES, V9, DOI 10.3390/metabo9100198
   Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11
   Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131
   Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005
   Zhang AH, 2012, ANALYST, V137, P293, DOI 10.1039/c1an15605e
NR 52
TC 9
Z9 9
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1573-3882
EI 1573-3890
J9 METABOLOMICS
JI Metabolomics
PD JAN 12
PY 2021
VL 17
IS 1
AR 10
DI 10.1007/s11306-020-01769-w
PG 16
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA PW3DV
UT WOS:000610554300001
PM 33438095
DA 2024-11-01
ER

PT J
AU Mukai, M
   Nagata, E
   Mizuma, A
   Yamano, M
   Sugaya, K
   Nishino, I
   Goto, Y
   Takizawa, S
AF Mukai, Masako
   Nagata, Eiichiro
   Mizuma, Atsushi
   Yamano, Mitsuhiko
   Sugaya, Keizo
   Nishino, Ichizo
   Goto, Yu-ichi
   Takizawa, Shunya
TI Adult-onset Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and
   Stroke (MELAS)-like Encephalopathy Diagnosed Based on the Complete
   Sequencing of Mitochondrial DNA Extracted from Biopsied Muscle without
   any Myopathic Changes
SO INTERNAL MEDICINE
LA English
DT Article
DE MELAS; stroke-like episodes; MT-ND3; adult onset; m.10158T > C mutation
ID ND3 GENE; LEIGH-SYNDROME; I DEFICIENCY; MUTATION; EPISODES; MT-ND3;
   MELAS
AB The clinical features of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) are not uniform. We herein report a male patient with unusual MELAS-like encephalopathy who had been experiencing isolated recurrent stroke-like episodes since he was 33 years old without any particular family history. Despite an extensive investigation, he had no other signs suggestive of MELAS. Although the muscle pathology showed a normal appearance, a mitochondrial genome sequence analysis of the biopsied muscle revealed a heteroplasmic m. 10158T>C mutation in the mitochondrial complex I subunit gene, MT-ND3. To prevented further deterioration of the higher brain function, the early diagnosis and treatment of mitochondrial stroke-like episodes is important.
C1 [Mukai, Masako; Nagata, Eiichiro; Mizuma, Atsushi; Yamano, Mitsuhiko; Takizawa, Shunya] Tokai Univ, Sch Med, Dept Neurol, Hiratsuka, Kanagawa 25912, Japan.
   [Sugaya, Keizo] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Tokyo, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Kodaira, Tokyo, Japan.
C3 Tokai University; Tokyo Metropolitan Institute for Neuroscience;
   National Center for Neurology & Psychiatry - Japan; National Center for
   Neurology & Psychiatry - Japan
RP Mukai, M (corresponding author), Tokai Univ, Sch Med, Dept Neurol, Hiratsuka, Kanagawa 25912, Japan.
EM mmukai@tokai.ac.jp
RI Nishino, Ichizo/G-2676-2010
OI Sugaya, Kiminobu/0000-0002-2788-5457
CR Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Levy RJ, 2014, J CHILD NEUROL, V29, pNP105, DOI 10.1177/0883073813506783
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mukai M, 2015, NEUROL CLIN NEUROSCI, V3, P153, DOI 10.1111/ncn3.173
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
NR 12
TC 11
Z9 15
U1 0
U2 4
PU JAPAN SOC INTERNAL MEDICINE
PI TOKYO
PA 34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN
SN 0918-2918
EI 1349-7235
J9 INTERNAL MED
JI Intern. Med.
PY 2017
VL 56
IS 1
BP 95
EP 99
DI 10.2169/internalmedicine.56.7301
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA EI4AS
UT WOS:000392435400015
PM 28050007
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Krishnan, KJ
   Ratnaike, TE
   De Gruyter, HLM
   Jaros, E
   Turnbull, DM
AF Krishnan, Kim J.
   Ratnaike, Thiloka E.
   De Gruyter, Heidi L. M.
   Jaros, Evelyn
   Turnbull, Doug M.
TI Mitochondrial DNA deletions cause the biochemical defect observed in
   Alzheimer's disease
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE Mitochondrial DNA; mtDNA deletions; Alzheimer's disease; Aging;
   Mitochondrial dysfunction
ID HUMAN SKELETAL-MUSCLE; SUBSTANTIA-NIGRA NEURONS; REAL-TIME PCR;
   INDIVIDUAL CELLS; OXIDASE; ACCUMULATE; MUTATIONS; BRAIN
AB Alzheimer's disease (AD) is the most common form of dementia, increasing in prevalence with age. Most patients who develop AD have an unknown cause, but characteristic neuropathological features include the deposition of extracellular amyloid beta and of intraneuronal hyperphosphorylated tau protein. Researchers have previously implicated mitochondrial dysfunction in AD. We previously showed an increase in neurons displaying a mitochondrial biochemical defect-cytochrome-c oxidase (COX) deficiency-in the hippocampus in patients with sporadic AD compared with age-matched controls. COX deficiency is well described as a marker of mitochondrial (mt) DNA dysfunction. This present study analyzed the mtDNA in single neurons from both COX normal and COX-deficient cells. Analysis of the mtDNA revealed that COX deficiency is caused by high levels of mtDNA deletions which accumulate with age. Future research is needed to clarify the role mtDNA deletions have in normal aging and investigate the relationship between mtDNA deletions and the pathogenesis of sporadic AD. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Krishnan, Kim J.] Newcastle Univ, Mitochondrial Res Grp, Sch Med, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Krishnan, Kim J.; Ratnaike, Thiloka E.; Turnbull, Doug M.] Newcastle Univ, Inst Ageing & Hlth, Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Jaros, Evelyn] NHS Fdn Trust, Newcastle Upon Tyne Hosp, UK NIHR Biomed Res Ctr Ageing & Age Related Dis, Newcastle Upon Tyne, Tyne & Wear, England.
   [Jaros, Evelyn] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon
   Tyne Hospitals NHS Foundation Trust; Newcastle University - UK;
   Newcastle University - UK
RP Krishnan, KJ (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Sch Med, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM k.j.krishnan@ncl.ac.uk
RI Clugston, Kim/KBA-3107-2024; Ratnaike, Thiloka/GNM-9569-2022
OI Turnbull, Doug/0000-0002-8878-9901; Ratnaike,
   Thiloka/0000-0001-5400-104X
FU Alzheimer's Research UK; Newcastle University Centre for Brain Ageing
   and Vitality; BBSRC; EPSRC; ESRC; MRC as part of the cross-council
   Lifelong Health and Wellbeing Initiative; MRC [G0700718, G0900652,
   G0800674, G0502157, MC_G0802536, G1100540, G0400074] Funding Source:
   UKRI
FX We are grateful for support from Alzheimer's Research UK and the
   Newcastle University Centre for Brain Ageing and Vitality supported by
   the BBSRC, EPSRC, ESRC, and MRC as part of the cross-council Lifelong
   Health and Wellbeing Initiative.
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(20)32205-4
   BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G.R., 2010, ANN NEUROL, V2010, P8
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Melberg A, 2005, ACTA NEUROPATHOL, V110, P315, DOI 10.1007/s00401-005-1047-z
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
NR 22
TC 75
Z9 81
U1 2
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0197-4580
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD SEP
PY 2012
VL 33
IS 9
BP 2210
EP 2214
DI 10.1016/j.neurobiolaging.2011.08.009
PG 5
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA 981TW
UT WOS:000306994600032
PM 21925769
DA 2024-11-01
ER

PT J
AU Capristo, M
   Del Dotto, V
   Tropeano, CV
   Fiorini, C
   Caporali, L
   La Morgia, C
   Valentino, ML
   Montopoli, M
   Carelli, V
   Maresca, A
AF Capristo, Mariantonietta
   Del Dotto, Valentina
   Tropeano, Concetta Valentina
   Fiorini, Claudio
   Caporali, Leonardo
   La Morgia, Chiara
   Valentino, Maria Lucia
   Montopoli, Monica
   Carelli, Valerio
   Maresca, Alessandra
TI Rapamycin rescues mitochondrial dysfunction in cells carrying the
   m.8344A &gt; G mutation in the mitochondrial tRNA<SUP>Lys</SUP>
SO MOLECULAR MEDICINE
LA English
DT Article
DE MERRF; Mitochondrial DNA; Niacin; PGC-1 alpha; Rapamycin; mTORC1;
   Mitochondrial dysfunction; Mitochondrial biogenesis
ID RAGGED-RED FIBERS; MYOCLONIC EPILEPSY; PROTEIN-SYNTHESIS; POINT
   MUTATIONS; MTDNA MUTATION; MOUSE MODEL; MERRF; DNA; DISEASE; MTOR
AB Background: Myoclonus, Epilepsy and Ragged-Red-Fibers (MERRF) is a mitochondrial encephalomyopathy due to heteroplasmic mutations in mitochondrial DNA (mtDNA) most frequently affecting the tRNA(Lys) gene at position m.8344A > G. Defective tRNA(Lys) severely impairs mitochondrial protein synthesis and respiratory chain when a high percentage of mutant heteroplasmy crosses the threshold for full-blown clinical phenotype. Therapy is currently limited to symptomatic management of myoclonic epilepsy, and supportive measures to counteract muscle weakness with co-factors/supplements.
   Methods: We tested two therapeutic strategies to rescue mitochondrial function in cybrids and fibroblasts carrying different loads of the m.8344A > G mutation. The first strategy was aimed at inducing mitochondrial biogenesis directly, over-expressing the master regulator PGC-1 alpha, or indirectly, through the treatment with nicotinic acid, a NAD(+) precursor. The second was aimed at stimulating the removal of damaged mitochondria through prolonged rapamycin treatment.
   Results: The first approach slightly increased mitochondrial protein expression and respiration in the wild type and intermediate-mutation load cells, but was ineffective in high-mutation load cell lines. This suggests that induction of mitochondrial biogenesis may not be sufficient to rescue mitochondrial dysfunction in MERRF cells with high-mutation load. The second approach, when administered chronically (4 weeks), induced a slight increase of mitochondrial respiration in fibroblasts with high-mutation load, and a significant improvement in fibroblasts with intermediate-mutation load, rescuing completely the bioenergetics defect. This effect was mediated by increased mitochondrial biogenesis, possibly related to the rapamycin-induced inhibition of the Mechanistic Target of Rapamycin Complex 1 (mTORC1) and the consequent activation of the Transcription Factor EB (TFEB).
   Conclusions: Overall, our results point to rapamycin-based therapy as a promising therapeutic option for MERRF.
C1 [Capristo, Mariantonietta; Del Dotto, Valentina; Tropeano, Concetta Valentina; Fiorini, Claudio; Caporali, Leonardo; La Morgia, Chiara; Valentino, Maria Lucia; Carelli, Valerio; Maresca, Alessandra] IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Via Altura 3, I-40139 Bologna, Italy.
   [Valentino, Maria Lucia; Carelli, Valerio] Univ Bologna, Dept Biomed & NeuroMotor Sci, Via Altura 3, I-40139 Bologna, Italy.
   [Montopoli, Monica] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Via Largo Meneghetti 2, I-3513 Padua, Italy.
C3 IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University
   of Bologna; University of Padua
RP Carelli, V; Maresca, A (corresponding author), IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Via Altura 3, I-40139 Bologna, Italy.
EM valerio.carelli@unibo.it; alessandra.maresca@isnb.it
RI Del Dotto, Valentina/AAB-7073-2020; Capristo,
   Mariantonietta/K-7627-2016; La Morgia, Chiara/H-6765-2012; Montopoli,
   Monica/W-9666-2019; Caporali, Leonardo/J-7398-2016; Maresca,
   Alessandra/J-7393-2016
OI Caporali, Leonardo/0000-0002-0666-4380; DEL DOTTO,
   VALENTINA/0000-0002-6053-0893; Tropeano, Concetta
   Valentina/0000-0001-5257-5648; Maresca, Alessandra/0000-0002-8959-8832;
   Fiorini, Claudio/0000-0003-2099-0745
FU Italian Ministry of Health; Telethon Foundation [GGP20115]
FX This study was supported by the Italian Ministry of Health (Ricerca
   Corrente funding to VC and AM) and by the Telethon Foundation (Grant
   GGP20115 to VC).
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Antonická H, 1999, BIOCHEM J, V342, P537, DOI 10.1042/0264-6021:3420537
   ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brantová O, 2006, ULTRASTRUCT PATHOL, V30, P239, DOI 10.1080/01913120600820112
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Carelli V, 2018, ESSAYS BIOCHEM, V62, P235, DOI 10.1042/EBC20170097
   Cassandrini D, 2006, BIOCHEM BIOPH RES CO, V342, P387, DOI 10.1016/j.bbrc.2006.01.152
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003
   Cheema NJ, 2021, AM J PHYSIOL-CELL PH, V321, pC176, DOI 10.1152/ajpcell.00471.2020
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   Chomyn A, 1998, AM J HUM GENET, V62, P745, DOI 10.1086/301813
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Chung CY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26746-2
   Civiletto G, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708799
   Cogliati S, 2021, BIOCHEM SOC T, V49, P2655, DOI 10.1042/BST20210460
   COQUET M, 1993, NEUROMUSCULAR DISORD, V3, P593, DOI 10.1016/0960-8966(93)90122-Z
   Crowley CL, 2000, CELL DEATH DIFFER, V7, P314, DOI 10.1038/sj.cdd.4400658
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fakruddin M, 2018, CELL REP, V22, P482, DOI 10.1016/j.celrep.2017.12.051
   Forsström S, 2019, CELL METAB, V30, P1040, DOI [10.1016/j.cmet.2019.013.019, 10.1016/j.cmet.2019.08.019]
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gammage PA, 2016, METHODS MOL BIOL, V1351, P145, DOI 10.1007/978-1-4939-3040-1_11
   Gureev AP, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00435
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   HOLME E, 1993, AM J HUM GENET, V52, P551
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Ignatenko O, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000797
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kim DS, 2002, J KOREAN MED SCI, V17, P103, DOI 10.3346/jkms.2002.17.1.103
   King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Koh JH, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094558
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y
   Mahalakshmi R, 2022, MOL BIOL REP, V49, P463, DOI 10.1007/s11033-021-06898-6
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Maresca A, 2020, HUM MOL GENET, V29, P1864, DOI 10.1093/hmg/ddaa014
   Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653
   Monden Y, 2013, BRAIN DEV-JPN, V35, P582, DOI 10.1016/j.braindev.2012.08.006
   Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572
   Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Perli E, 2020, FASEB J, V34, P7675, DOI 10.1096/fj.201903270R
   Perli E, 2016, HUM MOL GENET, V25, P903, DOI 10.1093/hmg/ddv619
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Richter U, 2021, FEBS LETT, V595, P1003, DOI 10.1002/1873-3468.14049
   Richter U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06471-z
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718
   Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32
   Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wang A, 2016, ONCOTARGET, V7, P80131, DOI 10.18632/oncotarget.12560
   Wang SJ, 2020, BIOMED PHARMACOTHER, V128, DOI 10.1016/j.biopha.2020.110272
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Zheng XD, 2016, ELIFE, V5, DOI 10.7554/eLife.13378
   Zhou L, 1997, J NEUROSCI, V17, P7746
NR 75
TC 3
Z9 3
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1076-1551
EI 1528-3658
J9 MOL MED
JI Mol. Med.
PD DEC
PY 2022
VL 28
IS 1
AR 90
DI 10.1186/s10020-022-00519-z
PG 18
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA 3M8PG
UT WOS:000835718100005
PM 35922766
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Hanisch, F
   Kornhuber, M
   Alston, CL
   Taylor, RW
   Deschauer, M
   Zierz, S
AF Hanisch, Frank
   Kornhuber, Malte
   Alston, Charlotte L.
   Taylor, Robert W.
   Deschauer, Marcus
   Zierz, Stephan
TI SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial
   DNA deletions
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Article
ID SENSORY ATAXIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   PROBABLE GERMLINE MOSAICISM; POLG MUTATIONS; GENE MUTATION; DISEASE;
   SPECTRUM; ANT1; DISORDERS; C10ORF2
AB Objective The sensory ataxic neuropathy with dysarthria and ophthalmoparesis (SANDO) syndrome is a subgroup of mitochondrial chronic progressive external ophthalmoplegia (CPEO)-plus disorders associated with multiple mitochondrial DNA (mtDNA) deletions. There is no systematic survey on SANDO in patients with CPEO with either single or multiple large-scale mtDNA deletions.
   Methods In this retrospective analysis, we characterised the frequency, the genetic and clinical phenotype of 107 index patients with mitochondrial CPEO (n=66 patients with single and n=41 patients with multiple mtDNA deletions) and assessed these for clinical evidence of a SANDO phenotype. Patients with multiple mtDNA deletions were additionally screened for mutations in the nuclear-encoded POLG, SLC25A4, PEO1 and RRM2B genes. The clinical, histological and genetic data of 11 patients with SANDO were further analysed.
   Results None of the 66 patients with single, large-scale mtDNA deletions fulfilled the clinical criteria of SANDO syndrome. In contrast, 9 of 41 patients (22%) with multiple mtDNA deletions and two additional family members fulfilled the clinical criteria for SANDO. Within this subgroup, multiple mtDNA deletions were associated with the following nuclear mutations: POLG (n=6), PEO1 (n=2), unidentified (n=2). The combination of sensory ataxic neuropathy with ophthalmoparesis (SANO) was observed in 70% of patients with multiple mtDNA deletions but only in 4% with single deletions. The combination of CPEO and sensory ataxic neuropathy (SANO, incomplete SANDO) was found in 43% of patients with multiple mtDNA deletions but not in patients with single deletions.
   Conclusion The SANDO syndrome seems to indicate a cluster of symptoms within the wide range of multisystemic symptoms associated with mitochondrial CPEO. SANO seems to be the most frequent phenotype associated with multiple mtDNA deletions in our cohort but not or is rarely associated with single, large-scale mtDNA deletions.
C1 [Hanisch, Frank; Kornhuber, Malte; Deschauer, Marcus; Zierz, Stephan] Univ Halle Wittenberg, Dept Neurol, D-06108 Halle, Saale, Germany.
   [Alston, Charlotte L.; Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Martin Luther University Halle Wittenberg; Newcastle University - UK
RP Hanisch, F (corresponding author), Univ Hosp Halle Saale, Dept Neurol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.
EM neurologie@uk-halle.de
RI Alston, Charlotte/ABG-9602-2020
OI Alston, Charlotte/0000-0003-2095-5464
FU German Federal Ministry of Education and Research (Bundesministerium fur
   Bildung und Forschung BMBF, Bonn, Germany) [01M1113AA-F]; Wellcome Trust
   [096919/Z/11/Z]; UK NHS; MRC [MR/K000608/1] Funding Source: UKRI
FX MD and SZ are members of mitoNET funded by the German Federal Ministry
   of Education and Research (Bundesministerium fur Bildung und Forschung
   BMBF, Bonn, Germany) grant to the German Network for Mitochondrial
   Disorders (mitoNET, 01M1113AA-F). RWT is supported by funding from the
   Wellcome Trust (Strategic Award, grant number 096919/Z/11/Z) and the UK
   NHS Specialist Commissioners who fund the "Rare Mitochondrial Disorders
   of Adults and Children" Diagnostic Service in Newcastle upon Tyne
   (http://www.newcastle-mitochondria.com/service/clinical/).
CR BASTIAENSEN LAK, 1978, ACTA NEUROL SCAND, V58, P9
   Chinnery PF, 2003, J NEUROL SCI, V211, P63, DOI 10.1016/S0022-510X(03)00039-X
   CORMIER V, 1991, AM J HUM GENET, V48, P643
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Deschauer M, 2010, CLIN NEUROPHYSIOL, V121, pS306
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Hanisch F, 2006, J NEUROL, V253, P417, DOI 10.1007/s00415-006-0987-0
   Hansen N, 2012, NEUROL SCI, V33, P209, DOI 10.1007/s10072-011-0631-3
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Kawai H, 1975, MUSCLE NERVE, V18, P753
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Okun MS, 2004, AM J OPHTHALMOL, V137, P951, DOI 10.1016/j.ajo.2003.10.046
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   ROWLAND LP, 1980, ARCH NEUROL-CHICAGO, V37, P256, DOI 10.1001/archneur.1980.00500530094031
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 29
TC 34
Z9 37
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD JUN
PY 2015
VL 86
IS 6
BP 630
EP 634
DI 10.1136/jnnp-2013-306748
PG 5
WC Clinical Neurology; Psychiatry; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychiatry; Surgery
GA CI1DN
UT WOS:000354482000008
PM 25143630
DA 2024-11-01
ER

PT J
AU Emma, F
   Pizzini, C
   Tessa, A
   Di Giandomenico, S
   Onetti-Muda, A
   Santorelli, FM
   Bertini, E
   Rizzoni, G
AF Emma, F
   Pizzini, C
   Tessa, A
   Di Giandomenico, S
   Onetti-Muda, A
   Santorelli, FM
   Bertini, E
   Rizzoni, G
TI "Bartter-like" phenotype in Kearns-Sayre syndrome
SO PEDIATRIC NEPHROLOGY
LA English
DT Article
DE mitochondrial DNA; Kearns-Sayre syndrome; Bartter syndrome; heteroplasmy
ID MITOCHONDRIAL-DNA DELETION; DEFICIENT MUSCLE-FIBERS; INVOLVEMENT;
   PATIENT; DYSFUNCTION; DISORDERS; ACIDOSIS; DISEASE
AB Kearns-Sayre syndrome (KSS) is a mitochondrial disease caused by large deletions in mitochondrial DNA (mtDNA). In most patients the disease is characterized by mtDNA heteroplasmy, where a mixture of wild-type and mutated mtDNA co-exist within cells in variable proportion, modulating the severity of the phenotype in different tissues. We report on the case of a 14-year-old child with classical symptoms of KSS and a renal phenotype characterized by hypokalaemic alkalosis, hypomagnesaemia, hyperreninaemia, hyperaldosteronism and nephrocalcinosis, resembling Bartter syndrome. Analysis of mtDNA demonstrated an 8,661 bp deletion involving eight mitochondrial genes. Uneven degrees of mtDNA heteroplasmy were demonstrated in several tissues, ranging from 24% to 60% of deleted/total mtDNA. Variable degrees of expression of mitochondrial enzymes were also found in biopsy specimens of renal and skeletal muscle by histocytochemistry. In particular, preserved cytochrome c oxidase was observed in tubular structures within medullary rays. It is proposed that a "Bartter-like" phenotype can arise in some patients with KSS as a result of heteroplasmy. In these cases aldosterone-responsive tubular structures have been spared during renal embryogenesis, allowing for the development of hypokalaemic alkalosis in response to salt and water losses from the more damaged tubular segments.
C1 Bambino Gesu Childrens Hosp & Res Inst, Div Nephrol, Dept Nephrol & Urol, I-00165 Rome, Italy.
   Bambino Gesu Childrens Hosp & Res Inst, Mol Med Lab, Dept Lab Med, Rome, Italy.
   Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy.
C3 IRCCS Bambino Gesu; IRCCS Bambino Gesu; Sapienza University Rome
RP Emma, F (corresponding author), Bambino Gesu Childrens Hosp & Res Inst, Div Nephrol, Dept Nephrol & Urol, Piazza S Onofrio 4, I-00165 Rome, Italy.
EM emma@opbg.net
RI Emma, Francesco/H-2116-2012; ONETTI MUDA, ANDREA/AAA-5105-2020; tessa,
   alessandra/AAA-4442-2021; Bertini, Enrico/A-2284-2014; Santorelli,
   Filippo M/ABE-5124-2020
OI ONETTI MUDA, ANDREA/0000-0002-0274-6178; tessa,
   alessandra/0000-0002-1445-6434; Bertini, Enrico/0000-0001-9276-4590;
   Santorelli, Filippo M/0000-0002-1359-9062
CR DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   EVIATAR L, 1990, NEUROLOGY, V40, P1761, DOI 10.1212/WNL.40.11.1761
   GARG LC, 1981, AM J PHYSIOL, V240, pF536, DOI 10.1152/ajprenal.1981.240.6.F536
   GOTO Y, 1990, J PEDIATR-US, V116, P904, DOI 10.1016/S0022-3476(05)80648-1
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Gullans SR, 1996, METABOLIC BASES ION, P211
   HANSEN GP, 1980, KIDNEY INT, V17, P326, DOI 10.1038/ki.1980.38
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Katsanos KH, 2001, AM J NEPHROL, V21, P150, DOI 10.1159/000046239
   MAJANDER A, 1991, PEDIATR RES, V30, P327, DOI 10.1203/00006450-199110000-00007
   Menegon LF, 2004, RENAL FAILURE, V26, P195, DOI 10.1081/JDI-120038522
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MOE OW, 1991, AM J PHYSIOL, V260, pF130, DOI 10.1152/ajprenal.1991.260.1.F130
   MORI K, 1991, AM J MED GENET, V38, P583, DOI 10.1002/ajmg.1320380417
   Neiberger RE, 2002, AM J KIDNEY DIS, V39, P12, DOI 10.1053/ajkd.2002.29872
   Niaudet P, 1997, KIDNEY INT, V51, P1000, DOI 10.1038/ki.1997.140
   Pistilli D, 2003, HUM PATHOL, V34, P1058, DOI 10.1053/S0046-8177(03)00344-7
   Rose BD., 1994, CLIN PHYSL ACID BASE, V4th
   Rötig A, 2003, J NEPHROL, V16, P286
   Rötig A, 2003, J AM SOC NEPHROL, V14, P2995, DOI 10.1097/01.ASN.0000095481.24091.C9
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SIMOPOULOS AP, 1971, J PEDIATR-US, V79, P633, DOI 10.1016/S0022-3476(71)80312-8
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
NR 25
TC 36
Z9 37
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0931-041X
J9 PEDIATR NEPHROL
JI Pediatr. Nephrol.
PD MAR
PY 2006
VL 21
IS 3
BP 355
EP 360
DI 10.1007/s00467-005-2092-5
PG 6
WC Pediatrics; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics; Urology & Nephrology
GA 013ZN
UT WOS:000235448600010
PM 16382326
DA 2024-11-01
ER

PT J
AU Katada, S
   Mito, T
   Ogasawara, E
   Hayashi, JI
   Nakada, K
AF Katada, Shun
   Mito, Takayuki
   Ogasawara, Emi
   Hayashi, Jun-Ichi
   Nakada, Kazuto
TI Mitochondrial DNA with a Large-Scale Deletion Causes Two Distinct
   Mitochondrial Disease Phenotypes in Mice
SO G3-GENES GENOMES GENETICS
LA English
DT Article
DE mitochondria; mitochondrial DNA; pathogenic mutation; mitochondrial
   diseases; model mice
ID PEARSON SYNDROME; MUTANT MTDNA; MITO-MICE; DISORDERS; MUSCLE; MOUSE
AB Studies in patients have suggested that the clinical phenotypes of some mitochondrial diseases might transit from one disease to another (e.g., Pearson syndrome [PS] to Kearns-Sayre syndrome) in single individuals carrying mitochondrial (mt) DNA with a common deletion (Delta mtDNA), but there is no direct experimental evidence for this. To determine whether Delta mtDNA has the pathologic potential to induce multiple mitochondrial disease phenotypes, we used trans-mitochondrial mice with a heteroplasmic state of wild-type mtDNA and Delta mtDNA (mito-mice Delta). Late-stage embryos carrying >= 50%.mtDNA showed abnormal hematopoiesis and iron metabolism in livers that were partly similar to PS (PS-like phenotypes), although they did not express sideroblastic anemia that is a typical symptom of PS. More than half of the neonates with PS-like phenotypes died by 1 month after birth, whereas the rest showed a decrease of Delta mtDNA load in the affected tissues, peripheral blood and liver, and they recovered from PS-like phenotypes. The proportion of mtDNA in various tissues of the surviving mito-mice. increased with time, and Kearns-Sayre syndrome 2 like phenotypes were expressed when the proportion of Delta mtDNA in various tissues reached > 70-80%. Our model mouse study clearly showed that a single Delta mtDNA was responsible for at least two distinct disease phenotypes at different ages and suggested that the level and dynamics of Delta mtDNA load in affected tissues would be important for the onset and transition of mitochondrial disease phenotypes in mice.
C1 [Katada, Shun; Mito, Takayuki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058575, Japan.
   [Ogasawara, Emi; Hayashi, Jun-Ichi; Nakada, Kazuto] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058575, Japan.
   [Hayashi, Jun-Ichi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan.
C3 University of Tsukuba; University of Tsukuba; University of Tsukuba
RP Nakada, K (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan.
EM knakada@biol.tsukuba.ac.jp
OI Mito, Takayuki/0000-0002-6796-5478; Katada, Shun/0000-0003-3241-4470
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   (MEXT) [23240058, 25250011]; MEXT [22650091]; Japan Society for the
   Promotion of Science; Ministry of Health, Labor and Welfare of Japan;
   Grants-in-Aid for Scientific Research [22650091, 25250011, 23240058]
   Funding Source: KAKEN
FX This work was supported by a Grant-in-Aid for Scientific Research (A)
   (No. 23240058 and No. 25250011) from the Ministry of Education, Culture,
   Sports, Science and Technology of Japan (MEXT) to K.N. and J.I.H.; by a
   Grant-in-Aid for Challenging Exploratory Research (No. 22650091) from
   MEXT to K.N.; and by a Grant-in-Aid for Scientific Research on
   Innovative Areas (No. 24117503) from Japan Society for the Promotion of
   Science to J.I.H. This work was also supported by Grants-in-Aid of the
   Research on Intractable Diseases (Mitochondrial Disorder) from the
   Ministry of Health, Labor and Welfare of Japan to K.N.
CR Camaschella C, 2008, BRIT J HAEMATOL, V143, P27, DOI 10.1111/j.1365-2141.2008.07290.x
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   DiMauro S, 2011, SEMIN FETAL NEONAT M, V16, P181, DOI 10.1016/j.siny.2011.04.010
   Gurgey A, 1996, PEDIATR NEPHROL, V10, P637
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nakada K, 2006, P NATL ACAD SCI USA, V103, P15148, DOI 10.1073/pnas.0604641103
   Ogasawara E, 2010, HUM MOL GENET, V19, P3179, DOI 10.1093/hmg/ddq228
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Sato A, 2007, GENETICS, V177, P2031, DOI 10.1534/genetics.107.081026
   Saugstad OD, 2005, BIOL NEONATE, V88, P228, DOI 10.1159/000087586
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Singer D, 2007, COMP BIOCHEM PHYS A, V148, P780, DOI 10.1016/j.cbpa.2007.05.004
   Tanaka D, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-21
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
NR 23
TC 15
Z9 15
U1 1
U2 12
PU GENETICS SOC AM
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 2160-1836
J9 G3-GENES GENOM GENET
JI G3-Genes Genomes Genet.
PD SEP 1
PY 2013
VL 3
IS 9
BP 1545
EP 1552
DI 10.1534/g3.113.007245
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 215XI
UT WOS:000324244000010
PM 23853091
OA Green Published
DA 2024-11-01
ER

PT J
AU Meyer, JN
   Leuthner, TC
   Luz, AL
AF Meyer, Joel N.
   Leuthner, Tess C.
   Luz, Anthony L.
TI Mitochondrial fusion, fission, and mitochondrial toxicity
SO TOXICOLOGY
LA English
DT Article
DE Mitochondrial fusion; Mitochondrial fission; Mitochondrial dynamics;
   Mitochondrial toxicity; Gene-environment interactions; Mitochondrial
   homeostasis; Mitochondrial DNA; Biomarker
ID INNATE IMMUNE-RESPONSES; QUALITY-CONTROL; MITOFUSIN 2;
   CAENORHABDITIS-ELEGANS; PARKINSONS-DISEASE; ARSENITE EXPOSURE; OXIDATIVE
   STRESS; DNA INSTABILITY; SKELETAL-MUSCLE; GENE-EXPRESSION
AB Mitochondrial dynamics are regulated by two sets of opposed processes: mitochondrial fusion and fission, and mitochondrial biogenesis and degradation (including mitophagy), as well as processes such as intracellular transport. These processes maintain mitochondrial homeostasis, regulate mitochondrial form, volume and function, and are increasingly understood to be critical components of the cellular stress response. Mitochondrial dynamics vary based on developmental stage and age, cell type, environmental factors, and genetic background. Indeed, many mitochondrial homeostasis genes are human disease genes. Emerging evidence indicates that deficiencies in these genes often sensitize to environmental exposures, yet can also be protective under certain circumstances. Inhibition of mitochondrial dynamics also affects elimination of irreparable mitochondrial DNA (mtDNA) damage and transmission of mtDNA mutations. We briefly review the basic biology of mitodynamic processes with a focus on mitochondrial fusion and fission, discuss what is known and unknown regarding how these processes respond to chemical and other stressors, and review the literature on interactions between mitochondrial toxicity and genetic variation in mitochondrial fusion and fission genes. Finally, we suggest areas for future research, including elucidating the full range of mitodynamic responses from low to high-level exposures, and from acute to chronic exposures; detailed examination of the physiological consequences of mitodynamic alterations in different cell types; mechanism-based testing of mitotoxicant interactions with inter individual variability in mitodynamics processes; and incorporating other environmental variables that affect mitochondria, such as diet and exercise.
C1 [Meyer, Joel N.] Duke Univ, Nicholas Sch Environm & Integrated Toxicol, Durham, NC 27708 USA.
   Duke Univ, Environm Hlth Program, Durham, NC 27708 USA.
C3 Duke University; Duke University
RP Meyer, JN (corresponding author), Duke Univ, Nicholas Sch Environm & Integrated Toxicol, Durham, NC 27708 USA.
EM joel.meyer@duke.edu; tess.leuthner@duke.edu; anthony.luz@duke.edu
RI Meyer, Joel/G-9836-2017
OI Meyer, Joel/0000-0003-1219-0983; Leuthner, Tess/0000-0001-8501-3473
FU NIH [R01ES017540, P42ES010356, F31ES026859, 1R21ES026743, T32ES021432]
FX This work was supported by the NIH (R01ES017540, P42ES010356,
   F31ES026859, 1R21ES026743, and T32ES021432).
CR Alaimo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091848
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amiri M, 2008, DEV NEUROBIOL, V68, P1348, DOI 10.1002/dneu.20668
   Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008
   [Anonymous], MITOCHONDRIA
   [Anonymous], INT J ENV RES PUBLIC
   [Anonymous], ETHAMBUTOL OPTIC NEU
   [Anonymous], SCI REP
   [Anonymous], COLD SPRING HARBOR P
   [Anonymous], 2012, PLOS ONE
   [Anonymous], BRAIN
   [Anonymous], COLD SPRING HARBOR P
   Aravamudan B, 2014, AM J PHYSIOL-LUNG C, V306, pL840, DOI 10.1152/ajplung.00155.2013
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Ashley N, 2009, ONCOGENE, V28, P3880, DOI 10.1038/onc.2009.242
   Babbar Mansi, 2013, Mol Cell Pharmacol, V5, P109
   Belenguer P, 2013, BBA-MOL CELL RES, V1833, P176, DOI 10.1016/j.bbamcr.2012.08.004
   Benard G, 2010, BBA-BIOENERGETICS, V1797, P698, DOI 10.1016/j.bbabio.2010.02.030
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   Benard G, 2013, ANTIOXID REDOX SIGN, V19, P350, DOI 10.1089/ars.2011.4244
   Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y
   Berthiaume JM, 2007, CARDIOVASC TOXICOL, V7, P178, DOI 10.1007/s12012-007-0026-0
   Bess Amanda S, 2013, Worm, V2, pe23763, DOI 10.4161/worm.23763
   Bess AS, 2012, NUCLEIC ACIDS RES, V40, P7916, DOI 10.1093/nar/gks532
   Bestman JE, 2015, DIFFERENTIATION, V89, P51, DOI 10.1016/j.diff.2015.01.001
   Bo H, 2010, ANN NY ACAD SCI, V1201, P121, DOI 10.1111/j.1749-6632.2010.05618.x
   Bobylev I., 2017, Mol Neurobiol
   Bohovych I, 2015, ANTIOXID REDOX SIGN, V22, P977, DOI 10.1089/ars.2014.6199
   Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82
   Branco AF, 2016, EUR J CLIN INVEST, V46, P285, DOI 10.1111/eci.12591
   Bukowiecki R, 2014, GERONTOLOGY, V60, P174, DOI 10.1159/000355050
   Busch KB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0442
   Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031
   Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chan SSL, 2007, ENVIRON MOL MUTAGEN, V48, P190, DOI 10.1002/em.20191
   Chan SSL, 2017, TOXICOLOGY, V391, P75, DOI 10.1016/j.tox.2017.07.014
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Choi BO, 2015, CLIN GENET, V87, P594, DOI 10.1111/cge.12432
   Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Correia-Melo C, 2015, BBA-BIOENERGETICS, V1847, P1373, DOI 10.1016/j.bbabio.2015.05.017
   Costanzo M, 2015, EUR J HISTOCHEM, V59, P129, DOI 10.4081/ejh.2015.2515
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Dalmasso G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168198
   Das S, 2017, ENVIRON TOXICOL, V32, P630, DOI 10.1002/tox.22265
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   de Quadros T, 2016, ECOTOX ENVIRON SAFE, V132, P279, DOI 10.1016/j.ecoenv.2016.06.018
   Dhingra R, 2014, CIRC J, V78, P803, DOI 10.1253/circj.CJ-14-0240
   Ding H, 2010, BBA-GEN SUBJECTS, V1800, P250, DOI 10.1016/j.bbagen.2009.08.007
   Ditzel EJ, 2016, ENVIRON HEALTH PERSP, V124, P201, DOI 10.1289/ehp.1409501
   Divi RL, 2010, TOXICOL SCI, V118, P191, DOI 10.1093/toxsci/kfq235
   Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024
   Fonkem E, 2013, MUSCLE NERVE, V48, P140, DOI 10.1002/mus.23766
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009
   González-Hunt CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114459
   Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18
   Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006
   Guillet V, 2010, MITOCHONDRION, V10, P115, DOI 10.1016/j.mito.2009.11.004
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   Held NM, 2015, BIOESSAYS, V37, P867, DOI 10.1002/bies.201500013
   Heng JE, 1999, INVEST OPHTH VIS SCI, V40, P190
   Hepple RT, 2009, EXERC SPORT SCI REV, V37, P23, DOI 10.1097/JES.0b013e3181877dc5
   Hirata N, 2016, BIOCHEM BIOPH RES CO, V470, P300, DOI 10.1016/j.bbrc.2016.01.063
   Hoffmann RF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-97
   Hoppins S, 2014, CURR OPIN CELL BIOL, V29, P46, DOI 10.1016/j.ceb.2014.03.005
   Huang XH, 2013, P NATL ACAD SCI USA, V110, P2846, DOI 10.1073/pnas.1300741110
   Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0
   Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001
   Barbosa DJ, 2014, TOXICOL SCI, V139, DOI 10.1093/toxsci/kfu042
   Jugé R, 2016, SCI REP-UK, V6, DOI 10.1038/srep35065
   Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022
   Khan M, 2015, BBA-MOL CELL RES, V1853, P2822, DOI 10.1016/j.bbamcr.2014.12.040
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007
   Lee EJ, 2008, J NEURO-OPHTHALMOL, V28, P269, DOI 10.1097/WNO.0b013e31818e3c6b
   Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004
   Lenaers G, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-46
   Leung MCK, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-9
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Liu SY, 2012, SCI WORLD J, DOI 10.1100/2012/614263
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   Lu HQ, 2013, AUTOPHAGY, V9, P1720, DOI 10.4161/auto.26550
   Lücking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103
   Luz AL, 2017, TOXICOLOGY, V387, P81, DOI 10.1016/j.tox.2017.05.018
   Lv H, 2015, J NEUROL SCI, V358, P153, DOI 10.1016/j.jns.2015.08.1528
   Manella G, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00162
   Melentijevic I, 2017, NATURE, V542, P367, DOI 10.1038/nature21362
   Merry TL, 2016, FREE RADICAL BIO MED, V98, P123, DOI 10.1016/j.freeradbiomed.2015.11.032
   Meyer JN, 2017, TOXICOLOGY, V391, P42, DOI 10.1016/j.tox.2017.07.019
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102
   Meyer JN, 2012, AUTOPHAGY, V8, P1822, DOI 10.4161/auto.21741
   Millet AMC, 2016, ANN CLIN TRANSL NEUR, V3, P408, DOI 10.1002/acn3.305
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985
   Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   NIRANJAN BG, 1982, SCIENCE, V215, P73, DOI 10.1126/science.6797067
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021
   Parameyong A, 2013, J PINEAL RES, V55, P313, DOI 10.1111/jpi.12078
   Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001
   Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311
   Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018
   Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820
   Podratz JL, 2011, NEUROBIOL DIS, V41, P661, DOI 10.1016/j.nbd.2010.11.017
   Pradhan M, 2010, SURV OPHTHALMOL, V55, P378, DOI 10.1016/j.survophthal.2009.10.005
   Quist EM, 2015, TOXICOL PATHOL, V43, P546, DOI 10.1177/0192623314551841
   Ravenscroft P., 2009, Arsenic Pollution: A Global Synthesis, DOI 10.1002/9781444308785
   Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543
   Roberts RF, 2016, INT J BIOCHEM CELL B, V79, P427, DOI 10.1016/j.biocel.2016.07.020
   Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007
   Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327
   Roubicek DA, 2017, TOXICOLOGY, V391, P100, DOI 10.1016/j.tox.2017.06.012
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002
   Schmeisser S, 2013, AGING CELL, V12, P508, DOI 10.1111/acel.12076
   Schon EA, 2010, BBA-GEN SUBJECTS, V1800, P245, DOI 10.1016/j.bbagen.2009.07.007
   Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022
   Senyilmaz D, 2015, NATURE, V525, P124, DOI 10.1038/nature14601
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374
   Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x
   Sitarz KS, 2012, BRAIN, V135, DOI 10.1093/brain/aws049
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Tang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004492
   Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00107
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Truban D, 2017, J PARKINSON DIS, V7, P13, DOI 10.3233/JPD-160989
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   van der Bliek AM, 2009, EMBO J, V28, P1533, DOI 10.1038/emboj.2009.130
   Vidoni S, 2013, ANTIOXID REDOX SIGN, V19, P379, DOI 10.1089/ars.2012.4800
   Voigt A, 2016, J NEUROCHEM, V139, P232, DOI 10.1111/jnc.13655
   Wang WL, 2012, MED ONCOL, V29, P70, DOI 10.1007/s12032-010-9779-6
   Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042
   Weimer LH, 2006, J NEUROL SCI, V242, P47, DOI 10.1016/j.jns.2005.11.014
   West AP, 2017, TOXICOLOGY, V391, P54, DOI 10.1016/j.tox.2017.07.016
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Wikstrom JD, 2009, INT J BIOCHEM CELL B, V41, P1914, DOI 10.1016/j.biocel.2009.06.006
   Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006
   Wood CE, 2015, CARCINOGENESIS, V36, P782, DOI 10.1093/carcin/bgv057
   Xu S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.7
   Yamada S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40925
   Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599
   Yang CC, 2011, AGING CELL, V10, P724, DOI 10.1111/j.1474-9726.2011.00711.x
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494
   Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013
   Zubovych IO, 2010, MOL BIOL CELL, V21, P956, DOI 10.1091/mbc.E09-08-0673
NR 173
TC 342
Z9 380
U1 15
U2 207
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
EI 1879-3185
J9 TOXICOLOGY
JI Toxicology
PD NOV 1
PY 2017
VL 391
BP 42
EP 53
DI 10.1016/j.tox.2017.07.019
PG 12
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA FO5FZ
UT WOS:000416880200006
PM 28789970
OA Green Accepted
HC Y
HP N
DA 2024-11-01
ER

PT B
AU Mancuso, M
   Orsucci, D
   Murri, L
   Siciliano, G
AF Mancuso, Michelangelo
   Orsucci, Daniele
   Murri, Luigi
   Siciliano, Gabriele
BE Svensson, OL
TI MITOCHONDRIAL DNA-RELATED RESPIRATORY CHAIN DISORDERS: FROM DIAGNOSTIC
   TO TREATMENT APPROACHES
SO MITOCHONDRIA: STRUCTURE, FUNCTIONS AND DYSFUNCTIONS
SE Cell Biology Research Progress
LA English
DT Article; Book Chapter
ID SKELETAL-MUSCLE; EXTERNAL OPHTHALMOPLEGIA; GLUTATHIONE DEFICIENCY;
   CREATINE MONOHYDRATE; FOREARM EXERCISE; DOUBLE-BLIND; LIPOIC ACID;
   MTDNA; MUTATION; DISEASE
AB Mitochondrial diseases (MD) are disorders caused by impairment of the mitochondrial respiratory chain, or electron transport chain (ETC). The genetic error can affect mitochondrial (mtDNA) or nuclear DNA (nDNA). Clinical phenotypes are polymorphic and range from pure myopathies to multisystemic disorders. The estimated prevalence of MD is 1-2 in 10000, which makes them among the commonest inherited neuromuscular disorders. At present, the diagnosis of MD requires a complex approach, including clinical and family data, measurement of serum lactate, exercise testing, electromyography, muscle histology and enzymology, and genetic analysis. Ragged red fibers, ragged blue fibers and cytochrome c oxidase (COX)-negative fibers are pathological hallmarks. However, reliable biomarkers for these disorders are still needed. Because mtDNA genes encode subunits of the mitochondrial ETC, oxidative base modifications to mtDNA can lead to bioenergetic dysfunctions, thus generating a vicious cycle of mitochondrial dysfunction, increased oxidative stress, and cellular death.
   The treatment of MD is still inadequate. Therapies that have been attempted include ETC cofactors, other metabolites secondarily decreased in MD, antioxidants and agents acting on lactic acidosis. However, their role in the treatment of the majority of MD remains unclear. This chapter reviews the diagnostic and therapeutic approaches to mtDNA-related disorders.
C1 [Mancuso, Michelangelo; Orsucci, Daniele; Murri, Luigi; Siciliano, Gabriele] Univ Pisa, Neurol Clin, Dept Neurosci, I-56126 Pisa, Italy.
C3 University of Pisa
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Dept Neurosci, Via Roma 67, I-56126 Pisa, Italy.
EM mmancuso@inwind.it
RI Orsucci, Daniele/AAA-7576-2019; Mancuso, Michelangelo/K-4170-2016
CR Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   BARBIROLI B, 1995, J NEUROL, V242, P472, DOI 10.1007/BF00873552
   Bardia A, 2008, MAYO CLIN PROC, V83, P23, DOI 10.4065/83.1.23
   Barshop BA, 2004, MITOCHONDRION, V4, P521, DOI 10.1016/j.mito.2004.07.010
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Bianchi MC, 2003, AM J NEURORADIOL, V24, P1958
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Bonakdar RA, 2005, AM FAM PHYSICIAN, V72, P1065
   Bugiani M, 2006, BRAIN DEV-JPN, V28, P576, DOI 10.1016/j.braindev.2006.04.001
   Burke DG, 2003, INT J SPORT NUTR EXE, V13, P294, DOI 10.1123/ijsnem.13.3.294
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Capaldi RA, 2004, MITOCHONDRION, V4, P417, DOI 10.1016/j.mito.2004.07.006
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   Dallner G, 2000, FREE RADICAL BIO MED, V29, P285, DOI 10.1016/S0891-5849(00)00307-5
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Guy J, 2008, MOL VIS, V14, P2443
   Hanisch F, 2006, J NEUROL, V253, P735, DOI 10.1007/s00415-006-0101-7
   Hargreaves IP, 2005, J INHERIT METAB DIS, V28, P81, DOI 10.1007/s10545-005-4160-1
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jeppesen TD, 2003, J NEUROL, V250, P293, DOI 10.1007/s00415-003-0993-4
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jeppesen TD, 2007, J NEUROL, V254, P29, DOI 10.1007/s00415-006-0229-5
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, pC658, DOI 10.1152/ajpcell.00224.2006
   Kim J, 2008, EUR RADIOL, V18, P1741, DOI 10.1007/s00330-008-0921-1
   Kin T, 2006, J HUM GENET, V51, P555, DOI 10.1007/s10038-006-0397-2
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   Kyriacou K., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P201
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Lee NC, 2009, ARCH DIS CHILD, V94, P55, DOI 10.1136/adc.2008.139584
   Lehnhardt FG, 2008, ARCH NEUROL-CHICAGO, V65, P407, DOI 10.1001/archneur.65.3.407
   Li FY, 2006, NEUROBIOL DIS, V21, P35, DOI 10.1016/j.nbd.2005.06.009
   Liet JM, 2003, J PEDIATR-US, V142, P62, DOI 10.1067/mpd.2003.mpd0333
   Lindroos MM, 2009, DIABETES, V58, P543, DOI 10.2337/db08-0981
   LINDROOS MM, 2009, CEREBRAL OXYGEN GLUC
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   LU J, 2009, MITOCHONDRION
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Mancuso M, 2010, J NEUROL, V257, P774, DOI 10.1007/s00415-009-5409-7
   Marcoff L, 2007, J AM COLL CARDIOL, V49, P2231, DOI 10.1016/j.jacc.2007.02.049
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Meulemans A, 2007, ACTA NEUROL BELG, V107, P78
   Mizuno K, 2008, NUTRITION, V24, P293, DOI 10.1016/j.nut.2007.12.007
   Morava E, 2006, BIOL NEONATE, V90, P207, DOI 10.1159/000093590
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645
   Narla VV, 2008, CLIN NUCL MED, V33, P531, DOI 10.1097/RLU.0b013e31817dec3c
   Nishigaki Y, 2002, NEUROLOGY, V58, P1282, DOI 10.1212/WNL.58.8.1282
   Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   Omar A, 2007, NEUROLOGY, V68, P1159, DOI 10.1212/01.wnl.0000258659.21421.b0
   Paddon-Jones D, 2004, J NUTR, V134, p2888S, DOI 10.1093/jn/134.10.2888S
   Pillen S, 2006, NEUROPEDIATRICS, V37, P142, DOI 10.1055/s-2006-924512
   Rizza T, 2009, BIOCHEM BIOPH RES CO, V383, P58, DOI 10.1016/j.bbrc.2009.03.121
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon Eric A, 2002, Methods Mol Biol, V197, P55, DOI 10.1385/1-59259-284-8:055
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Siciliano G, 2007, BIOSCIENCE REP, V27, P53, DOI 10.1007/s10540-007-9037-0
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tarnopolsky M, 2003, MUSCLE NERVE, V27, P359, DOI 10.1002/mus.10330
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042
   van Eijsden RGE, 2006, GENET MED, V8, P620, DOI 10.1097/01.gim.0000237782.94878.05
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Xie J, 2005, PROTEOMICS, V5, P2981, DOI 10.1002/pmic.200401191
   Yano S, 2003, J INHERIT METAB DIS, V26, P481, DOI 10.1023/A:1025125427868
   Yuri T, 2008, MED MOL MORPHOL, V41, P233, DOI 10.1007/s00795-008-0420-0
NR 96
TC 0
Z9 0
U1 0
U2 1
PU NOVA SCIENCE PUBLISHERS, INC
PI HAUPPAUGE
PA 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA
BN 978-1-61668-346-7
J9 CELL BIO RES PROG
PY 2010
BP 659
EP 682
PG 24
WC Cell Biology
WE Book Citation Index – Science (BKCI-S)
SC Cell Biology
GA BTG89
UT WOS:000286916800015
DA 2024-11-01
ER

PT J
AU Scaglia, F
   Wong, LJC
AF Scaglia, Fernando
   Wong, Lee-Jun C.
TI Human mitochondrial transfer RNAs: Role of pathogenic mutation in
   disease
SO MUSCLE & NERVE
LA English
DT Review
DE cardiomyopathy; chronic progressive external ophthalmoplegia; diabetes
   mellitus; encephalomyopathy; focal segmental glomerulosclerosis; human
   mitochondrial tRNA genes; mitochondrial cytopathies; mitochondrial
   myopathy; myoclonic epilepsy; pathogenic mutations; ragged-red fibers;
   retinitis pigmentosa; sensorineural hearing loss; stroke-like episodes
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; STROKE-LIKE EPISODES; MTDNA POINT
   MUTATION; RAGGED-RED FIBERS; INHERITED HYPERTROPHIC CARDIOMYOPATHY;
   WOBBLE MODIFICATION DEFICIENCY; SENSORINEURAL HEARING-LOSS; TRNA(VAL)
   GENE MUTATION; KEARNS-SAYRE-SYNDROME; C-OXIDASE DEFICIENCY
AB The human mitochondrial genome encodes 13 proteins. All are subunits of the respiratory chain complexes involved in energy metabolism. These proteins are translated by a set of 22 mitochondrial transfer RNAs (tRNAs) that are required for codon reading. Human mitochondrial tRNA genes are hotspots for pathogenic mutations and have attracted interest over the last two decades with the rapid discovery of point mutations associated with a vast array of neuromuscular disorders and diverse clinical phenotypes. In this review, we use a scoring system to determine the pathogenicity of the mutations and summarize the current knowledge of structure-function relationships of these mutant tRNAs. We also provide readers with an overview of a large variety of mechanisms by which mutations may affect the mitochondrial translation machinery and cause disease.
C1 [Scaglia, Fernando; Wong, Lee-Jun C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Wong, LJC (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.
EM ljwong@bcm.tmc.edu
CR Allen JF, 1996, J MOL EVOL, V42, P482, DOI 10.1007/BF02352278
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529
   Bacman SR, 2003, BIOCHEM J, V374, P131, DOI 10.1042/BJ20030222
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Blakely EL, 2004, J NEUROL SCI, V225, P99, DOI 10.1016/j.jns.2004.07.007
   Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758
   BROWN MD, 1992, AM J HUM GENET, V51, P446
   Brulé H, 1998, NUCLEIC ACIDS RES, V26, P537, DOI 10.1093/nar/26.2.537
   Bruno C, 2003, J CHILD NEUROL, V18, P300, DOI 10.1177/08830738030180040401
   Campos Y, 2001, NEUROMUSCULAR DISORD, V11, P477, DOI 10.1016/S0960-8966(00)00223-6
   Cardaioli E, 2005, BIOCHEM BIOPH RES CO, V327, P675, DOI 10.1016/j.bbrc.2004.11.170
   Carnpos Y, 2003, NEUROMUSCULAR DISORD, V13, P416, DOI 10.1016/S0960-8966(03)00039-7
   CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172
   Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   Chapiro E, 2002, EUR J HUM GENET, V10, P851, DOI 10.1038/sj.ejhg.5200894
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   Coulbault L, 2005, BIOCHEM BIOPH RES CO, V329, P1152, DOI 10.1016/j.bbrc.2005.02.083
   Crimi M, 2004, MITOCHONDRION, V3, P279, DOI 10.1016/j.mito.2004.02.004
   Crimi M, 2003, NEUROLOGY, V60, P1200, DOI 10.1212/01.WNL.0000055865.30580.39
   Darin N, 2006, NEUROMUSCULAR DISORD, V16, P504, DOI 10.1016/j.nmd.2006.05.010
   de Coo IFM, 1998, NEUROLOGY, V50, P293, DOI 10.1212/WNL.50.1.293
   Degoul F, 1998, HUM MOL GENET, V7, P347, DOI 10.1093/hmg/7.3.347
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Dey R, 2000, NEUROMUSCULAR DISORD, V10, P488, DOI 10.1016/S0960-8966(00)00125-5
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Feigenbaum A, 2006, AM J MED GENET A, V140A, P2216, DOI 10.1002/ajmg.a.31436
   Finnilä S, 2001, J MED GENET, V38, P400, DOI 10.1136/jmg.38.6.400
   Finnilä S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111
   Franceschina L, 1998, J NEUROL, V245, P755, DOI 10.1007/s004150050283
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gabriel K, 1996, SCIENCE, V271, P195, DOI 10.1126/science.271.5246.195
   Gambello MJ, 2006, MUSCLE NERVE, V34, P437, DOI 10.1002/mus.20605
   Gattermann N, 1996, BRIT J HAEMATOL, V93, P845, DOI 10.1046/j.1365-2141.1996.d01-1724.x
   Goldstein JD, 1999, PEDIATR DEVEL PATHOL, V2, P78, DOI 10.1007/s100249900094
   GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Grafakou O, 2003, J INHERIT METAB DIS, V26, P593, DOI 10.1023/A:1025960300710
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Grasso M, 2001, EUR J HUM GENET, V9, P311, DOI 10.1038/sj.ejhg.5200622
   Hadjigeorgiou GM, 1999, J NEUROL SCI, V164, P153, DOI 10.1016/S0022-510X(99)00062-3
   Hamann CS, 2000, J MOL BIOL, V295, P777, DOI 10.1006/jmbi.1999.3353
   Hanna MG, 1999, CELL MOL LIFE SCI, V55, P691, DOI 10.1007/s000180050327
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HATTORI Y, 1994, J NEUROL SCI, V125, P50, DOI 10.1016/0022-510X(94)90241-0
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g
   Horváth R, 2003, J MED GENET, V40, P752, DOI 10.1136/jmg.40.10.752
   Houshmand M, 1999, HUM MUTAT, V13, P203, DOI 10.1002/(SICI)1098-1004(1999)13:3<203::AID-HUMU4>3.0.CO;2-3
   Hutchin TP, 2001, EUR J HUM GENET, V9, P385, DOI 10.1038/sj.ejhg.5200640
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   IONASESCU VV, 1994, NEUROLOGY, V44, P975, DOI 10.1212/WNL.44.5.975
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Jaksch M, 2001, NEUROLOGY, V57, P1930, DOI 10.1212/WNL.57.10.1930
   Janssen GMC, 1999, J BIOL CHEM, V274, P29744, DOI 10.1074/jbc.274.42.29744
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Karadimas C, 2001, J CHILD NEUROL, V16, P531, DOI 10.1177/088307380101600715
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Kawarai T, 1997, NEUROLOGY, V49, P598, DOI 10.1212/WNL.49.2.598
   Kelley SO, 2001, J BIOL CHEM, V276, P10607, DOI 10.1074/jbc.M008320200
   Kelley SO, 2000, NAT STRUCT BIOL, V7, P862, DOI 10.1038/79612
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5
   Koge Y, 1998, ANN NEUROL, V43, P835, DOI 10.1002/ana.410430620
   Kogelnik AM, 1998, NUCLEIC ACIDS RES, V26, P112, DOI 10.1093/nar/26.1.112
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884
   Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282
   Lombes A, 1998, HUM MUTAT, pS175
   Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Manfredi G, 1996, HUM MUTAT, V7, P158
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Mansergh FC, 1999, AM J HUM GENET, V64, P971, DOI 10.1086/302344
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   MERANTE F, 1994, AM J HUM GENET, V55, P437
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   Meulemans A, 2007, EUR J PAEDIATR NEURO, V11, P17, DOI 10.1016/j.ejpn.2006.10.004
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nishigaki Y, 2002, NEUROLOGY, V58, P1282, DOI 10.1212/WNL.58.8.1282
   Nishino I, 1996, BIOCHEM BIOPH RES CO, V225, P180, DOI 10.1006/bbrc.1996.1150
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Pandya A, 1999, AM J HUM GENET, V65, P1803, DOI 10.1086/302658
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Perucca-Lostanlen D, 2002, BBA-MOL BASIS DIS, V1588, P210, DOI 10.1016/S0925-4439(02)00167-9
   Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487
   Pulkes T, 2000, NEUROLOGY, V55, P1210, DOI 10.1212/WNL.55.8.1210
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   PUTZ J, 1994, NAT STRUCT BIOL, V1, P580, DOI 10.1038/nsb0994-580
   Raffelsberger T, 2001, NEUROLOGY, V57, P2298, DOI 10.1212/WNL.57.12.2298
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Rossmanith W, 2003, ANN NEUROL, V54, P820, DOI 10.1002/ana.10753
   ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885
   Sacconi S, 2002, ARCH NEUROL-CHICAGO, V59, P1013, DOI 10.1001/archneur.59.6.1013
   Sahashi K, 2001, J MED GENET, V38, P703, DOI 10.1136/jmg.38.10.703
   Sakuta R, 2002, PEDIATR NEUROL, V27, P397, DOI 10.1016/S0887-8994(02)00456-3
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   SANTORELLI FM, 1995, BIOCHEM BIOPH RES CO, V216, P835, DOI 10.1006/bbrc.1995.2697
   Santorelli FM, 1996, PEDIATR NEUROL, V15, P145, DOI 10.1016/0887-8994(96)00163-4
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Santorelli FM, 1997, NEUROMUSCULAR DISORD, V7, P156, DOI 10.1016/S0960-8966(97)00444-6
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Scheffler IE, 2001, ADV DRUG DELIVER REV, V49, P3, DOI 10.1016/S0169-409X(01)00123-5
   SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/0005-2728(92)90226-R
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Seki A, 1997, PEDIATR NEUROL, V17, P161, DOI 10.1016/S0887-8994(97)00080-5
   Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
   Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   Seneca S, 1998, J MED GENET, V35, P963, DOI 10.1136/jmg.35.11.963
   Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.0.CO;2-M
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   Shin WS, 2000, AM J HUM GENET, V67, P1617, DOI 10.1086/316896
   SHOFFNER JM, 1995, NEUROLOGY, V45, P286, DOI 10.1212/WNL.45.2.286
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Silvestri G, 1996, BIOCHEM BIOPH RES CO, V220, P623, DOI 10.1006/bbrc.1996.0453
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Spinazzola A, 2004, NEUROMUSCULAR DISORD, V14, P815, DOI 10.1016/j.nmd.2004.09.002
   STEINBERG S, 1994, J MOL BIOL, V236, P982, DOI 10.1016/0022-2836(94)90004-3
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   SWEENEY MG, 1993, Q J MED, V86, P709
   TANAKA M, 1990, LANCET, V336, P1452, DOI 10.1016/0140-6736(90)93162-I
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Taylor RW, 2004, NEUROLOGY, V62, P1420, DOI 10.1212/01.WNL.0000120667.77372.46
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Terasaki F, 2001, JPN CIRC J, V65, P691, DOI 10.1253/jcj.65.691
   Tessa A, 1999, EUR J HUM GENET, V7, P847, DOI 10.1038/sj.ejhg.5200380
   Tiranti V, 1999, NEUROMUSCULAR DISORD, V9, P66, DOI 10.1016/S0960-8966(98)00103-5
   Tiranti V, 1998, ANN NEUROL, V43, P98, DOI 10.1002/ana.410430116
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Tomari Y, 2003, J BIOL CHEM, V278, P16828, DOI 10.1074/jbc.M213216200
   Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   TUOHY TMF, 1992, J MOL BIOL, V228, P1042, DOI 10.1016/0022-2836(92)90313-9
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   Van Camp G, 2000, CLIN GENET, V57, P409, DOI 10.1034/j.1399-0004.2000.570601.x
   van den Bosch BJC, 2004, NEUROMUSCULAR DISORD, V14, P683, DOI 10.1016/j.nmd.2004.06.004
   Verhoeven K, 1999, EUR J HUM GENET, V7, P45, DOI 10.1038/sj.ejhg.5200247
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Vives-Bauza C, 2003, J INHERIT METAB DIS, V26, P507, DOI 10.1023/A:1025133629685
   Vives-Bauza C, 2001, ANN MED, V33, P493, DOI 10.3109/07853890109002099
   Vos MH, 2001, BIOCHEMISTRY-US, V40, P7806, DOI 10.1021/bi010060x
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Wittenhagen LM, 2003, NUCLEIC ACIDS RES, V31, P596, DOI 10.1093/nar/gkg131
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
   Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200
   Yasukawa T, 2000, NUCLEIC ACIDS RES, V28, P3779, DOI 10.1093/nar/28.19.3779
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   YOON KL, 1991, BIOCHEM BIOPH RES CO, V176, P1112, DOI 10.1016/0006-291X(91)90399-R
NR 204
TC 60
Z9 68
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD FEB
PY 2008
VL 37
IS 2
BP 150
EP 171
DI 10.1002/mus.20917
PG 22
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 258WK
UT WOS:000252900500002
PM 17999409
OA Bronze
DA 2024-11-01
ER

PT J
AU Trifunovic, A
AF Trifunovic, Aleksandra
TI Mitochondrial DNA and ageing
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT 14th European Bioenergetic Conference
CY JUL 22-27, 2006
CL Moscow, RUSSIA
DE mitochondria; ageing; mtDNA mutations; mtDNA deletion
ID MTDNA POINT MUTATIONS; HUMAN SKELETAL-MUSCLE; GENE-EXPRESSION; CONTROL
   REGION; HUMAN BRAIN; DELETIONS; MICE; AGE; ACCUMULATE; CELLS
AB The accumulation of mitochondrial DNA mutations has been proposed as a potential mechanism in the physiological processes of ageing and age-related disease. Although mitochondria have long been anticipated as a perpetrator of ageing, there was little experimental evidence to link these changes directly with the cellular pathology of ageing. Recently, considerable progress in understanding basic mitochondrial genetics and in identifying acquired mtDNA mutations in ageing has been made. Furthermore, the creation of mtDNA-mutator mice has provided the first direct evidence that accelerating the mtDNA mutation rate can result in premature ageing, consistent with the view that loss of mitochondrial function is a major causal factor in ageing. This review will, therefore, focus on recent developments in ageing research related to the role played by mtDNA. (c) 2006 Elsevier B.V. All rights reserved.
C1 Karolinska Inst, Novum, Dept Lab Med, Div Metab Dis, SE-14186 Stockholm, Sweden.
C3 Karolinska Institutet
RP Trifunovic, A (corresponding author), Karolinska Inst, Novum, Dept Lab Med, Div Metab Dis, SE-14186 Stockholm, Sweden.
EM aleksandra.trifunovic@ki.se
RI Trifunovic, Aleksandra/HHZ-1296-2022
OI Trifunovic, Aleksandra/0000-0002-5472-3517
CR ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   CORTOPASSI GA, 1992, MUTAT RES, V277, P239, DOI 10.1016/0165-1110(92)90046-C
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   EDRIS W, 1994, MUTAT RES-DNAGING G, V316, P69, DOI 10.1016/0921-8734(94)90009-4
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hoppel CL, 2002, BIOGERONTOLOGY, V3, P41, DOI 10.1023/A:1015251212039
   KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W
   KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kopsidas G, 1998, MUTAT RES-FUND MOL M, V421, P27, DOI 10.1016/S0027-5107(98)00150-X
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LEE CM, 1993, J GERONTOL, V48, P201
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   MELOV S, 1994, NUCLEIC ACIDS RES, V22, P1075, DOI 10.1093/nar/22.6.1075
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Nie F, 1996, J COMP NEUROL, V370, P350, DOI 10.1002/(SICI)1096-9861(19960701)370:3<350::AID-CNE6>3.0.CO;2-3
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Song XF, 2005, GENE, V350, P193, DOI 10.1016/j.gene.2005.02.008
   SOONG NW, 1992, NAT GENET, V2, P318
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TRIFUNOVIC A, 2005, P NATL ACAD SCI US
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang ED, 1997, MUTAT RES-FUND MOL M, V377, P157, DOI 10.1016/S0027-5107(97)00091-2
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   YEN TC, 1992, BIOCHEM INT, V26, P457
NR 49
TC 83
Z9 96
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD MAY-JUN
PY 2006
VL 1757
IS 5-6
BP 611
EP 617
DI 10.1016/j.bbabio.2006.03.003
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 069XF
UT WOS:000239481800041
PM 16624248
OA Bronze
DA 2024-11-01
ER

PT J
AU Kaphan, E
   Ali, HB
   Gastaldi, M
   Acquaviva, C
   Vianey-Saban, C
   Rouzier, C
   Fragaki, K
   Bannwarth, S
   Paquis-Flucklinger, V
   Romero, N
   Behin, A
   Lombès, A
   Jardel, C
   Rigal, O
   Laforêt, P
AF Kaphan, E.
   Ali, H. Bou
   Gastaldi, M.
   Acquaviva, C.
   Vianey-Saban, C.
   Rouzier, C.
   Fragaki, K.
   Bannwarth, S.
   Paquis-Flucklinger, V
   Romero, N.
   Behin, A.
   Lombes, A.
   Jardel, C.
   Rigal, O.
   Laforet, P.
TI Myopathy with MTCYB mutation mimicking Multiple Acyl-CoA Dehydrogenase
   Deficiency
SO REVUE NEUROLOGIQUE
LA English
DT Article
DE Mitochondrial disease; MADD; Multiple acyl-CoA dehydrogenase deficiency;
   Myopathy; Exercise intolerance; Cytochrome b
ID COMPLEX-III DEFICIENCY; STOP-CODON MUTATION; CYTOCHROME-B GENE; MISSENSE
   MUTATION; MITOCHONDRIAL
AB We describe two patients with mitochondrial DNA mutations in the gene encoding cytochrome b (m. 15579A>G, p. Tyr278Cys and m. 15045G>A p. Arg100Gln), which presented as a pure myopathic form (exercise intolerance), with an onset in childhood. Diagnosis was delayed, because acylcarnitine profile showed an increase in medium and long-chain acylcarnitines, suggestive of multiple acyl-CoA dehydrogenase deficiency, riboflavin transporter deficiency or FAD metabolism disorder. Implication of cytochrome b in fatty acid oxidation, and physiopathology of the mutations are discussed. (C) 2018 Elsevier Masson SAS. All rights reserved.
C1 [Kaphan, E.; Ali, H. Bou] CHU Timone, AP HM, Serv Neurol, Pole Neurosci Clin, 264 Rue St Pierre, F-13005 Marseille, France.
   [Gastaldi, M.] CHU Timone, AP HM, Lab Biochim Metab, F-13005 Marseille, France.
   [Acquaviva, C.; Vianey-Saban, C.] CHU Lyon, Grp Hosp Est, Ctr Biol & Pathol Est, Serv Malad Hereditaires Metab, F-69500 Bron, France.
   [Rouzier, C.; Fragaki, K.; Bannwarth, S.; Paquis-Flucklinger, V] Univ Cote dAzur, CHU, Inserm, CNRS,IRCAN, Nice, France.
   [Lombes, A.; Jardel, C.] GHU Pitie Salpetriere, AP HP, Inserm, Serv Biochim Metab,U1016, F-75651 Paris, France.
   [Lombes, A.; Jardel, C.] GHU Pitie Salpetriere, AP HP, Ctr Genet Mol & Chromosom, Inst Cochin, F-75651 Paris, France.
   [Rigal, O.] Hop Robert Debre, AP HP, Ctr Reference Malad Metab, Serv Biochim Hormonol, F-75019 Paris, France.
   [Romero, N.; Behin, A.; Laforet, P.] GH Pitie Salpetriere, Inst Myol, Ctr Reference Pathol Neuromusculaire Paris Est, F-75013 Paris, France.
C3 Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU
   Lyon; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et
   de la Recherche Medicale (Inserm); Centre National de la Recherche
   Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et
   de la Recherche Medicale (Inserm); Universite Paris Cite; Sorbonne
   Universite; Sorbonne Universite; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP;
   Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Robert-Debre - APHP; Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne
   Universite
RP Kaphan, E (corresponding author), CHU Timone, AP HM, Serv Neurol, Pole Neurosci Clin, 264 Rue St Pierre, F-13005 Marseille, France.
EM elsa.kaphan@mail.ap-hm.fr
RI Kaphan, Elsa/AAC-7574-2020; Gastaldi, Matteo/K-8398-2016; Rouzier,
   Cecile/KCY-3619-2024
OI kaphan, elsa/0000-0002-0155-8597
CR Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Bosch AM, 2011, J INHERIT METAB DIS, V34, P159, DOI 10.1007/s10545-010-9242-z
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053
   Ghelli A, 2013, HUM MOL GENET, V22, P2141, DOI 10.1093/hmg/ddt067
   Hogrel JY, 2014, NEUROMUSCULAR DISORD, V24, P604, DOI 10.1016/j.nmd.2014.04.009
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   Mancuso M, 2003, J NEUROL SCI, V209, P61, DOI 10.1016/S0022-510X(02)00462-8
   Olsen RKJ, 2016, AM J HUM GENET, V98, P1130, DOI 10.1016/j.ajhg.2016.04.006
   Olsen RKJ, 2003, HUM MUTAT, V22, P12, DOI 10.1002/humu.10226
   Sauer SW, 2008, BBA-BIOENERGETICS, V1777, P1276, DOI 10.1016/j.bbabio.2008.05.447
   Schiff M, 2016, NEW ENGL J MED, V374, P795, DOI 10.1056/NEJMc1513610
   Spaan AN, 2005, MOL GENET METAB, V86, P441, DOI 10.1016/j.ymgme.2005.07.014
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
NR 15
TC 5
Z9 6
U1 0
U2 3
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD DEC
PY 2018
VL 174
IS 10
BP 731
EP 735
DI 10.1016/j.neurol.2018.03.014
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA HC0BH
UT WOS:000451459300014
PM 30318261
DA 2024-11-01
ER

PT J
AU Massie, R
   Wong, LJC
   Milone, M
AF Massie, Rami
   Wong, Lee-Jun C.
   Milone, Margherita
TI EXERCISE INTOLERANCE DUE TO CYTOCHROME <i>b</i> MUTATION
SO MUSCLE & NERVE
LA English
DT Article
DE cytochrome b; exercise intolerance; mitochondrial myopathy; mutation;
   ragged-red fibers
ID COMPLEX-III DEFICIENCY; YEAST MITOCHONDRIAL-MEMBRANE; STOP-CODON
   MUTATION; NONSENSE MUTATION; MISSENSE MUTATION; DNA MUTATIONS; GENE;
   MYOPATHY; PATIENT; CARDIOMYOPATHY
AB Cytochrome b mutations are rare causes of exercise intolerance. We report an 18-year-old man with exercise intolerance since childhood, resting lactic acidosis, cytochrome c oxidase (COX)-positive ragged-red fibers, and isolated muscle complex III deficiency due to a heteroplasmic m.14849T>C mutation in cytochrome b. We review previously described patients carrying mutations in the same gene. COX-positive ragged-red fibers together with exercise intolerance and lactic acidemia provide a clue for the diagnosis of this rare mitochondrial disorder. Muscle Nerve 42: 136-140, 2010
C1 [Massie, Rami; Milone, Margherita] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.
   [Wong, Lee-Jun C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Mayo Clinic; Baylor College of Medicine
RP Milone, M (corresponding author), Mayo Clin, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.
EM milone.margherita@mayo.edu
CR Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444
   Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   BOUZIDI MF, 1993, NEUROMUSCULAR DISORD, V3, P599
   Bruno C, 2003, MUSCLE NERVE, V28, P508, DOI 10.1002/mus.10429
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   DIRAGO JP, 1993, FEBS LETT, V328, P153, DOI 10.1016/0014-5793(93)80984-3
   Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   LIN LFH, 1978, EUR J BIOCHEM, V87, P171, DOI 10.1111/j.1432-1033.1978.tb12364.x
   Mancuso M, 2003, J NEUROL SCI, V209, P61, DOI 10.1016/S0022-510X(02)00462-8
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   MITA S, 1995, MUSCLE NERVE, pS113
   MOUSSON B, 1995, ACTA NEUROL SCAND, V91, P488
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   SIDHU A, 1983, J BIOL CHEM, V258, P2308
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
NR 30
TC 15
Z9 15
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD JUL
PY 2010
VL 42
IS 1
BP 136
EP 140
DI 10.1002/mus.21649
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 619US
UT WOS:000279456400019
PM 20544923
DA 2024-11-01
ER

PT J
AU Herbst, A
   Pak, JW
   McKenzie, D
   Bua, E
   Bassiouni, M
   Aiken, JM
AF Herbst, Allen
   Pak, Jeong W.
   McKenzie, Debbie
   Bua, Entela
   Bassiouni, Marwa
   Aiken, Judd M.
TI Accumulation of mitochondrial DNA deletion mutations in aged muscle
   fibers: Evidence for a causal role in muscle fiber loss
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID SKELETAL-MUSCLE; RHESUS-MONKEYS; ABNORMALITIES; DISEASES; SARCOPENIA;
   ATROPHY; NUMBER; PCR; PATHOLOGY; GENOMES
AB Although mitochondrial mutation abundance has been recognized to increase in an age-dependent manner, the impact of mutation has been more difficult to establish. Using quantitative polymerase chain reaction, we measured the intracellular abundance of mutant and wild-type mitochondrial genomes along the length of individual laser-captured microdissected muscle fibers from aged rat quadriceps. Aged muscle fibers possessed segmental, clonal intracellular expansions of unique somatically derived mitochondrial DNA (mtDNA) deletion mutations. When the mutation abundance surpassed 90% of the total mitochondrial genomes, the fiber lost cytochrome c oxidase activity and exhibited an increase in succinate dehydrogenase activity. In addition to the mitochondrial enzymatic abnormalities, some fibers displayed abnornal morphology such as fiber splitting, atrophy, and breakage. Deletion mutation accumulation was linked to these aberrant morphologies with more severe cellular pathologies resulting from higher deletion mutation abundance. In summary, our measurements indicate that age-induced mtDNA deletion mutations expand within individual muscle fibers, eliciting fiber dysfunction and breakage.
C1 Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA.
C3 University of Wisconsin System; University of Wisconsin Madison
RP Aiken, JM (corresponding author), Univ Wisconsin, Dept Anim Hlth & Biomed Sci, 1656 Linden Dr, Madison, WI 53706 USA.
EM aiken@svm.vetmed.wisc.edu
RI ; McKenzie, Debbie/G-4459-2015
OI Herbst, Allen/0000-0001-6601-1245; Aiken, Judd/0000-0001-6119-4521;
   McKenzie, Debbie/0000-0002-9291-6977
FU NIA NIH HHS [AG011604, R01 AG011604, R01 AG030423, R01 AG011604-04A1]
   Funding Source: Medline; NIEHS NIH HHS [ES09090] Funding Source: Medline
CR Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CHUNG SS, 1994, AGING-CLIN EXP RES, V6, P193, DOI 10.1007/BF03324239
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Dimauro Salvatore, 1998, Biofactors, V7, P277
   EDRIS W, 1994, MUTAT RES-DNAGING G, V316, P69, DOI 10.1016/0921-8734(94)90009-4
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Evans W, 1997, J Nutr, V127, p998S, DOI 10.1093/jn/127.5.998S
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   LEE CM, 1993, J GERONTOL, V48, P201
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   McKiernan S, 2004, FASEB J, V18, P580, DOI 10.1096/fj.03-0667fje
   MELOV S, 1994, NUCLEIC ACIDS RES, V22, P1075, DOI 10.1093/nar/22.6.1075
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   SATO T, 1984, MECH AGEING DEV, V28, P99, DOI 10.1016/0047-6374(84)90156-8
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
NR 39
TC 142
Z9 163
U1 0
U2 11
PU GERONTOLOGICAL SOC AMER
PI WASHINGTON
PA 1030 15TH ST NW, STE 250, WASHINGTON, DC 20005202-842 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAR
PY 2007
VL 62
IS 3
BP 235
EP 245
DI 10.1093/gerona/62.3.235
PG 11
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 228WM
UT WOS:000250763300002
PM 17389720
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Pontarin, G
   Ferraro, P
   Bee, L
   Reichard, P
   Bianchi, V
AF Pontarin, Giovanna
   Ferraro, Paola
   Bee, Leonardo
   Reichard, Peter
   Bianchi, Vera
TI Mammalian ribonucleotide reductase subunit p53R2 is required for
   mitochondrial DNA replication and DNA repair in quiescent cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE DNA precursors; dNTP de novo synthesis; cell cycle; mitochondrial
   disease
ID HISTONE H2AX PHOSPHORYLATION; NUCLEOTIDE EXCISION-REPAIR; STRAND BREAKS;
   DAMAGE; GENE; INHIBITION; MUTATIONS; DEPLETION; RRM2B; FIBROBLASTS
AB In postmitotic mammalian cells, protein p53R2 substitutes for protein R2 as a subunit of ribonucleotide reductase. In human patients with mutations in RRM2B, the gene for p53R2, mitochondrial (mt) DNA synthesis is defective, and skeletal muscle presents severe mtDNA depletion. Skin fibroblasts isolated from a patient with a lethal homozygous missense mutation of p53R2 grow normally in culture with an unchanged complement of mtDNA. During active growth, the four dNTP pools do not differ in size from normal controls, whereas during quiescence, the dCTP and dGTP pools decrease to 50% of the control. We investigate the ability of these mutated fibroblasts to synthesize mtDNA and repair DNA after exposure to UV irradiation. Ethidium bromide depleted both mutant and normal cells of mtDNA. On withdrawal of the drug, mtDNA recovered equally well in cycling mutant and control cells, whereas during quiescence, the mutant fibroblasts remained deficient. Addition of deoxynucleosides to the medium increased intracellular dNTP pools and normalized mtDNA synthesis. Quiescent mutant fibroblasts were also deficient in the repair of UV-induced DNA damage, as indicated by delayed recovery of dsDNA analyzed by fluorometric analysis of DNA unwinding and the more extensive and prolonged phosphorylation of histone H2AX after irradiation. Supplementation by deoxynucleosides improved DNA repair. Our results show that in nontransformed cells only during quiescence, protein p53R2 is required for maintenance of mtDNA and for optimal DNA repair after UV damage.
C1 [Pontarin, Giovanna; Ferraro, Paola; Bee, Leonardo; Reichard, Peter; Bianchi, Vera] Univ Padua, Dept Biol, I-35131 Padua, Italy.
C3 University of Padua
RP Reichard, P (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.
EM reichard@bio.unipd.it; vbianchi@bio.unipd.it
FU Italian Telethon Grant [GGP09019]; Italian Association for Cancer
   Research (AIRC) [1091]; University of Padova; Strategic Project "Models
   of Mitochondrial Diseases"; Cariparo Foundation
FX We thank Dr. Arianna Calistri for advice and help with the
   immortalization of the fibroblasts. This work was supported by Italian
   Telethon Grant GGP09019 (to V. B.), Italian Association for Cancer
   Research (AIRC) Grant 1091 (to V. B.), the University of Padova,
   Strategic Project 2008 "Models of Mitochondrial Diseases," and the
   Cariparo Foundation.
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9
   Baumstark-Khan C, 2000, PHOTOCHEM PHOTOBIOL, V72, P477, DOI 10.1562/0031-8655(2000)072<0477:FAODUF>2.0.CO;2
   BIRNBOIM HC, 1981, CANCER RES, V41, P1889
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   CARSON DA, 1976, J CLIN INVEST, V57, P274, DOI 10.1172/JCI108278
   Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200
   Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100
   Chaouch S, 2009, HUM GENE THER, V20, P784, DOI 10.1089/hum.2008.163
   Cleaver JE, 2011, PHOTOCHEM PHOTOBIOL, V87, P1230, DOI 10.1111/j.1751-1097.2011.00995.x
   Devlin HL, 2008, MOL CANCER RES, V6, P808, DOI 10.1158/1541-7786.MCR-07-2027
   ERIXON K, 1979, MUTAT RES, V59, P257, DOI 10.1016/0027-5107(79)90164-7
   Friedberg ECW, 2006, DNA REPAIR MUTAGENES
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   HUBERMAN JA, 1981, CELL, V23, P647, DOI 10.1016/0092-8674(81)90426-8
   King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   KRAKOFF IH, 1968, CANCER RES, V28, P1559
   Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829
   Kunos CA, 2010, RADIAT RES, V174, P574, DOI 10.1667/RR2273.1
   Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103
   Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391
   MEUTH M, 1989, EXP CELL RES, V181, P305, DOI 10.1016/0014-4827(89)90090-6
   Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774
   Niida H, 2010, CANCER SCI, V101, P2505, DOI 10.1111/j.1349-7006.2010.01719.x
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Pontarin G, 2011, J BIOL CHEM, V286, P11132, DOI 10.1074/jbc.M110.202283
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Schramm VL, 2002, BBA-MOL BASIS DIS, V1587, P107, DOI 10.1016/S0925-4439(02)00073-X
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
NR 38
TC 91
Z9 100
U1 0
U2 12
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 14
PY 2012
VL 109
IS 33
BP 13302
EP 13307
DI 10.1073/pnas.1211289109
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 992VC
UT WOS:000307807000040
PM 22847445
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Danieli, MG
   Antonelli, E
   Piga, MA
   Cozzi, MF
   Allegra, A
   Gangemi, S
AF Danieli, Maria Giovanna
   Antonelli, Eleonora
   Piga, Mario Andrea
   Cozzi, Maria Francesca
   Allegra, Alessandro
   Gangemi, Sebastiano
TI Oxidative stress, mitochondrial dysfunction, and respiratory chain
   enzyme defects in inflammatory myopathies
SO AUTOIMMUNITY REVIEWS
LA English
DT Article
DE Antioxidant; Electron transport chain; Inflammatory myopathies;
   Inclusion body myositis; Mitochondria; Muscle aging; Nitric oxide;
   Oxidative stress; Reactive oxygen species; Respiratory chain; Redox
ID INCLUSION-BODY MYOSITIS; NITRIC-OXIDE SYNTHASES; SKELETAL-MUSCLE; DNA
   DELETIONS; HISTOLOGICAL ASSESSMENT; AUTOIMMUNE MYOSITIS; HEPATIC
   STEATOSIS; POTENTIAL ROLE; FACTOR-I; KAPPA-B
AB We investigated the relationship between oxidative stress and inflammatory myopathies. We searched in the current literature the role of mitochondria and respiratory chain defects as sources of oxidative stress and reactive oxygen species production that led to muscle weakness and fatigue. Different molecules and pathways contribute to redox milieu, reactive oxygen species generation, accumulation of misfolded and carbonylated proteins that lose their ability to fulfil cellular activities. Small peptides and physical techniques proved, in mice models, to reduce oxidative stress. We focused on inclusion body myositis, as a major expression of myopathy related to oxidative stress, where mitochondrial abnormalities are causative agents as well. We described the effect of physical exercise in inclusion body myositis that showed to increase strength and to reduce beta amyloid accumulation with subsequent improvement of the mitochondrial functions. We illustrated the influence of epigenetic control on the immune system by non-coding genetic material in the interaction between oxidative stress and inflammatory myopathies.
C1 [Danieli, Maria Giovanna] Univ Politecn Marche, Dipartimento Sci Clin & Mol, Clin Med, Via Tronto 10 A, I-60126 Torrette Di Ancona, Italy.
   [Danieli, Maria Giovanna; Piga, Mario Andrea] Univ Politecn Marche, Postgrad Sch Allergy & Clin Immunol, Via Tronto 10 A, I-60126 Ancona, Italy.
   [Antonelli, Eleonora; Cozzi, Maria Francesca] Univ Politecn Marche, Postgrad Sch Internal Med, Via Tronto 10 A, I-60126 Ancona, Italy.
   [Allegra, Alessandro] Univ Messina, Dept Human Pathol Adulthood & Childhood Gaetano Ba, Div Haematol, Via Consolare Valeria 1, I-98125 Messina, Italy.
   [Gangemi, Sebastiano] Univ Messina, Sch & Operat Unit Allergy & Clin Immunol, Dept Clin & Expt Med, Via Consolare Valeria 1, I-98125 Messina, Italy.
   [Danieli, Maria Giovanna] Clin Med, Dipartimento Sci Clin & Mol, Via Tronto 10A, I-60126 Torrette Di Ancona, Italy.
C3 Marche Polytechnic University; Marche Polytechnic University; Marche
   Polytechnic University; University of Messina; University of Messina
RP Danieli, MG (corresponding author), Clin Med, Dipartimento Sci Clin & Mol, Via Tronto 10A, I-60126 Torrette Di Ancona, Italy.
EM m.g.danieli@univpm.it; m.a.piga@pm.univpm.it;
   alessandro.allegra@unime.it; sebastiano.gangemi@unime.it
RI Gangemi, Sebastiano/IQR-5110-2023; Danieli, Maria/ABD-1259-2020
CR Alexander Matthew S, 2015, J Neuromuscul Dis, V2, P1
   Alhatou MI, 2004, J MOL HISTOL, V35, P615
   Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647
   Arenas J, 1996, ARTHRITIS RHEUM, V39, P1869, DOI 10.1002/art.1780391113
   Arnardottir S, 2003, J REHABIL MED, V35, P31, DOI 10.1080/16501970306110
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   Askanas V, 1998, ARCH NEUROL-CHICAGO, V55, P915, DOI 10.1001/archneur.55.7.915
   Bae SS, 2020, RHEUMATOLOGY, V59, P3515, DOI 10.1093/rheumatology/keaa273
   Bae SS, 2022, RHEUMATOLOGY, V61, P2512, DOI 10.1093/rheumatology/keab795
   Barsotti S, 2019, CLIN EXP RHEUMATOL, V37, P1036
   Basualto-Alarcón C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242443
   Vignola MB, 2012, ELECTROMAGN BIOL MED, V31, P320, DOI 10.3109/15368378.2011.641706
   Bertolucci F, 2014, EUR J PHYS REHAB MED, V50, P161
   Bhatt PS, 2019, NEUROMUSCULAR DISORD, V29, P242, DOI 10.1016/j.nmd.2019.02.001
   Blume G, 1997, BRAIN, V120, P39, DOI 10.1093/brain/120.1.39
   Boison D, 2002, P NATL ACAD SCI USA, V99, P6985, DOI 10.1073/pnas.092642899
   Boursereau R, 2017, SCI REP-UK, V7, DOI 10.1038/srep43437
   Broccolini A, 2000, NEUROSCI LETT, V287, P1, DOI 10.1016/S0304-3940(00)01156-3
   Broccolini A, 2004, J NEUROPATH EXP NEUR, V63, P650, DOI 10.1093/jnen/63.6.650
   Buzkova J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809091
   CAMPOS Y, 1995, ANN RHEUM DIS, V54, P491, DOI 10.1136/ard.54.6.491
   Catalán-García M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051446
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163
   Chariot P, 1996, ACTA NEUROPATHOL, V91, P530, DOI 10.1007/s004010050462
   Charles-Schoeman C, 2018, CLIN RHEUMATOL, V37, P615, DOI 10.1007/s10067-017-3896-y
   Chen J, 2017, EXP THER MED, V14, P2085, DOI 10.3892/etm.2017.4766
   Chen ZB, 2017, INT J NEUROSCI, V127, P617, DOI 10.1080/00207454.2016.1220380
   Cordeiro de Souza Leonardo, 2014, Case Rep Crit Care, V2014, P902541, DOI 10.1155/2014/902541
   Coudert JD, 2022, CLIN TRANSL IMMUNOL, V11, DOI 10.1002/cti2.1416
   Cristani M, 2016, CURR MED CHEM, V23, P3862, DOI 10.2174/0929867323666160902154748
   Cron MA, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01074
   Davila Soledad, 2011, Laser Ther, V20, P287
   De Paepe B, 2004, ACTA NEUROPATHOL, V108, P37, DOI 10.1007/s00401-004-0859-6
   Diederichsen LP, 2017, CURR OPIN RHEUMATOL, V29, P598, DOI 10.1097/BOR.0000000000000442
   Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261
   Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104
   Gao SM, 2019, EPIGENOMICS-UK, V11, P23, DOI 10.2217/epi-2018-0064
   Georgantas RW, 2014, ARTHRITIS RHEUMATOL, V66, P1022, DOI 10.1002/art.38292
   Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142
   Gong T, 2012, BIOCHEM BIOPH RES CO, V427, P461, DOI 10.1016/j.bbrc.2012.08.068
   Gualano B, 2010, MED SCI SPORT EXER, V42, P250, DOI 10.1249/MSS.0b013e3181b18fb8
   Haslbeck KM, 2005, ACTA NEUROPATHOL, V110, P247, DOI 10.1007/s00401-005-1043-3
   Hedberg-Oldfors C, 2022, NEUROPATH APPL NEURO, V48, DOI 10.1111/nan.12841
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12931
   Horak M, 2016, DEV BIOL, V410, P1, DOI 10.1016/j.ydbio.2015.12.013
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   Ito M, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-24
   Jackson MJ, 2013, ANTIOXID REDOX SIGN, V19, P804, DOI 10.1089/ars.2013.5383
   Jansson M, 2000, ACTA NEUROPATHOL, V100, P23, DOI 10.1007/s004010051188
   Jensen KY, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-2036-2
   Jeong HJ, 2013, BIOCHEM BIOPH RES CO, V434, P503, DOI 10.1016/j.bbrc.2013.03.104
   Jeong JH, 2017, MED SCI SPORT EXER, V49, P1562, DOI 10.1249/MSS.0000000000001286
   Johnson LG., 2007, Clin Neuromuscul Dis, V8, P187
   Johnson Liam G, 2009, J Clin Neuromuscul Dis, V10, P178, DOI 10.1097/CND.0b013e3181a23c86
   Jorgensen A, 2018, SCAND J RHEUMATOL, V47, P400, DOI 10.1080/03009742.2017.1423109
   Jorgensen AN, 2016, CLIN PHYSIOL FUNCT I, V36, P504, DOI 10.1111/cpf.12259
   Joshi PR, 2014, J CLIN NEUROSCI, V21, P1959, DOI 10.1016/j.jocn.2014.05.051
   Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200
   Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008
   Kok CC, 2000, NEUROMUSCULAR DISORD, V10, P604, DOI 10.1016/S0960-8966(00)00144-9
   Koo JH, 2019, GERONTOLOGY, V65, P240, DOI 10.1159/000494723
   Kwon Insu, 2015, J Exerc Nutrition Biochem, V19, P225, DOI 10.5717/jenb.2015.15090710
   Li YQ, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05029-w
   Lightfoot AP, 2015, CURR OPIN RHEUMATOL, V27, P580, DOI 10.1097/BOR.0000000000000212
   Lightfoot AP, 2015, ANN RHEUM DIS, V74, P1340, DOI 10.1136/annrheumdis-2014-207172
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Lodi R, 1998, BRAIN, V121, P2119, DOI 10.1093/brain/121.11.2119
   McCarthy JJ, 2011, EXERC SPORT SCI REV, V39, P150, DOI 10.1097/JES.0b013e31821c01e1
   Menzel A, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10030414
   Meyer A, 2017, ACTA NEUROPATHOL, V134, P655, DOI 10.1007/s00401-017-1731-9
   Min K, 2011, J APPL PHYSIOL, V111, P1459, DOI 10.1152/japplphysiol.00591.2011
   Miquel E, 2014, FREE RADICAL BIO MED, V70, P204, DOI 10.1016/j.freeradbiomed.2014.02.019
   Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51
   Morosetti R, 2010, NEUROBIOL AGING, V31, P1205, DOI 10.1016/j.neurobiolaging.2008.08.011
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Munters LA, 2016, ARTHRITIS RHEUMATOL, V68, P1738, DOI 10.1002/art.39624
   Musolino C, 2018, ANN HEMATOL, V97, P1259, DOI 10.1007/s00277-018-3296-7
   Naddaf E, 2018, NEUROTHERAPEUTICS, V15, P995, DOI 10.1007/s13311-018-0658-8
   Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103
   Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200
   Oikawa Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231064
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Olivé M, 2004, MUSCLE NERVE, V29, P261, DOI 10.1002/mus.10550
   Paik JJ, 2023, CLIN EXP RHEUMATOL, V41, P348, DOI 10.55563/clinexprheumatol/hxin6o
   Parkes JE, 2020, BMC RHEUMATOL, V4, DOI 10.1186/s41927-020-00125-8
   Parkes JE, 2015, CURR OPIN RHEUMATOL, V27, P608, DOI 10.1097/BOR.0000000000000225
   Rayavarapu S, 2013, ARTHRITIS RHEUM-US, V65, P3248, DOI 10.1002/art.38180
   Ress AL, 2015, MOL CARCINOGEN, V54, P1442, DOI 10.1002/mc.22218
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Saito Y, 2014, CLIN REV ALLERG IMMU, V47, P128, DOI 10.1007/s12016-013-8401-z
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Santos AR, 2014, BIOL SPORT, V31, P121, DOI 10.5604/20831862.1097479
   Servetto N, 2010, LASER SURG MED, V42, P577, DOI 10.1002/lsm.20910
   Shabrokh E., 2014, Open J Mol Integr Physiol, V04, P11, DOI [DOI 10.4236/ojmip.2014.42002, 10.4236/OJMIP.2014.42002, DOI 10.4236/OJMIP.2014.42002]
   Shen QM, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10721
   Spector SA, 1997, MUSCLE NERVE, V20, P1242, DOI 10.1002/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.3.CO;2-X
   Stangel M, 2001, MICROSC RES TECHNIQ, V55, P249, DOI 10.1002/jemt.1174
   Sukkar SG, 2004, AUTOIMMUN REV, V3, P199, DOI 10.1016/j.autrev.2003.09.002
   Terracciano C, 2008, FREE RADICAL BIO MED, V45, P773, DOI 10.1016/j.freeradbiomed.2008.05.030
   Tews DS, 1998, CLIN IMMUNOL IMMUNOP, V87, P240, DOI 10.1006/clin.1998.4527
   van Dooren SHJ, 2011, BIOCHEM CELL BIOL, V89, P545, DOI [10.1139/O11-055, 10.1139/o11-055]
   van Gelder H, 2014, RHEUM DIS CLIN N AM, V40, P1, DOI 10.1016/j.rdc.2013.10.002
   Wanchu A, 1999, NITRIC OXIDE-BIOL CH, V3, P454, DOI 10.1006/niox.1999.0261
   Yamada T, 2022, ARTHRITIS RES THER, V24, DOI 10.1186/s13075-022-02846-2
   Yang CC, 1996, NEUROREPORT, V8, P153, DOI 10.1097/00001756-199612200-00031
   Yang CC, 1998, NEUROSCI LETT, V254, P77, DOI 10.1016/S0304-3940(98)00657-0
   Yang M, 2023, CLIN EXP RHEUMATOL, V41, P393, DOI 10.55563/clinexprheumatol/jikxzi
   Zamecnik J, 2011, Cesk Patol, V47, P62
   Zhang YK, 2020, AGING-US, V12, P2049, DOI 10.18632/aging.102721
   Zhao YF, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-09943-x
   Zilahi Erika, 2019, EJIFCC, V30, P237
NR 114
TC 24
Z9 25
U1 2
U2 21
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD MAY
PY 2023
VL 22
IS 2
AR 103308
DI 10.1016/j.autrev.2023.103308
EA FEB 2023
PG 13
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 9W0EU
UT WOS:000948756300001
PM 36822387
OA hybrid
DA 2024-11-01
ER

PT J
AU Shi, Z
   Hayashi, YK
   Mitsuhashi, S
   Goto, K
   Kaneda, D
   Choi, YC
   Toyoda, C
   Hieda, S
   Kamiyama, T
   Sato, H
   Wada, M
   Noguchi, S
   Nonaka, I
   Nishino, I
AF Shi, Z.
   Hayashi, Y. K.
   Mitsuhashi, S.
   Goto, K.
   Kaneda, D.
   Choi, Y. -C.
   Toyoda, C.
   Hieda, S.
   Kamiyama, T.
   Sato, H.
   Wada, M.
   Noguchi, S.
   Nonaka, I.
   Nishino, I.
TI Characterization of the Asian myopathy patients with VCP mutations
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE amyotrophic lateral sclerosis; cytoplasmic inclusion; inclusion body
   myopathy with Paget's disease of bone and frontotemporal dementia;
   rimmed vacuolar myopathy; nuclear inclusion; transactivation response
   DNA-binding protein 43; ubiquitin; valosin-containing protein
ID VALOSIN-CONTAINING PROTEIN; INCLUSION-BODY MYOPATHY; FRONTOTEMPORAL
   DEMENTIA; PAGET-DISEASE; GENE-MUTATIONS; CELL-DEATH; TDP-43; BONE;
   AUTOPHAGY; YEAST
AB Background and purpose: Mutations in the valosin-containing protein (VCP) gene are known to cause inclusion body myopathy with Pagets disease of bone and frontotemporal dementia (IBMPFD) and familial amyotrophic lateral sclerosis (ALS). Despite an increasing number of clinical reports, only one Asian family with IBMPFD has been described.
   Methods: To characterize patients with VCP mutations, we screened a total of 152 unrelated Asian families who were suspected to have rimmed vacuolar myopathy.
   Results: We identified VCP mutations in seven patients from six unrelated Asian families. Five different missense mutations were found, including a novel p. Ala439Pro substitution. All patients had adult-onset progressive muscle wasting with variable involvement of axial, proximal, and distal muscles. Two of seven patients were suggested to have mild brain involvement including cerebellar ataxia, and only one showed radiological findings indicating a change in bone. Findings from skeletal muscle indicated mixed neurogenic and myogenic changes, fibers with rimmed vacuoles, and the presence of cytoplasmic and nuclear inclusions. These inclusions were immunopositive for VCP, ubiquitin, transactivation response DNA-binding protein 43, and also histone deacetylase 6 (HDAC6), of which function is regulated by VCP. Evidence of early nuclear and mitochondrial damage was also characteristic.
   Conclusions: Valosin-containing protein mutations are not rare in Asian patients, and gene analysis should be considered for patients with adult-onset rimmed vacuolar myopathy with neurogenic changes. A wide variety of central and peripheral nervous system symptoms coupled with rare bone abnormalities may complicate diagnosis.
C1 [Shi, Z.; Hayashi, Y. K.; Mitsuhashi, S.; Goto, K.; Noguchi, S.; Nonaka, I.; Nishino, I.] NCNP, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan.
   [Kaneda, D.] Osaka Red Cross Hosp, Dept Neurol, Osaka, Japan.
   [Choi, Y. -C.] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea.
   [Toyoda, C.] Jikei Med Univ, Daisan Hosp, Dept Neurol, Tokyo, Japan.
   [Hieda, S.] Showa Med Univ, Dept Neurol, Tokyo, Japan.
   [Kamiyama, T.] Jikei Med Univ, Dept Neurol, Tokyo, Japan.
   [Sato, H.; Wada, M.] Yamagata Univ, Fac Med, Dept Neurol Hematol Metab Endocrinol & Diabetol, Yamagata 990, Japan.
C3 National Center for Neurology & Psychiatry - Japan; Osaka Red Cross
   Hospital; Yonsei University; Yonsei University Health System; Jikei
   University; Showa University; Jikei University; Yamagata University
RP Hayashi, YK (corresponding author), NCNP, Natl Inst Neurosci, Dept Neuromuscular Res, 4-1-1 Ogawa Higashi, Tokyo 1878502, Japan.
EM hayasi_y@ncnp.go.jp
RI ; Nishino, Ichizo/G-2676-2010
OI Wada, Manabu/0000-0001-9103-2320; Choi, Young-Chul/0000-0001-5525-6861;
   Nishino, Ichizo/0000-0001-9452-112X
FU Japan Society for the Promotion of Science; Research on Psychiatric and
   Neurological Diseases and Mental Health; Research on Measures for
   Intractable Diseases; Ministry of Health, Labor, and Welfare [20B-12,
   20B-13]; Neurological and Psychiatric Disorders of NCNP [23-4, 23-5,
   23-6]
FX This study was supported by: a Grant-in-Aid for Scientific Research from
   Japan Society for the Promotion of Science; Research on Psychiatric and
   Neurological Diseases and Mental Health, Research on Measures for
   Intractable Diseases, Health Labour Sciences Research Grant for Nervous
   and Mental Disorders (20B-12, 20B-13) from the Ministry of Health,
   Labor, and Welfare, and Intramural Research Grant (23-4, 23-5, 23-6) for
   Neurological and Psychiatric Disorders of NCNP.
CR Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105
   Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210
   Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015
   Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200
   Braun RJ, 2011, J BIOL CHEM, V286, P19958, DOI 10.1074/jbc.M110.194852
   Guinto JB, 2007, ACTA NEUROPATHOL, V114, P55, DOI 10.1007/s00401-007-0224-7
   Guyant-Maréchal L, 2006, NEUROLOGY, V67, P644, DOI 10.1212/01.wnl.0000225184.14578.d3
   Hashimoto Jun, 2007, Nihon Rinsho, V65 Suppl 9, P56
   Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021
   Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086
   Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036
   Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157
   Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115
   Kim EJ, 2011, ARCH NEUROL-CHICAGO, V68, P787, DOI 10.1001/archneurol.2010.376
   Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862
   Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405
   Miller TM, 2005, MUSCLE NERVE, V32, P431, DOI 10.1002/mus.20341
   Miyachi K, 2004, CLIN EXP IMMUNOL, V136, P568, DOI 10.1111/j.1365-2249.2004.02456.x
   Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Nonaka Ikuya, 2005, Curr Neurol Neurosci Rep, V5, P61, DOI 10.1007/s11910-005-0025-0
   Schröder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407
   Sivakumar K, 1996, NEUROLOGY, V47, P977, DOI 10.1212/WNL.47.4.977
   Stojkovic T, 2009, NEUROMUSCULAR DISORD, V19, P316, DOI 10.1016/j.nmd.2009.02.012
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334
   Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009
   Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010
NR 28
TC 45
Z9 47
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1351-5101
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD MAR
PY 2012
VL 19
IS 3
BP 501
EP 509
DI 10.1111/j.1468-1331.2011.03575.x
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 895OM
UT WOS:000300505800027
PM 22040362
DA 2024-11-01
ER

PT J
AU Someya, S
   Kujoth, GC
   Kim, MJ
   Hacker, TA
   Vermulst, M
   Weindruch, R
   Prolla, TA
AF Someya, Shinichi
   Kujoth, Gregory C.
   Kim, Mi-Jung
   Hacker, Timothy A.
   Vermulst, Marc
   Weindruch, Richard
   Prolla, Tomas A.
TI Effects of calorie restriction on the lifespan and healthspan of POLG
   mitochondrial mutator mice
SO PLOS ONE
LA English
DT Article
ID OXIDATIVE DAMAGE; DNA POLYMERASE; AGED RAT; MUTATIONS; OVEREXPRESSION;
   MUSCLE; REPLICATION; PHENOTYPES; STRESS; BRAIN
AB Mitochondrial DNA (mtDNA) mutations are thought to have a causative role in age-related pathologies. We have shown previously that mitochondrial mutator mice (Polg(D257A/D257A)), harboring a proofreading-deficient version of the mtDNA polymerase gamma (POLG), accumulate mtDNA mutations in multiple tissues and display several features of accelerated aging. Calorie restriction (CR) is known to delay the onset of age-related diseases and to extend the lifespan of a variety of species, including rodents. In the current study we investigated the effects of CR on the lifespan and healthspan of mitochondrial mutator mice. Longterm CR did not increase the median or maximum lifespan of Polg(D257A/D257A) mice. Furthermore, CR did not reduce mtDNA deletions in the heart and muscle, accelerated sarcopenia, testicular atrophy, nor improve the alterations in cardiac parameters that are present in aged mitochondrial mutator mice. Therefore, our findings suggest that accumulation of mtDNA mutations may interfere with the beneficial action of CR in aging retardation.
C1 [Someya, Shinichi; Kim, Mi-Jung] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA.
   [Kujoth, Gregory C.] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA.
   [Hacker, Timothy A.] Univ Wisconsin, Dept Med, Madison, WI USA.
   [Vermulst, Marc] Univ Penn, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.
   [Weindruch, Richard] Univ Wisconsin, Geriatr Res Educ & Clin Ctr, Vet Adm Hosp, Madison, WI USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.
C3 State University System of Florida; University of Florida; University of
   Wisconsin System; University of Wisconsin Madison; University of
   Wisconsin System; University of Wisconsin Madison; University of
   Pennsylvania; Geriatric Research Education & Clinical Center; University
   of Wisconsin System; University of Wisconsin Madison; University of
   Wisconsin System; University of Wisconsin Madison; University of
   Wisconsin System; University of Wisconsin Madison
RP Prolla, TA (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.; Prolla, TA (corresponding author), Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.
EM taprolla@wisc.edu
OI Someya, Shinichi/0000-0001-9895-6227
FU NIH [RO1 AG021905, RO1 DC012552, R01 DC014437, R03 DC011840]; American
   Federation for Aging Research Grant; NIH/NIA Claude D. Pepper Older
   Americans Independence Center Junior Scholar Award
FX This research was supported by NIH grants RO1 AG021905 (T.A.P.), RO1
   DC012552 (S.S.), R01 DC014437 (S.S.) and R03 DC011840 (S.S.), American
   Federation for Aging Research Grant (S.S.), and NIH/NIA Claude D. Pepper
   Older Americans Independence Center Junior Scholar Award (S.S.).
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120
   Alderman JM, 2010, GERONTOLOGY, V56, P404, DOI 10.1159/000235720
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Diderich K, 2011, DNA REPAIR, V10, P772, DOI 10.1016/j.dnarep.2011.04.025
   FINDLAY WA, 1995, BIOCHEMISTRY-US, V34, P2087, DOI 10.1021/bi00007a001
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011
   Hamilton R, 2016, J NEUROL SCI, V370, P47, DOI 10.1016/j.jns.2016.09.021
   Han C, 2013, EXP GERONTOL, V48, P1091, DOI 10.1016/j.exger.2013.02.014
   Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222
   Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Lezza AMS, 2008, NEUROCHEM RES, V33, P2609, DOI 10.1007/s11064-008-9866-7
   Masternak MM, 2009, J GERONTOL A-BIOL, V64, P516, DOI 10.1093/gerona/glp024
   McKiernan SH, 2011, EXP GERONTOL, V46, P23, DOI 10.1016/j.exger.2010.09.011
   Muller FL, 2007, AM J PHYSL REGUL INT, V293
   Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3
   Safdar A, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0075-9
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
NR 36
TC 15
Z9 16
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 3
PY 2017
VL 12
IS 2
AR e0171159
DI 10.1371/journal.pone.0171159
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EN7DG
UT WOS:000396161700034
PM 28158260
OA gold, Green Submitted, Green Published
DA 2024-11-01
ER

PT J
AU Singh, B
   Low, PS
   Yeo, JF
AF Singh, B
   Low, PS
   Yeo, JF
TI MELAS: A case report
SO ANNALS ACADEMY OF MEDICINE SINGAPORE
LA English
DT Article
DE general anaesthesia; MELAS; mitochondrial DNA mutations; oral cavity;
   preventive dentistry
ID MITOCHONDRIAL MYOPATHY; LACTIC-ACIDOSIS; EPISODES MELAS;
   CLINICAL-FEATURES; POINT MUTATION; ENCEPHALOPATHY
AB Introduction: Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a rare, neurodegenerative and fatal disease caused by mutations in the mitochondrial DNA. Multiple systems of the body, including the oral cavity, can be affected by this disease. An electronic search of Medline spanning the years 1985 to 2003 was carried out using the key words "MELAS, Dentistry." It yielded no literature on the dental aspects of MELAS. Clinical Picture: This report documents the case of a 6-year-old Chinese boy diagnosed with MELAS and highlights problems encountered in the multidisciplinary management of MELAS patients, including its dental management. Treatment and Outcome: Dental management was successfully performed under general anaesthesia with close medical supervision by paediatrician and anaesthetist. Conclusions: There is no known treatment of the underlying disease and the clinical course is usually unpredictable. Preventive dental care is important in this group of patients as concurrent medical conditions can complicate dental care.
C1 Nalt Univ Hosp, Dept Oral & Maxillofacial Surg, Singapore 119074, Singapore.
   Natl Univ Singapore Hosp, Dept Pediat, Singapore 117548, Singapore.
C3 National University of Singapore
RP Nalt Univ Hosp, Dept Oral & Maxillofacial Surg, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.
EM BaldevS@nuh.com.sg
CR BURNS AM, 1989, ANAESTHESIA, V44, P975, DOI 10.1111/j.1365-2044.1989.tb09200.x
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   CRAWFORD JS, 1981, ANAESTHESIA, V36, P821, DOI 10.1111/j.1365-2044.1981.tb08826.x
   Fang W, 1996, NEUROLOGY, V46, P1494, DOI 10.1212/WNL.46.5.1494
   Finsterer J, 1998, CAN J ANAESTH, V45, P781, DOI 10.1007/BF03012149
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1995, MUSCLE NERVE, pS107
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   OHTANI Y, 1985, BRAIN DEV-JPN, V7, P249
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Thompson VA, 1997, ANESTH ANALG, V85, P1404, DOI 10.1097/00000539-199712000-00041
NR 13
TC 6
Z9 7
U1 1
U2 4
PU ACAD MEDICINE SINGAPORE
PI REPUBLIC SINGAPORE
PA 142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE
SN 0304-4602
J9 ANN ACAD MED SINGAP
JI Ann. Acad. Med. Singap.
PD JUL
PY 2004
VL 33
IS 4
SU S
BP 69
EP 71
PG 3
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 856DJ
UT WOS:000224023700013
PM 15389312
DA 2024-11-01
ER

PT J
AU Conforto, AB
   Yamamoto, FL
   Oba-Shinjo, SM
   Pinto, JGC
   Hoshino, M
   Scaff, M
   Marie, SKN
AF Conforto, Adriana Bastos
   Yamamoto, Fabio luji
   Oba-Shinjo, Sueli Mieko
   Pinto, Julio Guy C.
   Hoshino, Mauricio
   Scaff, Milberto
   Marie, Suely Kazue Nagahashi
TI Screening for MELAS mutations in young patients with stroke of
   undetermined origin
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE cerebrovascular disease; diagnostic methods; mitochondrial disease;
   myopathy; cryptogenic stroke
ID MITOCHONDRIAL-DNA A3243G; LACTIC-ACIDOSIS; ISCHEMIC-STROKE; ARTERIAL
   TERRITORIES; EPISODES MELAS; HUMAN BRAIN; MYOPATHY; ENCEPHALOPATHY;
   ENCEPHALOMYOPATHY; DIAGNOSIS
AB Purpose: It has been suggested that mitochondrial disease may be responsible for a substantial proportion of strokes of indetermined origin. We have preliminarily screened for MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) mutations in young patients with cryptogenic strokes. Method: The mitochondrial mutations A3243G and T3271C were investigated in 38 subjects 14 aged less than 46 years. Group 1: 15 patients with cryptogenic strokes; Group 2: 3 patients with diagnosis of MELAS syndrome, including stroke-like episodes; Group 3: 20 healthy subjects. Results: The A3243G mutation was absent in all subjects in Groups 1 and 3 but was present in all subjects in Group 2. Conclusion: Our results do not support screening for these mutations to diagnose oligosymptomatic forms of MELAS in cryptogenic strokes in the absence of other features of the syndrome. We suggest that clinical findings should guide mitochondrial genetic testing.
C1 Univ Sao Paulo, Div Neurol, Hosp Clin, HC,FMUSP, Sao Paulo, Brazil.
C3 Universidade de Sao Paulo
RP Conforto, AB (corresponding author), FMUSP, Dept Neurol, HC, Ave Dr Eneas Carvalho Aguiar 255-5084, BR-05403000 Sao Paulo, Brazil.
EM abconf@yahoo.com
RI Conforto, Adriana/C-9371-2014; Marie, Suely/D-1870-2012; Shinjo,
   Sueli/C-4017-2012
OI Marie, Suely/0000-0003-4419-7928; Conforto, Adriana/0000-0001-7869-3490;
   Shinjo, Sueli/0000-0002-1650-5973
CR ADAMS HP, 1995, ARCH NEUROL-CHICAGO, V52, P491, DOI 10.1001/archneur.1995.00540290081021
   ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
   Di Gennaro G, 2000, HEADACHE, V40, P568, DOI 10.1046/j.1526-4610.2000.00088.x
   Dickerson BC, 2005, NEW ENGL J MED, V353, P2271, DOI 10.1056/NEJMcpc059032
   Dubowitz V., 1985, Muscle Biopsy-A Practical Approach, VSecond, P19
   FANG W, 1993, ARCH NEUROL-CHICAGO, V50, P977, DOI 10.1001/archneur.1993.00540090074013
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Jacobs BS, 2002, STROKE, V33, P2789, DOI 10.1161/01.STR.0000038988.64376.3A
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Kristensen B, 1997, STROKE, V28, P1702, DOI 10.1161/01.STR.28.9.1702
   Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331
   MARIE SKN, 1994, BIOCHEM MED METAB B, V52, P136, DOI 10.1006/bmmb.1994.1045
   Martínez-Fernández E, 2001, STROKE, V32, P2507, DOI 10.1161/hs1101.098328
   Melberg A, 1996, ACTA NEUROL SCAND, V94, P233, DOI 10.1111/j.1600-0404.1996.tb07058.x
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Musolino R, 2003, CEREBROVASC DIS, V15, P121, DOI 10.1159/000067139
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pulkes T, 2000, LANCET, V356, P2068, DOI 10.1016/S0140-6736(00)03408-5
   Rozen TD, 2004, HEADACHE, V44, P674, DOI 10.1111/j.1526-4610.2004.04126.x
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Shoffner JM, 2000, NEUROL CLIN, V18, P105, DOI 10.1016/S0733-8619(05)70180-8
   Siqueira JI, 1996, STROKE, V27, P2016
   Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699
   Tatu L, 1996, NEUROLOGY, V47, P1125, DOI 10.1212/WNL.47.5.1125
   Thompson VA, 1997, ANESTH ANALG, V85, P1404, DOI 10.1097/00000539-199712000-00041
   Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Werneck L C, 1987, Arq Neuropsiquiatr, V45, P288
   Yonemura K, 2001, AM J NEURORADIOL, V22, P269
NR 33
TC 6
Z9 6
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2007
VL 65
IS 2B
BP 371
EP 376
DI 10.1590/S0004-282X2007000300001
PG 6
WC Neurosciences; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychiatry
GA 192TD
UT WOS:000248225000001
PM 17664998
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Sprason, C
   Tucker, T
   Clancy, D
AF Sprason, Charlotte
   Tucker, Trudy
   Clancy, David
TI MtDNA deletions and aging
SO FRONTIERS IN AGING
LA English
DT Review
DE aging; mitochondria; mitochondrial DNA deletions; mitochondrial DNA;
   mitochondrial dysfunction
ID MITOCHONDRIAL-DNA-DELETION; POINT MUTATIONS; MATERNAL INHERITANCE;
   SKELETAL-MUSCLE; DIRECT REPEATS; HUMAN BRAIN; DISEASE; ACCUMULATION;
   MECHANISMS; GENOME
AB Aging is the major risk factor in most of the leading causes of mortality worldwide, yet its fundamental causes mostly remain unclear. One of the clear hallmarks of aging is mitochondrial dysfunction. Mitochondria are best known for their roles in cellular energy generation, but they are also critical biosynthetic and signaling organelles. They also undergo multiple changes with organismal age, including increased genetic errors in their independent, circular genome. A key group of studies looking at mice with increased mtDNA mutations showed that premature aging phenotypes correlated with increased deletions but not point mutations. This generated an interest in mitochondrial deletions as a potential fundamental cause of aging. However, subsequent studies in different models have yielded diverse results. This review summarizes the research on mitochondrial deletions in various organisms to understand their possible roles in causing aging while identifying the key complications in quantifying deletions across all models.
C1 [Sprason, Charlotte; Tucker, Trudy; Clancy, David] Univ Lancaster, Biomed & Life Sci, Lancaster, England.
C3 Lancaster University
RP Clancy, D (corresponding author), Univ Lancaster, Biomed & Life Sci, Lancaster, England.
EM d.clancy@lancaster.ac.uk
CR Abascal F, 2021, NATURE, V593, P405, DOI 10.1038/s41586-021-03477-4
   Alexe G, 2007, HUM GENET, V121, P347, DOI 10.1007/s00439-007-0330-6
   Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arai T, 2003, AGING CLIN EXP RES, V15, P1
   Arbeithuber B, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000745
   Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bilal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002421
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bratic A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9808
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Camus MF, 2012, CURR BIOL, V22, P1717, DOI 10.1016/j.cub.2012.07.018
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Chen Z, 2019, J GENET GENOMICS, V46, P201, DOI 10.1016/j.jgg.2019.03.009
   Cheng YW, 2019, RESPIR MED CASE REP, V28, DOI 10.1016/j.rmcr.2019.100901
   Chevigny N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010328
   Chocron ES, 2019, BBA-MOL BASIS DIS, V1865, P285, DOI 10.1016/j.bbadis.2018.09.035
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Dabravolski SA, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23147863
   Dattani S., 2023, Our World in Data
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Filograna R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9824
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Gao J, 2016, CLIN LAB, V62, P689, DOI 10.7754/Clin.Lab.2015.150837
   Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002
   Gems D, 2021, AGEING RES REV, V70, DOI 10.1016/j.arr.2021.101407
   Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Haroon S, 2018, CELL REP, V22, P3115, DOI 10.1016/j.celrep.2018.02.099
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Kauppila TES, 2018, P NATL ACAD SCI USA, V115, pE9620, DOI 10.1073/pnas.1721683115
   Khaidakov M, 2006, MECH AGEING DEV, V127, P808, DOI 10.1016/j.mad.2006.07.008
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Lax NZ, 2011, NEUROSCIENTIST, V17, P645, DOI 10.1177/1073858411385469
   Lee William, 2023, Nat Genet, V55, P1632, DOI 10.1038/s41588-023-01505-9
   Liang P, 1997, DIABETES, V46, P920, DOI 10.2337/diabetes.46.5.920
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu Y, 2021, MOL THER-NUCL ACIDS, V23, P657, DOI 10.1016/j.omtn.2020.12.017
   López-Otin C, 2023, CELL, V186, P243, DOI 10.1016/j.cell.2022.11.001
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Maeda R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67686-z
   Matam K, 2014, MOL GENET GENOMICS, V289, P533, DOI 10.1007/s00438-014-0828-2
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1994, NUCLEIC ACIDS RES, V22, P1075, DOI 10.1093/nar/22.6.1075
   Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5
   Mikhailova A., 2019, bioRxiv, P603282, DOI [10.1101/603282, DOI 10.1101/603282]
   Nagarajan-Radha V, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0178
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Rojansky R, 2016, ELIFE, V5, DOI 10.7554/eLife.17896
   Ross JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rygiel KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09906
   Samstag CL, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007805
   Sanchez-Contreras M, 2022, FRONT AGING-LAUSANNE, V2, DOI 10.3389/fragi.2021.805126
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Shokolenko Inna N, 2014, World J Exp Med, V4, P46
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Valentine CC, 2020, P NATL ACAD SCI USA, V117, P33414, DOI 10.1073/pnas.2013724117
   Vandiver AR, 2022, MITOCHONDRION, V65, P176, DOI 10.1016/j.mito.2022.06.003
   Vecoli C, 2020, MUTAT RES-REV MUTAT, V784, DOI 10.1016/j.mrrev.2020.108309
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990
   Xirocostas ZA, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2019.0867
   Yui R, 2006, MUTAT RES-FUND MOL M, V594, P155, DOI 10.1016/j.mrfmmm.2005.08.003
   Yui R, 2003, GENES GENET SYST, V78, P245
NR 84
TC 0
Z9 0
U1 2
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2673-6217
J9 FRONT AGING-LAUSANNE
JI Front. Aging
PD FEB 15
PY 2024
VL 5
AR 1359638
DI 10.3389/fragi.2024.1359638
PG 13
WC Geriatrics & Gerontology
WE Emerging Sources Citation Index (ESCI)
SC Geriatrics & Gerontology
GA JM6Z0
UT WOS:001173637000001
PM 38425363
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Sasarman, F
   Thiffault, I
   Weraarpachai, W
   Salomon, S
   Maftei, C
   Gauthier, J
   Ellazam, B
   Webb, N
   Antonicka, H
   Janer, A
   Brunel-Guitton, C
   Elpeleg, O
   Mitchell, G
   Shoubridge, EA
AF Sasarman, Florin
   Thiffault, Isabelle
   Weraarpachai, Woranontee
   Salomon, Steven
   Maftei, Catalina
   Gauthier, Julie
   Ellazam, Benjamin
   Webb, Neil
   Antonicka, Hana
   Janer, Alexandre
   Brunel-Guitton, Catherine
   Elpeleg, Orly
   Mitchell, Grant
   Shoubridge, Eric A.
TI The 3' addition of CCA to mitochondrial tRNA<SUP>Ser(AGY)</SUP> is
   specifically impaired in patients with mutations in the tRNA nucleotidyl
   transferase <i>TRNT1</i>
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID SIDEROBLASTIC ANEMIA-MLASA; LACTIC-ACIDOSIS; ADDING ENZYME; DNA;
   POLYMERIZATION; DELETIONS; MECHANISM; TEMPLATE; MYOPATHY; GENE
AB Addition of the trinucleotide cytosine/cytosine/adenine (CCA) to the 3' end of transfer RNAs (tRNAs) is essential for translation and is catalyzed by the enzyme TRNT1 (tRNA nucleotidyl transferase), which functions in both the cytoplasm and mitochondria. Exome sequencing revealed TRNT1 mutations in two unrelated subjects with different clinical features. The first presented with acute lactic acidosis at 3 weeks of age and developed severe developmental delay, hypotonia, microcephaly, seizures, progressive cortical atrophy, neurosensorial deafness, sideroblastic anemia and renal Fanconi syndrome, dying at 21 months. The second presented at 3.5 years with gait ataxia, dysarthria, gross motor regression, hypotonia, ptosis and ophthalmoplegia and had abnormal signals in brainstem and dentate nucleus. In subject 1, muscle biopsy showed combined oxidative phosphorylation (OXPHOS) defects, but there was no OXPHOS deficiency in fibroblasts from either subject, despite a 10-fold-reduction in TRNT1 protein levels in fibroblasts of the first subject. Furthermore, in normal controls, TRNT1 protein levels are 10-fold lower in muscle than in fibroblasts. High resolution northern blots of subject fibroblast RNA suggested incomplete CCA addition to the non-canonical mitochondrial tRNA(Ser(AGY)), but no obvious qualitative differences in other mitochondrial or cytoplasmic tRNAs. Complete knockdown of TRNT1 in patient fibroblasts rendered mitochondrial tRNA(Ser(AGY)) undetectable, and markedly reduced mitochondrial translation, except polypeptides lacking Ser(AGY) codons. These data suggest that the clinical phenotypes associated with TRNT1 mutations are largely due to impaired mitochondrial translation, resulting from defective CCA addition to mitochondrial tRNA(Ser(AGY)), and that the severity of this biochemical phenotype determines the severity and tissue distribution of clinical features.
C1 [Sasarman, Florin; Weraarpachai, Woranontee; Salomon, Steven; Webb, Neil; Antonicka, Hana; Janer, Alexandre; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada.
   [Sasarman, Florin; Weraarpachai, Woranontee; Salomon, Steven; Webb, Neil; Antonicka, Hana; Janer, Alexandre; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada.
   [Sasarman, Florin; Thiffault, Isabelle; Maftei, Catalina; Gauthier, Julie; Webb, Neil; Brunel-Guitton, Catherine; Mitchell, Grant] CHU St Justine, Dept Pediat, Div Med Genet, Montreal, PQ, Canada.
   [Ellazam, Benjamin] CHU St Justine, Dept Pathol, Montreal, PQ, Canada.
   Univ Montreal, Montreal, PQ, Canada.
   [Thiffault, Isabelle] Childrens Mercy Hosp, Ctr Pediat Genom Med, Kansas City, MO 64108 USA.
   [Elpeleg, Orly] Hebrew Univ Jerusalem, Med Ctr, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel.
C3 McGill University; McGill University; Universite de Montreal; Centre
   Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre
   Hospitalier Universitaire Sainte-Justine; Universite de Montreal;
   Children's Mercy Hospital; Hebrew University of Jerusalem
RP Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.
EM eric@ericpc.mni.mcgill.ca
RI janer, alexandre/AAV-3192-2021; GAUTHIER, Julie/KXR-3700-2024
OI Antonicka, Hana/0000-0002-2525-2867; Brunel-Guitton,
   Catherine/0000-0002-5470-2249
FU CIHR [MT-15460, 178978]; Fondation GO
FX This work was supported by grants from the CIHR (MT-15460) to E.A.S. and
   CIHR (178978) to G.M. and by a joint grant from la Fondation GO to
   C.B.G. and E.A.S.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Betat H, 2010, CELL MOL LIFE SCI, V67, P1447, DOI 10.1007/s00018-010-0271-4
   Bottomley SS, 2014, HEMATOL ONCOL CLIN N, V28, P653, DOI 10.1016/j.hoc.2014.04.008
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370
   CHEN JY, 1992, J BIOL CHEM, V267, P14879
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14
   Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Toh Y, 2009, EMBO J, V28, P3353, DOI 10.1038/emboj.2009.260
   Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712
   Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027
   Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711
   Yarham JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004424
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 23
TC 57
Z9 61
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 15
PY 2015
VL 24
IS 10
BP 2841
EP 2847
DI 10.1093/hmg/ddv044
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CJ2PK
UT WOS:000355326800012
PM 25652405
OA Green Published
DA 2024-11-01
ER

PT J
AU Damas, J
   Samuels, DC
   Carneiro, J
   Amorim, A
   Pereira, F
AF Damas, Joana
   Samuels, David C.
   Carneiro, Joao
   Amorim, Antonio
   Pereira, Filipe
TI Mitochondrial DNA Rearrangements in Health and Disease-A Comprehensive
   Study
SO HUMAN MUTATION
LA English
DT Review
DE mitochondrial DNA; deletions; duplications; breakage hotspots;
   mitochondrial disease; tumors
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; LARGE-SCALE DELETIONS;
   KEARNS-SAYRE SYNDROME; D-LOOP; TANDEM DUPLICATION; MULTIPLE DELETIONS;
   MTDNA DUPLICATIONS; GENE-MUTATIONS; DIRECT REPEATS; REPLICATION
AB Mitochondrial DNA (mtDNA) rearrangements cause a wide variety of highly debilitating and often fatal disorders and have been implicated in aging and age-associated disease. Here, we present a meta-analytical study of mtDNA deletions (n=730) and partial duplications (n=37) using information from more than 300 studies published over the last 30 years. We show that both classes of mtDNA rearrangements are unequally distributed among disorders and their breakpoints have different genomic locations. We also demonstrate that 100% of cases with sporadic mtDNA deletions and 97.3% with duplications have no breakpoints in the 16,071 breakage hotspot site, in contrast with deletions from healthy and aged tissues. Notably, most deletions removing a section of the D-loop are found in tumors. Deleted mtDNA molecules lacking the origin of L-strand replication (O-L) represent only 9.5% of all reported cases, whereas extra origins of replication occur in all duplications. As previously shown for deletions, imperfect stretches of homology are common in duplication breakpoints. Finally, we provide a dedicated Website with detailed information on deleted/duplicated mtDNA regions to facilitate the design of efficient methods for identification and screening of rearranged mitochondrial genomes (available at http://www.portugene.com/mtDNArearrangements.html).
C1 [Damas, Joana; Carneiro, Joao; Amorim, Antonio; Pereira, Filipe] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.
   [Samuels, David C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA.
   [Amorim, Antonio] Univ Porto, Fac Sci, P-4050123 Oporto, Portugal.
   [Pereira, Filipe] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, P-4050123 Oporto, Portugal.
C3 Universidade do Porto; Vanderbilt University; Universidade do Porto;
   Universidade do Porto
RP Pereira, F (corresponding author), Univ Porto, CIIMAR CIMAR, Rua Bragas 289, P-4050123 Oporto, Portugal.
EM fpereirapt@gmail.com
RI Miguel Sotto Maior Faria Carneiro, Joao/A-6289-2009; Pereira,
   Filipe/F-6391-2010; Damas, Joana/J-6045-2013; Amorim,
   Antonio/A-7938-2008; Samuels, David/A-5393-2008
OI Miguel Sotto Maior Faria Carneiro, Joao/0000-0002-5153-2395; Pereira,
   Filipe/0000-0001-8950-1036; Damas, Joana/0000-0003-4857-2510; Amorim,
   Antonio/0000-0002-7518-6247; Samuels, David/0000-0003-3529-7791
FU Portuguese Foundation for Science and Technology; Fundo Social Europeu;
   Programa Operacional Potencial Humano [SFRH/BPD/44637/2008,
   PTDC/CVT/100881/2008]; Investigator FCT program; European Regional
   Development Fund (ERDF) [PEst-C/MAR/LA0015/2013]; Fundação para a
   Ciência e a Tecnologia [PTDC/CVT/100881/2008, SFRH/BPD/44637/2008]
   Funding Source: FCT
FX Contract grant sponsors: Portuguese Foundation for Science and
   Technology, Fundo Social Europeu and Programa Operacional Potencial
   Humano (SFRH/BPD/44637/2008, PTDC/CVT/100881/2008, Investigator FCT
   program); European Regional Development Fund (ERDF)
   (PEst-C/MAR/LA0015/2013).
CR Antes A, 2010, NUCLEIC ACIDS RES, V38, P6466, DOI 10.1093/nar/gkq493
   Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Bank C, 2000, BIOCHEM BIOPH RES CO, V279, P595, DOI 10.1006/bbrc.2000.3951
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Bouzidi MF, 1998, HUM MOL GENET, V7, P385, DOI 10.1093/hmg/7.3.385
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Cohen O, 1996, HUM GENET, V97, P659
   Cooper DN, 2011, HUM MUTAT, V32, P1075, DOI 10.1002/humu.21557
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   Di Rienzi SC, 2009, GENOME BIOL EVOL, V1, P350, DOI 10.1093/gbe/evp034
   DiMauro S., 2003, GeneReviews
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   EICHLER DC, 1977, J BIOL CHEM, V252, P7888
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Fromenty B, 1997, AM J MED GENET, V71, P443, DOI 10.1002/(SICI)1096-8628(19970905)71:4<443::AID-AJMG14>3.0.CO;2-G
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Hao HL, 1997, AM J HUM GENET, V60, P1363, DOI 10.1086/515474
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   HIXSON JE, 1986, J BIOL CHEM, V261, P2384
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251
   Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2010, METHODS MOL BIOL, V628, P227, DOI 10.1007/978-1-60327-367-1_13
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Lakshmanan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035271
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Muraki K, 2001, AM J MED GENET, V98, P205, DOI 10.1002/1096-8628(20010122)98:3<205::AID-AJMG1077>3.0.CO;2-P
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   Nardi F, 2012, MITOCHONDRION, V12, P483, DOI 10.1016/j.mito.2012.07.105
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Odoardi F, 2003, AM J MED GENET A, V118A, P247, DOI 10.1002/ajmg.a.20006
   Oliveira P, 2013, PLOS ONE, V8
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pereira F, 2008, MOL BIOL EVOL, V25, P2759, DOI 10.1093/molbev/msn225
   Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   POULTON J, 1989, NUCLEIC ACIDS RES, V17, P10223, DOI 10.1093/nar/17.24.10223
   POULTON J, 1992, J INHERIT METAB DIS, V15, P487, DOI 10.1007/BF01799607
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Rogounovitch TI, 2002, CANCER RES, V62, P7031
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROTIG A, 1989, LANCET, V1, P902
   Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sbisà E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sembongi H, 2007, HUM MOL GENET, V16, P2306, DOI 10.1093/hmg/ddm182
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349
   Tengan CH, 1998, BBA-MOL BASIS DIS, V1406, P73, DOI 10.1016/S0925-4439(97)00087-2
   Tengan CH, 2002, BBA-MOL BASIS DIS, V1588, P65, DOI 10.1016/S0925-4439(02)00140-0
   TORRONI A, 1994, AM J HUM GENET, V55, P760
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   WALBERG MW, 1981, NUCLEIC ACIDS RES, V9, P5411, DOI 10.1093/nar/9.20.5411
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wei YH, 1996, ANN NY ACAD SCI, V786, P82, DOI 10.1111/j.1749-6632.1996.tb39054.x
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005
NR 94
TC 62
Z9 66
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD JAN
PY 2014
VL 35
IS 1
BP 1
EP 14
DI 10.1002/humu.22452
PG 14
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 289JP
UT WOS:000329678600001
PM 24115352
DA 2024-11-01
ER

PT J
AU Tam, ZY
   Gruber, J
   Halliwell, B
   Gunawan, R
AF Tam, Zhi Yang
   Gruber, Jan
   Halliwell, Barry
   Gunawan, Rudiyanto
TI Mathematical Modeling of the Role of Mitochondrial Fusion and Fission in
   Mitochondrial DNA Maintenance
SO PLOS ONE
LA English
DT Article
ID IN-VIVO; DELETION MUTATIONS; CLONAL EXPANSION; HUMAN-CELLS; TURNOVER;
   DYNAMICS; MTDNA; COMPLEMENTATION; NUCLEOIDS; MUSCLE
AB Accumulation of mitochondrial DNA (mtDNA) mutations has been implicated in a wide range of human pathologies, including neurodegenerative diseases, sarcopenia, and the aging process itself. In cells, mtDNA molecules are constantly turned over (i.e. replicated and degraded) and are also exchanged among mitochondria during the fusion and fission of these organelles. While the expansion of a mutant mtDNA population is believed to occur by random segregation of these molecules during turnover, the role of mitochondrial fusion-fission in this context is currently not well understood. In this study, an in silico modeling approach is taken to investigate the effects of mitochondrial fusion and fission dynamics on mutant mtDNA accumulation. Here we report model simulations suggesting that when mitochondrial fusion-fission rate is low, the slow mtDNA mixing can lead to an uneven distribution of mutant mtDNA among mitochondria in between two mitochondrial autophagic events leading to more stochasticity in the outcomes from a single random autophagic event. Consequently, slower mitochondrial fusion-fission results in higher variability in the mtDNA mutation burden among cells in a tissue over time, and mtDNA mutations have a higher propensity to clonally expand due to the increased stochasticity. When these mutations affect cellular energetics, nuclear retrograde signalling can upregulate mtDNA replication, which is expected to slow clonal expansion of these mutant mtDNA. However, our simulations suggest that the protective ability of retrograde signalling depends on the efficiency of fusion-fission process. Our results thus shed light on the interplay between mitochondrial fusion-fission and mtDNA turnover and may explain the mechanism underlying the experimentally observed increase in the accumulation of mtDNA mutations when either mitochondrial fusion or fission is inhibited.
C1 [Tam, Zhi Yang; Gunawan, Rudiyanto] ETH, Inst Chem & Bioengn, Zurich, Switzerland.
   [Gruber, Jan; Halliwell, Barry] Natl Univ Singapore, Dept Biochem, Ctr Life Sci, Singapore 117548, Singapore.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich; National
   University of Singapore
RP Gunawan, R (corresponding author), ETH, Inst Chem & Bioengn, Zurich, Switzerland.
EM rudi.gunawan@chem.ethz.ch
RI Halliwell, Barry/C-8318-2009; Gunawan, Rudiyanto/D-4650-2009
OI Halliwell, Barry/0000-0002-3560-7123; Gunawan,
   Rudiyanto/0000-0002-6480-7976
FU ETH Zurich; National University of Singapore (FRC) [R-279-000-299-112];
   Ministry of Education Singapore [MOE2010-T2-2-048]
FX This study was supported by funding from ETH Zurich, the National
   University of Singapore (FRC Grant R-279-000-299-112) and the Ministry
   of Education Singapore (MOE2010-T2-2-048). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101
   Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060
   BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480
   Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292
   Capaldi RA, 2002, BBA-BIOENERGETICS, V1555, P192, DOI 10.1016/S0005-2728(02)00277-3
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002
   D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Figge MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002576
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hori A, 2011, GENES CELLS, V16, P527, DOI 10.1111/j.1365-2443.2011.01504.x
   Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274
   HUEMER RP, 1971, EXP GERONTOL, V6, P259, DOI 10.1016/0531-5565(71)90038-6
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kraytsberg Y, 2003, MECH AGEING DEV, V124, P49, DOI 10.1016/S0047-6374(02)00169-0
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001
   Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995
   Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257
   Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054
   Poovathingal SK, 2012, BIOGERONTOLOGY, V13, P557, DOI 10.1007/s10522-012-9390-7
   Poovathingal SK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000572
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Saunter CD, 2009, FEBS LETT, V583, P1267, DOI 10.1016/j.febslet.2009.02.041
   Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043
   Twig G, 2006, AM J PHYSIOL-CELL PH, V291, pC176, DOI 10.1152/ajpcell.00348.2005
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
NR 50
TC 39
Z9 43
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 11
PY 2013
VL 8
IS 10
AR e76230
DI 10.1371/journal.pone.0076230
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 236SL
UT WOS:000325819400049
PM 24146842
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT B
AU Filosto, M
   Mancuso, M
AF Filosto, Massimiliano
   Mancuso, Michelangelo
BE Pezzini, A
   Padovani, A
TI Mitochondrial Diseases
SO CEREBRAL ISCHEMIA IN YOUNG ADULTS: PATHOGENIC AND CLINICAL PERSPECTIVES
SE Neurology Laboratory and Clinical Research Series
LA English
DT Article; Book Chapter
ID STROKE-LIKE EPISODES; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; KEARNS-SAYRE
   SYNDROME; ADENINE-NUCLEOTIDE TRANSLOCATOR; WOBBLE MODIFICATION
   DEFICIENCY; RESPIRATORY-CHAIN DISORDERS; HEREDITARY OPTIC NEUROPATHY;
   A3243G MTDNA MUTATION; CYTOCHROME-C-OXIDASE; LARGE-SCALE DELETION
AB Mitochondrial diseases (MD) are disorders caused by an impairment of the mitochondrial respiratory chain function. They are usually progressive, isolated or multisystem diseases and have variable times of onset between birth and senescence.
   Mitochondria have their own DNA called mitochondrial DNA (mtDNA). Therefore MD have the unique characteristic that they can be caused by mutations in both mtDNA and nuclear DNA (nDNA). The complexity of mitochondrial genetics is in part responsible for the intra- and inter-familiar clinical heterogeneity of this class of diseases.
   MD are currently classified according to the location of the genetic defect either on mtDNA (sporadic or of maternal inheritance) or on nDNA (autosomic inheritance).
   Among the variety of symptoms and signs caused by respiratory chain deficiency, stroke may be secondary to classical vascular and non-vascular mechanisms.
   Vascular mechanisms include atherothrombotic and cardioembolic processes linked to classical vascular risk factors which are present in many MD patients. Non-vascular mechanisms are typical of MELAS, which is characterized by stroke-like lesions located in the cortical posterior regions of the brain with a distribution that does not respect vascular territories. Stroke-like episodes are most likely related to the increased hyperexcitability and susceptibility of cortical neurons to excitotoxic injury.
C1 [Filosto, Massimiliano] Univ Brescia, Sch Med, Neurol Clin, Dept Med & Surg Sci, I-25123 Brescia, Italy.
   [Mancuso, Michelangelo] Univ Pisa, Neurol Clin, Dept Neurosci, Pisa, Italy.
C3 University of Brescia; University of Pisa
RP Filosto, M (corresponding author), Pzle Spedali Civili 1, I-25123 Brescia, Italy.
EM filosto@med.unibs.it
RI Filosto, Massimiliano/S-9446-2019; Mancuso, Michelangelo/K-4170-2016
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Apostolova LG, 2005, ARCH NEUROL-CHICAGO, V62, P1154, DOI 10.1001/archneur.62.7.1154
   Asoh S, 1996, J BIOCHEM-TOKYO, V120, P600
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Brown GK, 1996, J INHERIT METAB DIS, V19, P553, DOI 10.1007/BF01799116
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.0.CO;2-S
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carmi E, 2001, ANN DERMATOL VENER, V128, P1031
   Chabrol B, 1997, NEUROLOGY, V49, P308, DOI 10.1212/WNL.49.1.308-b
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Clark JM, 1996, NEUROLOGY, V46, P223, DOI 10.1212/WNL.46.1.223
   Cock H, 1999, EPILEPSIA, V40, P33, DOI 10.1111/j.1528-1157.1999.tb00897.x
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Deschauer M, 2004, J NEUROL NEUROSUR PS, V75, P1204, DOI 10.1136/jnnp.2003.026278
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   DiMauro S, 1999, J CHILD NEUROL, V14, pS23, DOI 10.1177/0883073899014001051
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Filosto M, 2004, ACTA NEUROPATHOL, V108, P168, DOI 10.1007/s00401-004-0872-9
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Filosto M, 2002, ACTA NEUROPATHOL, V103, P215, DOI 10.1007/s004010100455
   Filosto M, 2008, NEUROMUSCULAR DISORD, V18, P204, DOI 10.1016/j.nmd.2007.12.005
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Finsterer J, 2004, CARDIOLOGY, V102, P228, DOI 10.1159/000081015
   Gardner JL, 2007, BIOSCIENCE REP, V27, P139, DOI 10.1007/s10540-007-9042-3
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   Gillis L, 2002, PEDIATR CLIN N AM, V49, P203, DOI 10.1016/S0031-3955(03)00115-9
   GOTO Y, 1995, MUSCLE NERVE       S, V3, P107
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M., 1996, Handbook of Muscle Disease, P479
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Jacobs HT, 2000, HUM MOL GENET, V9, P463, DOI 10.1093/hmg/9.4.463
   Kamada K, 2001, J NEUROL NEUROSUR PS, V70, P675, DOI 10.1136/jnnp.70.5.675
   Kanaumi T, 2006, PEDIATR NEUROL, V34, P235, DOI 10.1016/j.pediatrneurol.2005.08.024
   Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kharasch ED, 2006, ANESTHESIOLOGY, V105, P737, DOI 10.1097/00000542-200610000-00020
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Komura K, 2003, PEDIATR NEUROL, V28, P53, DOI 10.1016/S0887-8994(02)00469-1
   KOSINSKI C, 1995, STROKE, V26, P1950, DOI 10.1161/01.STR.26.10.1950
   Kroemer G, 1997, CELL DEATH DIFFER, V4, P443, DOI 10.1038/sj.cdd.4400266
   KUHL CK, 1994, RADIOLOGY, V192, P223, DOI 10.1148/radiology.192.1.8208943
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Lodi R, 2004, BBA-BIOENERGETICS, V1657, P146, DOI 10.1016/j.bbabio.2004.05.003
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lorenc A, 2003, MITOCHONDRION, V3, P119, DOI 10.1016/S1567-7249(03)00106-5
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mancuso M, 2007, BIOSCIENCE REP, V27, P31, DOI 10.1007/s10540-007-9035-2
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   MATTHEWS PM, 1993, NEUROLOGY, V43, P2484, DOI 10.1212/WNL.43.12.2484
   Michelson DJ, 2004, MITOCHONDRION, V4, P665, DOI 10.1016/j.mito.2004.07.019
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   *MIT, 2007, HUM MIT GEN DAT
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   OHAMA E, 1987, ACTA NEUROPATHOL, V75, P1, DOI 10.1007/BF00686785
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580
   Provenzale JM, 1996, NEUROLOGY, V46, P826, DOI 10.1212/WNL.46.3.826
   Pulkes T, 2000, LANCET, V356, P2068, DOI 10.1016/S0140-6736(00)03408-5
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Roy MD, 2005, RNA, V11, P254, DOI 10.1261/rna.7143305
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sangkhathat S, 2005, PEDIATR SURG INT, V21, P745, DOI 10.1007/s00383-005-1471-0
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/0005-2728(92)90226-R
   Schon EA, 2003, GENETICS MITOCHONDRI, P111
   SCHON EA, 2001, MITOCHONDRIA PATHOGE, P53
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Simonati A, 2003, J NEUROL, V250, P702, DOI 10.1007/s00415-003-1065-5
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Strachan J, 2001, J INHERIT METAB DIS, V24, P409, DOI 10.1023/A:1010573122748
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Suzuki Y, 2004, DIABETES RES CLIN PR, V63, P225, DOI 10.1016/j.diabres.2003.10.024
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   WOLVETANG EJ, 1994, FEBS LETT, V339, P40, DOI 10.1016/0014-5793(94)80380-3
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
   Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 149
TC 1
Z9 1
U1 0
U2 0
PU NOVA SCIENCE PUBLISHERS, INC
PI HAUPPAUGE
PA 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA
BN 978-1-60741-627-2
J9 NEUROL LAB CLIN RES
PY 2009
BP 617
EP 651
PG 35
WC Clinical Neurology
WE Book Citation Index – Science (BKCI-S)
SC Neurosciences & Neurology
GA BNU21
UT WOS:000275556300023
DA 2024-11-01
ER

PT J
AU Friedman, SD
   Shaw, DWW
   Ishak, G
   Gropman, AL
   Saneto, RP
AF Friedman, Seth D.
   Shaw, Dennis W. W.
   Ishak, Gisele
   Gropman, Andrea L.
   Saneto, Russell P.
TI THE USE OF NEUROIMAGING IN THE DIAGNOSIS OF MITOCHONDRIAL DISEASE
SO DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
LA English
DT Review
DE lactate; magnetic resonance imaging (MRI); magnetic resonance
   spectroscopy (MRS); mitochondiral disease
ID MAGNETIC-RESONANCE-SPECTROSCOPY; COMPLEX-I DEFICIENCY; RESPIRATORY-CHAIN
   DISORDERS; PROTON MR SPECTROSCOPY; ALPERS-HUTTENLOCHER-SYNDROME;
   STROKE-LIKE EPISODES; LEIGH-SYNDROME; LACTIC-ACIDOSIS; BRAIN MRI;
   NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY
AB Mutations in nuclear and mitochondrial DNA impacting mitochondrial function result in disease manifestations ranging from early death to abnormalities in all major organ systems and to symptoms that can be largely confined to muscle fatigue. The definitive diagnosis of a mitochondrial disorder can be difficult to establish. When the constellation of symptoms is suggestive of mitochondrial disease, neuroimaging features may be diagnostic and suggestive, can help direct further workup, and can help to further characterize the underlying brain abnormalities. Magnetic resonance imaging changes may be nonspecific, such as atrophy (both general and involving specific structures, such as cerebellum), more suggestive of particular disorders such as focal and often bilateral lesions confined to deep brain nuclei, or clearly characteristic of a given disorder such as stroke-like lesions that do not respect vascular boundaries in mitochondria! myopathy, encephalopathy, lactic acidosis, and stroke-like episode (MELAS). White matter hyperintensities with or without associated gray matter involvement may also be observed. Across patients and discrete disease subtypes (e.g., MELAS, Leigh syndrome, etc.), patterns of these features are helpful for diagnosis. However, it is also true that marked variability in expression occurs in all mitochondrial disease subtypes, illustrative of the complexity of the disease process. The present review summarizes the role of neuroimaging in the diagnosis and characterization of patients with suspected mitochondrial disease. (C) 2010 Wiley-Liss, Inc. Dev Disabil Res Rev 2010;16:129-135.
C1 [Friedman, Seth D.; Shaw, Dennis W. W.; Ishak, Gisele] Univ Washington, Seattle Childrens Hosp, Div Radiol, Seattle, WA 98105 USA.
   [Gropman, Andrea L.] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA.
   [Saneto, Russell P.] Univ Washington, Seattle Childrens Hosp, Div Pediat Neurol, Seattle, WA 98105 USA.
C3 University of Washington; University of Washington Seattle; Seattle
   Children's Hospital; Children's National Health System; Seattle
   Children's Hospital; University of Washington; University of Washington
   Seattle
RP Saneto, RP (corresponding author), Univ Washington, Seattle Childrens Hosp, Div Radiol, Mail Stop B-5552,4800 Sand Point Way,NE, Seattle, WA 98105 USA.
EM russ.saneto@seattlechildrens.org
OI friedman, seth/0000-0001-8785-7215
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   ANTOZZI C, 1995, J NEUROL SCI, V129, P152, DOI 10.1016/0022-510X(94)00267-R
   Apostolova LG, 2005, ARCH NEUROL-CHICAGO, V62, P1154, DOI 10.1001/archneur.62.7.1154
   Barbiroli B, 1997, CELL MOL BIOL, V43, P741
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Bianchi MC, 2003, AM J NEURORADIOL, V24, P1958
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   Boddaert N, 2008, MOL GENET METAB, V93, P85, DOI 10.1016/j.ymgme.2007.09.003
   Brunetti-Pierri N, 2008, NEUROPEDIATRICS, V39, P179, DOI 10.1055/s-0028-1093334
   Burgeois M, 1992, BRAIN DEV, V14, P404
   Cassandrini D, 2006, J CHILD NEUROL, V21, P983, DOI 10.1177/08830738060210111001
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   Castro-Gago M, 1999, REV NEUROLOGIA, V29, P912, DOI 10.33588/rn.2910.99062
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   Choi C, 2000, YONSEI MED J, V41, P676, DOI 10.3349/ymj.2000.41.5.676
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   Dinopoulos A, 2005, NEUROPEDIATRICS, V36, P290, DOI 10.1055/s-2005-872807
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Feng Feng, 2006, Chinese Medical Sciences Journal, V21, P234
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P143, DOI 10.1017/S0317167100006508
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Gibson K, 2008, PEDIATRICS, V122, P1003, DOI 10.1542/peds.2007-3502
   Gire C, 2002, CHILD NERV SYST, V18, P621, DOI 10.1007/s00381-002-0621-0
   Goto Tamako, 2002, Nihon Rinsho, V60 Suppl 4, P236
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   HATTEN HP, 1991, PEDIATR RADIOL, V21, P477, DOI 10.1007/BF02011716
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Isobe T, 2007, AUSTRALAS RADIOL, V51, P330, DOI 10.1111/j.1440-1673.2007.01745.x
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Jeppesen TD, 2007, J NEUROL, V254, P29, DOI 10.1007/s00415-006-0229-5
   Jiang YW, 2002, J CHILD NEUROL, V17, P450, DOI 10.1177/088307380201700611
   Kamada K, 2001, J NEUROL NEUROSUR PS, V70, P675, DOI 10.1136/jnnp.70.5.675
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kim JT, 2009, ACTA PAEDIATR, V98, P1825, DOI 10.1111/j.1651-2227.2009.01428.x
   Kimura S, 1997, BRAIN DEV-JPN, V19, P535, DOI 10.1016/S0387-7604(97)00074-0
   Kingsley PB, 2006, NMR BIOMED, V19, P435, DOI 10.1002/nbm.1039
   Kowalchuk JM, 2000, J APPL PHYSIOL, V89, P200, DOI 10.1152/jappl.2000.89.1.200
   Kumakura A, 2009, PEDIATR NEUROL, V41, P309, DOI 10.1016/j.pediatrneurol.2009.04.028
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leshinsky-Silver E, 2008, EUR J PAEDIATR NEURO, V12, P309, DOI 10.1016/j.ejpn.2007.09.005
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Lin DDM, 2003, AM J NEURORADIOL, V24, P33
   Lincke CR, 1996, NEUROPEDIATRICS, V27, P216, DOI 10.1055/s-2007-973792
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Maricich SM, 2007, AM J NEURORADIOL, V28, P1602, DOI 10.3174/ajnr.A0602
   MATTHEWS PM, 1991, NEUROLOGY, V41, P1043, DOI 10.1212/WNL.41.7.1043
   MEDINA L, 1990, AM J ROENTGENOL, V154, P1269, DOI 10.2214/ajr.154.6.2159689
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Muñoz A, 1999, NEURORADIOLOGY, V41, P920
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nissenkorn A, 2000, J CHILD NEUROL, V15, P44, DOI 10.1177/088307380001500110
   Oppenheim C, 2000, J NEUROL NEUROSUR PS, V69, P248, DOI 10.1136/jnnp.69.2.248
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Panetta J, 2005, NEUROPEDIATRICS, V36, P256, DOI 10.1055/s-2005-865866
   Rohrbach M, 2009, FETAL DIAGN THER, V25, P177, DOI 10.1159/000209385
   Saitoh S, 1998, NEUROLOGY, V50, P531, DOI 10.1212/WNL.50.2.531
   Saneto RP, 2001, NEUROLOGY, V56, pA42
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2006, J CHILD NEUROL, V21, P77, DOI 10.1177/08830738060210010601
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Takanashi J, 2003, AM J NEURORADIOL, V24, P1184
   Takanashi J, 1997, J NEUROL SCI, V145, P83, DOI 10.1016/S0022-510X(96)00248-1
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Timothy J, 2009, J CHILD NEUROL, V24, P1296, DOI 10.1177/0883073809333543
   TOSCANO A, 1995, J NEUROL, V242, P203, DOI 10.1007/BF00919592
   Tzoulis C, 2009, STROKE, V40, pE15, DOI 10.1161/STROKEAHA.108.523118
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Weinstock A, 2002, J CHILD NEUROL, V17, P47, DOI 10.1177/088307380201700112
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Wolf NI, 2003, NEUROPEDIATRICS, V34, P156
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a
   Yis U, 2009, EUR J PAEDIATR NEURO, V13, P550, DOI 10.1016/j.ejpn.2008.10.009
   Yonemura K, 2001, AM J NEURORADIOL, V22, P269
   Zafeiriou DI, 2008, NEUROPEDIATRICS, V39, P172, DOI 10.1055/s-0028-1093336
NR 91
TC 41
Z9 43
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1940-5510
EI 1940-5529
J9 DEV DISABIL RES REV
JI Dev. Disabil. Res. Rev.
PY 2010
VL 16
IS 2
BP 129
EP 135
DI 10.1002/ddrr.103
PG 7
WC Clinical Neurology; Neurosciences; Pediatrics; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics; Psychiatry
GA 642IB
UT WOS:000281201100005
PM 20818727
DA 2024-11-01
ER

PT J
AU Hudson, G
   Schaefer, AM
   Taylor, RW
   Tiangyou, W
   Gibson, A
   Venables, G
   Griffiths, P
   Burn, DJ
   Turnbull, DM
   Chinnery, PF
AF Hudson, Gavin
   Schaefer, Andrew M.
   Taylor, Robert W.
   Tiangyou, Watcharee
   Gibson, Andrew
   Venables, Graham
   Griffiths, Philip
   Burn, David J.
   Turnbull, Douglass M.
   Chinnery, Patrick F.
TI Mutation of the linker region of the polymerase γ-1 (<i>POLG1</i>) gene
   associated with progressive external ophthalmoplegia and parkinsonism
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA POLYMERASE; GAMMA MUTATIONS; ALPERS-SYNDROME;
   NEUROPATHY; DEFECTS; FAMILY
AB Objective: To define the molecular basis of the autosomal dominant progressive external ophthalmoplegia and parkinsonism in a large family with a dominantly transmitted multiple mitochondrial DNA deletion disorder.
   Design: Microsatellite analysis and screening of the progressive external ophthalmoplegia 1 (PEO1), adenine nucleotide translocator 1 (ANT1), and polymerase gamma-1 (POLG1) genes.
   Results: We identified 3 novel heterozygous POLG1 substitutions in the same family. Autosomal dominant progressive external ophthalmoplegia segregated with 1532G > A in exon 8 and an intronic variant c. 2070 + 158G > A in cis. The one patient with parkinsonism had an additional heterozygous substitution in exon 7 in trans (1389G > T). Both coding region mutations were predicted to alter conserved amino acids in the linker region of polymerase gamma. None of the substitutions were found in 192 ethnically matched control chromosomes, 108 patients with progressive external ophthalmoplegia, nor 140 cases of sporadic idiopathic Parkinson disease.
   Conclusion: Both autosomal dominant progressive external ophthalmoplegia and parkinsonism can because caused by mutations that directly affect the polymerase domain of polymerase gamma.
C1 Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Neurol, Newcastle Upon Tyne, Tyne & Wear, England.
   Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Ophthalmol, Newcastle Upon Tyne, Tyne & Wear, England.
   Sheffield Teaching Hosp NHS Fdn, Dept Neurol, Sheffield, S Yorkshire, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon
   Tyne Hospitals NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS
   Foundation Trust
RP Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, M41014,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
RI Burn, David/ABD-6052-2021; Hudson, Gavin/E-7117-2017
OI Burn, David/0000-0001-7658-1209; Schaefer, Andrew/0000-0001-9891-7332;
   Hudson, Gavin/0000-0001-7210-2733; Chinnery, Patrick/0000-0002-7065-6617
FU Wellcome Trust Funding Source: Medline
CR Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   *CTR BIOL SEQ AN, NETGENE2 SERV
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 17
TC 66
Z9 72
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610-0946 USA
SN 0003-9942
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD APR
PY 2007
VL 64
IS 4
BP 553
EP 557
DI 10.1001/archneur.64.4.553
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 155AG
UT WOS:000245549300013
PM 17420318
DA 2024-11-01
ER

PT J
AU Harrower, T
   Stewart, JD
   Hudson, G
   Houlden, H
   Warner, G
   O'Donovan, DG
   Findlay, LJ
   Taylor, RW
   De Silva, R
   Chinnery, PF
AF Harrower, Timothy
   Stewart, Joanna D.
   Hudson, Gavin
   Houlden, Henry
   Warner, Graham
   O'Donovan, Dominic G.
   Findlay, Leslie J.
   Taylor, Robert W.
   De Silva, Rajith
   Chinnery, Patrick F.
TI <i>POLG1</i> mutations manifesting as autosomal recessive axonal
   Charcot-Marie-Tooth disease
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLYMERASE-GAMMA; MITOCHONDRIAL;
   SPECTRUM; ATAXIA
AB Background: Although a molecular diagnosis is possible in most patients having Charcot-Marie-Tooth disease (CMT), recessively inherited and axonal neuropathies still present a diagnostic challenge.
   Objective: To determine the cause of axonal CMT type 2 in 3 siblings.
   Design: Case report.
   Setting: Academic research.
   participants: Three siblings who subsequently developed profound cerebellar ataxia.
   Main outcome Measures: Muscle biopsy specimen molecular genetic analysis of the POLG1 (polymerase gamma-1) gene, as well as screening of control subjects for POLG1 sequence variants.
   Results: Cytochrome c oxidase deficient fibers and multiple deletions of mitochondrial DNA were detected in skeletal muscle. Three compound heterozygous substitutions were detected in POLG1.
   Conclusion: Even in the absence of classic features of mitochondrial disease, POLG1 should be considered in patients having axonal CMT that may be associated with tremor or ataxia.
C1 [Stewart, Joanna D.; Hudson, Gavin; Taylor, Robert W.; Chinnery, Patrick F.] Univ Newcastle, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Harrower, Timothy; O'Donovan, Dominic G.; Findlay, Leslie J.; De Silva, Rajith] Queens Hosp, Dept Neurol, Romford, Essex, England.
   [Harrower, Timothy; O'Donovan, Dominic G.; Findlay, Leslie J.; De Silva, Rajith] Queens Hosp, Dept Neuropathol, Romford, Essex, England.
   [O'Donovan, Dominic G.] Queens Hosp, Essex Ctr Neurol Sci, Romford, Essex, England.
   [Taylor, Robert W.; Chinnery, Patrick F.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Houlden, Henry] Inst Neurol, London WC1N 3BG, England.
   [Houlden, Henry] UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Warner, Graham] Royal Surrey Cty Hosp, Dept Neurol, Guildford, Surrey, England.
C3 Newcastle University - UK; Newcastle University - UK; University of
   London; University College London; University of London; University
   College London; UCL Medical School; University College London Hospitals
   NHS Foundation Trust; Royal Surrey County Hospital
RP Chinnery, PF (corresponding author), Univ Newcastle, Sch Med, Mitochondrial Res Grp, Room M41014,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
RI Houlden, Henry/C-1532-2008; Hudson, Gavin/E-7117-2017; Stewart, Joanna
   D/H-1614-2012
OI Hudson, Gavin/0000-0001-7210-2733; Houlden, Henry/0000-0002-2866-7777;
   Chinnery, Patrick/0000-0002-7065-6617; Stewart, Joanna
   D/0000-0002-2608-1967
FU Medical Research Council [G108/638] Funding Source: Medline; MRC
   [G108/638] Funding Source: UKRI
CR Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Züchner S, 2006, NAT CLIN PRACT NEURO, V2, P45, DOI 10.1038/ncpneuro0071
NR 12
TC 30
Z9 32
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JAN
PY 2008
VL 65
IS 1
BP 133
EP 136
DI 10.1001/archneurol.2007.4
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 250PR
UT WOS:000252313000018
PM 18195151
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Au, KM
   Lau, SC
   Mak, YF
   Lai, WM
   Chow, TC
   Chen, ML
   Chiu, MC
   Chan, AYW
AF Au, Kam Ming
   Lau, Shing Chi
   Mak, Yuen Fun
   Lai, Wai Ming
   Chow, Tat Chong
   Chen, Mo Lung
   Chiu, Man Chun
   Chan, Albert Yan Wo
TI Mitochondrial DNA deletion in a girl with Fanconi's syndrome
SO PEDIATRIC NEPHROLOGY
LA English
DT Article
DE mtDNA deletion; Fanconi's syndrome; cytochrome c oxidase deficiency;
   mitochondriopathy
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MARROW-PANCREAS SYNDROME;
   KEARNS-SAYRE SYNDROME; TUBULOINTERSTITIAL NEPHRITIS; ACIDOSIS; PATIENT
AB We report a sporadic large-scale mitochondrial deletion in a paediatric patient with Fanconi's syndrome. Renal biopsy disclosed chronic interstitial nephritis. Ultrastructural examination of the renal tissue showed many giant atypical mitochondria. Histochemical stains revealed markedly reduced cytochrome c oxidase (COX). Genetic analysis disclosed a novel mitochondrial deletion of 7.3 kb in both peripheral blood and renal tissue. Mitochondrial diseases have heterogeneous clinical phenotypes; mutation analysis has proved to be an effective tool in confirming the diagnosis.
C1 Princess Margaret Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.
   Princess Margaret Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.
RP Au, KM (corresponding author), Princess Margaret Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.
EM aukm@ha.org.hk
CR BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   CAMPOS Y, 1995, PEDIATR NEUROL, V13, P69, DOI 10.1016/0887-8994(95)00082-Q
   CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350
   EVIATAR L, 1990, NEUROLOGY, V40, P1761, DOI 10.1212/WNL.40.11.1761
   Grunfeld JP, 1996, NEPHROL DIAL TRANSPL, V11, P760, DOI 10.1093/oxfordjournals.ndt.a027391
   KREUDER J, 1995, EUR J PEDIATR, V154, P996, DOI 10.1007/BF01958647
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164, DOI 10.1007/BF00865468
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1995, J PEDIATR-US, V126, P597, DOI 10.1016/S0022-3476(95)70359-4
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   Wong LJC, 2001, GENET MED, V3, P399, DOI 10.1097/00125817-200111000-00004
NR 16
TC 20
Z9 28
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0931-041X
EI 1432-198X
J9 PEDIATR NEPHROL
JI Pediatr. Nephrol.
PD JAN
PY 2007
VL 22
IS 1
BP 136
EP 140
DI 10.1007/s00467-006-0288-y
PG 5
WC Pediatrics; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics; Urology & Nephrology
GA 112GG
UT WOS:000242513200024
PM 16967281
DA 2024-11-01
ER

PT J
AU Castro-Gago, M
   Dacruz-Alvarez, D
   Pintos-Martínez, E
   Beiras-Iglesias, A
   Delmiro, A
   Arenas, J
   Martín, MA
   Martínez-Azorín, F
AF Castro-Gago, Manuel
   Dacruz-Alvarez, David
   Pintos-Martinez, Elena
   Beiras-Iglesias, Andres
   Delmiro, Aitor
   Arenas, Joaquin
   Martin, Miguel Angel
   Martinez-Azorin, Francisco
TI Exome sequencing identifies a <i>CHKB</i> mutation in Spanish patient
   with Megaconial Congenital Muscular Dystrophy and mtDNA depletion
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Article
DE CHKB; Megaconial Congenital Muscular; Dystrophy; Mitochondria; mtDNA
   depletion; Whole-exome sequencing
ID CHOLINE KINASE BETA; MITOCHONDRIAL STRUCTURAL ABNORMALITIES; GENE;
   EASTERN; DEFECT
AB Background: Choline kinase beta gene (CHKB) mutations have been identified in Megaconial Congenital Muscular Dystrophy (MDCMC) patients, but never in patients with an additional combined deficiency of complexes I, III and IV and mitochondrial DNA (mtDNA) depletion.
   Aims: To report mutations in carry genes for MDCMC with respiratory chain defects and mtDNA depletion.
   Methods: Whole-exome sequencing (WES) was used to identify the carry genes in a Spanish child with muscle weakness, mild hypotonia at lower limb muscles, mildly elevated creatine kinase (CK), enlarged mitochondria in the periphery of the fibers, combined deficiency of complex I, III and IV and depletion of mtDNA.
   Results: With WES data, it was possible to get the whole mtDNA sequencing and discard any pathogenic variant in this genome. The first filter of WES data with the nuclear-encoded mitochondrial genes (MitoCarta) did not get any candidate. However, the analysis of whole exome uncovered a homozygous nonsense pathogenic mutation in CHKB gene (NM_005198.4:c.810T>A, p.Tyr270*).
   Conclusions: Our data confirm the role of CHKB in MDCMC and point to this gene as unique candidate for the combined deficiency of respiratory chain and mtDNA depletion observed in this patient. (C) 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
C1 [Castro-Gago, Manuel; Dacruz-Alvarez, David] Hosp Clin Univ, Fac Med, Dept Pediat, Serv Neuropediat, Santiago De Compostela, Spain.
   [Pintos-Martinez, Elena; Beiras-Iglesias, Andres] Hosp Clin Univ, Fac Med, Serv Anatomia Patol, Santiago De Compostela, Spain.
   [Delmiro, Aitor; Arenas, Joaquin; Martin, Miguel Angel; Martinez-Azorin, Francisco] Inst Invest Hosp 12 Octubre i 12, Lab Enfermedades Mitocondri, E-28041 Madrid, Spain.
   [Delmiro, Aitor; Arenas, Joaquin; Martin, Miguel Angel; Martinez-Azorin, Francisco] CIBERER, E-28041 Madrid, Spain.
C3 Complexo Hospitalario Universitario de Santiago de Compostela;
   Universidade de Santiago de Compostela; Complexo Hospitalario
   Universitario de Santiago de Compostela; Universidade de Santiago de
   Compostela; Hospital Universitario 12 de Octubre; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER
RP Martínez-Azorín, F (corresponding author), Inst Invest Hosp 12 Octubre i 12, CAA, Lab Enfermedades Mitocondri, 6a Planta,Bloque E,Avda Cordoba S-N, E-28041 Madrid, Spain.
EM fmartinez@h12o.es
RI Martin, Miguel/S-2758-2018; Magdalena, Aitor/H-4769-2017;
   Martínez-Azorín, Francisco/HJZ-3939-2023; Martin, Miguel
   Angel/B-6261-2017
OI Arenas, Joaquin/0000-0002-2877-5049; Beiras-Iglesias,
   Andres/0000-0002-7333-5819; Martinez-Azorin,
   Francisco/0000-0001-6250-7745; Martin, Miguel Angel/0000-0003-4741-772X;
   Dacruz-Alvarez, David/0000-0002-7336-5102
FU Spanish Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos
   III (ISCIII) [CP08/00018, PI10/00063, PI12/01683];  [ISCIII-PI12/01683]
FX The study was supported by the Spanish Ministerio de Ciencia e
   Innovacion, Instituto de Salud Carlos III (ISCIII) (grants CP08/00018
   and PI10/00063 to F.M-A, and PI12/01683 to MA-M). AD is recipient of a
   grant from ISCIII-PI12/01683. We would like to thank Alicia Torrado for
   valuable comments on the manuscript.
CR Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Delmiro A, 2013, HUM MUTAT, V34, P1623, DOI 10.1002/humu.22445
   Hagopian K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012696
   Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d
   Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305
   Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010
   Nishino I, 1998, MUSCLE NERVE, V21, P40, DOI 10.1002/(SICI)1097-4598(199801)21:1<40::AID-MUS6>3.0.CO;2-G
   Ottoni C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013378
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Quinlivan R, 2013, NEUROMUSCULAR DISORD, V23, P549, DOI 10.1016/j.nmd.2013.04.002
   Ríos PG, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333
   Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173
   Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304
   Yamazaki N, 2000, J BIOL CHEM, V275, P31739, DOI 10.1074/jbc.M006322200
NR 14
TC 21
Z9 24
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD NOV
PY 2014
VL 18
IS 6
BP 796
EP 800
DI 10.1016/j.ejpn.2014.06.005
PG 5
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA AS7LO
UT WOS:000344437800022
PM 24997086
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Zarrouk-Mahjoub, S
   Shoffner, JM
AF Finsterer, Josef
   Zarrouk-Mahjoub, Sinda
   Shoffner, John M.
TI MERRF Classification: Implications for Diagnosis and Clinical Trials
SO PEDIATRIC NEUROLOGY
LA English
DT Review
DE myoclonic epilepsy; mitochondrial myopathy; MT-TK; MT-TL1; POLG;
   MT-tRNA; gene-disease relationship; variant curation
ID RAGGED-RED FIBERS; MITOCHONDRIAL-DNA MUTATION; STROKE-LIKE EPISODES;
   MERRF/MELAS OVERLAP SYNDROME; TRANSFER-RNA MUTATIONS; MT-TRANSFER-RNA;
   MYOCLONIC EPILEPSY; POINT MUTATION; TRNA(LYS) GENE; LACTIC-ACIDOSIS
AB BACKGROUND: Given the etiologic heterogeneity of disease classification using clinical phenomenology, we employed contemporary criteria to classify variants associated with myoclonic epilepsy with ragged-red fibers (MERRF) syndrome and to assess the strength of evidence of gene-disease associations. Standardized approaches are used to clarify the definition of MERRF, which is essential for patient diagnosis, patient classification, and clinical trial design. METHODS: Systematic literature and database search with application of standardized assessment of gene disease relationships using modified Smith criteria and of variants reported to be associated with MERRF using modified Yarham criteria. RESULTS: Review of available evidence supports a gene-disease association for two MT-tRNAs and for POW. Using modified Smith criteria, definitive evidence of a MERRF gene-disease association is identified for MT-TK. Strong gene-disease evidence is present for MT-TL1 and POLG. Functional assays that directly associate variants with oxidative phosphorylation impairment were critical to mtDNA variant classification. In silico analysis was of limited utility to the assessment of individual MT-tRNA variants. With the use of contemporary classification criteria, several mtDNA variants previously reported as pathogenic or possibly pathogenic are reclassified as neutral variants. CONCLUSIONS: MERRF is primarily an MT-TK disease, with pathogenic variants in this gene accounting for similar to 90% of MERRF patients. Although MERRF is phenotypically and genotypically heterogeneous, myoclonic epilepsy is the clinical feature that distinguishes MERRF from other categories of mitochondrial disorders. Given its low frequency in mitochondrial disorders, myoclonic epilepsy is not explained simply by an impairment of cellular energetics. Although MERRF phenocopies can occur in other genes, additional data are needed to establish a MERRF disease gene association. This approach to MERRF emphasizes standardized classification rather than clinical phenomenology, thus improving patient diagnosis and clinical trial design.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
   [Zarrouk-Mahjoub, Sinda] Univ Tunis El Manar, Tunis, Tunisia.
   [Zarrouk-Mahjoub, Sinda] Pasteur Inst Tunis, Genom Platform, Tunis, Tunisia.
   [Shoffner, John M.] Mol Genet, Biochem Genet, Neurol, Atlanta, GA USA.
C3 Rudolfstiftung Hospital; Universite de Tunis-El-Manar; Pasteur Network;
   Universite de Tunis-El-Manar; Institut Pasteur Tunis
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Ahadi AM, 2008, NEUROL NEUROCHIR POL, V42, P263
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Amendola LM, 2016, AM J HUM GENET, V99, P247, DOI 10.1016/j.ajhg.2016.06.001
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Arpa J, 1997, ACTA NEUROL SCAND, V96, P65
   ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Biesecker LG, 2014, NEW ENGL J MED, V371, P1170, DOI [10.1056/NEJMra1312543, 10.1056/NEJMc1408914]
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716
   Blumenthal DT, 1998, NEUROLOGY, V50, P524, DOI 10.1212/WNL.50.2.524
   Bornstein B, 2005, BIOCHEM J, V387, P773, DOI 10.1042/BJ20040949
   Bornstein B, 2002, HUM MUTAT, V19, P234, DOI 10.1002/humu.10050
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   BYRNE E, 1991, ACTA NEUROPATHOL, V81, P318, DOI 10.1007/BF00305874
   CALABRESI PA, 1994, MUSCLE NERVE, V17, P943, DOI 10.1002/mus.880170815
   Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.0.CO;2-S
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chan PA, 2007, HUM MUTAT, V28, P683, DOI 10.1002/humu.20492
   Chandra SR, 2015, J POSTGRAD MED, V61, P200, DOI 10.4103/0022-3859.150905
   CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   Chong P Siao Tick, 2003, J Clin Neuromuscul Dis, V5, P1, DOI 10.1097/00131402-200309000-00001
   COQUET M, 1993, NEUROMUSCULAR DISORD, V3, P593, DOI 10.1016/0960-8966(93)90122-Z
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   CRIMMINS D, 1993, J NEUROL NEUROSUR PS, V56, P900, DOI 10.1136/jnnp.56.8.900
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   O'Callaghan MD, 2012, NEUROGENETICS, V13, P245, DOI 10.1007/s10048-012-0322-0
   DiMauro S, 2003, GENEREVIEWS, P1993
   Herrero-Martín MD, 2010, J NEUROL NEUROSUR PS, V81, P471, DOI 10.1136/jnnp.2009.173831
   Doss CGP, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-42
   Eberhardt O, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080103
   El Meziane A, 1998, NAT GENET, V18, P350
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   FANG W, 1994, MUSCLE NERVE, V17, P52, DOI 10.1002/mus.880170107
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Fekete A, 2017, ORVOSI HETILAP, V158, P468, DOI 10.1556/650.2017.30634
   Fetoni V, 2004, NEUROMUSCULAR DISORD, V14, P723, DOI 10.1016/j.nmd.2004.07.002
   Finnila Saara, 2001, Mutation Research, V458, P31, DOI 10.1016/S1383-5726(01)00012-7
   Finsterer J, 2017, IRAN J NEUROL, V16, P45
   Finsterer J, 2016, J NEUROL, V263, P586, DOI 10.1007/s00415-016-8028-0
   Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036
   FOLGERO T, 1995, EUR NEUROL, V35, P168, DOI 10.1159/000117115
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Fujioka H, 2014, ULTRASTRUCT PATHOL, V38, P13, DOI 10.3109/01913123.2013.831158
   Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200
   Garber KB, 2016, AM J HUM GENET, V99, P1140, DOI 10.1016/j.ajhg.2016.09.015
   Gebhart SSP, 1996, METABOLISM, V45, P526, DOI 10.1016/S0026-0495(96)90231-0
   Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7
   González-Vioque E, 2014, MOL GENET GENOM MED, V2, P107, DOI 10.1002/mgg3.47
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Hahn A, 2011, NEUROPEDIATRICS, V42, P148, DOI 10.1055/s-0031-1283167
   Hallmann K, 2014, NEUROLOGY, V83, P2183, DOI 10.1212/WNL.0000000000001055
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   Hogarth MW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14143
   Houshmand M., 2011, NOVEL TREATMENT EPIL
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Hutchin TP, 2001, J MED GENET, V38, P229, DOI 10.1136/jmg.38.4.229
   Hutchin TP, 2001, EUR J HUM GENET, V9, P385, DOI 10.1038/sj.ejhg.5200640
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   Isotani H, 1999, DIABETOLOGIA, V42, P1266
   Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895
   Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437
   Kameoka K, 1998, DIABETES CARE, V21, P2034, DOI 10.2337/diacare.21.11.2034
   Kazakos K, 2012, ANN HUM GENET, V76, P296, DOI 10.1111/j.1469-1809.2012.00711.x
   Kelland E, 2016, MOL GENET METAB REP, V6, P64, DOI 10.1016/j.ymgmr.2016.02.003
   Kerr ID, 2017, J COMMUN GENET, V8, P87, DOI 10.1007/s12687-016-0289-x
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   Klopstock T, 1997, MOL CELL BIOCHEM, V174, P271, DOI 10.1023/A:1006877012241
   Kobayashi J, 2010, INTERNAL MED, V49, P479, DOI 10.2169/internalmedicine.49.2996
   KOGA Y, 1995, MUSCLE NERVE, pS119
   Koge Junpei, 2016, Rinsho Shinkeigaku, V56, P667
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lagarde J, 2012, MOVEMENT DISORD, V27, P1805, DOI 10.1002/mds.25206
   Larsson N G, 1995, Muscle Nerve Suppl, V3, pS102
   Leong IUS, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0176-z
   Levy RJ, 2014, J CHILD NEUROL, V29, pNP105, DOI 10.1177/0883073813506783
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   Lopez-Blanco R, 2017, BMJ CASE REP, V2017
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Luigetti M, 2016, EUR J NEUROL, V23, P1020, DOI 10.1111/ene.12954
   MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Martín-Jiménez R, 2012, MITOCHONDRION, V12, P288, DOI 10.1016/j.mito.2011.10.004
   MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872
   Masucci JP, 1997, MOL CELL BIOCHEM, V174, P215, DOI 10.1023/A:1006808524536
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   Miosge LA, 2015, P NATL ACAD SCI USA, V112, pE5189, DOI 10.1073/pnas.1511585112
   Mkaouar-Rebai E, 2014, MITOCHONDR DNA, V25, P394, DOI 10.3109/19401736.2013.803086
   Möllers M, 2005, NUCLEIC ACIDS RES, V33, P5647, DOI 10.1093/nar/gki876
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Mongini T, 2002, CLIN NEUROPATHOL, V21, P72
   Muñoz-Málaga A, 2000, MUSCLE NERVE, V23, P538, DOI 10.1002/(SICI)1097-4598(200004)23:4<538::AID-MUS12>3.3.CO;2-K
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Nagashima T, 2001, NEUROMUSCULAR DISORD, V11, P470, DOI 10.1016/S0960-8966(01)00190-0
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Nakamura M, 2010, J MED GENET, V47, P659, DOI 10.1136/jmg.2009.072058
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x
   Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802
   Niroula A, 2016, NUCLEIC ACIDS RES, V44, P2020, DOI 10.1093/nar/gkw046
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Nykamp K, 2017, GENET MED, V19, P1105, DOI 10.1038/gim.2017.37
   OKEEFFE ST, 1995, MUSCLE NERVE, V18, P478, DOI 10.1002/mus.880180420
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X
   OZAWA M, 1995, NEUROMUSCULAR DISORD, V5, P483, DOI 10.1016/0960-8966(95)00009-C
   Peng Y, 2003, MOVEMENT DISORD, V18, P716, DOI 10.1002/mds.10428
   Pepin MG, 2016, GENET MED, V18, P20, DOI 10.1038/gim.2015.31
   Pronicki M, 2007, FOLIA NEUROPATHOL, V45, P187
   Quattrocelli M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007070
   Rachad L, 2017, MOL NEUROBIOL, V54, P939, DOI 10.1007/s12035-016-9712-x
   Remes AM, 2003, J NEUROL NEUROSUR PS, V74, P1158, DOI 10.1136/jnnp.74.8.1158
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rommelaere G, 2012, INT J BIOCHEM CELL B, V44, P139, DOI 10.1016/j.biocel.2011.10.009
   Rossmanith W, 2003, ANN NEUROL, V54, P820, DOI 10.1002/ana.10753
   Sakuta R, 2002, PEDIATR NEUROL, V27, P397, DOI 10.1016/S0887-8994(02)00456-3
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schaffer SW, 2014, AMINO ACIDS, V46, P47, DOI [10.1007/s00726-012-1414-8, 10.1007/s00726-013-1632-8]
   Schiemann AH, 2016, BRIT J ANAESTH, V117, P124, DOI 10.1093/bja/aew065
   Schinwelski M, 2015, METAB BRAIN DIS, V30, P1083, DOI 10.1007/s11011-014-9645-x
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   SEIBEL P, 1991, J NEUROL SCI, V105, P217, DOI 10.1016/0022-510X(91)90148-Z
   Sekino Y, 2012, WORLD J GASTROENTERO, V18, P4557, DOI 10.3748/wjg.v18.i33.4557
   Serra G, 1996, BRAIN DEV-JPN, V18, P185, DOI 10.1016/0387-7604(95)00147-6
   Shinde A, 2000, Rinsho Shinkeigaku, V40, P561
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOFFNER JM, 1991, REV NEUROL-FRANCE, V147, P431
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   Slawek J, 2012, J CLIN PATHOL, V65, P1147, DOI 10.1136/jclinpath-2012-200778
   Smith ED, 2017, HUM MUTAT, V38, P600, DOI 10.1002/humu.23183
   Stenqvist L, 2005, PEDIATR RES, V58, P258, DOI 10.1203/01.PDR.0000169966.82325.1A
   Stratilova L, 1999, Cas Lek Cesk, V138, P401
   Sunami Y, 2011, NEUROL SCI, V32, P861, DOI 10.1007/s10072-011-0719-9
   Suzuki Hidefumi, 2016, Rinsho Shinkeigaku, V56, P196, DOI 10.5692/clinicalneurol.cn-000783
   SUZUKI S, 1994, DIABETES CARE, V17, P1428, DOI 10.2337/diacare.17.12.1428
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Takeda A, 1998, JPN CIRC J, V62, P695, DOI 10.1253/jcj.62.695
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   TANNO Y, 1991, BIOCHEM BIOPH RES CO, V179, P880, DOI 10.1016/0006-291X(91)91900-W
   Tarnopolsky MA, 1998, MUSCLE NERVE, V21, P25, DOI 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.0.CO;2-I
   Taylor RW, 2004, NEUROLOGY, V62, P1420, DOI 10.1212/01.WNL.0000120667.77372.46
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445
   Tiranti V, 1999, NEUROMUSCULAR DISORD, V9, P66, DOI 10.1016/S0960-8966(98)00103-5
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   TOKUNAGA M, 1993, ANN NEUROL, V33, P275, DOI 10.1002/ana.410330308
   Toompuu M, 1999, HUM MOL GENET, V8, P2275, DOI 10.1093/hmg/8.12.2275
   Toompuu M, 2004, BIOCHEM BIOPH RES CO, V322, P803, DOI 10.1016/j.bbrc.2004.07.181
   Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   TRAFF J, 1995, ACTA NEUROL SCAND, V92, P394
   Turner CJ, 2005, GENETICS, V170, P1879, DOI 10.1534/genetics.105.043653
   Uehara DT, 2010, GENET TEST MOL BIOMA, V14, P611, DOI 10.1089/gtmb.2010.0011
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   Valdmanis PN, 2009, HUM MUTAT, V30, pE481, DOI 10.1002/humu.20939
   Valentino ML, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037507
   van de Glind G, 2007, EUR J PAEDIATR NEURO, V11, P243, DOI 10.1016/j.ejpn.2007.01.004
   Verhoeven K, 1999, EUR J HUM GENET, V7, P45, DOI 10.1038/sj.ejhg.5200247
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   Vilela H, 2005, PEDIATR ANESTH, V15, P77, DOI 10.1111/j.1460-9592.2005.01384.x
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   Vollono C, 2017, CEPHALALGIA, DOI [10.1177/0333102417723568.333102417723568, DOI 10.1177/0333102417723568.333102417723568]
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Walters-Sen LC, 2015, MOL GENET GENOM MED, V3, P99, DOI 10.1002/mgg3.116
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Williams AJ, 1999, HUM MOL GENET, V8, P1691, DOI 10.1093/hmg/8.9.1691
   Wong LJC, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040626
   Yanagawa T, 1998, INTERNAL MED, V37, P780, DOI 10.2169/internalmedicine.37.780
   Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023
   Yarham JW, 2013, J NEUROL SCI, V325, P165, DOI 10.1016/j.jns.2012.12.003
   Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Ye KX, 2014, P NATL ACAD SCI USA, V111, pE4548, DOI 10.1073/pnas.1415171111
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yen HC, 2016, BBA-GEN SUBJECTS, V1860, P1864, DOI 10.1016/j.bbagen.2016.05.005
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   YOON KL, 1993, PEDIATR RES, V33, P433, DOI 10.1203/00006450-199305000-00002
   ZEVIANI M, 1991, AM J HUM GENET, V48, P203
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
   Zhou L, 1997, J NEUROSCI, V17, P7746
   Zhu CC, 2017, OPHTHALMIC GENET, V38, P67, DOI 10.3109/13816810.2015.1130153
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
   Zsurka G, 2013, SEIZURE-EUR J EPILEP, V22, P483, DOI 10.1016/j.seizure.2013.03.003
NR 218
TC 57
Z9 60
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD MAR
PY 2018
VL 80
BP 8
EP 23
DI 10.1016/j.pediatrneurol.2017.12.005
PG 16
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA GD0AD
UT WOS:000430159200003
PM 29449072
DA 2024-11-01
ER

PT J
AU Santa, KM
AF Santa, Kristin M.
TI Treatment Options for Mitochondrial Myopathy, Encephalopathy, Lactic
   Acidosis, and Stroke-Like Episodes (MELAS) Syndrome
SO PHARMACOTHERAPY
LA English
DT Review
DE mitochondrial myopathy; encephalopathy; lactic acidosis; stroke-like
   episodes; MELAS syndrome; mitochondria; coenzyme Q(10); L-arginine
ID POINT MUTATION; MANAGEMENT; PATIENT; ENCEPHALOMYOPATHY; DNA;
   DICHLOROACETATE; NICOTINAMIDE; PREVALENCE; DEFICIENCY; NEUROPATHY
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a rare neurodegenerative disease caused by the decreased ability of cells to produce sufficient energy in the form of adenosine 5'-tripliosphate. Although it is one of the most common maternally inherited mitochondrial disorders, its exact incidence is unknown. Caused most frequently by an A-to-G point mutation at the 3243 position in the mitochondrial DNA, MELAS syndrome has a broad range of clinical manifestations and a highly variable course. The classic neurologic characteristics include encephalopathy, seizures, and stroke-like episodes. In addition to its neurologic manifestations, MELAS syndrome exhibits multisystem effects including cardiac conduction defects, diabetes mellitus, short stature, myopathy, and gastrointestinal disturbances. Unfortunately, no consensus guidelines outlining standard drug regimens exist for this syndrome. Many of the accepted therapies used in treating MELAS syndrome have been identified through a small number of clinical trials or isolated case reports. Currently, the drugs most often used include antioxidants and various vitamins aimed at minimizing the demands on the mitochondria and supporting and maximizing their function. Some of the most frequently prescribed agents include coenzyme Q(10), L-arginine, B vitamins, and levocarnitine. Although articles describing MELAS syndrome are available, few specifically target education for clinical pharmacists. This article will provide pharmacists with a practical resource to enhance their understanding of MELAS syndrome in order to provide safe and effective pharmaceutical care.
C1 Froedtert Hosp, Dept Pharm, Milwaukee, WI 53226 USA.
RP Santa, KM (corresponding author), Froedtert Hosp, Dept Pharm, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.
EM ksanta@fmlh.edu
CR Bandyopadhyay S K, 2005, J Assoc Physicians India, V53, P973
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   BRAUNWALD E, 2001, DIS CAUSED GENETIC D, P404
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   Chinnery P F, 2003, Neuromuscul Disord, V13, P757, DOI 10.1016/S0960-8966(03)00097-X
   Clay AS, 2001, CHEST, V120, P634, DOI 10.1378/chest.120.2.634
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Finsterer J, 2009, EUR J NEUROL, V16, P1178, DOI 10.1111/j.1468-1331.2009.02789.x
   Finsterer J, 1998, CAN J ANAESTH, V45, P781, DOI 10.1007/BF03012149
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   Gvozdjakova Anna, 2008, P1, DOI 10.1007/978-1-4020-6714-3_1
   Hilton G, 1995, J Neurosci Nurs, V27, P278
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HOWARD RS, 1995, QJM-INT J MED, V88, P197
   ICHIKI T, 1988, ANN NEUROL, V23, P287, DOI 10.1002/ana.410230312
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Karvonen SL, 1999, BRIT J DERMATOL, V140, P634
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Kurogouchi F, 1998, AM J NEPHROL, V18, P551, DOI 10.1159/000013406
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   MATTHEWS PM, 1993, NEUROLOGY, V43, P884, DOI 10.1212/WNL.43.5.884
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015
   Neargarder SA, 2007, COGN BEHAV NEUROL, V20, P83, DOI 10.1097/WNN.0b013e3180335faf
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147
   RANTIKOVA LA, 1978, BIOKHIMIYA, V43, P1989
   Remes AM, 2002, NEUROLOGY, V59, P1275, DOI 10.1212/WNL.59.8.1275
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rossi FH, 2002, NEUROLOGIST, V8, P313, DOI 10.1097/00127893-200209000-00004
   Salpeter S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub2
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Shinmei Y, 2007, J NEURO-OPHTHALMOL, V27, P22, DOI 10.1097/WNO.0b013e3180334cb0
   SPROULE DM, 2008, J INHERIT METAB DIS, V64, P625
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   STACPOOLE PW, 1990, FUND APPL TOXICOL, V14, P327, DOI 10.1016/0272-0590(90)90212-3
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Sue CM, 1997, NEUROLOGY, V49, P1013, DOI 10.1212/WNL.49.4.1013
   Tan TMM, 2009, CLIN ENDOCRINOL, V70, P340, DOI 10.1111/j.1365-2265.2008.03341.x
   Tanaka J, 1997, BRAIN DEV-JPN, V19, P262, DOI 10.1016/S0387-7604(97)00573-1
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Tarnopolsky Mark A., 2007, V46, P183
   Taylor RW, 2000, NEUROL SCI, V21, pS909, DOI 10.1007/s100720070002
   Thambisetty M, 2002, NEUROLOGIST, V8, P302, DOI 10.1097/00127893-200209000-00003
   Thomas JE, 2007, EUR NEUROL, V57, P232, DOI 10.1159/000101287
   VOROBJEV IA, 1983, FEBS LETT, V163, P311, DOI 10.1016/0014-5793(83)80842-4
NR 62
TC 39
Z9 45
U1 2
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0277-0008
EI 1875-9114
J9 PHARMACOTHERAPY
JI Pharmacotherapy
PD NOV
PY 2010
VL 30
IS 11
BP 1179
EP 1196
DI 10.1592/phco.30.11.1179
PG 18
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 676GK
UT WOS:000283898800009
PM 20973690
OA Bronze
DA 2024-11-01
ER

PT J
AU Broccolini, A
   Gidaro, T
   Morosetti, R
   Mirabella, M
AF Broccolini, Aldobrando
   Gidaro, Teresa
   Morosetti, Roberta
   Mirabella, Massimiliano
TI HEREDITARY INCLUSION-BODY MYOPATHY: CLUES ON PATHOGENESIS AND POSSIBLE
   THERAPY
SO MUSCLE & NERVE
LA English
DT Review
DE hereditary inclusion-body myopathy; distal myopathy with rimmed
   vacuoles; h-IBM; DMRV; GNE
ID ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; SIALIC-ACID
   BIOSYNTHESIS; MITOCHONDRIAL-DNA DELETIONS; N-ACETYLNEURAMINIC ACID;
   PRECURSOR PROTEIN GENE; RIMMED VACUOLES; DISTAL MYOPATHY; GNE GENE;
   HUMAN MUSCLE; UDP-N-ACETYLGLUCOSAMINE-2-EPIMERASE/N-ACETYLMANNOSAMINE
   KINASE
AB Hereditary inclusion-body myopathy (h-IBM), or distal myopathy with rimmed vacuoles (DMRV), is an autosomal recessive disorder with onset in early adult life and a progressive course leading to severe disability. h-IBM/DMRV is due to mutations of a gene (GNE) that codes for a rate-limiting enzyme in the sialic acid biosynthetic pathway. Despite the identification of the causative gene defect, it has not been unambiguously clarified how GNE gene mutations impair muscle metabolism. Although numerous studies have indicated a key role of hyposialylation of glycoproteins in h-IBM/DMRV pathogenesis, others have demonstrated new and unpredicted functions of the GNE gene, outside the sialic acid biosynthetic pathway, that may also be relevant. This review illustrates the clinical and pathologic characteristics of h-IBM/DMRV and the main clues available to date concerning the possible pathogenic mechanisms and therapeutic perspectives of this disorder. Muscle Nerve 40: 340-349, 2009
C1 [Broccolini, Aldobrando; Gidaro, Teresa; Morosetti, Roberta; Mirabella, Massimiliano] Catholic Univ, Dept Neurosci, I-00168 Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Mirabella, M (corresponding author), Catholic Univ, Dept Neurosci, Lgo Gemelli 8, I-00168 Rome, Italy.
EM mirabella@rm.unicatt.it
RI Broccolini, Aldobrando/ABE-1311-2021; MOROSETTI, ROBERTA/ABE-1045-2021;
   MIRABELLA, Massimiliano/AAC-4016-2020
OI MOROSETTI, ROBERTA/0000-0001-5017-4904; MIRABELLA,
   Massimiliano/0000-0002-7783-114X
FU Fondazione Don Gnocchi, Catholic University; Istituto Superiore di
   Sanita
FX Supported by grants from Fondazione Don Gnocchi, Catholic University and
   Istituto Superiore di Sanita. We thank all our colleagues for patient
   referrals and our collaborators in the laboratory.
CR Amouri R, 2005, NEUROMUSCULAR DISORD, V15, P361, DOI 10.1016/j.nmd.2005.01.012
   Amsili S, 2007, CELL DEATH DIFFER, V14, P1916, DOI 10.1038/sj.cdd.4402208
   Arai A, 2002, ANN NEUROL, V52, P516, DOI 10.1002/ana.10341
   Argov Z, 2003, NEUROLOGY, V60, P1519, DOI 10.1212/01.WNL.0000061617.71839.42
   ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4
   ASKANAS V, 1992, AM J PATHOL, V141, P31
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   ASKANAS V, 1993, ANN NEUROL, V34, P551, DOI 10.1002/ana.410340408
   Askanas V, 1997, NEUROREPORT, V8, P2155, DOI 10.1097/00001756-199707070-00012
   ASKANAS V, 1994, AM J PATHOL, V144, P177
   Askanas Valerie, 1998, Current Opinion in Rheumatology, V10, P530, DOI 10.1097/00002281-199811000-00005
   Broccolini A, 2005, NEUROMUSCULAR DISORD, V15, P177, DOI 10.1016/j.nmd.2004.10.001
   Broccolini A, 2002, NEUROLOGY, V59, P1808, DOI 10.1212/01.WNL.0000031808.04545.E0
   Broccolini A, 2008, J NEUROCHEM, V105, P971, DOI 10.1111/j.1471-4159.2007.05208.x
   Broccolini A, 2004, HUM MUTAT, V23, DOI 10.1002/humu.9252
   COLE AJ, 1988, BRAIN, V111, P1025, DOI 10.1093/brain/111.5.1025
   Darvish D, 2002, MOL GENET METAB, V77, P252, DOI 10.1016/S1096-7192(02)00141-5
   Del Bo R, 2003, MUSCLE NERVE, V28, P113, DOI 10.1002/mus.10391
   Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188
   Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718
   Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261
   Eisenberg Iris, 2003, Hum Mutat, V21, P99, DOI 10.1002/humu.9100
   Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954
   García-Ruiz C, 2000, FASEB J, V14, P847, DOI 10.1096/fasebj.14.7.847
   Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313
   Hinderlich S, 2001, BIOL CHEM, V382, P291, DOI 10.1515/BC.2001.036
   Hong YJ, 2003, J BIOL CHEM, V278, P53045, DOI 10.1074/jbc.M309967200
   Horstkorte R, 1999, EUR J BIOCHEM, V260, P923, DOI 10.1046/j.1432-1327.1999.00253.x
   HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B
   Huizing M, 2004, MOL GENET METAB, V81, P196, DOI 10.1016/j.ymgme.2003.11.012
   Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946
   Kayashima T, 2002, J HUM GENET, V47, P77, DOI 10.1007/s100380200004
   Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372
   Kim BJ, 2006, J HUM GENET, V51, P137, DOI 10.1007/s10038-005-0338-5
   Krause S, 2007, NEUROLOGY, V69, P655, DOI 10.1212/01.wnl.0000267426.97138.fd
   Krause S, 2003, NEUROMUSCULAR DISORD, V13, P830, DOI 10.1016/S0960-8966(03)00140-8
   LAFRANCE MH, 1994, BIOCHEM J, V302, P451, DOI 10.1042/bj3020451
   Liewluck T, 2006, MUSCLE NERVE, V34, P775, DOI 10.1002/mus.20583
   Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220
   Malicdan MCV, 2007, AUTOPHAGY, V3, P396, DOI 10.4161/auto.4270
   Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956
   Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179
   MASSA R, 1991, ARCH NEUROL-CHICAGO, V48, P519, DOI 10.1001/archneur.1991.00530170083024
   McFerrin J, 1998, NEUROREPORT, V9, P3201, DOI 10.1097/00001756-199810050-00013
   Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837
   Mirabella M, 1996, J NEUROPATH EXP NEUR, V55, P774, DOI 10.1097/00005072-199607000-00003
   MONTREUI.J, 1968, CLIN CHIM ACTA, V21, P61, DOI 10.1016/0009-8981(68)90011-9
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Motozaki Y, 2007, EUR J NEUROL, V14, pE14, DOI 10.1111/j.1468-1331.2007.01905.x
   Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045
   Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6
   Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Pilkington GJ, 2005, CELL PROLIFERAT, V38, P423, DOI 10.1111/j.1365-2184.2005.00358.x
   Rafuse VF, 1996, J CELL BIOL, V132, P969, DOI 10.1083/jcb.132.5.969
   Rafuse VF, 2000, J NEUROSCI, V20, P6529, DOI 10.1523/JNEUROSCI.20-17-06529.2000
   Ricci E, 2006, NEUROLOGY, V66, P755, DOI 10.1212/01.wnl.0000200956.76449.3f
   SADEH M, 1993, BRAIN, V116, P217, DOI 10.1093/brain/116.1.217
   Saito F, 2004, NEUROMUSCULAR DISORD, V14, P158, DOI 10.1016/j.nmd.2003.09.006
   SARKOZI E, 1994, EXP NEUROL, V128, P27, DOI 10.1006/exnr.1994.1109
   SARKOZI E, 1993, NEUROREPORT, V4, P815, DOI 10.1097/00001756-199306000-00055
   Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411
   Sparks S, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-3
   Tajima Y, 2005, AM J PATHOL, V166, P1121, DOI 10.1016/S0002-9440(10)62332-2
   Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029
   Vasconcelos OM, 2002, NEUROLOGY, V59, P1776, DOI 10.1212/01.WNL.0000039780.13681.AD
   Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200
   Weidemann W, 2006, FEBS LETT, V580, P6649, DOI 10.1016/j.febslet.2006.11.015
   Yan CZ, 2001, ACTA NEUROPATHOL, V101, P9
   Yang CC, 1996, NEUROREPORT, V8, P153, DOI 10.1097/00001756-199612200-00031
NR 70
TC 21
Z9 27
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD SEP
PY 2009
VL 40
IS 3
BP 340
EP 349
DI 10.1002/mus.21385
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 492ZH
UT WOS:000269701500002
PM 19618441
DA 2024-11-01
ER

PT J
AU An, WB
   Zhang, JL
   Chang, LX
   Zhang, YC
   Wan, Y
   Ren, YY
   Niu, DY
   Wu, J
   Zhu, XF
   Guo, Y
AF An, Wenbin
   Zhang, Jingliao
   Chang, Lixian
   Zhang, Yingchi
   Wan, Yang
   Ren, Yuanyuan
   Niu, Deyun
   Wu, Jian
   Zhu, Xiaofan
   Guo, Ye
TI Mutation analysis of Chinese sporadic congenital sideroblastic anemia by
   targeted capture sequencing
SO JOURNAL OF HEMATOLOGY & ONCOLOGY
LA English
DT Article
DE Congenital sideroblastic anemia; Targeted capture sequencing; Molecular
   genetics; Clinical characteristics
ID GENE; IRON; IMMUNODEFICIENCY; IDENTIFICATION; TRANSPORTER; MYOPATHY;
   FEVERS; ATAXIA; ABC7
AB Background: Congenital sideroblastic anemias (CSAs) comprise a group of heterogenous genetic diseases that are caused by the mutation of various genes involved in heme biosynthesis, iron-sulfur cluster biogenesis, or mitochondrial solute transport or metabolism. However, approximately 40 % of patients with CSA have not been found to have pathogenic gene mutations. In this study, we systematically analyzed the mutation profile in 10 Chinese patients with sporadic CSA.
   Findings: We performed targeted deep sequencing analysis in ten patients with CSA using a panel of 417 genes that included known CSA-related genes. Mitochondrial genomes were analyzed using next-generation sequencing with a mitochondria enrichment kit and the HiSeq2000 sequencing platform. The results were confirmed by Sanger sequencing. The ALAS2 mutation was detected in one patient. SLC25A38 mutations were detected in three patients, including three novel mutations. Mitochondrial DNA deletions were detected in two patients. No disease-causing mutations were detected in four patients.
   Conclusion: To our knowledge, the pyridoxine-effective mutation C471Y of ALAS2, the compound heterozygous mutation W87X, I143Pfs146X, and the homozygous mutation R134C of SLC25A38 were found for the first time. Our findings add to the number of reported cases of this rare disease and to the CSA pathogenic mutation database. Our findings expand the phenotypic profile of mitochondrial DNA deletion mutations. This work also demonstrates the application of a congenital blood disease assay and targeted capture sequencing for the genetic screening analysis and diagnosis of heterogenous genetic CSA.
C1 [An, Wenbin; Zhang, Jingliao; Chang, Lixian; Wan, Yang; Ren, Yuanyuan; Zhu, Xiaofan; Guo, Ye] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Blood Dis Ctr, Div Pediat, Tianjin 300020, Peoples R China.
   [An, Wenbin; Zhang, Jingliao; Chang, Lixian; Zhang, Yingchi; Wan, Yang; Ren, Yuanyuan; Zhu, Xiaofan; Guo, Ye] Peking Union Med Coll, Tianjin 300020, Peoples R China.
   [Niu, Deyun; Wu, Jian] MyGenostics Inc, Baltimore, MD USA.
   [Zhang, Yingchi; Zhu, Xiaofan; Guo, Ye] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College;
   Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese
   Academy of Medical Sciences - Peking Union Medical College; Peking Union
   Medical College; Chinese Academy of Medical Sciences - Peking Union
   Medical College; Institute of Hematology & Blood Diseases Hospital -
   CAMS
RP Guo, Y (corresponding author), Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Blood Dis Ctr, Div Pediat, 288 Nanjing Rd, Tianjin 300020, Peoples R China.
EM guoyanr@126.com
RI zhou, chen/KBC-4023-2024
OI Zhang, Jingliao/0000-0003-2962-9884
FU National Natural Science Foundation of China [81270651]; Ministry of
   Education [20121106110036]
FX We are grateful to the patients and their family members for
   participating in this study. This work was funded by the National
   Natural Science Foundation of China (No. 81270651) and by the Ministry
   of Education (No. 20121106110036).
CR Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792
   Bekri S, 2000, BLOOD, V96, P3256
   Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370
   COTTER PD, 1992, P NATL ACAD SCI USA, V89, P4028, DOI 10.1073/pnas.89.9.4028
   Fleming MD, 2011, HEMATOL-AM SOC HEMAT, P525, DOI 10.1182/asheducation-2011.1.525
   Fujiwara T, 2013, PEDIATR INT, V55, P675, DOI 10.1111/ped.12217
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Kaneko K, 2014, HAEMATOLOGICA, V99, P252, DOI 10.3324/haematol.2013.085449
   Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021
   Liu G, 2013, HAEMATOLOGICA, V98, pE158, DOI 10.3324/haematol.2013.095513
   Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283
   Ricketts CJ, 2006, ACTA PAEDIATR, V95, P99, DOI 10.1080/08035250500323715
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   Visconte V, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0089-x
   Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887
   Wiseman DH, 2013, BLOOD, V122, P112, DOI 10.1182/blood-2012-08-439083
   Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543
NR 25
TC 13
Z9 16
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1756-8722
J9 J HEMATOL ONCOL
JI J. Hematol. Oncol.
PD MAY 20
PY 2015
VL 8
AR 55
DI 10.1186/s13045-015-0154-0
PG 7
WC Oncology; Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Hematology
GA CI7EZ
UT WOS:000354927000001
PM 25985931
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Xia, CY
   Liu, Y
   Liu, H
   Zhang, YC
   Ma, YN
   Qi, Y
AF Xia, Chang-Yu
   Liu, Yu
   Liu, Hui
   Zhang, Yan-Chun
   Ma, Yi-Nan
   Qi, Yu
TI Clinical and Molecular Characteristics in 100 Chinese Pediatric Patients
   with m.3243A&gt;G Mutation in Mitochondrial DNA
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE Clinical Symptom; Heteroplasmy; Mitochondrial A3243G Mutation;
   Mitochondrial Disease
ID TRANSFER RNALEU(UUR) GENE; GREATER-THAN G; LACTIC-ACIDOSIS; A3243G
   MUTATION; MELAS MUTATION; POINT MUTATION; TRANSFER-RNA; PREVALENCE;
   FEATURES; ENCEPHALOPATHY
AB Background: Mitochondrial diseases are a group of energy metabolic disorders with multisystem involvements. Variable clinical features present a major challenge in pediatric diagnoses. We summarized the clinical spectrum of m.3243A>G mutation in Chinese pediatric patients, to define the common clinical manifestations and study the correlation between heteroplasmic degree of the mutation and clinical severity of the disease.
   Methods: Clinical data of one-hundred pediatric patients with symptomatic mitochondrial disease harboring m.3243A>G mutation from 2007 to 2013 were retrospectively reviewed. Detection of m.3243A>G mutation ratio was performed by polymerase chain reaction (PCR)-restriction fragment length polymorphism. Correlation between m.3243A>G mutation ratio and age was evaluated. The differences in clinical symptom frequency of patients with low, middle, and high levels of mutation ratio were analyzed by Chi-square test.
   Results: Sixty-six patients (66%) had suffered a delayed diagnosis for an average of 2 years. The most frequent symptoms were seizures (76%), short stature (73%), elevated plasma lactate (70%), abnormal magnetic resonance imaging/computed tomography (MRI/CT) changes (68%), vomiting (55%), decreased vision (52%), headache (50%), and muscle weakness (48%). The mutation ratio was correlated negatively with onset age (r = -0.470, P < 0.001). Myopathy was more frequent in patients with a high level of mutation ratio. However, patients with a low or middle level of m.3243A>G mutation ratio were more likely to suffer hearing loss, decreased vision, and gastrointestinal disturbance than patients with a high level of mutation ratio.
   Conclusions: Our study showed that half of Chinese pediatric patients with m.3243A>G mutation presented seizures, short stature, abnormal MRI/CT changes, elevated plasma lactate, vomiting, and headache. Pediatric patients with these recurrent symptoms should be considered for screening m.3243A>G mutation. Clinical manifestations and laboratory abnormalities should be carefully monitored in patients with this point mutation.
C1 [Xia, Chang-Yu; Liu, Yu; Liu, Hui; Zhang, Yan-Chun; Ma, Yi-Nan; Qi, Yu] Peking Univ, Dept Cent Lab, Hosp 1, Beijing 100034, Peoples R China.
C3 Peking University
RP Ma, YN (corresponding author), Peking Univ, Dept Cent Lab, Hosp 1, Beijing 100034, Peoples R China.
EM mayinan1014@163.com
RI LIU, YU/JTV-1294-2023
FU National Natural Science Foundation of China [81271256, 81471153];
   Capital Characteristic Clinical Application Research Projects
   [Z131107002213062]
FX This study was supported by grants from National Natural Science
   Foundation of China (No. 81271256 and No. 81471153) and the Capital
   Characteristic Clinical Application Research Projects (No.
   Z131107002213062).
CR Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chi CS, 2010, PEDIATR NEUROL, V43, P183, DOI 10.1016/j.pediatrneurol.2010.04.015
   Chin J, 2014, MITOCHONDRION, V17, P34, DOI 10.1016/j.mito.2014.05.005
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Deschauer M, 2004, J NEUROL NEUROSUR PS, V75, P1204, DOI 10.1136/jnnp.2003.026278
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Rahman S, 2015, EPILEPSY BEHAV, V49, P71, DOI 10.1016/j.yebeh.2015.05.003
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wang YX, 2015, CHINESE MED J-PEKING, V128, P1820, DOI 10.4103/0366-6999.159360
NR 31
TC 18
Z9 21
U1 1
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0366-6999
EI 2542-5641
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD AUG 20
PY 2016
VL 129
IS 16
BP 1945
EP 1949
DI 10.4103/0366-6999.187845
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA DV9DG
UT WOS:000383239400010
PM 27503020
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Fukuda, M
   Nagao, Y
AF Fukuda, Mai
   Nagao, Yoshiro
TI Dynamic derangement in amino acid profile during and after a stroke-like
   episode in adult-onset mitochondrial disease: a case report
SO JOURNAL OF MEDICAL CASE REPORTS
LA English
DT Article
DE Maternally inherited diabetes and deafness; Mitochondrial myopathy;
   encephalopathy; lactic acidosis; and stroke-like episodes; Growth
   differentiation factor-15; Arginine; Citrulline; Aspartic acid; Taurine;
   Case report
ID NITRIC-OXIDE PRODUCTION; DIABETES-MELLITUS; L-ARGININE; MELAS SYNDROME;
   MUTATION; DIAGNOSIS; PATIENT; GENE; ENCEPHALOPATHY; MANAGEMENT
AB Background Maternally inherited diabetes and deafness, and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes are examples of mitochondrial diseases that are relatively common in the adult population. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes are assumed to be associated with decreases in arginine and citrulline. Biomarkers, such as growth differentiation factor-15, were developed to assist in the diagnosis of mitochondrial diseases. Case presentation A 55-year-old Japanese man, an insulin user, presented after a loss of consciousness. A laboratory test showed diabetic ketoacidosis. He and his mother had severe hearing difficulty. Bilateral lesions on magnetic resonance imaging, the presence of seizure, and an elevated ratio of lactate to pyruvate, altogether suggested a diagnosis of mitochondrial disease. Mitochondrial DNA in our patient's peripheral blood was positive with a 3243A>G mutation, which is the most frequent cause of maternally inherited diabetes and deafness, and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. As a result, maternally inherited diabetes and deafness/mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes was diagnosed. We measured growth differentiation factor-15 and multiple amino acids in his blood, longitudinally during and after the stroke-like episode. Growth differentiation factor-15 was increased to an immeasurably high level on the day of the stroke-like episode. Although his diabetes improved with an increased dose of insulin, the growth differentiation factor-15 level gradually increased, suggesting that his mitochondrial insufficiency did not improve. Multiple amino acid species, including arginine, citrulline, and taurine, showed a decreased level on the day of the episode and a sharp increase the next day. In contrast, the level of aspartic acid increased to an extremely high level on the day of the episode, and decreased gradually thereafter. Conclusions Growth differentiation factor-15 can be used not only for the diagnosis of mitochondrial disease, but as an indicator of its acute exacerbation. A stroke-like episode of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes reflects a drastic derangement of multiple amino acids. The involvement of aspartic acid in the episodes should be explored in future studies.
C1 [Fukuda, Mai; Nagao, Yoshiro] Hidaka Tokushukai Hosp, 1-10-27 Shizunai Kose Cho, Shin Hidaka, Hokkaido 0560005, Japan.
   [Nagao, Yoshiro] Fukuoka Tokushukai Hosp, 4-5 Sugukita, Kasuga, Fukuoka 8160864, Japan.
RP Nagao, Y (corresponding author), Fukuoka Tokushukai Hosp, 4-5 Sugukita, Kasuga, Fukuoka 8160864, Japan.
EM in_the_pacific214@yahoo.co.jp
OI Nagao, Yoshiro/0000-0003-3411-0729
CR Abdullah Mishal, 2012, J Med Case Rep, V6, P55, DOI 10.1186/1752-1947-6-55
   Abu-Amero Khaled K, 2009, J Med Case Rep, V3, P77, DOI 10.1186/1752-1947-3-77
   Cai Stephen S, 2016, Radiol Case Rep, V11, P425
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   KADOWAKI H, 1993, LANCET, V341, P893, DOI 10.1016/0140-6736(93)93101-6
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y., 2012, BIOCH BIOPHYS ACTA, V608, P614
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Kolb SJ, 2003, J NEUROL SCI, V216, P11, DOI 10.1016/S0022-510X(03)00218-1
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Murakami T, 2016, TOHOKU J EXP MED, V239, P89, DOI 10.1620/tjem.239.89
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Nakamura S, 2000, DIABETES METAB, V26, P407
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Okuno Y, 2013, METABOLISM, V62, P1470, DOI 10.1016/j.metabol.2013.05.022
   Omata T, 2016, J NEUROL SCI, V360, P57, DOI 10.1016/j.jns.2015.11.043
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Saisho Y, 2011, ENDOCR J, V58, P315, DOI 10.1507/endocrj.K10E-399
   Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65
   Tetsuka Syuichi, 2017, J Clin Med Res, V9, P812, DOI 10.14740/jocmr3122w
   The Japanse Society of Mitochondrial Research and Medicine, 2017, MIT DIS MAN MAN 2017
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wang ZP, 2016, FOLIA NEUROPATHOL, V54, P66, DOI 10.5114/fn.2016.58917
   Yatsuga S., 2012, BIOCH BIOPHYS ACTA, V619, P624
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 36
TC 3
Z9 3
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1752-1947
J9 J MED CASE REP
JI J. Med. Case Rep.
PD OCT 21
PY 2019
VL 13
IS 1
AR 313
DI 10.1186/s13256-019-2255-9
PG 7
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA WD3GG
UT WOS:000704833000001
PM 31630688
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Tarpey, MD
   Valencia, AP
   Jackson, KC
   Amorese, AJ
   Balestrieri, NP
   Renegar, RH
   Pratt, SJP
   Ryan, TE
   McClung, JM
   Lovering, RM
   Spangenburg, EE
AF Tarpey, Michael D.
   Valencia, Ana P.
   Jackson, Kathryn C.
   Amorese, Adam J.
   Balestrieri, Nicholas P.
   Renegar, Randall H.
   Pratt, Stephen J. P.
   Ryan, Terence E.
   McClung, Joseph M.
   Lovering, Richard M.
   Spangenburg, Espen E.
TI Induced <i>in vivo</i> knockdown of the <i>Brca1</i> gene in skeletal
   muscle results in skeletal muscle weakness
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article
DE BRCA1; Skeletal muscle; kyphosis; Muscle physiology; mtDNA damage;
   Mitochondria
ID CANCER SUSCEPTIBILITY; OXIDATIVE STRESS; BREAST-CANCER; TRANSCRIPTIONAL
   REGULATION; MITOCHONDRIAL FISSION; DNA-REPAIR; CELL-CYCLE;
   PHOSPHORYLATION; MUTATIONS; EXPRESSION
AB Recent evidence suggests that the breast cancer 1 early onset gene (BRCA1) influences numerous peripheral tissues, including skeletal muscle. The present study aimed to determine whether induced-loss of the breast cancer type 1 susceptibility protein (Brca1) alters skeletal muscle function. We induced genetic ablation of exon 11 in the Brca1 gene specifically in the skeletal muscle of adult mice to generate skeletal muscle-specific Brca1 homozygote knockout (Brca1KO(smi)) mice. Brca1KO(smi) exhibited kyphosis and decreased maximal isometric force in limb muscles compared to age-matched wild-type mice. Brca1KO(smi) skeletal muscle shifted toward an oxidative muscle fibre type and, in parallel, increased myofibre size and reduced capillary numbers. Unexpectedly, myofibre bundle mitochondrial respiration was reduced, whereas contraction-induced lactate production was elevated in Brca1KO(smi) muscle. Brca1KO(smi) mice accumulated mitochondrial DNA mutations and exhibited an altered mitochondrial morphology characterized by distorted and enlarged mitochondria, and these were more susceptible to swelling. In summary, skeletal muscle-specific loss of Brca1 leads to a myopathy and mitochondriopathy characterized by reductions in skeletal muscle quality and a consequent kyphosis. Given the substantial impact of BRCA1 mutations on cancer development risk in humans, a parallel loss of BRCA1 function in patient skeletal muscle cells would potentially result in implications for human health.
C1 [Tarpey, Michael D.; Amorese, Adam J.; Balestrieri, Nicholas P.; Ryan, Terence E.; McClung, Joseph M.; Spangenburg, Espen E.] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27858 USA.
   [McClung, Joseph M.; Spangenburg, Espen E.] East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA.
   [Valencia, Ana P.; Jackson, Kathryn C.] Univ Maryland, Dept Kinesiol, Sch Publ Hlth, College Pk, MD 20742 USA.
   [Renegar, Randall H.] East Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27858 USA.
   [Pratt, Stephen J. P.; Lovering, Richard M.] Univ Maryland, Sch Med, Dept Orthoped, Baltimore, MD 21201 USA.
C3 University of North Carolina; East Carolina University; University of
   North Carolina; East Carolina University; University System of Maryland;
   University of Maryland College Park; University of North Carolina; East
   Carolina University; University System of Maryland; University of
   Maryland Baltimore
RP Spangenburg, EE (corresponding author), East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA.
EM spangenburge14@ecu.edu
RI Ryan, Terence/W-5576-2019; Valencia, Ana/HOH-4405-2023
OI , Stephen/0000-0003-3627-7258; Lovering, Richard/0000-0002-9899-5071;
   Balestrieri, Nicholas/0000-0001-9863-4420; Valencia,
   Ana/0000-0002-2833-6492
FU National Institutes of Health [R01AR06660, R21AR059913, R01HL25695,
   R01AR059179, R21AR067872, F32HL129632]
FX This work was supported by the National Institutes of Health: R01AR06660
   and R21AR059913 (EES); R01HL25695 (JMM); R01AR059179 and R21AR067872
   (RML); and F32HL129632 (TER).
CR [Anonymous], 2018, TISSUE EXPRESSION BR
   [Anonymous], COLD SPRING HARB PER
   Arun B, 2015, INT J ONCOL, V47, P262, DOI 10.3892/ijo.2015.3003
   Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119
   Barton ER., 2008, MEASURING ISOMETRIC, P1
   Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166
   Clark SL, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201204005
   Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895
   Cousineau I, 2007, CELL CYCLE, V6, P962, DOI 10.4161/cc.6.8.4105
   Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010
   desVries RLA, 2012, AUTOPHAGY, V8, P699
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Dulic A, 2001, BIOCHEMISTRY-US, V40, P5906, DOI 10.1021/bi002701e
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6
   Godet Ines, 2017, Integr Cancer Sci Ther, V4, DOI 10.15761/ICST.1000228
   Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337
   Gouspillou G, 2018, J PHYSIOL-LONDON, V596, P2565, DOI 10.1113/JP275604
   Hennessy BTJ, 2010, J CLIN ONCOL, V28, P3570, DOI 10.1200/JCO.2009.27.2997
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Iyer SR, 2016, METHODS MOL BIOL, V1460, P293, DOI 10.1007/978-1-4939-3810-0_20
   Jackson KC, 2018, FASEB J, V32, P3070, DOI 10.1096/fj.201700464R
   Jackson KC, 2014, J LIPID RES, V55, P668, DOI 10.1194/jlr.M043851
   Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002
   Kim SS, 2004, MOL CELL BIOL, V24, P9498, DOI 10.1128/MCB.24.21.9498-9507.2004
   Konishi H, 2011, P NATL ACAD SCI USA, V108, P17773, DOI 10.1073/pnas.1110969108
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lark DS, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00332
   Lee WK, 2005, AM J PHYSIOL-CELL PH, V289, pC656, DOI 10.1152/ajpcell.00049.2005
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   Liu YL, 2002, BREAST CANCER RES, V4, P9, DOI 10.1186/bcr417
   Lovren F, 2014, J THORAC CARDIOV SUR, V147, P1946, DOI 10.1016/j.jtcvs.2013.09.060
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915
   Maniccia AW, 2009, J CELL PHYSIOL, V219, P634, DOI 10.1002/jcp.21708
   Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877
   Mehrgou Amir, 2016, Med J Islam Repub Iran, V30, P369
   Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359
   MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954
   Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200
   Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114
   Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200
   O'Rourke AR, 2018, FEBS J, V285, P481, DOI 10.1111/febs.14367
   Ortega FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033233
   Otis JS, 2004, J APPL PHYSIOL, V96, P584, DOI 10.1152/japplphysiol.00724.2003
   Palmer CS, 2013, J BIOL CHEM, V288, P27584, DOI 10.1074/jbc.M113.479873
   Privat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102438
   Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181
   Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398
   Ryan TE, 2016, DIABETES, V65, P2553, DOI 10.2337/db16-0387
   Saha T, 2010, J BIOL CHEM, V285, P19092, DOI 10.1074/jbc.M110.104430
   Saha T, 2009, FEBS LETT, V583, P1535, DOI 10.1016/j.febslet.2009.04.005
   Salem AF, 2012, CELL CYCLE, V11, P4167, DOI 10.4161/cc.22316
   Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Schmidt CA, 2017, J VASC SURG, V65, P1504, DOI 10.1016/j.jvs.2016.04.041
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601
   Silver DP, 2012, CANCER DISCOV, V2, P679, DOI 10.1158/2159-8290.CD-12-0221
   Singh KK, 2013, J THORAC CARDIOV SUR, V146, P949, DOI 10.1016/j.jtcvs.2012.12.064
   Spangenburg EE, 2008, J PHYSIOL-LONDON, V586, P283, DOI 10.1113/jphysiol.2007.141507
   Suberbielle E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9897
   Szabo CI, 1996, HUM MOL GENET, V5, P1289, DOI 10.1093/hmg/5.9.1289
   Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Wang Y, 2000, GENE DEV, V14, P927
   Williams RS, 2005, BIOCHEM CELL BIOL, V83, P721, DOI 10.1139/O05-153
   Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x
   Yoshikawa K, 1999, CLIN CANCER RES, V5, P1249
   Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753
NR 72
TC 10
Z9 12
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD FEB 1
PY 2019
VL 597
IS 3
BP 869
EP 887
DI 10.1113/JP276863
PG 19
WC Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Physiology
GA HJ8UJ
UT WOS:000457475300022
PM 30556208
OA Green Published, Bronze, Green Submitted
DA 2024-11-01
ER

PT J
AU Herbst, A
   Johnson, CJ
   Hynes, K
   McKenzie, D
   Aiken, JM
AF Herbst, Allen
   Johnson, Chad J.
   Hynes, Kayla
   McKenzie, Debbie
   Aiken, Judd M.
TI Mitochondrial Biogenesis Drives a Vicious Cycle of Metabolic
   Insufficiency and Mitochondrial DNA Deletion Mutation Accumulation in
   Aged Rat Skeletal Muscle Fibers
SO PLOS ONE
LA English
DT Article
ID PROLIFERATOR-ACTIVATED RECEPTOR; CREATINE-KINASE; GENE-EXPRESSION;
   HUMAN-CELLS; WILD-TYPE; SARCOPENIA; ALPHA; RESPIRATION; DISEASE; NUMBER
AB Aged muscles possess dysfunctional fibers that contain intracellular expansions of somatically derived mitochondrial DNA deletion mutations. At high abundance, these mutations disrupt the expression of mitochondrially-encoded protein subunits of the electron transport chain resulting in aerobic respiration deficient muscle fiber segments. These fiber segments atrophy and break contributing to the loss of muscle mass and function that occurs with age. By combining micro-dissection of individual muscle fibers with microarray analysis, we observed the response induced within these abnormal muscle fibers and detected an increase in many genes affecting metabolism and metabolic regulation. The transcriptional profile and subsequent protein validation suggested that a non-compensatory program of mitochondrial biogenesis was initiated. We hypothesized that this non-adaptive program of mitochondrial biogenesis was driving mtDNA deletion mutation accumulation. We tested this hypothesis by treating aged rats with beta-Guanidinopropionic acid, a compound that stimulates mitochondrial biogenesis. beta-Guanidinopropionic acid treatment increased muscle mitochondrial genome copy number and resulted in a 3.7 fold increase in the abundance of electron transport chain negative muscle fiber segments. We conclude that in electron transport system abnormal muscle fiber segments, a vicious cycle of metabolic insufficiency and non-compensatory mitochondrial biogenesis drive mtDNA deletion mutation accumulation.
C1 [Herbst, Allen; Aiken, Judd M.] Univ Alberta, Ctr Prions & Prot Folding Dis Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [Johnson, Chad J.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA.
   [Hynes, Kayla; McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.
C3 University of Alberta; University of Wisconsin System; University of
   Wisconsin Madison; University of Alberta
RP Aiken, JM (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis Agr Food & Nutr Sci, Edmonton, AB, Canada.
EM Judd.Aiken@ualberta.ca
RI ; McKenzie, Debbie/G-4459-2015
OI Herbst, Allen/0000-0001-6601-1245; McKenzie, Debbie/0000-0002-9291-6977;
   Aiken, Judd/0000-0001-6119-4521
FU Senior Scholar Grant from the Ellison Medical Foundation; National
   Institutes of Health NIA [5R01AG030423-04]
FX This work was funded by a Senior Scholar Grant from the Ellison Medical
   Foundation and by the National Institutes of Health NIA 5R01AG030423-04
   (http://www.ellisonfoundation.org, http://www.nia.nih.gov/). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200
   Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cortopassi G, 2006, MITOCHONDRION, V6, P161, DOI 10.1016/j.mito.2006.05.002
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   EINSIEDEL LJ, 1992, J NEUROL SCI, V112, P170, DOI 10.1016/0022-510X(92)90147-D
   Evans W, 1997, J NUTR, V127, pS998
   Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x
   Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005
   Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921
   Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006
   Mueller-Hoecker J., 1993, Virchows Archiv A Pathological Anatomy and Histopathology, V422, P7
   OGorman E, 1997, FEBS LETT, V414, P253, DOI 10.1016/S0014-5793(97)01045-4
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Rosenberg IH, 1997, J NUTR, V127, P990
   ROWLEY GL, 1971, J AM CHEM SOC, V93, P5542, DOI 10.1021/ja00750a038
   Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   STADHOUDERS AM, 1994, P NATL ACAD SCI USA, V91, P5089, DOI 10.1073/pnas.91.11.5089
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Szulc P, 2005, J BONE MINER RES, V20, P721, DOI 10.1359/JBMR.041230
   Tien ES, 2003, CANCER RES, V63, P5767
   TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
NR 43
TC 17
Z9 19
U1 0
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 13
PY 2013
VL 8
IS 3
AR e59006
DI 10.1371/journal.pone.0059006
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 115YY
UT WOS:000316849200126
PM 23516592
OA gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Lahiri, D
   Sawale, VM
   Banerjee, S
   Dubey, S
   Roy, BK
   Das, SK
AF Lahiri, Durjoy
   Sawale, Vishal Madhukar
   Banerjee, Subhadeep
   Dubey, Souvik
   Roy, Biman Kanti
   Das, Shyamal Kumar
TI Chorea-ballism as a dominant clinical manifestation in heteroplasmic
   mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes
   syndrome with A3251G mutation in mitochondrial genome: a case report
SO JOURNAL OF MEDICAL CASE REPORTS
LA English
DT Article
DE Mitochondrial encephalopathy; lactic acidosis; and stroke-like episodes
   (MELAS); Chorea; Ballism; A3251G mutation
ID MELAS; DNA
AB Background Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes, the most common maternally inherited mitochondrial disease, can present with a wide range of neurological manifestations including both central and peripheral nervous system involvement. The most frequent genetic mutation reported in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome is A3243G in MT-TL1 gene. Stroke-like episodes, dementia, epilepsy, lactic acidemia, myopathy, recurrent headaches, hearing impairment, diabetes, and short stature constitute the known presentations in this syndrome. Among the abnormal involuntary movements in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome, myoclonus is the commonest. Other movement disorders, including chorea, are rarely reported in this disorder. Case presentation A 14-year-old South Asian boy from rural Bengal (India), born of a second degree consanguineous marriage, with normal birth and development history, presented with abnormal brief jerky movements involving his trunk and limbs, with recurrent falls for 10 months. We present here a case of heteroplasmic mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation, in which the clinical picture was dominated by a host of involuntary abnormal movements including chorea-ballism, myoclonus, and oromandibular dystonia in a backdrop of cognitive decline, seizure, and stroke-like episode. A final diagnosis was established by muscle biopsy and genetic study. Haloperidol was administered to control the involuntary movements along with introduction of co-enzyme Q, besides symptomatic management for his focal seizures. Six months into follow-up his seizures and abnormal movements were controlled significantly with slight improvement of cognitive abilities. Conclusion The dominance of hyperkinetic movements in the clinical scenario and the finding of a point mutation A3251G in MT-TL1 gene make this a rare presentation.
C1 [Lahiri, Durjoy; Sawale, Vishal Madhukar; Banerjee, Subhadeep; Dubey, Souvik; Roy, Biman Kanti; Das, Shyamal Kumar] IPGMER & SSKM Hosp, Bangur Inst Neurosci, Dept Neurol, Kolkata 700025, India.
C3 Institute of Post Graduate Medical Education & Research (IPGMER),
   Kolkata
RP Lahiri, D (corresponding author), IPGMER & SSKM Hosp, Bangur Inst Neurosci, Dept Neurol, Kolkata 700025, India.
EM dlahiri1998@gmail.com
CR De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Kang JH, 2005, J NEUROL, V252, P103, DOI 10.1007/s00415-005-0600-y
   Nakagaki Hideaki, 2005, Rinsho Shinkeigaku, V45, P502
   Singmaneesakulchai S, 2012, MOVEMENT DISORD, V27, P1495, DOI 10.1002/mds.24912
   Sudarsky L, 1999, MOVEMENT DISORD, V14, P488, DOI 10.1002/1531-8257(199905)14:3<488::AID-MDS1017>3.0.CO;2-4
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 10
TC 8
Z9 8
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1752-1947
J9 J MED CASE REP
JI J. Med. Case Rep.
PD MAR 6
PY 2019
VL 13
IS 1
AR 63
DI 10.1186/s13256-018-1936-0
PG 5
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA WD3GO
UT WOS:000704833800002
PM 30837005
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Hougaard, DD
   Hestoy, DH
   Hojland, AT
   Gaihede, M
   Petersen, MB
AF Hougaard, Dan Dupont
   Hestoy, Danjal Hofgaard
   Hojland, Allan Thomas
   Gaihede, Michael
   Petersen, Michael Bjorn
TI Audiological and Vestibular Findings in Subjects with MELAS Syndrome
SO JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY
LA English
DT Article; Proceedings Paper
CT 14th Annual Meeting of the
   Danish-Society-of-Otorhinolaryngology-Head-and-Neck-Surgery
CY APR 20-21, 2017
CL Nyborg, DENMARK
SP Danish Soc Otorhinolaryngol Head & Neck Surg
DE MELAS syndrome; mitochondrial diseases; sensorineural hearing loss;
   vestibular disease; inner ear disease
ID INHERITED DIABETES-MELLITUS; TRANSFER RNALEU(UUR) GENE; STROKE-LIKE
   EPISODES; LACTIC-ACIDOSIS; POINT MUTATION; MITOCHONDRIAL MYOPATHY;
   CLINICAL-APPLICATIONS; A3243G; DEAFNESS; ENCEPHALOMYOPATHY
AB OBJECTIVES: The mitochondrial DNA (mtDNA) point mutation m.3243A>G is known to express the following two syndromes among others: maternally inherited diabetes and deafness (MIDD) and mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Sensorineural hearing loss (SNHL) is the most frequent symptom in individuals harboring the m.3243A>G mutation. However, dysfunction of the vestibular organs has been scarcely examined. Therefore, the present study aimed to study the impact of the m.3243A>G mutation on the inner ear.
   MATERIALS and METHODS: A total of 8 subjects harboring the blood-verified m.3243A>G mutation underwent thorough audiological and vestibular examinations, including tone and speech audiometry, video head impulse test (vHIT), ocular and cervical vestibular-evoked myogenic potential (oVEMP and cVEMP), and full otoneurological examination. The subjects also answered a Dizziness Handicap Inventory (DHI) questionnaire.
   RESULTS: SNHL was identified in all the 8 subjects, with a mean pure-tone average-4 (PTA-4) of 59 dB. Speech discrimination score (n=7) ranged from 24% to 100% (mean 74%), and vHIT (n=42) detected pathology in nine lateral semicircular canals (SCCs), five posterior SCCs, and one anterior SCC, whereas three measurements were inconclusive. All oVEMPs (n=14 ears) were absent, nine cVEMPs were absent, and two were inconclusive. Based on the DHI scores, 6 subjects reported none to mild dizziness, 1 reported moderate, and 1 reported severe dizziness.
   CONCLUSION: Our study population had pathological findings from every audiological and vestibular end organs. The results indicated that the pathological findings originated from within the end organs themselves and not within the superior and inferior vestibular or cochlear nerve.
C1 [Hougaard, Dan Dupont; Gaihede, Michael] Aalborg Univ Hosp, Head & Neck Surg & Audiol, Dept Otolaryngol, Aalborg, Denmark.
   [Hougaard, Dan Dupont; Hojland, Allan Thomas; Gaihede, Michael; Petersen, Michael Bjorn] Aalborg Univ, Dept Clin Med, Sch Med, Aalborg, Denmark.
   [Hestoy, Danjal Hofgaard] Aalborg Univ, Sch Hlth Sci, Aalborg, Denmark.
   [Hojland, Allan Thomas; Petersen, Michael Bjorn] Aalborg Univ Hosp, Dept Clin Genet, Aalborg, Denmark.
   [Hougaard, Dan Dupont; Hestoy, Danjal Hofgaard; Hojland, Allan Thomas; Gaihede, Michael; Petersen, Michael Bjorn] Aalborg Univ Hosp, Res & Knowledge Ctr Sensory Genet, Aalborg, Denmark.
C3 Aalborg University; Aalborg University Hospital; Aalborg University;
   Aalborg University; Aalborg University; Aalborg University Hospital;
   Aalborg University; Aalborg University Hospital
RP Gaihede, M (corresponding author), Aalborg Univ Hosp, Head & Neck Surg & Audiol, Dept Otolaryngol, Aalborg, Denmark.; Gaihede, M (corresponding author), Aalborg Univ, Dept Clin Med, Sch Med, Aalborg, Denmark.; Gaihede, M (corresponding author), Aalborg Univ Hosp, Res & Knowledge Ctr Sensory Genet, Aalborg, Denmark.
EM michael.petersen@rn.dk
RI Petersen, Michael/D-1483-2017; Hojland, Allan/C-8405-2017
OI Hougaard, Dan Dupont/0000-0002-4164-1758; Hojland,
   Allan/0000-0003-0014-3004
FU Obelske Familiefond; Aalborg University
FX The Research and Knowledge Center was supported by a grant from the
   Obelske Familiefond. D.H.H. received financial support from Aalborg
   University to visit the MRC Mitochondrial Biology Unit, University of
   Cambridge, Cambridge, United Kingdom.
CR Blödow A, 2013, AURIS NASUS LARYNX, V40, P348, DOI 10.1016/j.anl.2012.11.002
   Cardenas-Robledo S, 2016, J NEURO-OPHTHALMOL, V36, P134, DOI 10.1097/WNO.0000000000000340
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hendrickx JJ, 2006, OTOL NEUROTOL, V27, P802, DOI 10.1097/01.mao.0000224091.02506.a0
   Iwasaki S, 2011, LARYNGOSCOPE, V121, P1821, DOI 10.1002/lary.21879
   JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424
   Kantner C, 2012, HEARING RES, V294, P55, DOI 10.1016/j.heares.2012.10.008
   Kim SH, 2016, NEUROL SCI, V37, P1159, DOI 10.1007/s10072-016-2577-y
   Kirkwood BR, 2010, Essential Medical Statistics
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mossman B, 2015, J OTOLARYNGOL-HEAD N, V44, DOI 10.1186/s40463-015-0081-7
   Murofushi T, 2002, CLIN NEUROPHYSIOL, V113, P305, DOI 10.1016/S1388-2457(01)00738-6
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Nguyen KD, 2010, OTOL NEUROTOL, V31, P793, DOI 10.1097/MAO.0b013e3181e3d60e
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Shin BS, 2012, CLIN NEUROPHYSIOL, V123, P369, DOI 10.1016/j.clinph.2011.05.029
   Vandana VP, 2016, CLIN NEUROL NEUROSUR, V148, P17, DOI 10.1016/j.clineuro.2016.04.024
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Vivero RJ, 2013, GENET TEST MOL BIOMA, V17, P383, DOI 10.1089/gtmb.2012.0403
   Watson SRD, 1998, ELECTROMYOGR MOTOR C, V109, P471, DOI 10.1016/S0924-980X(98)00033-2
   Welgampola MS, 2005, NEUROLOGY, V64, P1682, DOI 10.1212/01.WNL.0000161876.20552.AA
   Yamasoba T, 1996, LARYNGOSCOPE, V106, P49, DOI 10.1097/00005537-199601000-00010
NR 27
TC 9
Z9 10
U1 0
U2 5
PU AVES
PI SISLI
PA BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY
SN 1308-7649
EI 2148-3817
J9 J INT ADV OTOL
JI J. Int. Adv. Otol.
PD AUG
PY 2019
VL 15
IS 2
BP 296
EP 303
DI 10.5152/iao.2019.5913
PG 8
WC Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Otorhinolaryngology
GA IT6ZW
UT WOS:000483026300020
PM 31347509
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Burger, PA
   Steinborn, R
   Walzer, C
   Petit, T
   Mueller, M
   Schwarzenberger, F
AF Burger, PA
   Steinborn, R
   Walzer, C
   Petit, T
   Mueller, M
   Schwarzenberger, F
TI Analysis of the mitochondrial genome of cheetahs (<i>Acinonyx
   jubatus</i>) with neurodegenerative disease
SO GENE
LA English
DT Article
DE mitochondrial DNA; heteroplasmy; mitochondrial disease; myelopathy;
   real-time PCR; single nucleotide polymorphism
ID PATERNAL INHERITANCE; NUCLEAR GENOME; CONTROL REGION; DNA; SEQUENCE;
   ENCEPHALOMYELOPATHY; HETEROPLASMY; MYELOPATHY; MUTATIONS; MUSCLE
AB The complete mitochondrial genome of Acinonyx jubatus was sequenced and mitochondrial DNA (mtDNA) regions were screened for polymorphisms as candidates for the cause of a neurodegenerative demyelinating disease affecting captive cheetahs. The mtDNA reference sequences were established on the basis of the complete sequences of two diseased and two nondiseased animals as well as partial sequences of 26 further individuals. The A. jubatus mitochondrial genome is 17,047-bp long and shows a high sequence similarity (91%) to the domestic cat. Based on single nucleotide polymorphisms (SNPs) in the control region (CR) and pedigree information, the 18 myelopathic and 12 non-myelopathic cheetahs included in this study were classified into haplotypes I, II and III. In view of the phenotypic comparability of the neurodegenerative disease observed in cheetahs and human mtDNA-associated diseases, specific coding regions including the tRNAs leucine UUR, lysine, serine UCN, and partial complex I and V sequences were screened. We identified a heteroplasmic and a homoplasmic SNP at codon 507 in the subunit 5 (MTND5) of complex I. The heteroplasmic haplotype I-specific valine to methionine substitution represents a nonconservative amino acid change and was found in 11 myelopathic and eight non-myelopathic cheetahs with levels ranging from 29% to 79%. The homoplasmic conservative amino acid substitution valine to alanine was identified in two myelopathic animals of haplotype II. In addition, a synonymous SNP in the codon 76 of the MTND4L gene was found in the single haplotype III animal. The amino acid exchanges in the MTND5 gene were not associated with the occurrence of neurodegenerative disease in captive cheetahs. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Vet Med, Dept Nat Sci, Inst Biochem, A-1210 Vienna, Austria.
   Univ Vet Med, Clin Dept Anim Breeding & Reprod, Genet Inst, A-1210 Vienna, Austria.
   Zoo Salzburg, A-5081 Anif, Austria.
   Zoo Palmyre, F-17570 Les Mathes, France.
C3 University of Veterinary Medicine Vienna; University of Veterinary
   Medicine Vienna
RP Univ Vet Med, Dept Nat Sci, Inst Biochem, Veterinaerpl 1, A-1210 Vienna, Austria.
EM Franz.Schwarzenberger@vu-wien.ac.at
RI Schwarzenberger, Franz/A-9236-2013
OI Schwarzenberger, Franz/0000-0002-2961-0545; Burger,
   Pamela/0000-0002-6941-0257; Walzer, Chris/0000-0002-0437-5147
CR Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   Brenner O, 1997, ACTA NEUROPATHOL, V94, P390, DOI 10.1007/s004010050724
   Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Dayhoff M.O., 1978, Atlas of Protein Sequence and Structure, P345
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Driscoll CA, 2002, GENOME RES, V12, P414, DOI 10.1101/gr.185702
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Fleischer S, 1974, Methods Enzymol, V31, P6
   Freeman AR, 2001, HEREDITY, V86, P355, DOI 10.1046/j.1365-2540.2001.00840.x
   Jellinger KA, 2003, J NEURAL TRANSM-SUPP, P101
   Kotsch V, 2002, WIEN TIERARZTL MONAT, V89, P341
   Lopez JV, 1996, GENOMICS, V33, P229, DOI 10.1006/geno.1996.0188
   MARKERKRAUS L, 2001, 2000 2001 INT CHEETA
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Munson L, 1999, J ZOO WILDLIFE MED, V30, P342
   NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503
   PALMER AC, 1995, J SMALL ANIM PRACT, V36, P57, DOI 10.1111/j.1748-5827.1995.tb02822.x
   Ramakrishna C, 2002, J IMMUNOL, V168, P1204, DOI 10.4049/jimmunol.168.3.1204
   ROBERT N, 2003, ANN P AM ASS ZOO VET, P139
   Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Steinborn R, 2000, NAT GENET, V25, P255, DOI 10.1038/77000
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   TOENNIESSEN JG, 1995, COMP CONT EDUC PRACT, V17, P271
   Tourmen Y, 2002, GENOMICS, V80, P71, DOI 10.1006/geno.2002.6798
   Walzer C, 2003, J ZOO WILDLIFE MED, V34, P36, DOI 10.1638/1042-7260(2003)34[0036:IAOMIC]2.0.CO;2
   WALZER C, 1998, P EURO ASS ZOO WILDL, V2, P267
   XU XF, 1994, GENE, V148, P357, DOI 10.1016/0378-1119(94)90713-7
NR 32
TC 21
Z9 28
U1 0
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD AUG 18
PY 2004
VL 338
IS 1
BP 111
EP 119
DI 10.1016/j.gene.2004.05.020
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 850EI
UT WOS:000223593600012
PM 15302412
OA Green Accepted, Green Published
DA 2024-11-01
ER

PT J
AU Moore, AZ
   Biggs, ML
   Matteini, A
   O'Connor, A
   McGuire, S
   Beamer, BA
   Fallin, MD
   Fried, LP
   Walston, J
   Chakravarti, A
   Arking, DE
AF Moore, Ann Z.
   Biggs, Mary L.
   Matteini, Amy
   O'Connor, Ashley
   McGuire, Sarah
   Beamer, Brock A.
   Fallin, M. Danielle
   Fried, Linda P.
   Walston, Jeremy
   Chakravarti, Aravinda
   Arking, Dan E.
TI Polymorphisms in the Mitochondrial DNA Control Region and Frailty in
   Older Adults
SO PLOS ONE
LA English
DT Article
ID METABOLIC-RATE; FREE-RADICALS; DISEASES; REPLICATION; PHENOTYPE;
   LONGEVITY; PARADIGM; VARIANT; CANCER; RISK
AB Background: Mitochondria contribute to the dynamics of cellular metabolism, the production of reactive oxygen species, and apoptotic pathways. Consequently, mitochondrial function has been hypothesized to influence functional decline and vulnerability to disease in later life. Mitochondrial genetic variation may contribute to altered susceptibility to the frailty syndrome in older adults.
   Methodology/Principal Findings: To assess potential mitochondrial genetic contributions to the likelihood of frailty, mitochondrial DNA (mtDNA) variation was compared in frail and non-frail older adults. Associations of selected SNPs with a muscle strength phenotype were also explored. Participants were selected from the Cardiovascular Health Study (CHS), a population-based observational study (1989-1990, 1992-1993). At baseline, frailty was identified as the presence of three or more of five indicators (weakness, slowness, shrinking, low physical activity, and exhaustion). mtDNA variation was assessed in a pilot study, including 315 individuals selected as extremes of the frailty phenotype, using an oligonucleotide sequencing microarray based on the Revised Cambridge Reference Sequence. Three mtDNA SNPs were statistically significantly associated with frailty across all pilot participants or in sex-stratified comparisons: mt146, mt204, and mt228. In addition to pilot participants, 4,459 additional men and women with frailty classifications, and an overlapping subset of 4,453 individuals with grip strength measurements, were included in the study population genotyped at mt204 and mt228. In the study population, the mt204 C allele was associated with greater likelihood of frailty (adjusted odds ratio = 2.04, 95% CI = 1.07-3.60, p = 0.020) and lower grip strength (adjusted coefficient = 22.04, 95% CI = 23.33-20.74, p = 0.002).
   Conclusions: This study supports a role for mitochondrial genetic variation in the frailty syndrome and later life muscle strength, demonstrating the importance of the mitochondrial genome in complex geriatric phenotypes.
C1 [Moore, Ann Z.; Matteini, Amy; Fallin, M. Danielle] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Biggs, Mary L.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA.
   [O'Connor, Ashley; McGuire, Sarah; Chakravarti, Aravinda; Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA.
   [Beamer, Brock A.] Univ Maryland, Sch Med, Div Gerontol, Baltimore, MD 21201 USA.
   [Fried, Linda P.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA.
   [Walston, Jeremy] Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD 21205 USA.
C3 Johns Hopkins University; Johns Hopkins Bloomberg School of Public
   Health; University of Washington; University of Washington Seattle;
   Johns Hopkins University; University System of Maryland; University of
   Maryland Baltimore; Columbia University; Johns Hopkins University
RP Moore, AZ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
EM arking@jhmi.edu
OI Moore, Ann Zenobia/0000-0002-1471-4253
FU National Institute on Aging, Claude D. Pepper Older Americans
   Independence Centers [P30 AG021334]; National Heart, Lung, and Blood
   Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01
   HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295]; National Institute
   of Neurological Disorders and Stroke
FX This research was supported by the National Institute on Aging, Claude
   D. Pepper Older Americans Independence Centers, Grant P30 AG021334 and
   by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01
   HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant number U01
   HL080295 from the National Heart, Lung, and Blood Institute, with
   additional contribution from the National Institute of Neurological
   Disorders and Stroke. A full list of principal CHS investigators and
   institutions can be found at http://www.chs-nhlbi.org/pi.htm. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100
   Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695
   Fried Linda P., 1991, Annals of Epidemiology, V1, P263
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Liu VWS, 2003, HUM MUTAT, V22, P173, DOI 10.1002/humu.10244
   MITOMAP, 2009, MITOMAP HUM MIT GEN
   Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731
   Ruggiero C, 2006, J GERONTOL A-BIOL, V61, P466, DOI 10.1093/gerona/61.5.466
   Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
NR 26
TC 40
Z9 45
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 10
PY 2010
VL 5
IS 6
AR e11069
DI 10.1371/journal.pone.0011069
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 608QA
UT WOS:000278599600025
PM 20548781
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Houshmand, M
   Montazeri, M
   Kuchekian, N
   Noohi, F
   Nozar, G
   Zamani, A
AF Houshmand, Massoud
   Montazeri, Maryam
   Kuchekian, Nafiseh
   Noohi, Freidoon
   Nozar, Givtaj
   Zamani, Akram
TI Is 8860 variation a rare polymorphism or associated as a secondary
   effect in HCM disease?
SO ARCHIVES OF MEDICAL SCIENCE
LA English
DT Article
DE hypertrophic cardiomyopathy; mtDNA mutation disease
ID HUMAN MITOCHONDRIAL-DNA; RED FIBERS MERRF; HYPERTROPHIC CARDIOMYOPATHY;
   IDIOPATHIC CARDIOMYOPATHY; MYOCLONIC EPILEPSY; SKELETAL-MUSCLE;
   LACTIC-ACIDOSIS; EPISODES MELAS; MUTATION; GENE
AB Introduction: mtDNA defects, both deletions and point mutations, have been associated with hypertrophic cardiomyopathies. The aim of this study was to establish a spectrum for mtDNA mutations in Iranian hypertrophic cardiomyopathy (HCM) patients.
   Material and methods: The control group was chosen among the special medical centre visitors who did not have hypertrophic cardiomyopathy or any related heart disease. Hypertrophic cardiomyopathy (HCM) is widely accepted as a pluricausal or multifactorial disease. Because of the linkage between energy metabolism in the mitochondria and cardiac muscle contraction, it is reasonable to assume that mitochondrial abnormalities may be responsible for some forms of HCM. Point mutations and deletions in the two hot spot regions of mtDNA were investigated by PCR and sequencing methods.
   Results: Some unreported point mutations have been found in this study but no deletion was detected. Meanwhile some of these point mutations have been investigated among HCM patients for the first time.
   Conclusions: A8860G transition was detected in a high proportion, raising the question whether this rare polymorphism is associated as a secondary effect in HCM disease.
C1 [Houshmand, Massoud; Montazeri, Maryam] Natl Inst Genet Engn & Biotechnol, Tehran, Iran.
   [Kuchekian, Nafiseh; Zamani, Akram] Special Med Ctr, Tehran, Iran.
   [Noohi, Freidoon; Nozar, Givtaj] Iran Univ Med Sci, Shaheed Rajaei Cardiovasc Med Ctr, Tehran, Iran.
C3 Iran University of Medical Sciences; Rajaei Cardiovascular Medical &
   Research Center
RP Houshmand, M (corresponding author), Natl Inst Genet Engn & Biotechnol, Tehran, Iran.
EM massoudh@nigeb.ac.ir
RI Houshmand, Massoud/AEG-9909-2022; montazeri, maryam/B-6535-2019
OI , Masoud/0000-0001-7687-7464; Houshmand, Massoud/0000-0002-2198-223X;
   montazeri, maryam/0000-0003-2732-8551
FU National Institute for Genetic Engineering and Biotechnology, Ministry
   of Science, Research and Technology, Tehran, Iran [227]
FX This work was supported by a grant (with research project No. 227) from
   the National Institute for Genetic Engineering and Biotechnology,
   Ministry of Science, Research and Technology, Tehran, Iran. We would
   like to thank the patients and their families, whose collaboration and
   understanding allowed us to do this work.
CR Ahari SE, 2007, CELL MOL NEUROBIOL, V27, P695, DOI 10.1007/s10571-007-9160-2
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Houshmand M, 2006, MITOCHONDRION, V6, P82, DOI 10.1016/j.mito.2006.01.005
   Kirk R, 1999, AM J HUM GENET, V65, P508, DOI 10.1086/302507
   KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107
   Lee MS, 2002, MITOCHONDRION, V1, P321, DOI 10.1016/S1567-7249(01)00031-9
   Marian AJ, 2002, CURR OPIN CARDIOL, V17, P242, DOI 10.1097/00001573-200205000-00006
   MERANTE F, 1994, AM J HUM GENET, V55, P437
   Montazeri Maryam, 2005, Iranian Journal of Biotechnology, V3, P157
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Mostafaie N, 2004, J NEURAL TRANSM, V111, P1155, DOI 10.1007/s00702-004-0161-8
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B
   SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/0005-2728(92)90226-R
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Turner LF, 1998, EUR HEART J, V19, P1725, DOI 10.1053/euhj.1998.1125
NR 19
TC 17
Z9 17
U1 0
U2 1
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA WENEDOW ST 9-1, POZNAN, 61-614, POLAND
SN 1734-1922
J9 ARCH MED SCI
JI Arch. Med. Sci.
PD APR
PY 2011
VL 7
IS 2
BP 242
EP 246
DI 10.5114/aoms.2011.22074
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 768EU
UT WOS:000290915100009
PM 22291763
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Cadoni, G
   Primiano, G
   Picciotti, PM
   Calandrelli, R
   Galli, J
   Servidei, S
   Conti, G
AF Cadoni, Gabriella
   Primiano, Guido
   Picciotti, Pasqualina M.
   Calandrelli, Rosalinda
   Galli, Jacopo
   Servidei, Serenella
   Conti, Guido
TI Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases
SO JOURNAL OF PERSONALIZED MEDICINE
LA English
DT Article
DE mitochondrial diseases; mtDNA; deafness; cochlear; retrocochlear; MRI;
   brain changes
ID DISORDER; MUTATION; PATIENT; DNA
AB Mitochondrial diseases (MDs) are heterogeneous genetic disorders characterized by mitochondrial DNA (mtDNA) defects, involving tissues highly dependent on oxidative metabolism: the inner ear, brain, eye, skeletal muscle, and heart. We describe adult patients with genetically defined MDs, characterizing hearing function and neuroimaging results. We enrolled 34 patients (mean age: 50.02 +/- 15 years, range: 18-75 years; 20 females and 14 males) classified in four groups: MELAS, MIDD, PEO, and Encephalopathy/Polyneuropathy. Audiological evaluations included psychoacoustical tests (pure-tone and speech audiometry), electrophysiological tests (Auditory Brainstem Responses, ABRs), and Impedenzometry. Neuroimaging evaluations considered global MRI abnormalities or structural brain changes. In total, 19/34 patients carried the m.3243A > G mutation (6 affected by MELAS, 12 affected by MIDD, and 1 affected by PEO); 11 had an mtDNA deletion (all affected by PEO); 3 had nuclear genes associated with MDs (POLG1 and OPA1); and 1 patient had an mtDNA deletion without an identified nuclear gene defect (affected by PEO). Sensory neural, bilateral, and symmetrical hearing loss was present in 25 patients (73.5%) to different degrees: 9 mild, 9 moderate, 5 severe, and 2 profound. The severe/profound and mild hearing losses were associated with pantonal and high-frequency audiograms, respectively. Instead, moderate hearing losses were associated with both high-frequency (five cases) and pantonal (five cases) audiogram shapes. In addition, 21/25 patients showed a cochlear site of lesion (84%), and 4/25 (16%) showed a retrocochlear site. We found global MRI abnormalities or structural brain changes in 26/30 subjects (86.6%): 21 had white matter abnormalities, 15 had cortical atrophy, 10 had subcortical atrophy, 8 had basal nuclei involvement or cerebellar atrophy, 4 had stroke-like lesions or laminar necrosis, and 1 had cysts or vacuolated lesions. We concluded that genetic alterations are associated with different clinical presentations for both auditory function and neuroradiological findings. There is no fixed relationship between genotype and phenotype for the clinical conditions analyzed.
C1 [Cadoni, Gabriella; Primiano, Guido; Picciotti, Pasqualina M.; Galli, Jacopo; Servidei, Serenella; Conti, Guido] Fdn Policlin Univ Agostino Gemelli IRCCS, Dipartimento Neurosci Organi Senso & Torace, Rome 00168, Italy.
   [Cadoni, Gabriella; Picciotti, Pasqualina M.; Galli, Jacopo; Conti, Guido] Univ Cattolica Sacro Cuore, Dipartimento Testa Collo & Organi Senso, I-00168 Rome, Italy.
   [Primiano, Guido; Servidei, Serenella] Univ Cattolica Sacro Cuore, Dipartimento Neurosci, I-00168 Rome, Italy.
   [Calandrelli, Rosalinda] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Dipartimento Diagnost Immagini Radioterapia Oncolo, I-00168 Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli;
   Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli;
   Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli;
   Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Picciotti, PM (corresponding author), Fdn Policlin Univ Agostino Gemelli IRCCS, Dipartimento Neurosci Organi Senso & Torace, Rome 00168, Italy.; Picciotti, PM (corresponding author), Univ Cattolica Sacro Cuore, Dipartimento Testa Collo & Organi Senso, I-00168 Rome, Italy.
EM gabriella.cadoni@unicatt.it; guido.primiano@policlinicogemelli.it;
   pasqualinamaria.picciotti@unicatt.it;
   rosalinda.calandrelli@policlinicogemelli.it; jacopo.galli@unicatt.it;
   serenella.servidei@unicatt.it; guido.conti@unicatt.it
RI Servidei, Serenella/ABC-4262-2021; Primiano, Guido/AAB-7829-2019;
   Calandrelli, Rosalinda/IZE-2002-2023; PICCIOTTI, Pasqualina
   Maria/GQI-3634-2022
OI Calandrelli, Rosalinda/0000-0003-4517-3477; SERVIDEI,
   Serenella/0000-0001-8478-2799; PICCIOTTI, Pasqualina
   Maria/0000-0002-1502-6508
CR Alves CAPF, 2023, AM J NEURORADIOL, V44, P602, DOI 10.3174/ajnr.A7837
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Cheng WQ, 2022, FRONT NEUROL, V13, DOI 10.3389/fneur.2022.843386
   Elander J, 2022, MOL GENET METAB, V137, P230, DOI 10.1016/j.ymgme.2022.09.002
   Esterhuizen K, 2021, METABOLOMICS, V17, DOI 10.1007/s11306-020-01769-w
   Fancello V, 2023, MEDICINA-LITHUANIA, V59, DOI 10.3390/medicina59030608
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Hougaard DD, 2019, J INT ADV OTOL, V15, P296, DOI 10.5152/iao.2019.5913
   Kanungo S, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.12.13
   Kornblum C, 2005, J NEUROL, V252, P1101, DOI 10.1007/s00415-005-0827-7
   Kullar PJ, 2016, BRAIN, V139, pE33, DOI 10.1093/brain/aww051
   Li DY, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.951185
   Long HS, 2022, EUR J MED RES, V27, DOI 10.1186/s40001-022-00832-7
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Merlini E, 2022, TRENDS NEUROSCI, V45, P53, DOI 10.1016/j.tins.2021.10.014
   Miceli G, 2008, NEUROL SCI, V29, P459, DOI 10.1007/s10072-008-1028-9
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Orsucci D, 2021, J CLIN MED, V10, DOI 10.3390/jcm10061249
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Pinós T, 2011, MITOCHONDRION, V11, P228, DOI 10.1016/j.mito.2010.08.008
   Robinson KN, 2020, ENDOCR PRACT, V26, P241, DOI 10.4158/EP-2019-0270
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P161, DOI 10.1007/978-3-319-95046-4_30
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P163, DOI 10.1007/978-3-319-95046-4_31
   van Kempen CMA, 2022, MOL GENET METAB, V135, P333, DOI 10.1016/j.ymgme.2022.02.003
   Vandana VP, 2016, CLIN NEUROL NEUROSUR, V148, P17, DOI 10.1016/j.clineuro.2016.04.024
NR 25
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4426
J9 J PERS MED
JI J. Pers. Med.
PD SEP
PY 2023
VL 13
IS 9
AR 1329
DI 10.3390/jpm13091329
PG 12
WC Health Care Sciences & Services; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; General & Internal Medicine
GA T2TQ9
UT WOS:001076564400001
PM 37763097
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Lehmann, D
   Tuppen, HAL
   Campbell, GE
   Alston, CL
   Lawless, C
   Rosa, HS
   Rocha, MC
   Reeve, AK
   Nicholls, TJ
   Deschauer, M
   Zierz, S
   Taylor, RW
   Turnbull, DM
   Vincent, AE
AF Lehmann, Diana
   Tuppen, Helen A. L.
   Campbell, Georgia E.
   Alston, Charlotte L.
   Lawless, Conor
   Rosa, Hannah S.
   Rocha, Mariana C.
   Reeve, Amy K.
   Nicholls, Thomas J.
   Deschauer, Marcus
   Zierz, Stephan
   Taylor, Robert W.
   Turnbull, Doug M.
   Vincent, Amy E.
TI Understanding mitochondrial DNA maintenance disorders at the single
   muscle fibre level
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; REAL-TIME PCR; MTDNA REPLICATION;
   INDIVIDUAL CELLS; SKELETAL-MUSCLE; DELETIONS; MUTATIONS; DEFICIENCY;
   MECHANISMS; QUANTIFICATION
AB Clonal expansion of mitochondrial DNA (mtDNA) deletions is an important pathological mechanism in adults with mtDNA maintenance disorders, leading to a mosaic mitochondrial respiratory chain deficiency in skeletal muscle. This study had two aims: (i) to determine if different Mendelian mtDNA maintenance disorders showed similar pattern of mtDNA deletions and respiratory chain deficiency and (ii) to investigate the correlation between the mitochondrial genetic defect and corresponding respiratory chain deficiency. We performed a quantitative analysis of respiratory chain deficiency, at a single cell level, in a cohort of patients with mutations in mtDNA maintenance genes. Using the same tissue section, we performed laser microdissection and single cell genetic analysis to investigate the relationship between mtDNA deletion characteristics and the respiratory chain deficiency. The pattern of respiratory chain deficiency is similar with different genetic defects. We demonstrate a clear correlation between the level of mtDNA deletion and extent of respiratory chain deficiency within a single cell. Long-range and single molecule PCR shows the presence of multiple mtDNA deletions in approximately one-third of all muscle fibres. We did not detect evidence of a replicative advantage for smaller mtDNA molecules in the majority of fibres, but further analysis is needed to provide conclusive evidence.
C1 [Lehmann, Diana] Univ Ulm, Dept Neurol, D-89075 Ulm, Germany.
   [Lehmann, Diana; Zierz, Stephan] Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Germany.
   [Tuppen, Helen A. L.; Campbell, Georgia E.; Alston, Charlotte L.; Lawless, Conor; Rosa, Hannah S.; Rocha, Mariana C.; Reeve, Amy K.; Nicholls, Thomas J.; Taylor, Robert W.; Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Alston, Charlotte L.; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Reeve, Amy K.; Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Deschauer, Marcus] Tech Univ Munich, Dept Neurol, D-81675 Munich, Germany.
C3 Ulm University; Martin Luther University Halle Wittenberg; Newcastle
   University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust;
   Newcastle University - UK; Technical University of Munich
RP Vincent, AE (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Vincent, AE (corresponding author), Newcastle Univ, Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM amy.vincent@ncl.ac.uk
RI Alston, Charlotte/ABG-9602-2020; Vincent, Amy/J-7284-2019; Rocha,
   Mariana/O-4313-2017
OI Alston, Charlotte/0000-0003-2095-5464; Reeve, Amy/0000-0002-4474-2204;
   Vincent, Amy/0000-0002-0360-6644; Rosa, Hannah/0000-0003-4624-752X;
   Nicholls, Thomas/0000-0002-3034-4109
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical
   Research Council Centre for Ageing and Vitality [L016354]; Medical
   Research Council (MRC) Centre for Translational Research in
   Neuromuscular Disease Mitochondrial Disease Patient Cohort [G0800674];
   UK National Institute for Health Research Biomedical Research Centre in
   Age and Age Related Diseases; MRC/Engineering and Physical Sciences
   Research Council Molecular Pathology Node; UK NHS Specialist
   Commissioners Rare Mitochondrial Disorders of Adults and Children
   Service; European Academy of Neurology (EAN); MRC, Centre for Ageing and
   Vitality [MR/L016354/1]; National Institute for Health Research (NIHR)
   [NIHR-HCS-D12-03-04]; Parkinson's UK Fellowship [F-1401]; Wellcome Trust
   [213464/Z/18/Z]; Royal Society [213464/Z/18/Z]; Rosetrees and Stoneygate
   Trust Research Fellowship; RCUK (Gold Access funding) through MRC Centre
   for Ageing and Vitality; Lily Foundation; MRC [G0800674, MR/L016354/1]
   Funding Source: UKRI; Wellcome Trust [213464/Z/18/Z] Funding Source:
   Wellcome Trust
FX Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical
   Research Council Centre for Ageing and Vitality [L016354]; Medical
   Research Council (MRC) Centre for Translational Research in
   Neuromuscular Disease Mitochondrial Disease Patient Cohort [G0800674];
   UK National Institute for Health Research Biomedical Research Centre in
   Age and Age Related Diseases award to the Newcastle upon Tyne Hospitals
   National Health Service (NHS) Foundation Trust; MRC/Engineering and
   Physical Sciences Research Council Molecular Pathology Node; Lily
   Foundation; UK NHS Specialist Commissioners Rare Mitochondrial Disorders
   of Adults and Children Service; European Academy of Neurology (EAN) (to
   D.L.); MRC as part of the Centre for Ageing and Vitality [MR/L016354/1
   to A.E.V.]; National Institute for Health Research (NIHR) doctoral
   fellowship [NIHR-HCS-D12-03-04 to C.L.A.]. Parkinson's UK Fellowship
   [F-1401 to A.K.R.]; Sir Henry Dale Fellowship jointly funded by the
   Wellcome Trust and the Royal Society [213464/Z/18/Z to T.J.N.];
   Rosetrees and Stoneygate Trust Research Fellowship [to T.J.N]. Funding
   for open access charge: RCUK (Gold Access funding) through MRC Centre
   for Ageing and Vitality.
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Gouspillou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103044
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Kraytsberg Y, 2009, METHODS MOL BIOL, V554, P329, DOI 10.1007/978-1-59745-521-3_21
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   MULLERHOCKER J, 1983, VIRCHOWS ARCH A, V402, P61, DOI 10.1007/BF00695049
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Persson Ö, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Rygiel KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09906
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Tesarova M, 2004, NEUROPEDIATRICS, V35, P217, DOI 10.1055/s-2004-821081
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vincent AE, 2018, J PATHOL, V246, P261, DOI 10.1002/path.5146
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
NR 31
TC 11
Z9 13
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD AUG 22
PY 2019
VL 47
IS 14
BP 7430
EP 7443
DI 10.1093/nar/gkz472
PG 14
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA IU8EP
UT WOS:000483815100027
PM 31147703
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Rao, M
   Li, LJ
   Demello, C
   Guo, DQ
   Jaber, BL
   Pereira, BJG
   Balakrishnan, VS
AF Rao, Madhumathi
   Li, Lijun
   Demello, Caren
   Guo, Daqing
   Jaber, Bertrand L.
   Pereira, Brian J. G.
   Balakrishnan, Vaidyanathapurarn S.
CA Grp, HS
TI Mitochondrial DNA Injury and Mortality in Hemodialysis Patients
SO JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
LA English
DT Article
ID SKELETAL-MUSCLE; BIOGENESIS; MUTATIONS; DELETION; CELLS; METABOLISM;
   EXERCISE; DISEASES; DAMAGE; PCR
AB The role of mitochondrial injury in the pathogenesis of complications of uremia is incompletely defined, although diminished bioenergetic capacity and the accumulation of mitochondrial DNA (mtDNA) mutations have been reported. This study was undertaken to evaluate the prevalence of mtDNA injury in 180 patients who had ESRD and were enrolled into the baseline phase of the HEMO study and to relate these markers to all-cause mortality. The mitochondrial injury markers studied in peripheral blood mononuclear cells were the mtDNA copy number per cell, measured by quantitative PCR, and the presence of the mtDNA(4977) mutation. After frequency-matching healthy control subjects for age, mtDNA copy number was lower among older dialysis patients compared with older healthy subjects (P = 0.01). A one-log increase in mtDNA copy number was independently associated with a decreased hazard for mortality (adjusted hazard ratio 0.64; 95% confidence interval 0.46 to 0.89). The mtDNA(4977) deletion was present in 48 (31%) patients and was independently associated with a decreased hazard for mortality (adjusted hazard ratio 0.33; 95% confidence interval 0.19 to 0.56). In summary, the mtDNA(4977) seems to predict survival in ESRD, but a reduced mitochondrial copy number seems to predict a poor outcome. Although further exploration of these associations is needed, evaluation of mitochondrial DNA copy number and somatic mtDNA mutations may provide simple genomic biomarkers to predict clinical outcomes among patients with ESRD.
C1 [Rao, Madhumathi; Li, Lijun; Demello, Caren; Guo, Daqing; Jaber, Bertrand L.; Pereira, Brian J. G.; Balakrishnan, Vaidyanathapurarn S.; Grp, HS] Tufts New England Med Ctr Hosp, Dept Med, Div Nephrol, Boston, MA USA.
RP Rao, M (corresponding author), Tufts Univ New England Med Ctr, 35 Kneeland St, Boston, MA 02111 USA.
EM mrao@tufts-nemc.org
RI Guo, Diansheng/HSF-9039-2023
OI Guo, Dadong/0000-0002-1712-0055
FU National Institutes Of Health [DK 2819-O1A1]; Satellite Healthcare
FX This Study was supported by a grant from the National Institutes Of
   Health (DK 2819-O1A1). Additional support was provided by a grant from
   Satellite Healthcare.This Study was presented at the annual meeting of
   the American Society of Nephrology; November 2 through 5, 2007; San
   Francisco, CA.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Chabi B, 2005, MED SCI SPORT EXER, V37, P2102, DOI 10.1249/01.mss.0000177426.68149.83
   Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Greene T, 2000, CONTROL CLIN TRIALS, V21, P502, DOI 10.1016/S0197-2456(00)00062-3
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853
   Heilbronn LK, 2007, J CLIN ENDOCR METAB, V92, P1467, DOI 10.1210/jc.2006-2210
   Hood DA, 2007, NUTR METAB CARDIOVAS, V17, P332, DOI 10.1016/j.numecd.2007.02.009
   Jin SK, 2006, AUTOPHAGY, V2, P80, DOI 10.4161/auto.2.2.2460
   Kalantar-Zadeh K, 2005, SEMIN DIALYSIS, V18, P365, DOI 10.1111/j.1525-139X.2005.00074.x
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Lai LP, 2003, CHEST, V123, P539, DOI 10.1378/chest.123.2.539
   Lim PS, 2002, J BIOMED SCI, V9, P549, DOI 10.1159/000064728
   Liu CS, 2001, NEPHROL DIAL TRANSPL, V16, P561, DOI 10.1093/ndt/16.3.561
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Miskulin DC, 2001, KIDNEY INT, V60, P1498, DOI 10.1046/j.1523-1755.2001.00954.x
   Mohamed SA, 2004, EXP GERONTOL, V39, P181, DOI 10.1016/j.exger.2003.10.011
   Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   POUTSIAKA DD, 1991, BLOOD, V78, P1275
   Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200
   Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003
   Rötig A, 2003, J AM SOC NEPHROL, V14, P2995, DOI 10.1097/01.ASN.0000095481.24091.C9
   THOMPSON CH, 1993, NEPHROL DIAL TRANSPL, V8, P218
   Ukropcova B, 2007, DIABETES, V56, P720, DOI 10.2337/db06-0521
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
NR 33
TC 56
Z9 63
U1 0
U2 1
PU AMER SOC NEPHROLOGY
PI WASHINGTON
PA 1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA
SN 1046-6673
EI 1533-3450
J9 J AM SOC NEPHROL
JI J. Am. Soc. Nephrol.
PD JAN
PY 2009
VL 20
IS 1
BP 189
EP 196
DI 10.1681/ASN.2007091031
PG 8
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA 397QM
UT WOS:000262677200026
PM 18684894
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Seed, LM
   Dean, A
   Krishnakumar, D
   Phyu, P
   Horvath, R
   Harijan, PD
AF Seed, Lydia M.
   Dean, Andrew
   Krishnakumar, Deepa
   Phyu, Poe
   Horvath, Rita
   Harijan, Pooja Devi
TI Molecular and neurological features of MELAS syndrome in paediatric
   patients: A case series and review of the literature
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Review
DE encephalopathy; genetics; lactic acidosis; m.3243A > G; MELAS syndrome;
   mitochondrial disease; paediatric neurology; stroke-like episodes
ID STROKE-LIKE EPISODES; TRANSFER RNALEU(UUR) GENE; LACTIC-ACIDOSIS;
   MITOCHONDRIAL-DNA; MUTATION; ENCEPHALOMYOPATHY; ENCEPHALOPATHY;
   MYOPATHY; DISEASES; A3243G
AB Background: Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome is one of the most well-known mitochondrial diseases, with most cases attributed to m.3243A>G. MELAS syndrome patients typically present in the first two decades of life with a broad, multi-systemic phenotype that predominantly features neurological manifestations--stroke-like episodes. However, marked phenotypic variability has been observed among paediatric patients, creating a clinical challenge and delaying diagnoses.
   Methods: A literature review of paediatric MELAS syndrome patients and a retrospective analysis in a UK tertiary paediatric neurology centre were performed.
   Results: Three children were included in this case series. All patients presented with seizures and had MRI changes not confined to a single vascular territory. Blood heteroplasmy varied considerably, and one patient required a muscle biopsy. Based on a literature review of 114 patients, the mean age of presentation is 8.1 years and seizures are the most prevalent manifestation of stroke-like episodes. Heteroplasmy is higher in a tissue other than blood in most cases.
   Conclusion: The threshold for investigating MELAS syndrome in children with suspicious neurological symptoms should be low. If blood m.3243A>G analysis is negative, yet clinical suspicion remains high, invasive testing or further interrogation of the mitochondrial genome should be considered.
C1 [Seed, Lydia M.] Univ Cambridge, Sch Clin Med, Cambridge, England.
   [Dean, Andrew; Horvath, Rita] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
   [Dean, Andrew] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England.
   [Krishnakumar, Deepa; Harijan, Pooja Devi] Cambridge Univ Hosp NHS Fdn Trust, Dept Paediat Neurosci, Cambridge, England.
   [Phyu, Poe] Cambridge Univ Hosp NHS Fdn Trust, Dept Clin Neuroradiol, Cambridge, England.
C3 University of Cambridge; University of Cambridge; University of
   Cambridge; University of Cambridge; University of Cambridge
RP Harijan, PD (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Dept Paediat Neurosci, Cambridge, England.
EM pooja.harijan@addenbrookes.nhs.uk
OI Seed, Lydia/0000-0001-9405-3688
FU Medical Research Council (UK) [109,915/Z/15/Z]; European Research
   Council [MR/N025431/1, MR/V009346/1]; Newton Fund (UK/Turkey) [309548];
   Addenbrookes Charitable Trust [MR/N027302/1]; Evelyn Trust [G100142];
   Stoneygate Trust; Lily Foundation [MR/S005021/1]; NIHR Cambridge
   Biomedical Research Centre; Department of Health and Social Care
   [BRC-1215-20,014]
FX y R.H. is a Wellcome Trust Investigator (109,915/Z/15/Z), who receives
   support from the Medical Research Council (UK) (MR/N025431/1 and
   MR/V009346/1), the European Research Council (309548), the Newton Fund
   (UK/Turkey, MR/N027302/1), the Addenbrookes Charitable Trust (G100142),
   the Evelyn Trust, the Stoneygate Trust, the Lily Foundation and an MRC
   strategic award to establish an International Centre for Genomic
   Medicine in Neuromuscular Diseases (ICGNMD) MR/S005021/1. This research
   was supported by the NIHR Cambridge Biomedical Research Centre
   (BRC-1215-20,014). The views expressed are those of the authors and not
   necessarily those of the NIHR or the Department of Health and Social
   Care
CR Alcubilla-Prats P, 2017, MED CLIN-BARCELONA, V148, P357, DOI [10.1016/j.medcle.2017.04.002, 10.1016/j.medcli.2017.01.029]
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   [Anonymous], 2008, MITOMAP: A Human Mitochondrial Genome Database
   Bhatia KD, 2020, AM J NEURORADIOL, V41, P167, DOI 10.3174/ajnr.A6325
   Brisca G, 2015, BIOCHEM BIOPH RES CO, V458, P601, DOI 10.1016/j.bbrc.2015.01.157
   Calvaruso MA, 2011, MITOCHONDRION, V11, P778, DOI 10.1016/j.mito.2011.06.004
   Chakrabarty S., 2021, J NEUROL, V1, P3
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Emmanuele V, 2013, J CHILD NEUROL, V28, P236, DOI 10.1177/0883073812445787
   FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8
   Fujii A, 2004, INTERNAL MED, V43, P1126, DOI 10.2169/internalmedicine.43.1126
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0227-x
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Karvonen SL, 1999, BRIT J DERMATOL, V140, P634
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kraya T, 2019, MITOCHONDRION, V44, P53, DOI 10.1016/j.mito.2017.12.012
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153
   Li C, 2021, MITOCHONDRION, V58, P131, DOI 10.1016/j.mito.2021.02.015
   Longo N, 2008, AM J MED GENET A, V146A, P361, DOI 10.1002/ajmg.a.31841
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   McKusick-Nathans Institute of Genetic Medicine, 2022, ONLINE MENDELIAN INH
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   Muñoz MF, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00059
   Ng Yi Shiau, 2019, Wellcome Open Res, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Niu FN, 2017, CNS NEUROSCI THER, V23, P686, DOI 10.1111/cns.12714
   Ohno K, 1997, NEURORADIOLOGY, V39, P781, DOI 10.1007/s002340050505
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Phadke R, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070064
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Sharma R, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136055
   Sotiriou E, 2009, NEUROMUSCULAR DISORD, V19, P297, DOI 10.1016/j.nmd.2009.01.014
   Sproule D M, 2008, J Inherit Metab Dis, V31 Suppl 3, P497, DOI 10.1007/s10545-007-0735-3
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Stenqvist L, 2005, PEDIATR RES, V58, P258, DOI 10.1203/01.PDR.0000169966.82325.1A
   Uittenbogaard M, 2019, MOL GENET METAB, V126, P429, DOI 10.1016/j.ymgme.2019.01.022
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yorifuji T, 1996, J MED GENET, V33, P621, DOI 10.1136/jmg.33.7.621
NR 53
TC 7
Z9 7
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD JUL
PY 2022
VL 10
IS 7
AR e1955
DI 10.1002/mgg3.1955
EA APR 2022
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 2S7HT
UT WOS:000787570800001
PM 35474314
OA Green Published
DA 2024-11-01
ER

PT J
AU Sarzi, E
   Brown, MD
   Lebon, S
   Chretien, D
   Munnich, A
   Rotig, A
   Procaccio, V
AF Sarzi, Emmanuelle
   Brown, Michael D.
   Lebon, Sophie
   Chretien, Dominique
   Munnich, Arnold
   Rotig, Agnes
   Procaccio, Vincent
TI A novel recurrent mitochondrial DNA mutation in <i>ND3</i> gene is
   associated with isolated complex I deficiency causing Leigh syndrome and
   dystonia
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE Leigh syndrome; dystonia; complex I; mitochondrial genome; mtDNA; ND3
ID MISSENSE MUTATION; UBIQUINONE OXIDOREDUCTASE; HEART-MITOCHONDRIA;
   G13513A MUTATION; POINT MUTATION; HUMAN MTDNA; DISEASE; NADH; MELAS;
   STRATEGY
AB Defects in NADH:ubiquinone oxidoreductase (complex I), the largest complex of the mitochondrial respiratory chain, account for most cases of respiratory chain deficiency in human. Complex I contains at least 45 subunits, 7 of which are encoded by mitochondrial DNA (mtDNA). Here we report a novel 10197G > A mutation of the ND3 gene in three unrelated families with Leigh syndrome (LS) or dystonia. Variable degrees of heteroplasmy were found in all tissues tested and a high percentage of mutant mtDNA was observed in muscle. The 10197G > A mutation modifies a hydrophobic alanine residue into a hydrophilic threonine (A47T) in a highly conserved domain of ND3 subunit. Furthermore, this defect could be transferred along with the mutant mtDNAs to rho degrees lymphoblastoid cells in cybrid experiments. However, nuclear modifier genes may also play a role in the phenotypic expression and severity of 10197G > A mutation. The association of the 10197G > A ND3 mutation with an isolated biochemical defect involving complex I and the discovery of the 10197G > A mutation with a similar phenotype in three unrelated families establish its pathogenicity and demonstrate that the amino acid position A47 is important for the function of complex I. These results show that the 10197G > A mutation in the mitochondrial ND3 gene should be considered as a common mtDNA mutation responsible for LS and dystonia. (c) 2006 Wiley-Liss, Inc.
C1 Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.
   Hop Necker Enfants Malad, INSERM, Dept Genet, U781, F-75730 Paris, France.
   Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA.
   Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.
C3 University of California System; University of California Irvine;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Mercer University;
   University of California System; University of California Irvine
RP Procaccio, V (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.
EM vproca@uci.edu
RI Procaccio, Vincent/M-2596-2015; ROTIG, AGNES/G-9592-2017
OI Lebon, Sophie/0000-0003-0039-5519; procaccio,
   Vincent/0000-0002-1537-4684; ROTIG, AGNES/0000-0003-0589-0703;
   Dominique, Chretien/0000-0002-9954-1549; Sarzi,
   Emmanuelle/0000-0002-7623-6699
FU NIA NIH HHS [AG24373] Funding Source: Medline; NINDS NIH HHS [NS41850,
   R01 NS21328] Funding Source: Medline
CR Alves PC, 1998, BIOCHEM CELL BIOL, V76, P139, DOI 10.1139/bcb-76-1-139
   Bannwarth S, 2005, HUM MUTAT, V25, P575, DOI 10.1002/humu.20177
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   BRINK J, 1987, EUR J BIOCHEM, V166, P287, DOI 10.1111/j.1432-1033.1987.tb13513.x
   Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Fischel-Ghodsian N, 2004, MITOCHONDRION, V4, P675, DOI 10.1016/j.mito.2004.07.040
   Gigarel N, 2005, MOL GENET METAB, V84, P289, DOI 10.1016/j.ymgme.2004.10.008
   Guénebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518
   Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Malgat Monique, 1995, Journal of Biological Systems, V3, P165, DOI 10.1142/S0218339095000162
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rubio-Gozalbo ME, 2000, NEUROPEDIATRICS, V31, P114, DOI 10.1055/s-2000-7491
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SHOFFNER JM, 1995, ANN NEUROL, V38, P163, DOI 10.1002/ana.410380207
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957
   WALLACE DC, 2006, IN PRESS EMERY RIMOI
NR 37
TC 85
Z9 99
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD JAN 1
PY 2007
VL 143A
IS 1
BP 33
EP 41
DI 10.1002/ajmg.a.31565
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 124GY
UT WOS:000243357500004
PM 17152068
OA Bronze
DA 2024-11-01
ER

PT J
AU Oláhová, M
   Peter, B
   Szilagyi, Z
   Diaz-Maldonado, H
   Singh, M
   Sommerville, EW
   Blakely, EL
   Collier, JJ
   Hoberg, E
   Stránecky, V
   Hartmannová, H
   Bleyer, AJ
   McBride, KL
   Bowden, SA
   Korandová, Z
   Pecinová, A
   Ropers, HH
   Kahrizi, K
   Najmabadi, H
   Tarnopolsky, MA
   Brady, LI
   Weaver, KN
   Prada, CE
   Ounap, K
   Wojcik, MH
   Pajusalu, S
   Syeda, SB
   Pais, L
   Estrella, EA
   Bruels, CC
   Kunkel, LM
   Kang, PB
   Bonnen, PE
   Mrácek, T
   Kmoch, S
   Gorman, GS
   Falkenberg, M
   Gustafsson, CM
   Taylor, RW
AF Olahova, Monika
   Peter, Bradley
   Szilagyi, Zsolt
   Diaz-Maldonado, Hector
   Singh, Meenakshi
   Sommerville, Ewen W.
   Blakely, Emma L.
   Collier, Jack J.
   Hoberg, Emily
   Stranecky, Viktor
   Hartmannova, Hana
   Bleyer, Anthony J.
   McBride, Kim L.
   Bowden, Sasigarn A.
   Korandova, Zuzana
   Pecinova, Alena
   Ropers, Hans-Hilger
   Kahrizi, Kimia
   Najmabadi, Hossein
   Tarnopolsky, Mark A.
   Brady, Lauren I.
   Weaver, K. Nicole
   Prada, Carlos E.
   Ounap, Katrin
   Wojcik, Monica H.
   Pajusalu, Sander
   Syeda, Safoora B.
   Pais, Lynn
   Estrella, Elicia A.
   Bruels, Christine C.
   Kunkel, Louis M.
   Kang, Peter B.
   Bonnen, Penelope E.
   Mracek, Tomas
   Kmoch, Stanislav
   Gorman, Grainne S.
   Falkenberg, Maria
   Gustafsson, Claes M.
   Taylor, Robert W.
TI <i>POLRMT</i> mutations impair mitochondrial transcription causing
   neurological disease
SO NATURE COMMUNICATIONS
LA English
DT Article
ID RNA-POLYMERASE; STRUCTURAL BASIS; DNA; REPLICATION; MAINTENANCE;
   DELETIONS
AB While >300 disease-causing variants have been identified in the mitochondrial DNA (mtDNA) polymerase gamma, no mitochondrial phenotypes have been associated with POLRMT, the RNA polymerase responsible for transcription of the mitochondrial genome. Here, we characterise the clinical and molecular nature of POLRMT variants in eight individuals from seven unrelated families. Patients present with global developmental delay, hypotonia, short stature, and speech/intellectual disability in childhood; one subject displayed an indolent progressive external ophthalmoplegia phenotype. Massive parallel sequencing of all subjects identifies recessive and dominant variants in the POLRMT gene. Patient fibroblasts have a defect in mitochondrial mRNA synthesis, but no mtDNA deletions or copy number abnormalities. The in vitro characterisation of the recombinant POLRMT mutants reveals variable, but deleterious effects on mitochondrial transcription. Together, our in vivo and in vitro functional studies of POLRMT variants establish defective mitochondrial transcription as an important disease mechanism. POLRMT is key for transcription of the mitochondrial genome, yet has not been implicated in mitochondrial disease to date. Here, the authors identify mutations in POLRMT in individuals with mitochondrial disease-related phenotypes and characterise underlying defects in mitochondrial transcription.
C1 [Olahova, Monika; Sommerville, Ewen W.; Blakely, Emma L.; Collier, Jack J.; Gorman, Grainne S.; Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Peter, Bradley; Szilagyi, Zsolt; Diaz-Maldonado, Hector; Singh, Meenakshi; Hoberg, Emily; Falkenberg, Maria; Gustafsson, Claes M.] Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
   [Stranecky, Viktor; Hartmannova, Hana; Bleyer, Anthony J.; Korandova, Zuzana; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Res Unit Rare Dis, Prague 12000, Czech Republic.
   [Bleyer, Anthony J.] Wake Forest Sch Med, Sect Nephrol, Winston Salem, NC 27101 USA.
   [McBride, Kim L.] Ohio State Univ, Nationwide Childrens Hosp, Dept Pediat, Ctr Cardiovasc & Pulm Res,Coll Med, Columbus, OH 43210 USA.
   [Bowden, Sasigarn A.] Ohio State Univ, Nationwide Childrens Hosp, Div Endocrinol, Coll Med, Columbus, OH 43210 USA.
   [Korandova, Zuzana; Pecinova, Alena; Mracek, Tomas] Czech Acad Sci, Inst Physiol, Dept Bioenerget, Prague, Czech Republic.
   [Ropers, Hans-Hilger] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany.
   [Ropers, Hans-Hilger] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Human Genet, Mainz, Germany.
   [McBride, Kim L.; Bowden, Sasigarn A.; Kahrizi, Kimia; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran.
   [Tarnopolsky, Mark A.; Brady, Lauren I.] McMaster Univ, Div Neuromuscular & Neurometab Dis, Dept Pediat & Med, Childrens Hosp, Hamilton, ON, Canada.
   [Weaver, K. Nicole; Prada, Carlos E.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.
   [Weaver, K. Nicole; Prada, Carlos E.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.
   [Prada, Carlos E.] Cardiovasc Fdn Colombia, Dept Pediat, Floridablanca, Colombia.
   [Ounap, Katrin; Pajusalu, Sander] Tartu Univ Hosp, Dept Clin Genet, United Labs, Tartu, Estonia.
   [Ounap, Katrin; Pajusalu, Sander] Univ Tartu, Inst Clin Med, Dept Clin Genet, Tartu, Estonia.
   [Ounap, Katrin; Wojcik, Monica H.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Wojcik, Monica H.] Boston Childrens Hosp, Dept Pediat, Div Newborn Med & Genet, Boston, MA USA.
   [Wojcik, Monica H.] Boston Childrens Hosp, Dept Pediat, Div Genom, Boston, MA USA.
   [Pajusalu, Sander] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.
   [Syeda, Safoora B.; Bruels, Christine C.; Kang, Peter B.] Univ Florida, Coll Med, Dept Pediat, Div Pediat Neurol, Gainesville, FL USA.
   [Pais, Lynn] Broad Inst MIT & Harvard, Ctr Mendelian Genom, Cambridge, MA 02142 USA.
   [Estrella, Elicia A.; Kunkel, Louis M.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA.
   [Kunkel, Louis M.] Harvard Med Sch, Boston, MA 02115 USA.
   [Kang, Peter B.] Univ Florida, Dept Mol Genet & Microbiol, Coll Med, Gainesville, FL USA.
   [Kang, Peter B.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL USA.
   [Kang, Peter B.] Univ Florida, Genet Inst, Gainesville, FL USA.
   [Kang, Peter B.] Univ Florida, Myol Inst, Gainesville, FL USA.
   [Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Newcastle University - UK; University of Gothenburg; Charles University
   Prague; Wake Forest University; University System of Ohio; Ohio State
   University; Nationwide Childrens Hospital; Research Institute at
   Nationwide Children's Hospital; University System of Ohio; Ohio State
   University; Nationwide Childrens Hospital; Czech Academy of Sciences;
   Institute of Physiology of the Czech Academy of Sciences; Max Planck
   Society; Johannes Gutenberg University of Mainz; McMaster University;
   Cincinnati Children's Hospital Medical Center; University System of
   Ohio; University of Cincinnati; University of Tartu; Harvard University;
   Massachusetts Institute of Technology (MIT); Broad Institute; Harvard
   University; Boston Children's Hospital; Harvard University; Boston
   Children's Hospital; Yale University; State University System of
   Florida; University of Florida; Harvard University; Massachusetts
   Institute of Technology (MIT); Broad Institute; Harvard University;
   Boston Children's Hospital; Harvard University; Harvard Medical School;
   State University System of Florida; University of Florida; State
   University System of Florida; University of Florida; State University
   System of Florida; University of Florida; State University System of
   Florida; University of Florida; Baylor College of Medicine
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Gustafsson, CM (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
EM claes.gustafsson@medkem.gu.se; robert.taylor@ncl.ac.uk
RI Stranecky, Viktor/I-8524-2017; Najmabadi, Hossein/P-8182-2017; Ounap,
   Katrin/HOA-6000-2023; Pajusalu, Sander/HDO-6793-2022; Hartmannova,
   Hana/H-4735-2017; Singh, Meenakshi/AAD-7144-2022; Pajusalu,
   Sander/H-6119-2018; Kang, Peter/HKF-7815-2023; Korandova,
   Zuzana/AAF-9513-2021; Mracek, Tomas/C-5003-2012; Pecinova,
   Alena/A-8695-2010; Bowden, Sasigarn/J-7465-2013; OUNAP,
   KATRIN/Q-1103-2016
OI Falkenberg, Maria/0000-0001-8713-173X; Najmabadi,
   Hossein/0000-0002-6084-7778; Olahova, Monika/0000-0002-4082-3875;
   Pajusalu, Sander/0000-0002-5435-0781; Bruels, Christine
   C./0000-0001-8366-3691; Kang, Peter/0000-0002-4270-7325; Korandova,
   Zuzana/0000-0001-8143-3681; Mracek, Tomas/0000-0002-9492-0718; Pecinova,
   Alena/0000-0002-0204-7502; Diaz Maldonado, Hector/0000-0001-8473-4164;
   Bowden, Sasigarn/0000-0001-6917-5333; OUNAP, KATRIN/0000-0002-4594-6364;
   Gustafsson, Claes/0000-0003-3531-8468
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z];
   Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation;
   UK NIHR Biomedical Research Centre for Ageing and Age-related disease
   award; MRC/EPSRC Molecular Pathology Node; Medical Research Council
   (MRC); Swedish Research Council [2013-3621, 2012-2583]; Swedish Cancer
   Foundation [2013-3621, 2012-2583]; Knut and Alice Wallenberg foundation;
   Swedish government; county councils [ALFGBG-727491, ALFGBG-728151];
   Ministry of Health of the Czech Republic [NV19-07-00136]; Charles
   University [UNCE/MED/007, GA UK 772119]; Ministry of Education, Youth
   and Sports of the Czech Republic [LQ1604 NPU II]; National Center for
   Medical Genomics [LM2018132]; National Heart, Lung, and Blood Institute
   under the Trans-Omics for Precision Medicine (TOPMed) program; National
   Eye Institute; NIH [R01 NS080929]; Children's Miracle Network; National
   Human Genome Research Institute; National Heart, Lung and Blood
   Institute [NIH UM1 HG008900]; NIH NINDS [RO1 NS08372];  [RVO:67985823]; 
   [T32GM007748]
FX R.W.T. is supported by the Wellcome Centre for Mitochondrial Research
   (203105/Z/16/Z), Mitochondrial Disease Patient Cohort (UK) (G0800674),
   the Lily Foundation, the UK NIHR Biomedical Research Centre for Ageing
   and Age-related disease award to the Newcastle upon Tyne Foundation
   Hospitals NHS Trust, the MRC/EPSRC Molecular Pathology Node and the UK
   NHS Highly Specialised Service for Rare Mitochondrial Disorders of
   Adults and Children. E.W.S. was in receipt of a Medical Research Council
   (MRC) PhD studentship. C.M.G. and M.F. are supported by the Swedish
   Research Council (2013-3621 to M.F., 2012-2583 to C.M.G.), Swedish
   Cancer Foundation, the Knut and Alice Wallenberg foundation and grants
   from the Swedish state under the agreement between the Swedish
   government and the county councils, the ALF agreement to M.F.
   (ALFGBG-727491) and C.M.G. (ALFGBG-728151). S.K. was supported by the
   grant NV19-07-00136 from the Ministry of Health of the Czech Republic,
   acknowledge institutional program UNCE/MED/007 of the Charles
   University, the project LQ1604 NPU II from the Ministry of Education,
   Youth and Sports of the Czech Republic, and thanks to The National
   Center for Medical Genomics (LM2018132) for instrumental and
   methodologic support with the WES analyses. T.M. was supported by the
   grant NV19-07-00149 from the Ministry of Health of the Czech Republic
   and RVO:67985823 (to Institute of Physiology CAS); Z.K. was in receipt
   of Charles University PhD project GA UK 772119. K.O. and S.P. were
   supported by the Estonian Research Council grants PRG471 and PUTJD827.
   The Broad Center for Mendelian Genomics (UM1 HG008900) is funded by the
   National Human Genome Research Institute with supplemental funding
   provided by the National Heart, Lung, and Blood Institute under the
   Trans-Omics for Precision Medicine (TOPMed) program and the National Eye
   Institute. M.H.W. is supported by T32GM007748. P.B.K. is supported by
   NIH R01 NS080929 and the Children's Miracle Network. Exome sequencing
   and analysis were provided by the Broad Institute of Harvard and MIT
   Center for Mendelian Genomics (Broad CMG) and was funded by the National
   Human Genome Research Institute, the National Eye Institute, and the
   National Heart, Lung and Blood Institute grant NIH UM1 HG008900 to
   Daniel MacArthur and Heidi Rehm. We thank Daniel MacArthur and Anne
   O'Donnell-Luria at the Center for Mendelian Genetics of the Broad
   Institute for their contributions to exome sequencing and analysis.
   P.E.B. is supported by NIH NINDS RO1 NS08372. We thank Doug Turnbull and
   Andrew Schaefer for their long-term support and care of patient 3
   described in this manuscript and Laura Bone for technical support. We
   would like to thank Dan Wright and family and Warren Lammert and Kathy
   Corkins for donations to the McMaster Neuromuscular Clinic which has
   supported the care of patient 2 described in this manuscript.
CR Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Bowden SA, 2013, CASE REP PEDIAT, V2013, DOI 10.1155/2013/354314
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Farge G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112770
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hillen HS, 2018, NAT STRUCT MOL BIOL, V25, P754, DOI 10.1038/s41594-018-0122-9
   Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036
   Hillen HS, 2017, CELL, V171, P1082, DOI 10.1016/j.cell.2017.09.035
   HOLT IJ, 1988, LANCET, V1, P1462
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848
   Kühl I, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600963
   Kühl I, 2014, NATURE, V514, pE7, DOI 10.1038/nature13690
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Oliveira R, 2017, JIMD REP, V33, P61, DOI 10.1007/8904_2016_581
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Park CB, 2018, BIOCHEM BIOPH RES CO, V507, P148, DOI 10.1016/j.bbrc.2018.10.194
   Peter B, 2018, HUM MOL GENET, V27, P1743, DOI 10.1093/hmg/ddy080
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Posse V, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007781
   Posse V, 2015, NUCLEIC ACIDS RES, V43, P2615, DOI 10.1093/nar/gkv105
   Posse V, 2014, NUCLEIC ACIDS RES, V42, P3638, DOI 10.1093/nar/gkt1397
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rajala N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116726
   Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003
   Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435
   Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683
   Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
NR 39
TC 26
Z9 28
U1 0
U2 22
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 18
PY 2021
VL 12
IS 1
AR 1135
DI 10.1038/s41467-021-21279-0
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA QL9UT
UT WOS:000621426600002
PM 33602924
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Ueda, S
   Yagi, M
   Tomoda, E
   Matsumoto, S
   Ueyanagi, Y
   Do, Y
   Setoyama, D
   Matsushima, Y
   Nagao, A
   Suzuki, T
   Ide, T
   Mori, Y
   Oyama, N
   Kang, D
   Uchiumi, T
AF Ueda, Saori
   Yagi, Mikako
   Tomoda, Ena
   Matsumoto, Shinya
   Ueyanagi, Yasushi
   Do, Yura
   Setoyama, Daiki
   Matsushima, Yuichi
   Nagao, Asuteka
   Suzuki, Tsutomu
   Ide, Tomomi
   Mori, Yusuke
   Oyama, Noriko
   Kang, Dongchon
   Uchiumi, Takeshi
TI Mitochondrial haplotype mutation alleviates respiratory defect of MELAS
   by restoring taurine modification in tRNA with 3243A > G mutation
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID WOBBLE MODIFICATION DEFICIENCY; ATP SYNTHASE; TRANSCRIPTION TERMINATION;
   PROTEIN-SYNTHESIS; LACTIC-ACIDOSIS; BIOGENESIS; MYOPATHY; PATIENT;
   CELLS; MTDNA
AB The 3243A > G in mtDNA is a representative mutation in mitochondrial diseases. Mitochondrial protein synthesis is impaired due to decoding disorder caused by severe reduction of 5-taurinomethyluridine (& tau;m(5)U) modification of the mutant mt-tRNA(Leu(UUR)) bearing 3243A > G mutation. The 3243A > G heteroplasmy in peripheral blood reportedly decreases exponentially with age. Here, we found three cases with mild respiratory symptoms despite bearing high rate of 3243A > G mutation (>90%) in blood mtDNA. These patients had the 3290T > C haplotypic mutation in addition to 3243A > G pathogenic mutation in mt-tRNA(Leu(UUR)) gene. We generated cybrid cells of these cases to examine the effects of the 3290T > C mutation on mitochondrial function and found that 3290T > C mutation improved mitochondrial translation, formation of respiratory chain complex, and oxygen consumption rate of pathogenic cells associated with 3243A > G mutation. We measured & tau;m(5)U frequency of mt-tRNA(Leu(UUR)) with 3243A > G mutation in the cybrids by a primer extension method assisted with chemical derivatization of & tau;m(5)U, showing that hypomodification of & tau;m(5)U was significantly restored by the 3290T > C haplotypic mutation. We concluded that the 3290T > C is a haplotypic mutation that suppresses respiratory deficiency of mitochondrial disease by restoring hypomodified & tau;m(5)U in mt-tRNA(Leu(UUR)) with 3243A > G mutation, implying a potential therapeutic measure for mitochondrial disease associated with pathogenic mutations in mt-tRNAs.
C1 [Ueda, Saori; Yagi, Mikako; Matsumoto, Shinya; Ueyanagi, Yasushi; Do, Yura; Setoyama, Daiki; Matsushima, Yuichi; Kang, Dongchon; Uchiumi, Takeshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, 3-1-1 Maidashi,Higashi ku, Fukuoka 8128582, Japan.
   [Yagi, Mikako; Uchiumi, Takeshi] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, 3-1-1 Maidashi,Higashi ku, Fukuoka 8128582, Japan.
   [Tomoda, Ena; Nagao, Asuteka; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, 7-3-1 Hongo,Bunkyo ku, Tokyo 1138656, Japan.
   [Matsushima, Yuichi] Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama, Toyonaka 5600043, Japan.
   [Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, 3-1-1 Maidashi,Higashi ku, Fukuoka 8128582, Japan.
   [Mori, Yusuke] Kitakyushu City Yahata Hosp, Dept Internal Med, 2-6-2 Ogura,Yahatahigashi ku, Kitakyushu 8058534, Japan.
   [Oyama, Noriko] Fukuoka Childrens Hosp, Dept Endocrinol & Metab, 5-1-1 Kashiiteriha,Higashi ku, Fukuoka 8130017, Japan.
C3 Kyushu University; Kyushu University; University of Tokyo; Osaka
   University; Kyushu University
RP Uchiumi, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, 3-1-1 Maidashi,Higashi ku, Fukuoka 8128582, Japan.; Uchiumi, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, 3-1-1 Maidashi,Higashi ku, Fukuoka 8128582, Japan.
EM uchiumi.takeshi.008@m.med.kyushu-u.ac.jp
RI ; Suzuki, Tsutomu/J-1776-2015
OI Nagao, Asuteka/0000-0002-9152-1527; Matsumoto,
   Shinya/0000-0001-5166-9036; Suzuki, Tsutomu/0000-0002-9731-1731;
   Uchiumi, Takeshi/0000-0002-3665-233X
CR Amornvit Jakkrit, 2014, Journal of the Medical Association of Thailand, V97, P467
   Asano K, 2018, NUCLEIC ACIDS RES, V46, P1565, DOI 10.1093/nar/gky068
   Bakare AB, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126263
   Brunner V, 2016, BIOTECHNOL BIOENG, V113, P2394, DOI 10.1002/bit.26003
   Chang K. C., 2002, Hong Kong Medical Journal, V8, P137
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chomyn A, 1996, Methods Enzymol, V264, P334, DOI 10.1016/S0076-6879(96)64031-2
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109
   Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   El Meziane A, 1998, NAT GENET, V18, P350
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Holman KM, 2017, RNA, V23, P1685, DOI 10.1261/rna.061069.117
   Janssen GMC, 1999, J BIOL CHEM, V274, P29744, DOI 10.1074/jbc.274.42.29744
   KAMAKURA K, 1995, J NEUROL, V242, P253, DOI 10.1007/BF00919602
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   Kunz TC, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00617
   Lavie L, 2003, J MOL NEUROSCI, V21, P57, DOI 10.1385/JMN:21:1:57
   Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002
   Lin H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04250-4
   Liu GL, 2020, J NEUROL SCI, V408, DOI 10.1016/j.jns.2019.116562
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072
   Momiyama Y, 1999, JPN CIRC J, V63, P130, DOI 10.1253/jcj.63.130
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   Nijtmans LGJ, 1995, BBA-MOL BASIS DIS, V1272, P190, DOI 10.1016/0925-4439(95)00087-9
   Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013
   Pan XL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00780
   Pascucci B, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22137123
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Saito T, 2017, CARDIOVASC RES, V113, P1173, DOI 10.1093/cvr/cvx095
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Setoyama D, 2022, J CACHEXIA SARCOPENI, V13, P355, DOI 10.1002/jcsm.12889
   Sharma R, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136055
   Signes A, 2018, ESSAYS BIOCHEM, V62, P255, DOI 10.1042/EBC20170098
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Suzuki T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18068-6
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Suzuki Y, 2004, DIABETES RES CLIN PR, V63, P225, DOI 10.1016/j.diabres.2003.10.024
   Tomoda E, 2023, NUCLEIC ACIDS RES, V51, P7563, DOI 10.1093/nar/gkad139
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014
   VARSHNEY U, 1991, J BIOL CHEM, V266, P24712
   Veeresh P, 2019, ANN NY ACAD SCI, V1457, P41, DOI 10.1111/nyas.14212
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
   Worley B, 2016, CURR METABOL, V4, P97, DOI 10.2174/2213235X04666160613122429
   Yagi M, 2021, EMBO J, V40, DOI 10.15252/embj.2020105268
   Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774
   Yang CC, 1998, J FORMOS MED ASSOC, V97, P715
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zhu HY, 2009, CLIN CHIM ACTA, V410, P64, DOI 10.1016/j.cca.2009.09.023
NR 69
TC 1
Z9 1
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD AUG 11
PY 2023
VL 51
IS 14
BP 7480
EP 7495
DI 10.1093/nar/gkad591
EA JUL 2023
PG 16
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA O5OX4
UT WOS:001024276700001
PM 37439353
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Masser, DR
   Clark, NW
   Van Remmen, H
   Freeman, WM
AF Masser, Dustin R.
   Clark, Nicholas W.
   Van Remmen, Holly
   Freeman, Willard M.
TI Loss of the antioxidant enzyme CuZnSOD (<i>Sod1</i>) mimics an
   age-related increase in absolute mitochondrial DNA copy number in the
   skeletal muscle
SO AGE
LA English
DT Article
DE Mitochondria; Digital PCR; mtDNA; mtDNA copy number; Aging; Sod1;
   Synaptosomes
ID DROPLET DIGITAL PCR; OXIDATIVE STRESS; QUANTITATIVE PCR; TRANSCRIPTION;
   DYSFUNCTION; DISEASE; MTDNA; MUTATIONS; DELETION; DISTINCT
AB Mitochondria contain multiple copies of the circular mitochondrial genome (mtDNA) that encodes ribosomal RNAs and proteins locally translated for oxidative phosphorylation. Loss of mtDNA integrity, both altered copy number and increased mutations, is implicated in cellular dysfunction with aging. Published data on mtDNA copy number and aging is discordant which may be due to methodological limitations for quantifying mtDNA copy number. Existing quantitative PCR (qPCR) mtDNA copy number quantification methods provide only relative abundances and are problematic to normalize to different template input amounts and across tissues/sample types. As well, existing methods cannot quantify mtDNA copy number in subcellular isolates, such as isolated mitochondria and neuronal synaptic terminals, which lack nuclear genomic DNA for normalization. We have developed and validated a novel absolute mtDNA copy number quantitation method that uses chip-based digital polymerase chain reaction (dPCR) to count the number of copies of mtDNA and used this novel method to assess the literature discrepancy in which there is no clear consensus whether mtDNA numbers change with aging in skeletal muscle. Skeletal muscle in old mice was found to have increased absolute mtDNA numbers compared to young controls. Furthermore, young Sod1 (-/-) mice were assessed and show an age-mimicking increase in skeletal muscle mtDNA. These findings reproduce a number of previous studies that demonstrate age-related increases in mtDNA. This simple and cost effective dPCR approach should enable precise and accurate mtDNA copy number quantitation in mitochondrial studies, eliminating contradictory studies of mitochondrial DNA content with aging.
C1 [Masser, Dustin R.; Clark, Nicholas W.; Freeman, Willard M.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.
   [Masser, Dustin R.; Freeman, Willard M.] Univ Oklahoma, Dept Geriatr Med, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.
   [Masser, Dustin R.; Freeman, Willard M.] Univ Oklahoma, Harold Hamm Diabet Ctr, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.
   [Masser, Dustin R.; Van Remmen, Holly; Freeman, Willard M.] Oklahoma Nathan Shock Ctr Aging, Oklahoma City, OK 73104 USA.
   [Van Remmen, Holly] Oklahoma Med Res Fdn, Oklahoma City, OK 73102 USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Oklahoma System; University of Oklahoma Health
   Sciences Center; University of Oklahoma System; University of Oklahoma
   Health Sciences Center; Oklahoma Medical Research Foundation
RP Freeman, WM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.
EM dmasser@ouhsc.edu; Nicholas-clark@ouhsc.edu; Holly-vanremmen@omrf.org;
   wfreeman@ouhsc.edu
RI Freeman, Willard/GYQ-5841-2022
OI Clark, Nicholas/0000-0001-6543-799X; Freeman,
   Willard/0000-0001-7027-999X
FU National Institutes of Health [National Eye Institute] [R01EY02176,
   R21EY024520, T32EY023202]; National Institute on Aging Oklahoma Nathan
   Shock Center [P30AG050911]; Donald W. Reynolds Foundation; University of
   Oklahoma Health Sciences Center Graduate Student Association; Harold
   Hamm Diabetes Center at the University of Oklahoma
FX The authors wish to thank the Laboratory for Molecular Biology and
   Cytometry Research at OUHSC for providing Sanger sequencing assistance
   and Peter Eckhart for assistance with figure generation. This work was
   supported by the National Institutes of Health [National Eye Institute
   R01EY02176, R21EY024520 to WMF, T32EY023202 to DRM]; National Institute
   on Aging Oklahoma Nathan Shock Center (P30AG050911) to HVR, WMF; the
   Donald W. Reynolds Foundation [DRM & WMF]; The University of Oklahoma
   Health Sciences Center Graduate Student Association research grant to
   [DRM]; and in part by an award from Harold Hamm Diabetes Center at the
   University of Oklahoma [DRM].
CR Anson RM, 2000, J AM AGING ASSOC, V23, P199, DOI 10.1007/s11357-000-0020-y
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027
   Barja G, 2013, ANTIOXID REDOX SIGN, V19, P1420, DOI 10.1089/ars.2012.5148
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647
   Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dickinson A, 2013, CELL DEATH DIFFER, V20, P1644, DOI 10.1038/cdd.2013.115
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633
   Huang JH, 2009, IUBMB LIFE, V61, P201, DOI 10.1002/iub.164
   Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308
   Kowluru RA, 2013, CURR MED CHEM, V20, P3226, DOI 10.2174/09298673113209990029
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   Masser DR, 2014, J GERONTOL A-BIOL, V69, P1311, DOI 10.1093/gerona/glu091
   Masser DR, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-33
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639
   Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036
   Nagahisa H, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9345970
   Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887
   REIS RJS, 1983, J BIOL CHEM, V258, P9078
   Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003
   Sharma K, 2015, DIABETES, V64, P663, DOI 10.2337/db14-0874
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   van Leeuwen N, 2014, AGE, V36, P1463, DOI 10.1007/s11357-014-9629-0
   VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236
   Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012
   Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042
   Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
NR 49
TC 18
Z9 22
U1 5
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD AUG
PY 2016
VL 38
IS 4
BP 323
EP 333
DI 10.1007/s11357-016-9930-1
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA DY8SJ
UT WOS:000385400700007
PM 27444179
OA Green Published
DA 2024-11-01
ER

PT J
AU Montero, R
   Grazina, M
   López-Gallardo, E
   Montoya, J
   Briones, P
   Navarro-Sastre, A
   Land, JM
   Hargreaves, IP
   Artuch, R
   O'Callaghan, MD
   Jou, C
   Jimenez, C
   Buján, N
   Pineda, M
   García-Cazorla, A
   Nascimento, A
   Perez-Dueñas, B
   Ruiz-Pesini, E
   Fratter, C
   Salviati, L
   Simoes, M
   Mendes, C
   Santos, MJ
   Diogo, L
   Garcia, P
   Navas, P
AF Montero, Raquel
   Grazina, Manuela
   Lopez-Gallardo, Ester
   Montoya, Julio
   Briones, Paz
   Navarro-Sastre, Aleix
   Land, John M.
   Hargreaves, Iain P.
   Artuch, Rafael
   del Mar O'Callaghan, Maria
   Jou, Cristina
   Jimenez, Cecilia
   Bujan, Nuria
   Pineda, Merce
   Garcia-Cazorla, Angels
   Nascimento, Andres
   Perez-Duenas, Belen
   Ruiz-Pesini, Eduardo
   Fratter, Carl
   Salviati, Leonardo
   Simoes, Marta
   Mendes, Candida
   Santos, Maria Joao
   Diogo, Luisa
   Garcia, Paula
   Navas, Placido
CA Coenzyme Q10 Deficiency Study Grp
TI Coenzyme Q<sub>10</sub> deficiency in mitochondrial DNA depletion
   syndromes
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA depletion syndrome; Coenzyme Q(10) deficiency;
   Mitochondrial disorders
ID RESPIRATORY-CHAIN DISORDERS; SKELETAL-MUSCLE; MUTATIONS; DIAGNOSIS;
   HUMANS; CHILDREN; GENES; CELLS; FORM
AB We evaluated coenzyme Q(10) (CoQ) levels in patients studied under suspicion of mitochondrial DNA depletion syndromes (MDS) (n = 39). CoQ levels were quantified by HPLC, and the percentage of mtDNA depletion by quantitative real-time PCR. A high percentage of MDS patients presented with CoQ deficiency as compared to other mitochondrial patients (Mann-Whitney-U test: p = 0.001). Our findings suggest that MDS are frequently associated with CoQ deficiency, as a possible secondary consequence of disease pathophysiology. Assessment of muscle CoQ status seems advisable in MDS patients since the possibility of CoQ supplementation may then be considered as a candidate therapy. (c) 2013 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Montero, Raquel; Artuch, Rafael; del Mar O'Callaghan, Maria; Jou, Cristina; Jimenez, Cecilia; Pineda, Merce; Garcia-Cazorla, Angels; Nascimento, Andres; Perez-Duenas, Belen] Hosp St Joan de Deu, Dept Clin Chem, Barcelona 08950, Spain.
   [Montero, Raquel; Artuch, Rafael; del Mar O'Callaghan, Maria; Jou, Cristina; Jimenez, Cecilia; Pineda, Merce; Garcia-Cazorla, Angels; Nascimento, Andres; Perez-Duenas, Belen] Hosp St Joan de Deu, Dept Pathol, Barcelona 08950, Spain.
   [Montero, Raquel; Artuch, Rafael; del Mar O'Callaghan, Maria; Jou, Cristina; Jimenez, Cecilia; Pineda, Merce; Garcia-Cazorla, Angels; Nascimento, Andres; Perez-Duenas, Belen] Hosp St Joan de Deu, Dept Neurol, Barcelona 08950, Spain.
   [Montero, Raquel; Lopez-Gallardo, Ester; Montoya, Julio; Briones, Paz; Navarro-Sastre, Aleix; Artuch, Rafael; Pineda, Merce; Garcia-Cazorla, Angels; Navas, Placido] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.
   [Grazina, Manuela] Univ Coimbra, Fac Med, P-3000 Coimbra, Portugal.
   [Grazina, Manuela; Simoes, Marta; Mendes, Candida; Santos, Maria Joao] Univ Coimbra, Ctr Neurosci & Cell Biol, Lab Biochem Genet, P-3000 Coimbra, Portugal.
   [Lopez-Gallardo, Ester; Montoya, Julio; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, E-50009 Zaragoza, Spain.
   [Briones, Paz; Navarro-Sastre, Aleix; Bujan, Nuria] Hosp Clin Barcelona, IBC Seccio Errors Congenits Metab, Serv Bioquim & Genet Mol, Barcelona, Spain.
   [Briones, Paz] CSIC, Barcelona, Spain.
   [Land, John M.; Hargreaves, Iain P.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Fratter, Carl] Churchill Hosp, Oxford Med Genet Labs, Oxford OX3 7LJ, England.
   [Salviati, Leonardo] Univ Padua, Serv Genet Clin & Epidemiol, Dept Pediat, I-35100 Padua, Italy.
   [Diogo, Luisa; Garcia, Paula] Ctr Hosp, Hosp Pediat Coimbra, Coimbra, Portugal.
   [Diogo, Luisa; Garcia, Paula] Univ Coimbra, P-3000 Coimbra, Portugal.
   [Navas, Placido] Univ Pablo de Olavide CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain.
C3 University of Barcelona; University of Barcelona; University of
   Barcelona; Instituto de Salud Carlos III; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER; Universidade de Coimbra;
   Universidade de Coimbra; University of Zaragoza; University of
   Barcelona; Hospital Clinic de Barcelona; Consejo Superior de
   Investigaciones Cientificas (CSIC); University of London; University
   College London; UCL Medical School; University College London Hospitals
   NHS Foundation Trust; University of Oxford; University of Padua;
   Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra
   (CHUC); Universidade de Coimbra; Consejo Superior de Investigaciones
   Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian
   Center for Developmental Biology (CABD)
RP Artuch, R (corresponding author), Hosp St Joan de Deu, Dept Clin Biochem, Passeig St Joan de Deu 2, Barcelona 08950, Spain.
EM rartuch@hsjdbcn.org
RI Salviati, Leonardo/L-1007-2016; NAVAS, PLACIDO/R-5943-2019; García,
   Paula/JFK-7286-2023; Perez-Duenas, Belen/AAG-9054-2019; Hargreaves,
   Iain/AAJ-6757-2020; Jiménez-Mallebrera, Cecilia/F-5030-2016; Grazina,
   Manuela/W-3759-2017
OI PEREZ DUENAS, BELEN/0000-0002-4979-2788; Santos, Maria
   Joao/0000-0002-4018-8787; Grazina, Manuela/0000-0002-1173-6481; Lopez
   Gallardo, Ester/0000-0002-3217-1424; Diogo, Luisa/0000-0003-3821-6643;
   Simoes, Marta/0000-0003-3998-1611; Garcia, Paula/0000-0002-6847-745X;
   Artuch, Rafael/0000-0002-3422-9685
FU Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Spain
   (FIS) [PI11/00078, PI10/00662, PI11/01301, PI08/0307, PI08/0663,
   PI07/00184]; The Centro de Investigaciones Biomedicas en Red de
   Enfermedades Raras (CIBERER) by Departamento de Ciencia, Tecnologia y
   Universidad del Gobierno de Aragon y Fondo Social Europeo (Grupo B33);
   Asociacion de Enfermos de Patologia Mitocondrial (AEPMI); Department of
   Health's NIHR Biomedical Research Centres
FX This work has been supported by grant from the Instituto de Salud Carlos
   III, Ministerio de Ciencia e Innovacion, Spain (FIS: PI11/00078,
   PI10/00662, PI11/01301, PI08/0307 and PI08/0663 and a Fellowship to IMR
   PI07/00184). The Centro de Investigaciones Biomedicas en Red de
   Enfermedades Raras (CIBERER) is an initiative of the Instituto de Salud
   Carlos III by Departamento de Ciencia, Tecnologia y Universidad del
   Gobierno de Aragon y Fondo Social Europeo (Grupo B33) and Asociacion de
   Enfermos de Patologia Mitocondrial (AEPMI). Part of this work was
   undertaken at UCLH which received a proportion of funding from the
   Department of Health's NIHR Biomedical Research Centres funding scheme.
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Duncan AJ, 2005, CLIN CHEM, V51, P2380, DOI 10.1373/clinchem.2005.054643
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Grazina MM, 2012, METHODS MOL BIOL, V837, P73, DOI 10.1007/978-1-61779-504-6_6
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   López-Martín JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marcuello A, 2005, J APPL PHYSIOL, V99, P1372, DOI 10.1152/japplphysiol.00289.2005
   Miles MV, 2008, MITOCHONDRION, V8, P170, DOI 10.1016/j.mito.2008.01.003
   Montero R, 2005, BIOFACTORS, V25, P109, DOI 10.1002/biof.5520250112
   Montero R, 2008, CLIN BIOCHEM, V41, P697, DOI 10.1016/j.clinbiochem.2008.03.007
   Montero R, 2009, CLIN BIOCHEM, V42, P742, DOI 10.1016/j.clinbiochem.2008.10.027
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Nogueira C, 2011, J CHILD NEUROL, V26, P866, DOI 10.1177/0883073811402072
   O'Callaghan M., 2012, NEUROGENETICS, V26
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Quinzii CM, 2011, BIOFACTORS, V37, P361, DOI 10.1002/biof.155
   Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tavares MV, 2013, J INHERIT METAB DIS, V36, P805, DOI 10.1007/s10545-012-9567-x
   Trevisson E, 2011, CURR OPIN NEUROL, V24, P449, DOI 10.1097/WCO.0b013e32834ab528
   Yen HC, 2011, J BIOCHEM MOL TOXIC, V25, P280, DOI 10.1002/jbt.20387
NR 36
TC 44
Z9 48
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2013
VL 13
IS 4
BP 337
EP 341
DI 10.1016/j.mito.2013.04.001
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 162VR
UT WOS:000320294600010
PM 23583954
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Longo, N
   Schrijver, I
   Vogel, H
   Pique, LM
   Cowan, TM
   Pasquali, M
   Steinberg, GK
   Hedlund, GL
   Ernst, SL
   Gallagher, RC
   Enns, GM
AF Longo, Nicola
   Schrijver, Iris
   Vogel, Hannes
   Pique, Lynn M.
   Cowan, Tina M.
   Pasquali, Marzia
   Steinberg, Gary K.
   Hedlund, Gary L.
   Ernst, Sharon L.
   Gallagher, Renata C.
   Enns, Gregory M.
TI Progressive cerebral vascular degeneration with mitochondrial
   encephalopathy
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE MELAS; mitochondrial disorder; MCAD deficiency; Moyamoya; lactic
   acidosis; metabolic acidosis; mitochondrial encephalopathy; vascular
   disease
ID ANGIOPATHY; MUTATION; MELAS
AB MELAS (Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes) is a maternally inherited disorder characterized by recurrent cerebral infarctions that do not conform to discreet vascular territories. Here we report on a patient who presented at 7 years of age with loss of consciousness and severe metabolic acidosis following vomiting and dehydration. She developed progressive sensorineural hearing loss, myopathy, ptosis, short stature, and mild developmental delays after normal early development. Biochemical testing identified metabolites characteristic of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency (hexanoylglycine and suberylglycine), but also severe lactic acidemia (10-25 mM) and, in urine, excess of lactic acid, intermediates of the citric cycle, and marked ketonuria, suggesting mitochondrial dysfunction. She progressed rapidly to develop temporary cortical blindness. Brain imaging indicated generalized atrophy, more marked on the left side, in addition to white matter alterations consistent with a mitochondrial disorder. Magnetic resonance angiography indicated occlusion of the left cerebral artery with development of collateral circulation (Moyamoya syndrome). This process worsened over time to involve the other side of the brain. A muscle biopsy indicated the presence of numerous ragged red fibers. Molecular testing confirmed compound heterozygosity for the common mutation in the MCAD gene (985A>G) and a second pathogenic mutation (233T>C). MtDNA testing indicated that the muscle was almost homoplasmic for the 3243A>T mutation in tRNALeu, with a lower mutant load (about 50% heteroplasmy) in blood and skin fibroblasts. These results indicate that mitochondrial disorders may be associated with severe vascular disease resulting in Moyamoya syndrome. The contribution of the concomitant MCAD deficiency to the development of the phenotype in this case is unclear. (C) 2008 Wiley-Liss, Inc.
C1 [Longo, Nicola; Ernst, Sharon L.] Univ Utah, Dept Pediat, Div Med Genet, Ctr Hlth Sci, Salt Lake City, UT 84132 USA.
   [Longo, Nicola; Pasquali, Marzia] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA.
   [Longo, Nicola; Pasquali, Marzia] Univ Utah, Hlth Sci Ctr, ARUP Labs, Salt Lake City, UT 84132 USA.
   [Schrijver, Iris; Vogel, Hannes; Pique, Lynn M.; Cowan, Tina M.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.
   [Schrijver, Iris; Vogel, Hannes; Cowan, Tina M.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.
   [Steinberg, Gary K.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.
   [Hedlund, Gary L.] Primary Childrens Med Ctr, Dept Med Imaging, Salt Lake City, UT 84103 USA.
   [Gallagher, Renata C.; Enns, Gregory M.] Stanford Univ, Sch Med, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA.
C3 Utah System of Higher Education; University of Utah; Utah System of
   Higher Education; University of Utah; Utah System of Higher Education;
   University of Utah; ARUP Laboratories; Stanford University; Stanford
   University; Stanford University; Stanford University
RP Longo, N (corresponding author), Univ Utah, Dept Pediat, Div Med Genet, Ctr Hlth Sci, 2C412 SOM,50 N Med Dr, Salt Lake City, UT 84132 USA.
EM nicola.longo@hsc.utah.edu
OI Steinberg, Gary/0000-0001-6374-1058; Vogel, Otto
   Hannes/0000-0002-0960-3508
CR Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   FORSTER C, 1992, NEUROPEDIATRICS, V23, P165, DOI 10.1055/s-2008-1071335
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Longo N, 2003, NEUROL CLIN, V21, P817, DOI 10.1016/S0733-8619(03)00015-X
   McKinney JT, 2004, MOL GENET METAB, V82, P112, DOI 10.1016/j.ymgme.2004.04.004
   Noguchi A, 2005, PEDIATR NEUROL, V33, P70, DOI 10.1016/j.pediatrneurol.2005.01.013
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   Shoffner JM, 2001, METABOLIC MOL BASES, P2367
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Waddell L, 2006, MOL GENET METAB, V87, P32, DOI 10.1016/j.ymgme.2005.09.020
   Wallace D.C., 2001, The Metabolic and Molecular Basis of Inherited Disease, P2425
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
NR 15
TC 26
Z9 30
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD FEB 1
PY 2008
VL 146A
IS 3
BP 361
EP 367
DI 10.1002/ajmg.a.31841
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 260KD
UT WOS:000253008300014
PM 18203188
DA 2024-11-01
ER

PT J
AU DeBrosse, C
   Nanga, RPR
   Wilson, N
   D'Aquilla, K
   Elliott, M
   Hariharan, H
   Yan, F
   Wade, K
   Nguyen, S
   Worsley, D
   Parris-Skeete, C
   McCormick, E
   Xiao, R
   Cunningham, ZZ
   Fishbein, L
   Nathanson, KL
   Lynch, DR
   Stallings, VA
   Yudkoff, M
   Falk, MJ
   Reddy, R
   McCormack, SE
AF DeBrosse, Catherine
   Nanga, Ravi Prakash Reddy
   Wilson, Neil
   D'Aquilla, Kevin
   Elliott, Mark
   Hariharan, Hari
   Yan, Felicia
   Wade, Kristin
   Sara Nguyen
   Worsley, Diana
   Parris-Skeete, Chevonne
   McCormick, Elizabeth
   Xiao, Rui
   Cunningham, Zuela Zolkipli
   Fishbein, Lauren
   Nathanson, Katherine L.
   Lynch, David R.
   Stallings, Virginia A.
   Yudkoff, Marc
   Falk, Marni J.
   Reddy, Ravinder
   McCormack, Shana E.
TI Muscle oxidative phosphorylation quantitation using creatine chemical
   exchange saturation transfer (CrCEST) MRI in mitochondrial disorders
SO JCI INSIGHT
LA English
DT Article
ID MAGNETIC-RESONANCE-SPECTROSCOPY; COMPLEX II DEFICIENCY; SKELETAL-MUSCLE;
   FRIEDREICHS-ATAXIA; POINT MUTATION; DNA DELETIONS; FIBER TYPES; DISEASE;
   MYOPATHIES; CAPACITY
AB Systemic mitochondrial energy deficiency is implicated in the pathophysiology of many age-related human diseases. Currently available tools to estimate mitochondrial oxidative phosphorylation (OXPHOS) capacity in skeletal muscle in vivo lack high anatomic resolution. Muscle groups vary with respect to their contractile and metabolic properties. Therefore, muscle group-specific estimates of OXPHOS would be advantageous. To address this need, a noninvasive creatine chemical exchange saturation transfer (CrCEST) MRI technique has recently been developed, which provides a measure of free creatine. After exercise, skeletal muscle can be imaged with CrCEST in order to make muscle group-specific measurements of OXPHOS capacity, reflected in the recovery rate (tCr) of free Cr. In this study, we found that individuals with genetic mitochondrial diseases had significantly (P = 0.026) prolonged postexercise tCr in the medial gastrocnemius muscle, suggestive of less OXPHOS capacity. Additionally, we observed that lower resting CrCEST was associated with prolonged tau PCr, with a Pearson's correlation coefficient of -0.42 (P = 0.046), consistent with previous hypotheses predicting that resting creatine levels may correlate with P-31 magnetic resonance spectroscopy-based estimates of OXPHOS capacity. We conclude that CrCEST can noninvasively detect changes in muscle creatine content and OXPHOS capacity, with high anatomic resolution, in individuals with mitochondrial disorders.
C1 [DeBrosse, Catherine; Nanga, Ravi Prakash Reddy; Wilson, Neil; D'Aquilla, Kevin; Elliott, Mark; Hariharan, Hari; Reddy, Ravinder] Univ Penn, Dept Radiol, Ctr Magnet Resonance & Opt Imaging, Philadelphia, PA 19104 USA.
   [Yan, Felicia; Wade, Kristin; Sara Nguyen; Worsley, Diana; Parris-Skeete, Chevonne; McCormack, Shana E.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA.
   [McCormick, Elizabeth; Yudkoff, Marc; Falk, Marni J.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA.
   [Xiao, Rui] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.
   [Cunningham, Zuela Zolkipli; Lynch, David R.] Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA.
   [Fishbein, Lauren] Univ Colorado, Sch Med, Div Endocrinol Diabet & Metab, Aurora, CO USA.
   [Nathanson, Katherine L.] Univ Penn, Dept Med, Div Translat Med & Human Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Nathanson, Katherine L.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA.
   [Stallings, Virginia A.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.
   [Stallings, Virginia A.; Yudkoff, Marc; Falk, Marni J.; McCormack, Shana E.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; University of Pennsylvania; Pennsylvania
   Medicine; Childrens Hospital of Philadelphia; University of
   Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia;
   University of Pennsylvania; University of Pennsylvania; Pennsylvania
   Medicine; Childrens Hospital of Philadelphia; University of Colorado
   System; University of Colorado Anschutz Medical Campus; University of
   Pennsylvania; University of Pennsylvania; University of Pennsylvania;
   Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of
   Pennsylvania
RP McCormack, SE (corresponding author), Div Endocrinol & Diabet, 3401 Civ Ctr Blvd,Suite 11NW, Philadelphia, PA 19104 USA.
EM mccormacks1@email.chop.edu
RI Falk, Marni/K-1997-2014
OI Falk, Marni/0000-0002-1723-6728; Nanga, Ravi Prakash
   Reddy/0000-0002-3644-5656; Nathanson, Katherine/0000-0002-6740-0901
FU NCATS NIH HHS [UL1 TR000003, UL1 TR001878] Funding Source: Medline;
   NIBIB NIH HHS [T32 EB020087, P41 EB015893] Funding Source: Medline;
   NICHD NIH HHS [U54 HD086984] Funding Source: Medline; NIDDK NIH HHS [K12
   DK094723, P30 DK019525, K23 DK102659] Funding Source: Medline
CR Alston C, 2015, HUM GENET, V134, P869, DOI 10.1007/s00439-015-1568-z
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   ARNOLD DL, 1985, ANN NEUROL, V18, P189, DOI 10.1002/ana.410180205
   Barile JP, 2013, QUAL LIFE RES, V22, P1201, DOI 10.1007/s11136-012-0246-z
   Bates MGD, 2013, EUR HEART J-CARD IMG, V14, P650, DOI 10.1093/ehjci/jes226
   Bayot A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-112
   CHANCE B, 1995, BBA-MOL BASIS DIS, V1271, P7, DOI 10.1016/0925-4439(95)00003-M
   Cochran AJR, 2014, EXP PHYSIOL, V99, P782, DOI 10.1113/expphysiol.2013.077453
   Cree-Green M, 2014, MED SCI SPORT EXER, V46, P2030, DOI 10.1249/MSS.0000000000000316
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE
   Glatz C, 2011, MITOCHONDRION, V11, P615, DOI 10.1016/j.mito.2011.04.003
   Haris M, 2014, NAT MED, V20, P209, DOI 10.1038/nm.3436
   Haris M, 2012, NMR BIOMED, V25, P1305, DOI 10.1002/nbm.2792
   Horiuchi M, 2014, EXP PHYSIOL, V99, P348, DOI 10.1113/expphysiol.2013.075846
   Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3
   Kaplan J, 1999, P NATL ACAD SCI USA, V96, P10948, DOI 10.1073/pnas.96.20.10948
   KENTBRAUN JA, 1990, J APPL PHYSIOL, V69, P1165, DOI 10.1152/jappl.1990.69.3.1165
   Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873
   Kogan F, 2014, J MAGN RESON IMAGING, V40, P596, DOI 10.1002/jmri.24412
   Kogan Feliks, 2013, Curr Radiol Rep, V1, P102
   Kogan F, 2014, MAGN RESON MED, V71, P164, DOI 10.1002/mrm.24641
   Larsen RG, 2012, APPL PHYSIOL NUTR ME, V37, P88, DOI [10.1139/h11-135, 10.1139/H11-135]
   Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011
   Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010
   Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492
   MATTHEWS PM, 1991, NEUROLOGY, V41, P114, DOI 10.1212/WNL.41.1.114
   Milone M, 2013, JAMA NEUROL, V70, P1429, DOI 10.1001/jamaneurol.2013.3521
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Parasoglou P, 2013, NMR BIOMED, V26, P348, DOI 10.1002/nbm.2866
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147
   PROCTOR DN, 1995, J APPL PHYSIOL, V78, P2033, DOI 10.1152/jappl.1995.78.6.2033
   Ricardo AC, 2015, AM J KIDNEY DIS, V65, P412, DOI 10.1053/j.ajkd.2014.09.016
   Scheuermann-Freestone M, 2003, CIRCULATION, V107, P3040, DOI 10.1161/01.CIR.0000072789.89096.10
   SHOFFNER JM, 1991, REV NEUROL-FRANCE, V147, P431
   SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930
   Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stacpoole PW, 2012, MITOCHONDRION, V12, P623, DOI 10.1016/j.mito.2012.09.005
   Tarnopolsky MA, 1999, MUSCLE NERVE, V22, P1228, DOI 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.3.CO;2-Y
   Tarnopolsky MA, 2001, MUSCLE NERVE, V24, P682, DOI 10.1002/mus.1055
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Trappe SW, 2001, INT J SPORTS MED, V22, P186, DOI 10.1055/s-2001-16385
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wilson N.E., 2016, ExerciseCEST
   Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348
   Zierz CM, 2015, NEUROPATHOLOGY, V35, P130, DOI 10.1111/neup.12173
NR 53
TC 35
Z9 37
U1 0
U2 6
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD NOV 3
PY 2016
VL 1
IS 18
AR e88207
DI 10.1172/jci.insight.88207
PG 15
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA EB1PK
UT WOS:000387125700005
PM 27812541
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Craig, K
   Elliott, HR
   Keers, SM
   Lambert, C
   Pyle, A
   Graves, TD
   Woodward, C
   Sweeney, MG
   Davis, MB
   Hanna, MG
   Chinnery, PF
AF Craig, K.
   Elliott, H. R.
   Keers, S. M.
   Lambert, C.
   Pyle, A.
   Graves, T. D.
   Woodward, C.
   Sweeney, M. G.
   Davis, M. B.
   Hanna, M. G.
   Chinnery, P. F.
TI Episodic ataxia and hemiplegia caused by the 8993T→C mitochondrial DNA
   mutation
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID NUCLEOTIDE 8993; HETEROPLASMY; MIGRAINE; DISEASE; GENE
AB The m.8993T-->C MTATP6 mutation of mitochondrial DNA ( mtDNA) usually causes mitochondrial disease in childhood, but was recently described in a family with adult onset ataxia and polyneuropathy. Cytochrome c oxidase muscle histochemistry, which is the standard clinical investigation for mitochondrial disease in adults, is usually normal in patients with MTATP6 mutations. This raises the possibility that these cases have been missed in the past. We therefore studied 308 patients with unexplained ataxia and 96 patients with suspected Charcot-Marie-Tooth disease to determine whether the m.8993T-->C MTATP6 mutation is common in unexplained inherited ataxia and/or polyneuropathy. We identified a three-generation family with the m.8993T-->C mutation of mtDNA. One subject had episodic ataxia ( EA) and transient hemipareses, broadening the phenotype. However, no further cases were identified in an additional cohort of 191 patients with suspected EA. In conclusion, m.8993T-->C MTATP6 should be considered in patients with unexplained ataxia, CMT or EA, but cases are uncommon.
C1 Mitochondrial Res Ctr, Inst Neurol, London, England.
   Dept Mol Neurosci, Inst Neurol, London, England.
   Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 University of London; University College London; University of London;
   University College London; Newcastle University - UK
RP Chinnery, PF (corresponding author), The Med Sch, M41014,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
RI Elliott, Hannah/AAP-3170-2021; Hanna, Michael/B-1995-2009
OI Hanna, Michael/0000-0003-0825-4075; Chinnery,
   Patrick/0000-0002-7065-6617; Elliott, Hannah/0000-0002-1500-3533
FU NINDS NIH HHS [U54 NS059065, U54 NS059065-04] Funding Source: Medline;
   Wellcome Trust Funding Source: Medline
CR Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Ducros A, 1999, AM J HUM GENET, V64, P89, DOI 10.1086/302192
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Thomsen LL, 2007, BRAIN, V130, P346, DOI 10.1093/brain/awl334
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
NR 10
TC 25
Z9 28
U1 3
U2 5
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
J9 J MED GENET
JI J. Med. Genet.
PD DEC
PY 2007
VL 44
IS 12
BP 797
EP 799
DI 10.1136/jmg.2007.052902
PG 3
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 236QE
UT WOS:000251317700009
PM 18055910
OA Green Published
DA 2024-11-01
ER

PT J
AU Kato, T
AF Kato, Tadafumi
TI Mitochondrial dysfunction as the molecular basis of bipolar disorder -
   Therapeutic implications
SO CNS DRUGS
LA English
DT Review
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MAGNETIC-RESONANCE-SPECTROSCOPY;
   SUBUNIT GENE NDUFV2; EXPRESSION ANALYSIS; MOOD STABILIZERS; INVIVO P-31;
   I DISORDER; QUANTITATIVE-ANALYSIS; DNA POLYMORPHISMS; MTDNA DELETIONS
AB Multiple lines of evidence, such as impaired energy metabolism in the brain detected by magnetic resonance spectroscopy, a possible role of maternal inheritance, co-morbidity with mitoctiondrial diseases, the effects of mood stabilisers on mitochondria, increased mitochondrial DNA (mtDNA) deletion in the brain, and association with mtDNA mutations/polymorphisms or nuclear-encoded mitochondrial genes, suggest that mitochondrial dysfunction is an important component of bipolar disorder. Global reduction of mitochondria-related gene expression in the postmortem brains of patients with bipolar disorder may also be an indicator, but such findings are affected by sample pH and thus need to be interpreted with caution. A recently developed animal model carrying rntDNA deletion in neurons suggested that accumulation of mtDNA deletions causes bipolar disorder-like phenotypes.
   The next step in the study of mitochondrial dysfunction in bipolar disorder should be clarification of how mitochondrial dysfunction, a nonspecific risk factor, can cause specific symptoms of bipolar disorder. Two hypothetical mechanisms are rntDNA neuroplasticity and nonvisual photoreception impairment.
   Further study of mitochondrial dysfunction in bipolar disorder is expected to be useful for the development of new mood stabilisers.
C1 RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan.
C3 RIKEN
RP Kato, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM kato@brain.riken.go.jp
RI Kato, Tadafumi/J-3583-2014
OI Kato, Tadafumi/0000-0001-7856-3952
CR Bachmann RF, 2005, MOL NEUROBIOL, V32, P173, DOI 10.1385/MN:32:2:173
   Barbini B, 2005, BIPOLAR DISORD, V7, P98, DOI 10.1111/j.1399-5618.2004.00166.x
   BARBIROLI B, 1993, J CEREBR BLOOD F MET, V13, P469, DOI 10.1038/jcbfm.1993.61
   Benes FM, 2006, MOL PSYCHIATR, V11, P241, DOI 10.1038/sj.mp.4001758
   Boles RG, 2005, AM J MED GENET B, V137B, P20, DOI 10.1002/ajmg.b.30199
   Bowden CL, 2003, ARCH GEN PSYCHIAT, V60, P392, DOI 10.1001/archpsyc.60.4.392
   Bown CD, 2002, BIPOLAR DISORD, V4, P145, DOI 10.1034/j.1399-5618.2002.t01-1-40201.x
   Burnett BB, 2005, J AFFECT DISORDERS, V88, P109, DOI 10.1016/j.jad.2005.05.009
   Carlezon WA, 2005, BIOL PSYCHIAT, V57, P343, DOI 10.1016/j.biopsych.2004.11.038
   Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x
   Chen G, 1999, J NEUROCHEM, V72, P1327, DOI 10.1046/j.1471-4159.2000.0721327.x
   CHOU JC, 2000, ARCH GEN PSYCHIAT, V57, P481
   Chuang DM, 2005, ANN NY ACAD SCI, V1053, P195, DOI 10.1196/annals.1344.018
   Dager SR, 2004, ARCH GEN PSYCHIAT, V61, P450, DOI 10.1001/archpsyc.61.5.450
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dokucu ME, 2005, NEUROPSYCHOPHARMACOL, V30, P2216, DOI 10.1038/sj.npp.1300764
   Einat H, 2005, BEHAV BRAIN RES, V165, P172, DOI 10.1016/j.bbr.2005.06.012
   Einat Haim, 2003, Psychopharmacol Bull, V37, P47
   Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1
   Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217
   Glantz LA, 2006, SCHIZOPHR RES, V81, P47, DOI 10.1016/j.schres.2005.08.014
   Goodwin F. K., 1990, MANIC DEPRESSIVE ILL, V36
   Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x
   Hajek T, 2005, BIPOLAR DISORD, V7, P393, DOI 10.1111/j.1399-5618.2005.00238.x
   Haldane M, 2004, PROG NEURO-PSYCHOPH, V28, P943, DOI 10.1016/j.pnpbp.2004.05.040
   Hashimoto H, 2006, ANN NY ACAD SCI, V1070, P75, DOI 10.1196/annals.1317.038
   Hernández F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x
   Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022
   Kakiuchi C, 2005, INT J NEUROPSYCHOPH, V8, P515, DOI 10.1017/S1461145705005213
   Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235
   Karry R, 2004, BIOL PSYCHIAT, V55, P676, DOI 10.1016/j.biopsych.2003.12.012
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   KATO T, 1995, PSYCHOL MED, V25, P557, DOI 10.1017/S003329170003347X
   Kato T, 1996, J AFFECT DISORDERS, V37, P67, DOI 10.1016/0165-0327(95)00050-X
   Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7
   Kato T, 2005, DRUG TODAY, V41, P335, DOI 10.1358/dot.2005.41.5.893616
   Kato T, 1998, J NEUROPSYCH CLIN N, V10, P133, DOI 10.1176/jnp.10.2.133
   Kato T, 1998, EUR ARCH PSY CLIN N, V248, P301, DOI 10.1007/s004060050054
   Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1
   KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3
   KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4
   KATO T, 1991, J AFFECT DISORDERS, V22, P185, DOI 10.1016/0165-0327(91)90064-Y
   Kato T, 1997, BIOL PSYCHIAT, V42, P311, DOI 10.1016/S0006-3223(96)00377-0
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   Kato T, 2001, MOL PSYCHIATR, V6, P625, DOI 10.1038/sj.mp.4000926
   Kato T, 2000, AM J MED GENET, V96, P182, DOI 10.1002/(SICI)1096-8628(20000403)96:2<182::AID-AJMG12>3.0.CO;2-Q
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kazuno AA, 2005, PSYCHIAT CLIN NEUROS, V59, P497, DOI 10.1111/j.1440-1819.2005.01404.x
   Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128
   Kirk R, 1999, AM J HUM GENET, V65, P508, DOI 10.1086/302507
   Klivenyi P, 2004, NEUROMOL MED, V6, P87, DOI 10.1385/NMM:6:2-3:087
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716
   Lenox RH, 2002, AM J MED GENET, V114, P391, DOI 10.1002/ajmg.10360
   LEWY AJ, 1981, LANCET, V1, P383
   Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065
   Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Machado-Vieira R, 2004, PROG NEURO-PSYCHOPH, V28, P209, DOI 10.1016/j.pnpbp.2003.10.015
   Magariños AM, 1999, EUR J PHARMACOL, V371, P113, DOI 10.1016/S0014-2999(99)00163-6
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Manji H K, 2001, Psychopharmacol Bull, V35, P5
   MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277
   McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058
   Meesters Y, 1998, AM J PSYCHIAT, V155, P306
   Mott JL, 2005, REJUV RES, V8, P216, DOI 10.1089/rej.2005.8.216
   Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043
   Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041
   Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015
   NAKAMURA S, 1991, PROG BRAIN RES, V88, P587
   Nakatani N, 2004, PHARMACOGENOMICS J, V4, P114, DOI 10.1038/sj.tpj.6500234
   Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118
   OKUMA T, 1981, PSYCHOPHARMACOLOGY, V73, P95, DOI 10.1007/BF00431111
   Peng TI, 2006, BBA-MOL BASIS DIS, V1762, P241, DOI 10.1016/j.bbadis.2005.10.008
   Post RM, 1996, MOL NEUROBIOL, V13, P33, DOI 10.1007/BF02740751
   RENSHAW PF, 1987, MAGN RESON MED, V4, P221, DOI 10.1002/mrm.1910040303
   Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230
   Ryan MM, 2006, MOL PSYCHIATR, V11, P965, DOI 10.1038/sj.mp.4001875
   Saydoff JA, 2003, BRAIN RES, V994, P44, DOI 10.1016/j.brainres.2003.09.049
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Silverstone PH, 2002, HUM PSYCHOPHARM CLIN, V17, P425, DOI 10.1002/hup.434
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   STINE OC, 1993, BIOL PSYCHIAT, V42, P311
   Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711
   Sun XJ, 2006, J PSYCHIATR NEUROSCI, V31, P189
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Takao M, 2000, NEUROSCIENCE, V97, P779, DOI 10.1016/S0306-4522(00)00053-1
   Tohen M, 2006, AM J PSYCHIAT, V163, P247, DOI 10.1176/appi.ajp.163.2.247
   Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830
   Washizuka S, 2006, AM J MED GENET B, V141B, P301, DOI 10.1002/ajmg.b.30285
   Washizuka S, 2005, BIPOLAR DISORD, V7, P146, DOI 10.1111/j.1399-5618.2005.00184.x
   Washizuka S, 2004, BIOL PSYCHIAT, V56, P483, DOI 10.1016/j.biopsych.2004.07.004
   Washizuka S, 2003, AM J MED GENET B, V120B, P72, DOI 10.1002/ajmg.b.20041
   Wehr TA, 1998, BIOL PSYCHIAT, V43, P822, DOI 10.1016/S0006-3223(97)00542-8
   Yamawaki S, 1998, LIFE SCI, V62, P1665, DOI 10.1016/S0024-3205(98)00125-8
   Zhou R, 2005, J NEUROSCI, V25, P4493, DOI 10.1523/JNEUROSCI.4530-04.2005
NR 104
TC 69
Z9 76
U1 0
U2 5
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 1172-7047
EI 1179-1934
J9 CNS DRUGS
JI CNS Drugs
PY 2007
VL 21
IS 1
BP 1
EP 11
DI 10.2165/00023210-200721010-00001
PG 11
WC Clinical Neurology; Pharmacology & Pharmacy; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 135PO
UT WOS:000244165700001
PM 17190525
DA 2024-11-01
ER

PT J
AU Sasarman, F
   Nishimura, T
   Thiffault, I
   Shoubridge, EA
AF Sasarman, Florin
   Nishimura, Tamiko
   Thiffault, Isabelle
   Shoubridge, Eric A.
TI A novel mutation in YARS2 causes myopathy with lactic acidosis and
   sideroblastic anemia
SO HUMAN MUTATION
LA English
DT Article
DE mitochondrial aminoacyl-tRNA synthetase; YARS2; MLASA; TRMU; MTU1;
   mitochondrial translation
ID TRANSFER-RNA-SYNTHETASE; MITOCHONDRIAL-DNA MUTATIONS; TRANSLATION; GENE;
   DEFICIENCY; COMPLEXES
AB Mutations in the mitochondrial aminoacyl-tRNA synthetases (ARSs) are associated with a strikingly broad range of clinical phenotypes, the molecular basis for which remains obscure. Here, we report a novel missense mutation (c.137G>A, p.Gly46Asp) in the catalytic domain of YARS2, which codes for the mitochondrial tyrosyl-tRNA synthetase, in a subject with myopathy, lactic acidosis, and sideroblastic anemia (MLASA). YARS2 was undetectable by immunoblot analysis in subject myoblasts, resulting in a generalized mitochondrial translation defect. Retroviral expression of a wild-type YARS2 complementary DNA completely rescued the translation defect. We previously demonstrated that the respiratory chain defect in this subject was only present in fully differentiated muscle, and we show here that this likely reflects an increased requirement for YARS2 as muscle cells differentiate. An additional, heterozygous mutation was detected in TRMU/MTU1, a gene encoding the mitochondrial 2-thiouridylase. Although subject myoblasts and myotubes contained half the normal levels of TRMU, thiolation of mitochondrial tRNAs was normal. YARS2 eluted as part of high-molecular-weight complexes of similar to 250 kDa and 1 MDa by gel filtration. This study confirms mutations in YARS2 as a cause of MLASA and shows that, like some of the cytoplasmic ARSs, mitochondrial ARSs occur in high-molecular-weight complexes. Hum Mutat 33:12011206, 2012. (c) 2012 Wiley Periodicals, Inc.
C1 [Sasarman, Florin; Nishimura, Tamiko; Thiffault, Isabelle; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada.
   [Sasarman, Florin; Nishimura, Tamiko; Thiffault, Isabelle; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada.
C3 McGill University; McGill University
RP Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.
EM eric@ericpc.mni.mcgill.ca
FU CIHR [Mt-15460]
FX CIHR (Mt-15460) to E.A.S..
CR Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bonnefond L, 2007, STRUCTURE, V15, P1505, DOI 10.1016/j.str.2007.09.018
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x
   Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320
   Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005
   Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Pulkes T, 2000, NEUROLOGY, V55, P1210, DOI 10.1212/WNL.55.8.1210
   Raffelsberger T, 2001, NEUROLOGY, V57, P2298, DOI 10.1212/WNL.57.12.2298
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Sahashi K, 2001, J MED GENET, V38, P703, DOI 10.1136/jmg.38.10.703
   Sasarman F, 2002, HUM MOL GENET, V11, P1669, DOI 10.1093/hmg/11.14.1669
   Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14
   Sasarman F, 2011, HUM MOL GENET, V20, P4634, DOI 10.1093/hmg/ddr397
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Steenweg ME, 2012, BRAIN           0404
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   WALKER EJ, 1983, BIOCHEMISTRY-US, V22, P1934, DOI 10.1021/bi00277a030
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 36
TC 47
Z9 52
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD AUG
PY 2012
VL 33
IS 8
BP 1201
EP 1206
DI 10.1002/humu.22098
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 973QV
UT WOS:000306375800011
PM 22504945
OA gold
DA 2024-11-01
ER

PT J
AU Mignarri, A
   Rubegni, A
   Tessa, A
   Stefanucci, S
   Malandrini, A
   Cardaioli, E
   Meschini, MC
   Stromillo, ML
   Doccini, S
   Federico, A
   Santorelli, FM
   Dotti, MT
AF Mignarri, Andrea
   Rubegni, Anna
   Tessa, Alessandra
   Stefanucci, Stefano
   Malandrini, Alessandro
   Cardaioli, Elena
   Meschini, Maria Chiara
   Stromillo, Maria Laura
   Doccini, Stefano
   Federico, Antonio
   Santorelli, Filippo Maria
   Dotti, Maria Teresa
TI Mitochondrial dysfunction in hereditary spastic paraparesis with
   mutations in <i>DDHD1</i>/SPG28
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Hereditary spastic paraplegia; SPG28; DDHD1; Mitochondrial disease
ID FORM
AB Mutations in DDHD1 cause the SPG28 subtype of hereditary spastic paraplegia (HSP). Recent studies suggested that mitochondrial dysfunction occurs in SPG28. Here we describe two siblings with SPG28, and report evidence of mitochondrial impairment in skeletal muscle and skin fibroblasts.
   Patient 1 (Pt1) was a 35-year-old man with spastic paraparesis and urinary incontinence, while his 25-year-old brother (Pt2) had gait spasticity and motor axonal neuropathy. In these patients we identified the novel homozygous c.1429C>T/p.R477* mutation in DDHD1, using a next-generation sequencing (NGS) approach. Histochemical analyses in muscle showed mitochondrial alterations, and multiple mitochondrial DNA (mtDNA) deletions were evident. In Pt1, respiratory chain enzyme activities were altered in skeletal muscle, mitochondrial ATP levels reduced, and analysis of skin fibroblasts revealed mitochondrial fragmentation.
   It seems possible that the novel nonsense mutation identified abolishes DDHD1 protein function thus altering oxidative metabolism. Qualitative alterations of mtDNA could have a pathogenetic significance. We suggest to perform DDHD1 analysis in patients with multiple mtDNA deletions. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Mignarri, Andrea; Malandrini, Alessandro; Cardaioli, Elena; Stromillo, Maria Laura; Federico, Antonio; Dotti, Maria Teresa] Univ Siena, Dept Med Surg & Neurosci, Unit Neurol & Neurometab Disorders, I-53100 Siena, Italy.
   [Rubegni, Anna; Tessa, Alessandra; Meschini, Maria Chiara; Doccini, Stefano; Santorelli, Filippo Maria] IRCCS Stella Maris, Mol Med Unit, Pisa, Italy.
   [Stefanucci, Stefano] Nuovo Osped San Giovanni Battista, Neurol Unit, Foligno, Italy.
C3 University of Siena; IRCCS Fondazione Stella Maris
RP Santorelli, FM (corresponding author), IRCCS Stella Maris, Mol Med Unit, Pisa, Italy.
EM filippo3364@gmail.com
RI Rocca, Maria/K-1619-2018; Federico, Antonio/H-8871-2017; Rubegni,
   Anna/I-3221-2018; Santorelli, Filippo M/ABE-5124-2020; tessa,
   alessandra/AAA-4442-2021; DOCCINI, STEFANO/AAI-4709-2021
OI Meschini, Maria Chiara/0009-0006-6291-7852; Rubegni,
   Anna/0000-0002-0484-3799; Santorelli, Filippo M/0000-0002-1359-9062;
   Cardaioli, Elena/0000-0003-2850-6698; tessa,
   alessandra/0000-0002-1445-6434; DOCCINI, STEFANO/0000-0002-5534-8253; ,
   Maria Laura/0000-0001-6909-623X; Malandrini,
   Alessandro/0000-0003-1034-0845
CR Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921
   Bouslam N, 2005, ANN NEUROL, V57, P567, DOI 10.1002/ana.20416
   Coutelier M, 2015, BRAIN, V138, P2191, DOI 10.1093/brain/awv143
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Goizet C, 2011, HUM MUTAT, V32, P1118, DOI 10.1002/humu.21542
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Klebe S, 2015, REV NEUROL-FRANCE, V171, P505, DOI 10.1016/j.neurol.2015.02.017
   Kumar KR, 2013, J NEUROL, V260, P2516, DOI 10.1007/s00415-013-7008-x
   Liguori R, 2014, J NEUROL, V261, P1789, DOI 10.1007/s00415-014-7418-4
   Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011
   Nogueira C, 2015, J CHILD NEUROL, V30, P228, DOI 10.1177/0883073814527158
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Santambrogio P, 2015, NEUROBIOL DIS, V81, P144, DOI 10.1016/j.nbd.2015.02.030
   Schüle R, 2006, NEUROLOGY, V67, P430, DOI 10.1212/01.wnl.0000228242.53336.90
   Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001
   Wedding IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086340
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
NR 17
TC 19
Z9 20
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAR 15
PY 2016
VL 362
BP 287
EP 291
DI 10.1016/j.jns.2016.02.007
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DH1PW
UT WOS:000372558400057
PM 26944165
DA 2024-11-01
ER

PT J
AU Tam, ZY
   Gruber, J
   Halliwell, B
   Gunawan, R
AF Tam, Zhi Yang
   Gruber, Jan
   Halliwell, Barry
   Gunawan, Rudiyanto
TI Context-Dependent Role of Mitochondrial Fusion-Fission in Clonal
   Expansion of mtDNA Mutations
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID DNA DELETION MUTATIONS; SKELETAL-MUSCLE; COPY NUMBER; IN-VIVO;
   ORGANIZATION; EXPRESSION; TURNOVER; DYNAMICS; ACCUMULATION; AUTOPHAGY
AB The accumulation of mutant mitochondrial DNA (mtDNA) molecules in aged cells has been associated with mitochondrial dysfunction, age-related diseases and the ageing process itself. This accumulation has been shown to often occur clonally, where mutant mtDNA grow in number and overpopulate the wild-type mtDNA. However, the cell possesses quality control (QC) mechanisms that maintain mitochondrial function, in which dysfunctional mitochondria are isolated and removed by selective fusion and mitochondrial autophagy (mitophagy), respectively. The aim of this study is to elucidate the circumstances related to mitochondrial QC that allow the expansion of mutant mtDNA molecules. For the purpose of the study, we have developed a mathematical model of mitochondrial QC process by extending our previous validated model of mitochondrial turnover and fusion-fission. A global sensitivity analysis of the model suggested that the selectivity of mitophagy and fusion is the most critical QC parameter for clearing de novo mutant mtDNA molecules. We further simulated several scenarios involving perturbations of key QC parameters to gain a better understanding of their dynamic and synergistic interactions. Our model simulations showed that a higher frequency of mitochondrial fusion-fission can provide a faster clearance of mutant mtDNA, but only when mutant-rich mitochondria that are transiently created are efficiently prevented from re-fusing with other mitochondria and selectively removed. Otherwise, faster fusion-fission quickens the accumulation of mutant mtDNA. Finally, we used the insights gained from model simulations and analysis to propose a possible circumstance involving deterioration of mitochondrial QC that permits mutant mtDNA to expand with age.
C1 [Tam, Zhi Yang] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
   [Gruber, Jan; Halliwell, Barry] Natl Univ Singapore, Dept Biochem, Ctr Life Sci, Singapore 117548, Singapore.
   [Gruber, Jan] Natl Univ Singapore, Yale NUS Coll, Div Sci, Singapore 117548, Singapore.
   [Gunawan, Rudiyanto] Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland.
   [Gunawan, Rudiyanto] Swiss Inst Bioinformat, Lausanne, Switzerland.
C3 Nanyang Technological University; National University of Singapore;
   National University of Singapore; Yale NUS College; Swiss Federal
   Institutes of Technology Domain; ETH Zurich; Swiss Institute of
   Bioinformatics
RP Tam, ZY (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
EM rudi.gunawan@chem.ethz.ch
RI Gunawan, Rudiyanto/D-4650-2009; Halliwell, Barry/C-8318-2009
OI Gunawan, Rudiyanto/0000-0002-6480-7976; Halliwell,
   Barry/0000-0002-3560-7123
FU ETH Zurich; Swiss National Science Foundation [150522]; Ministry of
   Education Singapore [MOE2010-T2-2-048, MOE2012-T2-2-003]
FX TZY and RG would like to acknowledge research funding from ETH Zurich.
   In addition, JG and RG would like to acknowledge Swiss National Science
   Foundation (http://www.snf.ch) for an international short visit grant
   (project #150522). Finally, JG and BH would like to acknowledge research
   funding from Ministry of Education Singapore (http://www.moe.gov.sg,
   projects #MOE2010-T2-2-048 and MOE2012-T2-2-003). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57
   Bess AS, 2012, NUCL ACIDS RES
   Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015
   Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292
   Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Doria E, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/830257
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Dutta D, 2013, AUTOPHAGY, V9, P328, DOI 10.4161/auto.22971
   Figge MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002576
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x
   Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Gruber J, 2013, BIOTECHNOL ADV, V31, P563, DOI 10.1016/j.biotechadv.2012.09.005
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274
   HUEMER RP, 1971, EXP GERONTOL, V6, P259, DOI 10.1016/0531-5565(71)90038-6
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kraytsberg Y, 2003, MECH AGEING DEV, V124, P49, DOI 10.1016/S0047-6374(02)00169-0
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Leinninger GM, 2006, NAT CLIN PRACT NEURO, V2, P620, DOI 10.1038/ncpneuro0320
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001
   Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Moraes CT, 1999, MOL BIOL CELL, V10, P3345, DOI 10.1091/mbc.10.10.3345
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Narendra D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011338
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Patel PK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003108
   Pezze PD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003728
   Poovathingal SK, 2012, BIOGERONTOLOGY, V13, P557, DOI 10.1007/s10522-012-9390-7
   Poovathingal SK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000572
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Saltelli A., 2008, GLOBAL SENSITIVITY A
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Saunter CD, 2009, FEBS LETT, V583, P1267, DOI 10.1016/j.febslet.2009.02.041
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323
   Stroikin Y, 2004, EUR J CELL BIOL, V83, P583, DOI 10.1078/0171-9335-00433
   Struewing IT, 2007, FEBS J, V274, P2749, DOI 10.1111/j.1742-4658.2007.05809.x
   Tam ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076230
   Tam ZY, 2014, J GERONTOL A
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Turnbull DM, 1998, NAT GENET, V18, P199, DOI 10.1038/ng0398-199
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Ullah M, 2010, WIRES SYST BIOL MED, V2, P385, DOI 10.1002/wsbm.78
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Ziehn T, 2009, ENVIRON MODELL SOFTW, V24, P775, DOI 10.1016/j.envsoft.2008.12.002
NR 84
TC 42
Z9 49
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD MAY
PY 2015
VL 11
IS 5
AR e1004183
DI 10.1371/journal.pcbi.1004183
PG 22
WC Biochemical Research Methods; Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA CL1KA
UT WOS:000356700200011
PM 25996936
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Kornblum, C
   Kunz, WS
   Klockgether, T
   Roggenkämper, P
   Schröder, R
AF Kornblum, C
   Kunz, WS
   Klockgether, T
   Roggenkämper, P
   Schröder, R
TI Diagnostic value of mitochondrial DNA analysis in chronic progressive
   external ophthalmoplegia (CPEO)
SO KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
LA English
DT Article
DE CPEO; mitochondrial DNA deletion; diplopia
ID DELETIONS; DISEASES; DISORDERS; FEATURES; DEFECTS; MUSCLE
AB Background: Chronic progressive external ophthalmoplegia (CPEO) is a mitochondrial cytopathy presenting with ptosis and external ophthalmoparesis. Mitochondrial disorders are characterized by a broad clinical spectrum and genetic background with marked genotype/phenotype variability. The routine diagnostic work-up usually includes clinical and laboratory examinations as well as histological and histochemical analysis of skeletal muscle biopsy. In our case only an additional molecular biological examination allowed the diagnosis of CPEO. Patient and Methods: We report a 35-year-old woman with a 7-years history of slowly progressive diplopia due to impaired ocular motility and bilateral ptosis. We performed ophthalmological and neurological examinations, laboratory testing, lower limb skeletal muscle biopsy including histological and histochemical investigations, biochemical analysis of respiratory chain enzymes in skeletal muscle homogenate and molecular genetic testing of skeletal muscle DNA. Results: Although clinical, laboratory, histological and biochemical analyses did not give any hints suggesting a mitochondrial cytopathy, molecular genetic testing of total DNA from skeletal muscle tissue by Southern blot analysis finally revealed a 3.8 kb mitochondrial DNA deletion with a degree of heteroplasmy of 45%. Conclusions: In patients with unexplained binocular diplopia, oculo-motor deficits and/or acquired ptosis, an underlying mitochondrial cytopathy should be considered. Even in the case of inconspicuous skeletal muscle histology and biochemistry, molecular genetic testing of skeletal muscle DNA is advisable in order to establish the diagnosis.
C1 Univ Bonn, Neurol Klin & Poliklin, Fak Med, D-53105 Bonn, Germany.
   Univ Bonn, Fak Med, Klin & Poliklin Epileptol, D-5300 Bonn, Germany.
   Univ Bonn, Fak Med, Klin & Poliklin Augenheilkunde, D-5300 Bonn, Germany.
C3 University of Bonn; University of Bonn; University of Bonn
RP Kornblum, C (corresponding author), Univ Bonn, Neurol Klin & Poliklin, Fak Med, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM cornelia.kornblum@ukb.uni-bonn.de
RI Schröder, Rolf/B-2774-2011; Kornblum, Cornelia/IUM-4180-2023; Kunz,
   Wolfram/K-1232-2019
OI Schroder, Rolf/0000-0002-2772-2615; Kunz, Wolfram/0000-0003-1113-3493
CR Biousse V, 2003, CURR OPIN NEUROL, V16, P35, DOI 10.1097/00019052-200302000-00005
   Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   DiMauro S, 2001, SEMIN NEUROL, V21, P251, DOI 10.1055/s-2001-17942
   DUBOVITZ V, 1985, MUSCLE BIOPSY
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   OKULLA T, 2004, IN PRESS GRAEF ARCH
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Simon DK, 1999, ANNU REV MED, V50, P111
   Sommer F, 2003, KLIN MONATSBL AUGENH, V220, P315, DOI 10.1055/s-2003-39428
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
NR 14
TC 6
Z9 7
U1 0
U2 4
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0023-2165
J9 KLIN MONATSBL AUGENH
JI Klinische Monatsblat. Augenheilkunde
PD DEC
PY 2004
VL 221
IS 12
BP 1057
EP 1061
DI 10.1055/s-2004-813830
PG 5
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 886SW
UT WOS:000226249900009
PM 15599814
DA 2024-11-01
ER

PT J
AU Henriques, M
   Diogo, L
   Garcia, P
   Pratas, J
   Simoes, M
   Grazina, M
AF Henriques, Margarida
   Diogo, Luisa
   Garcia, Paula
   Pratas, Joao
   Simoes, Marta
   Grazina, Manuela
TI Mitochondrial DNA 8993T&gt;G Mutation in a Child With Ornithine
   Transcarbamylase Deficiency and Leigh Syndrome: An Unexpected
   Association
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mtDNA 8993T > G mutation; Leigh syndrome; ornithine transcarbamylase
   deficiency; mitochondrial disease; lactic acidosis
ID UREA CYCLE DISORDERS; GENE
AB MC, female, is the third child of a nonconsanguineous Portuguese couple, born after an uneventful pregnancy and delivery. A positive family history of ornithine transcarbamylase deficiency, associated with the IVS8+1 G>A mutation in the ornithine transcarbamylase gene, prompted prenatal diagnosis with identification of the same mutation in the proband. During an episode of Klebsiella pneumoniae sepsis at 1.5 months of age, lactic acidosis and moderate hyperammonemia were noticed. After a short asymptomatic period, progressive neurologic symptoms, with normal ammonemia, persistent hyperlactacidemia, and typical lesions in brain computed tomography (CT) scan led to a diagnosis of Leigh syndrome. Mitochondrial respiratory chain complex V was reduced in the liver. The mtDNA 8993T>G mutation was identified in the liver, muscle, and blood (82%-87% heteroplasmy). She died at 6 months of age. This case represents a benign phenotype of ornithine transcarbamylase deficiency, associated with a severe mitochondrial respiratory chain disorder due to an mtDNA pathogenic mutation.
C1 [Grazina, Manuela] Univ Coimbra, Fac Med Coimbra, Lab Biochem Genet, Ctr Neurosci & Cell Biol, P-3000354 Coimbra, Portugal.
   [Henriques, Margarida; Diogo, Luisa; Garcia, Paula] CHC, Ctr Desenvolvimento Dr Luis Borges, Hosp Pediat Coimbra, Coimbra, Portugal.
   [Grazina, Manuela] Univ Coimbra, Fac Med, Coimbra, Portugal.
C3 Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e
   Universitario de Coimbra (CHUC); Universidade de Coimbra
RP Grazina, M (corresponding author), Univ Coimbra, Fac Med Coimbra, Lab Biochem Genet, Ctr Neurosci & Cell Biol, Polo 3 Subunidade i Ensino,2 Andar,Gab 2-31, P-3000354 Coimbra, Portugal.
EM mgrazina@ci.uc.pt
RI García, Paula/JFK-7286-2023; Grazina, Manuela/W-3759-2017
OI Simoes, Marta/0000-0003-3998-1611; Diogo, Luisa/0000-0003-3821-6643;
   Grazina, Manuela/0000-0002-1173-6481
CR Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Bindoff L., 2006, Mitochondrial Medicine, P143
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Debray FG, 2010, J CHILD NEUROL, V25, P1000, DOI 10.1177/0883073809351983
   King LS, 2005, CRIT CARE CLIN, V21, pS37, DOI 10.1016/j.ccc.2005.08.001
   Leonard J, 2000, INBORN METABOLIC DIS, P215
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Wilcken B, 2004, MOL GENET METAB, V81, pS86, DOI 10.1016/j.ymgme.2003.10.016
NR 12
TC 6
Z9 7
U1 0
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
J9 J CHILD NEUROL
JI J. Child Neurol.
PD AUG
PY 2012
VL 27
IS 8
BP 1059
EP 1061
DI 10.1177/0883073811431015
PG 3
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 976UC
UT WOS:000306610100015
PM 22241703
DA 2024-11-01
ER

PT J
AU Goudenège, D
   Bris, C
   Hoffmann, V
   Desquiret-Dumas, V
   Jardel, C
   Rucheton, B
   Bannwarth, S
   Paquis-Flucklinger, V
   Lebre, AS
   Colin, E
   Amati-Bonneau, P
   Bonneau, D
   Reynier, P
   Lenaers, G
   Procaccio, V
AF Goudenege, David
   Bris, Celine
   Hoffmann, Virginie
   Desquiret-Dumas, Valerie
   Jardel, Claude
   Rucheton, Benoit
   Bannwarth, Sylvie
   Paquis-Flucklinger, Veronique
   Lebre, Anne Sophie
   Colin, Estelle
   Amati-Bonneau, Patrizia
   Bonneau, Dominique
   Reynier, Pascal
   Lenaers, Guy
   Procaccio, Vincent
TI eKLIPse: a sensitive tool for the detection and quantification of
   mitochondrial DNA deletions from next-generation sequencing data
SO GENETICS IN MEDICINE
LA English
DT Article
DE mitochondrial diseases; mitochondrial genome; mtDNA deletions;
   next-generation sequencing; soft clipping
ID MUTATIONS; PHENOTYPE; GENOTYPE; INFORMATION; MUSCLE; PCR
AB Purpose: Accurate detection of mitochondrial DNA (mtDNA) alterations is essential for the diagnosis of mitochondrial diseases. The development of high-throughput sequencing technologies has enhanced the detection sensitivity of mtDNA pathogenic variants, but the detection of mtDNA rearrangements, especially multiple deletions, is still poorly processed. Here, we present eKLIPse, a sensitive and specific tool allowing the detection and quantification of large mtDNA rearrangements from single and paired-end sequencing data.
   Methods: The methodology was first validated using a set of simulated data to assess the detection sensitivity and specificity, and second with a series of sequencing data from mitochondrial disease patients carrying either single or multiple deletions, related to pathogenic variants in nuclear genes involved in mtDNA maintenance.
   Results: eKLIPse provides the precise breakpoint positions and the cumulated percentage of mtDNA rearrangements at a given gene location with a detection sensitivity lower than 0.5% mutant. eKLIPse software is available either as a script to be integrated in a bioinformatics pipeline, or as user-friendly graphical interface to visualize the results through a Circos representation (https://github.com/dooguypapua/eKLIPse).
   Conclusion: Thus, eKLIPse represents a useful resource to study the causes and consequences of mtDNA rearrangements, for further genotype/phenotype correlations in mitochondrial disorders.
C1 [Goudenege, David; Bris, Celine; Hoffmann, Virginie; Desquiret-Dumas, Valerie; Colin, Estelle; Amati-Bonneau, Patrizia; Bonneau, Dominique; Reynier, Pascal; Lenaers, Guy; Procaccio, Vincent] Angers Univ, MitoVasc Inst, MitoLab, UMR CNRS 6015,INSERM U1083, Angers, France.
   [Goudenege, David; Bris, Celine; Desquiret-Dumas, Valerie; Colin, Estelle; Amati-Bonneau, Patrizia; Bonneau, Dominique; Reynier, Pascal; Procaccio, Vincent] Angers Hosp, Biochem & Genet Dept, Angers, France.
   [Jardel, Claude; Rucheton, Benoit] GHU Pitie Salpetriere, AP HP, Biochem Dept, Paris, France.
   [Jardel, Claude; Rucheton, Benoit] GHU Pitie Salpetriere, AP HP, Genet Ctr, Paris, France.
   [Bannwarth, Sylvie; Paquis-Flucklinger, Veronique] Univ Cote dAzur, IRCAN, CNRS, INSERM,CHU Nice, Nice, France.
   [Lebre, Anne Sophie] CHU Reims, Pole Biol, Serv Genet, Hop Maison Blanche, Reims, France.
C3 Universite d'Angers; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire
   d'Angers; Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere
   - APHP; Sorbonne Universite; Centre National de la Recherche
   Scientifique (CNRS); CHU Nice; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite Cote d'Azur; Universite de Reims
   Champagne-Ardenne; CHU de Reims
RP Procaccio, V (corresponding author), Angers Univ, MitoVasc Inst, MitoLab, UMR CNRS 6015,INSERM U1083, Angers, France.; Procaccio, V (corresponding author), Angers Hosp, Biochem & Genet Dept, Angers, France.
EM ViProcaccio@chu-angers.fr
RI colin, estelle/AAI-2447-2019; Lenaers, guy/X-4727-2019; Reynier,
   Pascal/K-3677-2015; Lebre, Anne-Sophie/AAO-1413-2020; Procaccio,
   Vincent/M-2596-2015; Desquiret-Dumas, Valérie/K-2695-2015
OI Goudenege, David/0000-0003-0738-2905; procaccio,
   Vincent/0000-0002-1537-4684; Reynier, Pascal/0000-0003-0802-4608;
   Desquiret-Dumas, Valerie/0000-0001-9551-9400; rucheton,
   benoit/0000-0002-5893-6595
FU Association contre les Maladies Mitochondriales; University and Hospital
   of Angers
FX This work was supported by grants from Association contre les Maladies
   Mitochondriales, and the University and Hospital of Angers.
CR BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1821-7
   Boucret L, 2017, HUM REPROD, V32, P2101, DOI 10.1093/humrep/dex268
   Caboche S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-264
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Grady JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114462
   Guo Y, 2013, BIOINFORMATICS, V29, P1210, DOI 10.1093/bioinformatics/btt118
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465
   Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   MORAES CT, 1995, MUSCLE NERVE, pS150
   Pirooznia M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00138
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Seneca S, 2015, EUR J HUM GENET, V23, P41, DOI 10.1038/ejhg.2014.49
   SPELBRINK JN, 1994, HUM MOL GENET, V3, P1989, DOI 10.1093/hmg/3.11.1989
   Suzuki S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S7
   Tonska K, 2012, GENE, V506, P161, DOI 10.1016/j.gene.2012.06.081
   Vancampenhout K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112950
   Wallace D., 2013, Emery and Rimoin's Principles and Practice of Medical Genetics, P1
   Wong LJC, 2013, NEUROTHERAPEUTICS, V10, P262, DOI 10.1007/s13311-012-0170-5
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Wu Yinghua, 2013, Frontiers in Genetics, V4, P157, DOI 10.3389/fgene.2013.00157
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 37
TC 35
Z9 35
U1 0
U2 8
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1098-3600
EI 1530-0366
J9 GENET MED
JI Genet. Med.
PD JUN
PY 2019
VL 21
IS 6
BP 1407
EP 1416
DI 10.1038/s41436-018-0350-8
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA IB2DN
UT WOS:000470079700020
PM 30393377
OA Bronze
DA 2024-11-01
ER

PT J
AU Park, SY
   Choi, GH
   Choi, HI
   Ryu, JW
   Jung, CY
   Lee, W
AF Park, SY
   Choi, GH
   Choi, HI
   Ryu, JW
   Jung, CY
   Lee, W
TI Depletion of mitochondrial DNA causes impaired glucose utilization and
   insulin resistance in L6 GLUT4myc myocytes
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HUMAN SKELETAL-MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASE; DIABETES-MELLITUS;
   ETHIDIUM BROMIDE; RAT ADIPOCYTES; RECEPTOR SUBSTRATE-1; SIGNALING
   PATHWAYS; TRANSPORTER GLUT4; PLASMA-MEMBRANE; NIDDM SUBJECTS
AB Mitochondrial dysfunction contributes to a number of human diseases, such as hyperlipidemia, obesity, and diabetes. The mutation and reduction of mitochondrial DNA (mtDNA) have been suggested as factors in the pathogenesis of diabetes. To elucidate the association of cellular mtDNA content and insulin resistance, we produced L6 GLUT4myc myocytes depleted of mtDNA by long term treatment with ethidium bromide. L6 GLUT4myc cells cultured with 0.2 mu g/ml ethidium bromide (termed depleted cells) revealed a marked decrease in cellular mtDNA and ATP content, concomitant with a lack of mRNAs encoded by mtDNA. Interestingly, the mtDNA-depleted cells showed a drastic decrease in basal and insulin-stimulated glucose uptake, indicating that L6 GLUT4myc cells develop impaired glucose utilization and insulin resistance. The repletion of mtDNA normalized basal and insulin-stimulated glucose uptake. The mRNA level and expression of insulin receptor substrate (IRS)-1 associated with insulin signaling were decreased by 76 and 90% in the depleted cells, respectively. The plasma membrane (PM) GLUT4 in the basal state was decreased, and the insulin-stimulated GLUT4 translocation to the PM was drastically reduced by mtDNA depletion. Moreover, insulin-stimulated phosphorylation of IRS-1 and Akt2/protein kinase B were drastically reduced in the depleted cells. Those changes returned to control levels after mtDNA repletion. Taken together, our data suggest that PM GLUT4 content and insulin signal pathway intermediates are modulated by the alteration of cellular mtDNA content, and the reductions in the expression of IRS-1 and insulin-stimulated phosphorylation of IRS-1 and Akt2/protein kinase B are associated with insulin resistance in the mtDNA-depleted L6 GLUT4myc myocytes.
C1 Dongguk Univ, Dept Biochem, Coll Med, Kyungju 780714, South Korea.
   SUNY Buffalo, Sch Med, Dept Physiol & Biophys, Vet Affairs Med Ctr,Biophys Lab, Buffalo, NY 14215 USA.
C3 Dongguk University; State University of New York (SUNY) System;
   University at Buffalo, SUNY; US Department of Veterans Affairs; Veterans
   Health Administration (VHA)
RP Dongguk Univ, Dept Biochem, Coll Med, Kyungju 780714, South Korea.
EM wanlee@mail.dongguk.ac.kr
RI Lee, Wan/B-6252-2013
OI Ryu, Jiwon/0000-0003-0251-7858; Lee, Wan/0000-0002-5181-2135
CR Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910
   Anai M, 1998, DIABETES, V47, P13, DOI 10.2337/diabetes.47.1.13
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790
   Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522
   Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104
   Bjornholm M, 1997, DIABETES, V46, P524, DOI 10.2337/diabetes.46.3.524
   Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782
   CHEN LB, 1989, METHOD CELL BIOL, V29, P103
   CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758
   DESJARDINS P, 1985, MOL CELL BIOL, V5, P1163, DOI 10.1128/MCB.5.5.1163
   Froguel P, 2001, RECENT PROG HORM RES, V56, P91, DOI 10.1210/rp.56.1.91
   Gerbitz KD, 1996, DIABETES, V45, P113, DOI 10.2337/diabetes.45.2.113
   GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329
   Han JC, 2003, ARCH BIOCHEM BIOPHYS, V413, P213, DOI 10.1016/S0003-9861(03)00120-6
   HANSEN PA, 1995, J BIOL CHEM, V270, P1679
   Hayakawa T, 1998, J BIOL CHEM, V273, P20300, DOI 10.1074/jbc.273.32.20300
   HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E
   Higaki Y, 1999, J BIOL CHEM, V274, P20791, DOI 10.1074/jbc.274.30.20791
   Holman GD, 2001, TRENDS CELL BIOL, V11, P173, DOI 10.1016/S0962-8924(01)01953-5
   Huang C, 2002, DIABETES, V51, P2090, DOI 10.2337/diabetes.51.7.2090
   JHUN BH, 1992, J BIOL CHEM, V267, P17710
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   KANAI F, 1993, J BIOL CHEM, V268, P14523
   Kanzaki M, 2003, CURR BIOL, V13, pR574, DOI 10.1016/S0960-9822(03)00478-0
   Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374
   Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872
   Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7
   Khayat ZA, 2000, J CELL SCI, V113, P279
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Krook A, 1998, DIABETES, V47, P1281, DOI 10.2337/diabetes.47.8.1281
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   Lee W, 2000, BIOCHEMISTRY-US, V39, P9358, DOI 10.1021/bi0007021
   Lee W, 1999, J BIOL CHEM, V274, P37755, DOI 10.1074/jbc.274.53.37755
   Li DL, 2001, J BIOL CHEM, V276, P22883, DOI 10.1074/jbc.M010143200
   Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200
   Malide D, 1997, J HISTOCHEM CYTOCHEM, V45, P1083, DOI 10.1177/002215549704500806
   MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x
   Park KS, 2001, AM J PHYSIOL-ENDOC M, V280, pE1007, DOI 10.1152/ajpendo.2001.280.6.E1007
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   SAAD MJA, 1993, J CLIN INVEST, V92, P2065, DOI 10.1172/JCI116803
   Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3
   Seidel-Rogol BL, 2002, NUCLEIC ACIDS RES, V30, P1929, DOI 10.1093/nar/30.9.1929
   SERRADAS P, 1995, ENDOCRINOLOGY, V136, P5623, DOI 10.1210/en.136.12.5623
   Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051
   SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930
   Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166
   Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096
   SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542
   Sweeney G, 1999, J BIOL CHEM, V274, P10071, DOI 10.1074/jbc.274.15.10071
   Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI200112348
   Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572
   Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2
   Wang QH, 1999, MOL CELL BIOL, V19, P4008
   Watson RT, 2001, RECENT PROG HORM RES, V56, P175, DOI 10.1210/rp.56.1.175
   White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952
   Whitehead JP, 2000, CURR OPIN CELL BIOL, V12, P222, DOI 10.1016/S0955-0674(99)00079-4
   Yamauchi T, 1996, MOL CELL BIOL, V16, P3074
   Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8
   ZYLBER E, 1969, J MOL BIOL, V44, P195, DOI 10.1016/0022-2836(69)90414-8
NR 66
TC 51
Z9 56
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 18
PY 2005
VL 280
IS 11
BP 9855
EP 9864
DI 10.1074/jbc.M409399200
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 905HQ
UT WOS:000227559600015
PM 15764607
OA hybrid
DA 2024-11-01
ER

PT J
AU Dong, DW
   Pereira, F
   Barrett, SP
   Kolesar, JE
   Cao, KJ
   Damas, J
   Yatsunyk, LA
   Johnson, FB
   Kaufman, BA
AF Dong, Dawei W.
   Pereira, Filipe
   Barrett, Steven P.
   Kolesar, Jill E.
   Cao, Kajia
   Damas, Joana
   Yatsunyk, Liliya A.
   Johnson, F. Brad
   Kaufman, Brett A.
TI Association of G-quadruplex forming sequences with human mtDNA deletion
   breakpoints
SO BMC GENOMICS
LA English
DT Article
DE G-quadruplex; mtDNA deletions; Mitochondrial disease; Mitochondrial
   genome instability; Non-B DNA; Nucleic acid structures
ID MITOCHONDRIAL-DNA DELETIONS; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   LARGE-SCALE DELETIONS; HUMAN PIF1 HELICASE; SECONDARY STRUCTURES; GENOME
   INSTABILITY; DIRECT REPEATS; REPLICATION; MUTATIONS; STABILITY
AB Background: Mitochondrial DNA (mtDNA) deletions cause disease and accumulate during aging, yet our understanding of the molecular mechanisms underlying their formation remains rudimentary. Guanine-quadruplex (GQ) DNA structures are associated with nuclear DNA instability in cancer; recent evidence indicates they can also form in mitochondrial nucleic acids, suggesting that these non-B DNA structures could be associated with mtDNA deletions. Currently, the multiple types of GQ sequences and their association with human mtDNA stability are unknown.
   Results: Here, we show an association between human mtDNA deletion breakpoint locations (sites where DNA ends rejoin after deletion of a section) and sequences with G-quadruplex forming potential (QFP), and establish the ability of selected sequences to form GQ in vitro. QFP contain four runs of either two or three consecutive guanines (2G and 3G, respectively), and we identified four types of QFP for subsequent analysis: intrastrand 2G, intrastrand 3G, duplex derived interstrand (ddi) 2G, and ddi 3G QFP sequences. We analyzed the position of each motif set relative to either 5' or 3' unique mtDNA deletion breakpoints, and found that intrastrand QFP sequences, but not ddi QFP sequences, showed significant association with mtDNA deletion breakpoint locations. Moreover, a large proportion of these QFP sequences occur at smaller distances to breakpoints relative to distribution-matched controls. The positive association of 2G QFP sequences persisted when breakpoints were divided into clinical subgroups. We tested in vitro GQ formation of representative mtDNA sequences containing these 2G QFP sequences and detected robust GQ structures by UV-VIS and CD spectroscopy. Notably, the most frequent deletion breakpoints, including those of the "common deletion", are bounded by 2G QFP sequence motifs.
   Conclusions: The potential for GQ to influence mitochondrial genome stability supports a high-priority investigation of these structures and their regulation in normal and pathological mitochondrial biology. These findings emphasize the potential importance of helicases that subsequently resolve GQ to maintain the stability of the mitochondrial genome.
C1 [Dong, Dawei W.; Kolesar, Jill E.; Kaufman, Brett A.] Univ Penn, Sch Vet Med, Dept Biol Anim, Philadelphia, PA 19104 USA.
   [Dong, Dawei W.] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA.
   [Pereira, Filipe; Damas, Joana] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal.
   [Pereira, Filipe] Univ Porto, CIIMAR CIMAR, Interdisciplinary Ctr Marine & Environm Res, P-4100 Oporto, Portugal.
   [Barrett, Steven P.; Yatsunyk, Liliya A.] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA.
   [Cao, Kajia] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
   [Johnson, F. Brad] Univ Penn, Perelman Sch Med, Dept Lab Med & Pathol, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; University of Pennsylvania; Universidade do
   Porto; Universidade do Porto; Swarthmore College; University of
   Pennsylvania; University of Pennsylvania
RP Kaufman, BA (corresponding author), Univ Penn, Sch Vet Med, Dept Biol Anim, Philadelphia, PA 19104 USA.
EM bkauf@vet.upenn.edu
RI Kolesar, Jill/AAA-9727-2020; Kaufman, Brett/IUP-1225-2023; Damas,
   Joana/J-6045-2013; Pereira, Filipe/F-6391-2010
OI Damas, Joana/0000-0003-4857-2510; Pereira, Filipe/0000-0001-8950-1036
FU University Research Foundation; University of Pennsylvania; NIH
   [R01-AG021521, P01-AG031862, P30-DK050306]; Portuguese Foundation for
   Science and Technology (FCT); Fundo Social Europeu and Programa
   Operacional Potencial Humano [PTDC/CVT/100881/2008]; Swarthmore College;
   Fundação para a Ciência e a Tecnologia [PTDC/CVT/100881/2008] Funding
   Source: FCT
FX We would like to thank Sion Williams for his thoughtful comments on this
   manuscript. DWD is supported by a grant from the University Research
   Foundation, University of Pennsylvania. FBJ was supported by NIH
   R01-AG021521 and FBJ and KC were supported by NIH P01-AG031862. BAK and
   JEK were supported by NIH P30-DK050306. FP and JD are supported by the
   Portuguese Foundation for Science and Technology (FCT), Fundo Social
   Europeu and Programa Operacional Potencial Humano [PTDC/CVT/100881/2008
   and Investigator FCT program]; LAY was supported by funds from
   Swarthmore College.
CR ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhattacharjee AJ, 2011, BIOCHIMIE, V93, P1297, DOI 10.1016/j.biochi.2011.05.038
   Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296
   Cao KJ, 2012, METHODS, V57, P3, DOI 10.1016/j.ymeth.2012.05.002
   Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089
   Douarre C, 2013, NUCLEIC ACIDS RES, V41, P3588, DOI 10.1093/nar/gkt073
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   George T, 2009, NUCLEIC ACIDS RES, V37, P6491, DOI 10.1093/nar/gkp671
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Huppert JL, 2008, BIOCHIMIE, V90, P1140, DOI 10.1016/j.biochi.2008.01.014
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347
   Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253
   Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152
   Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1324
   Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Lakshmanan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035271
   Lee DY, 1996, J BIOL CHEM, V271, P24262, DOI 10.1074/jbc.271.39.24262
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316
   Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1
   Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213
   Oliveira PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059907
   Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149
   Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015
   Petraccone L, 2005, NUCLEOS NUCLEOT NUCL, V24, P757, DOI 10.1081/NCN-200060080
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806
   Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475
   Risitano A, 2004, NUCLEIC ACIDS RES, V32, P2598, DOI 10.1093/nar/gkh598
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009
   Smith JS, 2011, NAT STRUCT MOL BIOL, V18, P478, DOI 10.1038/nsmb.2033
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   VANTUYLE GC, 1985, J CELL BIOL, V100, P251, DOI 10.1083/jcb.100.1.251
   Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802
   Wanrooij PH, 2010, P NATL ACAD SCI USA, V107, P16072, DOI 10.1073/pnas.1006026107
   Yang JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073318
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 67
TC 85
Z9 90
U1 0
U2 51
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD AUG 13
PY 2014
VL 15
AR 677
DI 10.1186/1471-2164-15-677
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA AO0XG
UT WOS:000341035600001
PM 25124333
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Filosto, M
   Tomelleri, G
   Tonin, P
   Scarpelli, M
   Vattemi, G
   Rizzuto, N
   Padovani, A
   Simonati, A
AF Filosto, Massimiliano
   Tomelleri, Giuliano
   Tonin, Paola
   Scarpelli, Mauro
   Vattemi, Gaetano
   Rizzuto, Nicolo
   Padovani, Alessandro
   Simonati, Alessandro
TI Neuropathology of mitochondrial diseases
SO BIOSCIENCE REPORTS
LA English
DT Article; Proceedings Paper
CT Conference on Mitochondrial Medicine
CY OCT   25, 2006
CL Univ Pisa, Dept Neurosci, Pisa, ITALY
HO Univ Pisa, Dept Neurosci
DE mitochondrial diseases; neuropathology; muscle pathology
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; ENCEPHALOMYOPATHIES; MYOPATHY;
   FEATURES; MELAS; ENCEPHALOPATHY; MUTATIONS
AB The term "mitochondrial diseases" (MD) refers to a group of disorders related to respiratory chain dysfunction. Clinical features are usually extremely heterogeneous because MD may involve several tissues with different degrees of severity. Muscle and brain are mostly affected, probably because of their high dependence on oxidative metabolism.
   Muscle can be the only affected tissue or involved as a part of a multi-system disease; ragged red fibers, accumulation of structurally altered mitochondria and cytochrome-c-oxidase (COX) negative fibers are the main pathological features.
   In mitochondrial encephalopathies, central nervous system (CNS) structures are affected according to different patterns of distribution and severity. Characteristic lesions are neuronal loss, vasculo-necrotic changes, gliosis, demyelination and spongy degeneration.
   In accordance with either grey matter or white matter involvement two main groups of diseases may be distinguished. Neuronal loss and vasculo-necrotic multifocal lesions are the common features of grey matter involvement; demyelination and spongy degeneration occur when white matter is affected, often associated with less severe lesions of the grey structures.
   Grey matter lesions are prevalent in MERRF, MELAS, Alpers and Leigh syndromes. White matter involvement is always seen in Kearns-Sayre syndrome and was recently described in mtDNA depletion syndrome linked to dGK mutations and in the rare conditions associated with complex I and II deficiency.
   In this review we describe the main histopathological features of muscle and CNS lesions in mitochondrial diseases.
C1 Univ Hosp, Spedali Civili, Sect Neuromuscular Dis & Neuropathies, I-25100 Brescia, Italy.
   Univ Verona, Dept Neurol Sci & Vis, Sect Clin Neurol, I-37100 Verona, Italy.
C3 Hospital Spedali Civili Brescia; University of Verona
RP Filosto, M (corresponding author), Univ Hosp, Spedali Civili, Sect Neuromuscular Dis & Neuropathies, P Spedali Civili 1, I-25100 Brescia, Italy.
EM filosto@med.unibs.it
RI Tonin, Paola/AAC-5052-2022; Padovani, Alessandro/ABI-7312-2020; Filosto,
   Massimiliano/S-9446-2019; Vattemi, Gaetano/AAC-4668-2022
OI Padovani, Alessandro/0000-0002-0119-3639; Vattemi,
   Gaetano/0000-0003-3412-8339; Filosto, Massimiliano/0000-0002-2852-7512
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   Brown GK, 1996, J INHERIT METAB DIS, V19, P553, DOI 10.1007/BF01799116
   Burgeois M, 1992, BRAIN DEV, V14, P404
   Clark JM, 1996, NEUROLOGY, V46, P223, DOI 10.1212/WNL.46.1.223
   DIDONATO S, 2002, MITOCHONDRIAL DISORD, P5
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2004, ACTA NEUROPATHOL, V108, P168, DOI 10.1007/s00401-004-0872-9
   FILOSTO M, 2007, ACTA NEUROLO SCAND
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   MONTPETIT VJ, 1971, BRAIN, V94, P1, DOI 10.1093/brain/94.1.1
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   Simonati A, 2003, ACTA NEUROPATHOL, V106, P57, DOI 10.1007/s00401-003-0698-x
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Vu TH, 2002, NEUROL CLIN, V20, P809, DOI 10.1016/S0733-8619(01)00017-2
NR 22
TC 75
Z9 91
U1 0
U2 6
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0144-8463
J9 BIOSCIENCE REP
JI Biosci. Rep.
PD JUN
PY 2007
VL 27
IS 1-3
BP 23
EP 30
DI 10.1007/s10540-007-9034-3
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 178YM
UT WOS:000247256300004
PM 17541738
DA 2024-11-01
ER

PT J
AU Arbeithuber, B
   Cremona, MA
   Hester, J
   Barrett, A
   Higgins, B
   Anthony, K
   Chiaromonte, F
   Diaz, FJ
   Makova, KD
AF Arbeithuber, Barbara
   Cremona, Marzia A.
   Hester, James
   Barrett, Alison
   Higgins, Bonnie
   Anthony, Kate
   Chiaromonte, Francesca
   Diaz, Francisco J.
   Makova, Kateryna D.
TI Advanced age increases frequencies of de novo mitochondrial mutations in
   macaque oocytes and somatic tissues
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE mitochondria; oocytes; mutations; duplex sequencing; heteroplasmy
ID RNA-POLYMERASE; IN-VIVO; DNA; GENERATION; TURNOVER; CELLS; MTDNA;
   REPRODUCTION; LIVER
AB Mutations in mitochondrial DNA (mtDNA) contribute to multiple diseases. However, how new mtDNA mutations arise and accumulate with age remains understudied because of the high error rates of current sequencing technologies. Duplex sequencing reduces error rates by several orders of magnitude via independently tagging and analyzing each of the two template DNA strands. Here, using duplex sequencing, we obtained high-quality mtDNA sequences for somatic tissues (liver and skeletal muscle) and single oocytes of 30 unrelated rhesus macaques, from 1 to 23 y of age. Sequencing single oocytes minimized effects of natural selection on germline mutations. In total, we identified 17,637 tissue-specific de novo mutations. Their frequency increased similar to 3.5-fold in liver and similar to 2.8-fold in muscle over the similar to 20 y assessed. Mutation frequency in oocytes increased similar to 2.5-fold until the age of 9 y, but did not increase after that, suggesting that oocytes of older animals maintain the quality of their mtDNA. We found the lightstrand origin of replication (OriL) to be a hotspot for mutation accumulation with aging in liver. Indeed, the 33-nucleotide-long OriL harbored 12 variant hotspots, 10 of which likely disrupt its hairpin structure and affect replication efficiency. Moreover, in somatic tissues, protein-coding variants were subject to positive selection (potentially mitigating toxic effects of mitochondrial activity), the strength of which increased with the number of macaques harboring variants. Our work illuminates the origins and accumulation of somatic and germline mtDNA mutations with aging in primates and has implications for delayed reproduction in modern human societies.
C1 [Arbeithuber, Barbara; Barrett, Alison; Higgins, Bonnie; Anthony, Kate; Makova, Kateryna D.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA.
   [Arbeithuber, Barbara] Johannes Kepler Univ Linz, Kepler Univ Hosp Linz, Expt Gynaecol Obstet & Gynaecol Endocrinol, A-4020 Linz, Austria.
   [Cremona, Marzia A.] Univ Laval, Dept Operat & Decis Syst, Quebec City, PQ G1V 0A6, Canada.
   [Cremona, Marzia A.] Univ Laval, CHU Quebec, Populat Hlth & Optimal Hlth Practices, Res Ctr, Quebec City, PQ G1V 4G2, Canada.
   [Cremona, Marzia A.; Chiaromonte, Francesca; Makova, Kateryna D.] Penn State Univ, Ctr Med Genom, University Pk, PA 16802 USA.
   [Hester, James; Diaz, Francisco J.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.
   [Chiaromonte, Francesca] Penn State Univ, Dept Stat, University Pk, PA 16802 USA.
   [Chiaromonte, Francesca] St Anna Sch Adv Studies, Inst Econ, I-56127 Pisa, Italy.
   [Chiaromonte, Francesca] St Anna Sch Adv Studies, EMbeDS, I-56127 Pisa, Italy.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; Johannes Kepler University Linz; Kepler University
   Hospital; Laval University; Laval University; Pennsylvania Commonwealth
   System of Higher Education (PCSHE); Pennsylvania State University;
   Pennsylvania State University - University Park; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); Pennsylvania State
   University; Pennsylvania State University - University Park;
   Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; Scuola Superiore Sant'Anna; Scuola Superiore Sant'Anna
RP Makova, KD (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.; Makova, KD (corresponding author), Penn State Univ, Ctr Med Genom, University Pk, PA 16802 USA.
EM kdm16@psu.edu
RI Cremona, Marzia/AAU-2989-2020; Arbeithuber, Barbara/AAE-8557-2022
OI Diaz, Francisco Javier/0000-0002-2875-7393; Arbeithuber,
   Barbara/0000-0001-8367-1560; Makova, Kateryna/0000-0002-6212-9526;
   Cremona, Marzia Angela/0000-0001-8899-7316
FU NIH [R01GM116044]; Schrodinger Fellowship from the Austrian Science Fund
   (FWF) [J-4096]; Office of Science Engagement; Huck Institute of Life
   Sciences; Institute for Computational and Data Sciences at Penn State;
   National Institutes of Health [P51OD011092]; Eberly College of Sciences
FX We are grateful to Nicholas Stoler for developing the duplex sequencing
   instance on Galaxy and for advice on the analysis, to Irene
   Tiemann-Boege for helpful discussions regarding the development of the
   library preparation protocols, and to Kristin Eckert and Suzanne Hile
   for their help in establishing the duplex sequencing method in the
   Makova lab. We are grateful to Southwest (Jera Pecotte), Oregon (Wendy
   Price), Wisconsin (Heather Simmons), and Washington (Chris English)
   National Primate Research Centers for collecting samples for this study.
   Sequencing was performed by the Penn State Genomics Core Facility,
   University Park, PA. This project was supported by a grant from NIH
   (R01GM116044) to K.D.M. and a Schrodinger Fellowship from the Austrian
   Science Fund (FWF) to B.A. (J-4096). Additional funding was provided by
   the Office of Science Engagement, Eberly College of Sciences, and The
   Huck Institute of Life Sciences and the Institute for Computational and
   Data Sciences at Penn State. This research was supported in part by the
   National Institutes of Health Grant P51OD011092 to the Oregon National
   Primate Research Center.
CR Ancora M, 2017, MITOCHONDRIAL DNA A, V28, P180, DOI 10.3109/19401736.2015.1115499
   Arbeithuber B., RAW SEQUENCING READS
   Arbeithuber B, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000745
   Barrett A, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0175
   Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026
   Boucret L, 2017, HUM REPROD, V32, P2101, DOI 10.1093/humrep/dex268
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Degtyareva NP, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000263
   Erwin JA, 2016, NAT NEUROSCI, V19, P1583, DOI 10.1038/nn.4388
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Fan LH, 2019, BIOCHEM BIOPH RES CO, V513, P912, DOI 10.1016/j.bbrc.2019.04.100
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gigarel N, 2011, AM J HUM GENET, V88, P494, DOI 10.1016/j.ajhg.2011.03.010
   Gorelick AN, 2021, NAT METAB, V3, P558, DOI 10.1038/s42255-021-00378-8
   Guiblet WM, 2021, NUCLEIC ACIDS RES, V49, P1497, DOI 10.1093/nar/gkaa1269
   Hendy MD, 2009, BIOL LETTERS, V5, P397, DOI 10.1098/rsbl.2009.0104
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Iismaa SE, 2018, NPJ REGEN MED, V3, DOI 10.1038/s41536-018-0044-5
   Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Kirillova A, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10092484
   Kopp JL, 2016, NAT CELL BIOL, V18, P238, DOI 10.1038/ncb3309
   Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lindsay SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12023-w
   Liu BJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23421
   May-Panloup P, 2016, HUM REPROD UPDATE, V22, P725, DOI 10.1093/humupd/dmw028
   Mechta M, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00166
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209
   Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x
   Moorjani P, 2016, P NATL ACAD SCI USA, V113, P10607, DOI 10.1073/pnas.1600374113
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Patil V, 2019, NUCLEIC ACIDS RES, V47, P10072, DOI 10.1093/nar/gkz762
   Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0
   Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469
   RAWLINS RG, 1985, AM J PRIMATOL, V9, P87, DOI 10.1002/ajp.1350090203
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541
   Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929
   Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109
   Shen QZ, 2021, BIOL REPROD, V104, P294, DOI 10.1093/biolre/ioaa194
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028
   Stoler N, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3419-8
   Suspène R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Tardif S, 2012, AM COLL LAB, P197, DOI 10.1016/B978-0-12-381365-7.00008-X
   Walker ErnestP., 1983, Walker's Mammals of the World
   Wang RJ, 2020, GENOME RES, V30, P826, DOI 10.1101/gr.255174.119
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990
   Wilton PR, 2018, GENETICS, V208, P1261, DOI 10.1534/genetics.118.300711
   Xue C, 2016, GENOME RES, V26, P1651, DOI 10.1101/gr.204255.116
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 60
TC 18
Z9 19
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 12
PY 2022
VL 119
IS 15
AR e2118740119
DI 10.1073/pnas.2118740119
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 2P6SA
UT WOS:000819867000014
PM 35394879
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Oexner, RR
   Pla-Martín, D
   Pass, T
   Wiesen, MHJ
   Zentis, P
   Schauss, A
   Baris, OR
   Kimoloi, S
   Wiesner, RJ
AF Oexner, Rafael R.
   Pla-Martin, David
   Pass, Thomas
   Wiesen, Martin H. J.
   Zentis, Peter
   Schauss, Astrid
   Baris, Olivier R.
   Kimoloi, Sammy
   Wiesner, Rudolf J.
TI Extraocular Muscle Reveals Selective Vulnerability of Type IIB Fibers to
   Respiratory Chain Defects Induced by Mitochondrial DNA Alterations
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
DE mtDNA deletions; extraocular muscle; type IIB fibers; cytochrome C
   oxidase; selective vulnerability
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; LAYER-SPECIFIC DIFFERENCES;
   SKELETAL-MUSCLE; DELETION MUTATIONS; ABNORMALITIES; EXPRESSION; CELLS
AB PURPOSE. The purpose of this study was to gain insights on the pathogenesis of chronic progressive external ophthalmoplegia, thus we investigated the vulnerability of five extra ocular muscles (EOMs) fiber types to pathogenic mitochondrial DNA deletions in a mouse model expressing a mutated mitochondrial helicase TWINKLE.
   METHODS. Consecutive pairs of EOM sections were analyzed by cytochrome C oxidase (COX)/succinate dehydrogenase (SDH) assay and fiber type specific immunohistochemistry (type I, IIA, IIB, embryonic, and EOM-specific staining).
   RESULTS. The mean average of COX deficient fibers (COX-) in the recti muscles of mutant mice was 1.04 +/- 0.52% at 12 months and increased with age (7.01 +/- 1.53% at 24 months). A significant proportion of these COX-fibers were of the fast-twitch, glycolytic type IIB (> 50% and > 35% total COX-fibers at 12 and 24 months, respectively), whereas embryonic myosin heavy chain-expressing fibers were almost completely spared. Furthermore, the proportion of COX-fibers in the type IIB-rich retractor bulbi muscle was > 2-fold higher compared to the M. recti at both 12 (2.6 +/- 0.78%) and 24 months (20.85 +/- 2.69%). Collectively, these results demonstrate a selective vulnerability of type IIB fibers to mitochondrial DNA (mtDNA) deletions in EOMs and retractor bulbi muscle. We also show that EOMs of mutant mice display histopathological abnormalities, including altered fiber type composition, increased fibrosis, ragged red fibers, and infiltration of mononucleated nonmuscle cells.
   CONCLUSIONS. Our results point to the existence of fiber type IIB-intrinsic factors and/or molecular mechanisms that predispose them to increased generation, clonal expansion, and detrimental effects of mtDNA deletions.
C1 [Oexner, Rafael R.; Pla-Martin, David; Pass, Thomas; Baris, Olivier R.; Kimoloi, Sammy; Wiesner, Rudolf J.] Univ Cologne, Ctr Physiol & Pathophysiol, Inst Vegetat Physiol, Cologne, Germany.
   [Kimoloi, Sammy] Masinde Muliro Univ Sci & Technol, Dept Med Lab Sci, POB 190-50100, Kakamega, Kenya.
   [Wiesen, Martin H. J.] Univ Hosp Koln, Med Fac, Ctr Pharmacol, Therapeut Drug Monitoring Unit, Cologne, Germany.
   [Pla-Martin, David; Zentis, Peter; Schauss, Astrid; Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
   [Wiesner, Rudolf J.] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.
   [Baris, Olivier R.] Univ Angers, Inst MitoVasc, INSERM U1083, Equipe MitoLab,UMR CNRS 6015, Angers, France.
C3 University of Cologne; University of Cologne; University of Cologne;
   University of Cologne; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite d'Angers
RP Kimoloi, S (corresponding author), Masinde Muliro Univ Sci & Technol, Dept Med Lab Sci, POB 190-50100, Kakamega, Kenya.
EM kimoloi@mmust.ac.ke
RI PlaMartin, David/LGY-6405-2024; Baris, Olivier/L-3463-2016
OI Kimoloi, Sammy/0000-0003-3364-4980; Wiesen, Martin/0000-0002-9669-446X;
   Baris, Olivier/0000-0003-0974-6856; Oexner, Rafael/0009-0005-0959-601X;
   Pla Martin, David/0000-0002-5189-0723
FU Deutscher Akademischer Austauschdienst (DAAD); Deutsche
   Forschungsgemeinschaft (DFG, German Research Fundation) [269925409,
   SFB1218]; Cologne Excellence cluster on Cellular stress responses in
   Aging associated diseases - CECAD; CECAD
FX S.K. was Supported by Deutscher Akademischer Austauschdienst (DAAD).
   R.J.W. was supported by Deutsche Forschungsgemeinschaft (DFG, German
   Research Fundation) - SFB1218 Projektnummer 269925409 and Cologne
   Excellence cluster on Cellular stress responses in Aging associated
   diseases -CECAD. R.R.O. was supported by CECAD.
CR Arganda-Carreras Ignacio., 2006, Consistent and elastic registration of histological sections using vector-spline regularization
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F
   Briggs MM, 2002, J EXP BIOL, V205, P3133
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Budak MT, 2004, PHYSIOL GENOMICS, V20, P55, DOI 10.1152/physiolgenomics.00191.2004
   CARRY MR, 1986, ANAT RECORD, V214, P8, DOI 10.1002/ar.1092140103
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   JA B-E, 1988, STRUCTURAL ORG EXTRA, V2
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482
   Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   KOERNER F, 1972, ARCH OPHTHALMOL-CHIC, V88, P155, DOI 10.1001/archopht.1972.01000030157005
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Porter JD, 1998, CELL TISSUE RES, V292, P495, DOI 10.1007/s004410051078
   Remington L.A., 2011, Clinical Anatomy and Physiology of the Visual System, V3rd
   Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Spencer RF, 2006, PROG BRAIN RES, V151, P43, DOI 10.1016/S0079-6123(05)51002-1
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Treuting P. M, 2012, COMP ANATOMY HISTOLO
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wasicky R, 2000, INVEST OPHTH VIS SCI, V41, P980
   Wiesen MHJ, 2007, INVEST OPHTH VIS SCI, V48, P1119, DOI 10.1167/iovs.06-0701
   WOOTEN GF, 1972, ARCH NEUROL-CHICAGO, V26, P350, DOI 10.1001/archneur.1972.00490100080008
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 45
TC 6
Z9 6
U1 1
U2 3
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD OCT
PY 2020
VL 61
IS 12
AR 14
DI 10.1167/iovs.61.12.14
PG 13
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA OR2IJ
UT WOS:000589298400006
PM 33057669
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Trifunov, S
   Pyle, A
   Valentino, ML
   Liguori, R
   Yu-Wai-Man, P
   Burté, F
   Duff, J
   Kleinle, S
   Diebold, I
   Rugolo, M
   Horvath, R
   Carelli, V
AF Trifunov, Selena
   Pyle, Angela
   Valentino, Maria Lucia
   Liguori, Rocco
   Yu-Wai-Man, Patrick
   Burte, Florence
   Duff, Jennifer
   Kleinle, Stephanie
   Diebold, Isabel
   Rugolo, Michela
   Horvath, Rita
   Carelli, Valerio
TI Clonal expansion of mtDNA deletions: different disease models assessed
   by digital droplet PCR in single muscle cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MITOCHONDRIAL-DNA-DELETION; SKELETAL-MUSCLE; OPTIC ATROPHY; MAINTENANCE;
   MECHANISMS; MITOPHAGY; DYNAMICS; GENOMES; LENGTH; SON
AB Deletions in mitochondrial DNA (mtDNA) are an important cause of human disease and their accumulation has been implicated in the ageing process. As mtDNA is a high copy number genome, the coexistence of deleted and wild-type mtDNA molecules within a single cell defines heteroplasmy. When deleted mtDNA molecules, driven by intracellular clonal expansion, reach a sufficiently high level, a biochemical defect emerges, contributing to the appearance and progression of clinical pathology. Consequently, it is relevant to determine the heteroplasmy levels within individual cells to understand the mechanism of clonal expansion. Heteroplasmy is reflected in a mosaic distribution of cytochrome c oxidase (COX)-deficient muscle fibers. We applied droplet digital PCR (ddPCR) to single muscle fibers collected by laser-capture microdissection (LCM) from muscle biopsies of patients with different paradigms of mitochondrial disease, characterized by the accumulation of single or multiple mtDNA deletions. By combining these two sensitive approaches, ddPCR and LCM, we document different models of clonal expansion in patients with single and multiple mtDNA deletions, implicating different mechanisms and time points for the development of COX deficiency in these molecularly distinct mitochondrial cytopathies.
C1 [Trifunov, Selena; Valentino, Maria Lucia; Liguori, Rocco; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Unit Neurol, Bologna, Italy.
   [Trifunov, Selena; Pyle, Angela; Burte, Florence; Duff, Jennifer; Horvath, Rita] Newcastle Univ, Inst Genet Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Valentino, Maria Lucia; Liguori, Rocco; Carelli, Valerio] Bellaria Hosp, IRCCS, Inst Neurol Sci Bologna ISNB, Bologna, Italy.
   [Yu-Wai-Man, Patrick] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England.
   [Yu-Wai-Man, Patrick] UCL Inst Ophthalmol, London, England.
   [Yu-Wai-Man, Patrick] Univ Cambridge, Dept Clin Neurosci, Cambridge Ctr Brain Repair, Cambridge, England.
   [Yu-Wai-Man, Patrick] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.
   [Kleinle, Stephanie; Diebold, Isabel] Med Genet Ctr Munich, D-80335 Munich, Germany.
   [Rugolo, Michela] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.
C3 University of Bologna; Newcastle University - UK; IRCCS Istituto delle
   Scienze Neurologiche di Bologna (ISNB); AUSL di Bologna; University of
   London; University College London; Moorfields Eye Hospital NHS
   Foundation Trust; University of London; University College London;
   University of Cambridge; University of Cambridge; University of Bologna
RP Carelli, V (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Unit Neurol, Bologna, Italy.; Carelli, V (corresponding author), Bellaria Hosp, IRCCS, Inst Neurol Sci Bologna ISNB, Bologna, Italy.
EM valerio.carelli@unibo.it
RI Liguori, Rocco/AAB-7860-2020; Rugolo, Michela/AAY-8640-2020; Horvath,
   Rita/AAY-7042-2020; Burte, Florence/U-8257-2017
OI Trifunov, Selena/0000-0002-1807-9621; Horvath, Rita/0000-0002-9841-170X;
   Kleinle, Stephanie/0000-0003-0135-7143; Burte,
   Florence/0000-0001-9020-7838
FU Mitochondrial European Educational Training (MEET), ITN MARIE CURIE
   PEOPLE [317433]; Wellcome Centre for Mitochondrial Research
   [109915/Z/15/Z, 203105/Z/16/Z]; Medical Research Council (UK)
   [MR/N025431/1]; European Research Council [309548]; Wellcome Trust
   [201064/Z/16/Z]; Newton Fund (UK/Turkey) [MR/N027302/1]; European Union
   [SC1-PM-03-2017]; Wellcome Trust [201064/Z/16/Z] Funding Source:
   Wellcome Trust; MRC [G1000848, MR/N010035/1, MR/N025431/1, G1002570,
   MR/N025431/2, G0701386] Funding Source: UKRI; Newton Fund [MR/N027302/1,
   MR/N027302/2] Funding Source: UKRI
FX This work was supported by the Mitochondrial European Educational
   Training (MEET), ITN MARIE CURIE PEOPLE, (317433). RH is a Wellcome
   Trust Investigator (109915/Z/15/Z), who receives support from the
   Wellcome Centre for Mitochondrial Research (203105/Z/16/Z), Medical
   Research Council (UK) (MR/N025431/1), the European Research Council
   (309548), the Wellcome Trust Pathfinder Scheme (201064/Z/16/Z), the
   Newton Fund (UK/Turkey, MR/N027302/1) and the European Union H2020 -
   Research and Innovation Actions (SC1-PM-03-2017, Solve-RD). We are
   grateful to Jonathan Coxhead and Rafiqul Hussain from Genomics Core
   Facility, Institute of Genetic Medicine, Newcastle University, Newcastle
   upon Tyne, UK. The authors thank to Michele Giunta and Juliane Mueller
   from Institute of Genetic Medicine, Newcastle University and to Leonardo
   Caporali and Alessandra Maresca from Department of Biomedical and
   NeuroMotor Sciences (DIBINEM), University of Bologna.
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE672, DOI 10.1152/ajpendo.00043.2007
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   Brenner CA, 1998, MOL HUM REPROD, V4, P887, DOI 10.1093/molehr/4.9.887
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2015, INT J BIOCHEM CELL B, V63, P21, DOI 10.1016/j.biocel.2015.01.023
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Herbst A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059006
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Iommarini L, 2012, NEUROLOGY, V79, P1517, DOI 10.1212/WNL.0b013e31826d5f72
   Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100
   Liao CY, 2017, NEUROLOGY, V88, P131, DOI 10.1212/WNL.0000000000003491
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Manoj P, 2016, MITOCHONDRIAL DNA A, V27, P742, DOI 10.3109/19401736.2014.913168
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   POULTON J, 1991, AM J HUM GENET, V48, P649
   Reichmann H, 1996, EUR NEUROL, V36, P98, DOI 10.1159/000117217
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Sitarz KS, 2012, NEUROLOGY, V79, P1515, DOI 10.1212/WNL.0b013e31826d5f60
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004183
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 40
TC 16
Z9 18
U1 0
U2 5
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 3
PY 2018
VL 8
AR 11682
DI 10.1038/s41598-018-30143-z
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GP2NG
UT WOS:000440670200045
PM 30076399
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Cormio, A
   Milella, F
   Vecchiet, J
   Felzani, G
   Gadaleta, MN
   Cantatore, P
AF Cormio, A
   Milella, F
   Vecchiet, J
   Felzani, G
   Gadaleta, MN
   Cantatore, P
TI Mitochondrial DNA mutations in RRF of healthy subjects of different age
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE human skeletal muscle; ragged red fibers; mtDNA; point mutations; aging
ID CYTOCHROME-C-OXIDASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MUSCLE-FIBER
   ANALYSIS; MTDNA CONTROL REGION; POINT MUTATIONS; SKELETAL-MUSCLE;
   REPLICATION; DELETION; DISEASE; CELLS
AB To obtain information on the mechanisms responsible of the generation of ragged red fibers (RRF) during aging, we analyzed the mitochondrial genotype of single skeletal muscle fibers of healthy individuals having an age comprised between 45 and 92 years. The sequencing of the D-loop region showed many sequence changes with respect to the Cambridge reference sequence (CRS), in both RRF and normal fibers. These changes were more abundant in RRF and their number increased between 50 and 60, and 61 and 70 years and then remained approximately constant. The analysis of the sequence changes showed that each subject contained one or more changes associated to RRF in positions of D-loop region that either do not change or that change very rarely. In general the same type of RRF-associated change was not found in more than one individual; exceptions were changes in positions 189, 295, 374 and 514, detected in 20-50% of analyzed subjects. In particular the A189G age-associated mutation was found only in old individuals and prevalently in RRE Sequencing of other two mtDNA regions showed no relevant changes in the 16S/ND1 region and two RRF-associated original mutations, G5847A and A5884C, in two very conserved positions of tRNA(Tyr). These results indicate that each subject has its own pattern of RRF-associated mutations in both coding and non-coding region of human mtDNA. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Bari, Dipartmento Biochim & Biol Mol, I-70125 Bari, Italy.
   Univ Chieti G Annunzio, Cattedra Malattie Infett, I-66013 Chieti, Italy.
   Univ Chieti G Annunzio, Dipartimento Med Interna & Sci Invecchiamento, I-66013 Chieti, Italy.
   CNR, Inst Biomembrane & Bioenerget, I-70125 Bari, Italy.
   Univ Bari, Ctr Eccellenza Genom Comparata Campo Biomed & Agr, Dipartimento Farmacobiol, I-70125 Bari, Italy.
C3 Universita degli Studi di Bari Aldo Moro; G d'Annunzio University of
   Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Consiglio
   Nazionale delle Ricerche (CNR); Universita degli Studi di Bari Aldo Moro
RP Univ Bari, Dipartmento Biochim & Biol Mol, Via Orabona,4, I-70125 Bari, Italy.
EM p.cantatore@biologia.uniba.it
RI Felzani, Giorgio/AAA-7551-2022; Cormio, Antonella/AAC-7303-2022;
   Vecchiet, Jacopo/AAL-5448-2020
OI Cormio, Antonella/0000-0002-6029-1722
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BYRNE E, 1985, J NEUROL SCI, V71, P257, DOI 10.1016/0022-510X(85)90064-4
   CANTATORE P, 1987, INT REV CYTOL, V108, P149, DOI 10.1016/S0074-7696(08)61438-2
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   DUBOWITZ UK, 1973, MUSLCE BIOPSY MODER
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Gadaleta Maria N., 1999, P693
   GHIVIZZANI SC, 1994, MOL CELL BIOL, V14, P7717, DOI 10.1128/MCB.14.12.7717
   Gibbs PEM, 1998, P NATL ACAD SCI USA, V95, P6876, DOI 10.1073/pnas.95.12.6876
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Johns DR, 2003, ANN NEUROL, V54, P422, DOI 10.1002/ana.10771
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   Mita S, 1998, MUSCLE NERVE, V21, P490, DOI 10.1002/(SICI)1097-4598(199804)21:4<490::AID-MUS7>3.0.CO;2-4
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Pesole G, 2001, GENETICS, V157, P859
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
NR 41
TC 31
Z9 34
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0197-4580
EI 1558-1497
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD MAY
PY 2005
VL 26
IS 5
BP 655
EP 664
DI 10.1016/j.neurobiolaging.2004.06.014
PG 10
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA 902QM
UT WOS:000227371600013
PM 15708440
DA 2024-11-01
ER

PT J
AU Percetti, M
   Franco, G
   Monfrini, E
   Caporali, L
   Minardi, R
   La Morgia, C
   Valentino, ML
   Liguori, R
   Palmieri, I
   Ottaviani, D
   Vizziello, M
   Ronchi, D
   Di Berardino, F
   Cocco, A
   Macao, B
   Falkenberg, M
   Comi, GP
   Albanese, A
   Giometto, B
   Valente, EM
   Carelli, V
   Di Fonzo, A
AF Percetti, Marco
   Franco, Giulia
   Monfrini, Edoardo
   Caporali, Leonardo
   Minardi, Raffaella
   La Morgia, Chiara
   Valentino, Maria Lucia
   Liguori, Rocco
   Palmieri, Ilaria
   Ottaviani, Donatella
   Vizziello, Maria
   Ronchi, Dario
   Di Berardino, Federica
   Cocco, Antoniangela
   Macao, Bertil
   Falkenberg, Maria
   Comi, Giacomo Pietro
   Albanese, Alberto
   Giometto, Bruno
   Valente, Enza Maria
   Carelli, Valerio
   Di Fonzo, Alessio
TI <i>TWNK</i> in Parkinson's Disease: A Movement Disorder and
   Mitochondrial Disease Center Perspective Study
SO MOVEMENT DISORDERS
LA English
DT Article
DE TWNK; twinkle; Parkinson's disease; parkinsonism; mitochondrial DNA
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ONSET SPINOCEREBELLAR ATAXIA;
   FAMILIAL PARKINSONISM; DNA DELETIONS; TWINKLE; MUTATIONS; POLG
AB Background Parkinsonian features have been described in patients harboring variants in nuclear genes encoding for proteins involved in mitochondrial DNA maintenance, such as TWNK. Objectives The aim was to screen for TWNK variants in an Italian cohort of Parkinson's disease (PD) patients and to assess the occurrence of parkinsonism in patients presenting with TWNK-related autosomal dominant progressive external ophthalmoplegia (TWNK-adPEO). Methods Genomic DNA of 263 consecutively collected PD patients who underwent diagnostic genetic testing was analyzed with a targeted custom gene panel including TWNK, as well as genes causative of monogenic PD. Genetic and clinical data of 18 TWNK-adPEO patients with parkinsonism were retrospectively analyzed. Results Six of 263 PD patients (2%), presenting either with isolated PD (n = 4) or in combination with bilateral ptosis (n = 2), carried TWNK likely pathogenic variants. Among 18 TWNK-adPEO patients, 5 (28%) had parkinsonism. Conclusions We show candidate TWNK variants occurring in PD without PEO. This finding will require further confirmatory studies. (c) 2022 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.
C1 [Percetti, Marco; Franco, Giulia; Monfrini, Edoardo; Vizziello, Maria; Ronchi, Dario; Comi, Giacomo Pietro; Di Fonzo, Alessio] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Neurosci Sect, Milan, Italy.
   [Percetti, Marco] ASST Monza, San Gerardo Hosp, Neurol Unit, Monza, Italy.
   [Franco, Giulia; Monfrini, Edoardo; Vizziello, Maria; Comi, Giacomo Pietro; Di Fonzo, Alessio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Via Francesco Sforza 35, I-20122 Milan, MI, Italy.
   [Caporali, Leonardo; Minardi, Raffaella; La Morgia, Chiara; Valentino, Maria Lucia; Liguori, Rocco; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Bologna, Italy.
   [Valentino, Maria Lucia; Liguori, Rocco; Carelli, Valerio] Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Unit Neurol, Bologna, Italy.
   [Palmieri, Ilaria; Valente, Enza Maria] IRCCS Mondino Fdn, Neurogenet Res Ctr, Pavia, Italy.
   [Ottaviani, Donatella; Giometto, Bruno] Azienda Prov & Servizi Sanitari APSS Trento, Rovereto Hosp, Neurol Unit, Trento, Italy.
   [Di Berardino, Federica] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Audiol Unit, Milan, Italy.
   [Cocco, Antoniangela] Univ Milan, Milan, Italy.
   [Cocco, Antoniangela; Albanese, Alberto] Ist Ricovero & Cura Carattere Sci Humanitas, Res Hosp, Dept Neurol, Milan, Italy.
   [Macao, Bertil; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
   [Valente, Enza Maria] Univ Pavia, Dept Mol Med, Pavia, Italy.
C3 University of Milan; San Gerardo Hospital; IRCCS Ca Granda Ospedale
   Maggiore Policlinico; IRCCS Istituto delle Scienze Neurologiche di
   Bologna (ISNB); University of Bologna; IRCCS Fondazione Casimiro
   Mondino; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of
   Milan; University of Gothenburg; University of Pavia
RP Di Fonzo, A (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Via Francesco Sforza 35, I-20122 Milan, MI, Italy.
EM alessio.difonzo@policlinico.mi.it
RI Franco, Giulia/AAB-3670-2019; Valente, Enza/G-2942-2017; Comi,
   Giacomo/K-5702-2016; Minardi, Raffaella/AAB-8290-2020; Percetti,
   Marco/AAL-4414-2021; Albanese, Alberto/K-7396-2016; La Morgia,
   Chiara/H-6765-2012; Liguori, Rocco/AAB-7860-2020; Ronchi,
   Dario/K-8011-2016; Cocco, Antoniangela/J-8693-2018; palmieri,
   ilaria/AAA-3103-2021; Di Fonzo, Alessio/A-5702-2013; Monfrini,
   Edoardo/P-1256-2018; Caporali, Leonardo/J-7398-2016
OI Vizziello, Maria/0000-0002-7005-689X; Monfrini,
   Edoardo/0000-0003-4720-9234; Caporali, Leonardo/0000-0002-0666-4380;
   Percetti, Marco/0000-0003-4679-3360; Di Berardino,
   Federica/0000-0001-7514-5624; Palmieri, Ilaria/0000-0002-0304-7299;
   Falkenberg, Maria/0000-0001-8713-173X; Cocco,
   Antoniangela/0000-0001-9144-1415; Di Fonzo, Alessio/0000-0001-6478-026X
FU Italian Ministry of Health; Italian region Emilia-Romagna funding
   (ER-MITO project-Programma di ricerca Regione-Universitaa 2010-2012)
   [PRUa1RI-2012-008]
FX Italian Ministry of Health Ricerca Corrente 20202021 (PARKNET project)
   to A.D.F., E.M.V., and V.C.; Italian region Emilia-Romagna funding
   (ER-MITO project-Programma di ricerca Regione-Universitaa 2010-2012,
   PRUa1RI-2012-008) to V.C.
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bitetto G, 2020, PARKINSONISM RELAT D, V74, P1, DOI 10.1016/j.parkreldis.2020.03.018
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Breen DP, 2020, NEUROLOGY, V95, P644, DOI 10.1212/WNL.0000000000010674
   Brichta L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00152
   Caporali L, 2018, BRAIN, V141, DOI 10.1093/brain/awx301
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Liu ZR, 2008, MOL VIS, V14, P1995
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Manini A, 2022, AGEING RES REV, V76, DOI 10.1016/j.arr.2022.101578
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Peter B, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040408
   Rani L, 2020, MITOCHONDRION, V50, P25, DOI 10.1016/j.mito.2019.09.010
   Remtulla S, 2019, PEDIATR NEUROL, V90, P61, DOI 10.1016/j.pediatrneurol.2018.08.007
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
NR 27
TC 8
Z9 8
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD SEP
PY 2022
VL 37
IS 9
BP 1938
EP 1943
DI 10.1002/mds.29139
EA JUL 2022
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 4P1ZW
UT WOS:000821119700001
PM 35792653
OA hybrid, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Konovalova, S
   Tyynismaa, H
AF Konovalova, Svetlana
   Tyynismaa, Henna
TI Mitochondrial aminoacyl-tRNA synthetases in human disease
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Review
DE Mitochondria; Mitochondrial disease; Aminoacyl-tRNA synthetases
ID SPINAL-CORD INVOLVEMENT; BRAIN-STEM; LACTIC-ACIDOSIS; CAUSES MYOPATHY;
   MUTATIONS; LEUKOENCEPHALOPATHY; GENE; RECOGNITION; YARS2; DARS2
AB Mitochondrial aminoacyl-tRNA synthetases (mtARSs) are essential in the process of transferring genetic information from mitochondrial DNA to the complexes of the oxidative phosphorylation system. These synthetases perform an integral step in the initiation of mitochondrial protein synthesis by charging tRNAs with their cognate amino acids. All mtARSs are encoded by nuclear genes, nine of which have recently been described as disease genes for mitochondrial disorders. Unexpectedly, the clinical presentations of these diseases are highly specific to the affected synthetase. Encephalopathy is the most common manifestation but again with gene-specific outcomes. Other clinical presentations include myopathy with anemia, cardiomyopathy, tubulopathy and hearing loss with female ovarian dysgenesis. Here we review the described mutation types and the associated patient phenotypes. The identified mutation spectrum suggests that only mutation types that allow some residual tRNA-charging activity can result in the described mtARS diseases but the molecular mechanisms behind the selective tissue involvement are not currently understood. (C) 2013 Elsevier Inc. All rights reserved.
C1 Biomed Helsinki, Res Programs Unit, Mol Neurol, Helsinki 00014, Finland.
   Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki 00014, Finland.
C3 University of Helsinki; University of Helsinki
RP Tyynismaa, H (corresponding author), Biomed Helsinki, R-C512A,Haartmaninkatu 8, Helsinki 00014, Finland.
EM henna.tyynismaa@helsinki.fi
RI Tyynismaa, Henna/F-1428-2011; Konovalova, Svetlana/KGL-1165-2024
OI Konovalova, Svetlana/0000-0001-7363-0271; Tyynismaa,
   Henna/0000-0002-2493-2422
FU Academy of Finland, Sigrid Juselius Foundation; University of Helsinki;
   Arvo and Lea Ylppo Foundation; Orion Farmos Research Foundation and
   Centre for International Mobility for research
FX The authors wish to thank the Academy of Finland, Sigrid Juselius
   Foundation, University of Helsinki, Arvo and Lea Ylppo Foundation, Orion
   Farmos Research Foundation and Centre for International Mobility for
   research funding on mtARS diseases.
CR Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527
   Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039
   Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9
   Chimnaronk S, 2005, EMBO J, V24, P3369, DOI 10.1038/sj.emboj.7600811
   Christian BE, 2012, BBA-GENE REGUL MECH, V1819, P1035, DOI 10.1016/j.bbagrm.2011.11.009
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956
   Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Isohanni P, 2010, J MED GENET, V47, P66, DOI 10.1136/jmg.2009.068221
   Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727
   KERJAN P, 1994, BBA-GEN SUBJECTS, V1199, P293, DOI 10.1016/0304-4165(94)90009-4
   Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005
   Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210
   McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008
   Miyake N, 2011, CLIN GENET, V80, P293, DOI 10.1111/j.1399-0004.2011.01644.x
   Motley WW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002399
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Synofzik M, 2011, J MED GENET, V48, P713, DOI 10.1136/jmg.2011.090282
   Talim B., BRAIN IN PRESS
   Thiffault I, 2006, BRAIN, V129, P2332, DOI 10.1093/brain/awl110
   van Berge L, 2012, BIOCHEM J, V441, P955, DOI 10.1042/BJ20110795
   Vester A, 2013, HUM MUTAT, V34, P191, DOI 10.1002/humu.22210
   Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11
   Xu XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1686
   Yamashita S., BRAIN DEV IN PRESS
NR 38
TC 124
Z9 138
U1 2
U2 35
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD APR
PY 2013
VL 108
IS 4
BP 206
EP 211
DI 10.1016/j.ymgme.2013.01.010
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 112HJ
UT WOS:000316583000002
PM 23433712
DA 2024-11-01
ER

PT J
AU Kumar, R
   Harilal, S
   Parambi, DT
   Kanthlal, SK
   Rahman, MA
   Alexiou, A
   Batiha, GE
   Mathew, B
AF Kumar, Rajesh
   Harilal, Seetha
   Thomas Parambi, Della Grace
   Kanthlal, S. K.
   Rahman, Md Atiar
   Alexiou, Athanasios
   Batiha, Gaber El-Saber
   Mathew, Bijo
TI The Role of Mitochondrial Genes in Neurodegenerative Disorders
SO CURRENT NEUROPHARMACOLOGY
LA English
DT Review
DE Alzheimer's disease; amyotrophic lateral sclerosis; mtDNA; multiple
   sclerosis; neurodegeneration; Parkinson's disease; stroke
ID RESPIRATORY-CHAIN FUNCTION; HUMAN SKELETAL-MUSCLE; MTDNA CONTROL-REGION;
   DNA MUTATIONS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA;
   POINT MUTATIONS; FRONTOTEMPORAL DEMENTIA; CYTOCHROME-OXIDASE
AB Mitochondrial disorders are clinically heterogeneous, resulting from nuclear gene and mitochondrial mutations that disturb the mitochondrial functions and dynamics. There is a lack of evidence linking mtDNA mutations to neurodegenerative disorders, mainly due to the absence of noticeable neuropathological lesions in postmortem samples. This review describes various gene mutations in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and stroke. These abnormalities, including PINK1, Parkin, and SOD1 mutations, seem to reveal mitochondrial dysfunctions due to either mtDNA mutation or deletion, the mechanism of which remains unclear in depth.
C1 [Kumar, Rajesh; Harilal, Seetha] Kerala Univ Hlth Sci, Dept Pharm, Trichur, Kerala, India.
   [Thomas Parambi, Della Grace] Jouf Univ, Coll Pharm, Dept Pharmaceut Chem, Sakaka 2014, Al Jouf, Saudi Arabia.
   [Kanthlal, S. K.] Amrita Vishwa Vidyapeetham, Amrita Sch Pharm, Dept Pharmacol, AIMS Hlth Sci Campus, Kochi 682041, Kerala, India.
   [Rahman, Md Atiar] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong, Bangladesh.
   [Alexiou, Athanasios] Novel Global Community Educ Fdn, Hebersham, Australia.
   [Alexiou, Athanasios] AFNP Med Austria, Vienna, Austria.
   [Batiha, Gaber El-Saber] Damanhour Univ, Fac Vet Med, Dept Pharmacol & Therapeut, Damanhour 22511, Albeheira, Egypt.
   [Mathew, Bijo] Amrita Vishwa Vidyapeetham, Amrita Sch Pharm, Dept Pharmaceut Chem, AIMS Hlth Sci Campus, Kochi 682041, Kerala, India.
C3 Al Jouf University; Amrita Vishwa Vidyapeetham; Amrita Vishwa
   Vidyapeetham Kochi; University of Chittagong; Egyptian Knowledge Bank
   (EKB); Damanhour University; Amrita Vishwa Vidyapeetham; Amrita Vishwa
   Vidyapeetham Kochi
RP Mathew, B (corresponding author), Amrita Vishwa Vidyapeetham, Amrita Sch Pharm, Dept Pharmaceut Chem, AIMS Hlth Sci Campus, Kochi 682041, Kerala, India.
EM bijovilaventgu@gmail.com
RI Kumar, Rajesh/AAC-9303-2020; Rahman, Atiar/ABD-6817-2021; Harilal,
   Seetha/AAC-8619-2020; Alexiou, Athanasios/AAT-8491-2021; Rahman, Md.
   Atiar/Q-1176-2015; Parambi, Della/JDD-2791-2023
OI Alexiou, Athanasios/0000-0002-2206-7236; Rahman, Md.
   Atiar/0000-0002-4902-8923; Harilal, Seetha/0000-0002-8141-8649; Parambi,
   Della/0000-0002-3954-4879; K, Rajesh/0000-0002-8712-4705
CR Alexiou A, 2020, Diagnosis and management in dementia, P365, DOI [10.1016/B978-0-12-815854-8.00023-9, DOI 10.1016/B978-0-12-815854-8.00023-9]
   Alexiou A, 2019, MOL NEUROBIOL, V56, P4530, DOI 10.1007/s12035-018-1397-x
   Alexiou A, 2018, CURR PROTEIN PEPT SC, V19, P850, DOI 10.2174/1389203718666170810150151
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blanch M, 2016, AM J PATHOL, V186, P385, DOI 10.1016/j.ajpath.2015.10.004
   Bobba KN, 2019, CHEM COMMUN, V55, P6429, DOI 10.1039/c9cc01483g
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bradley-Whitman MA, 2013, MECH AGEING DEV, V134, P486, DOI 10.1016/j.mad.2013.08.005
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021
   Chaudhary S.S., 2020, DIAGNOSIS MANAGEMENT, P73, DOI [10.1016/B978-0-12-815946-0.00005-3, DOI 10.1016/B978-0-12-815946-0.00005-3]
   Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011
   Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1
   Chinnery PF, 2001, AM J HUM GENET, V68, P529, DOI 10.1086/318204
   Cieslik M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137193
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Compagnoni GM, 2020, MOL NEUROBIOL, V57, P2959, DOI 10.1007/s12035-020-01926-1
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Coppedè F, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00086
   Corona JC, 2015, NEUROCHEM RES, V40, P308, DOI 10.1007/s11064-014-1377-0
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260
   D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   DELEON MJ, 1983, AM J NEURORADIOL, V4, P568
   Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Grazina M, 2004, NEUROBIOL DIS, V15, P306, DOI 10.1016/j.nbd.2003.11.004
   Guan Q, 2016, EXP GERONTOL, V82, P19, DOI 10.1016/j.exger.2016.05.011
   Hamblet NS, 1997, MUTAT RES-FUND MOL M, V379, P253, DOI 10.1016/S0027-5107(97)00158-9
   Harilal S, 2020, BRAIN RES BULL, V160, P121, DOI 10.1016/j.brainresbull.2020.03.018
   Harilal S, 2019, J PHARM PHARMACOL, V71, P1370, DOI 10.1111/jphp.13132
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Hudson G, 2012, NEUROLOGY, V78, P1038, DOI 10.1212/WNL.0b013e31824e8f1d
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hwang ES, 2019, TRANSL EPIGENET SER, V10, P781, DOI 10.1016/B978-0-12-813939-4.00029-2
   Ingram CJE, 2012, AMYOTROPH LATERAL SC, V13, P341, DOI 10.3109/17482968.2012.654394
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Jesko H, 2017, NEUROCHEM RES, V42, P876, DOI 10.1007/s11064-016-2110-y
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   Kieburtz K, 2007, NEUROLOGY, V68, P20
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lakatos A, 2010, NEUROBIOL AGING, V31, P1355, DOI 10.1016/j.neurobiolaging.2010.04.031
   Latsoudis H, 2008, J HUM GENET, V53, P349, DOI 10.1007/s10038-008-0259-1
   Li HZ, 2012, ADV EXP MED BIOL, V942, P39, DOI 10.1007/978-94-007-2869-1_2
   LIAO HX, 1991, J BIOL CHEM, V266, P20714
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Mancuso M, 2007, NEUROL SCI, V28, P142, DOI 10.1007/s10072-007-0807-z
   Mapa MST, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197946
   Mehta P, 2009, MOVEMENT DISORD, V24, P290, DOI 10.1002/mds.22389
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Müller SK, 2013, NEUROBIOL AGING, V34, P2231, DOI 10.1016/j.neurobiolaging.2013.03.016
   Müller T, 2003, NEUROSCI LETT, V341, P201, DOI 10.1016/S0304-3940(03)00185-X
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Nambiar J, 2019, MOL CELL BIOCHEM, V451, P79, DOI 10.1007/s11010-018-3395-8
   Narayanan SE, 2020, ENVIRON SCI POLLUT R, V27, P43542, DOI 10.1007/s11356-020-10477-w
   Palakkathondi A, 2020, ACS COMB SCI, V22, P592, DOI 10.1021/acscombsci.0c00136
   Parambi DT, 2020, NEUROCHEM RES, V45, P2786, DOI 10.1007/s11064-020-03130-y
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Polito L, 2017, NEUROPROTECTION IN ALZHEIMER'S DISEASE, P149, DOI 10.1016/B978-0-12-803690-7.00008-9
   Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675
   Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x
   Ridge PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045134
   Rorbach J, 2007, BIOCHEM SOC T, V35, P1290, DOI 10.1042/BST0351290
   Rose G, 2008, EUR J NEUROL, V15, P1006, DOI 10.1111/j.1468-1331.2008.02222.x
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   SCHWARTZBACH CJ, 1989, J BIOL CHEM, V264, P19125
   Sharma N, 2019, ENVIRON MOL MUTAGEN, V60, P668, DOI 10.1002/em.22319
   Siguroardóttir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902
   Simcox E M., 2016, Mitochondrial Dysfunction in Neurodegenerative Disorders, P3
   Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797
   Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031
   SOONG NW, 1992, NAT GENET, V2, P318
   SPELBRINK JN, 1994, HUM MOL GENET, V3, P1989, DOI 10.1093/hmg/3.11.1989
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stoccoro A, 2017, J ALZHEIMERS DIS, V59, P559, DOI 10.3233/JAD-170139
   Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   TORRONI A, 1993, AM J HUM GENET, V53, P563
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Wright AF, 2009, TRENDS GENET, V25, P253, DOI 10.1016/j.tig.2009.04.006
   Yang WX, 2015, NEUROCHEM RES, V40, P1576, DOI 10.1007/s11064-015-1630-1
   Zoccolella S, 2012, EUR J NEUROL, V19, pe63, DOI 10.1111/j.1468-1331.2012.03720.x
NR 123
TC 7
Z9 7
U1 1
U2 4
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-159X
EI 1875-6190
J9 CURR NEUROPHARMACOL
JI Curr. Neuropharmacol.
PY 2022
VL 20
IS 5
BP 824
EP 835
DI 10.2174/1570159X19666210908163839
PG 12
WC Neurosciences; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 2V0QS
UT WOS:000823558300003
PM 34503413
OA Green Published
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Melichart-Kotig, M
   Woehrer, A
AF Finsterer, Josef
   Melichart-Kotig, Madleine
   Woehrer, Adelheid
TI Mitochondrial disorder mimicking rheumatoid disease
SO ZEITSCHRIFT FUR RHEUMATOLOGIE
LA English
DT Article
DE MtDNA; Mitochondrion; Neuromuscular; Myopathy; Arthralgia; Pituitary
   insufficiency
ID CONGENITAL MYASTHENIC SYNDROMES; MOLECULAR CHARACTERIZATION; MUTATIONS;
   SKIN
AB Objective Mitochondrial disorders (MIDs) may manifest phenotypically with a plethora of clinical features, but polyarthralgia and cutaneous lesions are still infrequently reported and recognized as phenotypic manifestations of a MID. Case report The patient is a 27-year-old Caucasian female with a history of preterm birth, symptomatic myopathy, and polyarthralgia since infancy, followed by multiple endocrinopathies including pituitary insufficiency, cardiac conduction defects, nephrolithiasis, aseptic chronic pancreatitis and sialadenitis, anemia, hyperlipidemia, and dysmorphic features. The patient reported to have profited from hydrocortisone and long-term chloroquine, but hardly from long-term immunosuppression with various immunosuppressants. The diagnosis MID was established upon the multiorgan nature of the disease, presence of core clinical features of a MID, and a muscle biopsy indicative of a mitochondrial defect. The family history was positive for mitochondrial features in the mother and grandmother from the mother's side. Conclusion Seronegative and non-destructive polyarthralgia and unexplained cutaneous features mimicking cutaneous lupus should be considered as a phenotypic feature of a multisystem MID (mitochondrial multiorgan disorder syndrome, MIMODS). Mitochondrial metabolic defects may trigger secondary immune reactions. Core clinical features of a non-specific MID with infantile onset include symptomatic myopathy, endocrine abnormalities, cardiac conduction defects, dysmorphism, hyperlipidemia, anemia, and nephrolithiasis.
C1 [Finsterer, Josef] Vet Univ Vienna, Messerli Inst, Krankenanstalt Rudolfstiftung, Vienna, Austria.
   [Melichart-Kotig, Madleine] Krankenanstalt Rudolfstiftung Wien, Med Dept, Vienna, Austria.
   [Woehrer, Adelheid] Med Univ Vienna, Neurol Inst, Vienna, Austria.
C3 University of Veterinary Medicine Vienna; Rudolfstiftung Hospital;
   Rudolfstiftung Hospital; Medical University of Vienna
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
OI Woehrer, Adelheid/0000-0001-8435-8189
CR Alvarez-Garcia O, 2017, ARTHRITIS RHEUMATOL, V69, P1418, DOI 10.1002/art.40104
   Azuma Y, 2015, NEUROMUSCULAR DISORD, V25, P60, DOI 10.1016/j.nmd.2014.09.002
   Boulton SJ, 2015, EXP DERMATOL, V24, P12, DOI 10.1111/exd.12597
   Finsterer J, 2017, ACTA NEUROL BELG, V117, P969, DOI 10.1007/s13760-017-0821-8
   Finsterer J, 2015, PEDIATR NEUROL, V53, P301, DOI 10.1016/j.pediatrneurol.2015.03.005
   Harty LC, 2012, ANN RHEUM DIS, V71, P582, DOI 10.1136/annrheumdis-2011-200245
   Mihaylova V, 2010, J NEUROL NEUROSUR PS, V81, P973, DOI 10.1136/jnnp.2009.177816
   Müller JS, 2006, NEUROMUSCULAR DISORD, V16, P661, DOI 10.1016/j.nmd.2006.05.068
   Natera-de Benito D, 2017, NEUROMUSCULAR DISORD, V27, P1087, DOI 10.1016/j.nmd.2017.08.003
   Shen XM, 2016, HUM MUTAT, V37, P1051, DOI 10.1002/humu.23043
   Soto-Hermida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112735
   Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393
NR 12
TC 7
Z9 7
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-1855
EI 1435-1250
J9 Z RHEUMATOL
JI Z. Rheumatol.
PD NOV
PY 2019
VL 78
IS 9
SI SI
BP 875
EP 880
DI 10.1007/s00393-018-0551-1
PG 6
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA JJ3GJ
UT WOS:000494049400010
PM 30291434
DA 2024-11-01
ER

PT J
AU Scuderi, C
   Santa Paola, S
   Lo Giudice, M
   Blasi, FDD
   Giusto, S
   Di Vita, G
   Pettinato, R
   Vitello, GA
   Romano, C
   Buono, S
   Salpietro, V
   Houlden, H
   Borgione, E
AF Scuderi, Carmela
   Santa Paola, Sandro
   Lo Giudice, Mariangela
   Blasi, Francesco Domenico Di
   Giusto, Stefania
   Di Vita, Giuseppa
   Pettinato, Rosa
   Vitello, Girolamo Aurelio
   Romano, Corrado
   Buono, Serafino
   Salpietro, Vincenzo
   Houlden, Henry
   Borgione, Eugenia
TI Mitochondrial DNA involvement in patients with autism spectrum disorders
   and intellectual disability
SO RESEARCH IN AUTISM SPECTRUM DISORDERS
LA English
DT Article
DE Autism; Intellectual disability; MtDNA; Mitochondrial disease
ID DYSFUNCTION; MUTATION; DISEASE; ABNORMALITIES; ASSOCIATION; DEFICIENCY;
   GENETICS
AB Background: Autism spectrum disorders (ASD) are neurodevelopmental disorders, with hetero-geneous etiology, characterized by deficiencies in social interaction, communication, and by repetitive and stereotyped behaviors. Mitochondrial encephalomyopathies are inherited disorders of oxidative metabolism, with a wide clinical, biochemical and genetic heterogeneity, requiring a complex diagnostic flow-chart. In-fantile forms often occur with defects in development, intellectual disabilities and dysmorphisms. ASD has been associated with mitochondrial respiratory chain deficiency and/or mitochondrial DNA (mtDNA) mutations. However, few studies carried out detailed clinical, instrumental, morphological, biochemical investigations, and mtDNA sequencing in ASD patients.Method: The purpose of this study was the identification of mitochondrial dysfunction due to mtDNA variants in 19 selected subjects presenting ASD and clinical features of mitochondrial disease. For these patients we adopted a multidisciplinary approach combining clinical and laboratory investigations on muscle biopsy, with biochemical, histological and genetic techniques.Results: The histological examination showed myogenic or neurogenic changes in 79 % of pa-tients; furthermore, 58 % of the patients had lipid accumulation, mitochondrial proliferation and COX deficient fibers. The biochemical investigations reported in three patients impairments involving one or more of the respiratory chain complexes. In addition, genetic studies revealed in one patient with normal histology and biochemistry multiple mtDNA deletions, and in four pa-tients different mtDNA point mutations.Conclusions: The present study confirms the hypothesis of an association between ASD and mitochondrial dysfunction. However, further studies in a larger group of subjects are needed.
C1 [Scuderi, Carmela; Santa Paola, Sandro; Lo Giudice, Mariangela; Borgione, Eugenia] Oasi Res Inst IRCCS, Unit Neuromuscular Dis, Via Conte Ruggero 73, Troina, Italy.
   [Blasi, Francesco Domenico Di; Buono, Serafino] Oasi Res Inst IRCCS, Unit Psychol, Via Conte Ruggero 73, Troina, Italy.
   [Giusto, Stefania; Di Vita, Giuseppa] Acireale Hosp, Prov Hlth Serv Catania ASP CT, Child & Adolescent Neuropsychiat Unit, Acireale, Italy.
   [Pettinato, Rosa] Oasi Res Inst, Unit Pediat & Med Genet, Via Conte Ruggero 73, Troina, Italy.
   [Vitello, Girolamo Aurelio] Oasi Res Inst IRCCS, Unit Neurol, Via Conte Ruggero 73, Troina, Italy.
   [Romano, Corrado] Oasi Res Inst IRCCS, Res Unit Rare Dis & Neurodev Disorders, Via Conte Ruggero 73, Troina, Italy.
   [Romano, Corrado] Univ Catania, Dept Biomed & Biotechnol Sci, Sect Med Biochem, Med Genet, Catania, Italy.
   [Salpietro, Vincenzo] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, I-16132 Genoa, Italy.
   [Salpietro, Vincenzo] IRCCS Giannina Gaslini Inst, Pediat Neurol & Muscular Dis Unit, I-16147 Genoa, Italy.
   [Salpietro, Vincenzo; Houlden, Henry] UCL, UCL Queen Sq Inst Neurol, Dept Neuromuscular Disorders, London WC1N 3BG, England.
C3 University of Catania; University of Genoa; University of Genoa; IRCCS
   Istituto Giannina Gaslini; University of London; University College
   London
RP Scuderi, C (corresponding author), Oasi Res Inst IRCCS, Unit Neuromuscular Dis, Via Conte Ruggero 73, Troina, Italy.
EM cscuderi@oasi.en.it
RI Di Vita, Giuseppa/E-1282-2017; Houlden, Henry/C-1532-2008; Borgione,
   Eugenia/D-9168-2017; Buono, Serafino/D-8568-2017; Vitello, Girolamo
   Aurelio/HPG-0215-2023; Romano, Corrado/B-9695-2008; Santa Paola,
   Sandro/D-4174-2017; Di Blasi, Francesco Domenico/D-8146-2017; Lo
   Giudice, Mariangela/D-4261-2017
OI Borgione, Eugenia/0000-0001-5458-7415; Buono,
   Serafino/0000-0002-3786-3323; Vitello, Girolamo
   Aurelio/0000-0002-6285-9692; Romano, Corrado/0000-0003-1049-0683;
   Houlden, Henry/0000-0002-2866-7777; Santa Paola,
   Sandro/0000-0002-3310-782X; Di Blasi, Francesco
   Domenico/0000-0002-2958-2927; Lo Giudice, Mariangela/0000-0001-5961-0362
FU Italian Ministry of Health;  [RC2022]
FX Acknowledgments This work was supported by Grant number RC2022 from the
   Italian Ministry of Health.
CR Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   [Anonymous], 2013, Diagnostic and statistical manual of mental disorders
   Avdjieva-Tzavella D, 2012, BALK J MED GENET, V15, P47, DOI 10.2478/bjmg-2013-0006
   Aydin HI, 2018, INDIAN PEDIATR, V55, P67, DOI 10.1007/s13312-018-1232-5
   Buxbaum Joseph D, 2009, Dialogues Clin Neurosci, V11, P35
   Correia C, 2006, J AUTISM DEV DISORD, V36, P1137, DOI 10.1007/s10803-006-0138-6
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607
   Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596
   Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559
   Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003
   Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   Gu F, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.68
   Guevara-Campos J, 2015, INT J MOL SCI, V16, P3870, DOI 10.3390/ijms16023870
   Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627
   Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76
   Lord C., 2005, Autism diagnostic observation schedule (ADOS): Manual
   Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34
   Manzi B, 2008, J CHILD NEUROL, V23, P307, DOI 10.1177/0883073807308698
   Marin-Garcia J, 1999, PEDIATR NEUROL, V21, P538, DOI 10.1016/S0887-8994(99)00038-7
   Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Napoli E, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-2
   Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332
   Palmieri L, 2010, BBA-BIOENERGETICS, V1797, P1130, DOI 10.1016/j.bbabio.2010.04.018
   Pancrudo J, 2007, NEUROMUSCULAR DISORD, V17, P651, DOI 10.1016/j.nmd.2007.04.005
   Patowary A, 2017, AUTISM RES, V10, P1338, DOI 10.1002/aur.1792
   Persico AM, 2013, BEHAV BRAIN RES, V251, P95, DOI 10.1016/j.bbr.2013.06.012
   Petek E, 2007, MOL GENET GENOMICS, V277, P71, DOI 10.1007/s00438-006-0173-1
   Piryaei F, 2012, CELL J, V14, P98
   Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023
   Ramoz N, 2004, AM J PSYCHIAT, V161, P662, DOI 10.1176/appi.ajp.161.4.662
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Rose S, 2018, MOL DIAGN THER, V22, P571, DOI 10.1007/s40291-018-0352-x
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Rutter M., 2003, Autism Diagnostic InterviewRevised (ADI-R), V29, P30
   SANTORELLI FM, 1995, BIOCHEM BIOPH RES CO, V216, P835, DOI 10.1006/bbrc.1995.2697
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Shoffner J, 2010, J CHILD NEUROL, V25, P429, DOI 10.1177/0883073809342128
   Valenti D, 2014, NEUROSCI BIOBEHAV R, V46, P202, DOI 10.1016/j.neubiorev.2014.01.012
   Valiente-Pallejà A, 2018, HUM MOL GENET, V27, P891, DOI 10.1093/hmg/ddy009
   Varga NA, 2018, BEHAV BRAIN FUNCT, V14, DOI 10.1186/s12993-018-0135-x
   Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815
   Zeidan J, 2022, AUTISM RES, V15, P778, DOI 10.1002/aur.2696
   Zheng J, 2020, MITOCHONDRION, V52, P163, DOI 10.1016/j.mito.2020.03.005
NR 50
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1750-9467
EI 1878-0237
J9 RES AUTISM SPECT DIS
JI Res. Autism Spectr. Disord.
PD FEB
PY 2023
VL 100
AR 102084
DI 10.1016/j.rasd.2022.102084
EA DEC 2022
PG 9
WC Education, Special; Psychology, Developmental; Psychiatry;
   Rehabilitation
WE Social Science Citation Index (SSCI)
SC Education & Educational Research; Psychology; Psychiatry; Rehabilitation
GA 7F6PK
UT WOS:000901966800003
DA 2024-11-01
ER

PT J
AU Chen, JY
   Zheng, QZ
   Peiffer, LB
   Hicks, JL
   Haffner, MC
   Rosenberg, AZ
   Levi, M
   Wang, XXX
   Ozbek, B
   Baena-Del Valle, J
   Yegnasubramanian, S
   De Marzo, AM
AF Chen, Jiayu
   Zheng, Qizhi
   Peiffer, Lauren B.
   Hicks, Jessica L.
   Haffner, Michael C.
   Rosenberg, Avi Z.
   Levi, Moshe
   Wang, Xiaoxin X.
   Ozbek, Busra
   Baena-Del Valle, Javier
   Yegnasubramanian, Srinivasan
   De Marzo, Angelo M.
TI An <i>in Situ</i> Atlas of Mitochondrial DNA in Mammalian Tissues
   Reveals High Content in Stem and Proliferative Compartments
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID COPY NUMBER; TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; DOWN-REGULATION;
   GENE; REPLICATION; DEPLETION; MUTATIONS; TARGET; MTDNA
AB Mitochondria regulate ATP production, metabolism, and cell death. Alterations in mitochondrial DNA (mtDNA) sequence and copy number are implicated in aging and organ dysfunction in diverse inherited and sporadic diseases. Because most measurements of mtDNA use homogenates of complex tissues, little is known about cell-type-specific mtDNA copy number heterogeneity in normal physiology, aging, and disease. Thus, the precise cell types whose loss of mitochondrial activity and altered mtDNA copy number that result in organ dysfunction in aging and disease have often not been clarified. Here, an in situ hybridization approach to generate a single-cell-resolution atlas of mtDNA content in mammalian tissues was validated. In hierarchically organized self-renewing tissues, higher levels of mtDNA were observed in stem/proliferative compartments compared with differentiated compartments. Striking zonal patterns of mtDNA levels in the liver reflected the known oxygen tension gradient. In the kidney, proximal and distal tubules had markedly higher mtDNA levels compared with cells within glomeruli and collecting duct epithelial cells. In mice, decreased mtDNA levels were visualized in renal tubules as a function of aging, which was prevented by calorie restriction. This study provides a novel approach for quantifying species- and cell-type-specific mtDNA copy number and dynamics in any normal or diseased tissue that can be used for monitoring the effects of interventions in animal and human studies.
C1 [Chen, Jiayu; Zheng, Qizhi; Peiffer, Lauren B.; Hicks, Jessica L.; Haffner, Michael C.; Rosenberg, Avi Z.; Ozbek, Busra; Baena-Del Valle, Javier; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Pathol, CRB 2 Room 144,1550 Orleans St, Baltimore, MD 21231 USA.
   [Peiffer, Lauren B.; Yegnasubramanian, Srinivasan; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21231 USA.
   [Yegnasubramanian, Srinivasan; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Urol & Oncol, Baltimore, MD 21231 USA.
   [Haffner, Michael C.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.
   [Levi, Moshe; Wang, Xiaoxin X.] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC USA.
C3 Johns Hopkins University; Johns Hopkins University; Johns Hopkins
   University; Johns Hopkins University; Johns Hopkins Medicine; Georgetown
   University
RP De Marzo, AM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, CRB 2 Room 144,1550 Orleans St, Baltimore, MD 21231 USA.
EM ademarz@jhmi.edu
RI Ozbek, Busra/G-2958-2018
OI Baena-Del Valle, Javier/0000-0001-8417-8946; Rosenberg,
   Avi/0000-0003-2356-950X; Chen, Jiayu/0000-0002-0566-0396; levi,
   moshe/0000-0001-6403-2261; Peiffer, Lauren/0000-0003-1592-1980
FU NIH/National Cancer Institute (NCI) Specialized Programs of Research
   Excellence (SPORE) in Prostate Cancer grant [P50CA58236]; NIH/NCI [P30
   CA006973, U01 CA196390]; U.S. Department of Defense Prostate Cancer
   Research Program (PCRP) [W81XWH-18-2-0015]; National Institute of
   Diabetes and Digestive and kidney diseases (NIDDK) [R01 DK116567];
   National Institute of Aging (NIA) [R01 AG049493]; Office of the Director
   of the National Institutes of Health [S10OD016374]
FX Supported by NIH/National Cancer Institute (NCI) Specialized Programs of
   Research Excellence (SPORE) in Prostate Cancer grant P50CA58236
   (A.M.D.M.), NIH/NCI grant U01 CA196390 (A.M.D.M., S.Y.), U.S. Department
   of Defense Prostate Cancer Research Program (PCRP) grant
   W81XWH-18-2-0015 (A.M.D.M.); National Institute of Diabetes and
   Digestive and kidney diseases (NIDDK) grant R01 DK116567 (M.L.); and
   National Institute of Aging (NIA) grant R01 AG049493 (M.L.). The Johns
   Hopkins Sidney Kimmel Comprehensive Cancer Center Oncology Tissue
   Services Laboratory is supported by NIH/NCI grant P30 CA006973.
   Fluorescent confocal microscopy reported in this publication was
   supported by the Office of the Director of the National Institutes of
   Health under award number S10OD016374 (Johns Hopkins University School
   of Medicine Microscope Facility).
CR Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059
   Baena-Del Valle JA, 2018, J PATHOL, V244, P11, DOI 10.1002/path.4980
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Berger E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13171
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130
   Brayton C, 2014, TRANSGENIC ANIMAL TE, V1, P431, DOI DOI 10.1016/B978-0-12-410490-7.00016-5
   Brosch M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06611-5
   Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004
   Chatre Laurent, 2015, Methods Mol Biol, V1264, P133, DOI 10.1007/978-1-4939-2257-4_13
   Chatre L, 2013, J CELL SCI, V126, P914, DOI 10.1242/jcs.114322
   Chatre L, 2013, NUCLEIC ACIDS RES, V41, P3068, DOI 10.1093/nar/gkt015
   Choudhury D, 2011, NAT REV NEPHROL, V7, P706, DOI 10.1038/nrneph.2011.104
   Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Derényi I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14545
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Ertunc O, 2019, LAB INVEST, V99, P1
   Farmer SR, 2008, CELL, V134, P726, DOI 10.1016/j.cell.2008.08.018
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grayson AR, 2014, ONCOGENE, V33, P1736, DOI 10.1038/onc.2013.126
   Haffner MC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00084-8
   Hirose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24290-6
   Holdhoff M, 2017, CLIN CANCER RES, V23, P3150, DOI 10.1158/1078-0432.CCR-16-1490
   Janes MS, 2004, J HISTOCHEM CYTOCHEM, V52, P1011, DOI 10.1369/jhc.3a6209.2004
   Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067227
   Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 1997, HUM MOL GENET, V6, P185, DOI 10.1093/hmg/6.2.185
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Li B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29621-1
   Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005
   Liyanage SU, 2017, BLOOD, V129, P2657, DOI 10.1182/blood-2016-10-741207
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Marty L, 1996, J BIOL CHEM, V271, P11468, DOI 10.1074/jbc.271.19.11468
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   Meyer JN, 2018, TOXICOL SCI, V162, P15, DOI 10.1093/toxsci/kfy008
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Müller-Höcker J, 2011, J CELL MOL MED, V15, P445, DOI 10.1111/j.1582-4934.2009.00819.x
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06
   Nelson I, 1997, SOMAT CELL MOLEC GEN, V23, P287, DOI 10.1007/BF02674419
   Neuhaus JFG, 2017, NEUROENDOCRINOLOGY, V104, P72, DOI 10.1159/000444680
   Nyska A, 1999, PATHOLOGY MOUSE, P509
   O'Hara R, 2019, QUANTITATIVE MITOCHO, DOI [10.1101/579789, DOI 10.1101/579789]
   O'Sullivan ED, 2017, J AM SOC NEPHROL, V28, P407, DOI 10.1681/ASN.2015121308
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   Park E, 2016, CLIN CANC RES S, V22, pB03
   Rantanen A, 2001, MAMM GENOME, V12, P787, DOI 10.1007/s00335-001-2052-8
   Rantanen A, 2000, Hum Reprod, V15 Suppl 2, P86
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Saely CH, 2012, GERONTOLOGY, V58, P15, DOI 10.1159/000321319
   Schubert S, 2015, INT J MOL SCI, V16, P9850, DOI 10.3390/ijms16059850
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Tang Y, 2016, PEERJ, V4, DOI 10.7717/peerj.1821
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trabzonlu L, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a030403
   Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Wang HW, 2014, METHODS MOL BIOL, V1211, P201, DOI 10.1007/978-1-4939-1459-3_16
   Wang XXX, 2017, J BIOL CHEM, V292, P12018, DOI 10.1074/jbc.C117.794982
   Wang XX, 2019, ERR AGONISM REVERSES, DOI [10.1101/755801, DOI 10.1101/755801]
   Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200
   Yamagata K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019772.17954.F8
   Yamazawa T, 2016, MICROSC RES TECHNIQ, V79, P1179, DOI 10.1002/jemt.22773
NR 79
TC 20
Z9 21
U1 2
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JUL
PY 2020
VL 190
IS 7
BP 1565
EP 1579
DI 10.1016/j.ajpath.2020.03.018
PG 15
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA MC0AT
UT WOS:000542960200017
PM 32304697
OA Bronze, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Dahal, S
   Raghavan, SC
AF Dahal, Sumedha
   Raghavan, Sathees C.
TI Mitochondrial genome stability in human: understanding the role of DNA
   repair pathways
SO BIOCHEMICAL JOURNAL
LA English
DT Review
ID BASE-EXCISION-REPAIR; STRAND BREAK REPAIR; CYTOCHROME-C-OXIDASE;
   OXIDATIVE STRESS; NUCLEAR-DNA; LIGASE III; HOMOLOGOUS RECOMBINATION;
   ENDONUCLEASE-1 APE1; MTDNA REPLICATION; ESCHERICHIA-COLI
AB Mitochondria are semiautonomous organelles in eukaryotic cells and possess their own genome that replicates independently. Mitochondria play a major role in oxidative phosphorylation due to which its genome is frequently exposed to oxidative stress. Factors including ionizing radiation, radiomimetic drugs and replication fork stalling can also result in different types of mutations in mitochondrial DNA (mtDNA) leading to genome fragility. Mitochondria from myopathies, dystonia, cancer patient samples show frequent mtDNA mutations such as point mutations, insertions and large-scale deletions that could account for mitochondria-associated disease pathogenesis. The mechanism by which such mutations arise following exposure to various DNA-damaging agents is not well understood. One of the well-studied repair pathways in mitochondria is base excision repair. Other repair pathways such as mismatch repair, homologous recombination and microhomology-mediated end joining have also been reported. Interestingly, nucleotide excision repair and classical nonhomologous DNA end joining are not detected in mitochondria. In this review, we summarize the potential causes of mitochondrial genome fragility, their implications as well as various DNA repair pathways that operate in mitochondria.
C1 [Dahal, Sumedha; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.
C3 Indian Institute of Science (IISC) - Bangalore
RP Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.
EM sathees@iisc.ac.in
RI Dahal, Sumedha/ABG-8228-2021
OI Dahal, Sumedha/0000-0003-3682-5656; Raghavan,
   Sathees/0000-0003-3003-1417
FU CSIR [37(1692)/17/EMR-11]; DAE [21/01/2016-BRNS/35074]; DBT-COE
   [BT/PR/3458/COE/34/33/2015]; IISc-DBT partnership program
   [BT/PR27952-INF/22/212/2018]; IISc, India
FX This work was supported by grants from CSIR (37(1692)/17/EMR-11), DAE
   (21/01/2016-BRNS/35074), DBT-COE (BT/PR/3458/COE/34/33/2015), IISc-DBT
   partnership program [BT/PR27952-INF/22/212/2018] to SCR. SD is supported
   by IISc, India.
CR Abbotts R, 2010, CANCER TREAT REV, V36, P425, DOI 10.1016/j.ctrv.2009.12.006
   Abnet CC, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-30
   Akbari M, 2014, DNA REPAIR, V16, P44, DOI 10.1016/j.dnarep.2014.01.015
   Almpanis A, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000168
   ANDERSON CTM, 1980, NUCLEIC ACIDS RES, V8, P875
   [Anonymous], 2018, MOL CELL BIOL, DOI DOI 10.1128/MCB.00037-18
   Attene-Ramos MS, 2013, CHEM RES TOXICOL, V26, P1323, DOI 10.1021/tx4001754
   Ayora S, 2011, FEMS MICROBIOL REV, V35, P1055, DOI 10.1111/j.1574-6976.2011.00272.x
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Barchiesi A, 2015, NUCLEIC ACIDS RES, V43, P5451, DOI 10.1093/nar/gkv433
   Bardia A, 2012, INFLAMM RES, V61, P359, DOI 10.1007/s00011-011-0418-2
   Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008
   Bianchi NO, 2001, MUTAT RES-REV MUTAT, V488, P9, DOI 10.1016/S1383-5742(00)00063-6
   Birch-Machin MA, 2010, MUTAGENESIS, V25, P101, DOI 10.1093/mutage/gep061
   Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Canbay E, 2011, CURR MED RES OPIN, V27, P1295, DOI 10.1185/03007995.2011.573544
   Canbay E, 2010, ANTICANCER RES, V30, P1359
   Carelli V, 2007, ENVIRON HEALTH PERSP, V115, P113, DOI 10.1289/ehp.9245
   Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Chayot R, 2010, P NATL ACAD SCI USA, V107, P2141, DOI 10.1073/pnas.0906355107
   Chen L, 2006, J UROLOGY, V175, P108, DOI 10.1016/S0022-5347(05)00042-X
   Chen M, 2011, INVEST OPHTH VIS SCI, V52, P7027, DOI 10.1167/iovs.11-7524
   Chen SM, 2013, CANCER BIOTHER RADIO, V28, P169, DOI 10.1089/cbr.2012.1266
   Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   Coffey G, 1999, NUCLEIC ACIDS RES, V27, P3348, DOI 10.1093/nar/27.16.3348
   Dahal S, 2018, CELL MOL LIFE SCI, V75, P1641, DOI 10.1007/s00018-017-2702-y
   Dai Ji Gang, 2006, Indian J Cancer, V43, P20
   David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978
   Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02
   de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   Degli Esposti M, 2014, GENOME BIOL EVOL, V6, P3238, DOI 10.1093/gbe/evu257
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Dmitrieva NI, 2011, AM J PHYSIOL-REG I, V301, pR632, DOI 10.1152/ajpregu.00853.2010
   Doublié S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14
   Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1
   GAaF M.J., 2003, MITOCHONDRIAL DNA DE
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   GOLDMANN A, 1990, Roentgen-Blaetter, V43, P345
   Grasso S, 2014, DNA REPAIR, V21, P148, DOI 10.1016/j.dnarep.2014.05.006
   Gray MW, 2001, GENOME BIOL, V2
   Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403
   Gredilla Ricardo, 2010, J Aging Res, V2011, P257093, DOI 10.4061/2011/257093
   Gredilla R, 2010, EXP GERONTOL, V45, P478, DOI 10.1016/j.exger.2010.01.017
   Groothuizen FS, 2016, DNA REPAIR, V38, P14, DOI 10.1016/j.dnarep.2015.11.012
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942
   Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200
   Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200
   Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611
   Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467
   Jain S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005976
   Javadekar SM, 2015, FEBS J, V282, P2627, DOI 10.1111/febs.13311
   Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kalifa L, 2012, GENETICS, V190, P951, DOI 10.1534/genetics.111.138214
   Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008
   Kamalidehghan B, 2006, ARCH MED RES, V37, P730, DOI 10.1016/j.arcmed.2006.02.005
   Kamenisch Y, 2010, J EXP MED, V207, P379, DOI 10.1084/jem.20091834
   Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057
   Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014
   KELLY JL, 1986, J BIOL CHEM, V261, P340
   Kim JJ, 2019, CRIT REV BIOCHEM MOL, V54, P208, DOI 10.1080/10409238.2019.1620676
   Kim Yun-Jeong, 2012, Curr Mol Pharmacol, V5, P3
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583
   Krokan HE, 2001, PROG NUCLEIC ACID RE, V68, P365
   Krwawicz J, 2007, ACTA BIOCHIM POL, V54, P413, DOI 10.18388/abp.2007_3219
   Kuznetsov NA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P118, DOI 10.1134/S0006297911010123
   Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869
   Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029
   LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lee HM, 2002, J NEUROCHEM, V80, P928, DOI 10.1046/j.0022-3042.2002.00774.x
   Li CY, 2006, CARCINOGENESIS, V27, P1894, DOI 10.1093/carcin/bgl042
   Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115
   Li MX, 2008, FREE RADICAL BIO MED, V45, P592, DOI 10.1016/j.freeradbiomed.2008.05.007
   Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492
   Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1
   Li Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0505-z
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649
   LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425
   LING F, 1995, EMBO J, V14, P4090, DOI 10.1002/j.1460-2075.1995.tb00081.x
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Liu VWS, 2001, CANCER RES, V61, P5998
   Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345
   Ludwig DL, 1998, MUTAT RES-DNA REPAIR, V409, P17, DOI 10.1016/S0921-8777(98)00039-1
   Mandal SM, 2012, J BIOL CHEM, V287, P2819, DOI 10.1074/jbc.M111.272179
   Manjunath M, 2021, CANCER REP-US, V4, DOI 10.1002/cnr2.1341
   Marinc M, 2012, ECONOMICS OF BANK BANKRUPTCY LAW, P5, DOI [10.1128/ecosalplus.7.2.5, 10.1007/978-3-642-21807-1_2]
   Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822
   Martin SA, 2010, CANCER CELL, V17, P235, DOI 10.1016/j.ccr.2009.12.046
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200
   McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Meyer A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00536
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495
   Moore DH, 2000, CLIN CANCER RES, V6, P602
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750
   Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102
   Nomoto S, 2002, CLIN CANCER RES, V8, P481
   Oliveira MT, 2010, EXP GERONTOL, V45, P489, DOI 10.1016/j.exger.2010.01.019
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Pandey M., 2017, Journal of Radiation and Cancer Research, V8, P93, DOI [10.4103/jrcr.jrcr_18_17, DOI 10.4103/JRCR.JRCR_]
   Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9
   PETTEPHER CC, 1991, J BIOL CHEM, V266, P3113
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Pohjoismäki JLO, 2012, NUCLEIC ACIDS RES, V40, P6595, DOI 10.1093/nar/gks301
   Prakash A, 2015, J CELL BIOCHEM, V116, P1490, DOI 10.1002/jcb.25103
   Raghavan SC, 2004, CELL CYCLE, V3, P762
   Ray U, 2020, ONCOGENE, V39, P6393, DOI 10.1038/s41388-020-01445-2
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Schärer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Sharma S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.58
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Sia EA, 2000, P NATL ACAD SCI USA, V97, P250, DOI 10.1073/pnas.97.1.250
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   SLUPPHAUG G, 1993, NUCLEIC ACIDS RES, V21, P2579, DOI 10.1093/nar/21.11.2579
   Srivastava M, 2015, CHEM BIOL, V22, P17, DOI 10.1016/j.chembiol.2014.11.013
   Srivastava N, 2007, CELL BIOCHEM FUNCT, V25, P75, DOI 10.1002/cbf.1375
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stierum RH, 1999, NUCLEIC ACIDS RES, V27, P3712, DOI 10.1093/nar/27.18.3712
   Stierum RH, 1999, J BIOL CHEM, V274, P7128, DOI 10.1074/jbc.274.11.7128
   Subramani S, 2002, J CELL BIOL, V156, P415, DOI 10.1083/jcb.200112122
   Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435
   Szczepanowska K, 2017, ESSAYS BIOCHEM, V61, P325, DOI 10.1042/EBC20160090
   Szczesny B, 2003, P NATL ACAD SCI USA, V100, P10670, DOI 10.1073/pnas.1932854100
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917
   Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tekel A, 2008, IN VIVO, V22, P477
   Tell G, 2002, HORM METAB RES, V34, P303, DOI 10.1055/s-2002-33258
   Tell G, 2010, CELL MOL LIFE SCI, V67, P3589, DOI 10.1007/s00018-010-0486-4
   Thorslund T, 2002, DNA REPAIR, V1, P261, DOI 10.1016/S1568-7864(02)00003-4
   Trevors JT, 1997, ANTON LEEUW INT J G, V71, P257, DOI 10.1023/A:1000175217677
   Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1794, DOI 10.1016/j.bbamcr.2006.08.013
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030
   Wang D, 2004, MOL CANCER THER, V3, P679
   Wang MM, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.010
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3
   WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0
   Wisnovsky S, 2018, ACS CHEM BIOL, V13, P900, DOI 10.1021/acschembio.8b00072
   Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI [10.1038/nchembio.2102, 10.1038/NCHEMBIO.2102]
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919
   Xiang DB, 2008, CANCER GENE THER, V15, P625, DOI 10.1038/cgt.2008.30
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   YANG JH, 1994, ARCH DERMATOL RES, V286, P386, DOI 10.1007/BF00371798
   Yang XD, 2001, EUR J CELL BIOL, V80, P126, DOI 10.1078/0171-9335-00144
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Yu ZL, 2016, SEMIN CELL DEV BIOL, V54, P106, DOI 10.1016/j.semcdb.2016.03.014
   Zapico SC, 2013, AGING DIS, V4, P364, DOI 10.14336/AD.2013.0400364
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128624
   Zhao YB, 2005, WORLD J GASTROENTERO, V11, P3304, DOI 10.3748/wjg.v11.i21.3304
   Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2
NR 200
TC 8
Z9 10
U1 0
U2 25
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD MAR
PY 2021
VL 478
IS 6
BP 1179
EP 1197
DI 10.1042/BCJ20200920
PG 19
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA RA1LO
UT WOS:000631179600001
PM 33740046
DA 2024-11-01
ER

PT J
AU Cotta, A
   Carvalho, E
   Da-Cunha, A
   Navarro, MM
   Paim, JF
   Valicek, J
   Baptista, S
   da Silveira, EB
   Lima, MI
   Carellos, EVM
   de-La-Rocque-Ferreira, A
   Takata, RI
   Horvath, R
AF Cotta, Ana
   Carvalho, Elmano
   Da-Cunha-Junior, AntonioLopes
   Navarro, Monica Machado
   Paim, Julia Filardi
   Valicek, Jaquelin
   Baptista-Junior, Sidney
   da Silveira, Eni Braga
   Lima, Maria Isabel
   Carellos, Ericka Viana Machado
   De-La-Rocque-Ferreira, Alessandra
   Takata, Reinaldo Issao
   Horvath, Rita
TI Muscle fat replacement and modified ragged red fibers in two patients
   with reversible infantile respiratory chain deficiency
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Reversible infantile respiratory chain deficiency; Digenic inheritance;
   Mitochondrial myopathy; Imaging; Muscle biopsy; Ragged red fibers
ID MITOCHONDRIAL ENCEPHALOMYOPATHIES; DIAGNOSIS
AB Reversible infantile respiratory chain deficiency is a severe neonatal mitochondrial myopathy that resolves spontaneously. It is caused by the homoplasmic m.14674T>C mtDNA mutation and additional nuclear variants in genes interacting with mt-tRNAGlu have been detected in some patients. We present detailed clinical, imaging, and muscle biopsy findings in a boy and a girl with neonatal hypotonia, feeding difficulties, lactic acidosis, and ragged red fibers. Both patients show fat replacement on muscle imaging, which was mild in the boy, but severe in the girl, affecting mostly the posterior leg muscles. In addition to the homoplasmic m.14674T>C, both patients carried heterozygous variants in QRSL1 (c. 686T>G; p.Val299Gly) and EARS2 (c.358C>T; p.Arg120Trp), respectively. It is very important to recognize the clinical and morphological signs of reversible infantile respiratory chain deficiency as patients should receive intensive supportive care in the first 6 months of life. Understanding the mechanism of the spontaneous recovery may lead to novel therapeutic perspectives in other mitochondrial diseases. (C) 2021 Elsevier B.V. All rights reserved.
C1 [Cotta, Ana; Paim, Julia Filardi; Baptista-Junior, Sidney] SARAH Network Rehabil Hosp, Pathol Dept, Belo Horizonte, MG, Brazil.
   [Carvalho, Elmano; Valicek, Jaquelin] SARAH Network Rehabil Hosp, Neurophysiol Dept, Belo Horizonte, MG, Brazil.
   [Da-Cunha-Junior, AntonioLopes] SARAH Network Rehabil Hosp, Radiol Dept, Belo Horizonte, MG, Brazil.
   [Navarro, Monica Machado] SARAH Network Rehabil Hosp, Pediat & Genet Dept, Belo Horizonte, MG, Brazil.
   [da Silveira, Eni Braga; Lima, Maria Isabel] SARAH Network Rehabil Hosp, Electron Microscopy Dept, Brasilia, DF, Brazil.
   [Carellos, Ericka Viana Machado] Univ Fed Minas Gerais, Sch Med, Dept Pediat, Belo Horizonte, MG, Brazil.
   [Carellos, Ericka Viana Machado] Joao Paulo II Children Hosp, Minas Gerais Hosp Fdn, Belo Horizonte, MG, Brazil.
   [De-La-Rocque-Ferreira, Alessandra; Takata, Reinaldo Issao] SARAH Network Rehabil Hosp, Mol Biol Dept, Brasilia, DF, Brazil.
   [Horvath, Rita] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
C3 Universidade Federal de Minas Gerais; University of Cambridge
RP Cotta, A (corresponding author), SARAH Network Rehabil Hosp, Pathol Dept, Belo Horizonte, MG, Brazil.
EM cotta@sarah.br
RI Carellos, Ericka/AAW-4620-2021; Horvath, Rita/AAY-7042-2020; Cotta,
   Ana/AAC-6002-2022
OI Horvath, Rita/0000-0002-9841-170X; Cotta, Ana/0000-0003-2931-6589;
   Carellos, Ericka/0000-0002-3319-7597
FU European Research Council [309548]; Wellcome Investigator Award
   [109915/Z/15/Z]; Medical Research Council (UK) [MR/N025431/1]; Newton
   Fund [UK/Turkey] [MR/N027302/1]; Lily Foundation; Evelyn Trust; MRC
   [MR/S005021/1]; MRC [MR/N010035/1, MR/S005021/1, MR/V009346/1,
   MR/N025431/2, MR/N025431/1] Funding Source: UKRI; Newton Fund
   [MR/N027302/1, MR/N027302/2] Funding Source: UKRI; Wellcome Trust
   [109915/Z/15/Z] Funding Source: Wellcome Trust
FX We wish to thank the patients for participation in this study, and Mr.
   Cleides Campos de Oliveira and Mrs. Simone Ferreira Inacio for technical
   assistance. AC, EC, Ald-C-L, MMN, JFP, JV, SB-J, EBS, MIL, EVMC, AdLRF,
   RIT have no interest to declare. RH was supported by the European
   Research Council [309548], the Wellcome Investigator Award
   [109915/Z/15/Z], the Medical Research Council (UK) [MR/N025431/1]; the
   Newton Fund [UK/Turkey, MR/N027302/1], the Lily Foundation and the
   Evelyn Trust, and by an MRC strategic award to establish an
   International centre for Genomic Medicine in Neuromuscular Diseases
   (ICGNMD) MR/S005021/1'.
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Boczonadi V, 2013, HUM MOL GENET, V22, P4602, DOI 10.1093/hmg/ddt309
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Chen TH, 2013, QJM-INT J MED, V106, P953, DOI 10.1093/qjmed/hct151
   Hathazi D, 2020, EMBO J, V39, DOI 10.15252/embj.2020105364
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Jungbluth H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-25
   Kyriacou K, 2005, ULTRASTRUCT PATHOL, V29, P169, DOI 10.1080/01913120590951158
   Kyriacou K, 1999, ULTRASTRUCT PATHOL, V23, P163
   Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111
   Quijano-Roy S, 2011, SEMIN PEDIATR NEUROL, V18, P221, DOI 10.1016/j.spen.2011.10.003
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Straub Volker, 2012, Neuromuscul Disord, V22 Suppl 2, pS42, DOI 10.1016/j.nmd.2012.08.002
   Tulinius M, 2011, SEMIN FETAL NEONAT M, V16, P229, DOI 10.1016/j.siny.2011.04.001
   Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995
NR 17
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN
PY 2021
VL 31
IS 6
BP 551
EP 557
DI 10.1016/j.nmd.2021.02.017
EA JUN 2021
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA SU3LB
UT WOS:000663041300011
PM 33832841
DA 2024-11-01
ER

PT J
AU Spruijt, L
   Smeets, HJ
   Hendrickx, A
   Bettink-Remeijer, MW
   Maat-Kievit, A
   Schoonderwoerd, KC
   Sluiter, W
   de Coo, IF
   Hintzen, RQ
AF Spruijt, Liesbeth
   Smeets, Hubert J.
   Hendrickx, Alexandra
   Bettink-Remeijer, Marijke Wefers
   Maat-Kievit, A.
   Schoonderwoerd, Kees C.
   Sluiter, Wim
   de Coo, Ireneaus F.
   Hintzen, Rogier Q.
TI A MELAS-associated ND1 mutation causing Leber hereditary optic
   neuropathy and spastic dystonia
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA MUTATION; PLUS DYSTONIA; GENE; DEFECTS; FAMILY
AB Objective: To report a novel mutation that is associated with Leber hereditary optic neuropathy ( LHON) within the same family affected by spastic dystonia.
   Design: Leber hereditary optic neuropathy is a mitochondrial disorder characterized by isolated central visual loss. Of patients with LHON, 95% carry a mutation in 1 of 3 mitochondrial DNA - encoded complex i genes. The complete mitochondrial DNA was screened for mutations in a patient with LHON without 1 of these 3 primary mutations. The heteroplasmy level and biochemical consequence of the mutation were determined.
   Results: A pathogenic 3697G > A/ND1 mutation was detected and seemed associated with an isolated complex I deficiency. This family has similar clinical characteristics as the previously described families with LHON and dystonia with an ND6 mutation.
   Conclusions: The 3697G > A/ND1 mitochondrial DNA mutation causes the LHON and spastic dystonia phenotype in the same family. This mutation can also cause MELAS syndrome ( which encompasses mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke), and other genetic factors may contribute to the clinical expression.
C1 Univ Maastricht, Dept Genet & Cell Biol, NL-6200 MD Maastricht, Netherlands.
   Univ Maastricht, Res Inst Growth & Dev, NL-6200 MD Maastricht, Netherlands.
   Univ Med Ctr Nijmegen, Dept Human Genet, Nijmegen, Netherlands.
   Rotterdam Eye Hosp, Rotterdam, Netherlands.
   Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.
   Erasmus MC, Dept Biochem, Rotterdam, Netherlands.
   Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
C3 Maastricht University; Maastricht University; Radboud University
   Nijmegen; Rotterdam Eye Hospital; Erasmus University Rotterdam; Erasmus
   MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University
   Rotterdam; Erasmus MC
RP Smeets, HJ (corresponding author), Univ Maastricht, Dept Genet & Cell Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM bert.smeets@molcelb.unimaas.nl
RI Kievit, Anneke/O-8830-2014; Spruijt, L./L-4664-2015
OI de Coo, Irenaeus/0000-0003-0533-7422
CR Abu-Amero KK, 2005, BRIT J OPHTHALMOL, V89, P1380, DOI 10.1136/bjo.2005.072819
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   DeVries DD, 1996, AM J HUM GENET, V58, P703
   FINNILAS, 2001, AM J HUM GENET, V68, P1475
   Forster P, 1996, AM J HUM GENET, V59, P935
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053
   Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2
   SCHOLTE HR, 1987, J INHERIT METAB DIS, V10, P81, DOI 10.1007/BF01812849
   SCHOLTE HR, 1995, BBA-MOL BASIS DIS, V1271, P75, DOI 10.1016/0925-4439(95)00013-T
   SHOFFNER JM, 1995, ANN NEUROL, V38, P163, DOI 10.1002/ana.410380207
   SRERE PA, 1992, CURR TOP CELL REGUL, V33, P261
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   van Eijsden RGE, 2006, GENET MED, V8, P620, DOI 10.1097/01.gim.0000237782.94878.05
   Watanabe M, 2006, J NEUROL SCI, V243, P31, DOI 10.1016/j.jns.2005.11.003
NR 19
TC 35
Z9 42
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610-0946 USA
SN 0003-9942
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JUN
PY 2007
VL 64
IS 6
BP 890
EP 893
DI 10.1001/archneur.64.6.890
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 177HF
UT WOS:000247143500016
PM 17562939
DA 2024-11-01
ER

PT J
AU Farge, G
   Pham, XH
   Holmlund, T
   Khorostov, I
   Falkenberg, M
AF Farge, Geraldine
   Pham, Xuan Hoi
   Holmlund, Teresa
   Khorostov, Ivan
   Falkenberg, Maria
TI The accessory subunit B of DNA polymerase γ is required for
   mitochondrial replisome function
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID DEOXYRIBONUCLEIC-ACID; ESCHERICHIA-COLI; PHAGE T7; BINDING; REPLICATION;
   HELICASE; TWINKLE; PROCESSIVITY; PROTEIN; PRIMASE
AB The mitochondrial replication machinery in human cells includes the DNA polymerase gamma holoenzyme and the TWINKLE helicase. Together, these two factors form a processive replication machinery, a replisome, which can use duplex DNA as template to synthesize long stretches of single-stranded DNA. We here address the importance of the smaller, accessory B subunit of DNA polymerase gamma and demonstrate that this subunit is absolutely required for replisome function. The duplex DNA binding activity of the B subunit is needed for coordination of POL gamma holoenzyme and TWINKLE helicase activities at the mtDNA replication fork. In the absence of proof for direct physical interactions between the components of the mitochondrial replisome, these functional interactions may explain the strict interdependence of TWINKLE and DNA polymerase gamma for mitochondrial DNA synthesis. Furthermore, mutations in TWINKLE as well as in the catalytic A and accessory B subunits of the POL gamma holoenzyme, may cause autosomal dominant progressive external ophthalmoplegia, a disorder associated with deletions in mitochondrial DNA. The crucial importance of the B subunit for replisome function may help to explain why mutations in these three proteins cause an identical syndrome.
C1 Karolinska Inst, Div Metab Dis, SE-14186 Stockholm, Sweden.
C3 Karolinska Institutet
RP Falkenberg, M (corresponding author), Karolinska Inst, Div Metab Dis, SE-14186 Stockholm, Sweden.
EM maria.falkenberg@ki.se
RI farge, geraldine/M-2803-2018
OI Pham, Xuan Hoi/0000-0002-9629-2970; farge, geraldine/0000-0003-1054-4274
CR Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465
   Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102
   HUBER HE, 1986, J BIOL CHEM, V261, P5006
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   NAKAI H, 1988, J BIOL CHEM, V263, P9831
   Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767
   Wang YX, 1997, J BIOL CHEM, V272, P13640, DOI 10.1074/jbc.272.21.13640
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhu YL, 2003, J VIROL, V77, P10147, DOI 10.1128/JVI.77.18.10147-10153.2003
NR 24
TC 42
Z9 50
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD FEB
PY 2007
VL 35
IS 3
BP 902
EP 911
DI 10.1093/nar/gkl1116
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 139KD
UT WOS:000244429800024
PM 17251196
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Eelczak, P
   Lewandowska, E
   Stepniak, I
   Oldak, M
   Pollak, A
   Lechowicz, U
   Pasennik, E
   Stepiew, T
   Wierzba-Bobrowicz, T
AF Eelczak, Paulina
   Lewandowska, Eliza
   Stepniak, Iwona
   Oldak, Monika
   Pollak, Agnieszka
   Lechowicz, Urszula
   Pasennik, Elzbieta
   Stepiew, Tomasz
   Wierzba-Bobrowicz, Teresa
TI PATHOLOGY OF MITOCHONDRIA IN MELAS SYNDROME: AN ULTRASTRUCTURAL STUDY
SO POLISH JOURNAL OF PATHOLOGY
LA English
DT Article
DE MELAS; A3243G mutation; abnormal mitochondria; ultrastructure
ID STROKE-LIKE-EPISODES; TREATMENT OPTIONS; SKELETAL-MUSCLE;
   LACTIC-ACIDOSIS; DNA MUTATION; DISORDERS; MYOPATHY; ENCEPHALOPATHY;
   DIAGNOSIS; DISEASE
AB Ultrastructural changes in skeletal muscle biopsy in a 24-year-old female patient with clinically suspected mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS) syndrome are presented. We observed proliferation and/or pleomorphism of mitochondria in skeletal muscle and smooth muscle cells of arterioles, as well as in pericytes of capillaries. Paracrystalline inclusions were found only in damaged mitochondria of skeletal muscle. Genetic testing revealed a point mutation in A3243G tRNALeu(UUR) typical for MELAS syndrome. We conclude that differentiated pathological changes of mitochondria in the studied types of cells may be associated with the different energy requirements of these cells.
C1 [Eelczak, Paulina; Lewandowska, Eliza; Pasennik, Elzbieta; Stepiew, Tomasz; Wierzba-Bobrowicz, Teresa] Inst Psychiat & Neurol, Dept Neuropathol, 9 Sobieskiego St, PL-02957 Warsaw, Poland.
   [Stepniak, Iwona] Inst Psychiat & Neurol, Dept Genet, Warsaw, Poland.
   [Stepniak, Iwona; Oldak, Monika; Pollak, Agnieszka; Lechowicz, Urszula] Inst Physiol & Pathol Hearing, Dept Genet, Warsaw, Poland.
C3 Institute of Psychiatry & Neurology; Institute of Psychiatry &
   Neurology; Institute of Physiology & Hearing Pathology
RP Lewandowska, E (corresponding author), Inst Psychiat & Neurol, Dept Neuropathol, 9 Sobieskiego St, PL-02957 Warsaw, Poland.
EM lewandow@ipin.edu.pl
RI Stępień, Tomasz/HKF-3680-2023; Lechowicz, Urszula/ABB-9967-2020
OI Lechowicz, Urszula/0000-0002-2645-8779; Oldak,
   Monika/0000-0002-4216-9141; Felczak, Paulina/0000-0001-9574-582X;
   Stepien, Tomasz/0000-0003-2831-1321; Pollak,
   Agnieszka/0000-0002-2847-1782; Wierzba-Bobrowicz,
   Teresa/0000-0003-2518-8321
FU Polish National Science Centre [2012/05/N/NZ5/02629]
FX .This study was supported by the Polish National Science Centre grant
   no. 2012/05/N/NZ5/02629.
CR Abu-Amero KK, 2009, J MED CASE REPORTS, V3, P1
   BONILLA E, 1980, ACTA NEUROPATHOL, V52, P35, DOI 10.1007/BF00687226
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Calabrese C, 2014, BIOINFORMATICS, V30, P3115, DOI 10.1093/bioinformatics/btu483
   Cheldi A, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-8
   Chinnery PF, 1999, LANCET, V354, pSI17
   Christy A, 2014, SCH J MED CASE REP, V2, P145
   DiFrancesco JC, 2008, EXP NEUROL, V212, P152, DOI 10.1016/j.expneurol.2008.03.015
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   EPPENBERGEREBERHARDT M, 1991, J CELL BIOL, V113, P289, DOI 10.1083/jcb.113.2.289
   Farrar GJ, 2013, TRENDS GENET, V10, P1
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2011, REV INVEST CLIN, V63, P100
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Khan NA, 2015, INDIAN J MED RES, V141, P13
   Koenigsberger MR, 1976, CNS 5 ANN M MONT CA
   Lang T, 2010, ULTRASTRUCT PATHOL, V34, P78, DOI 10.3109/01913121003624684
   Lax NZ, 2011, NEUROSCIENTIST, V17, P645, DOI 10.1177/1073858411385469
   Lee SJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/327167
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Misonou Y, 2014, BIOL OPEN, V3, P387, DOI 10.1242/bio.20147138
   OHAMA E, 1987, ACTA NEUROPATHOL, V75, P1, DOI 10.1007/BF00686785
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pronicki M, 2007, FOLIA NEUROPATHOL, V45, P187
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   Stojanovski D, 2006, BBA-MOL CELL RES, V1763, P414, DOI 10.1016/j.bbamcr.2006.02.008
   Szalardy L, 2016, FOLIA NEUROPATHOL, V54, P9, DOI 10.5114/fn.2016.58911
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144
   Wang ZP, 2016, FOLIA NEUROPATHOL, V54, P66, DOI 10.5114/fn.2016.58917
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 42
TC 8
Z9 8
U1 0
U2 11
PU VESALIUS UNIV MEDICAL PUBL
PI CRACOW
PA WISLISKO 1, CRACOW, 00000, POLAND
SN 1233-9687
J9 POL J PATHOL
JI Pol. J. Pathol.
PD JUN
PY 2017
VL 68
IS 2
BP 173
EP 181
DI 10.5114/PJP.2017.65021
PG 9
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA FF8SX
UT WOS:000409289200012
PM 29025253
OA Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Chen, T
   He, J
   Huang, YS
   Zhao, WW
AF Chen, Tao
   He, Jing
   Huang, Yushan
   Zhao, Weiwei
TI The generation of mitochondrial DNA large-scale deletions in human cells
SO JOURNAL OF HUMAN GENETICS
LA English
DT Review
DE generation; large-scale deletions; mitochondrial DNA; repair;
   replication
ID HUMAN SKELETAL-MUSCLE; STRAND BREAK REPAIR; EXTERNAL OPHTHALMOPLEGIA;
   DEGENERATIVE DISEASES; MUTATIONS; REPLICATION; MTDNA; SEQUENCE;
   PATHWAYS; CANCER
AB Large-scale deletions of human mitochondrial DNA (mtDNA) are a common cause of mitochondrial diseases. In order to prevent and treat these mitochondrial diseases, it is important and necessary to understand the mechanisms behind the generation of these deletions. Generally, there exist three kinds of large-scale deletions: deletions almost occur within two direct repeats with identical sequences (class I deletions), deletions are flanked by imperfect repeats (class II deletions) and by no direct repeats (class III deletions). Two major hypotheses are suggested to generate these deletions: replication for class I/II deletions through slipped mispairing between two repeats, and repair mainly for class II/III deletions mediated by mtDNA double-strand breaks. It seems possible that these two mechanisms work together as a powerful and complementary system to compensate for their defects in the generation of all these deletions, not respectively. Journal of Human Genetics (2011) 56, 689-694; doi:10.1038/jhg.2011.97; published online 25 August 2011
C1 [Chen, Tao; Huang, Yushan; Zhao, Weiwei] Guangzhou Kingmed Ctr Clin Lab, Dept Mol Pathol, Guangzhou 510330, Guangdong, Peoples R China.
   [Chen, Tao] Guangzhou Kingmed Ctr Clin Lab, Dept Mol Genet, Guangzhou 510330, Guangdong, Peoples R China.
   [He, Jing] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China.
C3 Fudan University
RP Chen, T (corresponding author), Guangzhou Kingmed Ctr Clin Lab, Dept Mol Pathol, Guangzhou 510330, Guangdong, Peoples R China.
EM ct19840796@126.com
RI zhao, wei/IQS-1144-2023; He, Jing/M-5774-2015
OI He, Jing/0000-0002-1954-2892
CR Abnet CC, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-30
   ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010
   Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703
   Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059
   Kamalidehghan B, 2006, ARCH MED RES, V37, P848, DOI 10.1016/j.arcmed.2006.03.007
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MITONIAP, 2010, MITOMAP HUM MIT GEN
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Muqit MMK, 2008, J NEUROL NEUROSUR PS, V79, P68, DOI 10.1136/jnnp.2006.112250
   Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Rocher C, 2002, MOL GENET METAB, V76, P123, DOI 10.1016/S1096-7192(02)00024-0
   Rogounovitch T, 2004, ENDOCR J, V51, P265, DOI 10.1507/endocrj.51.265
   Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Shen LJ, 2010, ANN NY ACAD SCI, V1201, P26, DOI 10.1111/j.1749-6632.2010.05635.x
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Solano A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e86
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326
   van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WELTER C, 1989, NUCLEIC ACIDS RES, V17, P6077
   Wong LJC, 2003, J MED GENET, V40
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Wu J, 2001, J BIOL CHEM, V276, P14614, DOI 10.1074/jbc.M004402200
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   Ye CZ, 2008, BREAST CANCER RES TR, V108, P427, DOI 10.1007/s10549-007-9613-9
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZHANG CF, 1995, HUM MOL GENET, V4, P751, DOI 10.1093/hmg/4.4.751
NR 61
TC 47
Z9 58
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD OCT
PY 2011
VL 56
IS 10
BP 689
EP 694
DI 10.1038/jhg.2011.97
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 842DM
UT WOS:000296569900001
PM 21866113
OA Bronze
DA 2024-11-01
ER

PT J
AU Ortube, MC
   Bhola, R
   Demer, JL
AF Ortube, Maria Carolina
   Bhola, Rahul
   Demer, Joseph L.
TI Orbital magnetic resonance imaging of extraocular muscles in chronic
   progressive external ophthalmoplegia: Specific diagnostic findings
SO JOURNAL OF AAPOS
LA English
DT Article; Proceedings Paper
CT 30th Annual Meeting of the
   American-Association-for-Pediatric-Ophthalmology-and-Strabismus
CY MAR 27-31, 2004
CL Washington, DC
SP Amer Assoc Pediat Ophthalmol & Strabismus
ID MITOCHONDRIAL-DNA; STRABISMUS; NEUROOPHTHALMOLOGY; DELETIONS; FEATURES;
   DISEASES; PULLEYS; HUMANS
AB INTRODUCTION Chronic progressive external ophthalmoplegia (CPEO) is characterized by slowly progressive bilateral oplithalmoplegia and blepharoptosis. Molecular diagnosis is problematic because sporadic mitochondrial DNA deletions can be causative. We sought findings using magnetic resonance imaging (MRI) that might support the diagnosis of CPEO.
   METHODS Two men (ages 31 and 47 years) and 3 women (ages 40-49 years) with CPEO and symptom durations of 8 months to 28 years underwent high-resolution (2-mm slice thickness, 312 micron pixels), surface coil, T1-weighted orbital MRI in coronal planes. Images were analyzed quantitatively to determine extraocular muscle (EOM) sizes and were compared with 10 age- and gender-matched normal volunteers, one subject with myasthenia gravis, and with 30 subjects having EOM paralysis caused by oculomotor, trochlear,0 and abducens neuropathies.
   RESULTS EOM function was clinically diminished in CPEO, most markedly for the superior rectus (SR) and levator muscles. All EOMs in CPEO exhibited unusual qualitative T1 MRI signal abnormalities. Unlike the profound EOM atrophy typical of neurogenic paralysis, anterior volumes of medial rectus, lateral rectus, and inferior rectus muscles in CPEO were not smaller than normal (p > 0.003). Anterior volumes of the SR muscle-levator complex and superior oblique were significantly reduced (p < 0.003). Denervated EOMs exhibited statistically significant volume reduction when compared with normal and CPEO groups. Volume of the SR muscle-levator complex was the same in subjects with CPEO and oculomotor palsies.
   CONCLUSIONS CPEO is associated with minimal EOM volume reduction despite clinically severe weakness. This combination of findings may be specific for CPEO and could resolve the diagnostic dilemma in difficult cases.
C1 Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA USA.
   Univ Calif Los Angeles, Bioengn Interdept Programs, Los Angeles, CA USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; University of California System; University of
   California Los Angeles
RP Demer, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, 100 Stein Pl, Los Angeles, CA 90095 USA.
EM jld@ucla.edu
FU NEI NIH HHS [R01 EY008313, EY 08313] Funding Source: Medline; NIDCD NIH
   HHS [P50 DC005224] Funding Source: Medline
CR Biousse V, 2003, CURR OPIN NEUROL, V16, P35, DOI 10.1097/00019052-200302000-00005
   Biousse V, 2001, SEMIN NEUROL, V21, P275, DOI 10.1055/s-2001-17945
   BRODSKY MC, 1996, PEDIAT NEUROOPHTHALM, P390
   Carta A, 2000, ARCH OPHTHALMOL-CHIC, V118, P1441
   Clark RA, 1999, J AAPOS, V3, P18, DOI 10.1016/S1091-8531(99)70090-X
   DEMER JL, 1995, INVEST OPHTH VIS SCI, V36, P1125
   DEMER JL, 1994, J PEDIAT OPHTH STRAB, V31, P177
   Demer JL, 2000, INVEST OPHTH VIS SCI, V41, P1280
   Demer JL, 1997, INVEST OPHTH VIS SCI, V38, P1774
   Demer JL, 2005, INVEST OPHTH VIS SCI, V46, P530, DOI 10.1167/iovs.04-1125
   Demer JL, 2002, J AAPOS, V6, P337, DOI 10.1067/mpa.2002.129040
   Demer JL, 2002, ANN NY ACAD SCI, V956, P17, DOI 10.1111/j.1749-6632.2002.tb02805.x
   Demer JL, 2001, AM J OPHTHALMOL, V132, P757, DOI 10.1016/S0002-9394(01)01099-6
   Demer JL, 1999, CLIN STRABISMUS MANA, P84
   DURSTON JHJ, 1974, BRIT J OPHTHALMOL, V58, P193, DOI 10.1136/bjo.58.3.193
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   KAISSAR G, 1991, RADIOLOGY, V179, P541, DOI 10.1148/radiology.179.2.2014307
   KOORNNEEF L, 1977, ACTA MORPHOL NEER SC, V15, P35
   MILLER NR, 1985, WALSH HOYTS CLIN NEU, V2, P811
   Oh SY, 2001, INVEST OPHTH VIS SCI, V42, P17
   Oh SY, 2001, INVEST OPHTH VIS SCI, V42, P10
   Okamoto K, 1996, J NEURO-OPHTHALMOL, V16, P286
   PORTER JD, 1995, SURV OPHTHALMOL, V39, P451, DOI 10.1016/S0039-6257(05)80055-4
   Porter JD, 1996, NEUROLOGY, V46, P30, DOI 10.1212/WNL.46.1.30
   RINGEL SP, 1979, ANN NEUROL, V6, P326, DOI 10.1002/ana.410060406
   ROWLAND LP, 1992, HDB CLIN NEUROLOGY, V18, P287
   Shin GS, 1996, J PEDIATR OPHTHALMOL, V33, P282
   Spencer R F, 1988, Rev Oculomot Res, V2, P33
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Thacker NM, 2005, J AAPOS, V9, P174, DOI 10.1016/j.jaapos.2004.12.005
   Vilarinho L, 1998, EUR NEUROL, V39, P148, DOI 10.1159/000007925
   VONGRAEFE A, 1868, GESSELSCHAFTEN BERLI, V5, P125
NR 32
TC 22
Z9 24
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD OCT
PY 2006
VL 10
IS 5
BP 414
EP 418
DI 10.1016/j.jaapos.2006.04.012
PG 5
WC Ophthalmology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Ophthalmology; Pediatrics
GA 104ZG
UT WOS:000241998500010
PM 17070475
OA Green Accepted
DA 2024-11-01
ER

PT J
AU D'Souza, GGM
   Weissig, V
AF D'Souza, GGM
   Weissig, V
TI Approaches to mitochondrial gene therapy
SO CURRENT GENE THERAPY
LA English
DT Review
ID PEPTIDE NUCLEIC-ACID; MAMMALIAN-CELLS; ORNITHINE TRANSCARBAMYLASE;
   RNA/DNA OLIGONUCLEOTIDES; RESTRICTION-ENDONUCLEASE; DQASOME/DNA
   COMPLEXES; NUCLEOTIDE EXCHANGE; CATIONIC BOLASOMES; TARGETED DELIVERY;
   DNA HETEROPLASMY
AB Since their discovery during the end of the 80's the number of diseases found to be associated with defects in the mitochondrial genome has grown significantly. Organs affected by mutations in mitochondrial DNA (mtDNA) include in decreasing order of vulnerability the brain, skeletal muscle, heart, kidney and liver. Hence neuromuscular and neurodegenerative diseases represent the two largest groups of mtDNA diseases. Despite major advances in understanding mtDNA defects at the genetic and biochemical level, there is however no satisfactory treatment available to the vast majority of patients. This is largely due to the fact that most of these patients have respiratory chain defects, i.e. defects that involve the final common pathway of oxidative metabolism, making it impossible to bypass the defect by administering alternative metabolic carriers of energy. Conventional biochemical treatment having reached an impasse, the exploration of gene therapeutic approaches for patients with mtDNA defects is warranted. For now mitochondrial gene therapy appears to be only theoretical and speculative. Any possibility for gene replacement is dependent on the development of an efficient mitochondrial transfection vector. In this review we describe the current state of the development of mitochondria-specific DNA delivery systems. We summarize our own efforts in exploring the properties of dequalinium and other similar cationic bolaamphiphiles with delocalized charge centers, for the design of a vector suited for the transport of DNA to mitochondria in living cells. Further, we outline some unique hurdles that need to be overcome if the development of such delivery systems is to progress.
C1 Northeastern Univ, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, Boston, MA 02115 USA.
C3 Northeastern University
RP D'Souza, GGM (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, Boston, MA 02115 USA.
EM dsouza.g@ncu.edu
CR Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191
   Attardi Giuseppe M, 2001, ScientificWorldJournal, V1, P76, DOI 10.1100/tsw.2001.133
   Bandyopadhyay P, 1999, J BIOL CHEM, V274, P10163, DOI 10.1074/jbc.274.15.10163
   Bigger BW, 2001, J BIOL CHEM, V276, P23018, DOI 10.1074/jbc.M010873200
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Butow R A, 1996, Methods Enzymol, V264, P265, DOI 10.1016/S0076-6879(96)64026-9
   BUTOW RA, 1990, TRENDS BIOCHEM SCI, V15, P465, DOI 10.1016/0968-0004(90)90299-Q
   Chen ZY, 2001, BIOCHEM BIOPH RES CO, V285, P188, DOI 10.1006/bbrc.2001.5156
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Chrzanowska-Lightowlers ZM, 1999, GENE, V230, P241, DOI 10.1016/S0378-1119(99)00082-7
   Collombet JM, 1997, J BIOL CHEM, V272, P5342, DOI 10.1074/jbc.272.8.5342
   D'Souza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   de Grey ADNJ, 2000, TRENDS BIOTECHNOL, V18, P394, DOI 10.1016/S0167-7799(00)01476-1
   De Vivo Darryl C., 1993, P39
   Druzhyna NM, 2003, GLIA, V42, P370, DOI 10.1002/glia.10230
   Entelis NS, 1998, P NATL ACAD SCI USA, V95, P2838, DOI 10.1073/pnas.95.6.2838
   Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200
   Flierl A, 2003, MOL THER, V7, P550, DOI 10.1016/S1525-0016(03)00037-6
   GERGORIADIS G, 2000, TARGETING DRUGS STRA
   Geromel V, 2001, ANTISENSE NUCLEIC A, V11, P175, DOI 10.1089/108729001300338708
   HANNA MG, 1995, J NEUROL SCI, V130, P154, DOI 10.1016/0022-510X(95)00022-T
   HARDING AE, 1991, TRENDS NEUROSCI, V14, P132, DOI 10.1016/0166-2236(91)90081-5
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Inoue K, 2002, METHODS, V26, P358, DOI 10.1016/S1046-2023(02)00042-7
   JACOBS HT, 1991, J MOL EVOL, V32, P333, DOI 10.1007/BF02102192
   James AM, 2003, EUR J BIOCHEM, V270, P2827, DOI 10.1046/j.1432-1033.2003.03660.x
   JAUSLIN ML, 2003, FASEB J
   Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200
   JOHNSTON SA, 1988, SCIENCE, V240, P1538, DOI 10.1126/science.2836954
   Kagawa Y, 2001, ADV DRUG DELIVER REV, V49, P107, DOI 10.1016/S0169-409X(01)00129-6
   Kagawa Y, 1997, GENE THER, V4, P6, DOI 10.1038/sj.gt.3300347
   Kazakova HA, 1999, FEBS LETT, V442, P193, DOI 10.1016/S0014-5793(98)01653-6
   Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200
   Kelso GF, 2002, ANN NY ACAD SCI, V959, P263, DOI 10.1111/j.1749-6632.2002.tb02098.x
   Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931
   Kren BT, 2003, DNA REPAIR, V2, P531, DOI 10.1016/S1568-7864(03)00022-3
   Kren BT, 2002, GENE THER, V9, P686, DOI 10.1038/sj.gt.3301762
   Kren BT, 2002, METHOD ENZYMOL, V346, P14
   Kren BT, 1997, HEPATOLOGY, V25, P1462, DOI 10.1002/hep.510250626
   LACORAZZA HD, 1995, GENE THER, V2, P22
   Ledley FD, 1996, PHARM RES-DORDR, V13, P1595, DOI 10.1023/A:1016420102549
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Mukhopadhyay A, 2003, J BIOL CHEM, V278, P13712, DOI 10.1074/jbc.M212743200
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852
   Murphy MP, 1997, TRENDS BIOTECHNOL, V15, P326, DOI 10.1016/S0167-7799(97)01068-8
   NAGLEY P, 1989, TRENDS BIOCHEM SCI, V14, P31, DOI 10.1016/0968-0004(89)90087-X
   Nakabeppu Y, 2001, PROG NUCLEIC ACID RE, V68, P75
   Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863
   Owen R, 2000, HUM GENE THER, V11, P2067, DOI 10.1089/104303400750001381
   Owen R, 2001, ANTIOXID REDOX SIGN, V3, P451, DOI 10.1089/15230860152409086
   Papa S, 1996, MOL ASPECTS MED, V17, P513
   Pinkert CA, 1997, TRANSGENIC RES, V6, P379, DOI 10.1023/A:1018431316831
   Pulkes T, 2001, ADV DRUG DELIVER REV, V49, P27, DOI 10.1016/S0169-409X(01)00124-7
   Rachek LI, 2002, J BIOL CHEM, V277, P44932, DOI 10.1074/jbc.M208770200
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   ROLLAND A, 1999, ADV GENE DELIVERY
   Ross GF, 2003, BIOCONJUGATE CHEM, V14, P962, DOI 10.1021/bc034050f
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519
   Scheffler IE, 2001, ADV DRUG DELIVER REV, V49, P3, DOI 10.1016/S0169-409X(01)00123-5
   SCHEFFLER IE, 1999, EVOLUTIONARY ORIGIN, P7
   SEIBEL P, 1995, NUCLEIC ACIDS RES, V23, P10, DOI 10.1093/nar/23.1.10
   Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x
   SOBOL RE, 1995, INTERNET BOOK GENE T
   SOLIGNAC M, 1983, P NATL ACAD SCI-BIOL, V80, P6942, DOI 10.1073/pnas.80.22.6942
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   SULLIVAN S, 2003, LIPSOMES PRACTICAL A
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor D, 2000, IEEE INTELL SYST APP, V15, P2
   Taylor RW, 2000, NEUROL SCI, V21, pS909, DOI 10.1007/s100720070002
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Taylor RW, 2001, ADV DRUG DELIVER REV, V49, P121, DOI 10.1016/S0169-409X(01)00130-2
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Weissig V, 2000, DRUG DELIV, V7, P1, DOI 10.1080/107175400266722
   Weissig V, 2001, STP PHARMA SCI, V11, P91
   Weissig V, 2001, ADV DRUG DELIVER REV, V49, P127, DOI 10.1016/S0169-409X(01)00131-4
   Weissig V, 2001, J CONTROL RELEASE, V75, P401, DOI 10.1016/S0168-3659(01)00392-3
   Weissig V, 2001, J DRUG TARGET, V9, P1
   Wheeler VC, 1996, GENE, V169, P251, DOI 10.1016/0378-1119(95)00812-8
   Wheeler VC, 1997, GENE, V198, P203, DOI 10.1016/S0378-1119(97)00315-6
   Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019
   Yoon YG, 2003, NUCLEIC ACIDS RES, V31, P1407, DOI 10.1093/nar/gkg228
   ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997
   Zanta MA, 1999, P NATL ACAD SCI USA, V96, P91, DOI 10.1073/pnas.96.1.91
   Zimmer KP, 1999, MOL MED, V5, P244, DOI 10.1007/BF03402122
   Zullo SJ, 2001, SEMIN NEUROL, V21, P327, DOI 10.1055/s-2001-17949
NR 94
TC 25
Z9 32
U1 0
U2 12
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1566-5232
EI 1875-5631
J9 CURR GENE THER
JI Curr. Gene Ther.
PD SEP
PY 2004
VL 4
IS 3
BP 317
EP 328
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 864CW
UT WOS:000224611800008
PM 15384945
DA 2024-11-01
ER

PT J
AU Reiter, L
   Niehoff, N
   Weiland, D
   Helbig, D
   Eming, SA
   Krieg, T
   Etich, J
   Brachvogel, B
   Wiesner, RJ
   Knuever, J
AF Reiter, Lena
   Niehoff, Nadine
   Weiland, Daniela
   Helbig, Doris
   Eming, Sabine A.
   Krieg, Thomas
   Etich, Julia
   Brachvogel, Bent
   Wiesner, Rudolf J.
   Knuever, Jana
TI Mitochondrial DNA mutations attenuate Bleomycin-induced dermal fibrosis
   by inhibiting differentiation into myofibroblasts
SO MATRIX BIOLOGY
LA English
DT Article
DE Mitochondrial DNA; Twinkle helicase; Skin fibrosis;
   alpha-Smooth-muscle-actin; Myofibroblasts; Differentiation
ID COLLAGEN-LATTICES; MAST-CELLS; SKIN; FIBROBLASTS; DELETIONS; MECHANISMS;
   MITOPHAGY; EXPOSURE; PROMOTES; MARKER
AB Post-mitotic, non-proliferative dermal fibroblasts have crucial functions in maintenance and restoration of tissue homeostasis. They are involved in essential processes such as wound healing, pigmentation and hair growth, but also tumor development and aging-associated diseases. These processes are energetically highly demanding and error prone when mitochondrial damage occurs. However, mitochondrial function in fibroblasts and the influence of mitochondrial dysfunction on fibroblast-specific demands are still unclear. To address these questions, we created a mouse model in which accelerated cell-specific mitochondrial DNA (mtDNA) damage accumulates. We crossed mice carrying a dominant-negative mutant of the mitochondrial replicative helicase Twinkle (RosaSTOP system) with mice that express fibroblast-specific Cre Recombinase (Collagen1A2 CreERT) ERT ) which can be activated by Tamoxifen (TwinkleFIBRO). FIBRO ). Thus, we are able to induce mtDNA deletions and duplications in specific cells, a process which resembles the physiological aging process in humans, where this damage accumulates in all tissues. Upon proliferation in vitro, , Tamoxifen induced Twinkle fibroblasts deplete most of their mitochondrial DNA which, although not disturbing the stoichiometry of the respiratory chain complexes, leads to reduced ROS production and mitochondrial membrane potential as well as an anti-inflammatory and anti-fibrotic profile of the cells. In Sodium Azide treated wildtype fibroblasts, without a functioning respiratory chain, we observe the opposite, a rather pro-inflammatory and pro-fibrotic signature. Upon accumulation of mitochondrial DNA mutations in vivo the TwinkleFIBRO FIBRO mice are protected from fibrosis development induced by intradermal Bleomycin injections. This is due to dampened differentiation of the dermal fibroblasts into alpha- smooth-muscle-actin positive myofibroblasts in TwinkleFIBRO FIBRO mice. We thus provide evidence for striking differences of the impact that mtDNA mutations have in contrast to blunted mitochondrial function in dermal fibroblasts and skin homeostasis. These data contribute to improved understanding of mitochondrial function and dysfunction in skin and provide mechanistic insight into potential targets to treat skin fibrosis in the future.
C1 [Reiter, Lena; Niehoff, Nadine; Weiland, Daniela; Wiesner, Rudolf J.] Univ Cologne, Inst Vegetat Physiol, Ctr Physiol & Pathophysiol, D-50931 Cologne, Germany.
   [Weiland, Daniela] Univ Cologne, Inst Virol, Fac Med, Lab Expt Immunol, D-50931 Cologne, Germany.
   [Helbig, Doris; Eming, Sabine A.; Krieg, Thomas; Knuever, Jana] Univ Cologne, Fac Med, Dept Dermatol & Venereol, D-50937 Cologne, Germany.
   [Helbig, Doris; Eming, Sabine A.; Krieg, Thomas; Knuever, Jana] Univ Cologne, Univ Hosp Cologne, D-50937 Cologne, Germany.
   [Eming, Sabine A.; Krieg, Thomas; Brachvogel, Bent; Wiesner, Rudolf J.] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.
   [Eming, Sabine A.; Krieg, Thomas; Brachvogel, Bent; Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respons, D-50931 Cologne, Germany.
   [Eming, Sabine A.] Univ Cologne, Inst Zool, Dev Biol Unit, D-50674 Cologne, Germany.
   [Krieg, Thomas] Univ Cologne, Med Fac, Translat Matrix Biol, D-50931 Cologne, Germany.
   [Etich, Julia; Brachvogel, Bent] Univ Cologne, Fac Med, Dept Pediat & Adolescent Med, Expt Neonatol, D-50931 Cologne, Germany.
   [Etich, Julia; Brachvogel, Bent] Univ Cologne, Univ Hosp Cologne, D-50931 Cologne, Germany.
C3 University of Cologne; University of Cologne; University of Cologne;
   University of Cologne; University of Cologne; University of Cologne;
   University of Cologne; University of Cologne; University of Cologne;
   University of Cologne
RP Knuever, J (corresponding author), Univ Cologne, Fac Med, Dept Dermatol & Venereol, D-50937 Cologne, Germany.
EM jana.naetlitz@uk-koeln.de
RI Natlitz, geb. Knuver, Jana/KXR-3938-2024
OI Natlitz, geb. Knuver, Jana/0000-0003-1066-6431; Wiesner,
   Rudolf/0000-0003-1677-4476; Brachvogel, Bent/0000-0002-3923-0554;
   Reiter, Lena/0009-0009-8279-7810
FU Koeln Fortune program/Faculty of Medicine/University of Cologne
   [254/2022]; Deutsche Forschungsgemeinschaft (DFG, German Research
   Foundation) [FOR2722-BR2304/12-1-407146744, ET144/3-2384170921,
   BR2304/7-1-207342459]
FX This work was supported by the Koeln Fortune program/Faculty of
   Medicine/University of Cologne, project number 254/2022 to J.K.J.E. and
   B.B. were supported by the Deutsche Forschungsgemeinschaft (DFG, German
   Research Foundation) within the Research Unit
   FOR2722-BR2304/12-1-407146744, ET144/3-2384170921 and
   BR2304/7-1-207342459. We thank Michael Piekarek for technical assistance
   with the wounding experiments and the CRC 829 (2009-2020) Biobank for
   providing us with the tissue samples of Morphea patients. Additionally,
   we are grateful for technical support by Christian Juengst and Peter
   Zentis of CECAD (Cologne Excellence Cluster on Cellular Stress Responses
   in Aging-Associated Diseases) imaging facility.
CR Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345
   Birch-Machin MA, 1998, J INVEST DERMATOL, V110, P149, DOI 10.1046/j.1523-1747.1998.00099.x
   Blagov AV, 2024, FRONT PHARMACOL, V15, DOI 10.3389/fphar.2024.1378335
   Bubb K, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101224
   Cantanhede IG, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.1004949
   Chu XG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02431
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401
   Forsström S, 2019, CELL METAB, V30, P1040, DOI [10.1016/j.cmet.2019.013.019, 10.1016/j.cmet.2019.08.019]
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Huang JW, 2022, SEMIN CELL DEV BIOL, V128, P137, DOI 10.1016/j.semcdb.2022.02.027
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Insalata F, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2122073119
   Johnson BZ, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8050101
   Karan KR, 2022, J MOL MED, V100, P963, DOI 10.1007/s00109-022-02206-2
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x
   Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Leman G, 2022, J INVEST DERMATOL, V142, P2623, DOI 10.1016/j.jid.2022.01.035
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Majora M, 2009, AM J PATHOL, V175, P1019, DOI 10.2353/ajpath.2009.080832
   Mauro-Lizcano M, 2015, AUTOPHAGY, V11, P833, DOI 10.1080/15548627.2015.1034403
   Meng FR, 2021, MOL BIOL REP, V48, P7153, DOI 10.1007/s11033-021-06707-0
   Mia MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091559
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Oexner RR, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.12.14
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   Plikus MV, 2021, CELL, V184, P3852, DOI 10.1016/j.cell.2021.06.024
   Plikus MV, 2021, EXP DERMATOL, V30, P4, DOI 10.1111/exd.14257
   Ray AJ, 2000, J INVEST DERMATOL, V115, P674, DOI 10.1046/j.1523-1747.2000.00092.x
   Rigau AR, 2021, METHODS MOL BIOL, V2299, P371, DOI 10.1007/978-1-0716-1382-5_25
   Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151
   Rombold S, 2008, PHOTODERMATOL PHOTO, V24, P19, DOI 10.1111/j.1600-0781.2008.00328.x
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sawant M, 2021, WOUND REPAIR REGEN, V29, P515, DOI 10.1111/wrr.12950
   Sen A, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-34205-9
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sturm G, 2023, COMMUN BIOL, V6, DOI 10.1038/s42003-022-04303-x
   Sturm G, 2022, SCI DATA, V9, DOI 10.1038/s41597-022-01852-y
   Tigges J, 2014, MECH AGEING DEV, V138, P26, DOI 10.1016/j.mad.2014.03.004
   Tomer D, 2018, DEV BIOL, V434, P48, DOI 10.1016/j.ydbio.2017.11.009
   van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020
   Wang YY, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24043257
   Weiland D, 2018, J INVEST DERMATOL, V138, P132, DOI 10.1016/j.jid.2017.08.019
   Weiskirchen R, 2019, MOL ASPECTS MED, V65, P2, DOI 10.1016/j.mam.2018.06.003
   Wiley CD, 2021, NAT METAB, V3, P1290, DOI 10.1038/s42255-021-00483-8
   Willenborg S, 2021, CELL METAB, V33, P2398, DOI 10.1016/j.cmet.2021.10.004
   Willenborg S, 2014, J INVEST DERMATOL, V134, P2005, DOI 10.1038/jid.2014.12
   Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Xian HX, 2021, IMMUNITY, V54, P1463, DOI 10.1016/j.immuni.2021.05.004
   Yamamoto T, 2000, IMMUNOLOGY, V99, P435, DOI 10.1046/j.1365-2567.2000.00973.x
   Zhang K, 2022, ELIFE, V11, DOI 10.7554/eLife.68598
   Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X
   Zhou X, 2022, ARTHRITIS RHEUMATOL, V74, P871, DOI 10.1002/art.42033
   Zouboulis CC, 2011, CLIN DERMATOL, V29, P3, DOI 10.1016/j.clindermatol.2010.07.001
NR 59
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0945-053X
EI 1569-1802
J9 MATRIX BIOL
JI Matrix Biol.
PD SEP
PY 2024
VL 132
BP 72
EP 86
DI 10.1016/j.matbio.2024.07.002
EA JUL 2024
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA ZK0J6
UT WOS:001275071500001
PM 39009171
OA hybrid
DA 2024-11-01
ER

PT J
AU Hao, R
   Yao, YN
   Zheng, YG
   Xu, MG
   Wang, ED
AF Hao, R
   Yao, YN
   Zheng, YG
   Xu, MG
   Wang, ED
TI Reduction of mitochondrial tRNA <SUP>Leu</SUP>(UUR) aminoacylation by
   some MELAS-associated mutations
SO FEBS LETTERS
LA English
DT Article
DE human mitochondrion; MELAS-related mutation; tRNA(Leu)(UUR);
   aminoacylation
ID LACTIC-ACIDOSIS; EPISODES MELAS; TRNA(LEU(UUR)) MUTATION; POINT
   MUTATION; ENCEPHALOPATHY; MYOPATHY; SYNTHETASE; GENE; POLYMERASE; CELLS
AB The mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes syndrome (MELAS) is a rare congenital disorder of mitochondrial DNA. Five single nucleotide substitutions within the human mitochondrial tRNA (Leu)(UUR) gene have been reported to be associated with MELAS. Here, we provide in vitro evidence that the aminoacylation capacities of these five hmtRNA (Leu)(UUR) transcripts are reduced to different extents relative to the wild-type hmtRNA (Leu)(UUR) transcript. A thermal denaturation experiment showed that the A3243G and T3291C mutants, which were the least charged by LeuRS, have fragile structures. In addition, the T3291C mutant can inhibit aminoacylation of the wild-type hmtRNA (Leu)(UUR), indicating that it may act as an inhibitor in the mitochondrial heteroplasmic environment. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
C1 Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Beijing 100864, Peoples R China.
   Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China.
C3 Chinese Academy of Sciences; Chinese Academy of Sciences
RP Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Beijing 100864, Peoples R China.
EM edwang@sibs.ac.cn
RI Hao, Rui/I-5162-2013; Zheng, Yonggang/B-5009-2011; Li, Jia/F-9116-2011
CR Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Enríquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207
   Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636
   Kelley SO, 2001, J BIOL CHEM, V276, P10607, DOI 10.1074/jbc.M008320200
   Kelley SO, 2000, NAT STRUCT BIOL, V7, P862, DOI 10.1038/79612
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Li Y, 1999, PROTEIN EXPRES PURIF, V16, P355, DOI 10.1006/prep.1999.1083
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Piechota Janusz, 2001, Journal of Applied Genetics, V42, P351
   PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304
   QUIGLEY GJ, 1976, SCIENCE, V194, P796, DOI 10.1126/science.790568
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Sohm N, 2004, J MOL BIOL, V339, P17, DOI 10.1016/j.jmb.2004.03.066
   SOLL D, 1990, EXPERIENTIA, V46, P1089
   Takai D, 1999, J BIOL CHEM, V274, P11199, DOI 10.1074/jbc.274.16.11199
   Uziel G, 2000, NEUROMUSCULAR DISORD, V10, P415, DOI 10.1016/S0960-8966(99)00115-7
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Yao YN, 2003, PROTEIN EXPRES PURIF, V30, P112, DOI 10.1016/S1046-5928(03)00097-4
   Yao YN, 2003, FEBS LETT, V534, P139, DOI 10.1016/S0014-5793(02)03833-4
NR 30
TC 23
Z9 28
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD DEC 3
PY 2004
VL 578
IS 1-2
BP 135
EP 139
DI 10.1016/j.febslet.2004.11.004
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 878MI
UT WOS:000225650500025
PM 15581630
DA 2024-11-01
ER

PT J
AU Martin-Kleiner, I
   Pape-Medvidovic, E
   Pavlic-Renar, I
   Metelko, Z
   Kusec, R
   Gabrilovac, J
   Boranic, M
AF Martin-Kleiner, I
   Pape-Medvidovic, E
   Pavlic-Renar, I
   Metelko, Z
   Kusec, R
   Gabrilovac, J
   Boranic, M
TI A pilot study of mitochondrial DNA point mutation A3243G in a sample of
   Croatian patients having type 2 diabetes mellitus associated with
   maternal inheritance
SO ACTA DIABETOLOGICA
LA English
DT Article
DE diabetes type 2; MELAS syndrome; mito-chondrial DNA; mutation A3243G
ID CLINICAL-FEATURES; DEAFNESS; SUBTYPE; INSULIN; PHENOTYPE; GENOTYPE;
   GENETICS; BLOOD
AB In this work, patients having type 2 diabetes mellitus and diabetic mothers were tested for the presence of mitochondrial DNA point mutation A3243G. This mutation is associated with the MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes), diabetes and deafness. Twenty-two diabetic persons were screened. DNA was isolated from peripheral blood lymphocytes and from swabs of oral mucosa. The mitochondrial DNA point mutation A3243G was detected using PCR-RFLP test. The mutation was detected in oral mucosal DNA of two patients (but not from lymphocyte DNA). One patient was a man with hearing and visual impairments and proteinuria: the other was a woman having proteinuria but no hearing impairment. The mutation was not detectable in oral mucosal DNA from the control persons: 20 diabetic patients having diabetic fathers and 22 healthy, nondiabetic volunteers. The incidence of mitochondrial DNA point mutation A3243G in this study of Croatian diabetic patients is in line with data in the literature.
C1 Rudjer Boskovic Inst, Div Mol Med, HR-10002 Zagreb, Croatia.
   Univ Zagreb, Vuk Vrhovac Univ Clin, Zagreb, Croatia.
   Univ Zagreb, Univ Hosp Merkur, Inst Clin Chem, Dept Internal Med, Zagreb, Croatia.
C3 Rudjer Boskovic Institute; University of Zagreb; University of Zagreb
RP Rudjer Boskovic Inst, Div Mol Med, POB 180, HR-10002 Zagreb, Croatia.
EM kleiner@irb.hr
OI Boranic, Milivoj/0000-0003-2780-7165
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BONIFACIO E, 1990, LANCET, V335, P147, DOI 10.1016/0140-6736(90)90013-U
   CHINNERY PF, 1999, LANCET S1, V354, P17
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   DILENA BA, 1983, CLIN CHEM, V29, P1533
   FEINGENBAUM A, 1996, AM J MED GENET, V62, P404
   Fischel-Ghodsian N, 1998, P SOC EXP BIOL MED, V218, P1
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   Iwase M, 2001, DIABETES RES CLIN PR, V54, P215, DOI 10.1016/S0168-8227(01)00295-9
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kiechle FL, 1999, ANN CLIN LAB SCI, V29, P59
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   LIVESEY JH, 1980, CLIN BIOCHEM, V13, P151, DOI 10.1016/S0009-9120(80)91040-1
   Maassen JA, 1996, DIABETOLOGIA, V39, P375
   Maassen JA, 1997, HORM METAB RES, V29, P50, DOI 10.1055/s-2007-978984
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Mravak-Stipetic M, 1998, J ORAL PATHOL MED, V27, P1, DOI 10.1111/j.1600-0714.1998.tb02081.x
   Perucca-Lostanlen D, 2000, BIOCHEM BIOPH RES CO, V277, P771, DOI 10.1006/bbrc.2000.3751
   RENDELL M, 1983, ACTA DIABETOL LAT, V20, P105, DOI 10.1007/BF02624911
   SHIMOJO N, 1989, CLIN CHEM, V35, P1992
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   THART LM, 1994, DIABETOLOGIA, V37, P1169
   Trinder P., 1969, Journal of Clinical Pathology, V22, P158, DOI 10.1136/jcp.22.2.158
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Vucic M., 1999, Clinical Chemistry and Laboratory Medicine, V37, pS199
   Zambelli A, 1999, CLIN BIOCHEM, V32, P81, DOI 10.1016/S0009-9120(98)00102-7
   Zeviani M, 1997, MOL HUM REPROD, V3, P133, DOI 10.1093/molehr/3.2.133
NR 28
TC 7
Z9 7
U1 0
U2 1
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD DEC
PY 2004
VL 41
IS 4
BP 179
EP 184
DI 10.1007/s00592-004-0163-x
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 886CU
UT WOS:000226205300007
PM 15660201
DA 2024-11-01
ER

PT J
AU Koç, F
   Sarica, Y
   Bozdemir, H
   Zorludemir, S
AF Koç, F
   Sarica, Y
   Bozdemir, H
   Zorludemir, S
TI A MELAS patient with an unusual finding -: Subdural hematoma
SO NEUROSURGERY QUARTERLY
LA English
DT Article
DE MELAS; clinical and histopathologic findings; subdural hematoma
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; MITOCHONDRIAL MYOPATHY;
   CLINICAL-FEATURES; ENCEPHALOPATHY; MUTATION; ENCEPHALOMYOPATHY; GENE;
   DNA; MR
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a rare mitochondrial disorder. Seizures, headaches, nausea and vomiting, exercise intolerance, and ragged-red fibers may be seen. In most MELAS syndrome patients, a point mutation at nucleotide 3243 encoding transfer RNA for leucine has been found. A 28-year-old woman who lost consciousness was brought to emergency room. She had a history of migraine-like headaches and secondary amenorrhea for 7 years, hearing loss for 5 years, and complex partial seizures for 3 months. She had a subacute subdural hematoma of left temporo-occipital region and subacute infarcts in cortical and subcortical areas of the left temporal lobe. Based on her history, physical and neurologic examinations, neuroimaging, and histopathologic and mitochondrial DNA analyses, she was diagnosed as having MELAS syndrome. The most outstanding feature in this case was the presence of a subdural hematoma. To the best of our knowledge, this unusual finding has not been reported previously in the literature.
C1 Cukurova Univ, Sch Med, Dept Neurol, TR-01330 Adana, Turkey.
   Cukurova Univ, Sch Med, Dept Pathol, TR-01330 Adana, Turkey.
C3 Cukurova University; Cukurova University
RP Cukurova Univ, Sch Med, Dept Neurol, TR-01330 Adana, Turkey.
EM zaferkoc@superonline.com
CR ALLARD JC, 1988, AM J NEURORADIOL, V9, P1234
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107
   KUWABARA T, 1994, NEUROLOGY, V44, P557, DOI 10.1212/WNL.44.3_Part_1.557
   Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331
   MIZUKAMI K, 1992, ACTA NEUROPATHOL, V83, P449, DOI 10.1007/BF00713541
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Penisson-Besnier I, 2000, NEUROLOGY, V55, P317, DOI 10.1212/WNL.55.2.317
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   Thompson VA, 1997, ANESTH ANALG, V85, P1404, DOI 10.1097/00000539-199712000-00041
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
NR 21
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1050-6438
EI 1534-4916
J9 NEUROSURG QUART
JI Neurosurg. Q.
PD JUN
PY 2004
VL 14
IS 2
BP 93
EP 96
PG 4
WC Neurosciences; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Surgery
GA 843UZ
UT WOS:000223113400004
DA 2024-11-01
ER

PT J
AU Schaefer, PM
   Rathi, K
   Butic, A
   Tan, W
   Mitchell, K
   Wallace, DC
AF Schaefer, Patrick M.
   Rathi, Komal
   Butic, Arrienne
   Tan, Wendy
   Mitchell, Katherine
   Wallace, Douglas C.
TI Mitochondrial mutations alter endurance exercise response and
   determinants in mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE mitochondrial disease; endurance exercise; skeletal muscle adaption
ID ELITE ATHLETIC STATUS; SKELETAL-MUSCLE; DILATED CARDIOMYOPATHY; CARDIAC
   ADAPTATION; DNA VARIATION; MOUSE MODEL; DEFICIENCY; HAPLOGROUPS;
   PERFORMANCE; CAPACITY
AB Primary mitochondrial diseases (PMDs) are a heterogeneous group of metabolic disorders that can be caused by hundreds of mutations in both mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) genes. Current therapeutic approaches are limited, although one approach has been exercise training. Endurance exercise is known to improve mitochondrial function in heathy subjects and reduce risk for secondary metabolic disorders such as diabetes or neurodegenerative disorders. However, in PMDs the benefit of endurance exercise is unclear, and exercise might be beneficial for some mitochondrial disorders but contraindicated in others. Here we investigate the effect of an endurance exercise regimen in mouse models for PMDs harboring distinct mitochondrial mutations. We show that while an mtDNA ND6 mutation in complex I demonstrated improvement in response to exercise, mice with a CO1 mutation affecting complex IV showed significantly fewer positive effects, and mice with an ND5 complex I mutation did not respond to exercise at all. For mice deficient in the nDNA adenine nucleotide translocase 1 (Ant1), endurance exercise actually worsened the dilated cardiomyopathy. Correlating the gene expression profile of skeletal muscle and heart with the physiologic exercise response identified oxidative phosphorylation, amino acid metabolism, matrisome (extracellular matrix [ECM]) structure, and cell cycle regulation as key pathways in the exercise response. This emphasizes the crucial role of mitochondria in determining the exercise capacity and exercise response. Consequently, the benefit of endurance exercise in PMDs strongly depends on the underlying mutation, although our results suggest a general beneficial effect.
C1 [Schaefer, Patrick M.; Butic, Arrienne; Tan, Wendy; Mitchell, Katherine; Wallace, Douglas C.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.
   [Rathi, Komal] Childrens Hosp Philadelphia, Dept Biomed Informat, Philadelphia, PA 19104 USA.
   [Wallace, Douglas C.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Pennsylvania; Pennsylvania Medicine;
   Childrens Hospital of Philadelphia; University of Pennsylvania
RP Wallace, DC (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.; Wallace, DC (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.
EM wallaced1@email.chop.edu
FU German Research Foundation [SCHA 2182/1-1]; NIH [NS021328, MH108592,
   OD010944]; US Department of Defense [W81XWH-16-1-0401, W81XWH-21-1-0128
   (PR202887.e002)]
FX This work was supported by the German Research Foundation (Grant SCHA
   2182/1-1) to P.M.S. and NIH grants NS021328, MH108592, and OD010944 plus
   US Department of Defense grants W81XWH-16-1-0401 and W81XWH-21-1-0128
   (PR202887.e002) awarded to D.C.W. Schematics were created with
   BioRender.com.
CR Abulí M, 2020, J CARDIOVASC TRANSL, V13, P265, DOI 10.1007/s12265-020-10021-8
   Andersen K, 2013, EUR HEART J, V34, P3624, DOI 10.1093/eurheartj/eht188
   Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018
   Barbieri E, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/917085
   Basu J, 2020, CLIN CARDIOL, V43, P889, DOI 10.1002/clc.23343
   Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282
   Bernardo BC, 2016, CARDIOL CLIN, V34, P515, DOI 10.1016/j.ccl.2016.06.002
   Bertholet AM, 2019, NATURE, V571, P515, DOI 10.1038/s41586-019-1400-3
   Bertram S, 2016, ENDOCRINE, V53, P350, DOI 10.1007/s12020-016-0976-8
   Bouchard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037887
   Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010
   Brosnan M, 2018, HEART LUNG CIRC, V27, P1052, DOI 10.1016/j.hlc.2018.04.297
   Cantó C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006
   Deason M, 2012, SCAND J MED SCI SPOR, V22, P217, DOI 10.1111/j.1600-0838.2010.01289.x
   DIONNE FT, 1991, MED SCI SPORT EXER, V23, P177
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fiuza-Luces C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00790
   Fiuza-Luces C, 2018, MED SCI SPORT EXER, V50, P1142, DOI 10.1249/MSS.0000000000001546
   Gabriel BM, 2017, CELL METAB, V25, P1000, DOI 10.1016/j.cmet.2017.04.018
   Gardner JL, 2007, BIOSCIENCE REP, V27, P139, DOI 10.1007/s10540-007-9042-3
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   He Z, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.042945
   Hoshino A, 2019, NATURE, V575, P375, DOI 10.1038/s41586-019-1667-4
   Irving BA, 2015, J CLIN ENDOCR METAB, V100, P1654, DOI 10.1210/jc.2014-3081
   Jacobs RA, 2013, EXP PHYSIOL, V98, P908, DOI 10.1113/expphysiol.2012.070037
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Karch J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw4597
   Kim KC, 2012, INT J SPORTS MED, V33, P76, DOI 10.1055/s-0031-1285866
   Kjær M, 2006, J ANAT, V208, P445, DOI 10.1111/j.1469-7580.2006.00549.x
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Komlódi T, 2018, METHODS MOL BIOL, V1782, P137, DOI 10.1007/978-1-4939-7831-1_8
   La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Luijkx T, 2012, BRIT J SPORT MED, V46, P1119, DOI 10.1136/bjsports-2011-090520
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mann TN, 2014, SPORTS MED, V44, P1113, DOI 10.1007/s40279-014-0197-3
   Martinez-Huenchullan S, 2017, OBES REV, V18, P776, DOI 10.1111/obr.12548
   Maruszak A, 2014, SCAND J MED SCI SPOR, V24, P311, DOI 10.1111/sms.12012
   McKenzie JA, 2011, EXP PHYSIOL, V96, P338, DOI 10.1113/expphysiol.2010.055400
   Mikami E, 2013, J HUM GENET, V58, P780, DOI 10.1038/jhg.2013.102
   Montero D, 2015, J PHYSIOL-LONDON, V593, P4677, DOI 10.1113/JP270250
   Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114
   Murakami H, 2002, JPN J PHYSIOL, V52, P247, DOI 10.2170/jjphysiol.52.247
   Narula N, 2011, JACC-CARDIOVASC IMAG, V4, P1, DOI 10.1016/j.jcmg.2010.06.018
   Niemi AK, 2005, EUR J HUM GENET, V13, P965, DOI 10.1038/sj.ejhg.5201438
   Nogales-Gadea G, 2011, MITOCHONDRION, V11, P905, DOI 10.1016/j.mito.2011.08.002
   Onkelinx S, 2011, ACTA CARDIOL, V66, P407, DOI 10.1080/AC.66.4.2126586
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pérusse L, 2001, MED SCI SPORT EXER, V33, P597
   Rankinen T, 2000, J APPL PHYSIOL, V88, P346, DOI 10.1152/jappl.2000.88.1.346
   Reichard A, 2019, MOL BIOL REP, V46, P1393, DOI 10.1007/s11033-018-4488-x
   Robbins JM, 2021, NAT METAB, V3, P786, DOI 10.1038/s42255-021-00400-z
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sanford JA, 2020, CELL, V181, P1464, DOI 10.1016/j.cell.2020.06.004
   Schaefer P. M., GENE EXPRESSION OMNI
   Scott RA, 2009, MED SCI SPORT EXER, V41, P123, DOI 10.1249/MSS.0b013e31818313a2
   Seo YG, 2019, J CARDIOPULM REHABIL, V39, P235, DOI 10.1097/HCR.0000000000000382
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Thirupathi A, 2017, J PHYSIOL BIOCHEM, V73, P487, DOI 10.1007/s13105-017-0576-y
   Timmons JA, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-19
   Vega RB, 2017, CELL METAB, V25, P1012, DOI 10.1016/j.cmet.2017.04.025
   Wallace DC, 2016, NATURE, V535, P498, DOI 10.1038/nature18902
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   White AT, 2012, AM J PHYSIOL-ENDOC M, V303, pE308, DOI 10.1152/ajpendo.00054.2012
   Williams CJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4192-6
   Yardeni T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021429118
   Zarebska A, 2014, BIOL SPORT, V31, P261, DOI 10.5604/20831862.1120932
   Zhang WY, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00579-4
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
NR 74
TC 6
Z9 6
U1 2
U2 13
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 3
PY 2022
VL 119
IS 18
AR e2200549119
DI 10.1073/pnas.2200549119
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 1V6OW
UT WOS:000806207700005
PM 35482926
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Reeve, AK
   Krishnan, KJ
   Elson, JL
   Morris, CM
   Bender, A
   Lightowlers, RN
   Turnbull, DM
AF Reeve, Amy K.
   Krishnan, Kim J.
   Elson, Joanna L.
   Morris, Christopher M.
   Bender, Andreas
   Lightowlers, Robert N.
   Turnbull, Douglass M.
TI Nature of mitochondrial DNA deletions in substantial nigra neurons
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID MTDNA DELETIONS; LAGGING-STRAND; MUSCLE-FIBERS; REPLICATION; MUTATIONS;
   DEFECTS; REGION
AB Mitochondrial DNA (mtDNA) deletions have been investigated in a number of neurodegenerative diseases. This study aimed to investigate the characteristics of mtDNA deletions found in single substantia nigra neurons from three patient groups: controls, Parkinson disease patients, and a patient with Parkinsonism due to multiple mtDNA deletions. We have identified 89 deletions from these neurons and examined the breakpoint characteristics of them. There was no difference in the types of mtDNA deletions detected in these neurons. These results suggest that the mechanism leading to the formation of these deletions in these three distinct groups could be the same.
C1 [Reeve, Amy K.; Krishnan, Kim J.; Elson, Joanna L.; Lightowlers, Robert N.; Turnbull, Douglass M.] Univ Newcastle, Sch Med, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Krishnan, Kim J.; Morris, Christopher M.; Turnbull, Douglass M.] Univ Newcastle, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.
   [Bender, Andreas] Univ Munich, Dept Neurol, D-81377 Munich, Germany.
C3 Newcastle University - UK; Newcastle University - UK; University of
   Munich
RP Turnbull, DM (corresponding author), Univ Newcastle, Sch Med, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM d.m.turnbull@ncl.ac.uk
RI Bender, Andreas/A-7401-2012; Clugston, Kim/KBA-3107-2024
OI /0000-0002-3551-5624; Reeve, Amy/0000-0002-4474-2204; Morris,
   Christopher/0000-0002-3749-0993; Bender, Andreas/0000-0002-6328-7104
FU Medical Research Council [G0502157, G90/63, G0400074, G0700718] Funding
   Source: Medline; Wellcome Trust [074454] Funding Source: Medline; MRC
   [G90/63, G0400074, G0502157, G0700718] Funding Source: UKRI
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 14
TC 107
Z9 110
U1 1
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0002-9297
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD JAN
PY 2008
VL 82
IS 1
BP 228
EP 235
DI 10.1016/j.ajhg.2007.09.018
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 263NM
UT WOS:000253223800026
PM 18179904
OA Green Published, Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Wang, JW
   Yuan, XB
   Chen, HF
AF Wang, Jian-Wei
   Yuan, Xiao-Bo
   Chen, Hong-Fang
TI Late-onset mitochondrial encephalomyopathy with lactic acidosis and
   stroke-like episodes syndrome with mitochondrial DNA 3243A>G mutation
   masquerading as autoimmune encephalitis: A case report
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Article
DE MELAS; Mitochondrial DNA mutation; Encephalitis; Case report
ID HERPES-SIMPLEX ENCEPHALITIS; MELAS; ENCEPHALOPATHY; MYOPATHY; COHORT
AB BACKGROUND Here, we present a unique case of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome, which initially appeared to be autoimmune encephalitis and was ultimately confirmed as MELAS with the mitochondrial DNA 3243A>G mutation.CASE SUMMARY A 58-year-old female presented with acute-onset speech impediment and auditory hallucinations, symmetrical bitemporal lobe abnormalities, clinical and laboratory findings, and a lack of relevant prodromal history, which suggested diagnosis of autoimmune encephalitis. Further work-up, in conjunction with the patient's medical history, family history, and lactate peak on brain lesions on magnetic resonance imaging, suggested a mitochondrial disorder. Mitochondrial genome analysis revealed the m.3243A>G variant in the MT-TL1 gene, which led to a diagnosis of MELAS syndrome.CONCLUSION This case underscores the importance of considering MELAS as a potential cause of autoimmune encephalitis even if patients are over 40 years of age, as the symptoms and signs are atypical for MELAS syndrome.
C1 [Wang, Jian-Wei; Chen, Hong-Fang] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Neurol, Sch Med, Jinhua 321000, Zhejiang, Peoples R China.
   [Yuan, Xiao-Bo] First Peoples Hosp Yongkang, Dept Neurol, Jinhua 321300, Zhejiang, Peoples R China.
   [Chen, Hong-Fang] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Neurol, Sch Med, 356 Renmin East Rd, Jinhua 321000, Zhejiang, Peoples R China.
C3 Zhejiang University; Zhejiang University
RP Chen, HF (corresponding author), Zhejiang Univ, Affiliated Jinhua Hosp, Dept Neurol, Sch Med, 356 Renmin East Rd, Jinhua 321000, Zhejiang, Peoples R China.
EM jhchf894@163.com
FU Science and Technology Plan of Jinhua City [2020-3-026]
FX Supported by the Science and Technology Plan of Jinhua City, No.
   2020-3-026.
CR Bhatia KD, 2020, AM J NEURORADIOL, V41, P167, DOI 10.3174/ajnr.A6325
   Chow FC, 2015, CLIN INFECT DIS, V60, P1377, DOI 10.1093/cid/civ051
   CRIMMINS D, 1993, J NEUROL NEUROSUR PS, V56, P900, DOI 10.1136/jnnp.56.8.900
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Farrar MA, 2010, PEDIATRICS, V126, pE734, DOI 10.1542/peds.2009-2930
   Geberhiwot T, 2006, NEW ENGL J MED, V354, P1096
   Gieraerts C, 2013, J COMPUT ASSIST TOMO, V37, P279, DOI 10.1097/RCT.0b013e3182811170
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hsu Yu-Chuan, 2012, J Emerg Med, V43, pe163, DOI 10.1016/j.jemermed.2009.10.021
   Ienco EC, 2016, MITOCHONDRION, V30, P148, DOI 10.1016/j.mito.2016.07.008
   JOHNS DR, 1993, NEUROLOGY, V43, P2471, DOI 10.1212/WNL.43.12.2471
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Miyahara H, 2019, NEUROPATHOLOGY, V39, P212, DOI 10.1111/neup.12551
   Pauli W, 2013, POL J RADIOL, V78, P61, DOI 10.12659/PJR.884010
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Tzoulis C, 2009, STROKE, V40, pE15, DOI 10.1161/STROKEAHA.108.523118
   Xu WXZ, 2018, J COMPUT ASSIST TOMO, V42, P510, DOI 10.1097/RCT.0000000000000712
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yokota Y, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01818-w
   Zhang Z, 2018, J NEUROL SCI, V385, P151, DOI 10.1016/j.jns.2017.12.033
NR 26
TC 0
Z9 0
U1 0
U2 0
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 2307-8960
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD MAY 16
PY 2023
VL 11
IS 14
BP 3275
EP 3281
DI 10.12998/wjcc.v11.i14.3275
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA I6JI2
UT WOS:001003823300018
PM 37274040
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Haghighi, A
   Haack, TB
   Atiq, M
   Mottaghi, H
   Haghighi-Kakhki, H
   Bashir, RA
   Ahting, U
   Feichtinger, RG
   Mayr, JA
   Rötig, A
   Lebre, AS
   Klopstock, T
   Dworschak, A
   Pulido, N
   Saeed, MA
   Saleh-Gohari, N
   Holzerova, E
   Chinnery, PF
   Taylor, RW
   Prokisch, H
AF Haghighi, Alireza
   Haack, Tobias B.
   Atiq, Mehnaz
   Mottaghi, Hassan
   Haghighi-Kakhki, Hamidreza
   Bashir, Rani A.
   Ahting, Uwe
   Feichtinger, Rene G.
   Mayr, Johannes A.
   Rotig, Agnes
   Lebre, Anne-Sophie
   Klopstock, Thomas
   Dworschak, Andrea
   Pulido, Nathan
   Saeed, Mahmood A.
   Saleh-Gohari, Nasrollah
   Holzerova, Eliska
   Chinnery, Patrick F.
   Taylor, Robert W.
   Prokisch, Holger
TI Sengers syndrome: six novel <i>AGK</i> mutations in seven new families
   and review of the phenotypic and mutational spectrum of 29 patients
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE Sengers syndrome; AGK; Acylglycerol Kinase; Mutation; Genotype-Phenotype
   Correlation
ID ACYLGLYCEROL KINASE; MITOCHONDRIAL MYOPATHY; BARTH-SYNDROME; CONGENITAL
   CATARACT; LACTIC-ACIDOSIS; MEMBRANE; CARDIOLIPIN; SKELETAL; PROTEIN;
   MUSCLE
AB Background: Sengers syndrome is an autosomal recessive condition characterized by congenital cataract, hypertrophic cardiomyopathy, skeletal myopathy and lactic acidosis. Mutations in the acylglycerol kinase (AGK) gene have been recently described as the cause of Sengers syndrome in nine families.
   Methods: We investigated the clinical and molecular features of Sengers syndrome in seven new families; five families with the severe and two with the milder form.
   Results: Sequence analysis of AGK revealed compound heterozygous or homozygous predicted loss-of-function mutations in all affected individuals. A total of eight different disease alleles were identified, of which six were novel, homozygous c.523_524delAT (p.Ile175Tyrfs*2), c.424-1G > A (splice site), c.409C > T (p.Arg137*)and c.877 + 3G > T (splice site), and compound heterozygous c.871C > T (p.Gln291*)and c.1035dup (p.Ile346Tyrfs*39). All patients displayed perinatal or early-onset cardiomyopathy and cataract, clinical features pathognomonic for Sengers syndrome. Other common findings included blood lactic acidosis and tachydyspnoea while nystagmus, eosinophilia and cervical meningocele were documented in only either one or two cases. Deficiency of the adenine nucleotide translocator was found in heart and skeletal muscle biopsies from two patients associated with respiratory chain complex I deficiency. In contrast to previous findings, mitochondrial DNA content was normal in both tissues.
   Conclusion: We compare our findings to those in 21 previously reported AGK mutation-positive Sengers patients, confirming that Sengers syndrome is a clinically recognisable disorder of mitochondrial energy metabolism.
C1 [Haghighi, Alireza] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.
   [Haghighi, Alireza] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.
   [Haghighi, Alireza] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.
   [Haack, Tobias B.; Ahting, Uwe; Holzerova, Eliska; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany.
   [Haack, Tobias B.; Ahting, Uwe; Holzerova, Eliska; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Atiq, Mehnaz] Aga Khan Univ, Dept Pediat, Karachi, Pakistan.
   [Mottaghi, Hassan] Mashhad Univ Med Sci, Imam Reza Hosp, Dept Pediat, Mashhad, Iran.
   [Haghighi-Kakhki, Hamidreza] Mashhad Azad Univ, Fac Med, Mashhad, Iran.
   [Bashir, Rani A.; Saeed, Mahmood A.] Kuwait Oil Co, Dept Paediat & Neonatol, Ahmadi Hosp, Kuwait, Kuwait.
   [Feichtinger, Rene G.; Mayr, Johannes A.] Paracelsus Med Univ, Dept Paediat, Salzburg, Austria.
   [Rotig, Agnes] Paris Descartes Univ, Imagine Inst, INSERM, UMR 1163, Paris, France.
   [Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany.
   [Dworschak, Andrea] Rhein Westfal TH Aachen, Univ Hosp, Dept Pediat Cardiol, Aachen, Germany.
   [Pulido, Nathan] Hosp Dr Gustavo Fricke, Dept Pediat, Vina Del Mar, Chile.
   [Saleh-Gohari, Nasrollah] Kerman Univ Med Sci, Sch Med, Dept Genet, Kerman, Iran.
   [Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Harvard University; Harvard Medical School; Harvard University; Brigham
   & Women's Hospital; Harvard University; Brigham & Women's Hospital;
   Howard Hughes Medical Institute; Helmholtz Association; Helmholtz-Center
   Munich - German Research Center for Environmental Health; Technical
   University of Munich; Aga Khan University; Mashhad University of Medical
   Sciences; Kuwait Oil Company; Paracelsus Private Medical University;
   Universite Paris Cite; Institut National de la Sante et de la Recherche
   Medicale (Inserm); University of Munich; RWTH Aachen University; RWTH
   Aachen University Hospital; Kerman University of Medical Sciences;
   Newcastle University - UK; Newcastle University - UK
RP Haghighi, A (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
EM haghighi@genetics.med.harvard.edu; prokisch@helmholtz-muenchen.de
RI Lebre, Anne-Sophie/AAO-1413-2020; Haack, Tobias/JLM-8099-2023; Bashir,
   Rani/AAV-9608-2021; Prokisch, Holger/N-8964-2013; Gohari,
   Nasrollah/ABB-4209-2020; ROTIG, AGNES/G-9592-2017; Mottaghi Moghaddam
   Shahri, Hassan/D-4849-2018
OI Chinnery, Patrick/0000-0002-7065-6617; Mayr,
   Johannes/0000-0001-6970-336X; ROTIG, AGNES/0000-0003-0589-0703;
   Konarikova, Eliska/0000-0001-7365-5006; saleh-gohari,
   Nasrollah/0000-0003-1256-0323; Prokisch, Holger/0000-0003-2379-6286;
   Mottaghi Moghaddam Shahri, Hassan/0000-0002-3979-2151
FU EU FP7 Mitochondrial European Educational Training project (MEET);
   E-Rare project GENOMIT [01GM1207, FWF I 920-B13]; German Federal
   Ministry of Education and Research (BMBF, Bonn, Germany) [01GM1113A];
   Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; UK NHS
   Highly Specialised "Rare Mitochondrial Disorders of Adults and Children"
   Service; MRC [MR/K000608/1] Funding Source: UKRI
FX This study was undertaken as part of GENE-ME (a research initiative for
   investigation of inherited diseases from the Middle-East), EU FP7
   Mitochondrial European Educational Training project (MEET) and E-Rare
   project GENOMIT (01GM1207 for H.P. and FWF I 920-B13 for J.A.M). In
   addition, T.K. and H.P. acknowledge a German Federal Ministry of
   Education and Research (BMBF, Bonn, Germany) grant to the German Network
   for Mitochondrial Disorders (mitoNET, 01GM1113A, C). PFC and RWT receive
   support from the Wellcome Trust Centre for Mitochondrial Research
   (096919Z/11/Z) and the UK NHS Highly Specialised "Rare Mitochondrial
   Disorders of Adults and Children" Service.
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Aldahmesh MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/humu.22071
   Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123
   Borchman D, 2010, J LIPID RES, V51, P2473, DOI 10.1194/jlr.R004119
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23
   Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kalari S, 2009, AM J PHYSIOL-LUNG C, V296, pL328, DOI 10.1152/ajplung.90431.2008
   Karkucinska-Wieckowska A, 2013, J INHERIT METAB DIS, V36, P929, DOI 10.1007/s10545-013-9584-4
   KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   Perry MS, 2008, PEDIATR NEUROL, V39, P113, DOI 10.1016/j.pediatrneurol.2008.05.003
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   Siriwardena K, 2013, MOL GENET METAB, V108, P40, DOI 10.1016/j.ymgme.2012.11.282
   SMEITINK JAM, 1989, EUR J PEDIATR, V148, P656, DOI 10.1007/BF00441527
   VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157
   Waggoner DW, 2004, J BIOL CHEM, V279, P38228, DOI 10.1074/jbc.M405932200
NR 21
TC 67
Z9 70
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD AUG 20
PY 2014
VL 9
AR 119
DI 10.1186/s13023-014-0119-3
PG 12
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA AU5QM
UT WOS:000345661700001
PM 25208612
OA Green Published, Green Accepted, gold
DA 2024-11-01
ER

PT J
AU Spinazzola, A
   Invernizzi, F
   Carrara, F
   Lamantea, E
   Donati, A
   DiRocco, M
   Giordano, I
   Meznaric-Petrusa, M
   Baruffini, E
   Ferrero, I
   Zeviani, M
AF Spinazzola, A.
   Invernizzi, F.
   Carrara, F.
   Lamantea, E.
   Donati, A.
   DiRocco, M.
   Giordano, I.
   Meznaric-Petrusa, M.
   Baruffini, E.
   Ferrero, I.
   Zeviani, M.
TI Clinical and molecular features of mitochondrial DNA depletion syndromes
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article; Proceedings Paper
CT Annual Symposium of the
   Society-for-the-Study-of-Inborn-Errors-of-Metabolism
CY SEP 02-05, 2008
CL Lisbon, PORTUGAL
SP Soc Study Inborn Errors Metabolism
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DEOXYGUANOSINE KINASE; MTDNA
   DEPLETION; THYMIDINE KINASE; POLG MUTATIONS; ATAXIC NEUROPATHY; SUCLA2
   MUTATIONS; ALPERS-SYNDROME; GENE; DEFICIENCY
AB Mitochondrial DNA depletion syndromes (MDSs) form a group of autosomal recessive disorders characterized by profoundly decreased mitochondrial DNA copy numbers in affected tissues. Three main clinical presentations are known: myopathic, encephalomyopathic and hepatocerebral. The first is associated with mutations in thymidine kinase 2 (TK2) and p53-induced ribonucleotide reductase B subunit (RRM2B); the second with mutations in succinate synthase A (SUCLA2) and B (SUCLG1); the third with mutations in Twinkle (PEO1), pol-gamma A (POLG1), deoxyguanosine kinase (DGUOK) and MPV17 (MPV17). In this work, we review the MDS-associated phenotypes and present our own experience of 32 MDS patients, with the aim of defining the mutation frequency of the known genes, the clinical spectrum of the diseases, and the genotype-phenotype correlations. Five of our patients carried previously unreported mutations in one of the eight MDS genes.
C1 [Spinazzola, A.; Invernizzi, F.; Carrara, F.; Lamantea, E.; Zeviani, M.] IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Donati, A.] AOU Meyer, Clin Pediat Neurol, Metab & Muscular Unit, Florence, Italy.
   [DiRocco, M.] Inst G Gaslini, Genoa, Italy.
   [Giordano, I.] Spedali Civil Brescia, Dept Child & Adolescent Neuropsychiat, I-25125 Brescia, Italy.
   [Meznaric-Petrusa, M.] Univ Ljubljana, Fac Med, Inst Anat, Ljubljana, Slovenia.
   [Baruffini, E.; Ferrero, I.] Univ Parma, Dept Genet Biol Microrganisms Anthropol & Evolut, I-43100 Parma, Italy.
C3 University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER;
   University of Genoa; IRCCS Istituto Giannina Gaslini; Hospital Spedali
   Civili Brescia; University of Ljubljana; University of Parma
RP Zeviani, M (corresponding author), IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Via Temolo 4, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
RI Zeviani, Massimo/K-2891-2014; Baruffini, Enrico/C-1057-2015; Spinazzola,
   Antonella/P-5298-2017; Meznaric, Marija/A-5112-2016; Invernizzi,
   Federica/J-9849-2016; Lamantea, Eleonora/J-8339-2016
OI Baruffini, Enrico/0000-0002-8280-7849; Spinazzola,
   Antonella/0000-0003-4242-8091; Meznaric, Marija/0000-0002-5907-6929;
   Invernizzi, Federica/0000-0001-8072-0152; Lamantea,
   Eleonora/0000-0001-5090-6028; Zeviani, Massimo/0000-0002-9067-5508
FU Telethon [GGP07019] Funding Source: Medline
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MARIOTTI C, 1995, J NEUROL, V242, P547, DOI 10.1007/BF00868806
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Poggi GM, 2000, J INHERIT METAB DIS, V23, P755, DOI 10.1023/A:1005663804214
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   SLONIMSKI PP, 1976, EUR J BIOCHEM, V61, P27, DOI 10.1111/j.1432-1033.1976.tb09994.x
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Spinazzola A, 2008, NEUROMUSCULAR DISORD, V18, P315, DOI 10.1016/j.nmd.2007.12.007
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Tanji K, 2001, METHOD CELL BIOL, V65, P311, DOI 10.1016/S0091-679X(01)65019-2
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   zum Gottesberge AMM, 2005, HISTOCHEM CELL BIOL, V124, P507, DOI 10.1007/s00418-005-0027-7
NR 53
TC 143
Z9 162
U1 0
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD APR
PY 2009
VL 32
IS 2
BP 143
EP 158
DI 10.1007/s10545-008-1038-z
PG 16
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 428NX
UT WOS:000264856300002
PM 19125351
DA 2024-11-01
ER

PT J
AU Wen, B
   Li, DL
   Shan, JL
   Liu, SP
   Li, W
   Zhao, YY
   Lin, PF
   Zheng, JF
   Li, DN
   Gong, YQ
   Yan, CZ
AF Wen, Bing
   Li, Duoling
   Shan, Jingli
   Liu, Shuping
   Li, Wei
   Zhao, Yuying
   Lin, Pengfei
   Zheng, Jinfan
   Li, Danian
   Gong, Yaoqin
   Yan, Chuanzhu
TI Increased muscle coenzyme Q10 in riboflavin responsive MADD with
   <i>ETFDH</i> gene mutations due to secondary mitochondrial proliferation
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE ETFDH gene; CoQ10; Riboflavin; Mitochondrion
ID ELECTRON-TRANSFER; PPAR-ALPHA; METABOLISM; UBIQUINONE; DEFICIENCY;
   ENZYMES; TISSUES
AB Multiple acyl-coenzyme A dehydrogenation deficiency (MADD) has a wide range of phenotypic variation ranging from a neonatal lethal form to a mild late-onset form. Our previous data showed that in a group of Chinese patients, a mild type of MADD characterized by myopathy with clinically no other systemic involvement was caused by mutations in electron transfer flavoprotein dehydrogenase (ETFDH) gene, which encodes electron transfer flavoprotein: ubiquinone oxidoreductase (ETF:QO). Coenzyme Q10 (CoQ10), a downstream electron receptor of ETF:QO was first reported deficient in muscle of MADD patients with ETFDH gene mutations. Nevertheless, this result was not confirmed in a recently published study. Therefore to elucidate muscle CoQ10 level in a large group of MADD patients may provide further insight into the pathomechanism and therapeutic strategies. In this study, we found that 34 riboflavin responsive patients with ETFDH gene mutations had an elevated CoQ10 pool in muscle by high performance liquid chromatography (HPLC). However, when CoQ10 levels were normalized to citrate synthase, a marker of mitochondrial mass, there was no significant difference between patients and normal controls. Meanwhile, the increased mitochondrial DNA copy number in muscle also supported that the elevated CoQ10 pool was mainly due to mitochondrial mass proliferation. The expression of CoQ10 biosynthesis genes showed no significant changes whereas genes involved in lipid metabolism, such as PPAR alpha, were marked up regulated. Our results suggested that CoQ10 seems not to be a primary factor in riboflavin responsive MADD and the apparent increase in CoQ10 may be secondary to mitochondrial proliferation. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Wen, Bing; Li, Duoling; Shan, Jingli; Liu, Shuping; Li, Wei; Zhao, Yuying; Lin, Pengfei; Zheng, Jinfan; Li, Danian; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Lab Neuromuscular Disorders, Brain Sci Res Inst, Jinan 250012, Peoples R China.
   [Wen, Bing; Li, Duoling; Shan, Jingli; Liu, Shuping; Li, Wei; Zhao, Yuying; Lin, Pengfei; Zheng, Jinfan; Li, Danian; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Peoples R China.
   [Gong, Yaoqin; Yan, Chuanzhu] Shandong Univ, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Peoples R China.
   [Gong, Yaoqin; Yan, Chuanzhu] Shandong Univ, Inst Med Genet, Sch Med, Jinan 250012, Peoples R China.
C3 Shandong University; Shandong University; Shandong University; Shandong
   University
RP Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Lab Neuromuscular Disorders, Jinan 250012, Peoples R China.
EM czyan@yahoo.cn
RI Liu, ShuPing/D-6748-2019; Wang, Zhiqiang/G-7827-2019; Wang,
   Yitong/KBA-1959-2024
OI Wen, Bing/0000-0001-8141-6662
FU National Natural Science Foundation of China [30970993, 81171182];
   Ministry of Health of China
FX This work was supported by the National Natural Science Foundation of
   China [30970993 and 81171182] and the Key Clinical Program of the
   Ministry of Health of China [2010-2012]. The authors confirm
   independence from the sponsors; the content of the article has not been
   influenced by the sponsors.
CR Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017
   Aberg F, 1996, CHEM-BIOL INTERACT, V99, P205, DOI 10.1016/0009-2797(95)03670-9
   Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678
   Dipple KM, 2001, MOL GENET METAB, V74, P45, DOI 10.1006/mgme.2001.3227
   ERNSTER L, 1992, BIOFACTORS, V3, P241
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439
   IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   Liang WC, 2009, NEUROMUSCULAR DISORD, V19, P212, DOI 10.1016/j.nmd.2009.01.008
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P539, DOI 10.1007/s10545-010-9121-7
   Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799
   Tang PH, 2004, CLIN CHIM ACTA, V341, P173, DOI 10.1016/j.cccn.2003.12.002
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   Vockley J, 2008, J INHERIT METAB DIS, V31, P619, DOI 10.1007/s10545-008-1005-8
   Wang ZQ, 2011, J MOL MED, V89, P569, DOI 10.1007/s00109-011-0725-7
   Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007
   Wen B, 2010, J NEUROL NEUROSUR PS, V81, P231, DOI 10.1136/jnnp.2009.176404
   Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002
   Zhang J, 2006, P NATL ACAD SCI USA, V103, P16212, DOI 10.1073/pnas.0604567103
NR 21
TC 24
Z9 27
U1 1
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JUN
PY 2013
VL 109
IS 2
BP 154
EP 160
DI 10.1016/j.ymgme.2013.04.007
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 163RO
UT WOS:000320354800006
PM 23628458
DA 2024-11-01
ER

PT J
AU Barcia, G
   Khirani, S
   Amaddeo, A
   Assouline, Z
   Pennisi, A
   Boddaert, N
   Romero, N
   Desguerre, I
   Schiff, M
   Rötig, A
   Besmond, C
   Bonnefont, JP
   Munnich, A
   Fauroux, B
AF Barcia, Giulia
   Khirani, Sonia
   Amaddeo, Alessandro
   Assouline, Zahra
   Pennisi, Alessandra
   Boddaert, Nathalie
   Romero, Norma
   Desguerre, Isabelle
   Schiff, Manuel
   Rotig, Agnes
   Besmond, Claude
   Bonnefont, Jean-Paul
   Munnich, Arnold
   Fauroux, Brigitte
TI Evidence of diaphragmatic dysfunction with severe alveolar
   hypoventilation syndrome in mitochondrial respiratory chain deficiency
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial disease; Diaphragmatic dysfunction; mtDNA; MT-CYB; TK2
ID CYTOCHROME-B MUTATION
AB Diaphragmatic dysfunction has been reported in congenital myopathies, muscular dystrophies, and occasionally, mitochondrial respiratory chain deficiency. Using a minimally invasive procedure in 3 young girls, 1 with a heteroplasmic MT-CYB mutation and 2 with biallelic pathogenic TK2 variants, we provided functional evidence of diaphragmatic dysfunction with global respiratory muscle weakness in mitochondrial respiratory chain deficiency. Analysis of respiratory muscle performance using esogastric pressures revealed paradoxical breathing and severe global inspiratory and expiratory muscle weakness with a sniff esophageal inspiratory pressure and a gastric pressure during cough averaging 50% and 40% of predicted values, respectively. This diaphragmatic dysfunction was responsible for severe undiagnosed nocturnal hypoventilation, requiring noninvasive ventilation. Our results underline the interest of this minimally invasive procedure for the evaluation of respiratory muscle performance and its potential value for the monitoring of future clinical trials in respiratory chain deficiency. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Barcia, Giulia; Assouline, Zahra; Pennisi, Alessandra; Boddaert, Nathalie; Desguerre, Isabelle; Schiff, Manuel; Rotig, Agnes; Bonnefont, Jean-Paul; Munnich, Arnold] Hop Necker Enfants Malad, Federat Genet Med, 149 Rue Sevres, F-75015 Paris, France.
   [Barcia, Giulia; Assouline, Zahra; Pennisi, Alessandra; Boddaert, Nathalie; Desguerre, Isabelle; Schiff, Manuel; Rotig, Agnes; Besmond, Claude; Bonnefont, Jean-Paul; Munnich, Arnold] Univ Paris, Inst IMAGINE, UMR 1163, Paris, France.
   [Khirani, Sonia; Amaddeo, Alessandro; Fauroux, Brigitte] Hop Necker Enfants Malad, Pediat Noninvas Ventilat & Sleep Unit, Paris, France.
   [Khirani, Sonia; Amaddeo, Alessandro; Fauroux, Brigitte] Univ Paris, VIFASOM, Paris, France.
   [Khirani, Sonia] ASV Sante, Gennevilliers, France.
   [Romero, Norma] Hop La Pitie Salpetriere, Neuromuscular Morphol Unit, Paris, France.
   [Romero, Norma] Hop La Pitie Salpetriere, Myol Inst, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Universite Paris
   Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Universite Paris
   Cite; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP;
   Sorbonne Universite
RP Rötig, A (corresponding author), Hop Necker Enfants Malad, Federat Genet Med, 149 Rue Sevres, F-75015 Paris, France.
EM arnold.munnich@inserm.fr
RI BESMOND, Claude/L-8451-2018; boddaert, nathalie/GWV-2865-2022; Barcia,
   Giulia/H-7907-2017; ROTIG, AGNES/G-9592-2017
OI BESMOND, Claude/0000-0001-9073-8225; ROTIG, AGNES/0000-0003-0589-0703;
   AMADDEO, Alessandro/0000-0003-2117-0781
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Caggiano S, 2017, NEUROMUSCULAR DISORD, V27, P747, DOI 10.1016/j.nmd.2017.04.010
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z
   Fauroux B, 2018, NEUROMUSCULAR DISORD, V28, P731, DOI 10.1016/j.nmd.2018.06.013
   Finsterer Josef, 2017, Open Neurol J, V11, P1, DOI 10.2174/1874205X01711010001
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Koo P, 2018, CLIN CHEST MED, V39, P401, DOI 10.1016/j.ccm.2018.02.001
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Munnich A, 1996, EUR J PEDIATR, V155, P262
   Osanai S, 2001, Respirology, V6, P163, DOI 10.1046/j.1440-1843.2001.00318.x
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Quijano-Roy S, 2014, NEUROMUSCULAR DISORD, V24, P125, DOI 10.1016/j.nmd.2013.11.002
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Sommerville EW, 2017, JAMA NEUROL, V74, P686, DOI 10.1001/jamaneurol.2016.4357
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
NR 24
TC 2
Z9 2
U1 2
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUL
PY 2020
VL 30
IS 7
BP 593
EP 598
DI 10.1016/j.nmd.2020.06.002
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA MQ1VB
UT WOS:000552685000012
PM 32654952
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Gehrig, SM
   Mihaylova, V
   Frese, S
   Mueller, SM
   Ligon-Auer, M
   Spengler, CM
   Petersen, JA
   Lundby, C
   Jung, HH
AF Gehrig, Saskia Maria
   Mihaylova, Violeta
   Frese, Sebastian
   Mueller, Sandro Manuel
   Ligon-Auer, Maria
   Spengler, Christina M.
   Petersen, Jens A.
   Lundby, Carsten
   Jung, Hans H.
TI Altered skeletal muscle (mitochondrial) properties in patients with
   mitochondrial DNA single deletion myopathy
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE Bioenergetics; Fat oxidation; Mitochondria; Mitochondrial cytopathy;
   Neuromuscular disease; Skeletal muscle phenotype
ID RESPIRATORY-CHAIN DYSFUNCTION; EXERCISE PERFORMANCE; ENDURANCE EXERCISE;
   OXYGEN-UPTAKE; METABOLISM; CAPACITY; ADAPTATIONS; LIMITATION; DIAGNOSIS;
   INCREASE
AB Background: Mitochondrial myopathy severely affects skeletal muscle structure and function resulting in defective oxidative phosphorylation. However, the major pathomechanisms and therewith effective treatment approaches remain elusive. Therefore, the aim of the present study was to investigate disease-related impairments in skeletal muscle properties in patients with mitochondrial myopathy. Accordingly, skeletal muscle biopsies were obtained from six patients with moleculargenetically diagnosed mitochondrial myopathy (one male and five females, 53 +/- 9 years) and eight age-and gender-matched healthy controls (two males and six females, 58 +/- 14 years) to determine mitochondrial respiratory capacity of complex I-V, mitochondrial volume density and fiber type distribution.
   Results: Mitochondrial volume density (4.0 +/- 0.5 vs. 5.1 +/- 0.8 %) as well as respiratory capacity of complex I-V were lower (P < 0.05) in mitochondrial myopathy and associated with a higher (P < 0.001) proportion of type II fibers (65.2 +/- 3.6 vs. 44.3 +/- 5.9 %). Additionally, mitochondrial volume density and maximal oxidative phosphorylation capacity correlated positively (P < 0.05) to peak oxygen uptake.
   Conclusion: Mitochondrial myopathy leads to impaired mitochondrial quantity and quality and a shift towards a more glycolytic skeletal muscle phenotype.
C1 [Gehrig, Saskia Maria; Mihaylova, Violeta; Frese, Sebastian; Mueller, Sandro Manuel; Ligon-Auer, Maria; Petersen, Jens A.; Jung, Hans H.] Univ Zurich Hosp, Dept Neurol, Frauenklinikstr 26, CH-8091 Zurich, Switzerland.
   [Gehrig, Saskia Maria; Lundby, Carsten] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
   [Gehrig, Saskia Maria; Spengler, Christina M.; Lundby, Carsten; Jung, Hans H.] Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
   [Spengler, Christina M.] Swiss Fed Inst Technol, Inst Human Movement Sci, Exercise Physiol Lab, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
C3 University of Zurich; University Zurich Hospital; University of Zurich;
   University of Zurich; Zurich Center Integrative Human Physiology (ZIHP);
   Swiss Federal Institutes of Technology Domain; ETH Zurich
RP Jung, HH (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklinikstr 26, CH-8091 Zurich, Switzerland.; Jung, HH (corresponding author), Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM hans.jung@usz.ch
RI Spengler, Christina M./E-9776-2012
OI Spengler, Christina M./0000-0002-4598-3595; De Gani, Saskia
   Maria/0000-0002-7992-7209
FU Zurich Center for Integrative Human Physiology (ZIHP); Neuromuscular
   Research Association Basel (NeRAB)
FX This work was supported by grants from the Zurich Center for Integrative
   Human Physiology (ZIHP) and Neuromuscular Research Association Basel
   (NeRAB).
CR Aydin J, 2009, HUM MOL GENET, V18, P278, DOI 10.1093/hmg/ddn355
   Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63
   Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012
   BOOTH FW, 1983, MED SCI SPORT EXER, V15, P415
   DANDURAND RJ, 1995, CHEST, V108, P182, DOI 10.1378/chest.108.1.182
   DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003
   DiMauro S, 2010, Acta Myol, V29, P333
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173
   Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P425, DOI 10.1164/ajrccm.164.3.2005110
   GALLANTI A, 1992, NEUROPEDIATRICS, V23, P10, DOI 10.1055/s-2008-1071303
   Gineste C, 2015, HUM MOL GENET, V24, P6580, DOI 10.1093/hmg/ddv361
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   Gouspillou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103044
   Gram M, 2014, EXP GERONTOL, V58, P269, DOI 10.1016/j.exger.2014.08.013
   Hassani A, 2010, CURR OPIN NEUROL, V23, P459, DOI 10.1097/WCO.0b013e32833d1096
   Heinicke K, 2011, AM J PHYSIOL-REG I, V301, pR873, DOI 10.1152/ajpregu.00001.2011
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   HOPPELER H, 1987, J PHYSIOL-LONDON, V385, P661, DOI 10.1113/jphysiol.1987.sp016513
   Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838
   Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012
   Jacobs RA, 2012, FASEB J, V26, P5192, DOI 10.1096/fj.12-218206
   Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2013, NEUROMUSCULAR DISORD, V23, P629, DOI 10.1016/j.nmd.2013.05.007
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   LINDERHOLM H, 1969, ACTA MED SCAND, V185, P153
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   Moggio Maurizio, 2014, Acta Myol, V33, P86
   Montero D, 2015, J PHYSIOL-LONDON, V593, P4677, DOI 10.1113/JP270250
   MORGANHUGHES JA, 1990, BIOCHIM BIOPHYS ACTA, V1018, P217, DOI 10.1016/0005-2728(90)90252-Y
   Muranaka H, 1997, BRAIN DEV-JPN, V19, P362, DOI 10.1016/S0387-7604(97)00036-3
   NASHEF L, 1989, J NEUROL NEUROSUR PS, V52, P1090, DOI 10.1136/jnnp.52.9.1090
   Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SALTIN B, 1992, MED SCI SPORT EXER, V24, P30
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2004, BBA-BIOENERGETICS, V1659, P221, DOI 10.1016/j.bbabio.2004.09.007
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Tryon LD, 2014, INTEGR MED RES, V3, P161, DOI 10.1016/j.imr.2014.09.001
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Venhoff N, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4076
   Vissing J, 1996, ANN NEUROL, V40, P655, DOI 10.1002/ana.410400416
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   West Mark J, 2012, Cold Spring Harb Protoc, V2012, P1129, DOI 10.1101/pdb.top071787
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Zhong H, 2005, J APPL PHYSIOL, V99, P1494, DOI 10.1152/japplphysiol.00394.2005
NR 55
TC 17
Z9 18
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD JUL 29
PY 2016
VL 11
AR 105
DI 10.1186/s13023-016-0488-x
PG 12
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA DT9EM
UT WOS:000381798600002
PM 27473873
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Deschauer, M
   Swalwell, H
   Strauss, M
   Zierz, S
   Taylor, RW
AF Deschauer, Marcus
   Swalwell, Helen
   Strauss, Maria
   Zierz, Stephan
   Taylor, Robert W.
TI Novel mitochondrial transfer RNA<SUP>Phe</SUP> gene mutation associated
   with late-onset neuromuscular disease
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID DNA MUTATIONS; MUSCLE; MTDNA; DELETION; SINGLE
AB Background: An extensive range of molecular defects have been identified in the human mitochondrial genome (mitochondrial DNA); many are associated with well-characterized, progressive neurological syndromes, but a minority of patients have uncharacteristic phenotypes in which symptoms may be relatively mild.
   Objective: To describe a novel transfer RNA(Phe) mutation of mitochondrial DNA in a late-onset case with a mild phenotype of mitochondrial disease.
   Design: Case report.
   Patient: A 66-year-old woman presented with a 4-year history of walking difficulties due to exercise intolerance and paresthesia in the feet. Clinical examination results were normal. Her deceased mother had similar walking difficulties, but her sister and 2 children were unaffected.
   Results: The demonstration of a marked histochemical defect in cytochrome c oxidase activity on muscle biopsy prompted molecular investigation of mitochondrial DNA, revealing a novel maternally inherited mutation in the variable loop of the mitochondrial transfer RNA(Phe) gene. This 622G > A transition was heteroplasmic and segregated with cytochrome c oxidase deficiency in single fibers.
   Conclusion: This case serves to illustrate that primary defects of the mitochondrial genome should be considered even in older patients with late-onset, mild neuromuscular symptoms.
C1 Univ Newcastle Upon Tyne, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Univ Halle Wittenberg, Dept Neurol, Halle, Germany.
C3 Newcastle University - UK; Martin Luther University Halle Wittenberg
RP Taylor, RW (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
RI Strauss, Maria/LCD-9676-2024
OI Strauss, Maria/0000-0002-0072-2199
FU Wellcome Trust Funding Source: Medline
CR Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   Deschauer M, 2004, GENET TEST, V8, P395, DOI 10.1089/gte.2004.8.395
   DiMauro S, 2001, ANN MED, V33, P472, DOI 10.3109/07853890109002096
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   Grafakou O, 2003, J INHERIT METAB DIS, V26, P593, DOI 10.1023/A:1025960300710
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Nishigaki Y, 2002, NEUROLOGY, V58, P1282, DOI 10.1212/WNL.58.8.1282
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Weber K, 1997, AM J HUM GENET, V60, P373
NR 13
TC 24
Z9 26
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JUN
PY 2006
VL 63
IS 6
BP 902
EP 905
DI 10.1001/archneur.63.6.902
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 051YM
UT WOS:000238197600017
PM 16769874
DA 2024-11-01
ER

PT J
AU Hollingsworth, KG
   Gorman, GS
   Trenell, MI
   McFarland, R
   Taylor, RW
   Turnbull, DM
   MacGowan, GA
   Blamire, AM
   Chinnery, PF
AF Hollingsworth, Kieren G.
   Gorman, Grainne S.
   Trenell, Michael I.
   McFarland, Robert
   Taylor, Robert W.
   Turnbull, Douglass M.
   MacGowan, Guy A.
   Blamire, Andrew M.
   Chinnery, Patrick F.
TI Cardiomyopathy is common in patients with the mitochondrial DNA
   m.3243A&gt;G mutation and correlates with mutation load
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial disease; Cardiomyopathy; Tagging; MRI
ID 3243A-GREATER-THAN-G MUTATION; MTDNA; DEPLETION; REVERSAL
AB Although neuromuscular clinical features often dominate the clinical presentation of mitochondrial disease due to the m.3243A>G mitochondrial DNA (mtDNA) mutation, many patients develop cardiac failure, which is often overlooked until it reaches an advanced stage. We set out to determine whether cardiac complications are sufficiently common to warrant prospective screening in all mutation carriers. Routine clinical echocardiography and 3 Tesla cardiac MRI were performed on ten m.3243A>G mutation carriers and compared to age and gender matched controls, with contemporaneous quadriceps muscle biopsies to measure respiratory chain activity and mtDNA mutation levels. Despite normal echocardiography, all ten m.3243A>G mutation carriers had evidence of abnormal cardiac function on MRI. The degree of cardiac dysfunction correlated with the percentage level of mutant mtDNA in skeletal muscle. Sub-clinical cardiac dysfunction was a universal finding in this study, adding weight to the importance of screening for cardiac complications in patients with m.3243A>G. The early detection of cardiac dysfunction with MRI opens up opportunities to prevent heart failure in these patients through early intervention. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Hollingsworth, Kieren G.; Trenell, Michael I.; Blamire, Andrew M.] Newcastle Univ, Inst Cellular Med, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Gorman, Grainne S.; McFarland, Robert; Taylor, Robert W.; Turnbull, Douglass M.; Chinnery, Patrick F.] Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gorman, Grainne S.; McFarland, Robert; Taylor, Robert W.; Turnbull, Douglass M.; Chinnery, Patrick F.] Newcastle Univ, Inst Ageing & Hlth, NIHR Biomed Res Ctr Ageing & Age Related Dis, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [MacGowan, Guy A.] Freeman Rd Hosp, Dept Cardiol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.
   [MacGowan, Guy A.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; Newcastle University - UK; Newcastle Freeman Hospital;
   Newcastle University - UK; Newcastle University - UK
RP Chinnery, PF (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
RI Blamire, Andrew/AAU-6100-2021
OI Turnbull, Doug/0000-0002-8878-9901; McFarland,
   Robert/0000-0002-8833-2688; Gorman, Grainne/0000-0002-7585-3409;
   Chinnery, Patrick/0000-0002-7065-6617; Blamire,
   Andrew/0000-0002-8749-1257; Trenell, Michael/0000-0001-8253-5620
FU UK NHS; Medical Research Council (UK) Translational Muscle Centre,
   Parkinson's UK; Association Francaise contre les Myopathies; UK NIHR
   Biomedical Research Centre for Ageing and Agerelated disease; MRC
   [G0700718, G0900686, G0800674, MC_G0802536] Funding Source: UKRI
FX We thank the patients and volunteers for contributing to this study. In
   addition we would like to acknowledge the significant contribution from
   Carol Smith and Louise Morris, the Research Radiographers. Dr Alistair
   Young from the University of Auckland is thanked for the cardiac tagging
   software. The Mitochondrial Diagnostic laboratory in Newcastle is funded
   by the UK NHS Specialised Services to provide the "Rare Mitochondrial
   Disease of Adults and Children" service
   (http://www.mitochondrialncg.nhs. uk/index.html). P.F.C. is a Wellcome
   Trust Senior Fellow in Clinical Science and a UK National Institute of
   Health Senior Investigator who also receives funding from the Medical
   Research Council (UK) Translational Muscle Centre, Parkinson's UK, the
   Association Francaise contre les Myopathies, and the UK NIHR Biomedical
   Research Centre for Ageing and Age-related disease award to the
   Newcastle upon Tyne Foundation Hospitals NHS Trust.
CR Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Colucci WS, 2007, CIRCULATION, V116, P49, DOI 10.1161/CIRCULATIONAHA.106.666016
   Durham SE, 2006, NEUROLOGY, V67, P502, DOI 10.1212/01.wnl.0000227961.55640.2f
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hsu PC, 2008, INT J CARDIOL, V129, P441, DOI 10.1016/j.ijcard.2007.06.098
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.122648
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Taylor RW, 1997, ORGANELLE DIS
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
NR 11
TC 31
Z9 32
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUL
PY 2012
VL 22
IS 7
BP 592
EP 596
DI 10.1016/j.nmd.2012.03.001
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 975VH
UT WOS:000306539100003
PM 22513320
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Su, TH
   Grady, JP
   Afshar, S
   McDonald, SAC
   Taylor, RW
   Turnbull, DM
   Greaves, LC
AF Su, Tianhong
   Grady, John P.
   Afshar, Sorena
   McDonald, Stuart A. C.
   Taylor, Robert W.
   Turnbull, Doug M.
   Greaves, Laura C.
TI Inherited pathogenic mitochondrial DNA mutations and gastrointestinal
   stem cell populations
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE mitochondrial DNA mutation; selection; segregation; mitochondrial
   disease; intestinal stem cell; gastrointestinal epithelium; MELAS;
   MERRF; m.3243A>G; alimentary canal
ID MTDNA MUTATION; DISEASE; DEFICIENCY; MECHANISMS; ADULT; BLOOD
AB Inherited mitochondrial DNA (mtDNA) mutations cause mitochondrial disease, but mtDNA mutations also occur somatically and accumulate during ageing. Studies have shown that the mutation load of some inherited mtDNA mutations decreases over time in blood, suggesting selection against the mutation. However, it is unknown whether such selection occurs in other mitotic tissues, and where it occurs within the tissue. Gastrointestinal epithelium is a canonical mitotic tissue rapidly renewed by stem cells. Intestinal crypts (epithelium) undergo monoclonal conversion with a single stem cell taking over the niche and producing progeny. We show: (1) that there is a significantly lower mtDNA mutation load in the mitotic epithelium of the gastrointestinal tract when compared to the smooth muscle in the same tissue in patients with the pathogenic m.3243A>G and m.8344A>G mutations; (2) that there is considerable variation seen in individual crypts, suggesting changes in the stem cell population; (3) that this lower mutation load is reflected in the absence of a defect in oxidative phosphorylation in the epithelium. This suggests that there is selection against inherited mtDNA mutations in the gastrointestinal stem cells that is in marked contrast to the somatic mtDNA mutations that accumulate with age in epithelial stem cells leading to a biochemical defect. (c) 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
C1 [Su, Tianhong; Grady, John P.; Taylor, Robert W.; Turnbull, Doug M.; Greaves, Laura C.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Afshar, Sorena] Newcastle Univ, Inst Cellular Med, Human Nutr Res Ctr, Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England.
   [McDonald, Stuart A. C.] Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, London, England.
   [Turnbull, Doug M.; Greaves, Laura C.] Newcastle Univ, Med Sch, LLHW Ctr Ageing & Vital, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; University of
   London; Queen Mary University London; Newcastle University - UK
RP Greaves, LC (corresponding author), Newcastle Univ, Med Sch, Inst Neurosci, LLHW Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM laura.greaves@ncl.ac.uk
RI /E-9960-2014
OI /0000-0002-2386-4915; Turnbull, Doug/0000-0002-8878-9901; Grady,
   John/0000-0001-9667-3872; Greaves, Laura/0000-0002-8071-5916
FU Newcastle University Centre for Ageing and Vitality - BBSRC; EPSRC;
   ESRC; MRC as part of the cross-council Lifelong Health and Wellbeing
   Initiative [203105/Z/16/Z]; UK NIHR Biomedical Research Centre in Age
   and Age Related Diseases; UK NHS Highly Specialised Service for Rare
   Mitochondrial Disorders of Adults and Children; Wellcome Centre for
   Mitochondrial Research [203105/Z/16/Z]; MRC [MR/L016354/1] Funding
   Source: UKRI
FX This study was funded by the Newcastle University Centre for Ageing and
   Vitality supported by the BBSRC, EPSRC, ESRC, and MRC as part of the
   cross-council Lifelong Health and Wellbeing Initiative (DMT, LCG); the
   Wellcome Centre for Mitochondrial Research (203105/Z/16/Z; LCG, RWT,
   DMT); UK NIHR Biomedical Research Centre in Age and Age Related Diseases
   award to the Newcastle upon Tyne Hospitals NHS Foundation (DMT); and the
   UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of
   Adults and Children (DMT, RWT).
CR Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cardaioli E, 2000, J NEUROL, V247, P885, DOI 10.1007/s004150070080
   Chrysostomou A, 2016, NEUROPATH APPL NEURO, V42, P477, DOI 10.1111/nan.12282
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Greaves LC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003082
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Olsson C, 2001, EUR J HUM GENET, V9, P917, DOI 10.1038/sj.ejhg.5200742
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Rygiel KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09906
   Shin MG, 2004, BLOOD, V103, P4466, DOI 10.1182/blood-2003-11-3949
   Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
NR 21
TC 11
Z9 11
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD DEC
PY 2018
VL 246
IS 4
BP 427
EP 432
DI 10.1002/path.5156
PG 6
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA HA6AD
UT WOS:000450360400006
PM 30146801
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Malhotra, K
   Liebeskind, DS
AF Malhotra, Konark
   Liebeskind, David S.
TI Imaging of MELAS
SO CURRENT PAIN AND HEADACHE REPORTS
LA English
DT Review
DE MELAS; Mitochondrial myopathy; MRI; Stroke-like episodes
ID STROKE-LIKE EPISODES; MITOCHONDRIAL-DNA MUTATION;
   MAGNETIC-RESONANCE-SPECTROSCOPY; CEREBRAL-BLOOD-FLOW; LACTIC-ACIDOSIS;
   TRANSFER-RNA; ENCEPHALOPATHY; MYOPATHY; MR; DIFFUSION
AB Mitochondrial diseases are multisystem disorders that frequently involve the central nervous system. The clinical presentation of these disorders may be challenging to differentiate from cerebrovascular disorders. Various imaging techniques are now available that provide a wide range of imaging modalities during initial clinical evaluation and throughout the disease course. Recent technological advancements have introduced advanced neuroimaging modalities that provide detailed information of metabolic disorders at the tissue level. Imaging findings, though diverse, usually have characteristic features that support differentiating these disorders from vascular syndromes. This article provides an overview of various neuroimaging modalities available along with the advent of new imaging techniques being utilized in these disorders.
C1 [Malhotra, Konark] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.
   [Liebeskind, David S.] Neurovasc Imaging Res Core, Neurosci Res Bldg,635 Charles E Young Dr South, Los Angeles, CA 90095 USA.
C3 University of California System; University of California Los Angeles
RP Liebeskind, DS (corresponding author), Neurovasc Imaging Res Core, Neurosci Res Bldg,635 Charles E Young Dr South, Los Angeles, CA 90095 USA.
EM konark.malhotra@yahoo.com; davidliebeskind@yahoo.com
RI Liebeskind, David/B-1991-2008; Malhotra, Konark/N-5883-2016
OI Malhotra, Konark/0000-0002-5383-8101
FU NIH-NINDS
FX David S. Liebeskind declares NIH-NINDS grant support and being a
   consultant for Imaging Core Lab for Stryker and Medtronic.
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   ALLARD JC, 1988, AM J NEURORADIOL, V9, P1234
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Carolei Antonio, 2010, Handb Clin Neurol, V97, P529, DOI 10.1016/S0072-9752(10)97048-6
   Chinnery PF, 1993, GENEREVIEWS
   Chung SH, 2005, NEUROLOGY, V65, pE19, DOI 10.1212/01.wnl.0000184112.34211.d1
   DAVIS PC, 1987, AM J NEURORADIOL, V8, P71
   DEVOLDER A, 1988, J COMPUT ASSIST TOMO, V12, P854
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dindyal S, 2014, ANN R COLL SURG ENGL, V96, P101, DOI DOI 10.1308/003588414
   Finsterer J, 2010, EPILEPTIC DISORD, V12, P330, DOI 10.1684/epd.2010.0338
   Ganslandt O, 1997, NEUROSURGERY, V41, P621, DOI 10.1097/00006123-199709000-00023
   Gire C, 2002, CHILD NERV SYST, V18, P621, DOI 10.1007/s00381-002-0621-0
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   Hirano M, 1994, CHILD NEUROL, V9, P4, DOI DOI 10.1177/088307389400900102
   Huppi P S, 2001, Semin Neonatol, V6, P195, DOI 10.1053/siny.2001.0039
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2009, J NEUROL SCI, V278, P35, DOI 10.1016/j.jns.2008.11.016
   Ikawa M, 2013, MITOCHONDRION, V13, P676, DOI 10.1016/j.mito.2013.09.007
   Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Jamieson DG, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0444-1
   Johnson ECB, 2011, NEUROHOSPITALIST, V1, P48, DOI 10.1177/1941875210385948
   Kamada K, 2001, J NEUROL NEUROSUR PS, V70, P675, DOI 10.1136/jnnp.70.5.675
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kim IO, 1996, AM J ROENTGENOL, V166, P641, DOI 10.2214/ajr.166.3.8623642
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Kodaka R, 1996, STROKE, V27, P1350, DOI 10.1161/01.STR.27.8.1350
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Lazzaro MA, 2010, SEMIN NEUROL, V30, P492, DOI 10.1055/s-0030-1268860
   Liu JR, 2005, NEUROL INDIA, V53, P323, DOI 10.4103/0028-3886.16932
   Majoie CB, 2002, AM J NEURORADIOL, V23, P813
   Malhotra K, 2015, J NEUROIMAGING, V25, P517, DOI 10.1111/jon.12272
   Malhotra K, 2014, J STROKE CEREBROVASC, V23, P31, DOI 10.1016/j.jstrokecerebrovasdis.2012.08.004
   Möller HE, 2005, J NEUROL SCI, V229, P131, DOI 10.1016/j.jns.2004.11.014
   Molnár MJ, 2000, NEUROLOGY, V55, P544, DOI 10.1212/WNL.55.4.544
   Moroni I, 2002, NEUROPEDIATRICS, V33, P79, DOI 10.1055/s-2002-32372
   Nishioka J, 2008, BRAIN DEV-JPN, V30, P100, DOI 10.1016/j.braindev.2007.06.008
   Noguchi A, 2005, PEDIATR NEUROL, V33, P70, DOI 10.1016/j.pediatrneurol.2005.01.013
   OOIWA Y, 1993, STROKE, V24, P304, DOI 10.1161/01.STR.24.2.304
   Osborn AG., 2015, Diagnostic Imaging: Brain, V3rd
   Pauli W, 2013, POL J RADIOL, V78, P61, DOI 10.12659/PJR.884010
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Ramanathan RS, 2013, NEUROLOGY, V81, pE46, DOI 10.1212/WNL.0b013e3182a08d47
   Renard D, 2014, J NEUROL NEUROSUR PS, V85, P1055, DOI 10.1136/jnnp-2013-306933
   Rossini PM, 1998, BRAIN RES, V782, P153, DOI 10.1016/S0006-8993(97)01274-2
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Thajeb P, 2005, ANN NY ACAD SCI, V1042, P48, DOI 10.1196/annals.1338.005
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tsujikawa T, 2010, BRAIN DEV-JPN, V32, P143, DOI 10.1016/j.braindev.2008.12.003
   Tzoulis C, 2009, STROKE, V40, pE15, DOI 10.1161/STROKEAHA.108.523118
   Virtanen SM, 2011, AM J NEURORADIOL, V32, P522, DOI 10.3174/ajnr.A2309
   Wang XY, 2003, NEURORADIOLOGY, V45, P640, DOI 10.1007/s00234-003-1029-6
   Wang YX, 2015, CHINESE MED J-PEKING, V128, P1820, DOI 10.4103/0366-6999.159360
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Xie S, 2014, METHOD ENZYMOL, V547, P433, DOI 10.1016/B978-0-12-801415-8.00021-7
   Yeh HL, 2013, BRAIN DEV-JPN, V35, P158, DOI 10.1016/j.braindev.2012.03.017
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
   Yonemura K, 2001, AM J NEURORADIOL, V22, P269
   Yoshida T, 2013, INTERNAL MED, V52, P1389, DOI 10.2169/internalmedicine.52.0188
   Yu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079859
NR 69
TC 35
Z9 37
U1 0
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1531-3433
EI 1534-3081
J9 CURR PAIN HEADACHE R
JI Curr. Pain Headache Rep.
PD SEP
PY 2016
VL 20
IS 9
AR 54
DI 10.1007/s11916-016-0583-7
PG 8
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DV1NX
UT WOS:000382689000003
PM 27477183
DA 2024-11-01
ER

PT J
AU Dai, Y
   Zheng, KN
   Clark, J
   Swerdlow, RH
   Pulst, SM
   Sutton, JP
   Shinobu, LA
   Simon, DK
AF Dai, Ying
   Zheng, Kangni
   Clark, Joanne
   Swerdlow, Russell H.
   Pulst, Stefan M.
   Sutton, James P.
   Shinobu, Leslie A.
   Simon, David K.
TI Rapamycin drives selection against a pathogenic heteroplasmic
   mitochondrial DNA mutation
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; MTDNA MUTATIONS; OXIDATIVE STRESS;
   SKELETAL-MUSCLE; GENE-THERAPY; CYBRID CELLS; AUTOPHAGY; MITOPHAGY;
   DISEASE; CANCER
AB Mitochondrial DNA(mtDNA) mutations cause a variety of mitochondrial disorders for which effective treatments are lacking. Emerging data indicate that selective mitochondrial degradation through autophagy (mitophagy) plays a critical role in mitochondrial quality control. Inhibition of mammalian target of rapamycin (mTOR) kinase activity can activate mitophagy. To test the hypothesis that enhancing mitophagy would drive selection against dysfunctional mitochondria harboring higher levels of mutations, thereby decreasing mutation levels over time, we examined the impact of rapamycin on mutation levels in a human cytoplasmic hybrid (cybrid) cell line expressing a heteroplasmic mtDNA G11778A mutation, the most common cause of Leber's hereditary optic neuropathy. Inhibition of mTORC1/S6 kinase signaling by rapamycin induced colocalization of mitochondria with autophagosomes, and resulted in a striking progressive decrease in levels of the G11778A mutation and partial restoration of ATP levels. Rapamycin-induced upregulation of mitophagy was confirmed by electron microscopic evidence of increased autophagic vacuoles containing mitochondria-like organelles. The decreased mutational burden was not due to rapamycin-induced cell death or mtDNA depletion, as there was no significant difference in cytotoxicity/apoptosis or mtDNA copy number between rapamycin and vehicle treated cells. These data demonstrate the potential for pharmacological inhibition of mTOR kinase activity to activate mitophagy as a strategy to drive selection against a heteroplasmic mtDNA G11778A mutation and raise the exciting possibility that rapamycin may have therapeutic potential for the treatment of mitochondrial disorders associated with heteroplasmic mtDNA mutations, although further studies are needed to determine if a similar strategy will be effective for other mutations and other cell types.
C1 [Dai, Ying; Zheng, Kangni; Clark, Joanne; Simon, David K.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.
   [Dai, Ying; Zheng, Kangni; Clark, Joanne; Shinobu, Leslie A.; Simon, David K.] Harvard Univ, Sch Med, Boston, MA 02215 USA.
   [Swerdlow, Russell H.] Univ Kansas, Sch Med, Dept Neurol, Kansas City, KS 66160 USA.
   [Swerdlow, Russell H.] Univ Kansas, Sch Med, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA.
   [Swerdlow, Russell H.] Univ Kansas, Sch Med, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA.
   [Pulst, Stefan M.] Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA.
   [Sutton, James P.] Pacific Neurosci Med Grp, Oxnard, CA 93030 USA.
   [Shinobu, Leslie A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02215 USA.
C3 Harvard University; Beth Israel Deaconess Medical Center; Harvard
   University; Harvard Medical School; University of Kansas; University of
   Kansas Medical Center; University of Kansas; University of Kansas
   Medical Center; University of Kansas; University of Kansas Medical
   Center; Utah System of Higher Education; University of Utah; Harvard
   University; Massachusetts General Hospital
RP Dai, Y (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Room CLS 628, Boston, MA 02215 USA.
EM ydai@bidmc.harvard.edu
RI Sutton, James/KVY-7705-2024
FU National Institute of Neurological Disorders and Stroke [1R21NS077758];
   United Mitochondrial Disease Foundation [UMDF11-095]
FX This work was supported by the National Institute of Neurological
   Disorders and Stroke (1R21NS077758 to D. K. S.); and the United
   Mitochondrial Disease Foundation (UMDF11-095 to Y.D.).
CR Adhya S, 2011, MITOCHONDRION, V11, P839, DOI 10.1016/j.mito.2011.06.003
   Bakker A, 2000, PEDIATR RES, V48, P143, DOI 10.1203/00006450-200008000-00005
   Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chu CT, 2010, HUM MOL GENET, V19, pR28, DOI 10.1093/hmg/ddq143
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   de Vries RLA, 2012, AUTOPHAGY, V8, P699, DOI 10.4161/auto.19470
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Geoerger B, 2001, CANCER RES, V61, P1527
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7
   Jefferies H.B., 1997, EMBO J, V16, P3693
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Mahalati K, 2001, CLIN PHARMACOKINET, V40, P573, DOI 10.2165/00003088-200140080-00002
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Newman NJ, 2002, J NEURO-OPHTHALMOL, V22, P257, DOI 10.1097/00041327-200212000-00001
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   Pan T, 2009, NEUROSCIENCE, V164, P541, DOI 10.1016/j.neuroscience.2009.08.014
   Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Sangatsuda Y, 2012, MITOCHONDRION, V12, P617, DOI 10.1016/j.mito.2012.10.002
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Simon DK, 1999, ANNU REV MED, V50, P111
   SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tashima K, 2009, AM J PHYSIOL-GASTR L, V296, pG319, DOI 10.1152/ajpgi.90355.2008
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyler B, 2011, NEURO-ONCOLOGY, V13, P700, DOI 10.1093/neuonc/nor050
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Yano T, 2010, INT J MOL MED, V25, P153, DOI 10.3892/ijmm_00000325
   Zhang CF, 1998, HUM MUTAT, V11, P360
NR 52
TC 61
Z9 72
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD FEB 1
PY 2014
VL 23
IS 3
BP 637
EP 647
DI 10.1093/hmg/ddt450
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AA1FK
UT WOS:000330841700006
PM 24101601
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Wei, J
   Gao, DF
   Wang, H
   Yan, R
   Liu, ZQ
   Yuan, ZY
   Liu, J
   Chen, MX
AF Wei, Jin
   Gao, Deng-Feng
   Wang, Hao
   Yan, Rui
   Liu, Zhi-Quan
   Yuan, Zu-Yi
   Liu, Jian
   Chen, Ming-Xia
TI Impairment of Myocardial Mitochondria in Viral Myocardial Disease and
   Its Reflective Window in Peripheral Cells
SO PLOS ONE
LA English
DT Article
ID IDIOPATHIC DILATED CARDIOMYOPATHY; HEART-FAILURE; DNA MUTATIONS;
   DELETION; METABOLISM; CLASSIFICATION; EPIDEMIOLOGY; ASSOCIATION;
   CARDIOLOGY; DIAGNOSIS
AB Background: Viral myocardial disease (VMD) is a common disease inducing heart failure. It has not been clear the roles of mitochondrial damage in the pathological changes of cardiomyocytes in VMD.
   Methods: Myocardial tissues and lymphocytes were collected from 83 VMD patients. Control groups included 12 cases of healthy accidental death with myocardial autopsy and 23 healthy blood donors. The mouse model of viral myocarditis (VMC) was established by Coxsackie virus B-3 infection and myocardial tissues and skeletal muscle were collected. Mitochondrial DNA (mtDNA) deletion rate was quantitatively determined using polymerase chain reaction.
   Results: There was significantly difference of myocardial mitochondrial DNA deletion rate between VMD or VMC group and control group (P<0.05). Moreover, the loss of mitochondrial membrane phospholipids was significantly different between VMD or VMC group and control group. In VMC mice, there were negative correlations between myocardial mtDNA(3867) deletion rate and left ventricular peak systolic pressure (LVPSP) (r=-0.66, P<0.05), and between myocardial mtDNA(3867) deletion rate and +dp/dt(max) (r=-0.79, P<0.05), while there was positive correlation between myocardial mtDNA3867 deletion rate and -dp/dt(max) (r=0.80, P<0.05).
   Conclusion: Mitochondrial damage is an important pathophysiological mechanism leading to myocardial injury and cardiac dysfunction. The mitochondrial damage in the skeletal muscle and lymphocytes reflect a "window" of myocardial mitochondrial damage.
C1 [Wei, Jin; Gao, Deng-Feng; Yan, Rui] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 2, Xian 710049, Shaanxi, Peoples R China.
   [Wang, Hao] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA.
   [Liu, Zhi-Quan; Yuan, Zu-Yi] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 1, Xian 710049, Shaanxi, Peoples R China.
   [Liu, Jian; Chen, Ming-Xia] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Shaanxi, Peoples R China.
C3 Xi'an Jiaotong University; Wake Forest University; Wake Forest Baptist
   Medical Center; Xi'an Jiaotong University; Xi'an Jiaotong University
RP Wei, J (corresponding author), Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 2, Xian 710049, Shaanxi, Peoples R China.
EM weijin@mail.xjtu.edu.cn
OI Wang, Hao/0000-0003-1537-661X; Yuan, Zuyi/0000-0002-4141-0298
FU Science and Technology Projects of Shaanxi Province [2007K13-03];
   National Natural Science Foundation of China [81170209]
FX This study was supported by the Science and Technology Projects of
   Shaanxi Province (No. 2007K13-03 to J.W.), and grants from National
   Natural Science Foundation of China (No. 81170209 to J.W.). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR ADACHI K, 1993, BIOCHEM BIOPH RES CO, V195, P945, DOI 10.1006/bbrc.1993.2135
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Blauwet LA, 2010, PROG CARDIOVASC DIS, V52, P274, DOI 10.1016/j.pcad.2009.11.006
   Caforio ALP, 1997, EUR HEART J, V18, P1051
   Carvajal K, 2003, ARCH MED RES, V34, P89, DOI 10.1016/S0188-4409(03)00004-3
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   Chinese Heart Association, 2000, CHINESE J PRACTICAL, V15, P75
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   Craigen WJ, 2012, METHODS MOL BIOL, V837, P3, DOI 10.1007/978-1-61779-504-6_1
   Eynon N, 2011, PHYSIOL GENOMICS, V43, P789, DOI 10.1152/physiolgenomics.00029.2011
   Fan Zh, 2010, J LIAONING MED U, V31, P370
   GRIFFITHS GM, 1992, P NATL ACAD SCI USA, V89, P549, DOI 10.1073/pnas.89.2.549
   Haiyan D, 2006, J CHINESE MODERN PED, V3, P407
   Hanaki Y, 1989, J MOL CELL CARDIOL, V21, P175
   Hill MF, 1997, CIRCULATION, V96, P2414
   Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301
   INGWALL JS, 1993, CIRCULATION, V87, P58
   Jing Y, 2012, J CLIN CARDIOLOGY CH, V28, P81
   Kao SH, 1997, BIOCHEM MOL BIOL INT, V42, P285
   Katz Arnold M., 1998, Cardiology Clinics, V16, P633, DOI 10.1016/S0733-8651(05)70040-0
   Kim HE, 2000, J CLIN INVEST, V106, P857, DOI 10.1172/JCI8040
   Lan Y, 1998, J SHANXI MED, V27, P598
   Lezza AMS, 1999, FASEB J, V13, P1083, DOI 10.1096/fasebj.13.9.1083
   Lv SC, 2013, HELL J CARDIOL, V54, P382
   Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536
   Marín-García J, 2002, J CARD FAIL, V8, P347, DOI 10.1054/jcaf.2002.127774
   Marin-Garcia J, 1999, CARDIOVASC PATHOL, V8, P217, DOI 10.1016/S1054-8807(99)00010-1
   MarinGarcia J, 1996, CARDIOVASC RES, V31, P306
   Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287
   Molina H, 1997, MECH AGEING DEV, V97, P1, DOI 10.1016/S0047-6374(97)01876-9
   Panfoli I, 2011, EXPERT REV PROTEOMIC, V8, P231, DOI [10.1586/EPR.11.1, 10.1586/epr.11.1]
   Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841
   ROBINSON NC, 1982, BIOCHEMISTRY-US, V21, P184, DOI 10.1021/bi00530a031
   Rose NR, 2008, CURR TOP MICROBIOL, V323, P293
   Sen Z, 1964, PROGR PHYSL SCI, V6, P122
   Shenkar R, 1996, AM J HUM GENET, V59, P772
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Wu F, 2009, P NATL ACAD SCI USA, V106, P7143, DOI 10.1073/pnas.0812768106
   Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022
   Yanagawa B, 2003, LAB INVEST, V83, P75, DOI 10.1097/01.LAB.0000049349.56211.09
   Zhang XX, 2002, CHINESE MED J-PEKING, V115, P1390
   Zhiquan L, 1992, J MOL CELL CARDIOL, V24, P239
   Zhiquan L, 1993, CHINESE J CARDIOLOGY, V21, P209
NR 43
TC 7
Z9 9
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 31
PY 2014
VL 9
IS 12
AR e116239
DI 10.1371/journal.pone.0116239
PG 18
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AX7UC
UT WOS:000347119100113
PM 25551390
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Bacman, SR
   Kauppila, JHK
   Pereira, CV
   Nissanka, N
   Miranda, M
   Pinto, M
   Williams, SL
   Larsson, NG
   Stewart, JB
   Moraes, CT
AF Bacman, Sandra R.
   Kauppila, Johanna H. K.
   Pereira, Claudia, V
   Nissanka, Nadee
   Miranda, Maria
   Pinto, Milena
   Williams, Sion L.
   Larsson, Nils-Goeran
   Stewart, James B.
   Moraes, Carlos T.
TI MitoTALEN reduces mutant mtDNA load and restores tRNA<SUP>Ala</SUP>
   levels in a mouse model of heteroplasmic mtDNA mutation
SO NATURE MEDICINE
LA English
DT Article
ID MITOCHONDRIAL-DNA; ELIMINATION; PHENOTYPE; DELETIONS; DOMAIN
AB Mutations in the mitochondrial DNA ( mtDNA) are responsible for several metabolic disorders, commonly involving muscle and the central nervous system(1). Because of the critical role of mtDNA in oxidative phosphorylation, the majority of pathogenic mtDNA mutations are heteroplasmic, co-existing with wild-type molecules(1). Using a mouse model with a heteroplasmic mtDNA mutation(2), we tested whether mitochondrialtargeted TALENs (mitoTALENs)(3,4) could reduce the mutant mtDNA load in muscle and heart. AAV9-mitoTALEN was administered via intramuscular, intravenous, and intraperitoneal injections. Muscle and heart were efficiently transduced and showed a robust reduction in mutant mtDNA, which was stable over time. The molecular defect, namely a decrease in transfer RNA(Ala) levels, was restored by the treatment. These results showed that mitoTALENs, when expressed in affected tissues, could revert disease-related phenotypes in mice.
C1 [Bacman, Sandra R.; Pereira, Claudia, V; Nissanka, Nadee; Pinto, Milena; Williams, Sion L.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Kauppila, Johanna H. K.; Miranda, Maria; Larsson, Nils-Goeran; Stewart, James B.] Max Planck Inst Biol & Ageing, Dept Mitochondrial Biol, Cologne, Germany.
C3 University of Miami; Max Planck Society
RP Bacman, SR; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
EM sbacman@med.miami.edu; cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021; Larsson, Nils-Göran/GVS-5578-2022; pinto,
   milena/K-6095-2017; Stewart, Jim/C-9633-2011
OI Nissanka, Nadee/0000-0002-4639-7192; Miranda, Maria/0000-0002-0817-553X;
   Larsson, Nils-Goran/0000-0001-5100-996X; pinto,
   milena/0000-0001-9202-1527; Stewart, Jim/0000-0002-2902-4968
FU National Institutes of Health [5R01EY010804]; NIH [1R01AG036871,
   1R01NS079965]; Muscular Dystrophy Association; JDM Fund for
   Mitochondrial Research; American Heart Association [16PRE30480009];
   Biscardi family; American Heart Association (AHA) [16PRE30480009]
   Funding Source: American Heart Association (AHA)
FX This work was supported primarily by the National Institutes of Health
   Grant 5R01EY010804, with additional support from 1R01AG036871 and
   1R01NS079965 (NIH) and the Muscular Dystrophy Association (CTM). We also
   acknowledge support from The JDM Fund for Mitochondrial Research and the
   Biscardi family. N.N. is supported by an American Heart Association
   predoctoral fellowship (16PRE30480009). We are grateful to the
   University of Miami Flow Cytometry core facility (SCCC) for expert
   assistance.
CR Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Davies SMK, 2012, FEBS LETT, V586, P3555, DOI 10.1016/j.febslet.2012.07.043
   Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539
   El-Hattab AW, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00025
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Lamb BM, 2013, NUCLEIC ACIDS RES, V41, P9779, DOI 10.1093/nar/gkt754
   Lehmann D, 2015, EUR J HUM GENET, V23, P1735, DOI 10.1038/ejhg.2015.73
   Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704
   Lochmüller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407
   Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1
   Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Pinto M, 2018, J NEUROSCI, V38, P1042, DOI 10.1523/JNEUROSCI.1384-17.2017
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957
   Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155
NR 27
TC 175
Z9 205
U1 0
U2 40
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD NOV
PY 2018
VL 24
IS 11
BP 1696
EP +
DI 10.1038/s41591-018-0166-8
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA GZ4VS
UT WOS:000449404200021
PM 30250143
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Takata, A
   Kato, M
   Nakamura, M
   Yoshikawa, T
   Kanba, S
   Sano, A
   Kato, T
AF Takata, Atsushi
   Kato, Maiko
   Nakamura, Masayuki
   Yoshikawa, Takeo
   Kanba, Shigenobu
   Sano, Akira
   Kato, Tadafumi
TI Exome sequencing identifies a novel missense variant in <i>RRM2B</i>
   associated with autosomal recessive progressive external ophthalmoplegia
SO GENOME BIOLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA DELETIONS; MULTIPLE DELETIONS; BIPOLAR DISORDER;
   MUTATIONS; FEATURES; DISEASE; P53R2; CELLS
AB Background: Whole-exome sequencing using next-generation technologies has been previously demonstrated to be able to detect rare disease-causing variants. Progressive external ophthalmoplegia (PEO) is an inherited mitochondrial disease that follows either autosomal dominant or recessive forms of inheritance (adPEO or arPEO). AdPEO is a genetically heterogeneous disease and several genes, including POLG1 and C10orf2/Twinkle, have been identified as responsible genes. On the other hand, POLG1 was the only established gene causing arPEO with mitochondrial DNA deletions. We previously reported a case of PEO with unidentified genetic etiology. The patient was born of a first-cousin marriage. Therefore, the recessive form of inheritance was suspected.
   Results: To identify the disease-causing variant in this patient, we subjected the patient's DNA to whole-exome sequencing and narrowed down the candidate variants using public data and runs of homozygosity analysis. A total of 35 novel, putatively functional variants were detected in the homozygous segments. When we sorted these variants by the conservation score, a novel missense variant in RRM2B, whose heterozygous rare variant had been known to cause adPEO, was ranked at the top. The list of novel, putatively functional variants did not contain any other variant in genes encoding mitochondrial proteins registered in MitoCarta.
   Conclusions: Exome sequencing efficiently and effectively identified a novel, homozygous missense variant in RRM2B, which was strongly suggested to be causative for arPEO. The findings in this study indicate arPEO to be a genetically heterogeneous disorder, as is the case for adPEO.
C1 [Takata, Atsushi; Kato, Tadafumi] RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan.
   [Takata, Atsushi; Kanba, Shigenobu] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Higashi Ku, Fukuoka 8128582, Japan.
   [Takata, Atsushi; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan.
   [Kato, Maiko; Nakamura, Masayuki; Sano, Akira] Kagoshima Univ, Dept Psychiat, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan.
C3 RIKEN; Kyushu University; RIKEN; Kagoshima University
RP Kato, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM kato@brain.riken.jp
RI Yoshikawa, Takeo/F-9599-2019; Kato, Tadafumi/J-3583-2014
OI Takata, Atsushi/0000-0002-0928-4586; Sano, Akira/0000-0001-5843-9786;
   Kato, Tadafumi/0000-0001-7856-3952; Nakamura,
   Masayuki/0000-0001-5558-0418
FU Grants-in-Aid for Scientific Research [23659568, 23390291, 21591488]
   Funding Source: KAKEN
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   [Anonymous], Database of Genotypes and Phenotypes (dbGaP)
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   *GEN, GEN BROWS UCSC
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Kakiuchi C, 2005, INT J NEUROPSYCHOPH, V8, P515, DOI 10.1017/S1461145705005213
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kato M, 2011, NEUROSCI RES, V69, P331, DOI 10.1016/j.neures.2010.12.013
   Kato T, 2008, TRENDS NEUROSCI, V31, P495, DOI 10.1016/j.tins.2008.07.007
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Melberg A, 1996, MUSCLE NERVE, V19, P751
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390
   Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646
   Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Xue LJ, 2007, CANCER RES, V67, P16, DOI 10.1158/0008-5472.CAN-06-3200
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   REFSEQGENE PROJECT
NR 32
TC 32
Z9 36
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PY 2011
VL 12
IS 9
SI SI
AR R92
DI 10.1186/gb-2011-12-9-r92
PG 7
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 874AH
UT WOS:000298926900009
PM 21951382
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Tonska, K
   Piekutowska-Abramczuk, D
   Kaliszewska, M
   Kowalski, P
   Tanska, A
   Bartnik, E
   Pronicka, E
   Krajewska-Walasek, M
AF Tonska, Katarzyna
   Piekutowska-Abramczuk, Dorota
   Kaliszewska, Magdalena
   Kowalski, Pawel
   Tanska, Anna
   Bartnik, Ewa
   Pronicka, Ewa
   Krajewska-Walasek, Malgorzata
TI Molecular investigations of mitochondrial deletions: Evaluating the
   usefulness of different genetic tests
SO GENE
LA English
DT Article
DE mtDNA deletions; MLPA; Mitochondrial diseases
ID MULTIPLE DELETIONS; DNA DELETION; EPIDEMIOLOGY; SINGLE
AB Deletions in mitochondrial DNA are a common cause of mitochondrial disorders. The molecular diagnosis of mtDNA deletions for years was based on Southern hybridization later replaced by PCR methods such as PCR with primers specific for a particular deletion (mainly the so-called common deletion of 4977 bp) and long PCR.
   In order to evaluate the usefulness of MLPA (Multiplex Ligation-dependent Probe Amplification) in molecular diagnosis of large scale mtDNA deletions we compare four diagnostic methods: Southern hybridization, PCR, long-PCR and MLPA in a group of 16 patients with suspected deletions. Analysis was performed on blood, muscle and in one case hepatic tissue DNA.
   The MLPA was not able to confirm all the deletions detected by PCR methods, but due to its relative ease of processing, minimal equipment, low costs and the additional possibility to detect frequent point mtDNA mutations in one assay it is worth considering as a screening method. We recommend to always confirm MLPA results by PCR methods. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Tonska, Katarzyna; Kaliszewska, Magdalena; Bartnik, Ewa] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, PL-02106 Warsaw, Poland.
   [Piekutowska-Abramczuk, Dorota; Kowalski, Pawel; Tanska, Anna; Krajewska-Walasek, Malgorzata] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland.
   [Bartnik, Ewa] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland.
   [Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Metab Dis, PL-04730 Warsaw, Poland.
C3 University of Warsaw; Children's Memorial Health Institute; Polish
   Academy of Sciences; Institute of Biochemistry & Biophysics - Polish
   Academy of Sciences; Children's Memorial Health Institute
RP Tonska, K (corresponding author), Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Ul Pawinskiego 5A, PL-02106 Warsaw, Poland.
EM kaska@igib.uw.edu.pl
OI Tonska, Katarzyna/0000-0002-1793-6089; Piekutowska-Abramczuk,
   Dorota/0000-0002-9786-3704; Kowalski, Pawel/0000-0002-0240-6974;
   Krajewska-Walasek, Malgorzata/0000-0001-8721-210X; Kaliszewska,
   Magdalena/0000-0003-3649-4375; Pronicka, Ewa/0000-0002-5705-4814
FU CMHI [S111/2009]; National Science Centre [NN407285739, NN401049238]
FX The study was supported by CMHI Project No. S111/2009, National Science
   Centre Projects: Nos. NN407285739 and NN401049238. We thank Prof. Anna
   Kaminska from the Department of Neurology, Medical University of Warsaw
   for the muscle sample of patient P16.
CR Bank C, 2000, BIOCHEM BIOPH RES CO, V279, P595, DOI 10.1006/bbrc.2000.3951
   Carrozzo R, 1999, J NEUROL SCI, V170, P24, DOI 10.1016/S0022-510X(99)00193-8
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Deschauer M, 2004, GENET TEST, V8, P395, DOI 10.1089/gte.2004.8.395
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Kierdaszuk B, 2009, NEUROL NEUROCHIR POL, V43, P216
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Kozlowski P, 2008, ELECTROPHORESIS, V29, P4627, DOI 10.1002/elps.200800126
   Kwon MJ, 2011, ANN CLIN LAB SCI, V41, P385
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mierzewska H., 2010, ANN DIGAN PAEDIAT PA, V14, P11
   MITOMAP, 2011, HUM MIT GEN DAT
   Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Soong N W, 1996, Methods Enzymol, V264, P421, DOI 10.1016/S0076-6879(96)64038-5
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   van Veghel-Plandsoen MM, 2011, EUR J HUM GENET, V19, P1009, DOI 10.1038/ejhg.2011.60
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
NR 20
TC 8
Z9 8
U1 0
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD SEP 10
PY 2012
VL 506
IS 1
BP 161
EP 165
DI 10.1016/j.gene.2012.06.081
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 998SJ
UT WOS:000308260400024
PM 22766397
DA 2024-11-01
ER

PT J
AU Herbst, A
   Lee, CC
   Vandiver, AR
   Aiken, JM
   McKenzie, D
   Hoang, A
   Allison, D
   Liu, NJ
   Wanagat, J
AF Herbst, Allen
   Lee, Cathy C.
   Vandiver, Amy R.
   Aiken, Judd M.
   McKenzie, Debbie
   Hoang, Austin
   Allison, David
   Liu, Nianjun
   Wanagat, Jonathan
TI Mitochondrial DNA deletion mutations increase exponentially with age in
   human skeletal muscle
SO AGING CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
DE MtDNA; Mitochondria; Mutation; Deletion; Sarcopenia; Biomarker
ID DIFFERENT FIBER TYPES; VASTUS LATERALIS; ABNORMALITIES; ACCUMULATION;
   ATROPHY; MICE
AB Background Mitochondrial DNA (mtDNA) deletion mutations lead to electron transport chain-deficient cells and age-induced cell loss in multiple tissues and mammalian species. Accurate quantitation of somatic mtDNA deletion mutations could serve as an index of age-induced cell loss. Quantitation of mtDNA deletion molecules is confounded by their low abundance in tissue homogenates, the diversity of deletion breakpoints, stochastic accumulation in single cells, and mosaic distribution between cells. Aims Translate a pre-clinical assay to quantitate mtDNA deletions for use in human DNA samples, with technical and biological validation, and test this assay on human subjects of different ages. Methods We developed and validated a high-throughput droplet digital PCR assay that quantitates human mtDNA deletion frequency. Results Analysis of human quadriceps muscle samples from 14 male subjects demonstrated that mtDNA deletion frequency increases exponentially with age-on average, a 98-fold increase from age 20-80. Sequence analysis of amplification products confirmed the specificity of the assay for human mtDNA deletion breakpoints. Titration of synthetic mutation mixtures found a lower limit of detection of at least 0.6 parts per million. Using muscle DNA from 6-month-old mtDNA mutator mice, we measured a 6.4-fold increase in mtDNA deletion frequency (i.e., compared to wild-type mice), biologically validating the approach. Discussion/conclusions The exponential increase in mtDNA deletion frequency is concomitant with the known muscle fiber loss and accelerating mortality that occurs with age. The improved assay permits the accurate and sensitive quantification of deletion mutations from DNA samples and is sufficient to measure changes in mtDNA deletion mutation frequency in healthy individuals across the lifespan and, therefore, patients with suspected mitochondrial diseases.
C1 [Herbst, Allen; Aiken, Judd M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [Lee, Cathy C.; Wanagat, Jonathan] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
   [Lee, Cathy C.; Hoang, Austin; Wanagat, Jonathan] Univ Calif Los Angeles, Dept Med, Div Geriatr, Los Angeles, CA 90024 USA.
   [Vandiver, Amy R.] Univ Calif Los Angeles, Dept Med, Div Dermatol, 10945 Le Conte Ave,Suite 2339, Los Angeles, CA 90095 USA.
   [McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.
   [Allison, David; Liu, Nianjun] Indiana Univ Bloomington, Dept Epidemiol & Biostat, Bloomington, IN USA.
C3 University of Alberta; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); VA Greater Los Angeles Healthcare System;
   University of California System; University of California Los Angeles;
   University of California System; University of California Los Angeles;
   University of Alberta; Indiana University System; Indiana University
   Bloomington
RP Wanagat, J (corresponding author), Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.; Wanagat, J (corresponding author), Univ Calif Los Angeles, Dept Med, Div Geriatr, Los Angeles, CA 90024 USA.
EM jwanagat@mednet.ucla.edu
RI Wanagat, Jonathan/B-2856-2009; Altshuler, David/A-4476-2009
OI Wanagat, Jonathan/0000-0002-8460-8616; Vandiver,
   Amy/0000-0003-2176-9161; Herbst, Allen/0000-0001-6601-1245; Aiken,
   Judd/0000-0001-6119-4521
FU National Institute on Aging at the National Institutes of Health
   [R56AG060880, R01AG055518, K02AG059847, R21AR072950]
FX This work is supported by the National Institute on Aging at the
   National Institutes of Health (Grant numbers R56AG060880, R01AG055518,
   K02AG059847, and R21AR072950).
CR Administration SS, 2015, ACT LIF TABL
   Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   [Anonymous], 2018, Bioanalytical Method Validation Guidance for Industry
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186
   Belsky DW, 2018, AM J EPIDEMIOL, V187, P1220, DOI 10.1093/aje/kwx346
   Bielas J, 2018, EXP GERONTOL, V106, P125, DOI 10.1016/j.exger.2018.02.021
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Cheema N, 2015, AGING CELL, V14, P1085, DOI 10.1111/acel.12399
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ferrucci L, 2020, AGING CELL, V19, DOI 10.1111/acel.13080
   Finch CE, 2016, P NATL ACAD SCI USA, V113, P1121, DOI 10.1073/pnas.1524017113
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Gompertz B., 1825, Philosophical transactions of the Royal Society of London, V115, P513, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834
   Hepple RT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00211
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herbst A, 2019, MECH AGEING DEV, V182, DOI 10.1016/j.mad.2019.111126
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Kaeberlein Matt, 2013, F1000Prime Rep, V5, P5, DOI 10.12703/P5-5
   Lee CC, 2020, J CYTOL HISTOL, DOI 10.3742/jch.2020.11.553
   LEE CM, 1993, J GERONTOL, V48, pB201, DOI 10.1093/geronj/48.6.B201
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   LEXELL J, 1986, J NEUROL SCI, V72, P211, DOI 10.1016/0022-510X(86)90009-2
   McKiernan SH, 2007, AM J PHYSIOL-RENAL, V292, pF1751, DOI 10.1152/ajprenal.00307.2006
   Miller RA, 2001, BIOMARKERS AGING
   O'Hara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Oliveira MT, 2020, GENET MOL BIOL, V43, DOI [10.1590/1678-4685-GMB-2019-0069, 10.1590/1678-4685-gmb-2019-0069]
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Parikh S, 2019, J MED GENET, V56, P123, DOI 10.1136/jmedgenet-2018-105800
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SLICHTER SJ, 1976, TRANSFUSION, V16, P8
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wanagat J, 2002, J MOL CELL CARDIOL, V34, P17, DOI 10.1006/jmcc.2001.1483
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Warner HR, 1997, J AM GERIATR SOC, V45, P1140, DOI 10.1111/j.1532-5415.1997.tb05981.x
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 47
TC 28
Z9 29
U1 4
U2 18
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1594-0667
EI 1720-8319
J9 AGING CLIN EXP RES
JI Aging Clin. Exp. Res.
PD JUL
PY 2021
VL 33
IS 7
SI SI
BP 1811
EP 1820
DI 10.1007/s40520-020-01698-7
EA SEP 2020
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA TC8NN
UT WOS:000572315500001
PM 32965609
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Kohler, JJ
   Hosseini, SH
   Cucoranu, I
   Hoying-Brandt, A
   Green, E
   Johnson, D
   Wittich, B
   Srivastava, J
   Ivey, K
   Fields, E
   Russ, R
   Raper, CM
   Santoianni, R
   Lewis, W
AF Kohler, James J.
   Hosseini, Seyed H.
   Cucoranu, Ioan
   Hoying-Brandt, Amy
   Green, Elgin
   Johnson, David
   Wittich, Bree
   Srivastava, Jaya
   Ivey, Kristopher
   Fields, Earl
   Russ, Rodney
   Raper, C. Michael
   Santoianni, Robert
   Lewis, William
TI Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside
   phosphorylation
SO LABORATORY INVESTIGATION
LA English
DT Article
DE mtDNA; NRTI; cardiomyopathy; transgenic; murine
ID MITOCHONDRIAL THYMIDINE KINASE; DNA-POLYMERASE GAMMA; OVEREXPRESSION;
   CARDIOMYOPATHY; REPLICATION; EXPRESSION; DEPLETION; TOXICITY; DISEASES;
   MUSCLE
AB Mitochondrial toxicity results from pyrimidine nucleoside reverse transcriptase inhibitors (NRTIs) for HIV/AIDS. In the heart, this can deplete mitochondrial (mt) DNA and cause cardiac dysfunction (eg, left ventricle hypertrophy, LVH). Four unique transgenic, cardiac-targeted overexpressors (TGs) were generated to determine their individual impact on native mitochondrial biogenesis and effects of NRTI administration on development of mitochondrial toxicity. TGs included cardiac-specific overexpression of native thymidine kinase 2 (TK2), two pathogenic TK2 mutants (H121N and I212N), and a mutant of mtDNA polymerase, pol-gamma (Y955C). Each was treated with antiretrovirals (AZT-HAART, 3 or 10 weeks, zidovudine (AZT) + lamivudine (3TC) + indinavir, or vehicle control). Parameters included left ventricle (LV) performance (echocardiography), LV mtDNA abundance (real-time PCR), and mitochondrial fine structure ( electron microscopy, EM) as a function of duration of treatment and presence of TG. mtDNA abundance significantly decreased in Y955C TG, increased in TK2 native and I212N TGs, and was unchanged in H121N TGs at 10 weeks regardless of treatment. Y955C and I212N TGs exhibited LVH during growth irrespective of treatment. Y955C TGs exhibited cardiomyopathy ( CM) at 3 and 10 weeks irrespective of treatment, whereas H121N and I212N TGs exhibited CM only after 10 weeks AZT-HAART. EM features were consistent with cardiac dysfunction. mtDNA abundance and cardiac functional changes were related to TG expression of mitochondrially related genes, mutations thereof, and NRTIs. Laboratory Investigation (2009) 89, 122-130; doi: 10.1038/labinvest.2008.121; published online 15 December 2008
C1 [Kohler, James J.; Hosseini, Seyed H.; Cucoranu, Ioan; Hoying-Brandt, Amy; Green, Elgin; Johnson, David; Wittich, Bree; Srivastava, Jaya; Ivey, Kristopher; Fields, Earl; Russ, Rodney; Raper, C. Michael; Santoianni, Robert; Lewis, William] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
C3 Emory University
RP Kohler, JJ (corresponding author), Emory Univ, Sch Med, Dept Pathol, 7126 Woodruff Mem Bldg,101 Woodruff Circle, Atlanta, GA 30322 USA.
EM jjkohle@emory.edu
RI Johnson, David/F-2897-2011; Lewis, William/O-6571-2014
FU NIH NHLBI [R01 HL059798, HL079867]; NIDDK [K01 DK078513]
FX This work was supported by NIH NHLBI R01 HL059798 and HL079867 ( to WL)
   and NIDDK K01 DK078513 ( to JK).
CR BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Côté HCF, 2003, J INFECT DIS, V187, P1972, DOI 10.1086/375353
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Davies Stella M, 2006, Hematology Am Soc Hematol Educ Program, P111
   ERIKSSON S, 1991, ADV EXP MED BIOL, V309, P239
   Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hoit BD, 2002, GENOMICS, V79, P679, DOI 10.1006/geno.2002.6754
   Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655
   Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914
   Katz Arnold M., 1998, Cardiology Clinics, V16, P633, DOI 10.1016/S0733-8651(05)70040-0
   Kohler JJ, 2008, CARDIOVASC TOXICOL, V8, P57, DOI 10.1007/s12012-008-9015-1
   Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301
   Lewis W, 2000, LAB INVEST, V80, P187, DOI 10.1038/labinvest.3780022
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Lewis W, 2001, LAB INVEST, V81, P1527, DOI 10.1038/labinvest.3780366
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   McLeod CJ, 2005, TRENDS CARDIOVAS MED, V15, P118, DOI 10.1016/j.tcm.2005.05.001
   Moyes CD, 2003, ANNU REV PHYSIOL, V65, P177, DOI 10.1146/annurev.physiol.65.092101.142705
   Nebert DW, 2008, DRUG METAB REV, V40, P187, DOI 10.1080/03602530801952864 
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Thomopoulos S, 2007, J ORTHOP RES, V25, P1154, DOI 10.1002/jor.20418
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wang JH, 2000, BIOCHEM PHARMACOL, V59, P1583, DOI 10.1016/S0006-2952(00)00285-9
NR 28
TC 16
Z9 18
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD FEB
PY 2009
VL 89
IS 2
BP 122
EP 130
DI 10.1038/labinvest.2008.121
PG 9
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA 400KO
UT WOS:000262866700002
PM 19079325
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Viscomi, C
   Spinazzola, A
   Maggioni, M
   Fernandez-Vizarra, E
   Massa, V
   Pagano, C
   Vettor, R
   Mora, M
   Zeviani, M
AF Viscomi, Carlo
   Spinazzola, Antonella
   Maggioni, Marco
   Fernandez-Vizarra, Erika
   Massa, Valeria
   Pagano, Claudio
   Vettor, Roberto
   Mora, Marina
   Zeviani, Massimo
TI Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy
   in <i>Mpv17 knockout</i> mice
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA DEPLETION; MELANOCYTE STEM-CELL; MPV17 GENE;
   INNER-EAR; BASEMENT-MEMBRANE; TRANSGENIC MOUSE; THYMIDINE KINASE;
   INITIATION SITES; COPY NUMBER; MUTATIONS
AB In humans, MPV17 mutations are responsible for severe mitochondrial depletion syndrome, mainly affecting the liver and the nervous system. To gain insight into physiopathology of MPV17-related disease, we investigated an available Mpv17 knockout animal model. We found severe mtDNA depletion in liver and, albeit to a lesser extent, in skeletal muscle, whereas hardly any depletion was detected in brain and kidney, up to 1 year after birth. Mouse embryonic fibroblasts did show mtDNA depletion, but only after several culturing passages, or in a serumless culturing medium. In spite of severe mtDNA depletion, only moderate decrease in respiratory chain enzymatic activities, and mild cytoarchitectural alterations, were observed in the Mpv17(-/-) livers, but neither cirrhosis nor failure ever occurred in this organ at any age. The mtDNA transcription rate was markedly increased in liver, which could contribute to compensate the severe mtDNA depletion. This phenomenon was associated with specific downregulation of Mterf1, a negative modulator of mtDNA transcription. The most relevant clinical features involved skin, inner ear and kidney. The coat of the Mpv17(-/-) mice turned gray early in adulthood, and 18-month or older mice developed focal segmental glomerulosclerosis (FSGS) with massive proteinuria. Concomitant degeneration of cochlear sensory epithelia was reported as well. These symptoms were associated with significantly shorter lifespan. Coincidental with the onset of FSGS, there was hardly any mtDNA left in the glomerular tufts. These results demonstrate that Mpv17 controls mtDNA copy number by a highly tissue- and possibly cytotype-specific mechanism.
C1 [Viscomi, Carlo; Spinazzola, Antonella; Fernandez-Vizarra, Erika; Massa, Valeria; Zeviani, Massimo] IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, I-20126 Milan, Italy.
   [Mora, Marina] IRCCS Fdn Neurol Inst C Besta, Unit Neuromuscular Dis, I-20126 Milan, Italy.
   [Maggioni, Marco] San Paolo Univ Hosp, Serv Pathol, Milan, Italy.
   [Pagano, Claudio; Vettor, Roberto] Univ Padua, Sch Med, Dept Med & Surg Sci, Padua, Italy.
C3 University of Padua
RP Zeviani, M (corresponding author), IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, Via Temolo 4, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
RI Pagano, Claudio/O-1873-2013; viscomi, Carlo/R-1940-2016;
   Fernandez-Vizarra, Erika/AAE-5600-2020; Pane, Marika/K-1818-2017;
   VETTOR, ROBERTO/K-7121-2016; Zeviani, Massimo/K-2891-2014; Mora,
   Marina/J-2883-2018; Maggioni, Marco/AAC-4617-2022; Spinazzola,
   Antonella/P-5298-2017
OI PAGANO, CLAUDIO/0000-0002-4335-8411; Vettor,
   Roberto/0000-0003-0625-6667; Viscomi, Carlo/0000-0001-6050-0566; Mora,
   Marina/0000-0002-5765-2320; Fernandez-Vizarra,
   Erika/0000-0002-2469-142X; Zeviani, Massimo/0000-0002-9067-5508;
   Maggioni, Marco/0000-0001-8603-8998; Spinazzola,
   Antonella/0000-0003-4242-8091
FU Pierfranco and Luisa Mariani Foundation; Telethon-Italy Foundation
   [GGP07019]; Italian Ministry of University and Research [RBLA038RMA];
   Italian Ministry of Health [RF2006 ex 56/05/21]; MITOCIRCLE;
   EUMITOCOMBAT [LSHM-CT-2004-503116]; European Union; Marie Curie
   intra-European fellowship [FP6-2005-Mobility5]
FX This work was supported by the Pierfranco and Luisa Mariani Foundation,
   the Telethon-Italy Foundation grant no GGP07019, the Italian Ministry of
   University and Research (FIRB 2003 - project RBLA038RMA), the Italian
   Ministry of Health (RF2006 ex 56/05/21), MITOCIRCLE and EUMITOCOMBAT
   (LSHM-CT-2004-503116) network grants from the European Union framework
   program 6. E. F.-V. is a Marie Curie intra-European fellowship
   (FP6-2005-Mobility5) number 040140- MAD.
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104
   APPENZELLER O, 1976, ARCH NEUROL-CHICAGO, V33, P733, DOI 10.1001/archneur.1976.00500110001001
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Binder CJ, 1999, AM J PATHOL, V154, P1067, DOI 10.1016/S0002-9440(10)65359-X
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bugiani M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029926
   Clozel M, 1999, EXP GERONTOL, V34, P1007, DOI 10.1016/S0531-5565(99)00074-1
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fernández-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8
   Fernández-Vizarra E, 2008, CURR GENET, V54, P13, DOI 10.1007/s00294-008-0194-x
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005
   Gubler MC, 2008, NAT CLIN PRACT NEPHR, V4, P24, DOI 10.1038/ncpneph0671
   Hagiwara M, 2006, KIDNEY INT, V69, P1146, DOI 10.1038/sj.ki.5000207
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Lalwani AK, 2008, BRAIN RES, V1197, P13, DOI 10.1016/j.brainres.2007.12.058
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Mak SS, 2006, DEV BIOL, V291, P144, DOI 10.1016/j.ydbio.2005.12.025
   Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105
   MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9
   MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   O'Bryan T, 2000, J AM SOC NEPHROL, V11, P1067, DOI 10.1681/ASN.V1161067
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Reuter A, 1998, MOL BIOL CELL, V9, P1675, DOI 10.1091/mbc.9.7.1675
   Rötig A, 2003, J NEPHROL, V16, P286
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   SPINAZZOLA A, 2008, ARCH NEUROL-CHICAGO, V65, P1
   Spinazzola A, 2008, NEUROMUSCULAR DISORD, V18, P315, DOI 10.1016/j.nmd.2007.12.007
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Tobin DJ, 2001, EXP GERONTOL, V36, P29, DOI 10.1016/S0531-5565(00)00210-2
   WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   zum Gottesberge AMM, 2005, HISTOCHEM CELL BIOL, V124, P507, DOI 10.1007/s00418-005-0027-7
   zumGottesberge AMM, 1996, EUR ARCH OTO-RHINO-L, V253, P470, DOI 10.1007/BF00179952
   ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x
NR 58
TC 73
Z9 75
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 1
PY 2009
VL 18
IS 1
BP 12
EP 26
DI 10.1093/hmg/ddn309
PG 15
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 383NM
UT WOS:000261680300002
PM 18818194
OA Green Submitted, Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Vermulst, M
   Bielas, JH
   Loeb, LA
AF Vermulst, Marc
   Bielas, Jason H.
   Loeb, Lawrence A.
TI Quantification of random mutations in the mitochondrial genome
SO METHODS
LA English
DT Article
DE Mitochondria; Mitochondrial DNA; Random mutations; Mutagenesis; qPCR;
   Mutation detection
ID POINT MUTATIONS; DNA DELETIONS
AB Mitochondrial DNA (mtDNA) mutations contribute to the pathology of a number of age-related disorders, including Parkinson disease [A. Bender et aL, Nat. Genet. 38 (2006) 515,Y. Kraytsberg et al., Nat. Genet. 38 (2006) 5181, muscle-wasting [J. Wanagat, Z. Cao, P. Pathare, J.M. Aiken, FASEB J. 15 (2001) 3221, and the metastatic potential of cancers [K. Ishikawa et al., Science 320 (2008) 661]. The impact of mitochondrial DNA mutations on a wide variety of human diseases has made it increasingly important to understand the mechanisms that drive mitochondrial mutagenesis. In order to provide new insight into the etiology and natural history of mtDNA mutations, we have developed an assay that can detect mitochondrial mutations in a variety of tissues and experimental settings [M. Vermulst et al., Nat. Genet. 40 (2008) 4. M. Vermulst et al., Nat. Genet. 39 (2007) 540). This methodology, termed the Random Mutation Capture assay, relies on single-molecule amplification to detect rare mutations among millions of wild-type bases U.H. Bielas, L.A. Loeb, Nat. Methods 2 (2005) 2851, and can be used to analyze mitochondrial mutagenesis to a single base pair level in mammals. Published by Elsevier Inc.
C1 [Vermulst, Marc] CALTECH, Dept Biol, Pasadena, CA 91125 USA.
   [Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.
   [Loeb, Lawrence A.] Univ Washington, Dept Pathol, UW Med Sch, Seattle, WA 98195 USA.
C3 California Institute of Technology; Fred Hutchinson Cancer Center;
   University of Washington; University of Washington Seattle
RP Vermulst, M (corresponding author), CALTECH, Dept Biol, 1200 E Calif Blvd,MC114-96, Pasadena, CA 91125 USA.
EM vermulst@caltech.edu; laloeb@u.washington.edu
FU NCI NIH HHS [R01 CA102029-06, R01 CA102029] Funding Source: Medline; NIA
   NIH HHS [P01 AG001751-270007, P01 AG001751] Funding Source: Medline
CR AUSUBEL FM, 2002, CURRENT PROTOCOLS MO, V1
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751
   Fernández-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8
   Garcia Ana Maria, 2007, Methods Mol Biol, V371, P267
   Hendricks CA, 2003, P NATL ACAD SCI USA, V100, P6325, DOI 10.1073/pnas.1232231100
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497
   MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895
   Parsons BL, 1997, MUTAT RES-REV MUTAT, V387, P97, DOI 10.1016/S1383-5742(97)00026-4
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028
   Yoon YG, 2003, NUCLEIC ACIDS RES, V31, P1407, DOI 10.1093/nar/gkg228
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 20
TC 55
Z9 70
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD DEC
PY 2008
VL 46
IS 4
BP 263
EP 268
DI 10.1016/j.ymeth.2008.10.008
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 383AT
UT WOS:000261647200005
PM 18948200
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Song, SW
   Pursell, ZF
   Copeland, WC
   Longley, MJ
   Kunkel, TA
   Mathews, CK
AF Song, SW
   Pursell, ZF
   Copeland, WC
   Longley, MJ
   Kunkel, TA
   Mathews, CK
TI DNA precursor asymmetries in mammalian tissue mitochondria and possible
   contribution to mutagenesis through reduced replication fidelity
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; BASE EXCISION-REPAIR; RAT
   CARDIAC-MUSCLE; POLYMERASE-GAMMA; POINT MUTATIONS; HUMAN-CELLS; MTDNA;
   IDENTIFICATION; ACCUMULATION; MAINTENANCE
AB The mutation rate of the mammalian mitochondrial genome is higher than that of the nuclear genome. Because mitochondrial and nuclear deoxyribonucleoside triphosphate (dNTP) pools are physically distinct and because dNTP concentrations influence replication fidelity, we asked whether mitochondrial dNTP pools are asymmetric with respect to each other. We report here that the concentrations of the four dNTPs are not equal in mitochondria isolated from several tissues of both young and old rats. In particular, in most tissues examined, mitochondrial dGTP concentrations are high relative to the other dNTPs. Moreover, in the presence of the biased dNTP concentrations measured in heart and skeletal muscle, the fidelity of DNA synthesis in vitro by normally highly accurate mtDNA polymerase gamma is reduced, with error frequencies increased by as much as 3-fold, due to increased formation of template T-dGTP mismatches that are inefficiently corrected by proofreading. These data, plus some published data on specific mitochondrial mutations seen in human diseases, are consistent with the hypothesis that normal intramitochondrial dNTP pool asymmetries may contribute to spontaneous mutagenesis in the mammalian mitochondrial genome.
C1 Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.
   NIEHS, Genet Mol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA.
   NIEHS, Struct Biol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA.
C3 Oregon State University; National Institutes of Health (NIH) - USA; NIH
   National Institute of Environmental Health Sciences (NIEHS); National
   Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Oregon State Univ, Dept Biochem & Biophys, 2011 ALS, Corvallis, OR 97331 USA.
EM mathewsc@onid.orst.edu
RI Copeland, William/C-4242-2019; Kunkel, Thomas/D-5088-2019
OI Copeland, William/0000-0002-0359-0953; Pursell,
   Zachary/0000-0001-5871-7192; Kunkel, Thomas/0000-0002-9900-1788
FU NIEHS NIH HHS [P01 ES000040, ES00040] Funding Source: Medline
CR ANGELASTRO JM, 1992, J BIOL CHEM, V267, P25685
   BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946
   Bebenek K, 1995, METHOD ENZYMOL, V262, P217
   BESTWICK RK, 1982, J BIOL CHEM, V257, P9300
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006
   Dianov GL, 2001, PROG NUCLEIC ACID RE, V68, P285
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   KUNKEL TA, 1988, J BIOL CHEM, V263, P4450
   KUNKEL TA, 1989, BIOCHEMISTRY-US, V28, P988, DOI 10.1021/bi00429a011
   KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X
   Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1
   Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Marcelino LA, 1999, MUTAT RES-DNA REPAIR, V434, P177, DOI 10.1016/S0921-8777(99)00028-2
   Marin-Garcia J, 2001, CARDIOVASC RES, V49, P17, DOI 10.1016/S0008-6363(00)00241-8
   Mason PA, 2003, FEBS LETT, V554, P6, DOI 10.1016/S0014-5793(03)01169-4
   MATHEWS CK, 1992, BIOESSAYS, V14, P295, DOI 10.1002/bies.950140502
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mole ML, 1998, ANAL BIOCHEM, V259, P245, DOI 10.1006/abio.1998.2647
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   PALMER JW, 1977, J BIOL CHEM, V252, P8731
   Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200
   Regnier M, 2000, CIRC RES, V86, P1211, DOI 10.1161/01.RES.86.12.1211
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vinnakota KC, 2004, AM J PHYSIOL-HEART C, V286, pH1742, DOI 10.1152/ajpheart.00478.2003
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   WHIPPS DE, 1984, BIOCHEM J, V221, P147, DOI 10.1042/bj2210147
   WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210
   YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146
NR 45
TC 133
Z9 157
U1 0
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 5
PY 2005
VL 102
IS 14
BP 4990
EP 4995
DI 10.1073/pnas.0500253102
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 914AC
UT WOS:000228195800015
PM 15784738
OA Green Published
DA 2024-11-01
ER

PT J
AU Lundquist, AA
   Farholt, S
   Borresen, ML
   Duno, M
   Wibrand, F
   Witting, N
   Ostergaard, E
AF Lundquist, Alberte A.
   Farholt, Stense
   Borresen, Malene L.
   Duno, Morten
   Wibrand, Flemming
   Witting, Nanna
   Ostergaard, Elsebet
TI A novel homoplasmic mt-tRNA<SUP>Glu</SUP> m.14701C&gt;T variant
   presenting with a partially reversible infantile respiratory chain
   deficiency
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE Homoplasmy; Mitochondrial disorders; RIRCD; MT-TE; Mt-tRNA(Glu)
ID MITOCHONDRIAL MYOPATHY; MUTATION; LIPOMAS; DISEASE; MTDNA
AB Background: Reversible infantile respiratory chain deficiency (RIRCD) is a rare mitochondrial disorder associated with variable penetrance and partial to full remission of symptoms. Objective: To describe features of maternally related individuals with a novel variant associated with RIRCD. Materials and methods: Nine maternally related individuals aged 23 months to 64 years are described through physical examinations, muscle biopsies, histochemical and biochemical analyses, genome sequencing, and cerebral imaging. Results: A homoplasmic mitochondrial transfer ribonucleic acid for glutamic acid (mt-tRNAGlu) m.14701C>T variant was identified in eight tested individuals out of nine maternally related individuals. Two individuals presented with hypotonia, muscle weakness, feeding difficulties and lactic acidosis at age 3-4 months, and improvement around age 15-23 months with mild residual symptoms at last examination. One individual with less severe symptoms had unknown age at onset and improved around age 4-5 years. Five individuals developed lipoma on the upper back, and one adult individual developed ataxia, while one was unaffected. Conclusions: We have identified a novel homoplasmic mt-tRNAGlu m.14701C>T variant presenting with phenotypic and paraclinical features associated with RIRCD as well as ataxia and lipomas, which to our knowledge are new features associated to RIRCD.
C1 [Lundquist, Alberte A.; Duno, Morten; Wibrand, Flemming; Ostergaard, Elsebet] Copenhagen Univ Hosp, Dept Clin Genet, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
   [Farholt, Stense; Borresen, Malene L.] Copenhagen Univ Hosp, Ctr Rare Dis Pediat & Adolescent Med, Rigshosp, Copenhagen, Denmark.
   [Farholt, Stense] Aarhus Univ Hosp, Ctr Rare Dis Pediat & Adolescent Med, Aarhus, Denmark.
   [Witting, Nanna] Copenhagen Univ Hosp, Copenhagen Neuromuscular Ctr, Dept Neurol, Rigshosp, Copenhagen, Denmark.
C3 University of Copenhagen; Rigshospitalet; Rigshospitalet; University of
   Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen
RP Ostergaard, E (corresponding author), Copenhagen Univ Hosp, Dept Clin Genet, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM Elsebet.ostergaard.01@regionh.dk
RI Østergaard, Elsebet/IZE-6519-2023
OI Witting, Nanna/0000-0002-0664-0709; Ostergaard,
   Elsebet/0000-0002-8047-063X; Lundquist, Alberte/0000-0002-8574-9824
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209
   Garrison E., 2012, ARXIV12073907
   Guerrero J.C., 2019, 1093526619860362 PED, DOI [10.1177/1093526619860362, DOI 10.1177/1093526619860362]
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   HOLME E, 1993, AM J HUM GENET, V52, P551
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Jeppesen TD, 2017, CLIN CASE REP, V5, P2034, DOI 10.1002/ccr3.1096
   Lax NZ, 2013, J NEUROPATH EXP NEUR, V72, P164, DOI 10.1097/NEN.0b013e31828129c5
   Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111
   SALO MK, 1992, ARCH DIS CHILD, V67, P1033, DOI 10.1136/adc.67.8.1033
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300
   Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995
   Wada H, 1996, BRAIN DEV-JPN, V18, P263, DOI 10.1016/0387-7604(96)00017-4
   Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1769-7212
EI 1878-0849
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD OCT
PY 2021
VL 64
IS 10
AR 104306
DI 10.1016/j.ejmg.2021.104306
EA AUG 2021
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA UQ8NU
UT WOS:000696316400003
PM 34400372
DA 2024-11-01
ER

PT J
AU Shin, HJ
   Na, JH
   Lee, YM
AF Shin, Hui Jin
   Na, Ji-Hoon
   Lee, Young-Mock
TI A case of exacerbated encephalopathy with stroke-like episodes and
   lactic acidosis triggered by metformin in a patient with MELAS
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE MELAS syndrome; DNA, Mitochondrial; Metformin; Seizures; Point mutation
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a maternally inherited multisystemic disorder caused by mutations in mitochondrial DNA that result in cellular energy deficiency. MELAS affects the most metabolically active organs, including the brain, skeletal muscles, cochlea, retina, heart, kidneys, and pancreas. As a result, about 85% of carriers of m.3243A > G, the most common mutation in MELAS, develop diabetes by the age of 70. Although metformin is the most widely prescribed drug for diabetes, its usefulness in mitochondrial dysfunction remains controversial. Here, we present the case of a 32-year-old Korean patient diagnosed with MELAS who presented with exacerbated stroke-like episodes and lactic acidosis triggered by metformin.
C1 [Shin, Hui Jin; Na, Ji-Hoon; Lee, Young-Mock] Yonsei Univ, Gangnam Severance Hosp, Dept Pediat, Coll Med, 211 Eonju Ro, Seoul 06273, South Korea.
C3 Yonsei University; Yonsei University Health System
RP Na, JH (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Pediat, Coll Med, 211 Eonju Ro, Seoul 06273, South Korea.
EM jhnamd83@yuhs.ac
RI Lee, Jun Young/CAI-2335-2022
OI Na, Ji-Hoon/0000-0002-3051-2010; Shin, Hui Jin/0000-0002-1541-2564
CR Chen Wan-Ting, 2019, Acta Neurol Taiwan, V28(2), P46
   Crowley MJ., 2016, Metformin Use in Patients with Historical Contraindications or Precautions
   Fontaine E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00753
   Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000
   Kim NH, 2021, ANN INTERN MED, V174, P124, DOI 10.7326/L20-0292
   Lin WH, 2022, FRONT NEUROL, V13, DOI 10.3389/fneur.2022.863047
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Murakami K, 2023, J STROKE CEREBROVASC, V32, DOI 10.1016/j.jstrokecerebrovasdis.2023.107080
   Tong HF, 2022, J DIABETES COMPLICAT, V36, DOI 10.1016/j.jdiacomp.2021.108111
NR 10
TC 2
Z9 2
U1 1
U2 1
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD MAY
PY 2024
VL 45
IS 5
BP 2337
EP 2339
DI 10.1007/s10072-024-07343-9
EA JAN 2024
PG 3
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA PX0S3
UT WOS:001148986200003
PM 38265537
DA 2024-11-01
ER

PT J
AU Frederiksen, AL
   Andersen, PH
   Kyvik, KO
   Jeppesen, TD
   Vissing, J
   Schwartz, M
AF Frederiksen, A. L.
   Andersen, P. H.
   Kyvik, K. O.
   Jeppesen, T. D.
   Vissing, J.
   Schwartz, M.
TI Tissue specific distribution of the 3243A→G mtDNA mutation
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA MUTATIONS; A3243G MUTATION; HUMAN OOCYTES;
   PRENATAL-DIAGNOSIS; GENETIC BOTTLENECK; MUTANT MTDNA; HETEROPLASMY;
   SEGREGATION; DISEASE; TRNA(LEU(UUR))
AB Background: The 3243A -> RG is a common pathogenic mitochondrial DNA (mtDNA) point mutation causing a variety of different phenotypes. Segregation of this mutation to different tissues during embryonic life and postnatally is still enigmatic.
   Objective: To investigate the tissue distribution of this mutation.
   Methods: In 65 individuals from nine families segregating the 3243A -> G mutation, the mutation load (% mutated mtDNA) was determined in various tissues. Mutation load was measured in two to four cell types-blood leucocytes, buccal cells, skeletal muscle cells, and urine epithelial cells (UEC)-derived from all three embryogenic germ layers.
   Results: There was a significant correlation among mutation loads in the four tissues (r = 0.80-0.89, p < 0.0001). With blood serving as reference, the mutation load was increased by 16% in buccal mucosa, by 31% in UEC, and by 37% in muscle. There were significant differences between the mitotic tissues blood, buccal mucosa, and UEC (p < 0.0001), but no difference between UEC and muscle. Using the present data as a cross sectional investigation, a negative correlation of age with the mutation load was found in blood, while the mutation load in muscle did not change with time; 75% of the children presented with higher mutation loads than their mothers in mitotic tissues but not in the post-mitotic muscle.
   Conclusions: There appears to be a uniform distribution of mutant mtDNA throughout the three germ layers in embryogenesis. The significant differences between mutation loads of the individual tissue types indicate tissue specific segregation of the 3243A -> G mtDNA later in embryogenesis.
C1 Ribe Cty Hosp, Dept Endocrinol, Esbjerg, Denmark.
   Univ So Denmark, Inst Publ Hlth, Odense, Denmark.
   Univ Copenhagen, Rigshosp, Neuromust Res Unit, Dept Neurol, DK-1123 Copenhagen, Denmark.
   Univ Copenhagen, Rigshosp, Copenhagen Muscle Res Ctr, DK-1123 Copenhagen, Denmark.
   Univ Hosp, Rigshosp, Dept Clin Genet, Copenhagen, Denmark.
C3 University of Southern Denmark; University of Copenhagen;
   Rigshospitalet; Rigshospitalet; University of Copenhagen; University of
   Copenhagen; Rigshospitalet
RP Schwartz, M (corresponding author), Ribe Cty Hosp, Dept Endocrinol, Esbjerg, Denmark.
EM schwartz@rh.hosp.dk
RI Vissing, John/IUN-4271-2023; Frederiksen, Anja/AAF-1983-2019; Jeppesen,
   Tina/AAV-7195-2020; Kyvik, Kirsten Ohm/K-5680-2016
OI Frederiksen, Anja Lisbeth/0000-0002-7944-8910; Kyvik, Kirsten
   Ohm/0000-0003-2981-0245
CR Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Cardaioli E, 2000, J NEUROL, V247, P885, DOI 10.1007/s004150070080
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   CRIMMINS D, 1993, J NEUROL NEUROSUR PS, V56, P900, DOI 10.1136/jnnp.56.8.900
   Dean NL, 2003, MOL HUM REPROD, V9, P631, DOI 10.1093/molehr/gag077
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HART LT, 1996, HUM MUTAT, V7, P193
   Jansen R P, 2000, Hum Reprod, V15 Suppl 2, P112
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   LESTIENNE P, 1988, LANCET, V1, P885
   Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009
   Marchington DR, 1997, AM J HUM GENET, V60, P408
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Poulton J, 2002, REPRODUCTION, V123, P751, DOI 10.1530/rep.0.1230751
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Steinborn R, 2000, NAT GENET, V25, P255, DOI 10.1038/77000
   Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
NR 31
TC 74
Z9 79
U1 0
U2 4
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
J9 J MED GENET
JI J. Med. Genet.
PD AUG
PY 2006
VL 43
IS 8
AR 671
DI 10.1136/jmg.2005.039339
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 069FZ
UT WOS:000239433100007
PM 16490799
OA Green Published
DA 2024-11-01
ER

PT J
AU Kim, MJ
   Haroon, S
   Chen, GD
   Ding, DL
   Wanagat, J
   Liu, LJ
   Zhang, YP
   White, K
   Park, HJ
   Han, C
   Boyd, K
   Caicedo, I
   Evans, K
   Linser, PJ
   Tanokura, M
   Prolla, T
   Salvi, R
   Vermulst, M
   Someya, S
AF Kim, Mi-Jung
   Haroon, Suraiya
   Chen, Guang-Di
   Ding, Dalian
   Wanagat, Jonathan
   Liu, Lijie
   Zhang, Yanping
   White, Karessa
   Park, Hyo-Jin
   Han, Chul
   Boyd, Kevin
   Caicedo, Isabela
   Evans, Kaitlyn
   Linser, Paul J.
   Tanokura, Masaru
   Prolla, Tomas
   Salvi, Richard
   Vermulst, Marc
   Someya, Shinichi
TI Increased burden of mitochondrial DNA deletions and point mutations in
   early-onset age-related hearing loss in mitochondrial mutator mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Mitochondrial DNA mutations; Mitochondrial disease; Hearing loss; Aging
ID HAIR CELL LOSS; SKELETAL-MUSCLE; MTDNA MUTATIONS; COPY NUMBER;
   PRESBYCUSIS; DEFICIENCY; BRAIN; INNER; ABNORMALITIES; ACCUMULATION
AB Mitochondrial DNA (mtDNA) mutations are thought to have a causal role in a variety of age-related neurode-generative diseases, including age-related hearing loss (AHL). In the current study, we investigated the roles of mtDNA deletions and point mutations in AHL in mitochondrial mutator mice (Polg(mut/mut)) that were backcrossed onto CBA/CaJ mice, a well-established model of late-onset AHL. mtDNA deletions accumulated significantly with age in the inner ears of Polg(mut/mut) mice, while there were no differences in mtDNA deletion frequencies in the inner ears between 5 and 17 months old Polg(+/+)( )mice or 5 months old Polg(+/+) and Polg(mut/mut) mice. mtDNA deletions also accumulated significantly in the inner ears of CBA/CaJ mice during normal aging. In contrast, 5 months old Polg(mut/mut) mice displayed a 238-fold increase in mtDNA point mutation frequencies in the inner ears compared to age-matched Pole(+/+) mice, but there were no differences in mtDNA point mutation frequencies in the inner ears between 5 and 17 months old Polg(mut/mut )mice. Seventeen-month-old Polg(mut/mut) mice also displayed early-onset severe hearing loss associated with a significant reduction in neural output of the cochlea, while age-matched Polg(+/+) mice displayed little or no hearing impairment. Consistent with the physiological and mtDNA deletion test result, 17-month-old Polg(mut/mut) mice displayed a profound loss of spiral ganglion neurons in the cochlea. Thus, our data suggest that a higher burden of mtDNA point mutations from a young age and age-related accumulation of mtDNA deletions likely contribute to early-onset AHL in mitochondrial mutator mice.
C1 [Kim, Mi-Jung; White, Karessa; Park, Hyo-Jin; Han, Chul; Boyd, Kevin; Caicedo, Isabela; Evans, Kaitlyn; Someya, Shinichi] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32610 USA.
   [Haroon, Suraiya; Vermulst, Marc] Univ Penn, Ctr Mitochondria & Epigen Med, Philadelphia, PA 19104 USA.
   [Chen, Guang-Di; Ding, Dalian; Liu, Lijie; Salvi, Richard] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY USA.
   [Wanagat, Jonathan] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.
   [Zhang, Yanping] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gene Express & Genotyping, Gainesville, FL 32610 USA.
   [Linser, Paul J.] Univ Florida, Whitney Lab, 9505 Ocean Shore Blvd, St Augustine, FL 32086 USA.
   [Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan.
   [Prolla, Tomas] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.
   [Salvi, Richard] Asia Univ, Dept Audiol & Speech Language Pathol, Taichung, Taiwan.
C3 State University System of Florida; University of Florida; University of
   Pennsylvania; State University of New York (SUNY) System; University at
   Buffalo, SUNY; University of California System; University of California
   Los Angeles; State University System of Florida; University of Florida;
   State University System of Florida; University of Florida; University of
   Tokyo; University of Wisconsin System; University of Wisconsin Madison;
   Asia University Taiwan
RP Someya, S (corresponding author), Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32610 USA.
EM someya@ufl.edu
RI Wanagat, Jonathan/B-2856-2009; Zhang, Yanping/GNP-7511-2022
OI White, Karessa/0000-0003-3967-4486; Someya,
   Shinichi/0000-0001-9895-6227; Zhang, Yanping/0000-0002-1680-7592;
   Tanokura, Masaru/0000-0001-5072-2480
FU National Institutes of Health [R03 DC011840, R01 DC012552, R01
   DC014437]; National Institute on Deafness and Communication Disorders
   [R03 DC011840, R01 DC012552, R01 DC014437]; Claude D. Pepper Older
   Americans Independence Centers at the University of Florida from the
   National Institute of Health [P30 AG028740]; Claude D. Pepper Older
   Americans Independence Centers at the University of Florida from the
   National Institute on Aging; Japan Society for the Promotion of Science
   (JSPS) [26253081, 23228003]; Glenn Foundation for Medical Research;
   National Institute on Aging [AG032873, AG055518]; UCLA Older Americans
   Independence Center [P30 AG028748]; Ellison Medical Foundation New
   Scholar Award; UCSD/UCLA Diabetes Research Center Pilot and Feasibility
   Grant [DK063491]; Grants-in-Aid for Scientific Research [26253081]
   Funding Source: KAKEN
FX This research was supported by R03 DC011840 (SS), R01 DC012552 SS) and
   R01 DC014437 (SS) from the National Institutes of Health and National
   Institute on Deafness and Communication Disorders, the Claude D. Pepper
   Older Americans Independence Centers at the University of Florida (P30
   AG028740) from the National Institute of Health and National Institute
   on Aging, the Japan Society for the Promotion of Science (JSPS)
   Grant-in-Aid for Scientific Research (A) (Grant number, 26253081) and
   for Scientific Research (S) (Grant number, 23228003), and the Glenn
   Foundation for Medical Research (JW), National Institute on Aging Grants
   AG032873, AG055518 (JW), UCLA Older Americans Independence Center P30
   AG028748 (JW), Ellison Medical Foundation New Scholar Award (JW),
   UCSD/UCLA Diabetes Research Center Pilot and Feasibility Grant DK063491
   (JW).
CR Bai U, 1997, AM J OTOL, V18, P449
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Chen GD, 2014, HEARING RES, V317, P1, DOI 10.1016/j.heares.2014.08.004
   Chen GD, 2013, HEARING RES, V295, P100, DOI 10.1016/j.heares.2012.11.016
   Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Ding D, 1999, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V13, P510
   Ding DL, 2016, AGING-US, V8, P730, DOI 10.18632/aging.100927
   Ding DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079817
   Durrant JD, 1998, J ACOUST SOC AM, V104, P370, DOI 10.1121/1.423293
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Falah M, 2016, THER CLIN RISK MANAG, V12, P1573, DOI 10.2147/TCRM.S117491
   FischelGhodsian N, 1997, HEARING RES, V110, P147, DOI 10.1016/S0378-5955(97)00077-4
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Han C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180817
   Han C, 2013, MOL CELL NEUROSCI, V55, P95, DOI 10.1016/j.mcn.2012.07.004
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Jiang C, 2017, HEARING RES, V347, P28, DOI 10.1016/j.heares.2016.10.021
   Johnson KR, 2006, BRAIN RES, V1091, P79, DOI 10.1016/j.brainres.2006.02.021
   Kane KL, 2012, HEARING RES, V283, P80, DOI 10.1016/j.heares.2011.11.007
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Li-Harms X, 2015, BLOOD, V125, P162, DOI 10.1182/blood-2014-07-586396
   Markaryan A, 2008, MUTAT RES-FUND MOL M, V640, P38, DOI 10.1016/j.mrfmmm.2007.12.007
   Markaryan A, 2010, ACTA OTO-LARYNGOL, V130, P780, DOI 10.3109/00016480903397702
   Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McKiernan SH, 2007, AM J PHYSIOL-RENAL, V292, pF1751, DOI 10.1152/ajprenal.00307.2006
   Müller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011
   Nikoletopoulou V, 2018, TRENDS CELL BIOL, V28, P646, DOI 10.1016/j.tcb.2018.03.006
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226
   Ohlemiller KK, 2010, JARO-J ASSOC RES OTO, V11, P605, DOI 10.1007/s10162-010-0228-1
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Salvi R, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00621
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   Seidman MD, 1996, LARYNGOSCOPE, V106, P777, DOI 10.1097/00005537-199606000-00021
   Sheppard AM, 2017, NEUROSCIENCE, V359, P159, DOI 10.1016/j.neuroscience.2017.07.005
   Sheppard AM, 2015, HEARING RES, V327, P1, DOI 10.1016/j.heares.2015.04.007
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Someya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171159
   Spongr VP, 1997, J ACOUST SOC AM, V101, P3546, DOI 10.1121/1.418315
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang J, 1997, HEARING RES, V107, P67, DOI 10.1016/S0378-5955(97)00020-8
   White K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23436-w
   White K, 2017, J NEUROSCI, V37, P5770, DOI 10.1523/JNEUROSCI.0519-17.2017
   Xing GQ, 2007, CELL RES, V17, P227, DOI 10.1038/sj.cr.7310124
   Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021
   Yin S, 2007, NEUROBIOL DIS, V27, P370, DOI 10.1016/j.nbd.2007.06.006
   Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107
NR 63
TC 15
Z9 17
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT 1
PY 2019
VL 125
AR 110675
DI 10.1016/j.exger.2019.110675
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA IV1FD
UT WOS:000484021800012
PM 31344454
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Newell, C
   Khan, A
   Sinasac, D
   Shoffner, J
   Friederich, MW
   Van Hove, JLK
   Hume, S
   Shearer, J
   Sosova, I
AF Newell, Christopher
   Khan, Aneal
   Sinasac, David
   Shoffner, John
   Friederich, Marisa W.
   Van Hove, Johan L. K.
   Hume, Stacey
   Shearer, Jane
   Sosova, Iveta
TI Hybrid gel electrophoresis using skin fibroblasts to aid in diagnosing
   mitochondrial disease
SO NEUROLOGY-GENETICS
LA English
DT Article
ID BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES;
   OXIDATIVE-PHOSPHORYLATION; MUTATIONS; SUBCOMPLEXES; DISORDERS; PATHOLOGY
AB Objective We developed a novel, hybrid method combining both blue-native (BN-PAGE) and clear-native (CN-PAGE) polyacrylamide gel electrophoresis, termed BCN-PAGE, to perform in-gel activity stains on the mitochondrial electron transport chain (ETC) complexes in skin fibroblasts. Methods Four patients aged 46-65 years were seen in the Metabolic Clinic at Alberta Children's Hospital and investigated for mitochondrial disease and had BN-PAGE or CN-PAGE on skeletal muscle that showed incomplete assembly of complex V (CV) in each patient. Long-range PCR performed on muscle-extracted DNA identified 4 unique mitochondrial DNA (mtDNA) deletions spanning the ATP6 gene of CV. We developed a BCN-PAGE method in skin fibroblasts taken from the patients at the same time and compared the findings with those in skeletal muscle. Results In all 4 cases, BCN-PAGE in skin fibroblasts confirmed the abnormal CV activity found from muscle biopsy, suggesting that the mtDNA deletions involving ATP6 were most likely germline mutations that are associated with a clinical phenotype of mitochondrial disease. Conclusions The BCN-PAGE method in skin fibroblasts has a potential to be a less-invasive tool compared with muscle biopsy to screen patients for abnormalities in CV and other mitochondrial ETC complexes.
C1 [Newell, Christopher; Khan, Aneal; Sinasac, David; Shoffner, John] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp Res Inst, Dept Med Genet, Calgary, AB, Canada.
   [Khan, Aneal] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada.
   [Friederich, Marisa W.; Van Hove, Johan L. K.] Univ Colorado, Sect Clin Genet & Metab, Dept Pediat, Boulder, CO 80309 USA.
   [Hume, Stacey] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
   [Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.
   [Sosova, Iveta] Univ Alberta, Dept Lab Med, Edmonton, AB, Canada.
   [Sosova, Iveta] Univ Alberta, Dept Pathol, Edmonton, AB, Canada.
C3 University of Calgary; University of Calgary; University of Colorado
   System; University of Colorado Boulder; University of Alberta;
   University of Calgary; University of Alberta; University of Alberta
RP Khan, A (corresponding author), Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp Res Inst, Dept Med Genet, Calgary, AB, Canada.
EM khaa@ucalgary.ca
OI Sinasac, David/0000-0002-3749-5989; Hume, Stacey/0000-0002-3217-3032
FU Alberta Children's Hospital Research Foundation (ACHRF); MitoCanada;
   Alberta Innovates-Health Solutions MD/PhD Studentship; Alberta
   Children's Hospital Research Institute (ACHRI) Clinical Research
   Fellowship
FX This study was supported by Alberta Children's Hospital Research
   Foundation (ACHRF) and MitoCanada (A. Khan). This research was supported
   by PhD funding to C. Newell from MitoCanada and Alberta Innovates-Health
   Solutions MD/PhD Studentship. IS was a recipient of Alberta Children's
   Hospital Research Institute (ACHRI) Clinical Research Fellowship.
CR Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   CEUTERICK C, 1984, J NEUROL SCI, V65, P179, DOI 10.1016/0022-510X(84)90082-0
   Chatfield KC, 2015, MITOCHONDRION, V21, P1, DOI 10.1016/j.mito.2014.12.005
   Chretien D, 2003, J INHERIT METAB DIS, V26, P189, DOI 10.1023/A:1024437201166
   Coughlin CR, 2015, J MED GENET, V52, P532, DOI 10.1136/jmedgenet-2015-103049
   da Cunha ES, 2011, ANAL BIOCHEM, V418, P158, DOI 10.1016/j.ab.2011.06.044
   Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183
   Diaz Francisca, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1904s63
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Dimmock DP, 2017, PEDIATR CLIN N AM, V64, P161, DOI 10.1016/j.pcl.2016.08.011
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Fiala GJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2164
   Friederich M.W., 2016, HUM MOL GENET, V26
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Kramer KA, 2005, CLIN CHEM, V51, P2110, DOI 10.1373/clinchem.2005.050146
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022
   Newell C, 2018, MOL GENET METAB, V125, P332, DOI 10.1016/j.ymgme.2018.10.002
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Roels F, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-4
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Shoffner JM, 2000, NEUROL CLIN, V18, P105, DOI 10.1016/S0733-8619(05)70180-8
   Shukolyukov S.A., 2011, Cell tissue biol, V5, P311, DOI DOI 10.1134/S1990519X11030126
   Smet J, 2011, J INHERIT METAB DIS, V34, P741, DOI 10.1007/s10545-011-9315-7
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Baquedano MS, 2013, J CLIN ENDOCR METAB, V98, pE153, DOI 10.1210/jc.2012-2865
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Stephenson EJ, 2014, BBA-GEN SUBJECTS, V1840, P1285, DOI 10.1016/j.bbagen.2013.12.004
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Tucci A, 2014, J NEUROL NEUROSUR PS, V85, P486, DOI 10.1136/jnnp-2013-306387
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Vangipuram M, J VIS EXP, pe3779
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Williams SL, 2001, LAB INVEST, V81, P1069, DOI 10.1038/labinvest.3780319
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
NR 45
TC 5
Z9 6
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
J9 NEUROL-GENET
JI Neurol.-Genet.
PD JUN
PY 2019
VL 5
IS 3
AR e336
DI 10.1212/NXG.0000000000000336
PG 8
WC Genetics & Heredity; Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Neurosciences & Neurology
GA IR8BW
UT WOS:000481667200012
PM 31192304
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Hidalgo-Gutierrez, A
   Shintaku, J
   Ramon, J
   Barriocanal-Casado, E
   Pesini, A
   Saneto, RP
   Garrabou, G
   Milisenda, JC
   Matas-Garcia, A
   Gort, L
   Ugarteburu, O
   Gu, Y
   Koganti, L
   Wang, T
   Tadesse, S
   Meneri, M
   Sciacco, M
   Wang, S
   Tanji, K
   Horwitz, MS
   Dorschner, MO
   Mansukhani, M
   Comi, GP
   Ronchi, D
   Marti, R
   Ribes, A
   Tort, F
   Hirano, M
AF Hidalgo-Gutierrez, Agustin
   Shintaku, Jonathan
   Ramon, Javier
   Barriocanal-Casado, Eliana
   Pesini, Alba
   Saneto, Russell P.
   Garrabou, Gloria
   Milisenda, Jose Cesar
   Matas-Garcia, Ana
   Gort, Laura
   Ugarteburu, Olatz
   Gu, Yue
   Koganti, Lahari
   Wang, Tian
   Tadesse, Saba
   Meneri, Megi
   Sciacco, Monica
   Wang, Shuang
   Tanji, Kurenai
   Horwitz, Marshall S.
   Dorschner, Michael O.
   Mansukhani, Mahesh
   Comi, Giacomo Pietro
   Ronchi, Dario
   Marti, Ramon
   Ribes, Antonia
   Tort, Frederic
   Hirano, Michio
TI Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable
   Mitochondrial DNA Depletion/Deletions Disease
SO ANNALS OF NEUROLOGY
LA English
DT Article; Early Access
ID THYMIDINE KINASE; DEPLETION; PURINE; SUPPLEMENTATION; MONOPHOSPHATE;
   PHARMACOLOGY; FORODESINE
AB Objective: Mitochondrial DNA (mtDNA) depletion/deletions syndrome (MDDS) comprises a group of diseases caused by primary autosomal defects of mtDNA maintenance. Our objective was to study the etiology of MDDS in 4 patients who lack pathogenic variants in known genetic causes. Methods: Whole exome sequencing of the probands was performed to identify pathogenic variants. We validated the mitochondrial defect by analyzing mtDNA, mitochondrial dNTP pools, respiratory chain activities, and GUK1 activity. To confirm pathogenicity of GUK1 deficiency, we expressed 2 GUK1 isoforms in patient cells. Results: We identified biallelic GUK1 pathogenic variants in all 4 probands who presented with ptosis, ophthalmoparesis, and myopathic proximal limb weakness, as well as variable hepatopathy and altered T-lymphocyte profiles. Muscle biopsies from all probands showed mtDNA depletion, deletions, or both, as well as reduced activities of mitochondrial respiratory chain enzymes. GUK1 encodes guanylate kinase, originally identified as a cytosolic enzyme. Long and short isoforms of GUK1 exist. We observed that the long isoform is intramitochondrial and the short is cytosolic. In probands' fibroblasts, we noted decreased GUK1 activity causing unbalanced mitochondrial dNTP pools and mtDNA depletion in both replicating and quiescent fibroblasts indicating that GUK1 deficiency impairs de novo and salvage nucleotide pathways. Proband fibroblasts treated with deoxyguanosine and/or forodesine, a purine phosphatase inhibitor, ameliorated mtDNA depletion, indicating potential pharmacological therapies. Interpretation: Primary GUK1 deficiency is a new and potentially treatable cause of MDDS. The cytosolic isoform of GUK1 may contribute to the T-lymphocyte abnormality, which has not been observed in other MDDS disorders. ANN NEUROL 2024
C1 [Hidalgo-Gutierrez, Agustin; Shintaku, Jonathan; Barriocanal-Casado, Eliana; Pesini, Alba; Tadesse, Saba; Hirano, Michio] Columbia Univ, Irving Med Ctr, Dept Neurol, New York, NY USA.
   [Ramon, Javier; Garrabou, Gloria; Milisenda, Jose Cesar; Matas-Garcia, Ana; Gort, Laura; Ugarteburu, Olatz; Marti, Ramon; Ribes, Antonia; Tort, Frederic] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
   [Ramon, Javier; Marti, Ramon] Autonomous Univ Barcelona, Vall dHebron Res Inst, Barcelona, Spain.
   [Saneto, Russell P.] Seattle Childrens Hosp, Seattle, WA USA.
   [Garrabou, Gloria; Milisenda, Jose Cesar; Matas-Garcia, Ana] Univ Barcelona UB, Fac Med & Hlth Sci, Inherited Metab Dis & Muscle Disorders Lab, Cellex IDIBAPS, Barcelona, Spain.
   [Milisenda, Jose Cesar; Matas-Garcia, Ana] Hosp Clin Barcelona, Dept Internal Med, Barcelona, Spain.
   [Gort, Laura; Ugarteburu, Olatz; Ribes, Antonia; Tort, Frederic] Hosp Clin Barcelona, IDIBAPS, Dept Biochem & Mol Genet, Sect Inborn Errors Metab IBC, Barcelona, Spain.
   [Gu, Yue; Koganti, Lahari; Tanji, Kurenai; Mansukhani, Mahesh] Columbia Univ, Irving Med Ctr, Dept Pathol & Cell Biol, New York, NY USA.
   [Wang, Tian; Wang, Shuang] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA.
   [Meneri, Megi; Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Meneri, Megi; Comi, Giacomo Pietro; Ronchi, Dario] IRCCS Fdn CaGranda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Sciacco, Monica] IRCCS Fdn CaGranda Osped Maggiore Policlin, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Horwitz, Marshall S.; Dorschner, Michael O.] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA.
C3 Columbia University; NewYork-Presbyterian Hospital; Instituto de Salud
   Carlos III; University of Barcelona; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERER; Autonomous University of Barcelona; Hospital
   Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR);
   Seattle Children's Hospital; University of Barcelona; Hospital Clinic de
   Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de
   Barcelona; University of Barcelona; Hospital Clinic de Barcelona;
   IDIBAPS; NewYork-Presbyterian Hospital; Columbia University; Columbia
   University; University of Milan; IRCCS Ca Granda Ospedale Maggiore
   Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University
   of Washington; University of Washington Seattle
RP Hirano, M (corresponding author), Columbia Univ, Irving Med Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
EM ah3591@cumc.columbia.edu; jonathan.shintaku@gmail.com;
   javier.ramon@vhir.org; eb3471@cumc.columbia.edu;
   ap4072@cumc.columbia.edu; russ.saneto@seattlechildrens.org;
   GARRABOU@clinic.cat; JCMILISE@clinic.cat; ANMATAS@clinic.cat;
   lgort@clinic.cat; ougarteburu@gmail.com; yg2537@cumc.columbia.edu;
   lk2776@cumc.columbia.edu; tw2697@cumc.columbia.edu;
   st300@cumc.columbia.edu; megimeneri@gmail.com;
   monica.sciacco@policlinico.mi.it; sw2206@cumc.columbia.edu;
   kt8@cumc.columbia.edu; horwitz@uw.edu; mod@uw.edu;
   mm322@cumc.columbia.edu; giacomo.comi@unimi.it; dario.ronchi@gmail.com;
   ramon.marti@vhir.org; ARIBES@clinic.cat; FTORT@recerca.clinic.cat;
   mh29@columbia.edu
RI Ronchi, Dario/K-8011-2016; Casado, Eliana/Y-4121-2019; Gutierrez,
   Agustin/X-5891-2018; Barriocanal-Casado, Eliana/X-5993-2018
OI Milisenda, Jose Cesar/0000-0003-0151-7872; Ramon,
   Javier/0000-0002-0673-9338; Saneto, Russell/0000-0002-7250-2347;
   Barriocanal-Casado, Eliana/0000-0001-8828-1182; Shintaku,
   Jonathan/0000-0003-2729-9009; Hidalgo Gutierrez,
   Agustin/0000-0001-6414-6859; Gort Mas, Laura/0000-0003-4746-1034
FU Department of Defense Focused Program [W81XWH2010807]; Marie S. Curie
   Global Fellowship within the European Union research and innovation
   framework programme Horizon Europe; Shuman Mitochondrial Disease Fund;
   Geof Barker; NIH [U54 NS078059, P01 HD32062]; Marriott Mitochondrial
   Disease Clinic Research Fund from the J. Willard and Alice S. Marriott
   Foundation; Arturo Estopinan TK2 Research Fund; Nicholas Nunno
   Foundation; JDM Fund for Mitochondrial Research; Fundacion Alfonso
   Martin Escudero; Spanish Instituto de Salud Carlos III [PI21/00554];
   Catalan Fundacio La Marato de TV3 [202020]; European Union; Centro de
   Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Agencia
   de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [SGR 1428, SGR
   01423]; CERCA Programme/Generalitat de Catalunya; PNC "Hub Life Science
   - Diagnostica Avanzata" [PNC-E3-2022-23683266]; SEQMD project (IRCCS Ca
   Granda Ospedale Maggiore Policlinico); Italian Ministry of Education and
   Research (MUR) "Dipartimenti di Eccellenza Program 2023-2027" -
   Department of Pathophysiology and Transplantation, University of Milan;
   Associazione Centro Dino Ferrari; Italian Ministry of Health - Current
   research IRCCS Ca' Granda Ospedale Maggiore Policlinico;  [PI19/01310]; 
   [PI22/00856];  [ER20P2AC737]; U.S. Department of Defense (DOD)
   [W81XWH2010807] Funding Source: U.S. Department of Defense (DOD)
FX This work was supported by the Department of Defense Focused Program
   Award W81XWH2010807 (to M.H.), a Marie S. Curie Global Fellowship within
   the European Union research and innovation framework programme Horizon
   Europe (to A.H.G.), Shuman Mitochondrial Disease Fund (to M.H.), Geof
   Barker (to M.H.), NIH grant U54 NS078059 (to M.H.), and NIH research
   grant P01 HD32062 (to M.H.). M.H. is supported by the Marriott
   Mitochondrial Disease Clinic Research Fund from the J. Willard and Alice
   S. Marriott Foundation, Arturo Estopinan TK2 Research Fund, Nicholas
   Nunno Foundation, and JDM Fund for Mitochondrial Research. A.H.G. was
   funded by a Research grant at Foreign Universities from the Fundacion
   Alfonso Martin Escudero. E.B.C. was funded by a Research grant at
   Foreign Universities from the Fundacion Alfonso Martin Escudero. R.M.
   was supported by a grant from the Spanish Instituto de Salud Carlos III
   (project PI21/00554), cofounded by the European Regional Development
   Fund (ERDF), and a grant from the Catalan Fundacio La Marato de TV3
   (project number 202020). This research was also supported by the
   projects PI19/01310 and PI22/00856, funded by the Instituto de Salud
   Carlos III of Spain and co-funded by European Union. The study was
   supported by the Centro de Investigacion Biomedica en Red de
   Enfermedades Raras (CIBERER) and funded by the ER20P2AC737 project. This
   study was also supported by the Agencia de Gestio d'Ajuts Universitaris
   i de Recerca (AGAUR) (2017:SGR 1428 and 2021:SGR 01423) and the CERCA
   Programme/Generalitat de Catalunya. This study was (partially) funded by
   Italian Ministry of Health - Current research IRCCS Ca' Granda Ospedale
   Maggiore Policlinico, the PNC "Hub Life Science - Diagnostica Avanzata"
   (PNC-E3-2022-23683266) and by SEQMD project (IRCCS Ca Granda Ospedale
   Maggiore Policlinico). The support of Italian Ministry of Education and
   Research (MUR) "Dipartimenti di Eccellenza Program 2023-2027" -
   Department of Pathophysiology and Transplantation, University of Milan
   to G.O.C. and D.R. is gratefully acknowledged. This work was promoted
   within the European Reference Network (ERN) for Rare Neuromuscular
   Diseases. We thank the Associazione Centro Dino Ferrari for its support.
CR AGARWAL RP, 1971, BIOCHEM PHARMACOL, V20, P1341, DOI 10.1016/0006-2952(71)90261-9
   Alexander SPH, 2021, BRIT J PHARMACOL, V178, pS412, DOI 10.1111/bph.15543
   Amtmann D, 2023, MITOCHONDRION, V68, P1, DOI 10.1016/j.mito.2022.10.003
   [Anonymous], 2019, An OpenLabel Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency (2019) Clinical Trial
   [Anonymous], 2018, Treatment of TK2 Deficiency With Thymidine and Deoxycytidine (2018) Clinical Trial (Identification No. NCT03639701)
   Balakrishnan K, 2010, BLOOD, V116, P886, DOI 10.1182/blood-2010-02-272039
   Bantia S, 2001, INT IMMUNOPHARMACOL, V1, P1199, DOI 10.1016/S1567-5769(01)00056-X
   Basel D, 2020, CLIN PERINATOL, V47, P123, DOI 10.1016/j.clp.2019.10.008
   Berardo A, 2022, J NEUROMUSCULAR DIS, V9, P225, DOI 10.3233/JND-210786
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carvalho G, 2022, ANTIOXID REDOX SIGN, V36, P885, DOI 10.1089/ars.2021.0091
   Cheng J, 2023, SCIENCE, V381, P1303, DOI 10.1126/science.adg7492
   Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Gandhi V, 2007, SEMIN ONCOL, V34, pS8, DOI 10.1053/j.seminoncol.2007.11.003
   González-García P, 2022, REDOX BIOL, V55, DOI 10.1016/j.redox.2022.102403
   Hible G, 2006, BIOCHIMIE, V88, P1157, DOI 10.1016/j.biochi.2006.04.002
   Hidalgo-Gutierrez A, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9101457
   Hidalgo-Gutiérrez A, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809466
   Hirano Michio, 2023, Handb Clin Neurol, V194, P9, DOI 10.1016/B978-0-12-821751-1.00018-X
   Iino M, 2022, ANN HEMATOL, V101, P2351, DOI 10.1007/s00277-022-04898-5
   Ionescu MI, 2019, PROTEIN J, V38, P120, DOI 10.1007/s10930-019-09811-0
   Khan N, 2019, J BIOL CHEM, V294, P11920, DOI 10.1074/jbc.RA119.009251
   Landoni JC., 2018, Biol Methods Protocols, V3
   Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047
   López-Gómez C, 2022, NEUROMUSCULAR DISORD, V32, P609, DOI 10.1016/j.nmd.2022.05.008
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45
   Minton K, 2023, NAT REV GENET, V24, P804, DOI 10.1038/s41576-023-00668-9
   Morgenstern M, 2021, CELL METAB, V33, P2464, DOI 10.1016/j.cmet.2021.11.001
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Panayiotou C, 2014, INT J BIOCHEM CELL B, V49, P75, DOI 10.1016/j.biocel.2014.01.014
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Ramón J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126447
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Shintaku J, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI145660
   Somech R, 2013, IMMUNOL RES, V56, P150, DOI 10.1007/s12026-012-8380-9
   Sommerville EW, 2020, CLIN GENET, V97, P276, DOI 10.1111/cge.13652
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Topalis D, 2007, FEBS J, V274, P3704, DOI 10.1111/j.1742-4658.2007.05902.x
   Wang L, 2010, NUCLEOS NUCLEOT NUCL, V29, P370, DOI 10.1080/15257771003729732
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
NR 50
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD 2024 SEP 4
PY 2024
DI 10.1002/ana.27071
EA SEP 2024
PG 16
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA E8R7F
UT WOS:001305622000001
PM 39230499
OA hybrid
DA 2024-11-01
ER

PT J
AU Kazuhito, T
   Wei, FY
AF Kazuhito, Tomizawa
   Wei, Fan-Yan
TI Posttranscriptional modifications in mitochondria! tRNA and its
   implication in mitochondria! translation and disease
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Review
ID ANTICODON WOBBLE NUCLEOTIDE; TRANSFER RNALEU(UUR) GENE; LACTIC-ACIDOSIS;
   HYPERTROPHIC CARDIOMYOPATHY; STROKELIKE EPISODES; MODIFICATION DEFECT;
   MTO1; MUTATIONS; MYOPATHY; DNA
AB A fundamental aspect of mitochondria is that they possess DNA and protein translation machinery. Mitochondrial DNA encodes 22 tRNAs that translate mitochondrial mRNAs to 13 polypeptides of respiratory complexes. Various chemical modifications have been identified in mitochondrial tRNAs via complex enzymatic processes. A growing body of evidence has demonstrated that these modifications are essential for translation by regulating tRNA stability, structure and mRNA binding, and can be dynamically regulated by the metabolic environment. Importantly, the hypomodification of mitochondrial tRNA due to pathogenic mutations in mitochondrial tRNA genes or nuclear genes encoding modifying enzymes can result in lifethreatening mitochondrial diseases in humans. Thus, the mitochondrial tRNA modification is a fundamental mechanism underlying the tight regulation of mitochondrial translation and is essential for life. In this review, we focus on recent findings on the physiological roles of 5-taurinomethyl modification (herein referred as taurine modification) in mitochondrial tRNAs. We summarize the findings in human patients and animal models with a deficiency of taurine modifications and provide pathogenic links to mitochondrial diseases. We anticipate that this review will help understand the complexity of mitochondrial biology and disease.
   [GRAPHICS]
   .
C1 [Kazuhito, Tomizawa; Wei, Fan-Yan] Kumamoto Univ, Fac Life Sci, Dept Mol Physiol, Chuo Ku, Honjo 1-1-1, Kumamoto, Kumamoto 8608556, Japan.
   [Wei, Fan-Yan] Tohoku Univ, Inst Dev Aging & Canc, Dept Mod Biol & Med, Aoba Ku, Seriyo Machi 4-1, Sendai, Miyagi 9808575, Japan.
C3 Kumamoto University; Tohoku University
RP Wei, FY (corresponding author), Seiryo Machi 4-1,Aoba Ku, Sendai, Miyagi 9808575, Japan.
EM fanyan.wei.d3@tohoku.ac.jp
RI Wei, Fan-Yan/AAD-8461-2021
OI Wei, Fan-Yan/0000-0002-4843-724X
CR Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363
   Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158
   Agris Paul F, 2017, Enzymes, V41, P1, DOI 10.1016/bs.enz.2017.03.005
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641
   [Anonymous], 2014, PRION, DOI [10.4161/PRI, DOI 10.4161/PRI]
   Asano K, 2018, NUCLEIC ACIDS RES, V46, P1565, DOI 10.1093/nar/gky068
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bar-Yaacov D, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002557
   Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393
   Becker L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114918
   Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6
   Carter JM, 2019, NUCLEIC ACIDS RES, V47, pE113, DOI 10.1093/nar/gkz658
   Charif M, 2015, AM J MED GENET A, V167, P2366, DOI 10.1002/ajmg.a.37188
   Chen DN, 2019, NUCLEIC ACIDS RES, V47, P5341, DOI 10.1093/nar/gkz218
   Chujo T, 2012, RNA, V18, P2269, DOI 10.1261/rna.035600.112
   Clark WC, 2016, RNA, V22, P1771, DOI 10.1261/rna.056531.116
   Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945
   Fakruddin M, 2018, CELL REP, V22, P482, DOI 10.1016/j.celrep.2017.12.051
   FUKUHARA N, 1985, ANN NEUROL, V18, P368, DOI 10.1002/ana.410180323
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haag S, 2016, EMBO J, V35, P2104, DOI 10.15252/embj.201694885
   Hawkins PN, 2015, ANN MED, V47, P625, DOI 10.3109/07853890.2015.1068949
   Hino N, 2004, GENES CELLS, V9, P243, DOI 10.1111/j.1356-9597.2004.00718.x
   Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308
   Kawarada L, 2017, NUCLEIC ACIDS RES, V45, P7401, DOI 10.1093/nar/gkx354
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017
   Kurata Shinya, 2003, Nucleic Acids Res Suppl, P245
   Li XY, 2017, MOL CELL, V68, P993, DOI 10.1016/j.molcel.2017.10.019
   Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Marchand V, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010013
   Martín MA, 2017, CLIN GENET, V91, P46, DOI 10.1111/cge.12815
   Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003
   Morscher RJ, 2018, NATURE, V554, P128, DOI 10.1038/nature25460
   Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762
   Nachtergaele S, 2017, RNA BIOL, V14, P156, DOI 10.1080/15476286.2016.1267096
   Navarro-González C, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006921
   O'Byrne JJ, 2018, MOL GENET METAB, V123, P28, DOI 10.1016/j.ymgme.2017.11.003
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003
   Priesnitz C, 2018, GENE DEV, V32, P1285, DOI 10.1101/gad.316547.118
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Rikimaru M, 2012, INTERNAL MED, V51, P3351, DOI 10.2169/internalmedicine.51.7529
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Suzuki T, 2001, Nucleic Acids Res Suppl, P257
   Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390
   Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8
   Tani H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52372-6
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743
   Tuorto F, 2018, EMBO J, V37, DOI 10.15252/embj.201899777
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Yasukawa T, 2018, J BIOCHEM, V164, P183, DOI 10.1093/jb/mvy058
   YONEDA M, 1990, BIOCHEM INT, V21, P789
NR 66
TC 16
Z9 17
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0021-924X
EI 1756-2651
J9 J BIOCHEM
JI J. Biochem.
PD NOV
PY 2020
VL 168
IS 5
BP 435
EP 444
DI 10.1093/jb/mvaa098
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA OX2LA
UT WOS:000593401600001
PM 32818253
OA Bronze
DA 2024-11-01
ER

PT J
AU Sunde, K
   Blackburn, PR
   Cheema, A
   Gass, J
   Jackson, J
   Macklin, S
   Atwal, PS
AF Sunde, Kiri
   Blackburn, Patrick R.
   Cheema, Anvir
   Gass, Jennifer
   Jackson, Jessica
   Macklin, Sarah
   Atwal, Paldeep S.
TI Case report: 5 year follow-up of adult late-onset mitochondrial
   encephalomyopathy with lactic acid and stroke-like episodes (MELAS)
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
ID POINT MUTATION; ARGININE; ENCEPHALOPATHY; HETEROPLASMY; DIAGNOSIS;
   MYOPATHY
AB Mitochondrial encephalomyopathy with lactic acid and stroke-like episodes(MELAS) is a multisystem mitochondrial disorder that typically presents in childhood. We describe the follow-up of a patient who was diagnosed with late-onset MELAS at the age of 49. Her clinical course includes sensorineural hearing loss, seizures, and multiple episodes of stroke-like metabolic crises. Molecular genetic testing on whole blood revealed 31% heteroplasmy of a m.3243A>G variant in the mtDNA, the causative variant in approximately 80% of MELAS cases. The original diagnostic criteria for MELAS required the onset of stroke-like episodes prior to 40 years of age but this case and others demonstrate that onset may be delayed in certain individuals. Therefore, MELAS should be included in the differential diagnosis of stroke-like episodes in patients of any age. (C) 2016 The Authors. Published by Elsevier Inc.
C1 [Sunde, Kiri] Mayo Clin, Mayo Med Sch, Rochester, MN USA.
   [Blackburn, Patrick R.; Cheema, Anvir; Gass, Jennifer; Jackson, Jessica; Macklin, Sarah; Atwal, Paldeep S.] Mayo Clin, Ctr Individualized Med, Dept Clin Genom, Jacksonville, FL 32224 USA.
C3 Mayo Clinic; Mayo Clinic
RP Atwal, PS (corresponding author), Mayo Clin, Ctr Individualized Med, Dept Clin Genom, Jacksonville, FL 32224 USA.
EM Atwal.Paldeep@mayo.edu
RI Atwal, Paldeep/H-7472-2019
CR Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   DiMauro S., 1993, GENEREVIEWS
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Kimata KG, 1998, ARCH NEUROL-CHICAGO, V55, P722, DOI 10.1001/archneur.55.5.722
   Kisanuki YY, 2006, ARCH NEUROL-CHICAGO, V63, P1200, DOI 10.1001/archneur.63.8.1200
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Leff AP, 1998, EPILEPSIA, V39, P438, DOI 10.1111/j.1528-1157.1998.tb01397.x
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Narita Hiroyuki, 2004, No To Shinkei, V56, P345
   Olsson C, 1998, HUM MUTAT, V12, P52, DOI 10.1002/(SICI)1098-1004(1998)12:1<52::AID-HUMU8>3.0.CO;2-K
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Vanniarajan A, 2006, AM J MED GENET B, V141B, P440, DOI 10.1002/ajmg.b.30302
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
NR 19
TC 18
Z9 21
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD DEC
PY 2016
VL 9
BP 94
EP 97
DI 10.1016/j.ymgmr.2016.11.002
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA EE8FN
UT WOS:000389860800021
PM 27896131
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Schoffer, K
   Grant, I
AF Schoffer, K
   Grant, I
TI Multiple lipomas, alcoholism, and neuropathy: Madelung's disease or
   MERRF?
SO MUSCLE & NERVE
LA English
DT Article
DE Madelung's disease; MERRF; mitochondrial myopathy; multiple symmetrical
   lipomatosis; neuropathy
ID SYMMETRIC LIPOMATOSIS; MITOCHONDRIAL DYSFUNCTION; MUTATION;
   MANIFESTATION; EPILEPSY; DNA
AB We report a 51-year-old alcoholic man with a 10-year history of cervical lipomas and progressive symmetrical sensory neuropathy, initially diagnosed with Madelung's disease, an idiopathic syndrome often attributed to chronic alcoholism. The eventual development of proximal weakness led to pathological and genetic testing which identified a A8344G mutation in the mitochondrial tRNA lysine gene, associated with MERRF (myoclonic epilepsy with ragged-red fibers). This case demonstrates how the varied terminology for this syndrome has resulted in a lack of consistent recognition and assessment for mitochondrial cytopathy.
C1 Dalhousie Univ, Div Neurol, Halifax, NS, Canada.
C3 Dalhousie University
RP Royal Brisbane & Womens Hosp, Dept Neurol, Herston Rd, Herston, Qld 4029, Australia.
EM schoffer@bigpond.net.au
CR Abenavoli FM, 2002, BRIT J PLAST SURG, V55, P536, DOI 10.1054/bjps.2002.3911
   Becker-Wegerich P, 1998, ARCH DERMATOL RES, V290, P652, DOI 10.1007/s004030050368
   BERKOVIC SF, 1991, ANN NEUROL, V29, P566, DOI 10.1002/ana.410290519
   BRODIE BC, 1846, PATHOLOGY SURG, P275
   Busetto L, 2003, INT J OBESITY, V27, P1419, DOI 10.1038/sj.ijo.0802427
   CALABRESI PA, 1994, MUSCLE NERVE, V17, P943, DOI 10.1002/mus.880170815
   ENZI G, 1984, MEDICINE, V63, P56, DOI 10.1097/00005792-198401000-00004
   ENZI G, 1985, MEDICINE, V64, P388, DOI 10.1097/00005792-198511000-00003
   Feliciani C, 1999, NEW ENGL J MED, V340, P1481, DOI 10.1056/NEJM199905133401906
   Guastella C, 2002, OTOLARYNG HEAD NECK, V126, P191, DOI 10.1067/mhn.2002.122004
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Hervás ES, 2000, BRIT J DERMATOL, V143, P684
   Klopstock T, 1997, MOL CELL BIOCHEM, V174, P271, DOI 10.1023/A:1006877012241
   Kratz C, 2000, Eur J Paediatr Neurol, V4, P63, DOI 10.1053/ejpn.2000.0264
   LANOIS PE, 1898, B MEM SOC MED HOP P, V1, P298
   Lee HW, 2003, DERMATOL SURG, V29, P235, DOI 10.1046/j.1524-4725.2003.29056.x
   Madelung OW., 1888, Arch Klin Chir, V37, P106
   Martínez-Escribano JA, 1999, INT J DERMATOL, V38, P551, DOI 10.1046/j.1365-4362.1999.00743.x
   Muñoz-Málaga A, 2000, MUSCLE NERVE, V23, P538, DOI 10.1002/(SICI)1097-4598(200004)23:4<538::AID-MUS12>3.3.CO;2-K
   NAUMANN M, 1995, MUSCLE NERVE, V18, P693, DOI 10.1002/mus.880180704
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Nisoli E, 2002, J PATHOL, V198, P378, DOI 10.1002/path.1212
   POLLOCK M, 1988, BRAIN, V111, P1157, DOI 10.1093/brain/111.5.1157
   RUZICKA T, 1987, J AM ACAD DERMATOL, V17, P663, DOI 10.1016/S0190-9622(87)70253-9
   Stavropoulos PG, 1997, DERMATOLOGY, V194, P26, DOI 10.1159/000246052
   Stoll C, 1996, ANN GENET-PARIS, V39, P193
   Vargas-Díez E, 2000, J AM ACAD DERMATOL, V42, P511, DOI 10.1016/S0190-9622(00)90230-5
   Wilson D, 1994, W V Med J, V90, P145
NR 28
TC 15
Z9 17
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD JAN
PY 2006
VL 33
IS 1
BP 142
EP 146
DI 10.1002/mus.20406
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 000JC
UT WOS:000234456500017
PM 16007676
DA 2024-11-01
ER

PT J
AU Lim, SC
   Friemel, M
   Marum, JE
   Tucker, EJ
   Bruno, DL
   Riley, LG
   Christodoulou, J
   Kirk, EP
   Boneh, A
   DeGennaro, CM
   Springer, M
   Mootha, VK
   Rouault, TA
   Leimkuhler, S
   Thorburn, DR
   Compton, AG
AF Lim, Sze Chern
   Friemel, Martin
   Marum, Justine E.
   Tucker, Elena J.
   Bruno, Damien L.
   Riley, Lisa G.
   Christodoulou, John
   Kirk, Edwin P.
   Boneh, Avihu
   DeGennaro, Christine M.
   Springer, Michael
   Mootha, Vamsi K.
   Rouault, Tracey A.
   Leimkuehler, Silke
   Thorburn, David R.
   Compton, Alison G.
TI Mutations in LYRM4, encoding ironsulfur cluster biogenesis factor ISD11,
   cause deficiency of multiple respiratory chain complexes
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID IRON-SULFUR CLUSTER; SCAFFOLD PROTEIN; MITOCHONDRIAL DISEASE; CYSTEINE
   DESULFURASE; LACTIC-ACIDOSIS; CAUSES MYOPATHY; 1ST YEAR; GENE; ISCU;
   MATURATION
AB Ironsulfur clusters (ISCs) are important prosthetic groups that define the functions of many proteins. Proteins with ISCs (called ironsulfur or FeS proteins) are present in mitochondria, the cytosol, the endoplasmic reticulum and the nucleus. They participate in various biological pathways including oxidative phosphorylation (OXPHOS), the citric acid cycle, iron homeostasis, heme biosynthesis and DNA repair. Here, we report a homozygous mutation in LYRM4 in two patients with combined OXPHOS deficiency. LYRM4 encodes the ISD11 protein, which forms a complex with, and stabilizes, the sulfur donor NFS1. The homozygous mutation (c.203GT, p.R68L) was identified via massively parallel sequencing of 1000 mitochondrial genes (MitoExome sequencing) in a patient with deficiency of complexes I, II and III in muscle and liver. These three complexes contain ISCs. Sanger sequencing identified the same mutation in his similarly affected cousin, who had a more severe phenotype and died while a neonate. Complex IV was also deficient in her skeletal muscle. Several other FeS proteins were also affected in both patients, including the aconitases and ferrochelatase. Mutant ISD11 only partially complemented for an ISD11 deletion in yeast. Our in vitro studies showed that the l-cysteine desulfurase activity of NFS1 was barely present when co-expressed with mutant ISD11. Our findings are consistent with a defect in the early step of ISC assembly affecting a broad variety of FeS proteins. The differences in biochemical and clinical features between the two patients may relate to limited availability of cysteine in the newborn period and suggest a potential approach to therapy.
C1 [Lim, Sze Chern; Marum, Justine E.; Tucker, Elena J.; Bruno, Damien L.; Boneh, Avihu; Thorburn, David R.; Compton, Alison G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
   [Lim, Sze Chern; Marum, Justine E.; Tucker, Elena J.; Boneh, Avihu; Thorburn, David R.; Compton, Alison G.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.
   [Friemel, Martin; Leimkuehler, Silke] Univ Potsdam, Dept Mol Enzymol, Inst Biochem & Biol, D-14476 Potsdam, Germany.
   [Bruno, Damien L.; Boneh, Avihu; Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Parkville, Vic 3052, Australia.
   [Riley, Lisa G.; Christodoulou, John] Childrens Hosp, Genet Metab Disorders Res Unit, Westmead, NSW 2145, Australia.
   [Christodoulou, John] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia.
   [Christodoulou, John] Univ Sydney, Discipline Genet Med, Sydney, NSW 2006, Australia.
   [Kirk, Edwin P.] Sydney Childrens Hosp, Dept Med Genet, Randwick, NSW 2031, Australia.
   [DeGennaro, Christine M.; Springer, Michael; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.
   [Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.
   [Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   [Mootha, Vamsi K.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02141 USA.
   [Rouault, Tracey A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Mol Med, NIH, Bethesda, MD 20892 USA.
C3 Royal Children's Hospital Melbourne; Murdoch Children's Research
   Institute; University of Melbourne; University of Potsdam; Royal
   Children's Hospital Melbourne; Murdoch Children's Research Institute;
   Victorian Clinical Genetics Services; University of Sydney; NSW Health;
   Sydney Childrens Hospitals Network; University of Sydney; University of
   Sydney; NSW Health; Sydney Childrens Hospitals Network; Harvard
   University; Harvard Medical School; Harvard University; Massachusetts
   General Hospital; Harvard University; Massachusetts General Hospital;
   Harvard University; Massachusetts Institute of Technology (MIT); Broad
   Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
RP Compton, AG (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.
EM alison.compton@mcri.edu.au
RI Thorburn, David/G-6266-2013; Christodoulou, John/E-5866-2015;
   Leimkuehler, silke/KIK-8445-2024; Compton, Alison/KOT-7713-2024; Bruno,
   Damien/C-3665-2013; Tucker, Elena/B-3487-2012; Christodoulou,
   John/M-3628-2019; Lim, Sze Chern/I-6763-2013
OI thorburn, david/0000-0002-7725-9470; Christodoulou,
   John/0000-0002-8431-0641; Rouault, Tracey/0000-0003-0062-0245;
   DeGennaro, Christine/0000-0001-7318-9949; Leimkuhler,
   Silke/0000-0003-3238-2122; Tucker, Elena/0000-0002-6380-5100; Kirk,
   Edwin/0000-0002-4662-0024; Compton, Alison/0000-0002-2725-7055; Lim, Sze
   Chern/0000-0003-0312-9937
FU NHLBI Lung GO Sequencing Project [HL-102923]; NHLBI WHI Sequencing
   Project [HL-102924]; NHLBI Broad GO Sequencing Project [HL-102925];
   NHLBI Seattle GO Sequencing Project [HL-102926]; NHLBI Heart GO
   Sequencing Project [HL-103010]; NHLBI Melbourne Research Scholarship;
   NHLBI Australian National Health and Medical Research Council; NHLBI
   Victorian Government; NHLBI Eunice Kennedy Shriver National Institute of
   Child Health and Human Development; NHLBI Deutsche
   Forschungsgemeinschaft
FX The authors thank the NHLBI GO Exome Sequencing Project and its ongoing
   studies which produced and provided exome variant calls for comparison:
   the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project
   (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO
   Sequencing Project (HL-102926) and the Heart GO Sequencing Project
   (HL-103010). This work was supported by a Melbourne Research Scholarship
   (to S. C. L.), grants and a Principal Research Fellowship from the
   Australian National Health and Medical Research Council (to D. R. T.),
   the Victorian Government's Operational Infrastructure Support Program
   (to D. R. T.) and support from the intramural program of the Eunice
   Kennedy Shriver National Institute of Child Health and Human Development
   (to T. A. R.), and the Deutsche Forschungsgemeinschaft (to S.L.).
CR Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104
   Bruno DL, 2011, J MED GENET, V48, P831, DOI 10.1136/jmedgenet-2011-100372
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229
   Condò I, 2006, J BIOL CHEM, V281, P16750, DOI 10.1074/jbc.M511960200
   Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010
   Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38
   Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105
   Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672
   Ferrer- Corte` s X., 2012, J INHERIT METAB DIS, P1
   FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028
   Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07
   Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Haack TB, 2013, J INHERIT METAB DIS, V36, P55, DOI 10.1007/s10545-012-9489-7
   Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6
   Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161
   Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200
   Leimkühler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200
   Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200
   Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1445, DOI 10.1001/archneur.60.10.1445
   Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200
   Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Mühlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152
   Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Pandey A, 2011, J BIOL CHEM, V286, P38242, DOI 10.1074/jbc.M111.288522
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199
   Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038
   Shan YX, 2012, HUM MOL GENET, V21, P1457, DOI 10.1093/hmg/ddr582
   Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239
   Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014
   Springer M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.19
   Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679
   Tenisch EV, 2012, NEUROLOGY, V79, P391, DOI 10.1212/WNL.0b013e3182611232
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692
   Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003
   Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100
   Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906
   Xia HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047847
   Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
   ZLOTKIN SH, 1988, PEDIATR RES, V24, P326, DOI 10.1203/00006450-198809000-00010
   ZLOTKIN SH, 1982, PEDIATR RES, V16, P65
NR 71
TC 79
Z9 103
U1 1
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD NOV 15
PY 2013
VL 22
IS 22
BP 4460
EP 4473
DI 10.1093/hmg/ddt295
PG 14
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 248EA
UT WOS:000326675300002
PM 23814038
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Vanlander, AV
   Mosquera, LM
   Panzer, J
   Deconinck, T
   Smet, J
   Seneca, S
   Van Dorpe, J
   Ferdinande, L
   Ceuterick-de Groote, C
   De Jonghe, P
   Van Coster, R
   Baets, J
AF Vanlander, Arnaud V.
   Mosquera, Laura Muino
   Panzer, Joseph
   Deconinck, Tine
   Smet, Joel
   Seneca, Sara
   Van Dorpe, Jo
   Ferdinande, Liesbeth
   Ceuterick-de Groote, Chantal
   De Jonghe, Peter
   Van Coster, Rudy
   Baets, Jonathan
TI Megaconial muscular dystrophy caused by mitochondrial membrane
   homeostasis defect, new insights from skeletal and heart muscle analyses
SO MITOCHONDRION
LA English
DT Article
DE CHKB; Mitochondria; OXPHOS; Microscopy; Heart transplantation
ID CHKB GENE; MUTATIONS; MYOPATHY; TOOL
AB Megaconial congenital muscular dystrophy is a disease caused by pathogenic mutations in the gene encoding choline kinase beta (CHKB). Microscopically, the disease is hallmarked by the presence of enlarged mitochondria at the periphery of skeletal muscle fibres leaving the centre devoid of mitochondria. Clinical characteristics are delayed motor development, intellectual disability and dilated cardiomyopathy in half of reported cases. This study describes a patient presenting with the cardinal clinical features, in whom a homozygous nonsense mutation (c.248_249insT; p.Arg84Profs*209) was identified in CHKB and who was treated by heart transplantation. Microscopic evaluation of skeletal and heart muscles typically showed enlarged mitochondria. Spectrophotometric evaluation in both tissues revealed a mild decrease of all OXPHOS complexes. Using BN-PAGE analysis followed by activity staining subcomplexes of complex V were detected in both tissues, indicating incomplete complex V assembly. Mitochondrial DNA content was not depleted in analysed tissues. This is the first report describing the microscopic and biochemical abnormalities in the heart from an affected patient. A likely hypothesis is that the biochemical findings are caused by an abnormal lipid profile in the inner mitochondrial membrane resulting from a defective choline kinase B activity. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Vanlander, Arnaud V.; Smet, Joel; Van Coster, Rudy] Univ Hosp Ghent, Div Pediat Neurol & Metab, Dept Pediat, De Pintelaan 185, B-9000 Ghent, Belgium.
   [Mosquera, Laura Muino; Panzer, Joseph] Univ Hosp Ghent, Div Pediat Cardiol, Dept Pediat, De Pintelaan 185, B-9000 Ghent, Belgium.
   [Deconinck, Tine; Ceuterick-de Groote, Chantal; De Jonghe, Peter; Baets, Jonathan] Univ Antwerp, Labs Neurogenet & Ultrastruct Neuropathol, Inst Born Bunge, Univ Pl 1, B-2610 Antwerp, Belgium.
   [Deconinck, Tine; Ceuterick-de Groote, Chantal; De Jonghe, Peter; Baets, Jonathan] Univ Antwerp, Biobank, Inst Born Bunge, Univ Pl 1, B-2610 Antwerp, Belgium.
   [Deconinck, Tine; De Jonghe, Peter; Baets, Jonathan] VIB, Dept Mol Genet, Neurogenet Grp, Univ Pl 1, B-2610 Antwerp, Belgium.
   [Seneca, Sara] Vrije Univ Brussel, Res Grp Reprod & Genet REGE, Laarbeeklaan 101, B-1090 Brussels, Belgium.
   [Seneca, Sara] Vrije Univ Brussel, Ctr Med Genet, UZ Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.
   [Van Dorpe, Jo; Ferdinande, Liesbeth] Univ Hosp Ghent, Dept Pathol, De Pintelaan 185, B-9000 Ghent, Belgium.
   [De Jonghe, Peter; Baets, Jonathan] Univ Antwerp Hosp, Dept Neurol, Wilrijkstr 10, B-2650 Edegem, Belgium.
C3 Ghent University; Ghent University Hospital; Ghent University; Ghent
   University Hospital; University of Antwerp; University of Antwerp;
   Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel;
   University Hospital Brussels; Vrije Universiteit Brussel; Ghent
   University; Ghent University Hospital; University of Antwerp
RP Van Coster, R (corresponding author), Univ Hosp Ghent, Div Pediat Neurol & Metab, Dept Pediat, De Pintelaan 185, B-9000 Ghent, Belgium.
EM rudy.vancoster@ugent.be
RI Baets, Jonathan/HKM-5219-2023; Arnaud, Vanlander/ABB-5978-2021; Muino
   Mosquera, Laura/ABD-5010-2020; Panzer, Joseph/HHM-2095-2022
OI Vanlander, Arnaud/0000-0002-9520-5564; Seneca, Sara/0000-0002-0853-9890;
   Panzer, Joseph/0000-0002-8667-8001; Muino Mosquera,
   Laura/0000-0002-3094-7807
FU Association Belge contre les Maladies Neuromusculaires (ABMM); EU
   [2012-305121]; Ghent University (Ugent, BOF) [01DI2714]; Steunfonds
   Marguerite-Marie Delacroix; Fund for Scientific Research (FWO, Belgium)
   [G.0666.06]
FX JB is supported by a Senior Clinical Researcher mandate of the Research
   Fund - Flanders (FWO) and receives additional support from the
   Association Belge contre les Maladies Neuromusculaires (ABMM) and the EU
   FP7/2007-2013 under grant agreement number 2012-305121 (NEUROMICS). We
   thank the IBB-Biobank for technical assistance and Inge Bats for the
   images of neuropathology. AV was supported by the Ghent University
   (Ugent, BOF, grant number 01DI2714) and the Steunfonds Marguerite-Marie
   Delacroix. JS and RVC are supported by Fund for Scientific Research
   (FWO, Belgium) (grant number G.0666.06).
CR BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Bolar NA, 2013, HUM MOL GENET, V22, P2590, DOI 10.1093/hmg/ddt107
   Cabrera-Serrano Macarena, 2015, Muscle Nerve, V51, P140, DOI 10.1002/mus.24446
   Castro-Gago M, 2014, EUR J PAEDIATR NEURO, V18, P796, DOI 10.1016/j.ejpn.2014.06.005
   Kalra A. A., 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI DOI 10.1001/archneurol.2011.2333
   Martin JJ, 1997, NEUROMUSCULAR DISORD, V7, P512, DOI 10.1016/S0960-8966(97)00119-3
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d
   Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305
   Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010
   Nishino I, 1998, MUSCLE NERVE, V21, P40, DOI 10.1002/(SICI)1097-4598(199801)21:1<40::AID-MUS6>3.0.CO;2-G
   Oliveira J, 2015, J HUM GENET, V60, P305, DOI 10.1038/jhg.2015.20
   Quinlivan R, 2013, NEUROMUSCULAR DISORD, V23, P549, DOI 10.1016/j.nmd.2013.04.002
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Shaikh SR, 2014, BIOCHEMISTRY-US, V53, P5589, DOI 10.1021/bi500868g
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van der Westhuizen FH, 2010, J INHERIT METAB DIS, V33, pS55, DOI 10.1007/s10545-009-9020-y
   Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
   Wortmann S, 2006, MOL GENET METAB, V88, P47, DOI 10.1016/j.ymgme.2006.01.013
NR 21
TC 8
Z9 8
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR
PY 2016
VL 27
BP 32
EP 38
DI 10.1016/j.mito.2016.02.001
PG 7
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA DH3CQ
UT WOS:000372665500005
PM 26855408
DA 2024-11-01
ER

PT S
AU Lee, CF
   Liu, CY
   Chen, SM
   Sikorska, M
   Lin, CY
   Chen, TL
   Wei, YH
AF Lee, CF
   Liu, CY
   Chen, SM
   Sikorska, M
   Lin, CY
   Chen, TL
   Wei, YH
BE Wei, YH
   Lee, HM
   Hsu, CY
TI Attenuation of UV-induced apoptosis by coenzyme Q<sub>10</sub> in human
   cells harboring large-scale deletion of mitochondrial DNA
SO ROLE OF THE MITOCHONDRIA IN HUMAN AGING AND DISEASE: FROM GENES TO CELL
   SIGNALING
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 2nd Scientific Meeting of the
   Asian-Society-for-Mitochondrial-Research-and-Medicine
CY APR 01-02, 2004
CL Taipei, TAIWAN
SP Asian Soc Mitochondrial Res & Med
DE mitochondrial DNA; mutation; apoptosis; UV irradiation; coenzyme Q(10)
ID OXIDATIVE STRESS; MOLECULAR-MECHANISMS; ENCEPHALOMYOPATHY; ACTIVATION;
   MUTATIONS; INCREASE; DISEASES; COQ(10); PATHWAY
AB Chronic progressive external ophthalmoplegia (CPEO) syndrome is one of the mitochondrial diseases caused by large-scale deletions in mitochundrial DNA (mtDNA) that impair the respiratory function of mitochondria and result in decreased production of ATP in affected tissues. In order to investigate whether CPEO-associated mtDNA mutations (i.e., 4,366-bp and 4,977bp large-scale deletions) render human cells more vulnerable to apoptosis, we constructed cybrids carrying the deleted mtDNA. Assays for cell viability, DNA fragmentation, cytochrome c release, and caspase 3 activation revealed that UV irradiation at 20 J/m(2) triggered apoptosis in all the cybrids. This treatment also produced elevated intracellular levels of reactive oxygen species (ROS). The rate of UV-induced cell death was more pronounced in the cybrids harboring mtDNA deletions than in the control cybrid with wild-type mtDNA. Subsequently, we evaluated the effect of coenzyme Q10 on the UV-triggered apoptosis. The results showed that after pretreatment of the cybrids with 100 mu M coenzyme Q10 the UV-induced cell damage (i.e., ROS production and activation of caspase 3) was significantly reduced. Taken together, these findings suggest that large-scale deletions of mtDNA increased the susceptibility of human cells to the UV-triggered apoptosis and that coenzyme Q10 mitigated the damage; hence, it might potentially serve as a therapeutic agent to treat mitochondrial diseases resulting from mtDNA deletions.
C1 Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan.
   Natl Yang Ming Univ, Ctr Cellular & Mol Biol, Taipei 112, Taiwan.
   Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada.
C3 National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung
   University; National Research Council Canada
RP Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan.
EM joeman@ym.edu.tw
RI Wei, Yau-Huei/ABA-6841-2021; Sikorska, Martyna/JWP-8146-2024
OI Wei, Yau-Huei/0000-0002-6429-2546
CR Beal MF, 2002, FREE RADICAL RES, V36, P455, DOI 10.1080/10715760290021315
   BOROWYBOROWSKI M, 2004, Patent No. 6045826
   BOROWYBOROWSKI M, 2004, Patent No. 6191172
   Chuang YC, 2003, SHOCK, V19, P427, DOI 10.1097/01.shk.0000048900.46342.37
   FORSMARKANDREE P, 1994, MOL ASPECTS MED, V15, P73, DOI 10.1016/0098-2997(94)90015-9
   HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Jiang SN, 1999, J BIOL CHEM, V274, P29905, DOI 10.1074/jbc.274.42.29905
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kulms D, 2000, PHOTODERMATOL PHOTO, V16, P195, DOI 10.1034/j.1600-0781.2000.160501.x
   Langsjoen PH, 1999, BIOFACTORS, V9, P273, DOI 10.1002/biof.5520090224
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6
   Liou CW, 2000, EUR NEUROL, V43, P54, DOI 10.1159/000008130
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   McCarthy S, 2004, TOXICOL APPL PHARM, V201, P21, DOI 10.1016/j.taap.2004.04.019
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6
   Sandhu JK, 2003, J NEUROSCI RES, V72, P691, DOI 10.1002/jnr.10579
   Shiah SG, 1999, CANCER RES, V59, P391
   Sikorska M, 2003, BIOFACTORS, V18, P173, DOI 10.1002/biof.5520180220
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wei YH, 2001, ANN NY ACAD SCI, V928, P97
NR 25
TC 16
Z9 27
U1 0
U2 4
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-541-9
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2005
VL 1042
BP 429
EP 438
DI 10.1196/annals.1338.036
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Multidisciplinary
   Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Science & Technology -
   Other Topics
GA BCR22
UT WOS:000230893400050
PM 15965089
DA 2024-11-01
ER

PT J
AU Shao, JY
   Li, YH
   Gao, HY
   Mai, HQ
   Zhang, Y
   Guo, XA
   Zeng, YX
AF Shao, JY
   Li, YH
   Gao, HY
   Mai, HQ
   Zhang, Y
   Guo, XA
   Zeng, YX
TI High frequency of common deletion (4981 bp) in mitochondrial DNA in
   nasopharyngeal carcinoma and its correlation with patient age and
   clinical stages
SO CANCER BIOLOGY & THERAPY
LA English
DT Article
DE nasopharyngeal carcinoma; mitochondria; DNA; common deletion; real-time
   PCR
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; GENOME; MUTATIONS; DISEASE;
   ACCUMULATION; GENETICS; SMOKING; PLASMA; TUMORS; DAMAGE
AB Mitochondrial DNA ( mtDNA) has a high mutation rate due at least in part to a lack of protective histones and an inefficient DNA repair system. The most frequently change in mtDNA is the so-called Common Deletion (CD), which accumulates in patients with heteroplasmic mtDNA mutations and in normal individuals during aging. In this study, wild type mtDNA (WT-mtDNA) and mitochondrial DNA with CD (CD-mtDNA) were quantitatively analyzed in different nasopharynx lesions. A novel type of CD-mtDNA (4981 bp) was detected significantly higher in nasopharyngeal carcinoma (NPC) (93%, 54/58) than in nasopharyngitis (60%, 28/47) and the paired white blood cells (WBC) (26%, 8/31). The ratio of CD-mtDNA to WT-mtDNA in NPC (0.000625, median) was ten times that in nasopharyngitis (0.000064, median) (P=0.003), and was significantly higher than that in paired WBC (0.000000, median) (P=0.000). The CD/WT-mtDNA ratio was 0.000564 (quartile range, 0.000184-0.000919) in late stage NPC, which was nearly three times the ratio in early stage NPC (0.000164, quartile range, 0.000042-0.000353) (P=0.015, Mann-Whitney Test). In NPC patients with ages < 48yrs (mean age), the ratio of CD-mtDNA to WT-mtDNA was 0.000625, which was nearly ten times that in NPC patients with ages < 48yrs (0.000064) (P=0.005, Mann-Whitney Test). This is the first quantitative study of CD-mtDNA mutations in NPC, which provides evidences that CD-mtDNA mutation might be involved in the development and progression of NPC.
C1 Sun Yat Sen Univ, Ctr Canc, Guangzhou 510060, Peoples R China.
C3 Sun Yat Sen University
RP Sun Yat Sen Univ, Ctr Canc, 651 Dong Feng Rd E, Guangzhou 510060, Peoples R China.
EM yxzeng@gzsums.edu.cn
RI Li, yu/HHZ-5236-2022
OI Li, Yu-hong/0000-0002-5710-9096
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Ballinger SW, 1996, CANCER RES, V56, P5692
   Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9
   Cavalli LR, 1997, CELL GROWTH DIFFER, V8, P1189
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Feng BJ, 2002, NAT GENET, V31, P395, DOI 10.1038/ng932
   FUKUSHIMA S, 1995, HEPATOLOGY, V21, P1547
   GATTERMANN N, 1995, LEUKEMIA, V9, P1704
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Horton TM, 1996, GENE CHROMOSOME CANC, V15, P95, DOI 10.1002/(SICI)1098-2264(199602)15:2<95::AID-GCC3>3.0.CO;2-Z
   Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Lee HC, 2001, MUTAT RES-GEN TOX EN, V493, P67, DOI 10.1016/S1383-5718(01)00160-7
   Lewis PD, 2000, J PATHOL, V191, P274
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Liu CS, 1997, ENVIRON MOL MUTAGEN, V30, P47, DOI 10.1002/(SICI)1098-2280(1997)30:1<47::AID-EM7>3.0.CO;2-9
   Máximo V, 2000, J PATHOL, V192, P561
   Máximo V, 2002, AM J PATHOL, V160, P1857, DOI 10.1016/S0002-9440(10)61132-7
   Máximo V, 2001, GENE CHROMOSOME CANC, V32, P136, DOI 10.1002/gcc.1175
   MIN HQ, 1994, INT J RADIAT ONCOL, V30, P1037
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Nickander KK, 2002, J PERIPHER NERV SYST, V7, P96, DOI 10.1046/j.1529-8027.2002.02012.x
   Nomoto S, 2002, CLIN CANCER RES, V8, P481
   PANG CY, 1994, ARCH BIOCHEM BIOPHYS, V312, P534, DOI 10.1006/abbi.1994.1342
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Rogounovitch TI, 2002, CANCER RES, V62, P7031
   Shao JY, 2004, CANCER, V100, P1162, DOI 10.1002/cncr.20099
   Shao JY, 2000, INT J ONCOL, V17, P1267
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Tabaku M, 1999, GENET COUNSEL, V10, P285
   Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   YAMAMOTO H, 1992, BIOCHEM BIOPH RES CO, V182, P913, DOI 10.1016/0006-291X(92)91819-C
   Zhuang Z, 1998, Cell Vis, V5, P43
NR 38
TC 14
Z9 16
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4047
EI 1555-8576
J9 CANCER BIOL THER
JI Cancer Biol. Ther.
PD DEC
PY 2004
VL 3
IS 12
BP 1270
EP 1274
DI 10.4161/cbt.3.12.1243
PG 5
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 918WJ
UT WOS:000228578000025
PM 15477759
OA Bronze
DA 2024-11-01
ER

PT J
AU Chang, TM
   Chi, CS
   Tsai, CR
   Lee, HF
   Li, MC
AF Chang, TM
   Chi, CS
   Tsai, CR
   Lee, HF
   Li, MC
TI Paralytic ileus in MELAS with phenotypic features of MNGIE
SO PEDIATRIC NEUROLOGY
LA English
DT Article
ID STROKE-LIKE EPISODES; MITOCHONDRIAL NEUROGASTROINTESTINAL
   ENCEPHALOMYOPATHY; LACTIC-ACIDOSIS; RECTAL BIOPSY; ENCEPHALOPATHY;
   OBSTRUCTION; MYOPATHY; DISORDER
AB This report describes a child having the syndrome of overlapping phenotypic features of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE). Mitochondrial DNA analysis revealed a point mutation at position A3243G, whereas activity of thymidine phosphorylase and its corresponding gene analysis were normal. The most striking feature of this case was paralysis of one segment of the terminal ileum observed on laparotomy. The electron microscopic findings of the resected ileum and colon by limited right hemicolectomy disclosed accumulation of numerous enlarged mitochondria with ill-defined cristae which were similar to mitochondria reported in three previous MELAS cases and one MNGIE case with intestinal dysmotility. We emphasize that the MELAS and MNGIE phenotypes overlapped in this case and that the mechanism of acute ileus in MELAS was associated with functional paralysis of the intestine. (C) 2004 by Elsevier Inc. All rights reserved.
C1 Taichung Vet Gen Hosp, Dept Pediat, Taichung 407, Taiwan.
   Taichung Vet Gen Hosp, Dept Pathol, Taichung 407, Taiwan.
   Taichung Vet Gen Hosp, Dept Neurol, Taichung 407, Taiwan.
C3 Taichung Veterans General Hospital; Taichung Veterans General Hospital;
   Taichung Veterans General Hospital
RP Chi, CS (corresponding author), Taichung Vet Gen Hosp, Dept Pediat, 160 Sec,3 Chung Kang Rd, Taichung 407, Taiwan.
CR Hiel JAP, 1998, NETH J MED, V53, P27, DOI 10.1016/S0300-2977(98)00018-7
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Kuroiwa T, 1998, ACTA NEUROPATHOL, V96, P86, DOI 10.1007/s004010050863
   Mori O, 2000, ACTA NEUROPATHOL, V100, P712, DOI 10.1007/s004010000209
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Perez-Atayde AR, 1998, AM J SURG PATHOL, V22, P1141, DOI 10.1097/00000478-199809000-00014
   SCHUFFLER MD, 1980, ANN SURG, V192, P752, DOI 10.1097/00000658-198012000-00011
   Shimotake T, 1998, J PEDIATR SURG, V33, P1837, DOI 10.1016/S0022-3468(98)90301-3
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Vissing J, 2002, NEUROLOGY, V59, P926, DOI 10.1212/WNL.59.6.926
   YAMAMOTO M, 1987, J NEUROL NEUROSUR PS, V50, P1475, DOI 10.1136/jnnp.50.11.1475
NR 13
TC 26
Z9 27
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD NOV
PY 2004
VL 31
IS 5
BP 374
EP 377
DI 10.1016/j.pediatrneurol.2004.05.009
PG 4
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 873WY
UT WOS:000225313400014
PM 15519124
DA 2024-11-01
ER

PT J
AU Segrè, AV
   Groop, L
   Mootha, VK
   Daly, MJ
   Altshuler, D
AF Segre, Ayellet V.
   Groop, Leif
   Mootha, Vamsi K.
   Daly, Mark J.
   Altshuler, David
CA DIAGRAM Consortium
   MAGIC Investigators
TI Common Inherited Variation in Mitochondrial Genes Is Not Enriched for
   Associations with Type 2 Diabetes or Related Glycemic Traits
SO PLOS GENETICS
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; OXIDATIVE-PHOSPHORYLATION; INSULIN-RESISTANCE;
   PATHWAY ANALYSIS; CANDIDATE GENES; LOCI; GLUCOSE; SUSCEPTIBILITY;
   HOMEOSTASIS; DYSFUNCTION
AB Mitochondrial dysfunction has been observed in skeletal muscle of people with diabetes and insulin-resistant individuals. Furthermore, inherited mutations in mitochondrial DNA can cause a rare form of diabetes. However, it is unclear whether mitochondrial dysfunction is a primary cause of the common form of diabetes. To date, common genetic variants robustly associated with type 2 diabetes (T2D) are not known to affect mitochondrial function. One possibility is that multiple mitochondrial genes contain modest genetic effects that collectively influence T2D risk. To test this hypothesis we developed a method named Meta-Analysis Gene-set Enrichment of variaNT Associations (MAGENTA; http://www.broadinstitute.org/mpg/magenta). MAGENTA, in analogy to Gene Set Enrichment Analysis, tests whether sets of functionally related genes are enriched for associations with a polygenic disease or trait. MAGENTA was specifically designed to exploit the statistical power of large genome-wide association (GWA) study meta-analyses whose individual genotypes are not available. This is achieved by combining variant association p-values into gene scores and then correcting for confounders, such as gene size, variant number, and linkage disequilibrium properties. Using simulations, we determined the range of parameters for which MAGENTA can detect associations likely missed by single-marker analysis. We verified MAGENTA's performance on empirical data by identifying known relevant pathways in lipid and lipoprotein GWA meta-analyses. We then tested our mitochondrial hypothesis by applying MAGENTA to three gene sets: nuclear regulators of mitochondrial genes, oxidative phosphorylation genes, and,1,000 nuclear-encoded mitochondrial genes. The analysis was performed using the most recent T2D GWA meta-analysis of 47,117 people and meta-analyses of seven diabetes-related glycemic traits (up to 46,186 non-diabetic individuals). This well-powered analysis found no significant enrichment of associations to T2D or any of the glycemic traits in any of the gene sets tested. These results suggest that common variants affecting nuclear-encoded mitochondrial genes have at most a small genetic contribution to T2D susceptibility.
C1 [Segre, Ayellet V.; Mootha, Vamsi K.; Daly, Mark J.; Altshuler, David] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA.
   [Segre, Ayellet V.; Mootha, Vamsi K.; Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.
   [Segre, Ayellet V.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   [Groop, Leif] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Diabet & Endocrinol Res Unit, S-21401 Malmo, Sweden.
   [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA.
   [Mootha, Vamsi K.; Daly, Mark J.; Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA USA.
   [Altshuler, David] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Dept Genet, Boston, MA USA.
C3 Harvard University; Massachusetts Institute of Technology (MIT); Broad
   Institute; Harvard University; Massachusetts General Hospital; Harvard
   University; Massachusetts General Hospital; Lund University; Skane
   University Hospital; Harvard University; Harvard Medical School; Harvard
   University; Harvard Medical School; Harvard University; Massachusetts
   General Hospital; Harvard University; Harvard Medical School
RP Segrè, AV (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA.
EM asegre@broadinstitute.org; altshuler@molbio.mgh.harvard.edu
RI Daly, Mark/B-2453-2017; Segre, Ayellet/E-9800-2010; Altshuler,
   David/A-4476-2009
OI Altshuler, David/0000-0002-7250-4107
FU American Diabetes Association [7-08-MN-OK]; Swedish Research Council;
   Wallenberg Foundation; Sigrid Juselius Foundation; American Diabetes
   Association/Smith Family Foundation
FX For this project, AVS and DA acknowledge support from the American
   Diabetes Association (Award No.: 7-08-MN-OK); LG was supported by the
   Swedish Research Council (Linne grant), the Wallenberg Foundation, and
   the Sigrid Juselius Foundation; and VKM was supported by the American
   Diabetes Association/Smith Family Foundation. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Andrulionytè L, 2004, DIABETOLOGIA, V47, P2176, DOI 10.1007/s00125-004-1577-2
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120
   Chai HS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-102
   Chasman DI, 2008, GENET EPIDEMIOL, V32, P658, DOI 10.1002/gepi.20334
   Cho YM, 2007, DIABETES RES CLIN PR, V77, pS172, DOI 10.1016/j.diabres.2007.01.052
   Dumas JF, 2009, DIABETES METAB, V35, P159, DOI 10.1016/j.diabet.2009.02.002
   Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520
   Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395
   Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068
   Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003
   Giguère V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017
   Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500
   Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z
   JIA J, MOL BIOL REPORTS
   Jin WZ, 2009, CLIN SCI, V116, P99, DOI 10.1042/CS20080090
   Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   KOVES TR, 2010, CELL METABOLISM
   Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196
   Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115
   Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378
   PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI [DOI 10.1056/NEJMOA031314, 10.1056/NEJMoa031314]
   PURCELL S, 2003, BIOINFORMATICS, V19, P149, DOI [DOI 10.1093/BIOINFORMATICS/19.1.149, 10.1093/bioinformatics/19.1.149]
   Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185
   Reiling E, 2009, EUR J HUM GENET, V17, P1056, DOI 10.1038/ejhg.2009.4
   Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438
   Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358
   Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926
   Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521
   SCHIFF M, 2009, J INHERIT METAB DIS
   Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382
   Sokal, 1995, BIOMETRY PRINCIPLES
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tapper W, 2005, P NATL ACAD SCI USA, V102, P11835, DOI 10.1073/pnas.0505262102
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001
   Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214
   VOIGHT BF, 2010, NATURE GENE IN PRESS
   WAN J, 2009, BIOCH BIOPHYS RES CO
   Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374
   Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026
   Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x
   Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120
   Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364
NR 57
TC 363
Z9 387
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD AUG
PY 2010
VL 6
IS 8
AR e1001058
DI 10.1371/journal.pgen.1001058
PG 19
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 644NG
UT WOS:000281383800014
PM 20714348
OA gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT S
AU Balasubramaniam, S
   Lewis, B
   Mock, DM
   Said, HM
   Tarailo-Graovac, M
   Mattman, A
   van Karnebeek, CD
   Thorburn, DR
   Rodenburg, RJ
   Christodoulou, J
AF Balasubramaniam, Shanti
   Lewis, B.
   Mock, D. M.
   Said, H. M.
   Tarailo-Graovac, M.
   Mattman, A.
   van Karnebeek, C. D.
   Thorburn, D. R.
   Rodenburg, R. J.
   Christodoulou, J.
BE Baumgartner, M
   Patterson, M
   Rahman, S
   Zschocke, J
   Morava, E
   Peters, V
TI Leigh-Like Syndrome Due to Homoplasmic m.8993T&gt; Variant with
   Hypocitrullinemia and Unusual Biochemical Features Suggestive of
   Multiple Carboxylase Deficiency (MCD)
SO JIMD REPORTS, VOL 33
SE JIMD Reports
LA English
DT Article; Book Chapter
ID MITOCHONDRIAL-DNA MUTATIONS; CLINICAL-FEATURES; BIOTIN TRANSPORT;
   NUCLEOTIDE 8993; CITRULLINE; MARKER; DISEASE; ACID; HYPERAMMONEMIA;
   ABNORMALITIES
AB Leigh syndrome (LS), or subacute necrotizing encephalomyelopathy, is a genetically heterogeneous, relentlessly progressive, devastating neurodegenerative disorder that usually presents in infancy or early childhood. A diagnosis of Leigh-like syndrome may be considered in individuals who do not fulfil the stringent diagnostic criteria but have features resembling Leigh syndrome.
   We describe a unique presentation of Leigh-like syndrome in a 3-year-old boy with elevated 3-hydroxyisovalerylcarnitine (C5-OH) on newborn screening (NBS). Subsequent persistent plasma elevations of C5-OH and propionylcarnitine (C3) as well as fluctuating urinary markers were suggestive of multiple carboxylase deficiency (MCD). Normal enzymology and mutational analysis of genes encoding holocarboxylase synthetase (HLCS) and biotinidase (BTD) excluded MCD. Biotin uptake studies were normal excluding biotin transporter deficiency. His clinical features at 13 months of age comprised psychomotor delay, central hypotonia, myopathy, failure to thrive, hypocitrullinemia, recurrent episodes of decompensation with metabolic keto-lactic acidosis and an episode of hyperammonemia. Biotin treatment from 13 months of age was associated with increased patient activity, alertness, and attainment of new developmental milestones, despite lack of biochemical improvements. Whole exome sequencing (WES) analysis failed to identify any other variants which could likely contribute to the observed phenotype, apart from the homoplasmic (100%) m.8993T>G variant initially detected by mitochondrial DNA (mtDNA) sequencing.
   Hypocitrullinemia has been reported in patients with the m.8993T>G variant and other mitochondrial disorders. However, persistent plasma elevations of C3 and C5-OH have previously only been reported in one other patient with this homoplasmic mutation. We suggest considering the m.8993T>G variant early in the diagnostic evaluation of MCD-like biochemical disturbances, particularly when associated with hypocitrullinemia on NBS and subsequent confirmatory tests. An oral biotin trial is also warranted.
C1 [Balasubramaniam, Shanti] Princess Margaret Hosp, Metab Unit, Dept Rheumatol & Metab Med, Perth, WA, Australia.
   [Balasubramaniam, Shanti] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia.
   [Balasubramaniam, Shanti] Childrens Hosp Westmead, Western Sydney Genet Program, Westmead, NSW, Australia.
   [Lewis, B.] Princess Margaret Hosp, PathWest Labs WA, Perth, WA, Australia.
   [Mock, D. M.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.
   [Said, H. M.] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA.
   [Tarailo-Graovac, M.] Univ British Columbia, Ctr Mol Med, Dept Med Genet, Child & Family Res Inst, Vancouver, BC, Canada.
   [Mattman, A.] Univ British Columbia, Adult Metab Dis Clin, Div Endocrinol & Metab, Vancouver, BC, Canada.
   [van Karnebeek, C. D.] Univ British Columbia, Ctr Mol Med, Dept Pediat, Child & Family Res Inst, Vancouver, BC, Canada.
   [Thorburn, D. R.; Christodoulou, J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Thorburn, D. R.; Christodoulou, J.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Thorburn, D. R.; Christodoulou, J.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Rodenburg, R. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands.
C3 Princess Margaret Hospital for Children; University of Western
   Australia; University of Western Australia; NSW Health; The Children's
   Hospital at Westmead; Sydney Childrens Hospitals Network; University of
   Sydney; University of Western Australia; Princess Margaret Hospital for
   Children; University of Arkansas System; University of Arkansas Medical
   Sciences; University of California System; University of California
   Irvine; University of British Columbia; Child & Family Research
   Institute; University of British Columbia; Child & Family Research
   Institute; University of British Columbia; Murdoch Children's Research
   Institute; Royal Children's Hospital Melbourne; Royal Children's
   Hospital Melbourne; Murdoch Children's Research Institute; Victorian
   Clinical Genetics Services; University of Melbourne; Radboud University
   Nijmegen
RP Balasubramaniam, S (corresponding author), Childrens Hosp Westmead, Western Sydney Genet Program, Westmead, NSW, Australia.
EM saras329@hotmail.com
RI Thorburn, David/G-6266-2013; Rodenburg, Richard/N-3579-2014;
   Christodoulou, John/M-3628-2019
OI Rodenburg, Richard/0000-0001-5227-3527; Christodoulou,
   John/0000-0002-8431-0641; thorburn, david/0000-0002-7725-9470;
   Tarailo-Graovac, Maja/0000-0002-4472-8584
CR Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Baumgartner MR, 2000, HUM MOL GENET, V9, P2853, DOI 10.1093/hmg/9.19.2853
   Bindoff L., 2006, Mitochondrial Medicine, P143
   Blijlevens NMA, 2004, BONE MARROW TRANSPL, V34, P193, DOI 10.1038/sj.bmt.1704563
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Crenn P, 2000, GASTROENTEROLOGY, V119, P1496, DOI 10.1053/gast.2000.20227
   Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Debray FG, 2010, J CHILD NEUROL, V25, P1000, DOI 10.1177/0883073809351983
   Degoul F, 1997, J INHERIT METAB DIS, V20, P49, DOI 10.1023/A:1005357506614
   ELLIOTT KRF, 1974, BIOCHEM J, V141, P817, DOI 10.1042/bj1410817
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Hauser N, 2014, 64 ANN M AM SOC HUM
   Henriques M, 2012, J CHILD NEUROL, V27, P1059, DOI 10.1177/0883073811431015
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Ishigami A, 2002, ARCH BIOCHEM BIOPHYS, V407, P25, DOI 10.1016/S0003-9861(02)00516-7
   Ishiyama N, 2001, J STRUCT BIOL, V136, P30, DOI 10.1006/jsbi.2001.4421
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   Kumakura A, 2009, PEDIATR NEUROL, V41, P309, DOI 10.1016/j.pediatrneurol.2009.04.028
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lutgens LCHW, 2003, INT J RADIAT ONCOL, V57, P1067, DOI 10.1016/S0360-3016(03)00781-8
   MOCK DM, 1997, METHOD ENZYMOL, P265
   Mori M, 2014, JIMD REP, V17, P47, DOI 10.1007/8904_2014_332
   MORIN C, 1993, AM J HUM GENET, V53, P488
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   Rabier D, 1998, J INHERIT METAB DIS, V21, P216, DOI 10.1023/A:1005391300203
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   RIBES A, 1993, J INHERIT METAB DIS, V16, P537, DOI 10.1007/BF00711675
   SAID HM, 1988, GASTROENTEROLOGY, V94, P68, DOI 10.1016/0016-5085(88)90611-7
   Said HM, 1998, AM J PHYSIOL-CELL PH, V275, pC1365, DOI 10.1152/ajpcell.1998.275.5.C1365
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Sofou K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-52
   SPECTOR R, 1988, NEUROCHEM RES, V13, P213, DOI 10.1007/BF00971535
   SPECTOR R, 1987, J NEUROCHEM, V48, P400, DOI 10.1111/j.1471-4159.1987.tb04107.x
   Thorburn DR, 2014, GENEREVIEWS, P1993
   van Karnebeek CD, 2014, AM J HUM GENET, V94, P453, DOI 10.1016/j.ajhg.2014.01.006
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
NR 42
TC 12
Z9 14
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
BN 978-3-662-55012-0; 978-3-662-55011-3
J9 JIMD REP
PY 2017
VL 33
BP 99
EP 107
DI 10.1007/8904_2016_559
D2 10.1007/978-3-662-55012-0
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity
WE Book Citation Index – Science (BKCI-S)
SC Endocrinology & Metabolism; Genetics & Heredity
GA BI0RW
UT WOS:000405120800014
PM 27450367
OA Green Published
DA 2024-11-01
ER

PT J
AU Boczonadi, V
   King, MS
   Smith, AC
   Olahova, M
   Bansagi, B
   Roos, A
   Eyassu, F
   Borchers, C
   Ramesh, V
   Lochmüller, H
   Polvikoski, T
   Whittaker, RG
   Pyle, A
   Griffin, H
   Taylor, RW
   Chinnery, PF
   Robinson, AJ
   Kunji, ERS
   Horvath, R
AF Boczonadi, Veronika
   King, Martin S.
   Smith, Anthony C.
   Olahova, Monika
   Bansagi, Boglarka
   Roos, Andreas
   Eyassu, Filmon
   Borchers, Christoph
   Ramesh, Venkateswaran
   Lochmueller, Hanns
   Polvikoski, Tuomo
   Whittaker, Roger G.
   Pyle, Angela
   Griffin, Helen
   Taylor, Robert W.
   Chinnery, Patrick F.
   Robinson, Alan J.
   Kunji, Edmund R. S.
   Horvath, Rita
TI Mitochondrial oxodicarboxylate carrier deficiency is associated with
   mitochondrial DNA depletion and spinal muscular atrophy-like disease
SO GENETICS IN MEDICINE
LA English
DT Article
DE metabolite transport; metabolomics; mitochondrial respiratory chain
   deficiency; neural toxicity; spinal motor atrophy
ID KYNURENINE PATHWAY; MUTATIONS; EXPRESSION; PROTEIN; DHTKD1;
   IDENTIFICATION; METABOLISM; ASTROCYTES; ZELLWEGER; MYOPATHY
AB Purpose: To understand the role of the mitochondrial oxodicarboxylate carrier (SLC25A21) in the development of spinal muscular atrophy-like disease.
   Methods: We identified a novel pathogenic variant in a patient by whole-exome sequencing. The pathogenicity of the mutation was studied by transport assays, computer modeling, followed by targeted metabolic testing and in vitro studies in human fibroblasts and neurons.
   Results: The patient carries a homozygous pathogenic variant c.695A > G; p.(Lys232Arg) in the SLC25A21 gene, encoding the mitochondrial oxodicarboxylate carrier, and developed spinal muscular atrophy and mitochondrial myopathy. Transport assays show that the mutation renders SLC25A21 dysfunctional and 2-oxoadipate cannot be imported into the mitochondrial matrix. Computer models of central metabolism predicted that impaired transport of oxodicarboxylate disrupts the pathways of lysine and tryptophan degradation, and causes accumulation of 2-oxoadipate, pipecolic acid, and quinolinic acid, which was confirmed in the patient's urine by targeted metabolomics. Exposure to 2-oxoadipate and quinolinic acid decreased the level of mitochondrial complexes in neuronal cells (SH-SY5Y) and induced apoptosis.
   Conclusion: Mitochondrial oxodicarboxylate carrier deficiency leads to mitochondrial dysfunction and the accumulation of oxoadipate and quinolinic acid, which in turn cause toxicity in spinal motor neurons leading to spinal muscular atrophy-like disease.
C1 [Boczonadi, Veronika; Bansagi, Boglarka; Roos, Andreas; Lochmueller, Hanns; Pyle, Angela; Griffin, Helen; Horvath, Rita] Newcastle Univ, Inst Genet Med, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [King, Martin S.; Smith, Anthony C.; Eyassu, Filmon; Chinnery, Patrick F.; Robinson, Alan J.; Kunji, Edmund R. S.] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England.
   [Olahova, Monika; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Roos, Andreas] Leibniz Inst Analyt Sci ISAS, Dortmund, Germany.
   [Borchers, Christoph] UVic Genome BC Prote Ctr, Vancouver, BC, Canada.
   [Ramesh, Venkateswaran] Newcastle Upon Tyne Fdn Hosp NHS Trust, Royal Victoria Infirm, Dept Paediat Neurol, Newcastle Upon Tyne, Tyne & Wear, England.
   [Polvikoski, Tuomo] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England.
   [Whittaker, Roger G.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
C3 Newcastle University - UK; UK Research & Innovation (UKRI); Medical
   Research Council UK (MRC); University of Cambridge; Newcastle University
   - UK; Dortmund University of Technology; Leibniz Institut fur
   Analytische Wissenschaften (ISAS); University of Victoria; Newcastle
   Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK;
   Newcastle University - UK; Newcastle University - UK; University of
   Cambridge
RP Horvath, R (corresponding author), Newcastle Univ, Inst Genet Med, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.; Kunji, ERS (corresponding author), Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England.
EM ek@mrc-mbu.cam.ac.uk; rita.horvath@ncl.ac.uk
RI King, Martin/B-6361-2012; Horvath, Rita/AAY-7042-2020; BORCHERS,
   Christoph/U-5964-2019; Smith, Anthony/B-1891-2009; Kunji,
   Edmund/AAH-2362-2020
OI Horvath, Rita/0000-0002-9841-170X; King, Martin/0000-0001-6030-5154;
   Griffin, Helen R/0000-0002-5288-3322; Whittaker,
   Roger/0000-0002-3403-0182; Chinnery, Patrick/0000-0002-7065-6617; Smith,
   Anthony/0000-0003-0141-0434; Kunji, Edmund/0000-0002-0610-4500
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z,
   109915/Z/15/Z]; Medical Research Council (UK) [MR/N025431/1]; European
   Research Council [309548]; Newton Fund (UK/Turkey) [MR/N027302/1];
   European Union Seventh Framework Programme (FP7/2007-2013) [305444,
   305121]; Ministerium fur Innovation, Wissenschaft und Forschung des
   Landes Nordrhein-Westfalen; Senatsverwaltung fur Wirtschaft, Technologie
   und Forschung des Landes Berlin; Bundesministerium fur Bildung und
   Forschung; Lily Foundation; UK NHS Highly Specialised Service for Rare
   Mitochondrial Disorders of Adults and Children - Medical Research
   Council; Marie-Curie Initial Training Networks grant MEET (Mitochondrial
   European Educational Training Project) [317433]; Medical Research
   Council [MC_U105663139, MC_U105674181]; Wellcome Trust Pathfinder Scheme
   [201064/Z/16/Z]; MRC [MR/N025431/2, MR/N025431/1, MC_U105663139,
   G1000848, G0800674, MR/N010035/1, MC_U105674181, MC_UU_00015/1] Funding
   Source: UKRI; Newton Fund [MR/N027302/1, MR/N027302/2] Funding Source:
   UKRI
FX R.H. is aWellcome Trust Investigator (109915/Z/15/Z), who receives
   support from the Wellcome Centre for Mitochondrial Research
   (203105/Z/16/Z), Medical Research Council (UK) (MR/N025431/1), the
   European Research Council (309548), the Wellcome Trust Pathfinder Scheme
   (201064/Z/16/Z), and the Newton Fund (UK/Turkey, MR/N027302/1). H.L.
   receives funding from the European Union Seventh Framework Programme
   (FP7/2007-2013) under grant agreement no. 305444 (RD-Connect) and 305121
   (Neuromics). A.R. acknowledges the financial support by the Ministerium
   fur Innovation, Wissenschaft und Forschung des Landes
   Nordrhein-Westfalen, the Senatsverwaltung fur Wirtschaft, Technologie
   und Forschung des Landes Berlin, and the Bundesministerium fur Bildung
   und Forschung. R.W.T. is supported by the Wellcome Centre for
   Mitochondrial Research (203105/Z/16/Z), the Medical Research Council
   Centre for Translational Research in Neuromuscular Disease,
   Mitochondrial Disease Patient Cohort (UK) (G0800674), the Lily
   Foundation, and the UK NHS Highly Specialised Service for Rare
   Mitochondrial Disorders of Adults and Children. This research was funded
   by the Medical Research Council through programme grant MC_U105663139 to
   M.S.K. and E.R.S.K. and MC_U105674181 to A.C.S., F.E., and A.J.R. R.H.
   and E.R.S.K. also gratefully acknowledge the Marie-Curie Initial
   Training Networks grant MEET (Mitochondrial European Educational
   Training Project, grant agreement 317433) for the collaboration.
CR Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   BANOS G, 1978, J PHYSIOL-LONDON, V280, P471, DOI 10.1113/jphysiol.1978.sp012395
   Bansagi B, 2017, NEUROLOGY, V88, P1226, DOI 10.1212/WNL.0000000000003772
   Barker JE, 1996, DEV NEUROSCI-BASEL, V18, P391, DOI 10.1159/000111432
   Bartsakoulia Marina, 2016, J Neuromuscul Dis, V3, P363
   Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Boy N, 2013, J INHERIT METAB DIS, V36, P525, DOI 10.1007/s10545-012-9517-7
   Braidy N, 2009, NEUROTOX RES, V16, P77, DOI 10.1007/s12640-009-9051-z
   Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3
   Cappello AR, 2007, J MOL BIOL, V369, P400, DOI 10.1016/j.jmb.2007.03.048
   Chen YQ, 2011, J NEUROCHEM, V118, P816, DOI 10.1111/j.1471-4159.2010.07159.x
   DANCIS J, 1986, AM J HUM GENET, V38, P707
   Danhauser K, 2012, AM J HUM GENET, V91, P1082, DOI 10.1016/j.ajhg.2012.10.006
   Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200
   GOVAERTS L, 1982, EUR J PEDIATR, V139, P125, DOI 10.1007/BF00441495
   Han J, 2013, ELECTROPHORESIS, V34, P2891, DOI 10.1002/elps.201200601
   Houten SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-57
   KELLEY RI, 1984, AM J MED GENET, V19, P791, DOI 10.1002/ajmg.1320190420
   King MS, 2016, BBA-BIOENERGETICS, V1857, P14, DOI 10.1016/j.bbabio.2015.09.013
   King MS, 2015, METHOD ENZYMOL, V556, P77, DOI 10.1016/bs.mie.2014.12.009
   Lugo-Huitrón R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/104024
   MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127
   Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005
   Meyertholen K, 2012, MOL SYNDROMOL, V3, P25, DOI 10.1159/000339177
   Monné M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92
   Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006
   Shamseldin HE, 2016, HUM GENET, V135, P21, DOI 10.1007/s00439-015-1608-8
   Smith AC, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0500-7
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Tondo M, 2013, MOL GENET METAB, V110, P231, DOI 10.1016/j.ymgme.2013.06.021
   TRANCHANT C, 1993, NEUROLOGY, V43, P2044, DOI 10.1212/WNL.43.10.2044
   Vamos E, 2009, J NEUROL SCI, V283, P21, DOI 10.1016/j.jns.2009.02.326
   Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591
   Xu WY, 2012, AM J HUM GENET, V91, P1088, DOI 10.1016/j.ajhg.2012.09.018
   Xu WY, 2013, FEBS LETT, V587, P3587, DOI 10.1016/j.febslet.2013.08.047
NR 41
TC 34
Z9 35
U1 1
U2 11
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1098-3600
EI 1530-0366
J9 GENET MED
JI Genet. Med.
PD OCT
PY 2018
VL 20
IS 10
BP 1224
EP 1235
DI 10.1038/gim.2017.251
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA GY6AF
UT WOS:000448665700016
PM 29517768
OA Green Accepted, hybrid, Green Submitted
DA 2024-11-01
ER

PT J
AU Schröder, JM
   Züchner, S
   Dichgans, M
   Nagy, Z
   Molnar, MJ
AF Schröder, JM
   Züchner, S
   Dichgans, M
   Nagy, Z
   Molnar, MJ
TI Peripheral nerve and skeletal muscle involvement in CADASIL
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE CADASIL; notch3 mutations; neuropathy; myopathy; mitochondrial DNA
ID AUTOSOMAL-DOMINANT ARTERIOPATHY; HUMAN MITOCHONDRIAL-DNA; HUMAN SURAL
   NERVES; SUBCORTICAL INFARCTS; NOTCH3 MUTATIONS; BLOOD-VESSELS;
   LEUKOENCEPHALOPATHY CADASIL; SKIN BIOPSIES; HEREDITARY; NEUROPATHY
AB Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is characterized by degeneration of vascular smooth muscle cells (VSMC) of nearly all tissues studied so far. The clinical phenotype of CADASIL shows great variability. The disease is caused by mutations of the Notch3 gene encoding the transmembrane receptor Notch3, which is expressed predominantly in VSMC. In some patients, neuromuscular symptoms have been described. To investigate the fine structural features of peripheral nerve and muscle biopsy specimens in more cases and greater detail, seven electron microscopically confirmed CADASIL patients showing a variable amount of granular osmiophilic material on the surface of VSMC were included in this study. Pathogenic mutations within the cluster region (exon 3 and 4) of the Notch3 gene were identified in six cases. Degeneration and regeneration of nerve fibers in the sural nerves, studied in four cases, was present, although moderate, in all nerve biopsy specimens, whereas an intramuscular nerve fascicle showed more severe changes. Enlarged mitochondria with needle-like calcium precipitates were repeatedly seen. In muscle biopsy specimens, some degree of neurogenic atrophy was apparent in addition to myopathic changes, including occasional ragged red fibers with abnormally large mitochondria, focal tubular aggregates, abnormal terminal cisternae, and myofibrillary abnormalities. Automated sequence analysis of the whole mitochondrial DNA performed in one patient revealed several nucleotide polymorphisms, which were not considered pathogenic. The findings suggest that in CADASIL degeneration of small blood vessels is initiated by defects of the surface membrane of VSMC. Dysfunction of these blood vessels may cause low-grade chronic ischemia with secondary hypoxidosis and a large variety of structural changes noted in skeletal muscle and peripheral nerves, although a primary influence of the underlying genetic defect can not be excluded.
C1 Univ Hosp Aachen, Dept Neuropathol, Rhein Westfal TH Aachen, D-52074 Aachen, Germany.
   Natl Inst Psychiat & Neurol, H-1021 Budapest, Hungary.
   Univ Munich, Dept Neurol, Klinikum Grosshadern, Munich, Germany.
C3 RWTH Aachen University; RWTH Aachen University Hospital; University of
   Munich
RP Univ Hosp Aachen, Dept Neuropathol, Rhein Westfal TH Aachen, Pauwelstr 30, D-52074 Aachen, Germany.
EM molnarm@opni.hu
RI Dichgans, Martin/HCH-3247-2022; Nagy, Zoltan/E-8067-2014
OI Nagy, Zoltan/0000-0001-9756-5427
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], 2001, PATHOLOGY PERIPHERAL
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   BAUDRIMONT M, 1993, STROKE, V24, P122, DOI 10.1161/01.STR.24.1.122
   Bergmann M, 1996, ACTA NEUROPATHOL, V92, P341, DOI 10.1007/s004010050528
   CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5
   Chawda SJ, 2000, NEURORADIOLOGY, V42, P249, DOI 10.1007/s002340050880
   CHEN YS, 1995, AM J HUM GENET, V57, P133
   de la Peña P, 2001, NEUROLOGY, V57, P1235, DOI 10.1212/WNL.57.7.1235
   Dichgans M, 2000, EUR J HUM GENET, V8, P280, DOI 10.1038/sj.ejhg.5200460
   Dichgans M, 2002, J NEUROL SCI, V203, P77, DOI 10.1016/S0022-510X(02)00270-8
   Dichgans M, 1998, ANN NEUROL, V44, P731, DOI 10.1002/ana.410440506
   Finnilä S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268
   Goebel HH, 1997, MUSCLE NERVE, V20, P625, DOI 10.1002/(SICI)1097-4598(199705)20:5<625::AID-MUS17>3.0.CO;2-V
   GREHL H, 1991, ACTA NEUROPATHOL, V81, P680, DOI 10.1007/BF00296380
   Haritoglou C, 2004, AM J OPHTHALMOL, V138, P302, DOI 10.1016/j.ajo.2004.02.073
   Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047
   Joutel A, 2004, AM J HUM GENET, V74, P338, DOI 10.1086/381506
   Joutel A, 2001, LANCET, V358, P2049, DOI 10.1016/S0140-6736(01)07142-2
   Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5
   Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0
   Kalaria RN, 2004, J NEUROL SCI, V226, P35, DOI 10.1016/j.jns.2004.09.008
   Kalimo H, 2002, BRAIN PATHOL, V12, P371
   Malandrini A, 2002, NEUROLOGY, V59, P617, DOI 10.1212/WNL.59.4.617
   MARZUKI S, 1991, HUM GENET, V88, P139
   Mawrin C, 2001, ACTA NEUROPATHOL, V102, P364
   Mayer M, 1999, J NEUROL, V246, P526, DOI 10.1007/s004150050398
   Müller HD, 2001, ACTA NEUROPATHOL, V102, P27
   Nukada H, 1996, BRAIN, V119, P1449, DOI 10.1093/brain/119.5.1449
   Oberstein SAJL, 2003, ACTA NEUROPATHOL, V106, P107, DOI 10.1007/s00401-003-0701-6
   Opherk C, 2004, BRAIN, V127, P2533, DOI 10.1093/brain/awh282
   Peters N, 2004, EXP CELL RES, V299, P454, DOI 10.1016/j.yexcr.2004.06.004
   Prakash N, 2002, EXP CELL RES, V278, P31, DOI 10.1006/excr.2002.5544
   Rafalowska J, 2003, ACTA NEUROPATHOL, V106, P569, DOI 10.1007/s00401-003-0764-4
   Rubio A, 1997, ACTA NEUROPATHOL, V94, P247, DOI 10.1007/s004010050700
   Ruchoux MM, 1998, NEUROPATH APPL NEURO, V24, P60
   RUCHOUX MM, 1995, ACTA NEUROPATHOL, V89, P500
   Ruchoux MM, 2002, ANN NY ACAD SCI, V977, P224, DOI 10.1111/j.1749-6632.2002.tb04819.x
   Ruchoux MM, 2003, AM J PATHOL, V162, P329, DOI 10.1016/S0002-9440(10)63824-2
   SCHRODER JM, 1995, ACTA NEUROPATHOL, V89, P116, DOI 10.1007/BF00296354
   SCHRODER JM, 1993, BRAIN PATHOL, V3, P177, DOI 10.1111/j.1750-3639.1993.tb00742.x
   SCHRODER JM, 1991, ACTA NEUROPATHOL, V82, P471, DOI 10.1007/BF00293381
   SCHRODER JM, 1986, ACTA NEUROPATHOL, V72, P29, DOI 10.1007/BF00687944
   Schutz G, 1997, CELL TISSUE RES, V290, P31, DOI 10.1007/s004410050904
   Senderek J, 1998, ACTA NEUROPATHOL, V95, P443, DOI 10.1007/s004010050823
   SOURANDER P, 1977, ACTA NEUROPATHOL, V39, P247, DOI 10.1007/BF00691704
   Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33
   TOURNIERLASSERVE E, 1991, STROKE, V22, P1297, DOI 10.1161/01.STR.22.10.1297
   TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256
   Vielhaber S, 2001, J NEUROPATH EXP NEUR, V60, P1032, DOI 10.1093/jnen/60.11.1032
   Walsh JS, 2000, J AM ACAD DERMATOL, V43, P1125, DOI 10.1067/mjd.2000.110895
NR 51
TC 27
Z9 30
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD DEC
PY 2005
VL 110
IS 6
BP 587
EP 599
DI 10.1007/s00401-005-1082-9
PG 13
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA 992AW
UT WOS:000233857200007
PM 16328531
DA 2024-11-01
ER

PT J
AU Di Fonzo, A
   Ronchi, D
   Lodi, T
   Fassone, E
   Tigano, M
   Lamperti, C
   Corti, S
   Bordoni, A
   Fortunato, F
   Nizzardo, M
   Napoli, L
   Donadoni, C
   Salani, S
   Saladino, F
   Moggio, M
   Bresolin, N
   Ferrero, I
   Comi, GP
AF Di Fonzo, Alessio
   Ronchi, Dario
   Lodi, Tiziana
   Fassone, Elisa
   Tigano, Marco
   Lamperti, Costanza
   Corti, Stefania
   Bordoni, Andreina
   Fortunato, Francesco
   Nizzardo, Monica
   Napoli, Laura
   Donadoni, Chiara
   Salani, Sabrina
   Saladino, Francesca
   Moggio, Maurizio
   Bresolin, Nereo
   Ferrero, Iliana
   Comi, Giacomo P.
TI The Mitochondrial Disulfide Relay System Protein GFER Is Mutated in
   Autosomal-Recessive Myopathy with Cataract and Combined
   Respiratory-Chain Deficiency
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID CYTOCHROME-C-OXIDASE; INTERMEMBRANE SPACE; LIVER-REGENERATION;
   SACCHAROMYCES-CEREVISIAE; SULFHYDRYL OXIDASE; SKELETAL-MUSCLE;
   AUGMENTOR; IDENTIFICATION; DISORDERS; MUTATIONS
AB A disulfide relay system (DRS) was recently identified in the yeast mitochondrial intermembrane space (IMS) that consists of two essential components: the sulfhydryl oxidase Erv1 and the redox-regulated import receptor Mia40. The DRS drives the import of cysteine-rich proteins into the IMS via an oxidative folding mechanism. Erv1p is reoxidized within this system, transferring its electrons to molecular oxygen through interactions with cytochrome c and cytochrome c oxidase (COX), thereby linking the DRS to the respiratory chain. The role of the human Erv1 ortholog, GFER, in the DRS has been poorly explored. Using homozygosity mapping, we discovered that a mutation in the GFER gene causes an infantile mitochondrial disorder. Three children born to healthy consanguineous parents presented with progressive myopathy and partial combined respiratory-chain deficiency, congenital cataract, sensorineural hearing loss, and developmental delay. The consequences of the mutation at the level of the patient's muscle tissue and fibroblasts were 1) a reduction in complex I, II, and IV activity; 2) a lower cysteine-rich protein content; 3) abnormal ultrastructural morphology of the mitochondria, with enlargement of the IMS space; and 4) accelerated time-dependent accumulation of multiple mtDNA deletions. Moreover, the Saccharomyces cerevisiae erv1(R182H) mutant strain reproduced the complex IV activity defect and exhibited genetic instability of the mtDNA and mitochondrial morphological defects. These findings shed light on the mechanisms of mitochondrial biogenesis, establish the role of GFER in the human DRS, and promote an understanding of the pathogenesis of a new mitochondrial disease.
C1 [Di Fonzo, Alessio; Ronchi, Dario; Fassone, Elisa; Lamperti, Costanza; Corti, Stefania; Bordoni, Andreina; Fortunato, Francesco; Nizzardo, Monica; Napoli, Laura; Donadoni, Chiara; Salani, Sabrina; Saladino, Francesca; Moggio, Maurizio; Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Dino Ferrari Ctr, Dept Neurol Sci, I-20122 Milan, Italy.
   [Di Fonzo, Alessio; Ronchi, Dario; Fassone, Elisa; Lamperti, Costanza; Corti, Stefania; Bordoni, Andreina; Fortunato, Francesco; Nizzardo, Monica; Napoli, Laura; Donadoni, Chiara; Salani, Sabrina; Saladino, Francesca; Moggio, Maurizio; Bresolin, Nereo; Comi, Giacomo P.] Osped Maggiore Policlin, Fdn IRCCS, I-20122 Milan, Italy.
   [Lodi, Tiziana; Tigano, Marco; Ferrero, Iliana] Univ Parma, Dept Genet Anthropol & Evolut, I-43100 Parma, Italy.
   [Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy.
   [Bresolin, Nereo] IRCCS Eugenio Medea, I-23842 Bosisio Parini, Lecco, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico;
   University of Parma; University of Milan; IRCCS Eugenio Medea
RP Comi, GP (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Neurol Sci, I-20122 Milan, Italy.
EM giacomo.comi@unimi.it
RI lamperti, costanza/J-8801-2016; Di Fonzo, Alessio/A-5702-2013; Comi,
   Giacomo/K-5702-2016; Ronchi, Dario/K-8011-2016; corti,
   stefania/K-6034-2016; Lodi, Tiziana/A-5993-2012; Nizzardo,
   Monica/J-1817-2015
OI Ripolone, Michela/0000-0001-9293-6823; Napoli,
   Laura/0000-0003-4607-8084; Bresolin, Nereo/0000-0001-6694-3595; corti,
   stefania/0000-0001-5425-969X; Ronchi, Dario/0000-0002-6093-9816; Comi,
   Giacomo/0000-0002-1383-5248; Di Fonzo, Alessio/0000-0001-6478-026X;
   Tigano, Marco/0000-0002-4353-9220; Lodi, Tiziana/0000-0002-7294-8971;
   Nizzardo, Monica/0000-0001-5447-0882
FU Italian Ministry of University [PRIN 2006 2006069034]; Italian Ministry
   of Health; Telethon Network of Genetics Biobanks [GTB 07001E];
   Eurobiobank [QLTR-2001-02769]
FX We wish to thank the patients and their families for their support and
   collaboration. This research received support from Associazione Amici
   del Centro Dino Ferrari. G.RC. and I F. received funding from Research
   Grant PRIN 2006 2006069034 from the Italian Ministry of University and
   Research for the project entitled "An integrated approach to the Study
   of the etiopathogenesis of mitochondrial disorders." G.RC. was also
   funded by the Italian Ministry of Health for the 2009 project entitled
   "Mitochondrial disorders: From medical genetics to molecular mechanisms,
   toward the development of therapeutic strategies." The Telethon Network
   of Genetics Biobanks (no. GTB 07001E) was the source of muscle, DNA, and
   cells used in this study. Eurobiobank project QLTR-2001-02769 is also
   gratefully acknowledged. We thank M. Aguennouz and V. Bonifati for
   providing DNA from healthy Moroccan Subjects. We also thank T. G. Weiss
   for providing a control GFER antibody.
CR Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Becher D, 1999, YEAST, V15, P1171, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1171::AID-YEA443>3.0.CO;2-T
   Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123
   BRESOLIN N, 1985, NEUROLOGY, V35, P802, DOI 10.1212/WNL.35.6.802
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dubowitz V., 1985, MUSCLE BIOPSY PRACTI, V2nd
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   FRANCAVILLA A, 1994, HEPATOLOGY, V20, P747, DOI 10.1002/hep.1840200328
   Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951
   HECKMATT JZ, 1984, MUSCLE NERVE, V7, P594
   Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571
   Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003
   Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197
   Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x
   Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011
   Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200
   Périé S, 2006, NEUROMUSCULAR DISORD, V16, P770, DOI 10.1016/j.nmd.2006.07.022
   Salani S, 2004, MUSCLE NERVE, V30, P366, DOI 10.1002/mus.20106
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014
   Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019
   VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157
   Wharton D.C., 1967, Methods Enzymol, V10, P245, DOI [10.1016/0076-6879(67)10048-7, DOI 10.1016/0076-6879(67)10048-7]
   Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.3.CO;2-0
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
NR 31
TC 108
Z9 120
U1 0
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD MAY 15
PY 2009
VL 84
IS 5
BP 594
EP 604
DI 10.1016/j.ajhg.2009.04.004
PG 11
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 449OB
UT WOS:000266338800004
PM 19409522
OA Bronze, Green Accepted, Green Published
DA 2024-11-01
ER

PT J
AU Gamba, J
   Kiyomoto, BH
   de Oliveira, ASB
   Gabbai, AA
   Schmidt, B
   Tengan, CH
AF Gamba, Juliana
   Kiyomoto, Beatriz Hitomi
   Bulle de Oliveira, Acary Souza
   Gabbai, Alberto Alain
   Schmidt, Beny
   Tengan, Celia Harumi
TI The mutations m.5628T&gt;C and m18348A&gt;G in single muscle fibers of a
   patient with chronic progressive external ophthalmoplegia
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE mtDNA; tRNA; CPEO; Mitochondria; Mitochondrial diseases; Mutation;
   Polymorphism
ID MITOCHONDRIAL-DNA MUTATIONS; TRNA(LYS) GENE; TRANSFER-RNAS;
   HEARING-LOSS; DISEASE; DISORDER; SEQUENCE; GENOME
AB We identified a double mutation in a patient with chronic progressive external ophthalmoplegia, located in the tRNA(Ala) (m.5628T > C) and tRNA(LYs) (m.8348A > G) genes. Both mutations were previously described separately and considered pathogenic, however the same mutations were also reported as polymorphisms or phenotype modulator. We analyzed the proportion of each mutation in isolated muscle fibers by single fiber-polymerase chain reaction to investigate the contribution of each mutation to mitochondrial deficiency. Our findings demonstrated that the mutations were heteroplasmic in skeletal muscle and both mutations were present in all single muscle fibers. The proportions of the m.5628T > C mutation were not significantly different between normal and cytochrome-c-oxidase (COX) deficient fibers. However, a significant higher proportion of the m.8348A > G mutation was observed in COX deficient fibers. Homoplasmic m.8348A > G was only observed in COX negative fibers. In conclusion, we provide a piece of evidence toward the pathogenicity of the m.8348A > G mutation and suggest that m.5628T > C is probably a neutral polymorphism. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Gamba, Juliana; Kiyomoto, Beatriz Hitomi; Bulle de Oliveira, Acary Souza; Gabbai, Alberto Alain; Tengan, Celia Harumi] Univ Fed Sao Paulo, Dept Neurol & Neurosurg, Escola Paulista Med, BR-04039032 Sao Paulo, Brazil.
   [Schmidt, Beny] Univ Fed Sao Paulo, Dept Pathol, Escola Paulista Med, BR-04039032 Sao Paulo, Brazil.
C3 Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao
   Paulo (UNIFESP)
RP Tengan, CH (corresponding author), Univ Fed Sao Paulo, Dept Neurol & Neurosurg, Escola Paulista Med, Rua Pedro Toledo 781,7th Floor, BR-04039032 Sao Paulo, Brazil.
EM chtengan@unifesp.br
RI Tengan, Celia/D-8458-2013
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
FX This study was supported by research grants from Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) to CHT. JG received a
   scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES). We are thankful to Prof. Carlos T. Moraes for his
   helpful discussion.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], A Human Mitochondrial Genome Database
   Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Bertolin C, 2011, J HUM GENET, V56, P869, DOI 10.1038/jhg.2011.111
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Crispim D, 2008, ARQ BRAS ENDOCRINOL, V52, P1228, DOI 10.1590/S0004-27302008000800005
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Finsterer J, 2010, ACTA NEUROL BELG, V110, P110
   Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111
   Han DY, 2007, BIOCHEM BIOPH RES CO, V357, P554, DOI 10.1016/j.bbrc.2007.03.199
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Kato T, 2010, J HUM GENET, V55, P147, DOI 10.1038/jhg.2009.143
   Mamit-tRNA, 2007, COMP MAMM MIT TRNA G
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Moraes C T, 1996, Methods Enzymol, V264, P522, DOI 10.1016/S0076-6879(96)64046-4
   Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33
   Terasaki F, 2001, JPN CIRC J, V65, P691, DOI 10.1253/jcj.65.691
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   Zhu Y, 2009, MITOCHONDRION, V9, P418, DOI 10.1016/j.mito.2009.07.006
NR 27
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD SEP 15
PY 2012
VL 320
IS 1-2
BP 131
EP 135
DI 10.1016/j.jns.2012.05.037
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 000JC
UT WOS:000308381600025
PM 22743145
DA 2024-11-01
ER

PT J
AU Kierdaszuk, B
   Kaliszewska, M
   Rusecka, J
   Kosinska, J
   Bartnik, E
   Tonska, K
   Kaminska, AM
   Kostera-Pruszczyk, A
AF Kierdaszuk, Biruta
   Kaliszewska, Magdalena
   Rusecka, Joanna
   Kosinska, Joanna
   Bartnik, Ewa
   Tonska, Katarzyna
   Kaminska, Anna M.
   Kostera-Pruszczyk, Anna
TI Progressive External Ophthalmoplegia in Polish Patients-From Clinical
   Evaluation to Genetic Confirmation
SO GENES
LA English
DT Article
DE mitochondrial disorders; progressive external ophthalmoplegia; POLG
   gene; TWNK gene; RNASEH1 gene; mitochondrial DNA deletions; multiple
   mitochondrial DNA deletions; muscle biopsy
AB Mitochondrial encephalomyopathies comprise a group of heterogeneous disorders resulting from impaired oxidative phosphorylation (OxPhos). Among a variety of symptoms progressive external ophthalmoplegia (PEO) seems to be the most common. The aim of this study is to present clinical and genetic characteristics of Polish patients with PEO. Clinical, electrophysiological, neuroradiological, and morphological data of 84 patients were analyzed. Genetic studies of mitochondrial DNA (mtDNA) were performed in all patients. Among nuclear DNA (nDNA) genes POLG was sequenced in 41 patients, TWNK (C10orf2) in 13 patients, and RNASEH1 in 2 patients. Total of 27 patients were included in the chronic progressive external ophthalmoplegia (CPEO) group, 24 in the CPEO+ group. Twenty-six patients had mitochondrial encephalomyopathy (ME), six patients Kearns-Sayre syndrome (KSS), and one patient sensory ataxic neuropathy, dysarthria, ophthalmoparesis (SANDO) syndrome. Genetic analysis of nDNA genes revealed the presence of pathogenic or possibly pathogenic variants in the POLG gene in nine patients, the TWNK gene in five patients and the RNASEH1 gene in two patients. Detailed patients' history and careful assessment of family history are essential in the diagnostic work-up. Genetic studies of both mtDNA and nDNA are necessary for the final diagnosis of progressive external ophthalmoplegia and for genetic counseling.
C1 [Kierdaszuk, Biruta; Kaminska, Anna M.; Kostera-Pruszczyk, Anna] Med Univ Warsaw, Dept Neurol, Banacha 1a, PL-02097 Warsaw, Poland.
   [Kaliszewska, Magdalena; Rusecka, Joanna; Bartnik, Ewa; Tonska, Katarzyna] Univ Warsaw, Inst Genet & Biotechnol, Fac Biol, Pawinskiego 5a, PL-02106 Warsaw, Poland.
   [Kosinska, Joanna] Med Univ Warsaw, Dept Med Genet, Pawinskiego 3c, PL-02106 Warsaw, Poland.
C3 Medical University of Warsaw; University of Warsaw; Medical University
   of Warsaw
RP Kierdaszuk, B (corresponding author), Med Univ Warsaw, Dept Neurol, Banacha 1a, PL-02097 Warsaw, Poland.
EM bkierdaszuk@wum.edu.pl; mkaliszewska@gmail.com; ruseckaj@gmail.com;
   joanna.kosinska@wum.edu.pl; ebartnik@igib.uw.edu.pl;
   kaska@igib.uw.edu.pl; amkaminska@wum.edu.pl;
   anna.kostera-pruszczyk@wum.edu.pl
OI Kierdaszuk, Biruta/0000-0002-8072-2497; Kostera-Pruszczyk,
   Anna/0000-0002-7309-1914; Kaliszewska, Magdalena/0000-0003-3649-4375;
   Bartnik, Ewa/0000-0003-0489-7102; Tonska, Katarzyna/0000-0002-1793-6089;
   Rusecka, Joanna/0000-0002-6936-9645
FU Ministry of Science and Higher Education [N N401 049238]; Polish
   National Science Center [2014/15/B/NZ5/00434]; EU Operational Programme
   Innovative Economy via the Foundation for Polish Science
   [VENTURES/2011-8/3]
FX Department of Neurology is a member of European Reference Network of
   Rare Diseases: EURO-NMD. This work was supported by grant N N401 049238
   from the Ministry of Science and Higher Education, 2014/15/B/NZ5/00434
   awarded by Polish National Science Center and EU Operational Programme
   Innovative Economy via the Foundation for Polish Science
   (VENTURES/2011-8/3).
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Anteneová N, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110766
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bugiardini E, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000149
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Fekete B, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0934-4
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Galetta F, 2014, J NEUROL SCI, V345, P189, DOI 10.1016/j.jns.2014.07.044
   Gawel M, 2014, NEUROL NEUROCHIR POL, V48, P76, DOI 10.1016/j.pjnns.2013.09.003
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Jamali F, 2019, ARCH IRAN MED, V22, P728
   Kaliszewska M, 2015, HUM GENET, V134, P951, DOI 10.1007/s00439-015-1578-x
   Kierdaszuk B, 2009, NEUROL NEUROCHIR POL, V43, P216
   Komulainen T, 2015, JIMD REP, V23, P91, DOI 10.1007/8904_2015_438
   Kume K, 2020, BMC MED GENET, V21, DOI 10.1186/s12881-020-01002-4
   Lee SJ, 2018, YONSEI MED J, V59, P1190
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Peter B, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040408
   Ploski R, 2014, CIRC RES, V114, pE2, DOI 10.1161/CIRCRESAHA.114.302662
   Reyes A., J MED GENET
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Ronchi D, 2011, J NEUROL SCI, V308, P173, DOI 10.1016/j.jns.2011.05.042
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Seo GH, 2019, J HUM GENET, V64, P1117, DOI 10.1038/s10038-019-0660-y
   Soong N W, 1996, Methods Enzymol, V264, P421, DOI 10.1016/S0076-6879(96)64038-5
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Yu-Wai-Man C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075048
   Zhang LS, 2011, ARCH PATHOL LAB MED, V135, P925, DOI 10.1043/2010-0356-RAR.1
NR 40
TC 1
Z9 1
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD JAN
PY 2021
VL 12
IS 1
AR 54
DI 10.3390/genes12010054
PG 15
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA PV9EY
UT WOS:000610283600001
PM 33396418
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Holmlund, T
   Farge, G
   Pande, V
   Korhonen, J
   Nilsson, L
   Falkenberg, M
AF Holmlund, Teresa
   Farge, Geraldine
   Pande, Vineet
   Korhonen, Jenny
   Nilsson, Lennart
   Falkenberg, Maria
TI Structure-function defects of the twinkle amino-terminal region in
   progressive external ophthalmoplegia
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE DNA replication; Mitochondrion; DNA helicase; TWINKLE
ID BACTERIOPHAGE T7 PRIMASE; NUCLEOTIDE-BINDING SITE; DNA-POLYMERASE-GAMMA;
   HELICASE-PRIMASE; MUTATIONS; PROTEIN; GENE; CONTRIBUTES; SUBUNIT; KINASE
AB TWINKLE is a DNA helicase needed for mitochondrial DNA replication. In lower eukaryotes the protein also harbors a primase activity, which is lost from TWINKLE encoded by mammalian cells. Mutations in TWINKLE underlie autosomal dominant progressive external ophthalmoplegia (adPEO), a disorder associated with multiple deletions in the mtDNA. Four different adPEO-causing mutations (W315L, K319T, R334Q, and P335L) are located in the N-terminal domain of TWINKLE. The mutations cause a dramatic decrease in ATPase activity, which is partially overcome in the presence of single-stranded DNA. The mutated proteins have defects in DNA helicase activity and cannot support normal levels of DNA replication. To explain the phenotypes, we use a molecular model of TWINKLE based on sequence similarities with the phage T7 gene 4 protein. The four adPEO-causing mutations are located in a region required to bind single-stranded DNA. These mutations may therefore impair an essential element of the catalytic cycle in hexameric helicases, i.e. the interplay between single-stranded DNA binding and ATP hydrolysis. (c) 2008 Elsevier B.V. All rights reserved. IF
C1 [Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.
   [Pande, Vineet; Nilsson, Lennart] Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden.
   [Holmlund, Teresa; Farge, Geraldine; Korhonen, Jenny; Falkenberg, Maria] Karolinska Inst, Div Metab Dis, Dept Lab Med, SE-14186 Stockholm, Sweden.
C3 University of Gothenburg; Karolinska Institutet; Karolinska Institutet
RP Falkenberg, M (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Box 440, SE-40530 Gothenburg, Sweden.
EM maria.falkenberg@medkem.gu.se
RI farge, geraldine/M-2803-2018; Nilsson, Lennart/B-7208-2009
OI farge, geraldine/0000-0003-1054-4274; Nilsson,
   Lennart/0000-0002-5067-6397; Falkenberg, Maria/0000-0001-8713-173X
FU Swedish Research Council; Swedish Cancer Society, European Commission;
   The Swedish Strategic Foundation; Knut and Alice Wallenberg Foundation
FX This work was supported by grants from the Swedish Research Council, The
   Swedish Cancer Society, European Commission (fp6 EUMITOCOMBAT), The
   Swedish Strategic Foundation, and The Knut and Alice Wallenberg
   Foundation.
CR BERNSTEIN JA, 1989, J BIOL CHEM, V264, P13066
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957
   Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465
   GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kusakabe T, 1999, P NATL ACAD SCI USA, V96, P4295, DOI 10.1073/pnas.96.8.4295
   Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   MENDELMAN LV, 1993, J BIOL CHEM, V268, P27208
   NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Powers L, 1999, BIOCHEMISTRY-US, V38, P7413, DOI 10.1021/bi983059f
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Van Goethem G, 2002, ACTA NEUROL BELG, V102, P39
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
NR 34
TC 30
Z9 36
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD FEB
PY 2009
VL 1792
IS 2
BP 132
EP 139
DI 10.1016/j.bbadis.2008.11.009
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 408JH
UT WOS:000263430800006
PM 19084593
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Duff, RM
   Shearwood, AMJ
   Ermer, J
   Rossetti, G
   Gooding, R
   Richman, TR
   Balasubramaniam, S
   Thorburn, DR
   Rackham, O
   Lamont, PJ
   Filipovska, A
AF Duff, Rachael M.
   Shearwood, Anne-Marie J.
   Ermer, Judith
   Rossetti, Giulia
   Gooding, Rebecca
   Richman, Tara R.
   Balasubramaniam, Shanti
   Thorburn, David R.
   Rackham, Oliver
   Lamont, Phillipa J.
   Filipovska, Aleksandra
TI A mutation in <i>MT</i>-<i>TW</i> causes a tRNA processing defect and
   reduced mitochondrial function in a family with Leigh syndrome
SO MITOCHONDRION
LA English
DT Article
DE Leigh syndrome; Multi-organ mitochondrial disease; tRNA; MT-TW; tRNA
   tryptophan; Mitochondrial disease; OXPHOS
ID DNA; TRNA(TRP); DISORDERS; MYOPATHY; FEATURES; DISEASE
AB Leigh syndrome (LS) is a progressive mitochondrial neurodegenerative disorder, whose symptoms most commonly include psychomotor delay with regression, lactic acidosis and a failure to thrive. Here we describe three siblings with LS, but with additional manifestations including hypertrophic cardiomyopathy, hepatosplenomegaly, cholestatic hepatitis, and seizures. All three affected siblings were found to be homoplasmic for an m. 5559A>G mutation in the T stem of the mitochondrial DNA-encoded MT-TW by next generation sequencing. The m.5559A>G mutation causes a reduction in the steady state levels of tRNA(TrP) and this decrease likely affects the stability of other mitochondrial RNAs in the patient fibroblasts. We observe accumulation of an unprocessed transcript containing tRNA(TrP), decreased de novo protein synthesis and consequently lowered steady state levels of mitochondrial DNA-encoded proteins that compromise mitochondrial respiration. Our results show that the m.5559A>G mutation at homoplasmic levels causes LS in association with severe multi-organ disease (LS-plus) as a consequence of dysfunctional mitochondrial RNA metabolism. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Duff, Rachael M.; Shearwood, Anne-Marie J.; Ermer, Judith; Rossetti, Giulia; Richman, Tara R.; Rackham, Oliver; Filipovska, Aleksandra] Univ Western Australia, Harry Perkins Inst Med Res, Perth, WA 6009, Australia.
   [Duff, Rachael M.; Shearwood, Anne-Marie J.; Ermer, Judith; Rossetti, Giulia; Richman, Tara R.; Rackham, Oliver; Filipovska, Aleksandra] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia.
   [Gooding, Rebecca] QEII Med Ctr, PathWest Lab Med, Diagnost Genom, Nedlands, WA 6009, Australia.
   [Balasubramaniam, Shanti] Princess Margaret Hosp, Dept Pediat & Adolescent Med, Metab Unit, Perth, WA 6008, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Rackham, Oliver; Filipovska, Aleksandra] Univ Western Australia, Sch Chem & Biochem, Nedlands, WA 6009, Australia.
   [Lamont, Phillipa J.] Royal Perth Hosp, Dept Neurol, Neurogenet unit, Perth, WA, Australia.
C3 University of Western Australia; Harry Perkins Institute of Medical
   Research; University of Western Australia; Pathwest Laboratory Medicine;
   Queen Elizabeth II Medical Centre; University of Western Australia;
   Princess Margaret Hospital for Children; University of Western
   Australia; Royal Children's Hospital Melbourne; Murdoch Children's
   Research Institute; Murdoch Children's Research Institute; Victorian
   Clinical Genetics Services; Royal Children's Hospital Melbourne;
   University of Melbourne; University of Western Australia; East
   Metropolitan Health Service; Royal Perth Hospital; University of Western
   Australia
RP Filipovska, A (corresponding author), Univ Western Australia, Harry Perkins Inst Med Res, Perth, WA 6009, Australia.
EM aleksandra.filipovska@uwa.edu.au
RI Thorburn, David/G-6266-2013; Rossetti, Giulia/U-2448-2019; Rackham,
   Oliver/E-1264-2013
OI Rackham, Oliver/0000-0002-5301-9624; Richman, Tara/0000-0002-0610-6047;
   thorburn, david/0000-0002-7725-9470; Filipovska,
   Aleksandra/0000-0002-6998-8403
FU National Health and Medical Research Council [APP1058442, APP1045677,
   APP1041582, APP1023460, APP1005030]; Australian Mitochondrial Disease
   Foundation (AMDF); AMDF; NHMRC Dora Lush Scholarship
FX This project was supported by fellowships and project grants (to O.R.,
   P.L., DT and A.F) from the National Health and Medical Research Council
   (APP1058442, APP1045677, APP1041582, APP1023460, APP1005030) and the
   Australian Mitochondrial Disease Foundation (AMDF). R.D. was supported
   by funding from the AMDF and T.R. by a NHMRC Dora Lush Scholarship. We
   thank David Chandler from AGRF for the pyrosequencing.
CR Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272
   BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4
   Gardner JL, 2007, BIOSCIENCE REP, V27, P139, DOI 10.1007/s10540-007-9042-3
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710
   Mkaouar-Rebai E, 2009, MOL GENET METAB, V97, P179, DOI 10.1016/j.ymgme.2009.03.003
   MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0
   Rackham O, 2012, WIRES RNA, V3, P675, DOI 10.1002/wrna.1128
   Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Richman TR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005089
   Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060
   Sasarman F, 2011, HUM MOL GENET, V20, P4634, DOI 10.1093/hmg/ddr397
   Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tang S, 2010, MITOCHONDRION, V10, P350, DOI 10.1016/j.mito.2010.02.003
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thorburn D.R., 2014, MITOCHONDRIAL DNA AS
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
NR 32
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2015
VL 25
BP 113
EP 119
DI 10.1016/j.mito.2015.10.008
PG 7
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA CX8DW
UT WOS:000365933800014
PM 26524491
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Sazonova, MA
   Chicheva, MM
   Zhelankin, AV
   Sobenin, IA
   Bobryshev, YV
   Orekhov, AN
AF Sazonova, Margarita A.
   Chicheva, Mariya M.
   Zhelankin, Andrey V.
   Sobenin, Igor A.
   Bobryshev, Yuri V.
   Orekhov, Alexander N.
TI Association of mutations in the mitochondrial genome with the
   subclinical carotid atherosclerosis in women
SO EXPERIMENTAL AND MOLECULAR PATHOLOGY
LA English
DT Article
DE Mitochondria; Atherosclerosis; Heteroplasmy level; Mitochondrial genome;
   Mutations
ID CYTOCHROME-B GENE; SOMATIC MUTATIONS; SKELETAL-MUSCLE; POINT MUTATION;
   LATE-ONSET; MTDNA; DNA; POLYMORPHISMS; FREQUENT; PATIENT
AB The importance of the study of an association of mitochondrial DNA mutations with asymptomatic atherosclerosis in women is undeniable. In the present study, a series of PCR with primers for mutation region and further amplificate pyrosequencing were carried out to identify point substitutions or microdeletions of the mitochondrial genome. The results obtained were processed using the original method of estimating the level of heteroplasmy. Five mutations in the mitochondrial genome, namely C3256T, G14709A, G12315A, G13513A and G14846A, in which the heteroplasmy level was associated with the degree of preclinical atherosclerosis in women, were identified. The data obtained in the study showed that C3256T, G14709A and G12315A mutations have a positive correlation with atherosclerosis while G13513A and G14846A mutations have a negative correlation with atherosclerotic lesions. Total mutational load of the mitochondrial genome for C3256T, G14709A, G12315A, G13513A and G14846A mutations explains 68% of the variability of thickness of the carotid intimamedial layer, while the complex of traditional risk factors for cardiovascular diseases explains only 8% of the IMT variability. Data on the correlation between heteroplasmy levels of 0256T, G14709A, G12315A, G13513A and G14846A mutations prompt a suggestion that these mutations may be present on the same haplotypes of mitochondrial genome, associated with atherosclerosis. (C) 2015 Elsevier Inc All rights reserved.
C1 [Sazonova, Margarita A.; Chicheva, Mariya M.; Zhelankin, Andrey V.; Sobenin, Igor A.] Med Genet Lab, Moscow, Russia.
   [Sazonova, Margarita A.; Sobenin, Igor A.; Bobryshev, Yuri V.; Orekhov, Alexander N.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia.
   [Bobryshev, Yuri V.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW 2052, Australia.
   [Bobryshev, Yuri V.] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia.
   [Orekhov, Alexander N.] Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Moscow, Russia.
   [Orekhov, Alexander N.] Moscow MV Lomonosov State Univ, Dept Biophys, Fac Biol, Moscow, Russia.
C3 Russian Academy of Medical Sciences; Institute of General Pathology &
   Pathophysiology, RAMS; University of New South Wales Sydney; Western
   Sydney University; Lomonosov Moscow State University
RP Bobryshev, YV (corresponding author), Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia.
EM y.bobryshev@unsw.edu.au
RI Bobryshev, Yuri/J-2838-2013; Chicheva, Mariia/I-4196-2017; Sobenin,
   Igor/J-4282-2013; Zhelankin, Andrey/F-8247-2014; Sazonova,
   Margarita/O-9685-2017
OI Chicheva, Mariia/0000-0002-8014-8798; Sobenin, Igor/0000-0003-0978-6444;
   Zhelankin, Andrey/0000-0002-3014-2005; Sazonova,
   Margarita/0000-0002-8610-4593
FU Russian Scientific Foundation [14-14-01038]; Russian Science Foundation
   [14-14-01038] Funding Source: Russian Science Foundation
FX This study was supported by the Russian Scientific Foundation, grant
   #14-14-01038.
CR Andreassi MG, 2000, ENVIRON MOL MUTAGEN, V35, P265, DOI 10.1002/1098-2280(2000)35:4<265::AID-EM1>3.0.CO;2-M
   Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3
   Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Arvanitis DA, 2005, J CELL MOL MED, V9, P153, DOI 10.1111/j.1582-4934.2005.tb00345.x
   Ben Assayag E, 2009, THROMB RES, V124, P458, DOI 10.1016/j.thromres.2009.04.008
   Bhat HK, 1999, CIRCULATION, V99, P807, DOI 10.1161/01.CIR.99.6.807
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Chen SN, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-111
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Chu NF, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-136
   Finsterer J, 2007, VASA-J VASCULAR DIS, V36, P229, DOI 10.1024/0301-1526.36.4.229
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Kawamoto R, 2001, J HUM GENET, V46, P506, DOI 10.1007/s100380170031
   Mancuso M, 2005, J NEUROL SCI, V228, P93, DOI 10.1016/j.jns.2004.10.018
   Marian A J, 1997, J Cardiovasc Risk, V4, P333, DOI 10.1097/00043798-199710000-00003
   Matsunaga H, 2001, DIABETES CARE, V24, P500, DOI 10.2337/diacare.24.3.500
   Nomiyama T, 2004, ANN NY ACAD SCI, V1011, P193, DOI 10.1196/annals.1293.020
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Saukko M, 2010, METAB SYNDR RELAT D, V8, P425, DOI 10.1089/met.2010.0004
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   Sazonova MA, 2015, FRONT GENET, V6, DOI [10.3389/fgene.2015.00111, 10.3389/fgene.2015.0011]
   Sazonova MA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/825468
   Sobenin I. A., 2011, PROBLEMS PROSPECTS M, V3, P108
   Sobenin IA, 2013, CURR PHARM DESIGN, V19, P5942
   Sobenin IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068070
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Sobenin IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046573
   Szabó GV, 2013, INTERV MED APPL SCI, V5, P46, DOI 10.1556/IMAS.5.2013.1.10
NR 30
TC 14
Z9 16
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4800
EI 1096-0945
J9 EXP MOL PATHOL
JI Exp. Mol. Pathol.
PD AUG
PY 2015
VL 99
IS 1
BP 25
EP 32
DI 10.1016/j.yexmp.2015.04.003
PG 8
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA CO0BD
UT WOS:000358814200005
PM 25910413
DA 2024-11-01
ER

PT B
AU Smigrodzki, R
   Portell, FR
AF Smigrodzki, Rafal
   Portell, Francisco R.
BE Fahy, GM
   West, MD
   Coles, LS
   Harris, SB
TI Mitochondrial Manipulation as a Treatment for Aging
SO FUTURE OF AGING: PATHWAYS TO HUMAN LIFE EXTENSION
LA English
DT Article; Book Chapter
ID AMYLOID-BETA-PEPTIDE; TARGETED RESTRICTION-ENDONUCLEASE;
   ELECTRON-TRANSPORT CHAIN; SUBSTANTIA-NIGRA NEURONS; MTDNA DELETION
   MUTATIONS; HUMAN SKELETAL-MUSCLE; AFFECTING COMPLEX-I;
   ALZHEIMERS-DISEASE; DNA MUTATIONS; OXIDATIVE STRESS
C1 [Smigrodzki, Rafal; Portell, Francisco R.] Gencia Inc, Charlottesville, VA USA.
RP Smigrodzki, R (corresponding author), Gencia Inc, Charlottesville, VA USA.
EM rafal@genciabiotech.com; francisco@genciabiotech.com
CR Abramov AY, 2005, J NEUROSCI, V25, P9176, DOI 10.1523/JNEUROSCI.1632-05.2005
   ALLEN JF, 1993, J THEOR BIOL, V165, P609, DOI 10.1006/jtbi.1993.1210
   Barrett TG, 2001, BEST PRACT RES CL EN, V15, P325, DOI 10.1053/beem.2001.0149
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhat HK, 2004, J BIOCHEM MOL TOXIC, V18, P180, DOI 10.1002/jbt.20024
   Birket MJ, 2007, AGING CELL, V6, P557, DOI 10.1111/j.1474-9726.2007.00310.x
   Boddapati SV, 2005, J LIPOSOME RES, V15, P49, DOI 10.1081/LPR-200064958
   Bonnefoy Nathalie, 2007, Methods Mol Biol, V372, P153, DOI 10.1007/978-1-59745-365-3_11
   Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526
   Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171
   Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771
   Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7
   Cervin C, 2004, DIABETES, V53, P1894, DOI 10.2337/diabetes.53.7.1894
   Cetica P, 2002, REPRODUCTION, V124, P675, DOI 10.1530/rep.0.1240675
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   D'Souza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   Davidson Michael H., 2006, Metabolic Syndrome and Related Disorders, V4, P299, DOI 10.1089/met.2006.4.299
   de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Decanini A, 2007, AM J OPHTHALMOL, V143, P607, DOI 10.1016/j.ajo.2006.12.006
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026
   FRIDLENDER B, 1972, P NATL ACAD SCI USA, V69, P452, DOI 10.1073/pnas.69.2.452
   Gingrich JR, 2004, P NATL ACAD SCI USA, V101, P6237, DOI 10.1073/pnas.0401413101
   Godinot C, 2007, J BIOENERG BIOMEMBR, V39, P235, DOI 10.1007/s10863-007-9088-8
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   GRASSO DG, 1991, EUR J BIOCHEM, V199, P203, DOI 10.1111/j.1432-1033.1991.tb16110.x
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547
   Hong WK, 2007, NEUROCHEM RES, V32, P1483, DOI 10.1007/s11064-007-9336-7
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Kato Y, 2002, DIABETIC MED, V19, P784, DOI 10.1046/j.1464-5491.2002.00777.x
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Khan SM, 2000, ANN NEUROL, V48, P148, DOI 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lai LP, 2003, CHEST, V123, P539, DOI 10.1378/chest.123.2.539
   Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07
   LeDoux SP, 2007, NEUROSCIENCE, V145, P1249, DOI 10.1016/j.neuroscience.2006.10.002
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Lee HC, 2007, MITOCHONDRION, V7, P157, DOI 10.1016/j.mito.2006.11.016
   Lee M, 2007, J DRUG TARGET, V15, P115, DOI 10.1080/10611860600953555
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821
   Maassen JA, 2007, CURR OPIN CLIN NUTR, V10, P693, DOI 10.1097/MCO.0b013e3282f0b774
   MARK RJ, 1995, J NEUROSCI, V15, P6239
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   Mori M, 2004, BRAIN DEV-JPN, V26, P453, DOI 10.1016/j.braindev.2003.12.009
   Mott JL, 1999, ANN NY ACAD SCI, V893, P353, DOI 10.1111/j.1749-6632.1999.tb07853.x
   Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nicolson GL, 2007, J CELL BIOCHEM, V100, P1352, DOI 10.1002/jcb.21247
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Oguro H, 2007, CURR OPIN IMMUNOL, V19, P503, DOI 10.1016/j.coi.2007.05.001
   Oliveira-Sales EB, 2008, AM J HYPERTENS, V21, P98, DOI 10.1038/ajh.2007.12
   Pak JW, 2004, ANN NY ACAD SCI, V1019, P289, DOI 10.1196/annals.1297.049
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Perna NT, 1996, CURR BIOL, V6, P128, DOI 10.1016/S0960-9822(02)00441-4
   Pineau B, 2005, J BIOL CHEM, V280, P25994, DOI 10.1074/jbc.M500508200
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Przybylowski M, 2007, VACCINE, V25, P5013, DOI 10.1016/j.vaccine.2007.04.077
   Puddu P, 2007, CLIN EXP HYPERTENS, V29, P427, DOI 10.1080/10641960701613852
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sayre Lawrence M, 2005, Ann Ist Super Sanita, V41, P143
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Schoeler S, 2005, BIOCHEM BIOPH RES CO, V332, P43, DOI 10.1016/j.bbrc.2005.04.086
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Smigrodzki RM, 2005, REJUV RES, V8, P172, DOI 10.1089/rej.2005.8.172
   Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003
   Sun FZ, 2003, AM J HUM GENET, V72, P1515, DOI 10.1086/375656
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918
   Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045
   Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trounce IA, 2007, CURR TOP DEV BIOL, V77, P157, DOI 10.1016/S0070-2153(06)77006-5
   Turner C, 2003, HUM GENET, V112, P303, DOI 10.1007/s00439-002-0892-2
   VAN GG, 2002, ACTA NEUROL BELG, V102, P39
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0
   Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199
   Yang Q, 2007, J HYPERTENS, V25, P2067, DOI 10.1097/HJH.0b013e328285a36e
   Yechoor VK, 2004, P NATL ACAD SCI USA, V101, P16525, DOI 10.1073/pnas.0407574101
   Yoon YG, 2003, NUCLEIC ACIDS RES, V31, P1407, DOI 10.1093/nar/gkg228
   Zhang DX, 2005, AM J PHYSIOL-HEART C, V288, pH302, DOI 10.1152/ajpheart.00661.2004
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
NR 106
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-90-481-3998-9
PY 2010
BP 521
EP 541
DI 10.1007/978-90-481-3999-6_16
D2 10.1007/978-90-481-3999-6
PG 21
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
WE Book Citation Index – Science (BKCI-S)
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA BRL24
UT WOS:000283007100016
DA 2024-11-01
ER

PT J
AU Fay, A
   Garcia, Y
   Margeta, M
   Maharjan, S
   Jürgensen, C
   Briceño, J
   Garcia, M
   Yin, ST
   Bassaganyas, L
   McMahon, T
   Hou, YM
   Fu, YH
   Ptácek, LJ
AF Fay, Alexander
   Garcia, Yngo
   Margeta, Marta
   Maharjan, Sunita
   Jurgensen, Claudia
   Briceno, Jose
   Garcia, Mariaelena
   Yin, Sitao
   Bassaganyas, Laia
   McMahon, Thomas
   Hou, Ya-Ming
   Fu, Ying-Hui
   Ptacek, Louis J.
TI A MitochondrialtRNAMutation Causes AxonalCMTin a Large Venezuelan Family
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID PERIPHERAL NEUROPATHY; OPTIC ATROPHY; DNA INSTABILITY; MUTATIONS;
   DISEASE; GENE; GDAP1; PATHOGENESIS; DYSFUNCTION; DISORDERS
AB Objective The objective of this study was to identify the genetic cause for progressive peripheral nerve disease in a Venezuelan family. Despite the growing list of genes associated with Charcot-Marie-Tooth disease, many patients with axonal forms lack a genetic diagnosis. Methods A pedigree was constructed, based on family clinical data. Next-generation sequencing of mitochondrial DNA (mtDNA) was performed for 6 affected family members. Muscle biopsies from 4 family members were used for analysis of muscle histology and ultrastructure, mtDNA sequencing, and RNA quantification. Ultrastructural studies were performed on sensory nerve biopsies from 2 affected family members. Results Electrodiagnostic testing showed a motor and sensory axonal polyneuropathy. Pedigree analysis revealed inheritance only through the maternal line, consistent with mitochondrial transmission. Sequencing of mtDNA identified a mutation in the mitochondrial tRNA(Val)(mt-tRNA(Val)) gene, m.1661A>G, present at nearly 100% heteroplasmy, which disrupts a Watson-Crick base pair in the T-stem-loop. Muscle biopsies showed chronic denervation/reinnervation changes, whereas biochemical analysis of electron transport chain (ETC) enzyme activities showed reduction in multiple ETC complexes. Northern blots from skeletal muscle total RNA showed severe reduction in abundance ofmt-tRNA(Val), and mildly increasedmt-tRNA(Phe), in subjects compared with unrelated age- and sex-matched controls. Nerve biopsies from 2 affected family members demonstrated ultrastructural mitochondrial abnormalities (hyperplasia, hypertrophy, and crystalline arrays) consistent with a mitochondrial neuropathy. Conclusion We identify a previously unreported cause of Charcot-Marie-Tooth (CMT) disease, a mutation in themt-tRNA(Val), in a Venezuelan family. This work expands the list of CMT-associated genes from protein-coding genes to a mitochondrialtRNAgene. ANN NEUROL 2020
C1 [Fay, Alexander; McMahon, Thomas; Fu, Ying-Hui; Ptacek, Louis J.] Univ Calif San Francisco, Dept Neurol, 1550 4th St,RH546,MB2922, San Francisco, CA 94143 USA.
   [Garcia, Yngo] Univ Andes, Fac Med, Dept Biochem, Merida 5101, Venezuela.
   [Garcia, Yngo] Med Surg Clin Inst, Neurosurg Serv, Unit Surg, Merida, Venezuela.
   [Margeta, Marta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.
   [Maharjan, Sunita; Yin, Sitao; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.
   [Jurgensen, Claudia; Garcia, Mariaelena] Univ Andes, Fac Sci, Dept Biol, Merida, Venezuela.
   [Briceno, Jose] Univ Hosp Andes, Physiotherapy & Rehabil Serv, Merida, Venezuela.
   [Bassaganyas, Laia] Univ Cambridge, Dept Med Genet, Cambridge, England.
   [Bassaganyas, Laia] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.
C3 University of California System; University of California San Francisco;
   University of Los Andes Venezuela; University of California System;
   University of California San Francisco; Jefferson University; University
   of Los Andes Venezuela; University of Los Andes Venezuela; University of
   Cambridge; University of California System; University of California San
   Francisco
RP Fay, A (corresponding author), Univ Calif San Francisco, Dept Neurol, 1550 4th St,RH546,MB2922, San Francisco, CA 94143 USA.; Garcia, Y (corresponding author), Univ Andes, Fac Med, Dept Biochem, Merida 5101, Venezuela.
EM alexander.fay@ucsf.edu; garciayngo@ula.ve
OI Fay, Alexander/0000-0001-5818-1236
FU C.D.C.H.T, ULA, Merida, Venezuela [NIH-K12NS001692, A123822]; Alma Mater
   program from OPSU, Caracas, Venezuela [M-869-06-07-B]; Muscular
   Dystrophy Association [MDA514303];  [NIH-R01GM126210]; 
   [NIH-R01AI139202]
FX This study was supported by NIH-K12NS001692 (Award A123822, A.J.F.),
   C.D.C.H.T, ULA, Merida, Venezuela, and by the Alma Mater program from
   OPSU, Caracas, Venezuela (Grant M-869-06-07-B, Y.G.), NIH-R01GM126210
   and by NIH-R01AI139202 (Y.M.H.), and the Muscular Dystrophy Association
   (Grant MDA514303, M.M.).
CR Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158
   Almutawa W, 2019, EBIOMEDICINE, V45, P379, DOI 10.1016/j.ebiom.2019.06.018
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   Bacalhau M, 2017, EUR J MED GENET, V60, P172, DOI 10.1016/j.ejmg.2016.12.009
   Beerepoot S, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1220-4
   Bernard-Marissal N, 2019, P NATL ACAD SCI USA, V116, P2328, DOI 10.1073/pnas.1810932116
   Brockmann K, 2008, J NEUROL, V255, P1049, DOI 10.1007/s00415-008-0847-1
   Bruni F, 2018, HUM MUTAT, V39, P563, DOI 10.1002/humu.23398
   Campbell PD, 2014, J NEUROSCI, V34, P14717, DOI 10.1523/JNEUROSCI.2770-14.2014
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006
   Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590
   Echaniz-Laguna A, 2013, NEUROLOGY, V81, P1523, DOI 10.1212/WNL.0b013e3182a4a518
   El Fissi N, 2018, EMBO REP, V19, DOI 10.15252/embr.201745241
   Fraidakis MJ, 2014, MITOCHONDRION, V15, P34, DOI 10.1016/j.mito.2014.03.010
   Glatz C, 2011, MITOCHONDRION, V11, P615, DOI 10.1016/j.mito.2011.04.003
   GRAF WD, 1993, ANN NEUROL, V33, P640, DOI 10.1002/ana.410330613
   Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   Karle KN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-158
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Landrum MJ, 2018, NUCL ACIDS RES
   Laurá M, 2019, CURR OPIN NEUROL, V32, P641, DOI 10.1097/WCO.0000000000000735
   Lee JR, 2015, HUM MUTAT, V36, P69, DOI 10.1002/humu.22709
   Liao CY, 2017, NEUROLOGY, V88, P131, DOI 10.1212/WNL.0000000000003491
   Linnemann C, 2016, CEREBELLUM, V15, P165, DOI 10.1007/s12311-015-0684-6
   Lott MT., 2013, Curr Protoc Bioinf, V44, P1231, DOI DOI 10.1002/0471250953.BI0123S44
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Mckinney JL, 2014, MUSCLE NERVE, V49, P451, DOI 10.1002/mus.24108
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Morral JA, 2010, ACTA NEUROPATHOL, V120, P97, DOI 10.1007/s00401-010-0675-0
   Nelis E, 2002, NEUROLOGY, V59, P1865, DOI 10.1212/01.WNL.0000036272.36047.54
   Niemann A, 2014, BRAIN, V137, P668, DOI 10.1093/brain/awt371
   Orengo JP, 2018, ANN CLIN TRANSL NEUR, V5, P222, DOI 10.1002/acn3.525
   Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Preston D C., 2005, Electromyography and neuromuscular disorders: clinical-electrophysiologic correlations, DOI DOI 10.1002/MUS.23894
   Ranieri M, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0414-5
   Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rumora AE, 2019, INT REV NEUROBIOL, V145, P127, DOI 10.1016/bs.irn.2019.05.002
   Saneto RP, 2017, ADV GENET, V98, P63, DOI 10.1016/bs.adgen.2017.06.002
   Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590
   Stuppia G, 2015, J NEUROL SCI, V356, P7, DOI 10.1016/j.jns.2015.05.033
   Toyoshima Yuka, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2017-220934
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Yang Y, 2016, J NEUROL SCI, V365, P46, DOI 10.1016/j.jns.2016.04.007
NR 49
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2020
VL 88
IS 4
BP 830
EP 842
DI 10.1002/ana.25854
EA AUG 2020
PG 13
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA NP5MS
UT WOS:000563637500001
PM 32715519
OA Green Accepted, Green Submitted
DA 2024-11-01
ER

PT J
AU Yoon, MK
   Roorda, A
   Zhang, Y
   Nakanishi, C
   Wong, LJC
   Zhang, Q
   Gillum, L
   Green, A
   Duncan, JL
AF Yoon, Michael K.
   Roorda, Austin
   Zhang, Yuhua
   Nakanishi, Chiaki
   Wong, Lee-Jun C.
   Zhang, Qing
   Gillum, Leslie
   Green, Ari
   Duncan, Jacque L.
TI Adaptive Optics Scanning Laser Ophthalmoscopy Images in a Family with
   the Mitochondrial DNA T8993C Mutation
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID LIVING HUMAN EYE; 3 CONE CLASSES; RETINAL DEGENERATION; LEIGHS-SYNDROME;
   MTDNA MUTATION; POINT MUTATION; NARP SYNDROME; ROD; DISEASE;
   PHOTORECEPTORS
AB PURPOSE. This study was designed to assess the effect of mitochondrial DNA (mtDNA) mutation T8993C on cone structure in a family expressing neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP) syndrome.
   METHODS. Five family members were studied, using clinical examination, nerve conduction studies, perimetry, optical coherence tomography (OCT) measures of central retinal thickness, and electroretinography. High-resolution images of cone structure using adaptive optics scanning laser ophthalmoscopy (AOSLO) were obtained in four subjects with stable fixation. Cone spacing was compared to 18 age-similar normal subjects and converted to z-scores at each location where unambiguous cones were identified. Tissue levels of T8993C mutant heteroplasmy in blood and hair follicles were quantified using realtime allele-refractory mutations system (ARMS) quantitative polymerase chain reaction (qPCR).
   RESULTS. Subjects expressing the T8993C mutation showed varying levels of disease severity. The subject with the lowest mutant load (42%-54%) showed no neurologic or retinal abnormalities. The remaining four subjects with over 77% mutant load all expressed severe neurologic and/or retinal abnormalities. AOSLO images revealed three patterns of cone spacing: pattern 1, normal; pattern 2, increased cone spacing within a contiguous cone mosaic; and pattern 3, patchy cone loss with increased cone spacing. Visual function was most severely affected in pattern 3.
   CONCLUSIONS. High levels of T8993C mutant load were associated with severe neurologic or visual dysfunction, while lower levels caused no detectable abnormalities. Visual function was better in patients with a contiguous and regular cone mosaic. Patients expressing high levels of the mtDNA T8993C mutation show abnormal cone structure, suggesting normal mitochondrial DNA is necessary for normal waveguiding by cones. (Invest Ophthalmol Vis Sci. 2009; 50: 1838-1847) DOI:10.1167/iovs.08-2029
C1 [Yoon, Michael K.; Nakanishi, Chiaki; Duncan, Jacque L.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.
   [Gillum, Leslie; Green, Ari] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.
   [Roorda, Austin; Zhang, Yuhua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.
   [Wong, Lee-Jun C.; Zhang, Qing] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California Berkeley;
   Baylor College of Medicine
RP Duncan, JL (corresponding author), Univ Calif San Francisco, Sch Med, Beckman Vis Ctr, 10 Koret Way,Rm K-129, San Francisco, CA 94143 USA.
EM duncanj@vision.ucsf.edu
RI ZHANG, QING/AGY-7972-2022
FU Intramural NIH HHS [Z01 EY000415] Funding Source: Medline; NCRR NIH HHS
   [KL2 RR024130, KL2RR024130] Funding Source: Medline; NEI NIH HHS [P30
   EY002162, EY002162, R01 EY014375, EY014375, K08 EY000415, R01 EY023591]
   Funding Source: Medline
CR Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Baraas RC, 2007, J OPT SOC AM A, V24, P1438, DOI 10.1364/JOSAA.24.001438
   Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607
   Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101
   Choi SS, 2006, INVEST OPHTH VIS SCI, V47, P2080, DOI 10.1167/iovs.05-0997
   Chowers I, 1999, BRIT J OPHTHALMOL, V83, P190, DOI 10.1136/bjo.83.2.190
   Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Galli-Resta L, 1999, EUR J NEUROSCI, V11, P1461, DOI 10.1046/j.1460-9568.1999.00555.x
   Hayashi N, 2000, OPHTHALMOLOGY, V107, P1397, DOI 10.1016/S0161-6420(00)00110-X
   Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028
   Hogan M.J., 1971, Histology of the Human Eye: An Atlas and Text-Book, P687
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Li KY, 2007, J OPT SOC AM A, V24, P1358, DOI 10.1364/JOSAA.24.001358
   Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884
   Liang JZ, 1997, J OPT SOC AM A, V14, P2873, DOI 10.1364/JOSAA.14.002873
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45
   MITSUMOTO H, 1983, NEUROLOGY, V33, P452, DOI 10.1212/WNL.33.4.452
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8
   Newman NJ, 1992, OPHTHALMOL CLIN N AM, V5, P405
   ORTIZ RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1525, DOI 10.1001/archopht.1993.01090110091031
   Pallikaris A, 2003, INVEST OPHTH VIS SCI, V44, P4580, DOI 10.1167/iovs.03-0094
   Perkins GA, 2004, MITOCHONDRION, V4, P695, DOI 10.1016/j.mito.2004.07.020
   Perkins GA, 2003, MOL VIS, V9, P60
   Porto FBO, 2001, AM J OPHTHALMOL, V132, P935, DOI 10.1016/S0002-9394(01)01187-4
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Roorda A, 2001, VISION RES, V41, P1291, DOI 10.1016/S0042-6989(01)00043-8
   Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383
   Roorda A, 2007, INVEST OPHTH VIS SCI, V48, P2297, DOI 10.1167/iovs.06-1450
   Roorda A, 2002, J VISION, V2, P404, DOI 10.1167/2.5.4
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Sciacco M, 2003, J NEUROL, V250, P1498, DOI 10.1007/s00415-003-0246-6
   SHAPIRO MB, 1985, J AM STAT ASSOC, V80, P803, DOI 10.2307/2288535
   Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103
   Suzuki Y, 1998, PEDIATR NEUROL, V19, P283, DOI 10.1016/S0887-8994(98)00070-8
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wolfing JI, 2006, OPHTHALMOLOGY, V113, P1014, DOI 10.1016/j.ophtha.2006.01.056
   Wong LJC, 1997, CLIN CHEM, V43, P1241
NR 49
TC 50
Z9 56
U1 0
U2 5
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2009
VL 50
IS 4
BP 1838
EP 1847
DI 10.1167/iovs.08-2029
PG 10
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 424CP
UT WOS:000264543400049
PM 18997096
OA Green Accepted, Green Submitted
DA 2024-11-01
ER

PT J
AU Kakiuchi, C
   Ishiwata, M
   Kametani, M
   Nelson, C
   Iwamoto, K
   Kato, T
AF Kakiuchi, C
   Ishiwata, M
   Kametani, M
   Nelson, C
   Iwamoto, K
   Kato, T
TI Quantitative analysis of mitochondrial DNA deletions in the brains of
   patients with bipolar disorder and schizophrenia
SO INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
LA English
DT Article
DE bipolar disorder; deletions; frontal cortex; mitochondrial DNA;
   schizophrenia
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; PHOSPHORUS-METABOLISM;
   GENE-EXPRESSION; FRONTAL-LOBE; P-31; DYSFUNCTION; MUTATION; ASSOCIATION;
   DISEASE; CELLS
AB Several clinical, genetic and neuromaging studies implicate mitochondrial dysfunction in the pathophysiology of bipolar disorder and schizophrenia. It has been reported that a mitochondrial DNA (mtDNA) deletion of 4977 bp, known as the 'common deletion', is associated with both mental illnesses. A lack of normal age-related accumulation of this deletion in schizophrenia and increased occurrence of the common deletion in bipolar disorder have been reported. However, even in the affected bipolar samples, the levels of common deletion were relatively small, indicating that the common deletion did not play a pathophysiological role in respiratory function. We hypothesized that accumulation of multiple mtDNA deletions, rather than the common deletion alone, is involved in the pathophysiology of these two major mental disorders. To test this hypothesis, we assessed mtDNA deletion(s) by comparing the copy number of two re-ions in mtDNA - ND1 and ND4 - using real-time quantitative PCR in the frontal cortex of 84 subjects (30 control, 27 with bipolar disorder, and 27 with schizophrenia). We also assessed the relative amount of mtDNA vs. nuclear DNA and the expression level of DNA polymerase gamma (POLG), which is involved in replicating mtDNA. We observed no association between mtDNA deletions and the two major mental disorders in the frontal cortex, which did not support our hypothesis. We did, however, make the following observations, although they were not significant after Bonferroni correction: (1) the ratio of mtDNA to nuclear DNA was significantly higher in female patients with schizophrenia than in control females (p =0.040) and (2) in bipolar disorder, the relative amount of mtDNA decreased with age (p = 0.016). Furthermore, POLG expression was significantly up-regulated in bipolar disorder (p = 0.036). Our results suggest that abnormalities in the system maintaining replication of mtDNA may underlie bipolar disorder and schizophrenia.
C1 RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan.
C3 RIKEN
RP RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Hirosawa 2-1, Wako, Saitama 3510198, Japan.
EM kakiuchi@brain.riken.jp
RI Kakiuchi, Chihiro/AAO-1103-2020; Kato, Tadafumi/J-3583-2014
OI Kato, Tadafumi/0000-0001-7856-3952
CR ALTSHULER LL, 1995, AM J PSYCHIAT, V152, P1139
   [Anonymous], 1994, AM PSYCHIATR ASSOC
   Ben-Shachar D, 2002, J NEUROCHEM, V83, P1241, DOI 10.1046/j.1471-4159.2002.01263.x
   CAVELIER L, 1995, GENOMICS, V29, P217, DOI 10.1006/geno.1995.1234
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   DEICKEN RF, 1995, AM J PSYCHIAT, V152, P915
   Dror N, 2002, MOL PSYCHIATR, V7, P995, DOI 10.1038/sj.mp.4001116
   FUJIMOTO T, 1992, ACTA PSYCHIAT SCAND, V86, P455, DOI 10.1111/j.1600-0447.1992.tb03297.x
   GOLDSTEIN JM, 1990, BRIT J PSYCHIAT, V156, P819, DOI 10.1192/bjp.156.6.819
   Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437
   Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7
   Kato T, 1998, J NEUROPSYCH CLIN N, V10, P133, DOI 10.1176/jnp.10.2.133
   Kato T, 1998, EUR ARCH PSY CLIN N, V248, P301, DOI 10.1007/s004060050054
   Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1
   KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3
   KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   Kato T, 2000, AM J MED GENET, V96, P182, DOI 10.1002/(SICI)1096-8628(20000403)96:2<182::AID-AJMG12>3.0.CO;2-Q
   Kegeles LS, 1998, BIOL PSYCHIAT, V44, P382, DOI 10.1016/S0006-3223(97)00425-3
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3
   Marchbanks RM, 2003, SCHIZOPHR RES, V65, P33, DOI 10.1016/S0920-9964(03)00011-2
   Melberg A, 1996, MUSCLE NERVE, V19, P1561, DOI 10.1002/(SICI)1097-4598(199612)19:12<1561::AID-MUS5>3.0.CO;2-8
   MULCRONE J, 1995, SCHIZOPHR RES, V14, P203, DOI 10.1016/0920-9964(94)00040-F
   Murashita J, 2000, PSYCHOL MED, V30, P107, DOI 10.1017/S0033291799001439
   Oexle K, 1997, HUM MOL GENET, V6, P905, DOI 10.1093/hmg/6.6.905
   Prayson RA, 1998, ARCH PATHOL LAB MED, V122, P978
   Rango M, 2001, J CEREBR BLOOD F MET, V21, P85, DOI 10.1097/00004647-200101000-00011
   SHIMIZU A, 1987, JPN J PSYCHIAT NEUR, V41, P65
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   SOONG NW, 1992, NAT GENET, V2, P318
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Uranova N, 2001, BRAIN RES BULL, V55, P597, DOI 10.1016/S0361-9230(01)00528-7
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Volz HP, 2000, BIOL PSYCHIAT, V47, P954, DOI 10.1016/S0006-3223(00)00235-3
   Washizuka S, 2003, AM J MED GENET B, V120B, P72, DOI 10.1002/ajmg.b.20041
   WINOKUR G, 1970, COMPR PSYCHIAT, V11, P93, DOI 10.1016/0010-440X(70)90151-3
   WOLYNIEC PS, 1992, J PSYCHIAT RES, V26, P17, DOI 10.1016/0022-3956(92)90012-D
NR 43
TC 56
Z9 60
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1461-1457
EI 1469-5111
J9 INT J NEUROPSYCHOPH
JI Int. J. Neuropsychopharmacol.
PD DEC
PY 2005
VL 8
IS 4
BP 515
EP 522
DI 10.1017/S1461145705005213
PG 8
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 986VB
UT WOS:000233476700004
PM 16202181
OA Bronze
DA 2024-11-01
ER

PT J
AU Hussain, M
   Mohammed, A
   Saifi, S
   Khan, A
   Kaur, E
   Priya, S
   Agarwal, H
   Sengupta, S
AF Hussain, Mansoor
   Mohammed, Aftab
   Saifi, Shabnam
   Khan, Aamir
   Kaur, Ekjot
   Priya, Swati
   Agarwal, Himanshi
   Sengupta, Sagar
TI MITOL-dependent ubiquitylation negatively regulates the entry of PolγA
   into mitochondria
SO PLOS BIOLOGY
LA English
DT Article
AB Mutations in mitochondrial replicative polymerase Pol gamma A lead to progressive external ophthalmoplegia (PEO). While Pol gamma A is the known central player in mitochondrial DNA (mtDNA) replication, it is unknown whether a regulatory process exists on the mitochondrial outer membrane which controlled its entry into the mitochondria. We now demonstrate that Pol gamma A is ubiquitylated by mitochondrial E3 ligase, MITOL (or MARCH5, RNF153). Ubiquitylation in wild-type (WT) Pol gamma A occurs at Lysine 1060 residue via K6 linkage. Ubiquitylation of Pol gamma A negatively regulates its binding to Tom20 and thereby its mitochondrial entry. While screening different PEO patients for mitochondrial entry, we found that a subset of the Pol gamma A mutants is hyperubiquitylated by MITOL and interact less with Tom20. These Pol gamma A variants cannot enter into mitochondria, instead becomes enriched in the insoluble fraction and undergo enhanced degradation. Hence, mtDNA replication, as observed via BrdU incorporation into the mtDNA, was compromised in these PEO mutants. However, by manipulating their ubiquitylation status by 2 independent techniques, these PEO mutants were reactivated, which allowed the incorporation of BrdU into mtDNA. Thus, regulated entry of non-ubiquitylated Pol gamma A may have beneficial consequences for certain PEO patients.
C1 [Hussain, Mansoor; Mohammed, Aftab; Saifi, Shabnam; Khan, Aamir; Kaur, Ekjot; Priya, Swati; Agarwal, Himanshi; Sengupta, Sagar] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi, India.
C3 Department of Biotechnology (DBT) India; National Institute of
   Immunology (NII)
RP Sengupta, S (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi, India.
EM sagar@nii.ac.in
RI Hussain, Mansoor/GQI-2915-2022; Sengupta, Sagar/AGR-1063-2022
OI Hussain, Mansoor/0000-0003-4260-2256; Agarwal,
   Himanshi/0000-0003-1738-4525; Kaur, Ekjot/0000-0002-7937-6646; Priya,
   Swati/0000-0003-3362-6256; Mohammed, Aftab/0000-0003-1467-5984;
   Sengupta, Sagar/0000-0002-6365-1770
FU National Institute of Immunology (NII); Department of Biotechnology
   (DBT), India [BT/MED/30/SP11263/2015, BT/PR23545/BRB/10/1593/2017,
   BT/PR27681/GET/119/269/2018]; Council of Scientific and Industrial
   Research (CSIR), India [37(1699)/17/EMR-11]; Science & Engineering
   Research Board (SERB), India [EMR/2017/000541]; J C Bose Fellowship
   [JCB/2018/000013]; DBT-RA Fellowship [35/July 2019/10]; DST Inspire
   Faculty Fellowship [DST/INSPIRE/04/2017/000088]
FX Sagar Sengupta acknowledges National Institute of Immunology (NII)
   intramural funding and the following extramural funding sources:
   Department of Biotechnology (DBT), India (BT/MED/30/SP11263/2015,
   BT/PR23545/BRB/10/1593/2017, BT/PR27681/GET/119/269/2018), Council of
   Scientific and Industrial Research (CSIR), India (37(1699)/17/EMR-11),
   Science & Engineering Research Board (SERB), India (EMR/2017/000541) and
   J C Bose Fellowship (JCB/2018/000013). EK acknowledges DST Inspire
   Faculty Fellowship (DST/INSPIRE/04/2017/000088) for salary and funding.
   Shabnam Saifi acknowledges DBT-RA Fellowship (Batch 35/July 2019/10) for
   salary and funding. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678
   Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004
   Bragoszewski P, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170007
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chen ZH, 2017, EMBO REP, V18, P495, DOI 10.15252/embr.201643309
   Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633
   De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501
   Escobar-Henriques M, 2014, EMBO REP, V15, P231, DOI 10.1002/embr.201338225
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Gupta S, 2014, CARCINOGENESIS, V35, P34, DOI 10.1093/carcin/bgt315
   Jo A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/305716
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064
   Kasahara T, 2017, PSYCHIAT CLIN NEUROS, V71, P518, DOI 10.1111/pcn.12496
   Kim SH, 2016, FEBS J, V283, P294, DOI 10.1111/febs.13568
   Kowalski L, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0536-1
   Kumari J, 2016, J CELL SCI, V129, P1312, DOI 10.1242/jcs.181297
   Lee BH, 2016, NATURE, V532, P398, DOI 10.1038/nature17433
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005
   Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066
   Metzger MB, 2020, ELIFE, V9, DOI 10.7554/eLife.51065
   Michel MA, 2017, MOL CELL, V68, P233, DOI 10.1016/j.molcel.2017.08.020
   Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790
   Ordureau A, 2020, MOL CELL, V77, P1124, DOI 10.1016/j.molcel.2019.11.013
   Park YY, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-25
   Peter S, 2014, EMBO MOL MED, V6, P1525, DOI 10.15252/emmm.201403927
   Phu L, 2020, MOL CELL, V77, P1107, DOI 10.1016/j.molcel.2020.02.012
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Radke S, 2008, J BIOL CHEM, V283, P12681, DOI 10.1074/jbc.C800036200
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rusilowicz-Jones EV, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000768
   Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128
   Shi HX, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002057
   Shiiba I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113781
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023
   Sugiura A, 2011, MITOCHONDRION, V11, P139, DOI 10.1016/j.mito.2010.09.001
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249
   Yonashiro R, 2012, P NATL ACAD SCI USA, V109, P2382, DOI 10.1073/pnas.1114985109
   Yonashiro R, 2009, MOL BIOL CELL, V20, P4524, DOI 10.1091/mbc.E09-02-0112
   Yoo YS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8910
NR 51
TC 11
Z9 11
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD MAR
PY 2021
VL 19
IS 3
AR e3001139
DI 10.1371/journal.pbio.3001139
PG 28
WC Biochemistry & Molecular Biology; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA QS5WB
UT WOS:000625969200001
PM 33657094
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Holmes-Hampton, GP
   Crooks, DR
   Haller, RG
   Guo, S
   Freier, SM
   Monia, BP
   Rouault, TA
AF Holmes-Hampton, Gregory P.
   Crooks, Daniel R.
   Haller, Ronald G.
   Guo, Shuling
   Freier, Susan M.
   Monia, Brett P.
   Rouault, Tracey A.
TI Use of antisense oligonucleotides to correct the splicing error in ISCU
   myopathy patient cell lines
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID IRON-SULFUR PROTEINS; SUCCINATE-DEHYDROGENASE; MUSCULAR-DYSTROPHY;
   PAROXYSMAL MYOGLOBINURIA; LACTIC-ACIDOSIS; INTRON MUTATION;
   SKELETAL-MUSCLE; DNA METABOLISM; GENE; DISEASE
AB ISCU myopathy is an inherited disease that primarily affects individuals of northern Swedish descent who share a single point mutation in the fourth intron of the ISCU gene. The current study shows correction of specific phenotypes associated with disease following treatment with an antisense oligonucleotide (ASO) targeted to the site of the mutation. We have shown that ASO treatment diminished aberrant splicing and increased ISCU protein levels in both patient fibroblasts and patient myotubes in a concentration dependent fashion. Upon ASO treatment, levels of SDHB in patient myotubular cell lines increased to levels observed in control myotubular cell lines. Additionally, we have shown that both patient fibroblast and myotubular cell lines displayed an increase in complex II activity with a concomitant decrease in succinate levels in patient myotubular cell lines after ASO treatment. Mitochondrial and cytosolic aconitase activities increased significantly following ASO treatment in patient myotubes. The current study suggests that ASO treatment may serve as a viable approach to correcting ISCU myopathy in patients.
C1 [Holmes-Hampton, Gregory P.; Rouault, Tracey A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Med Branch, Bethesda, MD 20892 USA.
   [Crooks, Daniel R.] Natl Canc Inst, Ctr Canc Res, Urol Oncol Branch, Bethesda, MD USA.
   [Haller, Ronald G.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.
   [Haller, Ronald G.] Texas Hlth Presbyterian Hosp Dallas, Neuromuscular Ctr, Inst Exercise & Environm Med, Dallas, TX 75231 USA.
   [Guo, Shuling; Freier, Susan M.; Monia, Brett P.] Ionis Pharmaceut, Dept Antisense Drug Discovery, Carlsbad, CA USA.
C3 National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver
   National Institute of Child Health & Human Development (NICHD); National
   Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI);
   University of Texas System; University of Texas Southwestern Medical
   Center Dallas; Ionis Pharmaceuticals, Inc.
RP Rouault, TA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Med Branch, Bethesda, MD 20892 USA.; Rouault, TA (corresponding author), Bldg 35A,Room 2D 908,9000 Rockville Pike, Bethesda, MD 20892 USA.
EM Rouault@mail.nih.gov
RI HolmesHampton, Gregory/KIA-4046-2024
OI Rouault, Tracey/0000-0003-0062-0245
FU Intramural program of the Eunice Kennedy Shriver National Institute of
   Child Health and Human Development
FX This work was supported by the Intramural program of the Eunice Kennedy
   Shriver National Institute of Child Health and Human Development.
CR Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002
   BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329
   Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654
   Braun MM, 2010, NAT REV DRUG DISCOV, V9, P519, DOI 10.1038/nrd3160
   Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498
   Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445
   Christie PT, 2001, J CLIN ENDOCR METAB, V86, P3840, DOI 10.1210/jc.86.8.3840
   Corey DR, 2001, GENOME BIOL, V2
   Crooks DR, 2014, HUM MOL GENET, V23, P24, DOI 10.1093/hmg/ddt393
   Crooks DR, 2012, J BIOL CHEM, V287, P40119, DOI 10.1074/jbc.M112.418889
   de Smet MD, 1999, OCUL IMMUNOL INFLAMM, V7, P189, DOI 10.1076/ocii.7.3.189.4007
   Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664
   HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882
   HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422
   Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017
   Kakkis ED, 2016, NAT BIOTECHNOL, V34, P380, DOI 10.1038/nbt.3530
   Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442
   Kole R, 2015, ADV DRUG DELIVER REV, V87, P104, DOI 10.1016/j.addr.2015.05.008
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P833, DOI 10.1016/j.nmd.2009.09.011
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   LARSSON LE, 1964, J NEUROL NEUROSUR PS, V27, P361, DOI 10.1136/jnnp.27.5.361
   Liang XH, 2016, NAT BIOTECHNOL, V34, P875, DOI 10.1038/nbt.3589
   LINDERHOLM H, 1990, J INTERN MED, V228, P43, DOI 10.1111/j.1365-2796.1990.tb00191.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maio N, 2016, CELL METAB, V23, P292, DOI 10.1016/j.cmet.2015.12.005
   MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815
   Miyamoto BE, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-49
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Morel CF, 2006, J CLIN ENDOCR METAB, V91, P2689, DOI 10.1210/jc.2005-2746
   Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453
   Noack D, 2001, BBA-MOL BASIS DIS, V1537, P125, DOI 10.1016/S0925-4439(01)00065-5
   Nordin A, 2012, HUM MUTAT, V33, P467, DOI 10.1002/humu.22002
   Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Pérez B, 2010, J INHERIT METAB DIS, V33, P397, DOI 10.1007/s10545-010-9135-1
   Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909
   Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010
   Saxena N, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv287
   Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3
   Skotte NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107434
   Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723
   Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692
   Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003
   Touznik A, 2014, EXPERT OPIN BIOL TH, V14, P809, DOI 10.1517/14712598.2014.896335
   Tuffery-Giraud S, 2003, HUM MUTAT, V21, P608, DOI 10.1002/humu.10214
   Vandanmagsar B, 2016, CELL REP, V15, P1686, DOI 10.1016/j.celrep.2016.04.057
   Wang M, 1997, BREAST CANCER RES TR, V44, P145, DOI 10.1023/A:1005753117205
NR 47
TC 10
Z9 11
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 1
PY 2016
VL 25
IS 23
BP 5178
EP 5187
DI 10.1093/hmg/ddw338
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA EP0FT
UT WOS:000397063300010
PM 28007899
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Jang, YH
   Lim, KI
AF Jang, Yoon-ha
   Lim, Kwang-il
TI Recent Advances in Mitochondria-Targeted Gene Delivery
SO MOLECULES
LA English
DT Review
DE mitochondrial gene delivery; mitochondrial disease; mitochondrial
   genomes; heteroplasmy; mitochondrial matrix
ID HEREDITARY OPTIC NEUROPATHY; NADH-QUINONE OXIDOREDUCTASE;
   SKELETAL-MUSCLE; PLASMID DNA; MUTANT MTDNA; MITO-PORTER; IN-VITRO;
   SEQUENCE; PEPTIDE; THERAPY
AB Mitochondria are the energy-producing organelles of cells. Mitochondrial dysfunctions link to various syndromes and diseases including myoclonic epilepsy and ragged-red fiber disease (MERRF), Leigh syndrome (LS), and Leber hereditary optic neuropathy (LHON). Primary mitochondrial diseases often result from mutations of mitochondrial genomes and nuclear genes that encode the mitochondrial components. However, complete intracellular correction of the mutated genetic parts relevant to mitochondrial structures and functions is technically challenging. Instead, there have been diverse attempts to provide corrected genetic materials with cells. In this review, we discuss recent novel physical, chemical and biological strategies, and methods to introduce genetic cargos into mitochondria of eukaryotic cells. Effective mitochondria-targeting gene delivery systems can reverse multiple mitochondrial disorders by enabling cells to produce functional mitochondrial components.
C1 [Jang, Yoon-ha; Lim, Kwang-il] Sookmyung Womens Univ, Dept Chem & Biol Engn, Seoul 04310, South Korea.
   [Lim, Kwang-il] Sookmyung Womens Univ, Inst Adv Mat & Syst, Seoul 04310, South Korea.
   [Lim, Kwang-il] Sookmyung Womens Univ, Res Inst ICT Convergence, Seoul 04310, South Korea.
C3 Sookmyung Women's University; Sookmyung Women's University; Sookmyung
   Women's University
RP Lim, KI (corresponding author), Sookmyung Womens Univ, Dept Chem & Biol Engn, Seoul 04310, South Korea.; Lim, KI (corresponding author), Sookmyung Womens Univ, Inst Adv Mat & Syst, Seoul 04310, South Korea.; Lim, KI (corresponding author), Sookmyung Womens Univ, Res Inst ICT Convergence, Seoul 04310, South Korea.
EM miin_yj@sookmyung.ac.kr; klim@sookmyung.ac.kr
FU Medical Research Center Program through the National Research Foundation
   of Korea (NRF) grant - Korea government (MSIP) [2011-0030074]
FX This work was supported by the Medical Research Center Program (No.
   2011-0030074) through the National Research Foundation of Korea (NRF)
   grant funded by the Korea government (MSIP).
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bae Y, 2017, MITOCHONDRION, V37, P27, DOI 10.1016/j.mito.2017.06.005
   Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   Biswas S, 2012, J CONTROL RELEASE, V159, P393, DOI 10.1016/j.jconrel.2012.01.009
   Biswas S, 2012, BIOMATERIALS, V33, P4773, DOI 10.1016/j.biomaterials.2012.03.032
   Boddapati SV, 2008, NANO LETT, V8, P2559, DOI 10.1021/nl801908y
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Bonnefoy Nathalie, 2007, Methods Mol Biol, V372, P153, DOI 10.1007/978-1-59745-365-3_11
   BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8
   Cardoso AM, 2015, MOL PHARMACEUT, V12, P716, DOI 10.1021/mp5005349
   Cardoso AMS, 2011, BBA-BIOMEMBRANES, V1808, P341, DOI 10.1016/j.bbamem.2010.09.026
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Choi SK, 2013, ACS NANO, V7, P214, DOI 10.1021/nn3038995
   Chuah JA, 2016, BIOMACROMOLECULES, V17, P3547, DOI 10.1021/acs.biomac.6b01056
   Coutinho E, 2017, MOL PHARMACEUT, V14, P626, DOI 10.1021/acs.molpharmaceut.6b00823
   Cwerman-Thibault H, 2014, CR BIOL, V337, P193, DOI 10.1016/j.crvi.2013.11.011
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   D'Souza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08
   Del Gaizo V, 2003, MOL THER, V7, P720, DOI 10.1016/S1525-0016(03)00130-8
   Esaki M, 1999, P NATL ACAD SCI USA, V96, P11770, DOI 10.1073/pnas.96.21.11770
   Flierl A, 2003, MOL THER, V7, P550, DOI 10.1016/S1525-0016(03)00037-6
   Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Holt IJ., 2012, Cold Spring Harb Perspect Biol, V4
   Kogure K, 2008, ADV DRUG DELIVER REV, V60, P559, DOI 10.1016/j.addr.2007.10.007
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lyrawati D, 2011, PHARM RES-DORDR, V28, P2848, DOI 10.1007/s11095-011-0544-0
   Ma XC, 2013, ADV HEALTHC MATER, V2, P1638, DOI 10.1002/adhm.201300037
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Marí M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x
   NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210
   Pereira CV, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708084
   Pfanner N, 1997, CURR BIOL, V7, pR100, DOI 10.1016/S0960-9822(06)00048-0
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Salvado R, 2015, COLLOID SURFACE A, V480, P287, DOI 10.1016/j.colsurfa.2014.12.013
   Santos J, 2014, COLLOID SURFACE B, V121, P129, DOI 10.1016/j.colsurfb.2014.06.003
   Santos JL, 2010, MOL PHARMACEUT, V7, P763, DOI 10.1021/mp9002877
   Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tu MY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0344-y
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tzen CY, 2003, MUSCLE NERVE, V28, P575, DOI 10.1002/mus.10473
   van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635
   van Dongen MA, 2014, J PHYS CHEM B, V118, P7195, DOI 10.1021/jp504059p
   WALBERG MW, 1981, NUCLEIC ACIDS RES, V9, P5411, DOI 10.1093/nar/9.20.5411
   Wang WX, 2011, ACTA PHYS-CHIM SIN, V27, P156, DOI 10.3866/PKU.WHXB20110120
   Wang XY, 2014, J MATER CHEM B, V2, P2546, DOI 10.1039/c3tb21348j
   Warrington KH, 2004, J VIROL, V78, P6595, DOI 10.1128/JVI.78.12.6595-6609.2004
   Weissig V, 2000, DRUG DELIV, V7, P1, DOI 10.1080/107175400266722
   Yamada Y, 2017, BIOMATERIALS, V136, P56, DOI 10.1016/j.biomaterials.2017.05.016
   Yamada Y, 2015, MITOCHONDRION, V24, P50, DOI 10.1016/j.mito.2015.07.003
   Yamada Y, 2013, MITOCHONDRION, V13, P526, DOI 10.1016/j.mito.2012.09.001
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yasuzaki Y, 2015, MOL PHARMACEUT, V12, P4311, DOI 10.1021/acs.molpharmaceut.5b00511
   Yasuzaki Y, 2014, PHARMACEUTICALS, V7, P881, DOI 10.3390/ph7080881
   Yasuzaki Y, 2013, J CONTROL RELEASE, V172, P805, DOI 10.1016/j.jconrel.2013.09.029
   Yu H, 2013, MOL VIS, V19, P1482
   Yu H, 2012, MOL VIS, V18, P1668
   Yu H, 2012, P NATL ACAD SCI USA, V109, pE1238, DOI 10.1073/pnas.1119577109
   Zheng H, 2017, J BIOMED NANOTECHNOL, V13, P155, DOI 10.1166/jbn.2017.2337
   Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109
NR 71
TC 30
Z9 34
U1 1
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD SEP
PY 2018
VL 23
IS 9
AR 2316
DI 10.3390/molecules23092316
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA GW9YP
UT WOS:000447365100227
PM 30208599
OA Green Submitted, gold, Green Published
DA 2024-11-01
ER

PT J
AU Glatz, C
   D'Aco, K
   Smith, S
   Sondheimer, N
AF Glatz, Catherine
   D'Aco, Kristin
   Smith, Sabrina
   Sondheimer, Neal
TI Mutation in the mitochondrial tRNA<SUP>va1</SUP> causes mitochondrial
   encephalopathy, lactic acidosis and stroke-like episodes
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; Mitochondrial disease; Heteroplasmy; MELAS;
   Mitochondrial tRNA; Penetrance
ID TRANSFER-RNA; MELAS; MYOPATHY
AB An m.1630A>G mutation in the mitochondrial tRNA(va1) (MTTV) was identified in a patient with hearing impairment, short stature and new onset of stroke. This mutation has previously been identified in a patient with the mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE). The mother of the proband also had high levels of the m.1630A>G allele present in blood and other tissues, without symptoms. To confirm the pathogenicity of this mutation, we created cybrid cell lines with various mutation loads. The m.1630A>G mutation impairs oxygen consumption, affects the stability of the MTTV and reduces the levels of subunits of the electron transport chain. (C) 2011 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Glatz, Catherine; D'Aco, Kristin; Sondheimer, Neal] Childrens Hosp Philadelphia, Sect Biochem Genet, Philadelphia, PA 19104 USA.
   [Smith, Sabrina] Childrens Hosp Philadelphia, Neurol Sect, Philadelphia, PA 19104 USA.
   [Smith, Sabrina; Sondheimer, Neal] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Pennsylvania; Pennsylvania Medicine;
   Childrens Hospital of Philadelphia; University of Pennsylvania
RP Sondheimer, N (corresponding author), Childrens Hosp Philadelphia, Sect Biochem Genet, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM glatzc@email.chop.edu; dacok@email.chop.edu; smithsa@email.chop.edu;
   sondheimer@email.chop.edu
RI Sondheimer, Neal/X-7846-2019
OI Sondheimer, Neal/0000-0001-9982-5712
FU NIH [HD58022]
FX This work was supported by NIH grant HD58022 to NS. The authors thank
   Michael King for the gift of the 143B rho<SUP>0</SUP> cell line and
   guidance on making cybrids.
CR Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111
   Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Phasukkijwatana N, 2010, HUM GENET, V128, P39, DOI 10.1007/s00439-010-0821-8
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
NR 17
TC 27
Z9 31
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2011
VL 11
IS 4
BP 615
EP 619
DI 10.1016/j.mito.2011.04.003
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 779GD
UT WOS:000291765200010
PM 21540128
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Lönnqvist, T
   Paetau, A
   Valanne, L
   Pihko, H
AF Lonnqvist, Tuula
   Paetau, Anders
   Valanne, Leena
   Pihko, Helena
TI Recessive twinkle mutations cause severe epileptic encephalopathy
SO BRAIN
LA English
DT Article
DE Twinkle; IOSCA; epileptic encephalopathy
ID ONSET SPINOCEREBELLAR ATAXIA; STROKE-LIKE EPISODES; MITOCHONDRIAL
   DISORDERS; SENSORY NEUROPATHY; MTDNA DEPLETION; MELAS; GENE;
   PATHOPHYSIOLOGY; SPECTRUM; FEATURES
AB The C10orf2 gene encodes the mitochondrial DNA helicase Twinkle, which is one of the proteins important for mitochondrial DNA maintenance. Dominant mutations cause multiple mitochondrial DNA deletions and progressive external ophthalmoplegia, but recent findings associate recessive mutations with mitochondrial DNA depletion and encephalopathy or hepatoencephalopathy. The latter clinical phenotypes resemble those associated with recessive POLG1 mutations. We have previously described patients with infantile onset spinocerebellar ataxia (MIM271245) caused either by homozygous (Y508C) or compound heterozygous (Y508C and A318T) Twinkle mutations. Our earlier reports focused on the spinocerebellar degeneration, but the 20-year follow-up of 23 patients has shown that refractory status epilepticus, migraine-like headaches and severe psychiatric symptoms are also pathognomonic for the disease. All adolescent patients have experienced phases of severe migraine, and seven patients had antipsychotic medication. Epilepsia partialis continua occurred in 15 patients leading to generalized epileptic statuses in 13 of them. Eight of these patients have died. Valproate treatment was initiated on two patients, but had to be discontinued because of a severe elevation of liver enzymes. The patients recovered, and we have not used valproate in infantile onset spinocerebellar ataxia since. The first status epilepticus manifested between 15 and 34 years of age in the homozygotes, and at 2 and 4 years in the compound heterozygotes. The epileptic statuses lasted from several days to weeks. Focal, stroke-like lesions were seen in magnetic resonance imaging, but in infantile onset spinocerebellar ataxia these lesions showed no predilection. They varied from resolving small cortical to large hemispheric oedematous lesions, which reached from cerebral cortex to basal ganglia and thalamus and caused permanent necrotic damage and brain atrophy. Brain atrophy with focal laminar cortical necrosis and hippocampal damage was confirmed on neuropathological examination. The objective of our study was to describe the development and progression of encephalopathy in infantile onset spinocerebellar ataxia syndrome, and compare the pathognomonic features with those in other mitochondrial encephalopathies.
C1 [Lonnqvist, Tuula; Pihko, Helena] Univ Helsinki, Cent Hosp, Div Child Neurol, Helsinki 00029, Finland.
   [Paetau, Anders] Univ Helsinki, Dept Pathol, Helsinki 00029, Finland.
   [Paetau, Anders] HUSLAB, Helsinki, Finland.
   [Valanne, Leena] Univ Helsinki, Helsinki Med Imaging Ctr, Helsinki 00029, Finland.
C3 University of Helsinki; Helsinki University Central Hospital; University
   of Helsinki; University of Helsinki
RP Lönnqvist, T (corresponding author), Univ Helsinki, Cent Hosp, Div Child Neurol, POB 280, Helsinki 00029, Finland.
EM tuula.lonnqvist@hus.fi
OI Valanne, Leena/0000-0002-8572-829X
FU Helsinki University Central Hospital EVO; Finnish Foundation for
   Pediatric Research
FX Helsinki University Central Hospital EVO; Finnish Foundation for
   Pediatric Research.
CR Bartynski WS, 2008, AM J NEURORADIOL, V29, P1043, DOI 10.3174/ajnr.A0929
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Feddersen B, 2003, NEUROLOGY, V61, P1149, DOI 10.1212/01.WNL.0000092497.53706.1B
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   KOSKINEN T, 1995, NEUROPEDIATRICS, V26, P263, DOI 10.1055/s-2007-979769
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   KOSKINEN T, 1995, AM J NEURORADIOL, V16, P1427
   Kovács R, 2002, J NEUROPHYSIOL, V88, P2909, DOI 10.1152/jn.00149.2002
   Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009
   Liang LP, 2006, FREE RADICAL BIO MED, V40, P316, DOI 10.1016/j.freeradbiomed.2005.08.026
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Michelson DJ, 2004, MITOCHONDRION, V4, P665, DOI 10.1016/j.mito.2004.07.019
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Pandolfo M, 2008, ARCH NEUROL-CHICAGO, V65, P1296, DOI 10.1001/archneur.65.10.1296
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
NR 31
TC 80
Z9 84
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD JUN
PY 2009
VL 132
BP 1553
EP 1562
DI 10.1093/brain/awp045
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 451VG
UT WOS:000266498400022
PM 19304794
OA Bronze
DA 2024-11-01
ER

PT J
AU Ryu, JS
   Lee, SJ
   Sung, IY
   Ko, TS
   Yoo, HI
AF Ryu, Ju Seok
   Lee, Sook Joung
   Sung, In Young
   Ko, Tae Sung
   Yoo, Han Ik
TI Depressive Episode With Catatonic Features in a Case of Mitochondrial
   Myropathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes
   (MELAS)
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE MELAS; A3243G; depression
ID CLINICAL-FEATURES; DNA; MUTATION; MYOPATHY
AB Three months previously, a 17-year-old girl had complained of right-hand side hemiparesis, and her brain magnetic resonance imaging (MRI) showed a signal change in the left temporoparietooccipital area. The 3243A>G mutation was found in mitochondrial DNA. She was diagnosed with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and was prescribed dichloroacetic acid to treat lactic acidosis. Her health improved. Two months later, she developed drowsiness and generalized weakness. A New lesion was not found on brain MRI, and electrodiagnostic findings were compatible with acute motor sensory axonal neuropathy. Her negative symptoms, such as depressed mood, loss of interest in activities, psychomotor retardation, and hypersomnia, were aggravated. She was prescribed antidepressants and psychostimulants by a psychiatrist after diagnosis of severe depression episode with catatonic features. One month later, her catatonic condition had improved with medication. Our experience shows that psychiatric diagnostic evaluation of abruptly regressed neurologic and clinical features is important, even in a patient with devastating underlying disease.
C1 [Ryu, Ju Seok; Lee, Sook Joung; Sung, In Young] Univ Ulsan, Coll Med, Dept Rehabil Med, Seoul 138736, South Korea.
   [Ko, Tae Sung] Univ Ulsan, Coll Med, Dept Pediat, Seoul 138736, South Korea.
   [Yoo, Han Ik] Univ Ulsan, Coll Med, Dept Psychiat, Seoul 138736, South Korea.
C3 University of Ulsan; University of Ulsan; University of Ulsan
RP Sung, IY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Phys Med & Rehabil, 388-1 Pungnap 2Dong, Seoul 138736, South Korea.
EM iysung@amc.seoul.kr
RI Ryu, Ju/W-4027-2019
CR Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Frye CB, 1997, AM J HEALTH-SYST PH, V54, P2510, DOI 10.1093/ajhp/54.21.2510
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hoschl Cyril, 2008, Expert Rev Neurother, V8, P537, DOI 10.1586/14737175.8.4.537
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Miyaoka H, 1997, BIOL PSYCHIAT, V42, P524, DOI 10.1016/S0006-3223(97)00280-1
   Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041
   Sadock B.J., 2007, Kaplan Sadock's synopsis of psychiatry, V10th
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
NR 10
TC 7
Z9 7
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD OCT
PY 2009
VL 24
IS 10
BP 1307
EP 1309
DI 10.1177/0883073809334380
PG 3
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 502ZJ
UT WOS:000270499500015
DA 2024-11-01
ER

PT J
AU Pronicka, E
   Weglewska-Jurkiewicz, A
   Pronicki, M
   Sykut-Cegielska, J
   Kowalski, P
   Pajdowska, M
   Jankowska, I
   Kotulska, K
   Kalicinski, P
   Jakóbkiewicz-Banecka, J
   Wegrzyn, G
AF Pronicka, Ewa
   Weglewska-Jurkiewicz, Anna
   Pronicki, Maciej
   Sykut-Cegielska, Jolanta
   Kowalski, Pawel
   Pajdowska, Magdalena
   Jankowska, Irena
   Kotulska, Katarzyna
   Kalicinski, Piotr
   Jakobkiewicz-Banecka, Joanna
   Wegrzyn, Grzegorz
TI Drug-resistant epilepsia and fulminant valproate liver toxicity.
   Alpers-Huttenlocher syndrome in two children confirmed <i>post
   mortem</i> by identification of p.W748S mutation in <i>POLG</i> gene
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE drug-resistant epilepsy; valproate liver toxicity; Alpers-Huttenlocher
   syndrome; POLG gene mutation
ID MITOCHONDRIAL-DNA POLYMERASE; ATAXIC NEUROPATHY; GAMMA; DISEASE;
   DEGENERATION; DEPLETION; CHILDHOOD; W748S; A467T
AB Background: POLG (polymerase gamma) gene mutations lead to a variety of neurological disorders, including Alpers-Huttenlocher syndrome (AHS). The diagnostic triad of AHS is: resistant epilepsy, liver impairment triggered by sodium valproate (VA), and mitochondrial DNA depletion.
   Material/Methods: A cohort of 28 children with mitochondrial encephalopathy and liver failure was qualified for retrospective study of mitochondrial DNA depletion and POLG mutations.
   Results: The p. W748S POLG gene mutation was revealed in 2 children, the only ones in the cohort who fulfilled the AHS criteria. Depletion of mtDNA (16% of control value) was confirmed post mortem in available liver tissue and was not detected in the muscle. The disease started with drug-resistant seizures, failure to thrive and developmental regression at the ages of 7 and 18 months, respectively. Irreversible liver failure developed after VA administration. Co-existence of epilepsy, VA liver toxicity, lactic acidemia and muscle respiratory chain dysfunction led finally to the diagnosis of mitochondrial disorder (and AHS suspicion).
   Conclusions: Our results confirm, for the first time, the occurrence of a pathology caused by POLG gene mutation(s) in the Polish population. POLG mutation screening and mtDNA depletion assessment should be included in differential diagnosis of drug-resistant epilepsy associated with a hepatopathy.
C1 [Weglewska-Jurkiewicz, Anna; Jakobkiewicz-Banecka, Joanna; Wegrzyn, Grzegorz] Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland.
   [Pronicki, Maciej] CMHI, Dept Pathol, PL-04730 Warsaw, Poland.
   [Kowalski, Pawel] CMHI, Dept Med Genet, PL-04730 Warsaw, Poland.
   [Pajdowska, Magdalena] CMHI, Dept Biochem & Expt Med, PL-04730 Warsaw, Poland.
   [Jankowska, Irena] CMHI, Dept Gastroenterol, PL-04730 Warsaw, Poland.
   [Pronicka, Ewa; Weglewska-Jurkiewicz, Anna; Sykut-Cegielska, Jolanta] CMHI, Dept Metab Dis Endocrinol & Diabetol, PL-04730 Warsaw, Poland.
   [Kotulska, Katarzyna] CMHI, Dept Neurol & Epileptol, PL-04730 Warsaw, Poland.
   [Kalicinski, Piotr] CMHI, Dept Surg & Transplantol, PL-04730 Warsaw, Poland.
C3 Fahrenheit Universities; University of Gdansk; Children's Memorial
   Health Institute; Children's Memorial Health Institute; Children's
   Memorial Health Institute; Children's Memorial Health Institute;
   Children's Memorial Health Institute; Children's Memorial Health
   Institute; Children's Memorial Health Institute
RP Pronicka, E (corresponding author), CMHI, Dept Metab Dis Endocrinol & Diabetol, Aleja Dzieci Polskich 20 Str, PL-04730 Warsaw, Poland.
EM e.pronicka@czd.pl
RI Jakóbkiewicz-Banecka, Joanna/C-2365-2014; Sykut-Cegielska,
   Jolanta/V-4253-2019; Wegrzyn, Grzegorz/AAL-1179-2020; Kalicinski,
   Piotr/AEN-1920-2022; Pajdowska, Magdalena/V-9639-2018
OI Kalicinski, Piotr/0000-0003-0555-2229; Jankowska,
   Irena/0000-0001-6847-9570; Jakobkiewicz-Banecka,
   Joanna/0000-0002-8846-5448; Wegrzyn, Grzegorz/0000-0003-4042-7466;
   Pajdowska, Magdalena/0000-0002-1334-3534; Pronicki,
   Maciej/0000-0002-5589-0456; Pronicka, Ewa/0000-0002-5705-4814;
   Sykut-Cegielska, Jolanta/0000-0003-0762-3721; Kotulska-Jozwiak,
   Katarzyna/0000-0002-5015-250X; Kowalski, Pawel/0000-0002-0240-6974
FU CMHI [119/09]; Polish Mitochondrial Network;  [PB 0890/P05/2005/29]
FX The study was supported by grants PB 0890/P05/2005/29, CMHI 119/09 and
   the Polish Mitochondrial Network
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Boes M, 2009, SEIZURE-EUR J EPILEP, V18, P232, DOI 10.1016/j.seizure.2008.08.003
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, MITOCHONDRION, V9, P340, DOI 10.1016/j.mito.2009.05.002
   Constantin T, 2009, MED SCI MONITOR, V15, pCR164
   Craig K, 2007, BRAIN, V130, DOI 10.1093/brain/awm009
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Delarue A, 2000, Pediatr Transplant, V4, P67, DOI 10.1034/j.1399-3046.2000.00090.x
   DEVRIES MC, 2008, J INHERIT METAB DIS
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   DREIFUSS FE, 1989, NEUROLOGY, V39, P201, DOI 10.1212/WNL.39.2.201
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hassanein T, 2004, MITOCHONDRION, V4, P609, DOI 10.1016/j.mito.2004.07.015
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Jurkiewicz E, 2010, POL J RADIOL, V75, P51
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710
   LEE WM, 1995, NEW ENGL J MED, V333, P1118, DOI 10.1056/NEJM199510263331706
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   McHugh JC, 2010, MUSCLE NERVE, V41, P265, DOI 10.1002/mus.21494
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Paprocka J, 2010, MED SCI MONITOR, V16, pCR389
   Pronicka E, 2007, PEDIATR RES, V62, P101, DOI 10.1203/PDR.0b013e318068641a
   Pronicka E, 2011, J APPL GENET, V52, P61, DOI 10.1007/s13353-010-0008-y
   Rantamäki M, 2007, CLIN GENET, V72, P532, DOI 10.1111/j.1399-0004.2007.00908.x
   RETTIE AE, 1987, SCIENCE, V235, P890, DOI 10.1126/science.3101178
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tesarova M, 2004, NEUROPEDIATRICS, V35, P217, DOI 10.1055/s-2004-821081
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 48
TC 32
Z9 33
U1 0
U2 12
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD APR
PY 2011
VL 17
IS 4
BP CR203
EP CR209
DI 10.12659/MSM.881716
PG 7
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 748FC
UT WOS:000289374400020
PM 21455106
OA Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Miró, O
   López, S
   de la Concepción, MR
   Martínez, E
   Pedrol, E
   Garrabou, G
   Giralt, M
   Cardellach, F
   Gatell, JM
   Vilarroya, F
   Casademont, J
AF Miró, O
   López, S
   de la Concepción, MR
   Martínez, E
   Pedrol, E
   Garrabou, G
   Giralt, M
   Cardellach, F
   Gatell, JM
   Vilarroya, F
   Casademont, J
TI Upregulatory mechanisms compensate for mitochondrial DNA depletion in
   asymptomatic individuals receiving stavudine plus didanosine
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE peripheral blood mononuclear cells; mitochondrial DNA; cytochrome c
   oxidase subunit II; nucleoside reverse transcriptase inhibitors;
   stavudine; didanosine; DNA gamma-polymerase
ID BLOOD MONONUCLEAR-CELLS; HIV-INFECTED PATIENTS; SKELETAL-MUSCLE;
   ADIPOSE-TISSUE; TOXICITY; MYOPATHY; MARKER; DRUGS
AB Nucleoside analogue use is often related to mitochondrial DNA (mtDNA) depletion, but mitochondrial function is preserved in most asymptomatic patients. We determined whether homeostatic mechanisms are able to compensate for this mtDNA depletion in patients receiving stavudine plus didanosine (d4T + ddI), an antiretroviral combination with great in vitro and in vivo capacity to decrease mtDNA. We included 28 asymptomatic HIV-infected individuals: 17 subjects (cases) on a first-line antiretroviral regimen consisting of d4T + ddI as the nucleoside backbone plus nevirapine or nelfinavir for at least 6 months (mean: 16 +/- 8 months) and 11 naive subjects (controls). We assessed the following in peripheral blood mononuclear cells: mitochondrial mass by citrate synthase activity, mtDNA content by real-time polymerase chain reaction, cytochrome c oxidase subunit II (COX-II) expression by Western blot analysis, and COX activity by spectrophotometry. The mitochondrial mass and mtDNA content of cases decreased when compared with controls, whether normalized per cell or per mitochondrion. Conversely, COXII expression and COX activity were similar in cases and controls. COX-II expression was constant and independent of the mtDNA content, whereas it was closely related to COX activity. We concluded that treatment with dd4T + ddI is associated with decreased mitochondrial mass and mtDNA content but that COX-II expression and COX activity remain unaltered. These data suggest that upregulatory transcriptional or posttranscriptional mechanisms compensate for mtDNA depletion caused by d4T + ddI before profound mtDNA depletion occurs.
C1 Hosp Clin Barcelona, Dept Internal Med, Muscle Res Unit, Mitochondrial Res Lab,Inst Invest Bioued August P, E-08036 Barcelona, Spain.
   Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain.
   Hosp Clin Barcelona, Dept Infect Dis, Inst Invest Bioued August P, E-08036 Barcelona, Spain.
   Fdn Hosp Asil Granollers, Dept Internal Med, HIV Unit, Granollers, Spain.
C3 University of Barcelona; Hospital Clinic de Barcelona; University of
   Barcelona; University of Barcelona; Hospital Clinic de Barcelona
RP Hosp Clin Barcelona, Dept Internal Med, Muscle Res Unit, Mitochondrial Res Lab,Inst Invest Bioued August P, Villarroel 170, E-08036 Barcelona, Spain.
EM omiro@clinic.ub.es
RI Miro, Oscar/K-1798-2019; Lopez, Sonia/AAC-8830-2019; Casademont,
   Jordi/A-6828-2010; Giralt, Marta/A-4756-2013
OI MARTINEZ, ESTEBAN/0000-0002-6911-8846; Rodriguez de la
   Concepcion/0000-0002-6944-3462; Lopez, Sonia/0000-0002-5023-5153;
   Garrabou, Gloria/0000-0001-8973-9933; Miro Andreu,
   Oscar/0000-0001-8127-166X; Giralt, Marta/0000-0001-7968-4190
CR Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cherry CL, 2002, J ACQ IMMUN DEF SYND, V30, P271, DOI [10.1097/00126334-200207010-00002, 10.1097/01.QAI.0000017962.22053.0E]
   Chiappini F, 2004, LAB INVEST, V84, P908, DOI 10.1038/labinvest.3700113
   Cossarizza A, 2001, BIOESSAYS, V23, P1070, DOI 10.1002/bies.1152
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Gerschenson M, 2003, ANTIVIR THER, V8, P261
   Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   López S, 2004, ANTIVIR THER, V9, P47
   Miró O, 2003, ANTIVIR THER, V8, pL42
   Miró O, 1998, J NEUROSCI METH, V80, P107, DOI 10.1016/S0165-0270(97)00204-5
   Miró O, 2003, AIDS RES HUM RETROV, V19, P1027, DOI 10.1089/088922203322588387
   Miró O, 2004, CLIN INFECT DIS, V39, P710, DOI 10.1086/423176
   Miró O, 2003, ANTIVIR THER, V8, P333
   Nolan D, 2003, AIDS, V17, P1329, DOI 10.1097/00002030-200306130-00007
   Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7
   Polo R, 2003, JAIDS-J ACQ IMM DEF, V34, P32, DOI 10.1097/00126334-200309010-00004
   Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916
   Rodríguez-Santiago B, 2001, EUR J HUM GENET, V9, P279, DOI 10.1038/sj.ejhg.5200629
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Shikuma CM, 2001, AIDS, V15, P1801, DOI 10.1097/00002030-200109280-00009
   Vittecoq D, 2002, JAIDS, V31, P299, DOI 10.1097/00126334-200211010-00005
   Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009
   Walker UA, 2002, J ACQ IMMUN DEF SYND, V29, P117, DOI 10.1097/00042560-200202010-00002
   White AJ, 2001, SEX TRANSM INFECT, V77, P158, DOI 10.1136/sti.77.3.158
   Yerroum M, 2000, ACTA NEUROPATHOL, V100, P82, DOI 10.1007/s004010051196
   Zaera MG, 2001, AIDS, V15, P1643, DOI 10.1097/00002030-200109070-00006
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
NR 31
TC 37
Z9 40
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD DEC 15
PY 2004
VL 37
IS 5
BP 1550
EP 1555
PG 6
WC Immunology; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases
GA 881FY
UT WOS:000225850000002
PM 15577406
OA Bronze
DA 2024-11-01
ER

PT J
AU Debray, FG
   Lambert, M
   Allard, P
   Mitchell, GA
AF Debray, Francois-Guillaume
   Lambert, Marie
   Allard, Pierre
   Mitchell, Grant A.
TI Low Citrulline in Leigh Disease: Still a Biomarker of Maternally
   Inherited Leigh Syndrome
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Leigh syndrome; mitochondrial disease; lactic acidosis; amino acids;
   citrulline
ID MITOCHONDRIAL-DNA MUTATIONS; MTDNA MUTATION; HYPOCITRULLINAEMIA; T8993G
AB Two siblings presented with encephalopathy, lactic acidosis, and hypocitrullinemia. Muscle and liver biopsies were considered for respiratory chain studies, but because of hypocitrullinemia, molecular analysis for maternally inherited Leigh syndrome was first performed, revealing in both siblings the mitochondrial DNA T8993G mutation (95% heteroplasmy), allowing to avoid tissue biopsies. Hypocitrullinemia, an occasional finding in mitochondrial diseases, has been specifically associated with T8993G mutation. However, only few patients have been reported, and the prevalence of hypocitrullinemia in 8993 mitochondrial DNA mutations is unknown. In a small series of 16 Leigh syndrome patients, sensitivity and specificity of hypocitrullinemia (<= 12 mu mol/L) for 8993 mitochondrial DNA mutations were 66% and 85%, respectively. Although studies in larger cohorts are necessary, we suggest considering T8993G mutation early in the diagnostic evaluation of infantile mitochondrial diseases with hypocitrullinemia, which minimizes the need for invasive procedures associated with a small but nonnegligible risk of complications and incorrect diagnosis.
C1 [Debray, Francois-Guillaume] CHU Sart Tilman, Dept Human Genet, B-4000 Liege, Belgium.
   [Debray, Francois-Guillaume] Univ Liege, Liege, Belgium.
   [Lambert, Marie; Allard, Pierre; Mitchell, Grant A.] Univ Montreal, Dept Pediat, Div Med Genet, CHU St Justine, Montreal, PQ H3C 3J7, Canada.
C3 University of Liege; University of Liege; Universite de Montreal; Centre
   Hospitalier Universitaire Sainte-Justine
RP Debray, FG (corresponding author), CHU Sart Tilman, Dept Human Genet, Domaine Univ Sart Tilman,Bat B35, B-4000 Liege, Belgium.
EM fg.debray@chu.ulg.ac.be
CR Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   Rabier D, 1998, J INHERIT METAB DIS, V21, P216, DOI 10.1023/A:1005391300203
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   RIBES A, 1993, J INHERIT METAB DIS, V16, P537, DOI 10.1007/BF00711675
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Vázquez-Memije ME, 1998, J INHERIT METAB DIS, V21, P829, DOI 10.1023/A:1005418718299
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
NR 9
TC 16
Z9 17
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
J9 J CHILD NEUROL
JI J. Child Neurol.
PD AUG
PY 2010
VL 25
IS 8
BP 1000
EP 1002
DI 10.1177/0883073809351983
PG 3
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 625PS
UT WOS:000279908100009
PM 20472868
DA 2024-11-01
ER

PT J
AU Kiyomoto, BH
   Tengan, CH
   Godinho, RO
AF Kiyomoto, Beatriz H.
   Tengan, Celia H.
   Godinho, Rosely O.
TI Effects of short-term zidovudine exposure on mitochondrial DNA content
   and succinate dehydrogenase activity of rat skeletal muscle cells
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE zidovudine; skeletal muscle; mitochondria; succinate dehydrogenase;
   mitochondrial DNA
ID ULTRASTRUCTURAL-CHANGES; INDUCED DESTRUCTION; DIDANOSINE DDI; HUMAN
   MYOTUBES; L-CARNITINE; TOXICITY; AZT; MYOPATHY; THERAPY; AIDS
AB Long-term use of zidovudine (AZT) may cause mitochondrial abnormalities in various tissues, including a toxic myopathy in AIDS patients associated with mitochondrial DNA (mtDNA) depletion. In the present study, we examine the short-term (48 h) effect of AZT (10, 30 and 100 mu g/ml) on the mitochondrial succinate dehydrogenase (SDH) and mtDNA content of rat cultured skeletal muscle. The effect of AZT on cytochrome c oxidase (COX) enzyme was also analyzed. The histochemical quantitative analysis of SDH showed that AZT 10, 30 and 100 mu g/ml increased by 7%, 9% and 13% the mitochondrial content. Conversely, treatment of rat cultures with 10 to 100 mu g/ml AZT reduced the mtDNA content by 23% to 66%, when compared to control values. The spontaneous contraction and the COX activity were not modified by up to 100 mu g/ml AZT. Taken together, these results show that short-term treatment with AZT can induce severe myotoxicity that involves mitochondrial proliferation and mtDNA depletion in the rat cultured myotubes. Our results also indicate that rat cultured skeletal muscle might be a valuable in vitro assay to evaluate the effect of drugs on mitochondria to predict their potential to induce mitochondrial toxicity. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Godinho, Rosely O.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Pharmacol INFAR, BR-04044020 Sao Paulo, Brazil.
   [Kiyomoto, Beatriz H.; Tengan, Celia H.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, BR-04039032 Sao Paulo, Brazil.
C3 Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao
   Paulo (UNIFESP)
RP Godinho, RO (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Pharmacol INFAR, Rua 03 Maio 100, BR-04044020 Sao Paulo, Brazil.
EM godinho@farm.epm.br
RI Godinho, Rosely/E-7460-2012; Tengan, Celia/D-8458-2013
OI Godinho, Rosely/0000-0003-1687-2180
CR AMAUDO E, 2001, LANCET, V337, P508
   [Anonymous], 1983, J IMMUNOL METH
   [Anonymous], 2006, ANT THER HIV INF AD
   Benbrik E, 1997, J NEUROL SCI, V149, P19, DOI 10.1016/S0022-510X(97)05376-8
   Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002
   Casademont J, 1996, BRAIN, V119, P1357, DOI 10.1093/brain/119.4.1357
   Cazzalini O, 2001, BIOCHEM PHARMACOL, V62, P893, DOI 10.1016/S0006-2952(01)00713-4
   CHEN CH, 1989, J BIOL CHEM, V264, P11934
   CHEN CH, 1991, MOL PHARMACOL, V39, P625
   Clumeck N, 2000, BIOMED PHARMACOTHER, V54, P7, DOI 10.1016/S0753-3322(00)88634-5
   CUPLER EJ, 1995, ACTA NEUROPATHOL, V90, P1
   Dalakas MC, 2001, LAB INVEST, V81, P1537, DOI 10.1038/labinvest.3780367
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   DAMATI G, 1994, LAB INVEST, V71, P879
   de la Asunción JG, 1998, J CLIN INVEST, V102, P4, DOI 10.1172/JCI1418
   de Mendoza C, 2004, AIDS REV, V6, P169
   Godinho RO, 2003, BRIT J PHARMACOL, V138, P995, DOI 10.1038/sj.bjp.0705130
   HERZBERG NH, 1992, MUSCLE NERVE, V15, P706, DOI 10.1002/mus.880150613
   Höschele D, 2006, TOXICOL IN VITRO, V20, P535, DOI 10.1016/j.tiv.2005.11.007
   LAMPERTH L, 1991, LAB INVEST, V65, P742
   LEWIS LD, 1992, ANTIMICROB AGENTS CH, V36, P2061, DOI 10.1128/AAC.36.9.2061
   LEWIS W, 1991, LAB INVEST, V65, P228
   LEWIS W, 1992, J CLIN INVEST, V89, P1354, DOI 10.1172/JCI115722
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Masini A, 1999, J NEUROL SCI, V166, P131, DOI 10.1016/S0022-510X(99)00126-4
   MEDINA DJ, 1994, ANTIMICROB AGENTS CH, V38, P1824, DOI 10.1128/AAC.38.8.1824
   Moraes Carlos T., 1993, P97
   Pedrol E, 1996, J NEUROL SCI, V138, P42, DOI 10.1016/0022-510X(96)00009-3
   PETERS BS, 1993, Q J MED, V86, P5
   Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128
   Schroder JM, 1996, ACTA NEUROPATHOL, V92, P138, DOI 10.1007/s004010050501
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SELIGMAN AM, 1951, SCIENCE, V113, P317, DOI 10.1126/science.113.2934.317-a
   SEMINOMORA MC, 1994, LAB INVEST, V71, P773
   SEMINOMORA MC, 1994, LAB INVEST, V71, P102
   SIMPSON MV, 1989, BIOCHEM PHARMACOL, V38, P1033, DOI 10.1016/0006-2952(89)90245-1
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Tanji K, 2001, METHOD CELL BIOL, V65, P311, DOI 10.1016/S0091-679X(01)65019-2
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   YARCHOAN R, 1986, LANCET, V1, P575
NR 41
TC 7
Z9 7
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAY 15
PY 2008
VL 268
IS 1-2
BP 33
EP 39
DI 10.1016/j.jns.2007.10.026
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 292JH
UT WOS:000255261800006
PM 18045616
DA 2024-11-01
ER

PT J
AU Scuderi, C
   Borgione, E
   Castello, F
   Lo Giudice, M
   Fichera, M
   Elia, M
   Amato, C
   Savio, M
   Di Blasi, FD
   Vitello, GA
   Romano, S
   DiMauro, S
   Musumeci, SA
AF Scuderi, Carmela
   Borgione, Eugenia
   Castello, Filippa
   Lo Giudice, Mariangela
   Fichera, Marco
   Elia, Maurizio
   Amato, Carmelo
   Savio, Maria
   Di Blasi, Francesco Domenico
   Vitello, Girolamo Aurelio
   Romano, Salvatore
   DiMauro, Salvatore
   Musumeci, Sebastiano Antonino
TI Coexistence of mitochondrial and nuclear DNA mutations in a woman with
   mitochondrial encephalomyopathy and double cortex
SO MITOCHONDRION
LA English
DT Article
DE DCX; m.3243A > G; Mitochondrial disorders; Mental retardation
ID SUBCORTICAL BAND HETEROTOPIA; LACTIC-ACIDOSIS; NEURONAL MIGRATION;
   EPISODES MELAS; ENCEPHALOPATHY; BRAIN; GENE; DEFICIENCY; DCX;
   DISTURBANCES
AB We describe a 16-year-old girl with mental retardation, myoclonic epilepsy, ataxia, mitochondrial myopathy, sensorineural hearing loss, lactic acidosis, and MRI evidence of diffuse subcortical laminar heterotopia and agyria/pachygyria. Restriction fragment length polymorphism (RFLP) and DNA sequence analyses revealed two pathogenic mutations: a heteroplasmic m.3243A > G in muscle and blood, and a new heterozygous insertion at nt697 in the doublecortin gene (DCX), resulting in a frameshift after amino acid residue 232, with a premature stop codon at amino acid residue 244. This is yet another example of genetic "double trouble" resulting in a complex phenotype. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Scuderi, Carmela; Borgione, Eugenia; Castello, Filippa; Lo Giudice, Mariangela] IRCCS Oasi Maria SS, Unita Operat Malattie Neuromuscolari, I-94018 Troina, EN, Italy.
   [Fichera, Marco] IRCCS Oasi Maria SS, Lab Diagnosi Genet, Troina, Italy.
   [Amato, Carmelo] IRCCS Oasi Maria SS, Unita Operat Neuroradiol, Troina, Italy.
   [Savio, Maria; Di Blasi, Francesco Domenico] IRCCS Oasi Maria SS, Unita Operat Psicol, Troina, Italy.
   [Vitello, Girolamo Aurelio; Romano, Salvatore; Musumeci, Sebastiano Antonino] IRCCS Oasi Maria SS, Unita Operat Neurol Ritardo Mentale, Troina, Italy.
   [DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
C3 IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; IRCCS
   Oasi Maria SS; IRCCS Oasi Maria SS; Columbia University
RP Scuderi, C (corresponding author), IRCCS Oasi Maria SS, Unita Operat Malattie Neuromuscolari, V Conte Ruggero 73, I-94018 Troina, EN, Italy.
EM cscuderi@oasi.en.it
RI Vitello, Aurelio/E-3208-2017; Vitello, Girolamo Aurelio/HPG-0215-2023;
   Amato, Carmelo/D-5567-2017; Di Blasi, Francesco Domenico/D-8146-2017;
   Scuderi, Carmela/D-4734-2017; Borgione, Eugenia/D-9168-2017; Castello,
   Filippa/D-4266-2017; Musumeci, Sebastiano Antonino/E-3879-2017; Elia,
   Maurizio/K-3285-2016; Fichera, Marco/K-9220-2016; Lo Giudice,
   Mariangela/D-4261-2017
OI Vitello, Girolamo Aurelio/0000-0002-6285-9692; Amato,
   Carmelo/0000-0002-8058-344X; Di Blasi, Francesco
   Domenico/0000-0002-2958-2927; Scuderi, Carmela/0000-0001-5901-0041;
   Borgione, Eugenia/0000-0001-5458-7415; Castello,
   Filippa/0000-0002-2780-1583; Musumeci, Sebastiano
   Antonino/0000-0002-6865-5367; Elia, Maurizio/0000-0002-0414-1359;
   Fichera, Marco/0000-0002-8225-6880; Lo Giudice,
   Mariangela/0000-0001-5961-0362
CR BARKOVICH AJ, 1994, ANN NEUROL, V36, P609, DOI 10.1002/ana.410360409
   Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127
   Cai Y, 2009, EXP NEUROL, V216, P342, DOI 10.1016/j.expneurol.2008.12.008
   Calingasan NY, 2008, NEUROSCIENCE, V153, P986, DOI 10.1016/j.neuroscience.2008.02.071
   Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405
   Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505
   Damian MS, 1996, AM J MED GENET, V62, P398, DOI 10.1002/(SICI)1096-8628(19960424)62:4<398::AID-AJMG13>3.0.CO;2-J
   des Portes V, 1998, CELL, V92, P51
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3
   Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5
   Gressens P, 2000, PEDIATR RES, V48, P725, DOI 10.1203/00006450-200012000-00004
   Griffiths R., 1984, The Abilities of Young Children: A Comprehensive System of Mental Measurement for the First Eight Years of Life (Revised Edition)
   Keng WT, 2003, DEV MED CHILD NEUROL, V45, P704
   Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909
   Leger PL, 2008, NEUROGENETICS, V9, P277, DOI 10.1007/s10048-008-0141-5
   Matsumoto N, 2001, EUR J HUM GENET, V9, P5, DOI 10.1038/sj.ejhg.5200548
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Nissenkorn A, 2001, NEUROLOGY, V56, P1265, DOI 10.1212/WNL.56.10.1265
   Okhuijsen-Kroes EJ, 2001, NEUROPEDIATRICS, V32, P183, DOI 10.1055/s-2001-17372
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Poolos NP, 2002, NEUROLOGY, V58, P1559, DOI 10.1212/WNL.58.10.1559
   Roid G.H., 1997, LEITER INT PERFORMAN
   ROSEN CD, 1996, BRAIN RES, V15, P71
   Ross ME, 1997, HUM MOL GENET, V6, P555, DOI 10.1093/hmg/6.4.555
   Rusanen H, 2002, CELL MOTIL CYTOSKEL, V53, P231, DOI 10.1002/cm.10066
   Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sue CM, 1999, J PEDIATR-US, V134, P696, DOI 10.1016/S0022-3476(99)70283-0
   Wagner OI, 2003, J NEUROSCI, V23, P9046
   Wechsler D., 1997, Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV)
NR 34
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD AUG
PY 2010
VL 10
IS 5
BP 548
EP 554
DI 10.1016/j.mito.2010.04.004
PG 7
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 640LA
UT WOS:000281051500018
PM 20433951
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Höftberger, R
   Stöllberger, C
   Rolinski, B
AF Finsterer, Josef
   Hoeftberger, Romana
   Stoellberger, Claudia
   Rolinski, Boris
TI Mimicry between mitochondrial disorder and multiple sclerosis
SO METABOLIC BRAIN DISEASE
LA English
DT Article
DE Multiple sclerosis; Metabolic defect; Respiratory chain; Mitochondrial
   dysfunction; Metabolic myopathy; Leucencephalopathy
ID RESPIRATORY-CHAIN DEFECTS; OPTIC NEUROPATHY; IMAGING FINDINGS; DNA;
   DEFICIENCY; MUTATION; ILLNESS
AB Under certain conditions or at certain stages of the disease course, multiple sclerosis (MS) and mitochondrial disorder (MID) may be differential diagnoses and thus may be confused with each other. In a 30 years old female MS was diagnosed at age 16 year upon recurrent sensory disturbances of the right lower leg, an "inflammatory" cerebrospinal fluid, and a cerebral MRI with multiple non-enhancing white matter lesions. Steroids were repeatedly given but because of rapid deterioration treatment was switched to interferon and mitoxantrone, without improvement. Fourteen years after onset the patient additionally presented with a history of rhabdomyolysis, hypothyroidism, ophthalmoparesis, anarthria, tetraspasticity, tetraparesis, and joint contractures. After MID had been diagnosed in her mother she was re-evaluated and elevated resting lactate, axonal polyneuropathy, and empty sella were additionally found. Muscle biopsy revealed myophagy, fat deposition, and type-II predominance, and biochemical investigations showed a deficiency of complex I and IV of the respiratory chain. MID was diagnosed also in the index patient. It is concluded that even if CSF investigations or imaging studies suggest MS, differentials such as MIDs need to be excluded before prescribing medication possibly toxic to a MID. An "inflammatory CSF" may also occur in MIDs.
C1 [Finsterer, Josef] Danube Univ Krems, Krems, Austria.
   [Hoeftberger, Romana] Med Univ Vienna, Clin Inst Neurol, Vienna, Austria.
   [Stoellberger, Claudia] Krankenanstaltung Rudolfstiftung, Dept Med 2, Vienna, Austria.
   [Rolinski, Boris] Acad Hosp Munchen Schwabing, Inst Clin Chem, Munich, Germany.
C3 Danube University Krems; Medical University of Vienna; Rudolfstiftung
   Hospital
RP Finsterer, J (corresponding author), Postfach 20 Europe, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Ahlbeck K, 2009, ACTA ANAESTH SCAND, V53, P717, DOI 10.1111/j.1399-6576.2009.01952.x
   Bargalló N, 2000, AM J NEURORADIOL, V21, P479
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Castro-Gago M, 1999, REV NEUROLOGIA, V29, P912, DOI 10.33588/rn.2910.99062
   Chinnery PF, 1999, LANCET, V354, pSI17
   D'Aguanno S, 2008, J NEUROIMMUNOL, V193, P156, DOI 10.1016/j.jneuroim.2007.10.004
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Geldof K, 2007, JBR-BTR, V90, P288
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   Isohanni P, 2010, J MED GENET, V47, P66, DOI 10.1136/jmg.2009.068221
   Kihira Tameko, 2004, Rinsho Shinkeigaku, V44, P187
   Kim J, 2008, EUR RADIOL, V18, P1741, DOI 10.1007/s00330-008-0921-1
   Kumleh HH, 2006, J NEUROL SCI, V243, P65, DOI 10.1016/j.jns.2005.11.030
   Marie SKN, 1999, ARQ NEURO-PSIQUIAT, V57, P1017, DOI 10.1590/S0004-282X1999000600020
   Marrie RA, 2001, EPILEPSIA, V42, P430, DOI 10.1046/j.1528-1157.2001.15800.x
   Maruyama S, 1998, Rinsho Shinkeigaku, V38, P641
   OLSEN NK, 1995, ACTA NEUROL SCAND, V91, P326, DOI 10.1111/j.1600-0404.1995.tb07016.x
   Palace J, 2009, J NEUROL SCI, V286, P24, DOI 10.1016/j.jns.2009.09.009
   Parry-Jones A R, 2008, Pract Neurol, V8, P118, DOI 10.1136/jnnp.2007.139360
   Pato-Pato A, 2006, REV NEUROLOGIA, V42, P22, DOI 10.33588/rn.4201.2005404
   RESZKA K, 1986, Journal of Free Radicals in Biology and Medicine, V2, P25, DOI 10.1016/0748-5514(86)90120-0
   Robeck S, 1996, NERVENARZT, V67, P465
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Yis U, 2009, EUR J PAEDIATR NEURO, V13, P550, DOI 10.1016/j.ejpn.2008.10.009
NR 25
TC 4
Z9 6
U1 0
U2 1
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0885-7490
J9 METAB BRAIN DIS
JI Metab. Brain Dis.
PD JUN
PY 2012
VL 27
IS 2
BP 217
EP 220
DI 10.1007/s11011-012-9277-y
PG 4
WC Endocrinology & Metabolism; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA 940BO
UT WOS:000303865200014
PM 22311611
DA 2024-11-01
ER

PT J
AU Birtel, J
   von Landenberg, C
   Gliem, M
   Gliem, C
   Reimann, J
   Kunz, WS
   Herrmann, P
   Betz, C
   Caswell, R
   Nesbitt, V
   Kornblum, C
   Issa, PC
AF Birtel, Johannes
   von Landenberg, Christina
   Gliem, Martin
   Gliem, Carla
   Reimann, Jens
   Kunz, Wolfram S.
   Herrmann, Philipp
   Betz, Christian
   Caswell, Richard
   Nesbitt, Victoria
   Kornblum, Cornelia
   Issa, Peter Charbel
TI Mitochondrial Retinopathy
SO OPHTHALMOLOGY RETINA
LA English
DT Article
DE Autofluorescence; Genetics; Mitochondrial disease; OCT; Retinal imaging
ID NEAR-INFRARED AUTOFLUORESCENCE; KEARNS-SAYRE SYNDROME; MACULAR
   DYSTROPHY; RETINAL DYSTROPHY; EXTERNAL OPHTHALMOPLEGIA; DNA MUTATION;
   DELETIONS; FEATURES; GENE; MANIFESTATIONS
AB Purpose: To report the retinal phenotype and the associated genetic and systemic findings in patients with mitochondrial disease.
   Design: Retrospective case series.
   Participants: Twenty-three patients with retinopathy and mitochondrial disease, including chronic progressive external ophthalmoplegia (CPEO), maternally inherited diabetes and deafness (MIDD), mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), Kearns-Sayre syndrome, neuropathy, ataxia, and retinitis pigmentosa (NARP) syndrome, and other systemic manifestations.
   Methods: Review of case notes, retinal imaging, electrophysiologic assessment, molecular genetic testing including protein modeling, and histologic analysis of muscle biopsy.
   Main Outcome Measures: Phenotypic characteristics of mitochondrial retinopathy.
   Results: Genetic testing identified sporadic large-scale mitochondrial DNA deletions and variants in MT-TL1, MT-ATP6, MT-TK, MT-RNR1, or RRM2B. Based on retinal imaging, 3 phenotypes could be differentiated: type 1 with mild, focal pigmentary abnormalities; type 2 characterized by multifocal white-yellowish subretinal deposits and pigment changes limited to the posterior pole; and type 3 with widespread granular pigment alterations. Advanced type 2 and 3 retinopathy presented with chorioretinal atrophy that typically started in the peripapillary and paracentral areas with foveal sparing. Two patients exhibited a different phenotype: 1 revealed an occult retinopathy, and the patient with RRM2B-associated retinopathy showed no foveal sparing, no severe peripapillary involvement, and substantial photoreceptor atrophy before loss of the retinal pigment epithelium. Two patients with type 1 disease showed additional characteristics of mild macular telangiectasia type 2. Patients with type 1 and mild type 2 or 3 disease demonstrated good visual acuity and no symptoms associated with the retinopathy. In contrast, patients with advanced type 2 or 3 disease often reported vision problems in dim light conditions, reduced visual acuity, or both. Short-wavelength autofluorescence usually revealed a distinct pattern, and near-infrared autofluorescence may be severely reduced in type 3 disease. The retinal phenotype was key to suspecting mitochondrial disease in 11 patients, whereas 12 patients were diagnosed before retinal examination.
   Conclusions: Different types of mitochondrial retinopathy show characteristic features. Even in absence of visual symptoms, their recognition may facilitate the often challenging and delayed diagnosis of mitochondrial disease, in particular in patients with mild or nebulous multisystem disease. (C) 2021 by the American Academy of Ophthalmology.
C1 [Birtel, Johannes; Gliem, Martin; Issa, Peter Charbel] Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England.
   [Birtel, Johannes; Gliem, Martin; Issa, Peter Charbel] Univ Oxford, Nuffield Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford, England.
   [Birtel, Johannes; Herrmann, Philipp] Univ Hosp Bonn, Dept Ophthalmol, Bonn, Germany.
   [Birtel, Johannes; von Landenberg, Christina; Herrmann, Philipp; Kornblum, Cornelia] Univ Hosp Bonn, Ctr Rare Dis Bonn ZSEB, Bonn, Germany.
   [von Landenberg, Christina; Gliem, Carla; Reimann, Jens; Kornblum, Cornelia] Univ Hosp Bonn, Dept Neurol, Sect Neuromuscular Dis, Bonn, Germany.
   [Kunz, Wolfram S.] Univ Hosp Bonn, Life & Brain Ctr, Dept Epileptol, Bonn, Germany.
   [Betz, Christian] Bioscientia Ctr Human Genet, Ingelheim, Germany.
   [Caswell, Richard] Royal Devon & Exeter NHS Fdn Trust, Genom Lab, Exeter, Devon, England.
   [Caswell, Richard] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England.
   [Nesbitt, Victoria] Churchill Hosp, Nuffield Dept Womens & Reprod Hlth, NHS Highly Specialised Serv Rare Mitochondrial Di, Oxford, England.
C3 Oxford University Hospitals NHS Foundation Trust; University of Oxford;
   University of Bonn; University of Bonn; University of Bonn; University
   of Bonn; University of Exeter; University of Exeter; University of
   Oxford
RP Issa, PC (corresponding author), Oxford Eye Hosp, John Radcliffe Hosp, Oxford OX3 9DU, England.
EM study-enquiry@outlook.com
RI Issa, Peter/E-8935-2018; Kornblum, Cornelia/IUM-4180-2023; Reimann,
   Jens/AAT-1212-2021; Kunz, Wolfram/K-1232-2019
OI Gliem, Carla/0000-0003-3695-188X; Kunz, Wolfram/0000-0003-1113-3493;
   Caswell, Richard/0000-0003-0713-4602
FU Dr. Werner Jackstadt Foundation, Wuppertal, Germany [S0134-10.22]; Bayer
   Global Ophthalmology Awards Program; National Institute for Health
   Research (NIHR) Oxford Biomedical Research Centre (BRC); Chiesi
   Farmaceutici, Parma, Italy; German Federal Ministry of Education and
   Research [01GM1906E]
FX Employee Supported by the Dr. Werner Jackstadt Foundation, Wuppertal,
   Germany (grant no.: S0134-10.22 [J.B.] ) ; the Bayer Global
   Ophthalmology Awards Program (J.B.) ; the National Institute for Health
   Research (NIHR) Oxford Biomedical Research Centre (BRC) ; and Chiesi
   Farmaceutici, Parma, Italy. The views expressed are those of the authors
   and not necessarily those of the National Health Service, the National
   Institute for Health Research, or the Department of Health. The sponsor
   and funding organization had no role in the design or conduct of this
   research. C.K. and J.R. are members of the European Reference Network
   for Rare Neuromuscular Diseases. C.K. is co-coordinator and member of
   mitoNET, the German Network for mito-chondrial disorders, funded by the
   German Federal Ministry of Education and Research (project no.:
   01GM1906E) .
CR Alecu I, 2017, J LIPID RES, V58, P42, DOI 10.1194/jlr.M068676
   Ascaso FJ, 2010, CLIN EXP OPHTHALMOL, V38, P812, DOI 10.1111/j.1442-9071.2010.02335.x
   Birtel J, 2018, OPHTHALMOLOGE, V115, P1021, DOI 10.1007/s00347-018-0779-9
   Birtel J, 2021, KLIN MONATSBL AUGENH, V238, P249, DOI 10.1055/a-1388-7236
   Birtel J, 2019, AM J OPHTHALMOL, V199, P19, DOI 10.1016/j.ajo.2018.10.021
   Birtel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22096-0
   CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028
   Coppieters F, 2016, AM J HUM GENET, V99, P470, DOI 10.1016/j.ajhg.2016.06.017
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   Dubowitz V., 2013, MUSCLE BIOPSY PRACTI
   EAGLE RC, 1982, OPHTHALMOLOGY, V89, P1433
   Flynn J T, 1985, Trans Am Ophthalmol Soc, V83, P131
   Gantner ML, 2019, NEW ENGL J MED, V381, P1422, DOI 10.1056/NEJMoa1815111
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grier J, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000230
   Grönlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Heeren TFC, 2020, OPHTHALMOLOGY, V127, P1539, DOI 10.1016/j.ophtha.2020.03.040
   Hirano M., 1993, GENEREVIEWS
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Issa PC, 2008, INVEST OPHTH VIS SCI, V49, P1172, DOI 10.1167/iovs.07-0636
   Issa PC, 2016, RETINA-J RET VIT DIS, V36, P524, DOI 10.1097/IAE.0000000000000863
   Issa PC, 2013, PROG RETIN EYE RES, V34, P49, DOI 10.1016/j.preteyeres.2012.11.002
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Keilhauer CN, 2006, INVEST OPHTH VIS SCI, V47, P3556, DOI 10.1167/iovs.06-0122
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kozak Igor, 2018, Retin Cases Brief Rep, V12, P349, DOI 10.1097/ICB.0000000000000503
   Latkany P, 1999, AM J OPHTHALMOL, V128, P112, DOI 10.1016/S0002-9394(99)00057-4
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   MCKECHNIE NM, 1985, BRIT J OPHTHALMOL, V69, P63, DOI 10.1136/bjo.69.1.63
   Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Mucciolo DP, 2019, OPHTHALMOLOGICA, V242, P195, DOI 10.1159/000501282
   Müller PL, 2020, AM J OPHTHALMOL, V218, P136, DOI 10.1016/j.ajo.2020.05.023
   Müller PL, 2020, AM J OPHTHALMOL, V213, P134, DOI 10.1016/j.ajo.2020.01.013
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Nguyen MTB, 2019, NEUROLOGY, V92, pE519, DOI 10.1212/WNL.0000000000006861
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Ortiz Alvaro, 2017, Int J Retina Vitreous, V3, P24, DOI 10.1186/s40942-017-0077-8
   Padhy SK, 2018, BMJ CASE REP, V2018, DOI DOI 10.1136/BCR-2018-227394
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Rath PP, 2008, BRIT J OPHTHALMOL, V92, P623, DOI 10.1136/bjo.2007.131177
   RUNGE P, 1986, BRIT J OPHTHALMOL, V70, P782, DOI 10.1136/bjo.70.10.782
   Scerri TS, 2017, NAT GENET, V49, P559, DOI 10.1038/ng.3799
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Stendel C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000393
   Taubitz T, 2019, EBIOMEDICINE, V48, P592, DOI 10.1016/j.ebiom.2019.09.048
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Viscomi C, 2016, BIOCHEM SOC T, V44, P1483, DOI 10.1042/BST20160085
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Yusuf IH, 2020, JAMA OPHTHALMOL, V138, P900, DOI 10.1001/jamaophthalmol.2020.2364
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang T, 2018, MOL NEUROBIOL, V55, P7025, DOI 10.1007/s12035-017-0840-8
   Zucker CL, 2020, P NATL ACAD SCI USA, V117, P18780, DOI 10.1073/pnas.2011532117
NR 58
TC 24
Z9 25
U1 0
U2 5
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2468-6530
J9 OPHTHALMOL RETINA
JI Ophthalmol. Retina
PD JAN
PY 2022
VL 6
IS 1
BP 65
EP 79
DI 10.1016/j.oret.2021.02.017
EA JAN 2022
PG 15
WC Ophthalmology
WE Emerging Sources Citation Index (ESCI)
SC Ophthalmology
GA YE0WV
UT WOS:000740853700010
PM 34257060
OA hybrid
DA 2024-11-01
ER

PT J
AU Veitia, RA
AF Veitia, Reiner A.
TI How the most common mitochondrial DNA mutation (m.3243A>G) vanishes from
   leukocytes: a mathematical model
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID MTDNA MUTATION; CLINICAL-FEATURES; M.3243A-GREATER-THAN-G MUTATION;
   DIABETES-MELLITUS; MELAS SYNDROME; GENE MUTATION; HETEROPLASMY; DISEASE;
   BLOOD; DIAGNOSIS
AB Mitochondrial diseases may be caused by alterations of the mitochondrial genome. The pathogenic variant m.3243A>G is one of the most frequent causes of mitochondrial disease and the most common mitochondrial DNA mutation. Patients with a variant in mitochondrial DNA can have a mixture of mutated and wild-type genomes (heteroplasmy). In the case of the pathogenic variant m.3243A>G, the degree of heteroplasmy (H) correlates to some extent with the severity of the disease. Several longitudinal studies, where H is measured at two different time-points, have shown an annual decline in leukocyte H values. Thus far, only an exponential decay of H with time has been noted but a mechanistic model is lacking. Here, I describe a deterministic mathematical model that accounts for the decline of H in leukocytes based on selective mechanisms acting at the stem cell level. The 'inverted-sigmoid' model provides estimates of at-birth H levels closer to those observed in post-mitotic tissues, such as skeletal muscle, than the estimates provided by an exponential decay. The new model never leads to predictions of H > 100% and provides a stronger correlation between at-birth H values in leukocytes and the scores of the Newcastle Mitochondrial Disease Scale for Adults, which can be of practical utility. This model could be extended to other mitochondrial DNA disease-causing variants.
C1 [Veitia, Reiner A.] Univ Paris Diderot, Inst Jacques Monod, 15 Rue Helene Brion, F-75013 Paris, France.
C3 Universite Paris Cite
RP Veitia, RA (corresponding author), Univ Paris Diderot, Inst Jacques Monod, 15 Rue Helene Brion, F-75013 Paris, France.
EM reiner.veitia@ijm.fr
FU University Paris Diderot; Centre National de la Recherche Scientifique;
   Fondation pour la Recherche Medicale grant [DEQ20150331757]
FX Work in RAV's laboratory is supported by the University Paris Diderot,
   by the Centre National de la Recherche Scientifique and by the Fondation
   pour la Recherche Medicale grant (DEQ20150331757).
CR Chaussenot A, 2014, REV NEUROL-FRANCE, V170, P323, DOI 10.1016/j.neurol.2014.03.007
   de Laat P, 2015, MITOCHONDRION, V25, P98, DOI 10.1016/j.mito.2015.10.005
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Demain LAM, 2017, CLIN GENET, V91, P199, DOI 10.1111/cge.12896
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Langdahl JH, 2018, CLIN GENET, V93, P925, DOI 10.1111/cge.13201
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2016, NEUROMUSCULAR DISORD, V26, P702, DOI 10.1016/j.nmd.2016.08.009
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Saneto RP, 2013, NEUROTHERAPEUTICS, V10, P199, DOI 10.1007/s13311-012-0167-0
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Sunde K, 2016, MOL GENET METAB REP, V9, P94, DOI 10.1016/j.ymgmr.2016.11.002
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   tHart LM, 1996, HUM MUTAT, V7, P193
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 32
TC 6
Z9 7
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 1
PY 2018
VL 27
IS 9
BP 1565
EP 1571
DI 10.1093/hmg/ddy063
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA GF3UU
UT WOS:000431882900006
PM 29474538
OA Bronze
DA 2024-11-01
ER

PT B
AU Bass, MG
   Sokolova, VA
   Kustova, ME
   Kidgotko, OV
   Zakharova, FM
   Vasilyev, VB
AF Bass, Mikhail G.
   Sokolova, Vassilina A.
   Kustova, Maria E.
   Kidgotko, Oksana V.
   Zakharova, Faina M.
   Vasilyev, Vadim B.
BE Chesterton, JR
TI TRANSMITOCHONDRIAL MICE IN STUDYING MTDNA DISTRIBUTION AND TRANSMISSION
SO HORIZONS IN DNA RESEARCH, VOL 1
SE Horizons in DNA Research
LA English
DT Article; Book Chapter
ID HUMAN MITOCHONDRIAL-DNA; RAPID SEGREGATION; MISSENSE MUTATION; PROTEIN
   OPA1; ORGANIZATION; DISEASE; INHERITANCE; DYNAMIN; NUCLEOIDS; OOCYTES
AB Obtaining reliable animal models of human OXPHOS (oxidative phosphorylation) diseases caused by accumulation of mutant mtDNA in cells of certain tissues might be a noticeable step towards understanding their pathogenesis. Despite some attempts, so far no successful approach to the targeted delivery of mutant mtDNA to certain tissues/organs has been elaborated in experiments on animals. We have elaborated a model that allows studying some features of foreign mtDNA distribution at different stages of embryonic development and in organs of transmitochondrial mice developed from zygotes injected with human mitochondria. All pre-implantation embryos and some neonate animals were carrying copies of human mitochondrial genome along with murine mtDNA, which is an indication of artificial heteroplasmy. This feature persisted in the progeny of transmitochondrial animals obtained from injected zygotes i.e. among the mice in generations F-1-F-3 at least 14% were human mtDNA-carriers inheriting foreign genome along the maternal lineage. Only some transmitochondrial embryos had human mtDNA in all the blastomeres. Likewise it was found only in some organs of transmitochondrial mice. Statistical elaboration and Monte Carlo simulation taking into account Markovian process showed, firstly, that human mtDNA was unevenly distributed in zygotic cytoplasm within the time between the injection of human mitochondria and the first cleavage; secondly, that the number of mtDNA segregation units in the entire amount of mitochondria injected (ca. 5.10(2)) is about ten. Analysis of human mtDNA distribution among the organs of transmitochondrial animals showed that skeletal muscles, liver and gonads are the targets frequently hit.
C1 [Bass, Mikhail G.; Sokolova, Vassilina A.; Kustova, Maria E.; Kidgotko, Oksana V.; Zakharova, Faina M.; Vasilyev, Vadim B.] Russian Acad Med Sci, Expt Med Res Inst, St Petersburg, Russia.
C3 Russian Academy of Medical Sciences; Institute of Experimental Medicine
RP Bass, MG (corresponding author), Russian Acad Med Sci, Expt Med Res Inst, St Petersburg, Russia.
RI Vasilyev, Vadim/G-4297-2015; Zakharova, Faina/M-7263-2015
OI Kustova, Maria/0000-0002-4149-2895
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325
   Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513
   Bass MG, 2006, BBA-BIOENERGETICS, V1757, P679, DOI 10.1016/j.bbabio.2006.05.021
   BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   Borovkov A. A., 1986, PROBABILITY THEORY
   Brewer LR, 2003, BIOPHYS J, V85, P2519, DOI 10.1016/S0006-3495(03)74674-8
   Carlson B.M., 1981, Patten's foundations of embryology
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   de Magalhaes JP, 2005, J MOL EVOL, V61, P491, DOI 10.1007/s00239-004-0258-6
   DEBRITO OM, 2007, ANTIOXIDANTS REDOX S, V10, P2008, DOI DOI 10.1089/ARS.1934
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DVOIRIN VV, 1985, METHODS CONTROLLED C
   Friddle RW, 2004, BIOPHYS J, V86, P1632, DOI 10.1016/S0006-3495(04)74231-9
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Glantz S., 1994, Primer of Biostatistics
   Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112
   Hermann GJ, 1997, J CELL BIOL, V137, P141, DOI 10.1083/jcb.137.1.141
   Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Howell N, 1996, AM J HUM GENET, V59, P501
   Howell N, 1999, INT REV CYTOL, V186, P49
   Inoue K, 2004, GENESIS, V39, P79, DOI 10.1002/gene.20029
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Kaufman BA, 2003, J CELL BIOL, V163, P457, DOI 10.1083/jcb.200306132
   Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, pC658, DOI 10.1152/ajpcell.00224.2006
   Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605
   KUSTOVA ME, 2008, CELL TISSUE BIOL, V2, P609
   Li FY, 2006, NEUROBIOL DIS, V21, P35, DOI 10.1016/j.nbd.2005.06.009
   Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001
   MATTHEWS PM, 1995, HUM GENET, V96, P261
   McKenzie M, 2004, P NATL ACAD SCI USA, V101, P1685, DOI 10.1073/pnas.0303184101
   Nagao Yasumitsu, 1998, Journal of Reproduction and Development, V44, P129, DOI 10.1262/jrd.44.129
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   NOGAWA T, 1988, J MORPHOL, V195, P225, DOI 10.1002/jmor.1051950208
   Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X
   PENMAN S, 1995, P NATL ACAD SCI USA, V92, P5251, DOI 10.1073/pnas.92.12.5251
   Poulton J, 1996, PRENATAL DIAG, V16, P1247, DOI 10.1002/(SICI)1097-0223(199612)16:13<1247::AID-PD99>3.0.CO;2-P
   Poulton J, 2002, REPRODUCTION, V123, P751, DOI 10.1530/rep.0.1230751
   Sambrook J, 1989, MOL CLONING, V2, P9
   SMITH LC, 1993, J REPROD FERTIL, P31
   Sokolova VA, 2004, MOL REPROD DEV, V68, P299, DOI 10.1002/mrd.20075
   TORRONI A, 1992, GENETICS, V130, P153
   TOURTE M, 1991, MOL REPROD DEV, V30, P353, DOI 10.1002/mrd.1080300410
   Van Blerkom J, 2000, HUM REPROD, V15, P2621, DOI 10.1093/humrep/15.12.2621
   Van Blerkom J, 1998, HUM REPROD, V13, P2857, DOI 10.1093/humrep/13.10.2857
   van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1
   Vasilyev VB, 1999, ZYGOTE, V7, P279, DOI 10.1017/S0967199499000672
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Zeviani M, 1997, MOL HUM REPROD, V3, P133, DOI 10.1093/molehr/3.2.133
NR 55
TC 1
Z9 1
U1 0
U2 3
PU NOVA SCIENCE PUBLISHERS, INC
PI HAUPPAUGE
PA 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA
BN 978-1-60876-968-1
J9 HORIZ DNA RES
PY 2010
VL 1
BP 151
EP 170
PG 20
WC Genetics & Heredity
WE Book Citation Index – Science (BKCI-S)
SC Genetics & Heredity
GA BPT61
UT WOS:000279873200006
DA 2024-11-01
ER

PT J
AU Eerola, J
   Luoma, PT
   Peuralinna, T
   Scholz, S
   Paisan-Ruiz, C
   Suomalainen, A
   Singleton, AB
   Tienari, PJ
AF Eerola, Johanna
   Luoma, Petri T.
   Peuralinna, Terhi
   Scholz, Sonja
   Paisan-Ruiz, Coro
   Suomalainen, Anu
   Singleton, Andrew B.
   Tienari, Pentti J.
TI POLG1 polyglutamine tract variants associated with Parkinson's disease
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE Polymerase gamma; Trinucleotide repeat; Polyglutamine; Parkinson's
   disease; Genetic susceptibility; POLG1
ID DNA-POLYMERASE-GAMMA; SUBSTANTIA-NIGRA NEURONS; MITOCHONDRIAL COMPLEX-I;
   CAG REPEAT; GLUCOCEREBROSIDASE MUTATIONS; MALE-INFERTILITY;
   ALPHA-SYNUCLEIN; LRRK2 G2019S; GENE POLG; PATHOGENESIS
AB A possible role of allelic variation of the mitochondrial DNA polymerase gamma (POLG I) gene in Parkinson's disease (PD) has been suggested. First, POLG I missense mutations have been found in patients with familial parkinsonism and mitochondrial myopathy. Second, increased frequency of rare alleles of the POLG1 CAG-repeat (poly-Q) has been found in Finnish idiopathic apparently sporadic PD patients, but conflicting reports exist. The POLG1 poly-Q exhibits one major allele with 10 repeats (10Q, frequency >= 80%) and several less common alleles such as 11Q (frequency 6-9%), 6Q-9Q and 12Q-14Q (frequencies <4%). It is not known, whether the poly-Q variation modulates POLG1 function. Here we sequenced the poly-Q in 641 North American Caucasian PD patients and 292 controls. Caucasian literature controls were also used. Normal allele was defined either as 10/11Q or as 10Q according to the previous literature. The frequency of the non-10/11Q alleles in cases was not significantly different from the controls. Variant alleles defined as non-10Q were significantly increased in the PD patients compared to the North American controls (17.6% vs. 12.3%, p=0.004) as well as compared to the larger set of 897 controls (17.6% vs. 13.2%, p=0.0007). These results suggest that POLG1 poly-Q alleles other than the conserved 10Q allele may increase susceptibility to PD. This finding may be attributable to a beneficial function of the 10Q repeat protein or linkage disequilibrium between the 10Q allele and another variation within or close to POLG1. Other large case-control studies and analyses on functional differences of POLG1 poly-Q variants are warranted. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Eerola, Johanna; Luoma, Petri T.; Suomalainen, Anu; Tienari, Pentti J.] Univ Helsinki, Biomedicum, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
   [Eerola, Johanna; Luoma, Petri T.; Peuralinna, Terhi; Suomalainen, Anu; Tienari, Pentti J.] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
   [Scholz, Sonja; Singleton, Andrew B.] NIH, Neurogenet Lab, Bethesda, MD 20892 USA.
   [Paisan-Ruiz, Coro] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
   [Paisan-Ruiz, Coro] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
C3 University of Helsinki; University of Helsinki; Helsinki University
   Central Hospital; National Institutes of Health (NIH) - USA; University
   of London; University College London; University of London; University
   College London; UCL Medical School; University College London Hospitals
   NHS Foundation Trust
RP Tienari, PJ (corresponding author), Univ Helsinki, Biomedicum, Res Program Mol Neurol, Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
EM pentti.tienari@hus.fi
RI Singleton, Andrew/C-3010-2009; Tienari, Pentti/A-4893-2012; Ruiz,
   Coro/C-2912-2009; Scholz, Sonja/R-5524-2017
OI Scholz, Sonja/0000-0002-6623-0429; Tienari, Pentti/0000-0001-5686-2900;
   Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195
FU Helsinki University Central Hospital; Finnish Cultural Foundation; Oskar
   Oflund Foundation; Finnish Parkinson Foundation; Sigrid Juselius
   Foundation; Academy of Finland; National Institute on Aging; National
   Institutes of Health; Department of Health and Human Services [1 Z01
   AG000957-05]
FX This study has been financially supported by Helsinki University Central
   Hospital, Finnish Cultural Foundation, Oskar Oflund Foundation, Finnish
   Parkinson Foundation, Sigrid Juselius Foundation, the Academy of
   Finland, the Intramural Research Program of the National Institute on
   Aging, National Institutes of Health and Department of Health and Human
   Services; project number 1 Z01 AG000957-05. DNA panels from the NINDS
   Human Genetics Resource Center DNA and Cell Line Repository
   (http://ccr.coriell.org/ninds) were used in this study, as well as
   clinical data. The submitters that contributed samples are acknowledged
   in detailed descriptions of each panel: NDPT001, NDPT005, NDPT007,
   NDPT014, NDPT015, NDPT016, NDPT017, NDPT018, NDPT002, NDFT022, NDPT023,
   and NDPT024. P.T.L. and A.S. have filed a patent application concerning
   the results presented in a previous article [18].
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847
   Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   HAVULINNA AS, 2000, MOVEMENT DISORD, V23, P1024
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Jensen MB, 2008, ANN ONCOL, V19, P1910, DOI 10.1093/annonc/mdn407
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LANGSTON JW, 1984, BRAIN RES, V292, P390
   Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X
   Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004
   Malyarchuk BA, 2005, HUM BIOL, V77, P355, DOI 10.1353/hub.2005.0050
   Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438
   Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044
   Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509
   Piccini P, 1999, ANN NEUROL, V45, P577, DOI 10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Rovio AT, 2004, MAMM GENOME, V15, P492, DOI 10.1007/s00335-004-3049-x
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Sveinbjörnsdóttir S, 2000, NEW ENGL J MED, V343, P1765, DOI 10.1056/NEJM200012143432404
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Tobin JE, 2008, NEUROLOGY, V71, P28, DOI 10.1212/01.wnl.0000304051.01650.23
   Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004
NR 36
TC 39
Z9 42
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD JUN 14
PY 2010
VL 477
IS 1
BP 1
EP 5
DI 10.1016/j.neulet.2010.04.021
PG 5
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 614HG
UT WOS:000279045600001
PM 20399836
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Lopez-Gallardo, E
   Iceta, R
   Iglesias, E
   Montoya, J
   Ruiz-Pesini, E
AF Lopez-Gallardo, Ester
   Iceta, Ruth
   Iglesias, Eldris
   Montoya, Julio
   Ruiz-Pesini, Eduardo
TI OXPHOS toxicogenomics and Parkinson's disease
SO MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
LA English
DT Review
DE Mitochondrial DNA; Oxidative phosphorylation; Xenobiotics; Parkinson's
   disease; Toxicogenomics
ID MITOCHONDRIAL COMPLEX-I; MAGNETIC-RESONANCE-SPECTROSCOPY;
   CYANIDE-INDUCED PARKINSONISM; ALPHA-SYNUCLEIN; RESPIRATORY-CHAIN;
   SUBSTANTIA-NIGRA; SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; DNA
   DELETIONS; FAMILIAL PARKINSONISM
AB Activities and quantities of several oxidative phosphorylation (OXPHOS) system complexes are decreased in many Parkinson's disease (PD) patients. Mutations in PD-associated nuclear genes affect OXPHOS function. Moreover, the inactivation of other nuclear genes related to mitochondrial DNA (mtDNA) replication and expression also leads to Parkinsonism. MtDNA only encodes OXPHOS subunits and the RNAs required for their expression. Mutations in mtDNA genes have also been associated with PD. Furthermore, many xenobiotics that inhibit different OXPHOS complexes provoke Parkinsonism. The binding sites for these venoms are usually mtDNA-encoded subunits. However, and despite the existence of mutations or toxicants that can cause Parkinsonism, PD only rarely results from isolated genetic or environmental factors.
   Combinations of nuclear and mitochondrial genetic and environmental factors have additive effects and increase the risk of PD. It is also possible that population polymorphisms in mtDNA genes, affecting interactions with different xenobiotics, may behave as susceptibility factors for developing PD only in the presence of that particular xenobiotic. Therefore, a deeper analysis of the OXPHOS function in PD is required if we want to unravel the complexities of this disorder. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Lopez-Gallardo, Ester; Iceta, Ruth; Iglesias, Eldris; Montoya, Julio; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, CIBERER, Inst Aragones Ciencias Salud I CS, E-50013 Zaragoza, Spain.
   [Ruiz-Pesini, Eduardo] Univ Zaragoza, Fdn ARAID, E-50013 Zaragoza, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of
   Zaragoza; University of Zaragoza
RP Ruiz-Pesini, E (corresponding author), Univ Zaragoza, Dept Bioquim Biol Mol & Celular, CIBERER, Inst Aragones Ciencias Salud I CS, C Miguel Servet 177, E-50013 Zaragoza, Spain.
EM eduruiz@unizar.es
OI Lopez Gallardo, Ester/0000-0002-3217-1424; Iglesias,
   Eldris/0009-0006-3761-3021
FU Institut de Salud Carlos III-FIS [PI08-0264, PI10-00662]; Diputacion
   General de Aragon (Fundacion ARAID) [Grupos Consolidados B33, PIPAMER
   09-01]
FX Our work is supported by grants from Institut de Salud Carlos III-FIS
   (PI08-0264 and PI10-00662) and Diputacion General de Aragon (Grupos
   Consolidados B33, PIPAMER 09-01, Fundacion ARAID-Programa de Apoyo a la
   I+D+I para jovenes investigadores 2010). The CIBERER is an initiative of
   the ISCIII.
CR Abahuni N, 2007, NEUROSCI LETT, V414, P126, DOI 10.1016/j.neulet.2006.12.053
   Abeliovich A, 2010, NATURE, V463, P744, DOI 10.1038/463744a
   ALI SF, 1986, ACTA PHARMACOL TOX, V59, P179
   Amo T, 2011, NEUROBIOL DIS, V41, P111, DOI 10.1016/j.nbd.2010.08.027
   Amouyel P, 2002, CR BIOL, V325, P741, DOI 10.1016/S1631-0691(02)01481-6
   Andreassen OA, 2001, EXP NEUROL, V167, P189, DOI 10.1006/exnr.2000.7525
   Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25
   Arthur CR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-37
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007
   Barbiroli B, 1999, MOVEMENT DISORD, V14, P430, DOI 10.1002/1531-8257(199905)14:3<430::AID-MDS1007>3.0.CO;2-S
   Barton MD, 2000, NUTR RES REV, V13, P279, DOI 10.1079/095442200108729106
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451
   BERGEN WG, 1971, P SOC EXP BIOL MED, V136, P732, DOI 10.3181/00379727-136-35352
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484
   BOWEN BC, 1995, AM J NEURORADIOL, V16, P61
   Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095
   Büeler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   CARELLA F, 1988, J NEUROL NEUROSUR PS, V51, P1345, DOI 10.1136/jnnp.51.10.1345
   Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7
   Cassarino DS, 2000, J NEUROCHEM, V74, P1384, DOI 10.1046/j.1471-4159.2000.0741384.x
   Champy P, 2004, J NEUROCHEM, V88, P63, DOI 10.1046/j.1471-4159.2003.02138.x
   Chelvanayakam S J V, 2003, Ceylon Med J, V48, P133
   Chen JJ, 2010, AM J MANAG CARE, V16, pS87
   CLEETER MWJ, 1992, J NEUROCHEM, V58, P786, DOI 10.1111/j.1471-4159.1992.tb09789.x
   Corrigan FM, 2000, J TOXICOL ENV HEAL A, V59, P229, DOI 10.1080/009841000156907
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DEHAVEN DL, 1986, NEUROBEH TOXICOL TER, V8, P475
   DEHAVEN DL, 1984, TOXICOL APPL PHARM, V75, P182, DOI 10.1016/0041-008X(84)90200-X
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Di Filippo M, 2008, MOVEMENT DISORD, V23, P468, DOI 10.1002/mds.21871
   Drechsel DA, 2008, FREE RADICAL BIO MED, V44, P1873, DOI 10.1016/j.freeradbiomed.2008.02.008
   Drechsel DA, 2009, TOXICOL SCI, V112, P427, DOI 10.1093/toxsci/kfp223
   Egensperger R, 1997, NEUROPATH APPL NEURO, V23, P315, DOI 10.1046/j.1365-2990.1997.4098040.x
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, pS185, DOI 10.1016/S1353-8020(09)70811-9
   Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2
   Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x
   Esteves AR, 2009, ANTIOXID REDOX SIGN, V11, P439, DOI [10.1089/ars.2008.2247, 10.1089/ARS.2008.2247]
   Esteves ARF, 2008, MITOCHONDRION, V8, P219, DOI 10.1016/j.mito.2008.03.004
   ESTEVES AR, 2010, AGING NEUROSCI, V1, P5
   FELDMAN JM, 1990, INT J PSYCHIAT MED, V20, P173, DOI 10.2190/2XVU-MGTC-RUMJ-JY7X
   Ferrer I, 2007, NEUROSCI LETT, V415, P205, DOI 10.1016/j.neulet.2007.01.026
   FLEMING L, 1994, ANN NEUROL, V36, P100, DOI 10.1002/ana.410360119
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Gaweda-Walerych K, 2008, J NEURAL TRANSM, V115, P1521, DOI 10.1007/s00702-008-0121-9
   Gaweda-Walerych K, 2010, NEUROSCI LETT, V469, P24, DOI 10.1016/j.neulet.2009.11.037
   Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   GRANDAS F, 1989, MOVEMENT DISORD, V4, P188, DOI 10.1002/mds.870040211
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Hanagasi HA, 2009, INT J NEUROSCI, V119, P1572, DOI 10.1080/00207450903088019
   Hatcher JM, 2007, EXP NEUROL, V204, P619, DOI 10.1016/j.expneurol.2006.12.020
   Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293
   Hattori N, 1998, GENOMICS, V49, P52, DOI 10.1006/geno.1997.5192
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   Hayashi T, 2009, BIOCHEM BIOPH RES CO, V390, P667, DOI 10.1016/j.bbrc.2009.10.025
   Henchcliffe C, 2008, ANN NY ACAD SCI, V1147, P206, DOI 10.1196/annals.1427.037
   Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007
   Hu MTM, 2000, BRAIN, V123, P340, DOI 10.1093/brain/123.2.340
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   HUNTER CG, 1969, ARCH ENVIRON HEALTH, V18, P12, DOI 10.1080/00039896.1969.10665367
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   Jenkins SM, 2004, DEV BRAIN RES, V151, P1, DOI 10.1016/j.devbrainres.2004.03.015
   Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kitazawa M, 2001, FREE RADICAL BIO MED, V31, P1473, DOI 10.1016/S0891-5849(01)00726-2
   Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7
   Klivenyi P, 1998, NEUROBIOL DIS, V5, P253, DOI 10.1006/nbdi.1998.0191
   KOPIN IJ, 1988, ANNU REV NEUROSCI, V11, P81, DOI 10.1146/annurev.ne.11.030188.000501
   Koschel MJ, 2006, J EMERG NURS, V32, pS19, DOI 10.1016/j.jen.2006.05.010
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lannuzel A, 2003, NEUROSCIENCE, V121, P287, DOI 10.1016/S0306-4522(03)00441-X
   Li CH, 2010, TOXICOL SCI, V116, P140, DOI 10.1093/toxsci/kfq085
   Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056
   Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597
   Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902
   Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006
   MATSUNOYAGI A, 1993, J BIOL CHEM, V268, P1539
   McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200
   MECO G, 1994, SCAND J WORK ENV HEA, V20, P301, DOI 10.5271/sjweh.1394
   Meijer SN, 2001, ENVIRON SCI TECHNOL, V35, P1989, DOI 10.1021/es0000955
   MESSING B, 1991, J NEURAL TRANSM-GEN, P141
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166
   Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003
   Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006
   Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   Nagashima R, 2008, NEUROSCI LETT, V440, P232, DOI 10.1016/j.neulet.2008.05.100
   NAKAGAWAHATTORI Y, 1992, J NEUROL SCI, V107, P29, DOI 10.1016/0022-510X(92)90205-Y
   Navarro A, 2009, FREE RADICAL BIO MED, V46, P1574, DOI 10.1016/j.freeradbiomed.2009.03.007
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Onyango IG, 2005, MOL CELL NEUROSCI, V28, P452, DOI 10.1016/j.mcn.2004.10.006
   Onyango IG, 2005, NEUROBIOL DIS, V20, P141, DOI 10.1016/j.nbd.2005.02.009
   Ossowska K, 2005, EUR J NEUROSCI, V22, P1294, DOI 10.1111/j.1460-9568.2005.04301.x
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   Pacheu-Grau D, 2010, DRUG DISCOV TODAY, V15, P33, DOI 10.1016/j.drudis.2009.10.008
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Papa S, 2009, J BIOENERG BIOMEMBR, V41, P509, DOI 10.1007/s10863-009-9252-4
   Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   PENN AMW, 1995, NEUROLOGY, V45, P2097, DOI 10.1212/WNL.45.11.2097
   Pentore R, 1996, ITAL J NEUROL SCI, V17, P233, DOI 10.1007/BF01995689
   Prigione A, 2007, AUTOPHAGY, V3, P377, DOI 10.4161/auto.4239
   Rachinger J, 2002, AM J NEURORADIOL, V23, P1398
   Ramalho TC, 2010, J BIOMOL STRUCT DYN, V28, P227, DOI 10.1080/07391102.2010.10507355
   RAMSAY RR, 1986, BIOCHEM BIOPH RES CO, V134, P743, DOI 10.1016/S0006-291X(86)80483-1
   Rango M, 2006, J CEREBR BLOOD F MET, V26, P283, DOI 10.1038/sj.jcbfm.9600192
   Richardson JR, 2006, FASEB J, V20, P1695, DOI 10.1096/fj.06-5864fje
   Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X
   ROSENBERG NL, 1989, NEUROLOGY, V39, P142, DOI 10.1212/WNL.39.1.142
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327
   Ruiz-Pesini E, 2010, PHARMACOGENOMICS, V11, P1185, DOI [10.2217/pgs.10.115, 10.2217/PGS.10.115]
   Sarikaya I, 2006, CLIN NUCL MED, V31, P363, DOI 10.1097/01.rlu.0000219168.92370.77
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Sheehan JP, 1997, J NEUROCHEM, V68, P1221
   Shinde S, 2006, NEUROL INDIA, V54, P390, DOI 10.4103/0028-3886.28112
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Swerdlow RH, 2001, PARKINSONISM RELAT D, V7, P129, DOI 10.1016/S1353-8020(00)00029-8
   Talpade DJ, 2000, J NEUROCHEM, V75, P2611, DOI 10.1046/j.1471-4159.2000.0752611.x
   Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333
   Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x
   Trimmer PA, 2009, EXP NEUROL, V218, P320, DOI 10.1016/j.expneurol.2009.03.016
   UITTI RJ, 1985, NEUROLOGY, V35, P921, DOI 10.1212/WNL.35.6.921
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   VanItallie TB, 2008, METABOLISM, V57, pS50, DOI 10.1016/j.metabol.2008.07.015
   Varghese M, 2009, J NEUROL SCI, V279, P39, DOI 10.1016/j.jns.2008.12.021
   Veech GA, 2000, J NEUROSCI RES, V61, P693
   von Ballmoos C, 2004, P NATL ACAD SCI USA, V101, P11239, DOI 10.1073/pnas.0402869101
   von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007
   Wild P, 2010, NAT CELL BIOL, V12, P104, DOI 10.1038/ncb0210-104
   Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013
   Wooten GF, 1997, ANN NEUROL, V41, P265, DOI 10.1002/ana.410410218
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Yuan XL, 2010, BRAIN RES, V1351, P229, DOI 10.1016/j.brainres.2010.06.005
   Zhang J, 2003, J NEUROCHEM, V84, P336, DOI 10.1046/j.1471-4159.2003.01525.x
NR 165
TC 16
Z9 17
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1383-5742
EI 1388-2139
J9 MUTAT RES-REV MUTAT
JI Mutat. Res.-Rev. Mutat. Res.
PD NOV-DEC
PY 2011
VL 728
IS 3
BP 98
EP 106
DI 10.1016/j.mrrev.2011.06.004
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 846WH
UT WOS:000296933400003
PM 21763451
DA 2024-11-01
ER

PT J
AU Béreau, M
   Anheim, M
   Echaniz-Laguna, A
   Magot, A
   Verny, C
   Goideau-Sevrain, M
   Barth, M
   Amati-Bonneau, P
   Allouche, S
   Ayrignac, X
   Bédat-Millet, AL
   Guyant-Maréchal, L
   Kuntzer, T
   Ochsner, F
   Petiot, P
   Vial, C
   Omer, S
   Sole, G
   Taieb, G
   Carvalho, N
   Tio, G
   Kremer, S
   Acquaviva-Bourdain, C
   de Camaret, BM
   Tranchant, C
AF Bereau, M.
   Anheim, M.
   Echaniz-Laguna, A.
   Magot, A.
   Verny, C.
   Goideau-Sevrain, M.
   Barth, M.
   Amati-Bonneau, P.
   Allouche, S.
   Ayrignac, X.
   Bedat-Millet, A. -L.
   Guyant-Marechal, L.
   Kuntzer, T.
   Ochsner, F.
   Petiot, P.
   Vial, C.
   Omer, S.
   Sole, G.
   Taieb, G.
   Carvalho, N.
   Tio, G.
   Kremer, S.
   Acquaviva-Bourdain, C.
   de Camaret, B. Mousson
   Tranchant, C.
TI The wide <i>POLG</i>-related spectrum: An integrated view
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE POLG-related spectrum; Genotype-phenotype correlations
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ATAXIC NEUROPATHY; MUTATIONS;
   DEPLETION; A467T
AB The aims of this study were to describe the spectrum of recessively inherited POLG-related disorders, to report new POLG mutations and to discuss genotype-phenotype correlations in order to propose a strategy for diagnosis. Twenty eight patients diagnosed with two POLG mutations at 12 tertiary European centers of adult neurology were studied. Exhaustive phenotypic data, brain MRI, muscle analysis, mitochondrial DNA and POLG analysis findings were collected. Five distinct phenotypes were observed: Sensory Ataxic Neuropathy, Dysarthria and Ophthalmoparesis (SANDO), autosomal recessive Progressive External Ophthalmoplegia (arPEO), Spino Cerebellar Ataxia with Epilepsy (SCAE), Mitochondrial Neuro Gastro Intestinal Encephalopathy (MNGIE)-like phenotype and Sensory Ataxic Neuropathy with Ophthalmoparesis but without dysarthria which we propose to name SANG. An increasing gradient of functional severity was appreciated from PEO with the best prognosis, to SANG, SANDO and finally SCAE respectively. Four new missense mutations were found. Regarding genotype/phenotype correlations, P587L mutation was associated with SANG rather than with SANDO (p < 0.005) and W748S mutation was associated with SANDO or SCAE (with more severe disease progression), rather than with SANG or PEO (p < 0.004). Distinguishing between various phenotypes can have important diagnosis and prognosis implications. POLG mutations should be priority searched for in cases of SANDO or SANG. Mitochondrial respiratory chain and mitochondrial DNA studies should be considered in the case of negative POLG analysis or other phenotypes. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Bereau, M.] Hop Jean Minjoz, Dept Neurol, Besancon, France.
   [Anheim, M.; Echaniz-Laguna, A.; Tranchant, C.] Hop Hautepierre, Serv Neurol, Unite Pathol Mouvement, Strasbourg, France.
   [Anheim, M.; Echaniz-Laguna, A.; Tranchant, C.] Fac Med, Federat Med Translat FMTS, Strasbourg, France.
   [Echaniz-Laguna, A.] Ctr Reference Neuromusculaire Grand Est CERNEST, Paris, France.
   [Magot, A.] Hop Hotel Dieu, CHU Nantes, Ctr Reference Malad Neuromusculaires, Nantes, France.
   [Verny, C.; Goideau-Sevrain, M.] CHU Angers, Ctr Reference Malad Neurogenet, Angers, France.
   [Barth, M.; Amati-Bonneau, P.] CHU Angers, Dept Biochim & Genet, Angers, France.
   [Allouche, S.] CHU Caen, Hop Cote Nacre, Serv Biochim, Caen, France.
   [Ayrignac, X.] CHRU Montpellier, Dept Neurol, Montpellier, France.
   [Bedat-Millet, A. -L.] Hop Charles Nicolle, Dept Neurol, Rouen, France.
   [Guyant-Marechal, L.] Hop Charles Nicolle, Unite Genet Clin, Rouen, France.
   [Kuntzer, T.; Ochsner, F.] Lausanne Univ Hosp CHUV, Dept Clin Neurosci, Lausanne, Switzerland.
   [Petiot, P.] Hop Croix Rousse, Ctr Reference Malad Neuromusculaires Reg Rone Alp, Neurol & Explorat Fonct Neurol, Lyon, France.
   [Vial, C.] Hop Neurol, Serv ENMG & Pathol NeuroMusculaires, Lyon, France.
   [Omer, S.] St George Hosp, Dept Neurol, London, England.
   [Sole, G.] CHU Bordeaux, Dept Neurol, Bordeaux, France.
   [Taieb, G.] Hop Univ Caremeaux, Dept Neurol, Nimes, France.
   [Carvalho, N.] Univ Franche Comte, Neurosci Lab, EA 481, Besancon, France.
   [Tio, G.] CHRU Besancon, INSERM, Ctr Invest Clin & Innovat Technol, Dept Stat,CIT 808, Besancon, France.
   [Kremer, S.] Univ Strasbourg, Hop Hautepierre, CHU Strasbourg, Federat Med Translat Cube 1,Imagerie 2, Strasbourg, France.
   [Acquaviva-Bourdain, C.; de Camaret, B. Mousson] CHU Lyon, Ctr Biol & Pathol Est, Serv Malad Hereditaires Metab, F-69677 Bron, France.
C3 Universite de Franche-Comte; CHU Besancon; Universites de Strasbourg
   Etablissements Associes; Universite de Strasbourg; CHU Strasbourg;
   Nantes Universite; CHU de Nantes; Universite d'Angers; Centre
   Hospitalier Universitaire d'Angers; Universite d'Angers; Centre
   Hospitalier Universitaire d'Angers; CHU de Caen NORMANDIE; Universite de
   Caen Normandie; Universite de Montpellier; CHU de Montpellier;
   Universite de Rouen Normandie; CHU de Rouen; Universite de Rouen
   Normandie; CHU de Rouen; University of Lausanne; Centre Hospitalier
   Universitaire Vaudois (CHUV); CHU Lyon; CHU Lyon; City St Georges,
   University of London; CHU Bordeaux; Universite de Bordeaux; Universite
   de Franche-Comte; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite de Franche-Comte; CHU Besancon;
   Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg; CHU Strasbourg; CHU Lyon
RP Anheim, M (corresponding author), Hospices Civils Strasbourg, Dept Neurol, 1 Pl Hop BP 426, F-67091 Strasbourg, France.
EM mathieu.anheim@chru-strasbourg.fr
RI Allouche, Stephane/AFW-3810-2022; Christine,
   Tranchant-Dubreuil/JAC-6513-2023; carvalho, Nicolas/M-9650-2019; Sole,
   Gabriele/LEM-7147-2024; Echaniz-Laguna, Andoni/IUN-5392-2023; Kuntzer,
   Thierry/O-8589-2016
OI ayrignac, xavier/0000-0003-3834-2981; Anheim,
   Mathieu/0000-0001-8121-0605; Allouche, stephane/0000-0003-3134-7501;
   tranchant, christine/0000-0002-2895-1292; Tio,
   Gregory/0000-0002-2274-556X; Taieb, Guillaume/0000-0001-6940-8926;
   Kuntzer, Thierry/0000-0002-7788-1673; Bereau,
   Matthieu/0000-0003-0769-0289
CR Anheim M, 2010, NEUROGENETICS, V11, P1, DOI 10.1007/s10048-009-0196-y
   Anheim M, N ENGL J MED, V366, P636
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   Echaniz-Laguna A, 2010, ARCH NEUROL-CHICAGO, V67, P1140, DOI 10.1001/archneurol.2010.219
   Farnum G. A., 1837, BIOCHIM BIOPHYS ACTA, V7, P1113
   Feillet F, 1999, PEDIATR NEUROL, V20, P305, DOI 10.1016/S0887-8994(98)00162-3
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horga A, BRAIN 12, V137, P3200
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Kinghorn KJ, 2013, J NEUROL, V260, P3, DOI 10.1007/s00415-012-6564-9
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Sidiropoulos C, 2013, NEUROLOGY, V81, P197, DOI 10.1212/WNL.0b013e31829a3438
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tchikviladze M, J NEUROL NEUROSURG P, V86, P646
   Tzoulis C, BRAIN 5, V133, P1428
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 25
TC 9
Z9 9
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD SEP 15
PY 2016
VL 368
BP 70
EP 76
DI 10.1016/j.jns.2016.06.062
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DU7SU
UT WOS:000382415700013
PM 27538604
DA 2024-11-01
ER

PT J
AU Chou, HF
   Liang, WC
   Zhang, Q
   Goto, Y
   Jong, YJ
AF Chou, Hsiao-Feng
   Liang, Wen-Chen
   Zhang, Qing
   Goto, Yu-ichi
   Jong, Yuh-Jyh
TI Clinical and genetic features in a MELAS child with a 3271T&gt;C
   mutation
SO PEDIATRIC NEUROLOGY
LA English
DT Article
ID STROKE-LIKE EPISODES; MITOCHONDRIAL-DNA; LACTIC-ACIDOSIS;
   ENCEPHALOPATHY; MYOPATHY; MERRF
AB A mitochondrial DNA 3271T > C point mutation was reported to be the second most common mutation (following the mutation 3243A > G) in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) in Japan. This mutation has rarely been reported in other countries. We present an 11-year-old Taiwanese girl with MELAS, who harbored the 3271T > C mutation and had manifested short stature, epilepsia partialis continua, and recurrent basal ganglia infarctions since age 6 years, and rapid intellectual regression, dysarthria, and unsteady gait since age 10 years. The proportion of 3271T > C mutant genomes in various tissues, including urinary sediments, hair follicles, blood leukocytes, and buccal mucosa cells from the patient and her mother, was analyzed by polymerase chain reaction-restriction fragment length polymorphism analysis and quantitative real-time polymerase chain reaction. The proportion of mutant load in the patient's muscles was near 100%. Except for muscle, the highest mutation load was detected in urinary sediments of the patient by both methods. This is the first report involving mutant load analysis with quantitative real-time polymerase chain reaction in the 3271T > C mutation. The results suggest that urinary sediments may be an alternative tissue of choice which can be obtained noninvasively in the diagnosis of mitochondrial DNA 3271T > C mutations. (c) 2008 by Elsevier Inc. All rights reserved.
C1 [Chou, Hsiao-Feng; Liang, Wen-Chen; Jong, Yuh-Jyh] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung 807, Taiwan.
   [Zhang, Qing] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Jong, Yuh-Jyh] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung 807, Taiwan.
   [Jong, Yuh-Jyh] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.
C3 Kaohsiung Medical University; Kaohsiung Medical University Hospital;
   Baylor College of Medicine; National Center for Neurology & Psychiatry -
   Japan; Kaohsiung Medical University; Kaohsiung Medical University
   Hospital; Kaohsiung Medical University
RP Jong, YJ (corresponding author), Kaohsiung Med Univ Hosp, Dept Pediat, 100 Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.
EM yjjong@kmu.edu.tw
RI ZHANG, QING/AGY-7972-2022; Cheng, Tain-Lu/C-9645-2009; Jong,
   Yuh-Jyh/B-8782-2009
CR Barisic N, 2002, CROAT MED J, V43, P37
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107
   MARIE SKN, 1994, BIOCHEM MED METAB B, V52, P136, DOI 10.1006/bmmb.1994.1045
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Stenqvist L, 2005, PEDIATR RES, V58, P258, DOI 10.1203/01.PDR.0000169966.82325.1A
   Tarnopolsky MA, 1998, MUSCLE NERVE, V21, P25, DOI 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.0.CO;2-I
   Tay SKH, 2005, J CHILD NEUROL, V20, P142, DOI 10.1177/08830738050200022301
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
NR 12
TC 13
Z9 15
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD FEB
PY 2008
VL 38
IS 2
BP 143
EP 146
DI 10.1016/j.pediatrneurol.2007.09.015
PG 4
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 257IQ
UT WOS:000252792800013
PM 18206799
DA 2024-11-01
ER

PT J
AU Taanman, JW
   Schapira, AHV
AF Taanman, JW
   Schapira, AHV
TI Analysis of the trinucleotide CAG repeat from the DNA polymerase γ gene
   (<i>POLG</i>) in patients with Parkinson's disease
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE DNA polymerase gamma; POLG; Parkinson's disease; CAG repeat;
   polyglutamine tract; mitochondria
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL COMPLEX-I;
   HUNTINGTONS-DISEASE; MTDNA DELETIONS; MUTATIONS; FEATURES; FAMILY;
   DEFECT; BRAIN
AB The human gene for the catalytic subunit of the mitochondrial DNA (mtDNA) polymerase (POLG) contains a trinucleotide CAG repeat encoding a polyglutamine tract near the amino-terminus of the protein. Expansions of similar polyglutamine-encoding CAG microsatellite repeats in other genes are known to cause neurodegenerative disorders. As mitochondrial dysfunction has been implicated in the aetiology of Parkinson's disease, we determined the POLG CAG repeat length in DNA samples extracted from 22 idiopathic Parkinson's disease patients and 31 control subjects. The distribution of the POLG CAG repeat length in the control samples matched the distribution reported for control samples by others. Comparison between the CAG repeat length distribution of control and Parkinson's disease samples revealed no evidence of either germ line or somatic POLG CAG repeat instability in Parkinson's disease patients. Our results rule out POLG CAG repeat instability as a common pathogenic mechanism in idiopathic Parkinson's disease. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 UCL, Royal Free & Univ Coll Med Sch, Dept Clin Neurosci, London NW3 2PF, England.
   UCL, Inst Neurol, London WC1N 3BG, England.
C3 University of London; University College London; University of London;
   University College London
RP Taanman, JW (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Clin Neurosci, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.
EM j.taanman@rfc.ucl.ac.uk
RI Taanman, Jan-Willem/A-5379-2011; Schapira, Anthony/A-1245-2010
OI Taanman, Jan-Willem/0000-0002-5476-9785; Schapira,
   Anthony/0000-0002-3018-3966
CR ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   BOLDEN A, 1977, J BIOL CHEM, V252, P3351
   Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0
   Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802
   Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9
   Champy P, 2004, J NEUROCHEM, V88, P63, DOI 10.1046/j.1471-4159.2003.02138.x
   CHECCARELLI N, 1994, J NEUROL SCI, V123, P74, DOI 10.1016/0022-510X(94)90206-2
   Cordato DJ, 2004, J CLIN NEUROSCI, V11, P119, DOI 10.1016/j.jocn.2003.10.009
   Cottrell DA, 2000, J NEUROPATH EXP NEUR, V59, P621, DOI 10.1093/jnen/59.7.621
   Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352
   Kennedy L, 2000, HUM MOL GENET, V9, P2539, DOI 10.1093/hmg/9.17.2539
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rovio A, 1999, EUR J HUM GENET, V7, P140, DOI 10.1038/sj.ejhg.5200244
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
NR 31
TC 34
Z9 38
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD MAR 7
PY 2005
VL 376
IS 1
BP 56
EP 59
DI 10.1016/j.neulet.2004.11.023
PG 4
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 898UI
UT WOS:000227101300012
PM 15694274
DA 2024-11-01
ER

PT J
AU Phillips, AF
   Millet, AR
   Tigano, M
   Dubois, SM
   Crimmins, H
   Babin, L
   Charpentier, M
   Piganeau, M
   Brunet, E
   Sfeir, A
AF Phillips, Aaron F.
   Millet, Armel R.
   Tigano, Marco
   Dubois, Sonia M.
   Crimmins, Hannah
   Babin, Loelia
   Charpentier, Marine
   Piganeau, Marion
   Brunet, Erika
   Sfeir, Agnel
TI Single-Molecule Analysis of mtDNA Replication Uncovers the Basis of the
   Common Deletion
SO MOLECULAR CELL
LA English
DT Article
ID HUMAN MITOCHONDRIAL-DNA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   DOUBLE-STRAND BREAKS; LAGGING-STRAND; DIRECT REPEATS; LIGASE III;
   SACCHAROMYCES-CEREVISIAE; MAMMALIAN MITOCHONDRIA; OXIDATIVE STRESS;
   4977-BP DELETION
AB Mutations in mtDNA lead to muscular and neurological diseases and are linked to aging. The most frequent aberrancy is the "common deletion'' that involves a 4,977-bp region flanked by 13-bp repeats. To investigate the basis of this deletion, we developed a single-molecule mtDNA combing method. The analysis of replicating mtDNA molecules provided in vivo evidence in support of the asymmetric mode of replication. Furthermore, we observed frequent fork stalling at the junction of the common deletion, suggesting that impaired replication triggers the formation of this toxic lesion. In parallel experiments, we employed mito-TALENs to induce breaks in distinct loci of the mitochondrial genome and found that breaks adjacent to the 5' repeat trigger the common deletion. Interestingly, this process was mediated by the mitochondrial replisome independent of canonical DSB repair. Altogether, our data underscore a unique replication-dependent repair pathway that leads to the mitochondrial common deletion.
C1 [Phillips, Aaron F.; Tigano, Marco; Crimmins, Hannah; Sfeir, Agnel] NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA.
   [Millet, Armel R.; Dubois, Sonia M.; Babin, Loelia; Charpentier, Marine; Piganeau, Marion; Brunet, Erika] Museum Natl Hist Nat, Struct & Instabilite Genomes, INSERM, CNRS,U1154,UMR 7196, F-75005 Paris, France.
   [Millet, Armel R.; Babin, Loelia; Brunet, Erika] Inst Imagine, INSERM, UMR 1163, Genome Dynam Immune Syst Lab, F-75015 Paris, France.
C3 New York University; Centre National de la Recherche Scientifique
   (CNRS); CNRS - Institute of Chemistry (INC); Museum National d'Histoire
   Naturelle (MNHN); Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite Paris Cite; Institut National de la Sante
   et de la Recherche Medicale (Inserm)
RP Sfeir, A (corresponding author), NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA.; Brunet, E (corresponding author), Museum Natl Hist Nat, Struct & Instabilite Genomes, INSERM, CNRS,U1154,UMR 7196, F-75005 Paris, France.; Brunet, E (corresponding author), Inst Imagine, INSERM, UMR 1163, Genome Dynam Immune Syst Lab, F-75015 Paris, France.
EM erika.brunet@inserm.fr; agnel.sfeir@med.nyu.edu
RI BRUNET, ERIKA/H-9297-2017; BRUNET, ERIKA/K-7154-2016
OI BRUNET, ERIKA/0000-0002-1726-4673; Tigano, Marco/0000-0002-4353-9220
FU Human Frontier Science Program [HFSP RGY0088]; David and Lucile Packard
   Foundation; Damon Runyon-Rachleff innovator award; NIH
   [2T32GM007238-39]; Le Canceropole IdF; La Ligue Contre le Cancer;
   Fondation pour la Recherche Medicale [FDT20160435361]; Genome Technology
   Center (GTC); Perlmutter Cancer Center at NYU Langone Medical Center
FX We are grateful to Lillian Walton Masters and Khadija Lamribet for
   technical support. Eric Hendrickson, Gregory David, Johannes Spelbrink,
   and Nils-Goran Larsson are thanked for providing key reagents. We thank
   Eros Lazzerini-Denchi, Ruth Lehmann, Thomas Hurd, Flavia Fontanesi, and
   Antonio Barrientos for commenting on the manuscript and Loic Ponger,
   Carine Giovannangeli, and Jean-Paul Concordet for helpful discussions.
   This work was supported by a joint grant (to A.S. and E.B.) from the
   Human Frontier Science Program (HFSP RGY0088) and by grants (to A.S.)
   from the David and Lucile Packard Foundation and a Damon Runyon-Rachleff
   innovator award. A.F.P. was supported by NIH Training Grant
   2T32GM007238-39. M.P. was supported by a fellowship from Le Canceropole
   IdF and La Ligue Contre le Cancer and A.R.M. by a fellowship from the
   Fondation pour la Recherche Medicale (FDT20160435361). We acknowledge
   the support of the Genome Technology Center (GTC) and the Perlmutter
   Cancer Center at NYU Langone Medical Center. The Bio-Imaging Resource
   Center at the Rockefeller University is thanked for assistance with OMX
   imaging.
CR Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169
   Dmitrieva NI, 2011, AM J PHYSIOL-REG I, V301, pR632, DOI 10.1152/ajpregu.00853.2010
   Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539
   Duan XL, 2015, J BIOL CHEM, V290, P7722, DOI 10.1074/jbc.M114.628008
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Hou JH, 1998, MUTAT RES-FUND MOL M, V403, P75, DOI 10.1016/S0027-5107(98)00054-2
   Hua SB, 1997, PLASMID, V38, P91, DOI 10.1006/plas.1997.1305
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   KONG DC, 1994, J BACTERIOL, V176, P5904, DOI 10.1128/jb.176.19.5904-5911.1994
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kühl I, 2014, NATURE, V514, pE7, DOI 10.1038/nature13690
   Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034
   Murgha YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094752
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603
   Oh S, 2014, DNA REPAIR, V21, P97, DOI 10.1016/j.dnarep.2014.04.015
   Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091
   Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Quispe-Tintaya W, 2013, BIOTECHNIQUES, V55, P133, DOI 10.2144/000114077
   Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018
   ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Samuels DC, 2004, TRENDS GENET, V20, P226, DOI 10.1016/j.tig.2004.03.003
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stein A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005664
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wu Y, 2014, BIOCHEM BIOPH RES CO, V446, P261, DOI 10.1016/j.bbrc.2014.02.099
   YANG JH, 1994, ARCH DERMATOL RES, V286, P386, DOI 10.1007/BF00371798
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Yu M, 2001, J BACTERIOL, V183, P1862, DOI 10.1128/JB.183.6.1862-1869.2001
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
NR 70
TC 92
Z9 103
U1 1
U2 30
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD FEB 2
PY 2017
VL 65
IS 3
BP 527
EP +
DI 10.1016/j.molcel.2016.12.014
PG 18
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA EO1BA
UT WOS:000396431400016
PM 28111015
OA Bronze
DA 2024-11-01
ER

PT J
AU Sanderson, KG
   Millar, E
   Tumber, A
   Klatt, R
   Sondheimer, N
   Vincent, A
AF Sanderson, Kit Green
   Millar, Eoghan
   Tumber, Anupreet
   Klatt, Regan
   Sondheimer, Neal
   Vincent, Ajoy
TI Rod bipolar cell dysfunction in <i>POLG</i> retinopathy
SO DOCUMENTA OPHTHALMOLOGICA
LA English
DT Article
DE POLG; POLG1; Polymerase gamma; Electroretinography; Light signal
   transduction; Retinal bipolar cells
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA; NEURONAL
   DEGENERATION; ATAXIC NEUROPATHY; MUTATIONS; DISEASE;
   ELECTRORETINOGRAPHY; CHILDHOOD; SPECTRUM; DISORDERS
AB Objective To report the clinical and novel electrophysiological features in a child withPOLG-related sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO). Methods The proband, a male child of Indian descent, underwent serial systemic and ophthalmological evaluations from birth until 14 years of age. Eye examinations included visual acuity and extraocular movement assessments, fundus photography, spectral domain optical coherence tomography and full-field electroretinography (ERG). Detailed genetic testing was also performed. Results The child carried a homozygous mutation inPOLG(c.911T > G/p.Leu304Arg) and manifested systemic features such as seizures, headaches, areflexia, hypotonia, myopathy and vomiting. The child's distance visual acuity was 0.50 and 0.40 LogMAR in the right and left eyes, respectively. Bilateral ophthalmoplegia and ptosis were observed at 5 years of age. The dark-adapted (DA) ERG responses to 2.29 cd s m(-2)and 7.6 cd s m(-2)stimuli showed a markedly reducedb/aratio; an electronegative configuration was noted to a DA 7.6 ERG. Conclusion This is the first documented case of an electronegative ERG in aPOLG-related disorder consistent with generalized rod ON-bipolar dysfunction. The rest of the proband's systemic and ophthalmological features were consistent with SANDO but some features overlapped with otherPOLG-related disorders such as Alpers-Huttenlocher syndrome and autosomal dominant progressive external ophthalmoplegia demonstrating the wide phenotypic overlap expected due toPOLGmutations.
C1 [Sanderson, Kit Green; Sondheimer, Neal; Vincent, Ajoy] Hosp Sick Children, Genet & Genome Biol, Toronto, ON, Canada.
   [Millar, Eoghan; Tumber, Anupreet; Klatt, Regan; Vincent, Ajoy] Univ Toronto, Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada.
   [Sondheimer, Neal] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; Hospital for Sick Children (SickKids); University of
   Toronto; Hospital for Sick Children (SickKids)
RP Vincent, A (corresponding author), Univ Toronto, Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada.
EM ajoy.vincent@sickkids.ca
RI Sondheimer, Neal/X-7846-2019; Vincent, Ajoy/D-1149-2018
OI Sondheimer, Neal/0000-0001-9982-5712; Vincent, Ajoy/0000-0001-6446-3846
FU Foundation Fighting Blindness, USA [CD-CL-0617-0727-HSC]
FX This work was supported by the Foundation Fighting Blindness, USA (Grant
   No: CD-CL-0617-0727-HSC). The funding organization had no role in the
   design or conduct of this research. AV is a consultant for ADVERUM
   Biotechnologies INC; this had no role in the design or conduct of the
   research.
CR Audo I, 2008, SURV OPHTHALMOL, V53, P16, DOI 10.1016/j.survophthal.2007.10.010
   BOYD SG, 1986, NEUROPEDIATRICS, V17, P75, DOI 10.1055/s-2008-1052505
   Cardenas JF, 2010, SEMIN PEDIATR NEUROL, V17, P62, DOI 10.1016/j.spen.2010.02.012
   Cohen BH, 1993, GENEREVIEWS R
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kong YXG, 2011, AGING CELL, V10, P572, DOI 10.1111/j.1474-9726.2011.00690.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45
   McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Pillers DAH, 1999, HUM GENET, V105, P2, DOI 10.1007/s004390051056
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Sonam K, 2017, MITOCHONDRION, V32, P42, DOI 10.1016/j.mito.2016.11.002
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Worle H, 1998, CLIN NEUROPATHOL, V17, P63
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 43
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0012-4486
EI 1573-2622
J9 DOC OPHTHALMOL
JI Doc. Ophthalmol.
PD FEB
PY 2021
VL 142
IS 1
BP 111
EP 118
DI 10.1007/s10633-020-09777-w
EA JUN 2020
PG 8
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA QM5WY
UT WOS:000541682800001
PM 32567010
DA 2024-11-01
ER

PT J
AU Kumleh, HH
   Riazi, GH
   Houshmand, M
   Sanati, MH
   Gharagozli, K
   Shafa, M
AF Kumleh, HH
   Riazi, GH
   Houshmand, M
   Sanati, MH
   Gharagozli, K
   Shafa, M
TI Complex I deficiency in Persian multiple sclerosis patients
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE multiple sclerosis; mitochondrial complex I; encephalomyopathy;
   mitochondrial DNA; spectrophotometry
ID HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL-DNA MUTATION; DISEASE;
   ASSOCIATION
AB Multiple sclerosis (MS) is a demyelinating disease of the central nervous system characterized by the morphological hallmarks of inflammation, demyelination and axonal loss. Until now, little attention has been paid to the contribution of mitochondrial respiratory chain enzyme activities to MS. In this study, kinetic analysis of mitochondrial respiratory chain complex I enzyme (measured as NADH-ferricyanide reductase) was performed oil intact mitochondria isolated from fresh skeletal Muscle ill MS patients (n = 10) and control subjects (n = 11). Mitochondrial DNA common deletion and deletions were also tested in MS patients. Our findings showed that complex I activities were significantly reduced (P = 0.007) in patients compared with control. However, We could not find deletion in mtDNA of patients with MS. The presupposition of relationship between MS and mitochondrial disorders is due to predominant maternal transmission of MS in affected parent-child pairs, pathoaetiological role of respiratory chain dysfunction in multisystem disorders and important role of it in neurodegenerative disorders, a number of patients Such as LHON or other mtDNA abnormality with developed neurological symptoms indistinguishable From MS and similarity of clinical symptoms ill mitochondrial disorders to those of MS. This Study Suggested that a biochemical defect in complex I activity may be involved in pathogenesis of MS. (c) 2005 Elsevier B.V. All rights reserved.
C1 NIGEB, Dept Med Genet, Tehran, Iran.
   Univ Tehran, Inst Biochem & Biophys, Tehran, Iran.
   Loghman Hosp, Dept Neurol, Tehran, Iran.
C3 University of Tehran
RP NIGEB, Dept Med Genet, POB 14155-6343, Tehran, Iran.
EM massoudh@nregeb.ac.ir
RI Houshmand, Massoud/AEG-9909-2022
OI , Masoud/0000-0001-7687-7464; Riazi, Gholamhossein/0000-0001-5434-4042;
   sanati, Mohammad Hossein/0000-0002-0292-7673
CR BOOKELMAN H, 1978, BIOCHEM MED METAB B, V19, P366, DOI 10.1016/0006-2944(78)90037-6
   Böttcher B, 2002, J BIOL CHEM, V277, P17970, DOI 10.1074/jbc.M112357200
   CARRARA F, 1995, AM J HUM GENET, V57, P1949
   COMPSTON DAS, 1995, ACTA NEUROL SCAND, V91, P43, DOI 10.1111/j.1600-0404.1995.tb05855.x
   COOPER JM, 1992, BIOCHIM BIOPHYS ACTA, V1101, P198, DOI 10.1016/S0005-2728(05)80019-2
   DeVries DD, 1996, AM J HUM GENET, V58, P703
   DOOIJEWAARD G, 1976, BIOCHIM BIOPHYS ACTA, V440, P1, DOI 10.1016/0005-2728(76)90109-2
   FLANIGAN KM, 1993, NEUROLOGY, V43, P2720, DOI 10.1212/WNL.43.12.2720
   Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6
   Houshmand M, 2004, EUR NEUROL, V51, P68, DOI 10.1159/000075518
   Kalman B, 1998, ACTA NEUROL SCAND, V98, P232, DOI 10.1111/j.1600-0404.1998.tb07301.x
   KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   LEES F, 1964, J NEUROL NEUROSUR PS, V27, P415, DOI 10.1136/jnnp.27.5.415
   LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F
   Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9
   MARKWELL MAK, 1981, METHOD ENZYMOL, V72, P290
   Oldfors A, 2003, J NEUROPATH EXP NEUR, V62, P217, DOI 10.1093/jnen/62.3.217
   OLSEN NK, 1995, ACTA NEUROL SCAND, V91, P326, DOI 10.1111/j.1600-0404.1995.tb07016.x
   POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302
   Qi XP, 2003, ANN NEUROL, V53, P198, DOI 10.1002/ana.10426
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   SADOVNICK AD, 1991, ANN NEUROL, V29, P252, DOI 10.1002/ana.410290304
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   von Kleist-Retzow JC, 2003, EXP PHYSIOL, V88, P155, DOI 10.1113/eph8802509
   Vyshkina T, 2005, J NEUROL SCI, V228, P55, DOI 10.1016/j.jns.2004.09.027
   Williamson D., 1985, Parks, V10, P5
NR 29
TC 37
Z9 38
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD APR 15
PY 2006
VL 243
IS 1-2
BP 65
EP 69
DI 10.1016/j.jns.2005.11.030
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 032AU
UT WOS:000236747100013
PM 16413582
DA 2024-11-01
ER

PT J
AU de Laat, P
   van Engelen, N
   Wetzels, JF
   Smeitink, JAM
   Janssen, MCH
AF de Laat, Paul
   van Engelen, Nienke
   Wetzels, Jack F.
   Smeitink, Jan A. M.
   Janssen, Mirian C. H.
TI Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and
   stroke-like episodes phenotype adult patients with m.3243A>G mutation
   after kidney transplantation: follow-up and review of the literature
SO CLINICAL KIDNEY JOURNAL
LA English
DT Review
DE encephalomyopathy; kidney transplantation; mitochondrial
   encephalomyopathy; lactic acidosis and stroke-like episodes (MELAS)
   syndrome; m.3243A>G mutation; maternally inherited diabetes deafness
   (MIDD); mitochondrial disease; mitochondrial myopathy
ID TRANSFER RNALEU(UUR) GENE; MITOCHONDRIAL MYOPATHY;
   M.3243A-GREATER-THAN-G MUTATION; MELAS; DNA; COMPLICATIONS; INVOLVEMENT;
   DISORDERS; CYTOPATHY; CHILDREN
AB Background. Renal involvement in patients with the m.3243A>G mutation may result in end-stage renal disease (ESRD) requiring renal replacement therapy. Although kidney transplantations have been performed in a small number of patients, short- and long-term follow-up data are lacking.
   Methods. We describe five patients with the m.3243A<G mutation who received a kidney transplant, including follow-up data up to 13years. We also summarize all cases (n = 13) of kidney transplantation in m.3243A>G carriers described in the literature.
   Results. Proteinuria with or without renal failure was the first clinical presentation of renal involvement in 13 of 18 (72%) patients. Focal segmental glomerulosclerosis (FSGS) was found in 9 of 13 (69%) biopsies. Sixteen of 18 (84%) patients developed hearing loss. All patients were diagnosed with diabetes mellitus, of whom eight (44%) developed the disease after transplantation. All patients with reported follow-up data (13/18) had stable kidney function from 6 months to 13 years of follow-up after transplantation.
   Conclusions. Renal involvement in carriers of the m.3243A>G mutation most commonly leads to proteinuria and FSGS and may lead to ESRD. Proper recognition of the mitochondrial origin of the renal disease in these patients is important for adequate treatment selection and suitable supportive care. This case series and review of the available literature on long-term follow-up after kidney transplantation shows it is feasible for non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype carriers of the m.3243A>G mutation to be considered for kidney transplantation in case of ESRD. These patients should not be excluded from transplant solely for their mitochondrial diagnosis.
C1 [de Laat, Paul; van Engelen, Nienke; Smeitink, Jan A. M.; Janssen, Mirian C. H.] Radboud Univ Nijmegen, Amalia Childrens Hosp, Med Ctr, Dept Pediat,Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands.
   [Wetzels, Jack F.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands.
   [Janssen, Mirian C. H.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, Dept Internal Med, Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Radboud
   University Nijmegen
RP Janssen, MCH (corresponding author), Radboud Univ Nijmegen, Amalia Childrens Hosp, Med Ctr, Dept Pediat,Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands.; Janssen, MCH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, Dept Internal Med, Nijmegen, Netherlands.
EM mirian.janssen@radboudumc.nl
RI Wetzels, Jack/A-1720-2014; Smeitink, Jan/D-6064-2011; de Laat,
   Paul/O-9851-2019; de Laat, Paul/B-5855-2011; Janssen, Mirian/D-9777-2016
OI de Laat, Paul/0000-0003-2541-3090; Janssen, Mirian/0000-0003-4668-9977
FU ZonMW PMRare Grant [40-41900-98-033]
FX Part of this work was supported by the ZonMW PMRare Grant
   (40-41900-98-033).
CR Cheong HI, 1999, PEDIATR NEPHROL, V13, P477, DOI 10.1007/s004670050641
   de Laat P, 2015, NETH J MED, V73, P30
   de Laat P, 2015, MITOCHONDRION, V25, P98, DOI 10.1016/j.mito.2015.10.005
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   de Laat P, 2013, JIMD REP, V8, P47, DOI 10.1007/8904_2012_159
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Güçer S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   Hirano M, 2002, INTERNAL MED, V41, P113, DOI 10.2169/internalmedicine.41.113
   Humeidan ML, 2016, J CLIN ANESTH, V34, P344, DOI 10.1016/j.jclinane.2016.05.025
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131
   Lederer SR, 2010, WIEN KLIN WOCHENSCHR, V122, P363, DOI 10.1007/s00508-010-1388-z
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Liu CH, 2012, J FORMOS MED ASSOC, V111, P489, DOI 10.1016/j.jfma.2011.06.014
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Niaudet P, 1998, ARCH DIS CHILD, V78, P387, DOI 10.1136/adc.78.4.387
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Piccoli GB, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-9
   Sasano N, 2007, J ANESTH, V21, P72, DOI 10.1007/s00540-006-0449-y
   Seidowsky A, 2013, CLIN NEPHROL, V80, P456, DOI 10.5414/CN107063
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Yamagata K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019772.17954.F8
   Yanagihara C, 2001, INTERNAL MED, V40, P662, DOI 10.2169/internalmedicine.40.662
NR 33
TC 12
Z9 12
U1 1
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2048-8505
EI 2048-8513
J9 CLIN KIDNEY J
JI Clin. Kidney J.
PD DEC
PY 2019
VL 12
IS 6
BP 840
EP 846
DI 10.1093/ckj/sfz020
PG 7
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA KI2HX
UT WOS:000511169700014
PM 31807297
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Danhelovska, T
   Kolarova, H
   Zeman, J
   Hansikova, H
   Vaneckova, M
   Lambert, L
   Kucerova-Vidrova, V
   Berankova, K
   Honzik, T
   Tesarova, M
AF Danhelovska, Tereza
   Kolarova, Hana
   Zeman, Jiri
   Hansikova, Hana
   Vaneckova, Manuela
   Lambert, Lukas
   Kucerova-Vidrova, Vendula
   Berankova, Kamila
   Honzik, Tomas
   Tesarova, Marketa
TI Multisystem mitochondrial diseases due to mutations in mtDNA-encoded
   subunits of complex I
SO BMC PEDIATRICS
LA English
DT Article
DE mtDNA; MT-ND genes; Complex I; Leigh syndrome; MELAS syndrome; MEGS;
   Mitochondria
ID CYTOCHROME-C-OXIDASE; DNA G13513A MUTATION; STROKE-LIKE EPISODES;
   LEIGH-SYNDROME; 13513G-GREATER-THAN-A MUTATION; MUSCLE MITOCHONDRIA;
   LACTIC-ACIDOSIS; ATP SYNTHASE; MELAS; GENE
AB Background Maternally inherited complex I deficiencies due to mutations in MT-ND genes represent a heterogeneous group of multisystem mitochondrial disorders (MD) with a unfavourable prognosis. The aim of the study was to characterize the impact of the mutations in MT-ND genes, including the novel m.13091 T > C variant, on the course of the disease, and to analyse the activities of respiratory chain complexes, the amount of protein subunits, and the mitochondrial energy-generating system (MEGS) in available muscle biopsies and cultivated fibroblasts. Methods The respiratory chain complex activities were measured by spectrophotometry, MEGS were analysed using radiolabelled substrates, and protein amount by SDS-PAGE or BN-PAGE in muscle or fibroblasts. Results In our cohort of 106 unrelated families carrying different mtDNA mutations, we found heteroplasmic mutations in the genes MT-ND1, MT-ND3, and MT-ND5, including the novel variant m.13091 T > C, in 13 patients with MD from 12 families. First symptoms developed between early childhood and adolescence and progressed to multisystem disease with a phenotype of Leigh or MELAS syndromes. MRI revealed bilateral symmetrical involvement of deep grey matter typical of Leigh syndrome in 6 children, cortical/white matter stroke-like lesions suggesting MELAS syndrome in 3 patients, and a combination of cortico-subcortical lesions and grey matter involvement in 4 patients. MEGS indicated mitochondrial disturbances in all available muscle samples, as well as a significantly decreased oxidation of [1-C-14] pyruvate in fibroblasts. Spectrophotometric analyses revealed a low activity of complex I and/or complex I + III in all muscle samples except one, but the activities in fibroblasts were mostly normal. No correlation was found between complex I activities and mtDNA mutation load, but higher levels of heteroplasmy were generally found in more severely affected patients. Conclusions Maternally inherited complex I deficiencies were found in 11% of families with mitochondrial diseases in our region. Six patients manifested with Leigh, three with MELAS. The remaining four patients presented with an overlap between these two syndromes. MEGS, especially the oxidation of [1-C-14] pyruvate in fibroblasts might serve as a sensitive indicator of functional impairment due to MT-ND mutations. Early onset of the disease and higher level of mtDNA heteroplasmy were associated with a worse prognosis.
C1 [Danhelovska, Tereza; Kolarova, Hana; Zeman, Jiri; Hansikova, Hana; Kucerova-Vidrova, Vendula; Berankova, Kamila; Honzik, Tomas; Tesarova, Marketa] Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Danhelovska, Tereza; Kolarova, Hana; Zeman, Jiri; Hansikova, Hana; Vaneckova, Manuela; Lambert, Lukas; Kucerova-Vidrova, Vendula; Berankova, Kamila; Honzik, Tomas; Tesarova, Marketa] Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Vaneckova, Manuela; Lambert, Lukas] Charles Univ Prague, Fac Med 1, Dept Radiol, Prague, Czech Republic.
C3 Charles University Prague; General University Hospital Prague; Charles
   University Prague; Charles University Prague
RP Tesarova, M (corresponding author), Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Tesarova, M (corresponding author), Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM marketa.tesarova@lf1.cuni.cz
RI Vaneckova, Manuela/M-1301-2017; Rákosníková, Tereza/AAA-8037-2022;
   Lambert, Lukas/AAX-9254-2020; Hansikova, Hana/E-9350-2017; Tesarova,
   Marketa/I-1531-2016; Rakosnikova, Tereza/K-5741-2017
OI Tesarova, Marketa/0000-0002-5141-2289; Rakosnikova,
   Tereza/0000-0002-0888-6294; Vaneckova, Manuela/0000-0002-8784-7997
FU Ministry of Health of the Czech Republic [AZV 17-30965A, RVO VFN 64165];
   Charles University (Progress Q26/LF1) [UNCE 204064, SVV260367]
FX This study was supported by research grants from the Ministry of Health
   of the Czech Republic (AZV 17-30965A, RVO VFN 64165), and Charles
   University (Progress Q26/LF1, UNCE 204064, SVV260367). The funding
   bodies were not involved in the design of the study, collection,
   analysis and interpretation of data, and in the writing of the
   manuscript.
CR Alston CL, 2018, AM J HUM GENET, V103, P592, DOI 10.1016/j.ajhg.2018.08.013
   Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359
   Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716
   Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004
   Cameron JM, 2004, MITOCHONDRION, V4, P387, DOI 10.1016/j.mito.2004.07.039
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   Fassone E, 2012, J MED GENET, V49, P668, DOI 10.1136/jmedgenet-2012-101159corr1
   Finsterer J, 2018, NEURORADIOL J, V31, P596, DOI 10.1177/1971400918786054
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Ganetzky RD, 2018, MOL GENET METAB, V123, P301, DOI 10.1016/j.ymgme.2018.01.010
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012
   Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   KNEPPER LE, 1989, STROKE, V20, P1730, DOI 10.1161/01.STR.20.12.1730
   Kolarova H, 2016, OPHTHALMIC GENET, V37, P419, DOI 10.3109/13816810.2015.1092045
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860
   Lerman-Sagie T, 2005, MOL GENET METAB, V84, P127, DOI 10.1016/j.ymgme.2004.09.008
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Ma YY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011606
   MAKINEN MW, 1968, ARCH BIOCHEM BIOPHYS, V126, P75, DOI 10.1016/0003-9861(68)90561-4
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mascalchi M, 2018, ESSAYS BIOCHEM, V62, P409, DOI 10.1042/EBC20170109
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217
   Petruzzella V, 2003, NEUROLOGY, V61, P1017, DOI 10.1212/01.WNL.0000080363.10902.E9
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Smits P, 2011, EUR J HUM GENET, V19, P275, DOI 10.1038/ejhg.2010.208
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Srere P.A., 1969, Methods in Enzymology, V13, P3
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tzoulis C, 2012, BRAIN, V135, P3627, DOI 10.1093/brain/aws223
   Vondrackova A, 2012, J HUM GENET, V57, P442, DOI 10.1038/jhg.2012.49
   Wang Shi-Bing, 2008, Pediatrics and Neonatology, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   Yahata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15871-y
NR 56
TC 25
Z9 25
U1 2
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2431
J9 BMC PEDIATR
JI BMC Pediatr.
PD JAN 29
PY 2020
VL 20
IS 1
AR 41
DI 10.1186/s12887-020-1912-x
PG 13
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA KM1ND
UT WOS:000513885200006
PM 31996177
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Da Pozzo, P
   Cardaioli, E
   Malfatti, E
   Gallus, GN
   Malandrini, A
   Gaudiano, C
   Berti, G
   Invernizzi, F
   Zeviani, M
   Federico, A
AF Da Pozzo, Paola
   Cardaioli, Elena
   Malfatti, Edoardo
   Gallus, Gian Nicola
   Malandrini, Alessandro
   Gaudiano, Carmen
   Berti, Gianna
   Invernizzi, Federica
   Zeviani, Massimo
   Federico, Antonio
TI A novel mutation in the mitochondrial <i>tRNA<SUP>Pro</SUP></i> gene
   associated with late-onset ataxia, retinitis pigmentosa, deafness,
   leukoencephalopathy and complex I deficiency
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE mtDNA; transfer RNA(Pro); mitochondrial disease
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POINT MUTATION; A3243G MUTATION;
   DNA; DISORDERS; FEATURES; DISEASE; SEQUENCE; PATIENT
AB We present a patient with ataxia, retinitis pigmentosa, dysarthria, neurosensorial deafness, nystagmus and leukoencephalopathy. A novel heteroplasmic G to A transition at nucleotide 15 975 was found, affecting the T arm of the mitochondrial (mt) tRNA(Pro) gene. A biochemical analysis of respiratory chain enzymes in muscle revealed isolated complex I deficiency. This is the fourth pathogenic tRNA(Pro) point mutation to be associated with an mt disorder. The result highlights the importance of molecular dissection of mtDNA in patients with defined mt disorder and confirms the clinical and biochemical heterogeneity associated with tRNA(Pro) mutations. European Journal of Human Genetics (2009) 17, 1092-1096; doi:10.1038/ejhg.2009.12; published online 18 February 2009
C1 [Da Pozzo, Paola; Cardaioli, Elena; Malfatti, Edoardo; Gallus, Gian Nicola; Malandrini, Alessandro; Gaudiano, Carmen; Berti, Gianna; Federico, Antonio] Univ Siena, Sch Med, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy.
   [Invernizzi, Federica; Zeviani, Massimo] C Besta Neurol Inst Fdn IRCCS, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy.
C3 University of Siena
RP Federico, A (corresponding author), Univ Siena, Sch Med, Dept Neurol Neurosurg & Behav Sci, Viale Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
RI Zeviani, Massimo/K-2891-2014; Malfatti, Edoardo/KEI-9379-2024; Federico,
   Antonio/H-8871-2017; GALLUS, GIAN NICOLA/Q-3489-2016; Invernizzi,
   Federica/J-9849-2016
OI GALLUS, GIAN NICOLA/0000-0001-5801-223X; Invernizzi,
   Federica/0000-0001-8072-0152; Zeviani, Massimo/0000-0002-9067-5508;
   federico, antonio/0000-0002-5246-1621; Cardaioli,
   Elena/0000-0003-2850-6698
FU University of Siena; Regione Toscana
FX This study was partly supported by a grant from the University of Siena
   and Regione Toscana to AF.
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Cardaioli E, 2005, BIOCHEM BIOPH RES CO, V327, P675, DOI 10.1016/j.bbrc.2004.11.170
   Cardaioli E, 2007, NEUROMUSCULAR DISORD, V17, P681, DOI 10.1016/j.nmd.2007.05.001
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   Da Pozzo P, 2004, BIOCHEM BIOPH RES CO, V324, P360, DOI 10.1016/j.bbrc.2004.09.058
   Giegé R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   IONASESCU VV, 1994, NEUROLOGY, V44, P975, DOI 10.1212/WNL.44.5.975
   Keränen T, 2006, EPILEPTIC DISORD, V8, P200
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Koga Y, 2000, ACTA NEUROPATHOL, V99, P186, DOI 10.1007/PL00007423
   MITOMAP, 2008, HUM MIT GEN DAT
   Pancrudo J, 2007, J CHILD NEUROL, V22, P858, DOI 10.1177/0883073807304199
   SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100
   Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
   Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 21
TC 23
Z9 24
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD AUG
PY 2009
VL 17
IS 8
BP 1092
EP 1096
DI 10.1038/ejhg.2009.12
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 474DD
UT WOS:000268261700017
PM 19223931
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Kowald, A
   Kemeth, FP
   Kirkwood, TBL
AF Kowald, Axel
   Kemeth, Felix P.
   Kirkwood, Tom B. L.
TI An explanation of how mutant and wild-type mitochondria might stably
   co-exist in inherited mitochondrial diseases
SO PNAS NEXUS
LA English
DT Article
DE mitochondrial disease; mathematical model; aging
ID DNA DELETION MUTATIONS; AGED MUSCLE-FIBERS; QUALITY-CONTROL;
   ACCUMULATION; REPLICATION; TURNOVER; FUSION; SEGREGATION; MITOPHAGY;
   FISSION
AB Mitochondria are cellular organelles of crucial relevance for the survival of metazoan organisms. Damage to the mitochondrial DNA can give rise to a variety of mitochondrial diseases and is thought also to be involved in the aging process. The fate of mtDNA mutants is controlled by their synthesis as well as degradation and mathematical models can help to better understand this complex interplay. We present here a model that combines a replicative advantage for mtDNA mutants with selective degradation enabled by mitochondrial fission and fusion processes. The model not only shows that the cell has efficient means to deal with (many) types of mutants but, surprisingly, also predicts that under certain conditions a stable co-existence of mutant and wild-type mtDNAs is possible. We discuss how this new finding might explain how mitochondria can be at the heart of processes with such different phenotypes as mitochondrial diseases and aging.
C1 [Kowald, Axel; Kirkwood, Tom B. L.] Newcastle Univ, UK Natl Innovat Ctr Ageing, Catalyst,3 Sci Sq, Newcastle Upon Tyne NE4 5TG, Tyne & Wear, England.
   [Kowald, Axel] Rostock Univ, Inst Biostat & Informat Med & Aging Res IBIMA, Med Ctr, D-18057 Rostock, Germany.
   [Kirkwood, Tom B. L.] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Hlthy Aging, DK-2200 Copenhagen N, Denmark.
   [Kemeth, Felix P.] Tech Univ Munich, Phys Dept, Nonequilibrium Chem Phys, James Franck Str 1, D-85748 Garching, Germany.
C3 Newcastle University - UK; University of Rostock; University of
   Copenhagen; Technical University of Munich
RP Kowald, A (corresponding author), Newcastle Univ, UK Natl Innovat Ctr Ageing, Catalyst,3 Sci Sq, Newcastle Upon Tyne NE4 5TG, Tyne & Wear, England.; Kowald, A (corresponding author), Rostock Univ, Inst Biostat & Informat Med & Aging Res IBIMA, Med Ctr, D-18057 Rostock, Germany.
EM Axel.Kowald@ncl.ac.uk
OI Kowald, Axel/0000-0001-6448-4364; Kemeth, Felix/0000-0001-8535-8113
FU Federal Ministry of Education and Research (BMBF) of Germany [FKZ
   01ZX103A]; NORDEA Foundation [02-2013-0220]; Novo Nordisk Foundation
   [NNF17OC00278]
FX A.K. acknowledges financial support by the Federal Ministry of Education
   and Research (BMBF) of Germany for the SASKit study (FKZ 01ZX103A). T.K.
   acknowledges support from the NORDEA Foundation (02-2013-0220), Denmark,
   and Novo Nordisk Foundation (NNF17OC00278), Denmark.
CR Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Aryaman J, 2019, GENETICS, V212, P1429, DOI 10.1534/genetics.119.302423
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   Blackstone NW., 2003, Genetic and cultural evolution of cooperation
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Gottlieb RA, 2021, CELL MOL LIFE SCI, V78, P3791, DOI 10.1007/s00018-021-03772-3
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kowald A, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030126
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Lawless C, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200061
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   Shi RY, 2018, TRENDS CARDIOVAS MED, V28, P246, DOI 10.1016/j.tcm.2017.11.008
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004183
   Tam ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076230
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
NR 39
TC 1
Z9 1
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2752-6542
J9 PNAS NEXUS
JI PNAS Nexus
PD SEP
PY 2022
VL 1
IS 4
AR pgac192
DI 10.1093/pnasnexus/pgac192
EA OCT 2022
PG 11
WC Multidisciplinary Sciences; Social Sciences, Interdisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics; Social Sciences - Other Topics
GA R3LF2
UT WOS:001063393200057
PM 36714863
OA Green Published
DA 2024-11-01
ER

PT J
AU Rossato, LB
   Nunes, AC
   Pereira, ML
   de Souza, CFM
   Dummer, C
   Milani, V
   Porsch, DB
   de Mattos, CB
   Barros, EJ
AF Rossato, Liana Bertolin
   Fernandes Nunes, Ane Claudia
   Saraiva Pereira, Maria Luiza
   Moura de Souza, Carolina Fischinger
   Dummer, Claus
   Milani, Vagner
   Porsch, Daiana Benck
   de Mattos, Cristiane Bastos
   Guardao Barros, Elvino Jose
TI Prevalence of 4977bp deletion in mitochondrial DNA from patients with
   chronic kidney disease receiving conservative treatment or hemodialysis
   in Southern Brazil
SO RENAL FAILURE
LA English
DT Article
DE chronic kidney disease; 4977bp deletion; mitochondrial DNA
ID CHRONIC-RENAL-FAILURE; GENOMIC DAMAGE; UREMIC PATIENTS;
   PERITONEAL-DIALYSIS; OXIDATIVE STRESS; SKELETAL-MUSCLE; BLOOD-CELLS; BP
   DELETION; MUTATIONS; LESIONS
AB Background. Damage to mitochondrial DNA (mtDNA) has been described in patients with chronic kidney disease (CKD). The presence of mtDNA 4977bp deletion in many different tissues can serve as a marker of this damage. However, no attempt has been made to detect the presence of mtDNA 4977bp in blood cells of patients with CKD. Methods. Polymerase chain reaction techniques (PCR) were used to detect mtDNA 4977bp deletion in blood samples of 94 CKD patients. Results. The prevalence of 4977bp deletion in mtDNA was 73.1% (38/52) in patients with CKD undergoing hemodialysis, 57.1% (27/42) in patients with CKD receiving conservative treatment, and 27.8% (15/54) in control samples (p < 0.001). Higher prevalence of this mutation was not associated with patient age (p = 0.54) or time on hemodialysis (p = 0.70). Conclusion. The higher prevalence of mtDNA 4977bp deletion in patients in this study indicates that the CKD can induce damage to mtDNA in blood cells and could be exacerbated by hemodialysis.
C1 [Rossato, Liana Bertolin; Fernandes Nunes, Ane Claudia; Dummer, Claus; Milani, Vagner; Porsch, Daiana Benck; de Mattos, Cristiane Bastos; Guardao Barros, Elvino Jose] Univ Fed Rio Grande do Sul, Hemodialysis Serv, Clin Hosp Porto Alegre, BR-90035003 Porto Alegre, RS, Brazil.
   [Rossato, Liana Bertolin; Fernandes Nunes, Ane Claudia; Dummer, Claus; Milani, Vagner; Porsch, Daiana Benck; de Mattos, Cristiane Bastos; Guardao Barros, Elvino Jose] Univ Fed Rio Grande do Sul, Grad Program Med Sci, Clin Hosp Porto Alegre, BR-90035003 Porto Alegre, RS, Brazil.
   [Saraiva Pereira, Maria Luiza; Moura de Souza, Carolina Fischinger] Univ Fed Rio Grande do Sul, Genet Serv, Clin Hosp Porto Alegre, BR-90035003 Porto Alegre, RS, Brazil.
C3 Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio
   Grande do Sul; Universidade Federal do Rio Grande do Sul
RP Rossato, LB (corresponding author), Univ Fed Rio Grande do Sul, Hemodialysis Serv, Clin Hosp Porto Alegre, Rua Ramiro Barcelos,2350-2 Andar, BR-90035003 Porto Alegre, RS, Brazil.
EM liana_rossato@yahoo.com.br
RI Nunes, Ane/Q-8395-2019; de Souza, Carolina/V-9921-2019; Mattos,
   Cristiane/AAX-2115-2020; Barros, Elvino/M-8612-2014; Saraiva-Pereira,
   Maria-Luiza/H-6302-2013
OI Nunes, Ane Claudia Fernandes/0000-0002-7838-6463; Saraiva-Pereira,
   Maria-Luiza/0000-0003-3905-9563; Bastos de Mattos,
   Cristiane/0000-0002-5238-4021
CR Bhat HK, 1999, CIRCULATION, V99, P807, DOI 10.1161/01.CIR.99.6.807
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Buemi M, 2006, BLOOD PURIFICAT, V24, P569, DOI 10.1159/000097080
   CeballosPicot I, 1996, FREE RADICAL BIO MED, V21, P845, DOI 10.1016/0891-5849(96)00233-X
   CENGIZ K, 1988, CANCER GENET CYTOGEN, V36, P55, DOI 10.1016/0165-4608(88)90075-1
   CLAYTON DA, 1992, J INHERIT METAB DIS, V15, P439, DOI 10.1007/BF01799602
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   Dani Maria Angela C, 2004, Genet Mol Res, V3, P395
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   Ishibashi Y, 2002, PERITON DIALYSIS INT, V22, P11
   Kobras K, 2006, KIDNEY BLOOD PRESS R, V29, P10, DOI 10.1159/000092482
   KRISHNAN KJ, 2003, SOC INVESTIGATIVE DE, P981
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Lim PS, 2000, FREE RADICAL BIO MED, V29, P454, DOI 10.1016/S0891-5849(00)00334-8
   Liu CS, 2001, NEPHROL DIAL TRANSPL, V16, P561, DOI 10.1093/ndt/16.3.561
   Martin-Mateo MC, 1998, RENAL FAILURE, V20, P117, DOI 10.3109/08860229809045094
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Mohamed SA, 2004, EXP GERONTOL, V39, P181, DOI 10.1016/j.exger.2003.10.011
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Ozawa T, 1998, ANN NY ACAD SCI, V854, P128, DOI 10.1111/j.1749-6632.1998.tb09898.x
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Schupp N, 2006, SEMIN NEPHROL, V26, P28, DOI 10.1016/j.semnephrol.2005.06.007
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Stopper H, 2001, AM J KIDNEY DIS, V38, P296, DOI 10.1053/ajkd.2001.26094
   Stopper H, 1999, AM J KIDNEY DIS, V34, P433, DOI 10.1016/S0272-6386(99)70069-7
   Stopper H, 2005, J RENAL NUTR, V15, P81, DOI 10.1053/j.jrn.2004.09.017
   Tarng DC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013301.11876.7E
   von Wurmb N, 1998, MUTAT RES-FUND MOL M, V422, P247, DOI 10.1016/S0027-5107(98)00205-X
   Yamagata K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019772.17954.F8
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zima T, 1996, RENAL FAILURE, V18, P113, DOI 10.3109/08860229609052781
NR 31
TC 7
Z9 8
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0886-022X
J9 RENAL FAILURE
JI Ren. Fail.
PY 2008
VL 30
IS 1
BP 9
EP 14
DI 10.1080/08860220701741650
PG 6
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA 251WB
UT WOS:000252405700002
PM 18197537
OA Bronze
DA 2024-11-01
ER

PT J
AU Asadullah
   Din, AU
   Ul Ghafoor, S
   Akbar, F
   Akhtar, N
   Khan, MF
   Ullah, Z
   Kareem, A
AF Asadullah
   Din, Aziz Ud
   Ul Ghafoor, Sajid
   Akbar, Fazal
   Akhtar, Naveed
   Khan, Muhammad Fiaz
   Ullah, Zaib
   Kareem, Abdul
TI Analysis of mutations in leu tRNA gene in patients of heart diseases
SO SAUDI JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE Leu tRNA; Gene; Mutation; CVD
ID MATERNALLY INHERITED MYOPATHY; MITOCHONDRIAL-DNA; CARDIOMYOPATHY;
   BURDEN; RISK
AB Cardiovascular diseases (CVD) are the leading cause of death all over the world. Beside general risk factors, there are some genetic factors which lead to cardiovascular diseases. Various nuclear DNA mutation and also mitochondrial DNA mutations have been related with cardiovascular diseases. In the present study, a total of 21 samples were collected from different families residing in district Dir. DNA was extracted from buccal epithelial cells using saliva. The mitochondrial tRNA leu (MT TL1) gene was amplified by PCR and 10 samples of different families were sequenced. The sequence was aligned with revised Cambridge Reference Sequence (rCRS) accession # NC-012920.1. It is concluded that cardiovascular diseases in our subjects are not due to mutation in the mitochondrial leucine tRNA gene. However, a large population of subjects with cardiovascular diseases needs to be studied and whole mitochondrial DNA is needed to be sequenced in the subjects with CVD. This will give an idea about the probable DNA marker which can be used to prevent loses due to these diseases at a very early stages. (C) 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
C1 [Asadullah; Din, Aziz Ud; Ul Ghafoor, Sajid] Hazara Univ, Dept Genet, Mansehra, Pakistan.
   [Akbar, Fazal] Univ Swat, Ctr Biotechnol & Microbiol, Mingora, Pakistan.
   [Akhtar, Naveed; Ullah, Zaib] Hazara Univ, Dept Zool, Sub Campus, Battagram, Pakistan.
   [Khan, Muhammad Fiaz] Hazara Univ, Dept Zool, Mansehra, Pakistan.
   [Kareem, Abdul] Sanaa Univ, Dept Life Sci, Sanaa, Yemen.
C3 Hazara University; Hazara University
RP Asadullah (corresponding author), Hazara Univ Mansehra, Dept Genet, Mansehra, Khyber Pakhtunk, Pakistan.
EM asadgeneticist@gmail.com
RI Ullah, Zaib/HOF-9384-2023; ullah, aman/JQW-5104-2023
OI Ullah, Zaib/0000-0002-4035-5039; Ud-Din, Aziz/0000-0001-6572-1149
CR Aidar Marisi, 2007, Braz. Dent. J., V18, P148
   Almahmeed Wael, 2012, Ther Clin Risk Manag, V8, P65, DOI 10.2147/TCRM.S26414
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Auer J, 2006, INT J CARDIOL, V106, P398, DOI 10.1016/j.ijcard.2004.12.085
   Ben Romdhane H, 2004, REV EPIDEMIOL SANTE, V52, P558, DOI 10.1016/S0398-7620(04)99094-3
   EAKER ED, 1993, CIRCULATION, V88, P1999, DOI 10.1161/01.CIR.88.4.1999
   Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hadjigeorgiou GM, 1999, J NEUROL SCI, V164, P153, DOI 10.1016/S0022-510X(99)00062-3
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   Murray C. J. L., 1996, GLOBAL BURDEN DIS, P270
   Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2
   Nan DN, 2002, POSTGRAD MED J, V78, P298, DOI 10.1136/pmj.78.919.298
   Rehan Ahmad Rehan Ahmad, 2002, Pakistan Journal of Medical Sciences, V18, P95
   Sadiq M, 2001, Pak Paed J, V25, P63
   Santulli G, 2013, J Cardiovasc Dis Res, V1
   Sapa, 2006, MILLIONS DESCEND MEC
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423
NR 25
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-562X
EI 2213-7106
J9 SAUDI J BIOL SCI
JI Saudi J. Biol. Sci.
PD JAN
PY 2022
VL 29
IS 1
BP 436
EP 443
DI 10.1016/j.sjbs.2021.09.010
EA DEC 2021
PG 8
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA XV3LO
UT WOS:000734847800006
PM 35002439
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Taylor, RW
AF Taylor, RW
TI Gene therapy for the treatment of mitochondrial DNA disorders
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Review
DE complementation; exercise training; gene therapy; heteroplasmy;
   mitochondrial DNA; treatment
ID TRANSFER-RNA; IN-VITRO; SACCHAROMYCES-CEREVISIAE; PRENATAL-DIAGNOSIS;
   POINT MUTATION; MUSCLE-FIBERS; RIBOSOMAL-RNA; PLASMID DNA; WILD-TYPE;
   MTDNA
AB Despite recent epidemiological studies confirming that mitochondrial respiratory chain disorders due to mutations in either the mitochondrial or nuclear genome are amongst the most common inherited human diseases, realistic therapeutic strategies for these patients remain limited. The disappointing response to various vitamins, cofactors and electron acceptors that have been administered to patients in an attempt to bypass the underlying respiratory chain defect, coupled with the complexities of human mitochondrial genetics, means that novel and innovative means are required to offer realistic treatments. Several 'gene therapy' strategies have therefore been proposed to treat patients with pathogenic mitochondrial DNA mutations, and although these are not without their own inherent problems, several exciting approaches promise much in the near future. This review will provide a basic background to mitochondrial genetics and mitochondrial DNA disorders before introducing the various strategies being tested in vitro at present, in cell culture and animal models, and, in the example of therapeutic exercise, in patients themselves.
C1 Newcastle Univ, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Newcastle Univ, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Andrews RM, 1999, EYE, V13, P769, DOI 10.1038/eye.1999.225
   Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200
   Bayona-Bafaluy MP, 2003, AM J HUM GENET, V73, P627
   BIGGER B, 2003, GENETICS MITOCHRONDR, P327
   Bigger BW, 2001, J BIOL CHEM, V276, P23018, DOI 10.1074/jbc.M010873200
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Chinnery P F, 2003, Neuromuscul Disord, V13, P757, DOI 10.1016/S0960-8966(03)00097-X
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   CHRZANOWSKALIGHTOWLERS ZMA, 1995, GENE THER, V2, P311
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Collombet JM, 1997, J BIOL CHEM, V272, P5342, DOI 10.1074/jbc.272.8.5342
   D'Souza GGM, 2004, CURR GENE THER, V4, P317
   D'Souza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Dean NL, 2003, MOL HUM REPROD, V9, P631, DOI 10.1093/molehr/gag077
   Delage L, 2003, MOL CELL BIOL, V23, P4000, DOI 10.1128/MCB.23.11.4000-4012.2003
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2004, ANN NY ACAD SCI, V1011, P232, DOI 10.1196/annals.1293.023
   EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0
   Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Flierl A, 2003, MOL THER, V7, P550, DOI 10.1016/S1525-0016(03)00037-6
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Funes S, 2002, J BIOL CHEM, V277, P6051, DOI 10.1074/jbc.M109993200
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Khan SM, 2004, J BIOENERG BIOMEMBR, V36, P387, DOI 10.1023/B:JOBB.0000041773.20072.9e
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   Koulintchenko M, 2003, EMBO J, V22, P1245, DOI 10.1093/emboj/cdg128
   LeBlanc AJ, 1999, J BIOL CHEM, V274, P21071, DOI 10.1074/jbc.274.30.21071
   Leshinsky-Silver E, 2003, PRENATAL DIAG, V23, P31, DOI 10.1002/pd.516
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375
   Mahapatra S, 1996, J BIOL CHEM, V271, P20432, DOI 10.1074/jbc.271.34.20432
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McGregor A, 2003, BBA-GENE STRUCT EXPR, V1629, P73, DOI 10.1016/j.bbaexp.2003.08.005
   McGregor A, 2001, MOL GENET GENOMICS, V265, P721, DOI 10.1007/s004380100469
   Meirelles FV, 1997, GENETICS, V145, P445
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852
   NAGLEY P, 1988, P NATL ACAD SCI USA, V85, P2091, DOI 10.1073/pnas.85.7.2091
   Oca-Cossio J, 2003, GENETICS, V165, P707
   Ojaimi J, 2002, MOL BIOL CELL, V13, P3836, DOI 10.1091/mbc.E02-05-0306
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Poulton J, 2000, NEUROMUSCULAR DISORD, V10, P484, DOI 10.1016/S0960-8966(00)00130-9
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001
   Roberts RM, 1999, AM J MED GENET, V87, P265, DOI 10.1002/(SICI)1096-8628(19991126)87:3<265::AID-AJMG14>3.0.CO;2-S
   Ross GF, 2003, BIOCONJUGATE CHEM, V14, P962, DOI 10.1021/bc034050f
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Seo BB, 2000, J BIOL CHEM, V275, P37774, DOI 10.1074/jbc.M007033200
   Seo BB, 2004, HUM GENE THER, V15, P887, DOI 10.1089/1043034041839217
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   SMALL I, 1992, EMBO J, V11, P1291, DOI 10.1002/j.1460-2075.1992.tb05172.x
   Smith PM, 2004, BBA-BIOENERGETICS, V1659, P232, DOI 10.1016/j.bbabio.2004.09.003
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2004, BBA-BIOENERGETICS, V1659, P221, DOI 10.1016/j.bbabio.2004.09.007
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x
   TARASSOV IA, 1992, NUCLEIC ACIDS RES, V20, P1277, DOI 10.1093/nar/20.6.1277
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, P3404, DOI 10.1093/nar/29.16.3404
   Taylor RW, 1997, J BIOENERG BIOMEMBR, V29, P195, DOI 10.1023/A:1022646215643
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Weber K, 1997, AM J HUM GENET, V60, P373
   Weissig V, 2000, DRUG DELIV, V7, P1, DOI 10.1080/107175400266722
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 101
TC 6
Z9 9
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1471-2598
EI 1744-7682
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PD FEB
PY 2005
VL 5
IS 2
BP 183
EP 194
DI 10.1517/14712598.5.2.183
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 908FH
UT WOS:000227772300005
PM 15757380
DA 2024-11-01
ER

PT J
AU Meissner, C
AF Meissner, C.
TI Mutations of mitochondrial DNA - cause or consequence of the ageing
   process?
SO ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
LA English
DT Article
DE ageing; mitochondria; oxidative damage; point mutations; deletions
ID HUMAN SKELETAL-MUSCLE; MANGANESE SUPEROXIDE-DISMUTASE; OXIDATIVE DAMAGE;
   DELETION MUTATIONS; MTDNA MUTATIONS; LIFE-SPAN; INCREASE; DISEASE;
   BRAIN; NEURODEGENERATION
AB Ageing is a stochastic process which leads to a gradual decline in cellular, tissue and even organ function, especially in energy dependent postmitotic tissues like skeletal muscle, brain and heart. The mitochondrial theory of ageing is based on the assumption that reactive oxygen species (ROS) and free radicals generated in the immediate vicinity of the electron transport chain during the lifespan of an organism damage proteins, lipids and mitochondrial DNA (mtDNA). Whereas it was generally believed that mitochondria are among the important players regarding the ageing process, two recent important approaches shed new light on the complex interactions. It has been shown by single cell experiments and computer simulation models that mitochondrial mutations are generated stochastically in childhood or early adolescence and accumulate clonally in a cell or muscle fibre, leading to a local age related impairment of cellular energy supply. Other important observations come from mitochondrial mutator mice, harbouring mitochondrial mutations due to a deficient repair enzyme (POLG). These mice reveal a premature senescence but do not exhibit a vicious cycle of increased oxidative damage or ROS production as has been postulated by the mitochondrial theory of ageing. At the moment it is hard to decide, if mitochondrial mutations are the cause or consequence of human ageing, but it is suggested that mitochondrial point mutations are just the consequence, while deletions seem to play a causal role.
C1 Univ Hosp Schleswig Holstein, Dept Forens Med, D-23562 Lubeck, Germany.
C3 University of Kiel; Schleswig Holstein University Hospital
RP Meissner, C (corresponding author), Univ Hosp Schleswig Holstein, Dept Forens Med, Kahlhorststr 31-35, D-23562 Lubeck, Germany.
EM meissner@rmed.mu-luebeck.de
CR Ballard JWO, 2001, CURR OPIN GENET DEV, V11, P667, DOI 10.1016/S0959-437X(00)00251-3
   Bank C, 2000, BIOCHEM BIOPH RES CO, V279, P595, DOI 10.1006/bbrc.2000.3951
   Barja G, 2000, AGING CLIN EXP RES, V12, P342, DOI 10.1007/BF03339859
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berdanier CD, 2001, MUTAT RES-FUND MOL M, V475, P169, DOI 10.1016/S0027-5107(01)00068-9
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Graeber MB, 1998, J NEUROSCI RES, V52, P1
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hasty P, 2005, MECH AGEING DEV, V126, P71, DOI 10.1016/j.mad.2004.09.036
   Hayakawa M, 1996, BIOCHEM BIOPH RES CO, V226, P369, DOI 10.1006/bbrc.1996.1363
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   KEUTZER DA, 1998, P NATL ACAD SCI USA, V95, P3578
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kovalenko SA, 1997, BIOCHEM BIOPH RES CO, V232, P147, DOI 10.1006/bbrc.1997.6251
   Kowald A, 1999, EXP GERONTOL, V34, P605, DOI 10.1016/S0531-5565(99)00011-X
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Lezza AMS, 1999, FASEB J, V13, P1083, DOI 10.1096/fasebj.13.9.1083
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MO JQ, 1995, MECH AGEING DEV, V81, P73, DOI 10.1016/0047-6374(95)01586-O
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SOONG NW, 1992, NAT GENET, V2, P318
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Storm T, 2002, EXP GERONTOL, V37, P1389, DOI 10.1016/S0531-5565(02)00121-3
   Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154
   Sun JT, 1999, MOL CELL BIOL, V19, P216
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   VEMULST M, 2007, NAT GENET, V39, P540
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
   Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2
   Zhang CF, 1998, HUM MUTAT, V11, P360
   Zhong WX, 1996, CELL GROWTH DIFFER, V7, P1175
NR 62
TC 24
Z9 28
U1 0
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0948-6704
EI 1435-1269
J9 Z GERONTOL GERIATR
JI Z. Gerontol. Geriatr.
PD OCT
PY 2007
VL 40
IS 5
BP 325
EP 333
DI 10.1007/s00391-007-0481-z
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 221QV
UT WOS:000250243300003
PM 17943235
DA 2024-11-01
ER

PT J
AU Rahman, S
AF Rahman, Shamima
TI Mitochondrial disease and epilepsy
SO DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
LA English
DT Review
ID C-OXIDASE DEFICIENCY; COMPLEX-I DEFICIENCY; ALPERS-HUTTENLOCHER
   SYNDROME; COENZYME Q(10) DEFICIENCY; RESPIRATORY-CHAIN DEFECTS;
   LEIGH-SYNDROME; DNA DEPLETION; MYOCLONIC EPILEPSY; KETOGENIC DIET;
   GENE-MUTATIONS
AB Mitochondrial respiratory chain disorders are relatively common inborn errors of energy metabolism, with a combined prevalence of one in 5000. These disorders typically affect tissues with high energy requirements, and cerebral involvement occurs frequently in childhood, often manifesting in seizures. Mitochondrial diseases are genetically heterogeneous; to date, mutations have been reported in all 37 mitochondrially encoded genes and more than 80 nuclear genes. The major genetic causes of mitochondrial epilepsy are mitochondrial DNA mutations (including those typically associated with the mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS] and myoclonic epilepsy with ragged red fibres [MERRF] syndromes); mutations in POLG (classically associated with Alpers syndrome but also presenting as the mitochondrial recessive ataxia syndrome [MIRAS], spinocerebellar ataxia with epilepsy [SCAE], and myoclonus, epilepsy, myopathy, sensory ataxia [MEMSA] syndromes in older individuals) and other disorders of mitochondrial DNA maintenance; complex I deficiency; disorders of coenzyme Q10 biosynthesis; and disorders of mitochondrial translation such as RARS2 mutations. It is not clear why some genetic defects, but not others, are particularly associated with seizures. Epilepsy may be the presenting feature of mitochondrial disease but is often part of a multisystem clinical presentation. Mitochondrial epilepsy may be very difficult to manage, and is often a poor prognostic feature. At present there are no curative treatments for mitochondrial disease. Individuals with mitochondrial epilepsy are frequently prescribed multiple anticonvulsants, and the role of vitamins and other nutritional supplements and the ketogenic diet remain unproven.
C1 UCL Inst Child Hlth, Mitochondrial Res Grp, Clin & Mol Genet Unit, London WC1N 1EH, England.
C3 University of London; University College London
RP Rahman, S (corresponding author), UCL Inst Child Hlth, Mitochondrial Res Grp, Clin & Mol Genet Unit, 30 Guilford St, London WC1N 1EH, England.
EM s.rahman@ich.ucl.ac.uk
RI Rahman, Shamima/C-5232-2008
FU Great Ormond Street Hospital Children's Charity, Ataxia UK; Child Health
   Research Appeal Trust; Children's Liver Disease Foundation, Climb;
   Medical Research Council
FX SR receives funding from Great Ormond Street Hospital Children's
   Charity, Ataxia UK, the Child Health Research Appeal Trust, the
   Children's Liver Disease Foundation, Climb, and the Medical Research
   Council. An earlier version of this article was published in the
   Sheffield Children's Hospital Metabolic Disease Newsletter.
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Arpin S, 2009, METAB BRAIN DIS, V24, P453, DOI 10.1007/s11011-009-9144-7
   Barghuti F, 2008, MOL GENET METAB, V94, P78, DOI 10.1016/j.ymgme.2007.11.013
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   CHABROL B, 1994, EUR J PEDIATR, V153, P133, DOI 10.1007/BF01959226
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   Chrzanowska-Lightowlers Z M A, 2011, Neuromuscul Disord, V21, P142, DOI 10.1016/j.nmd.2010.10.005
   Cohen B. H., 1993, GeneReviews((R))
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   El Sabbagh S, 2010, EPILEPSIA, V51, P1225, DOI 10.1111/j.1528-1167.2009.02504.x
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fassone E, 2010, HUM MOL GENET, V19, P4837, DOI 10.1093/hmg/ddq414
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072
   Galimberti CA, 2006, NEUROLOGY, V67, P1715, DOI 10.1212/01.wnl.0000242882.58086.9a
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Glamuzina E, 2011, J INHERIT METAB 1116
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Harris MO, 2010, ARCH NEUROL-CHICAGO, V67, P493, DOI 10.1001/archneurol.2010.36
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Huigsloot M, 2011, AM J HUM GENET, V88, P488, DOI 10.1016/j.ajhg.2011.03.002
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   Lheureux PER, 2009, CLIN TOXICOL, V47, P101, DOI 10.1080/15563650902752376
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Mancuso M, 2006, J NEUROL SCI, V243, P97, DOI 10.1016/j.jns.2005.11.021
   Molinari F, 2005, AM J HUM GENET, V76, P334, DOI 10.1086/427564
   Molinari F, 2009, CLIN GENET, V76, P188, DOI 10.1111/j.1399-0004.2009.01236.x
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Parikh S, 2008, PEDIATR NEUROL, V38, P191, DOI 10.1016/j.pediatrneurol.2007.10.011
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rahman S, 2011, NEUROMUSCUL DIS 0630
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Rankin J, 2010, AM J MED GENET A, V152A, P2079, DOI 10.1002/ajmg.a.33531
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Thorburn DR, 1993, GENEREVIEWS
   Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Urbanska EM, 1998, EUR J PHARMACOL, V359, P55, DOI 10.1016/S0014-2999(98)00648-7
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Yamamoto HA, 1996, NEUROSCI LETT, V207, P89, DOI 10.1016/0304-3940(96)12493-9
   Zhang Y, 2007, J INHERIT METAB DIS, V30, P265, DOI 10.1007/s10545-006-0481-y
NR 94
TC 127
Z9 139
U1 0
U2 21
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0012-1622
J9 DEV MED CHILD NEUROL
JI Dev. Med. Child Neurol.
PD MAY
PY 2012
VL 54
IS 5
BP 397
EP 406
DI 10.1111/j.1469-8749.2011.04214.x
PG 10
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 922KP
UT WOS:000302546100010
PM 22283595
OA hybrid, Green Submitted
DA 2024-11-01
ER

PT J
AU El Sabbagh, S
   Lebre, AS
   Bahi-Buisson, N
   Delonlay, P
   Soufflet, C
   Boddaert, N
   Rio, M
   Rötig, A
   Dulac, O
   Munnich, A
   Desguerre, I
AF El Sabbagh, Sandra
   Lebre, Anne-Sophie
   Bahi-Buisson, Nadia
   Delonlay, Pascale
   Soufflet, Christine
   Boddaert, Nathalie
   Rio, Marlene
   Roetig, Agnes
   Dulac, Olivier
   Munnich, Arnold
   Desguerre, Isabelle
TI Epileptic phenotypes in children with respiratory chain disorders
SO EPILEPSIA
LA English
DT Article
DE Mitochondriopathy; Epilepsy-NARP; MELAS; POLG1; mtDNA depletion;
   Myoclonic epilepsy; Neonatal myoclonic encephalopathy; Infantile spasms;
   Status epilepticus; Epilepsia partialis continua
ID PROGRESSIVE NEURONAL DEGENERATION; MITOCHONDRIAL DISORDERS;
   ALPERS-DISEASE; MUTATIONS; MRI; ENCEPHALOPATHY; DEFICIENCY; CHILDHOOD;
   MYOPATHY; SPECTRUM
AB P>Purpose:
   Epilepsy is a commonly reported but rarely described clinical hallmark of mitochondrial respiratory chain defects (RCDs) with encephalopathy.
   Methods:
   From 1990-2006 we collected data about 56 children with RCD (single, n = 24 or multiple, n = 20 mitochondrial complex deficiencies; mtDNA mutation, n = 11; mtDNA depletion n = 10 of 21; and nuclear gene mutation n = 11). Epileptic features were reviewed retrospectively.
   Results:
   First seizures were frequently (47 patients, 82.5%) preceded by failure to thrive, psychomotor delay, ataxia, or multisystemic dysfunction. Sixty percent of the patients had several seizure types. Six age-related epilepsy phenotypes could be identified: status epilepticus complicating neonatal multivisceral deficiency (2 patients), neonatal myoclonic encephalopathy (3 patients), infantile spasms (8 patients), refractory or recurrent status epilepticus (21 patients), epilepsia partialis continua (4 patients), and myoclonic epilepsy (18 patients). Except for infantile spasms, epilepsy was difficult to control in most patients (95%). Valproate was administered to 25 patients, one of whom developed acute liver failure 6 days later. Twenty-two patients (45%) died, half of them within 9 months from the onset of epilepsy.
   Discussion:
   In RCD, epilepsy is not only difficult to control but its occurrence often indicates a severe turn in the course of the disease. For one-third of the patients, classical biochemical measures failed to reveal any abnormality and RCD could be detected in the liver only.
C1 [El Sabbagh, Sandra; Lebre, Anne-Sophie; Bahi-Buisson, Nadia; Boddaert, Nathalie; Rio, Marlene; Dulac, Olivier; Munnich, Arnold; Desguerre, Isabelle] Hop Necker Enfants Malad, AP HP, F-75450 Paris 15, France.
   [Bahi-Buisson, Nadia; Delonlay, Pascale; Boddaert, Nathalie; Dulac, Olivier; Munnich, Arnold] Univ Paris 05, Paris, France.
   [Delonlay, Pascale] Hop Necker Enfants Malad, AP HP, Metab Clin, F-75450 Paris 15, France.
   [Soufflet, Christine] Necker, Neurophysiol, Paris, France.
   [Roetig, Agnes; Munnich, Arnold] INSERM, U781, Paris, France.
   INSERM, U663, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Universite Paris
   Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique
   Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire
   Necker-Enfants Malades - APHP; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite Paris Cite; Institut National de
   la Sante et de la Recherche Medicale (Inserm)
RP Desguerre, I (corresponding author), Hop Necker Enfants Malad, AP HP, 149 Rue Sevres, F-75450 Paris 15, France.
EM isabelle.desguerre@nck.aphp.fr
RI boddaert, nathalie/GWV-2865-2022; Lebre, Anne-Sophie/AAO-1413-2020;
   ROTIG, AGNES/G-9592-2017
OI boddaert, nathalie/0000-0003-0991-7774; Rio,
   Marlene/0000-0003-2049-5058; ROTIG, AGNES/0000-0003-0589-0703
CR [Anonymous], 1981, Epilepsia, V22, P489
   Bahi-Buisson N, 2006, EPILEPSIA, V47, P380, DOI 10.1111/j.1528-1167.2006.00432.x
   Boitier E, 1998, J NEUROL SCI, V156, P41, DOI 10.1016/S0022-510X(98)00006-9
   BOYD SG, 1986, NEUROPEDIATRICS, V17, P75, DOI 10.1055/s-2008-1052505
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   COPPOLA G, 1995, EPILEPSIA, V36, P1017, DOI 10.1111/j.1528-1157.1995.tb00961.x
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Desguerre I, 2003, NEUROPEDIATRICS, V34, P265
   Folbergrová J, 2007, EXP NEUROL, V204, P597, DOI 10.1016/j.expneurol.2006.12.010
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009
   Lagrue E, 2007, PEDIATR RES, V62, P14, DOI 10.1203/PDR.0b013e31806790d7
   Leary LD, 2003, EPILEPSIA, V44, P701, DOI 10.1046/j.1528-1157.2003.05302.x
   Lee YC, 2008, PHYTOCHEM LETT, V1, P6, DOI 10.1016/j.phytol.2007.11.002
   Mancuso M, 2006, J NEUROL SCI, V243, P97, DOI 10.1016/j.jns.2005.11.021
   Mascalchi M, 2002, NEUROLOGY, V58, P1686, DOI 10.1212/WNL.58.11.1686
   Mikaeloff Y, 2006, EPILEPSY RES, V69, P67, DOI 10.1016/j.eplepsyres.2006.01.002
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Nabbout R, 1999, ARCH DIS CHILD-FETAL, V81, pF125, DOI 10.1136/fn.81.2.F125
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Panetta J, 2005, NEUROPEDIATRICS, V36, P256, DOI 10.1055/s-2005-865866
   Riquet A, 2008, EPILEPSY RES, V78, P1, DOI 10.1016/j.eplepsyres.2007.10.001
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   RYDING E, 1988, J CEREBR BLOOD F MET, V8, pS95, DOI 10.1038/jcbfm.1988.38
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Shah NS, 2002, J CHILD NEUROL, V17, P369, DOI 10.1177/088307380201700511
   Striano P, 2007, EPILEPSY BEHAV, V10, P187, DOI 10.1016/j.yebeh.2006.10.009
   Stromberger C, 2003, J INHERIT METAB DIS, V26, P299, DOI 10.1023/A:1024453704800
   TADA K, 1993, J INHERIT METAB DIS, V16, P691, DOI 10.1007/BF00711901
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Villanueva V, 2006, EPILEPSIA, V47, P788, DOI 10.1111/j.1528-1167.2006.00526.x
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
NR 39
TC 80
Z9 83
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0013-9580
EI 1528-1167
J9 EPILEPSIA
JI Epilepsia
PD JUL
PY 2010
VL 51
IS 7
BP 1225
EP 1235
DI 10.1111/j.1528-1167.2009.02504.x
PG 11
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 619PG
UT WOS:000279441500017
PM 20196775
OA Bronze
DA 2024-11-01
ER

PT J
AU La Morgia, C
   Maresca, A
   Caporali, L
   Valentino, ML
   Carelli, V
AF La Morgia, C.
   Maresca, A.
   Caporali, L.
   Valentino, M. L.
   Carelli, V.
TI Mitochondrial diseases in adults
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Review
DE mitochondrial diseases; mtDNA; mitochondria; neurology; neuromuscular
   disorders
ID HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   TRANSFER-RNA SYNTHETASE; LACTIC-ACIDOSIS; DNA MUTATION; SIDEROBLASTIC
   ANEMIA; PRENATAL-DIAGNOSIS; MYOCLONUS EPILEPSY; RESPIRATORY-CHAIN; MTDNA
   MUTATION
AB Mitochondrial medicine is a field that expanded exponentially in the last 30 years. Individually rare, mitochondrial diseases as a whole are probably the most frequent genetic disorder in adults. The complexity of their genotype-phenotype correlation, in terms of penetrance and clinical expressivity, natural history and diagnostic algorithm derives from the dual genetic determination. In fact, in addition to the about 1.500 genes encoding mitochondrial proteins that reside in the nuclear genome (nDNA), we have the 13 proteins encoded by the mitochondrial genome (mtDNA), for which 22 specific tRNAs and 2 rRNAs are also needed. Thus, besides Mendelian genetics, we need to consider all peculiarities of how mtDNA is inherited, maintained and expressed to fully understand the pathogenic mechanisms of these disorders. Yet, from the initial restriction to the narrow field of oxidative phosphorylation dysfunction, the landscape of mitochondrial functions impinging on cellular homeostasis, driving life and death, is impressively enlarged. Finally, from the clinical standpoint, starting from the neuromuscular field, where brain and skeletal muscle were the primary targets of mitochondrial dysfunction as energy-dependent tissues, after three decades virtually any subspecialty of medicine is now involved. We will summarize the key clinical pictures and pathogenic mechanisms of mitochondrial diseases in adults.
C1 [La Morgia, C.; Valentino, M. L.; Carelli, V.] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy.
   [La Morgia, C.; Maresca, A.; Caporali, L.; Valentino, M. L.; Carelli, V.] UOC Clin Neurol, IRCCS Ist Sci Neurol Bologna, Bologna, Italy.
C3 University of Bologna; IRCCS Istituto delle Scienze Neurologiche di
   Bologna (ISNB)
RP Carelli, V (corresponding author), Univ Bologna, IRCCS Ist Sci Neurol Bolognavia Altura 3, Dipartimento Sci Biomed & NeuroMotorie, I-40139 Bologna, Italy.
EM valerio.carelli@unibo.it
RI La Morgia, Chiara/H-6765-2012; Caporali, Leonardo/J-7398-2016; Maresca,
   Alessandra/J-7393-2016
OI Caporali, Leonardo/0000-0002-0666-4380; Maresca,
   Alessandra/0000-0002-8959-8832; CARELLI, VALERIO/0000-0003-4923-6404
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Balducci N, 2016, BRIT J OPHTHALMOL, V100, P1232, DOI 10.1136/bjophthalmol-2015-307326
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Caporali L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007210
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   CARELLI V, 2016, BRAIN 3, V139, DOI DOI 10.1093/BRAIN/AWV339
   Carelli V, 2018, ESSAYS BIOCHEM, V62, P235, DOI 10.1042/EBC20170097
   Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180
   Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Dionisi-Vici C, 2016, BRAIN, V139, P1045, DOI 10.1093/brain/aww013
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Giordano L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.364
   Giorgio V, 2012, BBA-BIOENERGETICS, V1817, P363, DOI 10.1016/j.bbabio.2011.10.012
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573
   Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787
   Hällberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hildick-Smith GJ, 2013, AM J HUM GENET, V93, P906, DOI 10.1016/j.ajhg.2013.09.011
   HOLME E, 1993, AM J HUM GENET, V52, P551
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Iannielli A, 2018, CELL REP, V22, P2066, DOI 10.1016/j.celrep.2018.01.089
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86
   Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498
   Karaa A, 2016, MOL GENET METAB, V119, P100, DOI 10.1016/j.ymgme.2016.07.005
   Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kullar PJ, 2018, BRAIN, V141, P55, DOI 10.1093/brain/awx295
   Lane N, 2017, J THEOR BIOL, V434, P58, DOI 10.1016/j.jtbi.2017.04.031
   Lane N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0253
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Leber T., 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Li JJ, 2019, CELL, V177, P38, DOI 10.1016/j.cell.2019.03.004
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Margulis L., 2004, MICROBIOLOGY TODAY, V31, P172
   Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096
   Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704
   MITA S, 1995, MUSCLE NERVE, pS113
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Pacitti D, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00669
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   POULTON J, 1991, AM J HUM GENET, V48, P649
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Reinson K, 2019, EUR J MED GENET, V62, DOI 10.1016/j.ejmg.2018.11.006
   Richter U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06471-z
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rowe RG, 2019, NAT REV GENET, V20, P377, DOI 10.1038/s41576-019-0100-z
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   RUMMELT V, 1993, OPHTHALMOLOGY, V100, P1757
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   Stenton SL, 2020, J INHERIT METAB DIS, V43, P25, DOI 10.1002/jimd.12130
   Stenton SL, 2018, ESSAYS BIOCHEM, V62, P399, DOI 10.1042/EBC20170110
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   TULINIUS MH, 1995, EUR J PEDIATR, V154, P35, DOI 10.1007/BF01972970
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   van Rahden VA, 2015, AM J HUM GENET, V96, P640, DOI 10.1016/j.ajhg.2015.02.002
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wallace DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0267
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wild KT, 2020, AM J MED GENET A, V182, P365, DOI 10.1002/ajmg.a.61433
   Wimplinger I, 2006, AM J HUM GENET, V79, P878, DOI 10.1086/508474
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 152
TC 37
Z9 40
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD JUN
PY 2020
VL 287
IS 6
BP 592
EP 608
DI 10.1111/joim.13064
PG 17
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LS6JN
UT WOS:000536488000002
PM 32463135
OA Bronze
DA 2024-11-01
ER

PT J
AU Kettwig, M
   Schubach, M
   Zimmermann, FA
   Klinge, L
   Mayr, JA
   Biskup, S
   Sperl, W
   Gärtner, J
   Huppke, P
AF Kettwig, Matthias
   Schubach, Max
   Zimmermann, Franz A.
   Klinge, Lars
   Mayr, Johannes A.
   Biskup, Saskia
   Sperl, Wolfgang
   Gaertner, Jutta
   Huppke, Peter
TI From ventriculomegaly to severe muscular atrophy: Expansion of the
   clinical spectrum related to mutations in AIFM1
SO MITOCHONDRION
LA English
DT Article
DE AIFM1; X-chromosomal mitochondriopathy; Leukodystrophy; External
   ophthalmoplegia; Muscle wasting
ID APOPTOSIS-INDUCING FACTOR; MITOCHONDRIAL NEUROGASTROINTESTINAL
   ENCEPHALOMYOPATHY; DISEASE; DEFICIENCY; DISORDER
AB The apoptosis-inducing factor (AIF) functions as a FAD-dependent NADH oxidase in mitochondria. Upon apoptotic stimulation it is released from mitochondria and migrates to the nucleus where it induces chromatin condensation and DNA fragmentation. So far mutations in AIFM1, a X-chromosomal gene coding for AIF, have been described in three families with 11 affected males. We report here on a further patient thereby expanding the clinical and mutation spectrum. In addition, we review the known phenotypes related to AIFM1 mutations. The clinical course in the male patient described here was characterized by phases with rapid deterioration and long phases without obvious progression of disease. At age 2.5 years he developed hearing loss and severe ataxia and at age 10 years muscle wasting, swallowing difficulties, respiratory insufficiency and external opthamoplegia. By next generation sequencing of whole exome we identified a hemizygous missense mutation in the AIFM1 gene, c.727G>T (p.Va1243Leu) affecting a highly conserved residue in the FAD-binding domain. Summarizing what is known today, mutations in AIFM1 are associated with a progressive disorder with myopathy, ataxia and neuropathy. Severity varies greatly even within one family with onset of symptoms between birth and adolescence. 3 of 12 patients died before age 5 years while others were still able to walk during young adulthood. Less frequent symptoms were hearing loss, seizures and psychomotor regression. Results from clinical chemistry, brain imaging and muscle biopsy were unspecific and inconsistent. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Kettwig, Matthias; Klinge, Lars; Gaertner, Jutta; Huppke, Peter] Univ Gottingen, Fac Med, Div Pediat Neurol, Dept Pediat & Adolescent Med, D-37075 Gottingen, Germany.
   [Schubach, Max; Biskup, Saskia] CeGaT GmbH, Ctr Genom & Transcript, Tubingen, Germany.
   [Zimmermann, Franz A.; Mayr, Johannes A.; Sperl, Wolfgang] Paracelsus Med Univ, Dept Paediat, Salzburg, Austria.
C3 University of Gottingen; CeGaT; Paracelsus Private Medical University
RP Kettwig, M (corresponding author), Univ Gottingen, Fac Med, Div Pediat Neurol, Dept Pediat & Adolescent Med, D-37075 Gottingen, Germany.
EM matthias.kettwig@med.uni-goettingen.de
RI Schubach, Max/AAE-4017-2019; Gärtner, Jutta/JFA-0937-2023
OI Mayr, Johannes/0000-0001-6970-336X; Schubach, Max/0000-0002-2032-6679;
   Kettwig, Matthias/0000-0003-4804-7716
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   AMOULT D, 2002, J CELL BIOL, V159, P923
   Berger I, 2011, MOL GENET METAB, V104, P517, DOI 10.1016/j.ymgme.2011.09.020
   Dubovitz V., 2007, MUSCLE BIOPSY
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Feichtinger RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-149
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Kapur RP, 2011, AM J SURG PATHOL, V35, P714, DOI 10.1097/PAS.0b013e31821433af
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Nishino I, 2000, ANN NEUROL, V47, P792
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200
   Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae
   Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135
   Vasta V, 2009, GENOME MED, V1, DOI 10.1186/gm100
   Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194
   Wong LJC, 2012, SEMIN NEUROL, V32, P55, DOI 10.1055/s-0032-1306387
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
NR 27
TC 43
Z9 49
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR
PY 2015
VL 21
BP 12
EP 18
DI 10.1016/j.mito.2015.01.001
PG 7
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA CD8ET
UT WOS:000351328700003
PM 25583628
DA 2024-11-01
ER

PT J
AU Mezghani, N
   Mnif, M
   Mkaouar-Rebai, E
   Kallel, N
   Salem, IH
   Charfi, N
   Abid, M
   Fakhfakh, F
AF Mezghani, Najla
   Mnif, Mouna
   Mkaouar-Rebai, Emna
   Kallel, Nozha
   Salem, Ikhlass Haj
   Charfi, Nadia
   Abid, Mohamed
   Fakhfakh, Faiza
TI The mitochondrial ND1 m.3337G&gt;A mutation associated to multiple
   mitochondrial DNA deletions in a patient with Wolfram syndrome and
   cardiomyopathy
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Wolfram syndrome; Mitochondrial deletion; m.3337G > A; Mitochondrial
   mutations; Skeletal muscle
ID DIABETES-MELLITUS; OPTIC ATROPHY; GENE; INSIPIDUS; DEAFNESS
AB Wolfram syndrome (WFS) is a rare hereditary disorder also known as DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness). It is a heterogeneous disease and full characterization of all clinical and biological features of this disorder is difficult. The wide spectrum of clinical expression, affecting several organs and tissues, and the similarity in phenotype between patients with Wolfram syndrome and those with certain types of respiratory chain diseases suggests mitochondrial DNA (mtDNA) involvement in Wolfram syndrome patients. We report a Tunisian patient with clinical features of moderate Wolfram syndrome including diabetes, dilated cardiomyopathy and neurological complications. The results showed the presence of the mitochondrial ND1 m.3337G>A mutation in almost homoplasmic form in 3 tested tissues of the proband (blood leukocytes, buccal mucosa and skeletal muscle). In addition, the long-range PCR amplifications revealed the presence of multiple deletions of the mitochondrial DNA extracted from the patient's skeletal muscle removing several tRNA and protein-coding genes. Our study reported a Tunisian patient with clinical features of moderate Wolfram syndrome associated with cardiomyopathy, in whom we detected the ND1 m.3337G>A mutation with mitochondrial multiple deletions. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Mezghani, Najla; Mkaouar-Rebai, Emna; Salem, Ikhlass Haj; Fakhfakh, Faiza] Univ Sfax, Lab Genet Mol Humaine, Fac Med Sfax, Sfax 3029, Tunisia.
   [Mnif, Mouna; Kallel, Nozha; Charfi, Nadia; Abid, Mohamed] CHU, Serv Endocrinol, Habib Bourguiba De Sfax, Tunisia.
C3 Universite de Sfax; Universite de Sfax; Hopital Habib Bourguiba
RP Mkaouar-Rebai, E (corresponding author), Univ Sfax, Lab Genet Mol Humaine, Fac Med Sfax, Ave Magida Boulila, Sfax 3029, Tunisia.
EM emna_mkaouar@mail2world.com
RI MKAOUAR-REBAI, Emna/AAE-6650-2019
OI Mkaouar-Rebai, Emna/0000-0003-3095-510X
FU The Ministry of Higher Education and Scientific Research in Tunisia
FX We thank the patient and his family for their cooperation in the present
   study. This work was supported by The Ministry of Higher Education and
   Scientific Research in Tunisia.
CR Barrientos A, 1996, AM J HUM GENET, V58, P963
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   BUNDEY S, 1992, J INHERIT METAB DIS, V15, P315, DOI 10.1007/BF02435965
   CREMERS CWR, 1977, ACTA PAEDIATR SCAND, V51, pS1
   El-Shanti H, 2000, AM J HUM GENET, V66, P1229, DOI 10.1086/302858
   GUNN T, 1976, J PEDIATR-US, V89, P565, DOI 10.1016/S0022-3476(76)80387-3
   Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474
   Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Mkaouar-Rebai E, 2007, BIOCHEM BIOPH RES CO, V355, P1031, DOI 10.1016/j.bbrc.2007.02.083
   PAGE MM, 1976, Q J MED, V45, P505
   POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267
   Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Van Hove JLK, 2008, EUR J PEDIATR, V167, P771, DOI 10.1007/s00431-007-0587-8
   Wolfram DJ, 1938, Mayo Clin Proc, V1, P715, DOI DOI 10.1186/1757-1626-2-9355
   Zifa E, 2008, MITOCHONDRION, V8, P229, DOI 10.1016/j.mito.2008.04.001
NR 20
TC 18
Z9 20
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 29
PY 2011
VL 411
IS 2
BP 247
EP 252
DI 10.1016/j.bbrc.2011.06.106
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 806LS
UT WOS:000293809900004
PM 21723259
DA 2024-11-01
ER

PT J
AU Guo, L
   Govindaraj, P
   Kievit, M
   de Coo, IFM
   Gerards, M
   Hellebrekers, DMEI
   Stassen, APM
   Gayathri, N
   Taly, AB
   Sankaran, BP
   Smeets, HJM
AF Guo, Le
   Govindaraj, Periyasamy
   Kievit, Marielle
   Coo, Irenaeus F. M. de
   Gerards, Mike
   Hellebrekers, Debby M. E. I.
   Stassen, Alphons P. M.
   Gayathri, Narayanappa
   Taly, Arun B.
   Sankaran, Bindu Parayil
   Smeets, Hubert J. M.
TI Whole exome sequencing reveals a homozygous<i> C1QBP</i> deletion as the
   cause of progressive external ophthalmoplegia and multiple mtDNA
   deletions
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Whole exome sequencing; C1QBP gene; Progressive external
   ophthalmoplegia; Multiple mtDNA deletions
ID CELL-METABOLISM; MITOCHONDRIAL; VARIANTS
AB Whole exome sequencing (WES), analyzed with GENESIS and WeGET, revealed a homozygous deletion in the C1QBP gene in a patient with progressive external ophthalmoplegia (PEO) and multiple mtDNA deletions. The gene encodes the mitochondria-located complementary 1 Q subcomponent-binding protein, involved in mitochondrial homeostasis. Biallelic mutations in C1QBP cause mitochondrial cardiomyopathy and/or PEO with variable age of onset. Our patient showed only late-onset PEO-plus syndrome without overt cardiac involvement. Available data suggest that early-onset cardiomyopathy variants localize in important structural domains and PEO-plus variants in the coiled-coil region. Our patient demonstrates that C1QBP mutations should be considered in individuals with PEO with or without cardiomyopathy. (c) 2021 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
C1 [Guo, Le; Kievit, Marielle; Coo, Irenaeus F. M. de; Smeets, Hubert J. M.] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Maastricht, Netherlands.
   [Guo, Le; Coo, Irenaeus F. M. de; Smeets, Hubert J. M.] Maastricht Univ, Dept Toxicogenom, Clin Genom Unit, Maastricht, Netherlands.
   [Govindaraj, Periyasamy; Gayathri, Narayanappa] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuropathol, Bangalore, Karnataka, India.
   [Govindaraj, Periyasamy; Gayathri, Narayanappa; Taly, Arun B.] Natl Inst Mental Hlth & Neurosci NIMHANS, Neurobiol Res Ctr, Neuromuscular Lab, Bangalore, Karnataka, India.
   [Govindaraj, Periyasamy] Ctr DNA Fingerprinting & Diagnost CDFD, Hyderabad, India.
   [Gerards, Mike] Maastricht Univ, Maastricht Ctr Syst Biol MacsBio, Maastricht, Netherlands.
   [Hellebrekers, Debby M. E. I.; Stassen, Alphons P. M.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands.
   [Taly, Arun B.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurol, Bangalore, Karnataka, India.
   [Sankaran, Bindu Parayil] Univ Sydney, Childrens Hosp, Westmead Clin Sch, Sydney Med Sch,Fac Med & Hlth, Sydney, NSW, Australia.
   [Smeets, Hubert J. M.] Maastricht Univ, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands.
C3 Maastricht University; Maastricht University; National Institute of
   Mental Health & Neurosciences - India; National Institute of Mental
   Health & Neurosciences - India; Department of Biotechnology (DBT) India;
   Centre for DNA Fingerprinting & Diagnostics (CDFD); Maastricht
   University; Maastricht University; National Institute of Mental Health &
   Neurosciences - India; NSW Health; The Children's Hospital at Westmead;
   University of Sydney; Maastricht University
RP Smeets, HJM (corresponding author), Maastricht Univ, Dept Toxicogenom, Clin Genom Unit, Maastricht, Netherlands.
EM smeets@maastrichtuniversity.nl
RI Taly, Arun/AAV-3517-2021
OI Gerards, Mike/0000-0003-4886-8055
FU China Scholarship Council [201606310036]; National Post-Doctoral
   Fellowship (N-PDF) from the SERB, DST Government of India
   [PDF/2016/001625]; Dutch Province of Limburg; Mito-Foundation Australia;
   Stichting NeMO [N9_2020]
FX LG is supported by a funding from China Scholarship Council (Grant
   Number: 201606310036). PG is supported by National Post-Doctoral
   Fellowship (N-PDF) from the SERB, DST Government of India
   (PDF/2016/001625). Part of this work has been made possible with the
   support of the Dutch Province of Limburg (MG). BPS is supported by a
   clinical research fellowship from Mito-Foundation Australia. IdC is
   supported by Stichting NeMO (N9_2020). We thank the family participating
   in this study and acknowledge Dr. Radek Szklarczyk for advice in using
   WeGET tool.
CR Amberger JS, 2019, NUCLEIC ACIDS RES, V47, pD1038, DOI 10.1093/nar/gky1151
   Bugiardini E, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000149
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Carreño-Gago L, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00576
   Feichtinger RG, 2017, AM J HUM GENET, V101, P525, DOI 10.1016/j.ajhg.2017.08.015
   Gonzalez M, 2015, HUM MUTAT, V36, P950, DOI 10.1002/humu.22836
   Gotoh K, 2018, CELL REP, V25, P1800, DOI 10.1016/j.celrep.2018.10.057
   Hu MJ, 2013, BIOCHEM J, V453, P381, DOI 10.1042/BJ20121829
   Marchet S, 2020, HUM MUTAT, V41, P1745, DOI 10.1002/humu.24081
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0652-7
   Nguyen M, 2016, EUR J HUM GENET, V24, P619, DOI 10.1038/ejhg.2015.158
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sachdev A, 2018, CAN J OPHTHALMOL, V53, pE203, DOI 10.1016/j.jcjo.2018.01.005
   Saha SK, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040513
   Saito T, 2017, CARDIOVASC RES, V113, P1173, DOI 10.1093/cvr/cvx095
   Shen LS, 2016, HUM MUTAT, V37, P540, DOI 10.1002/humu.22974
   Szklarczyk R, 2016, NUCLEIC ACIDS RES, V44, pD567, DOI 10.1093/nar/gkv1228
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang J, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.583047
   Wu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071006
   Yagi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15414-5
NR 23
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD SEP
PY 2021
VL 31
IS 9
BP 859
EP 864
DI 10.1016/j.nmd.2021.06.014
EA OCT 2021
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA WG0IR
UT WOS:000706683000009
PM 34419324
OA hybrid
DA 2024-11-01
ER

PT J
AU Sofou, K
   Moslemi, AR
   Kollberg, G
   Bjarnadóttir, I
   Oldfors, A
   Nennesmo, I
   Holme, E
   Tulinius, M
   Darin, N
AF Sofou, Kalliopi
   Moslemi, Ali-Reza
   Kollberg, Gittan
   Bjarnadottir, Ingibjorg
   Oldfors, Anders
   Nennesmo, Inger
   Holme, Elisabeth
   Tulinius, Mar
   Darin, Niklas
TI Phenotypic and genotypic variability in Alpers syndrome
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Article
DE Alpers; Mitochondrial encephalomyopathy; POLG1; OXPHOS; mtDNA
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DIFFUSE CEREBRAL DEGENERATION;
   MITOCHONDRIAL-DNA DEPLETION; POLYMERASE-GAMMA-A; POLG MUTATIONS;
   LEIGH-SYNDROME; AUTOSOMAL-DOMINANT; CLINICAL-FEATURES; MTDNA DEPLETION;
   COMMON-CAUSE
AB Background: Alpers syndrome is one of the most common phenotypes of mitochondrial disorders in early childhood and has been associated with pathogenic mutations in POLG1. Aims: To investigate the phenotypic genotypic correlations in Alpers syndrome and to identify potential differences among patients with Alpers syndrome with or without pathogenic POLG1 mutations.
   Methods: Patients with the phenotype of Alpers syndrome who were referred to our pediatric hospital during 1984-2007 and were diagnosed with mitochondrial encephalomyopathy underwent further biochemical, morphological and genetic investigations.
   Results: A total of 19 patients were included in the study, of whom six had pathogenic POLG1 mutations including a novel mutation (c.907 G > A, p.Gly303Arg). Complete mtDNA sequencing in the subgroup without POLG1 mutations showed 5 novel and 5 very rare mtDNA variants considered as rare polymorphisms. Compared to POLG1(-) patients, the POLG1(+) patients more frequently had seizures at onset, which often became refractory. Ataxia and stroke-like episodes were much more common, while microcephaly and spasticity were encountered almost solely in the POLG1(-) group. Hepatic and ophthalmological involvement developed in 79% and 88% of patients, respectively. Most of the patients in both groups had predominant deficiency of complex I. In addition to the major degenerative changes in the cerebral cortex, the basal ganglia, thalamus and white matter were also involved to variable extent.
   Conclusion: Alpers syndrome is a heterogeneous syndrome that should be considered in patients with early-onset progressive cortical encephalopathy regardless of liver involvement. The phenotype is different depending on the presence or absence of POLG1 mutations. (C) 2012 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
C1 [Sofou, Kalliopi; Bjarnadottir, Ingibjorg; Tulinius, Mar; Darin, Niklas] Univ Gothenburg, Dept Pediat, Queen Silvias Children Hosp, S-41685 Gothenburg, Sweden.
   [Moslemi, Ali-Reza; Oldfors, Anders] Univ Gothenburg, Dept Pathol, Sahlgrenska Univ Hosp, S-41345 Gothenburg, Sweden.
   [Kollberg, Gittan; Holme, Elisabeth] Univ Gothenburg, Dept Clin Chem, Sahlgrenska Univ Hosp, S-41345 Gothenburg, Sweden.
   [Nennesmo, Inger] Karolinska Univ Hosp, Dept Pathol, S-14186 Huddinge, Stockholm, Sweden.
C3 Queen Silvia Children's Hospital; University of Gothenburg; Sahlgrenska
   University Hospital; University of Gothenburg; University of Gothenburg;
   Sahlgrenska University Hospital; Karolinska Institutet; Karolinska
   University Hospital
RP Sofou, K (corresponding author), Univ Gothenburg, Dept Pediat, Queen Silvias Children Hosp, S-41685 Gothenburg, Sweden.
EM kalliopi.sofou@vgregion.se
RI Darin, Niklas/AAL-6345-2020
CR Absalon MJ, 2001, PEDIATR NEUROL, V24, P60, DOI 10.1016/S0887-8994(00)00226-5
   Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   BLACKWOOD W, 1963, ARCH DIS CHILD, V38, P193, DOI 10.1136/adc.38.199.193
   BULLARD WN, 1890, J NERV MENT DIS, V15, P699
   CHRISTENSEN E, 1949, ARCH NEURO PSYCHIATR, V61, P28, DOI 10.1001/archneurpsyc.1949.02310070034003
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   COURVILLE C B, 1960, Bull Los Angel Neuro Soc, V25, P72
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DREIFUSS FE, 1964, AM J DIS CHILD, V107, P649, DOI 10.1001/archpedi.1964.02080060651018
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   GABREELS FJM, 1984, ACTA NEUROL SCAND, V70, P145
   GREENHOUSE AH, 1964, ARCH NEUROL-CHICAGO, V10, P47, DOI 10.1001/archneur.1964.00460130051008
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HARDING BN, 1986, BRAIN, V109, P181, DOI 10.1093/brain/109.1.181
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   JELLINGER K, 1970, ACTA NEUROPATHOL, V16, P125, DOI 10.1007/BF00687667
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   MONTINE TJ, 1995, CLIN NEUROPATHOL, V14, P322
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Moslemi AR, 2007, MITOCHONDRION, V7, P241, DOI 10.1016/j.mito.2007.02.002
   Moslemi AR, 2003, NEUROLOGY, V61, P991, DOI 10.1212/01.WNL.0000082391.98672.0A
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   PRICK MJJ, 1981, ARCH NEUROL-CHICAGO, V38, P767, DOI 10.1001/archneur.1981.00510120067011
   PRICK MJJ, 1983, CLIN NEUROL NEUROSUR, V85, P57, DOI 10.1016/0303-8467(83)90024-0
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Tulinius M, 2005, EUR J PEDIATR, V164, P99, DOI 10.1007/s00431-004-1570-2
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Visser NA, 2010, NEUROLOGY, V74, P1231, DOI 10.1212/WNL.0b013e3181d90005
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   WOLF A, 1955, Res Publ Assoc Res Nerv Ment Dis, V34, P199
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 46
TC 19
Z9 20
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD JUL
PY 2012
VL 16
IS 4
BP 379
EP 389
DI 10.1016/j.ejpn.2011.12.006
PG 11
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 971LB
UT WOS:000306204300009
PM 22237560
DA 2024-11-01
ER

PT J
AU Kuthethur, R
   Prasad, K
   Chakrabarty, S
   Kabekkodu, SP
   Singh, KK
   Thangaraj, K
   Satyamoorthy, K
AF Kuthethur, Raviprasad
   Prasad, Keshava
   Chakrabarty, Sanjiban
   Kabekkodu, Shama Prasada
   Singh, Keshav K.
   Thangaraj, Kumarasamy
   Satyamoorthy, Kapaettu
TI Advances in mitochondrial medicine and translational research
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial disorders; Mitochondrial metabolism; Anterograde and
   retrograde signaling; Cancer and mitochondria; miRNAs and mitochondria;
   Therapeutics and mitochondria
ID MYOCLONIC EPILEPSY; MUTATION; DISEASE; DNA; DEFICIENCY; MYOPATHY; CELLS;
   THERAPIES; PATHOLOGY; PATIENT
AB Current knowledge of mitochondrial biology and function has provided tools and technologies that helped a better understanding of the molecular etiology of complex mitochondrial disorders. Dual genetic control of this subcellular organelle function regulates various signaling mechanisms which are essential for metabolism, bioenergetics, fatty acid biosynthesis, and DNA replication & repair. Understanding nuclear mitochondrial crosstalk through advanced genomics as well as clinical perspectives is the overall basis of mitochondrial research and medicine, also the sole objective of Society for Mitochondrial Medicine and Research (SMRM) - India. The eighth virtual international conference on 'Advances in Mitochondrial Medicine and Translational Research' was organized at the Manipal School of Life Sciences, MAHE, Manipal, India, during 6 - 7 November 2020. The aim of the virtual conference was to highlight the recent advances and future perspectives that represent comprehensive clinical and fundamental research interests in the area of mitochondrial biology of human diseases. To systematically present the various findings in mitochondrial biology, the meeting was themed with specific aspects comprising (a) mitochondrial disorders: clinical & genomic perspectives, (b) mitochondria in cancer, (c) mitochondrial metabolism & disorders, and (d) mitochondrial diseases & therapy. This report provides an overview of the recent advancements in the area of mitochondrial biology and medicine that was discussed at the conference.
C1 [Kuthethur, Raviprasad; Prasad, Keshava; Chakrabarty, Sanjiban; Kabekkodu, Shama Prasada; Satyamoorthy, Kapaettu] Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal 576104, India.
   [Singh, Keshav K.] Univ Alabama Birmingham, Sch Med, Dept Genet, Kaul Genet Bldg,Rm 620,720 20th St South, Birmingham, AL 35294 USA.
   [Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, India.
   [Thangaraj, Kumarasamy] Ctr DNA Fingerprinting & Diagnost, Hyderabad 500039, India.
C3 Manipal Academy of Higher Education (MAHE); University of Alabama
   System; University of Alabama Birmingham; Council of Scientific &
   Industrial Research (CSIR) - India; CSIR - Centre for Cellular &
   Molecular Biology (CCMB); Department of Biotechnology (DBT) India;
   Centre for DNA Fingerprinting & Diagnostics (CDFD)
RP Satyamoorthy, K (corresponding author), Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal 576104, India.
EM ksatyamoorthy@manipal.edu
RI chakrabarty, sanjiban/GXW-1652-2022; Satyamoorthy,
   Kapaettu/KIJ-2967-2024; Thangaraj, Kumarasamy/G-5596-2010; Kabekkodu,
   Shama/AAD-2947-2021
OI Chakrabarty, Sanjiban/0000-0002-6018-8098; Kabekkodu,
   Shama/0000-0002-4158-3893; Kuthethur, Raviprasad/0000-0003-0697-7835;
   Prasad, Keshava/0000-0001-7583-4075
CR Abad E, 2020, CANCER LETT, V474, P106, DOI 10.1016/j.canlet.2020.01.008
   Alston CL, 2020, AM J HUM GENET, V106, P92, DOI 10.1016/j.ajhg.2019.12.001
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Aranca TV, 2016, NEURODEGENER DIS MAN, V6, P49, DOI 10.2217/nmt.15.73
   Barcelos I, 2020, CURR OPIN PEDIATR, V32, P707, DOI 10.1097/MOP.0000000000000954
   Carden T, 2017, J BIOL CHEM, V292, P20694, DOI 10.1074/jbc.M117.797001
   Chou SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23661
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Fakouri NB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20586-9
   Falk MJ, 2021, J INHERIT METAB DIS, V44, P312, DOI 10.1002/jimd.12319
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Falk MJ, 2020, Mitochondrial Disease Genes Compendium: From Genes to Clinical Manifestations
   FANG W, 1994, MUSCLE NERVE, V17, P52, DOI 10.1002/mus.880170107
   Fanibunda SE, 2019, P NATL ACAD SCI USA, V116, P11028, DOI 10.1073/pnas.1821332116
   Farhan SMK, 2014, MOL GENET GENOM MED, V2, P73, DOI 10.1002/mgg3.46
   Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Ghosh A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9778
   Gurgel-Giannetti J, 2018, BRAIN, V141, P2289, DOI 10.1093/brain/awy172
   Holmes-Hampton GP, 2016, HUM MOL GENET, V25, P5178, DOI 10.1093/hmg/ddw338
   Jo Y, 2018, THERANOSTICS, V8, P5259, DOI 10.7150/thno.29098
   Kaufman DM, 2017, CELL DEATH DIFFER, V24, P1730, DOI 10.1038/cdd.2017.101
   Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   Legati A, 2017, J MED GENET, V54, P815, DOI 10.1136/jmedgenet-2017-104822
   Lim AZ, 2020, NEUROMUSCULAR DISORD, V30, P661, DOI 10.1016/j.nmd.2020.06.008
   Lim AZ, 2019, MITOCHONDRION, V47, P18, DOI 10.1016/j.mito.2019.04.007
   Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maniyadath B, 2019, CELL REP, V26, P2212, DOI 10.1016/j.celrep.2019.01.087
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   Maynard S, 2015, AGING-US, V7, P793, DOI 10.18632/aging.100810
   McCormack S, 2015, MITOCHONDRION, V22, P45, DOI 10.1016/j.mito.2015.02.005
   McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1
   Mishra A, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00489-17
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Patel J, 2020, CARCINOGENESIS, V41, P1625, DOI 10.1093/carcin/bgaa114
   Porporato PE, 2018, CELL RES, V28, P265, DOI 10.1038/cr.2017.155
   Rawat S, 2020, J CELL SCI, V133, DOI 10.1242/jcs.248492
   Rawat S, 2019, J MOL BIOL, V431, P996, DOI 10.1016/j.jmb.2019.01.022
   Shaw E, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00212-19
   Shen LS, 2016, HUM MUTAT, V37, P540, DOI 10.1002/humu.22974
   Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Vendramin R, 2017, EMBO J, V36, P1123, DOI 10.15252/embj.201695546
   Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014
   Wu YT, 2018, STEM CELL RES, V27, P10, DOI 10.1016/j.scr.2017.12.013
   Zhang Z, 2014, INT J BIOCHEM CELL B, V50, P106, DOI 10.1016/j.biocel.2014.02.012
   Zolkipli-Cunningham Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197513
NR 53
TC 0
Z9 0
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2021
VL 61
BP 62
EP 68
DI 10.1016/j.mito.2021.09.008
EA OCT 2021
PG 7
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA WC9QP
UT WOS:000704585100007
PM 34571249
DA 2024-11-01
ER

PT J
AU Payne, BAI
   Wilson, IJ
   Hateley, CA
   Horvath, R
   Santibanez-Koref, M
   Samuels, DC
   Price, DA
   Chinnery, PF
AF Payne, Brendan A. I.
   Wilson, Ian J.
   Hateley, Charlotte A.
   Horvath, Rita
   Santibanez-Koref, Mauro
   Samuels, David C.
   Price, D. Ashley
   Chinnery, Patrick F.
TI Mitochondrial aging is accelerated by anti-retroviral therapy through
   the clonal expansion of mtDNA mutations
SO NATURE GENETICS
LA English
DT Article
ID HIV-INFECTED PATIENTS; DNA MUTATIONS; POLYMERASE-GAMMA; POINT MUTATIONS;
   DELETIONS; CELLS; AGE; DISEASE; MUSCLE; ACCUMULATION
AB There is emerging evidence that people with successfully treated HIV infection age prematurely, leading to progressive multi-organ disease(1), but the reasons for this are not known. Here we show that patients treated with commonly used nucleoside analog anti-retroviral drugs progressively accumulate somatic mitochondrial DNA (mtDNA) mutations, mirroring those seen much later in life caused by normal aging(2,3). Ultra-deep re-sequencing by synthesis, combined with single-cell analyses, suggests that the increase in somatic mutation is not caused by increased mutagenesis but might instead be caused by accelerated mtDNA turnover. This leads to the clonal expansion of preexisting age-related somatic mtDNA mutations and a biochemical defect that can affect up to 10% of cells. These observations add weight to the role of somatic mtDNA mutations in the aging process and raise the specter of progressive iatrogenic mitochondrial genetic disease emerging over the next decade.
C1 [Payne, Brendan A. I.; Wilson, Ian J.; Hateley, Charlotte A.; Horvath, Rita; Santibanez-Koref, Mauro; Chinnery, Patrick F.] Newcastle Univ, Mitochondrial Res Grp, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Payne, Brendan A. I.; Price, D. Ashley] Royal Victoria Infirm, Dept Infect & Trop Med, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Samuels, David C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA.
C3 Newcastle University - UK; Newcastle University - UK; Vanderbilt
   University
RP Chinnery, PF (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
RI Horvath, Rita/AAY-7042-2020; Payne, Brendan/I-1233-2016; Samuels,
   David/A-5393-2008
OI Price, David/0000-0002-0562-7326; Wilson, Ian/0000-0001-6893-2873;
   Payne, Brendan/0000-0002-3101-3512; Samuels, David/0000-0003-3529-7791;
   Chinnery, Patrick/0000-0002-7065-6617; Horvath, Rita/0000-0002-9841-170X
FU Medical Research Council; British Infection Society; Newcastle
   Healthcare Charity; UK National Institute for Health Research (NIHR)
   Biomedical Research Centre for Aging and Age-related disease; Wellcome
   Trust; MRC [G0800470, G1000848] Funding Source: UKRI
FX This work was support by grants from the Medical Research Council (B. A.
   I. P.), British Infection Society (B. A. I. P.), the Newcastle
   Healthcare Charity (D. A. P.), the UK National Institute for Health
   Research (NIHR) Biomedical Research Centre for Aging and Age-related
   disease award to the Newcastle upon Tyne Foundation Hospitals National
   Health Service (NHS) Trust (P. F. C.) and the Wellcome Trust (P. F. C.).
   The authors thank G. L. Toms for the use of his containment level 3
   facility, E. L. C. Ong, M. L. Schmid, U. Schwab and R. Pattman for
   access to their clinic cohorts, J. Coxhead (NewGene, Newcastle upon
   Tyne, UK) for assistance with Roche 454 FLX and D. Deehan for assistance
   with obtaining control muscle samples.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   [Anonymous], 2006, ANT THER HIV INF AD
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cherry CL, 2006, JAIDS-J ACQ IMM DEF, V42, P435, DOI 10.1097/01.qai.0000224974.67962.ce
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   Guaraldi G, 2009, CLIN INFECT DIS, V49, P1756, DOI 10.1086/648080
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Maagaard A, 2006, ANTIVIR THER, V11, P601
   McComsey GA, 2005, AIDS, V19, P15, DOI 10.1097/00002030-200501030-00002
   Oursler KK, 2006, AIDS RES HUM RETROV, V22, P1113, DOI 10.1089/aid.2006.22.1113
   Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013
   Quinlan AR, 2008, NAT METHODS, V5, P179, DOI [10.1038/nmeth.1172, 10.1038/NMETH.1172]
   Shieh DB, 2007, CHEM-BIOL INTERACT, V165, P211, DOI 10.1016/j.cbi.2006.12.008
   Smyth K, 2007, HIV MED, V8, P367, DOI 10.1111/j.1468-1293.2007.00478.x
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
NR 35
TC 178
Z9 189
U1 0
U2 22
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1061-4036
J9 NAT GENET
JI Nature Genet.
PD AUG
PY 2011
VL 43
IS 8
BP 806
EP U121
DI 10.1038/ng.863
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 798CD
UT WOS:000293178300019
PM 21706004
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Mohamed, SA
   Hanke, T
   Erasmi, AW
   Bechtel, MJF
   Scharfschwerdt, M
   Meissner, C
   Sievers, HH
   Gosslau, A
AF Mohamed, SA
   Hanke, T
   Erasmi, AW
   Bechtel, MJF
   Scharfschwerdt, M
   Meissner, C
   Sievers, HH
   Gosslau, A
TI Mitochondrial DNA deletions and the aging heart
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE mitochondrial DNA; 4.977 bp deletion; oxidative stress; apotosis; aging
ID OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; VITAMIN-E; SKELETAL-MUSCLE;
   POLYMERASE-GAMMA; FREE-RADICALS; HUMAN TISSUES; COPY NUMBER; CELL-DEATH;
   APOPTOSIS
AB Mitochondrial DNA (mtDNA) mutations appear to be associated with a wide spectrum of human disorders and proposed to be a potential contributor of aging. However, in an age-dependent increase of the common 4977 bp deletion of human mtDNA still many unanswered questions remain. Comparing mtDNA copy levels in different tissues revealed that cardiac muscle had the highest, while the cortex cerebelli showed the lowest copy number of mtDNA in every donor. Intriguingly, mtDNA copy number showed no changes during aging, In heart tissue, the amount of 4977 bp mtDNA deletion increased in an age-dependent manner showing significant differences at the age of 40 years and older (p < 0.005). In vitro studies analyzing human normal cells transfected with telomerase (BJ-T) revealed that oxidative stress (OS)-a well accepted promoter of aging-induced 4977 bp deletion and point mutations as demonstrated by real-time PCR and DHPLC analysis. Interestingly, OS induced apoptosis only in transformed human fibroblasts by activation of the intrinsic (mitochondrial-mediated) signalling pathway as indicated by morphological damage of mitochondria, DNA laddering and increase of the Bax/Bcl-2 ratio. In conclusion, in heart tissue, the amount of the 4977 bp deletion increased in an age-dependent manner and it was more detectable after the 4th decade of life, although there was some scatter in the data. Since, apoptosis was induced by the mitochondria-mediated pathway only in transformed cells, the role for apoptosis in normal tissue of the aging heart remains unclear. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Schleswig Holstrein, Dept Cardiac Surg, D-23538 Lubeck, Germany.
   Univ Schleswig Holstrein, Dept Forens Med, D-23538 Lubeck, Germany.
   Rutgers State Univ, Dept Chem & Biol Chem, Piscataway, NJ USA.
C3 University of Kiel; Schleswig Holstein University Hospital; University
   of Kiel; Schleswig Holstein University Hospital; Rutgers University
   System; Rutgers University New Brunswick
RP Mohamed, SA (corresponding author), Univ Schleswig Holstrein, Dept Cardiac Surg, Campus Luebeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany.
EM s.mohamed@herzchirurgie-luebeck.de
RI Mohamed, Salah/O-2955-2018; Scharfschwerdt, Michael/B-1850-2016
OI Bechtel, Matthias/0000-0002-1393-1889; Scharfschwerdt,
   Michael/0000-0002-9331-6703
CR Arai T, 2003, AGING CLIN EXP RES, V15, P1
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Bågenholm R, 1998, PEDIATR RES, V43, P271, DOI 10.1203/00006450-199802000-00019
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Bayat A, 2005, INT J IMMUNOGENET, V32, P199, DOI 10.1111/j.1744-313X.2005.00508.x
   BECKMAN KB, 1998, ANN NY ACAD SCI, V20, P118
   BERG K, 1990, APMIS, V98, P156, DOI 10.1111/j.1699-0463.1990.tb01016.x
   Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345
   Bernecker Oliver Y, 2003, Cardiovasc Toxicol, V3, P183, DOI 10.1385/CT:3:3:183
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   Cottrell DA, 2000, ANN NY ACAD SCI, V908, P199
   Davies K J., 1995, Oxidative stress: the paradox of aerobic lifeBiochemical Society Symposia, P1
   Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Gosslau A, 2005, BRIT J CANCER, V92, P513, DOI 10.1038/sj.bjc.6602300
   Gosslau A, 2004, NUTRITION, V20, P95, DOI 10.1016/j.nut.2003.09.017
   Goyns MH, 2002, MECH AGEING DEV, V123, P791, DOI 10.1016/S0047-6374(01)00424-9
   Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710
   Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529
   JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990
   KATSUMATA K, 1994, BIOCHEM BIOPH RES CO, V202, P102, DOI 10.1006/bbrc.1994.1899
   Kim UK, 2000, BASIC RES CARDIOL, V95, P163, DOI 10.1007/s003950050178
   Kumar D, 2003, J LAB CLIN MED, V142, P288, DOI 10.1016/S0022-2143(03)00148-3
   Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7
   Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1159/000025424
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   LEWIS W, 1992, J CLIN INVEST, V89, P1354, DOI 10.1172/JCI115722
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Marín-García J, 2002, J CARD FAIL, V8, P347, DOI 10.1054/jcaf.2002.127774
   MarinGarcia J, 1996, CARDIOVASC RES, V31, P306
   Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Meydani M, 2004, ANN NY ACAD SCI, V1031, P271, DOI 10.1196/annals.1331.027
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Mohamed SA, 2004, EXP GERONTOL, V39, P181, DOI 10.1016/j.exger.2003.10.011
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   MUELLERHOECKER J, 1994, VERH DTSCH GES PATHO, V78, P48
   Munteanu A, 2004, J CELL MOL MED, V8, P59, DOI 10.1111/j.1582-4934.2004.tb00260.x
   Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200
   Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427
   Papiha SS, 1998, J CLIN PATHOL, V51, P117, DOI 10.1136/jcp.51.2.117
   Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726
   Sastre J, 2000, FREE RADICAL RES, V32, P189, DOI 10.1080/10715760000300201
   Sharma P, 1998, GERONTOLOGY, V44, P78, DOI 10.1159/000021988
   SHAY JW, 1990, J BIOL CHEM, V265, P14802
   SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   TOMKINSON AE, 1990, NUCLEIC ACIDS RES, V18, P929, DOI 10.1093/nar/18.4.929
   van Gurp M, 2003, BIOCHEM BIOPH RES CO, V304, P487, DOI 10.1016/S0006-291X(03)00621-1
   Violi F, 2004, ANN NY ACAD SCI, V1031, P292, DOI 10.1196/annals.1331.029
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
   WEISFELDT M, 1992, AGING HEART HEART DI
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302
   Zhang CF, 1999, BIOCHEM BIOPH RES CO, V254, P152, DOI 10.1006/bbrc.1998.9914
NR 68
TC 56
Z9 70
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAY
PY 2006
VL 41
IS 5
BP 508
EP 517
DI 10.1016/j.exger.2006.03.014
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 054UQ
UT WOS:000238404500010
PM 16632292
DA 2024-11-01
ER

PT J
AU Bannwarth, S
   Procaccio, V
   Paquis-Flucklinger, V
AF Bannwarth, S
   Procaccio, V
   Paquis-Flucklinger, V
TI Surveyor™ nuclease:: A new strategy for a rapid identification of
   heteroplasmic mitochondrial DNA mutations in patients with respiratory
   chain defects
SO HUMAN MUTATION
LA English
DT Article
DE mtDNA; surveyor endonuclease; heteroplasmic mutation; molecular
   screening; respiratory chain defects
ID DIABETES SECONDARY; GENOME; DISORDERS; DELETIONS; SEQUENCE;
   CARDIOMYOPATHY; VARIANT; MUSCLE; REGION; ASSAY
AB Molecular analysis of mitochondrial DNA (mtDNA) is a critical step in diagnosis and genetic counseling of respiratory chain defects. No fast method is currently available for the identification of unknown mtDNA point mutations. We have developed a new strategy based on complete mtDNA PCR amplification followed by digestion with a mismatch-specific DNA endonuclease, Surveyor" Nuclease. This enzyme, a member of the CEL nuclease family of plant DNA endonucleases, cleaves double-strand DNA at any mismatch site including base substitutions and small insertions/deletions. After digestion, cleavage products are separated and analyzed by agarose gel electrophoresis. The size of the digestion products indicates the location of the mutation, which is then confirmed and characterized by sequencing. Although this method allows the analysis of 2 kb mtDNA amplicons and the detection of multiple mutations within the same fragment, it does not lead to the identification of homoplasmic base substitutions. Homoplasmic pathogenic mutations have been described. Nevertheless, most homoplasmic base substitutions are neutral polymorphisms while deleterious mutations are typically heteroplasmic. Here, we report that this method can be used to detect mtDNA mutations such as m.3243A > G tRNA(Leu) and m.14709T > C tRNA(Glu) even when they are present at levels as low as 3% in DNA samples derived from patients with respiratory chain defects. Then, we tested five patients suffering from a mitochondrial respiratory chain defect and we identified a variant (m16189T > C) in two of them, which was previously associated with susceptibility to diabetes and cardiomyopathy. In conclusion, this method can be effectively used to rapidly and completely screen the entire human mitochondrial genome for heteroplasmic mutations and in this context represents an important advance for the diagnosis of mitochondrial diseases. (c) 2005 Wiley-Liss, Inc.
C1 CHU Nice, Hop Archet 2, Dept Med Genet, F-06202 Nice, France.
   Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA USA.
   Univ Nice, Sch Med, CNRS, FRE,UNSA 2720, Sophia Antipolis, France.
C3 CHU Nice; University of California System; University of California
   Irvine; Centre National de la Recherche Scientifique (CNRS); Universite
   Cote d'Azur
RP CHU Nice, Hop Archet 2, Dept Med Genet, 151,Route St Antoine Ginestiere,BP 3079, F-06202 Nice, France.
EM paquis@unice.fr
RI Procaccio, Vincent/M-2596-2015
OI procaccio, Vincent/0000-0002-1537-4684
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Barros F, 1997, ELECTROPHORESIS, V18, P52, DOI 10.1002/elps.1150180110
   Biggin A, 2005, MOL GENET METAB, V84, P61, DOI 10.1016/j.ymgme.2004.09.011
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   den Dunnen JT, 2003, HUM MUTAT, V22, P181, DOI 10.1002/humu.10262
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Hao HL, 1997, AM J HUM GENET, V60, P1363, DOI 10.1086/515474
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6
   Kulinski J, 2000, BIOTECHNIQUES, V29, P44, DOI 10.2144/00291bm07
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Narbonne H, 2001, EUR J ENDOCRINOL, V145, P541, DOI 10.1530/eje.0.1450541
   Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597
   Paul R, 1996, TRENDS GENET, V12, P131
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01
   ROTIG A, 1989, LANCET, V1, P902
   Scaffino M.F., 2004, TRANSGENICS, V4, P157
   Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e89
   VIALETTES B, 1995, DIABETES CARE, V18, P1023, DOI 10.2337/diacare.18.7.1023
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 35
TC 59
Z9 62
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD JUN
PY 2005
VL 25
IS 6
BP 575
EP 582
DI 10.1002/humu.20177
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 930ZX
UT WOS:000229456700009
PM 15880407
OA gold
DA 2024-11-01
ER

PT J
AU Liu, L
   Yang, JH
   Otani, Y
   Shiga, T
   Yamaguchi, A
   Oda, Y
   Hattori, M
   Goto, T
   Ishibashi, S
   Kawashima-Sonoyama, Y
   Ishihara, T
   Matsuzaki, Y
   Akamatsu, W
   Fujitani, M
   Taketani, T
AF Liu, Lu
   Yang, Jiahao
   Otani, Yoshinori
   Shiga, Takahiro
   Yamaguchi, Akihiro
   Oda, Yasuaki
   Hattori, Miho
   Goto, Tsukimi
   Ishibashi, Shuichi
   Kawashima-Sonoyama, Yuki
   Ishihara, Takaya
   Matsuzaki, Yumi
   Akamatsu, Wado
   Fujitani, Masashi
   Taketani, Takeshi
TI MELAS-Derived Neurons Functionally Improve by Mitochondrial Transfer
   from Highly Purified Mesenchymal Stem Cells (REC)
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE MELAS; rapidly expanding clones (RECs); mesenchymal stem cells (MSCs);
   mitochondrial transfer
ID LACTIC-ACIDOSIS; TUNNELING NANOTUBES; DNA; ENCEPHALOPATHY; MUTATION;
   DIFFERENTIATION; BIOMARKER; MYOPATHY; THERAPY; STRESS
AB Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episode (MELAS) syndrome, caused by a single base substitution in mitochondrial DNA (m.3243A>G), is one of the most common maternally inherited mitochondrial diseases accompanied by neuronal damage due to defects in the oxidative phosphorylation system. There is no established treatment. Our previous study reported a superior restoration of mitochondrial function and bioenergetics in mitochondria-deficient cells using highly purified mesenchymal stem cells (RECs). However, whether such exogenous mitochondrial donation occurs in mitochondrial disease models and whether it plays a role in the recovery of pathological neuronal functions is unknown. Here, utilizing induced pluripotent stem cells (iPSC), we differentiated neurons with impaired mitochondrial function from patients with MELAS. MELAS neurons and RECs/mesenchymal stem cells (MSCs) were cultured under contact or non-contact conditions. Both RECs and MSCs can donate mitochondria to MELAS neurons, but RECs are more excellent than MSCs for mitochondrial transfer in both systems. In addition, REC-mediated mitochondrial transfer significantly restored mitochondrial function, including mitochondrial membrane potential, ATP/ROS production, intracellular calcium storage, and oxygen consumption rate. Moreover, mitochondrial function was maintained for at least three weeks. Thus, REC-donated exogenous mitochondria might offer a potential therapeutic strategy for treating neurological dysfunction in MELAS.
C1 [Liu, Lu; Yang, Jiahao; Oda, Yasuaki; Hattori, Miho; Goto, Tsukimi; Kawashima-Sonoyama, Yuki; Taketani, Takeshi] Shimane Univ, Fac Med, Dept Pediat, 89-1 Enya Cho, Izumo 6938501, Japan.
   [Otani, Yoshinori; Fujitani, Masashi] Shimane Univ, Fac Med, Dept Anat & Neurosci, 89-1 Enya Cho, Izumo 6938501, Japan.
   [Shiga, Takahiro; Yamaguchi, Akihiro; Akamatsu, Wado] Juntendo Univ, Ctr Genom & Regenerat Med, Sch Med, Tokyo 1138421, Japan.
   [Goto, Tsukimi] Shimane Univ Hosp, Clin Lab Div, 89 1 Enya Cho, Izumo 6938501, Japan.
   [Ishibashi, Shuichi] Shimane Univ, Fac Med, Dept Digest & Gen Surg, 89-1 Enya Cho, Izumo 6938501, Japan.
   [Ishihara, Takaya; Matsuzaki, Yumi] Shimane Univ, Fac Med, Dept Life Sci, 89-1 Enya Cho, Izumo, 6938501, Japan.
C3 Shimane University; Shimane University; Juntendo University; Shimane
   University; Shimane University; Shimane University
RP Taketani, T (corresponding author), Shimane Univ, Fac Med, Dept Pediat, 89-1 Enya Cho, Izumo 6938501, Japan.
EM m209432@med.shimane-u.ac.jp; jiahao@med.shimane-u.ac.jp;
   yotani@med.shimane-u.ac.jp; t-shiga@juntendo.ac.jp;
   a.yamaguchi.fm@juntendo.ac.jp; y-oda@med.shimane-u.ac.jp;
   mhatt001@med.shimane-u.ac.jp; t.goto@med.shimane-u.ac.jp;
   shuichi466@gmail.com; yuki.kawashima@med.shimane-u.ac.jp;
   ishitky@med.shimane-u.ac.jp; ymatsuzak@gmail.com; awado@juntendo.ac.jp;
   fujitani@med.shimane-u.ac.jp; ttaketani@med.shimane-u.ac.jp
RI Akamatsu, Wado/L-1214-2013; Fujitani, Masashi/AAD-8874-2022;
   Kawashima-Sonoyama, Yuki/ABC-7061-2021
OI Kawashima-Sonoyama, Yuki/0000-0002-2338-8293; Ishihara,
   Takaya/0000-0001-7839-7691; ODA, Yasuaki/0009-0003-4452-9248; OTANI,
   YOSHINORI/0000-0002-3214-4637; Yang, Jiahao/0000-0001-5878-4563;
   Taketani, Takeshi/0000-0002-3257-1305; Fujitani,
   Masashi/0000-0002-1731-9793
FU JSPS Grants-in-Aid for Scientific Research (KAKENHI); Shimane
   University, Japan; Otsuka Toshimi Scholarship Foundation
FX We would like to acknowledge the technical expertise of the
   Interdisciplinary Center for Science Research, Head Office for Research
   and Academic Information, Shimane University, Japan. The authors would
   like to thank the Otsuka Toshimi Scholarship Foundation.
CR Abounit S, 2012, J CELL SCI, V125, P1089, DOI 10.1242/jcs.083279
   Austefjord Magnus Wiger, 2014, Commun Integr Biol, V7, pe27934, DOI 10.4161/cib.27934
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bertero E, 2018, CIRC RES, V122, P1460, DOI 10.1161/CIRCRESAHA.118.310082
   Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   Fujimori K, 2017, STEM CELL REP, V9, P1675, DOI 10.1016/j.stemcr.2017.09.024
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Gunnewiek TMK, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107538
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557
   Ljubojevic N, 2021, TRENDS CELL BIOL, V31, P130, DOI 10.1016/j.tcb.2020.11.008
   Mabuchi Y, 2013, STEM CELL REP, V1, P152, DOI 10.1016/j.stemcr.2013.06.001
   Madreiter-Sokolowski CT, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101678
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Paliwal S, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0429-1
   Pei LM, 2018, BIOL PSYCHIAT, V83, P722, DOI 10.1016/j.biopsych.2017.11.018
   PESKIN AV, 1986, FEBS LETT, V194, P317, DOI 10.1016/0014-5793(86)80109-0
   Prigione Alessandro, 2015, Methods Mol Biol, V1265, P349, DOI 10.1007/978-1-4939-2288-8_24
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Taketani T, 2015, CELL TRANSPLANT, V24, P1931, DOI 10.3727/096368914X685410
   Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987
   Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019
   Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001
   Yan CJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040379
   Yang JH, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms241210294
   Yang JH, 2023, STEM CELL RES THER, V14, DOI 10.1186/s13287-023-03274-y
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Zhang YL, 2016, STEM CELL REP, V7, P749, DOI 10.1016/j.stemcr.2016.08.009
   Zhou T, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01037-x
   Zhou XY, 2023, J EXTRACELL VESICLES, V12, DOI 10.1002/jev2.12320
NR 46
TC 1
Z9 1
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC
PY 2023
VL 24
IS 24
AR 17186
DI 10.3390/ijms242417186
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA DN3N2
UT WOS:001132686500001
PM 38139018
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Marín-García, J
AF Marin-Garcia, Jose
TI Thyroid hormone and myocardial mitochondrial biogenesis
SO VASCULAR PHARMACOLOGY
LA English
DT Review
DE Mitochondria; Thyroid hormone; Biogenesis; Myocardial hypertrophy;
   Signaling pathways
ID TRANSCRIPTION TERMINATION FACTOR; ACTIVATED RECEPTOR-ALPHA; HUMAN
   SKELETAL-MUSCLE; MESSENGER-RNA; GENE-EXPRESSION; CARDIAC-HYPERTROPHY;
   PROTEIN-COMPOSITION; HEART-MITOCHONDRIA; SEQUENCE-ANALYSIS;
   DNA-POLYMERASE
AB Mitochondria have been central in the development of some of the most important ideas in modern biology. Since the discovery that mitochondria have its own DNA and specific mutations and deletions were found in association with neuromuscular and heart diseases, as well as in aging, an extraordinary number of publications have followed, and the term mitochondrial medicine was coined. Recently, it has been found that thyroid hormone (TH) stimulates cardiac mitochondrial biogenesis increasing myocardial mitochondrial mass, mitochondrial respiration, oxidative phosphorylation (OXPHOS), enzyme activities, mitochondrial protein synthesis (by stimulation in a T3-dependent manner), cytochrome, phospholipid and mtDNA content. Also, TH therapy may modulate cardiac mitochondrial protein-import apparatus. To identify the sequence of events, molecules and signaling pathways that is activated by TH affecting mitochondrial structure, biogenesis and function further research is warranted. (C) 2009 Elsevier Inc. All rights reserved.
C1 Mol Cardiol & Neuromuscular Inst, Highland Pk, NJ 08904 USA.
RP Marín-García, J (corresponding author), Mol Cardiol & Neuromuscular Inst, 75 Raritan Ave, Highland Pk, NJ 08904 USA.
EM tmci@att.net
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE748, DOI 10.1152/ajpendo.00311.2006
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ANNEX BH, 1990, MOL CELL BIOL, V10, P5671, DOI 10.1128/MCB.10.11.5671
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Barbe P, 2001, FASEB J, V15, P13
   Barger PM, 2000, J CLIN INVEST, V105, P1723, DOI 10.1172/JCI9056
   Bigard Andre-Xavier, 2008, Journal de la Societe de Biologie, V202, P93, DOI 10.1051/jbio:2008011
   Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   Cahill A, 2000, ELECTROPHORESIS, V21, P3420, DOI 10.1002/1522-2683(20001001)21:16<3420::AID-ELPS3420>3.0.CO;2-Q
   Cai Y, 1996, ARCH BIOCHEM BIOPHYS, V325, P107, DOI 10.1006/abbi.1996.0013
   Casas F, 1999, MOL CELL BIOL, V19, P7913
   CASSARMALEK I, 1994, ONCOGENE, V9, P2197
   CASTORA FJ, 1985, BIOCHEM BIOPH RES CO, V130, P854, DOI 10.1016/0006-291X(85)90495-4
   Chow LS, 2007, J APPL PHYSIOL, V102, P1078, DOI 10.1152/japplphysiol.00791.2006
   Civitarese AE, 2007, CURR OPIN CLIN NUTR, V10, P679, DOI 10.1097/MCO.0b013e3282f0ecd2
   CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7
   Craig EE, 1998, AM J PHYSIOL-CELL PH, V275, pC1508, DOI 10.1152/ajpcell.1998.275.6.C1508
   DAGA A, 1993, J BIOL CHEM, V268, P8123
   DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W
   Enríquez JA, 1999, MOL CELL BIOL, V19, P657
   Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x
   Enríquez JA, 1999, BIOL CHEM, V380, P737, DOI 10.1515/BC.1999.094
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066
   FISHER RP, 1992, J BIOL CHEM, V267, P3358
   GAINES G, 1987, J BIOL CHEM, V262, P1907
   Gao J, 2001, GENOMICS, V74, P109, DOI 10.1006/geno.2001.6536
   GELFAND R, 1981, MOL CELL BIOL, V1, P497, DOI 10.1128/MCB.1.6.497
   Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C
   Goldenthal MJ, 2004, MOL CELL BIOCHEM, V265, P97, DOI 10.1023/B:MCBI.0000044321.17680.a2
   GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Hernández JM, 1999, GENE, V239, P283, DOI 10.1016/S0378-1119(99)00409-6
   Hertz R, 1996, BIOCHEM J, V319, P241, DOI 10.1042/bj3190241
   HILLAR M, 1979, ARCH INT PHYSIOL BIO, V87, P29
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kanki T, 2004, ANN NY ACAD SCI, V1011, P61, DOI 10.1196/annals.1293.007
   Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622
   KING MP, 1993, J BIOL CHEM, V268, P10228
   Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508
   Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lebuffe G, 2003, AM J PHYSIOL-HEART C, V284, pH299, DOI 10.1152/ajpheart.00706.2002
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Li B, 1999, J BIOL CHEM, V274, P17534, DOI 10.1074/jbc.274.25.17534
   MA JH, 1995, BBA-GENE STRUCT EXPR, V1261, P321, DOI 10.1016/0167-4781(95)00041-E
   MADSEN CS, 1993, MOL CELL BIOL, V13, P2162, DOI 10.1128/MCB.13.4.2162
   Marín-García J, 2002, J CARD FAIL, V8, P347, DOI 10.1054/jcaf.2002.127774
   Martí R, 2003, CLIN CHEM LAB MED, V41, P845, DOI 10.1515/CCLM.2003.128
   MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788
   Meisinger C, 1999, CELL MOL LIFE SCI, V56, P817, DOI 10.1007/s000180050028
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580
   NELSON BD, 1995, BBA-MOL BASIS DIS, V1271, P85, DOI 10.1016/0925-4439(95)00014-U
   O'Brien TW, 2002, GENE, V286, P73, DOI 10.1016/S0378-1119(01)00808-3
   Pantos C, 2006, HORM METAB RES, V38, P308, DOI 10.1055/s-2006-925404
   Pantos C, 2008, PHARMACOL THERAPEUT, V118, P277, DOI 10.1016/j.pharmthera.2008.02.011
   PARADIES G, 1994, BBA-MOL BASIS DIS, V1225, P165, DOI 10.1016/0925-4439(94)90074-4
   Portman MA, 2002, CLIN EXP PHARMACOL P, V29, P334, DOI 10.1046/j.1440-1681.2002.03654.x
   Prieto-Martín A, 2004, NUCLEIC ACIDS RES, V32, P2059, DOI 10.1093/nar/gkh528
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846
   Scheller K, 2000, EUR J CELL BIOL, V79, P299, DOI 10.1078/S0171-9335(04)70033-3
   SCHIEBER GL, 1985, J BIOL CHEM, V260, P6367
   Schleiff E, 1999, ARCH BIOCHEM BIOPHYS, V367, P95, DOI 10.1006/abbi.1999.1240
   Schönfeld P, 2000, FEBS LETT, V471, P108, DOI 10.1016/S0014-5793(00)01376-4
   Schultz RA, 1998, J BIOL CHEM, V273, P3447, DOI 10.1074/jbc.273.6.3447
   SEIDEN D, 1988, J MOL CELL CARDIOL, V20, P917, DOI 10.1016/S0022-2828(88)80146-9
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spirina O, 2000, GENE, V261, P229, DOI 10.1016/S0378-1119(00)00504-7
   SUZUKI H, 1995, BIOCHEM BIOPH RES CO, V213, P204, DOI 10.1006/bbrc.1995.2117
   Sylvester JE, 2004, GENET MED, V6, P73, DOI 10.1097/01.GIM.0000117333.21213.17
   TANAKA T, 1985, BASIC RES CARDIOL, V80, P165, DOI 10.1007/BF01910464
   Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499
   WIESNER RJ, 1994, AM J PHYSIOL, V267, pC229, DOI 10.1152/ajpcell.1994.267.1.C229
   WIESNER RJ, 1992, MOL ENDOCRINOL, V6, P1458, DOI 10.1210/me.6.9.1458
   WONG TW, 1985, J BIOL CHEM, V260, P1530
   Woriax VL, 1995, BBA-GENE STRUCT EXPR, V1264, P347, DOI 10.1016/0167-4781(95)00176-X
   WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347
   Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067
   Wrutniak-Cabello Chantal, 2008, Journal de la Societe de Biologie, V202, P83, DOI 10.1051/jbio:2008010
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   XIN H, 1995, J BIOL CHEM, V270, P17243, DOI 10.1074/jbc.270.29.17243
   Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x
   Young ME, 2001, FASEB J, V15, P833, DOI 10.1096/fj.00-0351com
   ZAK R, 1980, BASIC RES CARDIOL, V75, P171, DOI 10.1007/BF02001410
   Zhang CY, 2000, EUR J NEUROSCI, V12, P1013, DOI 10.1046/j.1460-9568.2000.00997.x
NR 97
TC 37
Z9 40
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1537-1891
EI 1879-3649
J9 VASC PHARMACOL
JI Vasc. Pharmacol.
PD MAR-APR
PY 2010
VL 52
IS 3-4
SI SI
BP 120
EP 130
DI 10.1016/j.vph.2009.10.008
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 566TI
UT WOS:000275395700004
PM 19857604
DA 2024-11-01
ER

PT J
AU Musumeci, O
   Barca, E
   Lamperti, C
   Servidei, S
   Comi, GP
   Moggio, M
   Mongini, T
   Siciliano, G
   Filosto, M
   Pegoraro, E
   Primiano, G
   Ronchi, D
   Vercelli, L
   Orsucci, D
   Bello, L
   Zeviani, M
   Mancuso, M
   Toscano, A
AF Musumeci, Olimpia
   Barca, Emanuele
   Lamperti, Costanza
   Servidei, Serenella
   Comi, Giacomo Pietro
   Moggio, Maurizio
   Mongini, Tiziana
   Siciliano, Gabriele
   Filosto, Massimiliano
   Pegoraro, Elena
   Primiano, Guido
   Ronchi, Dario
   Vercelli, Liliana
   Orsucci, Daniele
   Bello, Luca
   Zeviani, Massimo
   Mancuso, Michelangelo
   Toscano, Antonio
TI Lipomatosis Incidence and Characteristics in an Italian Cohort of
   Mitochondrial Patients
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE multiple symmetrical lipomatosis; MERRF; mitochondrial myopathy;
   madelung's disease; brown fat
ID MULTIPLE SYMMETRIC LIPOMATOSIS; DYSFUNCTION; NEUROPATHY; MUTATION
AB Lipomas have often been associated with mtDNA mutations and were mainly observed in patients with mutation in mitochondrial tRNAlysine which is also the most frequent mutation associated with MERRF. Up to date, no systematic studies have been developed in order to assess the incidence of lipomas in large cohorts of mitochondrial patients.The aim of this study is to analyze the incidence and characteristics of lipomas among an Italian cohort of patients with mitochondrial diseases. A retrospective, database-based study (Nation-wide Italian Collaborative Network of Mitochondrial Diseases) of patients with lipomas was performed. A total of 22 (1.7%) patients with lipomas have been identified among the 1,300 mitochondrial patients, enrolled in the Italian database. In about 18% multiple systemic lipomatosis (MSL) was the only clinical manifestation; 54% of patients showed a classical MERRF syndrome. Myopathy, alone or in association with other symptoms, was found in 27% of patients. Lactate was elevated in all the 12 patients in which was measured. Muscle biopsy was available in 18/22 patients: in all of them mitochondrial abnormalities were present. Eighty six percent had mutations in mtDNA coding for tRNA lysine. In most of patients, lipomas were localized along the cervical-cranial-thoracic region. In 68% of the patients were distributed symmetrically. Only two patients had lipomas in a single anatomical site (1 in right arm and 1 in gluteus maximum). MSL is often overlooked by clinicians in patients with mitochondrial diseases where the clinical picture could be dominated by a severe multi-systemic involvement. Our data confirmed that MSL is a rare sign of mitochondrial disease with a strong association between multiple lipomas and lysine tRNA mutations. MSL could be considered, even if rare, a red flag for mitochondrial disorders, even in patients with an apparently isolated MSL.
C1 [Musumeci, Olimpia; Toscano, Antonio] Univ Messina, Dept Clin & Expt Med, UOC Neurol & Malattie Neuromuscolari, Messina, Italy.
   [Barca, Emanuele] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA.
   [Lamperti, Costanza] Fdn Carlo Besta Inst Neurol IRCCS, UO Med Genet & Neurogenet, Milan, Italy.
   [Servidei, Serenella; Primiano, Guido] Fdn Policlin Univ A Gemelli IRCCS, UOC Neurofisiopatol, Ist Neurol Univ Cattolica Sacro Cuore, Rome, Italy.
   [Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat,Neurosci Sect,Ne, Milan, Italy.
   [Moggio, Maurizio] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Mongini, Tiziana; Vercelli, Liliana] Univ Torino, Dept Neurosci Rita Levi Montalcini, Turin, Italy.
   [Siciliano, Gabriele; Orsucci, Daniele; Mancuso, Michelangelo] Univ Pisa, Neurol Inst, Dept Clin & Expt Med, Pisa, Italy.
   [Filosto, Massimiliano] ASST Spedali Civili, Unit Neurol, Ctr Neuromuscular Dis, Brescia, Italy.
   [Filosto, Massimiliano] Univ Brescia, Brescia, Italy.
   [Pegoraro, Elena; Bello, Luca] Univ Padua, Dept Neurosci, Padua, Italy.
   [Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 University of Messina; Columbia University; Fondazione IRCCS Istituto
   Neurologico Carlo Besta; Catholic University of the Sacred Heart; IRCCS
   Policlinico Gemelli; University of Milan; IRCCS Ca Granda Ospedale
   Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico;
   University of Turin; University of Pisa; Hospital Spedali Civili
   Brescia; University of Brescia; University of Padua
RP Musumeci, O (corresponding author), Univ Messina, Dept Clin & Expt Med, UOC Neurol & Malattie Neuromuscolari, Messina, Italy.
EM omusumeci@unime.it
RI Orsucci, Daniele/AAA-7576-2019; Servidei, Serenella/ABC-4262-2021;
   Toscano, Antonio/AHE-4657-2022; Musumeci, Olimpia/AHE-3041-2022; Comi,
   Giacomo/K-5702-2016; Ronchi, Dario/K-8011-2016; Mancuso,
   Michelangelo/K-4170-2016; Primiano, Guido/AAB-7829-2019; lamperti,
   costanza/J-8801-2016; Bello, Luca/B-6397-2012; Zeviani,
   Massimo/AAU-2632-2021; Filosto, Massimiliano/S-9446-2019
OI SERVIDEI, Serenella/0000-0001-8478-2799; Primiano,
   Guido/0000-0001-7616-7008; Orsucci, Daniele/0000-0003-4847-7812; Bello,
   Luca/0000-0002-3075-6525; Zeviani, Massimo/0000-0002-9067-5508; Ronchi,
   Dario/0000-0002-6093-9816; Filosto, Massimiliano/0000-0002-2852-7512;
   BARCA, EMANUELE/0009-0007-6672-6524
FU Telethon Grant [GUP09004]; Telethon MITOCON Grant [GSP16001]; MRC
   [MC_UU_00015/5, MC_UP_1002/1, MC_EX_MR/P007031/1] Funding Source: UKRI
FX This study was supported by Telethon Grant GUP09004 and Telethon MITOCON
   Grant GSP16001.
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   BERKOVIC SF, 1991, ANN NEUROL, V29, P566, DOI 10.1002/ana.410290519
   Brodie BC, 1846, Lectures illustrative of various subjects in pathology and surgery. M, P275
   Carrière A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885
   Chong P Siao Tick, 2003, J Clin Neuromuscul Dis, V5, P1, DOI 10.1097/00131402-200309000-00001
   Coin A, 2000, J Clin Neuromuscul Dis, V1, P124, DOI 10.1097/00131402-200003000-00002
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Enzi G, 2002, INT J OBESITY, V26, P253, DOI 10.1038/sj.ijo.0801867
   ENZI G, 1985, MEDICINE, V64, P388, DOI 10.1097/00005792-198511000-00003
   Gámez J, 1998, NEUROLOGY, V51, P258, DOI 10.1212/WNL.51.1.258
   Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007
   KLOPSTOCK T, 1994, NEUROLOGY, V44, P862, DOI 10.1212/WNL.44.5.862
   Launois P.E., 1898, B SOC M D H P PARIS, V1, P298
   Madelung OW., 1888, Arch Klin Chir, V37, P106
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Sawyer SL, 2015, HUM MOL GENET, V24, P5109, DOI 10.1093/hmg/ddv229
   Schoffer K, 2006, MUSCLE NERVE, V33, P142, DOI 10.1002/mus.20406
   Vilà MR, 2000, BIOCHEM BIOPH RES CO, V278, P800, DOI 10.1006/bbrc.2000.3828
   Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546
NR 20
TC 22
Z9 24
U1 0
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD FEB 27
PY 2019
VL 10
AR 160
DI 10.3389/fneur.2019.00160
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA HM9FO
UT WOS:000459788500001
PM 30873109
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Stufková, H
   Kolárová, H
   Lokvencová, K
   Honzík, T
   Zeman, J
   Hansíková, H
   Tesarová, M
AF Stufkova, Hana
   Kolarova, Hana
   Lokvencova, Katerina
   Honzik, Tomas
   Zeman, Jiri
   Hansikova, Hana
   Tesarova, Marketa
TI A Novel <i>MTTK</i> Gene Variant m.8315A&gt;C as a Cause of MERRF
   Syndrome
SO GENES
LA English
DT Article
DE mtDNA; MTTK gene; OXPHOS; heteroplasmy; m.8315A > C
ID TRANSFER-RNA; ATP SYNTHASE; MUTATIONS
AB In this study, we report on a novel heteroplasmic pathogenic variant in mitochondrial DNA (mtDNA). The studied patient had myoclonus, epilepsy, muscle weakness, and hearing impairment and harbored a heteroplasmic m.8315A>C variant in the MTTK gene with a mutation load ranging from 71% to >96% in tested tissues. In muscle mitochondria, markedly decreased activities of respiratory chain complex I + III and complex IV were observed together with mildly reduced amounts of complex I and complex V (with the detection of V*- and free F1-subcomplexes) and a diminished level of complex IV holoenzyme. This pattern was previously seen in other MTTK pathogenic variants. The novel variant was not present in internal and publicly available control databases. Our report further expands the spectrum of MTTK variants associated with mitochondrial encephalopathies in adults.
C1 [Tesarova, Marketa] Charles Univ Prague, Fac Med 1, Dept Pediat & Inherited Metab Disorders, Prague 12808, Czech Republic.
   Gen Univ Hosp Prague, Prague 12808, Czech Republic.
C3 General University Hospital Prague; Charles University Prague; General
   University Hospital Prague
RP Tesarová, M (corresponding author), Charles Univ Prague, Fac Med 1, Dept Pediat & Inherited Metab Disorders, Prague 12808, Czech Republic.
EM hana.stufkova@lf1.cuni.cz; hana.kolarova@vfn.cz;
   katerina.lokvencova@vfn.cz; tomas.honzik@vfn.cz; jzem@lf1.cuni.cz;
   hana.hansikova@lf1.cuni.cz; marketa.tesarova@lf1.cuni.cz
RI Stufkova, Hana/AAT-1930-2021; Hansikova, Hana/E-9350-2017; Tesarova,
   Marketa/I-1531-2016; Zeman, Jiri/K-2691-2017
OI Stufkova, Hana/0000-0003-0084-7730; Hansikova, Hana/0000-0002-2734-225X;
   Tesarova, Marketa/0000-0002-5141-2289; Zeman, Jiri/0000-0002-2678-7919
FU Ministry of Health of the Czech Republic [AZV 17-30965A]
FX This work was supported by the Ministry of Health of the Czech Republic
   (grant number: AZV 17-30965A).
CR Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Bolze A, 2020, bioRxiv, DOI [10.1101/798264, 10.1101/798264, DOI 10.1101/798264]
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Laricchia KM, 2022, GENOME RES, V32, P569, DOI 10.1101/gr.276013.121
   MAKINE MW, 1968, NEUROLOGY, V18, P299
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   McCormick EM, 2020, HUM MUTAT, V41, P2028, DOI 10.1002/humu.24107
   MITOMAP, 2019, HUM MIT GEN DAT
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Richter U, 2021, FEBS LETT, V595, P1003, DOI 10.1002/1873-3468.14049
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Srere P.A., 1969, Methods in Enzymology, V13, P3
NR 19
TC 2
Z9 2
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD JUL
PY 2022
VL 13
IS 7
AR 1245
DI 10.3390/genes13071245
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 3J2NA
UT WOS:000833235900001
PM 35886028
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Kang, YL
   Hepojoki, J
   Maldonado, RS
   Mito, T
   Terzioglu, M
   Manninen, T
   Kant, R
   Singh, S
   Othman, A
   Verma, R
   Uusimaa, J
   Wartiovaara, K
   Kareinen, L
   Zamboni, N
   Nyman, TA
   Paetau, A
   Kipar, A
   Vapalahti, O
   Suomalainen, A
AF Kang, Yilin
   Hepojoki, Jussi
   Maldonado, Rocio Sartori
   Mito, Takayuki
   Terzioglu, Muegen
   Manninen, Tuula
   Kant, Ravi
   Singh, Sachin
   Othman, Alaa
   Verma, Rohit
   Uusimaa, Johanna
   Wartiovaara, Kirmo
   Kareinen, Lauri
   Zamboni, Nicola
   Nyman, Tuula Anneli
   Paetau, Anders
   Kipar, Anja
   Vapalahti, Olli
   Suomalainen, Anu
TI Ancestral allele of DNA polymerase gamma modifies antiviral tolerance
SO NATURE
LA English
DT Article
ID CRYO-EM; CITRATE SYNTHASE; PHYLOGENETIC ANALYSIS; SIERPINSKI TRIANGLES;
   ALGORITHMS; SYMMETRY; MUSCLE; FORMS
AB Mitochondria are critical modulators of antiviral tolerance through the release of mitochondrial RNA and DNA (mtDNA and mtRNA) fragments into the cytoplasm after infection, activating virus sensors and type-I interferon (IFN-I) response 1-4 . The relevance of these mechanisms for mitochondrial diseases remains understudied. Here we investigated mitochondrial recessive ataxia syndrome (MIRAS), which is caused by a common European founder mutation in DNA polymerase gamma (POLG1) 5 . Patients homozygous for the MIRAS variant p.W748S show exceptionally variable ages of onset and symptoms 5 , indicating that unknown modifying factors contribute to disease manifestation. We report that the mtDNA replicase POLG1 has a role in antiviral defence mechanisms to double-stranded DNA and positive-strand RNA virus infections (HSV-1, TBEV and SARS-CoV-2), and its p.W748S variant dampens innate immune responses. Our patient and knock-in mouse data show that p.W748S compromises mtDNA replisome stability, causing mtDNA depletion, aggravated by virus infection. Low mtDNA and mtRNA release into the cytoplasm and a slow IFN response in MIRAS offer viruses an early replicative advantage, leading to an augmented pro-inflammatory response, a subacute loss of GABAergic neurons and liver inflammation and necrosis. A population databank of around 300,000 Finnish individuals 6 demonstrates enrichment of immunodeficient traits in carriers of the POLG1 p.W748S mutation. Our evidence suggests that POLG1 defects compromise antiviral tolerance, triggering epilepsy and liver disease. The finding has important implications for the mitochondrial disease spectrum, including epilepsy, ataxia and parkinsonism.
   The POLG1 mutation p.W748S, which is associated with mitochondrial recessive ataxia syndrome, dampens innate immune responses by compromising mtDNA replisome stability, and this explains why a viral infection can trigger the development of the disease and contribute to its variable clinical manifestation.
C1 [Kang, Yilin; Maldonado, Rocio Sartori; Mito, Takayuki; Terzioglu, Muegen; Manninen, Tuula; Verma, Rohit; Wartiovaara, Kirmo; Paetau, Anders; Suomalainen, Anu] Univ Helsinki, Fac Med, Stem Cell & Metab Res Program Unit, Res Program Unit, Helsinki, Finland.
   [Hepojoki, Jussi; Kant, Ravi; Kareinen, Lauri; Vapalahti, Olli] Univ Helsinki, Fac Med, Dept Virol, Helsinki, Finland.
   [Hepojoki, Jussi; Kipar, Anja] Univ Zurich, Inst Vet Pathol, Vetsuisse Fac, Lab Anim Model Pathol, Zurich, Switzerland.
   [Kant, Ravi; Kareinen, Lauri; Kipar, Anja; Vapalahti, Olli] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.
   [Kant, Ravi] Med Univ Gdansk, Inst Maritime & Trop Med, Dept Trop Parasitol, Gdansk, Poland.
   [Singh, Sachin; Nyman, Tuula Anneli] Univ Oslo, Inst Clin Med, Dept Immunol, Oslo, Oslo, Norway.
   [Singh, Sachin; Nyman, Tuula Anneli] Rikshosp Oslo, Oslo, Norway.
   [Othman, Alaa; Zamboni, Nicola] Swiss Fed Inst Technol, Swiss Multiom Ctr, Zurich, Switzerland.
   [Uusimaa, Johanna] Univ Oulu, Med Res Ctr, Res Unit Clin Med, Oulu, Finland.
   [Uusimaa, Johanna] Oulu Univ Hosp, Dept Pediat & Adolescent Med, Unit Child Neurol, Oulu, Finland.
   [Wartiovaara, Kirmo; Paetau, Anders; Vapalahti, Olli; Suomalainen, Anu] Helsinki Univ Hosp, HUS Diagnost, Helsinki, Finland.
   [Kareinen, Lauri] Finnish Food Safety Author, Helsinki, Finland.
   [Paetau, Anders] Univ Helsinki, Fac Med, Dept Pathol, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, HiLife, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; University of Zurich;
   University of Helsinki; Fahrenheit Universities; Medical University
   Gdansk; University of Oslo; University of Oslo; National Hospital
   Norway; Swiss Federal Institutes of Technology Domain; ETH Zurich;
   University of Oulu; University of Oulu; University of Helsinki; Helsinki
   University Central Hospital; Finnish Food Authority; University of
   Helsinki; University of Helsinki
RP Suomalainen, A (corresponding author), Univ Helsinki, Fac Med, Stem Cell & Metab Res Program Unit, Res Program Unit, Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, HUS Diagnost, Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, HiLife, Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
RI Zamboni, Nicola/K-3042-2012; Sartori Maldonado, Rocio/CAF-0309-2022;
   Othman, Alaa/AAE-5897-2019; Kant, Ravi/AAF-8495-2021; Othman,
   Alaa/K-1388-2015; Hepojoki, Jussi/W-4667-2017; Kant, Ravi/F-7025-2013
OI Othman, Alaa/0000-0002-0092-5594; Mito, Takayuki/0000-0002-6796-5478;
   Wartiovaara, Kirmo/0000-0002-5677-1117; Hepojoki,
   Jussi/0000-0001-5699-214X; Kant, Ravi/0000-0003-3878-9775; Vapalahti,
   Olli/0000-0003-2270-6824; Zamboni, Nicola/0000-0003-1271-1021; Sartori
   Maldonado, Rocio/0000-0001-9077-1287
FU Research Council of Norway INFRASTRUKTUR-program [295910]; Swiss
   initiative on Personalized Health and Related Technology by the ETH
   Domain; Jane and Aatos Erkko Foundation; Academy of Finland; Sigrid
   Juselius Foundation; University of Helsinki; Helsinki University
   Hospital; European Molecular Biology Organization's postdoctoral
   fellowship; POLG foundation; Business Finland
FX We thank M. Innilae for coordination of patient and control sampling,
   for expertise in histology and for collecting autopsy controls; L. Euro
   for expert advice on native gel analyses; J. Arola for expert
   consultation of liver histology; B. Hollmann, S. Malinen, S. M. Jansson,
   A. Zhaivoron, V. Venkat and K. J. Aaltonen for technical help; T.
   Sironen for advice on mouse infection experiments; T. Rolova and J.
   Koistinaho for technical expertise; M. James and J. Vaeaenaenen for
   RNA-seq and bioinformatic analyses; P. Tienari for comments on the
   manuscript; H. Kallankari and A. M. Saukkonen for recruitment of
   patients with MIRAS; the members of the Laboratory Animal Center in the
   University of Helsinki and Transgenic Core Facility in the University of
   Oulu for animal husbandry and experimental support; the staff at the
   Biomedicum Functional Genomics Unit at the Helsinki Institute of Life
   Science and Biocenter Finland at the University of Helsinki for RNA-seq,
   bioinformatic and genomic services; the members of the Biomedicum
   Imaging Unit for imaging equipment and expertise; and the technical
   staff at the Histology Laboratory, Institute of Veterinary Pathology,
   Vetsuisse Faculty, University of Zurich for technical support. MS-based
   proteomic analyses were performed by the Proteomics Core Facility,
   Department of Immunology, University of Oslo/Oslo University Hospital,
   which is supported by the Core Facilities program of the South-Eastern
   Norway Regional Health Authority. This core facility is also a member of
   the National Network of Advanced Proteomics Infrastructure (NAPI), which
   is funded by the Research Council of Norway INFRASTRUKTUR-program
   (project number, 295910). Metabolomics analyses at the Swiss Multi-Omics
   Center were supported by the Swiss initiative on Personalized Health and
   Related Technology by the ETH Domain. We acknowledge the participants
   and investigators of the FinnGen study. This work was supported by the
   Jane and Aatos Erkko Foundation (to O.V. and A.S.), the Academy of
   Finland (to A.S., Y.K., J.H., O.V. and J.U.), the Sigrid Juselius
   Foundation, University of Helsinki and Helsinki University Hospital (to
   O.V. and A.S.); European Molecular Biology Organization's postdoctoral
   fellowship (to Y.K.); and the POLG foundation and Business Finland (to
   A.S.).
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Ahnert SE, 2015, SCIENCE, V350, DOI 10.1126/science.aaa2245
   Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Azpeitia E, 2021, SCIENCE, V373, P192, DOI 10.1126/science.abg5999
   Baneyx F, 2014, CURR OPIN BIOTECH, V28, P39, DOI 10.1016/j.copbio.2013.11.001
   Bepler T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18952-1
   Biyani N, 2017, J STRUCT BIOL, V198, P124, DOI 10.1016/j.jsb.2017.03.007
   Broddrick JT, 2016, P NATL ACAD SCI USA, V113, pE8344, DOI 10.1073/pnas.1613446113
   Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155
   Du JX, 2013, NEUROCOMPUTING, V116, P150, DOI 10.1016/j.neucom.2012.03.028
   East NJ, 2022, PROTEIN SCI, V31, DOI 10.1002/pro.4510
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459
   Garcia-Seisdedos H, 2017, NATURE, V548, P244, DOI 10.1038/nature23320
   Gonzato G, 2000, GEOPHYS J INT, V142, P108, DOI 10.1046/j.1365-246x.2000.00133.x
   Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105
   GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086
   Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383
   Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x
   Hasunuma T, 2018, METAB ENG, V48, P109, DOI 10.1016/j.ymben.2018.05.013
   Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438
   Husain A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85405-0
   James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X
   Jiang ZL, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101064
   Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kanamori E, 2015, BIOPHYS PHYSICOBIOL, V12, P47, DOI 10.2142/biophysico.12.0_47
   KARPUSAS M, 1990, BIOCHEMISTRY-US, V29, P2213, DOI 10.1021/bi00461a002
   Kempkes SN, 2019, NAT PHYS, V15, P127, DOI 10.1038/s41567-018-0328-0
   Kidmose RT, 2019, IUCRJ, V6, P526, DOI 10.1107/S2052252519007619
   Kieffer J, 2022, J SYNCHROTRON RADIAT, V29, P1318, DOI 10.1107/S1600577522007238
   Laniado J, 2020, P NATL ACAD SCI USA, V117, P31817, DOI 10.1073/pnas.2015183117
   Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067
   Li C, 2021, J AM CHEM SOC, V143, P14417, DOI 10.1021/jacs.1c05949
   Li C, 2017, J AM CHEM SOC, V139, P13749, DOI 10.1021/jacs.7b05720
   Mandelbrot BB., 1982, FRACTAL GEOMETRY NAT, P1, DOI DOI 10.1119/1.13295
   Mangan NM, 2016, P NATL ACAD SCI USA, V113, pE5354, DOI 10.1073/pnas.1525145113
   Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mo YP, 2019, J AM CHEM SOC, V141, P11378, DOI 10.1021/jacs.9b04815
   Moore KR, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01612
   Nguyen NT, 2001, BIOCHEMISTRY-US, V40, P13177, DOI 10.1021/bi010408o
   Pagès G, 2020, METHODS MOL BIOL, V2165, P245, DOI 10.1007/978-1-0716-0708-4_14
   Pillai AS, 2022, PROTEIN SCI, V31, DOI 10.1002/pro.4449
   Pillai AS, 2020, NATURE, V581, P480, DOI 10.1038/s41586-020-2292-y
   Pinevich A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00173
   Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]
   Sarkar R, 2020, J AM CHEM SOC, V142, P5526, DOI 10.1021/jacs.0c01168
   Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665
   Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010
   Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45
   Scholl J, 2020, MOL MICROBIOL, V114, P292, DOI 10.1111/mmi.14512
   Sendker F. L., 2024, V1 EDMOND, DOI [10.17617/3.KNEQIR, DOI 10.17617/3.KNEQIR]
   Shang J, 2015, NAT CHEM, V7, P389, DOI [10.1038/NCHEM.2211, 10.1038/nchem.2211]
   Sierpinski W, 1915, CR HEBD ACAD SCI, V160, P302
   SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Talatahari S, 2021, ARTIF INTELL REV, V54, P917, DOI 10.1007/s10462-020-09867-w
   Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]
   TARBOTON DG, 1988, WATER RESOUR RES, V24, P1317, DOI 10.1029/WR024i008p01317
   Tully MD, 2021, JOVE-J VIS EXP, DOI 10.3791/61578
   Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z
   Wang YF, 2019, CHEMPHYSCHEM, V20, P2262, DOI 10.1002/cphc.201900258
   Welkie DG, 2019, TRENDS MICROBIOL, V27, P231, DOI 10.1016/j.tim.2018.11.002
   WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97
   Yang J, 2010, BIOTECHNIQUES, V49, P817, DOI 10.2144/000113520
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003
   Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193
NR 75
TC 3
Z9 3
U1 10
U2 11
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD APR 25
PY 2024
VL 628
IS 8009
DI 10.1038/s41586-024-07260-z
PG 32
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA SK8N7
UT WOS:001234439100023
PM 38570685
OA hybrid
DA 2024-11-01
ER

PT J
AU Brunetti-Pierri, N
   Selby, K
   O'Sullivan, M
   Hendson, G
   Truong, C
   Waters, PJ
   Wong, LJ
AF Brunetti-Pierri, N.
   Selby, K.
   O'Sullivan, M.
   Hendson, G.
   Truong, C.
   Waters, P. J.
   Wong, L. -J.
TI Rapidly Progressive Neurological Deterioration in a Child with Alpers
   Syndrome Exhibiting a Previously Unremarkable Brain MRI
SO NEUROPEDIATRICS
LA English
DT Article
DE POLG; Alpers syndrome; mitochondrial DNA depletion; DNA polymerase gamma
ID DNA-POLYMERASE-GAMMA; DIFFUSE CEREBRAL DEGENERATION; POLG MUTATIONS;
   EXTERNAL OPHTHALMOPLEGIA; DISORDERS; DISEASE
AB Alpers syndrome is a fatal disorder due to mutations in the POLG gene encoding the catalytic subunit of mitochondrial DNA polymerase gamma (Pol gamma) involved in mitochondrial DNA (mtDNA) replication. We describe a case of Alpers syndrome due to POLG mutations, with rapidly progressive course, a fatal outcome, and an essentially normal brain MRI in the early oligo-symptomatic phase. Our observation suggests that Alpers syndrome should be considered even in patients with an initially unremarkable brain MRI. The patient was found to harbor the p.Q497H, p.W748S and p.E1143G mutations in cis on one allele, and a fourth mutation, the p.G848S on the other allele. Although the individual mutations detected in the presented case have been previously reported, the specific genotype formed by the particular combination of these is novel.
C1 [Brunetti-Pierri, N.; Truong, C.; Wong, L. -J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Selby, K.] Childrens & Womens Hlth Ctr British Columbia, Dept Pediat, Div Neurol, Vancouver, BC, Canada.
   [Selby, K.; O'Sullivan, M.; Hendson, G.; Waters, P. J.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.
   [O'Sullivan, M.; Hendson, G.; Waters, P. J.] Childrens & Womens Hlth Ctr British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.
C3 Baylor College of Medicine; BC Women's Hospital & Health Centre;
   University of British Columbia; BC Women's Hospital & Health Centre
RP Wong, LJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
RI ; Brunetti-Pierri, Nicola/K-8465-2016
OI Waters, Paula/0000-0003-4898-1859; Brunetti-Pierri,
   Nicola/0000-0002-6895-8819
FU Dr. Ken Poskitt, Neuroradiologist, British Columbia's Children's
   Hospital
FX We wish to acknowledge the care and counseling provided to this family
   by David Koehn and Dr. Lorne Clarke, of the BC Provincial Medical
   Genetics Program and the input from Dr. Ken Poskitt, Neuroradiologist,
   British Columbia's Children's Hospital.
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   BLACKWOOD W, 1963, ARCH DIS CHILD, V38, P193, DOI 10.1136/adc.38.199.193
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   de Laveaucoupet J, 2005, PRENATAL DIAG, V25, P307, DOI 10.1002/pd.1128
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   TAYLOR RW, 1997, LAB DIAGNOSIS MITOCH
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 20
TC 9
Z9 9
U1 0
U2 3
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0174-304X
J9 NEUROPEDIATRICS
JI Neuropediatrics
PD JUN
PY 2008
VL 39
IS 3
BP 179
EP 183
DI 10.1055/s-0028-1093334
PG 5
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 375MJ
UT WOS:000261117700008
PM 18991199
DA 2024-11-01
ER

PT J
AU Tesarova, M
   Vondrackova, A
   Stufkova, H
   Veprekova, L
   Stranecky, V
   Berankova, K
   Hansikova, H
   Magner, M
   Galoova, N
   Honzik, T
   Vodickova, E
   Stary, J
   Zeman, J
AF Tesarova, Marketa
   Vondrackova, Alzbeta
   Stufkova, Hana
   Veprekova, Lenka
   Stranecky, Viktor
   Berankova, Kamila
   Hansikova, Hana
   Magner, Martin
   Galoova, Natalia
   Honzik, Tomas
   Vodickova, Elena
   Stary, Jan
   Zeman, Jiri
TI Sideroblastic anemia associated with multisystem mitochondrial disorders
SO PEDIATRIC BLOOD & CANCER
LA English
DT Article
DE mitochondrial disorders; MLASA; mtDNA; Pearson syndrome; ring
   sideroblasts; sideroblastic anemia
ID LACTIC-ACIDOSIS; TRANSFER-RNA; MUSCLE MITOCHONDRIA; MUTATIONS;
   ERYTHROPOIETIN; MYOPATHY; GENE; SPECTRUM; SINGLE; PATHOPHYSIOLOGY
AB Background Sideroblastic anemia represents a heterogeneous group of inherited or acquired diseases with disrupted erythroblast iron utilization, ineffective erythropoiesis, and variable systemic iron overload. In a cohort of 421 patients with multisystem mitochondrial diseases, refractory anemia was found in 8 children. Results Five children had sideroblastic anemia with increased numbers of ring sideroblasts >15%. Two of the children had a fatal course of MLASA1 syndrome (mitochondrial myopathy, lactic acidosis, and sideroblastic anemia [SA]) due to a homozygous, 6-kb deletion in the PUS1 gene, part of the six-member family of pseudouridine synthases (pseudouridylases). Large homozygous deletions represent a novel cause of presumed PUS1-loss-of-function phenotype. The other three children with SA had Pearson syndrome (PS) due to mtDNA deletions of 4 to 8 kb; two of these children showed early onset of PS and died due to repeated sepsis; the other child had later onset of PS and survived as the hematological parameters normalized and the disease transitioned to Kearns-Sayre syndrome. In addition, anemia without ring sideroblasts was found in three other patients with mitochondrial disorders, including two children with later onset of PS and one child with failure to thrive, microcephaly, developmental delay, hypertrophic cardiomyopathy, and renal tubular acidosis due to the heterozygous mutations c.610A>G (p.Asn204Asp) and c.674C>T (p.Pro225Leu) in the COX10 gene encoding the cytochrome c oxidase assembly factor. Conclusions Sideroblastic anemia was found in fewer than 1.2% of patients with multisystem mitochondrial disease, and it was usually associated with an unfavorable prognosis.
C1 [Tesarova, Marketa; Vondrackova, Alzbeta; Stufkova, Hana; Veprekova, Lenka; Stranecky, Viktor; Berankova, Kamila; Hansikova, Hana; Magner, Martin; Honzik, Tomas; Zeman, Jiri] Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Tesarova, Marketa; Vondrackova, Alzbeta; Stufkova, Hana; Veprekova, Lenka; Stranecky, Viktor; Berankova, Kamila; Hansikova, Hana; Magner, Martin; Honzik, Tomas; Zeman, Jiri] Gen Univ Hosp, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Galoova, Natalia] Childrens Univ Hosp, Dept Paediat Oncol & Haematol, Kosice, Slovakia.
   [Vodickova, Elena] Motol Univ Hosp, Dept Haematol, Prague, Czech Republic.
   [Stary, Jan] Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic.
   [Stary, Jan] Motol Univ Hosp, Prague, Czech Republic.
C3 Charles University Prague; General University Hospital Prague; Motol
   University Hospital; Motol University Hospital; Charles University
   Prague; Motol University Hospital
RP Zeman, J (corresponding author), Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Zeman, J (corresponding author), Gen Univ Hosp, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM jzem@lf1.cuni.cz
RI Magner, Martin/J-3553-2017; Hansikova, Hana/E-9350-2017; Zeman,
   Jiri/K-2691-2017; Vondrackova, Alzbeta/I-9534-2017; Stary,
   Jan/AAB-9635-2020; Tesarova, Marketa/I-1531-2016; Stranecky,
   Viktor/I-8524-2017; Stufkova, Hana/AAT-1930-2021
OI Tesarova, Marketa/0000-0002-5141-2289; Stranecky,
   Viktor/0000-0002-2599-6479; Stufkova, Hana/0000-0003-0084-7730
FU Ministerstvo Zdravotnictvi Ceske Republiky [AZV 17-30965A, RVOVFN
   64165]; Univerzita Karlova v Praze [Progres Q26/LF1, UNCE 204064];
   Grantova Agentura Ceske Republiky [GACR 14-36804G]
FX Ministerstvo Zdravotnictvi Ceske Republiky. Grant/Award Numbers: AZV
   17-30965A, RVOVFN 64165; Univerzita Karlova v Praze, Grant/Award
   Numbers: Progres Q26/LF1, UNCE 204064; Grantova Agentura Ceske
   Republiky. Grant/Award Number: GACR 14-36804G
CR Ahlqvist KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7494
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Bader-Meunier B, 1999, PEDIATR RES, V46, P158, DOI 10.1203/00006450-199908000-00005
   Benderro GF, 2013, ADV EXP MED BIOL, V765, P9, DOI 10.1007/978-1-4614-4989-8_2
   Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Bottomley SS, 2014, HEMATOL ONCOL CLIN N, V28, P653, DOI 10.1016/j.hoc.2014.04.008
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013
   Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003
   Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229
   Czudnochowski N, 2013, J MOL BIOL, V425, P3875, DOI 10.1016/j.jmb.2013.05.014
   Diaz GA, 1999, NAT GENET, V22, P309, DOI 10.1038/10385
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Fujiwara T, 2013, PEDIATR INT, V55, P675, DOI 10.1111/ped.12217
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009
   Henkel A, 2013, SEMIN LIVER DIS, V33, P321, DOI 10.1055/s-0033-1358522
   Honzik T, 2008, EARLY HUM DEV, V84, P269, DOI 10.1016/j.earlhumdev.2006.07.008
   INBAL A, 1995, AM J MED GENET, V55, P372, DOI 10.1002/ajmg.1320550325
   Kimura S, 2015, BBA-MOL CELL RES, V1853, P1272, DOI 10.1016/j.bbamcr.2014.12.010
   Klug L, 2014, FEMS YEAST RES, V14, P369, DOI 10.1111/1567-1364.12141
   Lichtenstein DA, 2016, BLOOD, V128, P1913, DOI 10.1182/blood-2016-05-719062
   Lönnberg M, 2013, J PHARMACEUT BIOMED, V81-82, P187, DOI 10.1016/j.jpba.2013.04.009
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958
   MAKINEN MW, 1968, ARCH BIOCHEM BIOPHYS, V126, P75, DOI 10.1016/0003-9861(68)90561-4
   Malcovati L, 2016, BRIT J HAEMATOL, V174, P847, DOI 10.1111/bjh.14215
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Maxwell PH, 1997, KIDNEY INT, V51, P393, DOI 10.1038/ki.1997.52
   Mazurova S, 2017, CARDIOL YOUNG, V27, P936, DOI 10.1017/S1047951116001876
   Nagai T, 2014, BIOCHEM BIOPH RES CO, V449, P222, DOI 10.1016/j.bbrc.2014.05.014
   O'Toole JF, 2014, INT J NEPHROL RENOV, V7, P57, DOI 10.2147/IJNRD.S37887
   Patnaik MM, 2017, AM J HEMATOL, V92, P297, DOI 10.1002/ajh.24637
   Pitceathly RDS, 2013, JAMA NEUROL, V70, P1556, DOI 10.1001/jamaneurol.2013.3242
   Rickwood D, 1987, MITOCHONDRIA PRACTIC, P3
   Riley LG, 2016, JIMD REP, V28, P49, DOI 10.1007/8904_2015_515
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112
   Schmitz-Abe K, 2015, BLOOD, V126, P2734, DOI 10.1182/blood-2015-09-659854
   Sibert BS, 2008, RNA, V14, P1895, DOI 10.1261/rna.984508
   Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807
   Subirós N, 2012, THER ADV NEUROL DISO, V5, P161, DOI 10.1177/1756285611434926
   Suzuki N, 2011, MOL CELL BIOL, V31, P3896, DOI 10.1128/MCB.05463-11
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Wiseman DH, 2013, BLOOD, V122, P112, DOI 10.1182/blood-2012-08-439083
   Yun S, 2015, CRIT REV ONCOL HEMAT, V95, P12, DOI 10.1016/j.critrevonc.2015.02.006
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
NR 56
TC 16
Z9 17
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD APR
PY 2019
VL 66
IS 4
AR e27591
DI 10.1002/pbc.27591
PG 8
WC Oncology; Hematology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Hematology; Pediatrics
GA HM4RZ
UT WOS:000459463300020
PM 30588737
DA 2024-11-01
ER

PT J
AU Moustaine, MO
   Azemour, Z
   Mohammed, F
   Benlanda, O
   Nassik, H
   Karkouri, M
AF Moustaine, Moulay O.
   Azemour, Zakaria
   Mohammed, Frarchi
   Benlanda, Othman
   Nassik, Hicham
   Karkouri, Mehdi
TI Management of Ptosis in Kearns-Sayre Syndrome: A Case Report and
   Literature Review
SO ARCHIVES OF PLASTIC SURGERY-APS
LA English
DT Article
DE Kearns-Sayre syndrome; ptosis; chronic progressive external
   ophthalmoplegia; Frontal suspension
ID MITOCHONDRIAL-DNA; PATIENT
AB Kearns-Sayre syndrome (KSS) is a rare mitochondrial disease that affects young adults, due to a deletion of mitochondrial DNA and characterized by the triad: age of onset lower than 20 years, chronic progressive external ophthalmoplegia, and an atypical pigmentary retinopathy. It is also characterized by other endocrine, neurological, and especially cardiac impairment with a very high risk of cardiac complications during surgical procedures under all types of anesthesia. We report a case of KSS revealed by severe bilateral ptosis and confirmed by a muscle biopsy with "ragged red fibers." The ptosis was surgically managed by cautious Frontal suspension under local anesthesia "Frontal nerve block." Through this case, we discuss challenges in the management of KSS patients.
C1 [Moustaine, Moulay O.; Azemour, Zakaria; Mohammed, Frarchi] Ibn Zohr Univ, CHU Souss Massa, Dept Ophthalmol, Fac Med & Pharm, Agadir, Morocco.
   [Benlanda, Othman; Nassik, Hicham] Ibn Zohr Univ, CHU Souss Massa, Dept Anesthesia Resuscitat, Fac Med & Pharm, Agadir, Morocco.
   [Karkouri, Mehdi] Hassan II Univ, CHU Ibn Rochd, Gen Lab Pathol Anat, Fac Med & Pharm, Casablanca, Morocco.
C3 Ibn Zohr University of Agadir; University Hospital of Agadir; Ibn Zohr
   University of Agadir; University Hospital of Agadir; Hassan II
   University of Casablanca; Ibn Rochd University Hospital Center of
   Casablanca
RP Moustaine, MO (corresponding author), Ibn Zohr Univ, UHC Souss Massa, Fac Med & Pharm Agadir, Ophthalmol Dept, Agadir, Morocco.
EM o.moustaine@uiz.ac.ma
RI NASSIK, Hicham/KFQ-2380-2024; Moulay Omar, Moustaine/ABD-7602-2021
OI Hicham, NASSIK/0000-0002-8298-1054; Karkouri, Mehdi/0000-0002-6857-7442
CR Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   Çakmak BM, 2013, J CLIN ANAL MED, V4, P155, DOI 10.4328/JCAM.643
   Calzavacca Paolo, 2011, Case Rep Anesthesiol, V2011, P806086, DOI 10.1155/2011/806086
   Capkova M, 2002, Cas Lek Cesk, V141, P51
   Choi C, 2000, YONSEI MED J, V41, P676, DOI 10.3349/ymj.2000.41.5.676
   Gaboune L, 2012, J FR OPHTALMOL, V35, DOI 10.1016/j.jfo.2012.06.010
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   KITOH T, 1995, ANESTH ANALG, V80, P1240, DOI 10.1097/00000539-199506000-00030
   Laloi-Michelin M, 2006, DIABETES METAB, V32, P182, DOI 10.1016/S1262-3636(07)70267-7
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Serna JT, 2021, REV ESP ANEST REANIM, V68, P232, DOI 10.1016/j.redar.2020.04.007
   Shemesh A., 2022, Kearns Sayre Syndrome
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P161, DOI 10.1007/978-3-319-95046-4_30
   Weitgasser L, 2015, ARCH PLAST SURG-APS, V42, P214, DOI 10.5999/aps.2015.42.2.214
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 17
TC 0
Z9 0
U1 1
U2 1
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 2234-6163
EI 2234-6171
J9 ARCH PLAST SURG-APS
JI Arch. Plast. Surg.-APS
PD MAR
PY 2024
VL 51
IS 02
BP 182
EP 186
DI 10.1055/a-2207-7587
PG 5
WC Surgery
WE Emerging Sources Citation Index (ESCI)
SC Surgery
GA NC9C9
UT WOS:001198357800015
PM 38596148
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Gilbert, J
   Ibdah, JA
AF Gilbert, J
   Ibdah, JA
TI Intestinal pseudo-obstruction as a manifestation of impaired
   mitochondrial fatty acid oxidation
SO MEDICAL HYPOTHESES
LA English
DT Article
ID TRIFUNCTIONAL PROTEIN-DEFICIENCY; 3-HYDROXYACYL-COA
   DEHYDROGENASE-DEFICIENCY; LIVER-DISEASE; PREGNANCY; FAMILIES; SUBUNIT;
   DEFECT; MNGIE
AB Intestinal pseudo-obstruction can be caused by mitochondrial disorders. Understanding the association between genetic alterations in mitochondrial function and development of intestinal pseudo-obstruction may provide insight into the pathogenesis of this disorder. Although the association between mitochondrial DNA defects and pseudo-obstruction is documented, Little is known about the relationship between mitochondrial beta-oxidation disorders, which are caused by defects in nuclear genes, and development of intestinal pseudo-obstruction. Mitochondrial beta-oxidation defects have emerged recently as an important group of recessively inherited inborn errors of metabolism with multiple phenotypes. Here we report the case history of a 25-year-old patient with mitochondrial trifunctional protein (MTP) deficiency, the eldest known living patient with this disorder. MTP is an enzyme complex that consists of 4alpha and 4beta subunits and catalyzes the Last three steps in the beta-oxidation cycle. The patient's MTP deficiency is secondary to a compound heterozygosity for two mutations in the MTP P-subunit. Over the past 5 years, the patient had worsening symptoms consistent with intestinal pseudo-obstruction associated with progressive skeletal myopathy and potyneuropathy. We hypothesize that impairment of mitochondrial beta-oxidation causes intestinal pseudo-obstruction secondary to accumulation of intracellular tong chain fatty acids, activation of extramitochondrial fatty acid oxidation pathways, and generation of excessive reactive oxygen species leading to visceral. myopathy. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Wake Forest Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Winston Salem, NC 27157 USA.
C3 Wake Forest University
RP Wake Forest Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM jibdah@wfubmc.edu
OI Ibdah, Jamal/0000-0002-5646-9014
FU NIDDK NIH HHS [DK 56345] Funding Source: Medline
CR Chinnery PF, 1997, QJM-INT J MED, V90, P657, DOI 10.1093/qjmed/90.11.657
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Ibdah JA, 2004, GASTROENTEROLOGY, V126, pA670
   Ibdah JA, 2003, GASTROENTEROLOGY, V124, pA707, DOI 10.1016/S0016-5085(03)83571-0
   Ibdah JA, 2001, J CLIN INVEST, V107, P1403, DOI 10.1172/JCI12590
   Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204
   Ibdah JA, 1998, J CLIN INVEST, V102, P1193, DOI 10.1172/JCI2091
   Ibdah JA, 1999, J INHERIT METAB DIS, V22, P811, DOI 10.1023/A:1005506024055
   Ibdah JA, 2001, J PEDIATR-US, V138, P396, DOI 10.1067/mpd.2001.111503
   ILJST L, 1996, J CLIN INVEST, V98, P1028
   JACKSON S, 1992, J CLIN INVEST, V90, P1219, DOI 10.1172/JCI115983
   Kamata H, 2002, FEBS LETT, V519, P231, DOI 10.1016/S0014-5793(02)02712-6
   KAMIJO T, 1994, BIOCHEM BIOPH RES CO, V199, P818, DOI 10.1006/bbrc.1994.1302
   Kamm MA, 1996, SCAND J GASTROENTERO, V31, P91, DOI 10.3109/00365529609094758
   Mann SD, 1997, GUT, V41, P675, DOI 10.1136/gut.41.5.675
   Mansouri A, 1997, J HEPATOL, V27, P96, DOI 10.1016/S0168-8278(97)80286-3
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Saudubray JM, 1999, J INHERIT METAB DIS, V22, P488
   SIMON LT, 1990, ANN NEUROL, V28, P349, DOI 10.1002/ana.410280308
   SIMS HF, 1995, P NATL ACAD SCI USA, V92, P841, DOI 10.1073/pnas.92.3.841
   Spiekerkoetter U, 2003, HUM MUTAT, V21, P598, DOI 10.1002/humu.10211
   UCHIDA Y, 1992, J BIOL CHEM, V267, P1034
   Ushikubo S, 1996, AM J HUM GENET, V58, P979
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
   WANDERS RJA, 1989, LANCET, V2, P52, DOI 10.1016/S0140-6736(89)90300-0
   Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225
   Yang Z, 2002, AM J OBSTET GYNECOL, V187, P715, DOI 10.1067/mob.2002.125893
NR 27
TC 9
Z9 9
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PY 2005
VL 64
IS 3
BP 586
EP 589
DI 10.1016/j.mehy.2004.07.032
PG 4
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 899IX
UT WOS:000227139200030
PM 15617873
DA 2024-11-01
ER

PT J
AU Götz, A
   Isohanni, P
   Liljeström, B
   Rummukainen, J
   Nikolajev, K
   Herrgård, E
   Marjavaara, S
   Suomalainen, A
AF Gotz, Alexandra
   Isohanni, Pirjo
   Liljestrom, Brita
   Rummukainen, Jaana
   Nikolajev, Kari
   Herrgard, Eila
   Marjavaara, Sanna
   Suomalainen, Anu
TI Fatal neonatal lactic acidosis caused by a novel <i>de novo</i>
   mitochondrial G7453A tRNA-Serine<SUP>(UCN)</SUP> mutation
SO PEDIATRIC RESEARCH
LA English
DT Article
ID TRNA(SER(UCN)) GENE; POINT MUTATION; TRANSFER-RNAS; PURIFYING SELECTION;
   LEIGH-SYNDROME; DNA MUTATIONS; DISEASE; MTDNA; PREVALENCE; DEFECTS
AB INTRODUCTION: Heteroplasmic mitochondrial DNA (mtDNA) mutations are an important cause of childhood disorders, but the role of homoplasmic mtDNA mutations in severe neonatal manifestations is not well understood.
   METHODS: The following were performed: full mtDNA sequencing for mutation detection, blue-native protein analysis of autopsy-derived tissues to detect respiratory chain (RC) deficiency, light and electron microscopy for morphologic analysis, and northern blot and computational modeling to study the effect of mtDNA mutations on transfer RNA (tRNA) stability.
   RESULTS: We describe data from a patient with fatal neonatal lactic acidosis caused by a novel homoplasmic mutation at a highly conserved nucleotide G7453A within the tRNA(ser (UCN)) in mtDNA. The patient's heart, skeletal muscle, brain, and liver showed severe combined complex I and IV (Cl and CIV) deficiencies, accompanied by severe depletion of mature tRNA(ser (UCN)). The mutation was absent in the patient's mother and in a placental sample from a subsequent pregnancy of the mother, suggesting a de novo mutation.
   DISCUSSION: We conclude that the G7453A mutation of mtDNA manifests with exceptional severity as compared with other tRNA(ser (UCN)) mutations, typically associated with sensorineural deafness. De novo homoplasmic mtDNA tRNA-mutations should be considered as a cause of fatal neonatal lactic acidosis.
C1 [Gotz, Alexandra; Isohanni, Pirjo; Marjavaara, Sanna; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Cent Hosp, Dept Gynaecol & Pediat, Hosp Children & Adolescents, Helsinki, Finland.
   [Liljestrom, Brita] Kuopio Univ Hosp, Dept Clin Genet, SF-70210 Kuopio, Finland.
   [Rummukainen, Jaana] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland.
   [Nikolajev, Kari; Herrgard, Eila] Kuopio Univ Hosp, Dept Pediat, SF-70210 Kuopio, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University
   Central Hospital; University of Eastern Finland; Kuopio University
   Hospital; Kuopio University Hospital; University of Eastern Finland;
   Kuopio University Hospital; University of Eastern Finland; University of
   Helsinki; Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
OI Gotz, Alexandra/0000-0001-9737-6861; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195
FU Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; Academy of
   Finland; University of Helsinki; Helsinki University Central Hospital;
   Graduate School of Biotechnology and Molecular Biology; Finnish Cultural
   Foundation; Maud Kuistila Memorial Foundation
FX The study was supported by grants from the Sigrid Juselius Foundation,
   the Jane and Aatos Erkko Foundation, the Academy of Finland, the
   University of Helsinki, the Helsinki University Central Hospital (to
   A.S.), the Graduate School of Biotechnology and Molecular Biology, the
   Finnish Cultural Foundation (to A.G.), and the Maud Kuistila Memorial
   Foundation (to P.I.).
CR Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   Degoul F, 1995, J INHERIT METAB DIS, V18, P682, DOI 10.1007/BF02436757
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   MAJANDER A, 1995, J NEUROL SCI, V134, P95, DOI 10.1016/0022-510X(95)00225-5
   Nagao Asuteka, 2007, Nucleic Acids Symp Ser (Oxf), P41
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Ohtsuki T, 2007, IUBMB LIFE, V59, P68, DOI 10.1080/15216540701218722
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200
   TULINIUS MH, 1995, HUM GENET, V96, P290
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
NR 24
TC 14
Z9 15
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD JUL
PY 2012
VL 72
IS 1
BP 90
EP 94
DI 10.1038/pr.2012.43
PG 5
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 961BY
UT WOS:000305440100014
PM 22453297
OA Bronze
DA 2024-11-01
ER

PT J
AU Kowald, A
   Kirkwood, TBL
AF Kowald, Axel
   Kirkwood, Thomas B. L.
TI Transcription could be the key to the selection advantage of
   mitochondrial deletion mutants in aging
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE mitochondrial mutations; mathematical model
ID SKELETAL-MUSCLE FIBERS; DNA MUTATIONS; DEGENERATIVE DISEASES; CLONAL
   EXPANSION; MTDNA MUTATIONS; REPLICATION; ACCUMULATION; TURNOVER; FUSION;
   CELLS
AB The mitochondrial theory of aging is widely popular but confronted by several apparent inconsistencies. On the one hand, mitochondrial energy production is of central importance to the health and proper functioning of cells, and single-cell studies have shown that mtDNA deletion mutants accumulate in a clonal fashion in various mammalian species, displacing the wild-type mtDNAs. On the other hand, no explanation exists yet for the clonal expansion of mtDNA mutants that is compatible with experimental observations. We present here a new idea based on the distinctive connection between transcription and replication of metazoan mtDNA. Bioinformatic analysis of mtDNA deletion spectra strongly supports the predictions of this hypothesis and identifies specific candidates for proteins involved in transcriptional control of mtDNA replication. Computer simulations show the mechanism to be compatible with the available data from short-and long-lived mammalian species.
C1 [Kowald, Axel; Kirkwood, Thomas B. L.] Newcastle Univ, Inst Ageing & Hlth, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
C3 Newcastle University - UK
RP Kowald, A (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Ctr Integrated Syst Biol Ageing & Nutr, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
EM axel.kowald@ncl.ac.uk
OI Kowald, Axel/0000-0001-6448-4364
FU Glenn Foundation; National Institute for Health Research Newcastle
   Biomedical Research Centre based at Newcastle upon Tyne Hospitals
   National Health Service Foundation Trust; Newcastle University; MRC
   [MR/K006312/1] Funding Source: UKRI
FX We thank D. M. Turnbull for constructive comments and helpful
   discussion. This work was funded by a Glenn Foundation award to T. B. L.
   K. The research was also supported by the National Institute for Health
   Research Newcastle Biomedical Research Centre based at Newcastle upon
   Tyne Hospitals National Health Service Foundation Trust and Newcastle
   University.
CR [Anonymous], 2010, Mathematica, V7.0
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   BOGENHAGEN DF, 1986, J BIOL CHEM, V261, P8488
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   Khaidakov M, 2006, MECH AGEING DEV, V127, P808, DOI 10.1016/j.mad.2006.07.008
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kowald A, 2005, AGING CELL, V4, P273, DOI 10.1111/j.1474-9726.2005.00169.x
   Kowald A, 2014, J THEOR BIOL, V340, P111, DOI 10.1016/j.jtbi.2013.09.009
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   LABBE D, 1991, J BIOL CHEM, V266, P10844
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Lakshmanan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035271
   Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051
   Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241
   Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
NR 56
TC 42
Z9 47
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 25
PY 2014
VL 111
IS 8
BP 2972
EP 2977
DI 10.1073/pnas.1314970111
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AC0JP
UT WOS:000332180900029
PM 24569805
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Luigetti, M
   Sauchelli, D
   Primiano, G
   Cuccagna, C
   Bernardo, D
   Lo Monaco, M
   Servidei, S
AF Luigetti, M.
   Sauchelli, D.
   Primiano, G.
   Cuccagna, C.
   Bernardo, D.
   Lo Monaco, M.
   Servidei, S.
TI Peripheral neuropathy is a common manifestation of mitochondrial
   diseases: a single-centre experience
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE MELAS; MERRF; mitochondrial diseases; MNGIE; nerve; PEO; peripheral
   neuropathy
ID NERVE-CONDUCTION; MERRF MUTATION; DNA; DISORDERS; GENE
AB Background and purpose: Peripheral neuropathy in mitochondrial diseases (MDs) may vary from a subclinical finding in a multisystem syndrome to a severe, even isolated, manifestation in some patients.
   Methods: To investigate the involvement of the peripheral nervous system in MDs extensive electrophysiological studies were performed in 109 patients with morphological, biochemical and genetic diagnosis of MD [12 A3243G progressive external ophthalmoplegia (PEO)/mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), 16 myoclonic epilepsy with ragged-red fibres (MERRF), four mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), 67 PEO with single or multiple deletions of mitochondrial DNA, 10 others].
   Results: A neuropathy was found in 49 patients (45%). The incidence was very high in MNGIE (100%), MELAS (92%) and MERRF (69%), whilst 28% of PEO patients had evidence of peripheral involvement. The most frequent abnormality was a sensory axonal neuropathy found in 32/49 patients (65%). A sensory-motor axonal neuropathy was instead detected in 16% of the patients and sensory-motor axonal demyelinating neuropathy in 16%. Finally one Leigh patient had a motor axonal neuropathy. It is interesting to note that the great majority had preserved tendon reflexes and no sensory disturbances.
   Conclusions: In conclusion, peripheral involvement in MD is frequent even if often mild or asymptomatic. The correct identification and characterization of peripheral neuropathy through electrophysiological studies represents another tile in the challenge of MD diagnosis.
C1 [Luigetti, M.; Sauchelli, D.; Primiano, G.; Cuccagna, C.; Bernardo, D.; Lo Monaco, M.; Servidei, S.] Univ Cattolica Sacro Cuore, Inst Neurol, Dept Geriatr Neurosci & Orthoped, I-00168 Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Luigetti, M (corresponding author), Inst Neurol, Largo Francesco Vito 1, I-00168 Rome, Italy.
EM mluigetti@gmail.com
RI Primiano, Guido/AAB-7829-2019; Cuccagna, Cristina/AAB-3967-2019;
   Servidei, Serenella/ABC-4262-2021; Luigetti, Marco/J-2782-2018
OI Luigetti, Marco/0000-0001-7539-505X; Cuccagna,
   Cristina/0000-0001-8180-2942; Primiano, Guido/0000-0001-7616-7008;
   SERVIDEI, Serenella/0000-0001-8478-2799
CR [Anonymous], 1989, ELECTRODIAGNOSIS DIS
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Luigetti M, 2013, CLIN NEUROPHYSIOL, V124, P1899, DOI 10.1016/j.clinph.2013.02.116
   Luigetti M, 2012, CLIN NEUROPHYSIOL, V123, P1891, DOI 10.1016/j.clinph.2012.02.075
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Merolli A, 2013, J RECONSTR MICROSURG, V29, DOI 10.1055/s-0033-1348038
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Mnatsakanyan L, 2011, J NEURO-OPHTHALMOL, V31, P6, DOI 10.1097/WNO.0b013e3181fab1b4
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x
   Zochodne DW, 2007, MUSCLE NERVE, V36, P144, DOI 10.1002/mus.20785
NR 24
TC 36
Z9 39
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD JUN
PY 2016
VL 23
IS 6
BP 1020
EP 1027
DI 10.1111/ene.12954
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DL6QZ
UT WOS:000375765000007
PM 26822221
DA 2024-11-01
ER

PT J
AU Vanniarajan, A
   Nayak, D
   Reddy, AG
   Singh, L
   Thangaraj, K
AF Vanniarajan, Ayyasamy
   Nayak, Dinesh
   Reddy, Alla G.
   Singh, Lalji
   Thangaraj, Kumarasaray
TI Clinical and genetic uniqueness in an individual with MELAS
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
LA English
DT Article
DE genetic uniqueness; late onset; MELAS; mitochondrial DNA; mutation
ID MITOCHONDRIAL-DNA; DIABETES-MELLITUS; LACTIC-ACIDOSIS; MUTATION; GENOME;
   ENCEPHALOPATHY; MYOPATHY; SEQUENCE; EPISODES; PATIENT
AB Mitochondrial encephalopathy lactic acidosis stroke like episodes (MELAS) is a progressive neurodegenerative disorder with varying age of onset. It is a clinically and genetically heterogeneous disease. Molecular etiology of MELAS is not known in several cases. We have identified a unique individual with late onset MEILAS at the age of 55 years. We have analyzed the complete mitochondrial genome of the tissue and blood samples of the patient. One novel heteroplasmic mutation (C13565A) in NADH dehydrogenase 5 subunit (ND5) gene was found only in the tissue sample but not in the blood. This mutation is missense causing a change of amino acid serine to tyrosine at position 410. This mutation was found neither in controls nor in world populations. This study has also confirmed ND5 as a hotspot for the mitochondrial diseases. This will be of great help for the clinicians in the diagnosis of MELAS. (c) 2006 Wiley-Liss, Inc.
C1 Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.
   Kovai Med Ctr & Hosp, Dept Neurol, Coimbatore, Tamil Nadu, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Centre for Cellular & Molecular Biology (CCMB)
RP Thangaraj, K (corresponding author), Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.
EM thangs@ccmb.res.in
RI Vanniarajan, A./AAB-4896-2022; Thangaraj, Kumarasamy/G-5596-2010
OI Thangaraj, Kumarasamy/0000-0002-0075-0106
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961
   Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Kimata KG, 1998, ARCH NEUROL-CHICAGO, V55, P722, DOI 10.1001/archneur.55.5.722
   *MITOMAP, 2005, HUM MIT GEN DAT
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Servidei Serenella, 2004, Neuromuscul Disord, V14, P107
   Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304
   Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987
   Thangaraj K, 2002, J ANDROL, V23, P815
   Thomas AW, 1996, J MED GENET, V33, P253, DOI 10.1136/jmg.33.3.253
NR 23
TC 12
Z9 13
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4841
EI 1552-485X
J9 AM J MED GENET B
JI Am. J. Med. Genet. B
PD JUL 5
PY 2006
VL 141B
IS 5
BP 440
EP 444
DI 10.1002/ajmg.b.30302
PG 5
WC Genetics & Heredity; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Psychiatry
GA 057VC
UT WOS:000238622300002
PM 16741938
DA 2024-11-01
ER

PT J
AU Greaves, LC
   Beadle, NE
   Taylor, GA
   Commane, D
   Mathers, JC
   Khrapko, K
   Turnbull, DM
AF Greaves, Laura C.
   Beadle, Nina E.
   Taylor, Geoffrey A.
   Commane, Daniel
   Mathers, John C.
   Khrapko, Konstantin
   Turnbull, Doug M.
TI Quantification of mitochondrial DNA mutation load
SO AGING CELL
LA English
DT Article
DE ageing; cloning; colon; human; mitochondria; mitochondrial DNA; mutation
   load; polymerase chain reaction
ID HUMAN SKELETAL-MUSCLE; SINGLE-MOLECULE PCR; POINT MUTATIONS; STEM-CELLS;
   ORGANIZATION; DELETION; TISSUES; DISEASE; GENOME; MICE
AB P>Mitochondrial DNA (mtDNA) mutations are an important cause of genetic disease and have been proposed to play a role in the ageing process. Quantification of total mtDNA mutation load in ageing tissues is difficult as mutational events are rare in a background of wild-type molecules, and detection of individual mutated molecules is beyond the sensitivity of most sequencing based techniques. The methods currently most commonly used to document the incidence of mtDNA point mutations in ageing include post-PCR cloning, single-molecule PCR and the random mutation capture assay. The mtDNA mutation load obtained by these different techniques varies by orders of magnitude, but direct comparison of the three techniques on the same ageing human tissue has not been performed. We assess the procedures and practicalities involved in each of these three assays and discuss the results obtained by investigation of mutation loads in colonic mucosal biopsies from ten human subjects.
C1 [Greaves, Laura C.; Beadle, Nina E.; Taylor, Geoffrey A.; Turnbull, Doug M.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Commane, Daniel; Mathers, John C.] Newcastle Univ, Inst Ageing & Hlth, Human Nutr Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Khrapko, Konstantin] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
C3 Newcastle University - UK; Newcastle University - UK; Harvard
   University; Beth Israel Deaconess Medical Center
RP Greaves, LC (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM l.c.greaves@ncl.ac.uk
RI Khrapko, Konstantin/A-3244-2009; Mathers, Jonathan/ABE-1164-2021
OI Greaves, Laura/0000-0002-8071-5916; Mathers, John/0000-0003-3406-3002;
   khrapko, konstantin/0000-0002-9250-8033; Commane,
   Daniel/0000-0002-0154-8540
FU Wellcome Trust, Food Standards Agency (UK) [N12015]; Cancer Research UK;
   Biotechnology and Biomedical Sciences Research Council (UK); BBSRC;
   EPSRC; ESRC; MRC; NIH [AG19787, NS058988]; MRC [G0700718] Funding
   Source: UKRI
FX This work was supported by Wellcome Trust, Food Standards Agency (UK)
   [N12015], Cancer Research UK, Biotechnology and Biomedical Sciences
   Research Council (UK), Newcastle University Centre for Brain Ageing and
   Vitality (sponsored by BBSRC, EPSRC, ESRC and MRC) and by the NIH grants
   AG19787 and NS058988 to KK. We would like to thank Professor RN
   Lightowlers and Dr M Vermulst for helpful discussion.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   KHRAPKO K, 1994, PROG NUCLEIC ACID RE, V49, P285
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Kraytsberg Y, 2008, METHODS, V46, P269, DOI 10.1016/j.ymeth.2008.10.005
   KRAYTSBERG Y, 2004, ANAL SOMATIC MUTATIO
   Kraytsberg Yevgenya, 2007, Expert Opin Med Diagn, V1, P109, DOI 10.1517/17530059.1.1.109
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Simon DK, 2001, GENOMICS, V73, P113, DOI 10.1006/geno.2001.6515
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wilding CS, 2006, RADIAT RES, V165, P202, DOI 10.1667/RR3494.1
   Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202
NR 24
TC 36
Z9 46
U1 0
U2 11
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1474-9718
J9 AGING CELL
JI Aging Cell
PD OCT
PY 2009
VL 8
IS 5
BP 566
EP 572
DI 10.1111/j.1474-9726.2009.00505.x
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 498FU
UT WOS:000270123400006
PM 19624578
OA hybrid, Green Accepted, Green Published
DA 2024-11-01
ER

PT J
AU Callegari, S
   Gregory, PA
   Sykes, MJ
   Bellon, J
   Andrews, S
   McKinnon, RA
   Lopes, MAD
AF Callegari, Sylvie
   Gregory, Philip A.
   Sykes, Matthew J.
   Bellon, Jennifer
   Andrews, Stuart
   McKinnon, Ross A.
   Lopes, Miguel A. de Barros
TI Polymorphisms in the Mitochondrial Ribosome Recycling Factor
   EF-G2mt/MEF2 Compromise Cell Respiratory Function and Increase
   Atorvastatin Toxicity
SO PLOS GENETICS
LA English
DT Article
ID COA REDUCTASE INHIBITORS; SKELETAL-MUSCLE; YEAST MODELS; TRANSLATION;
   DNA; STATINS; MUTATIONS; IMPAIRMENT; MYOPATHY; DISEASES
AB Mitochondrial translation, essential for synthesis of the electron transport chain complexes in the mitochondria, is governed by nuclear encoded genes. Polymorphisms within these genes are increasingly being implicated in disease and may also trigger adverse drug reactions. Statins, a class of HMG-CoA reductase inhibitors used to treat hypercholesterolemia, are among the most widely prescribed drugs in the world. However, a significant proportion of users suffer side effects of varying severity that commonly affect skeletal muscle. The mitochondria are one of the molecular targets of statins, and these drugs have been known to uncover otherwise silent mitochondrial mutations. Based on yeast genetic studies, we identify the mitochondrial translation factor MEF2 as a mediator of atorvastatin toxicity. The human ortholog of MEF2 is the Elongation Factor Gene (EF-G) 2, which has previously been shown to play a specific role in mitochondrial ribosome recycling. Using small interfering RNA (siRNA) silencing of expression in human cell lines, we demonstrate that the EF-G2mt gene is required for cell growth on galactose medium, signifying an essential role for this gene in aerobic respiration. Furthermore, EF-G2mt silenced cell lines have increased susceptibility to cell death in the presence of atorvastatin. Using yeast as a model, conserved amino acid variants, which arise from non-synonymous single nucleotide polymorphisms (SNPs) in the EF-G2mt gene, were generated in the yeast MEF2 gene. Although these mutations do not produce an obvious growth phenotype, three mutations reveal an atorvastatin-sensitive phenotype and further analysis uncovers a decreased respiratory capacity. These findings constitute the first reported phenotype associated with SNPs in the EF-G2mt gene and implicate the human EF-G2mt gene as a pharmacogenetic candidate gene for statin toxicity in humans.
C1 [Callegari, Sylvie; Sykes, Matthew J.; Andrews, Stuart; Lopes, Miguel A. de Barros] Univ S Australia, Sch Pharm & Med Sci, Div Hlth Sci, Adelaide, SA 5001, Australia.
   [Gregory, Philip A.] SA Pathol, Ctr Canc Biol, Div Human Immunol, Adelaide, SA, Australia.
   [Gregory, Philip A.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia.
   [Sykes, Matthew J.] Univ S Australia, Sansom Inst, Div Hlth Sci, Adelaide, SA 5001, Australia.
   [Bellon, Jennifer] Australian Wine Res Inst, Glen Osmond, SA, Australia.
   [McKinnon, Ross A.] Flinders Univ S Australia, Sch Med, Flinders Ctr Innovat Canc, Bedford Pk, SA 5042, Australia.
C3 University of South Australia; SA Pathology; Centre for Cancer Biology;
   University of Adelaide; University of South Australia; Australian Wine
   Research Institute; Flinders University South Australia
RP Callegari, S (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Div Hlth Sci, Adelaide, SA 5001, Australia.
EM miguel.debarroslopes@unisa.edu.au
RI McKinnon, Ross/B-9340-2009; Callegari, Sylvie/T-1728-2019; Andrews,
   Stuart/AAW-2833-2020; Gregory, Philip/F-4089-2013; Sykes,
   Matthew/D-3996-2011
OI Callegari, Sylvie/0000-0002-4402-945X; Sykes,
   Matthew/0000-0002-2509-5531; Gregory, Philip/0000-0002-0999-0632;
   McKinnon, Ross/0000-0002-3725-793X; De Barros Lopes,
   Miguel/0000-0003-3955-3406
FU University of South Australia
FX This study is funded by an internal grant from the University of South
   Australia. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Araki M, 2008, BIOCHEM BIOPH RES CO, V367, P462, DOI 10.1016/j.bbrc.2007.12.166
   Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   Bergman M, 2003, J MUSCLE RES CELL M, V24, P417, DOI 10.1023/A:1027367022415
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Buettner C, 2008, J GEN INTERN MED, V23, P1182, DOI 10.1007/s11606-008-0636-7
   Callegari S, 2011, FEBS LETT, V585, P1140, DOI 10.1016/j.febslet.2011.03.022
   Callegari S, 2010, FEMS YEAST RES, V10, P188, DOI 10.1111/j.1567-1364.2009.00593.x
   CHARIOT P, 1993, AM J MED, V94, P109, DOI 10.1016/0002-9343(93)90129-D
   Chong PH, 2001, AM J MED, V111, P390, DOI 10.1016/S0002-9343(01)00870-1
   Christian B, 2009, MOL CELL, V35, P400, DOI 10.1016/j.molcel.2009.08.003
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   DePinieux G, 1996, BRIT J CLIN PHARMACO, V42, P333, DOI 10.1046/j.1365-2125.1996.04178.x
   Fowler DM, 2011, MOL BIOSYST, V7, P533, DOI 10.1039/c0mb00166j
   Gao N, 2007, J MOL BIOL, V374, P1345, DOI 10.1016/j.jmb.2007.10.021
   Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100
   Hammarsund M, 2001, HUM GENET, V109, P542, DOI 10.1007/s00439-001-0610-5
   Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016
   Hillenmeyer ME, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r30
   HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D
   Kaiser J, 2008, SCIENCE, V319, P395, DOI 10.1126/science.319.5862.395
   Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3
   Macreadie IG, 2006, FEMS MICROBIOL LETT, V262, P9, DOI 10.1111/j.1574-6968.2006.00370.x
   Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Nishimoto T, 2003, BIOCHEM PHARMACOL, V66, P2133, DOI 10.1016/j.bcp.2003.08.011
   Oh J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-7
   Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009
   REITZER LJ, 1979, J BIOL CHEM, V254, P2669
   Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x
   Rodríguez-Enríquez S, 2001, EUR J BIOCHEM, V268, P2512, DOI 10.1046/j.1432-1327.2001.02140.x
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576
   Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124
   Schwimmer Christine, 2006, Biotechnology Journal, V1, P270, DOI 10.1002/biot.200500053
   Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108
   Sirvent P, 2005, BIOCHEM BIOPH RES CO, V329, P1067, DOI 10.1016/j.bbrc.2005.02.070
   Sirvent P, 2012, TOXICOL APPL PHARM, V259, P263, DOI 10.1016/j.taap.2012.01.008
   Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385
   Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100
   Tay SKH, 2008, PEDIATR NEUROL, V39, P426, DOI 10.1016/j.pediatrneurol.2008.09.002
   Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053
   Thomas JE, 2007, EUR NEUROL, V57, P232, DOI 10.1159/000101287
   Towpik J, 2005, CELL MOL BIOL LETT, V10, P571
   Tsuboi M, 2009, MOL CELL, V35, P502, DOI 10.1016/j.molcel.2009.06.028
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Vergani L, 2000, NEUROMUSCULAR DISORD, V10, P454, DOI 10.1016/S0960-8966(00)00096-1
   Vladutiu GD, 2008, CURR OPIN RHEUMATOL, V20, P648, DOI 10.1097/BOR.0b013e328314b7b4
   Vladutiu GD, 2006, MUSCLE NERVE, V34, P153, DOI 10.1002/mus.20567
   Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387
   Westwood FR, 2008, TOXICOL PATHOL, V36, P345, DOI 10.1177/0192623307311412
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   Wittmann C, 2003, BIOTECHNOL LETT, V25, P377, DOI 10.1023/A:1022402212537
NR 58
TC 5
Z9 5
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD JUN
PY 2012
VL 8
IS 6
AR e1002755
DI 10.1371/journal.pgen.1002755
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 968EW
UT WOS:000305961000022
PM 22719265
OA gold, Green Submitted, Green Published
DA 2024-11-01
ER

PT J
AU Baloh, RH
   Salavaggione, E
   Milbrandt, J
   Pestronk, A
AF Baloh, Robert H.
   Salavaggione, Ezequiel
   Milbrandt, Jeffrey
   Pestronk, Alan
TI Familial parkinsonism and ophthalmoplegia from a mutation in the
   mitochondrial DNA helicase twinkle
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID SUBSTANTIA-NIGRA NEURONS; DELETIONS; DISEASE; NEUROPATHY; POLG
AB Objective: To describe the clinical phenotype and genetic basis of a family with autosomal dominant progressive external ophthalmoplegia and parkinsonism from a Twinkle mutation.
   Design: All coding exons of POLG1, Twinkle ( aka C10ORF2, PEO1), and ANT1 ( SLC25A4) were sequenced in the proband with targeted sequencing of the Twinkle gene in all additional subjects.
   Subjects: Members of a 3-generation family followed up in a neuromuscular disease center for dominantly inherited progressive external ophthalmoplegia.
   Results: We identified a heterozygous G1121A mutation ( R374Q) in exon 1 of Twinkle that segregated with the disease phenotype in all affected family members. No pathogenic mutations were present in POLG1 or ANT1.
   Conclusion: This finding broadens the clinical spectrum of Twinkle gene mutations and further implicates loss of mitochondrial DNA integrity in the pathogenesis of Parkinson disease.
C1 Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Hope Ctr Neurol Dis, St Louis, MO 63110 USA.
C3 Washington University (WUSTL); Washington University (WUSTL); Washington
   University (WUSTL)
RP Baloh, RH (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.
EM balohb@neuro.wustl.edu
OI Milbrandt, Jeffrey/0000-0002-5477-7689
FU NCRR NIH HHS [1K12RR023249-01] Funding Source: Medline
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schapira AHV, 2006, NEUROLOGY, V66, pS10, DOI 10.1212/WNL.66.10_suppl_4.S10
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   VYAS I, 1986, J NEUROCHEM, V46, P1501, DOI 10.1111/j.1471-4159.1986.tb01768.x
NR 11
TC 81
Z9 84
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610-0946 USA
SN 0003-9942
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JUL
PY 2007
VL 64
IS 7
BP 998
EP 1000
DI 10.1001/archneur.64.7.998
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 188AZ
UT WOS:000247892100011
PM 17620490
DA 2024-11-01
ER

PT J
AU Pang, CY
   Ma, YS
   Wei, YH
AF Pang, Cheng-Yoong
   Ma, Yi-Shing
   Wei, Yau-Huei
TI MtDNA mutations, functional decline and turnover of mitochondria in
   aging
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Review
DE aging; mitochondria; mitochondrial Dna; mutation; oxidative stress;
   proteasome; turnover; autophagy; review
ID HUMAN SKELETAL-MUSCLE; CYTOCHROME-C-OXIDASE; OXIDATIVELY MODIFIED
   PROTEIN; RESPIRATORY-CHAIN ACTIVITY; SUBSTANTIA-NIGRA NEURONS; DNA
   DELETIONS; SUPEROXIDE-DISMUTASE; PROTEOMIC IDENTIFICATION;
   DROSOPHILA-MELANOGASTER; DEGENERATIVE DISEASES
AB Aging is a complex biological process that involves gradual function deterioration in various tissues and organs of an individual. Mitochondrial function decline can lead to cellular overproduction of reactive oxygen species (ROS) and increase in oxidative damage to biological molecules in the aging process. We have hypothesized that increased production of ROS by the mitochondria in affected tissues in patients with mitochondrial diseases and elderly subject results in increased oxidative stress and oxidative damage. Due to the similarity of human aging process to diseases related to bioenergetic function decline and mitochondrial DNA (mtDNA) alterations, aging is sometimes viewed as a "chronic" version of such diseases. Recent studies have also established that the expression profiles of several clusters of genes are altered, oxidative modification of proteins are increased and their turnover are decreased in tissues of old human subjects and animals. Accumulating evidence has suggested that mtDNA mutations, oxidative stress, defective disposal of dysfunctional proteins and a slower turnover of mitochondria are associated with aging.
C1 [Ma, Yi-Shing; Wei, Yau-Huei] Natl Yang Ming Univ, Sch Life Sci, Dept Biochem & Mol Biol, Taipei 112, Taiwan.
   [Pang, Cheng-Yoong] Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan.
   [Pang, Cheng-Yoong] Tzu Chi Coll Technol, Gen Educ Ctr, Hualien 970, Taiwan.
   [Pang, Cheng-Yoong] Tzu Chi Gen Hosp, Dept Res, Hualien 970, Taiwan.
C3 National Yang Ming Chiao Tung University; Tzu Chi University; Tzu Chi
   University of Science & Technology; Buddhist Tzu Chi General Hospital;
   Hualien Tzu Chi Hospital
RP Wei, YH (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Dept Biochem & Mol Biol, Taipei 112, Taiwan.
EM joeman@ym.edu.tw
RI Wei, Yau-Huei/ABA-6841-2021; Pang, Cheng-Yoong/R-4990-2019
OI Pang, Cheng-Yoong/0000-0002-9063-2858; Wei, Yau-Huei/0000-0002-6429-2546
CR Agarwal S, 1995, MECH AGEING DEV, V85, P55, DOI 10.1016/0047-6374(95)01655-4
   [Anonymous], HUM DNA POL GAMM MUT
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200
   Brambilla L, 1997, FEBS LETT, V418, P247, DOI 10.1016/S0014-5793(97)01393-8
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x
   Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7
   Cavallini G, 2007, AUTOPHAGY, V3, P26, DOI 10.4161/auto.3268
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Dean RT, 1997, BIOCHEM J, V324, P1
   Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x
   Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178
   Deretic V, 2006, CURR OPIN IMMUNOL, V18, P375, DOI 10.1016/j.coi.2006.05.019
   Donati A, 2006, REJUV RES, V9, P408, DOI 10.1089/rej.2006.9.408
   Drew B, 2002, ANN NY ACAD SCI, V959, P66, DOI 10.1111/j.1749-6632.2002.tb02084.x
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Fahn HJ, 1996, AM J RESP CRIT CARE, V154, P1141, DOI 10.1164/ajrccm.154.4.8887618
   Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje
   FROMENTY B, 1995, GASTROENTEROLOGY, V108, P193, DOI 10.1016/0016-5085(95)90024-1
   Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X
   Grune T, 2000, BIOGERONTOLOGY, V1, P31, DOI 10.1023/A:1010037908060
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Higami Y, 1997, AM J PATHOL, V151, P659
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt PR, 1998, J GERONTOL A-BIOL, V53, pB168, DOI 10.1093/gerona/53A.3.B168
   Kanski J, 2005, AM J PHYSIOL-HEART C, V288, pH371, DOI 10.1152/ajpheart.01030.2003
   Kanski J, 2003, FREE RADICAL BIO MED, V35, P1229, DOI 10.1016/S0891-5849(03)00500-8
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Kopsidas G, 1998, MUTAT RES-FUND MOL M, V421, P27, DOI 10.1016/S0027-5107(98)00150-X
   Kovalenko SA, 1997, BIOCHEM BIOPH RES CO, V232, P147, DOI 10.1006/bbrc.1997.6251
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121
   Lee HC, 2001, MUTAT RES-GEN TOX EN, V493, P67, DOI 10.1016/S1383-5718(01)00160-7
   LEE HC, 1994, FEBS LETT, V354, P79, DOI 10.1016/0014-5793(94)01063-3
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lu CY, 1999, MUTAT RES-FUND MOL M, V423, P11, DOI 10.1016/S0027-5107(98)00220-6
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   Mitra S, 2007, DNA REPAIR, V6, P461, DOI 10.1016/j.dnarep.2006.10.010
   MO JQ, 1995, MECH AGEING DEV, V81, P73, DOI 10.1016/0047-6374(95)01586-O
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   Musatov A, 2006, FREE RADICAL BIO MED, V41, P238, DOI 10.1016/j.freeradbiomed.2006.03.018
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nixon RA, 2003, AGEING RES REV, V2, P407, DOI 10.1016/S1568-1637(03)00029-1
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200
   PANG CY, 1994, ARCH BIOCHEM BIOPHYS, V312, P534, DOI 10.1006/abbi.1994.1342
   Pansarasa O, 1999, FREE RADICAL BIO MED, V27, P617, DOI 10.1016/S0891-5849(99)00108-2
   Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9
   Paradies G, 1998, FEBS LETT, V424, P155, DOI 10.1016/S0014-5793(98)00161-6
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200
   Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220
   Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002
   Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sharma R, 2006, FREE RADICAL BIO MED, V40, P1179, DOI 10.1016/j.freeradbiomed.2005.11.013
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Sun JT, 2002, GENETICS, V161, P661
   Szczesny B, 2003, P NATL ACAD SCI USA, V100, P10670, DOI 10.1073/pnas.1932854100
   Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009
   Terman A, 2003, EXP GERONTOL, V38, P863, DOI 10.1016/S0531-5565(03)00114-1
   Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wauthier V, 2006, LIFE SCI, V79, P1913, DOI 10.1016/j.lfs.2006.06.046
   Webster KA, 2001, ANTIOXID REDOX SIGN, V3, P535, DOI 10.1089/15230860152542916
   Wei YH, 2001, CHINESE J PHYSIOL, V44, P1
   Wei YH, 1998, CURR SCI INDIA, V74, P887
   Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011
   Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003
   Wood-Kaczmar A, 2006, TRENDS MOL MED, V12, P521, DOI 10.1016/j.molmed.2006.09.007
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
   Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
   ZHANG CF, 1993, BIOCHEM BIOPH RES CO, V195, P1104, DOI 10.1006/bbrc.1993.2158
   Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030
   Zhang YP, 2002, EXP GERONTOL, V37, P777, DOI 10.1016/S0531-5565(02)00013-X
NR 123
TC 25
Z9 27
U1 0
U2 13
PU FRONTIERS IN BIOSCIENCE INC
PI IRVINE
PA 16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA
SN 1093-9946
EI 1093-4715
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD MAY
PY 2008
VL 13
BP 3661
EP U60
DI 10.2741/2957
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 301GS
UT WOS:000255885000038
PM 18508463
OA Bronze
DA 2024-11-01
ER

PT J
AU Miró, O
   López, S
   Martínez, E
   Pedrol, E
   Milinkovic, A
   Deig, E
   Garrabou, G
   Casademont, J
   Gatell, JM
   Cardellach, F
AF Miró, O
   López, S
   Martínez, E
   Pedrol, E
   Milinkovic, A
   Deig, E
   Garrabou, G
   Casademont, J
   Gatell, JM
   Cardellach, F
TI Mitochondrial effects of HIV infection on the peripheral blood
   mononuclear cells of HIV-infected patients who were never treated with
   antiretrovirals
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID LIPID-PEROXIDATION; UNDERGO APOPTOSIS; ADIPOSE-TISSUE; DNA; TOXICITY;
   PROTEIN; ZIDOVUDINE; DEPLETION; MYOPATHY; DAMAGE
AB To investigate the effects of HIV infection on mitochondrial DNA (mtDNA) content and other mitochondrial parameters, we used peripheral blood mononuclear cells (PBMCs) from 25 asymptomatic antiretroviral-naive human immunodeficiency virus (HIV)-infected patients and from 25 healthy control subjects. HIV-infected patients had significant decreases in mtDNA content (decrease, 23%; P<.05) and in the activities of mitochondrial respiratory chain (MRC) complex II (decrease, 41%; P<.001), MRC complex III (decrease, 38%; P<.001), MRC complex IV (decrease, 19%; P=.001), and glycerol-3-phosphate dehydrogenase (decrease, 22%; P<.001), along with increased lipid peroxidation of PBMC membranes (P=.007). Therefore, HIV infection is associated not only with mtDNA depletion, but also with extensive MRC disturbances and increased oxidative damage.
C1 Univ Barcelona, Sch Med,August Pi & Sunyer Biomed Res Inst, Hosp Clin, Infect Dis Unit, Barcelona, Spain.
   Univ Barcelona, Dept Internal Med, Muscle Res Unit, Mitochrondrial Res Lab, Barcelona, Spain.
   Fdn Hosp Asil de Granollers, Dept Internal Med, Granollers, Catalonia, Spain.
C3 University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS;
   University of Barcelona
RP Hosp Clin Barcelona, Dept Internal Med, Muscle Res Unit, Villarroel 170, E-08036 Barcelona, Spain.
EM omiro@clinic.ub.es
RI Lopez, Sonia/AAC-8830-2019; Casademont, Jordi/A-6828-2010; Miro,
   Oscar/K-1798-2019
OI Garrabou, Gloria/0000-0001-8973-9933; MARTINEZ,
   ESTEBAN/0000-0002-6911-8846; Lopez, Sonia/0000-0002-5023-5153; Miro
   Andreu, Oscar/0000-0001-8127-166X; Milinkovic, Ana/0000-0002-7732-9168
CR Badley AD, 2003, TRENDS PHARMACOL SCI, V24, P298, DOI 10.1016/S0165-6147(03)00125-1
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Casademont J, 1996, BRAIN, V119, P1357, DOI 10.1093/brain/119.4.1357
   Chariot P, 1999, J HEPATOL, V30, P156, DOI 10.1016/S0168-8278(99)80020-8
   Chen D, 2002, EMBO J, V21, P6801, DOI 10.1093/emboj/cdf683
   Cherry CL, 2003, J CLIN VIROL, V26, P195, DOI 10.1016/S1386-6532(02)00118-X
   Cherry CL, 2002, J ACQ IMMUN DEF SYND, V30, P271, DOI [10.1097/00126334-200207010-00002, 10.1097/01.QAI.0000017962.22053.0E]
   Cossarizza A, 1997, AIDS, V11, P19, DOI 10.1097/00002030-199701000-00004
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Creaven M, 1999, BIOCHEMISTRY-US, V38, P8826, DOI 10.1021/bi9907274
   Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423
   Hammond EL, 2003, J CLIN VIROL, V27, P97, DOI 10.1016/S1386-6532(02)00134-8
   HEDLEY D, 1992, CYTOMETRY, V13, P686, DOI 10.1002/cyto.990130704
   Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Macho A, 1999, ONCOGENE, V18, P7543, DOI 10.1038/sj.onc.1203095
   Martin AM, 2003, AM J HUM GENET, V72, P549, DOI 10.1086/367849
   Miró O, 1999, CARCINOGENESIS, V20, P1331, DOI 10.1093/carcin/20.7.1331
   Miró O, 2003, AIDS RES HUM RETROV, V19, P1027, DOI 10.1089/088922203322588387
   Miró O, 2003, ANTIVIR THER, V8, P333
   Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200
   Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7
   Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861
   Plymale DR, 1999, AIDS, V13, P1827, DOI 10.1097/00002030-199910010-00004
   Poirier MC, 2003, JAIDS-J ACQ IMM DEF, V33, P175, DOI 10.1097/00126334-200306010-00010
   Shikuma CM, 2001, AIDS, V15, P1801, DOI 10.1097/00002030-200109280-00009
   Shiramizu B, 2003, JAIDS-J ACQ IMM DEF, V32, P370, DOI 10.1097/00126334-200304010-00004
   Strack PR, 1996, P NATL ACAD SCI USA, V93, P9571, DOI 10.1073/pnas.93.18.9571
   Vittecoq D, 2002, JAIDS, V31, P299, DOI 10.1097/00126334-200211010-00005
   Walker UA, 2002, J ACQ IMMUN DEF SYND, V29, P117, DOI 10.1097/00042560-200202010-00002
   Walker UA, 2004, HEPATOLOGY, V39, P311, DOI 10.1002/hep.20074
   Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510
   Wood E, 2002, J ACQ IMMUN DEF SYND, V30, P159, DOI [10.1097/01.QAI.0000014765.47046.5A, 10.1097/00042560-200206010-00004]
   Zaera MG, 2001, AIDS, V15, P1643, DOI 10.1097/00002030-200109070-00006
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
NR 36
TC 126
Z9 143
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 1
PY 2004
VL 39
IS 5
BP 710
EP 716
DI 10.1086/423176
PG 7
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Microbiology
GA 847CU
UT WOS:000223367500016
PM 15356787
OA Bronze
DA 2024-11-01
ER

PT J
AU Luigetti, M
   Primiano, G
   Cuccagna, C
   Bernardo, D
   Sauchelli, D
   Vollono, C
   Servidei, S
AF Luigetti, Marco
   Primiano, Guido
   Cuccagna, Cristina
   Bernardo, Daniela
   Sauchelli, Donato
   Vollono, Catello
   Servidei, Serenella
TI Small fibre neuropathy in mitochondrial diseases explored with sudoscan
SO CLINICAL NEUROPHYSIOLOGY
LA English
DT Article
DE Mitochondrial diseases; Small fibres; Peripheral neuropathy; Sudoscan;
   MELAS; MERRF; PEO
ID FAMILIAL AMYLOID POLYNEUROPATHY; SINGLE-CENTER EXPERIENCE; PERIPHERAL
   NEUROPATHY; NERVE-CONDUCTION; MUTATION; DISORDERS; MELAS; GENE; DNA
AB Objective: Polyneuropathy in mitochondrial diseases (MDs) is relatively common and widely investigated, but few data are instead reported about small fibres involvement.
   Methods: In order to investigate the involvement of small fibres in MDs we performed extensive neurophysiological test (nerve conduction studies; sympathetic skin response; sudoscan) in 27 patients with genetic diagnosis of MD (7 m. 3243A > G; 4 m. 8344A > G; 9 single mtDNA deletion; 7 multiple mtDNA deletions).
   Results: NCS showed a polyneuropathy in 11/27 cases (41%). The incidence was very high in POLG1 (100%), m. 8344A > G (75%) and m. 3243A > G (43%), while only 11% of patients with single deletion had evidence of large fibres involvement. Sympathetic skin response was abnormal only in three patients (one progressive external ophthalmoplegia with single mtDNA deletion; one patient with m. 3243A > G mutation; one patient with POLG1 mutation). Sudoscan revealed the presence of an autonomic small fibres dysfunction in 9/27 cases (33%), most of them (7/9) carrying a single mtDNA deletion. Sudoscan data were also confirmed in a sub-group of patients by laser evoked potentials study. Considering only patients with single mtDNA deletion 7/9 (78%) showed abnormal results at sudoscan.
   Conclusions: Small fibre neuropathy is another feature to investigate in mitochondrial diseases and seems specifically associated with the presence of single mtDNA deletion.
   Significance: The correct identification through specific neurophysiological tests of small fibres involvement in MDs represents another tile in this challenging diagnosis. (C) 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.
C1 [Luigetti, Marco; Primiano, Guido; Cuccagna, Cristina; Bernardo, Daniela; Sauchelli, Donato; Vollono, Catello; Servidei, Serenella] Univ Cattolica Sacro Cuore, UOC Neurol, Fdn Policlin Univ A Gemelli, Inst Neurol, Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Luigetti, M (corresponding author), UOC Neurol, Largo A Gemelli 8, I-00168 Rome, Italy.
EM mluigetti@gmail.com
RI Servidei, Serenella/ABC-4262-2021; Vollono, Catello/AAU-7072-2021;
   Cuccagna, Cristina/AAB-3967-2019; Primiano, Guido/AAB-7829-2019;
   Luigetti, Marco/J-2782-2018
OI Vollono, Catello/0000-0001-9371-8035; Primiano,
   Guido/0000-0001-7616-7008; SERVIDEI, Serenella/0000-0001-8478-2799;
   Cuccagna, Cristina/0000-0001-8180-2942; Luigetti,
   Marco/0000-0001-7539-505X
CR [Anonymous], 1989, ELECTRODIAGNOSIS DIS
   Ayoub H, 2012, DEV ELECTROCHEMISTRY
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Castro J, 2016, CLIN NEUROPHYSIOL, V127, P2222, DOI 10.1016/j.clinph.2016.02.013
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Conceicao IM, 2008, CLIN NEUROPHYSIOL, V119, P1082, DOI 10.1016/j.clinph.2008.01.006
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Haanpää M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031
   Henning F, 2007, J NEUROL, V254, P1281, DOI 10.1007/s00415-006-0487-2
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   KUNDE V, 1993, ELECTROEN CLIN NEURO, V88, P280, DOI 10.1016/0168-5597(93)90052-Q
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lehmann HC, 2011, ANN NEUROL, V69, P100, DOI 10.1002/ana.22150
   Luigetti M, 2016, EUR J NEUROL, V23, pE55, DOI 10.1111/ene.13049
   Luigetti M, 2016, EUR J NEUROL, V23, P1020, DOI 10.1111/ene.12954
   Luigetti M, 2013, CLIN NEUROPHYSIOL, V124, P1899, DOI 10.1016/j.clinph.2013.02.116
   Luigetti M, 2012, CLIN NEUROPHYSIOL, V123, P1891, DOI 10.1016/j.clinph.2012.02.075
   Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Merolli A, 2013, J RECONSTR MICROSURG, V29, DOI 10.1055/s-0033-1348038
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Persson AK, 2016, TRENDS MOL MED, V22, P377, DOI 10.1016/j.molmed.2016.03.008
   Primiano G, 2014, NEUROLOGY, V82, P1932, DOI 10.1212/WNL.0000000000000458
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rawson RL, 2014, CURR BIOL, V24, P760, DOI 10.1016/j.cub.2014.02.025
   Yajnik Chittaranjan S, 2012, ISRN Endocrinol, V2012, P103714, DOI 10.5402/2012/103714
   Zochodne DW, 2007, MUSCLE NERVE, V36, P144, DOI 10.1002/mus.20785
NR 32
TC 14
Z9 14
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1388-2457
EI 1872-8952
J9 CLIN NEUROPHYSIOL
JI Clin. Neurophysiol.
PD AUG
PY 2018
VL 129
IS 8
BP 1618
EP 1623
DI 10.1016/j.clinph.2018.04.755
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA GM5BB
UT WOS:000438140900016
PM 29890373
DA 2024-11-01
ER

PT J
AU Fontanesi, F
   Palmieri, L
   Scarcia, P
   Lodi, T
   Donnini, C
   Limongelli, A
   Tiranti, V
   Zeviani, M
   Ferrero, I
   Viola, AM
AF Fontanesi, F
   Palmieri, L
   Scarcia, P
   Lodi, T
   Donnini, C
   Limongelli, A
   Tiranti, V
   Zeviani, M
   Ferrero, I
   Viola, AM
TI Mutations in <i>AAC2</i>, equivalent to human adPEO-associated ANT1
   mutations, lead to defective oxidative phosphorylation in
   <i>Saccharomyces cerevisiae</i> and affect mitochondrial DNA stability
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ADENINE-NUCLEOTIDE TRANSLOCASE;
   YEAST MITOCHONDRIA; ADP/ATP CARRIER; MULTIPLE DELETIONS;
   ESCHERICHIA-COLI; PROTEINS; GENE; TRANSFORMATION; TRANSPORT
AB Autosomal dominant and recessive forms of progressive external ophthalmoplegia (adPEO and arPEO) are mitochondrial disorders characterized by the presence of multiple deletions of mitochondrial DNA in affected tissues. Four adPEO-associated missense mutations have been identified in the ANT1 gene. In order to investigate their functional consequences on cellular physiology, we introduced three of them at equivalent positions in AAC2, the yeast orthologue of human ANT1. We demonstrate here that expression of the equivalent mutations in aac2-defective haploid strains of Saccharomyces cerevisiae results in (a) a marked growth defect on non-fermentable carbon sources, and (b) a concurrent reduction of the amount of mitochondrial cytochromes, cytochrome c oxidase activity and cellular respiration. The efficiency of ATP and ADP transport was variably affected by the different AAC2 mutations. However, irrespective of the absolute level of activity, the AAC2 pathogenic mutants showed a significant defect in ADP versus ATP transport compared with wild-type AAC2. In order to study whether a dominant phenotype, as in humans, could be observed, the aac2 mutant alleles were also inserted in combination with the endogenous wild-type AAC2 gene. The heteroallelic strains behaved as recessive for oxidative growth and petite-negative phenotype. In contrast, reduction in cytochrome content and increased mtDNA instability appeared to behave as dominant traits in heteroallelic strains. Our results indicate that S. cerevisiae is a suitable in vivo model to study the pathogenicity of the human ANT1 mutations and the pathophysiology leading to impairment of oxidative phosphorylation and damage of mtDNA integrity, as found in adPEO.
C1 Univ Parma, Dept Genet Anthropol Evolut, I-43100 Parma, Italy.
   Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, I-70125 Bari, Italy.
   Natl Neurol Inst C Besta, Div Mol Neurogenet, I-20126 Milan, Italy.
   CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy.
C3 University of Parma; Universita degli Studi di Bari Aldo Moro;
   Fondazione IRCCS Istituto Neurologico Carlo Besta; Consiglio Nazionale
   delle Ricerche (CNR)
RP Univ Parma, Dept Genet Anthropol Evolut, Parco Area Sci 11-A, I-43100 Parma, Italy.
EM iferrero@unipr.it
RI Scarcia, Pasquale/O-9550-2019; Tiranti, Valeria/AFN-5783-2022; Zeviani,
   Massimo/AAU-2632-2021; Scarcia, Pasquale/A-8830-2010; Lodi,
   Tiziana/A-5993-2012; Tiranti, Valeria/J-8233-2016; Donnini,
   Claudia/B-5548-2015
OI Scarcia, Pasquale/0000-0001-6216-0411; Fontanesi,
   Flavia/0000-0003-0509-3835; Lodi, Tiziana/0000-0002-7294-8971; Zeviani,
   Massimo/0000-0002-9067-5508; Tiranti, Valeria/0000-0002-3584-7338;
   Donnini, Claudia/0000-0002-4901-2358
FU Telethon [GGP030039] Funding Source: Medline
CR ADRIAN GS, 1986, MOL CELL BIOL, V6, P626, DOI 10.1128/MCB.6.2.626
   [Anonymous], METHOD ENZYMOL
   APRILLE JR, 1988, FASEB J, V2, P2547, DOI 10.1096/fasebj.2.10.3290024
   AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V2
   Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493
   BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609
   BULDER CJE, 1964, ANTON VAN LEE J M S, V30, P442, DOI 10.1007/BF02046758
   Capobianco L, 1996, BIOCHEMISTRY-US, V35, P8974, DOI 10.1021/bi960258v
   Chen XJ, 2002, HUM MOL GENET, V11, P1835, DOI 10.1093/hmg/11.16.1835
   CHEN YS, 1981, BIOCHEMISTRY-US, V20, P7557, DOI 10.1021/bi00529a034
   Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC
   DAUM G, 1982, J BIOL CHEM, V257, P3075
   DEFONTAINE A, 1991, NUCLEIC ACIDS RES, V19, P185, DOI 10.1093/nar/19.1.185
   DRGON T, 1992, FEBS LETT, V304, P277, DOI 10.1016/0014-5793(92)80637-V
   Dujon B., 1981, MOL BIOL YEAST SACCH, P505
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   FERRERO I, 1981, A VAN LEEUW J MICROB, V47, P11, DOI 10.1007/BF00399063
   Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7
   HAIDKAMPER D, 1996, BIOCHEMISTRY-US, V35, P16144
   Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8
   HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4
   ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445
   KLINGENBERG M, 1979, TRENDS BIOCHEM SCI, V4, P249, DOI 10.1016/0968-0004(79)90215-9
   KOLAROV J, 1990, J BIOL CHEM, V265, P12711
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   KOVACOVA V, 1968, BIOCHIM BIOPHYS ACTA, V162, P157, DOI 10.1016/0005-2728(68)90097-2
   KRAMER R, 1979, BIOCHEMISTRY-US, V18, P4209
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAWSON JE, 1988, J BIOL CHEM, V263, P14812
   Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490
   Muller V, 1996, BIOCHEMISTRY-US, V35, P16132, DOI 10.1021/bi960667r
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   NASMYTH KA, 1980, P NATL ACAD SCI-BIOL, V77, P2119, DOI 10.1073/pnas.77.4.2119
   OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928
   Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3
   Sambrook J, 1990, Cold Spring Harbor Laboratories, V186, P182
   SCHERER B, 1974, BIOCHEMISTRY-US, V13, P161, DOI 10.1021/bi00698a025
   Sherman F., 1986, LAB COURSE MANUAL ME
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   SLONIMSKI PP, 1968, BIOCHEM BIOPH RES CO, V30, P232, DOI 10.1016/0006-291X(68)90440-3
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200
   TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
   Zara V, 1996, MOL CELL BIOL, V16, P6524
   ZEVIANI M, 1989, NEUROL CLIN, V7, P123, DOI 10.1016/S0733-8619(18)30832-6
NR 51
TC 64
Z9 67
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 1
PY 2004
VL 13
IS 9
BP 923
EP 934
DI 10.1093/hmg/ddh108
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 813GW
UT WOS:000220896600003
PM 15016764
OA Bronze
DA 2024-11-01
ER

PT J
AU Güçer, S
   Talim, B
   Asan, E
   Korkusuz, P
   Özen, S
   Ünal, S
   Kalkanoglu, SH
   Kale, G
   Çaglar, M
AF Güçer, S
   Talim, B
   Asan, E
   Korkusuz, P
   Özen, S
   Ünal, S
   Kalkanoglu, SH
   Kale, G
   Çaglar, M
TI Focal segmental glomerulosclerosis associated with mitochondrial
   cytopathy:: Report of two cases with special emphasis on podocytes
SO PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
LA English
DT Article
DE focal segmental glomerulosclerosis; mitochondrial cytopathy; childhood;
   electron microscopy; podocyte
ID DEBRE-FANCONI-SYNDROME; DNA; MUTATIONS; DELETION; DISEASE
AB We report two children with focal segmental glomerulosclerosis (FSGS) associated with mitochondrial cytopathy (MC). Case 1 was diagnosed as MC with the findings of ptosis, ophthalmoplegia, failure to thrive, high serum lactate and pyruvate levels, ragged red fibers in muscle biopsy and the common 4.9 kb deletion in mtDNA when she was four years old. She subsequently developed FSGS four years later. Case 2 was a four month-old girl presenting with feeding difficulty from birth, with vomiting, seizures and nystagmoid eye movements, nephrotic proteinuria and hematuria. Renal biopsy revealed FSGS. Ultrastructural study demonstrated markedly pleomorphic mitochondria in podocytes with a severe effacement of foot processes. The analyses of muscle biopsy and skin fibroblasts for respiratory chain enzymes were found to be normal, while mitochondrial DNA analysis revealed the population of a single deleted mtDNA in the heteroplasmic state. The present cases illustrate FSGS as a rare renal complication of mitochondrial disease and provide further evidence of podocytes possessing abnormal mitochondria which may cause glomerular epithelial cell damage leading to glomerulosclerosis.
C1 Hacettepe Univ, Fac Med, Dept Pediat, Pathol Unit, TR-06100 Ankara, Turkey.
   Hacettepe Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey.
   Hacettepe Univ, Fac Med, Dept Pediat, Nephrol & Rheumatol Unit, TR-06100 Ankara, Turkey.
C3 Hacettepe University; Hacettepe University; Hacettepe University
RP Hacettepe Univ, Fac Med, Dept Pediat, Pathol Unit, TR-06100 Ankara, Turkey.
EM sgucer@hacettepe.edu.tr
RI UNAL, SERHAT/I-9034-2013; KORKUSUZ, PETEK/JCD-9195-2023
OI KORKUSUZ, PETEK/0000-0002-7553-3915
CR Borisov VB, 2002, MOL ASPECTS MED, V23, P385, DOI 10.1016/S0098-2997(02)00013-4
   Buemi M, 1997, NEPHRON, V76, P249, DOI 10.1159/000190188
   DEGIROLAMI U, 2000, DIAGNOSTIC ELECT MIC, P912
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   EVIATAR L, 1990, NEUROLOGY, V40, P1761, DOI 10.1212/WNL.40.11.1761
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456
   Kurogouchi F, 1998, AM J NEPHROL, V18, P551, DOI 10.1159/000013406
   LINDAL S, 1992, ULTRASTRUCT PATHOL, V16, P263, DOI 10.3109/01913129209061355
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   MORRIS AAM, 1995, PEDIATR NEPHROL, V9, P407, DOI 10.1007/BF00866711
   NAGATA M, 1992, KIDNEY INT, V42, P148, DOI 10.1038/ki.1992.272
   NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164, DOI 10.1007/BF00865468
   Niaudet P, 1997, KIDNEY INT, V51, P1000, DOI 10.1038/ki.1997.140
   Patterson K, 2004, PEDIATR DEVEL PATHOL, V7, P629, DOI 10.1007/s10024-004-5051-4
   Rutledge JC, 2004, PEDIATR DEVEL PATHOL, V7, P641, DOI 10.1007/s10024-004-5049-y
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   SPERL W, 1988, EUR J PEDIATR, V147, P418, DOI 10.1007/BF00496424
   THORNER P S, 1985, Pediatric Pathology, V4, P25
   Unal S, 2005, J CHILD NEUROL, V20, P83, DOI 10.1177/08830738050200011304
   Yamagata K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019772.17954.F8
NR 23
TC 53
Z9 59
U1 0
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1093-5266
EI 1615-5742
J9 PEDIATR DEVEL PATHOL
JI Pediatr. Dev. Pathol.
PD DEC
PY 2005
VL 8
IS 6
BP 710
EP 717
DI 10.1007/s10024-005-0058-z
PG 8
WC Pathology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Pediatrics
GA 995ZY
UT WOS:000234145400017
PM 16328667
DA 2024-11-01
ER

PT J
AU Kemp, JP
   Smith, PM
   Pyle, A
   Neeve, VCM
   Tuppen, HAL
   Schara, U
   Talim, B
   Topaloglu, H
   Holinski-Feder, E
   Abicht, A
   Czermin, B
   Lochmüller, H
   McFarland, R
   Chinnery, PF
   Chrzanowska-Lightowlers, ZM
   Lightowlers, RN
   Taylor, RW
   Horvath, R
AF Kemp, John P.
   Smith, Paul M.
   Pyle, Angela
   Neeve, Vivienne C. M.
   Tuppen, Helen A. L.
   Schara, Ulrike
   Talim, Beril
   Topaloglu, Haluk
   Holinski-Feder, Elke
   Abicht, Angela
   Czermin, Birgit
   Lochmueller, Hanns
   McFarland, Robert
   Chinnery, Patrick F.
   Chrzanowska-Lightowlers, Zofia M. A.
   Lightowlers, Robert N.
   Taylor, Robert W.
   Horvath, Rita
TI Nuclear factors involved in mitochondrial translation cause a subgroup
   of combined respiratory chain deficiency
SO BRAIN
LA English
DT Article
DE mitochondrial translation; combined respiratory chain deficiency;
   early-onset encephalomyopathy
ID SIDEROBLASTIC ANEMIA-MLASA; C-OXIDASE DEFICIENCY; RNA-SYNTHETASE GENE;
   DNA DEPLETION; MOLECULAR-BASIS; MUTATION; DISEASE; MYOPATHY;
   LEUKOENCEPHALOPATHY; ENCEPHALOMYOPATHY
AB Mutations in several mitochondrial DNA and nuclear genes involved in mitochondrial protein synthesis have recently been reported in combined respiratory chain deficiency, indicating a generalized defect in mitochondrial translation. However, the number of patients with pathogenic mutations is small, implying that nuclear defects of mitochondrial translation are either underdiagnosed or intrauterine lethal. No comprehensive studies have been reported on large cohorts of patients with combined respiratory chain deficiency addressing the role of nuclear genes affecting mitochondrial protein synthesis to date. We investigated a cohort of 52 patients with combined respiratory chain deficiency without causative mitochondrial DNA mutations, rearrangements or depletion, to determine whether a defect in mitochondrial translation defines the pathomechanism of their clinical disease. We followed a combined approach of sequencing known nuclear genes involved in mitochondrial protein synthesis (EFG1, EFTu, EFTs, MRPS16, TRMU), as well as performing in vitro functional studies in 22 patient cell lines. The majority of our patients were children (< 15 years), with an early onset of symptoms < 1 year of age (65%). The most frequent clinical presentation was mitochondrial encephalomyopathy (63%); however, a number of patients showed cardiomyopathy (33%), isolated myopathy (15%) or hepatopathy (13%). Genomic sequencing revealed compound heterozygous mutations in the mitochondrial transfer ribonucleic acid modifying factor (TRMU) in a single patient only, presenting with early onset, reversible liver disease. No pathogenic mutation was detected in any of the remaining 51 patients in the other genes analysed. In vivo labelling of mitochondrial polypeptides in 22 patient cell lines showed overall (three patients) or selective (four patients) defects of mitochondrial translation. Immunoblotting for mitochondrial proteins revealed decreased steady state levels of proteins in some patients, but normal or increased levels in others, indicating a possible compensatory mechanism. In summary, candidate gene sequencing in this group of patients has a very low detection rate (1/52), although in vivo labelling of mitochondrial translation in 22 patient cell lines indicate that a nuclear defect affecting mitochondrial protein synthesis is responsible for about one-third of combined respiratory chain deficiencies (7/22). In the remaining patients, the impaired respiratory chain activity is most likely the consequence of several different events downstream of mitochondrial translation. Clinical classification of patients with biochemical analysis, genetic testing and, more importantly, in vivo labelling and immunoblotting of mitochondrial proteins show incoherent results, but a systematic review of these data in more patients may reveal underlying mechanisms, and facilitate the identification of novel factors involved in combined respiratory chain deficiency.
C1 [Horvath, Rita] Newcastle Univ, Inst Human Genet, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Kemp, John P.; Smith, Paul M.; Pyle, Angela; Neeve, Vivienne C. M.; Tuppen, Helen A. L.; McFarland, Robert; Chinnery, Patrick F.; Chrzanowska-Lightowlers, Zofia M. A.; Lightowlers, Robert N.; Taylor, Robert W.; Horvath, Rita] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Pyle, Angela; Neeve, Vivienne C. M.; Holinski-Feder, Elke; Abicht, Angela; Czermin, Birgit; Horvath, Rita] Ctr Med Genet, Munich, Germany.
   [Schara, Ulrike] Univ Essen Gesamthsch, Dept Paediat Neurol, Essen, Germany.
   [Talim, Beril; Topaloglu, Haluk] Hacettepe Univ, Paediat Pathol Unit, Dept Paediat, Ankara, Turkey.
C3 Newcastle University - UK; Newcastle University - UK; University of
   Duisburg Essen; Hacettepe University
RP Horvath, R (corresponding author), Newcastle Univ, Inst Human Genet, Mitochondrial Res Grp, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM Rita.Horvath@ncl.ac.uk
RI TOPALOGLU, HALUK/I-9318-2013; Horvath, Rita/AAY-7042-2020; TALIM,
   BERIL/I-9103-2013; Kemp, John/R-3091-2018
OI Lochmuller, Hanns/0000-0003-2324-8001; Tuppen,
   Helen/0000-0001-8762-0824; McFarland, Robert/0000-0002-8833-2688; Kemp,
   John/0000-0002-9105-2249; Chinnery, Patrick/0000-0002-7065-6617;
   Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152; Horvath,
   Rita/0000-0002-9841-170X
FU Newcastle upon Tyne Hospitals NHS Charity [RES0211/7262]; Academy of
   Medical Sciences, UK [BH090164]; Parkinson's Disease Society (UK);
   Medical Research Council Translational Muscle Centre; UK NIHR Biomedical
   Research Centre in Aging and Age-related disease; Wellcome Trust
   [074454/Z/04/Z]; Biotechnology and Biological Sciences Research Council
   [BB/F011520/1]; Medical Research Council [G0700718]; German ministry of
   education and research (BMBF, Bonn, Germany); UK National Commissioning
   Group; MRC Centre for Translational Research in Neuromuscular Disease
   Mitochondrial Disease Patient Cohort (UK); BBSRC [BB/F011520/1] Funding
   Source: UKRI; MRC [G0800674, G0700718, G0601943] Funding Source: UKRI
FX Newcastle upon Tyne Hospitals NHS Charity (RES0211/7262 to R. H.);
   Academy of Medical Sciences, UK (BH090164 to R. H.); Wellcome Trust
   Senior Fellow in Clinical Science (to P. F. C.); Parkinson's Disease
   Society (UK), the Medical Research Council Translational Muscle Centre
   and the UK NIHR Biomedical Research Centre in Aging and Age-related
   disease. Wellcome Trust and the MRC Centre for Translational Research in
   Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK) (to R.
   W. T.); The Wellcome Trust (074454/Z/04/Z to R.N.L. and Z.M.A.C.L.),
   Biotechnology and Biological Sciences Research Council (BB/F011520/1 to
   R.N.L. and Z.M.A.C.L.) and the Medical Research Council (G0700718). The
   Muscle Tissue Culture Collection is part of the German network on
   muscular dystrophies (MD-NET, service structure S1, 01GM0601) funded by
   the German ministry of education and research (BMBF, Bonn, Germany). The
   Newcastle Biobank is part of the MRC Centre for Neuromuscular Diseases,
   UK. The Muscle Tissue Culture Collection is a partner of EuroBioBank
   (www.eurobiobank.org) and TREAT-NMD (EC, 6th FP, proposal # 036825).
   Mitochondrial diagnostic testing in Newcastle is funded by the UK
   National Commissioning Group to provide the 'Rare Mitochondrial
   Disorders of Adults and Children' service
   (http://www.mitochondrialncg.nhs.uk).
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   Isohanni P, 2010, J MED GENET, V47, P66, DOI 10.1136/jmg.2009.068221
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Karadimas C, 2001, J CHILD NEUROL, V16, P531, DOI 10.1177/088307380101600715
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Munaro M, 1997, HUM MOL GENET, V6, P221, DOI 10.1093/hmg/6.2.221
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Sasarman F, 2002, HUM MOL GENET, V11, P1669, DOI 10.1093/hmg/11.14.1669
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 41
TC 59
Z9 69
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD JAN
PY 2011
VL 134
BP 183
EP 195
DI 10.1093/brain/awq320
PN 1
PG 13
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 698WK
UT WOS:000285625000017
PM 21169334
OA Green Published, Green Submitted, Bronze
DA 2024-11-01
ER

PT J
AU Luoma, PT
   Eerola, J
   Ahola, S
   Hakonen, AH
   Hellström, O
   Kivistö, KT
   Tienari, PJ
   Suomalainen, A
AF Luoma, P. T.
   Eerola, J.
   Ahola, S.
   Hakonen, A. H.
   Hellstroem, O.
   Kivistoe, K. T.
   Tienari, P. J.
   Suomalainen, A.
TI Mitochondrial DNA polymerase gamma variants in idiopathic sporadic
   Parkinson disease
SO NEUROLOGY
LA English
DT Article
ID SUBSTANTIA-NIGRA NEURONS; TRINUCLEOTIDE CAG REPEAT; POLG MUTATIONS;
   GENE; DELETIONS; FAMILY; ATAXIA; OPHTHALMOPLEGIA; DISORDERS; BRAIN
AB Objective: Dysfunction of mitochondrial DNA polymerase gamma ( POLG) has been recently recognized as an important cause of inherited neurodegenerative diseases. We have reported dominant and recessive inheritance of parkinsonism, mitochondrial myopathy, and premature amenorrhea in five ethnically distinct families with POLG1 mutations. This prompted us to carry out a detailed analysis of the coding region and intron- exon boundaries of POLG1 in Finnish patients with idiopathic sporadic Parkinson disease ( PD) and in nonparkinsonian controls.
   Methods: The coding region of POLG1 was analyzed in 140 Finnish patients with PD and their 127 spouses as age- and ethnically matched controls. Further, we analyzed the intragenic CAGrepeat region of POLG1 in 126 additional patients with nonparkinsonian neurologic disorders and in 516 Finnish population controls.
   Results: We found clustering of rare variants of the POLG1 CAG- repeat, encoding a polyglutamine tract, in Finnish patients with idiopathic PD as compared to their spouses ( p = 0.003; OR 3.01, 95% CI 1.35 to 6.71), population controls ( p = 0.001; OR 2.45, 95% CI 1.45 to 4.14), and patients with nonparkinsonian neurologic disorders ( p = 0.05, OR 1.98, 95% CI 0.97 to 4.05). We found several amino acid substitutions, none of them associating with PD. These included a previously parkinsonism- associated POLG variant Y831C, found in one patient with PD, but also in five controls, suggesting that it is a neutral amino acid polymorphism.
   Conclusions: Our results suggest that POLG polyglutamine tract variants should be considered as a predisposing genetic factor in idiopathic sporadic Parkinson disease.
C1 Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, Helsinki 00290, Finland.
   Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00014 Helsinki, Finland.
   Seinajoki Cent Hosp, Seinajoki, Finland.
   Tampere Univ, Dept Pharmacol Sci, FIN-33101 Tampere, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University
   Central Hospital; Seinajoki Central Hospital; Tampere University
RP Suomalainen, A (corresponding author), Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, Room C523B,Haartmaninkatu 8, Helsinki 00290, Finland.
EM anu.wartiovaara@helsinki.fi
RI Tienari, Pentti/A-4893-2012; Ahola, Sofia/JEP-4595-2023
OI Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Ahola,
   Sofia/0000-0001-7552-4843; Tienari, Pentti/0000-0001-5686-2900
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   CHAN SS, 2006, HUM MOL GENET
   CLARIMON J, 2005, NEUROBIOL AGING
   Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Eerola J, 2005, J NEUROL NEUROSUR PS, V76, P1211, DOI 10.1136/jnnp.2004.045237
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Ide M, 2005, HUM GENET, V117, P520, DOI 10.1007/s00439-005-1342-8
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219
   LANGSTON JW, 1984, BRAIN RES, V292, P390
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Malyarchuk BA, 2005, HUM BIOL, V77, P355, DOI 10.1353/hub.2005.0050
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   MIZUNO Y, 1987, J NEUROCHEM, V48, P1787, DOI 10.1111/j.1471-4159.1987.tb05737.x
   Myllykangas L, 2005, J NEUROL SCI, V236, P17, DOI 10.1016/j.jns.2005.04.008
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Payami H, 2003, MOVEMENT DISORD, V18, P425, DOI 10.1002/mds.10375
   Rovio A, 1999, EUR J HUM GENET, V7, P140, DOI 10.1038/sj.ejhg.5200244
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Rovio AT, 2004, MAMM GENOME, V15, P492, DOI 10.1007/s00335-004-3049-x
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   TIANGYOU W, 2006, IDIOPATHIC PARKINSON
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
NR 36
TC 106
Z9 124
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD SEP 11
PY 2007
VL 69
IS 11
BP 1152
EP 1159
DI 10.1212/01.wnl.0000276955.23735.eb
PG 8
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 208VA
UT WOS:000249346100012
PM 17846414
DA 2024-11-01
ER

PT J
AU Tarnopoisky, M
   Meaney, B
   Robinson, B
   Sheidon, K
   Boles, RG
AF Tarnopoisky, Mark
   Meaney, Brandon
   Robinson, Brian
   Sheidon, Katherine
   Boles, Richard G.
TI Severe Infantile Leigh Syndrome Associated With a Rare Mitochondrial
   <i>ND</i>6 Mutation, m.14487T&gt;C
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE Leigh disease; deep sequencing; homoplasmy; mitochondrial disease
ID PRENATAL-DIAGNOSIS; MTDNA
AB We describe a case of severe infantile-onset complex I deficiency in association with an apparent de novo near-homoplasmic mutation (m.14487T>C) in the mitochondrial ND6 gene, which was previously associated with Leigh syndrome and other neurological disorders. The mutation was near-homoplasmic in muscle by NextGen sequencing (99.4% mutant), homoplasmic in muscle by Sanger sequencing, and it was associated with a severe complex I deficiency in both muscle and fibroblasts. This supports previous data regarding Leigh syndrome being on the severe end of a phenotypic spectrum including progressive myoclonic epilepsy, childhood-onset dystonia, bilateral striatal necrosis, and optic atrophy, depending on the proportion of mutant heteroplasmy. While the mother in all previously reported cases was heteroplasmic, the mother and brother of this case were homoplasmic for the wild-type, m.14487T. Importantly, the current data demonstrate the potential for cases of mutations that were previously reported to be homoplasmic by Sanger sequencing to be less homoplasmic by NextGen sequencing. This case underscores the importance of considering mitochondrial DNA mutations in families with a negative family history, even in offspring of those who have tested negative for a specific mtDNA mutation. Copyright (C) 2013 Wiley Periodicals, Inc.
C1 [Tarnopoisky, Mark; Meaney, Brandon] McMaster Univ, Med Ctr, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   [Robinson, Brian] Hosp Sick Children, Dept Genet & Genome Biol, Toronto, ON M5G 1X8, Canada.
   [Sheidon, Katherine; Boles, Richard G.] Courtagen Diagnost Lab, Woburn, MA USA.
C3 McMaster University; University of Toronto; Hospital for Sick Children
   (SickKids)
RP Tarnopoisky, M (corresponding author), McMaster Univ, Dept Pediat, 1200 Main St W,HSC 2H26, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
RI Meaney, Brandon/AAY-1138-2021; Robinson, B/LBH-2242-2024
FU Warren Lammert and Family; Dan Wright and family; MitoCanada
FX Grant sponsor: Warren Lammert and Family; Grant sponsor: Dan Wright and
   family; Grant sponsor: MitoCanada.
CR Christodoulou J, 1992, AM J HUM GENET, V50, P852
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   Fujii T, 1998, PEDIATR NEUROL, V18, P275, DOI 10.1016/S0887-8994(97)00187-2
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Robinson BH, 2001, SEMIN NEUROL, V21, P269, DOI 10.1055/s-2001-17944
   ROBINSON BH, 1994, J BIOENERG BIOMEMBR, V26, P311, DOI 10.1007/BF00763102
   Safdar A, 2010, PLOS ONE, V5
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Wang J, 2009, MOL GENET METAB, V96, P59, DOI 10.1016/j.ymgme.2008.10.006
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
NR 12
TC 19
Z9 21
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD AUG
PY 2013
VL 161
IS 8
BP 2020
EP 2023
DI 10.1002/ajmg.a.36000
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 263EM
UT WOS:000327789600026
PM 23813926
DA 2024-11-01
ER

PT J
AU Peter, B
   Farge, G
   Pardo-Hernandez, C
   Tångefjord, S
   Falkenberg, M
AF Peter, Bradley
   Farge, Geraldine
   Pardo-Hernandez, Carlos
   Tangefjord, Stefan
   Falkenberg, Maria
TI Structural basis for adPEO-causing mutations in the mitochondrial
   TWINKLE helicase
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; STRUCTURE-FUNCTION DEFECTS;
   IMAGE-PROCESSING PACKAGE; STRANDED-DNA-BINDING; CRYSTAL-STRUCTURE;
   LINKER REGION; MULTIPLE DELETIONS; PRIMASE-HELICASE; UL8 SUBUNIT;
   PROTEIN
AB TWINKLE is the helicase involved in replication and maintenance of mitochondrial DNA (mtDNA) in mammalian cells. Structurally, TWINKLE is closely related to the bacteriophage T7 gp4 protein and comprises a helicase and primase domain joined by a flexible linker region. Mutations in and around this linker region are responsible for autosomal dominant progressive external ophthalmoplegia (adPEO), a neuromuscular disorder associated with deletions in mtDNA. The underlying molecular basis of adPEO-causing mutations remains unclear, but defects in TWINKLE oligomerization are thought to play a major role. In this study, we have characterized these disease variants by single-particle electron microscopy and can link the diminished activities of the TWINKLE variants to altered oligomeric properties. Our results suggest that the mutations can be divided into those that (i) destroy the flexibility of the linker region, (ii) inhibit ring closure and (iii) change the number of subunits within a helicase ring. Furthermore, we demonstrate that wild-type TWINKLE undergoes large-scale conformational changes upon nucleoside triphosphate binding and that this ability is lost in the disease-causing variants. This represents a substantial advancement in the understanding of the molecular basis of adPEO and related pathologies and may aid in the development of future therapeutic strategies.
C1 [Peter, Bradley; Pardo-Hernandez, Carlos; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.
   [Farge, Geraldine] Univ Clermont Auvergne, Inst Natl Phys Nucl & Particules, Ctr Nacl Rech Sci, Lab Phys Clermont, BP 10448, F-63000 Clermont Ferrand, France.
   [Tangefjord, Stefan] AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden.
C3 University of Gothenburg; Centre National de la Recherche Scientifique
   (CNRS); CNRS - National Institute of Nuclear and Particle Physics
   (IN2P3); Universite Clermont Auvergne (UCA); AstraZeneca
RP Peter, B (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.
EM peter.bradley@gu.se
RI farge, geraldine/M-2803-2018
OI farge, geraldine/0000-0003-1054-4274; Falkenberg,
   Maria/0000-0001-8713-173X
FU Swedish Research Council [VR521-2013-3621]; Swedish Cancer Foundation
   [CAN 2016/816]; European Research Council [683191]; Inga Britt and Arne
   Lundberg Foundation; Knut and Alice Wallenbergs Foundation [KAW 2011,
   KAW 2014]; Association Francaise Contre les Myopathies Telethon [21411];
   European Research Council (ERC) [683191] Funding Source: European
   Research Council (ERC)
FX Swedish Research Council (VR521-2013-3621 to M.F.); Swedish Cancer
   Foundation (CAN 2016/816 to M.F.); European Research Council (683191 to
   M.F.); Inga Britt and Arne Lundberg Foundation; Knut and Alice
   Wallenbergs Foundation (KAW 2011 to M.F., KAW 2014 to M.F.); Association
   Francaise Contre les Myopathies Telethon (21411 to G.F.). We also
   acknowledge the Centre for Cellular Imaging at the University of
   Gothenburg and the National Microscopy Infrastructure (VR-RFI
   2016-00968) for providing assistance in microscopy.
CR Ariza A, 2005, NUCLEIC ACIDS RES, V33, P1465, DOI 10.1093/nar/gki288
   Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353
   Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101
   Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037
   Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Fernández-Millán P, 2015, NUCLEIC ACIDS RES, V43, P4284, DOI 10.1093/nar/gkv189
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   Hirano M, 2001, CURR OPIN CARDIOL, V16, P201, DOI 10.1097/00001573-200105000-00008
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kulczyk AW, 2017, P NATL ACAD SCI USA, V114, pE1848, DOI 10.1073/pnas.1701252114
   Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200
   Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200
   LeGac NT, 1996, J BIOL CHEM, V271, P21645
   Leipe DD, 2000, GENOME RES, V10, P5
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   O'Shea VL, 2014, CURR OPIN STRUC BIOL, V25, P16, DOI 10.1016/j.sbi.2013.11.006
   PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824
   Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088
   RICHARDSON JS, 1988, PROTEINS, V4, P229, DOI 10.1002/prot.340040402
   Sagermann M, 2002, PROTEIN SCI, V11, P516, DOI 10.1110/ps.39802
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62
   Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992
   Scheres SHW, 2009, J STRUCT BIOL, V166, P234, DOI 10.1016/j.jsb.2009.02.007
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5
   Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wallen JR, 2017, STRUCTURE, V25, P157, DOI 10.1016/j.str.2016.11.019
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang Y, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/37/374101
NR 50
TC 15
Z9 18
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD APR 1
PY 2019
VL 28
IS 7
BP 1090
EP 1099
DI 10.1093/hmg/ddy415
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA HR6FL
UT WOS:000463244700004
PM 30496414
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Blakely, EL
   Trip, SA
   Swalwell, H
   He, LP
   Wren, DR
   Rich, P
   Turnbull, DM
   Omer, SE
   Taylor, RW
AF Blakely, Emma L.
   Trip, S. Anand
   Swalwell, Helen
   He, Langping
   Wren, Damian R.
   Rich, Philip
   Turnbull, Douglass M.
   Omer, Salah E.
   Taylor, Robert W.
TI A New Mitochondrial Transfer RNA<SUP>Pro</SUP> Gene Mutation Associated
   With Myoclonic Epilepsy With Ragged-Red Fibers and Other Neurological
   Features
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID TRANSFER-RNA; MTDNA MUTATION; SKELETAL-MUSCLE; POINT MUTATION; DNA
   MUTATIONS; HUMAN-DISEASE; PATIENT; MERRF; TRANSMISSION; TRNA(LYS)
AB Background: Pathogenic mutations of the human mitochondrial genome are associated with well-characterized, progressive neurological syndromes, with mutations in the transfer RNA genes being particularly prominent.
   Objective: To describe a novel mitochondrial transfer RNA(Pro) gene mutation in a woman with a myoclonic epilepsy with ragged-red fibers-like disease.
   Design, Setting, and Patient: Case report of a 49-year-old woman presenting with a myoclonic epilepsy with ragged-red fibers-like disease comprising myoclonic jerks, cerebellar ataxia, and proximal muscle weakness.
   Results: Histochemical analysis of a muscle biopsy revealed numerous cytochrome-c oxidase-deficient, ragged-red fibers, while biochemical studies indicated decreased activity of respiratory chain complex I. Molecular investigation of mitochondrial DNA revealed a new heteroplasmic mutation in the T psi C stem of the mitochondrial transfer RNA(Pro) gene that segregated with cytochrome-c oxidase deficiency in single muscle fibers.
   Conclusions: Our case serves to illustrate the everevolving phenotypic spectrum of mitochondrial DNA disease and the importance of performing comprehensive mitochondrial genetic studies in the absence of common mitochondrial DNA mutations.
C1 [Blakely, Emma L.; Swalwell, Helen; He, Langping; Turnbull, Douglass M.; Taylor, Robert W.] Univ Newcastle, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Trip, S. Anand] Natl Hosp Neurol & Neurosurg, Dept Clin Neurol, London WC1N 3BG, England.
   [Wren, Damian R.; Rich, Philip; Omer, Salah E.] St George Hosp, Dept Neurol, London, England.
   [Wren, Damian R.; Rich, Philip; Omer, Salah E.] St George Hosp, Dept Neuroradiol, London, England.
C3 Newcastle University - UK; University of London; University College
   London; UCL Medical School; University College London Hospitals NHS
   Foundation Trust; City St Georges, University of London; City St
   Georges, University of London
RP Taylor, RW (corresponding author), Univ Newcastle, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
FU Wellcome Trust; Newcastle upon Tyne Hospitals NHS Trust; UK National
   Commissioning Group for Rare Mitochondrial Disorders of Adults and
   Children
FX This work was supported by the Wellcome Trust, the Newcastle upon Tyne
   Hospitals NHS Trust, and the UK National Commissioning Group for Rare
   Mitochondrial Disorders of Adults and Children (Drs Turnbull and
   Taylor).
CR Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Houshmand M, 1999, HUM MUTAT, V13, P203, DOI 10.1002/(SICI)1098-1004(1999)13:3<203::AID-HUMU4>3.0.CO;2-3
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
NR 21
TC 33
Z9 34
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 0003-9942
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD MAR
PY 2009
VL 66
IS 3
BP 399
EP 402
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 416EY
UT WOS:000263989600017
PM 19273760
OA Bronze
DA 2024-11-01
ER

PT J
AU Reichenbach, J
   Schubert, R
   Horváth, R
   Petersen, J
   Fütterer, N
   Malle, E
   Stumpf, A
   Gebhardt, BR
   Koehl, U
   Schraven, B
   Zielen, S
AF Reichenbach, Janine
   Schubert, Ralf
   Horvaeth, Rita
   Petersen, Jens
   Fuetterer, Nancy
   Malle, Elisabeth
   Stumpf, Andreas
   Gebhardt, Boris R.
   Koehl, Ulrike
   Schraven, Burkhart
   Zielen, Stefan
TI Fatal neonatal-onset mitochondrial respiratory chain disease with T cell
   immunodeficiency
SO PEDIATRIC RESEARCH
LA English
DT Article
ID POLYMERASE-GAMMA-A; DNA DEPLETION; POINT MUTATIONS; DEFICIENCY;
   DISORDERS; ENCEPHALOMYOPATHY; ANEMIA; KINASE; DEFECT; MTDNA
AB We present the clinical and laboratory features of a boy with a new syndrome of mitochondrial depletion syndrome and T cell immunodeficiency. The child suffered from severe recurrent infectious diseases, anemia, and thrombocytopenia. Clinically, he presented with severe psychomotor retardation, axial hypotonia, and a disturbed pain perception leading to debilitating biting of the thumb, lower lip, and tongue. Brain imaging showed hypoplasia of corpus callosum and an impaired myelinization of the temporooccipital region with consecutive supratentorial hydrocephalus. Histologic examination of a skeletal muscle biopsy was normal. Biochemical investigation showed combined deficiency of respiratory chain complexes II+III and IV. MtDNA depletion was found by real-time PCR. No pathogenic mutations were identified in the TK2, SUCLA2, DGUOK, and ECGF1 genes. A heterozygous missense mutation was found in POLG1. The pathogenic relevance of this mutation is unclear. Interestingly, a lack of CD8(+) T lymphocytes as well as NK cells was also observed. The percentage of CD45RO-expressing cells was decreased in activated CD8(+) T lymphocytes. Activation of T lymphocytes via IL-2 was diminished. The occurrence of the immunologic deficiency in our patient with mtDNA depletion is a rare finding, implying that cells of the immune system might also be affected by mitochondrial disease.
C1 Univ Frankfurt, Dept Gen Paediat, D-60590 Frankfurt, Germany.
   Univ Frankfurt, Dept Paediat Haematol Oncol & Haemostaseol, D-60590 Frankfurt, Germany.
   Tech Univ Munich, Inst Clin Chem Mol Diagnost & Mitochondrial Genet, D-80804 Munich, Germany.
   Tech Univ Munich, Acad Hosp Schwabing Munich, Childrens Hosp, D-80804 Munich, Germany.
   Tech Univ Munich, Inst Med Genet, D-80804 Munich, Germany.
   Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80336 Munich, Germany.
   Otto Von Guericke Univ, Inst Immunol, D-39120 Magdeburg, Germany.
C3 Goethe University Frankfurt; Goethe University Frankfurt; Technical
   University of Munich; Technical University of Munich; University of
   Munich; Technical University of Munich; University of Munich; Otto von
   Guericke University
RP Reichenbach, J (corresponding author), Univ Childrens Hosp Zurich, Dept Immunol Hematol BMT, Steinweisstr 75, CH-8032 Zurich, Switzerland.
EM janine.reichenbach@kispe.unizh.ch
RI Horvath, Rita/AAY-7042-2020; Zielen, Stefan/AAD-7243-2020; Reichenbach,
   Janine/U-2171-2018
OI Koehl, Ulrike/0000-0002-8159-9160; Reichenbach,
   Janine/0000-0002-9008-1312; Horvath, Rita/0000-0002-9841-170X
CR Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   BADERMEUNIER B, 1994, BRIT J HAEMATOL, V87, P381, DOI 10.1111/j.1365-2141.1994.tb04926.x
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Carrozzo R, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9135
   CormierDaire V, 1996, AM J MED GENET, V66, P457, DOI 10.1002/(SICI)1096-8628(19961230)66:4<457::AID-AJMG15>3.0.CO;2-T
   de Vries E, 2000, PEDIATR RES, V47, P528, DOI 10.1203/00006450-200004000-00019
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Hirano M, 2000, BRAIN PATHOL, V10, P451
   Koehl U, 2004, BLOOD CELL MOL DIS, V33, P261, DOI 10.1016/j.bcmd.2004.08.013
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SAMSOM JF, 1994, EUR J PEDIATR, V153, P510, DOI 10.1007/BF01957007
   Setzer B, 2005, J INFECT DIS, V191, P848, DOI 10.1086/427655
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   Zielen S, 1996, J IMMUNOL METHODS, V193, P1, DOI 10.1016/0022-1759(96)00033-6
NR 28
TC 29
Z9 34
U1 0
U2 0
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD SEP
PY 2006
VL 60
IS 3
BP 321
EP 326
DI 10.1203/01.pdr.0000233252.60457.cf
PG 6
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 075CW
UT WOS:000239861300015
PM 16857757
OA Bronze
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, P
   Newman, NJ
AF Yu-Wai-Man, Patrick
   Newman, Nancy J.
TI Inherited eye-related disorders due to mitochondrial dysfunction
SO HUMAN MOLECULAR GENETICS
LA English
DT Review
ID HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   PLURIPOTENT STEM-CELLS; WOLFRAM-SYNDROME; OPA1 MUTATIONS; DNA MUTATION;
   MTDNA-MAINTENANCE; RETINAL DYSTROPHY; SPINDLE TRANSFER; DISEASE
AB Genetic disorders due to mitochondrial dysfunction are not uncommon and the majority of these patients will have eye-related manifestations, including visual loss from the optic nerve and retinal disease, visual field loss from retrochiasmal visual pathway damage, and ptosis and ocular dysmotility from extraocular muscle involvement. Defects in both the nuclear and mitochondrial genomes cause mitochondrial dysfunction via several mechanisms, including impaired mitochondrial energy production, oxidative stress, mitochondrial DNA instability, abnormalities in the regulation of mitochondrial dynamics and mitochondrial quality control, and disturbed cellular interorganellar communication. Advances in our understanding of the molecular genetic basis of mitochondrial disease have not only improved genetic diagnosis, but they have provided important insights into the pathophysiologic basis of these disorders and potential therapeutic targets. In parallel, more sophisticated techniques for genetic manipulation are facilitating the development of animal and in vitro models that should prove powerful and versatile tools for disease modelling and therapeutic experimentation. Effective therapies for mitochondrial disorders are beginning to translate from bench to bedside along the paths of neuroprotection, gene replacement and stem cell-based regenerative paradigms. Additionally, preventing the transmission of pathogenic mtDNA mutations from mother to child is now a reality with in vitro fertilization mitochondrial replacement techniques.
C1 [Yu-Wai-Man, Patrick] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
   [Yu-Wai-Man, Patrick] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England.
   [Yu-Wai-Man, Patrick] UCL Inst Ophthalmol, London, England.
   [Yu-Wai-Man, Patrick] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England.
   [Newman, Nancy J.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA.
   [Newman, Nancy J.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.
   [Newman, Nancy J.] Emory Univ, Sch Med, Dept Neurol Surg, Atlanta, GA USA.
C3 University of Cambridge; University of London; University College
   London; Moorfields Eye Hospital NHS Foundation Trust; University of
   London; University College London; Newcastle University - UK; Emory
   University; Emory University; Emory University
RP Newman, NJ (corresponding author), Neuroophthalmol Unit, 1365-B Clifton Rd NE, Atlanta, GA 30322 USA.
EM ophtnjn@emory.edu
RI Newman, Nancy/AAB-2532-2021
FU Medical Research Council (UK); Fight for Sight (UK); UK National
   Institute of Health Research (NIHR) as part of the Rare Diseases
   Translational Research Collaboration; NIHR Biomedical Research Centre
   based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of
   Ophthalmology; Department of Ophthalmology, Emory University School of
   Medicine from Research to Prevent Blindness, Inc. (New York, N.Y.);
   NIH/NEI (Department of Ophthalmology, Emory University School of
   Medicine) [P30-EY06360]; MRC [G1002570, G0701386] Funding Source: UKRI
FX Medical Research Council (UK), Fight for Sight (UK), UK National
   Institute of Health Research (NIHR) as part of the Rare Diseases
   Translational Research Collaboration, and the NIHR Biomedical Research
   Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL
   Institute of Ophthalmology. Department of Ophthalmology, Emory
   University School of Medicine) from Research to Prevent Blindness, Inc.
   (New York, N.Y.) and by NIH/NEI core grant P30-EY06360 (Department of
   Ophthalmology, Emory University School of Medicine).
CR Alikani M, 2017, REPROD BIOMED ONLINE, V34, P333, DOI 10.1016/j.rbmo.2017.02.004
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Chaussenot A, 2011, ANN NEUROL, V69, P501, DOI 10.1002/ana.22160
   Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Craven L, 2011, HUM MOL GENET, V20, pR168, DOI 10.1093/hmg/ddr373
   de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177
   de la Barca JMC, 2016, BRAIN, V139, P2864, DOI 10.1093/brain/aww222
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   Dombi E, 2016, NEUROLOGY, V86, P1921, DOI 10.1212/WNL.0000000000002688
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Flachsbarth K, 2014, INVEST OPHTH VIS SCI, V55, P7029, DOI 10.1167/iovs.14-15266
   Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Herbert M, 2017, NEW ENGL J MED, V376, P171, DOI 10.1056/NEJMcibr1615669
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature183030, 10.1038/nature18303]
   Johnson TV, 2013, CURR OPIN PHARMACOL, V13, P78, DOI 10.1016/j.coph.2012.08.003
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Landes T, 2010, SEMIN CELL DEV BIOL, V21, P593, DOI 10.1016/j.semcdb.2009.12.012
   Liao CY, 2017, NEUROLOGY, V88, P131, DOI 10.1212/WNL.0000000000003491
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lombès A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012
   Lu SM, 2014, P NATL ACAD SCI USA, V111, pE5292, DOI 10.1073/pnas.1421055111
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0652-7
   Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Murley A, 2016, MOL CELL, V61, P648, DOI 10.1016/j.molcel.2016.01.031
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nishino I, 2000, ANN NEUROL, V47, P792
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Renaldo F, 2012, BRAIN, V135, DOI 10.1093/brain/aws111
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Rigoli L, 2012, CURR OPIN PEDIATR, V24, P512, DOI 10.1097/MOP.0b013e328354ccdf
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   Rouzier C, 2017, HUM MOL GENET, V26, P1599, DOI 10.1093/hmg/ddx060
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245
   Shoubridge EA, 2016, NATURE, V540, P210, DOI 10.1038/nature20483
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025
   Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429
   Xie BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112175
   Yu-Wai-Man P, 2014, EYE, V28, P521, DOI 10.1038/eye.2014.37
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2017, MITOCHONDRION
   Yu-Wai-Man P, 2016, ACTA NEUROPATHOL, V132, P789, DOI 10.1007/s00401-016-1625-2
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Yu-Wai-Man P, 2012, BRAIN, V135, P9, DOI 10.1093/brain/awr352
   Yu-Wai-Man P, 2011, OPHTHALMOLOGY, V118, P558, DOI 10.1016/j.ophtha.2010.07.029
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zhang J, 2017, REPROD BIOMED ONLINE, V34, P361, DOI 10.1016/j.rbmo.2017.01.013
   Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 80
TC 41
Z9 43
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD AUG 1
PY 2017
VL 26
IS R1
BP R12
EP R20
DI 10.1093/hmg/ddx182
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA FC4EW
UT WOS:000406792500003
PM 28481993
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Shen, XY
   Du, AL
AF Shen, Xiya
   Du, Ailian
TI The non-syndromic clinical spectrums of mtDNA 3243A&gt;G mutation
SO NEUROSCIENCES
LA English
DT Review
ID CHRONIC INTESTINAL PSEUDOOBSTRUCTION; MITOCHONDRIAL-DNA MUTATIONS;
   DEAFNESS MIDD; M.3243A-GREATER-THAN-G MUTATION; PHENOTYPIC SPECTRUM;
   NATURAL-HISTORY; MELAS; PREVALENCE; CARRIERS; DISEASE
AB The m.3243A >G mutation in the tRNA Leu (UUR) gene (MT-TL1) of the mitochondrial DNA is the most widely seen pathogenic mtDNA mutation which has major phenotypic variations. The clinical phenotype involves various organs such as the brain and nerves, skeletal muscles, heart, endocrine system, gastrointestinal tract, and skin. Some phenotypes conform to well established syndromes, while most of the symptoms appear individually or concomitant to other syndromes, making identification difficult. Furthermore, some progress has been made on cardiac manifestations as well as complications during pregnancy and perinatal period. This article provides a systematic review of the non-syndromic phenotypes and latest developments in m.3243A>G mutation.
C1 [Shen, Xiya; Du, Ailian] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Neurol, Sch Med, Shanghai, Peoples R China.
C3 Shanghai Jiao Tong University
RP Du, AL (corresponding author), Shanghai Jiao Tong Univ, Tongren Hosp, Dept Neurol, Sch Med, Shanghai, Peoples R China.
EM lotusdu@126.com
CR Al-Gadi IS, 2018, J ENDOCR SOC, V2, P361, DOI 10.1210/js.2017-00434
   Cardenas-Robledo S, 2016, J NEURO-OPHTHALMOL, V36, P134, DOI 10.1097/WNO.0000000000000340
   Chae HW, 2020, EUR J ENDOCRINOL, V183, P505, DOI 10.1530/EJE-20-0189
   Chin J, 2014, MITOCHONDRION, V17, P34, DOI 10.1016/j.mito.2014.05.005
   de Laat P, 2020, J MED GENET
   de Laat P, 2015, MITOCHONDRION, V25, P98, DOI 10.1016/j.mito.2015.10.005
   Dodick DW, 2018, LANCET, V391, P1315, DOI 10.1016/S0140-6736(18)30478-1
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Feeney CL, 2019, BJOG-INT J OBSTET GY, V126, P1380, DOI 10.1111/1471-0528.15667
   Finsterer J, 2016, MOL GENET METAB REP, V8, P33, DOI 10.1016/j.ymgmr.2016.07.001
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Guo S, 2016, EUR J NEUROL, V23, P175, DOI 10.1111/ene.12832
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Imai-Okazaki A, 2019, INT J CARDIOL, V279, P115, DOI 10.1016/j.ijcard.2019.01.017
   Inoue A, 2019, OTOL NEUROTOL, V40, P359, DOI 10.1097/MAO.0000000000002091
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Kraya T, 2018, HEADACHE, V58, P45, DOI 10.1111/head.13219
   Kuleva M, 2019, BJOG-INT J OBSTET GY, V126, P1372, DOI 10.1111/1471-0528.15515
   Liu GL, 2020, J NEUROL SCI, V408, DOI 10.1016/j.jns.2019.116562
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Miyaoka H, 1997, BIOL PSYCHIAT, V42, P524, DOI 10.1016/S0006-3223(97)00280-1
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Niedermayr K, 2018, CONGENIT HEART DIS, V13, P671, DOI 10.1111/chd.12634
   Pan XL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00780
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Say RE, 2011, OBSTET MED, V4, P90, DOI 10.1258/om.2011.110008
   Smeitink Jan, 2019, JIMD Rep, V46, P52, DOI 10.1002/jmd2.12017
   Stanghellini V, 2007, NEUROGASTROENT MOTIL, V19, P440, DOI 10.1111/j.1365-2982.2007.00902.x
   Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552
   [孙翀 Sun Chong], 2018, [中华神经科杂志, Chinese Journal of Neurology], V51, P118
   Tiehuis LH, 2020, MITOCHONDRION, V53, P128, DOI 10.1016/j.mito.2020.05.004
   Tsujikawa K, 2016, MITOCHONDRION, V30, P229, DOI 10.1016/j.mito.2016.08.011
   van den Ameele J, 2020, NEUROMUSCULAR DISORD, V30, P413, DOI 10.1016/j.nmd.2020.02.017
   Verhaak C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0403-5
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
   Yokoyama T, 2010, NEUROPATHOLOGY, V30, P56, DOI 10.1111/j.1440-1789.2009.01026.x
   Yu-Wai-Man P, 2017, HUM MOL GENET, V26, pR12, DOI 10.1093/hmg/ddx182
   [张哲 Zhang Zhe], 2016, [中华神经科杂志, Chinese Journal of Neurology], V49, P237
   Zhou Y, 2018, INT J NEUROSCI, V128, P231, DOI 10.1080/00207454.2017.1387113
NR 50
TC 8
Z9 8
U1 0
U2 9
PU RIYADH ARMED FORCES HOSPITAL
PI RIYADH
PA PO BOX 7897, RIYADH, KSA 11159, SAUDI ARABIA
SN 1319-6138
J9 NEUROSCIENCES
JI Neurosciences
PD APR
PY 2021
VL 26
IS 2
BP 128
EP 133
DI 10.17712/nsj.2021.2.20200145
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA TS5HW
UT WOS:000679680900002
PM 33814365
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Celik, D
   Campisi, M
   Cannella, L
   Pavanello, S
AF Celik, Dilek
   Campisi, Manuela
   Cannella, Luana
   Pavanello, Sofia
TI The effect of low birth weight as an intrauterine exposure on the early
   onset of sarcopenia through possible molecular pathways
SO JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
LA English
DT Review
DE Clock genes; DOHaD; Epigenetic; Genome-wide study; Low birth weight;
   Sarcopenia
ID DEVELOPMENTAL ORIGINS; SKELETAL-MUSCLE; BODY-COMPOSITION; GROWTH
   RESTRICTION; OXIDATIVE STRESS; GRIP STRENGTH; EARLY-LIFE; DISEASE;
   HEALTH; FETAL
AB Sarcopenia, a musculoskeletal disease characterized by the progressive loss of skeletal muscle mass, strength, and physical performance, presents significant challenges to global public health due to its adverse effects on mobility, morbidity, mortality, and healthcare costs. This comprehensive review explores the intricate connections between sarcopenia and low birth weight (LBW), emphasizing the developmental origins of health and disease (DOHaD) hypothesis, inflammatory processes (inflammaging), mitochondrial dysfunction, circadian rhythm disruptions, epigenetic mechanisms, and genetic variations revealed through genome-wide studies (GWAS). A systematic search strategy was developed using PubMed to identify relevant English-language publications on sarcopenia, LBW, DOHaD, inflammaging, mitochondrial dysfunction, circadian disruption, epigenetic mechanisms, and GWAS. The publications consist of 46.2% reviews, 21.2% cohort studies, 4.8% systematic reviews, 1.9% cross-sectional studies, 13.4% animal studies, 4.8% genome-wide studies, 5.8% epigenome-wide studies, and 1.9% book chapters. The review identified key factors contributing to sarcopenia development, including the DOHaD hypothesis, LBW impact on muscle mass, inflammaging, mitochondrial dysfunction, the influence of clock genes, the role of epigenetic mechanisms, and genetic variations revealed through GWAS. The DOHaD theory suggests that LBW induces epigenetic alterations during foetal development, impacting long-term health outcomes, including the early onset of sarcopenia. LBW correlates with reduced muscle mass, grip strength, and lean body mass in adulthood, increasing the risk of sarcopenia. Chronic inflammation (inflammaging) and mitochondrial dysfunction contribute to sarcopenia, with LBW linked to increased oxidative stress and dysfunction. Disrupted circadian rhythms, regulated by genes such as BMAL1 and CLOCK, are associated with both LBW and sarcopenia, impacting lipid metabolism, muscle mass, and the ageing process. Early-life exposures, including LBW, induce epigenetic modifications like DNA methylation (DNAm) and histone changes, playing a pivotal role in sarcopenia development. Genome-wide studies have identified candidate genes and variants associated with lean body mass, muscle weakness, and sarcopenia, providing insights into genetic factors contributing to the disorder. LBW emerges as a potential early predictor of sarcopenia development, reflecting the impact of intrauterine exposures on long-term health outcomes. Understanding the complex interplay between LBW with inflammaging, mitochondrial dysfunction, circadian disruption, and epigenetic factors is essential for elucidating the pathogenesis of sarcopenia and developing targeted interventions. Future research on GWAS and the underlying mechanisms of LBW-associated sarcopenia is warranted to inform preventive strategies and improve public health outcomes.
C1 [Celik, Dilek] Univ Padua, Dept Pharmceut & Pharmacol Sci, Padua, Italy.
   [Campisi, Manuela; Cannella, Luana; Pavanello, Sofia] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, Italy.
   [Pavanello, Sofia] Univ Hosp Padova, Padua, Italy.
C3 University of Padua; University of Padua; University of Padua; Azienda
   Ospedaliera - Universita di Padova
RP Pavanello, S (corresponding author), Univ Hosp Padova, Padua, Italy.
EM manuela.campisi@unipd.it; luana.cannella@phd.unipd.it;
   sofia.pavanello@unipd.it
OI Celik, Dilek/0009-0000-3874-2753; Cannella, Luana/0000-0002-3827-3632
FU European Union's Horizon 2020 research [101034319]; European Union's
   Horizon 2020 research and innovation programme under the Marie
   Sklstrok;odowska-Curie; European Union; Marie Curie Actions (MSCA)
   [101034319] Funding Source: Marie Curie Actions (MSCA)
FX This project has funded by the European Union's Horizon 2020 research
   and innovation programme under the Marie Sk & lstrok;odowska-Curie,
   grant agreement no 101034319, and from the European Union -
   NextGenerationEU.
CR Antuña E, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232315039
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730
   Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235
   Beauchamp B, 2015, INT J OBESITY, V39, P702, DOI 10.1038/ijo.2014.120
   Bellanti F, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10010031
   Bianchi ME, 2022, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.793990
   Bianco-Miotto T, 2017, J DEV ORIG HLTH DIS, V8, P513, DOI 10.1017/S2040174417000733
   Bielemann RM, 2016, NUTRITION, V32, P228, DOI 10.1016/j.nut.2015.08.014
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   Cannataro R, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22189724
   Castrogiovanni P., 2017, Journal of Functional Morphology and Kinesiology, V2, P30, DOI 10.3390/jfmk2030030
   Cech DJ., 2012, FUNCTIONAL MOVEMENT, P129
   Chen WD, 2014, BIOCHEM BIOPH RES CO, V451, P408, DOI 10.1016/j.bbrc.2014.07.138
   Chen YY, 2021, J INFLAMM RES, V14, P2019, DOI 10.2147/JIR.S313085
   Choi YI, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48161-w
   Choi Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093106
   Christian CJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13223
   Costello PM, 2008, J PHYSIOL-LONDON, V586, P2371, DOI 10.1113/jphysiol.2008.150987
   Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9
   da Rocha AL, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-24277-4
   Dalle S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01045
   Dodds R, 2012, J Dev Orig Health Dis, V3, DOI 10.1017/S204017441100081X
   Dodds R, 2012, J NUTR HEALTH AGING, V16, P609, DOI 10.1007/s12603-012-0053-9
   Jimenez-Gutierrez GE, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11152359
   Eriksson JG, 2016, ANN MED, V48, P456, DOI 10.1080/07853890.2016.1193786
   Fall CHD, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0123
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Gao HB, 2020, EXP CELL RES, V397, DOI 10.1016/j.yexcr.2020.112348
   Gensous N, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00996
   Goyal D, 2019, J ENDOCRINOL, V242, pT105, DOI 10.1530/JOE-19-0009
   Guarner-Lans V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041203
   Gustafsson PE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-346
   Hales CN, 2003, DIABETOLOGIA, V46, P1013, DOI 10.1007/s00125-003-1131-7
   Hemmeryckx B, 2011, OBESITY, V19, P659, DOI 10.1038/oby.2010.266
   Hildreth JR., 2022, J DEV ORIG HLTH DIS, V14, P1
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Hoffman DJ, 2021, PHYSIOL REV, V101, P739, DOI 10.1152/physrev.00002.2020
   Hsu CN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062232
   Inskip HM, 2007, J INTERN MED, V262, P368, DOI 10.1111/j.1365-2796.2007.01812.x
   Iozzo P, 2014, OBESITY FACTS, V7, P130, DOI 10.1159/000362656
   Irazoki A, 2022, AGING CELL, V21, DOI 10.1111/acel.13583
   Jones G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20918-w
   Jones G, 2020, J GERONTOL A-BIOL, V75, P301, DOI 10.1093/gerona/glz042
   Kamper RS, 2021, J CACHEXIA SARCOPENI, V12, P1641, DOI 10.1002/jcsm.12832
   Kaur S, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2797-2
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Kondratov RV, 2009, AGING-US, V1, P979, DOI 10.18632/aging.100113
   Kubota T, 2016, ENVIRON EPIGENETICS, V2, DOI 10.1093/eep/dvw017
   Leduc-Gaudet JP, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22158179
   Lee H, 2021, J CACHEXIA SARCOPENI, V12, P1925, DOI 10.1002/jcsm.12794
   Lekkas D, 2019, AUTON NEUROSCI-BASIC, V219, DOI 10.1016/j.autneu.2019.05.001
   Li CW, 2019, J CACHEXIA SARCOPENI, V10, P586, DOI 10.1002/jcsm.12417
   Li S, 2022, EBIOMEDICINE, V77, DOI 10.1016/j.ebiom.2022.103927
   Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004
   Lu AT, 2019, AGING-US, V11, P5895, DOI 10.18632/aging.102173
   Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684
   Madden RA, 2021, EPIGENETICS-US, V16, P783, DOI 10.1080/15592294.2020.1827713
   Malhan D, 2023, NPJ MICROGRAVITY, V9, DOI 10.1038/s41526-023-00273-4
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Mendez N, 2016, ENDOCRINOLOGY, V157, P4654, DOI 10.1210/en.2016-1282
   Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509
   Moore SE, 2016, J DEV ORIG HLTH DIS, V7, P123, DOI 10.1017/S2040174415007199
   Nakano Y, 2020, J ATHEROSCLER THROMB, V27, P397, DOI 10.5551/jat.RV17039
   Nebendahl C, 2016, J NUTR BIOCHEM, V29, P41, DOI 10.1016/j.jnutbio.2015.10.017
   Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x
   Nishikawa H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13103519
   Nishikawa H, 2021, INT J MOL MED, V48, DOI 10.3892/ijmm.2021.4989
   Ogawa S, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0022-5
   Oke SL, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136986
   Parisi F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041732
   Parsons E., 2022, J DEV ORIG HLTH DIS, V14, P1
   Patel HP, 2012, J GERONTOL A-BIOL, V67, P82, DOI 10.1093/gerona/glr020
   Patel HP, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-43
   Petermann-Rocha F, 2020, MATURITAS, V133, P60, DOI 10.1016/j.maturitas.2020.01.004
   Peterson MD, 2023, J CACHEXIA SARCOPENI, V14, P108, DOI 10.1002/jcsm.13110
   Ran S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61406-3
   Ridgway CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017955
   Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267
   Rodríguez-Rodríguez P, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00602
   Saito Y, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.739510
   Saver AA, 2004, AM J CLIN NUTR, V80, P199
   Sayer AA, 2010, J DEV ORIG HLTH DIS, V1, P150, DOI 10.1017/S2040174410000097
   Sayer AA, 2005, EARLY HUM DEV, V81, P735, DOI 10.1016/j.earlhumdev.2005.07.003
   Sayer AA, 2004, J GERONTOL A-BIOL, V59, P930, DOI 10.1093/gerona/59.9.M930
   Sayer AA, 1998, AGE AGEING, V27, P579, DOI 10.1093/ageing/27.5.579
   Sayer AA, 2022, AGE AGEING, V51, DOI 10.1093/ageing/afac220
   Sharples AP, 2016, AGING CELL, V15, P603, DOI 10.1111/acel.12486
   Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231
   Stein AD, 2019, DIABETOLOGIA, V62, P1773, DOI 10.1007/s00125-019-4930-1
   Tanaka Y, 2005, HYPERTENS RES, V28, P529, DOI 10.1291/hypres.28.529
   Tarry-Adkins JL, 2016, DIS MODEL MECH, V9, P1221, DOI 10.1242/dmm.026591
   Voisin S, 2021, J CACHEXIA SARCOPENI, V12, P1064, DOI 10.1002/jcsm.12741
   Wada K, 2008, CIRC J, V72, P757, DOI 10.1253/circj.72.757
   Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424
   Westbury LD, 2023, J CACHEXIA SARCOPENI, V14, P565, DOI 10.1002/jcsm.13160
   WHO, 2014, Low birth weight policy brief
   Woo J, 2014, AGE, V36, DOI 10.1007/s11357-014-9711-7
   Wu X, 2009, INT J OBESITY, V33, P971, DOI 10.1038/ijo.2009.137
   Wu Y, 2020, METABOLITES, V10, DOI 10.3390/metabo10060235
   Yang QM, 2022, AGING DIS, V13, P801, DOI 10.14336/AD.2021.1107
   Yildirim RM, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10102539
   Ylihärsilä H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612
NR 104
TC 1
Z9 1
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2190-5991
EI 2190-6009
J9 J CACHEXIA SARCOPENI
JI J. Cachexia Sarcopenia Muscle
PD JUN
PY 2024
VL 15
IS 3
BP 770
EP 780
DI 10.1002/jcsm.13455
EA MAR 2024
PG 11
WC Geriatrics & Gerontology; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; General & Internal Medicine
GA TR5H1
UT WOS:001193263300001
PM 38553412
OA gold
DA 2024-11-01
ER

PT J
AU Xiao, F
   Li, J
   Zhang, XG
   Wang, XF
AF Xiao, Fei
   Li, Jia
   Zhang, Xiaogang
   Wang, Xuefeng
TI Antiepileptic treatment and blood lactate level alteration in patients
   with myoclonic epilepsy with ragged-red fibers (MERRF) syndrome in a
   Chinese family
SO NEUROLOGY ASIA
LA English
DT Article
ID MITOCHONDRIAL-DNA; VALPROIC ACID; DEFECTS; MELAS; LEVETIRACETAM;
   METABOLISM; MYOPATHY; MUTATION; PROTEIN
AB Background: Myoclonic epilepsy with ragged-red fibers (MERRF) is a type of mitochondrial encephalomyopathy, clinical experience with the antiepileptic treatment for myoclonus in MERRF is still limited. Myoclonus appears to be intractable, and some antiepileptic drugs may change the blood lactate level. Objective: In this study, we report on two patients, a girl and her mother, both with MERRF in a Chinese family. We aimed to study their myoclonus attack, response to AEDs and blood lactate level. Methods: The diagnosis was based on muscle biopsies and a genetic test. We recorded their myoclonus and detected alterations of blood lactate when the patients received antiepileptic drugs. Results: The patients displayed substantial differences in their responses to antiepileptic drugs. The mother exhibited a good response to valproic acid, although valproic acid is not recommended for mitochondrial disease; however, her daughter was refractory to many antiepileptic drugs until she received a combination treatment of levetiracetam and topiramate. We did not find valproic acid, levetiracetam or topiramate affected the blood lactate levels.
   Conclusion: These findings imply that not all MERRF patients are resistant to antiepileptic drugs, and for those who are intractable, combination treatment involving levetiracetam and topiramate may be effective for treating myoclonus in MERRF and does not worsen lactic acidosis.
C1 [Xiao, Fei; Li, Jia; Zhang, Xiaogang; Wang, Xuefeng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Key Lab Neurol, Chongqing 400016, Peoples R China.
C3 Chongqing Medical University
RP Wang, XF (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing Key Lab Neurol, 1 You Yi Rd, Chongqing 400016, Peoples R China.
EM xfyp@163.com
OI Xiao, Fei/0000-0002-5981-2922
CR Alluin A, 2011, ANN FR ANESTH, V30, P752, DOI 10.1016/j.annfar.2011.05.019
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Close BR, 2010, ANN PHARMACOTHER, V44, P1112, DOI 10.1345/aph.1M617
   Crest C, 2004, NEUROLOGY, V62, P640, DOI 10.1212/01.WNL.0000110193.78872.DD
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2010, DRUG CHEM TOXICOL, V33, P138, DOI 10.3109/01480540903207076
   Finsterer J, 2010, EUR J PAEDIATR NEURO, V14, P29, DOI 10.1016/j.ejpn.2009.07.005
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Gropman A L, 2001, Curr Neurol Neurosci Rep, V1, P185
   GUELDRY S, 1987, EPILEPSIA, V28, P160, DOI 10.1111/j.1528-1157.1987.tb03642.x
   Jiménez-Caballero PE, 2006, REV NEUROLOGIA, V43, P724, DOI 10.33588/rn.4312.2006440
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   MACMILLAN V, 1987, BRAIN RES, V420, P268, DOI 10.1016/0006-8993(87)91247-9
   Mancuso M, 2006, J NEUROL SCI, V243, P97, DOI 10.1016/j.jns.2005.11.021
   Mikol J, 2005, ANN PATHOL, V25, P282, DOI 10.1016/S0242-6498(05)80132-4
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Price KE, 2011, CLIN PHARMACOL THER, V89, P867, DOI 10.1038/clpt.2011.47
   Rathman SC, 2003, J NUTR, V133, P2119, DOI 10.1093/jn/133.7.2119
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Zhang Zai-qiang, 2009, Zhonghua Yi Xue Za Zhi, V89, P1185
NR 26
TC 0
Z9 0
U1 0
U2 6
PU ASEAN NEUROLOGICAL ASSOC
PI KUALA LUMPUR
PA UNIV MALAYA MEDICAL CENTRE, NEUROLOGY LABORATORY, KUALA LUMPUR, 59100,
   MALAYSIA
SN 1823-6138
J9 NEUROL ASIA
JI Neurol. Asia
PD MAR
PY 2013
VL 18
IS 1
BP 47
EP 51
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 115BP
UT WOS:000316787600007
DA 2024-11-01
ER

PT J
AU Tucker, EJ
   Compton, AG
   Thorburn, DR
AF Tucker, Elena J.
   Compton, Alison G.
   Thorburn, David R.
TI Recent Advances in the Genetics of Mitochondrial Encephalopathies
SO CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
LA English
DT Review
DE Mitochondrial disease; Encephalopathy; High-throughput sequencing;
   Next-generation sequencing; Oxidative phosphorylation; Electron
   transport chain
ID CYTOCHROME-C-OXIDASE; OXIDATIVE-PHOSPHORYLATION DISORDERS;
   RESPIRATORY-CHAIN DEFICIENCY; DNA MUTATIONS; 1555A-GREATER-THAN-G
   MUTATION; SUCCINATE-DEHYDROGENASE; ATP SYNTHASE; DISEASE; PREVALENCE;
   DIAGNOSIS
AB Mitochondrial encephalopathy, the most common neurometabolic disorder, may be caused by mutations in approximately 100 different genes and may present with various symptoms, such as seizures, ataxia, myopathy, cognitive impairment, blindness, and stroke. Fewer than 50% of patients with mitochondrial encephalopathy receive a molecular diagnosis, primarily because of the large degree of clinical and genetic heterogeneity among patients and the limited knowledge of the genes involved in mitochondrial function. Here we review the most recent discoveries of genes associated with mitochondrial disease with variable neuropathology. All these genes have been identified via homozygosity mapping or linkage analysis; however, advances in sequencing technology indicate that the future of genetic diagnosis and disease gene discovery likely lies in high-throughput sequencing.
C1 [Tucker, Elena J.; Compton, Alison G.; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
   [Compton, Alison G.; Thorburn, David R.] Royal Childrens Hosp, Genet Hlth Serv Victoria, Melbourne, Vic, Australia.
   [Tucker, Elena J.; Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
C3 Royal Children's Hospital Melbourne; Murdoch Children's Research
   Institute; Royal Children's Hospital Melbourne; University of Melbourne
RP Tucker, EJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, 10th Floor,Flemington Rd, Parkville, Vic 3052, Australia.
EM e.tucker3@pgrad.unimelb.edu.au; alison.compton@mcri.edu.au;
   david.thorburn@mcri.edu.au
RI Compton, Alison/KOT-7713-2024; Thorburn, David/G-6266-2013; Tucker,
   Elena/B-3487-2012
OI Compton, Alison/0000-0002-2725-7055; Tucker, Elena/0000-0002-6380-5100;
   thorburn, david/0000-0002-7725-9470
FU National Health and Medical Research Council (NHMRC); Muscular Dystrophy
   Association
FX The authors' research was supported by grants from the National Health
   and Medical Research Council (NHMRC), the Muscular Dystrophy
   Association, an NHMRC Principal Research Fellowship to Dr. Thorburn, and
   an Australian Postgraduate Award to Ms. Tucker.
CR Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   GERARDS M, 2009, J MED GENET     0618
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Houstek J, 2009, BBA-BIOENERGETICS, V1787, P529, DOI 10.1016/j.bbabio.2008.11.013
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Nelson DL, 2009, NAT GENET, V41, P510, DOI 10.1038/ng0509-510
   Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V251, P883, DOI 10.1006/bbrc.1998.9553
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   Vasta V, 2009, GENOME MED, V1, DOI 10.1186/gm100
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 39
TC 38
Z9 45
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1528-4042
J9 CURR NEUROL NEUROSCI
JI Curr. Neurol. Neurosci. Rep.
PD JUL
PY 2010
VL 10
IS 4
BP 277
EP 285
DI 10.1007/s11910-010-0112-8
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 602AZ
UT WOS:000278111800004
PM 20446063
DA 2024-11-01
ER

PT J
AU Kaufmann, P
   Engelstad, K
   Wei, Y
   Kulikova, R
   Oskoui, M
   Battista, V
   Koenigsberger, DY
   Pascual, JM
   Sano, M
   Hirano, M
   DiMauro, S
   Shungu, DC
   Mao, XL
   De Vivo, DC
AF Kaufmann, Petra
   Engelstad, Kristin
   Wei, Ying
   Kulikova, Romana
   Oskoui, Maryam
   Battista, Vanessa
   Koenigsberger, Dorcas Y.
   Pascual, Juan M.
   Sano, Mary
   Hirano, Michio
   DiMauro, Salvatore
   Shungu, Dikoma C.
   Mao, Xiangling
   De Vivo, Darryl C.
TI Protean Phenotypic Features of the A3243G Mitochondrial DNA Mutation
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID LACTIC-ACIDOSIS; CLINICAL SPECTRUM; EPISODES MELAS; LOAD;
   ENCEPHALOPATHY; MYOPATHY; BRAIN; MERRF
AB Objective: To describe the spectrum of clinical symptoms, signs, and laboratory features associated with A3243G, a mitochondrial DNA point mutation that affects multiple organs with varying severity, making the diagnosis and treatment of these patients complex.
   Design: Cohort study.
   Setting: Columbia University Medical Center.
   Participants: A cohort of 123 matrilineal relatives from 45 families, including 45 fully symptomatic patients with mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes ( syndrome), 78 carrier relatives, and 30 controls. Main
   Outcome Measures: Data gathered from standardized medical history questionnaires, neurological and ophthalmological examination forms, and laboratory tests. We compared data between 3 groups.
   Results: Mutation carriers' clinical and laboratory results frequently had many abnormalities. In addition to neurological symptoms, they often had cardiac, endocrine, gastrointestinal, and psychiatric symptoms.
   Conclusions: The A3243G mutation carriers have multiple medical problems, suggesting that the A3243G mutation should be considered as an etiological factor in patients with multisystem clinical presentations or a family history compatible with matrilineal inheritance. Because some medical problems affecting A3243G mutation carriers are treatable, early detection and proactive management may mitigate the burden of morbidity.
C1 [Kaufmann, Petra] Columbia Univ, Neurol Inst, Dept Neurol, Med Ctr, New York, NY 10032 USA.
   [Kulikova, Romana; De Vivo, Darryl C.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA.
   [Wei, Ying] Columbia Univ, Med Ctr, Dept Biostat, New York, NY 10032 USA.
   [Sano, Mary] Cornell Univ, Dept Psychiat, Mt Sinai Sch Med, New York, NY 10021 USA.
   [Shungu, Dikoma C.] Cornell Univ, Dept Radiol, New York, NY 10021 USA.
   [Oskoui, Maryam] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.
   [Pascual, Juan M.] Univ Texas SW, Dept Neurol, Dallas, TX USA.
   [Pascual, Juan M.] Univ Texas SW, Dept Physiol, Dallas, TX USA.
   [Pascual, Juan M.] Univ Texas SW, Dept Pediat, Dallas, TX USA.
C3 Columbia University; Columbia University; Columbia University; Icahn
   School of Medicine at Mount Sinai; Cornell University; Cornell
   University; McGill University; University of Texas System; University of
   Texas Southwestern Medical Center Dallas; University of Texas System;
   University of Texas Southwestern Medical Center Dallas; University of
   Texas System; University of Texas Southwestern Medical Center Dallas
RP Kaufmann, P (corresponding author), Columbia Univ, Neurol Inst, Dept Neurol, Med Ctr, 710 W 168Th St, New York, NY 10032 USA.
EM pk88@columbia.edu
RI Shungu, Dikoma/H-7110-2019
OI Pascual, Juan/0000-0002-0843-8221; Shungu, Dikoma C/0000-0001-9452-2245
FU National Institute of Child Health and Human Development [PO1-HD32062];
   Clinical and Translational Science Award [RR024156]; Colleen Giblin
   Foundation; Marriott Mitochondrial Disorder Clinical Research Fund
FX This study was supported by grant PO1-HD32062 from the National
   Institute of Child Health and Human Development ( Drs Kaufmann, DiMauro,
   and De Vivo); Clinical and Translational Science Award 1 UL1 RR024156;
   an Irving Research Scholar Award ( Dr Kaufmann); the Marriott
   Mitochondrial Disorder Clinical Research Fund ( Drs Hirano and DiMauro);
   and the Colleen Giblin Foundation ( Dr Shungu).
CR Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   DAMIAN MS, 1995, ACTA NEUROL SCAND, V92, P409
   DEVIVO DC, 1990, BIOL NEONATE, V58, P54
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   DUYN JH, 1993, RADIOLOGY, V188, P277, DOI 10.1148/radiology.188.1.8511313
   FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   KARNOFSKY KA, 1949, EVALUATION CHEMOTHER, P196
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   KRUSKAL WILLIAM H., 1952, JOUR AMER STATIST ASSOC, V47, P583, DOI 10.2307/2280779
   MacKenzie DM, 1996, PSYCHOL MED, V26, P427, DOI 10.1017/S0033291700034826
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   MANTEL N, 1959, JNCI-J NATL CANCER I, V22, P719
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Morovvati S, 2002, ACTA NEUROL SCAND, V106, P104, DOI 10.1034/j.1600-0404.2002.01172.x
NR 21
TC 52
Z9 59
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JAN
PY 2009
VL 66
IS 1
BP 85
EP 91
PG 7
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 393UM
UT WOS:000262398900011
PM 19139304
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Li, HZ
   Slone, J
   Fei, L
   Huang, TS
AF Li, Huanzheng
   Slone, Jesse
   Fei, Lin
   Huang, Taosheng
TI Mitochondrial DNA Variants and Common Diseases: A Mathematical Model for
   the Diversity of Age-Related mtDNA Mutations
SO CELLS
LA English
DT Review
DE mitochondria; mitochondrial genetics; aging; cancer; diabetes; mutation
ID COPY NUMBER; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE;
   ALZHEIMERS-DISEASE; CARDIAC-MUSCLE; D-LOOP; DELETIONS; PROTEIN;
   METABOLISM; CANCER
AB The mitochondrion is the only organelle in the human cell, besides the nucleus, with its own DNA (mtDNA). Since the mitochondrion is critical to the energy metabolism of the eukaryotic cell, it should be unsurprising, then, that a primary driver of cellular aging and related diseases is mtDNA instability over the life of an individual. The mutation rate of mammalian mtDNA is significantly higher than the mutation rate observed for nuclear DNA, due to the poor fidelity of DNA polymerase and the ROS-saturated environment present within the mitochondrion. In this review, we will discuss the current literature showing that mitochondrial dysfunction can contribute to age-related common diseases such as cancer, diabetes, and other commonly occurring diseases. We will then turn our attention to the likely role that mtDNA mutation plays in aging and senescence. Finally, we will use this context to develop a mathematical formula for estimating for the accumulation of somatic mtDNA mutations with age. This resulting model shows that almost 90% of non-proliferating cells would be expected to have at least 100 mutations per cell by the age of 70, and almost no cells would have fewer than 10 mutations, suggesting that mtDNA mutations may contribute significantly to many adult onset diseases.
C1 [Li, Huanzheng] Nanchang Univ, Human Aging Res Inst, Nanchang 330031, Jiangxi, Peoples R China.
   [Li, Huanzheng] Wenzhou Cent Hosp, Wenzhou Key Lab Birth Defects, Wenzhou 325000, Zhejiang, Peoples R China.
   [Slone, Jesse; Huang, Taosheng] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
   [Fei, Lin] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
C3 Nanchang University; Cincinnati Children's Hospital Medical Center;
   Cincinnati Children's Hospital Medical Center
RP Huang, TS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
EM oceanuniversity@126.com; jesse.slone@cchmc.org; lin.fei@cchmc.org;
   Taosheng.Huang@cchmc.org
RI Fei, Lin/N-8299-2015
OI Huang, Taosheng/0000-0001-6601-6687
CR Abudu YP, 2019, DEV CELL, V49, P509, DOI 10.1016/j.devcel.2019.03.013
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Banoei MM, 2007, CELL MOL NEUROBIOL, V27, P867, DOI 10.1007/s10571-007-9206-5
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178
   Baysal BE, 2015, ENDOCR-RELAT CANCER, V22, pT71, DOI 10.1530/ERC-15-0226
   BENDALL KE, 1995, AM J HUM GENET, V57, P248
   Bi R, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.10.009
   Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878
   Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Cadonic C, 2016, MOL NEUROBIOL, V53, P6078, DOI 10.1007/s12035-015-9515-5
   Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537
   Choi J, 2014, MITOCHONDRION, V18, P41, DOI 10.1016/j.mito.2014.09.005
   Colijn C, 2005, J THEOR BIOL, V237, P117, DOI 10.1016/j.jtbi.2005.03.033
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coto E, 2011, NEUROGENETICS, V12, P345, DOI 10.1007/s10048-011-0295-4
   Coxhead J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.036
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   El-Hattab AW, 2014, MITOCHONDRION, V18, P63, DOI 10.1016/j.mito.2014.07.008
   Farshbaf MJ, 2017, NEUROTOX RES, V32, P518, DOI 10.1007/s12640-017-9766-1
   Fesahat F, 2007, CELL MOL NEUROBIOL, V27, P329, DOI 10.1007/s10571-006-9126-9
   Fliedner TM, 2002, CANCER BIOTHER RADIO, V17, P405, DOI 10.1089/108497802760363204
   Foote K, 2018, AGING CELL, V17, DOI 10.1111/acel.12773
   Fouquerel E, 2019, MOL CELL, V75, P117, DOI 10.1016/j.molcel.2019.04.024
   Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gómez-Serrano M, 2017, REDOX BIOL, V11, P415, DOI 10.1016/j.redox.2016.12.013
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   Grünewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027
   Guo JH, 2011, CANCER RES, V71, P2978, DOI 10.1158/0008-5472.CAN-10-3482
   Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911
   Hong YB, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-125
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Kasraie S, 2008, CELL MOL NEUROBIOL, V28, P933, DOI 10.1007/s10571-008-9261-6
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Khalil B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.581
   Kim YK, 2015, DIABETOLOGIA, V58, P771, DOI 10.1007/s00125-015-3506-y
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Krishnan KJ, 2012, NEUROBIOL AGING, V33, P2210, DOI 10.1016/j.neurobiolaging.2011.08.009
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lakshmanan LN, 2018, AGING CELL, V17, DOI 10.1111/acel.12814
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200
   Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011
   Lim JA, 2015, AUTOPHAGY, V11, P385, DOI 10.1080/15548627.2015.1009779
   Liou CW, 2016, EUR J NEUROL, V23, P1289, DOI 10.1111/ene.13020
   Marin S, 2003, FEBS LETT, V554, P342, DOI 10.1016/S0014-5793(03)01185-2
   Maruszak A, 2011, J ALZHEIMERS DIS, V27, P197, DOI 10.3233/JAD-2011-110710
   Mehta P, 2009, MOVEMENT DISORD, V24, P290, DOI 10.1002/mds.22389
   Mena NP, 2015, MITOCHONDRION, V21, P92, DOI 10.1016/j.mito.2015.02.001
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Morozova KN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204735
   Mousavizadeh K, 2015, MITOCHONDR DNA, V26, P579, DOI 10.3109/19401736.2013.878902
   Myhill S, 2009, INT J CLIN EXP MED, V2, P1
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Neuhaus JFG, 2017, NEUROENDOCRINOLOGY, V104, P72, DOI 10.1159/000444680
   Nie HR, 2016, MITOCHONDRION, V26, P104, DOI 10.1016/j.mito.2015.12.001
   Niemann J, 2017, FREE RADICAL BIO MED, V102, P174, DOI 10.1016/j.freeradbiomed.2016.11.035
   Onyango IG, 2016, AGING DIS, V7, P201, DOI 10.14336/AD.2015.1007
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   Parra V, 2014, DIABETES, V63, P75, DOI 10.2337/db13-0340
   Petersen MH, 2014, MITOCHONDRION, V17, P14, DOI 10.1016/j.mito.2014.05.001
   Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.13
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Poovathingal SK, 2012, BIOGERONTOLOGY, V13, P557, DOI 10.1007/s10522-012-9390-7
   Purevsuren J, 2009, MOL GENET METAB, V98, P372, DOI 10.1016/j.ymgme.2009.07.011
   Rana A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00525-4
   Reddy PH, 2004, HUM MOL GENET, V13, P1225, DOI 10.1093/hmg/ddh140
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014
   Santoro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012037
   Schulte Joost, 2011, Curr Trends Neurol, V5, P65
   Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533
   Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013
   Shiba-Fukushima K, 2017, HUM MOL GENET, V26, P3172, DOI 10.1093/hmg/ddx201
   Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024
   Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Slone J, 2017, J Mol Genet Med, V11, DOI 10.4172/1747-0862.1000258
   Slone J, 2018, J HUM GENET, V63, P1211, DOI 10.1038/s10038-018-0515-y
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Song LY, 2017, NEUROBIOL DIS, V100, P30, DOI 10.1016/j.nbd.2016.12.024
   Stadler K, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0611-8
   Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585
   Szklarczyk R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0439
   Tanaka N, 2010, MITOCHONDRION, V10, P32, DOI 10.1016/j.mito.2009.08.008
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Tranah GJ, 2012, J ALZHEIMERS DIS, V32, P357, DOI 10.3233/JAD-2012-120466
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Weber DD, 2018, AGING-US, V10, P164, DOI 10.18632/aging.101382
   Zhang BF, 2015, BIOMATERIALS, V61, P178, DOI 10.1016/j.biomaterials.2015.05.027
   Zhou J, 2017, AGING-US, V9, P583, DOI 10.18632/aging.101181
   Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004
NR 106
TC 61
Z9 68
U1 0
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD JUN
PY 2019
VL 8
IS 6
DI 10.3390/cells8060608
PG 21
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA II6MY
UT WOS:000475309200096
PM 31216686
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT B
AU Valentine, RC
   Valentine, DL
AF Valentine, Raymond C.
   Valentine, David L.
BA Valentine, RC
   Valentine, DL
BF Valentine, RC
   Valentine, DL
TI Revised Mitochondrial Hypothesis of Aging Highlights Energy Deficiency
   Caused by Errors of Replication (Mutations) of mtDNA
SO HUMAN LONGEVITY: OMEGA-3 FATTY ACIDS, BIOENERGETICS, MOLECULAR BIOLOGY,
   AND EVOLUTION
LA English
DT Article; Book Chapter
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   HUMAN-DISEASE; POLG MUTATIONS; OPTIC ATROPHY; HEARING-LOSS; MOUSE; MICE;
   DYNAMICS; DEFECTS
C1 [Valentine, Raymond C.] Calgene Inc, Davis, CA USA.
RP Valentine, RC (corresponding author), Univ Calif, Davis, CA 95616 USA.
RI Valentine, David/E-5594-2012
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bensch KG, 2009, AM J PHYSIOL-ENDOC M, V296, pE672, DOI 10.1152/ajpendo.90839.2008
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   Dogan SA, 2011, PHYSIOL RES, V60, pS61, DOI 10.33549/physiolres.932179
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Kirkland RA, 2002, NEUROSCIENCE, V115, P587, DOI 10.1016/S0306-4522(02)00512-2
   Kukat A, 2011, BIOCHEM BIOPH RES CO, V409, P394, DOI 10.1016/j.bbrc.2011.04.145
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Valentine R.C., 2013, Neurons and the DHA principles
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697
NR 38
TC 0
Z9 0
U1 0
U2 2
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-4665-9487-6; 978-1-4665-9486-9
PY 2015
BP 95
EP 105
PG 11
WC Biochemistry & Molecular Biology; Biology
WE Book Citation Index – Science (BKCI-S)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA BC7CR
UT WOS:000354742500011
DA 2024-11-01
ER

PT J
AU Chiyonobu, T
   Noda, R
   Yoshida, M
   Fujiki, A
   Ishii, R
   Nukina, S
   Fujita, K
   Goto, YI
   Morimoto, M
AF Chiyonobu, Tomohiro
   Noda, Rei
   Yoshida, Michiko
   Fujiki, Atsushi
   Ishii, Rumiko
   Nukina, Sadayuki
   Fujita, Kinya
   Goto, Yu-ichi
   Morimoto, Masafumi
TI Intestinal pseudo-obstruction in a patient with mitochondrial myopathy,
   encephalopathy, lactic acidosis, and stroke-like episodes (MELAS)
   associated with phenytoin therapy
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE MELAS; intestinal pseudo-obstruction; phenytoin
ID ENCEPHALOMYOPATHY; FEATURES
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is most commonly associated with a mitochondrial DNA A to G point mutation at nucleotide 3243 (A3243G) and individuals with the disorder present a wide range of multisystemic symptoms. Seizures in MELAS patients are often intractable and require multiple antiepileptic drugs. Here we report a MELAS patient who presented with acute intestinal pseudo-obstruction following the administration of phenytoin (PHT) as an antiepileptic treatment. She presented with the first stroke-like episode at the age of 6 years and mitochondrial DNA analysis revealed A3243G with 94% mutation load in skeletal muscle. Despite treatment with phenobarbital and clobazam at the age of 16 years, she developed status epilepticus which ceased following PHT infusion. Thereafter, she was started on PHT treatment. One month later, however, she was readmitted because of remarkable abdominal distention. Although abdominal CT showed acute ileus with hepatic portal venous gas mimicking surgical emergency, the abdominal distention gradually recovered over several days following the discontinuation of PHT. Our clinical observations suggest the possibility that intestinal pseudo-obstruction in this patient related to PHT therapy. Careful clinical observation including gastrointestinal symptoms is required in the management of epilepsy in MELAS patients. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Chiyonobu, Tomohiro; Noda, Rei; Yoshida, Michiko; Fujiki, Atsushi; Ishii, Rumiko; Nukina, Sadayuki] Akashi Municipal Hosp, Dept Pediat, Akashi, Hyogo 6738501, Japan.
   [Fujita, Kinya] Akashi Municipal Hosp, Dept Gastroenterol, Akashi, Hyogo, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1870031, Japan.
   [Morimoto, Masafumi] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto 602, Japan.
C3 National Center for Neurology & Psychiatry - Japan; Kyoto Prefectural
   University of Medicine
RP Chiyonobu, T (corresponding author), Akashi Municipal Hosp, Dept Pediat, 1-33 Takasho Machi, Akashi, Hyogo 6738501, Japan.
EM chiyonobu@kobe.zaq.jp
OI Chiyonobu, Tomohiro/0000-0001-6678-060X
CR Chang TM, 2004, PEDIATR NEUROL, V31, P374, DOI 10.1016/j.pediatrneurol.2004.05.009
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   ISOJARVI JIT, 1992, EPILEPSIA, V33, P142, DOI 10.1111/j.1528-1157.1992.tb02297.x
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Lyford GL, 2003, CURR OPIN PHARMACOL, V3, P583, DOI 10.1016/j.coph.2003.06.010
   Mori O, 2000, ACTA NEUROPATHOL, V100, P712, DOI 10.1007/s004010000209
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   SHAFER RB, 1984, GASTROENTEROLOGY, V86, P852
   Shimotake T, 1998, J PEDIATR SURG, V33, P1837, DOI 10.1016/S0022-3468(98)90301-3
NR 10
TC 25
Z9 26
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD JUN
PY 2008
VL 30
IS 6
BP 430
EP 433
DI 10.1016/j.braindev.2007.12.006
PG 4
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 303UH
UT WOS:000256065900010
PM 18226864
DA 2024-11-01
ER

PT J
AU Hiniker, A
   Wong, LJ
   Berven, S
   Truong, CK
   Adesina, AM
   Margeta, M
AF Hiniker, Annie
   Wong, Lee-Jun
   Berven, Sigurd
   Truong, Cavatina K.
   Adesina, Adekunle M.
   Margeta, Marta
TI Axial mitochondrial myopathy in a patient with rapidly progressive
   adult-onset scoliosis
SO ACTA NEUROPATHOLOGICA COMMUNICATIONS
LA English
DT Article
DE mtDNA; Mitochondrial myopathy; Camptocormia; Adult scoliosis
ID MUTATION; CAMPTOCORMIA; GENOME
AB Axial myopathy can be the underlying cause of rapidly progressive adult-onset scoliosis; however, the pathogenesis of this disorder remains poorly understood. Here we present a case of a 69-year old woman with a family history of scoliosis affecting both her mother and her son, who over 4 years developed rapidly progressive scoliosis. The patient had a history of stable scoliosis since adolescence that worsened significantly at age 65, leading to low back pain and radiculopathy. Paraspinal muscle biopsy showed morphologic evidence of a mitochondrial myopathy. Diagnostic deficiencies of electron transport chain enzymes were not detected using standard bioassays, but mitochondrial immunofluorescence demonstrated many muscle fibers totally or partially deficient for complexes I, III, IV-I, and IV-IV. Massively parallel sequencing of paraspinal muscle mtDNA detected multiple deletions as well as a 40.9% heteroplasmic novel m. 12293G > A (MT-TL2) variant, which changes a G:C pairing to an A:C mispairing in the anticodon stem of tRNA LeuCUN. Interestingly, these mitochondrial abnormalities were not detected in the blood of either the patient or her son, suggesting that the patient's rapidly progressive late onset scoliosis was due to the acquired paraspinal mitochondrial myopathy; the cause of non-progressive scoliosis in the other two family members currently remains unexplained. Notably, this case illustrates that isolated mitochondrial myopathy can underlie rapidly-progressive adult-onset scoliosis and should be considered in the differential diagnosis of the primary axial myopathy.
C1 [Hiniker, Annie; Margeta, Marta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.
   [Wong, Lee-Jun; Truong, Cavatina K.] Baylor Coll Med, Dept Mol Human Genet, Houston, TX 77030 USA.
   [Berven, Sigurd] Univ Calif San Francisco, Dept Orthoped Surg, San Francisco, CA 94143 USA.
   [Adesina, Adekunle M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
C3 University of California System; University of California San Francisco;
   Baylor College of Medicine; University of California System; University
   of California San Francisco; Baylor College of Medicine
RP Margeta, M (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.
EM Marta.Margeta@ucsf.edu
RI marconi, anna/O-2580-2017
OI Margeta, Marta/0000-0001-6889-2488
CR Berardelli A, 2009, J NEUROL NEUROSUR PS, V80, P145
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Cardaioli E, 2005, BIOCHEM BIOPH RES CO, V327, P675, DOI 10.1016/j.bbrc.2004.11.170
   COKU J, 2010, NEUROL SCI, V290, P166, DOI DOI 10.1016/JJNS.2009.12.001
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gdynia HJ, 2009, PARKINSONISM RELAT D, V15, P633, DOI 10.1016/j.parkreldis.2009.06.003
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI [10.1016/j.mito.20.04.07.007, DOI 10.1016/J.MITO.20.04.07.007]
   Gómez-Puerta JA, 2007, CLIN RHEUMATOL, V26, P1017, DOI 10.1007/s10067-006-0259-5
   Grasso M, 2001, EUR J HUM GENET, V9, P311, DOI 10.1038/sj.ejhg.5200622
   Hanson BJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1281, DOI 10.1177/002215540205001001
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lenoir T, 2010, EUR SPINE J, V19, P1229, DOI 10.1007/s00586-010-1370-5
   Mahjneh I, 2002, J NEUROL, V249, P730, DOI 10.1007/s00415-002-0701-9
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D
   Sakiyama Y, 2011, ACTA NEUROPATHOL, V121, P775, DOI 10.1007/s00401-011-0818-y
   Serratrice G, 2007, Acta Myol, V26, P11
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Wang J, 2009, MOL GENET METAB, V96, P59, DOI 10.1016/j.ymgme.2008.10.006
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wrede A, 2012, ACTA NEUROPATHOL, V123, P419, DOI 10.1007/s00401-011-0927-7
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 25
TC 12
Z9 12
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2051-5960
J9 ACTA NEUROPATHOL COM
JI Acta Neuropathol. Commun.
PY 2014
VL 2
AR 137
DI 10.1186/s40478-014-0137-3
PG 9
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA V9K3A
UT WOS:000422389300103
PM 25223649
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Dorado, B
   Area, E
   Akman, HO
   Hirano, M
AF Dorado, Beatriz
   Area, Estela
   Akman, Hasan O.
   Hirano, Michio
TI Onset and organ specificity of Tk2 deficiency depends on Tk1
   down-regulation and transcriptional compensation
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA DEPLETION; THYMIDINE KINASE 2; NUCLEAR RESPIRATORY
   FACTORS; DEVELOPING RAT-BRAIN; MTDNA DEPLETION; HUMAN-CELLS;
   DEOXYNUCLEOTIDE POOLS; TRIPHOSPHATE POOLS; GENE; BIOGENESIS
AB Deficiency of thymidine kinase 2 (TK2) is a frequent cause of isolated myopathy or encephalomyopathy in children with mitochondrial DNA (mtDNA) depletion. To determine the bases of disease onset, organ specificity and severity of TK2 deficiency, we have carefully characterized Tk2 H126N knockin mice (Tk2(-/-)). Although normal until postnatal day 8, Tk2(-/-) mice rapidly develop fatal encephalomyopathy between postnatal days 10 and 13. We have observed that wild-type Tk2 activity is constant in the second week of life, while Tk1 activity decreases significantly between postnatal days 8 and 13. The down-regulation of Tk1 activity unmasks Tk2 deficiency in Tk2(-/-) mice and correlates with the onset of mtDNA depletion in the brain and the heart. Resistance to pathology in Tk2 mutant organs depends on compensatory mechanisms to the reduced mtDNA level. Our analyses at postnatal day 13 have revealed that Tk2(-/-) heart significantly increases mitochondrial transcript levels relative to the mtDNA content. This transcriptional compensation allows the heart to maintain normal levels of mtDNA-encoded proteins. The up-regulation in mitochondrial transcripts is not due to increased expression of the master mitochondrial biogenesis regulators peroxisome proliferator-activated receptor-gamma coactivator 1 alpha and nuclear respiratory factors 1 and 2, or to enhanced expression of the mitochondrial transcription factors A, B1 or B2. Instead, Tk2(-/-) heart compensates for mtDNA depletion by down-regulating the expression of the mitochondrial transcriptional terminator transcription factor 3 (MTERF3). Understanding the molecular mechanisms that allow Tk2 mutant organs to be spared may help design therapies for Tk2 deficiency.
C1 [Dorado, Beatriz; Area, Estela; Akman, Hasan O.; Hirano, Michio] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
C3 Columbia University
RP Hirano, M (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, 630 W 168th St,P&S 4-423, New York, NY 10032 USA.
EM mh29@columbia.edu
OI Dorado, Beatriz/0000-0002-1958-4558; Area Gomez,
   Estela/0000-0002-0962-1570
FU Muscular Dystrophy Association, USA; FUNDISMUN Foundation; Muscular
   Dystrophy Association; National Institutes of Health [R01 HD057543, R01
   HD056103, RC1 NS070232, P01 HD032062]; Marriott Mitochondrial Disorder
   Clinical Research Fund (MMDCRF)
FX The work was supported in part by the Muscular Dystrophy Association,
   USA, and the FUNDISMUN Foundation. The authors are supported by grants
   from the Muscular Dystrophy Association, National Institutes of Health
   (R01 HD057543, R01 HD056103, RC1 NS070232, P01 HD032062) and the
   Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF).
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6
   Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522
   Bruni F, 2010, J BIOL CHEM, V285, P3939, DOI 10.1074/jbc.M109.044305
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141
   Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147
   Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   HAAS RJ, 1970, J ANAT, V107, P421
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   LI K, 1995, AM J PHYSIOL-CELL PH, V269, pC1265, DOI 10.1152/ajpcell.1995.269.5.C1265
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040
   Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580
   MORI K, 1970, J NEUROCHEM, V17, P835, DOI 10.1111/j.1471-4159.1970.tb02237.x
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   RAMPAZZO C, 2010, MUTAT RES
   Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200
   REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Vilá MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Villarroya J, 2009, EXP CELL RES, V315, P1429, DOI 10.1016/j.yexcr.2009.02.018
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wang L, 2010, NUCLEOS NUCLEOT NUCL, V29, P400, DOI 10.1080/15257771003741042
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang LY, 2008, NUCLEOS NUCLEOT NUCL, V27, P858, DOI 10.1080/15257770802146510
   Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   YAMAGAMI S, 1972, J NEUROCHEM, V19, P369, DOI 10.1111/j.1471-4159.1972.tb01346.x
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   Zhou XS, 2010, J INHERIT METAB DIS, V33, P231, DOI 10.1007/s10545-010-9102-x
NR 61
TC 28
Z9 34
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN
PY 2011
VL 20
IS 1
BP 155
EP 164
DI 10.1093/hmg/ddq453
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 692ZE
UT WOS:000285193600013
PM 20940150
OA Green Published
DA 2024-11-01
ER

PT S
AU Leung, GPH
AF Leung, George P. H.
BE Scatena, R
   Bottoni, P
   Giardina, B
TI Iatrogenic Mitochondriopathies: A Recent Lesson from
   Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
SO ADVANCES IN MITOCHONDRIAL MEDICINE
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE NRTIs; Mitochondrial toxicity; Polymerase-gamma; DNA depletion; Reactive
   oxygen species
ID HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS;
   DNA-POLYMERASE-GAMMA; ACTIVE ANTIRETROVIRAL THERAPY; CHRONIC
   HEPATITIS-B; EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS; STIMULATED
   HUMAN-LYMPHOCYTES; RAT-LIVER MITOCHONDRIA; SEVERE LACTIC-ACIDOSIS;
   TUMOR-NECROSIS-FACTOR
AB The use of nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) has revolutionized the treatment of infection by human immunodeficiency virus (HIV) and hepatitis-B virus. NRTIs can suppress viral replication in the long-term, but possess significant toxicity that can seriously compromise treatment effectiveness. The major toxicity of NRTIs is mitochondrial toxicity. This manifests as serious side effects such as myopathy, peripheral neuropathy and lactic acidosis. In general, it is believed that the mitochondrial pathogenesis is closely related to the effect of NRTIs on mitochondrial DNA polymerase-g. Depletion and mutation of mitochondrial DNA during chronic NRTI therapy may lead to cellular respiratory dysfunction and release of reactive oxidative species, resulting in cellular damage. It is now apparent that the etiology is far more complex than originally thought. It appears to involve multiple mechanisms as well as host factors such as HIV per se, inborn mitochondrial mutation, and sex. Management of mitochondrial toxicity during NRTI therapy remains a challenge. Interruption of NRTI therapy and substitution of the causative agents with alternative better-tolerated NRTIs represents the mainstay of management for mitochondrial toxicity and its clinical manifestations. A range of pharmacological approaches has been proposed as treatments and prophylaxes.
C1 Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.
C3 University of Hong Kong
RP Leung, GPH (corresponding author), Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.
EM gphleung@hkucc.hku.hk
RI Leung, George Pak Heng/B-4529-2009
OI Leung, George Pak Heng/0000-0003-3529-9367
CR Adani GL, 2005, AM J TRANSPLANT, V5, P634, DOI 10.1111/j.1600-6143.2005.00691.x
   Affandi JS, 2008, AIDS RES HUM RETROV, V24, P1281, DOI 10.1089/aid.2008.0045
   Al-Madhoun AS, 2004, MINI-REV MED CHEM, V4, P341
   Allaouchiche B, 1999, J ANTIMICROB CHEMOTH, V44, P137, DOI 10.1093/jac/44.1.137
   Amacher DE, 2005, CURR MED CHEM, V12, P1829, DOI 10.2174/0929867054546663
   Amarapurkar DN, 2007, WORLD J GASTROENTERO, V13, P6150, DOI 10.3748/wjg.13.6150
   Anderson PL, 2004, CLIN INFECT DIS, V38, P743, DOI 10.1086/381678
   Anderson PL, 2003, AIDS, V17, P2159, DOI 10.1097/00002030-200310170-00003
   ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200
   BALZARINI J, 1994, PHARM WORLD SCI, V16, P113, DOI 10.1007/BF01880662
   BALZARINI J, 1989, J BIOL CHEM, V264, P6127
   Bani-Sadr F, 2005, JAIDS-J ACQ IMM DEF, V40, P47, DOI 10.1097/01.qai.0000174649.51084.46
   BARILE M, 1994, BIOCHEM PHARMACOL, V48, P1405, DOI 10.1016/0006-2952(94)90564-9
   Barile M, 1997, BIOCHEM PHARMACOL, V53, P913, DOI 10.1016/S0006-2952(96)00831-3
   BARRY M, 1994, AIDS, V8, pF1, DOI 10.1097/00002030-199408000-00002
   Behbahani H, 2000, J ACQ IMMUN DEF SYND, V25, P150, DOI 10.1097/00126334-200010010-00009
   Benbrik E, 1997, J NEUROL SCI, V149, P19, DOI 10.1016/S0022-510X(97)05376-8
   Birkus G, 2003, J VIRAL HEPATITIS, V10, P50, DOI 10.1046/j.1365-2893.2003.00399.x
   Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P1610, DOI 10.1128/AAC.46.5.1610-1613.2002
   BISSUEL F, 1994, J INTERN MED, V235, P367, DOI 10.1111/j.1365-2796.1994.tb01088.x
   Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0
   Bolhaar MG, 2007, CLIN INFECT DIS, V45, P254, DOI 10.1086/518976
   Bourdais J, 1996, J BIOL CHEM, V271, P7887, DOI 10.1074/jbc.271.14.7887
   BREMER J, 1990, J CLIN CHEM CLIN BIO, V28, P297
   Bridges EG, 1999, J BIOL CHEM, V274, P4620, DOI 10.1074/jbc.274.8.4620
   BRINKMAN K, 1999, AIDS REV, V1, P141
   Butt Adeel A, 2003, AIDS Read, V13, P344
   Carr A, 2002, JAMA-J AM MED ASSOC, V288, P207, DOI 10.1001/jama.288.2.207
   Casademont J, 1996, BRAIN, V119, P1357, DOI 10.1093/brain/119.4.1357
   Cepeda JA, 2000, AIDS, V14, P332, DOI 10.1097/00002030-200002180-00022
   Chariot P, 1999, J HEPATOL, V30, P156, DOI 10.1016/S0168-8278(99)80020-8
   Chen R, 2000, BIOCHEM PHARMACOL, V60, P215, DOI 10.1016/S0006-2952(00)00334-8
   Cherry CL, 2006, JAIDS-J ACQ IMM DEF, V42, P435, DOI 10.1097/01.qai.0000224974.67962.ce
   Cherry CL, 2003, J CLIN VIROL, V26, P195, DOI 10.1016/S1386-6532(02)00118-X
   Cherry CL, 2002, J ACQ IMMUN DEF SYND, V30, P271, DOI [10.1097/00126334-200207010-00002, 10.1097/01.QAI.0000017962.22053.0E]
   Cihlar T, 2008, ANTIMICROB AGENTS CH, V52, P655, DOI 10.1128/AAC.01215-07
   Collier AC, 2003, TOXICOL APPL PHARM, V192, P164, DOI 10.1016/S0041-008X(03)00274-6
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Currier JS, 2007, CLIN INFECT DIS, V45, P261, DOI 10.1086/518977
   Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2
   Dagan T, 2002, MITOCHONDRION, V1, P397, DOI 10.1016/S1567-7249(02)00003-X
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Dambrova M, 2002, TRENDS CARDIOVAS MED, V12, P275, DOI 10.1016/S1050-1738(02)00175-5
   De Clercq E, 2004, BIOCHEM PHARMACOL, V68, P2301, DOI [10.1016/j.bep.2004.07.039, 10.1016/j.bcp.2004.07.039]
   de la Asunción JG, 1998, J CLIN INVEST, V102, P4, DOI 10.1172/JCI1418
   Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998
   DOLIN R, 1995, ARCH INTERN MED, V155, P961, DOI 10.1001/archinte.155.9.961
   DOMANSKI MJ, 1995, J PEDIATR-US, V127, P137, DOI 10.1016/S0022-3476(95)70275-X
   Elimadi A, 1997, BRIT J PHARMACOL, V121, P1295, DOI 10.1038/sj.bjp.0701276
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Faletto MB, 1997, ANTIMICROB AGENTS CH, V41, P1099, DOI 10.1128/AAC.41.5.1099
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Famularo G, 1997, AIDS, V11, P185, DOI 10.1097/00002030-199702000-00008
   FICHTENBAUM CJ, 1995, J ACQ IMMUN DEF SYND, V10, P169, DOI 10.1097/00042560-199510020-00009
   Fleischer RD, 2009, J HEPATOL, V51, P787, DOI 10.1016/j.jhep.2009.06.011
   Fodale V, 2005, ANAESTHESIA, V60, P806, DOI 10.1111/j.1365-2044.2005.04208.x
   Foli A, 2001, AIDS, V15, P1687, DOI 10.1097/00002030-200109070-00012
   Fouty B, 1998, LANCET, V352, P291, DOI 10.1016/S0140-6736(05)60266-8
   Frank I, 2004, AIDS RES HUM RETROV, V20, P916, DOI 10.1089/aid.2004.20.916
   FRICK LW, 1988, BIOCHEM BIOPH RES CO, V154, P124, DOI 10.1016/0006-291X(88)90659-6
   FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333
   GAO WY, 1993, J CLIN INVEST, V91, P2326, DOI 10.1172/JCI116463
   GAO WY, 1994, J BIOL CHEM, V269, P12633
   Gattermann N, 2004, NUCLEOS NUCLEOT NUCL, V23, P1275, DOI 10.1081/NCN-200027545
   Gerschenson M, 2000, ANN NY ACAD SCI, V918, P269
   GERTNER E, 1989, AM J MED, V86, P814, DOI 10.1016/0002-9343(89)90478-6
   GODFRIED MH, 1993, AIDS, V7, P33, DOI 10.1097/00002030-199301000-00005
   Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008
   GRAY NM, 1995, BIOCHEM PHARMACOL, V50, P1043, DOI 10.1016/0006-2952(95)96620-A
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Han HK, 1998, PHARMACEUT RES, V15, P1154, DOI 10.1023/A:1011919319810
   Hanes JW, 2008, ANTIMICROB AGENTS CH, V52, P253, DOI 10.1128/AAC.00778-07
   Hart AM, 2004, AIDS, V18, P1549, DOI 10.1097/01.aids.0000131354.14408.fb
   Hashimoto K, 1997, AIDS RES HUM RETROV, V13, P193, DOI 10.1089/aid.1997.13.193
   Hendrickson SL, 2009, JAIDS-J ACQ IMM DEF, V51, P111, DOI 10.1097/QAI.0b013e3181a324d6
   Hervey PS, 2000, DRUGS, V60, P447, DOI 10.2165/00003495-200060020-00015
   Hestdal K, 1997, BLOOD, V90, P2670, DOI 10.1182/blood.V90.7.2670.2670_2670_2679
   Hill A, 2007, EXPERT OPIN PHARMACO, V8, P679, DOI 10.1517/14656566.8.5.679
   Hoggard PG, 2002, AIDS, V16, P2439, DOI 10.1097/00002030-200212060-00009
   Hsu CH, 2007, ANTIMICROB AGENTS CH, V51, P1687, DOI 10.1128/AAC.01432-06
   Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1
   Hulgan T, 2008, J INFECT DIS, V197, P858, DOI 10.1086/528697
   Imaoka T, 2007, MOL PHARMACOL, V71, P619, DOI 10.1124/mol.106.028233
   Izzedine H, 2004, KIDNEY INT, V66, P1153, DOI 10.1111/j.1523-1755.2004.00866.x
   Izzedine H, 2009, NAT REV NEPHROL, V5, P564, DOI 10.1038/nrneph.2009.142
   JOHNSON MA, 1989, MOL PHARMACOL, V36, P291
   Jüllig M, 2000, EUR J BIOCHEM, V267, P5466, DOI 10.1046/j.1432-1327.2000.01607.x
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   KESTENS L, 1994, CLIN EXP IMMUNOL, V95, P436, DOI 10.1111/j.1365-2249.1994.tb07015.x
   Kewn S, 2000, BRIT J CLIN PHARMACO, V50, P597
   Klusa V, 2006, BASIC CLIN PHARMACOL, V99, P323, DOI 10.1111/j.1742-7843.2006.pto_543.x
   KUNKEL TA, 1989, BIOCHEMISTRY-US, V28, P988, DOI 10.1021/bi00429a011
   Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200
   Lam W, 2005, MOL PHARMACOL, V67, P408, DOI 10.1124/mol.104.007120
   Lebrecht D, 2008, ARTHRITIS RHEUM-US, V58, P318, DOI 10.1002/art.23235
   Lenzo NP, 1997, AIDS, V11, P1294, DOI 10.1097/00002030-199710001-00003
   Leung GPH, 2007, EXPERT OPIN DRUG MET, V3, P705, DOI 10.1517/17425225.3.5.705
   Leung S, 1999, CAN J PHYSIOL PHARM, V77, P625, DOI 10.1139/cjpp-77-8-625
   Lewis W, 2006, AIDS, V20, P675, DOI 10.1097/01.aids.0000216367.23325.58
   Lewis W, 2005, LAB INVEST, V85, P972, DOI 10.1038/labinvest.3700301
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   LEWIS W, 1992, J CLIN INVEST, V89, P1354, DOI 10.1172/JCI115722
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Lichtenstein KA, 2005, CLIN INFECT DIS, V40, P148, DOI 10.1086/426076
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lipshultz SE, 2000, NEW ENGL J MED, V343, P759, DOI 10.1056/NEJM200009143431102
   Lonergan JT, 2004, JAIDS-J ACQ IMM DEF, V36, P935, DOI 10.1097/00126334-200408010-00007
   Lund KC, 2008, TOXICOL APPL PHARM, V226, P94, DOI 10.1016/j.taap.2007.08.015
   Lund Kaleb C, 2004, Cardiovasc Toxicol, V4, P217, DOI 10.1385/CT:4:3:217
   Lynx MD, 2009, ANTIMICROB AGENTS CH, V53, P1252, DOI 10.1128/AAC.01115-08
   Martin AM, 2003, AM J HUM GENET, V72, P549, DOI 10.1086/367849
   MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743
   Mazzucco CE, 2008, ANTIMICROB AGENTS CH, V52, P598, DOI 10.1128/AAC.01122-07
   McComsey G, 2005, JAIDS-J ACQ IMM DEF, V39, P181
   McComsey G, 2003, JAIDS-J ACQ IMM DEF, V33, P605, DOI 10.1097/00126334-200308150-00009
   McComsey G, 2002, AIDS, V16, P513, DOI 10.1097/00002030-200203080-00001
   McComsey GA, 2004, CLIN INFECT DIS, V38, P263, DOI 10.1086/380790
   McComsey GA, 2003, JAIDS-J ACQ IMM DEF, V34, P45, DOI 10.1097/00126334-200309010-00006
   McKee Edward E, 2004, Cardiovasc Toxicol, V4, P155, DOI 10.1385/CT:4:2:155
   MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702
   Meng QX, 2000, MUTAGENESIS, V15, P405, DOI 10.1093/mutage/15.5.405
   MERTA A, 1992, BIOCHEM PHARMACOL, V44, P2067, DOI 10.1016/0006-2952(92)90110-5
   Miller KD, 2000, ANN INTERN MED, V133, P192, DOI 10.7326/0003-4819-133-3-200008010-00010
   Miró O, 2004, JAIDS-J ACQ IMM DEF, V37, P1550, DOI 10.1097/00126334-200412150-00002
   MODICANAPOLITANO JS, 1993, BIOCHEM BIOPH RES CO, V194, P170, DOI 10.1006/bbrc.1993.1800
   Modrzejewski KA, 2004, ANN PHARMACOTHER, V38, P1006, DOI 10.1345/aph.1D302
   Mokrzycki MH, 2000, CLIN INFECT DIS, V30, P198, DOI 10.1086/313594
   Moore RD, 2000, AIDS, V14, P273, DOI 10.1097/00002030-200002180-00009
   Moreno A, 2004, ANTIVIR THER, V9, P133
   Moretti S, 2002, ANTIOXID REDOX SIGN, V4, P391, DOI 10.1089/15230860260196191
   Morris GW, 2009, BIOCHEM J, V422, P513, DOI 10.1042/BJ20082427
   Moyle G, 2005, ANTIVIR THER, V10, pM47
   Moyle G, 2000, CLIN THER, V22, P911, DOI 10.1016/S0149-2918(00)80064-8
   Moyle GJ, 2002, AIDS, V16, P1341, DOI 10.1097/00002030-200207050-00005
   MUNCHPETERSEN B, 1984, MOL CELL BIOCHEM, V64, P173
   MUNCHPETERSEN B, 1977, BIOCHIM BIOPHYS ACTA, V478, P364, DOI 10.1016/0005-2787(77)90152-6
   Negredo E, 2009, CLIN INFECT DIS, V49, P892, DOI 10.1086/605440
   Opii WO, 2007, EXP NEUROL, V204, P29, DOI 10.1016/j.expneurol.2006.09.010
   Pan-Zhou XR, 2000, ANTIMICROB AGENTS CH, V44, P496, DOI 10.1128/AAC.44.3.496-503.2000
   Panel on Antiretroviral Guidelines for Adults and Adolescents, 2008, GUID US ANT AG HIV 1, P139
   Peltier AC, 2006, DRUG SAFETY, V29, P23, DOI 10.2165/00002018-200629010-00002
   PERNO CF, 1992, BLOOD, V80, P995
   Ronan A, 2000, AIDS, V14, P615
   Rossi L, 1999, BIOCHEM J, V344, P915, DOI 10.1042/0264-6021:3440915
   Rylova SN, 2005, BIOCHEM PHARMACOL, V69, P951, DOI 10.1016/j.bcp.2004.12.010
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   SAKAMOTO S, 1984, CARCINOGENESIS, V5, P183, DOI 10.1093/carcin/5.2.183
   Sales SD, 2001, TOXICOL APPL PHARM, V177, P54, DOI 10.1006/taap.2001.9288
   Scadden DT, 1996, AIDS RES HUM RETROV, V12, P1151, DOI 10.1089/aid.1996.12.1151
   Schramm C, 1999, EUR J ANAESTH, V16, P733
   SEMINOMORA MC, 1994, LAB INVEST, V71, P773
   Setzer B, 2008, AM J PATHOL, V172, P681, DOI 10.2353/ajpath.2008.070613
   Shaer AJ, 2000, AM J NEPHROL, V20, P332, DOI 10.1159/000013610
   Shikuma CM, 2001, AIDS, V15, P1801, DOI 10.1097/00002030-200109280-00009
   Shiramizu B, 2003, JAIDS-J ACQ IMM DEF, V32, P370, DOI 10.1097/00126334-200304010-00004
   Skuta G, 1999, BIOCHEM PHARMACOL, V58, P1915, DOI 10.1016/S0006-2952(99)00282-8
   Smyth K, 2007, HIV MED, V8, P367, DOI 10.1111/j.1468-1293.2007.00478.x
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Sussman HE, 1999, MUTAT RES-FUND MOL M, V429, P249, DOI 10.1016/S0027-5107(99)00111-6
   Szabados E, 1999, FREE RADICAL BIO MED, V26, P309, DOI 10.1016/S0891-5849(98)00199-3
   Tanji N, 2001, HUM PATHOL, V32, P734, DOI 10.1053/hupa.2001.25586
   TESCO G, 1992, DEMENTIA, V3, P58, DOI 10.1159/000106995
   Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312
   TSAI CH, 1994, BIOCHEM PHARMACOL, V48, P1477, DOI 10.1016/0006-2952(94)90573-8
   Tuon FF, 2008, BRAZ J INFECT DIS, V12, P263, DOI 10.1590/S1413-86702008000400001
   Turriziani O, 2005, AIDS, V19, P473, DOI 10.1097/01.aids.0000162335.12815.12
   Uwai Y, 2007, PHARM RES, V24, P811, DOI 10.1007/s11095-006-9196-x
   Valenti D, 1999, FEBS LETT, V444, P291, DOI 10.1016/S0014-5793(99)00071-X
   Valenti D, 2002, BIOCHEM PHARMACOL, V64, P201, DOI 10.1016/S0006-2952(02)01065-1
   Van Huyen JPD, 2006, MODERN PATHOL, V19, P1277, DOI 10.1038/modpathol.3800652
   Velsor LW, 2004, TOXICOL APPL PHARM, V199, P10, DOI 10.1016/j.taap.2004.03.005
   Venhoff N, 2007, ANTIVIR THER, V12, P1075
   Vrouenraets SME, 2002, ANTIVIR THER, V7, P239
   Wada S, 2000, J PHARMACOL EXP THER, V294, P844
   Walker UA, 2005, ANTIVIR THER, V10, pM117
   Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009
   Walker UA, 2004, HEPATOLOGY, V39, P311, DOI 10.1002/hep.20074
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wang LY, 2003, FEBS LETT, V554, P319, DOI 10.1016/S0014-5793(03)01181-5
   Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Wu YS, 2009, MUTAT RES-FUND MOL M, V664, P28, DOI 10.1016/j.mrfmmm.2009.02.006
   Yamanaka G, 1999, ANTIMICROB AGENTS CH, V43, P190, DOI 10.1128/AAC.43.1.190
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang XS, 2008, WORLD J GASTROENTERO, V14, P3549, DOI 10.3748/wjg.14.3549
NR 189
TC 13
Z9 14
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-94-007-2868-4; 978-94-007-2869-1
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2012
VL 942
BP 347
EP 369
DI 10.1007/978-94-007-2869-1_16
D2 10.1007/978-94-007-2869-1
PG 23
WC Oncology; Medicine, Research & Experimental
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA BA2RR
UT WOS:000333840200017
PM 22399431
DA 2024-11-01
ER

PT J
AU Dufour, E
   Terzioglu, M
   Sterky, FH
   Sörensen, L
   Galter, D
   Olson, L
   Wilbertz, J
   Larsson, NG
AF Dufour, Eric
   Terzioglu, Muegen
   Sterky, Fredrik Hansson
   Sorensen, Lene
   Galter, Dagmar
   Olson, Lars
   Wilbertz, Johannes
   Larsson, Nils-Goeran
TI Age-associated mosaic respiratory chain deficiency causes
   <i>trans</i>-neuronal degeneration
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA DELETIONS; OXIDATIVE-PHOSPHORYLATION; TRANSCRIPTION
   FACTOR; SKELETAL-MUSCLE; POINT MUTATIONS; NERVOUS-SYSTEM; FLUORO-JADE;
   HUMAN BRAIN; STEM-CELLS; MICE
AB Heteroplasmic mitochondrial DNA (mtDNA) mutations (mutations present only in a subset of cellular mtDNA copies) arise de novo during the normal ageing process or may be maternally inherited in pedigrees with mitochondrial disease syndromes. A pathogenic mtDNA mutation causes respiratory chain deficiency only if the fraction of mutated mtDNA exceeds a certain threshold level. These mutations often undergo apparently random mitotic segregation and the levels of normal and mutated mtDNA can vary considerably between cells of the same tissue. In human ageing, segregation of somatic mtDNA mutations leads to mosaic respiratory chain deficiency in a variety of tissues, such as brain, heart and skeletal muscle. A similar pattern of mutation segregation with mosaic respiratory chain deficiency is seen in patients with mitochondrial disease syndromes caused by inherited pathogenic mtDNA mutations. We have experimentally addressed the role of mosaic respiratory chain deficiency in ageing and mitochondrial disease by creating mouse chimeras with a mixture of normal and respiratory chain-deficient neurons in cerebral cortex. We report here that a low proportion (> 20%) of respiratory chain-deficient neurons in the forebrain are sufficient to cause symptoms, whereas premature death of the animal occurs only if the proportion is high (> 60-80%). The presence of neurons with normal respiratory chain function does not only prevent mortality but also delays the age at which onset of disease symptoms occur. Unexpectedly, respiratory chain-deficient neurons have adverse effect on normal adjacent neurons and induce trans-neuronal degeneration. In summary, our study defines the minimal threshold level of respiratory chain-deficient neurons needed to cause symptoms and also demonstrate that neurons with normal respiratory chain function ameliorate disease progression. Finally, we show that respiratory chain-deficient neurons induce death of normal neurons by a trans-neuronal degeneration mechanism. These findings provide novel insights into the pathogenesis of mosaic respiratory chain deficiency in ageing and mitochondrial disease.
C1 [Larsson, Nils-Goeran] Karolinska Inst, Dept Lab Med, Div Metab Dis, S-14186 Stockholm, Sweden.
   [Galter, Dagmar; Olson, Lars] Karolinska Inst, Dept Neurosci, S-14186 Stockholm, Sweden.
   [Wilbertz, Johannes] Karolinska Inst, Dept Cell & Mol Biol, S-14186 Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska Institutet; Karolinska Institutet
RP Larsson, NG (corresponding author), Karolinska Inst, Dept Lab Med, Div Metab Dis, S-14186 Stockholm, Sweden.
EM nils-goran.larsson@ki.se
RI Larsson, Nils-Göran/GVS-5578-2022; Dufour, Eric/AAF-6210-2020; Sterky,
   Fredrik/ABZ-7879-2022; Galter, Dagmar/C-4826-2011
OI Galter, Dagmar/0000-0001-6485-6244; Terzioglu,
   Mugen/0000-0003-0872-3046; Dufour, Eric/0000-0001-6690-5329; Sorensen,
   Lene/0000-0002-0309-4247; Larsson, Nils-Goran/0000-0001-5100-996X
CR AGNATI LF, 1995, PROG NEUROBIOL, V46, P561, DOI 10.1016/0301-0082(95)00017-P
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cottrell D A, 2000, Curr Opin Clin Nutr Metab Care, V3, P473, DOI 10.1097/00075197-200011000-00009
   Cottrell DA, 2002, NEUROPATH APPL NEURO, V28, P390, DOI 10.1046/j.1365-2990.2002.00414.x
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X
   MUELLER-HOECKER J, 1989, American Journal of Pathology, V134, P1167
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   SATO W, 1989, BIOCHEM BIOPH RES CO, V162, P664, DOI 10.1016/0006-291X(89)92362-0
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X
   Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   SOONG NW, 1992, NAT GENET, V2, P318
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Wallace D C, 2001, Novartis Found Symp, V235, P247
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789
NR 38
TC 31
Z9 36
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 15
PY 2008
VL 17
IS 10
BP 1418
EP 1426
DI 10.1093/hmg/ddn030
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 296DJ
UT WOS:000255523400007
PM 18245781
OA hybrid, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Lodi, T
   Bove, C
   Fontanesi, F
   Viola, AM
   Ferrero, I
AF Lodi, T
   Bove, C
   Fontanesi, F
   Viola, AM
   Ferrero, I
TI Mutation D104G in ANT1 gene:: Complementation study in <i>Saccharomyces
   cerevisiae</i> as a model system
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE ANTI; AAC2; PEO; mitochondrial diseases; ADP/ATP carrier; yeast
ID MITOCHONDRIAL ADP/ATP CARRIER; ADENINE-NUCLEOTIDE TRANSLOCATOR;
   PROTEINS; EQUIVALENT; EXPRESSION; DNA
AB Mutations in the human ANT1 gene, coding for the ADP/ATP carrier, are responsible for the autosomal dominant and recessive forms of progressive external ophthalmoplegia, mitochondrial disorders characterized by the presence of multiple deletions of mitochondrial DNA in affected tissues. By introducing these mutations at equivalent position in AAC2, the yeast orthologue of ANT1, we created a suitable model for validation of the pathogenicity of the human mutations. Here, we describe the use of this approach in the case of mutations mapping in domains not conserved between human and yeast, taking advantage of a yAAC2/hANT1 chimeric construction as a template to introduce pathogenic hANT1 mutations. Application to the case of the D104G mutation indicated that the chimeric construction could be a tool for validation of pathogenic ANT1 mutations in yeast. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Parma, Dept Genet Anthropol Evolut, I-43100 Parma, Italy.
C3 University of Parma
RP Univ Parma, Dept Genet Anthropol Evolut, I-43100 Parma, Italy.
EM tiziana.lodi@unipr.it
RI ; Lodi, Tiziana/A-5993-2012
OI Fontanesi, Flavia/0000-0003-0509-3835; Lodi, Tiziana/0000-0002-7294-8971
FU Telethon [GGP030039] Funding Source: Medline
CR ADRIAN GS, 1986, MOL CELL BIOL, V6, P626, DOI 10.1128/MCB.6.2.626
   Ausubel FM., 1994, Curr. Protoc. Mol. Biol
   Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493
   BULDER CJE, 1964, ANTON VAN LEE J M S, V30, P442, DOI 10.1007/BF02046758
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   DRGON T, 1992, FEBS LETT, V304, P277, DOI 10.1016/0014-5793(92)80637-V
   Dujon B., 1981, MOL BIOL YEAST SACCH, P505
   Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8
   Hatanaka T, 2001, BIOL PHARM BULL, V24, P595, DOI 10.1248/bpb.24.595
   ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KLINGENBERG M, 1979, TRENDS BIOCHEM SCI, V4, P249, DOI 10.1016/0968-0004(79)90215-9
   KOLAROV J, 1990, J BIOL CHEM, V265, P12711
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   LAWSON JE, 1988, J BIOL CHEM, V263, P14812
   Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Sambrook J, 1990, Cold Spring Harbor Laboratories, V186, P182
   Sherman F., 1986, LAB COURSE MANUAL ME
NR 22
TC 15
Z9 16
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 17
PY 2006
VL 341
IS 3
BP 810
EP 815
DI 10.1016/j.bbrc.2006.01.034
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 014PW
UT WOS:000235493200022
PM 16438935
DA 2024-11-01
ER

PT J
AU Blakely, EL
   Rennie, KJ
   Jones, L
   Elstner, M
   Chrzanowska-Lightowlers, ZMA
   White, CB
   Shield, JPH
   Pilz, DT
   Turnbull, DM
   Poulton, J
   Taylor, RW
AF Blakely, EL
   Rennie, KJ
   Jones, L
   Elstner, M
   Chrzanowska-Lightowlers, ZMA
   White, CB
   Shield, JPH
   Pilz, DT
   Turnbull, DM
   Poulton, J
   Taylor, RW
TI Sporadic intragenic inversion of the mitochondrial DNA <i>MTND1</i> gene
   causing fatal infantile lactic acidosis
SO PEDIATRIC RESEARCH
LA English
DT Article
ID COMPLEX-I DEFICIENCY; LEIGH-SYNDROME; ND3 GENE; MUTATIONS; DISEASE;
   MTDNA; DIAGNOSIS; DISORDER; DELETION; PATIENT
AB Mutations of mitochondrial DNA (mtDNA) are an important cause of genetic disease, yet rarely present in the neonatal period. Here we report the clinical, biochemical, and molecular genetic findings of an infant who died at the age of 1 mo with marked biventricular hypertrophy, aortic coarctation, and severe lactic acidosis due to a previously described but unusual mtDNA mutation, a 7-bp intragenic inversion within the mitochondrial gene encoding ND1 protein of complex I (MTND1). In direct contrast to the previous case, an adult with exercise intolerance who only harbored the mutation in muscle, the MTND1 inversion in our patient was present at high levels in several tissues including the heart, muscle, liver, and cultured skin fibroblasts. There was no evidence of the mutation or respiratory complex I defect in a muscle biopsy from the patient's mother. Transmitochondrial cytoplasmic hybrids (cybrids) containing high mutant loads of the inversion expressed the biochemical defect but apparently normal levels of the assembled complex. Our report highlights the enormous phenotypic diversity that exists among pathogenic mtDNA mutations and reemphasizes the need for appropriate genetic counseling for families affected by mtDNA disease.
C1 Univ Newcastle Upon Tyne, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Univ Wales Hosp, Inst Med Genet, Cardiff CF14 4XW, Wales.
   Royal Hosp Children, Bristol BS2 8AE, Avon, England.
   John Radcliffe Hosp, Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
C3 Newcastle University - UK; Cardiff University; Bristol Royal Hospital
   For Children; University of Oxford
RP Univ Newcastle Upon Tyne, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
RI Poulton, Joanna/AAB-4828-2021; Hamilton-Shield, Julian/D-6297-2014
OI Poulton, Joanna/0000-0002-2460-5587; Hamilton-Shield,
   Julian/0000-0003-2601-7575; Chrzanowska-Lightowlers,
   Zofia/0000-0002-0045-3152
FU Wellcome Trust [074454] Funding Source: Medline
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003
   Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Musumeci O, 2000, AM J HUM GENET, V66, P1900, DOI 10.1086/302927
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Poulton J, 2000, NEUROMUSCULAR DISORD, V10, P484, DOI 10.1016/S0960-8966(00)00130-9
   POULTON J, 2001, J NEUROL SCI, V187, pS435
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Taylor R.W., 1997, Organelle Diseases : Clinical Features, Diagnosis, Pathogenesis, and Management, P341
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Villani G, 2001, METHOD CELL BIOL, V65, P119, DOI 10.1016/S0091-679X(01)65007-6
   Zickermann V, 1998, BIOCHEMISTRY-US, V37, P11792, DOI 10.1021/bi9810555
NR 30
TC 16
Z9 17
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD MAR
PY 2006
VL 59
IS 3
BP 440
EP 444
DI 10.1203/01.pdr.0000198771.78290.c4
PG 5
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 016NK
UT WOS:000235626700018
PM 16492986
OA Bronze
DA 2024-11-01
ER

PT J
AU Wang, J
   Brautbar, A
   Chan, AK
   Dzwiniel, T
   Fang-Yuan, L
   Waters, PJ
   Graham, BH
   Wong, LJ
AF Wang, Jing
   Brautbar, Ariel
   Chan, Alicia K.
   Dzwiniel, Tara
   Fang-Yuan, Li
   Waters, Paula J.
   Graham, Brett H.
   Wong, Lee-Jun
TI Two mtDNA mutations 14487T&gt;C (M63V, ND6) and 12297T&gt;C (tRNA Leu)
   in a Leigh syndrome family
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondrial disease; Leigh syndrome; mtDNA; 1448TF > C; 12297T > C
ID MITOCHONDRIAL-DNA MUTATIONS; COMPLEX-I DEFICIENCY; DILATED
   CARDIOMYOPATHY; A12308G POLYMORPHISM; DISEASE; GENE; RISK
AB Mitochondrial cytopathies are characterized by a large variability of clinical phenotypes and severity. The 14487T>C mutation in mtDNA has been recently described to be associated with Leigh syndrome. The 12297T>C mutation has been described in isolated dilated cardiomyopathy patients. Here, we report a family with multiple members who harbor both mutations, with only a few individuals who are affected with Leigh syndrome. Mitochondrial whole genome sequencing analysis in the proband's muscle specimen detected two nearly homoplasmic mutations: 14487T>C (M63V in ND6) and 12297T>C in the tRNA 11 (CUN) gene. These two mutations were also detected in the blood, urine sediments, hair follicles, and buccal swab samples of all matrilineal relatives tested. All individuals tested were nearly homoplasmic for the 12297T>C mutation, but had variable degrees of heteroplasmy for 14487T>C. We also screened for the frequency of these two mutations. Of 268 patients with Leigh or Leigh-like disease, one case was found to harbor the 14487T>C mutation (0.3%), and one had the 12297T>C mutation (0.3%). Neither mutation was detected in the 88 patients meeting MELAS syndrome criteria nor in the 56 patients with respiratory chain complex I or I + III deficiency. In conclusion, the 14487T>C mutation appears as the primary etiology of Leigh syndrome in this family, demonstrating the high level of heteroplasmy needed for a clinically significant phenotype with this mutation. The 12297T>C mutation was not associated with dilated cardiomyopathy for the family members who were clinically evaluated and who were shown by testing to be nearly homoplasmic for that mutation. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Wang, Jing; Brautbar, Ariel; Fang-Yuan, Li; Graham, Brett H.; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Chan, Alicia K.; Dzwiniel, Tara] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
   [Waters, Paula J.] Childrens & Womens Hlth Ctr, Dept Pathol & Lab Med, Vancouver, BC, Canada.
C3 Baylor College of Medicine; University of Alberta
RP Wong, LJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
RI Graham, Brett/R-8685-2018
OI Graham, Brett/0000-0001-8451-8154; Waters, Paula/0000-0003-4898-1859
CR Bai RK, 2008, CANCER RES, V68, P624, DOI 10.1158/0008-5472.CAN-07-5706
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Covarrubias D, 2008, J HUM GENET, V53, P924, DOI 10.1007/s10038-008-0331-x
   Crimi M, 2003, EUR J HUM GENET, V11, P896, DOI 10.1038/sj.ejhg.5201056
   DAVIS PC, 1987, AM J NEURORADIOL, V8, P71
   DEMARCHI JM, 1994, HUM MUTAT, V4, P281, DOI 10.1002/humu.1380040409
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Gonzalo R, 2005, FEBS LETT, V579, P6909, DOI 10.1016/j.febslet.2005.11.034
   Grasso M, 2001, EUR J HUM GENET, V9, P311, DOI 10.1038/sj.ejhg.5200622
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Nishioka T, 2004, J HUM GENET, V49, P701, DOI 10.1007/s10038-004-0209-5
   Pulkes T, 2000, LANCET, V356, P2068, DOI 10.1016/S0140-6736(00)03408-5
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Shanske S, 2004, MITOCHONDRION, V4, P403, DOI 10.1016/j.mito.2004.07.026
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Tessa A, 1999, EUR J HUM GENET, V7, P847, DOI 10.1038/sj.ejhg.5200380
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
NR 25
TC 16
Z9 17
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD FEB
PY 2009
VL 96
IS 2
BP 59
EP 65
DI 10.1016/j.ymgme.2008.10.006
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 399QG
UT WOS:000262813800003
PM 19062322
DA 2024-11-01
ER

PT J
AU Nikali, K
   Suomalainen, A
   Saharinen, J
   Kuokkanen, M
   Spelbrink, JN
   Lönnqvist, T
   Peltonen, L
AF Nikali, K
   Suomalainen, A
   Saharinen, J
   Kuokkanen, M
   Spelbrink, JN
   Lönnqvist, T
   Peltonen, L
TI Infantile onset spinocerebellar ataxia is caused by recessive mutations
   in mitochondrial proteins Twinkle and Twinky
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID SENSORY NEUROPATHY; DNA DELETIONS; GENE; IRON; FRIEDREICHS; EXPRESSION;
   ASSIGNMENT; HOMOLOG; CLONING; IOSCA
AB Infantile onset spinocerebellar ataxia (IOSCA) (MIM 271245) is a severe autosomal recessively inherited neurodegenerative disorder characterized by progressive atrophy of the cerebellum, brain stem and spinal cord and sensory axonal neuropathy. We report here the molecular background of this disease based on the positional cloning/candidate approach of the defective gene. Having established the linkage to chromosome 10q24, we restricted the critical DNA region using single nucleotide polymorphism-based haplotypes. After analyzing all positional candidate transcripts, we identified two point mutations in the gene C10orf2 encoding Twinkle, a mitochondrial deoxyribonucleic acid (mtDNA)-specific helicase, and a rarer splice variant Twinky, underlying IOSCA. The founder IOSCA mutation, homozygous in all but one of the patients, leads to a Y508C amino acid change in the polypeptides. One patient, heterozygous for Y508C, carries a silent coding region cytosine to thymine transition mutation in his paternal disease chromosome. This allele is expressed at a reduced level, causing the preponderance of messenger RNAs encoding Y508C polypeptides and thus leads to the IOSCA disease phenotype. Previously, we have shown that different mutations in this same gene cause autosomal dominant progressive external ophthalmoplegia (adPEO) with multiple mtDNA deletions (MIM 606075), a neuromuscular disorder sharing a spectrum of symptoms with IOSCA. IOSCA phenotype is the first recessive one due to Twinkle and Twinky mutations, the dominant PEO mutations affecting mtDNA maintenance, but in IOSCA, mtDNA stays intact. The severe neurological phenotype observed in IOSCA, a result of only a single amino acid substitution in Twinkle and Twinky, suggests that these proteins play a crucial role in the maintenance and/or function of specific affected neuronal subpopulations.
C1 Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland.
   Univ Helsinki, Biomedicum Helsinki, Dept Med Genet, Programme Neurosci, FIN-00290 Helsinki, Finland.
   Univ Tampere, Tampere Univ Hosp, Inst Med Technol, Tampere 33014, Finland.
   Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Dept Child Neurol, Helsinki 00250, Finland.
C3 Finland National Institute for Health & Welfare; University of Helsinki;
   Tampere University; Tampere University Hospital; University of Helsinki;
   Helsinki University Central Hospital
RP Kings Coll London, MRC, Dev Neurobiol Ctr, New Hunts House,Guys Hosp Campus, London SE1 1UL, England.
EM kaisu.nikali@tiscali.co.uk
RI Kuokkanen, Mikko/M-8247-2016; Spelbrink, Johannes/L-4661-2015
OI Spelbrink, Johannes/0000-0002-9756-2602; Kuokkanen,
   Mikko/0000-0003-4375-9327; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195
CR Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709
   Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200
   HARDING AE, 1983, ADV NEUROL, V61, P1
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   Kuokkanen M, 2003, GUT, V52, P647, DOI 10.1136/gut.52.5.647
   Li HZ, 1999, MECH DEVELOP, V87, P169, DOI 10.1016/S0925-4773(99)00125-2
   Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   LONNQVIST T, 1995, THESIS U HELSINKI FI
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   NIKALI K, 1995, AM J HUM GENET, V56, P1088
   Nikali K, 1997, GENOMICS, V39, P185, DOI 10.1006/geno.1996.4465
   Nikali K, 2002, GENE, V299, P111, DOI 10.1016/S0378-1119(02)01019-3
   NIKALI K, 1998, THESIS NATL PUBLIC H
   NORIO R, 1973, ANN CLIN RES, V5, P109
   Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003
   Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913
   Puccio H, 2002, CURR OPIN GENET DEV, V12, P272, DOI 10.1016/S0959-437X(02)00298-8
   Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   Scarano V, 2001, NEUROLOGY, V57, P159, DOI 10.1212/WNL.57.1.159
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123
   Tengan CH, 1996, BIOCHEM MOL MED, V58, P130, DOI 10.1006/bmme.1996.0040
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164
   Varilo T, 1996, GENOME RES, V6, P870, DOI 10.1101/gr.6.9.870
   Wilson RB, 2000, ANN NEUROL, V47, P659, DOI 10.1002/1531-8249(200005)47:5<659::AID-ANA17>3.0.CO;2-T
   Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425
   Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545
NR 38
TC 150
Z9 160
U1 0
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD OCT 15
PY 2005
VL 14
IS 20
BP 2981
EP 2990
DI 10.1093/hmg/ddi328
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 972AG
UT WOS:000232425600003
PM 16135556
OA Bronze
DA 2024-11-01
ER

PT J
AU Khrapko, K
   Vijg, J
AF Khrapko, Konstantin
   Vijg, Jan
TI Mitochondrial DNA mutations and aging: devils in the details?
SO TRENDS IN GENETICS
LA English
DT Review
ID CAUSE DILATED CARDIOMYOPATHY; SUBSTANTIA-NIGRA NEURONS; MTDNA POINT
   MUTATIONS; DEGENERATIVE DISEASES; DELETION MUTATIONS; OXIDATIVE STRESS;
   STEM-CELLS; MAMMALIAN MITOCHONDRIA; SKELETAL-MUSCLE; HIGH-FREQUENCY
AB Although several lines of evidence support a role for accumulating somatic mitochondrial DNA (mtDNA) mutations in the etiology of aging, it remains unclear if they are a major cause of age-related deterioration and death. Mouse models that harbor elevated mtDNA mutation frequencies age prematurely; these findings were thought to provide conclusive evidence for a causal role of such mutations in aging. Yet, the presence of several conflicting reports has sparked controversy in the field and this is further aggravated by discrepancies in the estimates of mtDNA mutant fractions, which disagree by orders of magnitude. Here, we briefly review the evidence and some of the unresolved questions surrounding a causative role for accumulating mtDNA mutations in aging.
C1 [Khrapko, Konstantin] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
   [Khrapko, Konstantin] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.
C3 Harvard University; Beth Israel Deaconess Medical Center; Harvard
   University; Harvard Medical School; Yeshiva University; Montefiore
   Medical Center; Albert Einstein College of Medicine
RP Khrapko, K (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
EM khrapko@hms.harvard.edu; jvijg@aecom.yu.edu
RI Khrapko, Konstantin/A-3244-2009
OI khrapko, konstantin/0000-0002-9250-8033
FU NIH [AG17242, AG20438, NS058988, AG19787]; Ellison Medical Foundation;
   United Mitochondrial Disease Foundation
FX The authors are grateful to Nils Larsson and three anonymous reviewers
   for criticisms and suggestions, which improved the manuscript and to
   Jun-Ihi Hayashi, Doug Turnbull and Judd Aiken for helpful discussions.
   This work was supported in part by grants from the NIH: AG17242 and
   AG20438 to J.V., and NS058988 and AG19787 to K.K., and by a grant from
   the Ellison Medical Foundation to J.V. and from the United Mitochondrial
   Disease Foundation to K.K.
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bensch KG, 2007, DIABETES OBES METAB, V9, P74, DOI 10.1111/j.1463-1326.2007.00776.x
   Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Coller HA, 2005, MUTAT RES-FUND MOL M, V578, P256, DOI 10.1016/j.mrfmmm.2005.05.014
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dubec SJ, 2008, REJUV RES, V11, P611, DOI 10.1089/rej.2007.0617
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   Jacobs L, 2007, MOL HUM REPROD, V13, P149, DOI 10.1093/molehr/gal112
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Khaidakov A, 2005, EXP GERONTOL, V40, P396, DOI 10.1016/j.exger.2005.02.007
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895
   Mott JL, 1999, ANN NY ACAD SCI, V893, P353, DOI 10.1111/j.1749-6632.1999.tb07853.x
   Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Rorbach J, 2007, BIOCHEM SOC T, V35, P1290, DOI 10.1042/BST0351290
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Sato A, 2005, P NATL ACAD SCI USA, V102, P6057, DOI 10.1073/pnas.0408666102
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Simon DK, 2001, GENOMICS, V73, P113, DOI 10.1006/geno.2001.6515
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   SOONG NW, 1992, NAT GENET, V2, P318
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Tanaka M, 1996, ANN NY ACAD SCI, V786, P102, DOI 10.1111/j.1749-6632.1996.tb39055.x
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vijg J., 2007, AGING GENOME
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   Zhang D, 2005, AM J PHYSIOL-HEART C, V288, pH2476, DOI 10.1152/ajpheart.00670.2004
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 66
TC 87
Z9 93
U1 0
U2 9
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0168-9525
J9 TRENDS GENET
JI Trends Genet.
PD FEB
PY 2009
VL 25
IS 2
BP 91
EP 98
DI 10.1016/j.tig.2008.11.007
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 415IF
UT WOS:000263926800006
PM 19110336
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Di Toro, A
   Urtis, M
   Narula, N
   Giuliani, L
   Grasso, M
   Pasotti, M
   Pellegrini, C
   Serio, A
   Pilotto, A
   Antoniazzi, E
   Rampino, T
   Magrassi, L
   Valentini, A
   Cavallini, A
   Scelsi, L
   Ghio, S
   Abelli, M
   Olivotto, I
   Porcu, M
   Gavazzi, A
   Kodama, T
   Arbustini, E
AF Di Toro, Alessandro
   Urtis, Mario
   Narula, Nupoor
   Giuliani, Lorenzo
   Grasso, Maurizia
   Pasotti, Michele
   Pellegrini, Carlo
   Serio, Alessandra
   Pilotto, Andrea
   Antoniazzi, Elena
   Rampino, Teresa
   Magrassi, Lorenzo
   Valentini, Adele
   Cavallini, Anna
   Scelsi, Laura
   Ghio, Stefano
   Abelli, Massimo
   Olivotto, Iacopo
   Porcu, Maurizio
   Gavazzi, Antonello
   Kodama, Takahide
   Arbustini, Eloisa
TI Impediments to Heart Transplantation in Adults With
   MELAS<SUP><i>MT-TL1:</i>m.3243A&gt;G</SUP> Cardiomyopathy
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE heart transplantation; MELAS; mitochondrial cardiomyopathy;
   MT-TL1:m.3243A > G
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; MITOCHONDRIAL; ENCEPHALOPATHY;
   MUTATIONS; RISK
AB BACKGROUND The heart is commonly involved in maternally inherited mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome caused by the MT-TL1m.3243A>G mutation of the mitochondrial DNA. Heart transplantation (HTx) is controversial and has rarely been performed with conflicting results.
   OBJECTIVES We analyzed factors preventing HTx in consecutive adult patients with MELAS(MT-TL1:m.3243A>G) cardiomyopathy diagnosed and followed during the last 23 years in our HTx referral center.
   METHODS The series consists of 14 unrelated adult probands who were referred for evaluation of cardiomyopathy from 1998 to 2021. None had a suspected diagnosis of MELAS before referral. All patients underwent clinical and genetic visit and counseling, mitochondrial DNA sequencing, cardiovascular investigation (including right heart catheterization and endo-myocardial biopsy in 10), multidisciplinary assessment, and biochemical tests. Family screening identified 2 affected relatives.
   RESULTS The cardiac phenotype was characterized by hypertrophic, concentric, nonobstructive cardiomyopathy that often evolved into a dilated cardiomyopathy-like phenotype. Of the 14 probands, 7 were potential candidates for HTx, 2 for heart and kidney Tx, and 1 was on the active HTx list for 3 years. None of the 10 probands underwent HTx. One is currently being evaluated for HTx. All had diabetes, hearing loss, and myopathy, and 10 had chronic kidney disease and progressive encephalomyopathy. During follow-up, 10 died from heart failure associated with multiorgan failure within 5 years of the genetic diagnosis.
   CONCLUSIONS High risk of stroke-like episodes, chronic kidney disease, and wasting myopathy in MELAS(MT-TL1:m.3243A>G) patients prevents activation of plans for HTx. As a result, the management of their cardiomyopathy in this syndromic context remains an unmet clinical need. (C) 2022 by the American College of Cardiology Foundation.
C1 [Di Toro, Alessandro; Urtis, Mario; Narula, Nupoor; Giuliani, Lorenzo; Grasso, Maurizia; Serio, Alessandra; Pilotto, Andrea; Arbustini, Eloisa] Fdn IRCCS Policlin San Matteo, Transplant Res Area, Pavia, Italy.
   [Di Toro, Alessandro; Urtis, Mario; Narula, Nupoor; Giuliani, Lorenzo; Grasso, Maurizia; Serio, Alessandra; Pilotto, Andrea; Arbustini, Eloisa] Dept Med Sci & Infect Dis, Ctr Inherited Cardiovascular Dis, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
   [Narula, Nupoor] Univ Pavia, Dept Elect Comp & Biomed Engn, Pavia, Italy.
   [Pasotti, Michele] Weill Cornell Med, Div Cardiol, Dept Med, New York, NY USA.
   [Pellegrini, Carlo] Osped Civile Voghera, Dept Cardiol, Voghera, Italy.
   [Pellegrini, Carlo] Fdn IRCCS Policlin San Matteo, Cardiac Surg Div, Dept Intens Med, Pavia, Italy.
   [Antoniazzi, Elena] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.
   [Rampino, Teresa] Fdn IRCCS Policlin San Matteo, Ophthalmol Div, Pavia, Italy.
   [Magrassi, Lorenzo] Fdn IRCCS Policlin San Matteo, Unit Nephrol Dialysis & Transplantat, Pavia, Italy.
   [Valentini, Adele] Univ Pavia, Neurosurg Div, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.
   [Valentini, Adele] Fdn IRCCS Policlini San Matteo, Radiol Dept, Pavia, Italy.
   [Cavallini, Anna] Fdn IRCCS Policlin San Matteo, Stroke Unit, Pavia, Italy.
   [Scelsi, Laura] Fdn IRCCS Policlin San Matteo, Div Cardiol, Pavia, Italy.
   [Abelli, Massimo] Univ Pavia, Renal Transplantat Div, Dept Surg, Pavia, Italy.
   [Abelli, Massimo] Fdn IRCCS Policlin San Matteo, Pavia, Italy.
   [Olivotto, Iacopo] Univ Florence, Cardiomyopathy Unit, Florence, Italy.
   [Porcu, Maurizio] Mater Olbia Hosp, Cardiol Serv, Olbia, Italy.
   [Gavazzi, Antonello] Res Fdn, Bergamo, Italy.
   [Kodama, Takahide] Toranomon Gen Hosp, Dept Cardiovasc Ctr, Tokyo, Japan.
C3 IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of
   Pavia; Cornell University; Weill Cornell Medicine; IRCCS Fondazione San
   Matteo; University of Pavia; IRCCS Fondazione San Matteo; IRCCS
   Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo;
   IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San
   Matteo; University of Florence; Toranomon Hospital
RP Arbustini, E (corresponding author), Fdn IRCCS Policlin San Matteo, Dept Med Sci & Infect Dis, Transplant Res Area & Ctr Inherited Cardiovasc, Piazzale Camillo Golgi 19, I-27100 Pavia, Italy.
EM e.arbustini@smatteo.pv.it
RI Arbustini, Eloisa/K-8174-2016; Giuliani, Lorenzo/AAB-6387-2022;
   Olivotto, Iacopo/AAC-5950-2022; Di Toro, Alessandro/AAC-3139-2021;
   Magrassi, Lorenzo/AAJ-3105-2020; Grasso, Marina/AAC-8722-2019; rampino,
   teresa/AFI-8315-2022; Urtis, Mario/AAA-6425-2021
OI Olivotto, Iacopo/0000-0003-1751-9266; rampino,
   teresa/0000-0002-5311-9174; Urtis, Mario/0000-0003-3289-9228
FU Ministry of Health [888-rcr2017i-71, RCR-2019-23669116_001 CV-PREVITAL]
FX The study was supported by continuous funds on cardiomyopathies and
   heart transplantation from the Ministry of Health to the IRCCS
   Foundation Policlinico San Matteo by project numbers 888-rcr2017i-71 and
   RCR-2019-23669116_001 CV-PREVITAL (Genetic Section). The authors have
   reported that they have no relationships relevant to the contents of
   this paper to disclose.
CR Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Bhati RS, 2005, J HEART LUNG TRANSPL, V24, P2286, DOI 10.1016/j.healun.2005.05.012
   Bonnet D, 2001, HEART, V86, P570, DOI 10.1136/heart.86.5.570
   Brambilla A, 2019, INT J CARDIOL, V276, P14, DOI 10.1016/j.ijcard.2018.10.051
   Chen T, 2021, CAN J NEUROL SCI, V48, P715, DOI 10.1017/cjn.2020.282
   de Laat P, 2019, CLIN KIDNEY J, V12, P840, DOI 10.1093/ckj/sfz020
   DeFronzo R, 2016, METABOLISM, V65, P20, DOI 10.1016/j.metabol.2015.10.014
   El-Hattab A.W., 1993, GENEREVIEWS
   Finsterer J, 2021, CAN J NEUROL SCI, V48, P744, DOI 10.1017/cjn.2021.25
   Finsterer J, 2020, J NEUROL SCI, V412, DOI 10.1016/j.jns.2020.116726
   Ganetzky RD, 2018, MOL GENET METAB, V123, P301, DOI 10.1016/j.ymgme.2018.01.010
   Heindryckx B, 2014, MITOCHONDRION, V18, P12, DOI 10.1016/j.mito.2014.08.005
   Hsu YHR, 2016, HEART FAIL REV, V21, P103, DOI 10.1007/s10741-015-9524-5
   Kim Sang Hun, 2019, Anesth Pain Med (Seoul), V14, P416, DOI 10.17085/apm.2019.14.4.416
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   McCormick EM, 2020, HUM MUTAT, V41, P2028, DOI 10.1002/humu.24107
   McMillan RP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42262-2
   Murakami Hidetomo, 2017, Brain Nerve, V69, P111, DOI 10.11477/mf.1416200650
   Niedermayr K, 2018, CONGENIT HEART DIS, V13, P671, DOI 10.1111/chd.12634
   OHTANI Y, 1985, BRAIN DEV-JPN, V7, P249
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Tranah GJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30255-6
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Xu P, 2022, AM J CLIN PATHOL, V157, P664, DOI 10.1093/ajcp/aqab174
   Zaragoza MV, 2011, EUR J HUM GENET, V19, P200, DOI 10.1038/ejhg.2010.169
   Zaragoza MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012295
NR 30
TC 4
Z9 4
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD OCT 11
PY 2022
VL 80
IS 15
BP 1431
EP 1443
DI 10.1016/j.jacc.2022.04.067
EA OCT 2022
PG 13
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 6C9CT
UT WOS:000882303300002
PM 36202533
OA Bronze
DA 2024-11-01
ER

PT J
AU Kerr, M
   Hume, S
   Omar, F
   Koo, D
   Barnes, H
   Khan, M
   Aman, S
   Wei, XC
   Alfuhaid, H
   McDonald, R
   McDonald, L
   Newell, C
   Sparkes, R
   Hittel, D
   Khan, A
AF Kerr, Marina
   Hume, Stacey
   Omar, Fadya
   Koo, Desmond
   Barnes, Heather
   Khan, Maida
   Aman, Suhaib
   Wei, Xing-Chang
   Alfuhaid, Hanen
   McDonald, Roman
   McDonald, Liam
   Newell, Christopher
   Sparkes, Rebecca
   Hittel, Dustin
   Khan, Aneal
TI MITO-FIND: A study in 390 patients to determine a diagnostic strategy
   for mitochondrial disease
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
ID RESPIRATORY-CHAIN DISORDERS; MUSCLE BIOPSY; MULTIPLE DELETIONS;
   SKELETAL-MUSCLE; DNA MUTATIONS; NUCLEAR GENES; GENOME; EXOME; PATHOLOGY;
   CRITERIA
AB Mitochondrial diseases, due to nuclear or mitochondrial genome mutations causing mitochondrial dysfunction, have a wide range of clinical features involving neurologic, muscular, cardiac, hepatic, visual, and auditory symptoms. Making a diagnosis of a mitochondrial disease is often challenging since there is no gold standard and traditional testing methods have required tissue biopsy which presents technical challenges and most patients prefer a non-invasive approach. Since a diagnosis invariably involves finding a disease-causing DNA variant, new approaches such as next generation sequencing (NGS) have the potential to make it easier to make a diagnosis. We evaluated the ability of our traditional diagnostic pathway (metabolite analysis, tissue neuropathology and respiratory chain enzyme activity) in 390 patients. The traditional diagnostic pathway provided a diagnosis of mitochondrial disease in 115 patients (29.50%). Analysis of mtDNA, tissue neuropathology, skin electron microscopy, respiratory chain enzyme analysis using inhibitor assays, blue native polyacrylamide gel electrophoresis were all statistically significant in distinguishing patients between a mitochondrial and non-mitochondrial diagnosis. From these 390 patients who underwent traditional analysis, we recruited 116 patients for the NGS part of the study (36 patients who had a mitochondrial diagnosis (MITO) and 80 patients who had no diagnosis (No-Dx)). In the group of 36 MITO patients, nuclear whole exome sequencing (nWES) provided a second diagnosis in 2 cases who already had a pathogenic variant in mtDNA, and a revised diagnosis (GLUL) in one case that had abnormal pathology but no pathogenic mtDNA variant. In the 80 NO-Dx patients, nWES found non-mitochondrial diagnosis in 26 patients and a mitochondrial diagnosis in 1 patient. A genetic diagnosis was obtained in 53/116 (45.70%) cases that were recruited for NGS, but not in 11/116 (9.48%) of cases with abnormal mitochondrial neuropathology. Our results show that a non-invasive, bigenomic sequencing (BGS) approach (using both a nWES and optimized mtDNA analysis to include large deletions) should be the first step in investigating for mitochondrial diseases. There may still be a role for tissue biopsy in unsolved cases or when the diagnosis is still not clear after NGS studies.
C1 [Kerr, Marina; Omar, Fadya; Koo, Desmond; Barnes, Heather; Khan, Maida; Aman, Suhaib; Alfuhaid, Hanen; McDonald, Roman; McDonald, Liam; Newell, Christopher; Sparkes, Rebecca; Khan, Aneal] Univ Calgary, Alberta Childrens Hosp, Cumming Sch Med, Dept Med Genet,Res Inst, Calgary, AB, Canada.
   [Hume, Stacey] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
   [Wei, Xing-Chang] Univ Calgary, Alberta Childrens Hosp, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada.
   [Hittel, Dustin] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada.
C3 Alberta Childrens Hospital; University of Calgary; University of
   Alberta; University of Calgary; Alberta Childrens Hospital; University
   of Calgary
RP Khan, A (corresponding author), Univ Calgary, Alberta Childrens Hosp, Cumming Sch Med, Dept Med Genet,Res Inst, Calgary, AB, Canada.
EM khaa@ucalgary.ca
OI Hume, Stacey/0000-0002-3217-3032
FU MitoCanada; Alberta Children's Hospital Research Foundation; Alberta
   Children's Hospital Research Institute; Alberta Health Services;
   University of Calgary Cumming School of Medicine
FX This project was funded received funding from MitoCanada
   (https://mitocanada.org).We would like to thank the Alberta Children's
   Hospital Research Foundation, Alberta Children's Hospital Research
   Institute, Alberta Health Services and the University of Calgary Cumming
   School of Medicine for their support of this project. We thank Karin
   Klassen, Sheryl Jackson and Karen Sabo for logistical support.
CR Abicht A, 2018, MOL GENET GENOM MED, V6, P1188, DOI 10.1002/mgg3.500
   Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bennett J, 2020, MOL GENET METAB REP, V24, DOI 10.1016/j.ymgmr.2020.100616
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Carta A, 2000, ARCH OPHTHALMOL-CHIC, V118, P1441
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249
   Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   Dames S, 2013, J MOL DIAGN, V15, P526, DOI 10.1016/j.jmoldx.2013.03.005
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DiMauro S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225643
   Dinwiddie DL, 2013, GENOMICS, V102, P148, DOI 10.1016/j.ygeno.2013.04.013
   Driessen J, 2007, PEDIATR ANESTH, V17, P16, DOI 10.1111/j.1460-9592.2006.02043.x
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   ERNSTER L, 1959, NATURE, V184, P1851, DOI 10.1038/1841851a0
   Falk MJ, 2012, DISCOV MED, V14, P389
   FERNANDEZSOLA J, 1992, POSTGRAD MED J, V68, P212, DOI 10.1136/pgmj.68.797.212
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   HALTIA M, 1992, BRAIN PATHOL, V2, P133, DOI 10.1111/j.1750-3639.1992.tb00681.x
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Harvey NR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224847
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   KELLEY RI, 1993, CLIN CHIM ACTA, V220, P157, DOI 10.1016/0009-8981(93)90044-5
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Khan A., 2019, Child Neurol Open, V6, p2329048x19829520
   Köhler S, 2019, NUCLEIC ACIDS RES, V47, pD1018, DOI 10.1093/nar/gky1105
   Krusche P, 2019, NAT BIOTECHNOL, V37, P567, DOI 10.1038/s41587-019-0108-0
   Krusche P, 2019, NAT BIOTECHNOL, V37, P555, DOI 10.1038/s41587-019-0054-x
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153
   LINDAL S, 1992, ULTRASTRUCT PATHOL, V16, P263, DOI 10.3109/01913129209061355
   Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932
   Mancuso M, 2007, BIOSCIENCE REP, V27, P31, DOI 10.1007/s10540-007-9035-2
   Marquis J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3695-5
   Miyamoto Y, 2016, MITOCHONDRION, V26, P26, DOI 10.1016/j.mito.2015.11.004
   Morava E, 2015, J INHERIT METAB DIS, V38, P387, DOI 10.1007/s10545-015-9852-6
   Newell C, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000336
   Newell C, 2018, MOL GENET METAB, V125, P332, DOI 10.1016/j.ymgme.2018.10.002
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   Paik K, 2019, CAN J NEUROL SCI, V46, P717, DOI 10.1017/cjn.2019.240
   Palculict ME, 2016, METHODS MOL BIOL, V1351, P3, DOI 10.1007/978-1-4939-3040-1_1
   Parikh S, 2019, J MED GENET, V56, P123, DOI 10.1136/jmedgenet-2018-105800
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Plutino M, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0568-y
   Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109
   Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Sarnat HB, 2012, NEUROPATHOLOGY, V32, P617, DOI 10.1111/j.1440-1789.2012.01308.x
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Shanske S, 2004, MITOCHONDRION, V4, P403, DOI 10.1016/j.mito.2004.07.026
   Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539
   Singleton MV, 2014, AM J HUM GENET, V94, P599, DOI 10.1016/j.ajhg.2014.03.010
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Theunissen TEJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00400
   TRIJBELS JMF, 1988, EUR J PEDIATR, V148, P92, DOI 10.1007/BF00445910
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Uusimaa J, 2000, PEDIATRICS, V105, P598, DOI 10.1542/peds.105.3.598
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Witters P, 2018, GENET MED, V20, P444, DOI 10.1038/gim.2017.125
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
   Zook JM, 2019, NAT BIOTECHNOL, V37, P561, DOI 10.1038/s41587-019-0074-6
NR 82
TC 18
Z9 18
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD SEP-OCT
PY 2020
VL 131
IS 1-2
BP 66
EP 82
DI 10.1016/j.ymgme.2020.08.009
PG 17
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA PH7ZV
UT WOS:000600626600006
PM 32980267
DA 2024-11-01
ER

PT J
AU Horvath, R
   Kley, RA
   Lochmüller, H
   Vorgerd, M
AF Horvath, Rita
   Kley, Rudolf Andre
   Lochmueller, Hanns
   Vorgerd, Matthias
TI Parkinson syndrome, neuropathy, and myopathy caused by the mutation
   A8344G (MERRF) in tRNA<SUP>Lys</SUP>
SO NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL; DISEASE; DELETIONS; FAMILY
AB We describe a patient who presented with parkinsonism associated with the A8344G myoclonus epilepsy, ataxia, and myopathy with ragged red fibers mutation in the tRNALys gene. In addition, neurogenic changes and mitochondrial myopathy with ragged red fibers were observed. Neither myoclonus epilepsy nor other clinical signs described in association with A8344G were noted. Similar to previously reported patients with parkinsonism and mtDNA deletions, the symptoms of our patient responded favorably to levodopa therapy.
C1 Med Genet Ctr Munich, D-80335 Munich, Germany.
   Univ Munich, Friedrich Baur Inst, Munich, Germany.
   Univ Munich, Dept Neurol, Munich, Germany.
   Ruhr Univ Bochum, Neuromuscular Ctr Ruhrgebiet, D-4630 Bochum, Germany.
C3 University of Munich; University of Munich; Ruhr University Bochum
RP Horvath, R (corresponding author), Med Genet Ctr Munich, Bayerstr 3-5, D-80335 Munich, Germany.
EM Rita.Horvath@lrz.uni-muenchen.de
RI Horvath, Rita/AAY-7042-2020; Kley, Rudolf/AAT-8094-2020; Vorgerd,
   Matthias/GRS-7540-2022
OI Horvath, Rita/0000-0002-9841-170X; Lochmuller, Hanns/0000-0003-2324-8001
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Jain S, 2005, CLIN SCI, V109, P355, DOI 10.1042/CS20050106
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Siciliano G, 2001, J NEUROL NEUROSUR PS, V71, P685, DOI 10.1136/jnnp.71.5.685
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   VANERVEN PMM, 1989, DEV MED CHILD NEUROL, V31, P81
NR 10
TC 56
Z9 61
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0028-3878
J9 NEUROLOGY
JI Neurology
PD JAN 2
PY 2007
VL 68
IS 1
BP 56
EP 58
DI 10.1212/01.wnl.0000250334.48038.7a
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 122KA
UT WOS:000243224000014
PM 17200493
DA 2024-11-01
ER

PT J
AU Jackson, CB
   Hahn, D
   Schröter, B
   Richter, U
   Battersby, BJ
   Schmitt-Mechelke, T
   Marttinen, P
   Nuoffer, JM
   Schaller, A
AF Jackson, Christopher B.
   Hahn, Dagmar
   Schroter, Barbara
   Richter, Uwe
   Battersby, Brendan J.
   Schmitt-Mechelke, Thomas
   Marttinen, Paula
   Nuoffer, Jean-Marc
   Schaller, Andre
TI A novel mitochondrial <i>ATP6</i> frameshift mutation causing isolated
   complex V deficiency, ataxia and encephalomyopathy
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE MT-ATP6; ATP synthase; Mitochondrial disease; Mitochondrial DNA (mtDNA);
   Complex V deficiency
ID BIOCHEMICAL-CHARACTERIZATION; HYPERTROPHIC CARDIOMYOPATHY; POINT
   MUTATION; LEIGH-SYNDROME; GENE MUTATION; SYNTHASE; DNA; ORGANIZATION;
   DISORDERS; DISEASES
AB We describe a novel frameshift mutation in the mitochondrial ATP6 gene in a 4-year-old girl associated with ataxia, microcephaly, developmental delay and intellectual disability.
   A heteroplasmic frameshift mutation in the MT-ATP6 gene was confirmed in the patient's skeletal muscle and blood. The mutation was not detectable in the mother's DNA extracted from blood or buccal cells. Enzymatic and oxymetric analysis of the mitochondrial respiratory system in the patients' skeletal muscle and skin fibroblasts demonstrated an isolated complex V deficiency. Native PAGE with subsequent immunoblotting for complex V revealed impaired complex V assembly and accumulation of ATPase subcomplexes. Whilst northern blotting confirmed equal presence of ATP8/6 mRNA, metabolic S-35-labelling of mitochondrial translation products showed a severe depletion of the ATP6 protein together with aberrant translation product accumulation. In conclusion, this novel isolated complex V defect expands the clinical and genetic spectrum of mitochondrial defects of complex V deficiency. Furthermore, this work confirms the benefit of native PAGE as an additional diagnostic method for the identification of OXPHOS defects, as the presence of complex V subcomplexes is associated with pathogenic mutations of mtDNA. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Jackson, Christopher B.; Hahn, Dagmar; Nuoffer, Jean-Marc] Univ Hosp Bern, Inst Clin Chem, Bern, Switzerland.
   [Jackson, Christopher B.] Univ Helsinki, Res Programs Mol Neurol, Biomedicum Helsinki, Haartmaninkatu 8, Helsinki, Finland.
   [Schroter, Barbara; Schmitt-Mechelke, Thomas] Cantonal Hosp Lucerne, Childrens Hosp, Dept Neuropaediat, Luzern, Switzerland.
   [Richter, Uwe; Battersby, Brendan J.; Marttinen, Paula] Univ Helsinki, Inst Biotechnol, Helsinki, Finland.
   [Schaller, Andre] Univ Hosp Bern, Div Human Genet, Bern, Switzerland.
C3 University of Bern; University Hospital of Bern; University of Helsinki;
   Lucerne Cantonal Hospital; University of Helsinki; University of Bern;
   University Hospital of Bern
RP Jackson, CB (corresponding author), Univ Helsinki, Res Programs Mol Neurol, Biomedicum Helsinki, Haartmaninkatu 8, Helsinki, Finland.
EM christopher.jackson@helsinki.fi; Schroeter.Barbara@bluewin.ch;
   Uwe.Richter@helsinki.fi; Brendan.Battersby@helsinki.fi;
   Thomas.Schmitt@luks.ch; Paula.Marttinen@helsinki.fi;
   Jean-Marc.Nuoffer@insel.ch; Andre.Schaller@insel.ch
RI Richter, Uwe/Y-3643-2019; Jackson, Christopher B./M-3222-2013; Nuoffer,
   Jean-Marc/C-8936-2009; Schaller, Andre/L-4174-2018
OI Jackson, Christopher B./0000-0003-1035-6417; Richter,
   Uwe/0000-0002-0724-6957; Nuoffer, Jean-Marc/0000-0003-3650-6153;
   Schaller, Andre/0000-0001-5174-5764
FU Swiss National Science Foundation [P2BEP3_162065]; Novartis Foundation
   for medical biological research; Academy of Finland; University of
   Helsinki; Swiss National Science Foundation (SNF) [P2BEP3_162065]
   Funding Source: Swiss National Science Foundation (SNF)
FX We are indebted to the family participating in this study. We thank A.
   Haberli for excellent technical assistance and the Electron microscopy
   unit of the Institute of Biotechnology at the University of Helsinki for
   their service. Following funding sources are acknowledged: Swiss
   National Science Foundation [CJ] (Grant number: P2BEP3_162065), Novartis
   Foundation for medical biological research [CJ, AS], Academy of Finland
   and University of Helsinki (BB, UR).
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Blanco-Grau A, 2013, GENES BRAIN BEHAV, V12, P812, DOI 10.1111/gbb.12089
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109
   Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   deCoo IFM, 1996, AM J HUM GENET, V58, P636
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   Dittrich M, 2003, BIOPHYS J, V85, P2253, DOI 10.1016/S0006-3495(03)74650-5
   Houstek J, 2004, BBA-BIOENERGETICS, V1658, P115, DOI 10.1016/j.bbabio.2004.04.012
   Imai A, 2016, INT J CARDIOL, V207, P203, DOI 10.1016/j.ijcard.2016.01.026
   Jackson CB, 2014, MITOCHONDRION, V17, P67, DOI 10.1016/j.mito.2014.05.011
   Jackson CB, 2014, BRIT J OPHTHALMOL, V98, P1453, DOI 10.1136/bjophthalmol-2014-305300
   Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kabala AM, 2014, BIOCHIMIE, V100, P200, DOI 10.1016/j.biochi.2013.11.024
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   López-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Richter U, 2015, J CELL BIOL, V211, P373, DOI 10.1083/jcb.201504062
   Richter U, 2013, CURR BIOL, V23, P535, DOI 10.1016/j.cub.2013.02.019
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Schaller A, 2011, MITOCHONDRION, V11, P488, DOI 10.1016/j.mito.2011.01.005
   Schaller A, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-4
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Wittig I, 2008, BBA-BIOENERGETICS, V1777, pS10, DOI 10.1016/j.bbabio.2008.05.044
NR 35
TC 23
Z9 25
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1769-7212
EI 1878-0849
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD JUN
PY 2017
VL 60
IS 6
BP 345
EP 351
DI 10.1016/j.ejmg.2017.04.006
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA EW4OT
UT WOS:000402481500012
PM 28412374
OA Bronze
DA 2024-11-01
ER

PT J
AU Belmonte, FR
   Martin, JL
   Frescura, K
   Damas, J
   Pereira, F
   Tarnopolsky, MA
   Kaufman, BA
AF Belmonte, Frances R.
   Martin, James L.
   Frescura, Kristin
   Damas, Joana
   Pereira, Filipe
   Tarnopolsky, Mark A.
   Kaufman, Brett A.
TI Digital PCR methods improve detection sensitivity and measurement
   precision of low abundance mtDNA deletions
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MITOCHONDRIAL-DNA DELETIONS; REAL-TIME PCR; MUSCLE-FIBERS; COPY NUMBER;
   SUBSTANTIA-NIGRA; DISEASE; MUTATIONS; ACCUMULATION; MECHANISMS; NEURONS
AB Mitochondrial DNA (mtDNA) mutations are a common cause of primary mitochondrial disorders, and have also been implicated in a broad collection of conditions, including aging, neurodegeneration, and cancer. Prevalent among these pathogenic variants are mtDNA deletions, which show a strong bias for the loss of sequence in the major arc between, but not including, the heavy and light strand origins of replication. Because individual mtDNA deletions can accumulate focally, occur with multiple mixed breakpoints, and in the presence of normal mtDNA sequences, methods that detect broad-spectrum mutations with enhanced sensitivity and limited costs have both research and clinical applications. In this study, we evaluated semi-quantitative and digital PCR-based methods of mtDNA deletion detection using double-stranded reference templates or biological samples. Our aim was to describe key experimental assay parameters that will enable the analysis of low levels or small differences in mtDNA deletion load during disease progression, with limited false-positive detection. We determined that the digital PCR method significantly improved mtDNA deletion detection sensitivity through absolute quantitation, improved precision and reduced assay standard error.
C1 [Belmonte, Frances R.; Martin, James L.; Kaufman, Brett A.] Univ Pittsburgh, Sch Med, Div Cardiol, Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15261 USA.
   [Belmonte, Frances R.; Martin, James L.; Kaufman, Brett A.] Vasc Med Inst, Pittsburgh, PA 15261 USA.
   [Frescura, Kristin; Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   [Frescura, Kristin; Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Med, Hamilton, ON L8N 3Z5, Canada.
   [Damas, Joana] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England.
   [Pereira, Filipe] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; McMaster University; McMaster University; University of
   London; University of London Royal Veterinary College; Universidade do
   Porto
RP Kaufman, BA (corresponding author), Univ Pittsburgh, Sch Med, Div Cardiol, Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15261 USA.; Kaufman, BA (corresponding author), Vasc Med Inst, Pittsburgh, PA 15261 USA.
EM bkauf@pitt.edu
RI Damas, Joana/AHE-6278-2022; Pereira, Filipe/F-6391-2010; Damas,
   Joana/J-6045-2013
OI Pereira, Filipe/0000-0001-8950-1036; Damas, Joana/0000-0003-4857-2510
FU NIGMS [R01GM110424]; Foundation for Science and Technology
   [VIH/SAU/0011/2011]; Fundação para a Ciência e a Tecnologia
   [VIH/SAU/0011/2011] Funding Source: FCT
FX We would like to thank Martin Picard, Micol Falabella, and InHae Kang
   for review of this manuscript. Research reported in this manuscript was
   supported by NIGMS grant R01GM110424. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. FP is supported by
   Foundation for Science and Technology (Investigator FCT program) and
   research project VIH/SAU/0011/2011.
CR Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CARIELLO NF, 1991, GENE, V99, P105, DOI 10.1016/0378-1119(91)90040-I
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Damas J., 2014, NUCL ACIDS RES, V42
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677
   Elstner M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-43
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Grady JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114462
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1324
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   Manoj P., 2014, Mitochondrial DNA, V1736, P1
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887
   Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266
   Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Van Haute L, 2013, NAT BIOTECHNOL, V31, P20, DOI 10.1038/nbt.2473
   Villarroya J, 2011, BIOCHEM BIOPH RES CO, V407, P333, DOI 10.1016/j.bbrc.2011.03.018
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012
   Wong LJC, 2013, NEUROTHERAPEUTICS, V10, P262, DOI 10.1007/s13311-012-0170-5
NR 43
TC 55
Z9 59
U1 0
U2 19
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 28
PY 2016
VL 6
AR 25186
DI 10.1038/srep25186
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DK5FB
UT WOS:000374944100001
PM 27122135
OA Green Accepted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Evangelisti, S
   Gramegna, LL
   La Morgia, C
   Di Vito, L
   Maresca, A
   Talozzi, L
   Bianchini, C
   Mitolo, M
   Manners, DN
   Caporali, L
   Valentino, ML
   Liguori, R
   Carelli, V
   Lodi, R
   Testa, C
   Tonon, C
AF Evangelisti, Stefania
   Gramegna, Laura Ludovica
   La Morgia, Chiara
   Di Vito, Lidia
   Maresca, Alessandra
   Talozzi, Lia
   Bianchini, Claudio
   Mitolo, Micaela
   Manners, David Neil
   Caporali, Leonardo
   Valentino, Maria Lucia
   Liguori, Rocco
   Carelli, Valerio
   Lodi, Raffaele
   Testa, Claudia
   Tonon, Caterina
TI Molecular biomarkers correlate with brain grey and white matter changes
   in patients with mitochondrial m.3243A &gt; G mutation
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE M.3243A > G mutation; Molecular biomarkers; MR neuroimaging; Brain gray
   matter atrophy; Brain white matter microstructure
ID NITRIC-OXIDE; MELAS; RESPONSES
AB Introduction: The mitochondrial DNA (mtDNA) m.3243A > G mutation in the MT-TL1 gene results in a multi systemic disease, that is commonly associated with neurodegenerative changes in the brain.
   Methods: Seventeen patients harboring the m3243A > G mutation were enrolled (age 43.1 +/- 11.4 years, 10 M/7F). A panel of plasma biomarkers including lactate acid, alanine, L-arginine, fibroblast growth factor 21 (FGF-21), growth/differentiation factor 15 (GDF-15) and circulating cell free-mtDNA (ccf-mtDNA), as well as blood, urine and muscle mtDNA heteroplasmy were evaluated.
   Patients also underwent a brain standardized MR protocol that included volumetric T1-weighted images and diffusion-weighted MRI. Twenty sex-and age-matched healthy controls were included. Voxel-wise analysis was performed on T1-weighted and diffusion imaging, respectively with VBM (voxel-based morphometry) and TBSS (Tract-based Spatial Statistics). Ventricular lactate was also evaluated by H-1-MR spectroscopy.
   Results: A widespread cortical gray matter (GM) loss was observed, more severe (p < 0.001) in the bilateral calcarine, insular, frontal and parietal cortex, along with infratentorial cerebellar cortex.
   High urine mtDNA mutation load, high levels of plasma lactate and alanine, low levels of plasma arginine, high levels of serum FGF-21 and ventricular lactate accumulation significantly (p < 0.05) correlated with the reduced brain GM density.
   Widespread microstructural alterations were highlighted in the white matter, significantly (p < 0.05) correlated with plasma alanine and arginine levels, with mtDNA mutation load in urine, with high level of serum GDF-15 and with high content of plasma ccf-mtDNA.
   Conclusions: Our results suggest that the synergy of two pathogenic mechanisms, mtDNA-related mitochondrial respiratory deficiency and defective nitric oxide metabolism, contributes to the brain neurodegeneration in m.3243A > G patients. (c) 2021 Elsevier Inc. All rights reserved.
C1 [Evangelisti, Stefania; Gramegna, Laura Ludovica; Talozzi, Lia; Bianchini, Claudio; Manners, David Neil; Valentino, Maria Lucia; Liguori, Rocco; Carelli, Valerio; Lodi, Raffaele; Tonon, Caterina] Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy.
   [Gramegna, Laura Ludovica; Mitolo, Micaela; Lodi, Raffaele; Testa, Claudia; Tonon, Caterina] IRCCS Ist Sci Neurol Bologna, Funct & Mol Neuroimaging Unit, Via Altura 3, I-40139 Bologna, Italy.
   [La Morgia, Chiara; Di Vito, Lidia; Caporali, Leonardo; Valentino, Maria Lucia; Liguori, Rocco] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Bologna, Italy.
   [La Morgia, Chiara; Maresca, Alessandra; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Bologna, Italy.
   [Testa, Claudia] Univ Bologna, Dept Phys & Astron, Bologna, Italy.
C3 University of Bologna; IRCCS Istituto delle Scienze Neurologiche di
   Bologna (ISNB); IRCCS Istituto delle Scienze Neurologiche di Bologna
   (ISNB); IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB);
   University of Bologna
RP Tonon, C (corresponding author), IRCCS Ist Sci Neurol Bologna, Funct & Mol Neuroimaging Unit, Via Altura 3, I-40139 Bologna, Italy.
EM caterina.tonon@unibo.it
RI Liguori, Rocco/AAB-7860-2020; Talozzi, Lia/M-4786-2019; Gramegna,
   Laura/AAC-6718-2022; Manners, David/J-2415-2012; Tonon,
   Caterina/K-6680-2016; La Morgia, Chiara/H-6765-2012; Di Vito,
   Lidia/AAB-8691-2022; Caporali, Leonardo/J-7398-2016; Maresca,
   Alessandra/J-7393-2016
OI TALOZZI, LIA/0000-0003-1827-0407; Caporali,
   Leonardo/0000-0002-0666-4380; Bianchini, Claudio/0000-0002-8335-3623;
   Maresca, Alessandra/0000-0002-8959-8832; Di Vito,
   Lidia/0000-0002-0266-6776
CR Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007
   Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344
   Benarroch EE, 2011, NEUROLOGY, V77, P1568, DOI 10.1212/WNL.0b013e318233b3e4
   Carelli V, 2018, ESSAYS BIOCHEM, V62, P235, DOI 10.1042/EBC20170097
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Ceccarelli A, 2012, AM J NEURORADIOL, V33, P1579, DOI 10.3174/ajnr.A3083
   Chinnery P.F., 2018, CLIN MITOCHONDRIAL M
   Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045
   Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056
   El-Hattab Ayman W., 2017, J. inborn errors metab. screen., V5, pe160051, DOI 10.1177/2326409817697399
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   Formichi P, 2020, NEUROL SCI, V41, P3653, DOI 10.1007/s10072-020-04422-5
   Gambardella S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01064
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Gramegna L.L., 2021, J NEURORADIOLOGY
   Gramegna LL, 2021, ANN CLIN TRANSL NEUR, V8, P1200, DOI 10.1002/acn3.51329
   Gramegna LL, 2018, NEUROMUSCULAR DISORD, V28, P144, DOI 10.1016/j.nmd.2017.10.007
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Gunnewiek TMK, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107538
   Haast RAM, 2018, NEUROIMAGE-CLIN, V18, P231, DOI 10.1016/j.nicl.2018.01.017
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Lax N., 2012, Mitochondrial Dysfunction in Neurodegenerative Disorders, P21
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lindroos MM, 2009, BRAIN, V132, P3274, DOI 10.1093/brain/awp259
   Lodi R, 2004, BBA-BIOENERGETICS, V1657, P146, DOI 10.1016/j.bbabio.2004.05.003
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Montano V, 2021, NEUROL SCI, V42, P383, DOI 10.1007/s10072-020-04638-5
   Ridgway GR, 2008, NEUROIMAGE, V40, P1429, DOI 10.1016/j.neuroimage.2008.01.003
   Rodan LH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238224
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Schreglmann SR, 2018, MOVEMENT DISORD, V33, P146, DOI 10.1002/mds.27174
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Testa C, 2019, PARKINSONISM RELAT D, V62, P226, DOI 10.1016/j.parkreldis.2018.11.018
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tsujikawa K, 2016, MITOCHONDRION, V30, P229, DOI 10.1016/j.mito.2016.08.011
   Tsygankova PG, 2019, J INHERIT METAB DIS, V42, P918, DOI 10.1002/jimd.12142
   Virtanen SM, 2011, AM J NEURORADIOL, V32, P522, DOI 10.3174/ajnr.A2309
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yokoyama T, 2010, NEUROPATHOLOGY, V30, P56, DOI 10.1111/j.1440-1789.2009.01026.x
   Zanigni S, 2017, PARKINSONISM RELAT D, V39, P44, DOI 10.1016/j.parkreldis.2017.03.001
   Zanigni S, 2016, NEUROIMAGE-CLIN, V11, P678, DOI 10.1016/j.nicl.2016.04.012
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
NR 52
TC 4
Z9 4
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JAN
PY 2022
VL 135
IS 1
BP 72
EP 81
DI 10.1016/j.ymgme.2021.11.012
EA JAN 2022
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA YV2MV
UT WOS:000752566300011
PM 34916127
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, P
   Lai-Cheong, J
   Borthwick, GM
   He, LP
   Taylor, GA
   Greaves, LC
   Taylor, RW
   Griffiths, PG
   Turnbull, DM
AF Yu-Wai-Man, Patrick
   Lai-Cheong, Joey
   Borthwick, Gillian M.
   He, Langping
   Taylor, Geoffrey A.
   Greaves, Laura C.
   Taylor, Robert W.
   Griffiths, Philip G.
   Turnbull, Douglass M.
TI Somatic Mitochondrial DNA Deletions Accumulate to High Levels in Aging
   Human Extraocular Muscles
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID CYTOCHROME-C-OXIDASE; POINT MUTATIONS; WILD-TYPE; FUNCTIONALLY DOMINANT;
   INDIVIDUAL CELLS; AGE; FIBERS; MTDNA; DISEASE; COMMON
AB PURPOSE. Mitochondrial function and the presence of somatic mitochondrial DNA (mtDNA) defects were investigated in extraocular muscles (EOMs) collected from individuals covering a wide age range, to document the changes seen with normal aging.
   METHODS. Cytochrome c oxidase (COX) and succinate dehydrogenase (SDH) histochemistry was performed on 46 EOM samples to determine the level of COX deficiency in serial cryostat muscle sections (mean age, 42.6 years; range, 3.0-96.0 years). Competitive three-primer and real-time PCR were performed on single-fiber lysates to detect and quantify mtDNA deletions. Whole-genome mitochondrial sequencing was also performed to evaluate the contribution of mtDNA point mutations to the overall mutational load.
   RESULTS. COX-negative fibers were seen in EOMs beginning in the third decade of life, and there was a significant age-related increase: <30 years, 0.05% (n = 17); 30 to 60 years, 1.94% (n = 13); and >60 years, 3.34% (n = 16, P = 0.0001). Higher levels of COX deficiency were also present in EOM than in skeletal muscle in all three age groups (P < 0.0001). Most of the COX-negative fibers harbored high levels (>70%) of mtDNA deletions (206/284, 72.54%) and the mean deletion level was 66.64% (SD 36.45%). The mutational yield from whole mitochondrial genome sequencing was relatively low (1/19, 5.3%), with only a single mtDNA point mutation identified among COX-negative fibers with low deletion levels <= 70%.
   CONCLUSIONS. The results show an exponential increase in COX deficiency in EOMs beginning in early adulthood, which suggests an accelerated aging process compared with other post-mitotic tissues. (Invest Ophthalmol Vis Sci. 2010; 51:3347-3353) DOI:10.1167/iovs.09-4660
C1 [Yu-Wai-Man, Patrick; Borthwick, Gillian M.; He, Langping; Taylor, Geoffrey A.; Greaves, Laura C.; Taylor, Robert W.; Griffiths, Philip G.; Turnbull, Douglass M.] Med Sch Newcastle Upon Tyne, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick; Griffiths, Philip G.] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Lai-Cheong, Joey] Kings Coll London, St Johns Inst Dermatol, Div Genet & Mol Med, London WC2R 2LS, England.
C3 Newcastle University - UK; Newcastle University - UK; University of
   London; King's College London
RP Yu-Wai-Man, P (corresponding author), Med Sch Newcastle Upon Tyne, Res Grp, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM patrick.yu-wai-man@ncl.ac.uk
RI McGrath, John/N-3529-2019
OI Turnbull, Doug/0000-0002-8878-9901; Greaves, Laura/0000-0002-8071-5916
FU Wellcome Trust; Medical Research Council Translational Muscle Centre;
   Newcastle upon Tyne Hospitals NHS Trust; UK National Commissioning Group
   for Rare Mitochondrial Disorders of Adults and Children; Newcastle
   University Centre for Brain Ageing and Vitality; MRC [G0701386,
   G0601943, G0800674] Funding Source: UKRI
FX Supported in part by a Wellcome Trust program grant, the Medical
   Research Council Translational Muscle Centre, the Newcastle upon Tyne
   Hospitals NHS Trust, and the UK National Commissioning Group for Rare
   Mitochondrial Disorders of Adults and Children (RWT, DMT). PYWM is an
   MRC Research Fellow in Neuro-ophthalmology and LCG is supported by
   Newcastle University Centre for Brain Ageing and Vitality.
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Barron MJ, 2001, INVEST OPHTH VIS SCI, V42, P3016
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CARRY MR, 1986, ANAT RECORD, V214, P8, DOI 10.1002/ar.1092140103
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   FUCHS AF, 1983, J NEUROPHYSIOL, V49, P28, DOI 10.1152/jn.1983.49.1.28
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   JOHNSON MA, 1996, HDB MUSCLE DIS, P61
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   McLoon LK, 2004, MUSCLE NERVE, V29, P707, DOI 10.1002/mus.20012
   McLoon LK, 2003, INVEST OPHTH VIS SCI, V44, P1927, DOI 10.1167/iovs.02-0673
   McLoon LK, 2002, MUSCLE NERVE, V25, P348, DOI 10.1002/mus.10056
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   PORTER JD, 1995, SURV OPHTHALMOL, V39, P451, DOI 10.1016/S0039-6257(05)80055-4
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Reeve Amy K., 2008, Biotechnology Journal, V3, P750, DOI 10.1002/biot.200800066
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Spencer RF, 2006, PROG BRAIN RES, V151, P43, DOI 10.1016/S0079-6123(05)51002-1
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   WOOTEN GF, 1972, ARCH NEUROL-CHICAGO, V26, P350, DOI 10.1001/archneur.1972.00490100080008
   Wu CH, 2003, NUCLEIC ACIDS RES, V31, P345, DOI 10.1093/nar/gkg040
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yu CY, 2005, NEUROMUSCULAR DISORD, V15, P17, DOI 10.1016/j.nmd.2004.10.002
NR 57
TC 39
Z9 44
U1 0
U2 3
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2010
VL 51
IS 7
BP 3347
EP 3353
DI 10.1167/iovs.09-4660
PG 7
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 614HX
UT WOS:000279047500004
PM 20164450
OA Green Published, Green Accepted
DA 2024-11-01
ER

PT J
AU El-Hattab, AW
   Craigen, WJ
   Scaglia, F
AF El-Hattab, Ayman W.
   Craigen, William J.
   Scaglia, Fernando
TI Mitochondrial DNA maintenance defects
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Review
DE mitochondrial diseases; mitochondrial DNA (mtDNA); mtDNA depletion
   syndromes; multiple mtDNA deletions; mitochondrial fusion; mtDNA
   replication
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ENCEPHALOMYOPATHY (MNGIE)-LIKE
   PHENOTYPE; DEOXYGUANOSINE KINASE-DEFICIENCY; ADENINE-NUCLEOTIDE
   TRANSLOCATOR; ONSET SPINOCEREBELLAR ATAXIA; IMPAIR MTDNA REPLICATION;
   COA LIGASE DEFICIENCY; LOSS-OF-FUNCTION; AUTOSOMAL-DOMINANT;
   POLYMERASE-GAMMA
AB The maintenance of mitochondrial DNA (mtDNA) depends on a number of nuclear gene-encoded proteins including a battery of enzymes forming the replisome needed to synthesize mtDNA. These enzymes need to be in balanced quantities to function properly that is in part achieved by exchanging intramitochondrial contents through mitochondrial fusion. In addition, mtDNA synthesis requires a balanced supply of nucleotides that is achieved by nucleotide recycling inside the mitochondria and import from the cytosol. Mitochondrial DNA maintenance defects (MDMDs) are a group of diseases caused by pathogenic variants in the nuclear genes involved in mtDNA maintenance resulting in impaired mtDNA synthesis leading to quantitative (mtDNA depletion) and qualitative (multiple mtDNA deletions) defects in mtDNA. Defective mtDNA leads to organ dysfunction due to insufficient mtDNA-encoded protein synthesis, resulting in an inadequate energy production to meet the needs of affected organs. MDMDs are inherited as autosomal recessive or dominant traits, and are associated with a broad phenotypic spectrum ranging from mild adult-onset ophthalmoplegia to severe infantile fatal hepatic failure. To date, pathogenic variants in 20 nuclear genes known to be crucial for mtDNA maintenance have been linked to MDMDs, including genes encoding enzymes of mtDNA replication machinery (POLG, POLG2, TWNK, TEAM, RNASEH1, MGME1, and DNA2), genes encoding proteins that function in maintaining a balanced mitochondrial nucleotide pool (TIC2, DGUOK, SUCLGI, SUCLA2, ABAT, RRM2B, TYMP, SLC25A4, AGK, and MPV17), and genes encoding proteins involved in mitochondrial fusion (OPA1, MFN2, and FBXL4). (C) 2017 Published by Elsevier B.V.
C1 [El-Hattab, Ayman W.] Tawam Hosp, Dept Pediat, Div Clin Genet & Metab Disorders, Al Ain, U Arab Emirates.
   [Craigen, William J.; Scaglia, Fernando] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Craigen, WJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.
EM wcraigen@bcm.edu
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Akman G, 2016, P NATL ACAD SCI USA, V113, pE4276, DOI 10.1073/pnas.1600537113
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Antoun G, 2016, JIMD REP, V27, P1, DOI 10.1007/8904_2015_491
   Baroy T, 2016, EUR J MED GENET, V59, P342, DOI 10.1016/j.ejmg.2016.05.005
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bonneau D, 2014, BRAIN, V137, DOI 10.1093/brain/awu184
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Carelli V, 2015, BRAIN, V138, DOI 10.1093/brain/awu234
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006
   Delettre-Cribaillet C., 1993, GENEREVIEWS
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Doerner A, 1997, FEBS LETT, V414, P258, DOI 10.1016/S0014-5793(97)01000-4
   Ebrahimi-Fakhari D, 2015, PEDIATR NEUROL, V53, P549, DOI 10.1016/j.pediatrneurol.2015.08.018
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   El-Hattab A.W., 1993, GENEREVIEWS
   El-Hattab A.W., 2016, Cell Calcium
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Epand RM, 2009, BIOCHEMISTRY-US, V48, P12358, DOI 10.1021/bi901769r
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Fusté JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Goh V, 2012, J PEDIATR GASTR NUTR, V54, P291, DOI 10.1097/MPG.0b013e318227e53c
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   Gorman GS, 2014, GENEREVIEWS
   Grabhorn E, 2014, LIVER TRANSPLANT, V20, P464, DOI 10.1002/lt.23830
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0119-3
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hanchard NA, 2011, MOL GENET METAB, V103, P262, DOI 10.1016/j.ymgme.2011.03.006
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Holve S, 1999, J PEDIATR-US, V135, P482, DOI 10.1016/S0022-3476(99)70172-1
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   JAEKEN J, 1984, NEUROPEDIATRICS, V15, P165, DOI 10.1055/s-2008-1052362
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Landsverk ML, 2014, MOLEC GENET METAB RE, V1, P451, DOI 10.1016/j.ymgmr.2014.09.007
   Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351
   Barreto LCLS, 2016, NEUROEPIDEMIOLOGY, V46, P157, DOI 10.1159/000443706
   Löllgen S, 2015, BIOL CHEM, V396, P13, DOI 10.1515/hsz-2014-0198
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Louro P, 2016, J INHERIT METAB DIS, V39, P743, DOI 10.1007/s10545-016-9951-z
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Medina-Kauwe LK, 1999, J INHERIT METAB DIS, V22, P414, DOI 10.1023/A:1005500122231
   Milone M, 2011, NEUROLOGY, V77, P1847, DOI 10.1212/WNL.0b013e318238863a
   Munnich A., 2012, INBORN METABOLIC DIS, P223
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Paradas C, 2013, JAMA NEUROL, V70, P1425, DOI 10.1001/jamaneurol.2013.3185
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pohjoismäki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Prasad C, 2013, MOL GENET METAB, V108, P190, DOI 10.1016/j.ymgme.2012.12.007
   Prasun P, 2014, J NEUROL, V261, P1818, DOI 10.1007/s00415-014-7428-2
   Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9
   Randolph LM, 2011, MOL GENET METAB, V102, P149, DOI 10.1016/j.ymgme.2010.10.014
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schaaf CP, 2011, MOL GENET METAB, V103, P383, DOI 10.1016/j.ymgme.2011.04.018
   Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715
   Tsuji M, 2010, J INHERIT METAB DIS, V33, P85, DOI 10.1007/s10545-009-9022-9
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   van Rij MC, 2016, CLIN CASE REP, V4, P425, DOI 10.1002/ccr3.511
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wong LJC, 2012, SEMIN NEUROL, V32, P55, DOI 10.1055/s-0032-1306387
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146
   Zuchner S., 2014, GENEREVIEWS
NR 137
TC 194
Z9 213
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUN
PY 2017
VL 1863
IS 6
BP 1539
EP 1555
DI 10.1016/j.bbadis.2017.02.017
PG 17
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA EZ4TE
UT WOS:000404704600037
PM 28215579
OA Bronze
DA 2024-11-01
ER

PT J
AU Munakata, K
   Iwamoto, K
   Bundo, M
   Kato, T
AF Munakata, K
   Iwamoto, K
   Bundo, M
   Kato, T
TI Mitochondrial DNA 3243A&gt;G mutation and increased expression of
   <i>LARS2</i> gene in the brains of patients with bipolar disorder and
   schizophrenia
SO BIOLOGICAL PSYCHIATRY
LA English
DT Article
DE DNA microarray; leucyl-tRNA synthetase 2; mitochondrial (LARS2);
   aminoacylation; mitochondrial DNA 3243A > G; peptide nucleic acid
   (PNA)-clamped PCR; postmortem brain
ID MAGNETIC-RESONANCE SPECTROSCOPY; STROKE-LIKE EPISODES; LACTIC-ACIDOSIS;
   EXTERNAL OPHTHALMOPLEGIA; DIABETES-MELLITUS; MENTAL-DISORDERS; POINT
   MUTATIONS; HUMAN-CELLS; MELAS; NUCLEOTIDE
AB Background. Accumulating evidence suggests mitochondrial dysfunction in bipolar disorder. Analyses of mitochondria-related genes using DNA microarray showed significantly increased LARS2 (mitochondrial leucyl-tRNA synthetase) in the postmortem prefrontal cortices of patients with bipolar disorder provided by the Stanley Foundation Brain Collection. LARS2 is a nuclear gene encoding the enzyme catalyzing the aminoacylation of mitochondrial tRNA(Leu). A well-studied mitochondrial DNA point mutation, 3243A>G, in the region of tRNA(Leu (UUR)), related with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes), is known to decrease the efficiency of aminoacylation of tRNA(Leu (UUR)).
   Methods. The steady state level of LARS2 was examined in the transmitochondrial cybrids carrying 3243A>G. We examined the 3243A>G mutation in these brains using the peptide nucleic acid-clamped polymerase chain reaction restriction fragment length polymorphism method.
   Results. LARS2 was upregulated in the transmitochrondrial cybrids carrying 3243A>G. The 3243A>G was detected in the postmortem brains of two patients with bipolar disorder and one with schizophrenia. These patients also showed higher levels of the mutation in their livers and significantly higher gene expression of LARS2 compared with other subjects.
   Conclusions: These results suggest that upregulation of LARS2 is a hallmark of 324A>G mutation. The accumulation of 3243A>G mutation in the brain may have a pathophysiologic role in bipolar disorder and schizophrenia.
C1 RIKEN, Brain Sci Inst, Lab Mol Dynam Met Disorders, Wako, Saitama 3510198, Japan.
C3 RIKEN
RP RIKEN, Brain Sci Inst, Lab Mol Dynam Met Disorders, Hirosawa 2-1, Wako, Saitama 3510198, Japan.
EM kato@brain.riken.go.jp
RI Kato, Tadafumi/J-3583-2014
OI Kato, Tadafumi/0000-0001-7856-3952
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649
   Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   Dager SR, 2004, ARCH GEN PSYCHIAT, V61, P450, DOI 10.1001/archpsyc.61.5.450
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hancock DK, 2002, CLIN CHEM, V48, P2155
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437
   James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013
   Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, pC867, DOI 10.1152/ajpcell.00191.2003
   KAKIUCHI C, IN PRES INT J NEUROP
   Karry R, 2004, BIOL PSYCHIAT, V55, P676, DOI 10.1016/j.biopsych.2003.12.012
   KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3
   KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   King L, 1999, SYNAPSE, V31, P67, DOI 10.1002/(SICI)1098-2396(199901)31:1<67::AID-SYN9>3.0.CO;2-#
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Liu VWS, 1997, HUM MUTAT, V9, P265, DOI 10.1002/(SICI)1098-1004(1997)9:3<265::AID-HUMU8>3.3.CO;2-6
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Maurer I, 2001, SCHIZOPHR RES, V48, P125, DOI 10.1016/S0920-9964(00)00075-X
   MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277
   Miyaoka H, 1997, BIOL PSYCHIAT, V42, P524, DOI 10.1016/S0006-3223(97)00280-1
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015
   Odawara M, 1998, HUM GENET, V102, P708, DOI 10.1007/s004390050768
   Odawara M, 1997, DIABETIC MED, V14, P503, DOI 10.1002/(SICI)1096-9136(199706)14:6<503::AID-DIA394>3.0.CO;2-1
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Onishi H, 1997, BIOL PSYCHIAT, V41, P1137, DOI 10.1016/S0006-3223(97)00005-X
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   PETTEGREW JW, 1991, ARCH GEN PSYCHIAT, V48, P563
   Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511
   Prayson RA, 1998, ARCH PATHOL LAB MED, V122, P978
   Prince JA, 1999, NEUROPSYCHOPHARMACOL, V21, P372, DOI 10.1016/S0893-133X(99)00016-0
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   SHANSKE AL, 1993, NEUROMUSCULAR DISORD, V3, P191, DOI 10.1016/0960-8966(93)90058-R
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Sohm N, 2004, J MOL BIOL, V339, P17, DOI 10.1016/j.jmb.2004.03.066
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suzuki Y, 1997, MOL ASPECTS MED, V18, pS181
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Thomeer EC, 1998, J NEUROL NEUROSUR PS, V64, P692, DOI 10.1136/jnnp.64.5.692
   Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9
   Ueda Y, 2004, PEDIATR NEPHROL, V19, P107, DOI 10.1007/s00467-003-1318-7
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Washizuka S, 2004, BIOL PSYCHIAT, V56, P483, DOI 10.1016/j.biopsych.2004.07.004
   Washizuka S, 2003, AM J MED GENET B, V120B, P72, DOI 10.1002/ajmg.b.20041
   Whatley SA, 1996, NEUROCHEM RES, V21, P995, DOI 10.1007/BF02532409
   Yamazaki M, 1991, Rinsho Shinkeigaku, V31, P1219
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
NR 54
TC 108
Z9 121
U1 1
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0006-3223
EI 1873-2402
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD MAR 1
PY 2005
VL 57
IS 5
BP 525
EP 532
DI 10.1016/j.biopsych.2004.11.041
PG 8
WC Neurosciences; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychiatry
GA 903HB
UT WOS:000227415400012
PM 15737668
DA 2024-11-01
ER

PT J
AU Tang, Y
   Qin, Q
   Xing, Y
   Guo, DM
   Di, L
   Jia, JP
AF Tang, Yi
   Qin, Qi
   Xing, Yi
   Guo, Dongmei
   Di, Li
   Jia, Jianping
TI <i>AARS2</i> leukoencephalopathy: A new variant of mitochondrial
   encephalomyopathy
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE AARS2 leukoencephalopathy; alanyl-transfer (t)RNA synthetase 2;
   leukoencephalopathies; mitochondrial encephalomyopathy
ID LEUKODYSTROPHY; MUTATIONS; MUSCLE; DNA
AB Background Mutations in the mitochondrial alanyl-transfer (t)RNA synthetase 2 (AARS2,OMIM:612035) have been linked to leukoencephalopathy recently. Till now, there have been 19 cases reported so far. However, the clinical and genetic characteristics of this disease are not fully understood. We reported an adult-onset male leukoencephalopathy patient related to novel AARS2 gene mutations and reviewed all previous cases regarding the clinical and genetic features of AARS2 leukoencephalopathy. Methods The spectrum of clinical symptoms and the genetic analysis of the presented patient were identified and investigated. Besides this case, we assessed previously reported cases with AARS2 gene mutations. Results Here, we present a 30-year-old man with progressive motor deficits in the right lower limb and severe cerebellar ataxia for one year. MRI revealed extensive white matter lesions in periventricular regions and along the corticospinal tract. Genetic analysis revealed two new heterogeneous missense mutations in AARS2: c.179C>A and c.1703_1704del. We described the ragged red fiber (RRF) for the first time, suggesting that AARS2-related leukoencephalopathy be a new variant of mitochondrial encephalomyopathy. Gradual improvement in motor function was observed with intravenous coenzyme complex treatment. We also summarized our case and all previously reported cases to provide an overview of AARS2-related late-onset leukoencephalopathy. Then, we compared clinical and neuroimaging features of AARS2-related leukoencephalopathy with three other frequently diagnosed types of adult-onset leukoencephalopathy to provide insight into diagnostic strategies. Conclusion The characteristic MRI abnormalities and clinical symptoms described here may help to distinguish AARS2-related leukoencephalopathy from other adult-onset leukoencephalopathies. The combination of encephalopathy and myopathy strongly suggest that AARS2-related leukoencephalopathy is a new variant of mitochondrial encephalomyopathy. The response to coenzyme complex will shed light on future therapy investigation.
C1 [Tang, Yi; Qin, Qi; Xing, Yi; Guo, Dongmei; Di, Li; Jia, Jianping] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Innovat Ctr Neurol Disorders, Beijing, Peoples R China.
   [Jia, Jianping] Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing Key Lab Geriatr Cognit Disorders, Neurodegenerat Lab,Minist Educ Peoples, Beijing, Peoples R China.
C3 Capital Medical University
RP Tang, Y; Qin, Q (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Innovat Ctr Neurol Disorders, Beijing, Peoples R China.; Tang, Y; Qin, Q (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China.; Tang, Y; Qin, Q (corresponding author), Capital Med Univ, Xuan Wu Hosp, Innovat Ctr Neurol Disorders, Beijing, Peoples R China.
EM tangyixw@163.com; qinqibao@126.com
RI Di, Li/ACU-1329-2022; dongmei, guo/AAC-3418-2019
OI QIN, Qi/0000-0002-3019-2061; Jia, Jianping/0000-0003-4624-0336
FU National Key R&D Program of China [2017YFC1310102]; National Natural
   Science Foundation of China [81671040]
FX This study was supported by National Key R&D Program of China
   (2017YFC1310102) and National Natural Science Foundation of China
   (81671040).
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956
   Dong Q, 2018, J HUM GENET, V63, P841, DOI 10.1038/s10038-018-0446-7
   Euro L, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00021
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343
   Hamatani M, 2016, J HUM GENET, V61, P899, DOI 10.1038/jhg.2016.64
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kaye EM, 2004, NEUROLOGY, V62, P1464, DOI 10.1212/WNL.62.9.1464
   Lakshmanan R, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000135
   Lee JM, 2017, EUR J NEUROL, V24, pE21, DOI 10.1111/ene.13245
   Lynch DS, 2017, BRAIN, V140, P1204, DOI 10.1093/brain/awx045
   Lynch DS, 2016, JAMA NEUROL, V73, P1433, DOI 10.1001/jamaneurol.2016.2229
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   Moulinier L, 2017, HUM MUTAT, V38, P1316, DOI 10.1002/humu.23277
   Peragallo JH, 2018, OPHTHALMIC GENET, V39, P99, DOI 10.1080/13816810.2017.1350723
   Renaud DL, 2012, SEMIN NEUROL, V32, P3, DOI 10.1055/s-0032-1306380
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8
   Shoubridge EA, 1998, CURR OPIN NEUROL, V11, P491, DOI 10.1097/00019052-199810000-00012
   SHY G. MILTON, 1964, REV NEURO PSIQUIAT, V27, P238
   Szpisjak L, 2017, J HUM GENET, V62, P329, DOI 10.1038/jhg.2016.126
   Taglia I, 2018, ACTA NEUROL SCAND, V138, P278, DOI 10.1111/ane.12954
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   van der Knaap MS, 1999, RADIOLOGY, V213, P121, DOI 10.1148/radiology.213.1.r99se01121
NR 29
TC 20
Z9 23
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD APR
PY 2019
VL 7
IS 4
AR e582
DI 10.1002/mgg3.582
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA HU2LJ
UT WOS:000465102200006
PM 30706699
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Felk, S
   Ohrt, S
   Kussmaul, L
   Storch, A
   Gillardon, F
AF Felk, Sandra
   Ohrt, Susanne
   Kussmaul, Lothar
   Storch, Alexander
   Gillardon, Frank
TI Activation of the mitochondrial protein quality control system and actin
   cytoskeletal alterations in cells harbouring the MELAS mitochondrial DNA
   mutation
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE MELAS; Mitochondria; Proteome; 2D DIGE; Lon protease; Actin cytoskeleton
ID LON PROTEASE; LACTIC-ACIDOSIS; ENCEPHALOPATHY; STRESS; MYOPATHY;
   PROTEOLYSIS; PROTEOMICS; ACONITASE; SUBGROUP; EPISODES
AB Point mutations in the mitochondrial genome are associated with a variety of metabolic disorders. The myopathy, encephalopathy, lactic acidosis, stroke-like episodes syndrome (MELAS), is most frequently associated with an A to G transition at position 3243 of the mitochondrial tRNA(Leu(UUR)) gene, and is characterized by biochemical and structural alterations of mitochondria.
   In the present study, we analyzed proteomic changes in an immortalized B-cell line harbouring the MELAS A3243G mutation by two-dimensional difference gel electrophoresis and immunoblot analysis.
   Although the cell line contained only 10% mutated mitochondrial genomes, we detected significant alterations in numerous proteins associated with the actin cytoskeleton and in nuclear-encoded subunits of mitochondrial respiratory chain complexes. Notably, mitochondria! Lon protease and Hsp60 were deregulated in MELAS cells, indicating an effect on the mitochondrial protein quality control system. By immunofluorescence microscopy, we detected mitochondrial Lon protease accumulation and changes in actin-binding proteins preferentially in MELAS cells containing numerous mitochondria with mutated genomes. Enzymatic assays revealed that Lon protease activity is increased in MELAS cell lysates. Although Lon protease has been shown to degrade misfolded proteins and to stabilize respiratory chain complexes within mitochondria, our MELAS cell line exhibited a higher sensitivity to mitochondria! stress. These findings provide novel insights into the cellular response to dysfunctional mitochondria containing mutated genomes. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Gillardon, Frank] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, D-88397 Biberach, Germany.
   [Ohrt, Susanne; Storch, Alexander] Tech Univ Dresden, Dept Neurol, D-8027 Dresden, Germany.
C3 Boehringer Ingelheim; Technische Universitat Dresden
RP Gillardon, F (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, Birkendorfer Str 65, D-88397 Biberach, Germany.
EM Frank.Gillardon@boehringer-ingelheim.com
FU Medical Faculty Carl Gustav Carus at the Dresden University of
   Technology; Roland Ernst Foundation [AZ 21-0563]
FX The study was supported by the Research Program of the Medical Faculty
   Carl Gustav Carus at the Dresden University of Technology, and the
   Roland Ernst Foundation (AZ 21-0563). The authors thank Sylvia Kanzler
   for initial help with lymphoblastoid suspension cultures and Wolfgang
   Rist for mass spectrometric analyses.
CR Bakker A, 2000, PEDIATR RES, V48, P143, DOI 10.1203/00006450-200008000-00005
   Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522
   Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200
   Campian JL, 2007, J BIOL CHEM, V282, P12430, DOI 10.1074/jbc.M604547200
   Charrin S, 2006, FRONT BIOSCI-LANDMRK, V11, P1987, DOI 10.2741/1940
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07
   Danzeisen R, 2006, J PHARMACOL EXP THER, V316, P189, DOI 10.1124/jpet.105.092312
   Deocaris C, 2008, BIOGERONTOLOGY, V9, P391, DOI 10.1007/s10522-008-9174-2
   Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043
   FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOBAYASHI M, 1987, J PEDIATR-US, V110, P223, DOI 10.1016/S0022-3476(87)80158-0
   Lee I, 2008, BBA-PROTEINS PROTEOM, V1784, P727, DOI 10.1016/j.bbapap.2008.02.010
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MAURIZI MR, 1987, J BIOL CHEM, V262, P2696
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rabilloud T, 2002, BIOCHEMISTRY-US, V41, P144, DOI 10.1021/bi0114776
   Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Stanyer L, 2008, NEUROCHEM INT, V53, P95, DOI 10.1016/j.neuint.2008.06.004
   Swatton JE, 2004, MOL PSYCHIATR, V9, P128, DOI 10.1038/sj.mp.4001475
   TANAKA M, 1991, BIOCHEM BIOPH RES CO, V174, P861, DOI 10.1016/0006-291X(91)91497-Z
   Tonge R, 2001, PROTEOMICS, V1, P377
   van Dijl JM, 1998, P NATL ACAD SCI USA, V95, P10584, DOI 10.1073/pnas.95.18.10584
   Vasilyeva OV, 2002, FEBS LETT, V526, P66, DOI 10.1016/S0014-5793(02)03117-4
   Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200
   Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WAXMAN L, 1985, J BIOL CHEM, V260, P2022
NR 42
TC 10
Z9 12
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD AUG 15
PY 2010
VL 295
IS 1-2
BP 46
EP 52
DI 10.1016/j.jns.2010.05.013
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 628LA
UT WOS:000280120000010
PM 20570288
DA 2024-11-01
ER

PT J
AU Fraidakis, MJ
   Jardel, C
   Allouche, S
   Nelson, I
   Auré, K
   Slama, A
   Lemière, I
   Thenint, JP
   Hamon, JB
   Zagnoli, F
   Heron, D
   Sedel, F
   Lombès, A
AF Fraidakis, Matthew J.
   Jardel, Claude
   Allouche, Stephane
   Nelson, Isabelle
   Aure, Karine
   Slama, Abdelhamid
   Lemiere, Isabelle
   Thenint, Jean Philippe
   Hamon, Jean Baptiste
   Zagnoli, Fabien
   Heron, Delphine
   Sedel, Frederic
   Lombes, Anne
TI Phenotypic diversity associated with the <i>MT-TV</i> gene m.1644G &gt;
   A mutation, a matter of quantity
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; Heteroplasmy; Mitochondrial diseases; Clinical
   diagnosis
ID WIDESPREAD TISSUE DISTRIBUTION; MITOCHONDRIAL-DNA; MELAS SYNDROME;
   MTDNA; DIAGNOSIS
AB We describe four patients from three independent families with the m.1 644G> A in the MT-1Vgene, previously reported without demonstration of its deleterious impact.
   Very high mutation proportion co-segregated with cytochrome oxidase defect in single muscle fibers and respiratory defect in cybrids as shown by spectrophotometric assays and polarography.
   The mutation appeared to have a very steep threshold effect with asymptomatic life up to 70% mutation propor: tion, progressive encephalopathy above 80% and severe Leigh-like syndrome above 95% mutation. One patient did not fit within that frame but presented with characteristics suggesting the presence of an additional disease. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Fraidakis, Matthew J.; Sedel, Frederic] Hop La Pitie Salpetriere, AP HP, F-75651 Paris, France.
   [Jardel, Claude; Lemiere, Isabelle; Lombes, Anne] Hop La Pitie Salpetriere, AP HP, Serv Biochim Metab, F-75651 Paris, France.
   [Jardel, Claude; Lemiere, Isabelle; Lombes, Anne] Ctr Genet Mol & Chromosom, F-75651 Paris, France.
   [Jardel, Claude; Aure, Karine; Lombes, Anne] Inst Cochin, INSERM, UMRS 1016, F-75014 Paris, France.
   [Allouche, Stephane] CHU, Serv Biochim, F-14033 Caen 09, France.
   [Allouche, Stephane] Normandie Univ UNICAEN, EA 4650, F-14032 Caen, France.
   [Nelson, Isabelle] Hop La Pitie Salpetriere, Inst Myol, INSERM, U974, F-75654 Paris, France.
   [Aure, Karine] Hop Ambroise Pare, AP HP, Serv Explorat Fonctionnelles, F-92100 Boulogne, France.
   [Aure, Karine] Univ Versailles St Quentin Yvelines, F-78180 Versailles, France.
   [Slama, Abdelhamid] Hop Bicetre, AP HP, Serv Biochim, F-94275 Le Kremlin Bicetre, France.
   [Thenint, Jean Philippe] CHG Serv Neurol, F-61000 Alencon, France.
   [Hamon, Jean Baptiste] CHU, Hop Cavale Blanche, F-29200 Brest, France.
   [Zagnoli, Fabien] Hop Instruct Armees, Serv Neurol, F-29200 Brest, France.
   [Heron, Delphine] Hop La Pitie Salpetriere, AP HP, Ctr Reference Deficiences Intellectuelles Causes, GRC, F-75651 Paris, France.
   [Lombes, Anne] CNRS, Inst Cochin, UMR 8104, F-75014 Paris, France.
   [Lombes, Anne] Univ Paris 05, F-75014 Paris, France.
C3 Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere
   - APHP; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite Paris Cite; Universite de Caen Normandie; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere
   - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Ambroise-Pare - APHP; Universite Paris Saclay;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Antoine-Beclere - APHP; Universite Paris Saclay; Hopital Universitaire
   Bicetre - APHP; CHU Brest; Universite de Bretagne Occidentale;
   Val-de-Grace Hospital; Sorbonne Universite; Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB); Universite Paris Cite; Institut National de la Sante
   et de la Recherche Medicale (Inserm); Universite Paris Cite
RP Lombès, A (corresponding author), Inst Cochin, 24 Rue Fb St Jacques, F-75014 Paris, France.
EM anne.lombes@inserm.fr
RI Lombes, Anne/G-4684-2014; Allouche, Stephane/AFW-3810-2022
OI nelson, isabelle/0000-0001-6390-622X; Allouche,
   stephane/0000-0003-3134-7501
FU NR (Agence Nationale pour la Recherche) (ANR MNP Mitopark)
   [ANR-08-MNPS-020-01]; AFM (Association Francaise contre les Myopathies);
   AMMi (Association contre les Maladies Mitochondriales)
FX The study was supported by grants from ANR (Agence Nationale pour la
   Recherche) (ANR MNP 2008 Mitopark: ANR-08-MNPS-020-01), AFM (Association
   Francaise contre les Myopathies) and AMMi (Association contre les
   Maladies Mitochondriales) to AL.
CR Auré K, 2007, NEUROMUSCULAR DISORD, V17, P368, DOI 10.1016/j.nmd.2007.01.019
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Kim MJ, 2008, ANTIMICROB AGENTS CH, V52, P1670, DOI 10.1128/AAC.01449-07
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Menotti Francesca, 2004, Ital Heart J, V5, P460
   Rehder CW, 2013, GENET MED, V15, P150, DOI 10.1038/gim.2012.169
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tanji K, 2008, J NEUROL SCI, V270, P23, DOI 10.1016/j.jns.2008.01.016
   Tuppen HAL, 2008, J MED GENET, V45, P55, DOI 10.1136/jmg.2007.051185
   van Eijsden RGE, 2006, GENET MED, V8, P620, DOI 10.1097/01.gim.0000237782.94878.05
NR 15
TC 7
Z9 8
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR
PY 2014
VL 15
BP 34
EP 39
DI 10.1016/j.mito.2014.03.010
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA AH3FR
UT WOS:000336009600005
PM 24691472
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Alemi, M
   Prigione, A
   Wong, A
   Schoenfeld, R
   DiMauro, S
   Hirano, M
   Taroni, F
   Cortopassi, G
AF Alemi, Mansour
   Prigione, Alessandro
   Wong, Alice
   Schoenfeld, Robert
   DiMauro, Salvatore
   Hirano, Michio
   Taroni, Franco
   Cortopassi, Gino
TI Mitochondrial DNA deletions inhibit proteasomal activity and stimulate
   an autophagic transcript
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SKELETAL-MUSCLE; OXIDIZED
   PROTEINS; OXIDATIVE STRESS; AMINO-ACIDS; HUMAN-CELLS; GENE-EXPRESSION;
   ENERGY DEMAND; TRANSFER-RNA; MTDNA
AB Deletions within the mitochondrial DNA (mtDNA) cause Kearns Sayre syndrome (KSS) and chronic progressive external opthalmoplegia (CPEO). The clinical signs of KSS include muscle weakness, heart block, pigmentary retinopathy, ataxia, deafness, short stature, and dementia. The identical deletions occur and rise exponentially as humans age; particularly in substantia nigra. Deletions at > 30% concentration cause deficits in basic bioenergetic parameters, including membrane potential and ATP synthesis, but it is poorly understood how these alterations cause the pathologies observed in patients. To better understand the consequences of mtDNA deletions, we microarrayed six cell types containing mtDNA deletions from KSS and CPEO patients. There was a prominent inhibition of transcripts encoding ubiquitin-mediated proteasome activity, and a prominent induction of transcripts involved in the AMP kinase pathway, macroautophagy, and amino acid degradation. In mutant cells, we confirmed a decrease in proteasome biochemical activity, significantly lower concentration of several amino acids, and induction of an autophagic transcript. An interpretation consistent with the data is that mtDNA deletions increase protein damage, inhibit the ubiquitin-proteasome system, decrease amino acid salvage, and activate autophagy. This provides a novel pathophysiological mechanism for these diseases, and suggests potential therapeutic strategies. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA.
   Columbia Univ, Ctr Med, Dept Neurol, New York, NY 10032 USA.
   Ist Nazl Neurol Carlo Besta, Div Biochem & Genet, Milan, Italy.
C3 University of California System; University of California Davis;
   Columbia University; Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Cortopassi, G (corresponding author), Univ Calif Davis, Dept Mol Biosci, 1311 Haring Hall, Davis, CA 95616 USA.
EM gcortopassi@ucdavis.edu
RI Taroni, Franco/N-3879-2013; Prigione, Alessandro/ABA-1584-2021;
   Alessandro, Prigione/B-2959-2013
OI Alessandro, Prigione/0000-0001-9457-1952
FU NCI NIH HHS [R01 CA042742] Funding Source: Medline; NEI NIH HHS
   [EY12245, R01 EY012245] Funding Source: Medline; NIA NIH HHS [R01
   AG011967, R03 AG023311, R01 AG016719, AG16719, R01 AG11967] Funding
   Source: Medline; NIEHS NIH HHS [P30 ES005707] Funding Source: Medline;
   NINDS NIH HHS [R01 NS077777] Funding Source: Medline; PHS HHS [V440C21]
   Funding Source: Medline
CR Anthony JC, 2000, J NUTR, V130, P2413
   Anthony JC, 1999, J NUTR, V129, P1102, DOI 10.1093/jn/129.6.1102
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003
   Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200
   Bossy-Wetzel E, 1999, MUTAT RES-DNA REPAIR, V434, P243, DOI 10.1016/S0921-8777(99)00032-4
   Brierley EJ, 1997, MOL CELL BIOCHEM, V174, P325, DOI 10.1023/A:1006847319162
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2
   Charrueau C, 2000, J GASTROEN HEPATOL, V15, P1199, DOI 10.1046/j.1440-1746.2000.02310.x
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   CORTOPASSI G, 2006, IN PRESS MITOCHONDRI
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Danielson SR, 2005, BRAIN, V128, P1026, DOI 10.1093/brain/awh447
   Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517
   Davies KJA, 2006, NEUROLOGY, V66, pS93, DOI 10.1212/01.wnl.0000192308.43151.63
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   Gibson BW, 2005, INT J BIOCHEM CELL B, V37, P927, DOI 10.1016/j.biocel.2004.11.013
   Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690
   Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200
   Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   Jefferson LS, 2003, J NUTR, V133, p2046S, DOI 10.1093/jn/133.6.2046S
   JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059
   Jou MJ, 2005, ANN NY ACAD SCI, V1042, P221, DOI 10.1196/annals.1338.024
   Kadowaki M, 2003, J NUTR, V133, p2052S, DOI 10.1093/jn/133.6.2052S
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1
   Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698
   Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Kopsidas G, 1998, MUTAT RES-FUND MOL M, V421, P27, DOI 10.1016/S0027-5107(98)00150-X
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005
   Lim PS, 2002, J BIOMED SCI, V9, P549, DOI 10.1159/000064728
   Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014
   Lu CY, 1999, MUTAT RES-FUND MOL M, V423, P11, DOI 10.1016/S0027-5107(98)00220-6
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   Mizushima N, 2003, INT J BIOCHEM CELL B, V35, P553, DOI 10.1016/S1357-2725(02)00343-6
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1995, MUSCLE NERVE, pS150
   Nakada K, 2002, MITOCHONDRION, V2, P59, DOI 10.1016/S1567-7249(02)00007-7
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Powell SR, 2005, FREE RADICAL BIO MED, V38, P1093, DOI 10.1016/j.freeradbiomed.2005.01.003
   Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Santorelli FM, 1996, NEUROLOGY, V47, P1320, DOI 10.1212/WNL.47.5.1320
   Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Shamoto-Nagai M, 2003, J NEUROSCI RES, V74, P589, DOI 10.1002/jnr.10777
   Shorer H, 2005, J BIOL CHEM, V280, P16219, DOI 10.1074/jbc.M500554200
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Simonsen A, 1998, EUR J CELL BIOL, V75, P223, DOI 10.1016/S0171-9335(98)80116-7
   Slocum RH., 1991, TECHNIQUES DIAGNOSTI, P87
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUDOYO H, 1993, J NEUROL SCI, V117, P83, DOI 10.1016/0022-510X(93)90159-V
   Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200
   Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vielhaber S, 2000, BIOCHEM SOC T, V28, P159, DOI 10.1042/bst0280159
   Wang ED, 1997, MUTAT RES-FUND MOL M, V377, P157, DOI 10.1016/S0027-5107(97)00091-2
   Wang Y, 2005, MOL MEMBR BIOL, V22, P313, DOI 10.1080/09687860500143829
   Wei YH, 2001, ANN NY ACAD SCI, V928, P97
   WEK SA, 1995, MOL CELL BIOL, V15, P4497
   Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059
   Wonsey DR, 2002, P NATL ACAD SCI USA, V99, P6649, DOI 10.1073/pnas.102523299
   ZEVIANI M, 1995, BBA-MOL BASIS DIS, V1271, P153, DOI 10.1016/0925-4439(95)00022-V
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 85
TC 40
Z9 45
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JAN 1
PY 2007
VL 42
IS 1
BP 32
EP 43
DI 10.1016/j.freeradbiomed.2006.09.014
PG 12
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 118WW
UT WOS:000242975200003
PM 17157191
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Szigeti, K
   Wong, LJC
   Perng, CL
   Saifi, GM
   Eldin, K
   Adesina, AM
   Cass, DL
   Hirano, M
   Lupski, JR
   Scaglia, F
AF Szigeti, K
   Wong, LJC
   Perng, CL
   Saifi, GM
   Eldin, K
   Adesina, AM
   Cass, DL
   Hirano, M
   Lupski, JR
   Scaglia, F
TI MNGIE with lack of skeletal muscle involvement and a novel <i>TP</i>
   splice site mutation
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID THYMIDINE PHOSPHORYLASE-DEFICIENCY; MITOCHONDRIAL-DNA; GENE-MUTATIONS;
   DISORDERS; DEFECTS; GROWTH
AB Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive multisystem disorder caused by thymidine phosphorylase (TP) deficiency, resulting in severe gastrointestinal dysmotility and skeletal muscle abnormalities. A patient is reported with a classical MNGIE clinical presentation but without skeletal muscle involvement at morphological, enzymatic, or mitochondrial DNA level, though gastrointestinal myopathy was present. MNGIE was diagnosed by markedly raised plasma thymidine and reduced thymidine phosphorylase activity. Molecular genetic analysis showed a homozygous novel splice site mutation in TP. On immunohistochemical studies there was marked TP expression in the CNS, in contrast to what has been observed in rodents. It is important to examine the most significantly affected tissue and to measure TP activity and plasma thymidine in order to arrive at an accurate diagnosis in this condition.
C1 Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   Texas Childrens Hosp, Houston, TX 77030 USA.
   Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
   Baylor Coll Med, Dept Surg, Houston, TX 77030 USA.
   Georgetown Univ, Med Ctr, Inst Mol & Human Genet, Washington, DC 20007 USA.
   Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Baylor College of Medicine; Georgetown University; Columbia
   University
RP Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Rm604B, Houston, TX 77030 USA.
EM jlupski@bcm.tmc.edu
OI Cass, Darrell/0000-0001-9082-2494
CR den Dunnen JT, 2000, HUM MUTAT, V15, P7
   ECCLESTON PA, 1995, NEUROSCI LETT, V192, P137, DOI 10.1016/0304-3940(95)11622-4
   Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HIRANO M, IN PRESS NEUROLOGIST
   Kocaefe YÇ, 2003, EUR J HUM GENET, V11, P102, DOI 10.1038/sj.ejhg.5200908
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Martí R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8
   McComsey G, 2002, AIDS, V16, P513, DOI 10.1097/00002030-200203080-00001
   MIYADERA K, 1995, CANCER RES, V55, P1687
   MOGHADDAM A, 1995, P NATL ACAD SCI USA, V92, P998, DOI 10.1073/pnas.92.4.998
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Rick SW, 1999, PROTEINS, V37, P242, DOI 10.1002/(SICI)1097-0134(19991101)37:2<242::AID-PROT9>3.0.CO;2-5
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2
NR 17
TC 35
Z9 37
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD FEB 1
PY 2004
VL 41
IS 2
BP 125
EP 129
DI 10.1136/jmg.2003.013789
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 769VE
UT WOS:000188669800008
PM 14757860
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Lee, YM
   Kang, HC
   Lee, JS
   Kim, SH
   Kim, EY
   Lee, SK
   Slama, A
   Kim, HD
AF Lee, Young Mock
   Kang, Hoon Chul
   Lee, Joon Soo
   Kim, Se Hoon
   Kim, Eung Yeop
   Lee, Seung Koo
   Slama, Abdelhamid
   Kim, Heung Dong
TI Mitochondrial respiratory chain defects: Underlying etiology in various
   epileptic conditions
SO EPILEPSIA
LA English
DT Article
DE mitochondrial disorder; respiratory chain; epilepsy
ID KETOGENIC DIET; PEDIATRIC-PATIENTS; CLINICAL-FEATURES; DNA; MICE;
   ENCEPHALOMYOPATHIES; MUTATIONS; DISEASE; DEFICIENCY; DISORDERS
AB Purpose: To determine if defects in mitochondrial respiratory chain enzyme complexes (MRCs) contribute to the etiology of childhood epilepsy.
   Methods: We reviewed the clinical and laboratory features of 48 epileptic patients (23 male, 25 female) with MRC defects that were confirmed by biochemical assays using muscle biopsies.
   Results: (1) Thirty-five cases (72.9%) were MRC I deficient, one case (2.1%) was MRC II deficient, 11 cases (22.9%) were MRC IV deficient, and one case (2.1%) had combined MRC I and IV deficiencies. (2) In our clinical diagnosis, there were 10 cases (20.8%) with Leigh disease and one case each with myopathy, encephalopathy, lactic acidosis, stroke-like episodes (MELAS) or Alpers' disease (2.1%). Most of the remaining cases (75.0%) had uncategorized mitochondrial cytopathy with nonspecific encephalopathy. (3) For epileptic classification, there were two cases (4.2%) of Ohtahara syndrome, 10 cases (20.8%) of West syndrome, 12 cases (25.0%) of Lennox-Gastaut syndrome, two cases (4.2%) of Landau-Kleffner syndrome, 14 cases (29.2%) of generalized epilepsy, and eight cases (16.7%) of partial epilepsy. (4) The mean age of seizure onset was 2.68 +/- 2.21 (range: 1 month - 5.5 years). (5) Magnetic resonance imaging (MRI) showed diffuse cortical atrophy in 34 cases (70.8%), basal ganglia signal changes in 18 cases (37.5%) and thalamus signal changes in 12 cases (25.0%). (6) A ketogenic diet produced clinical improvements, including seizure reduction and global functional improvement in 75% of 24 patients.
   Conclusions: MRC defects are one of the important causes of probably symptomatic childhood epilepsy. A ketogenic diet should be carefully considered for treatment of intractable epilepsy related to MRC defects.
C1 [Lee, Young Mock; Lee, Joon Soo; Kim, Heung Dong] Yonsei Univ, Coll Med, Dept Pediat, Severance Childrens Hosp,Inst Handicapped Childre, Seoul 120752, South Korea.
   [Kang, Hoon Chul] Inje Univ, Coll Med, Dept Pediat, Sanggye Paik Hosp, Seoul, South Korea.
   [Kang, Hoon Chul] Inje Univ, Coll Med, Epilepsy Ctr, Sanggye Paik Hosp, Seoul, South Korea.
   [Kim, Se Hoon] Yonsei Univ, Coll Med, Dept Pathol, Seoul 120752, South Korea.
   [Kim, Eung Yeop; Lee, Seung Koo] Univ Coll Med, Dept Radiol, Seoul, South Korea.
   [Slama, Abdelhamid] Hop Bicetre, APHP, Biochim Lab, Le Kremlin Bicetre, France.
C3 Yonsei University; Yonsei University Health System; Inje University;
   Inje University; Yonsei University; Yonsei University Health System;
   Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire
   Bicetre - APHP; Hopital Universitaire Ambroise-Pare - APHP
RP Kim, HD (corresponding author), Yonsei Univ, Coll Med, Dept Pediat, Severance Childrens Hosp,Inst Handicapped Childre, 134 Shinchon Dong, Seoul 120752, South Korea.
EM hdkimmd@yumc.yonsei.ac.kr
RI Kim, Eun-Kyung/E-5211-2017; LEE, SOOYEON/KAM-6204-2024; Kim,
   Hyoungil/M-7288-2019; Lee, Jun Young/CAI-2335-2022; Kim, Eung
   Yeop/A-9807-2013
OI Kim, Heung Dong/0000-0002-8031-7336; LEE,
   YOUNG-MOCK/0000-0002-5838-249X; Kang, Hoon-Chul/0000-0002-3659-8847;
   Lee, Joon Soo/0000-0001-9036-9343; Kim, Se Hoon/0000-0001-7516-7372;
   Kim, Eung Yeop/0000-0002-9579-4098; Lee, Seung-Koo/0000-0001-5646-4072
CR Blume Warren T., 2001, Epilepsia, V42, P1212, DOI 10.1046/j.1528-1157.2001.22001.x
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6
   Cock H, 1999, EPILEPSIA, V40, P33, DOI 10.1111/j.1528-1157.1999.tb00897.x
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DEVIVO DC, 1999, PEDIAT NEUROLOGY PRI, P494
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   DiMauro S, 2004, ANN NY ACAD SCI, V1011, P232, DOI 10.1196/annals.1293.023
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Kang HC, 2005, EPILEPSIA, V46, P272, DOI 10.1111/j.0013-9580.2005.48504.x
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kim DW, 2004, PEDIATRICS, V114, P1627, DOI 10.1542/peds.2004-1001
   Kunz WS, 1999, J NEUROCHEM, V72, P1580, DOI 10.1046/j.1471-4159.1999.721580.x
   Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Liang LP, 2004, FREE RADICAL BIO MED, V36, P542, DOI 10.1016/j.freeradbiomed.2003.11.029
   Lodi R, 2001, ANN NEUROL, V49, P590
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sadleir LG, 2004, EUR J NEUROL, V11, P103, DOI 10.1046/j.1351-5101.2003.00724.x
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9
   Urbanska EM, 1998, EUR J PHARMACOL, V359, P55, DOI 10.1016/S0014-2999(98)00648-7
   Wexler ID, 1997, NEUROLOGY, V49, P1655, DOI 10.1212/WNL.49.6.1655
   Yamamoto HA, 1996, NEUROSCI LETT, V207, P89, DOI 10.1016/0304-3940(96)12493-9
NR 29
TC 108
Z9 115
U1 0
U2 9
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD APR
PY 2008
VL 49
IS 4
BP 685
EP 690
DI 10.1111/j.1528-1167.2007.01522.x
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 279VF
UT WOS:000254382500018
PM 18266755
DA 2024-11-01
ER

PT J
AU Schapira, AHV
AF Schapira, Anthony H. V.
TI Mitochondrial disease
SO LANCET
LA English
DT Review
ID CYTOCHROME-C-OXIDASE; HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; RESPIRATORY-CHAIN DISORDERS; INTRACYTOPLASMIC SPERM
   INJECTION; ELECTRON-TRANSPORT CHAIN; AMYLOID-BETA PEPTIDE; GAMMA-GENE
   POLG; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE
AB Defects of mitochondrial metabolism cause a wide range of human diseases that include examples from all medical subspecialties. This review updates the topic of mitochondrial diseases by reviewing the most important recent advances in this area. The factors influencing inheritance, maintenance and replication of mtDNA are reviewed and the genotype-phenotype of mtDNA disorders has been expanded, with new insights into epidemiology, pathogenesis and its role in ageing. Recently identified nuclear gene mutations of mitochondrial proteins include mutations of frataxin causing Friedreich's ataxia, PINK1, DJ1 causing Parkinson's disease and POLG causing infantile mtDNA depletion syndrome, ophthalmoplegia, parkinsonism, male subfertility and, in a transgenic mouse model, premature senescence. Mitochondrial defects in neurodegenerative diseases include Parkinson's, Alzheimer's and Huntington's disease. Improved understanding of mtDNA inheritance and mutation penetrance patterns, and novel techniques for mtDNA modification offer significant prospects for more accurate genetic counselling and effective future therapies.
C1 UCL, Inst Neurol, London NW3 2PF, England.
   Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, London NW3 2PF, England.
C3 University of London; University College London; University of London;
   University College London
RP Schapira, AHV (corresponding author), Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, London NW3 2PF, England.
EM a.schapira@medasch.ucl.ac.uk
RI Schapira, Anthony/A-1245-2010
OI Schapira, Anthony/0000-0002-3018-3966
FU Wellcome Trust Funding Source: Medline
CR Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4
   Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   BOHNERT B, 1974, ARCH PSYCHIAT NERVEN, V218, P353, DOI 10.1007/BF00342578
   Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9
   Canet-Avilés RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101
   Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x
   Chandrasekaran K, 1997, MOL BRAIN RES, V44, P99, DOI 10.1016/S0169-328X(96)00191-X
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   COCK HR, 1995, NEUROLOGY, V45, pA294
   Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229
   COOPER JM, 1993, LANCET, V341, P969, DOI 10.1016/0140-6736(93)91269-R
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Du Yan S, 1999, J BIOL CHEM, V274, P2145, DOI 10.1074/jbc.274.4.2145
   Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200
   Ezquerra M, 2005, ARCH NEUROL-CHICAGO, V62, P306, DOI 10.1001/archneur.62.2.306
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   HARDING AE, 1995, AM J HUM GENET, V57, P77
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621
   Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346
   Höglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251
   Houshmand M, 1997, J ASSIST REPROD GEN, V14, P223, DOI 10.1007/BF02766114
   Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317
   Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC
   Lee SJ, 2003, ANTIOXID REDOX SIGN, V5, P337, DOI 10.1089/152308603322110904
   Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Lodi R, 2001, ANN NEUROL, V49, P590
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Marchington DR, 2002, MOL HUM REPROD, V8, P1046, DOI 10.1093/molehr/8.11.1046
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Mootha VK, 2005, P NATL ACAD SCI USA, V102, P10405, DOI 10.1073/pnas.0505194102
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Ojaimi J, 1999, ANN NEUROL, V46, P656, DOI 10.1002/1531-8249(199910)46:4<656::AID-ANA16>3.3.CO;2-H
   Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   PARKER WD, 1995, NEUROLOGY, V45, P482, DOI 10.1212/WNL.45.3.482
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Qi XP, 2004, ANN NEUROL, V56, P182, DOI 10.1002/ana.20175
   Qi XP, 2003, INVEST OPHTH VIS SCI, V44, P1088, DOI 10.1167/iovs.02-0864
   Qi XP, 2003, ANN NEUROL, V53, P198, DOI 10.1002/ana.10426
   REICHMANN H, 1993, J NEUROL, V240, P377, DOI 10.1007/BF00839971
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schapira AHV, 2002, J NEUROL NEUROSUR PS, V72, P144, DOI 10.1136/jnnp.72.2.144
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Servidei Serenella, 2004, Neuromuscul Disord, V14, P107
   Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042
   Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114
   Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smith PM, 2004, BBA-BIOENERGETICS, V1659, P232, DOI 10.1016/j.bbabio.2004.09.003
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   St John J, 2000, LANCET, V355, P200, DOI 10.1016/S0140-6736(99)03842-8
   Sutovsky P, 2004, REPROD BIOMED ONLINE, V8, P24, DOI 10.1016/S1472-6483(10)60495-6
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Tan EK, 2000, NEUROLOGY, V55, P533, DOI 10.1212/WNL.55.4.533
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349
   Tay SKH, 2004, ARCH NEUROL-CHICAGO, V61, P1935, DOI 10.1001/archneur.61.12.1935
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Torroja L, 1998, J CELL BIOL, V141, P1009, DOI 10.1083/jcb.141.4.1009
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   TRANEBJAERG L, 1995, J MED GENET, V32, P257, DOI 10.1136/jmg.32.4.257
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2002, ACTA NEUROL BELG, V102, P39
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   WALLACE DC, 1992, ANN NEUROL, V32, P113, DOI 10.1002/ana.410320123
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Yan SD, 1997, NATURE, V389, P689
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 139
TC 504
Z9 626
U1 0
U2 72
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 1
PY 2006
VL 368
IS 9529
BP 70
EP 82
DI 10.1016/S0140-6736(06)68970-8
PG 13
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 058TQ
UT WOS:000238687900032
PM 16815381
DA 2024-11-01
ER

PT J
AU Kowald, A
   Jendrach, M
   Pohl, S
   Bereiter-Hahn, J
   Hammerstein, P
AF Kowald, A
   Jendrach, M
   Pohl, S
   Bereiter-Hahn, J
   Hammerstein, P
TI On the relevance of mitochondrial fusions for the accumulation of
   mitochondrial deletion mutants: A modelling study
SO AGING CELL
LA English
DT Article
DE aging; computer simulations; free radicals; mitochondrial fusion;
   mitochondrial mutants
ID DNA MUTATIONS; MUSCLE-FIBERS; COPY NUMBER; HUMAN LIVER; HUMAN HEART;
   MTDNA; REPLICATION; FISSION; ORGANELLES; DISEASE
AB The molecular mechanisms underlying the aging process are still unclear, but the clonal accumulation of mitochondrial deletion mutants is one of the prime candidates. An important question for the mitochondrial theory of aging is to discover how defective organelles might be selected at the expense of wild-type mitochondria. We propose that mitochondrial fission and fusion events are of critical importance for resolving this apparent contradiction. We show that the occurrence of fusions removes the problems associated with the idea that smaller DNA molecules accumulate because they replicate in a shorter time - the survival of the tiny (SOT) hypothesis. Furthermore, stochastic simulations of mitochondrial replication, mutation and degradation show that two important experimental findings, namely the overall low mosaic pattern of oxidative phosphorylation (OXPHOS) impaired cells in old organisms and the distribution of deletion sizes, can be reproduced and explained by this hypothesis. Finally, we make predictions that can be tested experimentally to further verify our explanation for the age-related accumulation of mitochondrial deletion mutants.
C1 Max Planck Inst Mol Genet, Kinet Modeling Grp, D-14195 Berlin, Germany.
   Goethe Univ Frankfurt, Kinemat Cell Res Grp, D-6000 Frankfurt, Germany.
   Humboldt Univ, Inst Theoret Biol, Berlin, Germany.
C3 Max Planck Society; Goethe University Frankfurt; Humboldt University of
   Berlin
RP Max Planck Inst Mol Genet, Kinet Modeling Grp, Ihnestr 73, D-14195 Berlin, Germany.
EM kowald@molgen.mpg.de
OI Kowald, Axel/0000-0001-6448-4364
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101
   Berdanier CD, 2001, MUTAT RES-FUND MOL M, V475, P169, DOI 10.1016/S0027-5107(01)00068-9
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   de Grey ADJ., 1999, MITOCHONDRIAL FREE R
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Díez-Sánchez C, 2003, BIOL REPROD, V68, P180, DOI 10.1095/biolreprod.102.005140
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   KIRKWOOD TBL, 1992, ANN NY ACAD SCI, V663, P412, DOI 10.1111/j.1749-6632.1992.tb38685.x
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kowald A, 2000, J THEOR BIOL, V202, P145, DOI 10.1006/jtbi.1999.1046
   Kowald A., 1999, J ANTI-AGING MED, V2, P243
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Moraes CT, 1999, MOL BIOL CELL, V10, P3345, DOI 10.1091/mbc.10.10.3345
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233
   RAMSEY S, 2005, J BIOINF COMPUT BIOL, V3, P1
   Randerath Kurt, 1996, P198
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   SCHWARTZ RM, 1978, SCIENCE, V199, P395, DOI 10.1126/science.202030
   Shenkar R, 1996, AM J HUM GENET, V59, P772
   Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Yoon Y, 2001, CURR BIOL, V11, pR67, DOI 10.1016/S0960-9822(01)00011-2
NR 55
TC 31
Z9 32
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD OCT
PY 2005
VL 4
IS 5
BP 273
EP 283
DI 10.1111/j.1474-9726.2005.00169.x
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 964SE
UT WOS:000231900000005
PM 16164426
OA hybrid, Green Submitted
DA 2024-11-01
ER

PT J
AU Debray, FG
   Lambert, M
   Chevalier, I
   Robitaille, Y
   Decarie, JC
   Shoubridge, EA
   Robinson, BH
   Mitchell, GA
AF Debray, Francois-Guillaume
   Lambert, Marie
   Chevalier, Isabelle
   Robitaille, Yves
   Decarie, Jean-Claude
   Shoubridge, Eric A.
   Robinson, Brian H.
   Mitchell, Grant A.
TI Long-term outcome and clinical spectrum of 73 pediatric patients with
   mitochondrial diseases
SO PEDIATRICS
LA English
DT Article
DE mitochondrial diseases; long-term outcome; functional status
ID PYRUVATE-DEHYDROGENASE COMPLEX; RESPIRATORY-CHAIN DISORDERS; C-OXIDASE
   DEFICIENCY; OXIDATIVE-PHOSPHORYLATION; SKELETAL-MUSCLE; LACTIC-ACIDOSIS;
   CHILDREN; MUTATIONS; ELECTROPHORESIS; CARDIOMYOPATHY
AB OBJECTIVES. We sought to determine the clinical spectrum, survival, and long-term functional outcome of a cohort of pediatric patients with mitochondrial diseases and to identify prognostic factors.
   METHODS. Medical charts were reviewed for 73 children diagnosed between 1985 and 2005. The functional status of living patients was assessed prospectively by using the standardized Functional Independence Measure scales.
   RESULTS. Patients fell into 7 phenotypic categories: neonatal-onset lactic acidosis (10%), Leigh syndrome (18%), nonspecific encephalopathy (32%), mitochondrial (encephalo) myopathy (19%), intermittent neurologic (5%), visceral (11%), and Leber hereditary optic neuropathy (5%). Age at first symptoms ranged from prenatal to 16 years ( median: 7 months). Neurologic symptoms were the most common (90%). Visceral involvement was observed in 29% of the patients. A biochemical or molecular diagnosis was identified for 81% of the patients as follows: deficiency of complex IV (27%), of pyruvate dehydrogenase or complex I (25% each), of multiple complexes (13%), and of pyruvate carboxylase (5%) or complexes II + III (5%). A mitochondrial DNA mutation was found in 20% of patients. At present, 46% of patients have died (median age: 13 months), 80% of whom were < 3 years of age. Multivariate analysis showed that age at first symptoms was a major independent predictor of mortality: patients with first symptoms before 6 months had a highly increased risk of mortality. Cardiac or visceral involvement and neurologic crises were not independent prognostic factors. Living patients showed a wide range of independence levels that correlated positively with age at first symptoms. Among patients aged > 5 years (n = 32), 62% had Functional Independence Measure quotients of > 0.75.
   CONCLUSIONS. Mitochondrial diseases in children span a wide range of symptoms and severities. Age at first symptoms is the strongest predictor mortality. Despite a high mortality rate in the cohort, 62% of patients aged > 5 years have only mild impairment or normal functional outcome.
C1 Univ Montreal, CHU St Justine, Dept Pediat, Div Med Genet, Montreal, PQ H31 1C5, Canada.
   Univ Montreal, CHU St Justine, Dept Pediat, Div Pediat, Montreal, PQ H3C 3J7, Canada.
   Univ Montreal, CHU St Justine, Dept Pathol, Montreal, PQ H3C 3J7, Canada.
   Univ Montreal, CHU St Justine, Dept Med Imaging, Montreal, PQ H3C 3J7, Canada.
   McGill Univ, Montreal Neurol Inst, Dept Human Genet, Montreal, PQ H3A 2T5, Canada.
   Univ Toronto, Hosp Sick Children, Res Inst, Dept Pediat,Metab Res Program, Toronto, ON M5G 1X8, Canada.
   Univ Toronto, Hosp Sick Children, Res Inst, Dept Biochem,Metab Res Program, Toronto, ON M5G 1X8, Canada.
C3 Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine;
   Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine;
   Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine;
   Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine;
   McGill University; University of Toronto; Hospital for Sick Children
   (SickKids); University of Toronto; Hospital for Sick Children (SickKids)
RP Mitchell, GA (corresponding author), Univ Montreal, CHU St Justine, Dept Pediat, Div Med Genet, 3175 Cote St Catherine, Montreal, PQ H31 1C5, Canada.
EM mitchell@recherche-ste-justine.qc.ca
RI Robinson, B/LBH-2242-2024
CR [Anonymous], 1997, GUID UN DAT SET MED
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Applegarth DA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e10
   Berendzen K, 2006, MITOCHONDRION, V6, P126, DOI 10.1016/j.mito.2006.04.001
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   BROWN GK, 1988, EUR J PEDIATR, V147, P10, DOI 10.1007/BF00442603
   Brun N, 1999, AM J MED GENET, V84, P94, DOI 10.1002/(SICI)1096-8628(19990521)84:2<94::AID-AJMG3>3.0.CO;2-1
   Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386
   CHARIOT P, 1994, ARCH PATHOL LAB MED, V118, P695
   Chretien D, 2003, J INHERIT METAB DIS, V26, P189, DOI 10.1023/A:1024437201166
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Debray FG, 2006, EUR J PEDIATR, V165, P462, DOI 10.1007/s00431-006-0104-5
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Fouque F, 2003, PEDIATR RES, V53, P793, DOI 10.1203/01.PDR.0000057987.46622.64
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204
   Marin-Garcia J, 1999, PEDIATR NEUROL, V21, P538, DOI 10.1016/S0887-8994(99)00038-7
   McKenzie S, 2000, AM J PHYSIOL-ENDOC M, V278, pE580, DOI 10.1152/ajpendo.2000.278.4.E580
   MIYABAYASHI S, 1985, EUR J PEDIATR, V143, P278, DOI 10.1007/BF00442301
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORIN C, 1993, AM J HUM GENET, V53, P488
   MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Naito E, 1998, EUR J PEDIATR, V157, P648, DOI 10.1007/s004310050903
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Nissenkorn A, 2000, J CHILD NEUROL, V15, P44, DOI 10.1177/088307380001500110
   Nissenkorn A, 1999, ARCH DIS CHILD, V81, P209, DOI 10.1136/adc.81.3.209
   Ottenbacher KJ, 1996, DEV MED CHILD NEUROL, V38, P907
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Robinson B.H., 2001, METABOLIC MOL BASIS, VII, P2275
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   SHEU KFR, 1981, J CLIN INVEST, V67, P1463, DOI 10.1172/JCI110176
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Swaine BR, 2000, AM J PHYS MED REHAB, V79, P412, DOI 10.1097/00002060-200009000-00002
   Thorburn D R, 2000, Hum Reprod, V15 Suppl 2, P57
   Touati G, 1997, ARCH DIS CHILD, V76, P16, DOI 10.1136/adc.76.1.16
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   Wexler ID, 1997, NEUROLOGY, V49, P1655, DOI 10.1212/WNL.49.6.1655
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   Zeviani M, 1996, J INHERIT METAB DIS, V19, P504, DOI 10.1007/BF01799111
   ZUH Z, 1998, NAT GENET, V20, P337
NR 44
TC 124
Z9 132
U1 0
U2 4
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD APR
PY 2007
VL 119
IS 4
BP 722
EP 733
DI 10.1542/peds.2006-1866
PG 12
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 153BH
UT WOS:000245406200034
PM 17403843
DA 2024-11-01
ER

PT J
AU McKiernan, SH
   Tuen, VC
   Baldwin, K
   Wanagat, J
   Djamali, A
   Aiken, JM
AF McKiernan, Susan H.
   Tuen, Victoria C.
   Baldwin, Katherine
   Wanagat, Jonathan
   Djamali, Arjang
   Aiken, Judd M.
TI Adult-onset calorie restriction delays the accumulation of mitochondrial
   enzyme abnormalities in aging rat kidney tubular epithelial cells
SO AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
LA English
DT Article
DE dietary restriction; cytochrome c oxidase; mtDNA deletion mutations
ID DNA-DELETION MUTATIONS; SKELETAL-MUSCLE; GENE-EXPRESSION; GENOMIC
   DAMAGE; RENAL-FAILURE; DISEASE; NEPHROPATHY; PROGRESSION; PRODUCTS;
   FIBERS
AB Adult-onset calorie restriction (A-CR) is an experimental model of life extension and healthy aging less explored, compared with calorie restriction begun at early ages, but one more realistic for human application. We examined the effect of A-CR on the aging rat kidney with respect to common structural age-dependent changes and the accumulation of mitochondrial enzyme abnormalities in tubular epithelial cells. A 40% calorie restriction was initiated in middle-aged rats, before the onset of significant age-related changes in the Fischer x Brown Norway rat kidney. This dietary intervention effectively reduced glomerulosclerosis and tubular atrophy within 6 mo and changed the rate of interstitial fibrosis formation within 1 yr and vascular wall thickening and the expression cytochrome c oxidase (COX)-deficient tubular epithelial cells in 18 mo compared with age-matched ad libitum-fed rats. Our histological approach (histochemical staining for mitochondrial enzyme activity and laser capture microdissection) coupled with mitochondrial DNA (mtDNA) PCR analyses demonstrated that COX-deficient renal tubular epithelial cells accumulated mtDNA deletion mutations and that these cells contained unique, clonally expanded mtDNA deletion mutations. Renal tubular epithelial cells with mitochondrial abnormalities presented cellular characteristics indicative of physiological dysfunction.
C1 Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA.
   Univ Wisconsin, Dept Med, Madison, WI 53706 USA.
   Univ Washington, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA.
C3 University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison;
   University of Washington; University of Washington Seattle
RP McKiernan, SH (corresponding author), Univ Wisconsin, Dept Anim Hlth & Biomed Sci, 1656 Linden Dr, Madison, WI 53706 USA.
EM mckiernan@svm.vetmed.wisc.edu
RI Djamali, Arjang/AAG-4115-2020; Wanagat, Jonathan/B-2856-2009
OI Aiken, Judd/0000-0001-6119-4521; Wanagat, Jonathan/0000-0002-8460-8616
FU NIA NIH HHS [AG-17543, AG-11604] Funding Source: Medline; NIDDK NIH HHS
   [DK-067981] Funding Source: Medline
CR Alexeyev MF, 2004, CLIN SCI, V107, P355, DOI 10.1042/CS20040148
   ANDERSON S, 1986, AM J MED, V80, P435, DOI 10.1016/0002-9343(86)90718-7
   Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675
   BUA EA, IN PRESS FASEB J
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CHOUDHURY D, 2004, KIDNEY
   Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   DUBOWITZ V, 1985, HISTOLOGICAL HISTOCH
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Hard GC, 2004, TOXICOL PATHOL, V32, P171, DOI 10.1080/01926230490422574
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HERBST A, IN PRESS J GERON A
   Holthöfer H, 1999, FASEB J, V13, P523, DOI 10.1096/fasebj.13.3.523
   Hütter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011
   Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701
   JOHNSON BC, 1986, P NATL ACAD SCI USA, V83, P5659, DOI 10.1073/pnas.83.15.5659
   Julian D, 2004, AM J PHYSIOL-REG I, V286, pR20, DOI 10.1152/ajpregu.00522.2003
   Kakimoto M, 2002, DIABETES, V51, P1588, DOI 10.2337/diabetes.51.5.1588
   Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7
   Lane MA, 2004, J GERONTOL A-BIOL, V59, P405
   Lebrecht D, 2004, NEPHROL DIAL TRANSPL, V19, P329, DOI 10.1093/ndt/gfg564
   Lee JH, 2004, EXP GERONTOL, V39, P1361, DOI 10.1016/j.exger.2004.06.015
   Lim PS, 2000, FREE RADICAL BIO MED, V29, P454, DOI 10.1016/S0891-5849(00)00334-8
   Liu CS, 2001, NEPHROL DIAL TRANSPL, V16, P561, DOI 10.1093/ndt/16.3.561
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com
   Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006
   Martin William F, 2005, Nutr Metab (Lond), V2, P25, DOI 10.1186/1743-7075-2-25
   Masoro EJ, 2006, J GERONTOL A-BIOL, V61, P14, DOI 10.1093/gerona/61.1.14
   MCKIERNAN SH, IN PRESS FASEB J
   Nicoletti VG, 2005, NEUROCHEM RES, V30, P737, DOI 10.1007/s11064-005-6867-7
   PREISIG PA, 1995, SEMIN NEPHROL, V15, P327
   Rao GN, 2002, TOXICOL PATHOL, V30, P651, DOI 10.1080/01926230290166733
   Razzaque M S, 1999, Mol Cell Biol Res Commun, V1, P82, DOI 10.1006/mcbr.1999.0104
   Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699
   Ruiz-Torres MP, 1998, J AM SOC NEPHROL, V9, P782
   Sanders PW, 2006, CURR OPIN NEPHROL HY, V15, P54, DOI 10.1097/01.mnh.0000186853.23512.a5
   SAS, 1989, SAS US GUID
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Sheehan D.C., 1980, Theory and Practice of Histotechnology, Vsecond
   Solin ML, 2000, LAB INVEST, V80, P1227, DOI 10.1038/labinvest.3780130
   Stern JS, 2001, J NUTR, V131, p913S, DOI 10.1093/jn/131.3.913S
   Stopper H, 2005, J RENAL NUTR, V15, P81, DOI 10.1053/j.jrn.2004.09.017
   Stopper H, 2004, SEMIN NEPHROL, V24, P474, DOI 10.1016/j.semnephrol.2004.06.025
   Takaki A, 2004, ANN NY ACAD SCI, V1011, P332, DOI 10.1196/annals.1293.033
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   VANLIEW JB, 1992, AM J PHYSIOL, V263, pF554, DOI 10.1152/ajprenal.1992.263.3.F554
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   WEINDRUCH R, 1988, RETARDATION AGING DI, P73
   Yamagata K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019772.17954.F8
   Yowe DL, 1998, GENE, V209, P23, DOI 10.1016/S0378-1119(97)00628-8
NR 53
TC 51
Z9 51
U1 0
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1931-857X
EI 1522-1466
J9 AM J PHYSIOL-RENAL
JI Am. J. Physiol.-Renal Physiol.
PD JUN
PY 2007
VL 292
IS 6
BP F1751
EP F1760
DI 10.1152/ajprenal.00307.2006
PG 10
WC Physiology; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Urology & Nephrology
GA 188TK
UT WOS:000247942000011
PM 17344189
DA 2024-11-01
ER

PT J
AU Sissler, M
   González-Serrano, LE
   Westhof, E
AF Sissler, Marie
   Gonzalez-Serrano, Ligia Elena
   Westhof, Eric
TI Recent Advances in Mitochondrial Aminoacyl-tRNA Synthetases and Disease
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Review
ID SPINAL-CORD INVOLVEMENT; UNFOLDED PROTEIN RESPONSE; LACTATE ELEVATION;
   BRAIN-STEM; MUTATION; TRANSLATION; DNA; GENE; LEUKOENCEPHALOPATHY;
   MYOPATHY
AB Dysfunctions in mitochondria - the powerhouses of the cell - lead to several human pathologies. Because mitochondria integrate nuclear and mitochondrial genetic systems, they are richly intertwined with cellular activities. The nucleus-encoded mitochondrial aminoacyl-tRNA synthetases (mt-aaRSs) are key components of the mitochondrial translation apparatus. Mutations in these enzymes predominantly affect the central nervous system (CNS) but also target other organs. Comparable mutations in mt-aaRSs can lead to vastly diverse diseases, occurring at different stages in life, and within different tissues; this represents a confounding issue. With newer information available, we propose that the pleiotropy and tissue-specificity of mt-aaRS-associated diseases result from the molecular integration of mitochondrial translation events within the cell; namely, through specific crosstalk between the cellular program and the energy demands of the cell. We place particular focus on neuronal cells.
C1 [Sissler, Marie; Gonzalez-Serrano, Ligia Elena; Westhof, Eric] Univ Strasbourg, CNRS, Unite Propre Rech 9002, Architecture & Reactivite ARN, F-67084 Strasbourg, France.
C3 Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); Universites de Strasbourg Etablissements
   Associes; Universite de Strasbourg
RP Sissler, M (corresponding author), Univ Strasbourg, CNRS, Unite Propre Rech 9002, Architecture & Reactivite ARN, F-67084 Strasbourg, France.
EM m.sissler@ibmc-cnrs.unistra.fr
OI Gonzalez Serrano, Ligia Elena/0009-0009-6360-1149; SISSLER,
   Marie/0000-0001-8594-5238
FU CNRS; Universite de Strasbourg (UNISTRA); French National Program
   Investissement d'Avenir (Labex MitoCross and Labex NetRNA)
   [ANR-11-LABX-0057_MITOCROSS, ANR-10-LABX-0036_NETRNA]; LabEx MitoCross
FX This work was supported by the CNRS, the Universite de Strasbourg
   (UNISTRA), and by the French National Program Investissement d'Avenir
   (Labex MitoCross and Labex NetRNA) administered by the Agence National
   de la Recherche (ref. ANR-11-LABX-0057_MITOCROSS and
   ANR-10-LABX-0036_NETRNA). L.E.G-S. was supported by LabEx MitoCross.
CR Alexander RW, 2001, PROG NUCLEIC ACID RE, V69, P317, DOI 10.1016/S0079-6603(01)69050-0
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016
   Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099
   Carapito C, 2017, METHODS, V113, P111, DOI 10.1016/j.ymeth.2016.10.012
   Castellana S, 2011, GENOME BIOL EVOL, V3, P1067, DOI 10.1093/gbe/evr040
   Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Christian BE, 2012, BBA-GENE REGUL MECH, V1819, P1035, DOI 10.1016/j.bbagrm.2011.11.009
   CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0
   Delano W.L., 2002, PROTEINS STRUCT FUNC, V30, P442
   DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007
   Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Echevarría L, 2014, BIOCHEM J, V460, P91, DOI 10.1042/BJ20131107
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Engelhard J, 2011, FREE RADICAL BIO MED, V50, P1234, DOI 10.1016/j.freeradbiomed.2011.01.035
   ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Giegé R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017
   Giegé R, 2006, J BIOSCIENCES, V31, P477, DOI 10.1007/BF02705187
   Godin JD, 2016, TRENDS NEUROSCI, V39, P394, DOI 10.1016/j.tins.2016.04.002
   Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956
   Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064
   Hällberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001
   Han JM, 2008, P NATL ACAD SCI USA, V105, P11206, DOI 10.1073/pnas.0800297105
   Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044
   Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498
   Jovaisaite V, 2015, CURR OPIN CELL BIOL, V33, P74, DOI 10.1016/j.ceb.2014.12.003
   Karadimas C, 2001, J CHILD NEUROL, V16, P531, DOI 10.1177/088307380101600715
   Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124
   Klipcan L, 2008, STRUCTURE, V16, P1095, DOI 10.1016/j.str.2008.03.020
   Klipcan L, 2012, J MOL BIOL, V415, P527, DOI 10.1016/j.jmb.2011.11.029
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096
   Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943
   Messmer M, 2011, BIOCHEM J, V433, P441, DOI 10.1042/BJ20101902
   Monaghan RM, 2015, TRENDS BIOCHEM SCI, V40, P728, DOI 10.1016/j.tibs.2015.10.003
   Moulinier L., 2017, HUM MUTAT
   Mudge SJ, 1998, GENE, V209, P45, DOI 10.1016/S0378-1119(98)00007-9
   Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Nouws J, 2016, J BIOL CHEM, V291, P989, DOI 10.1074/jbc.M115.689299
   Oprescu SN, 2017, METHODS, V113, P139, DOI 10.1016/j.ymeth.2016.11.013
   Pearce S, 2013, MOL CELL NEUROSCI, V55, P1, DOI 10.1016/j.mcn.2012.08.013
   Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487
   Quirós PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Rath VL, 1998, STRUCT FOLD DES, V6, P439, DOI 10.1016/S0969-2126(98)00046-X
   Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003
   Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Santamaría-Gómez J, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmcb.2016.00857, 10.3389/fmicb.2016.00857]
   Sauter C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17332
   Scheffler IE, 2001, MITOCHONDRION, V1, P3, DOI 10.1016/S1567-7249(00)00002-7
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schwenzer H, 2014, TOP CURR CHEM, V344, P247, DOI 10.1007/128_2013_457
   Schwenzer H, 2014, BIOCHIMIE, V100, P18, DOI 10.1016/j.biochi.2013.09.027
   Scuderi C, 2007, NEUROMUSCULAR DISORD, V17, P258, DOI 10.1016/j.nmd.2006.11.006
   Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854
   Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123
   SHIBA K, 1994, J BIOL CHEM, V269, P30049
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Storkebaum E, 2016, BIOESSAYS, V38, P818, DOI 10.1002/bies.201600052
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200
   van Berge L, 2014, BRAIN, V137, P1019, DOI 10.1093/brain/awu026
   van Berge L, 2013, BIOCHEM J, V450, P345, DOI 10.1042/BJ20121564
   van Berge L, 2012, BIOCHEM J, V441, P955, DOI 10.1042/BJ20110795
   Wallace DC, 2016, NATURE, V535, P498, DOI 10.1038/nature18902
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wang M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12061
   Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041
   Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373
   ZEVIANI M, 1989, NEUROL CLIN, V7, P123, DOI 10.1016/S0733-8619(18)30832-6
NR 83
TC 131
Z9 148
U1 2
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD AUG
PY 2017
VL 23
IS 8
BP 693
EP 708
DI 10.1016/j.molmed.2017.06.002
PG 16
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA FC0QZ
UT WOS:000406545100004
PM 28716624
OA hybrid
DA 2024-11-01
ER

PT J
AU Gokey, NG
   Cao, ZJ
   Pak, JW
   Lee, D
   McKiernan, SH
   McKenzie, D
   Weindruch, R
   Aiken, JM
AF Gokey, NG
   Cao, ZJ
   Pak, JW
   Lee, D
   McKiernan, SH
   McKenzie, D
   Weindruch, R
   Aiken, JM
TI Molecular analyses of mtDNA deletion mutations in microdissected
   skeletal muscle fibers from aged rhesus monkeys
SO AGING CELL
LA English
DT Article
DE aging; mtDNA; rhesus monkey; skeletal muscle
ID MITOCHONDRIAL-DNA DELETIONS; CYTOCHROME-C-OXIDASE; HUMAN TISSUES;
   ABNORMALITIES; MULTIPLE; ASSOCIATION; ATROPHY; DISEASE; DAMAGE; HEART
AB Mitochondrial DNA (mtDNA) deletion mutations colocalize with electron transport system (ETS) abnormalities in rhesus monkey skeletal muscle fibers. Using laser capture microdissection in conjunction with PCR and DNA sequence analysis, mitochondrial genomes from single sections of ETS abnormal fibers were characterized. All ETS abnormal fibers contained mtDNA deletion mutations. Deletions were large, removing 20-78% of the genome, with some to nearly all of the functional genes lost. In one-third of the deleted genomes, the light strand origin was deleted, whereas the heavy strand origin of replication was conserved in all fibers. A majority (27/39) of the deletion mutations had direct repeat sequences at their breakpoints and most (36/39) had one breakpoint within or in close proximity to the cytochrome b gene. Several pieces of evidence support the clonality of the mtDNA deletion mutation within an ETS abnormal region of a fiber: (a) only single, smaller than wild-type, PCR products were obtained from each ETS abnormal region; (b) the amplification of mtDNA from two regions of the same ETS abnormal fiber identified identical deletion mutations, and (c) a polymorphism was observed at nucleotide position 16103 (A and G) in the wild-type mtDNA of one animal (sequence analysis of an ETS abnormal region revealed that mtDNA deletion mutations contained only A or G at this position). Species-specific differences in the regions of the genomes lost as well as the presence of direct repeat sequences at the breakpoints suggest mechanistic differences in deletion mutation formation between rodents and primates.
C1 Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA.
C3 University of Wisconsin System; University of Wisconsin Madison
RP 1656 Linden Dr, Madison, WI 53706 USA.
EM aiken@svm.vetmed.wisc.edu
RI ; McKenzie, Debbie/G-4459-2015
OI Aiken, Judd/0000-0001-6119-4521; McKenzie, Debbie/0000-0002-9291-6977
FU NCRR NIH HHS [5P51 RR 000167] Funding Source: Medline; NIA NIH HHS [P01
   AG11915, R01 AG11604] Funding Source: Medline
CR Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Dubowitz V., 1985, Muscle Biopsy-A Practical Approach, VSecond, P19
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   LEE CM, 1993, J GERONTOL, V48, pB201, DOI 10.1093/geronj/48.6.B201
   LEE CM, 1994, MECH AGEING DEV, V75, P69, DOI 10.1016/0047-6374(94)90029-9
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   VanTuyle GC, 1996, MUTAT RES-FUND MOL M, V349, P95, DOI 10.1016/0027-5107(95)00165-4
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
NR 23
TC 74
Z9 81
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9726
J9 AGING CELL
JI Aging Cell
PD OCT
PY 2004
VL 3
IS 5
BP 319
EP 326
DI 10.1111/j.1474-9728.2004.00122.x
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 860FO
UT WOS:000224328100011
PM 15379855
OA hybrid
DA 2024-11-01
ER

PT J
AU Kauppila, TES
   Kauppila, JHK
   Larsson, NG
AF Kauppila, Timo E. S.
   Kauppila, Johanna H. K.
   Larsson, Nils-Goeran
TI Mammalian Mitochondria and Aging: An Update
SO CELL METABOLISM
LA English
DT Review
ID DNA-DELETION MUTATIONS; SOMATIC MTDNA MUTATIONS; HUMAN SKELETAL-MUSCLE;
   OXIDATIVE DAMAGE; MOUSE MODEL; POLYMERASE-GAMMA; POINT MUTATIONS;
   LIFE-SPAN; DEOXYRIBONUCLEIC-ACID; PROTEIN ACETYLATION
AB Mitochondria were first postulated to contribute to aging more than 40 years ago. During the following decades, multiple lines of evidence in model organisms and humans showed that impaired mitochondrial function can contribute to age-associated disease phenotypes and aging. However, in contrast to the original theory favoring oxidative damage as a cause for mtDNA mutations, there are now strong data arguing that most mammalian mtDNA mutations originate as replication errors made by the mtDNA polymerase. Currently, a substantial amount of mitochondrial research is focused on finding ways to either remove or counteract the effects of mtDNA mutations with the hope of extending the human health-and lifespan. This review summarizes the current knowledge regarding the formation of mtDNA mutations and their impact on mitochondrial function. We also critically discuss proposed pathways interlinked withmammalian mtDNA mutations and suggest future research strategies to elucidate the role of mtDNA mutations in aging.
C1 [Kauppila, Timo E. S.; Kauppila, Johanna H. K.; Larsson, Nils-Goeran] Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany.
   [Larsson, Nils-Goeran] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
C3 Max Planck Society; Karolinska Institutet
RP Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany.; Larsson, NG (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
EM larsson@age.mpg.de
RI Larsson, Nils-Göran/GVS-5578-2022
OI Larsson, Nils-Goran/0000-0001-5100-996X
FU Max Planck Society; Swedish Research Council [2015-00418]; Knut and
   Alice Wallenberg Foundation; Swedish Research Council [2015-00418]
   Funding Source: Swedish Research Council
FX N.-G.L. receives support from the Max Planck Society, the Swedish
   Research Council (2015-00418), and the Knut and Alice Wallenberg
   Foundation.
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Alavi MV, 2009, EXP NEUROL, V220, P404, DOI 10.1016/j.expneurol.2009.09.026
   Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   [Anonymous], 2017, CELL METABOLISM
   Anson RM, 1999, FREE RADICAL BIO MED, V27, P456, DOI 10.1016/S0891-5849(99)00091-X
   ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198
   Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054
   Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barreau E, 1996, INVEST OPHTH VIS SCI, V37, P384
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bratic A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9808
   Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6
   Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490
   Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177
   Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Ciron C, 2012, HUM MOL GENET, V21, P1861, DOI 10.1093/hmg/ddr618
   CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349
   Cochemé HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003
   Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677
   Dumont M, 2014, FASEB J, V28, P1745, DOI 10.1096/fj.13-236331
   DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Escobar-Henriques M, 2014, EMBO REP, V15, P231, DOI 10.1002/embr.201338225
   Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fedorowicz MA, 2014, EMBO REP, V15, P86, DOI 10.1002/embr.201337294
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109
   Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   Gedik CM, 2005, FASEB J, V19, P82, DOI 10.1096/fj.04-1767fje
   Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gram M, 2015, J PHYSIOL-LONDON, V593, P4011, DOI 10.1113/JP270211
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003082
   Guaraldi G, 2009, CLIN INFECT DIS, V49, P1756, DOI 10.1086/648080
   HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y
   HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6
   Halsne R, 2012, DNA REPAIR, V11, P278, DOI 10.1016/j.dnarep.2011.12.001
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200
   Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914
   Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659
   Kao SH, 1998, MOL HUM REPROD, V4, P657, DOI 10.1093/molehr/4.7.657
   KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   KITAGAWA T, 1993, BIOL REPROD, V49, P730, DOI 10.1095/biolreprod49.4.730
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2013, TRENDS CELL BIOL, V23, P457, DOI 10.1016/j.tcb.2013.04.009
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lei XG, 2016, PHYSIOL REV, V96, P307, DOI 10.1152/physrev.00010.2014
   Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007
   Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lewis KN, 2013, ANTIOXID REDOX SIGN, V19, P1388, DOI 10.1089/ars.2012.4911
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919
   Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Miller BF, 2012, AGING CELL, V11, P150, DOI 10.1111/j.1474-9726.2011.00769.x
   Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034
   Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161
   Mortensen M, 2010, CELL CYCLE, V9, P1901, DOI 10.4161/cc.9.10.11603
   Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   NOVIKOFF ALEX B., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P179, DOI 10.1083/jcb.2.4.179
   Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004
   Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169
   Padman BS, 2013, AUTOPHAGY, V9, P1862, DOI 10.4161/auto.26557
   Parihar P, 2015, EXP GERONTOL, V61, P130, DOI 10.1016/j.exger.2014.12.004
   Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pereira L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-53
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231
   Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Roberts LJ, 2001, BIOCHEM BIOPH RES CO, V287, P254, DOI 10.1006/bbrc.2001.5583
   Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429
   Ross JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023
   Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005
   SAKUMI K, 1993, J BIOL CHEM, V268, P23524
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x
   Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118
   Seiferling D, 2016, EMBO REP, V17, P953, DOI 10.15252/embr.201642077
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Slupska MM, 1999, J BACTERIOL, V181, P6210, DOI 10.1128/JB.181.19.6210-6213.1999
   Sohl CD, 2015, P NATL ACAD SCI USA, V112, P8596, DOI 10.1073/pnas.1421733112
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stewart JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005333
   Stewart JB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004670
   Stojkovic G, 2016, SCI REP-UK, V6, DOI 10.1038/srep28942
   Stram AR, 2016, CELL MOL LIFE SCI, V73, P4063, DOI 10.1007/s00018-016-2280-4
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Takao M, 1999, NUCLEIC ACIDS RES, V27, P3638, DOI 10.1093/nar/27.18.3638
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Vaitkus JA, 2015, INT J MOL SCI, V16, P16158, DOI 10.3390/ijms160716158
   Vassilopoulos A, 2014, ANTIOXID REDOX SIGN, V21, P551, DOI 10.1089/ars.2013.5420
   Velarde Michael C, 2014, Longev Healthspan, V3, P2, DOI 10.1186/2046-2395-3-2
   Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003
   Villena JA, 2015, FEBS J, V282, P647, DOI 10.1111/febs.13175
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Weinert BT, 2015, EMBO J, V34, P2620, DOI 10.15252/embj.201591271
   Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766
   Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902
   WEISIGER RA, 1973, J BIOL CHEM, V248, P4793
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206
   Yu-Wai-Man P, 2009, INVEST OPHTH VIS SCI, V50, P4561, DOI 10.1167/iovs.09-3634
   Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008
   Zhao W, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-51
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 220
TC 418
Z9 460
U1 6
U2 183
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD JAN 10
PY 2017
VL 25
IS 1
BP 57
EP 71
DI 10.1016/j.cmet.2016.09.017
PG 15
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Cell Biology; Endocrinology & Metabolism
GA EI9RC
UT WOS:000392845500009
PM 28094012
OA Bronze
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Goldstein, A
   Wolfe, LA
AF Goldstein, Amy
   Wolfe, Lynne A.
TI The Elusive Magic Pill: Finding Effective Therapies for Mitochondrial
   Disorders
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Mitochondria; ATP; mtDNA; nDNA; Respiratory chain; OXPHOS
ID FATTY-ACID OXIDATION; LIPOIC ACID; EXERCISE; METABOLISM; DISEASE; DNA;
   DICHLOROACETATE; PHOSPHORYLATION; MUTATIONS; MYOPATHY
AB The incidence of mitochondrial diseases has been estimated at 11.5/100,000 (1:8500) worldwide. In the USA up to 4000 newborns annually are expected to develop a mitochondrial disease. More than 50 million adults in the USA also suffer from diseases in which primary or secondary mitochondrial dysfunction is involved. Mitochondrial dysfunction has been identified in cancer, infertility, diabetes, heart diseases, blindness, deafness, kidney disease, liver disease, stroke, migraine, dwarfism, and resulting from numerous medication toxicities. Mitochondrial dysfunction is also involved in normal aging and age-related neurodegenerative diseases, such as Parkinson and Alzheimer diseases. Yet most treatments available are based on empiric data and clinician experience because of the lack of randomized controlled clinical trials to provide evidence-based treatments for these disorders. Here we explore the current state of research for the treatment of mitochondrial disorders.
C1 [Goldstein, Amy] UPMC, Childrens Hosp Pittsburgh, Div Child Neurol, Pittsburgh, PA USA.
   [Wolfe, Lynne A.] NIH, Undiagnosed Dis Program, Bethesda, MD 20892 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; National Institutes of Health (NIH) - USA
RP Wolfe, LA (corresponding author), NIH, Undiagnosed Dis Program, 10 Ctr DR,MSC 1205,RM 3-2551, Bethesda, MD 20892 USA.
EM lynne.wolfe@nih.gov
CR Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281
   Alavian KN, 2012, BRAIN RES, V1446, P1, DOI 10.1016/j.brainres.2012.01.046
   Bastin J, 2011, HUM MOL GENET, V20, P2048, DOI 10.1093/hmg/ddr089
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   Duncan GE, 2004, J CLIN ENDOCR METAB, V89, P1733, DOI 10.1210/jc.2003-031684
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Enns GM, 2000, J PEDIAT, V136, P1
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200
   Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koene S., 2011, MITOCHONDRIAL MED CL
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Kossoff EH, 2009, J CHILD NEUROL, V24, P979, DOI 10.1177/0883073809337162
   Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   Matsubara K, 2008, INT J MOL MED, V22, P381, DOI 10.3892/ijmm_00000034
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Nasser M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006659.pub3
   Packer L, 2011, J CLIN BIOCHEM NUTR, V48, P26, DOI 10.3164/jcbn.11-005FR
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Sadun AA, 2012, ARCH NEUROL-CHICAGO, V69, P331, DOI 10.1001/archneurol.2011.2972
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x
   Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493
   Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
NR 44
TC 11
Z9 14
U1 0
U2 23
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1933-7213
EI 1878-7479
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD APR
PY 2013
VL 10
IS 2
BP 320
EP 328
DI 10.1007/s13311-012-0175-0
PG 9
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 127EC
UT WOS:000317677900012
PM 23355364
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Wanrooij, S
   Falkenberg, M
AF Wanrooij, Sjoerd
   Falkenberg, Maria
TI The human mitochondrial replication fork in health and disease
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Review
DE mtDNA; DNA replication; Mitochondria; POLRMT; Twinkle; Mitochondrial
   disease
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ONSET
   SPINOCEREBELLAR ATAXIA; TRANSCRIPTION FACTOR-A; DOUBLE-STRAND BREAKS;
   MOUSE L-CELLS; STRUCTURE-FUNCTION DEFECTS; MULTIPLE MTDNA DELETIONS;
   TWINKLE LINKER REGION; RIBOSOMAL-RNA GENES
AB Mitochondria are organelles whose main function is to generate power by oxidative phosphorylation. Some of the essential genes required for this energy production are encoded by the mitochondrial genome, a small circular double stranded DNA molecule. Human mtDNA is replicated by a specialized machinery distinct from the nuclear replisome. Defects in the mitochondrial replication machinery can lead to loss of genetic information by deletion and/or depletion of the mtDNA, which subsequently may cause disturbed oxidative phosphorylation and neuromuscular symptoms in patients. We discuss here the different components of the mitochondrial replication machinery and their role in disease. We also review the mode of mammalian mtDNA replication. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wanrooij, Sjoerd; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.
   [Falkenberg, Maria] Max Planck Inst Biol Alters, D-50931 Cologne, Germany.
C3 University of Gothenburg; Max Planck Society
RP Wanrooij, S (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.
EM sjoerd.wanrooij@medkem.gu.se
RI Wanrooij, Sjoerd/J-1367-2019
OI Wanrooij, Sjoerd/0000-0001-6126-4382; Falkenberg,
   Maria/0000-0001-8713-173X
FU Swedish Research Council
FX We would like to thank Claes Gustafsson, Per Elias, Javier Miralles
   Fuste, Paulina Wanrooij and Stefan Backstrom for their useful comments
   on the manuscript. SW is supported by the Swedish Research Council.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   AHOLAERKKILA S, 2010, HUM MOL GENET
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ARNBERG A, 1971, BIOCHIM BIOPHYS ACTA, V246, P353, DOI 10.1016/0005-2787(71)90147-X
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003
   BARAT M, 1985, EXP CELL RES, V157, P207, DOI 10.1016/0014-4827(85)90163-6
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181
   Boehmer PE, 2003, IUBMB LIFE, V55, P13, DOI 10.1080/1521654031000070645
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8
   Bohlega S, 2009, NEUROMUSCULAR DISORD, V19, P845, DOI 10.1016/j.nmd.2009.10.002
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8
   BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X
   Brewer LR, 2003, BIOPHYS J, V85, P2519, DOI 10.1016/S0006-3495(03)74674-8
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Brown TA, 2006, CELL CYCLE, V5, P917, DOI 10.4161/cc.5.9.2710
   Brown TA, 2008, J BIOL CHEM, V283, P36743, DOI 10.1074/jbc.M806174200
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   CHANG DD, 1985, EMBO J, V4, P1559, DOI 10.1002/j.1460-2075.1985.tb03817.x
   CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451
   Clayton DA, 2000, EXP CELL RES, V255, P4, DOI 10.1006/excr.1999.4763
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Conaway JW, 1999, ANNU REV BIOCHEM, V68, P301, DOI 10.1146/annurev.biochem.68.1.301
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144
   CREWS S, 1979, NATURE, V277, P192, DOI 10.1038/277192a0
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Duggin IG, 2009, J MOL BIOL, V387, P532, DOI 10.1016/j.jmb.2009.02.027
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   ERIKSSON S, 1984, J BIOL CHEM, V259, P1695
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   FISHER RP, 1992, J BIOL CHEM, V267, P3358
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Friddle RW, 2004, BIOPHYS J, V86, P1632, DOI 10.1016/S0006-3495(04)74231-9
   FUCHS E, 1971, FEBS LETT, V19, P159, DOI 10.1016/0014-5793(71)80503-3
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Futami K, 2007, BIOL PHARM BULL, V30, P1685, DOI 10.1248/bpb.30.1685
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   GENGA A, 1986, J BIOL CHEM, V261, P9328
   GENUARIO R, 1993, CELL MOL BIOL RES, V39, P625
   GILLUM AM, 1978, P NATL ACAD SCI USA, V75, P677, DOI 10.1073/pnas.75.2.677
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   GREENLEAF AL, 1986, P NATL ACAD SCI USA, V83, P3391, DOI 10.1073/pnas.83.10.3391
   GROSSMAN LI, 1973, P NATL ACAD SCI USA, V70, P3339, DOI 10.1073/pnas.70.12.3339
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233
   Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275
   Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KELLY JL, 1986, J BIOL CHEM, V261, P348
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Krasilnikov AS, 1997, NUCLEIC ACIDS RES, V25, P1339, DOI 10.1093/nar/25.7.1339
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X
   Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198
   LANDES T, 2010, SEMIN CELL DEV BIOL
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lee DY, 1997, GENE DEV, V11, P582, DOI 10.1101/gad.11.5.582
   Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Li K, 1997, J BIOL CHEM, V272, P8686, DOI 10.1074/jbc.272.13.8686
   Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   LITTLE RD, 1993, MOL CELL BIOL, V13, P6600, DOI 10.1128/MCB.13.10.6600
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   MADSEN CS, 1993, MOL CELL BIOL, V13, P2162, DOI 10.1128/MCB.13.4.2162
   MARTENS PA, 1979, J MOL BIOL, V135, P327, DOI 10.1016/0022-2836(79)90440-6
   MASUKATA H, 1990, CELL, V62, P331, DOI 10.1016/0092-8674(90)90370-T
   Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430
   MIGNOTTE B, 1988, EUR J BIOCHEM, V174, P479, DOI 10.1111/j.1432-1033.1988.tb14123.x
   Mikhailov VS, 1996, J BIOL CHEM, V271, P30774, DOI 10.1074/jbc.271.48.30774
   Milone M, 2009, MITOCHONDRION, V9, P279, DOI 10.1016/j.mito.2009.03.001
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nossal NG, 2001, MOL CELL, V7, P31, DOI 10.1016/S1097-2765(01)00152-6
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115
   Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schvartzman JB, 2010, PLASMID, V63, P1, DOI 10.1016/j.plasmid.2009.11.001
   Seligmann H, 2008, J MOL BIOL, V379, P188, DOI 10.1016/j.jmb.2008.03.066
   Seligmann H, 2006, J THEOR BIOL, V241, P321, DOI 10.1016/j.jtbi.2005.11.035
   Seligmann H, 2010, BIOSYSTEMS, V99, P85, DOI 10.1016/j.biosystems.2009.09.003
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   STONINGT.OG, 1971, P NATL ACAD SCI USA, V68, P6, DOI 10.1073/pnas.68.1.6
   STUMPF JD, 2010, HUM MOL GENET
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, LANCET, V340, P1319, DOI 10.1016/0140-6736(92)92496-3
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   TERSCHEGGET J, 1971, BIOCHIM BIOPHYS ACTA, V254, P1
   THOMMES P, 1995, J BIOL CHEM, V270, P21137, DOI 10.1074/jbc.270.36.21137
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   TIRANTI V, 1991, NUCLEIC ACIDS RES, V19, P4291, DOI 10.1093/nar/19.15.4291
   TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I
   Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   TSURUMI T, 1990, J VIROL, V64, P450, DOI 10.1128/JVI.64.1.450-452.1990
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105
   Wang YH, 1999, P NATL ACAD SCI USA, V96, P8046, DOI 10.1073/pnas.96.14.8046
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Webb MR, 2007, J BIOL CHEM, V282, P34401, DOI 10.1074/jbc.M705913200
   Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200
   White DJ, 2009, MOL BIOL EVOL, V26, P1435, DOI 10.1093/molbev/msp073
   WONG TW, 1986, CELL, V45, P817, DOI 10.1016/0092-8674(86)90556-8
   WONG TW, 1985, J BIOL CHEM, V260, P1530
   WONG TW, 1985, CELL, V42, P951, DOI 10.1016/0092-8674(85)90291-0
   Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843
   Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606
NR 193
TC 87
Z9 102
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD AUG
PY 2010
VL 1797
IS 8
BP 1378
EP 1388
DI 10.1016/j.bbabio.2010.04.015
PG 11
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 625IM
UT WOS:000279888700004
PM 20417176
OA Bronze
DA 2024-11-01
ER

PT J
AU Thomas, M
   Salpietro, V
   Canham, N
   Ruggieri, M
   Phadke, R
   Kinali, M
AF Thomas, Mark
   Salpietro, Vincenzo
   Canham, Natalie
   Ruggieri, Martino
   Phadke, Rahul
   Kinali, Maria
TI Mitochondria DNA Depletion Syndrome in a Infant with Multiple Congenital
   Malformations, Severe Myopathy, and Prolonged Postoperative Paralysis
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mitochondrial depletion syndrome; congenital malformation; anaesthesia;
   curare; VACTERL
ID RESPIRATORY-CHAIN DEFICIENCY; MTDNA DEPLETION; VATER ASSOCIATION;
   ANESTHESIA; DISORDERS; DEFECTS; KINASE
AB Mitochondrial DNA depletion syndromes are an important cause of mitochondrial cytopathies in both children and adults. We describe a newborn with multiple congenital malformations including a right aberrant subclavian artery and a trachea-oesophageal fistula in whom mitochondrial depletion syndrome was unmasked by perioperative muscle relaxation. After vecuronium infusion, the infant developed an irreversible postoperative paralysis, leading to death 32 days after surgery. The present case highlights (a) the clinical heterogeneity of mitochondrial depletion syndrome; (b) the importance of rigorous antemortem and postmortem investigations when the cause of a severe myopathy is uncertain; (c) the possible coexistence of mitochondrial depletion syndrome and congenital malformations as a result of a likely abnormal antenatal embryofetal development and (d) the importance of a careful anaesthetic management of children with mitochondrial depletion syndrome, which could be prone to complications related to the possible depressive effects on mitochondrial electron transport chain mediated by some anaesthetic agents.
C1 [Thomas, Mark] Chelsea & Westminster Hosp NHS Fdn Trust, Dept Neonatal Med, London SW10 9NH, England.
   [Salpietro, Vincenzo; Kinali, Maria] Chelsea & Westminster Hosp NHS Fdn Trust, Dept Paediat Neurol, London SW10 9NH, England.
   [Salpietro, Vincenzo] Univ Messina, Dept Pediat, Messina, Italy.
   [Canham, Natalie] Northwick Pk Hosp & Clin Res Ctr, North West London Hosp NHS Trust, North West Thames Reg Genet Serv, Kennedy Galton Ctr, London, England.
   [Ruggieri, Martino] Univ Catania, Dept Educ Sci, Catania, Italy.
   [Phadke, Rahul] UCLH, Dubowitz Neuromuscular Ctr, London, England.
C3 Imperial College London; Imperial College London; University of Messina;
   Imperial College London; University of Catania; University College
   London Hospitals NHS Foundation Trust; University of London; University
   College London
RP Thomas, M (corresponding author), Chelsea & Westminster Hosp NHS Fdn Trust, Dept Neonatal Med, 369 Fulham Rd, London SW10 9NH, England.
EM mark.thomas@chelwest.nhs.uk
RI Ruggieri, Martino/A-3055-2014; Salpietro, Vincenzo/AAA-8706-2020;
   Phadke, Rahul/U-6960-2019
OI Salpietro, Vincenzo/0000-0003-0132-7921; Ruggieri,
   Martino/0000-0002-2658-4249
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   [Anonymous], 2013, MUSCLE BIOPSY PRACTI
   Damian MS, 1996, AM J MED GENET, V62, P398, DOI 10.1002/(SICI)1096-8628(19960424)62:4<398::AID-AJMG13>3.0.CO;2-J
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   Finsterer J, 1998, CAN J ANAESTH, V45, P781, DOI 10.1007/BF03012149
   Footitt EJ, 2008, BRIT J ANAESTH, V100, P436, DOI 10.1093/bja/aen014
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   KOCH JH, 1960, BIOCHEM PHARMACOL, V3, P231, DOI 10.1016/0006-2952(60)90111-8
   Lee IC, 2013, J CHILD NEUROL, V28, P404, DOI 10.1177/0883073812469722
   LU C, 1994, CLIN CARDIOL, V17, P503, DOI 10.1002/clc.4960170909
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Rafique MB, 2013, J ANESTH, V27, P186, DOI 10.1007/s00540-012-1488-1
   Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Thauvin-Robinet C, 2006, EUR J MED GENET, V49, P71, DOI 10.1016/j.ejmg.2005.04.001
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   WIESEL S, 1991, ANESTH ANALG, V72, P696
NR 19
TC 3
Z9 4
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD APR
PY 2015
VL 30
IS 5
BP 654
EP 658
DI 10.1177/0883073814532546
PG 5
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA CE7IR
UT WOS:000352013100026
PM 24789116
DA 2024-11-01
ER

PT J
AU Zeharia, A
   Fischel-Ghodsian, N
   Casas, K
   Bykhovskaya, Y
   Tamari, H
   Lev, D
   Mimouni, M
   Lerman-Sagie, T
AF Zeharia, A
   Fischel-Ghodsian, N
   Casas, K
   Bykhovskaya, Y
   Tamari, H
   Lev, D
   Mimouni, M
   Lerman-Sagie, T
TI Mitochondrial myopathy, sideroblastic anemia, and lactic acidosis:: An
   autosomal recessive syndrome in Persian Jews caused by a mutation in the
   <i>PUS1</i> gene
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
ID MARROW-PANCREAS SYNDROME; MULTIPLE DELETIONS; RESPIRATORY-CHAIN;
   WOLFRAM-SYNDROME; DISORDER; DNA; INFANCY; REGION; DEFECT
AB We report the seventh case of autosomal recessive inherited mitochondrial myopathy, lactic acidosis, and sideroblastic anemia. The patient, a product of consanguineous Persian Jews, had the association of mental retardation, dysmorphic features, lactic acidosis, myopathy, and sideroblastic anemia. Muscle biopsy demonstrated low activity of complexes 1 and 4 of the respiratory chain. Electron microscopy revealed paracrystalline inclusions in most mitochondria. Southern blot of the mitochondrial DNA did not show any large-scale rearrangements. The patient was found to be homozygous for the 656C -> T mutation in the pseudouridine synthase 1 gene (PUS1). Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia is an oxidative phosphorylation disorder causing sideroblastic anemia, myopathy, and, in some cases, mental retardation that is due to mutations in the nuclear-encoded PUS1 gene. This finding provides additional evidence that mitochondrial ribonucleic acid modification impacts the phenotypic expression of oxidative phosphorylation disorders.
C1 United Arab Emirates Univ, Fac Med, Dept Paediat, Al Ain, U Arab Emirates.
   United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Radiol, Al Ain, U Arab Emirates.
   United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Nucl Med, Al Ain, U Arab Emirates.
   United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates.
C3 United Arab Emirates University; United Arab Emirates University; United
   Arab Emirates University; United Arab Emirates University
RP United Arab Emirates Univ, Fac Med, Dept Paediat, POB 17666, Al Ain, U Arab Emirates.
EM asagie@post.tau.ac.il
RI Lerman-Sagie, Tally/AAY-7598-2021
OI Lerman-Sagie, Tally/0000-0001-6641-6875
FU NIDCD NIH HHS [R01DC01402] Funding Source: Medline
CR Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Barrientos A, 1996, J CLIN INVEST, V97, P1570, DOI 10.1172/JCI118581
   BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025
   BORGNAPIGNATTI C, 1989, J PEDIATR-US, V114, P405, DOI 10.1016/S0022-3476(89)80558-X
   BOTTOMLEY SS, 1995, J BIOENERG BIOMEMBR, V27, P161, DOI 10.1007/BF02110031
   Bridges KR, 1997, J PEDIAT HEMATOL ONC, V19, P274, DOI 10.1097/00043426-199707000-00002
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Bykhovskaya Y, 2004, MOL GENET METAB, V82, P27, DOI 10.1016/j.ymgme.2004.01.020
   CASADEMONT J, 1994, HUM MOL GENET, V3, P1945, DOI 10.1093/hmg/3.11.1945
   Casas K, 2004, AM J MED GENET A, V127A, P44, DOI 10.1002/ajmg.a.20652
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   CORMIER V, 1990, J PEDIATR-US, V117, P599, DOI 10.1016/S0022-3476(05)80698-5
   INBAL A, 1995, AM J MED GENET, V55, P372, DOI 10.1002/ajmg.1320550325
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAY A, 1994, BAILLIERE CLIN HAEM, V7, P851, DOI 10.1016/S0950-3536(05)80128-3
   NUSBAUM NJ, 1991, AM J HEMATOL, V37, P41, DOI 10.1002/ajh.2830370109
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   RAWLES JM, 1974, AM J MED, V56, P891, DOI 10.1016/0002-9343(74)90820-1
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SHERRATT HSA, 1988, METHOD BIOCHEM ANAL, V33, P243
   Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 24
TC 59
Z9 61
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAY
PY 2005
VL 20
IS 5
BP 449
EP 452
DI 10.1177/08830738050200051301
PG 4
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 932TI
UT WOS:000229575900013
PM 15971356
DA 2024-11-01
ER

PT J
AU Koczor, CA
   Torres, RA
   Fields, EJ
   Boyd, A
   He, S
   Patel, N
   Lee, EK
   Samarel, AM
   Lewis, W
AF Koczor, Christopher A.
   Torres, Rebecca A.
   Fields, Earl J.
   Boyd, Amy
   He, Stanley
   Patel, Nilamkumar
   Lee, Eva K.
   Samarel, Allen M.
   Lewis, William
TI Thymidine kinase and mtDNA depletion in human cardiomyopathy: epigenetic
   and translational evidence for energy starvation
SO PHYSIOLOGICAL GENOMICS
LA English
DT Article
DE dilated cardiomyopathy; mitochondria; mitochondrial DNA; thymidine
   kinase
ID MITOCHONDRIAL-DNA DEPLETION; LARGE GENE LISTS; FAILING HEART;
   DEOXYRIBONUCLEOSIDE KINASES; SUBSTRATE-SPECIFICITY; OXIDATIVE STRESS;
   TK2 DEFICIENCY; PHOSPHORYLATION; MYOPATHY; FAILURE
AB This study addresses how depletion of human cardiac left ventricle (LV) mitochondrial DNA (mtDNA) and epigenetic nuclear DNA methylation promote cardiac dysfunction in human dilated cardiomyopathy (DCM) through regulation of pyrimidine nucleotide kinases. Samples of DCM LV and right ventricle (n = 18) were obtained fresh at heart transplant surgery. Parallel samples from nonfailing (NF) controls (n = 12) were from donor hearts found unsuitable for clinical use. We analyzed abundance of mtDNA and nuclear DNA (nDNA) using qPCR. LV mtDNA was depleted in DCM (50%, P < 0.05 each) compared with NF. No detectable change in RV mtDNA abundance occurred. DNA methylation and gene expression were determined using microarray analysis (GEO accession number: GSE43435). Fifty-seven gene promoters exhibited DNA hypermethylation or hypomethylation in DCM LVs. Among those, cytosolic thymidine kinase 1 (TK1) was hypermethylated. Expression arrays revealed decreased abundance of the TK1 mRNA transcript with no change in transcripts for other relevant thymidine metabolism enzymes. Quantitative immunoblots confirmed decreased TK1 polypeptide steady state abundance. TK1 activity remained unchanged in DCM samples while mitochondrial thymidine kinase (TK2) activity was significantly reduced. Compensatory TK activity was found in cardiac myocytes in the DCM LV. Diminished TK2 activity is mechanistically important to reduced mtDNA abundance and identified in DCM LV samples here. Epigenetic and genetic changes result in changes in mtDNA and in nucleotide substrates for mtDNA replication and underpin energy starvation in DCM.
C1 [Koczor, Christopher A.; Torres, Rebecca A.; Fields, Earl J.; Boyd, Amy; He, Stanley; Lewis, William] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Patel, Nilamkumar; Samarel, Allen M.] Loyola Univ, Chicago Stritch Sch Med, Cardiovasc Inst, Maywood, IL 60153 USA.
   [Lee, Eva K.] Georgia Inst Technol, Ctr Operat Res Med & Healthcare, Atlanta, GA 30332 USA.
C3 Emory University; Loyola University Chicago; University System of
   Georgia; Georgia Institute of Technology
RP Lewis, W (corresponding author), Emory Univ, Sch Med, Dept Pathol, 7117 Woodruff Mem Bldg,101 Woodruff Circle, Atlanta, GA 30322 USA.
EM wlewis@emory.edu
RI Lewis, William/O-6571-2014; Samarel, Allen/Q-9810-2019
OI Samarel, Allen/0000-0001-8765-9884; Koczor,
   Christopher/0000-0003-3565-7953
FU National Institute on Drug Abuse Grant [DA-030996]
FX Supported by National Institute on Drug Abuse Grant DA-030996 to W.
   Lewis.
CR Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9
   BAANDRUP U, 1981, BRIT HEART J, V45, P475
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Elpeleg O, 2003, PEDIATR RES, V54, P153, DOI 10.1203/01.PDR.0000072796.25097.A5
   Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147
   Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Jüllig M, 2008, PROTEOMICS, V8, P2556, DOI 10.1002/pmic.200700977
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Koczor CA, PHYSIOL GENOMICS, DOI [10.1152/physiolgenomics.00013.2013, DOI 10.1152/PHYSI0LGEN0MICS.00013.2013]
   KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686
   Kohler JJ, 2008, CARDIOVASC TOXICOL, V8, P57, DOI 10.1007/s12012-008-9015-1
   Kohler JJ, 2008, CHEM RES TOXICOL, V21, P990, DOI 10.1021/tx8000219
   Kohler JJ, 2009, LAB INVEST, V89, P782, DOI 10.1038/labinvest.2009.39
   Kohler JJ, 2009, LAB INVEST, V89, P122, DOI 10.1038/labinvest.2008.121
   Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7
   Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Marín-García J, 2008, HEART FAIL REV, V13, P137, DOI 10.1007/s10741-007-9079-1
   Mestroni L, 2008, HURSTS HEART, P803
   MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032
   Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pérez-Pérez MJ, 2005, CURR TOP MED CHEM, V5, P1205, DOI 10.2174/156802605774463097
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rosca MG, 2009, J BIOENERG BIOMEMBR, V41, P107, DOI 10.1007/s10863-009-9215-9
   Saada A, 2004, DNA CELL BIOL, V23, P797
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada-Reisch A, 2004, NUCLEOS NUCLEOT NUCL, V23, P1205, DOI 10.1081/NCN-200027480
   Samarel A, 2008, HURSTS HEART, P123
   Van Rompay AR, 2003, PHARMACOL THERAPEUT, V100, P119, DOI 10.1016/j.pharmthera.2003.07.001
   Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006
   Villarroya J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029691
   Wang L, 2010, NUCLEOS NUCLEOT NUCL, V29, P400, DOI 10.1080/15257771003741042
   Wang L, 2011, ANTIMICROB AGENTS CH, V55, P2552, DOI 10.1128/AAC.00109-11
NR 46
TC 16
Z9 19
U1 0
U2 4
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1094-8341
EI 1531-2267
J9 PHYSIOL GENOMICS
JI Physiol. Genomics
PD JUL
PY 2013
VL 45
IS 14
BP 590
EP 596
DI 10.1152/physiolgenomics.00014.2013
PG 7
WC Cell Biology; Genetics & Heredity; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity; Physiology
GA 183KY
UT WOS:000321814800003
PM 23695887
OA Green Published
DA 2024-11-01
ER

PT J
AU Miguel, R
   Gago, MF
   Martins, J
   Barros, P
   Vale, J
   Rosas, MJ
AF Miguel, Rita
   Gago, Miguel Fernandes
   Martins, Joao
   Barros, Pedro
   Vale, Jose
   Rosas, Maria Jose
TI POLG1-related levodopa-responsive parkinsonism
SO CLINICAL NEUROLOGY AND NEUROSURGERY
LA English
DT Article
DE Parkinsonism; PEO; SANDO; DNA polymerase gamma gene; Mitochondria
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DNA POLYMERASE-GAMMA; POLG1 GENE;
   ALPHA-SYNUCLEIN; MUTATIONS; DELETIONS; DISEASE; ENCEPHALOMYOPATHY;
   INHERITANCE; SPECTRUM
AB Parkinsonian features have been described in patients with POLG1 mutations. Notwithstanding, the clinical expression has been revealed heterogeneous and the response to dopaminergic treatment has been document in few cases. We aim to describe the longitudinal clinical features and the treatment response of three unrelated patients with neurodegenerative parkinsonism, preceded by PEO and SANDO syndromes, who harbor POLG1 mutations, including two novel mutations. It was documented a sustained response to levodopa, at 3 and 8 years of follow-up of parkinsonian syndrome, and reduced striatal dopamine uptake. We review the genotypic and phenotypic spectrum of POLG1-related parkinsonism. Our observations stimulate the debate around the role of mitochondrial DNA defects in the pathogenesis of neurodegenerative parkinsonism. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Miguel, Rita] Ctr Hosp Lisboa Ocidental, Dept Neurol, Hosp Egas Moniz, P-1349019 Lisbon, Portugal.
   [Gago, Miguel Fernandes] Ctr Hosp Alto Ave, Dept Neurol, Guimaraes, Portugal.
   [Gago, Miguel Fernandes] Univ Minho, Escola Ciencias Saude, Braga, Portugal.
   [Martins, Joao] Hosp Pedro Hispano, Dept Neurol, Matosinhos, Portugal.
   [Barros, Pedro] Ctr Hosp Vila Nova de Gaia Espinho, Dept Neurol, Vila Nova De Gala, Portugal.
   [Vale, Jose] Hosp Beatriz Angelo, Dept Neurol, Loures, Portugal.
   [Rosas, Maria Jose] Ctr Hosp Sao Joao, Dept Neurol, Oporto, Portugal.
C3 Universidade de Lisboa; Centro Hospitalar de Lisboa Ocidental, EPE; Egas
   Moniz Hospital; Universidade do Minho; Sao Joao Hospital
RP Miguel, R (corresponding author), Ctr Hosp Lisboa Ocidental, Dept Neurol, Hosp Egas Moniz, Rua Junqueira 126, P-1349019 Lisbon, Portugal.
EM rita.migue185@gmail.com
RI Gago, Miguel Fernandes/F-2355-2015
OI Gago, Miguel Fernandes/0000-0003-0894-6207; Martins,
   Joao/0000-0003-2123-8977
CR Albanese A, 2001, MOVEMENT DISORD, V16, P197, DOI 10.1002/mds.1069
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   di Poggio MB, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-105
   Dolhun R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-92
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Gurgel-Giannetti J, 2012, MUSCLE NERVE, V45, P453, DOI 10.1002/mus.22330
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mehta AR, 2011, MOVEMENT DISORD, V26, P753, DOI 10.1002/mds.23510
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Takeda A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/19365
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Vekrellis K, 2011, LANCET NEUROL, V10, P1015, DOI 10.1016/S1474-4422(11)70213-7
NR 27
TC 27
Z9 27
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0303-8467
EI 1872-6968
J9 CLIN NEUROL NEUROSUR
JI Clin. Neurol. Neurosurg.
PD NOV
PY 2014
VL 126
BP 47
EP 54
DI 10.1016/j.clineuro.2014.08.020
PG 8
WC Clinical Neurology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Surgery
GA AT3GN
UT WOS:000344824000010
PM 25203713
DA 2024-11-01
ER

PT J
AU Zhong, Y
   Hu, YJ
   Yang, Y
   Peng, W
   Sun, Y
   Chen, B
   Huang, X
   Kong, WJ
AF Zhong, Yi
   Hu, Yu-Juan
   Yang, Yang
   Peng, Wei
   Sun, Yu
   Chen, Bei
   Huang, Xiang
   Kong, Wei-Jia
TI Contribution of common deletion to total deletion burden in
   mitochondrial DNA from inner ear of D-galactose-induced aging rats
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE Aging; Mitochondrial DNA; Common deletion; Cytochrome c oxidase subunit
   III; Mitochondrial dysfunction; Inner ear
ID 4977 BP DELETION; HUMAN SKELETAL-MUSCLE; COPY NUMBER; OXIDATIVE DAMAGE;
   MTDNA DELETIONS; TEMPORAL BONE; HEARING-LOSS; BLOOD-CELLS; MUTATIONS;
   DISEASE
AB Mitochondrial DNA (mtDNA) mutations, especially deletions, have been suggested to play an important role in aging and degenerative diseases. In particular, the common deletion in humans and rats (4977 bp and 4834 bp deletion, respectively) has been shown to accumulate with age in post-mitotic tissues with high energetic demands. Among numerous deletions, the common deletion has been proposed to serve as a molecular marker for aging and play a critical role in presbyacusis. However, so far no previous publication has quantified the contribution of common deletion to the total burden of mtDNA deletions in tissues during aging process. In the present study, we established a rat model with various degrees of aging in inner ear induced by three different doses of n-galactose (D-gal) administration. Firstly, multiple mtDNA deletions in inner ear were detected by nested PCR and long range PCR. In addition to the common deletion, three novel mtDNA deletions were identified. All four deletions, located in the major arc of mtDNA, are flanked by direct repeats and involve the cytochrome c oxidase (COX) subunit III gene, encoded by mtDNA. Additionally, absolute quantitative real-time PCR assay was used to detect the level of common deletion and total deletion burden of mtDNA. The quantitative data show that the common deletion is the most frequent type of mtDNA deletions, exceeding 67.86% of the total deletion burden. Finally, increased mtDNA copy number, reduced COX activity and mosaic ultrastructural impairments in inner ear were identified in D-gal-induced aging rats. The increase of mtDNA replication may contribute to the accelerated accumulation of mtDNA deletions, which may result in impairment of mitochondrial function in inner ear. Taken together, these findings suggest that the common deletion may serve as an ideal molecular marker to assess the mtDNA damage in inner ear during aging. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Zhong, Yi; Hu, Yu-Juan; Yang, Yang; Peng, Wei; Sun, Yu; Chen, Bei; Kong, Wei-Jia] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Otorhinolaryngol, Wuhan 430022, Peoples R China.
   [Chen, Bei] Zhengzhou Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Zhengzhou 450002, Peoples R China.
   [Huang, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Otorhinolaryngol, Wuhan 430022, Peoples R China.
C3 Huazhong University of Science & Technology; Zhengzhou University;
   Huazhong University of Science & Technology
RP Kong, WJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Otorhinolaryngol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.
EM entwjkong@yahoo.com.cn
RI Sun, Yu/AAX-9942-2021
OI Sun, Yu/0000-0002-1771-3715; Zhong, Yi/0000-0002-7138-5302; Kong,
   Wei-Jia/0000-0001-5410-2297
FU National Nature Science Foundation of China [30730094, 81000409];
   National Science and Technology Pillar Program [2007BAI18B13]; Major
   State Basic Research Development Program of China (973 Program)
   [2011CB504504]
FX This work was supported by grants from the National Nature Science
   Foundation of China (Nos. 30730094 and 81000409), the National Science
   and Technology Pillar Program during the Eleventh Five-year Plan Period
   (No. 2007BAI18B13) and the Major State Basic Research Development
   Program of China (973 Program) (No. 2011CB504504).
CR Arai T, 2003, AGING CLIN EXP RES, V15, P1
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bai U, 1997, AM J OTOL, V18, P449
   Bai UM, 2001, HEARING RES, V154, P73, DOI 10.1016/S0378-5955(01)00221-0
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   EDRIS W, 1994, MUTAT RES-DNAGING G, V316, P69, DOI 10.1016/0921-8734(94)90009-4
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   FRIEDMANN I, 1984, ULTRASTRUCTURAL ATAL, P99
   Futyma K, 2008, ONCOL REP, V20, P683, DOI 10.3892/or_00000060
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   HARMAN D, 1972, AM J CLIN NUTR, V25, P839
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616
   Kong WJ, 2006, EXP GERONTOL, V41, P628, DOI 10.1016/j.exger.2006.04.008
   Kong WJ, 2006, BIOCHEM BIOPH RES CO, V344, P425, DOI 10.1016/j.bbrc.2006.03.060
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lezza AMS, 1999, FASEB J, V13, P1083, DOI 10.1096/fasebj.13.9.1083
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu Cheng, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P661
   Liu CY, 2007, MITOCHONDRION, V7, P89, DOI 10.1016/j.mito.2006.11.020
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Markaryan A, 2008, MUTAT RES-FUND MOL M, V640, P38, DOI 10.1016/j.mrfmmm.2007.12.007
   Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Mohamed SA, 2004, EXP GERONTOL, V39, P181, DOI 10.1016/j.exger.2003.10.011
   Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050
   Pang LJ, 2008, CANCER BIOL THER, V7, P198, DOI 10.4161/cbt.7.2.5256
   Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
   Yin S, 2007, NEUROBIOL DIS, V27, P370, DOI 10.1016/j.nbd.2007.06.006
NR 49
TC 34
Z9 38
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0027-5107
EI 1873-135X
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD JUL 1
PY 2011
VL 712
IS 1-2
BP 11
EP 19
DI 10.1016/j.mrfmmm.2011.03.013
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 786YF
UT WOS:000292343100002
PM 21473872
DA 2024-11-01
ER

PT J
AU Tellis, CM
   Rosen, C
   Close, JM
   Horton, M
   Yaruss, JS
   Verdolini-Abbott, K
   Sciote, JJ
AF Tellis, Cari M.
   Rosen, Clark
   Close, John M.
   Horton, Michael
   Yaruss, J. Scott
   Verdolini-Abbott, Katherine
   Sciote, James J.
TI Cytochrome c Oxidase Deficiency in Human Posterior Cricoarytenoid Muscle
SO JOURNAL OF VOICE
LA English
DT Article
DE Laryngeal muscles; Cytochrome c oxidase; Aging; Posterior cricoarytenoid
   muscle
ID HUMAN THYROARYTENOID MUSCLE; AGE-RELATED-CHANGES; LASER-SCANNING
   MICROSCOPY; DNA DELETION MUTATIONS; SKELETAL-MUSCLE; MOTOR UNITS;
   MITOCHONDRIAL MYOPATHY; LARYNGEAL SYNKINESIS; RESPIRATORY-CHAIN;
   SATELLITE CELLS
AB Background. Mitochondrial alterations occur in skeletal muscle fibers throughout the normal aging process, resulting from increased accumulation of reactive oxide species (ROS). These result in respiratory chain abnormalities, which decrease the oxidative capacity of muscle fibers, leading to decreased contractile force, sarcopenia, or fiber necrosis. Intrinsic laryngeal muscles are a cranial muscle group that possesses some distinctive genotypic, phenotypic, and physiologic properties. Their susceptibility to mitochondrial alterations resulting from biological processes that increase levels of oxidative stress may be one of these distinctive characteristics.
   Objectives. The incidence of cytochrome c oxidase (COX) deficiency (COX-) was determined in human posterior cricoarytenoid (PCA) muscle when compared with the human thyrohyoid (TH) muscle, an extrinsic laryngeal muscle that served as "control" muscle. Ten PCA and 10TH muscles were harvested postlaryngectomy from 10 subjects ranging in age from 55 to 86 years. Differences in COX- were compared within and between muscle types using tissue section staining and standard morphometric analysis.
   Results and Conclusions. COX- fibers were identified in both the PCA and TH muscles. The PCA muscle had 10 times as may affected fibers as the TH muscle, with significant differences in COX- found between muscle type and fiber type (P = 0.003). Almost all of this effect was the result of elevated levels of COX- in type 1 fibers from the PCA muscle (P = 0.002) that showed a strong positive correlation with increased age. These results suggest that increased mitochondrial alterations may occur in the PCA muscle during normal aging.
C1 [Tellis, Cari M.] Misericordia Univ, Speech Language Pathol Dept, Dallas, PA 18612 USA.
   [Rosen, Clark] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA.
   [Close, John M.] Univ Pittsburgh, Sch Dent Med, Dept Publ Hlth, Pittsburgh, PA USA.
   [Horton, Michael; Sciote, James J.] Temple Univ, Kornberg Sch Dent, Dept Orthodont, Philadelphia, PA 19122 USA.
   [Yaruss, J. Scott; Verdolini-Abbott, Katherine] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA USA.
C3 Misericordia University; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth
   System of Higher Education (PCSHE); University of Pittsburgh;
   Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple
   University; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh
RP Tellis, CM (corresponding author), Misericordia Univ, Speech Language Pathol Dept, Dallas, PA 18612 USA.
EM ctellis@misericordia.edu
RI Yaruss, J Scott/L-4636-2019
OI Yaruss, J Scott/0000-0003-1964-575X
FU NIDCD NIH HHS [R01 DC005058] Funding Source: Medline
CR Andrade FH, 2000, MICROSC RES TECHNIQ, V48, P192, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<192::AID-JEMT7>3.0.CO;2-J
   ANSVED T, 1989, J NEUROL SCI, V93, P105, DOI 10.1016/0022-510X(89)90165-2
   Barron MJ, 2005, NEUROMUSCULAR DISORD, V15, P768, DOI 10.1016/j.nmd.2005.06.018
   Borisov AB, 2000, ANAT RECORD, V258, P305
   Brandon CA, 2003, J VOICE, V17, P63, DOI 10.1016/S0892-1997(03)00027-4
   BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313
   BROWN WF, 1972, J NEUROL NEUROSUR PS, V35, P845, DOI 10.1136/jnnp.35.6.845
   BROWN WM, 1971, P NATL ACAD SCI USA, V76, P1969
   BYRNE E, 1992, MUTAT RES, V275, P125, DOI 10.1016/0921-8734(92)90017-J
   CAMPBELL MJ, 1973, J NEUROL NEUROSUR PS, V36, P174, DOI 10.1136/jnnp.36.2.174
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CARLSON BM, 1995, J GERONTOL A-BIOL, V50, P96
   Chargé SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Chinnery PF, 2003, J NEUROL SCI, V211, P63, DOI 10.1016/S0022-510X(03)00039-X
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003
   Connor NP, 2002, ANN OTO RHINOL LARYN, V111, P579, DOI 10.1177/000348940211100703
   Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155
   CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526
   Crumley RL, 2000, ANN OTO RHINOL LARYN, V109, P365, DOI 10.1177/000348940010900405
   Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Goding GS, 2005, ANN OTO RHINOL LARYN, V114, P552, DOI 10.1177/000348940511400711
   Hammond TH, 2000, ANN OTO RHINOL LARYN, V109, P913, DOI 10.1177/000348940010901004
   Kadhiresan VA, 1996, J PHYSIOL-LONDON, V493, P543, DOI 10.1113/jphysiol.1996.sp021402
   Kahane J.C., 1983, Vocal fold physiology: Contemporary research and clinical issues, P44
   KALRA J, 1991, INT J EXP PATHOL, V72, P1
   Kersing W, 2004, EUR ARCH OTO-RHINO-L, V261, P386, DOI 10.1007/s00405-003-0702-z
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Linville SE, 2001, J VOICE, V15, P323, DOI 10.1016/S0892-1997(01)00034-0
   Malmgren LT, 1999, OTOLARYNG HEAD NECK, V121, P441, DOI 10.1016/S0194-5998(99)70235-4
   Malmgren LT, 2001, OTOLARYNG HEAD NECK, V125, P34, DOI 10.1067/mhn.2001.116449
   Malmgren LT, 2000, ARCH OTOLARYNGOL, V126, P851, DOI 10.1001/archotol.126.7.851
   Maronian NC, 2004, ANN OTO RHINOL LARYN, V113, P877, DOI 10.1177/000348940411301106
   MCCOMAS AJ, 1971, J NEUROL NEUROSUR PS, V34, P121, DOI 10.1136/jnnp.34.2.121
   MCCULLY KK, 1985, J APPL PHYSIOL, V59, P119, DOI 10.1152/jappl.1985.59.1.119
   MCLOON KL, 2003, INVEST OPHTH VIS SCI, V44, P1927
   McLoon LK, 2004, MUSCLE NERVE, V29, P707, DOI 10.1002/mus.20012
   McMullen CA, 2006, J APPL PHYSIOL, V100, P602, DOI 10.1152/japplphysiol.01066.2005
   MullerHocker J, 1996, MECH AGEING DEV, V86, P197, DOI 10.1016/0047-6374(95)01692-9
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P12
   NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420, DOI 10.1177/5.4.420
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Rader EP, 2006, J APPL PHYSIOL, V101, P887, DOI 10.1152/japplphysiol.00380.2006
   RODENO MT, 1993, ACTA OTO-LARYNGOL, V113, P445, DOI 10.3109/00016489309135842
   RODRIGUES AD, 1995, ANAT RECORD, V243, P430
   ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231
   ROUBENOFF R, 2000, J GERONTOL A-BIOL, V55, pM20
   Sastre J, 2000, FREE RADICAL RES, V32, P189, DOI 10.1080/10715760000300201
   Sataloff RT, 1997, J VOICE, V11, P156, DOI 10.1016/S0892-1997(97)80072-0
   SKOWRONEK P, 1992, BIOCHEM BIOPH RES CO, V187, P991, DOI 10.1016/0006-291X(92)91295-2
   Suzuki T, 2002, ANN OTO RHINOL LARYN, V111, P962, DOI 10.1177/000348940211101102
   TUCKER HM, 1978, LARYNGOSCOPE, V88, P598
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   WARD PH, 1989, OTOLARYNG HEAD NECK, V100, P283, DOI 10.1177/019459988910000405
   Welle S, 2002, CAN J APPL PHYSIOL, V27, P19, DOI 10.1139/h02-002
   WILDER C, 1979, 7 S CAR PROF VOIC 2
   YAMAMOTO M, 1988, ACTA NEUROPATHOL, V76, P558, DOI 10.1007/BF00689593
NR 59
TC 1
Z9 1
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0892-1997
EI 1873-4588
J9 J VOICE
JI J. Voice
PD JUL
PY 2011
VL 25
IS 4
BP 387
EP 394
DI 10.1016/j.jvoice.2010.03.002
PG 8
WC Audiology & Speech-Language Pathology; Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Audiology & Speech-Language Pathology; Otorhinolaryngology
GA 790HL
UT WOS:000292579000001
PM 20685075
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Szczepanowska, K
   Foury, F
AF Szczepanowska, Karolina
   Foury, Francoise
TI A cluster of pathogenic mutations in the 3'-5' exonuclease domain of DNA
   polymerase gamma defines a novel module coupling DNA synthesis and
   degradation
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; VIRION RNA-POLYMERASE;
   BETA-HAIRPIN LOOP; MITOCHONDRIAL-DNA; SACCHAROMYCES-CEREVISIAE;
   CRYSTAL-STRUCTURE; YEAST MITOCHONDRIA; POLG1 MUTATIONS; DEPLETION;
   DISEASE
AB Mutations in DNA polymerase gamma (pol g), the unique replicase inside mitochondria, cause a broad and complex spectrum of diseases in human. We have used Mip1, the yeast pol g, as a model enzyme to characterize six pathogenic pol g mutations. Four mutations clustered in a highly conserved 3'-5' exonuclease module are localized in the DNA-binding channel in close vicinity to the polymerase domain. They result in an increased frequency of point mutations and high instability of the mitochondrial DNA (mtDNA) in yeast cells, and unexpectedly for mutator mutations in the exonuclease domain, they favour exonucleolysis versus polymerization. This trait is associated with highly decreased DNA-binding affinity and poorly processive DNA synthesis. Our data show for the first time that a 3'-5' exonuclease module of pol g plays a crucial role in the coordination of the polymerase and exonuclease functions and they strongly suggest that in patients the disease is not caused by defective proofreading but results from poor mtDNA replication generated by a severe imbalance between DNA synthesis and degradation.
C1 [Szczepanowska, Karolina; Foury, Francoise] Catholic Univ Louvain, Inst Life Sci, B-1348 Louvain, Belgium.
C3 Universite Catholique Louvain
RP Foury, F (corresponding author), Catholic Univ Louvain, Inst Life Sci, Croix du Sud 4-15, B-1348 Louvain, Belgium.
EM francoise.foury@uclouvain.be
RI Szczepanowska, Karolina/ABC-1404-2020
OI Szczepanowska, Karolina/0000-0003-4689-2350
FU Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture
   (Belgium); Belgian National Fund for Scientific Research; Association
   Francaise contre les Myopathies; Interuniversity Attraction Poles
   Program-Belgian Science Policy
FX K.S. was supported by a fellowship from the 'Fonds pour la Formation a
   la Recherche dans l'Industrie et l'Agriculture' (Belgium). This work was
   supported by grants from the Belgian National Fund for Scientific
   Research, the Association Francaise contre les Myopathies and the
   Interuniversity Attraction Poles Program-Belgian Science Policy.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   [Anonymous], Human DNA Polymerase Gamma Mutation Database
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2007, GENETICS, V177, P1227, DOI 10.1534/genetics.107.079293
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   CHI NW, 1994, J BIOL CHEM, V269, P29984
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Foury F, 2004, CELL MOL LIFE SCI, V61, P2799, DOI 10.1007/s00018-004-4220-y
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010
   Goodman MF, 1998, GENETICS, V148, P1475
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Hogg M, 2007, J BIOL CHEM, V282, P1432, DOI 10.1074/jbc.M605675200
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaiser C, 1994, METHODS YEAST GENETI
   Kim SW, 2008, INT J BIOL MACROMOL, V42, P356, DOI 10.1016/j.ijbiomac.2008.01.010
   KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497
   Kuroita T, 2005, J MOL BIOL, V351, P291, DOI 10.1016/j.jmb.2005.06.015
   LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Murakami KS, 2008, P NATL ACAD SCI USA, V105, P5046, DOI 10.1073/pnas.0712325105
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   PEREZAMAIZ P, 2006, NUCLEIC ACIDS RES, V34, P107
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Simonati A, 2003, ACTA NEUROPATHOL, V106, P57, DOI 10.1007/s00401-003-0698-x
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Subuddhi U, 2008, BIOCHEMISTRY-US, V47, P6130, DOI 10.1021/bi800211f
   Tatsuta T, 2009, J BIOCHEM, V146, P455, DOI 10.1093/jb/mvp122
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Truniger V, 1996, EMBO J, V15, P3430, DOI 10.1002/j.1460-2075.1996.tb00709.x
   Trzemecka A, 2009, J MOL BIOL, V389, P797, DOI 10.1016/j.jmb.2009.04.055
   Tuske S, 2000, J BIOL CHEM, V275, P23759, DOI 10.1074/jbc.M001804200
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Voos W, 2009, RES MICROBIOL, V160, P718, DOI 10.1016/j.resmic.2009.08.003
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 54
TC 37
Z9 40
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD SEP 15
PY 2010
VL 19
IS 18
BP 3516
EP 3529
DI 10.1093/hmg/ddq267
PG 14
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 644AU
UT WOS:000281343600003
PM 20601675
OA Bronze
DA 2024-11-01
ER

PT J
AU Broomfield, A
   Sweeney, M
   Woodward, C
   Fratter, C
   Morris, A
   Leonard, J
   Abulhoul, L
   Grunewald, S
   Clayton, P
   Hanna, M
   Poulton, J
   Rahman, S
AF Broomfield, Alexander
   Sweeney, Mary G.
   Woodward, Cathy E.
   Fratter, Carl
   Morris, Andrew M.
   Leonard, James V.
   Abulhoul, Lara
   Grunewald, Stephanie
   Clayton, Peter T.
   Hanna, Michael G.
   Poulton, Joanna
   Rahman, Shamima
TI Paediatric single mitochondrial DNA deletion disorders: an overlapping
   spectrum of disease
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID COMPLETE HEART-BLOCK; PEARSON-SYNDROME; EXTERNAL OPHTHALMOPLEGIA; PLUS;
   REARRANGEMENTS; DUPLICATIONS; DYSFUNCTION; EVOLUTION; ANEMIA
AB Background Single large-scale mitochondrial DNA (mtDNA) deletions (SLSMDs) are amongst the most frequently diagnosed mtDNA disorders in childhood, yet their natural history remains poorly understood. We report the natural history of a large multicentre cohort of such children.
   Methods We reviewed case notes from three different UK centres to determine the clinical course of 34 patients (16 female, 18 male) with childhood-onset mitochondrial disease caused by SLSMDs. Kaplan-Meier analysis was used to compare survival of patients presenting with haematological features (Pearson syndrome) and those with nonhaematological presentations.
   Results The most frequent initial presentation was with isolated ptosis (16/34, 47 %). Eleven (32 %) patients presented with transfusion-dependent anaemia soon after birth and were diagnosed with Pearson syndrome, whilst ten were classified as having Kearns-Sayre syndrome, three as having progressive external ophthalmoplegia (PEO) and seven as having PEO-plus. Three patients did not conform to any specific mitochondrial syndrome. The most frequently affected organ during the disease course was the kidney, with documented tubular or glomerular dysfunction in 17 of 20 (85 %) cases who had detailed investigations. SLSMDs were present in blood and/or urine cells in all cases tested, indicating that muscle biopsy is not necessary for diagnosis in the paediatric age range. Kaplan-Meier survival analysis revealed significantly worse mortality in patients with Pearson syndrome compared with the rest of the cohort.
   Conclusions Mitochondrial disease caused by SLSMDs is clinically heterogeneous, and not all cases conform to a classical mitochondrial syndrome. Multisystem disease is the norm, with anaemia, renal impairment and endocrine disturbance being the most frequent extraneurological features. SLSMDs should be considered in the differential diagnosis of all children presenting with ptosis.
C1 [Broomfield, Alexander; Morris, Andrew M.] Cent Manchester Univ, Hosp NHS Fdn trust, St Marys Hosp, Genet Med, Manchester M13 9WL, Lancs, England.
   [Sweeney, Mary G.; Woodward, Cathy E.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Fratter, Carl] Univ Oxford, Hosp NHS Trust, Churchill Hosp, Oxford Med Genet Labs, Oxford OX3 7LE, England.
   [Abulhoul, Lara; Grunewald, Stephanie; Rahman, Shamima] Hosp NHS Fdn Trust, Inst Child Hlth, Metab Unit, London WC1N 3JH, England.
   [Grunewald, Stephanie; Clayton, Peter T.; Rahman, Shamima] UCL Inst Child Hlth, Genet & Genom Med, London WC1N 1EH, England.
   [Hanna, Michael G.] UCL Inst Neurol, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Hanna, Michael G.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Poulton, Joanna] John Radcliffe Hosp, Womens Ctr, NDOG, Oxford OX3 9DU, Oxon, England.
   [Rahman, Shamima] UCL Inst Child Hlth, Mitochondrial Res Grp, Genet & Genom Med, London WC1N 3JH, England.
C3 University of Manchester; University of London; University College
   London; UCL Medical School; University College London Hospitals NHS
   Foundation Trust; University of Oxford; Oxford University Hospitals NHS
   Foundation Trust; University of London; University College London;
   University of London; University College London; University of London;
   University College London; University of London; University College
   London; UCL Medical School; University College London Hospitals NHS
   Foundation Trust; University of Oxford; University of London; University
   College London
RP Rahman, S (corresponding author), UCL Inst Child Hlth, Mitochondrial Res Grp, Genet & Genom Med, 30 Guilford St, London WC1N 3JH, England.
EM shamima.rahman@ucl.ac.uk
RI Rahman, Shamima/C-5232-2008; Hanna, Michael/B-1995-2009; Poulton,
   Joanna/AAB-4828-2021; Clayton, Peter/C-1523-2008
OI Broomfield, Alexander/0000-0001-5674-0882; Clayton,
   Peter/0000-0001-7592-4302; Poulton, Joanna/0000-0002-2460-5587; Hanna,
   Michael/0000-0003-0825-4075
FU Great Ormond Street Hospital Children's Charity; MRC [MR/K000608/1,
   G0800674] Funding Source: UKRI
FX SR and PTC are supported by the Great Ormond Street Hospital Children's
   Charity. The authors thank the audiological physicians, biochemists,
   cardiologists, endocrinologists, gastroenterologists, haematologists,
   nephrologists, neurologists, ophthalmologists, palliative care
   physicians and pathologists involved in the diagnosis and management of
   these patients. MtDNA breakage points of patient E were determined in
   the NSCT mitochondrial laboratory, Newcastle.
CR Akaike M, 1997, CLIN CARDIOL, V20, P239, DOI 10.1002/clc.4960200310
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   BERNARD AM, 1987, CLIN CHEM, V33, P775
   Biousse V, 2001, SEMIN NEUROL, V21, P275, DOI 10.1055/s-2001-17945
   Di Mauro S, 1993, GENEREVIEW
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Herget-Rosenthal S, 2004, CLIN CHEM, V50, P552, DOI 10.1373/clinchem.2003.027763
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Krauch G, 2002, AM J MED GENET, V110, P57, DOI 10.1002/ajmg.10410
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lamont PJ, 1998, ARCH DIS CHILD, V79, P22, DOI 10.1136/adc.79.1.22
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Morel AS, 2009, EUR J PEDIATR, V168, P311, DOI 10.1007/s00431-008-0756-4
   Morris AAM, 1997, ARCH DIS CHILD, V77, P56, DOI 10.1136/adc.77.1.56
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Riera ARP, 2008, J ELECTROCARDIOL, V41, P675, DOI 10.1016/j.jelectrocard.2008.04.001
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   Rahman S, 2000, J INHERIT METAB DIS, V23, P753, DOI 10.1023/A:1005611803306
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROWLAND LP, 1983, NEUROLOGY, V33, P1179, DOI 10.1212/WNL.33.9.1179
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   van Straaten HLM, 2005, NEUROPEDIATRICS, V36, P193, DOI 10.1055/s-2005-865713
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 37
TC 76
Z9 80
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD MAY
PY 2015
VL 38
IS 3
BP 445
EP 457
DI 10.1007/s10545-014-9778-4
PG 13
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA CI1JJ
UT WOS:000354500000008
PM 25352051
OA Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Jeong, MH
   Kim, JH
   Seo, KS
   Kwak, TH
   Park, WJ
AF Jeong, Moon Hee
   Kim, Jin Hwan
   Seo, Kang-sik
   Kwak, Tae Hwan
   Park, Woo Jin
TI β-Lapachone attenuates mitochondrial dysfunction in MELAS cybrid cells
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE beta-Lapachone; NQO1; MELAS; Mitochondria
ID PROTEIN-SYNTHESIS; DISEASE; DISORDERS; SIRTUINS; DNA; FIBROBLASTS;
   ACTIVATION; EXPRESSION; MUTATIONS; INDUCTION
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a mitochondrial disease caused by mutations in the mitochondrial genome. This study investigated the efficacy of B-lapachone (beta-lap), a natural quinone compound, in rescuing mitochondrial dysfunction in MELAS cybrid cells. beta-Lap significantly restored energy production and mitochondrial membrane potential as well as normalized the elevated ROS level in MELAS cybrid cells. Additionally, beta-lap reduced lactic acidosis and restored glucose uptake in the MELAS cybrid cells. Finally, beta-lap activated Sirt1 by increasing the intracellular NAD(+)/NADH ratio, which was accompanied by increased mtDNA content. Two other quinone compounds (idebenone and CoQ10) that have rescued mitochondrial dysfunction in previous studies of MELAS cybrid cells had a minimal effect in the current study. Taken together, these results demonstrated that beta-lap may provide a novel therapeutic modality for the treatment of MELAS. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Jeong, Moon Hee; Park, Woo Jin] Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju 500712, South Korea.
   [Kim, Jin Hwan; Seo, Kang-sik; Kwak, Tae Hwan] KT&G Life Sci Corp, R&D Ctr, Suwon, South Korea.
C3 Gwangju Institute of Science & Technology (GIST); Samsung
RP Park, WJ (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, 123 Cheomdan Gwagiro, Kwangju 500712, South Korea.
EM woojinpark@me.com
FU Global Research Laboratory Program of the Korean Ministry of Education,
   Science and Technology [M6-0605-00-0001]; Systems Biology Infrastructure
   Establishment Program of GIST
FX W.J.P. was supported by a grant (M6-0605-00-0001) from the Global
   Research Laboratory Program of the Korean Ministry of Education, Science
   and Technology and a grant from the Systems Biology Infrastructure
   Establishment Program of GIST.
CR Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486
   Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963
   Hussein Ahmed, 2009, Eur J Intern Med, V20, pe114, DOI 10.1016/j.ejim.2008.09.018
   Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183
   Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285
   Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Jeong MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091039
   Kim SY, 2009, CIRC RES, V104, P842, DOI 10.1161/CIRCRESAHA.108.189837
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lazzarino G, 2003, ANAL BIOCHEM, V322, P51, DOI 10.1016/j.ab.2003.07.013
   Lee JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047122
   Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002
   Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140
   Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Shin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064953
   Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Wang CH, 2013, FEBS J, V280, P1039, DOI 10.1111/febs.12096
   Woo HJ, 2006, J MED FOOD, V9, P161, DOI 10.1089/jmf.2006.9.161
   Wuerzberger SM, 1998, CANCER RES, V58, P1876
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 33
TC 11
Z9 12
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 21
PY 2014
VL 454
IS 3
BP 417
EP 422
DI 10.1016/j.bbrc.2014.10.093
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA AX1EJ
UT WOS:000346690600011
PM 25451262
DA 2024-11-01
ER

PT J
AU Murakami, T
   Shinoto, Y
   Yonemitsu, S
   Muro, S
   Oki, S
   Koga, Y
   Goto, Y
   Kaneda, D
AF Murakami, Takaaki
   Shinoto, Yuya
   Yonemitsu, Shin
   Muro, Seiji
   Oki, Shogo
   Koga, Yasutoshi
   Goto, Yu-ichi
   Kaneda, Daita
TI Early Onset of Diabetes Mellitus Accelerates Cognitive Decline in
   Japanese Patients with Mitochondrial Myopathy, Encephalopathy, Lactic
   Acidosis, and Stroke-Like Episodes
SO TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE cognitive decline; hypoglycemia; MELAS; mitochondrial diabetes mellitus;
   A3243G mutation
ID CLINICAL-FEATURES; DNA MUTATION; MELAS; DEMENTIA; DISEASE; RISK
AB Approximately 80% of patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS) carry the A3243G mutation in the mitochondrial tRNALeu (UUR) gene. Conversely, this mutation has also been identified as one of the most prevalent genetic abnormalities in patients with diabetes mellitus. Mitochondrial diabetes mellitus complicated with MELAS is relatively common, and 12.5% of patients with the A3243G mutation develop MELAS after being diagnosed with diabetes mellitus. However, the clinical impact of diabetes mellitus in MELAS patients remains unclear. Therefore, we retrospectively studied 14 Japanese MELAS patients with the A3243G mutation: three men and eleven women, with the mean age of 48.0 (+/- 15.4) years. Eight patients had been diagnosed with diabetes mellitus prior to the diagnosis of mitochondrial disease, and all of them were treated with insulin. The other six included four patients with concurrent diagnosis of diabetes and mitochondrial disease, one patient diagnosed with diabetes after the diagnosis of mitochondrial disease, and one patient without developing diabetes currently. We thus compared the patients' characteristics between those with and without early onset of diabetes mellitus. Cognitive decline (75.0% vs. 0%; p = 0.03) and poor glycemic control with severe hypoglycemic events (75.0% vs. 16.7%; p = 0.05) were more common in MELAS patients with a prior diagnosis of diabetes than in those without the prior diagnosis of diabetes. Our data suggest that the latent progress of cognitive decline is accelerated because of early onset of diabetes mellitus in MELAS patients.
C1 [Murakami, Takaaki; Yonemitsu, Shin; Muro, Seiji; Oki, Shogo] Osaka Red Cross Hosp, Dept Endocrinol & Diabet, Osaka, Japan.
   [Shinoto, Yuya] Osaka Red Cross Hosp, Dept Neurol, Osaka, Japan.
   [Koga, Yasutoshi] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 830, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1870031, Japan.
   [Kaneda, Daita] Tokyo Metropolitan Geriatr Hosp & Inst Gerontol, Dept Neurol, Tokyo, Japan.
C3 Osaka Red Cross Hospital; Osaka Red Cross Hospital; Kurume University;
   National Center for Neurology & Psychiatry - Japan; Tokyo Metropolitan
   Institute of Gerontology
RP Murakami, T (corresponding author), Osaka Red Cross Hosp, Dept Endocrinol & Diabet, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka 5430027, Japan.
EM t.murakami@osaka-med.jrc.or.jp
RI Murakami, Takaaki/ABH-6301-2020
OI Koga, Yasutoshi/0000-0002-6664-1295
FU Ministry of Health, Labour and Welfare, Japan
FX This work was supported by Grants-in-Aid for the Research on Intractable
   Diseases (Mitochondrial Disorder) from the Ministry of Health, Labour
   and Welfare, Japan.
CR El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Gudala K, 2013, J DIABETES INVEST, V4, P640, DOI 10.1111/jdi.12087
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x
   Simoncini C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/803942
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   VANDENOUWELAND JMW, 1995, MUSCLE NERVE, pS124
   Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 14
TC 5
Z9 6
U1 0
U2 2
PU TOHOKU UNIV MEDICAL PRESS
PI SENDAI
PA 2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN
SN 0040-8727
EI 1349-3329
J9 TOHOKU J EXP MED
JI Tohoku J. Exp. Med.
PD APR
PY 2016
VL 238
IS 4
BP 311
EP 316
DI 10.1620/tjem.238.311
PG 6
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA DK4WH
UT WOS:000374920500007
PM 27063563
OA gold
DA 2024-11-01
ER

PT J
AU Hou, Y
   Xie, ZY
   Zhao, XT
   Yuan, Y
   Dou, P
   Wang, ZX
AF Hou, Yue
   Xie, Zhiying
   Zhao, Xutong
   Yuan, Yun
   Dou, Pan
   Wang, Zhaoxia
TI Appendicular skeletal muscle mass: A more sensitive biomarker of disease
   severity than BMI in adults with mitochondrial diseases
SO PLOS ONE
LA English
DT Article
ID BIOELECTRICAL-IMPEDANCE ANALYSIS; BODY-COMPOSITION; ABNORMAL GROWTH; DNA
   DELETION; SARCOPENIA; FAT; CAPACITY; MYOPATHY; AGE; MANIFESTATIONS
AB The study aimed to evaluate the body composition of patients with mitochondrial diseases (MD) and correlate it with disease severity. Overall, 89 patients (age. 18 years) with MD were recruited, including 49 with chronic progressive external ophthalmoplegia (CPEO) and 40 with mitochondrial encephalomyopathy with lactate acidosis and stroke-like episodes (MELAS). Body composition, including fat mass index (FMI), fat-free mass index (FFMI), skeletal muscle mass index (SMI), and appendicular skeletal muscle mass index (ASMI), were examined using multifrequency bioelectric impedance analysis. Clinical assessments, including muscle strength, usual gait speed, and disease severity determined by the Newcastle Mitochondrial Disease Adult Scale score (NMDAS), were performed. The comparisons between patients group and age-and gender-matched healthy controls, as well as the correlations between anthropometric measurements, body composition, and disease severity were analyzed. Height, weight, body mass index (BMI), FFMI, SMI, and ASMI were significantly lower in patients with MD than in healthy controls. Notably, low muscle mass was noted in 69.7% (62/89) of MD patients, with 22 patients also presenting with compromised physical performance as indicated by decreased gait speed, resulting in 24.7% satisfied the sarcopenia diagnostic criteria. Disease severity was more negatively correlated with ASMI than it was with height, weight, and BMI. Subgroup analysis showed that in the MELAS subgroup, disease severity was negatively correlated with height, weight, and ASMI; whereas in the CPEO subgroup, it was only negatively correlated with ASMI and SMI. Additionally, ASMI was positively associated with muscle strength. Altogether, compared with BMI, ASMI is a more sensitive biomarker predicting disease severity of MD, both in MELAS and CPEO patients.
C1 [Hou, Yue; Xie, Zhiying; Zhao, Xutong; Yuan, Yun; Wang, Zhaoxia] Peking Univ, Hosp 1, Dept Neurol, Beijing, Peoples R China.
   [Dou, Pan] Peking Univ, Hosp 1, Dept Clin Nutr, Beijing, Peoples R China.
C3 Peking University; Peking University
RP Wang, ZX (corresponding author), Peking Univ, Hosp 1, Dept Neurol, Beijing, Peoples R China.; Dou, P (corresponding author), Peking Univ, Hosp 1, Dept Clin Nutr, Beijing, Peoples R China.
EM doupan@pkufh.cn; drwangzx@163.com
OI Xie, Zhiying/0000-0003-2102-6026
FU Ministry of Science and Technology of China [2011ZX09307-001-07];
   Beijing Municipal Science and Technology Commission [Z151100003915126]
FX This work was financially supported by grants from the Ministry of
   Science and Technology of China (No. 2011ZX09307-001-07 to YY) and
   Beijing Municipal Science and Technology Commission (No.
   Z151100003915126 to ZW).
CR Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Béghin L, 2016, CLIN NUTR, V35, P1414, DOI 10.1016/j.clnu.2016.03.015
   Boal RL, 2018, J CLIN ENDOCRINOL ME, V10
   Bovenschen HJ, 2006, DIGEST DIS SCI, V51, P1509, DOI 10.1007/s10620-006-9120-6
   Brioche T, 2016, MOL ASPECTS MED, V50, P56, DOI 10.1016/j.mam.2016.04.006
   BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307
   Canapari CA, 2015, PEDIATR PULM, V50, P63, DOI 10.1002/ppul.23004
   Castro-Gago M, 2010, ACTA PAEDIATR, V99, P796, DOI 10.1111/j.1651-2227.2010.01738.x
   Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   Chien MY, 2008, J AM GERIATR SOC, V56, P1710, DOI 10.1111/j.1532-5415.2008.01854.x
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Dasarathy S, 2016, J HEPATOL, V65, P1232, DOI 10.1016/j.jhep.2016.07.040
   Davidson ZE, 2009, J HUM NUTR DIET, V22, P383, DOI 10.1111/j.1365-277X.2009.00979.x
   de Laat P, 2015, NETH J MED, V73, P30
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 2018, J CLIN MED, V7, DOI 10.3390/jcm7020016
   Ge Yu-Xing, 2017, eNeurologicalSci, V6, P16, DOI 10.1016/j.ensci.2016.11.005
   Gimenes AC, 2015, BRAZ J MED BIOL RES, V48, P354, DOI 10.1590/1414-431X20143467
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Gueugneau M, 2015, J GERONTOL A-BIOL, V70, P566, DOI 10.1093/gerona/glu086
   Han SS, 2010, J AM GERIATR SOC, V58, P312, DOI 10.1111/j.1532-5415.2009.02672.x
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kulich KR, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-12
   Kyle UG, 2015, EUR J CLIN NUTR, V69, P1298, DOI 10.1038/ejcn.2015.86
   Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860
   Ling CHY, 2011, CLIN NUTR, V30, P610, DOI 10.1016/j.clnu.2011.04.001
   Maetzler W, 2015, NERVENARZT, V86, P420, DOI 10.1007/s00115-014-4181-9
   Mathur S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00104
   Matsuzaki M, 2002, NEUROPEDIATRICS, V33, P271, DOI 10.1055/s-2002-36742
   Matusik E, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020071
   Molnar MJ, 2018, HAND CLINIC, V145, P147, DOI 10.1016/B978-0-12-802395-2.00010-9
   Morava E, 2006, J INHERIT METAB DIS, V29, P589, DOI 10.1007/s10545-006-0227-x
   Oh SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084052
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   Pestronk A, 2017, MUSCLE NERVE, V56, P122, DOI 10.1002/mus.25442
   Rahman S, 2013, J INHERIT METAB DIS, V36, P659, DOI 10.1007/s10545-013-9614-2
   Ranasinghe C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-797
   Rider LG, 2010, ARTHRIT CARE RES, V62, P465, DOI 10.1002/acr.20035
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422
   Sato E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36618
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Shah VO, 2009, GENET MED, V11, P147, DOI 10.1097/GIM.0b013e31819307a2
   Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V55, pE9, DOI 10.1016/j.archger.2012.06.015
   Thrift AP, 2014, J CLIN GASTROENTEROL, V48, P218, DOI 10.1097/MCG.0b013e31829ae98c
   Widen EM, 2014, OBES SURG, V24, P847, DOI 10.1007/s11695-014-1182-5
   Wolny S, 2009, ACTA PAEDIATR, V98, P553, DOI 10.1111/j.1651-2227.2008.01148.x
   Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a
   Yu M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175343
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zhao DH, 2013, CLIN NEUROL NEUROSUR, V115, P1490, DOI 10.1016/j.clineuro.2012.11.011
NR 58
TC 15
Z9 16
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 25
PY 2019
VL 14
IS 7
AR e0219628
DI 10.1371/journal.pone.0219628
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA IW4VN
UT WOS:000484977900021
PM 31344055
OA Green Submitted, gold, Green Published
DA 2024-11-01
ER

PT J
AU Abramov, AY
   Smulders-Srinivasan, TK
   Kirby, DM
   Acin-Perez, R
   Enriquez, JA
   Lightowlers, RN
   Duchen, MR
   Turnbull, DM
AF Abramov, Andrey Y.
   Smulders-Srinivasan, Tora K.
   Kirby, Denise M.
   Acin-Perez, Rebeca
   Antonio Enriquez, Jose
   Lightowlers, Robert N.
   Duchen, Michael R.
   Turnbull, Douglass M.
TI Mechanism of neurodegeneration of neurons with mitochondrial DNA
   mutations
SO BRAIN
LA English
DT Article
DE mitochondrial diseases; oxidative stress; calcium signalling; neuronal
   degeneration; neuronal loss
ID SUBSTANTIA-NIGRA NEURONS; CELL-DEATH; 1555A-GREATER-THAN-G MUTATION;
   MTDNA MUTATIONS; HUMAN-DISEASE; CALCIUM; GLUTATHIONE; PREVALENCE;
   DELETIONS; BRAIN
AB Mutations of mitochondrial DNA are associated with a wide spectrum of disorders, primarily affecting the central nervous system and muscle function. The specific consequences of mitochondrial DNA mutations for neuronal pathophysiology are not understood. In order to explore the impact of mitochondrial mutations on neuronal biochemistry and physiology, we have used fluorescence imaging techniques to examine changes in mitochondrial function in neurons differentiated from mouse embryonic stem-cell cybrids containing mitochondrial DNA polymorphic variants or mutations. Surprisingly, in neurons carrying a severe mutation in respiratory complex I (< 10% residual complex I activity) the mitochondrial membrane potential was significantly increased, but collapsed in response to oligomycin, suggesting that the mitochondrial membrane potential was maintained by the F(1)F(o) ATPase operating in 'reverse' mode. In cells with a mutation in complex IV causing similar to 40% residual complex IV activity, the mitochondrial membrane potential was not significantly different from controls. The rate of generation of mitochondrial reactive oxygen species, measured using hydroethidium and signals from the mitochondrially targeted hydroethidine, was increased in neurons with both the complex I and complex IV mutations. Glutathione was depleted, suggesting significant oxidative stress in neurons with a complex I deficiency, but not in those with a complex IV defect. In the neurons with complex I deficiency but not the complex IV defect, neuronal death was increased and was attenuated by reactive oxygen species scavengers. Thus, in neurons with a severe mutation of complex I, the maintenance of a high potential by F(1)F(o) ATPase activity combined with an impaired respiratory chain causes oxidative stress which promotes cell death.
C1 [Abramov, Andrey Y.] UCL, Dept Mol Neurosci, Inst Neurol, London WC1N 3BG, England.
   [Smulders-Srinivasan, Tora K.; Kirby, Denise M.; Lightowlers, Robert N.; Turnbull, Douglass M.] Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Kirby, Denise M.] Royal Childrens Hosp, Mitochondrial & Metab Res, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
   [Acin-Perez, Rebeca; Antonio Enriquez, Jose] Univ Zaragoza, Dept Bioquim, Zaragoza, Spain.
   [Acin-Perez, Rebeca; Antonio Enriquez, Jose] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain.
   [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.
C3 University of London; University College London; Newcastle University -
   UK; Murdoch Children's Research Institute; Royal Children's Hospital
   Melbourne; University of Zaragoza; Centro Nacional de Investigaciones
   Cardiovasculares (CNIC); University of London; University College London
RP Abramov, AY (corresponding author), UCL, Dept Mol Neurosci, Inst Neurol, Queen Sq, London WC1N 3BG, England.
EM a.abramov@ucl.ac.uk
RI Acin-Perez, Rebeca/AAU-4913-2020; Smulders-Srinivasan,
   Tora/GQZ-3230-2022; Enriquez, Jose Antonio/M-8468-2016; Abramov,
   Andrey/H-9053-2012; Smulders-Srinivasan, Tora K./F-8198-2011; Duchen,
   Michael/A-2116-2009; Acin-Perez, Rebeca/H-6160-2015
OI Enriquez, Jose Antonio/0000-0002-3671-2961; Abramov,
   Andrey/0000-0002-7646-7235; Turnbull, Doug/0000-0002-8878-9901;
   Smulders-Srinivasan, Tora K./0000-0002-3851-5160; Duchen,
   Michael/0000-0003-2548-4294; Acin-Perez, Rebeca/0000-0001-9553-8337
FU Wellcome Trust; UK NIHR Biomedical Research Centre for Ageing and Age-
   related disease; BBSRC; EPSRC; ESRC; MRC; NRSA (NINDS, NIH, USA);
   National Health and Medical Research Council of AUSTRALIA (NHMRC); MRC
   [G0700718, G0601943] Funding Source: UKRI
FX Wellcome Trust, UK NIHR Biomedical Research Centre for Ageing and Age-
   related disease award to the Newcastle upon Tyne Hospitals NHS
   Foundation Trust, Newcastle University Centre for Brain Ageing and
   Vitality supported by BBSRC, EPSRC, ESRC and MRC; Ruth L. Kirschstein
   NRSA (NINDS, NIH, USA) (to T. K. S.); National Health and Medical
   Research Council of AUSTRALIA (NHMRC) CJ Martin Postdoctoral Training
   Fellowship (to D. M. K.). Work in the Duchen lab is supported by grants
   from the Wellcome Trust and MRC.
CR Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017
   Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795
   CARAFOLI E, 1964, J BIOL CHEM, V239, P3055
   CROMPTON M, 1978, EUR J BIOCHEM, V91, P599, DOI 10.1111/j.1432-1033.1978.tb12713.x
   Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059
   Duchen MR, 2003, METHOD ENZYMOL, V361, P353
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Keelan J, 2001, J NEUROSCI RES, V66, P873, DOI 10.1002/jnr.10085
   Kirby DM, 2009, CELL PROLIFERAT, V42, P413, DOI 10.1111/j.1365-2184.2009.00612.x
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   OLDFORS A, 1990, ACTA NEUROPATHOL, V80, P541, DOI 10.1007/BF00294616
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SNYDER CD, 1983, J NEUROCHEM, V40, P1178, DOI 10.1111/j.1471-4159.1983.tb08111.x
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   VASINGTON FD, 1962, J BIOL CHEM, V237, P2670
   Vesce S, 2005, J BIOL CHEM, V280, P38720, DOI 10.1074/jbc.M506575200
   WERTH JL, 1994, J NEUROSCI, V14, P348
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
NR 35
TC 99
Z9 107
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD MAR
PY 2010
VL 133
BP 797
EP 807
DI 10.1093/brain/awq015
PN 3
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 575DI
UT WOS:000276046000015
PM 20157008
OA Green Submitted, Green Published
DA 2024-11-01
ER

PT J
AU Fukui, H
   Moraes, CT
AF Fukui, Hirokazu
   Moraes, Carlos T.
TI Mechanisms of formation and accumulation of mitochondrial DNA deletions
   in aging neurons
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID SUBSTANTIA-NIGRA NEURONS; MULTIPLE MTDNA DELETIONS;
   CENTRAL-NERVOUS-SYSTEM; AGED MUSCLE-FIBERS; OXIDATIVE STRESS; HELICASE
   TWINKLE; MUTATIONS; MICE; DISEASE; NEURODEGENERATION
AB Age-dependent accumulation of partially deleted mitochondrial DNA (Delta mtDNA) has been suggested to contribute to aging and the development of age-associated diseases including Parkinson's disease. However, the molecular mechanisms underlying the generation and accumulation of Delta mtDNA have not been addressed in vivo. In this study, we have developed a mouse model expressing an inducible mitochondria-targeted restriction endonuclease (PstI). Using this system, we could trigger mtDNA double-strand breaks (DSBs) in adult neurons. We found that this transient event leads to the generation of a family of Delta mtDNA with features that closely resemble naturally-occurring mtDNA deletions. The formation of these deleted species is likely to be mediated by yet uncharacterized DNA repairing machineries that participate in homologous recombination and non-homologous end-joining. Furthermore, we obtained in vivo evidence that Delta mtDNAs with larger deletions accumulate faster than those with smaller deletions, implying a replicative advantage of smaller mtDNAs. These findings identify DSB, DNA repair systems and replicative advantage as likely mechanisms underlying the generation and age-associated accumulation of Delta mtDNA in mammalian neurons.
C1 [Moraes, Carlos T.] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Fukui, Hirokazu; Moraes, Carlos T.] Univ Miami, Sch Med, Neurosci Program, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.
C3 University of Miami; University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Sch Med, Dept Neurol, 1095 NW 14th Terrace, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021
OI Fukui, Hirokazu/0000-0001-8754-2547
FU US Public Health Service Grant [R01-NS41777, R01-EY10804, R01-CA85700];
   University of Miami Neuroscience Center; Lois Pope LIFE Fellowship
FX This work was supported by US Public Health Service Grant R01-NS41777,
   R01-EY10804, R01-CA85700 and by the University of Miami Neuroscience
   Center (to C. T. M.). H. F. was supported by the Lois Pope LIFE
   Fellowship.
CR Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007
   Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   Fukui H, 2007, HUM MOL GENET, V16, P783, DOI 10.1093/hmg/ddm023
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678
   O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
NR 28
TC 146
Z9 172
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAR 15
PY 2009
VL 18
IS 6
BP 1028
EP 1036
DI 10.1093/hmg/ddn437
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 413XT
UT WOS:000263828100004
PM 19095717
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Hovhannisyan, Y
   Li, ZL
   Callon, D
   Suspène, R
   Batoumeni, V
   Canette, A
   Blanc, J
   Hocini, H
   Lefebvre, C
   El-Jahrani, N
   Kitsara, M
   L'honoré, A
   Kordeli, E
   Fornes, P
   Concordet, JP
   Tachdjian, G
   Rodriguez, AM
   Vartanian, JP
   Béhin, A
   Wahbi, K
   Joanne, P
   Agbulut, O
AF Hovhannisyan, Yeranuhi
   Li, Zhenlin
   Callon, Domitille
   Suspene, Rodolphe
   Batoumeni, Vivien
   Canette, Alexis
   Blanc, Jocelyne
   Hocini, Hakim
   Lefebvre, Cecile
   El-Jahrani, Nora
   Kitsara, Maria
   L'honore, Aurore
   Kordeli, Ekaterini
   Fornes, Paul
   Concordet, Jean-Paul
   Tachdjian, Gerard
   Rodriguez, Anne-Marie
   Vartanian, Jean-Pierre
   Behin, Anthony
   Wahbi, Karim
   Joanne, Pierre
   Agbulut, Onnik
TI Critical contribution of mitochondria in the development of
   cardiomyopathy linked to desmin mutation
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Desmin; Cardiomyocytes; Stem cells; Mitochondria; iPSC; Heart failure;
   Dilated cardiomyopathy; Myofibrillar myopathy
ID PLURIPOTENT STEM-CELLS; HEART-FAILURE; R-PACKAGE; IN-VIVO; MUSCLE; DNA;
   TRANSPLANTATION; DYSFUNCTION; CYTOSKELETON; REPERFUSION
AB BackgroundBeyond the observed alterations in cellular structure and mitochondria, the mechanisms linking rare genetic mutations to the development of heart failure in patients affected by desmin mutations remain unclear due in part, to the lack of relevant human cardiomyocyte models.MethodsTo shed light on the role of mitochondria in these mechanisms, we investigated cardiomyocytes derived from human induced pluripotent stem cells carrying the heterozygous DESE439K mutation that were either isolated from a patient or generated by gene editing. To increase physiological relevance, cardiomyocytes were either cultured on an anisotropic micropatterned surface to obtain elongated and aligned cardiomyocytes, or as a cardiac spheroid to create a micro-tissue. Moreover, when applicable, results from cardiomyocytes were confirmed with heart biopsies of suddenly died patient of the same family harboring DESE439K mutation, and post-mortem heart samples from five control healthy donors.ResultsThe heterozygous DESE439K mutation leads to dramatic changes in the overall cytoarchitecture of cardiomyocytes, including cell size and morphology. Most importantly, mutant cardiomyocytes display altered mitochondrial architecture, mitochondrial respiratory capacity and metabolic activity reminiscent of defects observed in patient's heart tissue. Finally, to challenge the pathological mechanism, we transferred normal mitochondria inside the mutant cardiomyocytes and demonstrated that this treatment was able to restore mitochondrial and contractile functions of cardiomyocytes.ConclusionsThis work highlights the deleterious effects of DESE439K mutation, demonstrates the crucial role of mitochondrial abnormalities in the pathophysiology of desmin-related cardiomyopathy, and opens up new potential therapeutic perspectives for this disease.
C1 [Hovhannisyan, Yeranuhi; Li, Zhenlin; Callon, Domitille; Batoumeni, Vivien; Blanc, Jocelyne; Kitsara, Maria; L'honore, Aurore; Kordeli, Ekaterini; Rodriguez, Anne-Marie; Joanne, Pierre; Agbulut, Onnik] Sorbonne Univ, Inst Biol Paris Seine IBPS, UMR CNRS 8256, INSERM U1164,Biol Adaptat & Ageing, 7 Quai St Bernard,Case 256, F-75005 Paris, France.
   [Callon, Domitille; Fornes, Paul] Acad Hosp Reims, Dept Pathol, Reims, France.
   [Suspene, Rodolphe; Vartanian, Jean-Pierre] Univ Paris Cite, Inst Pasteur, Dept Virol, Virus & Cellular Stress Unit, Paris, France.
   [Batoumeni, Vivien] Ksilink, Strasbourg, France.
   [Canette, Alexis] Sorbonne Univ, Inst Biol Paris Seine IBPS, Serv Microscopie Elect IBPS SME, CNRS, Paris, France.
   [Hocini, Hakim; Lefebvre, Cecile; El-Jahrani, Nora] Univ Paris Est, INSERM U955, Equipe 16, Creteil, France.
   [Concordet, Jean-Paul] Museum Natl Hist Nat, INSERM U1154, CNRS, UMR7196, Paris, France.
   [Tachdjian, Gerard] Univ Paris Saclay, Hop Antoine Beclere, AP HP, Lab Cytogenet,Serv Histol Embryol Cytogenet, Clamart, France.
   [Behin, Anthony] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Reference Ctr Muscle Dis Paris Est,Myol Inst, Paris, France.
   [Wahbi, Karim] Univ Paris Cite, Cochin Hosp, AP HP, Cardiol Dept, Paris, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Sorbonne Universite; Pasteur Network; Universite Paris Cite; Institut
   Pasteur Paris; Centre National de la Recherche Scientifique (CNRS);
   Sorbonne Universite; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC);
   Museum National d'Histoire Naturelle (MNHN); Institut National de la
   Sante et de la Recherche Medicale (Inserm); Centre National de la
   Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC);
   Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Antoine-Beclere - APHP; Universite Paris Saclay;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique
   Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire
   Cochin - APHP
RP Joanne, P; Agbulut, O (corresponding author), Sorbonne Univ, Inst Biol Paris Seine IBPS, UMR CNRS 8256, INSERM U1164,Biol Adaptat & Ageing, 7 Quai St Bernard,Case 256, F-75005 Paris, France.
EM pierre.joanne@sorbonne-universite.fr;
   onnik.agbulut@sorbonne-universite.fr
RI Joanne, Pierre/D-1866-2012; Li, Zhenlin/GLS-1297-2022; concordet,
   jean-paul/C-3417-2015; RODRIGUEZ, Anne-Marie/M-1190-2018
OI Nora, El Jahrani/0000-0003-3570-1846; LI, Zhenlin/0000-0002-3706-4505;
   Canette, Alexis/0000-0002-2750-6568; RODRIGUEZ,
   Anne-Marie/0000-0001-5557-8975; Concordet, Jean-Paul/0000-0001-8924-4316
FU Sorbonne Universite; CNRS; INSERM; Agence Nationale de la Recherche
   [ANR-21-CE19-0027-MoHeDis]; AFM-Telethon [22142, 20479]; Cifre PhD
   scholarship - Ksilink (Strasbourg); ANRT [2020/0074]; Agence Nationale
   de la Recherche (ANR) [ANR-21-CE19-0027] Funding Source: Agence
   Nationale de la Recherche (ANR)
FX This work was supported by funds from Sorbonne Universite, the CNRS, the
   INSERM, the Agence Nationale de la Recherche (ANR-21-CE19-0027-MoHeDis)
   and the AFM-Telethon (contract number: 22142). Y.H. was supported by a
   Ph.D. fellowship from the AFM-Telethon (contract number: 20479) and V.B.
   was supported by a Cifre PhD scholarship provided by Ksilink
   (Strasbourg) and supported by an ANRT grant (contract number:
   2020/0074).
CR Agnetti G, 2022, FEBS J, V289, P2755, DOI 10.1111/febs.15864
   Agnetti G, 2014, CARDIOVASC RES, V102, P24, DOI 10.1093/cvr/cvu003
   Agudelo D, 2017, NAT METHODS, V14, P615, DOI [10.1038/NMETH.4265, 10.1038/nmeth.4265]
   Alam S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009289
   Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2
   Barron MJ, 2005, NEUROMUSCULAR DISORD, V15, P768, DOI 10.1016/j.nmd.2005.06.018
   Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046
   Béhin A, 2015, REV NEUROL-FRANCE, V171, P715, DOI 10.1016/j.neurol.2015.06.002
   Berry N, 2021, MBIO, V12, DOI 10.1128/mBio.02557-21
   Billon P, 2017, MOL CELL, V67, P1068, DOI 10.1016/j.molcel.2017.08.008
   Birket MJ, 2015, CELL REP, V13, P733, DOI 10.1016/j.celrep.2015.09.025
   Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057
   Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brodehl A, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11233906
   Brodehl A, 2019, GENES-BASEL, V10, DOI 10.3390/genes10110918
   Brodehl Andreas, 2018, Biophys Rev, V10, P983, DOI 10.1007/s12551-018-0429-0
   Bryant JD, 2022, CURR PROTOC, V2, DOI 10.1002/cpz1.372
   Butler J, 2020, J CARD FAIL, V26, P429, DOI 10.1016/j.cardfail.2020.02.001
   Capetanaki Y, 2015, CURR OPIN CELL BIOL, V32, P113, DOI 10.1016/j.ceb.2015.01.004
   Chourbagi O, 2011, EXP CELL RES, V317, P886, DOI 10.1016/j.yexcr.2011.01.013
   Dayal AA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218122
   Doulamis IP, 2020, EUR J CARDIO-THORAC, V57, P836, DOI 10.1093/ejcts/ezz326
   Elsnicova B, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms231912020
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Favre B, 2011, EUR J CELL BIOL, V90, P390, DOI 10.1016/j.ejcb.2010.11.013
   Fornès P, 2021, ANN PATHOL, V41, P85, DOI 10.1016/j.annpat.2020.09.008
   Fountoulakis M, 2005, J MOL CELL CARDIOL, V38, P461, DOI 10.1016/j.yjmcc.2004.12.008
   Giacomelli E, 2020, CELL STEM CELL, V26, P862, DOI 10.1016/j.stem.2020.05.004
   Guichard JL, 2017, AM J PHYSIOL-HEART C, V313, pH32, DOI 10.1152/ajpheart.00027.2017
   Guzun R, 2012, BBA-BIOMEMBRANES, V1818, P1545, DOI 10.1016/j.bbamem.2011.12.034
   Hnia K, 2015, CELL TISSUE RES, V360, P591, DOI 10.1007/s00441-014-2016-4
   Huang XY, 2022, PHARMACEUTICS, V14, DOI 10.3390/pharmaceutics14122760
   Ikeda G, 2021, J AM COLL CARDIOL, V77, P1073, DOI 10.1016/j.jacc.2020.12.060
   Joanne Pierre, 2011, Biologie Aujourd hui, V205, P163, DOI 10.1051/jbio/2011016
   Kay L, 1997, BBA-BIOENERGETICS, V1322, P41, DOI 10.1016/S0005-2728(97)00071-6
   Kaza AK, 2017, J THORAC CARDIOV SUR, V153, P934, DOI 10.1016/j.jtcvs.2016.10.077
   Khalfi P, 2023, PLOS PATHOG, V19, DOI 10.1371/journal.ppat.1011170
   Knollmann BC, 2013, CIRC RES, V112, P969, DOI 10.1161/CIRCRESAHA.112.300567
   Koblan LW, 2018, NAT BIOTECHNOL, V36, P843, DOI 10.1038/nbt.4172
   Kubánek M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040937
   Kulikova O, 2021, GENES-BASEL, V12, DOI 10.3390/genes12010121
   Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01
   Li HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167908
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109
   Lindén M, 2001, J BIOENERG BIOMEMBR, V33, P333, DOI 10.1023/A:1010611408007
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012
   McCormick EM, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00199
   McCully JD, 2009, AM J PHYSIOL-HEART C, V296, pH94, DOI 10.1152/ajpheart.00567.2008
   Meyer JN, 2017, TOXICOLOGY, V391, P42, DOI 10.1016/j.tox.2017.07.019
   Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Mohamud Y, 2023, VIRUSES-BASEL, V15, DOI 10.3390/v15020351
   Moore J, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24054724
   Mussil B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39245-8
   Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054
   Ottaviani D, 2023, DEVELOPMENT, V150, DOI 10.1242/dev.201103
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Paulin D, 2004, J PATHOL, V204, P418, DOI 10.1002/path.1639
   Pautasso S, 2018, J VIROL, V92, DOI 10.1128/JVI.01224-18
   Pluess Marlene, 2015, Biophys Rev, V7, P25, DOI 10.1007/s12551-014-0146-2
   Protonotarios A, 2021, CAN J CARDIOL, V37, P857, DOI 10.1016/j.cjca.2020.11.017
   Rainer PP, 2018, CIRC RES, V122, pE75, DOI 10.1161/CIRCRESAHA.117.312082
   Ramaccini D, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.624216
   Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626
   Sabbah HN, 2020, JACC-BASIC TRANSL SC, V5, P88, DOI 10.1016/j.jacbts.2019.07.009
   Schmidt CA, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101140
   Schröder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060
   Schwarz N, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030030
   Seo KS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00552
   Servais L, 2020, NEUROMUSCULAR DISORD, V30, P5, DOI 10.1016/j.nmd.2019.10.008
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Singh A, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103244
   Singh SR, 2018, CIRC RES, V122, P1324, DOI 10.1161/CIRCRESAHA.118.312965
   Smolina N, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165745
   Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.2
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744
   Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630
   Suspène R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0
   Suspène R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554
   Suspène R, 2017, NUCLEIC ACIDS RES, V45, P3231, DOI 10.1093/nar/gkx001
   Suspène R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108
   Thebault C, 2008, EUR J ECHOCARDIOGR, V9, P840, DOI 10.1093/ejechocard/jen189
   Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446
   Tse HF, 2013, HUM MOL GENET, V22, P1395, DOI 10.1093/hmg/dds556
   Tsui HY, 2023, SCI TRANSL MED, V15, DOI 10.1126/scitranslmed.add4248
   van Meer Berend J, 2018, Curr Protoc Hum Genet, V99, pe67, DOI 10.1002/cphg.67
   van Opbergen CJM, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01496
   Vignais ML, 2023, CELLS-BASEL, V12, DOI 10.3390/cells12040582
   Vincent AE, 2016, NEUROMUSCULAR DISORD, V26, P691, DOI 10.1016/j.nmd.2016.08.004
   Vrabie A, 2005, ACTA NEUROPATHOL, V109, P411, DOI 10.1007/s00401-005-0980-1
   Walters AM, 2012, CIRC RES, V111, P1222, DOI 10.1161/CIRCRESAHA.112.265660
   Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151
   Winter L, 2016, ACTA NEUROPATHOL, V132, P453, DOI 10.1007/s00401-016-1592-7
   Wu BW, 2017, CELL PHYSIOL BIOCHEM, V42, P713, DOI 10.1159/000477889
   Yamada Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176365
   Yépez VA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199938
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang AL, 2023, MOL THER, V31, P1468, DOI 10.1016/j.ymthe.2023.02.016
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
NR 103
TC 2
Z9 2
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD JAN 2
PY 2024
VL 15
IS 1
AR 10
DI 10.1186/s13287-023-03619-7
PG 23
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA DX4F1
UT WOS:001135362700004
PM 38167524
OA gold, Green Submitted, Green Published
DA 2024-11-01
ER

PT J
AU Hjelm, BE
   Rollins, B
   Morgan, L
   Sequeira, A
   Mamdani, F
   Pereira, F
   Damas, J
   Webb, MG
   Weber, MD
   Schatzberg, A
   Barchas, JD
   Lee, FS
   Akil, H
   Watson, SJ
   Myers, RM
   Chao, EC
   Kimonis, V
   Thompson, PM
   Bunney, WE
   Vawter, MP
AF Hjelm, Brooke E.
   Rollins, Brandi
   Morgan, Ling
   Sequeira, Adolfo
   Mamdani, Firoza
   Pereira, Filipe
   Damas, Joana
   Webb, Michelle G.
   Weber, Matthieu D.
   Schatzberg, AlanF
   Barchas, Jack D.
   Lee, Francis S.
   Akil, Huda
   Watson, Stanley J.
   Myers, Richard M.
   Chao, Elizabeth C.
   Kimonis, Virginia
   Thompson, Peter M.
   Bunney, William E.
   Vawter, Marquis P.
TI Splice-Break: exploiting an RNA-seq splice junction algorithm to
   discover mitochondrial DNA deletion breakpoints and analyses of
   psychiatric disorders
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; REAL-TIME PCR; MUTATIONS; GENE;
   SINGLE; ACCURATE; GENOME
AB Deletions in the 16.6kb mitochondrial genome have been implicated in numerous disorders that often display muscular and/or neurological symptoms due to the high-energy demands of these tissues. We describe a catalogue of 4489 putative mitochondrial DNA (mtDNA) deletions, including their frequency and relative read rate, using a combinatorial approach of mitochondria-targeted PCR, next-generation sequencing, bioinformatics, post-hoc filtering, annotation, and validation steps. Our bioinformatics pipeline uses MapSplice, an RNA-seq splice junction detection algorithm, to detect and quantify mtDNA deletion breakpoints rather than mRNA splices. Analyses of 93 samples from postmortem brain and blood found (i) the 4977bp common deletion' was neither the most frequent deletion nor the most abundant; (ii) brain contained significantly more deletions than blood; (iii) many high frequency deletions were previously reported in MitoBreak, suggesting they are present at low levels in metabolically active tissues and are not exclusive to individuals with diagnosed mitochondrial pathologies; (iv) many individual deletions (and cumulative metrics) had significant and positive correlations with age and (v) the highest deletion burdens were observed in major depressive disorder brain, at levels greater than Kearns-Sayre Syndrome muscle. Collectively, these data suggest the Splice-Break pipeline can detect and quantify mtDNA deletions at a high level of resolution.
C1 [Hjelm, Brooke E.; Rollins, Brandi; Morgan, Ling; Sequeira, Adolfo; Mamdani, Firoza; Weber, Matthieu D.; Bunney, William E.; Vawter, Marquis P.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA.
   [Hjelm, Brooke E.; Webb, Michelle G.] Univ Southern Calif, Keck Sch Med, Dept Translat Genom, Los Angeles, CA 90033 USA.
   [Pereira, Filipe] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, P-4050123 Matosinhos, Portugal.
   [Damas, Joana] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.
   [Schatzberg, AlanF] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.
   [Barchas, Jack D.; Lee, Francis S.] Cornell Univ, Weill Cornell Med Coll, Dept Psychiat, New York, NY 10065 USA.
   [Akil, Huda; Watson, Stanley J.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.
   [Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA.
   [Chao, Elizabeth C.; Kimonis, Virginia] UCI, Div Genet & Genom Med, Dept Pediat, Irvine, CA USA.
   [Thompson, Peter M.] Texas Tech Univ, Hlth Sci Ctr, Southwest Brain Bank, Dept Psychiat, El Paso, TX 79905 USA.
C3 University of California System; University of California Irvine;
   University of Southern California; Universidade do Porto; University of
   California System; University of California Davis; Stanford University;
   Cornell University; Weill Cornell Medicine; University of Michigan
   System; University of Michigan; HudsonAlpha Institute for Biotechnology;
   University of California System; University of California Irvine; Texas
   Tech University System; Texas Tech University
RP Hjelm, BE; Vawter, MP (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA.; Hjelm, BE (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Translat Genom, Los Angeles, CA 90033 USA.
EM bhjelm@usc.edu; mvawter@uci.edu
RI Sequeira, Adolfo/K-7278-2015; Damas, Joana/AHE-6278-2022; Damas,
   Joana/J-6045-2013; Pereira, Filipe/F-6391-2010; Thompson,
   Paul/C-4194-2018
OI Damas, Joana/0000-0003-4857-2510; Pereira, Filipe/0000-0001-8950-1036;
   Thompson, Paul/0000-0002-4720-8867; Hjelm, Brooke/0000-0001-8234-2343
FU Della Martin Foundation; National Institute of Mental Health (NIMH),
   National Institutes of Health [R01MH08580, R21MH099440, R01MH097082];
   Portuguese Foundation for Science and Technology [IF/01356/2012]; McKee
   Foundation; TTUHSC-E1 Paso; Pritzker Neuropsychiatric Disorders Research
   Consortium; National Institute of Mental Health
FX Della Martin Foundation [to W.B., B.H. postdoctoral fellowship];
   National Institute of Mental Health (NIMH), National Institutes of
   Health [R01MH08580, R21MH099440 to M.V. and R01MH097082 to A.
   S.];Portuguese Foundation for Science and Technology [IF/01356/2012 to
   F.P.]. Funding support for postmortem brains collected at the Southwest
   Brain Bank at Texas Tech University Health Sciences Center (TTUHSC) was
   provided by the McKee Foundation and TTUHSC-E1 Paso. Funding support for
   postmortem brains collected at the University of California-Irvine (UCI)
   Brain Bank was provided by the Pritzker Neuropsychiatric Disorders
   Research Consortium. Funding for open access charge: National Institute
   of Mental Health.
CR BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1821-7
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   DiMauro S., 1993, GENEREVIEWS
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Grady JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114462
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Guo Y, 2013, BIOINFORMATICS, V29, P1210, DOI 10.1093/bioinformatics/btt118
   Harbottle A, 2004, J INVEST DERMATOL, V122, P1518, DOI 10.1111/j.0022-202X.2004.22608.x
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kasahara T, 2016, MOL PSYCHIATR, V21, P39, DOI 10.1038/mp.2015.156
   Koene S, 2009, J AFFECT DISORDERS, V114, P327, DOI 10.1016/j.jad.2008.06.023
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Leshinsky-Silver E, 2011, EUR J HUM GENET, V19, P287, DOI 10.1038/ejhg.2010.213
   LESTIENNE P, 1988, LANCET, V1, P885
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110
   Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229
   Milone M., 2013, MITOCHONDRIAL DISORD, P123
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   Morava É, 2013, NEUROSCI BIOBEHAV R, V37, P668, DOI 10.1016/j.neubiorev.2013.02.005
   Newsholme P, 2012, ADV EXP MED BIOL, V942, P235, DOI 10.1007/978-94-007-2869-1_10
   Parada GE, 2014, NUCLEIC ACIDS RES, V42, P10564, DOI 10.1093/nar/gku744
   Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006
   Peters SK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00104
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5
   ROTIG A, 1991, GENOMICS, V10, P502, DOI 10.1016/0888-7543(91)90342-C
   Seneca S, 2015, EUR J HUM GENET, V23, P41, DOI 10.1038/ejhg.2014.49
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Zambelli F, 2017, EUR J HUM GENET, V25, P1229, DOI 10.1038/ejhg.2017.129
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 56
TC 16
Z9 17
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUN 4
PY 2019
VL 47
IS 10
AR e59
DI 10.1093/nar/gkz164
PG 19
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Biochemistry & Molecular Biology
GA IC8RE
UT WOS:000471248400005
PM 30869147
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Çanakçi, CF
   Tatar, A
   Çanakçi, V
   Cicek, Y
   Oztas, S
   Orbak, R
AF Canakci, Cenk Fatih
   Tatar, Abdulgani
   Canakci, Varol
   Cicek, Yasin
   Oztas, Sitki
   Orbak, Recep
TI New evidence of premature oxidative DNA damage:: Mitochondrial DNA
   deletion in gingival tissue of patients with periodontitis
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE chronic periodontitis; gingiva; mitochondrial DNA; oxidative stress;
   reactive oxygen species
ID DISEASE; CELLS; STRESS; ANTIOXIDANTS; MUTATIONS; MUSCLE
AB Background: Overproduction of reactive oxygen species (ROS) causes increased oxidative stress in gingival tissue. It has been generally accepted that increased oxidative stress might contribute to additional damage of lipids, proteins, and DNA molecules. The mitochondrial DNA (mtDNA) mutation is a superb biomarker of oxidative damage. The aim of the present study was to investigate the mtDNA deletions in the gingival tissue of patients with periodontitis and to explain the correlations between mtDNA deletion in gingival tissue and clinical parameters of periodontitis and age.
   Methods: Gingival tissue and blood samples were collected from 30 patients with chronic periodontitis (CP group) and 30 healthy control subjects (H group). To determine the clinical condition of each subject, the plaque index, gingival index, clinical attachment level, and probing depth were measured. Using the polymerase chain reaction (PCR) method, we examined the 7.4- and 5-kbp mtDNA deletions in tissue and blood samples. Three different pairs of PCR primers were used in this study.
   Results: In this study, we did not detect any deletions in blood DNA samples in either the CP or H group. Also, the 7.4-kbp mtDNA deletion was not detected in gingival tissues of subjects. However, the 5-kbp mtDNA deletion was detected in 24 of the 30 subjects (80%) in the CP group and was not detected in the H group (0%). Significant correlations were found between the occurrence of the 5-kbp mtDNA deletion and all clinical parameters (P < 0.01). A similar correlation was found between the occurrence of the 5-kbp mtDNA deletion and age (P < 0.05).
   Conclusions: The overproduction of ROS by activated polymorphonuclear leukocytes in chronic inflammation may lead to premature oxidative damage of the mtDNA. In this study, the occurrence of the 5-kbp mtDNA deletion in 24 periodontitis subjects may be evidence of premature oxidative DNA damage.
C1 Ataturk Univ, Fac Dent, Dept Periodont, TR-25240 Erzurum, Turkey.
C3 Ataturk University
RP Çanakçi, CF (corresponding author), Ataturk Univ, Fac Dent, Dept Periodont, TR-25240 Erzurum, Turkey.
EM cfcanakci@yahoo.com
RI tatar, abdulgani/I-6300-2012; CANAKCI, VAROL/AFA-9502-2022
CR Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Çanakçi CF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P619, DOI 10.1007/s10541-005-0161-9
   Chapple ILC, 1997, J CLIN PERIODONTOL, V24, P287, DOI 10.1111/j.1600-051X.1997.tb00760.x
   Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X
   KATSUMATA K, 1994, BIOCHEM BIOPH RES CO, V202, P102, DOI 10.1006/bbrc.1994.1899
   LAMSTER IB, 1992, CRIT REV ORAL BIOL M, V3, P31, DOI 10.1177/10454411920030010501
   Lee HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P309, DOI 10.1006/abbi.1998.1036
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lim PS, 2000, FREE RADICAL BIO MED, V29, P454, DOI 10.1016/S0891-5849(00)00334-8
   Liu TY, 1996, MUTAT RES-GENET TOX, V367, P25, DOI 10.1016/S0165-1218(96)90018-X
   Loe H., 1963, ACTA ODONTOL SCAND, V21, P531
   MILLER DR, 1984, J CLIN PERIODONTOL, V11, P1, DOI 10.1111/j.1600-051X.1984.tb01303.x
   Moseley R, 1997, BBA-MOL BASIS DIS, V1362, P221, DOI 10.1016/S0925-4439(97)00083-5
   Ozmeric N, 2004, CLIN CHIM ACTA, V343, P1, DOI 10.1016/j.cccn.2004.01.022
   Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427
   RIMOIN DL, 2002, MITOCHONDIRAL GENES, V1, P299
   SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0
   Sculley DV, 2002, P NUTR SOC, V61, P137, DOI 10.1079/PNS2001141
   Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0
   SHACTER E, 1988, CARCINOGENESIS, V9, P2297, DOI 10.1093/carcin/9.12.2297
   SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968
   Sugano N, 2000, J Oral Sci, V42, P221
   Takane M, 2002, J PERIODONTOL, V73, P551, DOI 10.1902/jop.2002.73.5.551
   Tamori A, 2004, J GASTROENTEROL, V39, P1063, DOI 10.1007/s00535-004-1445-3
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Wilson GL, 1997, DIABETES, V46, P1291, DOI 10.2337/diabetes.46.8.1291
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
NR 29
TC 39
Z9 44
U1 0
U2 19
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD NOV
PY 2006
VL 77
IS 11
BP 1894
EP 1900
DI 10.1902/jop.2006.060108
PG 7
WC Dentistry, Oral Surgery & Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dentistry, Oral Surgery & Medicine
GA 130LM
UT WOS:000243801100014
PM 17076616
DA 2024-11-01
ER

PT J
AU Berio, A
   Mariottini, GL
   Frascio, M
   Piazzi, A
AF Berio, Agostino
   Mariottini, Gian Luigi
   Frascio, Marco
   Piazzi, Attilia
TI Kearns-Sayre syndrome with optic nerve atrophy phenotype: A possible
   biological and clinical concurrence of two mutations?
SO JOURNAL OF BIOLOGICAL RESEARCH-BOLLETTINO DELLA SOCIETA ITALIANA DI
   BIOLOGIA SPERIMENTALE
LA English
DT Article
DE Chronic progressive external ophthalmoplegia; Kearns-Sayre syndrome;
   Coenzyme Q10 therapy; optic nerve atrophy; OPA 1 mutation; coenzyme Q10
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA DELETIONS;
   RESPIRATORY-CHAIN DISORDERS; NEURODEGENERATIVE DISORDERS; DYSFUNCTION;
   IMPROVEMENT; DEPLETION; MUSCLE; PLUS; GENE
AB The authors report about the association of progressive external ophthalmoplegia, atypical pigmentary retinopathy, ataxia phenotype with onset in first months of life (Kearns-Sayre syndrome) and with optic nerve atrophy and deafness. The localization of retinal lesions was coincident with that reported by multifunctional electroretinogram (mfERG) in OPA 1 mutation. The authors hypothesize that Kearns-Sayre mitochondrial mutation may be associated with OPA 1 missense mutation, with worsening of symptomatology, as occurs in the reported case. The prolonged rehabilitation and treatment with coenzyme Q10 for many years gave positive results, with amelioration of ophthalmoplegia, stopping of aggravation of retinal damage and optic nerve atrophy, maintaining of vision some meters away, possibility of socialization and proprioceptive ability amelioration.
C1 [Berio, Agostino; Piazzi, Attilia] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mother C, Genoa, Italy.
   [Mariottini, Gian Luigi] Univ Genoa, Dept Earth Environm & Life Sci DISTAV, Genoa, Italy.
   [Frascio, Marco] Univ Genoa, Dept Surg Sci & Integrated Diagnost DISC, Genoa, Italy.
C3 University of Genoa; University of Genoa; University of Genoa
RP Berio, A (corresponding author), Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mother C, Genoa, Italy.; Mariottini, GL (corresponding author), Univ Genoa, Dept Earth Environm & Life Sci DISTAV, Genoa, Italy.
EM Agostinoberio@ospedale-gaslini.ge.it; Gian.Luigi.Mariottini@unige.it
RI FRASCIO, MARCO/KIH-4531-2024
CR Barbet F, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025502
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   BERIO A, 1994, OPHTHALMOLOGICA, V208, P342, DOI 10.1159/000310536
   Berio A, 2011, J BIOL RES-BOLL SOC, V84, P73, DOI 10.4081/jbr.2011.4496
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Cascavilla ML, 2018, ACTA OPHTHALMOL, V96, pe156, DOI 10.1111/aos.13557
   Cerri C, 1983, MITOCHONDRIAL PATHOL, P141
   Chertkof J, 2020, OPHTHALMIC GENET, V41, P497, DOI 10.1080/13816810.2020.1799416
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   EAGLE RC, 1982, OPHTHALMOLOGY, V89, P1433
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   HORWITZ SJ, 1978, ANN NEUROL, V3, P513, DOI 10.1002/ana.410030611
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805
   Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5
   Luca P, 2020, NEURORADIOLOGY, V62, P1315, DOI 10.1007/s00234-020-02501-0
   Melberg A, 1996, MUSCLE NERVE, V19, P751
   Mishra R, 2020, J MED RES, V6, P271
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   OGASAHARA S, 1985, NEUROLOGY, V35, P372, DOI 10.1212/WNL.35.3.372
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P161, DOI 10.1007/978-3-319-95046-4_30
   Willett W, 2002, AM J CLIN NUTR, V76, p274S, DOI 10.1093/ajcn/76.1.274S
   ZIERZ S, 1989, J NEUROL, V236, P97, DOI 10.1007/BF00314404
NR 33
TC 0
Z9 0
U1 1
U2 1
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 1826-8838
EI 2284-0230
J9 J BIOL RES-BOLL SOC
JI J. Biol. Res.-Boll. Soc. Biol. Sper.
PY 2022
VL 95
IS 1
AR 10308
DI 10.4081/jbr.2022.10308
PG 7
WC Biology
WE Emerging Sources Citation Index (ESCI)
SC Life Sciences & Biomedicine - Other Topics
GA 2K0CY
UT WOS:000816014500012
OA gold
DA 2024-11-01
ER

PT J
AU Marazziti, D
   Baroni, S
   Picchetti, M
   Landi, P
   Silvestri, S
   Vatteroni, E
   Dell'Osso, MC
AF Marazziti, D.
   Baroni, S.
   Picchetti, M.
   Landi, P.
   Silvestri, S.
   Vatteroni, E.
   Dell'Osso, M. Catena
TI Mitochondrial Alterations and Neuropsychiatric Disorders
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE Mitochondria; ATP; Genetics; Mitochondrial Diseases; Schizophrenia; Mood
   Disorders; Anxiety Disorders; Autism; ADHD; Alzheimer's disease
ID COMPLEX-I ACTIVITY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   MAGNETIC-RESONANCE-SPECTROSCOPY; CYTOCHROME-C-OXIDASE; STROKE-LIKE
   EPISODES; ALZHEIMERS-DISEASE; OXIDATIVE DAMAGE; PSYCHIATRIC-SYMPTOMS;
   MULTIPLE DELETIONS; BIPOLAR DISORDER
AB Mitochondria are membrane-enclosed organelle found in most eukaryotic cells, where they generate the majority of the cell's supply of adenosine triphosphate (ATP), used as a source of chemical energy. In addition, they are involved in a range of other processes, such as signalling, cellular differentiation, cell death, as well as the control of the cell cycle and cell growth. Mitochondria have been implicated in several neuropsychiatric disorders, in particular, depression, anxiety, schizophrenia, autism, and Alzheimer's dementia. Furthermore, the presence of mutations at the level of mitochondrial or nuclear DNA (mtDNA and nDNA, respectively) has been linked to personality disorders, behavioral disturbances, thought alterations, impulsivity, learning impairment, cognitive failures until dementia. The aim of this paper is to review the literature on the relationship between psychiatric symptoms or syndromes and mtDNA mutations or mitochondrial alterations, while highlighting novel therapeutic targets for a broad range of disorders.
C1 [Marazziti, D.; Baroni, S.; Picchetti, M.; Landi, P.; Silvestri, S.; Vatteroni, E.; Dell'Osso, M. Catena] Univ Pisa, Dipartimento Psichiatria Neurobiol Farmacol & Bio, I-56100 Pisa, Italy.
C3 University of Pisa
RP Marazziti, D (corresponding author), Univ Pisa, Dipartimento Psichiatria Neurobiol Farmacol & Bio, Via Roma 67, I-56100 Pisa, Italy.
EM dmarazzi@psico.med.unipi.it
RI Baroni, Stefano/AAL-2090-2020
OI Baroni, Stefano/0000-0001-7688-5069; Marazziti,
   Donatella/0000-0002-4021-5829
CR Alberts B., 1983, MOL BIOL CELL 2, P321
   ALTMANN R., 1890, ELEMENTARORGANISMEN
   Amemiya S, 2000, NEUROLOGY, V55, P600, DOI 10.1212/WNL.55.4.600
   Andreazza AC, 2010, ARCH GEN PSYCHIAT, V67, P360, DOI 10.1001/archgenpsychiatry.2010.22
   BARBIROLI B, 1993, J CEREBR BLOOD F MET, V13, P469, DOI 10.1038/jcbfm.1993.61
   BARON M, 1994, BIOL PSYCHIAT, V35, P757, DOI 10.1016/0006-3223(94)91135-5
   Beal MF, 2005, NEUROBIOL AGING, V26, P585, DOI 10.1016/j.neurobiolaging.2004.09.022
   Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649
   Ben-Shachar D, 2004, BIOCHEM PHARMACOL, V67, P1965, DOI 10.1016/j.bcp.2004.02.015
   Benda C., 1898, Arch Anat Physiol, V73, P393
   Berio A, 2002, PANMINERVA MED, V44, P265
   Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005
   Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   Boles RG, 2005, AM J MED GENET B, V137B, P20, DOI 10.1002/ajmg.b.30199
   BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605
   Burnett BB, 2005, J AFFECT DISORDERS, V88, P109, DOI 10.1016/j.jad.2005.05.009
   Campos Y, 2001, J INHERIT METAB DIS, V24, P685, DOI 10.1023/A:1012719211505
   Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389
   CAVELIER L, 1995, GENOMICS, V29, P217, DOI 10.1006/geno.1995.1234
   CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Chinnery PF, 1997, QJM-INT J MED, V90, P657, DOI 10.1093/qjmed/90.11.657
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORTOPASSI G, 1995, BBA-MOL BASIS DIS, V1271, P171, DOI 10.1016/0925-4439(95)00025-Y
   Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149
   Cutter WJ, 2003, J NEUROL NEUROSUR PS, V74, P837, DOI 10.1136/jnnp.74.7.837
   DEICKEN RF, 1995, J AFFECT DISORDERS, V33, P195, DOI 10.1016/0165-0327(94)00089-R
   DiMauro S, 1998, NEUROSCIENTIST, V4, P53, DOI 10.1177/107385849800400113
   Dror N, 2002, MOL PSYCHIATR, V7, P995, DOI 10.1038/sj.mp.4001116
   ELEFF SM, 1990, ANN NEUROL, V27, P626, DOI 10.1002/ana.410270607
   Fadic R, 1996, SEMIN NEUROL, V16, P11, DOI 10.1055/s-2008-1040954
   Friedrich T, 2004, BBA-BIOENERGETICS, V1608, P1, DOI 10.1016/j.bbabio.2003.10.002
   Gardner A, 2003, ACTA PSYCHIAT SCAND, V107, P233, DOI 10.1034/j.1600-0447.2003.02188.x
   Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6
   György H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016
   HART ZH, 1977, ARCH NEUROL-CHICAGO, V34, P180, DOI 10.1001/archneur.1977.00500150066013
   Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horsefield R, 2004, CURR PROTEIN PEPT SC, V5, P107, DOI 10.2174/1389203043486847
   Houshmand M, 2004, NEUROMUSCULAR DISORD, V14, P195, DOI 10.1016/j.nmd.2003.12.002
   IHARA Y, 1989, J NEUROL SCI, V90, P263, DOI 10.1016/0022-510X(89)90112-3
   Inagaki T, 1997, BIOL PSYCHIAT, V42, P1067, DOI 10.1016/S0006-3223(97)00351-X
   Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022
   Jaksch M, 2001, NEUROLOGY, V57, P1930, DOI 10.1212/WNL.57.10.1930
   KALCKAR HERMAN, 1937, ENZYMOLOGIA [HAGUE], V2, P47
   Kandel E.R., 2021, Principles of Neural Science, VSixth
   Karry R, 2004, BIOL PSYCHIAT, V55, P676, DOI 10.1016/j.biopsych.2003.12.012
   KATO T, 1995, PSYCHOL MED, V25, P557, DOI 10.1017/S003329170003347X
   Kato T, 1996, J AFFECT DISORDERS, V37, P67, DOI 10.1016/0165-0327(95)00050-X
   Kato T, 1998, J NEUROPSYCH CLIN N, V10, P133, DOI 10.1176/jnp.10.2.133
   KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3
   KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   KENNEDY EP, 1949, J BIOL CHEM, V179, P957
   Kiejna A., 2002, MED SCI MONITOR, V8, P66
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Lambert JC, 2004, J MED GENET, V41, P104, DOI 10.1136/jmg.2003.005033
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Lindholm E, 1997, EUR J HUM GENET, V5, P406, DOI 10.1159/000484799
   Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066
   MARCHBANKS RM, 1995, BRIT J PSYCHIAT, V167, P293, DOI 10.1192/bjp.167.3.293
   McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054
   Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5
   Mendlewicz J., 1994, GENETIC STUDIES AFFE
   Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miyaoka H, 1997, BIOL PSYCHIAT, V42, P524, DOI 10.1016/S0006-3223(97)00280-1
   Newman-Toker DE, 2003, ARCH OPHTHALMOL-CHIC, V121, P288
   Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003
   Oexle K, 1997, HUM MOL GENET, V6, P905, DOI 10.1093/hmg/6.6.905
   Onishi H, 1997, BIOL PSYCHIAT, V41, P1137, DOI 10.1016/S0006-3223(97)00005-X
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   PALADE GE, 1952, ANAT RECORD, V114, P427, DOI 10.1002/ar.1091140304
   Pantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034
   Praticò D, 2005, NEUROBIOL AGING, V26, P581, DOI 10.1016/j.neurobiolaging.2004.09.020
   Prayson RA, 1998, ARCH PATHOL LAB MED, V122, P978
   Prince JA, 2000, NEUROPSYCHOPHARMACOL, V22, P284, DOI 10.1016/S0893-133X(99)00111-6
   Rossier MF, 2006, CELL CALCIUM, V40, P155, DOI 10.1016/j.ceca.2006.04.020
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Schwartz M, 2003, BIOCHEM BIOPH RES CO, V310, P247, DOI 10.1016/j.bbrc.2003.09.037
   Shah NS, 2002, J CHILD NEUROL, V17, P369, DOI 10.1177/088307380201700511
   SHANSKE AL, 1993, NEUROMUSCULAR DISORD, V3, P191, DOI 10.1016/0960-8966(93)90058-R
   Sherwin BB, 2003, ENDOCR REV, V24, P133, DOI 10.1210/er.2001-0016
   Shinkai T, 2000, AUST NZ J PSYCHIAT, V34, P1034, DOI 10.1080/000486700286
   SHOFFNER JM, 1995, NEUROLOGY, V45, P286, DOI 10.1212/WNL.45.2.286
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942
   Spellberg B, 2001, ARCH INTERN MED, V161, P2497, DOI 10.1001/archinte.161.20.2497
   STEWART J B, 1990, Medical Science Research, V18, P265
   Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0
   Sullivan PG, 2005, PROG NEURO-PSYCHOPH, V29, P407, DOI 10.1016/j.pnpbp.2004.12.007
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suzuki Y, 1997, MOL ASPECTS MED, V18, pS181
   SWEENEY MG, 1993, Q J MED, V86, P709
   Thomeer EC, 1998, J NEUROL NEUROSUR PS, V64, P692, DOI 10.1136/jnnp.64.5.692
   TOROK TL, 1989, PROG NEUROBIOL, V32, P11, DOI 10.1016/0301-0082(89)90027-0
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Varvogli L, 1999, J INHERIT METAB DIS, V22, P615, DOI 10.1023/A:1005521828360
   Voet D, 2006, FUNDAMENTALS BIOCH
   WALLACE DC, 1994, EPILEPSIA, V35, pS43, DOI 10.1111/j.1528-1157.1994.tb05928.x
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC., 1997, MITOCHONDRIA FREE RA, P283
   Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105
   Warburg O, 1913, PFLUG ARCH GES PHYS, V154, P599, DOI 10.1007/BF01681207
   Wei YH, 1996, ANN NY ACAD SCI, V786, P24, DOI 10.1111/j.1749-6632.1996.tb39049.x
   WOLFF DJ, 1977, J BIOL CHEM, V252, P4108
   Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 114
TC 36
Z9 38
U1 1
U2 17
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PD OCT
PY 2011
VL 18
IS 30
BP 4715
EP 4721
DI 10.2174/092986711797379221
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 875EC
UT WOS:000299012200009
PM 21864278
DA 2024-11-01
ER

PT J
AU De la Casa-Fages, B
   Fernández-Eulate, G
   Gamez, J
   Barahona-Hernando, R
   Morís, G
   García-Barcina, M
   Infante, J
   Zulaica, M
   Fernández-Pelayo, U
   Muñoz-Oreja, M
   Urtasun, M
   Olaskoaga, A
   Zelaya, V
   Jericó, I
   Saez-Villaverde, R
   Catalina, I
   Sola, E
   Martínez-Sáez, E
   Pujol, A
   Ruiz, M
   Schlüter, A
   Spinazzola, A
   Muñoz-Blanco, JL
   Grandas, F
   Holt, I
   Alvarez, V
   de Munaín, AL
AF De la Casa-Fages, Beatriz
   Fernandez-Eulate, Gorka
   Gamez, Josep
   Barahona-Hernando, Raul
   Moris, German
   Garcia-Barcina, Maria
   Infante, Jon
   Zulaica, Miren
   Fernandez-Pelayo, Uxoa
   Munoz-Oreja, Mikel
   Urtasun, Miguel
   Olaskoaga, Ander
   Zelaya, Victoria
   Jerico, Ivonne
   Saez-Villaverde, Raquel
   Catalina, Irene
   Sola, Emma
   Martinez-Saez, Elena
   Pujol, Aurora
   Ruiz, Montserrat
   Schluter, Agatha
   Spinazzola, Antonella
   Luis Munoz-Blanco, Jose
   Grandas, Francisco
   Holt, Ian
   Alvarez, Victoria
   Lopez de Munain, Adolfo
TI Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of
   mitochondrial Parkinsonism
SO MOVEMENT DISORDERS
LA English
DT Article
DE hereditary spastic paraplegia; mitochondria; parkinsonism; pathogenic
   genetic variants; SPG7 gene
ID SPG7 MUTATIONS; SUBSTANTIA-NIGRA; DNA DELETIONS; GENE; DISEASE;
   HOMEOSTASIS; IMPAIRMENT; PROTEIN
AB Background Pathogenic variants in the spastic paraplegia type 7 gene cause a complicated hereditary spastic paraplegia phenotype associated with classical features of mitochondrial diseases, including ataxia, progressive external ophthalmoplegia, and deletions of mitochondrial DNA. Objectives To better characterize spastic paraplegia type 7 disease with a clinical, genetic, and functional analysis of a Spanish cohort of spastic paraplegia type 7 patients. Methods Genetic analysis was performed in patients suspecting hereditary spastic paraplegia and in 1 patient with parkinsonism and Pisa syndrome, through next-generation sequencing, whole-exome sequencing, targeted Sanger sequencing, and multiplex ligation-dependent probe analysis, and blood mitochondrial DNA levels determined by quantitative polymerase chain reaction. Results Thirty-five patients were found to carry homozygous or compound heterozygous pathogenic variants in the spastic paraplegia type 7 gene. Mean age at onset was 40 years (range, 12-63); 63% of spastic paraplegia type 7 patients were male, and three-quarters of all patients had at least one allele with the c.1529C>T (p.Ala510Val) mutation. Eighty percent of the cohort showed a complicated phenotype, combining ataxia and progressive external ophthalmoplegia (65% and 26%, respectively). Parkinsonism was observed in 21% of cases. Analysis of blood mitochondrial DNA indicated that both patients and carriers of spastic paraplegia type 7 pathogenic variants had markedly lower levels of mitochondrial DNA than control subjects (228 per haploid nuclear DNA vs. 176 vs. 573, respectively; P < 0.001). Conclusions Parkinsonism is a frequent finding in spastic paraplegia type 7 patients. Spastic paraplegia type 7 pathogenic variants impair mitochondrial DNA homeostasis irrespective of the number of mutant alleles, type of variant, and patient or carrier status. Thus, spastic paraplegia type 7 supports mitochondrial DNA maintenance, and variants in the gene may cause parkinsonism owing to mitochondrial DNA abnormalities. Moreover, mitochondrial DNA blood analysis could be a useful biomarker to detect at risk families. (c) 2019 International Parkinson and Movement Disorder Society
C1 [De la Casa-Fages, Beatriz; Barahona-Hernando, Raul; Catalina, Irene; Luis Munoz-Blanco, Jose; Grandas, Francisco] Hosp Gen Univ Gregorio Maranon, Dept Neurol, Madrid, Spain.
   [De la Casa-Fages, Beatriz; Grandas, Francisco] Hosp Gen Univ Gregorio Maranon, Natl Referral Ctr Rare Dis Movement Disorders CSU, Movement Disorders Unit, Madrid, Spain.
   [De la Casa-Fages, Beatriz; Luis Munoz-Blanco, Jose; Grandas, Francisco] Inst Invest Sanitaria Gregorio Maranon, Neurosci Area, Madrid, Spain.
   [Fernandez-Eulate, Gorka; Urtasun, Miguel; Lopez de Munain, Adolfo] Hosp Univ Donostia, Dept Neurol, San Sebastian, Spain.
   [Fernandez-Eulate, Gorka; Fernandez-Pelayo, Uxoa; Munoz-Oreja, Mikel; Holt, Ian; Lopez de Munain, Adolfo] Inst Biodonostia, Dept Neurosci, San Sebastian, Spain.
   [Gamez, Josep] Hosp Gen Univ Vall dHebron UAB VHIR, Dept Neurol, Barcelona, Spain.
   [Gamez, Josep] Hosp Gen Univ Vall dHebron UAB, ERN RND, Barcelona, Spain.
   [Barahona-Hernando, Raul; Catalina, Irene; Luis Munoz-Blanco, Jose] Hosp Gen Univ Gregorio Maranon, ALS Neuromuscular Unit, Madrid, Spain.
   [Barahona-Hernando, Raul] Hosp Ruber Juan Bravo, Grp Quironsalud, Dept Neurol, Madrid, Spain.
   [Moris, German; Alvarez, Victoria] Inst Invest Biosanitaria Principado Asturias ISPA, Oviedo, Spain.
   [Moris, German] Hosp Univ Cent Asturias, Dept Neurol, Oviedo, Spain.
   [Garcia-Barcina, Maria] Hosp Univ Basurto, Genet Unit, Bilbao, Spain.
   [Infante, Jon] Univ Cantabria, Hosp Univ Marques Valdecilla IDIVAL, Dept Neurol, Santander, Spain.
   [Infante, Jon; Zulaica, Miren] Inst Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.
   [Olaskoaga, Ander] Hosp Zumarraga, Zumarraga, Spain.
   [Zelaya, Victoria] Complejo Hosp Navarra, Dept Pathol, Pamplona, Spain.
   [Jerico, Ivonne] Complejo Hosp Navarra, Dept Neurol, Pamplona, Spain.
   [Saez-Villaverde, Raquel] Hosp Univ Donostia, Dept Genet, San Sebastian, Spain.
   [Sola, Emma] Hosp Gen Univ Gregorio Maranon, Dept Pathol, Madrid, Spain.
   [Martinez-Saez, Elena] Hosp Gen Univ Vall dHebron UAB VHIR, Dept Pathol, Barcelona, Spain.
   [Martinez-Saez, Elena] UAB, Dept Med, Barcelona, Spain.
   [Pujol, Aurora; Ruiz, Montserrat; Schluter, Agatha] Bellvitge Biomed Res Inst IDIBELL, Neurometabol Dis Lab, Barcelona, Spain.
   [Pujol, Aurora] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain.
   [Pujol, Aurora; Ruiz, Montserrat; Schluter, Agatha] Inst Carlos III, Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain.
   [Spinazzola, Antonella] UCL Queen Sq Inst Neurol, Dept Clin Movement Neurosci, Royal Free Campus, London, England.
   [Spinazzola, Antonella] UCL Queen Sq Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.
   [Spinazzola, Antonella] Natl Hosp Neurol & Neurosurg, London, England.
   [Holt, Ian] Basque Fdn Sci, Ikerbasque, Bilbao, Spain.
   [Alvarez, Victoria] Hosp Univ Cent Asturias, AGC Med Lab, Genet Lab, Oviedo, Spain.
   [Lopez de Munain, Adolfo] Univ Basque Country, Dept Neurosci, San Sebastian, Spain.
   [Lopez de Munain, Adolfo] Minist Sci Innovat & Univ, Ciberned, Madrid, Spain.
C3 General University Gregorio Maranon Hospital; General University
   Gregorio Maranon Hospital; Instituto de Investigacion Sanitaria
   Biogipuzkoa; General University Gregorio Maranon Hospital; quironsalud
   Group; Instituto de Investigacion Sanitaria del Principado de Asturias
   (ISPA); Central University Hospital Asturias; Basurto Hospital;
   Universidad de Cantabria; Hospital Universitario Marques de Valdecilla
   (HUMV); CIBERNED; Servicio Navarro de Salud - Osasunbidea; Servicio
   Navarro de Salud - Osasunbidea; General University Gregorio Maranon
   Hospital; Autonomous University of Barcelona; Institut d'Investigacio
   Biomedica de Bellvitge (IDIBELL); ICREA; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERER; University of London; University College
   London; University of London; University College London; University of
   London; University College London; UCL Medical School; University
   College London Hospitals NHS Foundation Trust; Basque Foundation for
   Science; Central University Hospital Asturias; University of Basque
   Country; CIBERNED
RP Alvarez, V (corresponding author), Hosp Univ Cent Asturias, Genet Lab, Avda Roma S-N, Oviedo 30011, Spain.
EM victoria.alvarez@sespa.es
RI alvarez, victoria/GXV-1088-2022; DE MUNAIN, ADOLFO/AAB-1824-2020; Cenit,
   Maria/E-9538-2017; Fernández-Eulate, Gorka/HOF-8667-2023; Schluter,
   Agatha/AAA-9665-2021; Moris, German/AAT-8916-2021; Spinazzola,
   Antonella/P-5791-2019; holt, ian/AFT-2565-2022; Ruiz,
   Montse/N-4085-2014; alvarez, victoria/ABC-7891-2021; SOLA,
   EMMA/ABC-6808-2020; Infante, Jon/GRJ-4050-2022; Spinazzola,
   Antonella/P-5298-2017; Martinez-Saez, Elena/E-9097-2018; Pujol,
   Aurora/N-4990-2014; Moris, German/M-2920-2018
OI holt, ian/0000-0001-5468-0193; Schluter, Agatha/0000-0001-6732-1528;
   Gamez, Josep/0000-0003-3127-7486; Ruiz, Montse/0000-0003-0466-2653;
   alvarez, victoria/0000-0002-1916-2523; , MARIA/0000-0002-3849-8778;
   SOLA, EMMA/0000-0002-3919-7862; Infante, Jon/0000-0003-4025-4606; De la
   Casa-Fages, Beatriz/0000-0003-0486-3308; Spinazzola,
   Antonella/0000-0003-4242-8091; Martinez-Saez, Elena/0000-0001-6004-5364;
   Pujol, Aurora/0000-0002-9606-0600; Fernandez-Eulate,
   Gorka/0000-0003-1112-7464; /0000-0002-9509-4032; Moris,
   German/0000-0001-7608-2194; Fernandez-Pelayo, Uxoa/0000-0002-2197-2058;
   Zelaya, Maria Victoria/0000-0002-3692-3515; Munoz,
   Mikel/0000-0002-9239-1971
FU MRC [MC_PC_13029/2] Funding Source: UKRI
CR Arnoldi A, 2008, HUM MUTAT, V29, P522, DOI 10.1002/humu.20682
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bernardi P, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00320
   Caporali L, 2018, BRAIN, V141, DOI 10.1093/brain/awx301
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Choquet K, 2016, EUR J HUM GENET, V24, P1016, DOI 10.1038/ejhg.2015.240
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   Denora PS, 2013, HAND CLINIC, V113, P1899, DOI 10.1016/B978-0-444-59565-2.00060-5
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15
   Fernández A, 2015, J MOL NEUROSCI, V56, P613, DOI 10.1007/s12031-015-0560-3
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Gómez J, 2014, CIRC J, V78, P2963, DOI 10.1253/circj.CJ-14-0628
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   HARDING AE, 1983, LANCET, V1, P1151
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549
   Magri S, 2018, HUM MUTAT, V39, P2060, DOI 10.1002/humu.23658
   Mancini C, 2019, EUR J NEUROL, V26, P80, DOI 10.1111/ene.13768
   Mancuso Michelangelo, 2008, Human Genomics, V3, P71
   McDermott CJ, 2001, NEUROLOGY, V56, P467, DOI 10.1212/WNL.56.4.467
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Moss CF, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1009
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Patron M, 2018, CELL RES, V28, P296, DOI 10.1038/cr.2018.17
   Pedroso JL, 2018, PARKINSONISM RELAT D, V47, P88, DOI 10.1016/j.parkreldis.2017.12.004
   Pfeffer G, 2015, NEUROLOGY, V84, P1174, DOI 10.1212/WNL.0000000000001369
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Roxburgh RH, 2013, J NEUROL, V260, P1286, DOI 10.1007/s00415-012-6792-z
   Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8
   Settasatian C, 1999, HUM GENET, V105, P139, DOI 10.1007/s004390051076
   Shanmughapriya S, 2015, MOL CELL, V60, P47, DOI 10.1016/j.molcel.2015.08.009
   SPATAX Network, 2009, DIAGN SPIN DEG AT SP, P1
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Trinh J, 2019, MOVEMENT DISORD, V34, P133, DOI 10.1002/mds.27559
   van Gassen KLI, 2012, BRAIN, V135, P2994, DOI 10.1093/brain/aws224
   Venegas V, 2012, METHODS MOL BIOL, V837, P327, DOI 10.1007/978-1-61779-504-6_22
   Wedding IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086340
   Wilkinson PA, 2004, BRAIN, V127, P973, DOI 10.1093/brain/awh125
NR 45
TC 37
Z9 40
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD OCT
PY 2019
VL 34
IS 10
BP 1547
EP 1561
DI 10.1002/mds.27812
EA AUG 2019
PG 15
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA JF1DQ
UT WOS:000482168600001
PM 31433872
DA 2024-11-01
ER

PT J
AU Tchikviladze, M
   Gilleron, M
   Maisonobe, T
   Galanaud, D
   Laforet, P
   Durr, A
   Eymard, B
   Mochel, F
   Ogier, H
   Béhin, A
   Stojkovic, T
   Degos, B
   Gourfinkel-An, I
   Sedel, F
   Anheim, M
   Elbaz, A
   Viala, K
   Vidailhet, M
   Brice, A
   Jardel, C
   Lombès, A
AF Tchikviladze, Maya
   Gilleron, Mylene
   Maisonobe, Thierry
   Galanaud, Damien
   Laforet, Pascal
   Durr, Alexandra
   Eymard, Bruno
   Mochel, Fanny
   Ogier, Helene
   Behin, Anthony
   Stojkovic, Tanya
   Degos, Bertrand
   Gourfinkel-An, Isabelle
   Sedel, Frederic
   Anheim, Mathieu
   Elbaz, Alexis
   Viala, Karine
   Vidailhet, Marie
   Brice, Alexis
   Jardel, Claude
   Lombes, Anne
TI A diagnostic flow chart for <i>POLG</i>-related diseases based on signs
   sensitivity and specificity
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Article
ID SENSORY NEURONOPATHY; ATAXIC NEUROPATHY; MUTATIONS CAUSE; MITOCHONDRIAL;
   OPHTHALMOPLEGIA; MRI; DEFICIENCY; EPILEPSY; SPECTRUM; CRITERIA
AB Objective Diseases due to mutations of POLG gene, encoding the mitochondrial DNA polymerase, are reputed to have very diverse clinical presentations and have been proposed to cause up to 25% adult mitochondrial diseases. Our objective was the evaluation of the specificity and sensitivity of the signs encountered with POLG mutations.
   Design Forty-four patients out of 154 with sequenced POLG gene had mutations affecting either one (POLG(+/) group) or two POLG alleles (POLG(+/+) group). Phenotyping included clinical signs, electroneuromyography and brain imaging while mitochondrial investigations encompassed muscle histochemistry, respiratory chain assays and search for multiple mitochondrial deletions. The specificity and sensitivity of the signs associated with POLG mutations were analysed by comparison between POLG+/+ and patients without POLG mutation.
   Results High sensitivity but low specificity was observed with single signs such as axonal sensory neuropathy, cerebellar syndrome, movement disorders and weakness involving ocular, pharyngeal, axial and/or limb muscles. Specificity was increased with combination of previous signs plus psychiatric symptoms, cognitive impairment and epilepsy. High specificity and sensitivity was only obtained with sensory neuronopathy associated with one of the following signs: weakness of ocular, pharyngeal, axial and/or limb muscles. Mitochondrial investigations did not suffice for diagnosis. The widespread neuromuscular signs were often present since disease onset and were the rule above 50 years of age leading to a very low probability of POLG mutations in patients with less than three signs and absent sensory neuropathy.
   Conclusions Phenotypes associated with POLG mutations follow a reproducible pattern, which allows establishing a diagnostic flow chart.
C1 [Tchikviladze, Maya; Degos, Bertrand; Anheim, Mathieu] GHU Pitie Salpetriere, AP HP, Dept Neurol, Paris, France.
   [Tchikviladze, Maya] GHU Pitie Salpetriere, INSERM, CIC9503, Paris, France.
   [Gilleron, Mylene; Jardel, Claude; Lombes, Anne] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France.
   [Gilleron, Mylene; Jardel, Claude; Lombes, Anne] CNRS, UMR 8104, Paris, France.
   [Gilleron, Mylene; Jardel, Claude; Lombes, Anne] GHU Pitie Salpetriere, AP HP, Serv Biochim Metab, Paris, France.
   [Gilleron, Mylene; Jardel, Claude; Lombes, Anne] GHU Pitie Salpetriere, AP HP, Ctr Genet Mol & Chromosom, Paris, France.
   [Gilleron, Mylene; Durr, Alexandra; Eymard, Bruno; Brice, Alexis] Univ Paris 06, UMR S975, Paris, France.
   [Maisonobe, Thierry] GHU Pitie Salpetriere, AP HP, Dept Neurophysiol & Neuropathol, Paris, France.
   [Galanaud, Damien] GHU Pitie Salpetriere, AP HP, Dept Neuroradiol, Paris, France.
   [Laforet, Pascal; Eymard, Bruno; Behin, Anthony; Stojkovic, Tanya] GHU Pitie Salpetriere, AP HP, Inst Myol, Ctr Reference Pathol Neuromusculaire Paris Est, Paris, France.
   [Durr, Alexandra; Mochel, Fanny; Sedel, Frederic; Brice, Alexis] GHU Pitie Salpetriere, AP HP, Dept Genet, Paris, France.
   [Durr, Alexandra; Eymard, Bruno; Mochel, Fanny; Sedel, Frederic; Vidailhet, Marie; Brice, Alexis] CRICM, INSERM, UMR S975, Paris, France.
   [Durr, Alexandra; Eymard, Bruno; Mochel, Fanny; Sedel, Frederic; Vidailhet, Marie; Brice, Alexis] CNRS, UMR 7225, Paris, France.
   [Durr, Alexandra; Vidailhet, Marie; Brice, Alexis] GH Pitie Salpetriere, ICM Brain & Spine Inst, Paris, France.
   [Mochel, Fanny; Sedel, Frederic; Vidailhet, Marie] GH Pitie Salpetriere, AP HP, Neurometab Unit, Paris, France.
   [Ogier, Helene] GH Robert Debre, AP HP, Malad Hereditaires Metab, Paris, France.
   [Gourfinkel-An, Isabelle] GH Pitie Salpetriere, AP HP, Ctr Reference Epilepsies Rares, Paris, France.
   [Elbaz, Alexis] CESP, INSERM, U1018, Social & Occupat Determinants Hlth, Villejuif, France.
   [Elbaz, Alexis] Univ Versailles St Quentin, UMRS 1018, Villejuif, France.
   [Lombes, Anne] Univ Paris 05, Paris, France.
C3 Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et
   de la Recherche Medicale (Inserm); Sorbonne Universite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere
   - APHP; Universite Paris Cite; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Centre National de la Recherche
   Scientifique (CNRS); CNRS - National Institute for Biology (INSB);
   Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Sorbonne Universite; Sorbonne Universite;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Sorbonne Universite; Sorbonne Universite;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite;
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et
   de la Recherche Medicale (Inserm); Centre National de la Recherche
   Scientifique (CNRS); CNRS - National Institute for Biology (INSB);
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne
   Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris
   Cite; Hopital Universitaire Robert-Debre - APHP; Sorbonne Universite;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Universite Paris Saclay; Institut National de
   la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay;
   Universite Paris Cite
RP Lombès, A (corresponding author), Inst Cochin Genet Mol, Inserm 1016, Fac Med, 24 Rue Fb St Jacques, F-75014 Paris, France.
EM anne.lombes@inserm.fr
RI Lombes, Anne/G-4684-2014; STOJKOVIC, Tanya/AAA-3967-2021; brice,
   alexis/AAE-8275-2019; Elbaz, Alexis/F-8952-2017
OI Mochel, Fanny/0000-0003-3970-3486; Behin, Anthony/0000-0001-7179-5152;
   Anheim, Mathieu/0000-0001-8121-0605; Elbaz, Alexis/0000-0001-9724-5490;
   Brice, Alexis/0000-0002-0941-3990
FU FRM (Fondation pour la Recherche Medicale); Association Francaise contre
   les Myopathies (AFM); Association contre les Maladies Mitochondriales
   (AMMi); programme 'Investissements d'avenir' [ANR-10-IAIHU-06]
FX This work was supported by grants from the FRM (Fondation pour la
   Recherche Medicale); from the Association Francaise contre les
   Myopathies (AFM) and Association contre les Maladies Mitochondriales
   (AMMi) to AL. The research leading to these results has received funding
   from the programme 'Investissements d'avenir' ANR-10-IAIHU-06.
CR Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Barkhof F, 2002, CEREBROVASC DIS, V13, P21, DOI 10.1159/000049146
   Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bolszak M, 2009, EPILEPSY RES, V85, P300, DOI 10.1016/j.eplepsyres.2009.03.004
   Camdessanché JP, 2012, J PERIPHER NERV SYST, V17, P331, DOI 10.1111/j.1529-8027.2012.00411.x
   Camdessanché JP, 2009, BRAIN, V132, P1723, DOI 10.1093/brain/awp136
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Dubowitz V., 1973, MUSCLE BIOPSY MODERN
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Fazekas F, 2002, CEREBROVASC DIS, V13, P31, DOI 10.1159/000049147
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Pitceathly RDS, 2013, J NEUROL NEUROSUR PS, V84, P107, DOI 10.1136/jnnp-2012-303232
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schicks J, 2010, MOVEMENT DISORD, V25, P2678, DOI 10.1002/mds.23286
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Serrano M, 2010, MITOCHONDRION, V10, P429, DOI 10.1016/j.mito.2010.04.001
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Synofzik M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-41
   Synofzik M, 2012, CEREBELLUM, V11, P1002, DOI 10.1007/s12311-012-0378-2
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
NR 41
TC 25
Z9 26
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD JUN
PY 2015
VL 86
IS 6
BP 646
EP 654
DI 10.1136/jnnp-2013-306799
PG 9
WC Clinical Neurology; Psychiatry; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychiatry; Surgery
GA CI1DN
UT WOS:000354482000011
PM 25118206
DA 2024-11-01
ER

PT J
AU Anagnostou, ME
   Ng, YS
   Taylor, RW
   McFarland, R
AF Anagnostou, Maria-Eleni
   Ng, Yi Shiau
   Taylor, Robert W.
   McFarland, Robert
TI Epilepsy due to mutations in the mitochondrial polymerase gamma
   (<i>POLG</i>) gene: A clinical and molecular genetic review
SO EPILEPSIA
LA English
DT Review
DE Mitochondrial disease; Status epilepticus; Stroke-like lesion; mtDNA
   copy number; Treatment
ID ALPERS-HUTTENLOCHER SYNDROME; REFRACTORY STATUS EPILEPTICUS;
   DNA-POLYMERASE; MYOCEREBROHEPATOPATHY SPECTRUM; HEPATOCEREBRAL
   SYNDROMES; MTDNA DELETIONS; DISEASE; DEPLETION; CHILDHOOD;
   ENCEPHALOPATHY
AB We performed a systematic review of the clinical, molecular, and biochemical features of polymerase gamma (POLG)-related epilepsy and current evidence on seizure management. Patients were identified from a combined electronic search of articles using Ovid Medline and Scopus databases, published from January 2000 to January 2015. Only patients with a confirmed genetic diagnosis of POLG mutations were considered. Seventy-two articles were included for analysis. We identified 128 pathogenic variants in 372 patients who had POLG-related epilepsy. Among these, 84% of the cases harbored at least one of these pathogenic variants: p.Ala467Thr, p.Trp748Ser, and p.Gly848Ser. A bimodal distribution of disease onset was present in early childhood (<5 years) and adolescence; female patients had a later presentation than male patients (median age 4.00 vs. 1.83 years, p-value = 0.041). Focal-onset seizure including convulsive, myoclonus, and occipital seizures was common at the outset and was refractory to pharmacotherapy. We confirmed that homozygous pathogenic variants located in the linker region of POLG were associated with later age of onset and longer survival compared to compound heterozygous variants. In addition, biochemical and molecular heterogeneities in different tissues were frequently observed. POLG-related epilepsy is clinically heterogeneous, and the prognosis is, in part, influenced by the location of the variants in the gene and the presence of hepatic involvement. Normal muscle and fibroblast studies do no exclude the diagnosis of POLG-related mitochondrial disease and direct sequencing of the POLG gene should be the gold standard when investigating suspected cases.
C1 [Anagnostou, Maria-Eleni; Ng, Yi Shiau; Taylor, Robert W.; McFarland, Robert] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP McFarland, R (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.mcfarland@newcastle.ac.uk
RI Ng, Yi/AFF-1445-2022
OI McFarland, Robert/0000-0002-8833-2688; Ng, Yi Shiau/0000-0002-7591-2034
FU Wellcome Trust [096919Z/11/Z]; Medical Research Council [G0601943,
   G0800674]; Lily Foundation; UK NHS Specialized Services and Newcastle
   upon Tyne Hospitals NHS Foundation Trust; MRC [G0601943, G0200373,
   G0800674] Funding Source: UKRI
FX We would like to thank Charlotte L. Alston for her help in verifying the
   pathogenicity of certain variants using predictor software (Alamut
   Visual version 2.7.1). This work was supported by the Wellcome Trust
   (096919Z/11/Z, R.W.T.), The Medical Research Council (G0601943,
   G0800674, R.M., R.W.T.), The Lily Foundation, and the UK NHS Specialized
   Services and Newcastle upon Tyne Hospitals NHS Foundation Trust
   supporting the "Rare Mitochondrial Disorders of Adults and Children"
   Diagnostic Service (http://www.newcastle-mitochondria.com/). MEA
   receives funding from the charity Ryan Stanford Appeal for her PhD study
   and YSN is funded by the MRC Centre for Neuromuscular Diseases.
CR Allen NM, 2014, SEIZURE-EUR J EPILEP, V23, P237, DOI 10.1016/j.seizure.2013.07.005
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Bao XH, 2008, BRAIN DEV-JPN, V30, P295, DOI 10.1016/j.braindev.2007.08.009
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Boes M, 2009, SEIZURE-EUR J EPILEP, V18, P232, DOI 10.1016/j.seizure.2008.08.003
   Brinjikji W, 2011, JIMD REP, V1, P89, DOI 10.1007/8904_2011_22
   Cardenas JF, 2010, SEMIN PEDIATR NEUROL, V17, P62, DOI 10.1016/j.spen.2010.02.012
   Cheldi A, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-8
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   de Camaret BM, 2011, MITOCHONDRION, V11, P223, DOI 10.1016/j.mito.2010.07.011
   de Vries MC, 2008, J INHERIT METAB DIS, V31, pS299, DOI 10.1007/s10545-008-0871-4
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hansen N, 2012, NEUROL SCI, V33, P209, DOI 10.1007/s10072-011-0631-3
   HARDING BN, 1986, BRAIN, V109, P181, DOI 10.1093/brain/109.1.181
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   Horst DM, 2014, PEDIATR NEUROL, V51, P734, DOI 10.1016/j.pediatrneurol.2014.06.015
   Hunter MF, 2011, PEDIATR NEUROL, V45, P311, DOI 10.1016/j.pediatrneurol.2011.07.008
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Janssen W, 2016, ACTA NEUROL BELG, V116, P17, DOI 10.1007/s13760-015-0499-8
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Khan A, 2012, J CHILD NEUROL, V27, P636, DOI 10.1177/0883073811423973
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Li SB, 2015, HEPATOLOGY, V61, P1730, DOI 10.1002/hep.27712
   Lupashko S, 2011, CHILD NERV SYST, V27, P1321, DOI 10.1007/s00381-011-1495-9
   Lutz RE, 2009, J PEDIATR GASTR NUTR, V49, P126, DOI 10.1097/MPG.0b013e31817d9cad
   Mangalat N, 2012, ULTRASTRUCT PATHOL, V36, P219, DOI 10.3109/01913123.2012.666334
   Martikainen MH, 2012, EPILEPTIC DISORD, V14, P438, DOI 10.1684/epd.2012.0543
   Mccoy B, 2011, EUR J PAEDIATR NEURO, V15, P558, DOI 10.1016/j.ejpn.2011.05.012
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Mohamed K, 2011, J INHERIT METAB DIS, V34, P439, DOI 10.1007/s10545-011-9278-8
   Montassir H, 2015, BRAIN DEV-JPN, V37, P719, DOI 10.1016/j.braindev.2014.10.013
   Naess K, 2012, JIMD REP, V4, P67, DOI 10.1007/8904_2011_73
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nolte KW, 2013, NEUROPATHOLOGY, V33, P59, DOI 10.1111/j.1440-1789.2012.01317.x
   Prasun P, 2014, J NEUROL, V261, P2218, DOI 10.1007/s00415-014-7493-6
   Prüss H, 2008, EPILEPSY RES, V82, P219, DOI 10.1016/j.eplepsyres.2008.08.005
   Roels F, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-4
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Roshal D, 2011, EPILEPSY BEHAV, V21, P206, DOI 10.1016/j.yebeh.2011.03.003
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scalais E, 2012, EUR J PAEDIATR NEURO, V16, P542, DOI 10.1016/j.ejpn.2012.01.013
   Schaller A, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-4
   Simon M, 2014, JIMD REP, V14, P29, DOI 10.1007/8904_2013_280
   Sofou K, 2012, EUR J PAEDIATR NEURO, V16, P379, DOI 10.1016/j.ejpn.2011.12.006
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuladhar AM, 2013, J NEUROL, V260, P903, DOI 10.1007/s00415-012-6776-z
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
   van den Heuvel LP, 2004, MITOCHONDRION, V4, P395, DOI 10.1016/j.mito.2004.07.005
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Visser NA, 2011, J NEUROL, V258, P218, DOI 10.1007/s00415-010-5721-2
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Witters P, 2010, J INHERIT METAB DIS, V33, P451, DOI 10.1007/s10545-010-9108-4
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9
NR 80
TC 54
Z9 63
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0013-9580
EI 1528-1167
J9 EPILEPSIA
JI Epilepsia
PD OCT
PY 2016
VL 57
IS 10
BP 1531
EP 1545
DI 10.1111/epi.13508
PG 15
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EB8QV
UT WOS:000387656800003
PM 27554452
OA Bronze
DA 2024-11-01
ER

PT J
AU Uittenbogaard, M
   Chiaramello, A
AF Uittenbogaard, Martine
   Chiaramello, Anne
TI Novel subcellular localization of the DNA helicase Twinkle at the
   kinetochore complex during mitosis in neuronal-like progenitor cells
SO HISTOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article
DE Chromosomal segregation; Hexameric DNA helicases; Kinetochore complex;
   Mitochondria; Mitosis; Twinkle
ID ONSET SPINOCEREBELLAR ATAXIA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; PC12
   CELLS; CENP-A; MITOCHONDRIAL BIOGENESIS; MULTIPLE DELETIONS; MUTATIONS;
   ANEUPLOIDY; ARCHITECTURE; COMPONENTS
AB During mitosis, the kinetochore, a multi-protein structure located on the centromeric DNA, is responsible for proper segregation of the replicated genome. More specifically, the outer kinetochore complex component Ndc80/Hec1 plays a critical role in regulating microtubule attachment to the spindle for accurate sister chromatid segregation. In addition, DNA helicases play a key contribution for precise and complete disjunction of sister chromatids held together through double-stranded DNA catenations until anaphase. In this study, we focused our attention on the nuclear-encoded DNA helicase Twinkle, which functions as an essential helicase for replication of mitochondrial DNA. It regulates the copy number of the mitochondrial genome, while maintaining its integrity, two processes essential for mitochondrial biogenesis and bioenergetic functions. Although the majority of the Twinkle protein is imported into mitochondria, a small fraction remains cytosolic with an unknown function. In this study, we report a novel expression pattern of Twinkle during chromosomal segregation at distinct mitotic phases. By immunofluorescence microscopy, we found that Twinkle protein colocalizes with the outer kinetochore protein HEC1 as early as prophase until late anaphase in neuronal-like progenitor cells. Thus, our collective results have revealed an unexpected cell cycle-regulated expression pattern of the DNA helicase Twinkle, known for its role in mtDNA replication. Therefore, its recruitment to the kinetochore suggests an evolutionary conserved function for both mitochondrial and nuclear genomic inheritance.
C1 [Uittenbogaard, Martine; Chiaramello, Anne] George Washington Univ, Med Ctr, Dept Anat & Regenerat Biol, 2300 1 St NW, Washington, DC 20037 USA.
C3 George Washington University
RP Chiaramello, A (corresponding author), George Washington Univ, Med Ctr, Dept Anat & Regenerat Biol, 2300 1 St NW, Washington, DC 20037 USA.
EM achiaram@gwu.edu
RI Chiaramello, Anne/AAG-9825-2020
OI Uittenbogaard, Martine/0000-0003-0371-3041; Chiaramello,
   Anne/0000-0001-8424-0826
FU National Institutes of Health, National Institute of Neurological
   Disorders and Stroke [R21NS085282]; National Center for Research
   Resources [S10RR025565]; National Institute of Child Health and Human
   Development [P30HD40677]
FX The work was supported in part by the National Institutes of Health,
   National Institute of Neurological Disorders and Stroke (Grant Number
   R21NS085282 to A.C.), by the National Center for Research Resources
   (S10RR025565) and by the National Institute of Child Health and Human
   Development (P30HD40677).
CR Aldrup-MacDonald ME, 2014, GENES-BASEL, V5, P33, DOI 10.3390/genes5010033
   Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041
   Baxter J, 2011, SCIENCE, V331, P1328, DOI 10.1126/science.1201538
   Baxter KK, 2012, EXP CELL RES, V318, P2200, DOI 10.1016/j.yexcr.2012.07.004
   Baxter KK, 2009, ASN NEURO, V1, DOI 10.1042/AN20090036
   Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4
   Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310
   Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039
   Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200
   Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852
   Dierssen M, 2009, PHYSIOL REV, V89, P887, DOI 10.1152/physrev.00032.2007
   Ding L, 2015, INT J MOL SCI, V16, P10870, DOI 10.3390/ijms160510870
   Dunster K, 2002, EUR J CELL BIOL, V81, P117, DOI 10.1078/0171-9335-00232
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Emanuele MJ, 2005, MOL BIOL CELL, V16, P4882, DOI 10.1091/mbc.E05-03-0239
   Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494
   Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Futami K, 2007, BIOL PHARM BULL, V30, P1685, DOI 10.1248/bpb.30.1685
   Gilkerson R, 2013, COLD SPRING HARB PER, V5
   Gilkerson RW, 2009, INT J BIOCHEM CELL B, V41, P1899, DOI 10.1016/j.biocel.2009.03.016
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Iourov IY, 2009, NEUROBIOL DIS, V34, P212, DOI 10.1016/j.nbd.2009.01.003
   Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x
   Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226
   Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200
   Kingsbury MA, 2006, CELL MOL LIFE SCI, V63, P2626, DOI 10.1007/s00018-006-6169-5
   Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Lawrence Elizabeth, 2013, Commun Integr Biol, V6, pe27557, DOI 10.4161/cib.27557
   Lawrence EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072886
   Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020
   Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Minczuk M, 2002, NUCLEIC ACIDS RES, V30, P5074, DOI 10.1093/nar/gkf647
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535
   Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396
   Park MH, 2014, NEUROGENETICS, V15, P171, DOI 10.1007/s10048-014-0405-1
   Peterson SE, 2012, J NEUROSCI, V32, P16213, DOI 10.1523/JNEUROSCI.3706-12.2012
   Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398
   Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rouzeau S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033905
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stimpson KM, 2011, EMBO J, V30, P233, DOI 10.1038/emboj.2010.339
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Uittenbogaard M, 2005, J NEUROCHEM, V92, P585, DOI 10.1111/j.1471-4159.2004.02886.x
   Uittenbogaard M, 2004, J NEUROCHEM, V91, P1332, DOI 10.1111/j.1471-4159.2004.02814.x
   Uittenbogaard M, 2002, J NEUROSCI RES, V67, P235, DOI 10.1002/jnr.10119
   Uittenbogaard M, 2014, CURR PHARM DESIGN, V20, P5574, DOI 10.2174/1381612820666140305224906
   Uittenbogaard M, 2010, ASN NEURO, V2, DOI 10.1042/AN20100005
   Uittenbogaard M, 2010, J NEUROSCI RES, V88, P33, DOI 10.1002/jnr.22182
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wei JH, 2009, J CELL BIOL, V184, P391, DOI 10.1083/jcb.200809090
   Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010
   Wu GK, 2009, MOL BIOL CELL, V20, P4686, DOI 10.1091/mbc.E08-11-1123
   Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102
   Yang AH, 2003, J NEUROSCI, V23, P10454
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zierbarth TD, 2007, J MOL BIOL, V367, P1382
NR 77
TC 3
Z9 4
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0948-6143
EI 1432-119X
J9 HISTOCHEM CELL BIOL
JI Histochem. Cell Biol.
PD MAR
PY 2016
VL 145
IS 3
BP 275
EP 286
DI 10.1007/s00418-015-1388-1
PG 12
WC Cell Biology; Microscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Microscopy
GA DE7LM
UT WOS:000370818200002
PM 26678504
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Iu, ECY
   So, H
   Chan, CB
AF Iu, Elsie Chit Yu
   So, Ho
   Chan, Chi Bun
TI Mitochondrial defects in sporadic inclusion body myositis-causes and
   consequences
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE mitochondria; myositis; muscle; pathogenesis; pyroptosis; necroptosis
ID AMYLOID PRECURSOR PROTEIN; OXIDATIVE DNA-DAMAGE; SKELETAL-MUSCLE;
   INFLAMMATORY MYOPATHIES; PATHOGENIC SIGNIFICANCE; ABNORMALITIES; STRESS;
   EXPRESSION; ACCUMULATION; AUTOPHAGY
AB Sporadic inclusion body myositis (sIBM) is a distinct subcategory of Idiopathic Inflammatory Myopathies (IIM), characterized by unique pathological features such as muscle inflammation, rimmed vacuoles, and protein aggregation within the myofibers. Although hyperactivation of the immune system is widely believed as the primary cause of IIM, it is debated whether non-immune tissue dysfunction might contribute to the disease's onset as patients with sIBM are refractory to conventional immunosuppressant treatment. Moreover, the findings that mitochondrial dysfunction can elicit non-apoptotic programmed cell death and the subsequent immune response further support this hypothesis. Notably, abnormal mitochondrial structure and activities are more prominent in the muscle of sIBM than in other types of IIM, suggesting the presence of defective mitochondria might represent an overlooked contributor to the disease onset. The large-scale mitochondrial DNA deletion, aberrant protein aggregation, and slowed organelle turnover have provided mechanistic insights into the genesis of impaired mitochondria in sIBM. This article reviews the disease hallmarks of sIBM, the plausible contributors of mitochondrial damage in the sIBM muscle, and the immunological responses associated with mitochondrial perturbations. Additionally, the potential application of mitochondrial-targeted chemicals as a new treatment strategy to sIBM is explored and discussed.
C1 [Iu, Elsie Chit Yu; Chan, Chi Bun] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.
   [So, Ho] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.
C3 University of Hong Kong; Chinese University of Hong Kong
RP Chan, CB (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.
EM chancb@hku.hk
RI SO, Ho/AGP-2808-2022
OI Chan, Chi Bun/0000-0002-2787-9575
FU HKU Seed Fund for Basic Research; Hong Kong Health and Medical Research
   Fund [HMRF21222301]
FX The author(s) declare that financial support was received for the
   research, authorship, and/or publication of this article. This work is
   supported by the HKU Seed Fund for Basic Research to CC and Hong Kong
   Health and Medical Research Fund (HMRF21222301) to CC and HS.
CR Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   Askanas V, 1998, ARCH NEUROL-CHICAGO, V55, P915, DOI 10.1001/archneur.55.7.915
   Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0
   Askanas V, 2015, BBA-MOL BASIS DIS, V1852, P633, DOI [10.1016/j.bbadis.201409.005, 10.1016/j.bbadis.2014.09.005]
   Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8
   Bhatt PS, 2019, NEUROMUSCULAR DISORD, V29, P242, DOI 10.1016/j.nmd.2019.02.001
   Boncompagni S, 2012, J BIOL CHEM, V287, P20534, DOI 10.1074/jbc.M112.359588
   Britson KA, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abi9196
   Cacciottolo M, 2013, NEUROPATH APPL NEURO, V39, P750, DOI 10.1111/nan.12038
   Çanakçi CF, 2006, J PERIODONTOL, V77, P1894, DOI 10.1902/jop.2006.060108
   Cantó-Santos J, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12081639
   Cantó-Santos J, 2023, J CACHEXIA SARCOPENI, V14, P964, DOI 10.1002/jcsm.13178
   Catalán-García M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051446
   Catalán-García M, 2015, MOL MED, V21, P817, DOI 10.2119/molmed.2015.00168
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Chen SF, 2018, APOPTOSIS, V23, P299, DOI 10.1007/s10495-018-1455-x
   Ching JK, 2013, AUTOPHAGY, V9, P2115, DOI 10.4161/auto.26150
   Coudert JD, 2022, CLIN TRANSL IMMUNOL, V11, DOI 10.1002/cti2.1416
   Damian L, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23137358
   Danieli MG, 2023, AUTOIMMUN REV, V22, DOI 10.1016/j.autrev.2023.103308
   De Bleecker JL, 2001, ACTA NEUROPATHOL, V101, P572
   De Paepe B, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9010015
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   Di Leo V, 2023, BIOCHEM J, V480, P1767, DOI 10.1042/BCJ20220233
   Diederichsen LP, 2023, MUSCLE NERVE, V68, P73, DOI 10.1002/mus.27841
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Faitg J, 2024, CALCIFIED TISSUE INT, V114, P53, DOI 10.1007/s00223-023-01145-5
   Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9
   Fréret M, 2013, AM J PATHOL, V183, P893, DOI 10.1016/j.ajpath.2013.06.003
   Fyhr IM, 1998, ANN NEUROL, V43, P127, DOI 10.1002/ana.410430123
   Gang Q, 2016, NEUROBIOL AGING, V47, DOI 10.1016/j.neurobiolaging.2016.07.024
   García-Villalba R, 2022, MOL NUTR FOOD RES, V66, DOI 10.1002/mnfr.202101019
   Goebels N, 1996, J CLIN INVEST, V97, P2905, DOI 10.1172/JCI118749
   Gonzalez Chapa Jorge Armando, 2024, Clin Exp Rheumatol, V42, P394, DOI 10.55563/clinexprheumatol/5lfq5x
   Gonzalez-Chapa JA, 2023, RAMBAM MAIMONIDES ME, V14, DOI 10.5041/RMMJ.10493
   Greenberg MVC, 2019, NAT REV MOL CELL BIO, V20, P590, DOI 10.1038/s41580-019-0159-6
   Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20
   Greenberg SA, 2019, NAT REV RHEUMATOL, V15, P257, DOI 10.1038/s41584-019-0186-x
   Güttsches AK, 2017, ANN NEUROL, V81, P227, DOI 10.1002/ana.24847
   Gunawardena H, 2009, RHEUMATOLOGY, V48, P607, DOI 10.1093/rheumatology/kep078
   Hall DT, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708307
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12931
   Hiniker A, 2016, J NEUROPATH EXP NEUR, V75, P239, DOI 10.1093/jnen/nlv023
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   Huntley ML, 2019, LAB INVEST, V99, P1041, DOI 10.1038/s41374-019-0233-x
   Irazoki A, 2023, NAT COMMUN, V14, DOI 10.1038/s41467-022-35732-1
   Ito A, 2022, J CACHEXIA SARCOPENI, V13, P1864, DOI 10.1002/jcsm.12988
   Jang S, 2019, NAT STRUCT MOL BIOL, V26, P695, DOI 10.1038/s41594-019-0261-7
   Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje
   Jiang Q, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8837893
   Joaquim M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.572182
   Johnson GA, 2023, FRONT NEUROSCI-SWITZ, V17, DOI 10.3389/fnins.2023.1202167
   Joshi PR, 2014, J CLIN NEUROSCI, V21, P1959, DOI 10.1016/j.jocn.2014.05.051
   Jou C, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms231911002
   Kamiya M, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-021-27875-4
   Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015
   Khoo T, 2023, NAT REV RHEUMATOL, V19, P695, DOI 10.1038/s41584-023-01033-0
   Koo JH, 2019, GERONTOLOGY, V65, P240, DOI 10.1159/000494723
   Landfeldt Erik, 2015, J Neuromuscul Dis, V2, P63, DOI 10.3233/JND-140053
   Lee DY, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms242216542
   Lightfoot AP, 2015, ANN RHEUM DIS, V74, P1340, DOI 10.1136/annrheumdis-2014-207172
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Liu D, 2021, RHEUMATOLOGY, V60, P2177, DOI 10.1093/rheumatology/keaa473
   LJUNGMAN M, 1992, MOL CARCINOGEN, V5, P264, DOI 10.1002/mc.2940050406
   Lodi R, 1998, BRAIN, V121, P2119, DOI 10.1093/brain/121.11.2119
   Lu JQ, 2020, J NEUROL SCI, V413, DOI 10.1016/j.jns.2020.116816
   Lu YY, 2023, THERANOSTICS, V13, P736, DOI 10.7150/thno.79876
   Luan PL, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abb0319
   Lünemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115
   Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5
   Marchi S, 2023, NAT REV IMMUNOL, V23, P159, DOI 10.1038/s41577-022-00760-x
   Marek-Iannucci S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.151981
   Mavroudis Ioannis, 2021, J Clin Neuromuscul Dis, V23, P31, DOI 10.1097/CND.0000000000000353
   McCord B, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-42824-5
   Mccord B, 2023, MEDIAT INFLAMM, V2023, DOI 10.1155/2023/9018470
   Miller FW, 2018, NAT REV RHEUMATOL, V14, P255, DOI 10.1038/nrrheum.2018.48
   Moriya K, 2001, CANCER RES, V61, P4365
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Nicot AS, 2014, AUTOPHAGY, V10, P1036, DOI 10.4161/auto.28479
   Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050
   Oddis CV, 2016, J INTERN MED, V280, P63, DOI 10.1111/joim.12511
   Oikawa Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231064
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Olivé M, 2008, NEUROPATH APPL NEURO, V34, P76, DOI 10.1111/j.1365-2990.2007.00864.x
   Olivé M, 2009, J NEUROPATH EXP NEUR, V68, P262, DOI 10.1097/NEN.0b013e3181996d8f
   Papadimas GK, 2019, RHEUMATOL INT, V39, P1459, DOI 10.1007/s00296-019-04314-8
   Papadopoulos C, 2017, EMBO J, V36, P135, DOI 10.15252/embj.201695148
   Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191
   Peng QL, 2022, ARTHRITIS RHEUMATOL, V74, P1048, DOI 10.1002/art.42071
   Pérez-Torres I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102098
   Phillips MCL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.582402
   Picca A, 2023, NAT METAB, V5, P2047, DOI 10.1038/s42255-023-00930-8
   Pruitt JN, 1996, ANN NEUROL, V39, P139, DOI 10.1002/ana.410390122
   Qiu XF, 2018, CELL DEATH DIFFER, V25, P821, DOI 10.1038/s41418-018-0075-x
   Rinnenthal JL, 2014, NEUROMUSCULAR DISORD, V24, P151, DOI 10.1016/j.nmd.2013.11.004
   Romani M, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108660
   Rostamzadeh F, 2024, BIOMED PHARMACOTHER, V170, DOI 10.1016/j.biopha.2023.116020
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Sachdev R, 2018, MOL NEUROBIOL, V55, P8355, DOI 10.1007/s12035-018-0997-9
   Salam S, 2022, CLIN EXP RHEUMATOL, V40, P384, DOI 10.55563/clinexprheumatol/r625rm
   Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053
   Sharma BR, 2021, NAT IMMUNOL, V22, P550, DOI 10.1038/s41590-021-00886-5
   Shelly S, 2021, NEUROLOGY, V96, pE2653, DOI 10.1212/WNL.0000000000012004
   Shelton GD, 2019, J NEUROMUSCULAR DIS, V6, P485, DOI 10.3233/JND-190421
   Skolka MP, 2023, CURR OPIN RHEUMATOL, V35, P404, DOI 10.1097/BOR.0000000000000958
   Snedden AM, 2022, CLIN EXP RHEUMATOL, V40, P414, DOI 10.55563/clinexprheumatol/pp0oso
   Sorriento D, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.660068
   Sulaimon LA., 2022, Adv. Redox Res, DOI DOI 10.1016/J.ARRES.2022.100037
   Suzuki N, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1122-5
   Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074
   Tanboon J, 2020, CURR OPIN NEUROL, V33, P590, DOI 10.1097/WCO.0000000000000855
   Tawara N, 2017, ANN NEUROL, V81, P512, DOI 10.1002/ana.24919
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Terracciano C, 2008, FREE RADICAL BIO MED, V45, P773, DOI 10.1016/j.freeradbiomed.2008.05.030
   Tsamis KI, 2022, CRIT REV CL LAB SCI, V59, P219, DOI 10.1080/10408363.2021.2000584
   Tsuruta Y, 2002, ACTA NEUROPATHOL, V103, P59, DOI 10.1007/s004010100428
   Urbina-Varela R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207704
   Weihl CC, 2015, NEUROMUSCULAR DISORD, V25, P289, DOI 10.1016/j.nmd.2014.12.009
   Winkler M, 2021, J NEUROPATH EXP NEUR, V80, P1060, DOI 10.1093/jnen/nlab101
   Xiao WS, 2020, ANTIOXID REDOX SIGN, V32, P1330, DOI 10.1089/ars.2019.7803
   Yamashita S, 2023, J NEUROL NEUROSUR PS, V94, P1018, DOI 10.1136/jnnp-2023-331474
   Yang ZT, 2018, NAT CELL BIOL, V20, P186, DOI 10.1038/s41556-017-0022-y
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zeng R, 2022, NEUROTHERAPEUTICS, V19, P911, DOI 10.1007/s13311-022-01220-z
   Zhang ZL, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01252-z
   Zhao YF, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-09943-x
   Zubair AS, 2023, FRONT NEUROL, V14, DOI 10.3389/fneur.2023.1146015
NR 131
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD MAY 14
PY 2024
VL 12
AR 1403463
DI 10.3389/fcell.2024.1403463
PG 11
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA SB4L9
UT WOS:001231986100001
PM 38808223
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Limongelli, G
   Tome-Esteban, M
   Dejthevaporn, C
   Rahman, S
   Hanna, MG
   Elliott, PM
AF Limongelli, Giuseppe
   Tome-Esteban, Maite
   Dejthevaporn, Charungthai
   Rahman, Shamima
   Hanna, Michael G.
   Elliott, Perry M.
TI Prevalence and natural history of heart disease in adults with primary
   mitochondrial respiratory chain disease
SO EUROPEAN JOURNAL OF HEART FAILURE
LA English
DT Article
DE Mitochondrial respiratory chain disease; Cardiomyopathy; Outcome
ID MUTATIONS; CHILDREN; DNA; CARDIOMYOPATHY; CRITERIA; GENE
AB The prevalence and natural history of cardiovascular disease in adult patients with respiratory chain disease (RCD) is poorly characterized. We sought to determine the frequency and natural history of cardiac disease in patients with primary RCD.
   Thirty-two patients (37.8 +/- 12.6 years) with a definite diagnosis of RCD underwent clinical examination, electrocardiography (ECG), 24 h Holter ECG, and cardiopulmonary exercise testing. Patients were classified into six different phenotypes: mitochondrial myopathy (MM; n = 8), chronic progressive ophthalmoplegia (CPEO; n = 2), chronic progressive ophthalmoplegia with myopathy (CPEO + MM; n = 12), Kearns-Sayre syndrome (KSS; n = 2), mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS; n = 7), neuropathy, ataxia, and retinitis pigmentosa (NARP; n = 1). Twenty-two patients (69%) had a mitochondrial DNA mutation. Twenty-six patients (81%) had evidence for cardiac involvement: ECG abnormalities (69%) and cardiomyopathy (hypertrophic 19%; restrictive 3%; left ventricular non-compaction 3%). During follow-up (4.1 +/- 2.8 years), two patients with CPEO + MM developed hypertrophic cardiomyopathy and one patient with NARP developed peripartum dilated cardiomyopathy. Four patients (KSS = 2; MM = 1; MELAS = 1) developed arrhythmias or syncope requiring device therapy or invasive procedures. One patient with MM and cardiomyopathy had an orthotopic heart transplant. One patient with CPEO + MM died from respiratory failure. Freedom from all cardiovascular events at 5 years was 67% (95% CI 47.4-86.6).
   All patients with RCD should undergo careful and repeated clinical assessment to diagnose and manage cardiovascular involvement. However, life-threatening cardiovascular complications rarely occur, and the prognosis is generally favourable.
C1 [Limongelli, Giuseppe; Tome-Esteban, Maite; Elliott, Perry M.] UCL, Heart Hosp, London W1G 8PH, England.
   [Dejthevaporn, Charungthai; Rahman, Shamima; Hanna, Michael G.] UCL, MRC Ctr Neuromuscular Dis, Inst Neurol, London W1G 8PH, England.
   [Dejthevaporn, Charungthai; Rahman, Shamima; Hanna, Michael G.] UCL, Natl Hosp Neurol & Neurosurg, London W1G 8PH, England.
C3 University of London; University College London; University College
   London Hospitals NHS Foundation Trust; University of London; University
   College London; University of London; University College London; UCL
   Medical School; University College London Hospitals NHS Foundation Trust
RP Elliott, PM (corresponding author), UCL, Heart Hosp, 16-18 Westmoreland St, London W1G 8PH, England.
EM perry.elliott@ucl.ac.uk
RI Rahman, Shamima/C-5232-2008; Elliott, Perry/AAR-3430-2020; Hanna,
   Michael/B-1995-2009; Tome Esteban, Maria Teresa/E-1196-2019; LImongelli,
   Giuseppe/K-4885-2018
OI Elliott, Perry/0000-0003-3383-3984; Tome Esteban, Maria
   Teresa/0000-0002-8962-3524; LImongelli, Giuseppe/0000-0002-8291-9517;
   Hanna, Michael/0000-0003-0825-4075
FU MRC [G0601943, G0800674] Funding Source: UKRI; Medical Research Council
   [G0800674, G0601943] Funding Source: Medline
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], 1978, AM J CARDIOL, V41, P130
   Arbustini E, 1998, HEART, V80, P548, DOI 10.1136/hrt.80.6.548
   Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4
   Cohen BH, 2001, CLEV CLIN J MED, V68, P625, DOI 10.3949/ccjm.68.7.625
   DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Douglas PS, 2007, J AM SOC ECHOCARDIOG, V20, P787, DOI 10.1016/j.echo.2007.06.011
   Elliott PM, 1999, HEART, V81, P441, DOI 10.1136/hrt.81.4.441
   Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P425, DOI 10.1164/ajrccm.164.3.2005110
   Gimeno JR, 2009, EUR HEART J, V30, P2599, DOI 10.1093/eurheartj/ehp327
   Hanna MG, 1999, CELL MOL LIFE SCI, V55, P691, DOI 10.1007/s000180050327
   HANSEN JE, 1984, AM REV RESPIR DIS, V129, pS49, DOI 10.1164/arrd.1984.129.2P2.S49
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   INO H, 1991, LANCET, V337, P234, DOI 10.1016/0140-6736(91)92196-9
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Sorajja P, 2003, HEART, V89, P791, DOI 10.1136/heart.89.7.791
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
NR 27
TC 105
Z9 108
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1388-9842
EI 1879-0844
J9 EUR J HEART FAIL
JI Eur. J. Heart Fail.
PD FEB
PY 2010
VL 12
IS 2
BP 114
EP 121
DI 10.1093/eurjhf/hfp186
PG 8
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 547EN
UT WOS:000273868800004
PM 20083621
OA Bronze
DA 2024-11-01
ER

PT J
AU Chu, X
   Dai, J
   Cui, HX
   Shen, HL
   Wu, Q
   Zhu, XY
   Zhu, BF
AF Chu, Xin
   Dai, Jie
   Cui, Hengxiang
   Shen, Hailin
   Wu, Qi
   Zhu, Xiangyang
   Zhu, Baofeng
TI A Patient with MELAS Syndrome Carried an M.3243A>G Mutation in
   Mitochondrial DNA and Multiple Nuclear Genetic Variants: A Case Report
SO IRANIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Mitochondrial DNA mutation; MELAS Syndrome; Epilepsy; Myelinloss; Case
   report
ID NEUREGULIN-1; DISEASE; EPILEPSY
AB We discuss the involvement of nuclear genetic variants correlating to observed phenotype in this case study. In January 2020, the 19-year-old boy from Nantong, Jiangsu Province, China with epilepsy symptom was identified to have myelin loss in the motor and sensory nerves in the electromyogram examination. Brain magnetic resonance imaging (MRI) demonstrated high-intensity areas of small multifocal gray matter regions in the bilateral temporal, parietal, and occipital lobes. In the serum of the patient, the levels of lactate dehydrogenase (LDH) and lactic acid were higher than the normal range values in multiple tests. By subsequent whole exome sequencing (WES) including analysis of the mitochondrial genome, the patient was revealed to carry an m.3243A>G mutation in mitochondria MTTL1 gene which was confirmed by direct Sanger sequencing analysis. Thus, disease of the patient was diagnosed as mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. According to WES analysis, the patient also carried multiple homozygous variants, which correlating to myelinloss and epilepsy in nuclear genes. The peripheral neuropathy of the patient carrying single mitochondrial m.3243A>G mutation could be caused by multiple nuclear DNA defect.
C1 [Chu, Xin; Wu, Qi; Zhu, Baofeng] Nantong Univ, Affiliated Hosp 2, Emergency Dept, Nantong, Jiangsu, Peoples R China.
   [Dai, Jie; Shen, Hailin; Zhu, Xiangyang] Nantong Univ, Affiliated Hosp 2, Neurol Dept, Nantong, Jiangsu, Peoples R China.
   [Cui, Hengxiang] Nantong Univ, Affiliated Hosp 2, Clin Med Res Ctr, Nantong, Jiangsu, Peoples R China.
C3 Nantong University; Nantong University; Nantong University
RP Zhu, BF (corresponding author), Nantong Univ, Affiliated Hosp 2, Emergency Dept, Nantong, Jiangsu, Peoples R China.
EM Baofengdr123@oudook.com
RI xin, chu/AAC-5332-2021; zhu, y/IVU-7833-2023; Wu, Qi/ABD-6304-2021
FU Science Fund for Research Initiation for Doctor of Second Affiliated
   Hospital of Nantong University [SFRI-2020-4218]; general project of
   Jiangsu Provincial Health Committee [H2019057]
FX This study was supported, in part, by the Science Fund for Research
   Initiation for Doctor of Second Affiliated Hospital of Nantong
   University (SFRI-2020-4218) and the general project of Jiangsu
   Provincial Health Committee (H2019057).
CR Aridon P, 2006, AM J HUM GENET, V79, P342, DOI 10.1086/506459
   Conrad K, 2007, ANN NY ACAD SCI, V1109, P256, DOI 10.1196/annals.1398.031
   de Laat P, 2013, JIMD REP, V8, P47, DOI 10.1007/8904_2012_159
   Geng X, 2019, DIABETIC MED, V36, P776, DOI 10.1111/dme.13874
   Haast RAM, 2018, NEUROIMAGE-CLIN, V18, P231, DOI 10.1016/j.nicl.2018.01.017
   Hong LE, 2008, BIOL PSYCHIAT, V63, P17, DOI 10.1016/j.biopsych.2007.05.011
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kuijf M, 2009, J PERIPHER NERV SYST, V2009
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392
   Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007
   Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Park J, 2013, J CLIN NEUROL, V9, P283, DOI 10.3988/jcn.2013.9.4.283
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
NR 16
TC 0
Z9 0
U1 3
U2 4
PU IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY
PI TEHRAN
PA SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL
   SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN
SN 2251-6085
EI 2251-6093
J9 IRAN J PUBLIC HEALTH
JI Iran J. Public Health
PD DEC
PY 2022
VL 51
IS 12
BP 2817
EP 2825
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA 9Q2KN
UT WOS:000944799600019
PM 36742238
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Jafari, A
   Hosseinpourfaizi, MA
   Houshmand, M
   Ravasi, AA
AF Jafari, A
   Hosseinpourfaizi, MA
   Houshmand, M
   Ravasi, AA
TI Effect of aerobic exercise training on mtDNA deletion in soleus muscle
   of trained and untrained Wistar rats
SO BRITISH JOURNAL OF SPORTS MEDICINE
LA English
DT Article
ID MITOCHONDRIAL-DNA DELETION; SKELETAL-MUSCLE; HUMAN-LEUKOCYTES;
   METABOLISM; MUTATIONS
AB Background: According to the theory of mitochondrial aging, oxidative stress plays a major role in aging and age related degenerative diseases. Since oxygen consumption and reactive oxygen species rate increase during aerobic exercise, we hypothesised that heavy aerobic training could lead to enhanced mitochondrial DNA ( mtDNA) deletion in postmitotic tissues, leading in turn to premature aging and degenerative diseases.
   Methods: Sixty adult male 2 month old Wistar(14848) rats were divided into six equal groups. Two groups were trained for 3 months by running on a treadmill ( 5 days/week, incline 6 degrees; group 1: 40 m/min, 20 min/day; group 2: 20 m/min, 40 min/ day), while two sedentary groups participated in aerobic exercise only at the end of the study ( incline 6 degrees; group 3: 40 m/min; group 4: 20 m/min). To control for physical and physiological parameters, two groups of untrained animals were killed at the beginning ( group 6) and end ( group 5) of the study. Expand long PCR was used to investigate mtDNA deletion in soleus muscle and a sequencing method was used to confirm the mtDNA deletion break point.
   Results: Our results did not show any mtDNA deletion in untrained rats or in those that underwent moderate training ( group 2) We only found mtDNA deletion ( 4.6 kb) in the soleus muscle of heavily trained rats ( group 1).
   Conclusions: These results demonstrate that one session of aerobic exercise does not cause mtDNA deletion in skeletal muscle. The difference in results between heavy and moderate aerobic training may be due to low work rate or up-regulation of inducible antioxidant systems in moderate training.
C1 Tabriz Univ, Dept Phys Educ & Sport Sci, Tabriz 98, Iran.
   Natl Res Ctr Genet Engn & Biotechnol, Tehran, Iran.
C3 University of Tabriz
RP Tabriz Univ, Dept Phys Educ & Sport Sci, 29 Bahman St, Tabriz 98, Iran.
EM ajafari@tabrizu.ac.ir
RI Jafari, Afshar/ABD-9158-2021; Houshmand, Massoud/AEG-9909-2022
OI Jafari, Afshar/0000-0003-1186-4923; , Masoud/0000-0001-7687-7464
CR AMES BN, 1991, OXIDATIVE DAMAGE & REPAIR, P181
   ARMSTRONG RB, 1983, J APPL PHYSIOL, V55, P518, DOI 10.1152/jappl.1983.55.2.518
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Hartmann A, 1998, FREE RADICAL BIO MED, V24, P245, DOI 10.1016/S0891-5849(97)00249-9
   Iwai K, 2003, EUR J APPL PHYSIOL, V88, P515, DOI 10.1007/s00421-002-0745-7
   Jackson MJ, 1994, EXERCISE OXYGEN TOXI, P49
   KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W
   La J. H., 2000, FREE RADICALS EXERCI, P35
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   LAWLER JM, 1993, MED SCI SPORT EXER, V25, P1259
   Leeuwenburgh C, 1997, AM J PHYSIOL-REG I, V272, pR363, DOI 10.1152/ajpregu.1997.272.1.R363
   LINNANE AW, 1992, MUTAT RES, V275, P195, DOI 10.1016/0921-8734(92)90023-I
   McCurdy DT, 1996, J APPL PHYSIOL, V81, P326, DOI 10.1152/jappl.1996.81.1.326
   MEYDANI M, 1993, FREE RADICALS AGING, P183
   MULLERHOCKER J, 1992, BRAIN PATHOL, V2, P149, DOI 10.1111/j.1750-3639.1992.tb00683.x
   Ohishi S, 1997, CLIN EXP PHARMACOL P, V24, P326, DOI 10.1111/j.1440-1681.1997.tb01196.x
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Poulsen HE, 1996, J SPORT SCI, V14, P343, DOI 10.1080/02640419608727720
   POWERS SK, 1994, AM J PHYSIOL, V266, pR375, DOI 10.1152/ajpregu.1994.266.2.R375
   Radák Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6
   RADAK Z, 2000, FREE RADICALS EXERCI, P177
   REZNICK AZ, 2000, FREE RADICALS EXERCI, P73
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   Sakai Y, 1999, MUSCLE NERVE, V22, P258, DOI 10.1002/(SICI)1097-4598(199902)22:2<258::AID-MUS15>3.0.CO;2-1
   Sambrook J., 1989, Molecular Cloning
   SEN CK, 1992, J APPL PHYSIOL, V73, P1265, DOI 10.1152/jappl.1992.73.4.1265
   Sumida S, 1997, FREE RADICAL RES, V27, P607, DOI 10.3109/10715769709097864
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
NR 33
TC 19
Z9 19
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-3674
EI 1473-0480
J9 BRIT J SPORT MED
JI Br. J. Sports Med.
PD AUG 1
PY 2005
VL 39
IS 8
BP 517
EP 520
DI 10.1136/bjsm.2004.014068
PG 4
WC Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Sport Sciences
GA 949AA
UT WOS:000230756000011
PM 16046334
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Parikh, S
AF Parikh, Sumit
TI THE NEUROLOGIC MANIFESTATIONS OF MITOCHONDRIAL DISEASE
SO DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
LA English
DT Review
DE mitochondria; mitochondrial disease; neurological; neuropathy; white
   matter; stroke; hearing loss; pigmentary retinopathy; Leigh syndrome;
   ataxia; Alper syndrome; POLG; epilepsia partialis continua-epilepsy;
   seizures; cerebellar degeneration; optic atrophy; myopathy; hypotonia;
   dysmotility
ID RIBOSOMAL-RNA MUTATION; DNA POLYMERASE-GAMMA; OXIDATIVE-PHOSPHORYLATION;
   OXIDASE DEFICIENCY; STATUS EPILEPTICUS; POLG MUTATIONS; LEIGH-SYNDROME;
   L-ARGININE; CHILDREN; DEPLETION
AB The nervous system contains some of the body's most metabolically demanding cells that are highly dependent on ATP produced via mitochondrial oxidative phosphorylation. Thus, the neurological system is consistently involved in patients with mitochondrial disease. Symptoms differ depending on the part of the nervous system affected. Although almost any neurological symptom can be due to mitochondrial disease, there are select symptoms that are more suggestive of a mitochondrial problem. Certain symptoms that have become sine qua non with underlying mitochondrial cytopathies can serve as diagnostic "red-flags." Here, the typical and atypical presentations of mitochondrial disease in the nervous system are reviewed, focusing on "red flag" neurological symptoms as well as associated symptoms that can occur in, but are not specific to, mitochondrial disease. The multitudes of mitochondria! syndromes are not reviewed in-depth, though a select few are discussed in some detail. (C) 2010 Wiley-Liss, Inc. Dev Disabil Res Rev 2010;16:120-128.
C1 Cleveland Clin, Cleveland, OH 44195 USA.
C3 Cleveland Clinic Foundation
RP Parikh, S (corresponding author), Cleveland Clin, 9500 Euclid Ave,S60, Cleveland, OH 44195 USA.
EM sumit.parikh@gmail.com
CR Arthur TM, 2007, MITOCHONDRION, V7, P279, DOI 10.1016/j.mito.2007.04.003
   Benarroch EE, 2010, NEUROLOGY, V74, P601, DOI 10.1212/WNL.0b013e3181d03762
   Blanco-Barca O, 2004, REV NEUROLOGIA, V39, P618
   Bough K, 2008, EPILEPSIA, V49, P91, DOI 10.1111/j.1528-1167.2008.01846.x
   Brown GK, 2005, J INHERIT METAB DIS, V28, P393, DOI 10.1007/s10545-005-7051-6
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   Chitkara DK, 2003, AM J GASTROENTEROL, V98, P871, DOI 10.1016/S0002-0270(03)00049-2
   *CMG, 2002, GENET MED, V4, P162
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DEVRIES MC, 2008, J INHERIT METAB DIS
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elia M, 1996, BRAIN DEV-JPN, V18, P207, DOI 10.1016/0387-7604(95)00126-3
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Finsterer J, 2005, METAB BRAIN DIS, V20, P219, DOI 10.1007/s11011-005-7209-9
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P543, DOI 10.1017/S0317167100008027
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   Garcia-Cazorla A, 2008, NEUROLOGY, V70, P1360, DOI 10.1212/01.wnl.0000309223.98616.e4
   García-Cazorla A, 2007, DEV MED CHILD NEUROL, V49, P740, DOI 10.1111/j.1469-8749.2007.00740.x
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   KARTSOUNIS LD, 1992, ARCH NEUROL-CHICAGO, V49, P158, DOI 10.1001/archneur.1992.00530260058020
   Keng WT, 2003, DEV MED CHILD NEUROL, V45, P704
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   KOTAGAL S, 1988, PEDIATR NEUROL, V4, P241, DOI 10.1016/0887-8994(88)90038-0
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Lachhwani DK, 2008, EPILEPSIA, V49, P223
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lerman-Sagie T, 2005, MOL GENET METAB, V84, P127, DOI 10.1016/j.ymgme.2004.09.008
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Morgan PG, 2002, ANESTHESIOLOGY, V96, P1268, DOI 10.1097/00000542-200205000-00036
   Muravchick S, 2006, ANESTHESIOLOGY, V105, P819, DOI 10.1097/00000542-200610000-00029
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Neilson DE, 2009, AM J HUM GENET, V84, P44, DOI 10.1016/j.ajhg.2008.12.009
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishino I, 1998, MUSCLE NERVE, V21, P40, DOI 10.1002/(SICI)1097-4598(199801)21:1<40::AID-MUS6>3.0.CO;2-G
   Nye JS, 2000, TERATOLOGY, V61, P165, DOI 10.1002/(SICI)1096-9926(200003)61:3<165::AID-TERA3>3.3.CO;2-5
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Parikh S, 2008, PEDIATR NEUROL, V38, P191, DOI 10.1016/j.pediatrneurol.2007.10.011
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P184, DOI 10.1055/s-2007-991150
   Rose LVT, 2008, PEDIATR NEUROL, V38, P395, DOI 10.1016/j.pediatrneurol.2008.02.003
   Sadleir LG, 2004, EUR J NEUROL, V11, P103, DOI 10.1046/j.1351-5101.2003.00724.x
   Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Scruggs ER, 2008, PHARMACOLOGY, V82, P83, DOI 10.1159/000134943
   Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.0.CO;2-M
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Taban M, 2006, J CHILD NEUROL, V21, P956, DOI 10.1177/08830738060210111601
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Toribe Yasuhisa, 2007, No To Hattatsu, V39, P38
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Waldbaum S, 2010, EPILEPSY RES, V88, P23, DOI 10.1016/j.eplepsyres.2009.09.020
   Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815
   Willis TA, 2000, DEV MED CHILD NEUROL, V42, P414, DOI 10.1017/S0012162200000761
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   WRAY SH, 1995, AM J NEURORADIOL, V16, P1167
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zimmer V, 2009, NEUROGASTROENT MOTIL, V21, P627, DOI 10.1111/j.1365-2982.2009.01264.x
NR 74
TC 16
Z9 19
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1940-5510
EI 1940-5529
J9 DEV DISABIL RES REV
JI Dev. Disabil. Res. Rev.
PY 2010
VL 16
IS 2
BP 120
EP 128
DI 10.1002/ddrr.110
PG 9
WC Clinical Neurology; Neurosciences; Pediatrics; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics; Psychiatry
GA 642IB
UT WOS:000281201100004
PM 20818726
DA 2024-11-01
ER

PT J
AU Patton, JR
   Bykhovskaya, Y
   Mengesha, E
   Bertolotto, C
   Fischel-Ghodsian, N
AF Patton, JR
   Bykhovskaya, Y
   Mengesha, E
   Bertolotto, C
   Fischel-Ghodsian, N
TI Mitochondrial myopathy and sideroblastic anemia (MLASA) -: Missense
   mutation in the pseudouridine synthase 1 (<i>PUS1</i>) gene is
   associated with the loss of tRNA pseudouridylation
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID U2 SNRNA; DYSKERATOSIS-CONGENITA; RIBOSOMAL-RNA; IN-VIVO; CONSERVED
   PSEUDOURIDINE; ANTICODON LOOP; CHAIN-REACTION; DNA INVITRO; BIOGENESIS;
   STABILIZATION
AB A missense mutation in the PUS1 gene affecting a highly conserved amino acid has been associated with mitochondrial myopathy and sideroblastic anemia (MLASA), a rare autosomal recessive oxidative phosphorylation disorder. The PUS1 gene encodes the enzyme pseudouridine synthase 1 (Pus1p) that is known to pseudouridylate tRNAs in other species. Total RNA was isolated from lymphoblastoid cell lines established from patients, parents, unaffected siblings, and unrelated controls, and the tRNAs were assayed for the presence of pseudouridine (Psi) at the expected positions. Mitochondrial and cytoplasmic tRNAs from MLASA patients are lacking modification at sites normally modified by Pus1p, whereas tRNAs from controls, unaffected siblings, or parents all have Psi at these positions. In addition, there was no Pus1p activity in an extract made from a cell line derived from a patient with MLASA. Immunohistochemical staining of Pus1p in cell lines showed nuclear, cytoplasmic, and mitochondrial distribution of the protein, and there is no difference in staining between patients and unaffected family members. MLASA is thus associated with absent or greatly reduced tRNA pseudouridylation at specific sites, implicating this pathway in its molecular pathogenesis.
C1 Univ S Carolina, Sch Med, Dept Pathol & Microbiol, Columbia, SC 29209 USA.
   Univ Calif Los Angeles, Cedars Sinai Med Ctr, Inst Med Genet,David Geffen Sch Med, Ahmanson Dept Pediat,Steven Spielberg Pediat Res, Los Angeles, CA 90048 USA.
C3 University of South Carolina System; University of South Carolina
   Columbia; Cedars Sinai Medical Center; University of California System;
   University of California Los Angeles; University of California Los
   Angeles Medical Center; David Geffen School of Medicine at UCLA
RP Cedars Sinai Med Ctr, Dept Pediat, 8700 Beverly Blvd,Ste 1165 WT, Los Angeles, CA 90048 USA.
EM nathan.fischel@cshs.org
OI Mengesha, Emebet/0000-0001-7830-1557
FU NIDCD NIH HHS [R01DC01402] Funding Source: Medline
CR Ansmant I, 2000, NUCLEIC ACIDS RES, V28, P1941, DOI 10.1093/nar/28.9.1941
   Auffinger P., 2014, MODIFICATION EDITING, P103, DOI [10.1128/9781555818296.ch6, DOI 10.1128/9781555818296.CH6]
   Auffinger P., 1998, MODIFICATION EDITING, P569
   Bakin AV, 1998, METH MOL B, V77, P297
   Baumstark T, 2001, RNA, V7, P1652
   Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   Chen JG, 2000, BIOCHEMISTRY-US, V39, P12723, DOI 10.1021/bi001109m
   Chen JG, 1999, RNA, V5, P409, DOI 10.1017/S1355838299981591
   Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020
   Davis DR, 1998, J BIOMOL STRUCT DYN, V15, P1121, DOI 10.1080/07391102.1998.10509006
   DAVIS DR, 1991, BIOCHEMISTRY-US, V30, P4223, DOI 10.1021/bi00231a017
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   Dönmez G, 2004, RNA, V10, P1925, DOI 10.1261/rna.7186504
   GRIFFEY RH, 1985, J BIOL CHEM, V260, P9734
   Grosshans H, 2001, J BIOL CHEM, V276, P46333, DOI 10.1074/jbc.M107141200
   Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32
   Hellmuth K, 2000, NUCLEIC ACIDS RES, V28, P4604, DOI 10.1093/nar/28.23.4604
   Helm M, 2004, J MOL BIOL, V337, P545, DOI 10.1016/j.jmb.2004.01.036
   Huang LX, 1998, BIOCHEMISTRY-US, V37, P344, DOI 10.1021/bi971874+
   Lecointe F, 1998, J BIOL CHEM, V273, P1316, DOI 10.1074/jbc.273.3.1316
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Motorin Y, 1998, RNA, V4, P856, DOI 10.1017/S1355838298980396
   MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032
   MULLIS KB, 1987, METHOD ENZYMOL, V155, P335
   Newby MI, 2002, NAT STRUCT BIOL, V9, P958, DOI 10.1038/nsb873
   Newby MI, 2001, RNA, V7, P833, DOI 10.1017/S1355838201002308
   Nishimura S, 1972, Prog Nucleic Acid Res Mol Biol, V12, P49
   Patton JR, 2003, BIOCHEM J, V372, P595, DOI 10.1042/BJ20021938
   Ramamurthy V, 1999, J BIOL CHEM, V274, P22225, DOI 10.1074/jbc.274.32.22225
   Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447
   SAMBROOK J, 2001, MOL CLONING LAB MANU, P776
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Simos G, 1996, EMBO J, V15, P2270, DOI 10.1002/j.1460-2075.1996.tb00580.x
   Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   WU XQ, 1993, NUCLEIC ACIDS RES, V21, P5589, DOI 10.1093/nar/21.24.5589
   Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783
   Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461
   Zhao XL, 2004, RNA, V10, P681, DOI 10.1261/rna.5159504
   Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044
NR 43
TC 108
Z9 123
U1 0
U2 8
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 20
PY 2005
VL 280
IS 20
BP 19823
EP 19828
DI 10.1074/jbc.M500216200
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 926HH
UT WOS:000229113700049
PM 15772074
OA hybrid
DA 2024-11-01
ER

PT J
AU Gaweda-Walerych, K
   Zekanowski, C
AF Gaweda-Walerych, Katarzyna
   Zekanowski, Cezary
TI The Impact of Mitochondrial DNA and Nuclear Genes Related to
   Mitochondrial Functioning on the Risk of Parkinson's Disease
SO CURRENT GENOMICS
LA English
DT Article
DE Association studies; Mitochondrial dysfunction; mtDNA haplogroups;
   Nuclear genes; Parkinson's disease; Polymorphism
ID TRANSCRIPTION-FACTOR-A; COMPLEX-I DEFICIENCY; SINGLE-NUCLEOTIDE
   POLYMORPHISMS; ONSET ALZHEIMERS-DISEASE; GENOME-WIDE ASSOCIATION;
   TELOMERE LENGTH; RESPIRATORY-CHAIN; POLYMERASE-GAMMA; SUBSTANTIA-NIGRA;
   SKELETAL-MUSCLE
AB Mitochondrial dysfunction and oxidative stress are the major factors implicated in Parkinson's disease (PD) pathogenesis. The maintenance of healthy mitochondria is a very complex process coordinated bi-genomically. Here, we review association studies on mitochondrial haplogroups and subhaplogroups, discussing the underlying molecular mechanisms. We also focus on variation in the nuclear genes (NDUFV2, PGC-1alpha, HSPA9, LRPPRC, MTIF3, POLG1, and TFAM encoding NADH dehydrogenase (ubiquinone) flavoprotein 2, peroxisome proliferator-activated receptor gamma coactivator 1-alpha, mortalin, leucine-rich pentatricopeptide repeat containing protein, translation initiation factor 3, mitochondrial DNA polymerase gamma, and mitochondrial transcription factor A, respectively) primarily linked to regulation of mitochondrial functioning that recently have been associated with PD risk. Possible interactions between mitochondrial and nuclear genetic variants and related proteins are discussed.
C1 [Gaweda-Walerych, Katarzyna; Zekanowski, Cezary] Polish Acad Sci, Mossakowski Med Res Ctr, Neurogenet Lab, PL-02106 Warsaw, Poland.
C3 Polish Academy of Sciences; Mossakowski Medical Research Institute of
   the Polish Academy of Sciences
RP Gaweda-Walerych, K (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Neurogenet Lab, Pawinskiego 5, PL-02106 Warsaw, Poland.
EM kasiawal@libero.it
RI ; Gaweda-Walerych, Katarzyna/HII-5614-2022
OI Zekanowski, Cezary/0000-0001-7332-8494; Gaweda-Walerych,
   Katarzyna/0000-0001-8670-1200
CR Abahuni N, 2007, NEUROSCI LETT, V414, P126, DOI 10.1016/j.neulet.2006.12.053
   Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alvarez V, 2008, NEUROSCI LETT, V432, P79, DOI 10.1016/j.neulet.2007.12.010
   Amo T, 2008, GENE, V411, P69, DOI 10.1016/j.gene.2008.01.007
   Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609
   Anvret A, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/491751
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Arning L, 2010, J MOL MED, V88, P431, DOI 10.1007/s00109-010-0589-2
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   Behrouz B, 2010, NEUROSCI LETT, V486, P228, DOI 10.1016/j.neulet.2010.09.059
   Belin AC, 2007, NEUROSCI LETT, V420, P257, DOI 10.1016/j.neulet.2007.05.010
   Bellizzi D, 2012, EPIGENOMICS-UK, V4, P17, DOI [10.2217/EPI.11.109, 10.2217/epi.11.109]
   Bender A., 2006, NAT GENET
   Berg Daniela, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS195, DOI 10.1016/S1353-8020(11)70061-X
   Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Borland MK, 2009, BBA-MOL BASIS DIS, V1792, P68, DOI 10.1016/j.bbadis.2008.09.014
   Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484
   Braak H, 2004, NEUROBIOL AGING, V25, P19, DOI 10.1016/j.neurobiolaging.2003.04.001
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   Brown MD, 1997, AM J HUM GENET, V60, P381
   Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370
   Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2
   Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865
   Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647
   Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178
   Ciron C, 2012, HUM MOL GENET, V21, P1861, DOI 10.1093/hmg/ddr618
   Clark J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-69
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   Coto E, 2011, NEUROGENETICS, V12, P345, DOI 10.1007/s10048-011-0295-4
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   Aguiar PDC, 2008, MOVEMENT DISORD, V23, P1228, DOI 10.1002/mds.22032
   De Mena L, 2009, J NEURAL TRANSM, V116, P1289, DOI 10.1007/s00702-009-0273-2
   Deeb SS, 2009, PPAR RES, V2009, DOI 10.1155/2009/649286
   Ding HL, 2011, MOVEMENT DISORD, V26, P2283, DOI 10.1002/mds.23934
   Domínguez-Garrido E, 2009, BIOGERONTOLOGY, V10, P435, DOI 10.1007/s10522-008-9186-y
   Drozak Jakub, 2005, Postepy Hig Med Dosw (Online), V59, P405
   Eerola J, 2010, J GERONTOL A-BIOL, V65, P1181, DOI 10.1093/gerona/glq125
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Ek J, 2001, DIABETOLOGIA, V44, P2220, DOI 10.1007/s001250100032
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Elbaz A, 2002, J CLIN EPIDEMIOL, V55, P25, DOI 10.1016/S0895-4356(01)00425-5
   Elson Joanna L, 2007, Biochem J, V404, pe3
   Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977
   Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283
   Fernández-Moreno M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-283
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Fujioka S, 2012, NEURODEGENER DIS, V10, P257, DOI 10.1159/000334285
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x
   Gaweda-Walerych K, 2008, J NEURAL TRANSM, V115, P1521, DOI 10.1007/s00702-008-0121-9
   Gaweda-Walerych K, 2013, ACTA NEUROBIOL EXP, V73, P199, DOI 10.55782/ane-2013-1931
   Gaweda-Walerych K, 2012, PARKINSONISM RELAT D, V18, P520, DOI 10.1016/j.parkreldis.2012.01.021
   Gaweda-Walerych K, 2010, NEUROSCI LETT, V469, P24, DOI 10.1016/j.neulet.2009.11.037
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003
   Grimm J, 2004, P NATL ACAD SCI USA, V101, P13891, DOI 10.1073/pnas.0405340101
   Gu M, 1998, J NEUROL SCI, V158, P24, DOI 10.1016/S0022-510X(98)00095-1
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Günther C, 2004, NEUROSCI LETT, V369, P219, DOI 10.1016/j.neulet.2004.07.070
   Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Hattori N, 1998, GENOMICS, V49, P52, DOI 10.1006/geno.1997.5192
   Hawkes CH, 2008, MOVEMENT DISORD, V23, P1799, DOI 10.1002/mds.22242
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Holt IJ., 2012, Cold Spring Harb Perspect Biol
   Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hudson G, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.022
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200
   Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022116
   Iwaasa M, 2002, J NEUROCHEM, V82, P30, DOI 10.1046/j.1471-4159.2002.00996.x
   Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045
   Jin JH, 2005, MOL BRAIN RES, V134, P119, DOI 10.1016/j.molbrainres.2004.10.003
   Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200
   Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023
   Kenney MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054339
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571
   Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834
   Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Latsoudis H, 2008, J HUM GENET, V53, P349, DOI 10.1007/s10038-008-0259-1
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   Leong DW, 2012, J BIOL CHEM, V287, P20652, DOI 10.1074/jbc.M111.327601
   Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin TK, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/824275
   Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889
   Liu XM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-104
   Lücking CB, 2003, ARCH NEUROL-CHICAGO, V60, P1253, DOI 10.1001/archneur.60.9.1253
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Maeda T, 2012, J NEUROGENET, V26, P245, DOI 10.3109/01677063.2011.651665
   Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002
   Martínez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005
   Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004
   Maruszak A, 2012, J ALZHEIMERS DIS, V28, P309, DOI 10.3233/JAD-2011-110743
   Maruszak A, 2011, J ALZHEIMERS DIS, V27, P197, DOI 10.3233/JAD-2011-110710
   Mata IF, 2011, MOVEMENT DISORD, V26, P819, DOI 10.1002/mds.23642
   Mawrin C, 2004, NEUROSCI LETT, V357, P111, DOI 10.1016/j.neulet.2003.11.073
   Mehta P, 2009, MOVEMENT DISORD, V24, P290, DOI 10.1002/mds.22389
   Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043
   Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003
   Monickaraj F, 2012, MOL CELL BIOCHEM, V365, P343, DOI 10.1007/s11010-012-1276-0
   Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052367
   Mullin S, 2013, MOL NEUROBIOL, V47, P587, DOI 10.1007/s12035-013-8394-x
   Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Nishioka K, 2010, PARKINSONISM RELAT D, V16, P686, DOI 10.1016/j.parkreldis.2010.09.007
   Noack H, 2006, BBA-GEN SUBJECTS, V1760, P141, DOI 10.1016/j.bbagen.2005.12.007
   Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Pacelli C, 2011, BBA-MOL BASIS DIS, V1812, P1041, DOI 10.1016/j.bbadis.2010.12.022
   Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9
   Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Peplonska B, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.02.018
   Pesce V, 2012, REJUV RES, V15, P136, DOI 10.1089/rej.2011.1255
   Picca A, 2013, AGE, V35, P1607, DOI 10.1007/s11357-012-9465-z
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Pihlstrom L, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.019
   Pilsl A, 2012, ACTA NEUROPATHOL, V123, P173, DOI 10.1007/s00401-011-0902-3
   Prabhakar S, 2010, NEUROEPIDEMIOLOGY, V35, P152, DOI 10.1159/000313855
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107
   Rakovic A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/153979
   Rego I, 2010, ANN RHEUM DIS, V69, P210, DOI 10.1136/ard.2008.105254
   Rego-Pérez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659
   Rhodes SL, 2011, ANN HUM GENET, V75, P195, DOI 10.1111/j.1469-1809.2010.00616.x
   Rideout HJ., 2013, NEUROCHEM RES
   Rosa A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-57
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040
   Sai Y, 2012, NEUROSCI BIOBEHAV R, V36, P2034, DOI 10.1016/j.neubiorev.2012.06.007
   Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8
   Sánchez-Ferrero E, 2009, PARKINSONISM RELAT D, V15, P468, DOI 10.1016/j.parkreldis.2008.09.004
   Sangar V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00404
   Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485
   Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schoeler S, 2007, CLIN NEUROPATHOL, V26, P164
   Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234
   Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353
   Sherer TB, 2002, J NEUROSCI, V22, P7006
   Shi M, 2008, J NEUROPATH EXP NEUR, V67, P117, DOI 10.1097/nen.0b013e318163354a
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Shutt TE, 2010, ENVIRON MOL MUTAGEN, V51, P360, DOI 10.1002/em.20571
   Silva WA, 2002, AM J HUM GENET, V71, P187, DOI 10.1086/341358
   Simon DK, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-53
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Simón-Sánchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254
   Simón-Sánchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Sterky FH, 2012, HUM MOL GENET, V21, P1078, DOI 10.1093/hmg/ddr537
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474
   Sun C, 2007, GENOMICS, V89, P338, DOI 10.1016/j.ygeno.2006.11.005
   Surh Young-Joon, 2010, Exp Neurobiol, V19, P63, DOI 10.5607/en.2010.19.2.63
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Takasaki S, 2009, J BIOENERG BIOMEMBR, V41, P407, DOI 10.1007/s10863-009-9240-8
   Takasaki S, 2009, J GENET GENOMICS, V36, P425, DOI 10.1016/S1673-8527(08)60132-0
   Tan EK, 2010, NEUROLOGY, V75, P508, DOI 10.1212/WNL.0b013e3181eccfcd
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Tanaka M, 2007, DIABETES, V56, P518, DOI 10.2337/db06-1105
   Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430
   Torroni A, 2000, AM J HUM GENET, V66, P1173, DOI 10.1086/302789
   Torroni A, 1996, GENETICS, V144, P1835
   Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x
   Trotta L, 2012, PARKINSONISM RELAT D, V18, P257, DOI 10.1016/j.parkreldis.2011.10.014
   Tsuboi Yoshio, 2012, Exp Neurobiol, V21, P123, DOI 10.5607/en.2012.21.3.123
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Umeda S, 2000, EUR J BIOCHEM, V267, P200, DOI 10.1046/j.1432-1327.2000.00990.x
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   van Nuenen BFL, 2009, MOVEMENT DISORD, V24, pS703, DOI 10.1002/mds.22635
   Vimaleswaran KS, 2008, J APPL PHYSIOL, V105, P1352, DOI 10.1152/japplphysiol.90423.2008
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867
   Warner TT, 2003, ANN NEUROL, V53, pS16, DOI 10.1002/ana.10487
   Watfa G, 2011, J NUTR HEALTH AGING, V15, P277, DOI 10.1007/s12603-010-0275-7
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   Wittkopp S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064444
   Wooten GF, 1997, ANN NEUROL, V41, P265, DOI 10.1002/ana.410410218
   Wu YR, 2010, AM J MED GENET B, V153B, P229, DOI 10.1002/ajmg.b.30977
   Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059
NR 238
TC 21
Z9 24
U1 0
U2 19
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2029
EI 1875-5488
J9 CURR GENOMICS
JI Curr. Genomics
PD DEC
PY 2013
VL 14
IS 8
BP 543
EP 559
PG 17
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AB6LW
UT WOS:000331901000006
PM 24532986
OA Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Koenig, MK
AF Koenig, Mary Kay
TI Presentation and diagnosis of mitochondrial disorders in children
SO PEDIATRIC NEUROLOGY
LA English
DT Review
ID MAGNETIC-RESONANCE-SPECTROSCOPY; RESPIRATORY-CHAIN DISORDERS; MUSCLE
   BIOPSY; INTRAMITOCHONDRIAL FIBERS; OXIDATIVE-PHOSPHORYLATION;
   ULTRASTRUCTURAL-CHANGES; DNA CHARACTERISTICS; ENCEPHALOMYOPATHIES;
   MYOPATHIES; EPIDEMIOLOGY
AB The first disorder of mitochondrial function was described by Luft in 1959. Over the ensuing decades, multiple cases of mitochondrial dysfunction were reported, and the term "mitochondrial disorder" arose to describe any defect in the mitochondrial electron transport chain. The sequence of the mitochondrial genome was elucidated in 1981 by Anderson et al., and during the next 20 years, >200 pathogenic point mutations, deletions, insertions, and rearrangements were described. Most of the original cases were adults, and the diagnosis of a mitochondrial disorder in an adult patient became relatively straightforward. Adults present with well-defined "mitochondrial syndromes" and generally carry mitochondrial DNA mutations that are easily identified. Children with mitochondrial disorders are much harder to define. Children are more likely to have a nuclear DNA mutation, whereas the "classic" syndromic findings tend to be absent. This review describes both the varying presentations of mitochondrial disorders and the common laboratory, imaging, and pathologic findings related to children. (C) 2008 by Elsevier Inc. All rights reserved.
C1 [Koenig, Mary Kay] Univ Texas Houston, Hlth Sci Ctr, Dept Pediat, Houston, TX 77030 USA.
   [Koenig, Mary Kay] Univ Texas Houston, Hlth Sci Ctr, Dept Neurol, Houston, TX 77030 USA.
C3 University of Texas System; University of Texas Health Science Center
   Houston; University of Texas System; University of Texas Health Science
   Center Houston
RP Koenig, MK (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Pediat, 6431 Fannin St, Houston, TX 77030 USA.
EM mary.k.koenig@uth.tmc.edu
FU NCRR NIH HHS [KL2 RR024149-05S1, KL2 RR024149] Funding Source: Medline
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ARGOV Z, 1991, ANN NEUROL, V30, P90, DOI 10.1002/ana.410300116
   Bank William, 1998, Biofactors, V7, P243
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Brantová O, 2006, ULTRASTRUCT PATHOL, V30, P239, DOI 10.1080/01913120600820112
   Casademont J, 2004, MED SCI MONITOR, V10, pCS49
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chretien D, 2003, J INHERIT METAB DIS, V26, P189, DOI 10.1023/A:1024437201166
   DiMauro S, 1999, J CHILD NEUROL, V14, pS23, DOI 10.1177/0883073899014001051
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   Dinopoulos A, 2005, NEUROPEDIATRICS, V36, P290, DOI 10.1055/s-2005-872807
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Gillis LA, 2003, GASTROENTEROL CLIN N, V32, P789, DOI 10.1016/S0889-8553(03)00052-9
   Gire C, 2002, CHILD NERV SYST, V18, P621, DOI 10.1007/s00381-002-0621-0
   Hagenfeldt L, 1998, J INHERIT METAB DIS, V21, P613, DOI 10.1023/A:1005431424744
   Hancock MR, 2002, ANN CLIN BIOCHEM, V39, P456, DOI 10.1258/000456302320314467
   Hodges SD, 2004, NUCLEOS NUCLEOT NUCL, V23, P1269, DOI 10.1081/NCN-200027537
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Hsu CH, 2005, ANN NY ACAD SCI, V1042, P36, DOI 10.1196/annals.1338.004
   Hui J, 2006, DEV MED CHILD NEUROL, V48, P132, DOI 10.1017/S0012162206000284
   Hutchesson A, 1997, CLIN CHEM, V43, P158
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Kang PB, 2001, J CHILD NEUROL, V16, P657, DOI 10.1177/088307380101600906
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Kyriacou K, 1999, ULTRASTRUCT PATHOL, V23, P163
   Lamont PJ, 1998, ARCH DIS CHILD, V79, P22, DOI 10.1136/adc.79.1.22
   LINDAL S, 1992, ULTRASTRUCT PATHOL, V16, P263, DOI 10.3109/01913129209061355
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mochel F, 2005, J CLIN ENDOCR METAB, V90, P3780, DOI 10.1210/jc.2005-0009
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   NARAYANA PA, 1989, MAGN RESON IMAGING, V7, P133, DOI 10.1016/0730-725X(89)90695-4
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   Panetta J, 2005, NEUROPEDIATRICS, V36, P256, DOI 10.1055/s-2005-865866
   Patterson K, 2004, PEDIATR DEVEL PATHOL, V7, P629, DOI 10.1007/s10024-004-5051-4
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Rötig A, 2003, J NEPHROL, V16, P286
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   RUSTIN P, 1991, LANCET, V338, P60, DOI 10.1016/0140-6736(91)90057-V
   Shoffner JM, 2000, NEUROL CLIN, V18, P105, DOI 10.1016/S0733-8619(05)70180-8
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   SLINDE E, 1975, ANAL BIOCHEM, V66, P151, DOI 10.1016/0003-2697(75)90733-2
   STADHOUDERS AM, 1987, J INHERIT METAB DIS, V10, P62, DOI 10.1007/BF01812848
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Thorburn DR, 2001, J INHERIT METAB DIS, V24, P312, DOI 10.1023/A:1010347808082
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006
NR 56
TC 110
Z9 133
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD MAY
PY 2008
VL 38
IS 5
BP 305
EP 313
DI 10.1016/j.pediatrneurol.2007.12.001
PG 9
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 293MU
UT WOS:000255340200001
PM 18410845
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Peralta, S
   Torraco, A
   Iommarini, L
   Diaz, F
AF Peralta, Susana
   Torraco, Alessandra
   Iommarini, Luisa
   Diaz, Francisca
TI Mitochondrial Diseases Part III: Therapeutic interventions in mouse
   models of OXPHOS deficiencies
SO MITOCHONDRION
LA English
DT Review
DE Mitochondria; Oxidative phosphorylation; OXPHOS; Mouse models;
   Mitochondrial diseases
ID GENE-THERAPY; MTDNA HETEROPLASMY; RESPIRATORY-CHAIN; DEOXYNUCLEOTIDE
   POOLS; NICOTINAMIDE RIBOSIDE; ALLOTOPIC EXPRESSION; SKELETAL-MUSCLE; DNA
   MUTATIONS; MURINE MODEL; BEZAFIBRATE
AB Mitochondrial defects are the cause of numerous disorders affecting the oxidative phosphorylation system (OXPHOS) in humans leading predominantly to neurological and muscular degeneration. The molecular origin, manifestations, and progression of mitochondrial diseases have a broad spectrum, which makes very challenging to find a globally effective therapy. The study of the molecular mechanisms underlying the mitochondrial dysfunction indicates that there is a wide range of pathways, enzymes and molecules that can be potentially targeted for therapeutic purposes. Therefore, focusing on the pathology of the disease is essential to design new treatments. In this review, we will summarize and discuss the different therapeutic interventions tested in some mouse models of mitochondrial diseases emphasizing the molecular mechanisms of action and their potential applications. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All tights reserved.
C1 [Peralta, Susana; Diaz, Francisca] Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA.
   [Torraco, Alessandra] IRCCS, Bambino Gesu Childrens Hosp, Mol Med Lab, Neuromuscular & Neurodegenerat Disorders, I-00146 Rome, Italy.
   [Iommarini, Luisa] Univ Bologna, Dept Pharm & Biotechnol FABIT, I-40126 Bologna, Italy.
C3 University of Miami; IRCCS Bambino Gesu; University of Bologna
RP Diaz, F (corresponding author), Two Story Labs, 1420 NW 9th Ave,Room 230B, Miami, FL 33136 USA.
EM SPeralta@med.miami.edu; alessandra.torraco@opbg.net;
   luisa.iommarini2@unibo.it; fdiaz1@med.miami.edu
RI Torraco, Alessandra/AAA-6212-2020; Iommarini, Luisa/J-2328-2018
OI Torraco, Alessandra/0000-0002-8148-9295; Iommarini,
   Luisa/0000-0002-6804-7302
FU James and Esther King Research Program Florida Department of Health
   [08KN-01]; National Institute of Health [GM101225]; United Mitochondrial
   Disease Foundation [14050R]
FX We would like to express our gratitude to Jose Oca-Cossio for critical
   comments of this manuscript. FD research has been funded by the James
   and Esther King Research Program Florida Department of Health (grant
   number 08KN-01), by the National Institute of Health (grant number
   GM101225) and by the United Mitochondrial Disease Foundation (grant
   number 14050R).
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023
   Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Benton CR, 2008, APPL PHYSIOL NUTR ME, V33, P843, DOI 10.1139/H08-074
   Bonnefont JP, 2009, NEW ENGL J MED, V360, P838, DOI 10.1056/NEJMc0806334
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Bouaita A, 2012, BRAIN, V135, P35, DOI 10.1093/brain/awr290
   Bundred N, 2013, INVEST NEW DRUG, V31, P949, DOI 10.1007/s10637-012-9922-7
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433
   Dillon LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044335
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Djouadi F, 2011, CELL METAB, V14, P715, DOI 10.1016/j.cmet.2011.11.003
   El-Khoury R, 2014, BRIT J PHARMACOL, V171, P2243, DOI 10.1111/bph.12570
   El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004
   Flierl A, 2005, GENE THER, V12, P570, DOI 10.1038/sj.gt.3302443
   Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Hirano M, 2004, NUCLEOS NUCLEOT NUCL, V23, P1217, DOI 10.1081/NCN-200027485
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Kakizaki Y, 2010, BBA-BIOENERGETICS, V1797, P20, DOI 10.1016/j.bbabio.2009.07.006
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mott JL, 2004, BIOCHEM BIOPH RES CO, V319, P1210, DOI 10.1016/j.bbrc.2004.05.104
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   Ojuka EO, 2004, P NUTR SOC, V63, P275, DOI 10.1079/PNS2004339
   Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769
   Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002
   Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923
   Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Saada A, 2011, MOL GENET METAB, V104, P39, DOI 10.1016/j.ymgme.2011.07.016
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schiff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028823
   Schleit J, 2013, AGING CELL, V12, P1050, DOI 10.1111/acel.12130
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tenenbaum A, 2005, ARCH INTERN MED, V165, P1154, DOI 10.1001/archinte.165.10.1154
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Torres-Torronteras J, 2011, GENE THER, V18, P795, DOI 10.1038/gt.2011.24
   Torres-Torronteras J, 2014, MOL THER, V22, P901, DOI 10.1038/mt.2014.6
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Yu H, 2012, P NATL ACAD SCI USA, V109, pE1238, DOI 10.1073/pnas.1119577109
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 86
TC 9
Z9 9
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2015
VL 23
BP 71
EP 80
DI 10.1016/j.mito.2015.01.007
PG 10
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA CO0EV
UT WOS:000358823800009
PM 25638392
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Remenyi, V
   Inczedy-Farkas, G
   Komlosi, K
   Horvath, R
   Maasz, A
   Janicsek, I
   Pentelenyi, K
   Gal, A
   Karcagi, V
   Melegh, B
   Molnar, MJ
AF Remenyi, Viktoria
   Inczedy-Farkas, Gabriella
   Komlosi, Katalin
   Horvath, Rita
   Maasz, Anita
   Janicsek, Ingrid
   Pentelenyi, Klara
   Gal, Aniko
   Karcagi, Veronika
   Melegh, Bela
   Molnar, Maria Judit
TI Retrospective assessment of the most common mitochondrial DNA mutations
   in a large Hungarian cohort of suspect mitochondrial cases
SO MITOCHONDRIAL DNA
LA English
DT Article
DE LHON; MELAS; MERRF; mitochondrial deletions; mutation frequency; NARP
ID HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   STROKE-LIKE EPISODES; DIABETES-MELLITUS; CLINICAL-FEATURES; CHINESE
   PATIENTS; LACTIC-ACIDOSIS; A3243G MUTATION; A8344G MUTATION; MTDNA
   MUTATIONS
AB Prevalence estimations for mitochondrial disorders still vary widely and only few epidemiologic studies have been carried out so far. With the present work we aim to give a comprehensive overview about frequencies of the most common mitochondrial mutations in Hungarian patients. A total of 1328 patients were tested between 1999 and 2012. Among them, 882 were screened for the m.3243A>G, m.8344A>G, m.8993T>C/G mutations and deletions, 446 for LHON primary mutations. The mutation frequency in our cohort was 2.61% for the m.3243A>G, 1.47% for the m.8344A>G, 17.94% for Leber's Hereditary Optic Neuropathy (m.3460G>A, m.11778G>A, m.14484T>C) and 0.45% for the m.8993T>C/G substitutions. Single mtDNA deletions were detected in 14.97%, while multiple deletions in 6.01% of the cases. The mutation frequency in Hungarian patients suggestive of mitochondrial disease was similar to other Caucasian populations. Further retrospective studies of different populations are needed in order to accurately assess the importance of mitochondrial diseases and manage these patients.
C1 [Remenyi, Viktoria; Inczedy-Farkas, Gabriella; Pentelenyi, Klara; Gal, Aniko; Molnar, Maria Judit] Semmelweis Univ, Inst Genom Med & Rare Disorders, H-1083 Budapest, Hungary.
   [Inczedy-Farkas, Gabriella] LIJ Hlth Syst, Zucker Hillside Hosp North Shore, Glen Oaks, NY USA.
   [Komlosi, Katalin; Maasz, Anita; Janicsek, Ingrid; Melegh, Bela] Univ Pecs, Dept Med Genet, Pecs, Hungary.
   [Horvath, Rita] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Karcagi, Veronika] Natl Inst Environm Hlth, Dept Mol Genet, Budapest, Hungary.
C3 Semmelweis University; Northwell Health; University of Pecs; Newcastle
   University - UK
RP Molnar, MJ (corresponding author), Semmelweis Univ, Inst Genom Med & Rare Disorders, Tomo Str 25-29, H-1083 Budapest, Hungary.
EM molnar.mariajudit@med.semmelweis-univ.hu
RI Horvath, Rita/AAY-7042-2020
OI Horvath, Rita/0000-0002-9841-170X; Maasz, Anita/0000-0002-5051-7708
FU [TAMOP-4-2-1/B-03/1/KMR-2010-001];  [KTIA_AIK_12-1-2013-0017]; 
   [BIOINF09-TET_10-1-2011-0058]; MRC [G1000848] Funding Source: UKRI
FX The authors declare no conflict of interest. The study was supported by
   the TAMOP-4-2-1/B-03/1/KMR-2010-001, KTIA_AIK_12-1-2013-0017 and
   BIOINF09-TET_10-1-2011-0058 grants
CR Aniko G, 2010, CENT EUR J MED, V5, P322, DOI 10.2478/s11536-009-0118-2
   Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Cao YY, 2010, MITOCHONDRION, V10, P330, DOI 10.1016/j.mito.2010.01.008
   Carrozzo R, 1999, J NEUROL SCI, V170, P24, DOI 10.1016/S0022-510X(99)00193-8
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Degoul F, 1995, J INHERIT METAB DIS, V18, P682, DOI 10.1007/BF02436757
   Francisco G, 2005, DIABETES METAB, V31, P621, DOI 10.1016/S1262-3636(07)70240-9
   Gal Aniko, 2008, Orvosi Hetilap, V149, P1593, DOI 10.1556/OH.2008.28398
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Inczedy-Farkas G, 2011, CENT EUR J MED, V6, P758, DOI 10.2478/s11536-011-0096-z
   Iwanicka-Pronicka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044054
   Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2
   Klemm T, 2001, EXP CLIN ENDOCR DIAB, V109, P283, DOI 10.1055/s-2001-16348
   Komlósi K, 2005, PATHOL ONCOL RES, V11, P82, DOI 10.1007/BF02893371
   Komlosi Katalin, 2004, Orvosi Hetilap, V145, P1805
   Kwon SJ, 2004, ANN NY ACAD SCI, V1011, P339, DOI 10.1196/annals.1293.034
   Lee YC, 2007, J NEUROL SCI, V254, P65, DOI 10.1016/j.jns.2007.01.005
   Leveque M, 2007, EUR J HUM GENET, V15, P1145, DOI 10.1038/sj.ejhg.5201891
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   Martikainen MH, 2012, NEUROEPIDEMIOLOGY, V38, P114, DOI 10.1159/000336112
   Martin-Kleiner I, 2004, ACTA DIABETOL, V41, P179, DOI 10.1007/s00592-004-0163-x
   Mascialino B, 2012, EUR J OPHTHALMOL, V22, P461, DOI 10.5301/ejo.5000055
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Muravchick S, 2008, ADV DRUG DELIVER REV, V60, P1553, DOI 10.1016/j.addr.2008.03.019
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Pang CY, 1999, J FORMOS MED ASSOC, V98, P326
   POULTON J, 1989, LANCET, V1, P236
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Remes AM, 2003, J NEUROL NEUROSUR PS, V74, P1158, DOI 10.1136/jnnp.74.8.1158
   Rodríguez-Hernández M, 2000, REV NEUROLOGIA, V30, P1001, DOI 10.33588/rn.3011.2000037
   Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687
   Salles JEN, 2007, ARQ BRAS ENDOCRINOL, V51, P559, DOI 10.1590/S0004-27302007000400009
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schroder JM, 1997, MOL CELL BIOCHEM, V174, P277, DOI 10.1023/A:1006829129079
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tonska K, 2012, GENE, V506, P161, DOI 10.1016/j.gene.2012.06.081
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Vastagh I, 2011, IDEGGYOGY SZEMLE, V64, P399
   Wang Zhao-xia, 2008, Zhonghua Yi Xue Za Zhi, V88, P3254
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang Y, 2007, J INHERIT METAB DIS, V30, P265, DOI 10.1007/s10545-006-0481-y
NR 56
TC 3
Z9 3
U1 0
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1940-1736
EI 1940-1744
J9 MITOCHONDR DNA
JI Mitochondrial DNA
PD AUG
PY 2015
VL 26
IS 4
BP 572
EP 578
DI 10.3109/19401736.2013.878901
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA CP7VW
UT WOS:000360098200013
PM 24438288
DA 2024-11-01
ER

EF